,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
16771,GO:0071944,5.91771207282051e-21,1,139,5014,cell periphery,CC,ITGA3;ITGA5;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;SLC52A3;ACVR1;NMT2;GUCY1B3;ADORA1;CASQ2;PLAU;RAB40B;RAB40A;PRKACB;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;FZD7;TYRO3;LPAR2;LIMS2;CDH2;FGF10;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;SNX18;AXIN1;RHOQ;RHOJ;RHOB;NPR1;FGF8;SDC4;SPTB;HBEGF;LGALS4;BMP2;DLL1;RAB20;DRP2;SLC2A14;VAMP1;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;AKT1;PKP3;PKP1;RAB17;CYTIP;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;RAB44;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;KCNG2;LZTS1;CLDN23;SHC4;SLC18B1;DSC3;GPSM1;AMOT;KCND1;TSPAN2;RAB38;RAB3D;MYZAP;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PARVB;EFNB2;PDE4B
2856,GO:0005886,1.03094941494393e-20,1,137,4920,plasma membrane,CC,ITGA3;ITGA5;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;SLC52A3;ACVR1;NMT2;GUCY1B3;ADORA1;CASQ2;PLAU;RAB40B;RAB40A;PRKACB;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;FZD7;TYRO3;LPAR2;LIMS2;CDH2;FGF10;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;SNX18;AXIN1;RHOQ;RHOJ;RHOB;NPR1;FGF8;SDC4;SPTB;HBEGF;LGALS4;BMP2;DLL1;RAB20;DRP2;SLC2A14;VAMP1;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;AKT1;PKP3;PKP1;RAB17;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;BCAR1;GJA3;RAB44;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;KCNG2;LZTS1;CLDN23;SHC4;SLC18B1;DSC3;GPSM1;AMOT;KCND1;TSPAN2;RAB38;RAB3D;MYZAP;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PARVB;EFNB2;PDE4B
4668,GO:0009888,8.44580847245265e-19,1,75,1837,tissue development,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;DSC2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;EDN1;PRKACB;FZD7;CDH2;FGF10;PDGFB;WNT5B;WNT5A;AXIN1;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;WNK4;MSN;DDR1;DSG3;CTGF;GJB2;AKT1;PKP3;PKP1;NRTN;WNT2B;KITLG;NPPC;NAB2;JAG2;MYO7A;CLDN1;CLDN3;CLDN5;PIK3CA;GAS6;MYH11;DSC3;VDR;LAMA5;GDNF;DUSP5;HEY1;ACTA2;EFNB2
3663,GO:0007155,2.06513942003452e-18,1,64,1311,cell adhesion,BP,ITGA3;ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;CDH23;ITGB5;ITGB4;ITGB8;DSC2;WNT7B;ACVR1;PLAU;MFGE8;TTYH1;FZD7;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;RHOB;SDC4;LGALS4;BMP7;BMP4;BMP2;CAMSAP3;DLL1;RND3;MSN;DDR1;DSG3;CTGF;AKT1;PKP3;PKP1;CYTIP;KITLG;JAG2;CDH1;BCAR1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;CLDN23;DSC3;LAMA1;LAMA5;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;PARVB;EFNB2
7112,GO:0022610,2.71055877135486e-18,1,64,1318,biological adhesion,BP,ITGA3;ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;CDH23;ITGB5;ITGB4;ITGB8;DSC2;WNT7B;ACVR1;PLAU;MFGE8;TTYH1;FZD7;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;RHOB;SDC4;LGALS4;BMP7;BMP4;BMP2;CAMSAP3;DLL1;RND3;MSN;DDR1;DSG3;CTGF;AKT1;PKP3;PKP1;CYTIP;KITLG;JAG2;CDH1;BCAR1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;CLDN23;DSC3;LAMA1;LAMA5;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;PARVB;EFNB2
13381,GO:0048731,5.14715155084785e-18,1,123,4323,system development,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;CDH23;STRA6;IGSF8;ITGB4;ITGB8;FASN;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;DRP2;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;DSC3;GPSM1;VDR;AMOT;LAMA5;UNC119;TSPAN2;GDNF;ACSL4;FZD8;HEY1;ACTA2;CLDN11;CLDN18;EFNB2
11868,GO:0044707,3.65753181131181e-17,1,146,5907,single-multicellular organism process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;PKN3;DRP2;SLC2A14;SFXN1;WNK4;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;TLE1;CLDN1;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;HAPLN3;DTX4;MYH11;LZTS1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;KCND1;TSPAN2;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;EFNB2;PDE4B
3751,GO:0007275,1.32084574243877e-16,1,129,4864,multicellular organism development,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;EFNB2
13379,GO:0048729,1.34004499411066e-16,1,41,607,tissue morphogenesis,BP,ITGA3;ITGA5;ARTN;LIF;WNT3;WNT2;WNT4;NOTCH1;ITGB4;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;EDN1;PRKACB;FZD7;FGF10;WNT5A;AXIN1;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;MSN;DDR1;WNT2B;JAG2;VDR;LAMA5;GDNF;HEY1;ACTA2;EFNB2
11863,GO:0044700,3.30609364820115e-16,1,143,5938,single organism signaling,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;DHH;DSC2;WNT6;WNT7A;WNT7B;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;KCNK6;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;DDR1;CTGF;GJB1;GJB2;RRAD;AKT1;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;GJA3;SPSB1;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;ZCCHC12;LZTS1;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
7172,GO:0023052,3.74998470812969e-16,1,143,5945,signaling,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;DHH;DSC2;WNT6;WNT7A;WNT7B;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;KCNK6;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;DDR1;CTGF;GJB1;GJB2;RRAD;AKT1;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;GJA3;SPSB1;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;ZCCHC12;LZTS1;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
4617,GO:0009653,5.99978904092977e-16,1,83,2328,anatomical structure morphogenesis,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;WNT3;WNT2;WNT4;ACTN2;NOTCH1;STRA6;ITGB5;ITGB4;CRISPLD2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;CASQ2;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;FZD7;TYRO3;LIMS2;CDH2;FGF10;PIK3R1;FOXO4;HRAS;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;NPR1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;DLL1;WNK4;MSN;DDR1;CTGF;GJB6;TPD52;NRTN;WNT2B;SEMA6C;NPPC;NAB2;JAG2;MYO7A;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;MYH11;LZTS1;VDR;AMOT;LAMA5;GDNF;FZD8;DUSP5;HEY1;ACTA2;PARVB;EFNB2
7211,GO:0030054,1.01832920950244e-15,1,56,1164,cell junction,CC,ITGA3;ITGA5;TMEM163;SYT5;ACTN3;ACTN2;NOTCH1;ITGB5;ITGB4;DSC2;PLAU;SPTBN4;MPZL1;RRAS2;LIMS2;CDH2;PIK3R1;CGN;TJP3;JAM3;RHOB;SDC4;CAMSAP3;DLL1;DRP2;VAMP1;WNK4;RND3;MSN;DSG3;GJB1;GJB2;GJB6;AKT1;PKP3;PKP1;CDH1;BCAR1;GJA3;CLDN1;CLDN2;CLDN3;CLDN5;LZTS1;CLDN23;SHC4;DSC3;AMOT;MYZAP;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;PARVB;EFNB2
3662,GO:0007154,1.268462470636e-15,1,142,5959,cell communication,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;DHH;DSC2;WNT6;WNT7A;WNT7B;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;DDR1;CTGF;GJB1;GJB2;GJB6;RRAD;AKT1;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;GJA3;SPSB1;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;ZCCHC12;LZTS1;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
2446,GO:0005102,1.77881544444323e-15,1,58,1400,receptor binding,MF,ITGA3;ITGA5;ARTN;LIF;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;TF;ITGB4;ITGB8;DHH;WNT6;WNT7A;WNT7B;ADORA1;EDN1;MFGE8;CCL20;FZD7;FGF10;FGF17;PIK3R2;PIK3R1;REEP1;PDGFB;WNT5B;WNT5A;JAM3;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;MSN;CTGF;NRTN;WNT2B;KITLG;NPPC;JAG2;INHBB;PIK3CG;GAS6;SHC4;VDR;LAMA1;LAMA5;GDNF;FZD8;EFNB2
13258,GO:0048513,1.79009194140716e-15,1,96,3169,animal organ development,BP,ITGA3;ARTN;TAGLN;FHOD3;LIF;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;CDH23;STRA6;IGSF8;ITGB4;ITGB8;FASN;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOJ;PFKFB3;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;NRTN;WNT2B;KITLG;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN5;PIK3CA;GAS6;MYH11;DSC3;VDR;LAMA5;TSPAN2;GDNF;FZD8;HEY1;ACTA2;CLDN18;EFNB2
14949,GO:0060429,1.79985288062613e-15,1,54,1200,epithelium development,BP,ITGA5;TAGLN;LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;STRA6;DSC2;WNT6;WNT7A;WNT7B;ACVR1;SALL4;EDN1;PRKACB;FZD7;CDH2;FGF10;PDGFB;WNT5B;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;WNK4;MSN;DDR1;DSG3;AKT1;PKP3;PKP1;WNT2B;JAG2;MYO7A;CLDN1;CLDN3;CLDN5;DSC3;VDR;LAMA5;GDNF;HEY1;ACTA2;EFNB2
5888,GO:0016338,1.82894383617221e-15,1,11,23,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,BMP2;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
13440,GO:0048856,2.2350516389771e-15,1,133,5288,anatomical structure development,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;CASQ2;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;PARVB;EFNB2
11898,GO:0044767,5.84355156939798e-15,1,137,5610,single-organism developmental process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;CASQ2;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;RAB38;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;PARVB;EFNB2
3673,GO:0007165,6.43077881543056e-15,1,132,5449,signal transduction,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;DHH;WNT6;WNT7A;WNT7B;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;DDR1;CTGF;RRAD;AKT1;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;DTX4;ZCCHC12;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
8550,GO:0032501,6.98101510548204e-15,1,152,6860,multicellular organismal process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;ACVR1;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;PKN3;DRP2;SLC2A14;ESPN;SFXN1;WNK4;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;TLE1;CLDN1;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;HAPLN3;DTX4;MYH11;LZTS1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;KCND1;TSPAN2;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;EFNB2;PDE4B
7263,GO:0030154,7.45252116881916e-15,1,105,3698,cell differentiation,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;CDH23;ITGB5;ITGB4;FASN;DHH;DSC2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;CASQ2;EDN1;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOB;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;SLC2A14;SFXN1;MSN;DDR1;DSG3;CTGF;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;MYO7A;INHBB;CLDN1;CLDN3;CLDN5;PIK3CA;GAS6;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;UNC119;TSPAN2;RAB38;GDNF;ACSL4;FZD8;HEY1;ACTA2;CLDN18;EFNB2
13450,GO:0048869,7.94385618236376e-15,1,108,3868,cellular developmental process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;CDH23;ITGB5;ITGB4;FASN;DHH;DSC2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;CASQ2;EDN1;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;SLC2A14;SFXN1;MSN;DDR1;DSG3;CTGF;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;MYO7A;INHBB;CLDN1;CLDN3;CLDN5;PIK3CA;GAS6;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;UNC119;TSPAN2;RAB38;GDNF;ACSL4;FZD8;HEY1;ACTA2;CLDN18;PARVB;EFNB2
7621,GO:0030855,1.23579935932505e-14,1,39,708,epithelial cell differentiation,BP,TAGLN;LIF;WNT4;POU3F1;NOTCH1;DSC2;WNT7A;WNT7B;ACVR1;FZD7;CDH2;FGF10;PDGFB;WNT5B;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;MSN;DSG3;AKT1;PKP3;PKP1;JAG2;MYO7A;CLDN1;CLDN3;CLDN5;DSC3;VDR;LAMA5;GDNF;HEY1;ACTA2
8551,GO:0032502,2.03513671124105e-14,1,137,5693,developmental process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;CASQ2;DKK3;EDN1;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;AXIN1;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;DRP2;SLC2A14;SFXN1;WNK4;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;INHBB;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;HAPLN3;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;UNC119;TSPAN2;RAB38;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN18;PARVB;EFNB2
16787,GO:0072001,9.30204947394297e-14,1,26,278,renal system development,BP,ITGA3;LIF;WNT4;NOTCH1;STRA6;ITGB4;WNT6;WNT7B;FSTL3;FGF10;PDGFB;WNT5A;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2;EFNB2
9759,GO:0035295,1.17554733589052e-13,1,36,566,tube development,BP,ITGA3;LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB4;CRISPLD2;WNT6;WNT7A;WNT7B;ACVR1;SALL4;EDN1;PRKACB;FSTL3;FGF10;WNT5A;RHOB;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;CDKN1A;DLL1;WNK4;DDR1;CTGF;WNT2B;VDR;LAMA5;GDNF;CLDN18;EFNB2
13236,GO:0048468,1.49744787260465e-13,1,68,1834,cell development,BP,ITGA3;ARTN;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;CDH23;DHH;WNT7A;WNT7B;ZFPM1;ACVR1;CASQ2;EDN1;SPTBN5;SPTBN4;FZD7;TYRO3;CDH2;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;MSN;DDR1;AKT1;RAB17;NRTN;KITLG;SEMA6C;NPPC;CDH1;MYO7A;INHBB;CLDN1;CLDN3;CLDN5;PIK3CA;MYH11;LZTS1;LAMA5;TSPAN2;GDNF;ACSL4;ACTA2;CLDN18
3675,GO:0007167,1.5282112143509e-13,1,47,963,enzyme linked receptor protein signaling pathway,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT4;NOTCH1;RASL11B;ITGB5;ACVR1;ADORA1;DKK3;MPZL1;MAPK12;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;FOXO4;HRAS;WNT5A;RHOQ;NPR1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;DDR1;CTGF;AKT1;NRTN;NPPC;EPN1;BCAR1;INHBB;CLDN5;PIK3CA;GAS6;ZCCHC12;SHC4;EFNB2
3674,GO:0007166,1.75942003692223e-13,1,81,2540,cell surface receptor signaling pathway,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;TSPAN15;TSPAN17;NOTCH1;RASL11B;ITGB5;ITGB4;ITGB8;PMAIP1;DHH;WNT6;WNT7A;WNT7B;ACVR1;ADORA1;DKK3;EDN1;PRKACB;CCL20;MPZL1;TSPAN13;MAPK12;FZD7;LIMS2;CDH2;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;AXIN1;RHOQ;NPR1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;DDR1;CTGF;AKT1;NRTN;WNT2B;KITLG;NPPC;JAG2;EPN1;BCAR1;INHBB;TLE1;CLDN5;PIK3CA;GAS6;DTX4;ZCCHC12;SHC4;LAMA1;LAMA5;TSPAN2;GDNF;FZD8;HEY1;CLDN18;EFNB2;PDE4B
4854,GO:0010562,1.88256769558911e-13,1,47,1022,positive regulation of phosphorus metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CHGA;CTGF;AKT1;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
12436,GO:0045937,1.88256769558911e-13,1,47,1022,positive regulation of phosphate metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CHGA;CTGF;AKT1;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
2871,GO:0005911,1.89469445321783e-13,1,30,394,cell-cell junction,CC,ITGA5;DSC2;CDH2;PIK3R1;CGN;TJP3;JAM3;CAMSAP3;WNK4;DSG3;GJB1;GJB2;GJB6;AKT1;PKP3;PKP1;CDH1;GJA3;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;DSC3;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
768,GO:0001944,2.43203820533941e-13,1,36,587,vasculature development,BP,ITGA5;LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOJ;RHOB;NPR1;FGF8;BMP7;BMP4;WT1;DLL1;CTGF;AKT1;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
13330,GO:0048646,2.46840028999143e-13,1,46,941,anatomical structure formation involved in morphogenesis,BP,ITGA3;ITGA5;FHOD3;WNT3;WNT2;WNT4;ACTN2;NOTCH1;STRA6;ITGB5;ITGB4;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;CASQ2;EDN1;PRKACB;MFGE8;FZD7;FGF10;FOXO4;WNT5A;JAM3;AXIN1;RHOB;NPR1;FGF8;SDC4;BMP7;BMP4;WT1;DLL1;CTGF;WNT2B;PIK3CA;PIK3CG;MYH11;AMOT;LAMA5;GDNF;FZD8;DUSP5;HEY1;EFNB2
759,GO:0001934,2.54816503624784e-13,1,43,868,positive regulation of protein phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
17019,GO:0072359,2.71920424705053e-13,1,45,901,circulatory system development,BP,ITGA3;ITGA5;FHOD3;LIF;WNT2;WNT4;ACTN2;NOTCH1;STRA6;ITGB8;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;EDN1;MFGE8;FZD7;CDH2;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOJ;RHOB;NPR1;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;CTGF;AKT1;CLDN5;PIK3CA;PIK3CG;MYH11;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
8796,GO:0032879,3.18294294768638e-13,1,78,2401,regulation of localization,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT4;ACTN2;NOTCH1;RAB27A;TF;PMAIP1;DSC2;WNT7A;ACVR1;ADORA1;CASQ2;EDN1;PLAU;KCNK6;MFGE8;CCL20;SPTBN4;TTYH1;RRAS2;TSPAN13;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;SESN2;RHOQ;RHOB;NPR1;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;RAB20;WNK4;CHGA;MSN;AKT1;RAB17;KITLG;JAG2;CDH1;BCAR1;INHBB;PIK3CG;RAB11FIP1;KCNG2;GAS6;AMOT;LAMA1;LAMA5;UNC119;KCND1;RAB3D;GDNF;CLDN18;PDE4B
17018,GO:0072358,3.82281948760024e-13,1,36,596,cardiovascular system development,BP,ITGA5;LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOJ;RHOB;NPR1;FGF8;BMP7;BMP4;WT1;DLL1;CTGF;AKT1;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
18089,GO:0098609,4.04921691272151e-13,1,41,771,cell-cell adhesion,BP,ITGA5;WNT4;CDH23;ITGB5;DSC2;WNT7B;ACVR1;TTYH1;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;SDC4;BMP7;BMP4;BMP2;CAMSAP3;MSN;DSG3;AKT1;PKP3;PKP1;CDH1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;CLDN23;DSC3;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;EFNB2
1447,GO:0003156,4.169438383019e-13,1,11,33,regulation of animal organ formation,BP,WNT2;NOTCH1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;WNT2B;GDNF
7159,GO:0023014,4.86777840499151e-13,1,43,880,signal transduction by protein phosphorylation,BP,ARTN;LIF;ADRA2B;ADRA2C;ACTN2;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;CCL20;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;CDH2;FGF10;FGF17;PDGFB;KCNH2;HRAS;WNT5A;AXIN1;FGF8;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CG;GAS6;ARAF;GDNF;FZD8;DUSP5
819,GO:0002009,4.999232719615e-13,1,33,509,morphogenesis of an epithelium,BP,ITGA5;LIF;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ACVR1;SALL4;EDN1;PRKACB;FZD7;FGF10;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;MSN;DDR1;WNT2B;JAG2;VDR;LAMA5;GDNF;EFNB2
14225,GO:0051716,7.72395825726226e-13,1,144,6569,cellular response to stimulus,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RASL11B;TF;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;DHH;DSC2;WNT6;WNT7A;WNT7B;SLC52A3;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;MSN;DDR1;CTGF;GJB2;GJB6;RRAD;AKT1;PKP1;NRTN;WNT2B;PTGES;KITLG;NPPC;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;DTX4;ZCCHC12;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
4646,GO:0009790,8.36412056774683e-13,1,45,931,embryo development,BP,ITGA3;ITGA5;LIF;WNT3;WNT2;WNT4;NOTCH1;STRA6;ITGB5;ITGB4;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;EDN1;PRKACB;FZD7;FGF10;PDGFB;WNT5A;AXIN1;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;GJB6;AKT1;WNT2B;KITLG;JAG2;EPN1;MYO7A;DSC3;AMOT;LAMA1;LAMA5;GDNF;ACSL4;DUSP5;HEY1
3537,GO:0006928,9.48703648194022e-13,1,64,1768,movement of cell or subcellular component,BP,ITGA3;ITGA5;ARTN;WNT3;WNT4;ACTN3;ACTN2;NOTCH1;IGSF8;ITGB4;DSC2;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;RRAS2;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;BMP2;B3GNT2;PKN3;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;SEMA6C;JAG2;MYO7A;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
10767,GO:0042327,1.06465635919118e-12,1,43,904,positive regulation of phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
3928,GO:0008083,1.16111867702838e-12,1,18,159,growth factor activity,MF,ARTN;LIF;FGF10;FGF17;PDGFB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CTGF;NRTN;KITLG;JAG2;INHBB;GDNF
568,GO:0001655,1.39847291242167e-12,1,26,313,urogenital system development,BP,ITGA3;LIF;WNT4;NOTCH1;STRA6;ITGB4;WNT6;WNT7B;FSTL3;FGF10;PDGFB;WNT5A;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2;EFNB2
678,GO:0001822,1.4102146566182e-12,1,24,263,kidney development,BP,ITGA3;LIF;WNT4;NOTCH1;STRA6;WNT6;WNT7B;FSTL3;FGF10;PDGFB;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2;EFNB2
525,GO:0001568,1.97470900559593e-12,1,34,564,blood vessel development,BP,ITGA5;WNT2;WNT4;NOTCH1;STRA6;ITGB8;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF10;PDGFB;FOXO4;WNT5A;JAM3;RHOB;NPR1;FGF8;BMP7;BMP4;WT1;DLL1;CTGF;AKT1;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;ACTA2;EFNB2
10583,GO:0040011,2.36181490498979e-12,1,58,1541,locomotion,BP,ITGA3;ITGA5;ARTN;WNT3;WNT4;NOTCH1;ITGB4;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;RRAS2;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;BMP2;B3GNT2;PKN3;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;SEMA6C;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
5943,GO:0016477,2.55512440612959e-12,1,50,1193,cell migration,BP,ITGA3;ITGA5;ARTN;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;HBEGF;BMP4;BMP2;PKN3;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
16790,GO:0072006,2.8868108118083e-12,1,18,139,nephron development,BP,ITGA3;LIF;WNT4;NOTCH1;WNT6;WNT7B;PDGFB;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;ACTA2
11322,GO:0043296,3.8279614623606e-12,1,17,123,apical junction complex,CC,CGN;TJP3;JAM3;CAMSAP3;WNK4;CDH1;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
13922,GO:0051179,3.97535534016599e-12,1,134,5858,localization,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;STRA6;TF;ITGB4;PMAIP1;CRISPLD2;SLC45A4;DSC2;SERPINA5;WNT7A;SLC52A3;ACVR1;RABIF;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;SLC25A53;TTYH1;RRAS2;TSPAN13;RAB39B;RAB39A;SYCN;FZD7;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;GPRASP1;SESN2;RHOQ;RHOB;NPR1;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;DLL1;PKN3;RAB20;SLC2A14;VAMP1;SFXN1;WNK4;CHGA;MSN;DDR1;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;KITLG;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;RAB44;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SLC18B1;VDR;AMOT;LAMA1;LAMA5;SH3BP4;UNC119;KCND1;RAB38;RAB3D;GDNF;ACSL4;CLDN16;CLDN15;CLDN18;EFNB2;PDE4B
15047,GO:0060562,5.83531723443214e-12,1,25,309,epithelial tube morphogenesis,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;SALL4;EDN1;PRKACB;FGF10;WNT5A;RHOB;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;DDR1;WNT2B;VDR;LAMA5;GDNF;EFNB2
4667,GO:0009887,6.0239404731739e-12,1,44,966,animal organ morphogenesis,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB4;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;FZD7;LIMS2;CDH2;FGF10;HRAS;WNT5A;AXIN1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;MSN;DDR1;CTGF;GJB6;WNT2B;NPPC;NAB2;JAG2;MYO7A;TLE1;CLDN5;VDR;LAMA5;GDNF;HEY1;ACTA2;EFNB2
9895,GO:0035556,6.18834931681018e-12,1,78,2530,intracellular signal transduction,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;RAB6C;NOTCH1;PMAIP1;GADD45A;WNT7A;WNT7B;RABIF;GUCY1B3;ADORA1;CASQ2;EDN1;RAB40B;RAB40A;CCL20;SPTBN5;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;RALB;HRAS;WNT5A;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;PKN3;WNK4;RND3;CTGF;RRAD;AKT1;NRTN;KITLG;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SHC4;AMOT;ARAF;SH3BP4;RAB38;GDNF;MYZAP;FZD8;DUSP5;PIM2
11894,GO:0044763,6.59181261838401e-12,1,191,10179,single-organism cellular process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;TTYH1;MPZL1;RRAS2;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;PLEKHH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;KHK;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;PTGES;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;MYO7A;BCAR1;INHBB;GJA3;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;PIM2;PARVB;EFNB2;PDE4B
15343,GO:0061061,6.87969898813363e-12,1,33,563,muscle structure development,BP,TAGLN;FHOD3;LIF;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;STRA6;IGSF8;ZFPM1;ACVR1;CASQ2;EDN1;MAPK12;FZD7;CDH2;FGF10;PDGFB;FOXO4;WNT5A;AXIN1;FGF8;HBEGF;BMP4;BMP2;WT1;DLL1;AKT1;MYH11;LAMA5;HEY1;EFNB2
13306,GO:0048608,6.97825890345862e-12,1,28,412,reproductive structure development,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;WT1;GJB1;GJB2;AKT1;WNT2B;KITLG;INHBB;VDR;HEY1
13395,GO:0048754,7.27559956497063e-12,1,18,148,branching morphogenesis of an epithelial tube,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DDR1;WNT2B;VDR;LAMA5;GDNF
13304,GO:0048598,7.8603410443624e-12,1,33,561,embryonic morphogenesis,BP,ITGA3;ITGA5;WNT3;WNT2;WNT4;NOTCH1;STRA6;ITGB5;ITGB4;WNT6;WNT7A;WNT7B;ACVR1;SALL4;EDN1;PRKACB;FZD7;FGF10;WNT5A;AXIN1;FGF8;SDC4;BMP7;BMP4;DLL1;GJB6;WNT2B;JAG2;MYO7A;AMOT;LAMA5;GDNF;DUSP5
3542,GO:0006935,7.97746563820066e-12,1,31,539,chemotaxis,BP,ARTN;WNT3;NOTCH1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;FGF8;SPTB;HBEGF;BMP7;BMP4;B3GNT2;CHGA;NRTN;SEMA6C;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;GDNF;EFNB2;PDE4B
15512,GO:0061458,8.09814069819771e-12,1,28,415,reproductive system development,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;WT1;GJB1;GJB2;AKT1;WNT2B;KITLG;INHBB;VDR;HEY1
82,GO:0000165,8.21897418385127e-12,1,40,846,MAPK cascade,BP,ARTN;LIF;ADRA2B;ADRA2C;ACTN2;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;SPTBN5;SPTBN4;MAPK12;FZD7;CDH2;FGF10;FGF17;PDGFB;HRAS;WNT5A;AXIN1;FGF8;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CG;GAS6;ARAF;GDNF;FZD8;DUSP5
10769,GO:0042330,8.25878800214686e-12,1,31,540,taxis,BP,ARTN;WNT3;NOTCH1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;FGF8;SPTB;HBEGF;BMP7;BMP4;B3GNT2;CHGA;NRTN;SEMA6C;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;GDNF;EFNB2;PDE4B
3208,GO:0006468,8.43656260412616e-12,1,63,1808,protein phosphorylation,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;MARK4;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;PKN3;WNK4;DDR1;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;GDNF;FZD8;DUSP5;PIM2
9722,GO:0035239,1.15973679313469e-11,1,26,346,tube morphogenesis,BP,WNT2;WNT4;NOTCH1;STRA6;WNT6;ACVR1;SALL4;EDN1;PRKACB;FGF10;WNT5A;RHOB;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;DDR1;WNT2B;VDR;LAMA5;GDNF;EFNB2
7078,GO:0022008,1.23241490751173e-11,1,55,1405,neurogenesis,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;NOTCH1;CDH23;WNT6;WNT7A;WNT7B;SALL4;SPTBN5;SPTBN4;FZD7;CDH2;FGF10;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;DDR1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;NAB2;JAG2;CDH1;MYO7A;PIK3CA;GAS6;LZTS1;UNC119;TSPAN2;GDNF;ACSL4;FZD8
1710,GO:0003924,1.37662923121366e-11,1,22,266,GTPase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
579,GO:0001667,2.09355702781868e-11,1,24,311,ameboidal-type cell migration,BP,ITGA3;NOTCH1;WNT7A;ACVR1;EDN1;PRR5L;FGF10;PDGFB;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP4;PKN3;AKT1;NRTN;KITLG;BCAR1;PIK3CA;AMOT;LAMA5;GDNF;EFNB2
13451,GO:0048870,2.28759082383135e-11,1,51,1317,cell motility,BP,ITGA3;ITGA5;ARTN;WNT4;NOTCH1;ITGB4;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;HBEGF;BMP4;BMP2;PKN3;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
14205,GO:0051674,2.28759082383135e-11,1,51,1317,localization of cell,BP,ITGA3;ITGA5;ARTN;WNT4;NOTCH1;ITGB4;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;RHOB;FGF8;SDC4;HBEGF;BMP4;BMP2;PKN3;CHGA;MSN;DDR1;CTGF;AKT1;NRTN;KITLG;JAG2;BCAR1;PIK3CA;PIK3CG;GAS6;AMOT;LAMA1;LAMA5;GDNF;EFNB2;PDE4B
4597,GO:0009611,2.86283300581413e-11,1,33,626,response to wounding,BP,ITGA5;ADRA2B;ADRA2C;WNT4;NOTCH1;RAB27A;ITGB4;SERPINA5;WNT7A;ZFPM1;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;FGF10;PIK3R1;PDGFB;PRKAR1B;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;DDR1;CTGF;AKT1;PIK3CA;PIK3CG;GAS6
10632,GO:0042060,3.02962680283825e-11,1,30,522,wound healing,BP,ITGA5;ADRA2B;ADRA2C;WNT4;NOTCH1;RAB27A;SERPINA5;WNT7A;ZFPM1;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;FGF10;PIK3R1;PDGFB;PRKAR1B;HRAS;WNT5B;WNT5A;RHOB;SDC4;HBEGF;DDR1;AKT1;PIK3CA;PIK3CG;GAS6
3792,GO:0007399,3.20699327959486e-11,1,70,2141,nervous system development,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;NOTCH1;MARK4;CDH23;IGSF8;DHH;WNT6;WNT7A;WNT7B;SALL4;ADORA1;PRKACB;SPTBN5;SPTBN4;FZD7;TYRO3;CDH2;FGF10;FGF17;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;DRP2;DDR1;GJB1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;NAB2;JAG2;CDH1;MYO7A;CLDN1;PIK3CA;GAS6;HAPLN3;LZTS1;GPSM1;UNC119;TSPAN2;GDNF;ACSL4;FZD8;CLDN11;EFNB2
12062,GO:0045165,3.33800909530835e-11,1,21,240,cell fate commitment,BP,WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;FZD7;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP4;BMP2;WT1;DLL1;WNT2B;JAG2
16830,GO:0072073,3.42950170110286e-11,1,17,140,kidney epithelium development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF;EFNB2
722,GO:0001883,5.20383251981287e-11,1,25,363,purine nucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;ADORA1;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
7401,GO:0030334,5.25111532894221e-11,1,34,653,regulation of cell migration,BP,ITGA3;ITGA5;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;PRR5L;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5
2449,GO:0005109,5.53390088386486e-11,1,10,36,frizzled binding,MF,WNT3;WNT2;WNT4;WNT6;WNT7A;WNT7B;FZD7;WNT5B;WNT5A;WNT2B
4673,GO:0009893,6.69074026673749e-11,1,84,3038,positive regulation of metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;RAB27A;ITGB8;FASN;PMAIP1;GADD45A;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;EDN1;PRKACB;CCL20;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;MSN;CTGF;AKT1;PKP3;PKP1;RAB12;KITLG;NPPC;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
10584,GO:0040012,6.71484286726418e-11,1,37,770,regulation of locomotion,BP,ITGA3;ITGA5;ARTN;WNT3;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;PRR5L;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5;EFNB2
2879,GO:0005923,6.82831538014628e-11,1,15,109,bicellular tight junction,CC,CGN;TJP3;JAM3;WNK4;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
16837,GO:0072080,7.58709007252276e-11,1,14,92,nephron tubule development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF
15290,GO:0060993,7.59064450448258e-11,1,14,92,kidney morphogenesis,BP,LIF;WNT4;WNT6;WNT7B;FGF10;FGF8;BMP7;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
13984,GO:0051270,7.69743311567569e-11,1,37,772,regulation of cellular component movement,BP,ITGA3;ITGA5;WNT3;WNT4;NOTCH1;DSC2;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;PRR5L;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5;PDE4B
13738,GO:0050896,7.70558029852588e-11,1,158,8010,response to stimulus,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;STRA6;RASL11B;TF;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;PKN3;WNK4;RND3;CHGA;MSN;DDR1;CTGF;GJB2;GJB6;RRAD;AKT1;PKP1;RAB17;NRTN;WNT2B;PTGES;KITLG;SEMA6C;NPPC;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;DTX4;ZCCHC12;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN18;PIM2;EFNB2;PDE4B
721,GO:0001882,8.53889068160519e-11,1,25,371,nucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;ADORA1;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
5871,GO:0016310,9.63810712689562e-11,1,67,2145,phosphorylation,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;MARK4;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;RALB;HRAS;WNT5A;KHK;SESN2;AXIN1;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;PKN3;WNK4;DDR1;CTGF;AKT1;NRTN;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;GDNF;FZD8;DUSP5;PIM2
15765,GO:0070160,1.11402789688412e-10,0.999999999991126,15,112,occluding junction,CC,CGN;TJP3;JAM3;WNK4;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;AMOT;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
15455,GO:0061326,1.12647455597028e-10,0.999999999991993,14,94,renal tubule development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF
13364,GO:0048699,1.12868883950484e-10,1,51,1311,generation of neurons,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;CDH23;WNT6;WNT7A;WNT7B;SPTBN5;SPTBN4;FZD7;CDH2;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;CLCF1;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;DDR1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;JAG2;CDH1;MYO7A;PIK3CA;GAS6;LZTS1;UNC119;TSPAN2;GDNF;ACSL4;FZD8
7286,GO:0030182,1.57665571576253e-10,1,48,1196,neuron differentiation,BP,ITGA3;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;CDH23;WNT6;WNT7A;WNT7B;SPTBN5;SPTBN4;FZD7;PIK3R1;HRAS;WNT5B;WNT5A;JAM3;AXIN1;FGF8;SDC4;SPTB;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DLL1;DDR1;AKT1;RAB17;NRTN;WNT2B;SEMA6C;JAG2;CDH1;MYO7A;PIK3CA;LZTS1;UNC119;TSPAN2;GDNF;ACSL4;FZD8
12388,GO:0045860,1.61064023294163e-10,1,28,468,positive regulation of protein kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;SDC4;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
5725,GO:0016020,2.06609017459427e-10,1,166,8566,membrane,CC,ITGA3;ITGA5;TMEM163;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;RAB27A;CDH23;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;RHBDL3;SLC45A4;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;PLAU;RAB40B;RAB40A;PRKACB;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;FZD7;TYRO3;LPAR2;LIMS2;CDH2;HRCT1;FGF10;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;AXIN1;RHOQ;RHOJ;RHOB;NPR1;FGF8;SDC4;SPTB;HBEGF;PGBD5;LGALS4;BMP2;B3GNT2;DLL1;RAB20;DRP2;SLC2A14;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;AKT1;PKP3;PKP1;RAB12;RAB17;PTGES;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;BCAR1;GJA3;TPBGL;HPCAL1;RAB44;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;LZTS1;CLDN23;SHC4;SLC18B1;DSC3;GPSM1;AMOT;LAMA1;SH3BP4;KCND1;TSPAN2;RAB38;RAB3D;ACSL4;MYZAP;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PARVB;EFNB2;PDE4B
2649,GO:0005525,2.07648611540449e-10,1,24,357,GTP binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
7926,GO:0031401,2.08176230357289e-10,1,44,1114,positive regulation of protein modification process,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
7792,GO:0031128,2.23158062199815e-10,0.999999999993678,9,30,developmental induction,BP,WNT3;WNT2;WNT4;FGF10;FGF8;BMP4;BMP2;WNT2B;GDNF
15383,GO:0061138,2.30354514529501e-10,0.999999999975051,18,180,morphogenesis of a branching epithelium,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DDR1;WNT2B;VDR;LAMA5;GDNF
8575,GO:0032550,2.4767677682334e-10,1,24,360,purine ribonucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
8574,GO:0032549,3.21289276763149e-10,1,24,364,ribonucleoside binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
13382,GO:0048732,3.33666493270829e-10,1,26,415,gland development,BP,WNT3;WNT2;WNT4;NOTCH1;STRA6;FASN;SERPINA5;WNT7B;DKK3;LIMS2;FSTL3;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;MSN;DDR1;AKT1;CDH1;CLDN1;PIK3CA;VDR;LAMA5
21025,GO:2000145,3.4644828168268e-10,1,34,704,regulation of cell motility,BP,ITGA3;ITGA5;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;PLAU;CCL20;RRAS2;PRR5L;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;JAM3;RHOB;SDC4;HBEGF;BMP4;BMP2;MSN;AKT1;KITLG;JAG2;BCAR1;GAS6;AMOT;LAMA1;LAMA5
13259,GO:0048514,3.92341199149561e-10,1,28,481,blood vessel morphogenesis,BP,ITGA5;WNT4;NOTCH1;STRA6;WNT7A;WNT7B;ACVR1;EDN1;MFGE8;CDH2;FGF10;FOXO4;WNT5A;JAM3;RHOB;NPR1;FGF8;BMP4;WT1;DLL1;CTGF;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;EFNB2
1379,GO:0003006,4.35972073767375e-10,1,31,607,developmental process involved in reproduction,BP,LIF;WNT2;WNT4;NOTCH1;STRA6;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;ACVR1;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;JAM3;FGF8;BMP7;BMP6;BMP4;WT1;GJB1;GJB2;AKT1;WNT2B;KITLG;NPPC;INHBB;VDR;HEY1
13961,GO:0051239,4.44975209623072e-10,1,74,2576,regulation of multicellular organismal process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;DSC2;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;CASQ2;EDN1;PLAU;PRKACB;KCNK6;CCL20;SPTBN4;FZD7;LIMS2;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;KCNH2;FOXO4;HRAS;WNT5A;RHOB;NPR1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;WNK4;CHGA;CTGF;AKT1;RAB17;WNT2B;KITLG;NPPC;BCAR1;INHBB;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;DTX4;LZTS1;VDR;AMOT;LAMA1;LAMA5;KCND1;GDNF;HEY1;CLDN18;EFNB2;PDE4B
5883,GO:0016331,5.33251817182426e-10,0.99999999994778,16,145,morphogenesis of embryonic epithelium,BP,WNT2;WNT4;WNT6;WNT7B;SALL4;PRKACB;FGF10;WNT5A;FGF8;SDC4;BMP7;BMP4;WNT2B;JAG2;LAMA5;GDNF
8586,GO:0032561,5.78441039806185e-10,1,24,375,guanyl ribonucleotide binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
6456,GO:0019001,6.14926532070648e-10,1,24,376,guanyl nucleotide binding,MF,TUBG2;RAB6C;RAB27A;RASL11B;GUCY1B3;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;RALB;HRAS;RHOQ;RHOJ;RHOB;NPR1;RAB20;RND3;RRAD;RAB12;RAB17;RAB44;RAB38;RAB3D
7402,GO:0030335,6.22743218816474e-10,1,24,379,positive regulation of cell migration,BP,ITGA3;ITGA5;NOTCH1;WNT7A;ACVR1;EDN1;PLAU;CCL20;RRAS2;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
15766,GO:0070161,6.29162412083413e-10,1,28,498,anchoring junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;NOTCH1;ITGB5;DSC2;PLAU;SPTBN4;MPZL1;RRAS2;LIMS2;CDH2;JAM3;RHOB;SDC4;CAMSAP3;DLL1;RND3;MSN;DSG3;PKP3;PKP1;CDH1;BCAR1;DSC3;PARVB;EFNB2
16520,GO:0071495,6.5773795588799e-10,1,46,1204,cellular response to endogenous stimulus,BP,ITGA3;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;ITGB5;WNT7A;ACVR1;CASQ2;DKK3;EDN1;PRKACB;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;PRKAR1B;FOXO4;WNT5A;SESN2;RHOQ;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CTGF;GJB2;AKT1;CDH1;BCAR1;INHBB;CLDN1;CLDN5;PIK3CA;PIK3CG;ZCCHC12;VDR;SH3BP4;HEY1;PDE4B
9161,GO:0033674,6.87492461295847e-10,1,28,498,positive regulation of kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;AXIN1;PSRC1;SDC4;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
634,GO:0001763,7.67789866686305e-10,0.999999999910554,18,193,morphogenesis of a branching structure,BP,WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DDR1;WNT2B;VDR;LAMA5;GDNF
11616,GO:0044057,8.82259656637524e-10,1,27,484,regulation of system process,BP,ADRA2B;ADRA2C;ACTN3;DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;FGF10;PDGFB;KCNH2;NPR1;HBEGF;BMP6;WNK4;CHGA;CTGF;AKT1;NPPC;INHBB;PIK3CG;RAB11FIP1;KCNG2;GAS6;KCND1;PDE4B
10589,GO:0040017,9.02253496213106e-10,1,25,421,positive regulation of locomotion,BP,ITGA3;ITGA5;ARTN;NOTCH1;WNT7A;ACVR1;EDN1;PLAU;CCL20;RRAS2;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
16793,GO:0072009,9.80435423053733e-10,0.999999999917331,14,110,nephron epithelium development,BP,LIF;WNT4;NOTCH1;WNT6;WNT7B;FGF8;BMP4;BMP2;WT1;DLL1;WNK4;WNT2B;LAMA5;GDNF
21027,GO:2000147,1.0824067425336e-09,1,24,393,positive regulation of cell motility,BP,ITGA3;ITGA5;NOTCH1;WNT7A;ACVR1;EDN1;PLAU;CCL20;RRAS2;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
4876,GO:0010604,1.23195949236927e-09,1,77,2817,positive regulation of macromolecule metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;ITGB8;PMAIP1;GADD45A;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;EDN1;PRKACB;CCL20;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;MSN;CTGF;AKT1;PKP3;PKP1;KITLG;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
16807,GO:0072028,1.35770911210279e-09,0.999999999908956,12,77,nephron morphogenesis,BP,LIF;WNT4;WNT6;FGF8;BMP7;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
11391,GO:0043410,1.39375240193002e-09,1,26,463,positive regulation of MAPK cascade,BP,LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;FZD7;CDH2;FGF10;PDGFB;HRAS;WNT5A;AXIN1;FGF8;BMP4;BMP2;CTGF;KITLG;PIK3CG;GAS6;ARAF;FZD8;DUSP5
10765,GO:0042325,1.40783992106376e-09,1,48,1349,regulation of phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
8214,GO:0031982,1.50329535304053e-09,1,96,4076,vesicle,CC,ITGA3;ITGA5;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;RAB39B;RAB39A;SYCN;FZD7;LPAR2;CDH2;FSTL3;PDGFB;FRMPD1;RALB;WNT5B;WNT5A;SNX18;KHK;AXIN1;RHOQ;RHOJ;RHOB;SDC4;CLCF1;HBEGF;BMP7;BMP6;B3GNT2;DAAM2;DLL1;RAB20;VAMP1;RND3;CHGA;MSN;DDR1;DSG3;AKT1;PKP1;RAB12;RAB17;CYTIP;NPPC;CDH1;MYO7A;HPCAL1;RAB44;CLDN2;CLDN3;CLDN5;RAB11FIP1;KCNG2;GAS6;MYH11;PM20D2;AMOT;LAMA5;SH3BP4;RAB38;RAB3D;ACSL4;ACTA2;CLDN11;RNF144A;PDE4B
20958,GO:2000027,1.60126368017535e-09,1,19,247,regulation of organ morphogenesis,BP,LIF;WNT2;WNT4;NOTCH1;WNT6;ACVR1;EDN1;FZD7;LIMS2;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;WNT2B;VDR;GDNF
18139,GO:0098742,1.60716835273449e-09,1,19,222,cell-cell adhesion via plasma-membrane adhesion molecules,BP,ITGA5;CDH23;DSC2;ACVR1;CDH2;BMP2;DSG3;CDH1;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;DSC3;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
7883,GO:0031325,1.62481757312671e-09,1,77,2825,positive regulation of cellular metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;RAB27A;FASN;PMAIP1;GADD45A;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;EDN1;PRKACB;CCL20;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;MSN;CTGF;AKT1;RAB12;KITLG;NPPC;CDH1;INHBB;PIK3CA;PIK3CG;GAS6;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
7103,GO:0022414,1.87124551126275e-09,1,46,1304,reproductive process,BP,ITGA3;LIF;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;STRA6;IGSF8;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;MFGE8;SPTBN4;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;JAM3;FGF8;BMP7;BMP6;BMP4;WT1;SLC2A14;DDR1;GJB1;GJB2;AKT1;WNT2B;KITLG;NPPC;JAG2;EPN1;INHBB;VDR;ACSL4;HEY1;CLDN11;PIM2
2,GO:0000003,1.90117231951246e-09,1,46,1305,reproduction,BP,ITGA3;LIF;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;STRA6;IGSF8;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;MFGE8;SPTBN4;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;JAM3;FGF8;BMP7;BMP6;BMP4;WT1;SLC2A14;DDR1;GJB1;GJB2;AKT1;WNT2B;KITLG;NPPC;JAG2;EPN1;INHBB;VDR;ACSL4;HEY1;CLDN11;PIM2
11792,GO:0044421,2.06577061617271e-09,1,87,3687,extracellular region part,CC,ITGA3;ARTN;LIF;WNT3;WNT2;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;DKK3;EDN1;PLAU;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;RRAS2;CDH2;FSTL3;FGF10;FGF17;PDGFB;FRMPD1;RALB;WNT5B;WNT5A;JAM3;SNX18;KHK;RHOQ;RHOJ;RHOB;SDC4;CLCF1;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;B3GNT2;DAAM2;RND3;CHGA;MSN;DDR1;DSG3;CTGF;PKP1;RAB17;WNT2B;KITLG;NPPC;CDH1;INHBB;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;HAPLN3;MYH11;PM20D2;LAMA1;LAMA5;SH3BP4;UNC119;RAB3D;ACSL4;ACTA2;CLDN11
13986,GO:0051272,2.19631599942869e-09,0.999999999638644,24,403,positive regulation of cellular component movement,BP,ITGA3;ITGA5;NOTCH1;WNT7A;ACVR1;EDN1;PLAU;CCL20;RRAS2;FGF10;PIK3R1;PDGFB;FOXO4;HRAS;WNT5B;WNT5A;RHOB;HBEGF;BMP4;BMP2;AKT1;KITLG;BCAR1;GAS6
9748,GO:0035270,2.47826069267643e-09,0.999999999755952,14,124,endocrine system development,BP,WNT4;STRA6;DKK3;FSTL3;FGF10;WNT5A;FGF8;BMP6;BMP4;BMP2;WT1;DLL1;AKT1;CDH1
6538,GO:0019220,2.58683761975463e-09,1,52,1573,regulation of phosphate metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;CDKN1A;CHGA;CTGF;AKT1;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
12468,GO:0045995,2.61687277434932e-09,0.999999999742158,14,117,regulation of embryonic development,BP,WNT2;WNT4;NOTCH1;PRKACB;FZD7;WNT5A;BMP7;BMP4;DLL1;WNT2B;AMOT;LAMA1;LAMA5;GDNF
11862,GO:0044699,2.67231610448677e-09,1,211,12673,single-organism process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;SLC45A4;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB17;NRTN;WNT2B;PTGES;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;HAPLN3;DTX4;ZCCHC12;MYH11;LZTS1;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;PIM2;PARVB;EFNB2;PDE4B
8371,GO:0032270,2.78920922052903e-09,1,48,1396,positive regulation of cellular protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;MAPK12;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;MSN;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5;RNF144A
11864,GO:0044702,2.993809860303e-09,1,43,1182,single organism reproductive process,BP,ITGA3;LIF;WNT3;WNT2;WNT4;NOTCH1;STRA6;IGSF8;ITGB8;DHH;SERPINA5;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;MFGE8;SPTBN4;TYRO3;FSTL3;FGF10;PDGFB;WNT5A;JAM3;FGF8;BMP7;BMP6;BMP4;WT1;SLC2A14;DDR1;GJB2;AKT1;WNT2B;KITLG;NPPC;JAG2;INHBB;VDR;ACSL4;HEY1;CLDN11;PIM2
4697,GO:0009966,3.07166098556894e-09,1,74,2670,regulation of signal transduction,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;GPSM1;AMOT;ARAF;SH3BP4;GDNF;FZD8;DUSP5;HEY1;PIM2
13957,GO:0051234,3.08607936176558e-09,1,110,4853,establishment of localization,BP,ITGA3;LIF;ADRA2B;ADRA2C;SYT5;WNT4;RIN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;STRA6;TF;PMAIP1;CRISPLD2;SLC45A4;SERPINA5;WNT7A;SLC52A3;RABIF;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;SLC25A53;TTYH1;TSPAN13;RAB39B;RAB39A;SYCN;FZD7;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;RALB;HRAS;WNT5A;SNX18;GPRASP1;SESN2;RHOQ;RHOB;NPR1;PSRC1;SDC4;SPTB;BMP7;BMP6;BMP4;CDKN1A;DLL1;RAB20;SLC2A14;VAMP1;SFXN1;WNK4;CHGA;MSN;DDR1;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;CDH1;EPN1;MYO7A;INHBB;GJA3;RAB44;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SLC18B1;VDR;LAMA5;SH3BP4;UNC119;KCND1;RAB38;RAB3D;GDNF;ACSL4;CLDN16;CLDN15;PDE4B
632,GO:0001759,3.21289865655434e-09,0.999999999938575,7,19,organ induction,BP,WNT2;FGF10;FGF8;BMP4;BMP2;WNT2B;GDNF
13919,GO:0051174,3.52787724245984e-09,1,52,1586,regulation of phosphorus metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACTN3;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;CDKN1A;CHGA;CTGF;AKT1;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
1381,GO:0003008,3.56332538886603e-09,1,55,1906,system process,BP,ITGA3;ITGA5;ADRA2B;ADRA2C;ACTN3;ACTN2;CDH23;STRA6;ITGB5;DSC2;SLC52A3;GUCY1B3;ADORA1;CASQ2;EDN1;PRKACB;KCNK6;SPTBN4;FGF10;PDGFB;KCNH2;PRKAR1B;JAM3;NPR1;HBEGF;BMP6;BMP4;B3GNT2;DLL1;ESPN;WNK4;CHGA;CTGF;GJB2;GJB6;AKT1;NPPC;JAG2;MYO7A;INHBB;GJA3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;MYH11;VDR;UNC119;KCND1;GDNF;ACTA2;CLDN16;PDE4B
4698,GO:0009967,3.60514722204109e-09,1,48,1402,positive regulation of signal transduction,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;CCL20;FZD7;LIMS2;CDH2;PRR5L;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;FZD8;DUSP5;PIM2
16427,GO:0071363,4.65753760191741e-09,0.999999999069117,30,610,cellular response to growth factor stimulus,BP,ITGA3;ITGA5;WNT2;WNT4;NOTCH1;RASL11B;ITGB5;WNT7A;ACVR1;DKK3;EDN1;FSTL3;FGF10;FGF17;CGN;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;DLL1;CTGF;AKT1;BCAR1;CLDN1;CLDN5;GAS6;ZCCHC12
757,GO:0001932,4.73652630101872e-09,1,45,1264,regulation of protein phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
15030,GO:0060541,4.79551523440455e-09,0.999999999348207,17,194,respiratory system development,BP,ITGA3;LIF;WNT2;NOTCH1;STRA6;CRISPLD2;WNT7B;FSTL3;FGF10;WNT5A;AXIN1;FGF8;BMP4;WT1;CTGF;WNT2B;LAMA5
3807,GO:0007423,5.6912556524132e-09,0.999999998932176,27,504,sensory organ development,BP,WNT2;NOTCH1;CDH23;STRA6;WNT6;WNT7A;WNT7B;EDN1;FGF10;WNT5B;WNT5A;AXIN1;RHOJ;FGF8;SDC4;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;DDR1;GJB2;GJB6;WNT2B;JAG2;MYO7A
2667,GO:0005576,5.92448641331735e-09,1,96,4413,extracellular region,CC,ITGA3;ARTN;LIF;WNT3;WNT2;WNT4;ACTN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;DKK3;EDN1;PLAU;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;RRAS2;PRND;CDH2;FSTL3;FGF10;FGF17;PDGFB;FRMPD1;RALB;WNT5B;WNT5A;JAM3;SNX18;KHK;RHOQ;RHOJ;RHOB;FGF8;OLFML2B;SDC4;CLCF1;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;B3GNT2;DAAM2;DLL1;RND3;CHGA;MSN;DDR1;DSG3;CTGF;PKP1;RAB17;NRTN;WNT2B;KITLG;NPPC;CST9L;CDH1;INHBB;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;HAPLN3;MYH11;PM20D2;DSC3;LAMA1;LAMA5;SH3BP4;UNC119;RAB3D;GDNF;ACSL4;ACTA2;CLDN11
13962,GO:0051240,6.616620936659e-09,1,48,1403,positive regulation of multicellular organismal process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;CCL20;SPTBN4;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;RHOB;NPR1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;NPPC;BCAR1;INHBB;GAS6;VDR;AMOT;GDNF;EFNB2;PDE4B
7194,GO:0030029,6.63627715038218e-09,0.999999998628215,31,646,actin filament-based process,BP,FHOD3;WNT4;ACTN3;ACTN2;ITGB5;DSC2;CASQ2;EDN1;SPTBN5;SPTBN4;FGF10;PIK3R1;KCNH2;PLEKHH2;HRAS;JAM3;RHOQ;RHOJ;NUAK2;SDC4;SPTB;DAAM2;ESPN;RND3;CTGF;MYO7A;BCAR1;MYH11;AMOT;PARVB;PDE4B
13965,GO:0051247,6.79105098515568e-09,1,49,1485,positive regulation of protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;MAPK12;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;MSN;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5;RNF144A
15508,GO:0061448,7.72583167258488e-09,0.999999998963385,18,230,connective tissue development,BP,NOTCH1;ITGB8;WNT7A;WNT7B;EDN1;PDGFB;WNT5B;WNT5A;BMP7;BMP6;BMP4;BMP2;WT1;CTGF;WNT2B;NPPC;PIK3CA;ACTA2
13266,GO:0048523,8.10464159755826e-09,1,98,4185,negative regulation of cellular process,BP,ITGA3;ITGA5;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;GADD45A;SERPINA5;WNT7A;ZFPM1;ACVR1;SALL4;ADORA1;CASQ2;DKK3;EDN1;PRKACB;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOB;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;ESPN;CHGA;DDR1;CTGF;GJB6;AKT1;PKP3;PKP1;PTGES;KITLG;NPPC;CST9L;NAB2;CDH1;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;LZTS1;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2
1449,GO:0003158,8.68627721895877e-09,0.999999999154103,13,109,endothelium development,BP,NOTCH1;WNT7A;WNT7B;ACVR1;RHOB;BMP6;BMP4;DLL1;MSN;CLDN1;CLDN5;LAMA5;HEY1
17400,GO:0090130,9.56282462521647e-09,0.999999998699846,18,235,tissue migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF10;PDGFB;WNT5A;RHOB;FGF8;HBEGF;BMP4;PKN3;AKT1;BCAR1;PIK3CA;AMOT;ACTA2;EFNB2
14995,GO:0060485,9.61686391136981e-09,0.999999998692247,18,234,mesenchyme development,BP,WNT2;WNT4;NOTCH1;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;NRTN;KITLG;LAMA5;GDNF;HEY1;ACTA2
7171,GO:0023051,9.80413144001174e-09,1,79,3019,regulation of signaling,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;NPPC;JAG2;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;LZTS1;GPSM1;AMOT;ARAF;SH3BP4;GDNF;FZD8;DUSP5;HEY1;PIM2
2698,GO:0005615,9.99696077236735e-09,1,43,1364,extracellular space,CC,ARTN;LIF;WNT3;WNT2;WNT4;TF;DHH;SERPINA5;WNT6;WNT7A;WNT7B;DKK3;EDN1;PLAU;MFGE8;CCL20;FSTL3;FGF10;FGF17;PDGFB;WNT5B;WNT5A;JAM3;CLCF1;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;CHGA;MSN;DDR1;CTGF;WNT2B;KITLG;NPPC;INHBB;GAS6;HAPLN3;LAMA1;LAMA5;ACTA2
13398,GO:0048762,1.02618494763942e-08,0.999999998619506,16,180,mesenchymal cell differentiation,BP,WNT2;WNT4;NOTCH1;ACVR1;EDN1;FGF10;WNT5A;FGF8;BMP7;BMP4;BMP2;NRTN;KITLG;LAMA5;GDNF;HEY1
11389,GO:0043408,1.07631683537235e-08,0.999999997777915,30,649,regulation of MAPK cascade,BP,LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;FZD7;CDH2;FGF10;PDGFB;HRAS;WNT5A;AXIN1;FGF8;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;KITLG;INHBB;PIK3CG;GAS6;ARAF;FZD8;DUSP5
19643,GO:1903522,1.11068469027557e-08,0.999999998391001,19,269,regulation of blood circulation,BP,ADRA2B;ADRA2C;DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;NPR1;HBEGF;CHGA;CTGF;AKT1;NPPC;PIK3CG;KCNG2;KCND1;PDE4B
12187,GO:0045446,1.12679116404151e-08,0.99999999901495,12,91,endothelial cell differentiation,BP,NOTCH1;WNT7A;WNT7B;ACVR1;BMP6;BMP4;DLL1;MSN;CLDN1;CLDN5;LAMA5;HEY1
16151,GO:0070848,1.12884625225145e-08,0.999999997666016,30,635,response to growth factor,BP,ITGA3;ITGA5;WNT2;WNT4;NOTCH1;RASL11B;ITGB5;WNT7A;ACVR1;DKK3;EDN1;FSTL3;FGF10;FGF17;CGN;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;DLL1;CTGF;AKT1;BCAR1;CLDN1;CLDN5;GAS6;ZCCHC12
18905,GO:1901700,1.14551780917724e-08,1,48,1464,response to oxygen-containing compound,BP,WNT3;WNT2;ACTN2;NOTCH1;DHH;WNT6;WNT7A;WNT7B;GUCY1B3;EDN1;PRKACB;CCL20;FZD7;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;WNT5B;WNT5A;KHK;SESN2;RHOQ;RHOB;BMP7;BMP6;WT1;CDKN1A;MSN;CTGF;GJB2;GJB6;AKT1;PTGES;NPPC;CDH1;BCAR1;INHBB;CLDN1;CLDN3;PIK3CA;PIK3CG;GAS6;VDR;SH3BP4;CLDN18;PDE4B
16841,GO:0072088,1.26132728870881e-08,0.999999999043229,11,75,nephron epithelium morphogenesis,BP,LIF;WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
13862,GO:0051094,1.26888339540374e-08,1,42,1140,positive regulation of developmental process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;WNT6;WNT7A;WNT7B;ACVR1;EDN1;SPTBN4;MAPK12;CDH2;FGF10;PDGFB;WNT5B;WNT5A;RHOB;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CTGF;AKT1;WNT2B;KITLG;NPPC;CLDN5;GAS6;VDR;AMOT;GDNF;EFNB2
10981,GO:0042692,1.38847787335203e-08,0.999999997326926,22,357,muscle cell differentiation,BP,FHOD3;WNT4;ACTN2;NOTCH1;ACVR1;CASQ2;EDN1;MAPK12;FZD7;CDH2;FGF10;PDGFB;FOXO4;AXIN1;BMP4;BMP2;WT1;DLL1;AKT1;MYH11;HEY1;EFNB2
13664,GO:0050793,1.54617689439578e-08,1,63,2180,regulation of developmental process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;PRKACB;SPTBN4;MAPK12;FZD7;LIMS2;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5B;WNT5A;AXIN1;RHOQ;RHOJ;RHOB;NPR1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;MSN;CTGF;AKT1;RAB17;WNT2B;KITLG;NPPC;NAB2;CLDN5;PIK3CA;GAS6;LZTS1;VDR;AMOT;LAMA1;LAMA5;GDNF;HEY1;CLDN18;PARVB;EFNB2
13385,GO:0048738,1.6582702644315e-08,0.999999997686104,16,186,cardiac muscle tissue development,BP,FHOD3;WNT2;ACTN2;NOTCH1;ZFPM1;ACVR1;EDN1;FZD7;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;MYH11;EFNB2
16750,GO:0071900,1.68138730077325e-08,0.99999999634103,25,467,regulation of protein serine/threonine kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;BMP7;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CG;ARAF;FZD8;DUSP5
16174,GO:0070887,1.74592440586981e-08,1,70,2645,cellular response to chemical stimulus,BP,ITGA3;ITGA5;WNT3;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;TF;ITGB5;FASN;PMAIP1;WNT6;WNT7A;WNT7B;ACVR1;GUCY1B3;CASQ2;DKK3;EDN1;PRKACB;CCL20;FZD7;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;WNT5B;WNT5A;JAM3;SESN2;RHOQ;RHOB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CHGA;MSN;CTGF;GJB2;GJB6;AKT1;CDH1;BCAR1;INHBB;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;VDR;SH3BP4;HEY1;CLDN18;PDE4B
4593,GO:0009605,1.81650029479482e-08,1,57,2000,response to external stimulus,BP,ARTN;WNT3;WNT4;NOTCH1;STRA6;PMAIP1;GADD45A;DSC2;NMT2;ADORA1;EDN1;PLAU;CCL20;SPTBN5;SPTBN4;TYRO3;FGF10;PIK3R1;PDGFB;FOXO4;RALB;HRAS;WNT5A;JAM3;NUAK2;FGF8;SPTB;HBEGF;BMP7;BMP6;BMP4;B3GNT2;CDKN1A;CHGA;GJB2;GJB6;AKT1;NRTN;WNT2B;PTGES;SEMA6C;BCAR1;INHBB;CLDN1;PIK3CA;PIK3CG;GAS6;VDR;AMOT;UNC119;RAB38;GDNF;ACSL4;ACTA2;PIM2;EFNB2;PDE4B
11181,GO:0043085,1.92191451716593e-08,1,50,1554,positive regulation of catalytic activity,BP,ARTN;ADRA2B;ADRA2C;WNT4;RIN3;ACTN2;PMAIP1;GADD45A;WNT7B;RABIF;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;AXIN1;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP4;BMP2;CDKN1A;CTGF;AKT1;NRTN;KITLG;PIK3CA;PIK3CG;GAS6;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5
4052,GO:0008283,2.00352387342772e-08,1,56,1890,cell proliferation,BP,ARTN;LIF;WNT3;WNT2;WNT4;NOTCH1;IGSF8;WNT7A;WNT7B;SALL4;ADORA1;EDN1;PLAU;FZD7;LIMS2;CDH2;FGF10;FGF17;PDGFB;FOXO4;HRAS;WNT5A;NPR1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;MSN;DDR1;CTGF;GJB6;AKT1;WNT2B;PTGES;KITLG;NPPC;NAB2;JAG2;BCAR1;PIK3CG;GAS6;SHC4;VDR;LAMA5;SH3BP4;GDNF;PIM2;EFNB2
19223,GO:1902578,2.03373600130884e-08,1,78,3072,single-organism localization,BP,ITGA3;LIF;ADRA2B;ADRA2C;SYT5;WNT4;ACTN2;TSPAN15;NOTCH1;RAB27A;STRA6;TF;PMAIP1;CRISPLD2;SLC45A4;SERPINA5;WNT7A;SLC52A3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;KCNK6;MFGE8;FLVCR2;SPTBN4;RAB39A;SYCN;FZD7;TYRO3;CDH2;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;RALB;WNT5A;SESN2;RHOQ;NPR1;SDC4;BMP7;BMP6;BMP4;CDKN1A;RAB20;SLC2A14;VAMP1;WNK4;CHGA;DDR1;CTGF;GJB1;TPD52;AKT1;PKP3;PKP1;RAB17;CDH1;MYO7A;INHBB;RAB44;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;VDR;LAMA5;UNC119;KCND1;RAB3D;GDNF;ACSL4
18906,GO:1901701,2.09935930956888e-08,0.999999995022579,37,948,cellular response to oxygen-containing compound,BP,WNT3;WNT2;ACTN2;WNT6;WNT7B;GUCY1B3;EDN1;PRKACB;CCL20;FZD7;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;WNT5B;WNT5A;SESN2;RHOQ;RHOB;BMP7;BMP6;WT1;MSN;GJB2;GJB6;AKT1;CDH1;BCAR1;INHBB;CLDN1;PIK3CA;PIK3CG;GAS6;VDR;SH3BP4;PDE4B
10708,GO:0042221,2.11800791063952e-08,1,90,4006,response to chemical,BP,ITGA3;ITGA5;ARTN;WNT3;WNT2;WNT4;ACTN2;RAB6C;NOTCH1;RASL11B;TF;ITGB5;FASN;PMAIP1;DHH;WNT6;WNT7A;WNT7B;ACVR1;GUCY1B3;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;SPTBN5;SPTBN4;FZD7;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;KHK;SESN2;RHOQ;RHOB;FGF8;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;CHGA;MSN;CTGF;GJB2;GJB6;AKT1;NRTN;PTGES;SEMA6C;NPPC;CDH1;BCAR1;INHBB;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;VDR;AMOT;SH3BP4;GDNF;ACSL4;HEY1;CLDN18;EFNB2;PDE4B
498,GO:0001525,2.15096649636334e-08,0.999999995582565,23,400,angiogenesis,BP,ITGA5;NOTCH1;WNT7A;ACVR1;EDN1;MFGE8;FGF10;FOXO4;WNT5A;JAM3;RHOB;NPR1;FGF8;BMP4;DLL1;CTGF;PIK3CA;PIK3CG;AMOT;LAMA5;FZD8;HEY1;EFNB2
13262,GO:0048519,2.31172952035205e-08,1,103,4623,negative regulation of biological process,BP,ITGA3;ITGA5;FHOD3;LIF;ADRA2B;ADRA2C;WNT3;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;ITGB8;GADD45A;SERPINA5;WNT7A;ZFPM1;ACVR1;SALL4;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;SPTBN5;SPTBN4;MAPK12;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOB;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;ESPN;WNK4;CHGA;DDR1;CTGF;GJB6;AKT1;PKP3;PKP1;PTGES;KITLG;NPPC;CST9L;NAB2;CDH1;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;LZTS1;VDR;AMOT;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;CLDN18;PIM2;EFNB2;PDE4B
4910,GO:0010646,2.3832894932854e-08,1,77,2967,regulation of cell communication,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;EPN1;INHBB;TLE1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;LZTS1;GPSM1;AMOT;ARAF;SH3BP4;GDNF;FZD8;DUSP5;HEY1;PIM2
859,GO:0002064,2.65428818802476e-08,0.99999999616243,16,190,epithelial cell development,BP,NOTCH1;WNT7A;WNT7B;PDGFB;WNT5B;WNT5A;BMP6;BMP4;CDKN1A;DLL1;MSN;MYO7A;CLDN1;CLDN3;CLDN5;ACTA2
860,GO:0002065,2.78589278589673e-08,0.999999997317772,12,101,columnar/cuboidal epithelial cell differentiation,BP,WNT4;NOTCH1;CDH2;WNT5A;FGF8;BMP6;BMP4;BMP2;CDKN1A;DLL1;JAG2;MYO7A
3890,GO:0008015,2.79246320469666e-08,0.999999993762067,25,487,blood circulation,BP,ADRA2B;ADRA2C;DSC2;GUCY1B3;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;PDGFB;KCNH2;NPR1;HBEGF;DLL1;CHGA;CTGF;AKT1;NPPC;PIK3CA;PIK3CG;KCNG2;GAS6;KCND1;ACTA2;PDE4B
14029,GO:0051347,2.79987475510138e-08,0.999999993013399,29,635,positive regulation of transferase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;AXIN1;PSRC1;SDC4;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
3828,GO:0007517,3.08846429836545e-08,0.999999994036985,21,343,muscle organ development,BP,TAGLN;LIF;WNT2;ACTN3;NOTCH1;STRA6;IGSF8;ZFPM1;EDN1;MAPK12;FZD7;FOXO4;WNT5A;FGF8;HBEGF;BMP4;BMP2;WT1;DLL1;LAMA5;EFNB2
1386,GO:0003013,3.25027550432147e-08,0.999999992682824,25,491,circulatory system process,BP,ADRA2B;ADRA2C;DSC2;GUCY1B3;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;PDGFB;KCNH2;NPR1;HBEGF;DLL1;CHGA;CTGF;AKT1;NPPC;PIK3CA;PIK3CG;KCNG2;GAS6;KCND1;ACTA2;PDE4B
13261,GO:0048518,3.41020048207832e-08,1,111,5094,positive regulation of biological process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;STRA6;TF;ITGB8;FASN;PMAIP1;GADD45A;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;CASQ2;EDN1;PLAU;PRKACB;MFGE8;CCL20;SPTBN4;RRAS2;MAPK12;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;RHOB;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;ESPN;CHGA;MSN;CTGF;AKT1;PKP3;PKP1;RAB12;WNT2B;KITLG;NPPC;JAG2;CDH1;BCAR1;INHBB;TLE1;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;SHC4;VDR;AMOT;ARAF;SH3BP4;UNC119;RAB3D;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;EFNB2;PDE4B
7392,GO:0030324,3.44046501212728e-08,0.999999995324476,15,169,lung development,BP,ITGA3;LIF;WNT2;NOTCH1;STRA6;CRISPLD2;WNT7B;FSTL3;FGF10;WNT5A;FGF8;BMP4;CTGF;WNT2B;LAMA5
576,GO:0001664,3.4609923008073e-08,0.999999995459717,16,245,G-protein coupled receptor binding,MF,ADRA2C;WNT3;WNT2;WNT4;ITGB4;WNT6;WNT7A;WNT7B;ADORA1;EDN1;CCL20;FZD7;REEP1;WNT5B;WNT5A;WNT2B
679,GO:0001823,3.4829947899843e-08,0.999999996573817,12,102,mesonephros development,BP,WNT4;WNT6;FGF10;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
12884,GO:0046934,3.64663009844876e-08,0.999999997384929,10,66,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
18088,GO:0098602,3.79012922167615e-08,0.999999990414423,29,633,single organism cell adhesion,BP,ITGA5;WNT4;ITGB5;DSC2;WNT7B;ACVR1;TTYH1;FZD7;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;SDC4;BMP7;BMP4;CAMSAP3;MSN;AKT1;PKP3;PKP1;CDH1;PIK3CA;PIK3CG;GAS6;LAMA5;EFNB2
16859,GO:0072109,3.93085431370329e-08,0.999999999279021,6,15,glomerular mesangium development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
11494,GO:0043583,4.14824888481993e-08,0.999999993871973,16,201,ear development,BP,NOTCH1;CDH23;STRA6;EDN1;FGF10;WNT5A;FGF8;SDC4;BMP4;BMP2;DLL1;DDR1;GJB2;GJB6;JAG2;MYO7A
17402,GO:0090132,4.1772380748736e-08,0.999999993377414,17,229,epithelium migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF10;PDGFB;WNT5A;RHOB;FGF8;HBEGF;BMP4;PKN3;AKT1;BCAR1;PIK3CA;AMOT;EFNB2
5737,GO:0016043,4.2361878513692e-08,1,121,5728,cellular component organization,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;SYT5;WNT3;WNT4;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;MARK4;RAB27A;CDH23;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRISPLD2;SERPINA5;WNT7A;WNT7B;ZFPM1;RABIF;CASQ2;EDN1;RAB40B;RAB40A;MFGE8;SPTBN5;SPTBN4;TTYH1;RAB39B;RAB39A;PRND;FZD7;TYRO3;LIMS2;CDH2;FGF10;PIK3R1;REEP1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;PSTPIP2;SNX18;SESN2;AXIN1;RHOQ;RHOJ;NPR1;NUAK2;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;RAB20;DRP2;ESPN;VAMP1;RND3;CHGA;MSN;DDR1;CTGF;GJB1;GJB2;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;SEMA6C;CDH1;EPN1;MYO7A;BCAR1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;KCNG2;GAS6;SIN3B;MYH11;LZTS1;VDR;AMOT;LAMA1;LAMA5;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;GDNF;ACSL4;PIM2;PARVB
3453,GO:0006793,4.36258935454589e-08,1,77,3069,phosphorus metabolic process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;MARK4;FASN;GADD45A;WNT7A;WNT7B;ACVR1;GUCY1B3;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MBOAT2;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;RALB;HRAS;WNT5A;KHK;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;CDKN1A;PKN3;WNK4;CHGA;DDR1;CTGF;AKT1;NRTN;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;GDNF;ACSL4;FZD8;DUSP5;PIM2;PDE4B
16387,GO:0071310,4.41872748051616e-08,1,61,2192,cellular response to organic substance,BP,ITGA3;ITGA5;WNT3;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;ITGB5;FASN;WNT6;WNT7A;WNT7B;ACVR1;CASQ2;DKK3;EDN1;PRKACB;CCL20;FZD7;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;PRKAR1B;FOXO4;RALB;WNT5B;WNT5A;SESN2;RHOQ;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;MSN;CTGF;GJB2;GJB6;AKT1;CDH1;BCAR1;INHBB;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;VDR;SH3BP4;HEY1;CLDN18;PDE4B
5167,GO:0012501,4.45246190912399e-08,1,55,1885,programmed cell death,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;DSC2;WNT7A;ACVR1;ADORA1;EDN1;PHLDA1;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;RALB;HRAS;WNT5A;AXIN1;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;DSG3;CTGF;GJB6;AKT1;PKP3;PKP1;KITLG;JAG2;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SHC4;DSC3;VDR;ARAF;GDNF;PIM2
13836,GO:0051049,4.60848564011832e-08,1,53,1748,regulation of transport,BP,LIF;ADRA2B;ADRA2C;SYT5;ACTN2;NOTCH1;RAB27A;TF;PMAIP1;ADORA1;CASQ2;EDN1;KCNK6;MFGE8;SPTBN4;TTYH1;TSPAN13;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;RALB;WNT5A;RHOQ;NPR1;SDC4;BMP7;BMP6;BMP4;CDKN1A;DLL1;RAB20;WNK4;CHGA;MSN;AKT1;RAB17;CDH1;INHBB;PIK3CG;RAB11FIP1;KCNG2;GAS6;UNC119;KCND1;RAB3D;GDNF;PDE4B
4623,GO:0009719,4.62262026733497e-08,1,49,1551,response to endogenous stimulus,BP,ITGA3;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;ITGB5;WNT7A;WNT7B;ACVR1;CASQ2;DKK3;EDN1;PRKACB;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;PRKAR1B;FOXO4;WNT5A;KHK;SESN2;RHOQ;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;CTGF;GJB2;AKT1;CDH1;BCAR1;INHBB;CLDN1;CLDN5;PIK3CA;PIK3CG;ZCCHC12;VDR;SH3BP4;HEY1;PDE4B
4017,GO:0008219,4.7560838017683e-08,1,57,1990,cell death,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;DSC2;WNT7A;ACVR1;ADORA1;EDN1;PHLDA1;RRAS2;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;RALB;HRAS;WNT5A;AXIN1;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;DSG3;CTGF;GJB6;AKT1;PKP3;PKP1;KITLG;JAG2;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SHC4;DSC3;VDR;ARAF;GDNF;PIM2
7391,GO:0030323,4.8236082747953e-08,0.999999993262661,15,173,respiratory tube development,BP,ITGA3;LIF;WNT2;NOTCH1;STRA6;CRISPLD2;WNT7B;FSTL3;FGF10;WNT5A;FGF8;BMP4;CTGF;WNT2B;LAMA5
4703,GO:0009986,4.96068330437956e-08,0.999999987009908,30,682,cell surface,CC,ITGA3;ITGA5;WNT4;TSPAN15;NOTCH1;TF;ITGB5;ITGB4;ITGB8;SERPINA5;WNT6;WNT7A;TMEM206;PLAU;MFGE8;MPZL1;LPAR2;FGF10;PDGFB;KCNH2;WNT5B;WNT5A;RHOB;FGF8;SDC4;HBEGF;BMP2;VAMP1;MSN;AMOT
4911,GO:0010647,5.09194102429289e-08,1,48,1530,positive regulation of cell communication,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;CCL20;FZD7;LIMS2;CDH2;PRR5L;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;FZD8;DUSP5;PIM2
14499,GO:0052813,5.92670664244024e-08,0.999999995500362,10,69,phosphatidylinositol bisphosphate kinase activity,MF,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
7173,GO:0023056,5.98014389369093e-08,1,48,1538,positive regulation of signaling,BP,ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;CCL20;FZD7;LIMS2;CDH2;PRR5L;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;FZD8;DUSP5;PIM2
7932,GO:0031410,6.08614359567309e-08,1,59,2095,cytoplasmic vesicle,CC,ITGA5;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;ITGB5;FASN;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RAB39A;SYCN;FZD7;LPAR2;FSTL3;PDGFB;WNT5B;WNT5A;SNX18;AXIN1;RHOQ;RHOB;HBEGF;DLL1;RAB20;VAMP1;CHGA;PKP1;RAB12;RAB17;CYTIP;NPPC;CDH1;MYO7A;RAB44;RAB11FIP1;GAS6;MYH11;AMOT;SH3BP4;RAB38;RAB3D;RNF144A;PDE4B
18023,GO:0097708,6.43830929939231e-08,1,59,2098,intracellular vesicle,CC,ITGA5;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN2;TSPAN15;NOTCH1;RAB27A;TF;ITGB5;FASN;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RAB39A;SYCN;FZD7;LPAR2;FSTL3;PDGFB;WNT5B;WNT5A;SNX18;AXIN1;RHOQ;RHOB;HBEGF;DLL1;RAB20;VAMP1;CHGA;PKP1;RAB12;RAB17;CYTIP;NPPC;CDH1;MYO7A;RAB44;RAB11FIP1;GAS6;MYH11;AMOT;SH3BP4;RAB38;RAB3D;RNF144A;PDE4B
3454,GO:0006796,6.55046865111502e-08,1,75,2984,phosphate-containing compound metabolic process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN3;ACTN2;MARK4;GADD45A;WNT7A;WNT7B;ACVR1;GUCY1B3;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MBOAT2;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;RALB;HRAS;WNT5A;KHK;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;CDKN1A;PKN3;WNK4;CHGA;DDR1;CTGF;AKT1;NRTN;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;GDNF;FZD8;DUSP5;PIM2;PDE4B
15677,GO:0065008,6.59304779103989e-08,1,82,3394,regulation of biological quality,BP,FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT4;ACTN2;RAB27A;CDH23;TF;PMAIP1;DSC2;SERPINA5;WNT7A;WNT7B;ZFPM1;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;KCNK6;SPTBN5;SPTBN4;RAB39A;PRND;TYRO3;LPAR2;CDH2;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;HRAS;WNT5A;JAM3;SESN2;RHOQ;RHOJ;RHOB;NPR1;SPTB;BMP6;BMP4;BMP2;CDKN1A;DLL1;RAB20;SFXN1;WNK4;CHGA;MSN;DDR1;CTGF;GJB6;AKT1;RAB17;KITLG;NPPC;INHBB;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;LZTS1;VDR;RAB38;RAB3D;GDNF;ACTA2;CLDN16;CLDN18;PIM2;PARVB;PDE4B
19200,GO:1902533,7.21982114942362e-08,0.999999979258736,34,885,positive regulation of intracellular signal transduction,BP,LIF;ADRA2B;ADRA2C;NOTCH1;PMAIP1;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;CCL20;FZD7;CDH2;PRR5L;FGF10;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP4;BMP2;CTGF;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;FZD8;DUSP5;PIM2
20957,GO:2000026,7.32983737367049e-08,1,51,1660,regulation of multicellular organismal development,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;EDN1;PRKACB;FZD7;LIMS2;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5A;RHOB;NPR1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;CTGF;AKT1;RAB17;WNT2B;KITLG;CLDN5;GAS6;LZTS1;VDR;AMOT;LAMA1;LAMA5;GDNF;HEY1;CLDN18;EFNB2
11475,GO:0043549,7.42450889962659e-08,0.999999978508332,32,772,regulation of kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;SDC4;BMP7;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
5887,GO:0016337,8.47949220067579e-08,0.999999978035885,27,582,single organismal cell-cell adhesion,BP,ITGA5;WNT4;ITGB5;DSC2;WNT7B;ACVR1;TTYH1;TYRO3;LIMS2;CDH2;FSTL3;PIK3R1;WNT5A;JAM3;SDC4;BMP7;BMP4;CAMSAP3;MSN;AKT1;PKP3;PKP1;CDH1;PIK3CA;PIK3CG;GAS6;EFNB2
15051,GO:0060572,9.10523638835354e-08,0.999999997971254,6,17,morphogenesis of an epithelial bud,BP,WNT2;FGF10;WNT5A;BMP7;BMP4;WNT2B
2640,GO:0005515,1.00596858043633e-07,1,183,10444,protein binding,MF,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;ACTN3;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;RABIF;SALL4;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;PHLDA1;RHPN1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;RAB39B;RAB39A;MAPK12;FZD7;TYRO3;LPAR2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;MB21D2;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;DAAM2;WT1;CDKN1A;DLL1;PKN3;ESPN;VAMP1;WNK4;RND3;MSN;DDR1;CTGF;GJB1;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;HPCAL1;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;ZCCHC12;MYH11;LZTS1;CLDN23;SHC4;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;RAB3D;GDNF;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
13724,GO:0050878,1.02555360961092e-07,0.999999975493254,24,495,regulation of body fluid levels,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;ADORA1;EDN1;PLAU;PRKACB;TYRO3;FGF10;PIK3R1;PDGFB;PRKAR1B;RHOB;NPR1;WNK4;DDR1;AKT1;CLDN1;PIK3CA;PIK3CG;GAS6;VDR
5120,GO:0010941,1.09021667285121e-07,1,46,1470,regulation of cell death,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;WNT7A;ACVR1;ADORA1;EDN1;RRAS2;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;KITLG;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;VDR;ARAF;GDNF;PIM2
5221,GO:0014065,1.10237255409648e-07,0.99999998487595,14,161,phosphatidylinositol 3-kinase signaling,BP,EDN1;TYRO3;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
16835,GO:0072078,1.1125293491323e-07,0.999999990906101,10,73,nephron tubule morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
2872,GO:0005912,1.11288637625766e-07,0.999999973303837,24,479,adherens junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;NOTCH1;ITGB5;DSC2;PLAU;SPTBN4;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;CAMSAP3;DLL1;RND3;MSN;PKP3;CDH1;BCAR1;PARVB;EFNB2
10665,GO:0042127,1.18624272684091e-07,1,46,1489,regulation of cell proliferation,BP,LIF;WNT3;WNT2;NOTCH1;WNT7A;ADORA1;EDN1;PLAU;FZD7;LIMS2;CDH2;FGF10;FGF17;PDGFB;FOXO4;HRAS;WNT5A;NPR1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;DDR1;CTGF;GJB6;AKT1;PTGES;KITLG;NPPC;JAG2;GAS6;SHC4;VDR;LAMA5;SH3BP4;GDNF;PIM2;EFNB2
3461,GO:0006810,1.20467227115317e-07,1,103,4735,transport,BP,LIF;ADRA2B;ADRA2C;SYT5;RIN3;ACTN2;RAB6C;NOTCH1;RAB27A;CDH23;STRA6;TF;PMAIP1;CRISPLD2;SLC45A4;SERPINA5;WNT7A;SLC52A3;RABIF;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;KCNK6;MFGE8;FLVCR2;SPTBN5;SPTBN4;SLC25A53;TTYH1;TSPAN13;RAB39B;RAB39A;SYCN;FZD7;TYRO3;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;RALB;HRAS;WNT5A;SNX18;GPRASP1;SESN2;RHOQ;RHOB;NPR1;SDC4;SPTB;BMP7;BMP6;BMP4;CDKN1A;DLL1;RAB20;SLC2A14;VAMP1;SFXN1;WNK4;CHGA;MSN;DDR1;CTGF;GJB1;GJB2;TPD52;AKT1;PKP1;RAB12;RAB17;CDH1;EPN1;MYO7A;INHBB;GJA3;RAB44;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SLC18B1;VDR;SH3BP4;UNC119;KCND1;RAB38;RAB3D;GDNF;ACSL4;CLDN16;CLDN15;PDE4B
13329,GO:0048645,1.2056252217965e-07,0.999999991826836,9,58,animal organ formation,BP,WNT2;FGF10;WNT5A;FGF8;BMP7;BMP4;WT1;WNT2B;GDNF
17327,GO:0090002,1.21039999604439e-07,0.999999984860162,13,136,establishment of protein localization to plasma membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
9641,GO:0035004,1.28433642468101e-07,0.999999989322686,10,74,phosphatidylinositol 3-kinase activity,MF,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
14677,GO:0060047,1.31384262017898e-07,0.999999976957913,17,255,heart contraction,BP,DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;NPR1;HBEGF;CHGA;CTGF;NPPC;PIK3CA;PIK3CG;KCNG2;KCND1;PDE4B
3891,GO:0008016,1.36648348944652e-07,0.999999977895058,16,225,regulation of heart contraction,BP,DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;NPR1;HBEGF;CHGA;CTGF;NPPC;PIK3CG;KCNG2;KCND1;PDE4B
8024,GO:0031589,1.44326312682019e-07,0.999999971479906,19,298,cell-substrate adhesion,BP,ITGA3;ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;ITGB5;ITGB4;PLAU;TTYH1;FZD7;TYRO3;PIK3R1;JAM3;SDC4;DDR1;CTGF;GAS6;LAMA5
3744,GO:0007267,1.50051373633171e-07,1,47,1519,cell-cell signaling,BP,ITGA3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;NOTCH1;DHH;WNT6;WNT7A;WNT7B;ADORA1;CASQ2;DKK3;EDN1;CCL20;MPZL1;FZD7;CDH2;FGF10;FGF17;PDGFB;HRAS;WNT5B;WNT5A;AXIN1;FGF8;BMP6;BMP4;BMP2;DLL1;GJB1;GJB2;AKT1;WNT2B;INHBB;GJA3;TLE1;RAB11FIP1;KCNG2;LZTS1;UNC119;GDNF;FZD8;EFNB2
1388,GO:0003015,1.5580875966853e-07,0.999999972327638,17,258,heart process,BP,DSC2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;KCNH2;NPR1;HBEGF;CHGA;CTGF;NPPC;PIK3CA;PIK3CG;KCNG2;KCND1;PDE4B
3684,GO:0007178,1.60375586308532e-07,0.999999968054628,19,309,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ITGA3;NOTCH1;RASL11B;ITGB5;ACVR1;DKK3;FSTL3;FGF10;CGN;PDGFB;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;INHBB;CLDN5;ZCCHC12
11175,GO:0043067,1.63688927473547e-07,0.999999955495563,44,1377,regulation of programmed cell death,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;MARK4;PMAIP1;GADD45A;WNT7A;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;VDR;ARAF;GDNF;PIM2
7629,GO:0030864,1.67063913653189e-07,0.999999988285059,9,55,cortical actin cytoskeleton,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;SPTB;CDH1;CLDN5;MYZAP
13072,GO:0048018,1.7247087755334e-07,0.999999995430521,6,21,receptor agonist activity,MF,WNT3;WNT2;WNT4;WNT7A;WNT5A;GAS6
15036,GO:0060548,1.78284390328725e-07,0.999999945268302,33,872,negative regulation of cell death,BP,ITGA5;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;FGF10;PIK3R1;HRAS;WNT5A;NUAK2;FGF8;CLCF1;BMP7;BMP4;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;KITLG;TLE1;PIK3CA;PIK3CG;GAS6;ARAF;GDNF;PIM2
12387,GO:0045859,1.80775109127849e-07,0.999999947693334,30,723,regulation of protein kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;SESN2;AXIN1;PSRC1;SDC4;BMP7;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
3677,GO:0007169,1.83408828850658e-07,0.999999947557114,29,671,transmembrane receptor protein tyrosine kinase signaling pathway,BP,ITGA5;ADRA2B;ADRA2C;WNT4;ADORA1;MPZL1;MAPK12;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;RHOQ;FGF8;HBEGF;BMP2;DLL1;DDR1;CTGF;AKT1;NRTN;EPN1;BCAR1;PIK3CA;SHC4;EFNB2
571,GO:0001658,1.92185070134974e-07,0.999999986195448,9,59,branching involved in ureteric bud morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
13291,GO:0048568,1.95342704561377e-07,0.999999954698045,22,417,embryonic organ development,BP,LIF;WNT2;NOTCH1;STRA6;WNT7B;ZFPM1;ACVR1;EDN1;FGF10;PDGFB;WNT5A;AXIN1;FGF8;BMP7;BMP4;DLL1;GJB6;AKT1;KITLG;EPN1;MYO7A;HEY1
15456,GO:0061333,1.96969058707747e-07,0.999999982779991,10,77,renal tubule morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNK4;WNT2B;LAMA5;GDNF
7113,GO:0022612,2.05926153859388e-07,0.999999975797256,12,120,gland morphogenesis,BP,WNT4;NOTCH1;LIMS2;FGF10;WNT5A;FGF8;BMP7;BMP4;MSN;DDR1;VDR;LAMA5
9374,GO:0034330,2.09655373514375e-07,0.999999962036298,17,242,cell junction organization,BP,ITGA5;WNT4;ACTN3;ACTN2;ITGB4;LIMS2;CDH2;SDC4;CAMSAP3;GJB1;GJB2;PKP3;CDH1;CLDN1;CLDN3;CLDN5;LAMA5
15027,GO:0060537,2.11803242585934e-07,0.999999954891865,20,345,muscle tissue development,BP,FHOD3;WNT2;ACTN3;ACTN2;NOTCH1;STRA6;IGSF8;ZFPM1;ACVR1;EDN1;FZD7;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;MYH11;EFNB2
570,GO:0001657,2.12541926414578e-07,0.999999978052509,11,97,ureteric bud development,BP,WNT4;WNT6;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
16710,GO:0071840,2.14264512980194e-07,1,121,5922,cellular component organization or biogenesis,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;SYT5;WNT3;WNT4;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;MARK4;RAB27A;CDH23;TF;ITGB5;ITGB4;ITGB8;PMAIP1;GADD45A;CRISPLD2;SERPINA5;WNT7A;WNT7B;ZFPM1;RABIF;CASQ2;EDN1;RAB40B;RAB40A;MFGE8;SPTBN5;SPTBN4;TTYH1;RAB39B;RAB39A;PRND;FZD7;TYRO3;LIMS2;CDH2;FGF10;PIK3R1;REEP1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;PSTPIP2;SNX18;SESN2;AXIN1;RHOQ;RHOJ;NPR1;NUAK2;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;RAB20;DRP2;ESPN;VAMP1;RND3;CHGA;MSN;DDR1;CTGF;GJB1;GJB2;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;SEMA6C;CDH1;EPN1;MYO7A;BCAR1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;KCNG2;GAS6;SIN3B;MYH11;LZTS1;VDR;AMOT;LAMA1;LAMA5;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;GDNF;ACSL4;PIM2;PARVB
11174,GO:0043066,2.18973202893997e-07,0.999999933927137,31,795,negative regulation of apoptotic process,BP,ITGA5;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;FGF10;PIK3R1;HRAS;WNT5A;NUAK2;FGF8;CLCF1;BMP7;BMP4;WT1;CDKN1A;DLL1;HMGN5;AKT1;KITLG;TLE1;PIK3CA;PIK3CG;GAS6;ARAF;GDNF;PIM2
4895,GO:0010631,2.19763042339636e-07,0.999999962539798,16,227,epithelial cell migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF10;PDGFB;WNT5A;RHOB;HBEGF;BMP4;PKN3;AKT1;BCAR1;PIK3CA;AMOT;EFNB2
11386,GO:0043405,2.25964672252983e-07,0.99999995390908,19,321,regulation of MAP kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;FGF10;PDGFB;HRAS;WNT5A;AXIN1;BMP7;BMP4;BMP2;KITLG;PIK3CG;ARAF;FZD8;DUSP5
11823,GO:0044459,2.29086033451749e-07,1,66,2478,plasma membrane part,CC,ITGA3;ITGA5;ADRA2B;ADRA2C;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;ITGB5;ITGB4;ITGB8;SERPINA5;SLC52A3;ACVR1;ADORA1;CASQ2;KCNK6;MFGE8;SPTBN5;TTYH1;MPZL1;TSPAN13;TYRO3;LPAR2;CDH2;PDGFB;KCNH2;PTPN7;SNX18;AXIN1;NPR1;FGF8;SDC4;SPTB;HBEGF;BMP2;DLL1;DRP2;VAMP1;MSN;DDR1;GJB1;GJB2;GJB6;RAB17;JAG2;CDH1;MYO7A;GJA3;CLDN1;CLDN3;CLDN5;KCNG2;LZTS1;SHC4;SLC18B1;AMOT;KCND1;TSPAN2;MYZAP;FZD8;CLDN12;CLDN15;EFNB2;PDE4B
599,GO:0001704,2.30033063741443e-07,0.999999972702308,12,118,formation of primary germ layer,BP,ITGA3;ITGA5;WNT3;ITGB5;ITGB4;ACVR1;FZD7;WNT5A;AXIN1;BMP7;BMP4;DUSP5
16888,GO:0072163,2.38928162757311e-07,0.999999975013959,11,98,mesonephric epithelium development,BP,WNT4;WNT6;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
16889,GO:0072164,2.38928162757311e-07,0.999999975013959,11,98,mesonephric tubule development,BP,WNT4;WNT6;FGF8;SDC4;BMP7;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
14796,GO:0060231,2.55232246674205e-07,0.999999992855093,6,20,mesenchymal to epithelial transition,BP,LIF;WNT4;FZD7;BMP4;WT1;GDNF
862,GO:0002067,2.56275885986762e-07,0.999999984932912,8,45,glandular epithelial cell differentiation,BP,WNT4;NOTCH1;WNT5A;FGF8;BMP6;BMP4;BMP2;DLL1
7200,GO:0030036,2.63706126949319e-07,0.999999928911795,26,562,actin cytoskeleton organization,BP,FHOD3;WNT4;ACTN2;ITGB5;CASQ2;EDN1;SPTBN5;SPTBN4;FGF10;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;RHOJ;NUAK2;SDC4;SPTB;DAAM2;ESPN;RND3;CTGF;BCAR1;MYH11;AMOT;PARVB
13740,GO:0050900,2.85248915467704e-07,0.999999937596993,20,391,leukocyte migration,BP,ITGA3;ITGA5;ARTN;ADORA1;EDN1;CCL20;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;SDC4;CHGA;MSN;KITLG;PIK3CA;PIK3CG;GAS6;PDE4B
4912,GO:0010648,2.87647861846716e-07,0.999999905404639,40,1182,negative regulation of cell communication,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT4;ACTN3;NOTCH1;RASL11B;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PRKACB;TYRO3;CDH2;PRR5L;FSTL3;FGF10;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;AKT1;EPN1;INHBB;TLE1;RAB11FIP1;GAS6;ARAF;SH3BP4;GDNF;DUSP5;HEY1
7254,GO:0030139,2.9001361714177e-07,0.999999946055045,17,270,endocytic vesicle,CC,WNT3;WNT4;TF;ITGB5;WNT6;WNT7A;WNT7B;RAB39A;LPAR2;WNT5B;WNT5A;HBEGF;RAB20;RAB17;RAB11FIP1;AMOT;RAB38
16752,GO:0071902,2.98787838171214e-07,0.999999941020261,18,297,positive regulation of protein serine/threonine kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;EDN1;FGF10;PDGFB;RALB;HRAS;WNT5A;AXIN1;PSRC1;BMP2;AKT1;KITLG;PIK3CG;FZD8;DUSP5
13265,GO:0048522,3.00120809894131e-07,1,100,4576,positive regulation of cellular process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;TF;FASN;PMAIP1;GADD45A;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;CASQ2;EDN1;PLAU;PRKACB;MFGE8;CCL20;RRAS2;MAPK12;FZD7;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;RHOB;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;ESPN;CHGA;MSN;CTGF;AKT1;RAB12;WNT2B;KITLG;NPPC;JAG2;CDH1;BCAR1;INHBB;CLDN1;CLDN5;PIK3CA;PIK3CG;GAS6;SHC4;VDR;ARAF;SH3BP4;UNC119;RAB3D;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2;EFNB2
11177,GO:0043069,3.02906058294384e-07,0.999999907161698,31,806,negative regulation of programmed cell death,BP,ITGA5;WNT4;NOTCH1;WNT7A;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;FGF10;PIK3R1;HRAS;WNT5A;NUAK2;FGF8;CLCF1;BMP7;BMP4;WT1;CDKN1A;DLL1;HMGN5;AKT1;KITLG;TLE1;PIK3CA;PIK3CG;GAS6;ARAF;GDNF;PIM2
7174,GO:0023057,3.15250334009391e-07,0.999999895981176,40,1186,negative regulation of signaling,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT4;ACTN3;NOTCH1;RASL11B;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PRKACB;TYRO3;CDH2;PRR5L;FSTL3;FGF10;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;AKT1;EPN1;INHBB;TLE1;RAB11FIP1;GAS6;ARAF;SH3BP4;GDNF;DUSP5;HEY1
16872,GO:0072132,3.2488821477264e-07,0.999999980229906,8,46,mesenchyme morphogenesis,BP,NOTCH1;ACVR1;WNT5A;FGF8;BMP7;BMP2;HEY1;ACTA2
4893,GO:0010628,3.29635505490428e-07,0.999999904570864,50,1687,positive regulation of gene expression,BP,ITGA3;LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;ITGB8;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;MSN;CTGF;AKT1;PKP3;PKP1;CDH1;TLE1;GAS6;VDR;GDNF;FZD8;HEY1;ACTA2;PIM2
4719,GO:0010033,3.47257826545034e-07,1,69,2793,response to organic substance,BP,ITGA3;ITGA5;WNT3;WNT2;WNT4;ACTN2;NOTCH1;RASL11B;ITGB5;FASN;PMAIP1;DHH;WNT6;WNT7A;WNT7B;ACVR1;CASQ2;DKK3;EDN1;PRKACB;CCL20;FZD7;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;PRKAR1B;FOXO4;RALB;WNT5B;WNT5A;KHK;SESN2;RHOQ;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;MSN;CTGF;GJB2;GJB6;AKT1;PTGES;NPPC;CDH1;BCAR1;INHBB;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;GAS6;ZCCHC12;VDR;SH3BP4;ACSL4;HEY1;CLDN18;PDE4B
11111,GO:0042981,3.54977444711546e-07,0.99999987862325,43,1363,regulation of apoptotic process,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;PMAIP1;GADD45A;WNT7A;ACVR1;ADORA1;EDN1;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;VDR;ARAF;GDNF;PIM2
7108,GO:0022603,3.57789314208514e-07,0.999999883171963,34,911,regulation of anatomical structure morphogenesis,BP,ITGA5;LIF;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;ACVR1;EDN1;FZD7;LIMS2;FGF10;FOXO4;WNT5A;RHOQ;RHOJ;RHOB;NPR1;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;MSN;WNT2B;LZTS1;VDR;AMOT;GDNF;HEY1;PARVB;EFNB2
19198,GO:1902531,3.67255360825657e-07,0.999999893369892,50,1683,regulation of intracellular signal transduction,BP,ITGA3;LIF;ADRA2B;ADRA2C;ACTN3;NOTCH1;PMAIP1;GADD45A;WNT7A;WNT7B;ADORA1;CASQ2;EDN1;CCL20;FZD7;CDH2;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5A;SESN2;AXIN1;RHOQ;RHOJ;RHOB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;KITLG;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;AMOT;ARAF;SH3BP4;FZD8;DUSP5;PIM2
21078,GO:2000242,3.77671708343841e-07,0.999999976280723,8,51,negative regulation of reproductive process,BP,LIF;WNT4;PRKACB;WNT5A;BMP7;BMP4;WT1;NPPC
1563,GO:0003338,3.80629056128109e-07,0.9999999824408,7,33,metanephros morphogenesis,BP,LIF;WNT4;WNT7B;FGF10;BMP4;WT1;GDNF
3784,GO:0007369,3.8741660204651e-07,0.999999940663304,14,176,gastrulation,BP,ITGA3;ITGA5;WNT3;ITGB5;ITGB4;ACVR1;FZD7;WNT5A;AXIN1;FGF8;BMP7;BMP4;AMOT;DUSP5
15110,GO:0060675,3.9120810649576e-07,0.999999969135435,9,64,ureteric bud morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
15048,GO:0060563,4.00756404728226e-07,0.999999974793508,8,48,neuroepithelial cell differentiation,BP,WNT4;NOTCH1;CDH2;FGF8;BMP2;DLL1;JAG2;MYO7A
13296,GO:0048584,4.07966849604545e-07,0.999999878474329,54,1941,positive regulation of response to stimulus,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;PMAIP1;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;BCAR1;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;FZD8;DUSP5;PIM2;PDE4B
8869,GO:0032989,4.35602929980453e-07,0.999999854128159,36,973,cellular component morphogenesis,BP,ARTN;FHOD3;WNT3;ACTN2;NOTCH1;WNT7A;WNT7B;ZFPM1;CASQ2;EDN1;SPTBN5;SPTBN4;FZD7;TYRO3;PIK3R1;HRAS;WNT5A;RHOQ;RHOJ;FGF8;SPTB;BMP7;B3GNT2;MSN;DDR1;NRTN;SEMA6C;MYO7A;CLDN3;PIK3CA;MYH11;LZTS1;VDR;LAMA5;GDNF;PARVB
16896,GO:0072171,4.4069505770237e-07,0.999999964675946,9,65,mesonephric tubule morphogenesis,BP,WNT4;WNT6;FGF8;BMP4;BMP2;WT1;WNT2B;LAMA5;GDNF
15405,GO:0061180,4.70390340011921e-07,0.999999961945613,9,66,mammary gland epithelium development,BP,WNT3;WNT2;WNT4;WNT7B;FGF10;WNT5A;DDR1;AKT1;VDR
5233,GO:0014706,4.72403162114351e-07,0.999999898227773,19,331,striated muscle tissue development,BP,FHOD3;WNT2;ACTN3;ACTN2;NOTCH1;IGSF8;ZFPM1;ACVR1;EDN1;FZD7;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;MYH11;EFNB2
2806,GO:0005796,5.46808040485761e-07,0.999999945586654,10,97,Golgi lumen,CC,WNT3;WNT4;WNT6;WNT7A;WNT7B;PDGFB;WNT5B;WNT5A;SDC4;GAS6
4898,GO:0010634,5.47806629945601e-07,0.999999937204716,11,109,positive regulation of epithelial cell migration,BP,ITGA3;WNT7A;EDN1;FGF10;PDGFB;WNT5A;RHOB;HBEGF;BMP4;AKT1;BCAR1
3790,GO:0007389,5.59718903611129e-07,0.999999866650031,21,413,pattern specification process,BP,WNT3;WNT2;NOTCH1;WNT6;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;FGF10;WNT5A;AXIN1;FGF8;BMP7;BMP4;BMP2;DAAM2;WT1;DLL1;WNT2B;GDNF
13898,GO:0051145,5.73597901151387e-07,0.999999961964994,8,50,smooth muscle cell differentiation,BP,WNT4;NOTCH1;ACVR1;FGF10;PDGFB;FOXO4;BMP4;HEY1
14697,GO:0060070,5.89786783078865e-07,0.99999988389783,17,283,canonical Wnt signaling pathway,BP,WNT3;WNT2;WNT4;NOTCH1;WNT7A;WNT7B;DKK3;FZD7;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP2;WNT2B;FZD8
17147,GO:0072659,5.90951432410659e-07,0.99999989848561,15,212,protein localization to plasma membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
7488,GO:0030546,6.31440314002136e-07,0.999999968024101,7,37,receptor activator activity,MF,WNT3;WNT2;WNT4;ACTN2;WNT7A;WNT5A;GAS6
569,GO:0001656,6.71967366410512e-07,0.999999931984591,10,88,metanephros development,BP,LIF;WNT4;WNT7B;FGF10;PDGFB;FGF8;BMP7;BMP4;WT1;GDNF
7010,GO:0021871,7.024744223856e-07,0.99999997574313,6,23,forebrain regionalization,BP,WNT7B;AXIN1;FGF8;BMP4;BMP2;WNT2B
13963,GO:0051241,7.17590261899354e-07,0.999999757976806,34,976,negative regulation of multicellular organismal process,BP,ADRA2C;WNT3;WNT4;NOTCH1;WNT7A;ZFPM1;ADORA1;EDN1;PLAU;PRKACB;SPTBN4;FZD7;LIMS2;FSTL3;PIK3R1;PDGFB;FOXO4;WNT5A;NPR1;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;WNK4;NPPC;INHBB;PIK3CG;RAB11FIP1;GAS6;AMOT;CLDN18;PDE4B
1468,GO:0003179,7.66945667447713e-07,0.999999960476046,7,34,heart valve morphogenesis,BP,NOTCH1;STRA6;ZFPM1;ACVR1;BMP4;BMP2;HEY1
2459,GO:0005125,8.27796560014749e-07,0.99999987482611,13,218,cytokine activity,MF,LIF;WNT2;WNT7A;EDN1;CCL20;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;KITLG;INHBB
3543,GO:0006936,9.08460184222919e-07,0.999999804790307,18,326,muscle contraction,BP,ADRA2B;ADRA2C;ACTN3;ACTN2;ITGB5;DSC2;ADORA1;CASQ2;EDN1;KCNH2;CHGA;CTGF;PIK3CA;PIK3CG;MYH11;GDNF;ACTA2;PDE4B
8412,GO:0032344,9.14897958684355e-07,0.999999994202118,4,6,regulation of aldosterone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
8415,GO:0032347,9.14897958684355e-07,0.999999994202118,4,6,regulation of aldosterone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
16796,GO:0072012,9.41863680192504e-07,0.99999996546488,6,24,glomerulus vasculature development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
5882,GO:0016328,9.78890583771998e-07,0.999999929940058,8,52,lateral plasma membrane,CC,AXIN1;GJB1;GJB2;CDH1;CLDN1;CLDN3;CLDN12;CLDN15
13662,GO:0050790,1.01915030934218e-06,0.99999968064195,60,2320,regulation of catalytic activity,BP,ARTN;ADRA2B;ADRA2C;WNT4;RIN3;ACTN2;NOTCH1;PMAIP1;GADD45A;SERPINA5;WNT7B;RABIF;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;SESN2;AXIN1;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;BMP2;CAMSAP3;CDKN1A;CTGF;AKT1;NRTN;KITLG;CST9L;PIK3CA;PIK3CG;GAS6;GPSM1;VDR;AMOT;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5
18775,GO:1901342,1.04158739081712e-06,0.999999811640254,15,230,regulation of vasculature development,BP,ITGA5;WNT4;NOTCH1;PDGFB;FOXO4;WNT5A;RHOB;NPR1;BMP7;BMP4;WT1;DLL1;AMOT;HEY1;EFNB2
1378,GO:0003002,1.14897697500537e-06,0.999999748896833,18,327,regionalization,BP,WNT3;WNT2;NOTCH1;WNT7A;WNT7B;ACVR1;EDN1;PRKACB;FGF10;WNT5A;AXIN1;FGF8;BMP4;BMP2;WT1;DLL1;WNT2B;GDNF
14020,GO:0051338,1.15112064360124e-06,0.999999607949892,33,933,regulation of transferase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;EDN1;PRKACB;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;SDC4;BMP7;BMP4;BMP2;CDKN1A;AKT1;KITLG;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
12094,GO:0045216,1.1649895016233e-06,0.999999787868936,15,214,cell-cell junction organization,BP,WNT4;ACTN3;ACTN2;LIMS2;CDH2;SDC4;CAMSAP3;GJB1;GJB2;PKP3;CDH1;CLDN1;CLDN3;CLDN5;LAMA5
3825,GO:0007507,1.17692970195628e-06,0.999999683691075,23,488,heart development,BP,ITGA3;FHOD3;WNT2;ACTN2;NOTCH1;STRA6;ZFPM1;ACVR1;SALL4;EDN1;FZD7;PDGFB;WNT5A;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;CLDN5;MYH11;HEY1;EFNB2
15050,GO:0060571,1.1770909471639e-06,0.999999954764411,6,25,morphogenesis of an epithelial fold,BP,WNT2;FGF10;WNT5A;BMP7;BMP4;WNT2B
3799,GO:0007411,1.17710791891862e-06,0.999999785348228,15,218,axon guidance,BP,ARTN;WNT3;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;PIK3CA;GDNF
15774,GO:0070169,1.28335300809877e-06,0.999999927108258,7,39,positive regulation of biomineral tissue development,BP,WNT4;WNT6;ACVR1;BMP7;BMP6;BMP4;BMP2
8313,GO:0032147,1.29479047602677e-06,0.999999729450087,17,294,activation of protein kinase activity,BP,ADRA2B;ADRA2C;GADD45A;WNT7B;ADORA1;PRKACB;FGF10;PDGFB;PRKAR1B;WNT5A;AXIN1;BMP4;BMP2;PIK3CA;GAS6;ARAF;DUSP5
562,GO:0001649,1.31945850989929e-06,0.999999774920529,14,201,osteoblast differentiation,BP,WNT3;WNT4;NOTCH1;FASN;DHH;WNT7B;ACVR1;RRAS2;BMP7;BMP6;BMP4;BMP2;AKT1;NPPC
17944,GO:0097485,1.33011531888334e-06,0.999999754919002,15,220,neuron projection guidance,BP,ARTN;WNT3;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;PIK3CA;GDNF
9701,GO:0035148,1.363237710184e-06,0.999999806076601,12,142,tube formation,BP,WNT4;NOTCH1;WNT6;SALL4;PRKACB;FGF10;WNT5A;FGF8;SDC4;BMP7;BMP4;GDNF
17437,GO:0090183,1.36856605121618e-06,0.999999896930546,8,55,regulation of kidney development,BP,LIF;WNT4;PDGFB;BMP7;BMP4;WT1;WNT2B;GDNF
9373,GO:0034329,1.38785320791878e-06,0.999999762006646,14,191,cell junction assembly,BP,ITGA5;WNT4;ACTN3;ACTN2;ITGB4;LIMS2;SDC4;GJB1;GJB2;PKP3;CLDN1;CLDN3;CLDN5;LAMA5
20875,GO:1990778,1.47049543084568e-06,0.999999726453314,15,229,protein localization to cell periphery,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
12836,GO:0046854,1.53924754584686e-06,0.999999828003893,10,96,phosphatidylinositol phosphorylation,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
12293,GO:0045669,1.61731127074721e-06,0.999999874988212,8,57,positive regulation of osteoblast differentiation,BP,WNT4;WNT7B;ACVR1;BMP7;BMP6;BMP4;BMP2;NPPC
15500,GO:0061437,1.63775217971743e-06,0.999999932828625,6,26,renal system vasculature development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
15503,GO:0061440,1.63775217971743e-06,0.999999932828625,6,26,kidney vasculature development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
9664,GO:0035051,1.65485580015036e-06,0.999999786020345,11,120,cardiocyte differentiation,BP,FHOD3;ACTN2;NOTCH1;ACVR1;EDN1;FZD7;BMP4;BMP2;WT1;MYH11;EFNB2
15446,GO:0061311,1.66097645712402e-06,0.999999931707761,6,26,cell surface receptor signaling pathway involved in heart development,BP,NOTCH1;ACVR1;WNT5A;BMP4;BMP2;HEY1
14562,GO:0055007,1.67807730636895e-06,0.999999810530288,10,97,cardiac muscle cell differentiation,BP,FHOD3;ACTN2;ACVR1;EDN1;FZD7;BMP4;BMP2;WT1;MYH11;EFNB2
7066,GO:0021983,1.69412394709422e-06,0.99999989871731,7,42,pituitary gland development,BP,WNT4;FGF10;WNT5A;FGF8;BMP4;BMP2;CDH1
1480,GO:0003197,1.70667290002764e-06,0.999999898746989,7,39,endocardial cushion development,BP,NOTCH1;ACVR1;FGF8;BMP7;BMP4;BMP2;HEY1
1461,GO:0003170,1.70839177293341e-06,0.999999898962122,7,38,heart valve development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;BMP4;BMP2;HEY1
15302,GO:0061005,1.75352399700831e-06,0.999999863172291,8,56,cell differentiation involved in kidney development,BP,LIF;WNT4;NOTCH1;PDGFB;BMP4;WT1;GDNF;ACTA2
8562,GO:0032526,1.8504262313537e-06,0.99999978802602,10,103,response to retinoic acid,BP,WNT3;WNT2;WNT6;WNT7B;FZD7;WNT5B;WNT5A;BMP6;GJB2;PTGES
13945,GO:0051216,1.85045686131717e-06,0.999999700305263,13,176,cartilage development,BP,ITGB8;WNT7A;WNT7B;EDN1;WNT5B;WNT5A;BMP7;BMP6;BMP4;BMP2;CTGF;WNT2B;NPPC
18776,GO:1901343,1.85757393099592e-06,0.9999998196879,9,79,negative regulation of vasculature development,BP,WNT4;NOTCH1;PDGFB;FOXO4;NPR1;BMP7;BMP4;WT1;AMOT
13427,GO:0048839,1.87253438204347e-06,0.999999696460458,13,175,inner ear development,BP,NOTCH1;CDH23;FGF10;WNT5A;FGF8;SDC4;BMP4;BMP2;DLL1;GJB2;GJB6;JAG2;MYO7A
13069,GO:0048015,1.88831604649207e-06,0.99999966688686,14,201,phosphatidylinositol-mediated signaling,BP,EDN1;TYRO3;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
17438,GO:0090184,1.90798751195157e-06,0.999999884496089,7,40,positive regulation of kidney development,BP,LIF;WNT4;PDGFB;BMP4;WT1;WNT2B;GDNF
15678,GO:0065009,1.91748766858724e-06,0.999999371199626,69,2865,regulation of molecular function,BP,ARTN;LIF;ADRA2B;ADRA2C;WNT2;WNT4;RIN3;ACTN2;NOTCH1;PMAIP1;GADD45A;SERPINA5;WNT7B;ZFPM1;RABIF;ADORA1;CASQ2;EDN1;PLAU;PRKACB;CCL20;SPTBN5;SPTBN4;TSPAN13;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;SESN2;AXIN1;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;BMP2;CAMSAP3;CDKN1A;WNK4;CTGF;AKT1;NRTN;KITLG;CST9L;PIK3CA;PIK3CG;GAS6;GPSM1;VDR;AMOT;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;PDE4B
13665,GO:0050794,1.98140837176571e-06,1,170,9810,regulation of cellular process,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;RASL11B;TF;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;ESPN;WNK4;RND3;CHGA;MSN;DDR1;CTGF;GJB6;RRAD;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;TSPAN2;RAB38;RAB3D;GDNF;MYZAP;FZD8;DUSP5;HEY1;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
3532,GO:0006915,2.03399643083207e-06,0.999999226012706,49,1763,apoptotic process,BP,ITGA5;WNT4;ACTN3;ACTN2;NOTCH1;PMAIP1;GADD45A;WNT7A;ACVR1;ADORA1;EDN1;PHLDA1;TYRO3;LIMS2;FGF10;PIK3R2;PIK3R1;RALB;HRAS;WNT5A;AXIN1;RHOB;NUAK2;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;GJB6;AKT1;KITLG;JAG2;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SHC4;VDR;ARAF;GDNF;PIM2
13661,GO:0050789,2.04903818814561e-06,1,177,10394,regulation of biological process,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;STRA6;RASL11B;TF;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;TTYH1;MPZL1;RRAS2;TSPAN13;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;ESPN;WNK4;RND3;CHGA;MSN;DDR1;CTGF;GJB6;RRAD;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
11896,GO:0044765,2.16715775357103e-06,0.999999089572758,70,2931,single-organism transport,BP,LIF;ADRA2B;ADRA2C;SYT5;ACTN2;NOTCH1;RAB27A;STRA6;TF;CRISPLD2;SLC45A4;SERPINA5;WNT7A;SLC52A3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;KCNK6;MFGE8;FLVCR2;RAB39A;SYCN;FZD7;TYRO3;FGF10;PIK3R2;PIK3R1;PDGFB;KCNH2;RALB;WNT5A;SESN2;RHOQ;NPR1;SDC4;BMP7;BMP6;BMP4;CDKN1A;RAB20;SLC2A14;VAMP1;WNK4;CHGA;DDR1;CTGF;GJB1;TPD52;AKT1;PKP1;RAB17;CDH1;MYO7A;INHBB;RAB44;CLDN1;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;VDR;UNC119;KCND1;RAB3D;GDNF;ACSL4
11468,GO:0043542,2.19735457625711e-06,0.999999671372002,12,153,endothelial cell migration,BP,NOTCH1;WNT7A;EDN1;PDGFB;WNT5A;RHOB;BMP4;AKT1;BCAR1;PIK3CA;AMOT;EFNB2
1529,GO:0003279,2.20141008670052e-06,0.999999743958794,10,95,cardiac septum development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;SALL4;WNT5A;FGF8;BMP7;BMP4;HEY1
4648,GO:0009792,2.22687758125119e-06,0.999999357418812,24,555,embryo development ending in birth or egg hatching,BP,LIF;WNT2;NOTCH1;WNT7B;ACVR1;SALL4;EDN1;PRKACB;PDGFB;WNT5A;AXIN1;FGF8;SDC4;BMP7;BMP4;BMP2;DLL1;AKT1;JAG2;EPN1;DSC3;AMOT;ACSL4;HEY1
11630,GO:0044093,2.27400826336422e-06,0.999999057123658,51,1841,positive regulation of molecular function,BP,ARTN;ADRA2B;ADRA2C;WNT2;WNT4;RIN3;ACTN2;PMAIP1;GADD45A;WNT7B;RABIF;ADORA1;EDN1;PRKACB;CCL20;SPTBN5;SPTBN4;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SNX18;AXIN1;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP4;BMP2;CDKN1A;CTGF;AKT1;NRTN;KITLG;PIK3CA;PIK3CG;GAS6;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5
13071,GO:0048017,2.27414896968629e-06,0.99999959203666,14,204,inositol lipid-mediated signaling,BP,EDN1;TYRO3;PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
13579,GO:0050679,2.29389710776494e-06,0.999999655036581,12,158,positive regulation of epithelial cell proliferation,BP,WNT2;NOTCH1;WNT7A;FZD7;FGF10;PDGFB;HRAS;WNT5A;BMP6;BMP4;BMP2;AKT1
10850,GO:0042475,2.33067502948101e-06,0.999999766917768,9,81,odontogenesis of dentin-containing tooth,BP,ITGB4;WNT6;FGF10;FGF8;BMP7;BMP4;BMP2;JAG2;LAMA5
5867,GO:0016303,2.35873895692277e-06,0.999999851256288,7,43,1-phosphatidylinositol-3-kinase activity,MF,FGF10;FGF17;PIK3R2;PIK3R1;FGF8;PIK3CA;PIK3CG
13626,GO:0050731,2.39900831057339e-06,0.999999637199392,12,163,positive regulation of peptidyl-tyrosine phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;FGF10;PDGFB;CLCF1;HBEGF;KITLG;GAS6;UNC119
427,GO:0001101,2.43966374705219e-06,0.999999463950951,17,313,response to acid chemical,BP,WNT3;WNT2;WNT6;WNT7B;EDN1;FZD7;PDGFB;WNT5B;WNT5A;SESN2;BMP6;CTGF;GJB2;AKT1;PTGES;CLDN1;SH3BP4
12346,GO:0045778,2.4671713215642e-06,0.999999751319711,9,82,positive regulation of ossification,BP,WNT4;WNT7B;ACVR1;WNT5A;BMP7;BMP6;BMP4;BMP2;NPPC
14734,GO:0060129,2.47885808356944e-06,1,3,3,thyroid-stimulating hormone-secreting cell differentiation,BP,WNT4;FGF8;BMP2
7214,GO:0030057,2.5255589018916e-06,0.999999889033395,6,25,desmosome,CC,DSC2;JAM3;DSG3;PKP3;PKP1;DSC3
17882,GO:0097367,2.6856631957166e-06,0.999998916432298,58,2130,carbohydrate derivative binding,MF,ITGA3;TUBG2;RAB6C;MARK4;RAB27A;RASL11B;CRISPLD2;SERPINA5;ACVR1;GUCY1B3;ADORA1;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;FGF10;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;HBEGF;LGALS4;BMP7;BMP4;PKN3;RAB20;WNK4;RND3;DDR1;CTGF;RRAD;AKT1;RAB12;RAB17;CDH1;MYO7A;RAB44;PIK3CA;PIK3CG;HAPLN3;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
12231,GO:0045595,2.6871918731293e-06,0.99999893826208,44,1471,regulation of cell differentiation,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;WNT7A;WNT7B;ZFPM1;ACVR1;EDN1;MAPK12;FZD7;CDH2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5B;WNT5A;AXIN1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;CTGF;AKT1;RAB17;KITLG;NPPC;CLDN5;GAS6;LZTS1;VDR;GDNF;HEY1;CLDN18;EFNB2
3590,GO:0007010,2.72803088030564e-06,0.999998972675135,37,1111,cytoskeleton organization,BP,FHOD3;WNT4;TUBG2;ACTN2;RAB6C;MARK4;ITGB5;GADD45A;CASQ2;EDN1;SPTBN5;SPTBN4;FGF10;PIK3R1;PLEKHH2;HRAS;JAM3;PSTPIP2;AXIN1;RHOQ;RHOJ;NUAK2;PSRC1;SDC4;SPTB;CAMSAP3;DAAM2;ESPN;RND3;MSN;CTGF;PKP1;BCAR1;MYH11;AMOT;LAMA5;PARVB
13415,GO:0048806,2.74591777716146e-06,0.999999822308357,7,44,genitalia development,BP,STRA6;TYRO3;FGF10;WNT5A;FGF8;BMP6;WT1
4736,GO:0010092,2.7682520264386e-06,0.999999873201523,6,29,specification of animal organ identity,BP,WNT2;FGF10;FGF8;BMP4;WNT2B;GDNF
11387,GO:0043406,2.77286702494893e-06,0.99999949305128,14,214,positive regulation of MAP kinase activity,BP,ADRA2B;ADRA2C;WNT7B;EDN1;FGF10;PDGFB;HRAS;WNT5A;AXIN1;BMP2;KITLG;PIK3CG;FZD8;DUSP5
16559,GO:0071560,3.07193815402144e-06,0.999999433448351,14,212,cellular response to transforming growth factor beta stimulus,BP,ITGA3;WNT2;WNT4;RASL11B;ITGB5;WNT7A;ACVR1;DKK3;EDN1;CGN;PDGFB;WNT5A;CLDN1;CLDN5
16900,GO:0072175,3.14444469805958e-06,0.999999563530092,11,128,epithelial tube formation,BP,WNT4;WNT6;SALL4;PRKACB;FGF10;WNT5A;FGF8;SDC4;BMP7;BMP4;GDNF
7924,GO:0031399,3.15695970272707e-06,0.999998723337894,46,1619,regulation of protein modification process,BP,ITGA5;LIF;ADRA2B;ADRA2C;GADD45A;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;CTGF;AKT1;KITLG;INHBB;PIK3CA;PIK3CG;GAS6;ARAF;UNC119;FZD8;DUSP5
7638,GO:0030879,3.22035177371406e-06,0.999999551701265,11,129,mammary gland development,BP,WNT3;WNT2;WNT4;FASN;WNT7B;FGF10;WNT5A;BMP4;DDR1;AKT1;VDR
16558,GO:0071559,3.47634272427427e-06,0.999999351634289,14,214,response to transforming growth factor beta,BP,ITGA3;WNT2;WNT4;RASL11B;ITGB5;WNT7A;ACVR1;DKK3;EDN1;CGN;PDGFB;WNT5A;CLDN1;CLDN5
7628,GO:0030863,3.62976760117137e-06,0.999999617022055,9,79,cortical cytoskeleton,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;SPTB;CDH1;CLDN5;MYZAP
7538,GO:0030666,3.66263321835438e-06,0.999999422090859,12,165,endocytic vesicle membrane,CC,WNT3;WNT4;WNT6;WNT7A;WNT7B;RAB39A;WNT5B;WNT5A;HBEGF;RAB20;RAB11FIP1;RAB38
1483,GO:0003203,3.68476765837256e-06,0.999999822496218,6,29,endocardial cushion morphogenesis,BP,NOTCH1;ACVR1;FGF8;BMP7;BMP2;HEY1
4650,GO:0009798,3.73735063572479e-06,0.99999960155646,9,88,axis specification,BP,WNT3;NOTCH1;WNT6;WNT7A;FGF10;WNT5A;BMP4;WT1;DLL1
12233,GO:0045597,3.84017915294697e-06,0.999998682079917,30,824,positive regulation of cell differentiation,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;NOTCH1;WNT7B;ACVR1;EDN1;MAPK12;CDH2;WNT5B;WNT5A;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;KITLG;NPPC;CLDN5;GAS6;VDR;GDNF;EFNB2
1387,GO:0003014,3.84313859442297e-06,0.999999520442703,10,107,renal system process,BP,ITGA3;ADORA1;EDN1;PRKACB;PDGFB;PRKAR1B;NPR1;BMP4;WNK4;GAS6
7296,GO:0030198,4.02641667992824e-06,0.999999081159499,17,306,extracellular matrix organization,BP,ITGA3;ITGA5;NOTCH1;ITGB5;ITGB4;ITGB8;CRISPLD2;PDGFB;JAM3;WT1;DDR1;CTGF;CDH1;GAS6;MYH11;LAMA1;LAMA5
11171,GO:0043062,4.22452322197839e-06,0.99999903229557,17,307,extracellular structure organization,BP,ITGA3;ITGA5;NOTCH1;ITGB5;ITGB4;ITGB8;CRISPLD2;PDGFB;JAM3;WT1;DDR1;CTGF;CDH1;GAS6;MYH11;LAMA1;LAMA5
14934,GO:0060411,4.34463150424282e-06,0.999999612668995,8,62,cardiac septum morphogenesis,BP,NOTCH1;ZFPM1;ACVR1;WNT5A;FGF8;BMP7;BMP4;HEY1
16343,GO:0071229,4.78228985659249e-06,0.999999151390479,13,190,cellular response to acid chemical,BP,WNT3;WNT2;WNT6;WNT7B;EDN1;FZD7;PDGFB;WNT5B;WNT5A;SESN2;AKT1;CLDN1;SH3BP4
12825,GO:0046834,4.93243051128183e-06,0.999999366272073,10,108,lipid phosphorylation,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
16864,GO:0072124,5.0036419320233e-06,0.999999928401085,4,9,regulation of glomerular mesangial cell proliferation,BP,PDGFB;BMP7;BMP4;WT1
10581,GO:0040008,5.13256945778124e-06,0.99999843989524,24,607,regulation of growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;WNT5A;SESN2;NPR1;PSRC1;FGF8;HBEGF;BMP4;WT1;CDKN1A;DLL1;DDR1;CTGF;AKT1;NPPC;BCAR1;PIK3CA;GAS6;SH3BP4
16091,GO:0070700,5.37479224415628e-06,0.999999921667086,4,9,BMP receptor binding,MF,BMP7;BMP6;BMP4;BMP2
14858,GO:0060317,5.37788308033187e-06,0.999999720286029,6,31,cardiac epithelial to mesenchymal transition,BP,WNT2;NOTCH1;ACVR1;FGF8;BMP2;HEY1
10083,GO:0035850,5.38403893350388e-06,0.999999611652888,7,46,epithelial cell differentiation involved in kidney development,BP,LIF;NOTCH1;PDGFB;BMP4;WT1;GDNF;ACTA2
1530,GO:0003281,5.40495463015007e-06,0.999999503359316,8,62,ventricular septum development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;SALL4;WNT5A;BMP4;HEY1
13445,GO:0048863,5.44957240204789e-06,0.999999105906582,12,162,stem cell differentiation,BP,LIF;WNT3;NOTCH1;WNT7A;ACVR1;EDN1;FOXO4;NRTN;KITLG;SHC4;LAMA5;GDNF
3855,GO:0007596,5.45985662465869e-06,0.99999872102795,17,343,blood coagulation,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;EDN1;PLAU;PRKACB;TYRO3;PIK3R1;PDGFB;PRKAR1B;RHOB;AKT1;PIK3CA;PIK3CG;GAS6
14577,GO:0055024,5.46951380084426e-06,0.999999494198625,8,66,regulation of cardiac muscle tissue development,BP,WNT2;NOTCH1;EDN1;FZD7;FGF8;BMP4;BMP2;EFNB2
7393,GO:0030325,5.70586433700287e-06,0.99999980963773,5,20,adrenal gland development,BP,WNT4;STRA6;DKK3;FSTL3;WT1
21077,GO:2000241,6.03567278872146e-06,0.999999201089993,10,124,regulation of reproductive process,BP,LIF;WNT4;NOTCH1;PRKACB;WNT5A;BMP7;BMP4;WT1;NPPC;INHBB
13295,GO:0048583,6.04696856319469e-06,0.999997098170375,79,3506,regulation of response to stimulus,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;ACTN3;ACTN2;NOTCH1;RASL11B;PMAIP1;GADD45A;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5B;WNT5A;JAM3;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;FGF8;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;DLL1;CHGA;CTGF;AKT1;WNT2B;KITLG;JAG2;EPN1;BCAR1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;GPSM1;AMOT;ARAF;SH3BP4;GDNF;FZD8;DUSP5;HEY1;PIM2;EFNB2;PDE4B
480,GO:0001501,6.07964622325942e-06,0.999998300020612,21,473,skeletal system development,BP,ITGB8;WNT7A;WNT7B;ZFPM1;EDN1;WNT5B;WNT5A;AXIN1;FGF8;BMP7;BMP6;BMP4;BMP2;CTGF;WNT2B;NPPC;NAB2;JAG2;HAPLN3;VDR;CLDN18
10851,GO:0042476,6.10253391383601e-06,0.999999193942258,10,115,odontogenesis,BP,ITGB4;WNT6;EDN1;FGF10;FGF8;BMP7;BMP4;BMP2;JAG2;LAMA5
11233,GO:0043168,6.20226017647823e-06,0.999997147187893,65,2575,anion binding,MF,SYT5;TUBG2;ACTN2;RAB6C;GLDC;MARK4;RAB27A;RASL11B;FASN;CRISPLD2;SERPINA5;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;MFGE8;SPTBN4;RRAS2;RAB39B;RAB39A;MAPK12;FZD7;TYRO3;FGF10;PRKAR1B;RALB;HRAS;SNX18;KHK;SESN2;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;HBEGF;BMP7;BMP4;PKN3;RAB20;WNK4;RND3;DDR1;CTGF;RRAD;AKT1;RAB12;RAB17;PTGES;MYO7A;RAB44;PIK3CA;PIK3CG;GAS6;MYH11;VDR;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
8791,GO:0032874,6.26249926372221e-06,0.99999906150659,11,137,positive regulation of stress-activated MAPK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;FZD8
13682,GO:0050817,6.40424546246299e-06,0.999998480410261,17,347,coagulation,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;EDN1;PLAU;PRKACB;TYRO3;PIK3R1;PDGFB;PRKAR1B;RHOB;AKT1;PIK3CA;PIK3CG;GAS6
14485,GO:0052742,6.5500242846923e-06,0.99999950999556,7,49,phosphatidylinositol kinase activity,MF,FGF10;FGF17;PIK3R2;PIK3R1;FGF8;PIK3CA;PIK3CG
482,GO:0001503,6.60728203387985e-06,0.999998352166559,18,366,ossification,BP,WNT3;WNT4;NOTCH1;FASN;DHH;WNT7B;ACVR1;RRAS2;FSTL3;WNT5A;BMP7;BMP6;BMP4;BMP2;CTGF;AKT1;NPPC;NAB2
3544,GO:0006937,6.61434332328111e-06,0.999999000383095,11,146,regulation of muscle contraction,BP,ADRA2B;ADRA2C;ACTN3;DSC2;ADORA1;CASQ2;EDN1;CHGA;CTGF;PIK3CG;PDE4B
17356,GO:0090066,6.64130081706781e-06,0.999998198493768,20,439,regulation of anatomical structure size,BP,FHOD3;ADRA2B;ADRA2C;WNT3;ACTN2;WNT7A;WNT7B;ADORA1;EDN1;SPTBN5;SPTBN4;PLEKHH2;WNT5A;NPR1;SPTB;CHGA;MSN;AKT1;NPPC;ACTA2
3858,GO:0007599,6.64219919425335e-06,0.999998419363582,17,348,hemostasis,BP,ADRA2B;ADRA2C;RAB27A;SERPINA5;ZFPM1;EDN1;PLAU;PRKACB;TYRO3;PIK3R1;PDGFB;PRKAR1B;RHOB;AKT1;PIK3CA;PIK3CG;GAS6
11137,GO:0043009,6.72349980938099e-06,0.999997981048204,23,552,chordate embryonic development,BP,LIF;WNT2;NOTCH1;WNT7B;ACVR1;SALL4;EDN1;PRKACB;PDGFB;WNT5A;AXIN1;FGF8;SDC4;BMP7;BMP4;BMP2;DLL1;AKT1;JAG2;EPN1;DSC3;AMOT;HEY1
15863,GO:0070304,6.7597542193897e-06,0.999998978315464,11,138,positive regulation of stress-activated protein kinase signaling cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;FZD8
4873,GO:0010595,6.97443098022718e-06,0.999999330787523,8,69,positive regulation of endothelial cell migration,BP,WNT7A;EDN1;PDGFB;WNT5A;RHOB;BMP4;AKT1;BCAR1
7487,GO:0030545,7.16958524356111e-06,0.999999452287449,7,53,receptor regulator activity,MF,WNT3;WNT2;WNT4;ACTN2;WNT7A;WNT5A;GAS6
15011,GO:0060513,7.41743149951806e-06,0.999999876099463,4,10,prostatic bud formation,BP,FGF10;WNT5A;BMP7;BMP4
602,GO:0001707,7.48748027431838e-06,0.999999275172304,8,68,mesoderm formation,BP,ITGA3;WNT3;ITGB4;ACVR1;WNT5A;AXIN1;BMP7;BMP4
17339,GO:0090030,7.51877394230416e-06,0.99999988056452,4,9,regulation of steroid hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
20468,GO:1905332,7.56886282693404e-06,0.99999957988547,6,32,positive regulation of morphogenesis of an epithelium,BP,LIF;WNT2;WNT4;BMP4;WNT2B;GDNF
8410,GO:0032341,7.69655764123101e-06,0.999999877004286,4,9,aldosterone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
8411,GO:0032342,7.69655764123101e-06,0.999999877004286,4,9,aldosterone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
10227,GO:0036092,7.71617663450525e-06,0.999999406766452,7,50,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGF10;FGF17;PIK3R2;PIK3R1;FGF8;PIK3CA;PIK3CG
5222,GO:0014066,8.05885798529432e-06,0.999998756863889,11,143,regulation of phosphatidylinositol 3-kinase signaling,BP,PRR5L;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;AKT1;KITLG;PIK3CA
3727,GO:0007229,8.11610092353238e-06,0.999999045451205,9,89,integrin-mediated signaling pathway,BP,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8;LIMS2;CTGF;BCAR1;LAMA5
3668,GO:0007160,8.15538810460495e-06,0.999998476996093,13,193,cell-matrix adhesion,BP,ITGA3;WNT4;ACTN3;ACTN2;ITGB5;ITGB4;PLAU;PIK3R1;JAM3;SDC4;DDR1;CTGF;LAMA5
5809,GO:0016202,8.18497278937667e-06,0.999998881383418,10,115,regulation of striated muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;FZD7;FGF8;BMP4;BMP2;DLL1;EFNB2
15772,GO:0070167,8.23606836063808e-06,0.999999188173398,8,73,regulation of biomineral tissue development,BP,WNT4;WNT6;ACVR1;BMP7;BMP6;BMP4;BMP2;GAS6
4054,GO:0008285,8.47812801107113e-06,0.999997340440209,24,623,negative regulation of cell proliferation,BP,LIF;NOTCH1;ADORA1;LIMS2;FGF10;FOXO4;HRAS;WNT5A;NPR1;SDC4;BMP7;BMP4;BMP2;WT1;CDKN1A;DLL1;DDR1;GJB6;PTGES;NPPC;VDR;SH3BP4;PIM2;EFNB2
15676,GO:0065007,8.52514761308304e-06,0.999997034364106,183,10987,biological regulation,BP,ITGA3;ITGA5;ARTN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;CDH23;STRA6;RASL11B;TF;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39A;PRND;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;SNX18;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;ESPN;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;CTGF;GJB6;RRAD;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;BCAR1;INHBB;SPSB1;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN16;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
20389,GO:1905114,8.73261514183151e-06,0.999997332709847,23,565,cell surface receptor signaling pathway involved in cell-cell signaling,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ADORA1;DKK3;FZD7;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP4;BMP2;AKT1;WNT2B;TLE1;FZD8
16860,GO:0072110,8.7483827224363e-06,0.999999847542017,4,10,glomerular mesangial cell proliferation,BP,PDGFB;BMP7;BMP4;WT1
12596,GO:0046330,8.76988175362286e-06,0.999998791284597,10,116,positive regulation of JNK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;CTGF;FZD8
16861,GO:0072111,8.80511854132139e-06,0.999999678377006,5,20,cell proliferation involved in kidney development,BP,PDGFB;BMP7;BMP4;BMP2;WT1
4896,GO:0010632,8.88332189378349e-06,0.999998465357398,12,173,regulation of epithelial cell migration,BP,ITGA3;NOTCH1;WNT7A;EDN1;FGF10;PDGFB;WNT5A;RHOB;HBEGF;BMP4;AKT1;BCAR1
15311,GO:0061024,9.04960511279796e-06,0.999996580760375,33,1001,membrane organization,BP,ITGA3;SYT5;WNT4;RIN3;ACTN2;TSPAN15;RAB27A;TF;PMAIP1;SERPINA5;RABIF;RAB40B;RAB40A;MFGE8;SPTBN4;RAB39A;CDH2;PIK3R1;REEP1;WNT5A;SNX18;RHOQ;RAB20;VAMP1;AKT1;PKP3;RAB12;CDH1;EPN1;GAS6;LAMA5;RAB38;GDNF
820,GO:0002011,9.13146574768449e-06,0.999999280610913,7,49,morphogenesis of an epithelial sheet,BP,ITGA5;NOTCH1;WNT7A;WNT5A;HBEGF;BMP7;DDR1
14721,GO:0060113,9.20979148758426e-06,0.999999269633135,7,52,inner ear receptor cell differentiation,BP,NOTCH1;CDH23;SDC4;BMP4;DLL1;JAG2;MYO7A
5805,GO:0016192,9.31918092452988e-06,0.999995910052355,48,1770,vesicle-mediated transport,BP,SYT5;RIN3;ACTN2;RAB6C;NOTCH1;RAB27A;TF;CRISPLD2;WNT7A;RABIF;ADORA1;PLAU;RAB40B;RAB40A;MFGE8;SPTBN5;SPTBN4;RAB39B;RAB39A;SYCN;TYRO3;PIK3R2;PIK3R1;PDGFB;RALB;HRAS;WNT5A;SNX18;SDC4;SPTB;DLL1;RAB20;VAMP1;CHGA;MSN;PKP1;RAB17;EPN1;MYO7A;RAB44;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SH3BP4;UNC119;RAB38;RAB3D
13203,GO:0048332,9.53693792438683e-06,0.999999043188719,8,70,mesoderm morphogenesis,BP,ITGA3;WNT3;ITGB4;ACVR1;WNT5A;AXIN1;BMP7;BMP4
16865,GO:0072125,9.59970995434808e-06,0.999999967703002,3,4,negative regulation of glomerular mesangial cell proliferation,BP,BMP7;BMP4;WT1
17448,GO:0090194,9.59970995434808e-06,0.999999967703002,3,4,negative regulation of glomerulus development,BP,BMP7;BMP4;WT1
10629,GO:0042056,9.65287692845842e-06,0.99999962373382,5,26,chemoattractant activity,MF,FGF10;PDGFB;WNT5A;FGF8;BMP4
18944,GO:1901861,9.7119535647838e-06,0.99999864487974,10,117,regulation of muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;FZD7;FGF8;BMP4;BMP2;DLL1;EFNB2
328,GO:0000902,9.81187403010371e-06,0.999996394670552,31,883,cell morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;ZFPM1;SPTBN5;SPTBN4;FZD7;TYRO3;PIK3R1;HRAS;WNT5A;RHOQ;RHOJ;FGF8;SPTB;BMP7;B3GNT2;MSN;DDR1;NRTN;SEMA6C;MYO7A;CLDN3;PIK3CA;LZTS1;VDR;LAMA5;GDNF;PARVB
567,GO:0001654,1.02164418743623e-05,0.99999748765031,17,333,eye development,BP,WNT2;STRA6;WNT6;WNT7A;WNT7B;FGF10;WNT5B;WNT5A;AXIN1;RHOJ;BMP7;BMP6;BMP4;WT1;DLL1;WNT2B;MYO7A
14946,GO:0060425,1.02502239429476e-05,0.999999173428036,7,52,lung morphogenesis,BP,LIF;WNT2;WNT7B;FGF10;FGF8;BMP4;WNT2B
14669,GO:0060039,1.03527190803519e-05,0.999999608804584,5,20,pericardium development,BP,NOTCH1;WNT5A;BMP7;BMP2;WT1
13319,GO:0048634,1.04076225664408e-05,0.999998534905513,10,119,regulation of muscle organ development,BP,WNT2;ACTN3;NOTCH1;EDN1;FZD7;FGF8;BMP4;BMP2;DLL1;EFNB2
2512,GO:0005198,1.04252914966444e-05,0.999996771249154,23,677,structural molecule activity,MF,TUBG2;ACTN3;ACTN2;SPTBN4;MPZL1;AXIN1;SPTB;MSN;PKP1;CLDN1;CLDN2;CLDN3;CLDN5;HAPLN3;MYH11;CLDN23;LAMA1;LAMA5;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
17379,GO:0090092,1.05290476352477e-05,0.999997981203407,13,206,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ITGA3;NOTCH1;RASL11B;ACVR1;DKK3;FSTL3;FGF10;WNT5A;BMP7;BMP6;BMP4;BMP2;INHBB
7624,GO:0030858,1.06937873742287e-05,0.999999129192204,7,54,positive regulation of epithelial cell differentiation,BP,LIF;NOTCH1;BMP6;BMP4;CLDN5;VDR;GDNF
13899,GO:0051146,1.13690560314433e-05,0.999997633675402,14,238,striated muscle cell differentiation,BP,FHOD3;ACTN2;NOTCH1;ACVR1;CASQ2;EDN1;FZD7;CDH2;BMP4;BMP2;WT1;AKT1;MYH11;EFNB2
5747,GO:0016055,1.1874117541007e-05,0.999996641630113,20,461,Wnt signaling pathway,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;DKK3;FZD7;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP2;WNT2B;TLE1;FZD8
7459,GO:0030501,1.18976589092051e-05,0.999999275994371,6,35,positive regulation of bone mineralization,BP,WNT4;ACVR1;BMP7;BMP6;BMP4;BMP2
7533,GO:0030659,1.19261848044943e-05,0.999995984467013,26,711,cytoplasmic vesicle membrane,CC,TMEM163;SYT5;WNT3;WNT4;RAB27A;TF;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;RAB39A;SYCN;WNT5B;WNT5A;SNX18;HBEGF;RAB20;VAMP1;CHGA;PKP1;RAB44;RAB11FIP1;RAB38;RAB3D;RNF144A
7465,GO:0030509,1.20830562230414e-05,0.999998050804647,11,146,BMP signaling pathway,BP,ITGA3;NOTCH1;ACVR1;FSTL3;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;ZCCHC12
18904,GO:1901699,1.21363635511681e-05,0.999996212910412,23,574,cellular response to nitrogen compound,BP,ACTN2;GUCY1B3;CASQ2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RALB;SESN2;RHOQ;BMP4;WT1;GJB2;AKT1;CDH1;BCAR1;INHBB;PIK3CA;PIK3CG;SH3BP4;PDE4B
7212,GO:0030055,1.21778613292273e-05,0.999996815172096,18,391,cell-substrate junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;ITGB5;ITGB4;PLAU;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;RND3;MSN;BCAR1;PARVB;EFNB2
18426,GO:0198738,1.22091847234919e-05,0.999996539920273,20,462,cell-cell signaling by wnt,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;DKK3;FZD7;CDH2;FGF10;WNT5B;WNT5A;AXIN1;FGF8;BMP2;WNT2B;TLE1;FZD8
13374,GO:0048711,1.23170242369393e-05,0.999999755944847,4,11,positive regulation of astrocyte differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
15333,GO:0061047,1.25366518443485e-05,0.999999953838262,3,4,positive regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4;WNT2B
13578,GO:0050678,1.25640892178691e-05,0.999997180474795,15,282,regulation of epithelial cell proliferation,BP,WNT2;NOTCH1;WNT7A;FZD7;LIMS2;FGF10;PDGFB;HRAS;WNT5A;BMP6;BMP4;BMP2;AKT1;VDR;EFNB2
17412,GO:0090150,1.27254428931112e-05,0.999996964041915,16,359,establishment of protein localization to membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;PMAIP1;ADORA1;SPTBN4;CDH2;PIK3R1;REEP1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
4699,GO:0009968,1.32870051073011e-05,0.999994799880234,34,1080,negative regulation of signal transduction,BP,ITGA3;LIF;WNT4;ACTN3;NOTCH1;RASL11B;ACVR1;CASQ2;DKK3;PRKACB;TYRO3;CDH2;PRR5L;FSTL3;FGF10;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;AKT1;EPN1;TLE1;GAS6;ARAF;SH3BP4;GDNF;DUSP5;HEY1
15120,GO:0060688,1.3331443359796e-05,0.999998876289769,7,54,regulation of morphogenesis of a branching structure,BP,WNT2;FGF10;WNT5A;BMP7;BMP4;WNT2B;GDNF
597,GO:0001701,1.35669520670718e-05,0.999996756608804,16,307,in utero embryonic development,BP,LIF;WNT2;NOTCH1;WNT7B;ACVR1;SALL4;EDN1;PDGFB;BMP7;BMP2;AKT1;JAG2;EPN1;DSC3;AMOT;HEY1
1524,GO:0003272,1.39772377152561e-05,0.999999427000457,5,22,endocardial cushion formation,BP,NOTCH1;ACVR1;FGF8;BMP7;HEY1
3680,GO:0007173,1.40407618986832e-05,0.999997951329974,10,121,epidermal growth factor receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;PIK3R1;HRAS;HBEGF;AKT1;EPN1;BCAR1;PIK3CA
11813,GO:0044448,1.41873280747426e-05,0.999997928933734,10,119,cell cortex part,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;RALB;SPTB;CDH1;CLDN5;MYZAP
15118,GO:0060686,1.45781062471532e-05,0.999999943509111,3,4,negative regulation of prostatic bud formation,BP,WNT5A;BMP7;BMP4
1470,GO:0003181,1.47189552684595e-05,0.999999395290422,5,21,atrioventricular valve morphogenesis,BP,NOTCH1;ZFPM1;ACVR1;BMP2;HEY1
10858,GO:0042490,1.49417818370125e-05,0.999998714101766,7,56,mechanoreceptor differentiation,BP,NOTCH1;CDH23;SDC4;BMP4;DLL1;JAG2;MYO7A
7264,GO:0030155,1.49515621665263e-05,0.99999513882223,24,634,regulation of cell adhesion,BP,ITGA3;ITGA5;WNT4;NOTCH1;PLAU;FZD7;FSTL3;PIK3R1;WNT5A;SDC4;BMP7;BMP4;BMP2;DLL1;DDR1;AKT1;CYTIP;JAG2;CDH1;PIK3CA;PIK3CG;LAMA1;LAMA5;EFNB2
18534,GO:1900180,1.5013685539782e-05,0.99999701816473,13,214,regulation of protein localization to nucleus,BP,LIF;FZD7;PIK3R2;PIK3R1;SESN2;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6;CLDN18
11865,GO:0044703,1.53644917834814e-05,0.999994409223798,29,909,multi-organism reproductive process,BP,ITGA3;LIF;ADRA2C;WNT3;WNT4;NOTCH1;IGSF8;DHH;SERPINA5;ACVR1;EDN1;MFGE8;SPTBN4;TYRO3;FSTL3;JAM3;BMP4;WT1;SLC2A14;DDR1;GJB2;AKT1;NPPC;JAG2;EPN1;INHBB;VDR;ACSL4;CLDN11
1385,GO:0003012,1.55103280737359e-05,0.999995866565617,18,397,muscle system process,BP,ADRA2B;ADRA2C;ACTN3;ACTN2;ITGB5;DSC2;ADORA1;CASQ2;EDN1;KCNH2;CHGA;CTGF;PIK3CA;PIK3CG;MYH11;GDNF;ACTA2;PDE4B
10580,GO:0040007,1.56482381011818e-05,0.999994199572184,30,907,growth,BP,WNT3;WNT2;ACTN3;NOTCH1;STRA6;WNT7A;WNT7B;SALL4;EDN1;SPTBN4;FZD7;FGF10;WNT5A;SESN2;NPR1;PSRC1;FGF8;HBEGF;BMP4;WT1;CDKN1A;DLL1;DDR1;CTGF;AKT1;NPPC;BCAR1;PIK3CA;GAS6;SH3BP4
3589,GO:0007009,1.57010666976673e-05,0.99999640977028,15,275,plasma membrane organization,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5
13338,GO:0048666,1.57260281226634e-05,0.999993975786742,32,954,neuron development,BP,ITGA3;ARTN;LIF;WNT3;NOTCH1;CDH23;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;JAM3;FGF8;SDC4;SPTB;BMP7;CAMSAP3;B3GNT2;DDR1;AKT1;RAB17;NRTN;SEMA6C;CDH1;MYO7A;PIK3CA;LZTS1;TSPAN2;GDNF;ACSL4
15709,GO:0070062,1.60395022389267e-05,0.999992301911326,60,2675,extracellular exosome,CC,ITGA3;WNT3;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;CDH2;FRMPD1;RALB;WNT5B;WNT5A;SNX18;KHK;RHOQ;RHOJ;RHOB;SDC4;CLCF1;B3GNT2;DAAM2;RND3;MSN;DDR1;DSG3;PKP1;RAB17;CDH1;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;MYH11;PM20D2;LAMA5;SH3BP4;RAB3D;ACSL4;ACTA2;CLDN11
14935,GO:0060412,1.6412432307548e-05,0.999998938568726,6,36,ventricular septum morphogenesis,BP,NOTCH1;ZFPM1;ACVR1;WNT5A;BMP4;HEY1
15363,GO:0061098,1.65988583622862e-05,0.999998920996665,6,37,positive regulation of protein tyrosine kinase activity,BP,ADRA2B;ADRA2C;ADORA1;PDGFB;GAS6;UNC119
12434,GO:0045935,1.72108471873251e-05,0.999992353610318,45,1645,positive regulation of nucleobase-containing compound metabolic process,BP,LIF;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;CHGA;AKT1;KITLG;NPPC;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
15550,GO:0061564,1.72863523833202e-05,0.999994980468032,20,450,axon development,BP,ARTN;WNT3;NOTCH1;WNT7A;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;JAM3;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;TSPAN2;GDNF
19802,GO:1903827,1.73702311993244e-05,0.999994607848611,22,553,regulation of cellular protein localization,BP,ITGA3;LIF;ACTN2;PMAIP1;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;RALB;WNT5A;SESN2;RHOQ;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;CDH1;GAS6;CLDN18
5170,GO:0012506,1.78906332982455e-05,0.999993825617735,26,727,vesicle membrane,CC,TMEM163;SYT5;WNT3;WNT4;RAB27A;TF;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;RAB39A;SYCN;WNT5B;WNT5A;SNX18;HBEGF;RAB20;VAMP1;CHGA;PKP1;RAB44;RAB11FIP1;RAB38;RAB3D;RNF144A
16935,GO:0072215,1.84409533045184e-05,0.999999192341882,5,23,regulation of metanephros development,BP,LIF;PDGFB;BMP4;WT1;GDNF
13901,GO:0051148,1.853208252305e-05,0.999998343690532,7,59,negative regulation of muscle cell differentiation,BP,NOTCH1;FZD7;PDGFB;FOXO4;BMP4;BMP2;DLL1
8858,GO:0032970,1.90259895603446e-05,0.99999531803289,16,318,regulation of actin filament-based process,BP,FHOD3;WNT4;ACTN2;DSC2;EDN1;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;SDC4;SPTB;CTGF;PDE4B
19669,GO:1903561,1.9582979796965e-05,0.999990535599868,60,2690,extracellular vesicle,CC,ITGA3;WNT3;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;CDH2;FRMPD1;RALB;WNT5B;WNT5A;SNX18;KHK;RHOQ;RHOJ;RHOB;SDC4;CLCF1;B3GNT2;DAAM2;RND3;MSN;DDR1;DSG3;PKP1;RAB17;CDH1;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;MYH11;PM20D2;LAMA5;SH3BP4;RAB3D;ACSL4;ACTA2;CLDN11
3840,GO:0007548,1.97137345296045e-05,0.999995676114819,14,257,sex differentiation,BP,WNT4;STRA6;DHH;WNT7A;TYRO3;FSTL3;FGF10;WNT5A;FGF8;BMP6;WT1;WNT2B;KITLG;INHBB
11277,GO:0043230,1.98139412599283e-05,0.999990420047113,60,2691,extracellular organelle,CC,ITGA3;WNT3;WNT4;ACTN3;ACTN2;TSPAN15;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;PRKACB;MFGE8;SPTBN5;SPTBN4;RRAS2;CDH2;FRMPD1;RALB;WNT5B;WNT5A;SNX18;KHK;RHOQ;RHOJ;RHOB;SDC4;CLCF1;B3GNT2;DAAM2;RND3;MSN;DDR1;DSG3;PKP1;RAB17;CDH1;HPCAL1;CLDN2;CLDN3;CLDN5;KCNG2;GAS6;MYH11;PM20D2;LAMA5;SH3BP4;RAB3D;ACSL4;ACTA2;CLDN11
8314,GO:0032148,1.98916220766689e-05,0.999999097593509,5,26,activation of protein kinase B activity,BP,ADRA2B;ADRA2C;PDGFB;WNT5A;GAS6
1484,GO:0003205,2.03003667048677e-05,0.999996527713667,11,153,cardiac chamber development,BP,WNT2;NOTCH1;STRA6;ZFPM1;ACVR1;SALL4;WNT5A;FGF8;BMP7;BMP4;HEY1
12857,GO:0046888,2.04685055160395e-05,0.999998133177925,7,63,negative regulation of hormone secretion,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;INHBB;RAB11FIP1
10852,GO:0042481,2.08871592755045e-05,0.999999048182959,5,25,regulation of odontogenesis,BP,WNT6;EDN1;FGF8;BMP4;BMP2
4858,GO:0010566,2.20721419887678e-05,0.999999475393256,4,12,regulation of ketone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
16673,GO:0071772,2.22062919475895e-05,0.999996161309074,11,156,response to BMP,BP,ITGA3;NOTCH1;ACVR1;FSTL3;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;ZCCHC12
16674,GO:0071773,2.22062919475895e-05,0.999996161309074,11,156,cellular response to BMP stimulus,BP,ITGA3;NOTCH1;ACVR1;FSTL3;WNT5A;FGF8;BMP7;BMP6;BMP4;BMP2;ZCCHC12
4053,GO:0008284,2.23451035998852e-05,0.999992009747418,27,816,positive regulation of cell proliferation,BP,LIF;WNT2;NOTCH1;WNT7A;EDN1;FZD7;FGF10;FGF17;PDGFB;HRAS;WNT5A;FGF8;CLCF1;HBEGF;BMP6;BMP4;BMP2;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;GAS6;SHC4;GDNF;EFNB2
3401,GO:0006705,2.31467104557441e-05,0.999999443052923,4,12,mineralocorticoid biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
4010,GO:0008212,2.31467104557441e-05,0.999999443052923,4,12,mineralocorticoid metabolic process,BP,WNT4;DKK3;BMP6;BMP2
3519,GO:0006897,2.37859582485542e-05,0.999992238773653,23,603,endocytosis,BP,SYT5;RIN3;RAB27A;TF;ADORA1;MFGE8;RAB39A;TYRO3;PIK3R2;PIK3R1;HRAS;WNT5A;SNX18;DLL1;RAB20;RAB17;EPN1;MYO7A;PIK3CA;PIK3CG;GAS6;SH3BP4;UNC119
1467,GO:0003177,2.46211605880035e-05,0.999999398040415,4,12,pulmonary valve development,BP,NOTCH1;STRA6;BMP4;HEY1
1472,GO:0003184,2.46211605880035e-05,0.999999398040415,4,12,pulmonary valve morphogenesis,BP,NOTCH1;STRA6;BMP4;HEY1
13900,GO:0051147,2.46647523730104e-05,0.999995680106377,11,163,regulation of muscle cell differentiation,BP,NOTCH1;EDN1;MAPK12;FZD7;CDH2;PDGFB;FOXO4;BMP4;BMP2;DLL1;EFNB2
4221,GO:0008544,2.49358393784085e-05,0.999993381218692,17,440,epidermis development,BP,POU3F1;NOTCH1;DSC2;FGF10;WNT5A;BMP4;DLL1;DSG3;CTGF;PKP3;PKP1;NAB2;JAG2;MYO7A;DSC3;VDR;LAMA5
12291,GO:0045667,2.50194799367381e-05,0.999996569915938,9,107,regulation of osteoblast differentiation,BP,WNT4;NOTCH1;WNT7B;ACVR1;BMP7;BMP6;BMP4;BMP2;NPPC
16932,GO:0072210,2.57974823796513e-05,0.999998169664736,6,40,metanephric nephron development,BP,LIF;WNT4;PDGFB;BMP4;WT1;GDNF
2438,GO:0005088,2.58789946215989e-05,0.999994183958713,14,249,Ras guanyl-nucleotide exchange factor activity,MF,ARTN;RIN3;ACTN2;SPTBN5;SPTBN4;FGF10;FGF17;PDGFB;FGF8;SPTB;HBEGF;NRTN;KITLG;GDNF
5531,GO:0015629,2.70031963591701e-05,0.999992184757658,19,433,actin cytoskeleton,CC,FHOD3;ACTN3;ACTN2;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;RHOQ;SPTB;ESPN;CDH1;MYO7A;BCAR1;CLDN5;MYH11;AMOT;MYZAP;ACTA2
17145,GO:0072657,2.76904590662477e-05,0.999991953949924,19,493,protein localization to membrane,BP,ITGA3;WNT4;ACTN2;TSPAN15;PMAIP1;ADORA1;RAB40B;RAB40A;SPTBN4;CDH2;PIK3R1;REEP1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5;RAB38
1462,GO:0003171,2.77779733272931e-05,0.999998664158162,5,24,atrioventricular valve development,BP,NOTCH1;ZFPM1;ACVR1;BMP2;HEY1
7234,GO:0030111,2.8054415251114e-05,0.999993234975227,15,303,regulation of Wnt signaling pathway,BP,ITGA3;WNT3;WNT2;WNT4;NOTCH1;WNT7A;DKK3;CDH2;FGF10;WNT5B;WNT5A;AXIN1;BMP2;WNT2B;TLE1
12594,GO:0046328,2.81117687493696e-05,0.999995007658492,11,160,regulation of JNK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;CTGF;AKT1;FZD8
16882,GO:0072144,2.84692008789554e-05,0.999999796456152,3,5,glomerular mesangial cell development,BP,NOTCH1;PDGFB;ACTA2
3548,GO:0006942,2.8612972666832e-05,0.999996611532197,8,84,regulation of striated muscle contraction,BP,ACTN3;DSC2;ADORA1;CASQ2;CHGA;CTGF;PIK3CG;PDE4B
15077,GO:0060601,2.87119765405586e-05,0.999999250871739,4,13,lateral sprouting from an epithelium,BP,FGF10;WNT5A;BMP7;BMP4
18903,GO:1901698,2.95709818751366e-05,0.99998883234508,29,900,response to nitrogen compound,BP,ACTN2;NOTCH1;PMAIP1;GUCY1B3;CASQ2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RALB;KHK;SESN2;RHOQ;BMP7;BMP4;WT1;CDKN1A;CTGF;GJB2;AKT1;CDH1;BCAR1;INHBB;PIK3CA;PIK3CG;SH3BP4;PDE4B
18910,GO:1901722,2.9590828452666e-05,0.999999221892435,4,13,regulation of cell proliferation involved in kidney development,BP,PDGFB;BMP7;BMP4;WT1
16087,GO:0070696,3.0027441879227e-05,0.999999207411438,4,13,transmembrane receptor protein serine/threonine kinase binding,MF,BMP7;BMP6;BMP4;BMP2
7195,GO:0030030,3.0141172717186e-05,0.999987082931785,38,1276,cell projection organization,BP,ITGA3;ARTN;WNT3;ACTN2;NOTCH1;MARK4;CDH23;WNT7A;WNT7B;SPTBN5;SPTBN4;TTYH1;PIK3R1;HRAS;WNT5A;JAM3;RHOQ;FGF8;SDC4;SPTB;BMP7;CAMSAP3;B3GNT2;ESPN;DDR1;AKT1;RAB17;NRTN;SEMA6C;CDH1;MYO7A;PIK3CA;LZTS1;LAMA5;TSPAN2;GDNF;ACSL4;PARVB
13446,GO:0048864,3.08394271997638e-05,0.999997002123762,7,62,stem cell development,BP,WNT7A;ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
880,GO:0002088,3.13701296122229e-05,0.99999693895117,7,63,lens development in camera-type eye,BP,WNT2;WNT7A;WNT7B;WNT5B;WNT5A;BMP4;WNT2B
5190,GO:0014031,3.25148860818868e-05,0.9999968125838,7,62,mesenchymal cell development,BP,NOTCH1;ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
16924,GO:0072202,3.26602814967171e-05,0.999998354712656,5,26,cell differentiation involved in metanephros development,BP,LIF;WNT4;PDGFB;BMP4;GDNF
16967,GO:0072273,3.31934223489358e-05,0.999998322108626,5,26,metanephric nephron morphogenesis,BP,LIF;WNT4;BMP4;WT1;GDNF
6103,GO:0016773,3.37142442060501e-05,0.999987655756807,27,752,phosphotransferase activity, alcohol group as acceptor,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;NPR1;NUAK2;PFKFB3;FGF8;HBEGF;CDKN1A;PKN3;WNK4;DDR1;AKT1;KITLG;PIK3CA;PIK3CG;ARAF;PIM2
7804,GO:0031175,3.38246937731198e-05,0.999987366630089,28,811,neuron projection development,BP,ITGA3;ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;JAM3;FGF8;SPTB;BMP7;CAMSAP3;B3GNT2;DDR1;AKT1;RAB17;NRTN;SEMA6C;CDH1;PIK3CA;LZTS1;TSPAN2;GDNF;ACSL4
13297,GO:0048585,3.41770826334637e-05,0.999985257310688,38,1339,negative regulation of response to stimulus,BP,ITGA3;LIF;WNT3;WNT4;ACTN3;NOTCH1;RASL11B;ACVR1;ADORA1;CASQ2;DKK3;EDN1;PLAU;PRKACB;TYRO3;CDH2;PRR5L;FSTL3;FGF10;PDGFB;WNT5B;WNT5A;GPRASP1;SESN2;AXIN1;HBEGF;BMP7;BMP4;BMP2;AKT1;EPN1;TLE1;GAS6;ARAF;SH3BP4;GDNF;DUSP5;HEY1
2881,GO:0005925,3.48889777413734e-05,0.999990505373986,17,384,focal adhesion,CC,ITGA3;ITGA5;ACTN3;ACTN2;ITGB5;PLAU;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;RND3;MSN;BCAR1;PARVB;EFNB2
5226,GO:0014070,3.55082323863133e-05,0.999986446961635,29,908,response to organic cyclic compound,BP,NOTCH1;PMAIP1;DHH;WNT7A;WNT7B;CASQ2;EDN1;PRKACB;FGF10;PDGFB;RALB;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;MSN;CTGF;GJB2;AKT1;PTGES;CDH1;CLDN1;PIK3CG;VDR;HEY1;PDE4B
16463,GO:0071417,3.66661365727292e-05,0.999988741040082,20,491,cellular response to organonitrogen compound,BP,ACTN2;CASQ2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;SESN2;RHOQ;WT1;GJB2;AKT1;CDH1;BCAR1;INHBB;PIK3CA;PIK3CG;SH3BP4;PDE4B
329,GO:0000904,3.72863573967655e-05,0.999987144663114,24,634,cell morphogenesis involved in differentiation,BP,ARTN;WNT3;NOTCH1;WNT7A;ZFPM1;SPTBN5;SPTBN4;FZD7;TYRO3;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;MYO7A;CLDN3;PIK3CA;LZTS1;LAMA5;GDNF
14107,GO:0051493,3.75726306830236e-05,0.999989267802053,18,413,regulation of cytoskeleton organization,BP,FHOD3;WNT4;ACTN2;RAB6C;EDN1;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;PSRC1;SDC4;SPTB;CAMSAP3;ESPN;CTGF
9694,GO:0035116,3.7661751597348e-05,0.999998024601733,5,28,embryonic hindlimb morphogenesis,BP,WNT3;NOTCH1;WNT7A;FGF8;BMP4
19225,GO:1902580,3.7735583433208e-05,0.999985548405313,29,894,single-organism cellular localization,BP,ITGA3;SYT5;WNT4;ACTN2;TSPAN15;RAB27A;PMAIP1;WNT7A;RAB40B;RAB40A;SPTBN4;FZD7;CDH2;PIK3R2;PIK3R1;RHOQ;BMP7;BMP6;BMP4;CDKN1A;CHGA;AKT1;PKP3;RAB17;CDH1;MYO7A;PIK3CG;GAS6;LAMA5
2880,GO:0005924,3.77682505294518e-05,0.999989653617366,17,387,cell-substrate adherens junction,CC,ITGA3;ITGA5;ACTN3;ACTN2;ITGB5;PLAU;MPZL1;RRAS2;LIMS2;CDH2;RHOB;SDC4;RND3;MSN;BCAR1;PARVB;EFNB2
12465,GO:0045992,3.78771865088388e-05,0.999998030993937,5,26,negative regulation of embryonic development,BP,PRKACB;FZD7;WNT5A;BMP7;BMP4
15162,GO:0060740,4.03037168434313e-05,0.999997877045458,5,26,prostate gland epithelium morphogenesis,BP,NOTCH1;FGF10;WNT5A;BMP7;BMP4
8789,GO:0032872,4.09944558157068e-05,0.999991674290554,12,198,regulation of stress-activated MAPK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
729,GO:0001890,4.14901735027914e-05,0.999993068541342,10,143,placenta development,BP,LIF;WNT2;ITGB8;WNT7B;PDGFB;BMP7;GJB2;AKT1;VDR;HEY1
12383,GO:0045844,4.16018685294827e-05,0.999995753981415,7,63,positive regulation of striated muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;BMP4;DLL1;EFNB2
13321,GO:0048636,4.16018685294827e-05,0.999995753981415,7,63,positive regulation of muscle organ development,BP,WNT2;ACTN3;NOTCH1;EDN1;BMP4;DLL1;EFNB2
12865,GO:0046903,4.16917603351473e-05,0.999981457816796,40,1489,secretion,BP,LIF;ADRA2B;ADRA2C;SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;WNT7A;ADORA1;EDN1;PLAU;RAB40B;RAB40A;SYCN;TYRO3;FGF10;PDGFB;RALB;WNT5A;NPR1;SDC4;BMP6;VAMP1;WNK4;CHGA;DDR1;CTGF;TPD52;PKP1;INHBB;RAB44;PIK3CG;RAB11FIP1;KCNG2;GAS6;VDR;RAB3D;GDNF
17446,GO:0090192,4.24924563441219e-05,0.99999874707245,4,14,regulation of glomerulus development,BP,PDGFB;BMP7;BMP4;WT1
14684,GO:0060054,4.31052712926103e-05,0.999999533757227,3,7,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A;FZD7;FGF10
15861,GO:0070302,4.32554691044739e-05,0.999991164278058,12,199,regulation of stress-activated protein kinase signaling cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
18010,GO:0097651,4.34214919441869e-05,0.999999641696165,3,5,phosphatidylinositol 3-kinase complex, class I,CC,PIK3R1;PIK3CA;PIK3CG
763,GO:0001938,4.44372886801356e-05,0.999995394213453,7,68,positive regulation of endothelial cell proliferation,BP,WNT2;PDGFB;WNT5A;BMP6;BMP4;BMP2;AKT1
16936,GO:0072216,4.55554515786402e-05,0.999998632253645,4,14,positive regulation of metanephros development,BP,LIF;PDGFB;WT1;GDNF
4872,GO:0010594,4.57548438608898e-05,0.999993194207376,9,115,regulation of endothelial cell migration,BP,NOTCH1;WNT7A;EDN1;PDGFB;WNT5A;RHOB;BMP4;AKT1;BCAR1
12734,GO:0046622,4.5879127887811e-05,0.99999635464995,6,44,positive regulation of organ growth,BP,WNT2;NOTCH1;EDN1;FGF8;WT1;AKT1
16382,GO:0071300,4.60513482100663e-05,0.99999520851917,7,66,cellular response to retinoic acid,BP,WNT3;WNT2;WNT6;WNT7B;FZD7;WNT5B;WNT5A
14963,GO:0060443,4.63068369961029e-05,0.999996307197418,6,45,mammary gland morphogenesis,BP,WNT4;FGF10;WNT5A;BMP4;DDR1;VDR
18946,GO:1901863,4.66205139651557e-05,0.999995149359742,7,64,positive regulation of muscle tissue development,BP,WNT2;ACTN3;NOTCH1;EDN1;BMP4;DLL1;EFNB2
12400,GO:0045893,4.68358354788385e-05,0.999979481312319,38,1335,positive regulation of transcription, DNA-templated,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;AKT1;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
19633,GO:1903508,4.68358354788385e-05,0.999979481312319,38,1335,positive regulation of nucleic acid-templated transcription,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;AKT1;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
11404,GO:0043434,4.94038863883785e-05,0.999986158712744,17,396,response to peptide hormone,BP,ACTN2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;BMP7;CTGF;GJB2;AKT1;BCAR1;INHBB;PIK3CA
2885,GO:0005938,4.98785181400567e-05,0.999988836060245,13,229,cell cortex,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;RALB;SPTB;CTGF;CYTIP;CDH1;MYO7A;CLDN5;MYZAP
9134,GO:0033612,5.05508458854369e-05,0.999998413507299,4,15,receptor serine/threonine kinase binding,MF,BMP7;BMP6;BMP4;BMP2
13625,GO:0050730,5.05762035246051e-05,0.999989474213186,12,216,regulation of peptidyl-tyrosine phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;FGF10;PDGFB;CLCF1;HBEGF;KITLG;GAS6;UNC119
15010,GO:0060512,5.17720827697532e-05,0.999997094462899,5,28,prostate gland morphogenesis,BP,NOTCH1;FGF10;WNT5A;BMP7;BMP4
16883,GO:0072148,5.21008084042659e-05,0.999998351973267,4,15,epithelial cell fate commitment,BP,NOTCH1;ACVR1;DLL1;JAG2
4625,GO:0009725,5.24156019902933e-05,0.999980262801715,27,837,response to hormone,BP,ITGA3;ACTN2;NOTCH1;WNT7B;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;BMP7;BMP6;BMP4;WT1;CDKN1A;CTGF;GJB2;AKT1;BCAR1;INHBB;CLDN1;PIK3CA;VDR;HEY1
16881,GO:0072143,5.33844299175377e-05,0.999999438242591,3,6,mesangial cell development,BP,NOTCH1;PDGFB;ACTA2
12372,GO:0045833,5.49395472940566e-05,0.999994093972782,7,71,negative regulation of lipid metabolic process,BP,WNT4;ADORA1;DKK3;PDGFB;BMP2;AKT1;PIK3CG
18911,GO:1901723,5.60483482113934e-05,0.999999400361272,3,6,negative regulation of cell proliferation involved in kidney development,BP,BMP7;BMP4;WT1
13756,GO:0050918,5.62752431272495e-05,0.999995296607181,6,52,positive chemotaxis,BP,ARTN;FGF10;PDGFB;WNT5A;FGF8;BMP4
1485,GO:0003206,5.71352693269801e-05,0.999991244231436,9,117,cardiac chamber morphogenesis,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A;FGF8;BMP7;BMP4;HEY1
21415,GO:2000725,5.72028622856577e-05,0.999996706019445,5,29,regulation of cardiac muscle cell differentiation,BP,EDN1;FZD7;BMP4;BMP2;EFNB2
14865,GO:0060326,5.77225041478552e-05,0.999987781184101,12,245,cell chemotaxis,BP,NOTCH1;EDN1;CCL20;PDGFB;WNT5A;JAM3;HBEGF;CHGA;BCAR1;PIK3CG;GAS6;PDE4B
18874,GO:1901652,5.82801266702422e-05,0.999982744583051,18,442,response to peptide,BP,ACTN2;NOTCH1;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;BMP7;CTGF;GJB2;AKT1;BCAR1;INHBB;PIK3CA
4651,GO:0009799,5.84211535774171e-05,0.999991014862201,9,119,specification of symmetry,BP,NOTCH1;ACVR1;FGF10;WNT5A;AXIN1;FGF8;BMP4;DAAM2;DLL1
8846,GO:0032956,5.84663843692464e-05,0.999985780198329,14,278,regulation of actin cytoskeleton organization,BP,FHOD3;WNT4;ACTN2;EDN1;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;HRAS;JAM3;RHOQ;SDC4;SPTB;CTGF
15332,GO:0061046,5.87970223833449e-05,0.999999360624188,3,6,regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4;WNT2B
16792,GO:0072008,5.89462297856345e-05,0.999999358448615,3,6,glomerular mesangial cell differentiation,BP,NOTCH1;PDGFB;ACTA2
13972,GO:0051254,6.03120711349859e-05,0.999972964783249,39,1403,positive regulation of RNA metabolic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;AKT1;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
10498,GO:0038127,6.09663415418628e-05,0.999989329994809,10,143,ERBB signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;PIK3R1;HRAS;HBEGF;AKT1;EPN1;BCAR1;PIK3CA
15117,GO:0060685,6.32216584945573e-05,0.999999295320254,3,6,regulation of prostatic bud formation,BP,WNT5A;BMP7;BMP4
19263,GO:1902680,6.34013448215448e-05,0.999971798067886,38,1357,positive regulation of RNA biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;AKT1;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
4711,GO:0010001,6.37152751640028e-05,0.999987556875831,11,178,glial cell differentiation,BP,LIF;POU3F1;NOTCH1;CDH2;FGF10;CLCF1;BMP2;DLL1;AKT1;NAB2;TSPAN2
18176,GO:0098805,6.39908710941201e-05,0.999970678636155,41,1511,whole membrane,CC,TMEM163;SYT5;WNT3;WNT4;TSPAN15;RAB27A;TF;PMAIP1;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;RAB39A;SYCN;FZD7;CDH2;WNT5B;WNT5A;SNX18;RHOQ;RHOB;SDC4;HBEGF;DLL1;RAB20;VAMP1;CHGA;PKP1;RAB12;RAB17;CDH1;EPN1;MYO7A;RAB44;RAB11FIP1;SH3BP4;RAB38;RAB3D;ACSL4;RNF144A
13861,GO:0051093,6.43219948170821e-05,0.999975951875298,26,796,negative regulation of developmental process,BP,WNT3;WNT4;NOTCH1;WNT7A;ZFPM1;PRKACB;FZD7;LIMS2;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5A;AXIN1;NPR1;FGF8;BMP7;BMP4;BMP2;WT1;DLL1;NPPC;GAS6;AMOT;CLDN18
5054,GO:0010862,6.52109201087948e-05,0.999994435198693,6,48,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
13111,GO:0048146,6.55357486967728e-05,0.999994376288131,6,51,positive regulation of fibroblast proliferation,BP,WNT2;FGF10;PDGFB;WNT5A;CDKN1A;GAS6
9760,GO:0035296,6.56987048349741e-05,0.999989725067096,9,123,regulation of tube diameter,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
18038,GO:0097746,6.56987048349741e-05,0.999989725067096,9,123,regulation of blood vessel diameter,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
10933,GO:0042592,6.60597822216145e-05,0.999969676132262,41,1571,homeostatic process,BP,CDH23;TF;PMAIP1;WNT7B;ZFPM1;ADORA1;CASQ2;EDN1;PRKACB;RAB39A;PRND;TYRO3;LPAR2;CDH2;PIK3R2;PIK3R1;KCNH2;PRKAR1B;JAM3;SESN2;NPR1;BMP6;BMP4;DLL1;RAB20;SFXN1;WNK4;CTGF;GJB6;AKT1;KITLG;CLDN1;PIK3CA;PIK3CG;GAS6;VDR;RAB38;RAB3D;CLDN16;CLDN18;PDE4B
2460,GO:0005126,6.62955095726722e-05,0.999985740745292,12,260,cytokine receptor binding,MF,ITGA5;LIF;RASL11B;CCL20;PIK3R1;CLCF1;BMP7;BMP6;BMP4;BMP2;KITLG;INHBB
857,GO:0002062,6.63602707100297e-05,0.999991097795063,8,91,chondrocyte differentiation,BP,WNT7A;WNT5B;BMP6;BMP4;BMP2;CTGF;WNT2B;NPPC
9231,GO:0033993,6.64358081921794e-05,0.999974609704114,27,859,response to lipid,BP,WNT3;WNT2;NOTCH1;DHH;WNT6;WNT7A;WNT7B;EDN1;CCL20;FZD7;FGF10;WNT5B;WNT5A;BMP7;BMP6;BMP4;CDKN1A;MSN;CTGF;GJB2;GJB6;AKT1;PTGES;CLDN1;VDR;HEY1;PDE4B
15220,GO:0060842,6.66625017754204e-05,0.999999243437621,3,6,arterial endothelial cell differentiation,BP,NOTCH1;DLL1;HEY1
12561,GO:0046184,6.69331109814023e-05,0.999997740099039,4,15,aldehyde biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
14678,GO:0060048,6.72211655288515e-05,0.999989458462361,9,122,cardiac muscle contraction,BP,DSC2;ADORA1;CASQ2;KCNH2;CHGA;CTGF;PIK3CA;PIK3CG;PDE4B
6353,GO:0018108,6.78186854779012e-05,0.999981357011407,16,360,peptidyl-tyrosine phosphorylation,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;TYRO3;FGF10;FGF17;PDGFB;FGF8;CLCF1;HBEGF;DDR1;KITLG;GAS6;UNC119
13835,GO:0051048,6.89380984004884e-05,0.999986388963759,11,191,negative regulation of secretion,BP,LIF;ADRA2B;ADRA2C;NOTCH1;ADORA1;EDN1;WNK4;CHGA;INHBB;RAB11FIP1;GAS6
13322,GO:0048638,6.92050577613311e-05,0.999982893893899,14,280,regulation of developmental growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;WNT5A;FGF8;BMP4;WT1;DLL1;AKT1;NPPC;PIK3CA
17636,GO:0090596,6.9474996499702e-05,0.999983899162864,13,245,sensory organ morphogenesis,BP,WNT2;STRA6;EDN1;FGF10;WNT5A;AXIN1;FGF8;BMP7;BMP4;DLL1;GJB6;WNT2B;MYO7A
13299,GO:0048589,7.03728564484922e-05,0.99997659883301,21,551,developmental growth,BP,WNT3;WNT2;ACTN3;NOTCH1;STRA6;WNT7A;WNT7B;SALL4;EDN1;SPTBN4;FZD7;FGF10;WNT5A;FGF8;BMP4;WT1;DLL1;DDR1;AKT1;NPPC;PIK3CA
13758,GO:0050920,7.09664708655359e-05,0.999987280604561,10,169,regulation of chemotaxis,BP,ARTN;WNT3;NOTCH1;EDN1;FGF10;PDGFB;WNT5A;JAM3;GAS6;EFNB2
2491,GO:0005160,7.19286897850725e-05,0.999993740760215,6,49,transforming growth factor beta receptor binding,MF,RASL11B;BMP7;BMP6;BMP4;BMP2;INHBB
6387,GO:0018212,7.2033720982852e-05,0.99998009237816,16,362,peptidyl-tyrosine modification,BP,ITGA5;LIF;ADRA2B;ADRA2C;ADORA1;TYRO3;FGF10;FGF17;PDGFB;FGF8;CLCF1;HBEGF;DDR1;KITLG;GAS6;UNC119
645,GO:0001775,7.25468695992077e-05,0.9999685483452,35,1279,cell activation,BP,ADRA2B;ADRA2C;WNT4;RAB27A;CRISPLD2;WNT7A;ZFPM1;EDN1;PLAU;FZD7;TYRO3;FGF10;PIK3R1;PDGFB;WNT5A;RHOB;SDC4;CLCF1;BMP4;CDKN1A;DLL1;CHGA;MSN;CTGF;TPD52;AKT1;PKP1;JAG2;RAB44;PIK3CA;PIK3CG;GAS6;RAB3D;FZD8;EFNB2
13918,GO:0051173,7.41356851848069e-05,0.999964636155464,45,1750,positive regulation of nitrogen compound metabolic process,BP,LIF;WNT2;WNT4;POU3F1;ACTN3;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;CHGA;AKT1;KITLG;NPPC;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
12239,GO:0045603,7.59766194781968e-05,0.999997309502087,4,16,positive regulation of endothelial cell differentiation,BP,NOTCH1;BMP6;BMP4;CLDN5
4520,GO:0009267,7.70803475837125e-05,0.999987699758461,9,120,cellular response to starvation,BP,WNT4;PMAIP1;DSC2;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6
20984,GO:2000064,7.75767492740601e-05,0.999999072882679,3,6,regulation of cortisol biosynthetic process,BP,WNT4;DKK3;BMP2
20463,GO:1905314,7.81401752529812e-05,0.999997212531006,4,16,semi-lunar valve development,BP,NOTCH1;STRA6;BMP4;HEY1
12764,GO:0046661,7.8715995672306e-05,0.999985749836431,10,155,male sex differentiation,BP,WNT4;DHH;FSTL3;FGF10;WNT5A;FGF8;BMP6;WT1;WNT2B;KITLG
3820,GO:0007498,7.90531424879796e-05,0.999987326788325,9,124,mesoderm development,BP,ITGA3;WNT3;ITGB4;ACVR1;WNT5A;AXIN1;FGF8;BMP7;BMP4
12325,GO:0045740,7.9622202642925e-05,0.99999289074728,6,54,positive regulation of DNA replication,BP,FGF10;PDGFB;HRAS;BMP6;BMP4;KITLG
693,GO:0001838,8.1254651948627e-05,0.999986942790449,9,120,embryonic epithelial tube formation,BP,WNT4;WNT6;SALL4;PRKACB;WNT5A;SDC4;BMP7;BMP4;GDNF
7485,GO:0030540,8.13371806053738e-05,0.999997030917878,4,17,female genitalia development,BP,STRA6;TYRO3;FGF10;WNT5A
15079,GO:0060603,8.4900218558844e-05,0.999994638020875,5,31,mammary gland duct morphogenesis,BP,WNT4;FGF10;WNT5A;DDR1;VDR
14627,GO:0055117,8.5014899878965e-05,0.999990187659458,7,72,regulation of cardiac muscle contraction,BP,DSC2;ADORA1;CASQ2;CHGA;CTGF;PIK3CG;PDE4B
1488,GO:0003209,8.56657925335026e-05,0.999994599850162,5,30,cardiac atrium morphogenesis,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A
18155,GO:0098772,8.59584566902213e-05,0.999961541425666,37,1372,molecular function regulator,MF,ARTN;WNT3;WNT2;WNT4;RIN3;ACTN2;NOTCH1;SERPINA5;WNT7A;RABIF;SPTBN5;SPTBN4;TSPAN13;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;PRKAR1B;WNT5A;SESN2;AXIN1;FGF8;SPTB;HBEGF;BMP2;CDKN1A;WNK4;AKT1;NRTN;KITLG;CST9L;PIK3CA;GAS6;GPSM1;SH3BP4;GDNF
11499,GO:0043588,8.95537807565359e-05,0.999975910661205,15,398,skin development,BP,ITGA3;POU3F1;NOTCH1;ITGB4;DSC2;FGF10;WNT5A;DLL1;DSG3;PKP3;PKP1;CLDN1;DSC3;VDR;LAMA5
18173,GO:0098801,8.99556496709049e-05,0.999994190445908,5,34,regulation of renal system process,BP,ADORA1;EDN1;PDGFB;NPR1;GAS6
1481,GO:0003198,8.99745261987773e-05,0.999996627887535,4,17,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,NOTCH1;ACVR1;FGF8;HEY1
692,GO:0001837,9.10921630920223e-05,0.999985124273552,9,123,epithelial to mesenchymal transition,BP,WNT2;WNT4;NOTCH1;ACVR1;WNT5A;FGF8;BMP7;BMP2;HEY1
21475,GO:2000811,9.24945243627378e-05,0.999996551813032,4,16,negative regulation of anoikis,BP,ITGA5;NOTCH1;TLE1;PIK3CA
15909,GO:0070374,9.29848952200658e-05,0.999982760578292,10,174,positive regulation of ERK1 and ERK2 cascade,BP,CCL20;FGF10;PDGFB;HRAS;FGF8;BMP4;BMP2;CTGF;GAS6;ARAF
13677,GO:0050810,9.40635067092999e-05,0.999991375650667,6,51,regulation of steroid biosynthetic process,BP,WNT4;DHH;DKK3;BMP6;BMP2;VDR
6834,GO:0021536,9.65934695977361e-05,0.999988584777972,7,76,diencephalon development,BP,WNT4;FGF10;WNT5A;FGF8;BMP4;BMP2;CDH1
16791,GO:0072007,9.69074029374187e-05,0.999998619252176,3,7,mesangial cell differentiation,BP,NOTCH1;PDGFB;ACTA2
13574,GO:0050673,9.81979164338447e-05,0.999973439114109,15,335,epithelial cell proliferation,BP,WNT2;NOTCH1;WNT7A;FZD7;LIMS2;FGF10;PDGFB;HRAS;WNT5A;BMP6;BMP4;BMP2;AKT1;VDR;EFNB2
13726,GO:0050880,9.88171001361082e-05,0.999983649661703,9,131,regulation of blood vessel size,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
7712,GO:0031012,0.00010033286606617,0.999967800539029,19,517,extracellular matrix,CC,WNT3;WNT2;WNT4;CRISPLD2;WNT6;WNT7A;WNT7B;MFGE8;FGF10;PDGFB;WNT5B;WNT5A;BMP7;BMP4;CTGF;WNT2B;HAPLN3;LAMA1;LAMA5
7275,GO:0030168,0.000100438485512087,0.999981258701209,10,157,platelet activation,BP,ADRA2B;ADRA2C;TYRO3;PIK3R1;PDGFB;RHOB;AKT1;PIK3CA;PIK3CG;GAS6
9702,GO:0035150,0.000103275132641233,0.999982806789818,9,132,regulation of tube size,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
11183,GO:0043087,0.000105061719301594,0.999961157149317,24,695,regulation of GTPase activity,BP,ARTN;WNT4;RIN3;ACTN2;RABIF;CCL20;SPTBN5;SPTBN4;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;SPTB;HBEGF;NRTN;KITLG;AMOT;SH3BP4;GDNF
11138,GO:0043010,0.000106391913893101,0.999972578637314,14,288,camera-type eye development,BP,WNT2;STRA6;WNT6;WNT7A;WNT7B;FGF10;WNT5B;WNT5A;RHOJ;BMP7;BMP4;WT1;DLL1;WNT2B
14861,GO:0060322,0.000106511513910829,0.999960582038898,24,699,head development,BP,WNT3;WNT2;WNT4;POU3F1;NOTCH1;STRA6;CRISPLD2;WNT7A;WNT7B;TYRO3;CDH2;FGF10;WNT5A;AXIN1;PFKFB3;FGF8;BMP7;BMP4;BMP2;DLL1;WNT2B;CDH1;CLDN5;TSPAN2
13885,GO:0051128,0.000107044510515595,0.999945370249562,53,2195,regulation of cellular component organization,BP,ITGA3;FHOD3;LIF;WNT3;WNT4;ACTN2;RAB6C;NOTCH1;RAB27A;TF;PMAIP1;WNT7A;EDN1;MFGE8;SPTBN5;SPTBN4;CDH2;PIK3R1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;SESN2;RHOQ;RHOJ;NPR1;PSRC1;FGF8;SDC4;SPTB;HBEGF;BMP7;BMP4;CAMSAP3;WT1;CDKN1A;DLL1;RAB20;ESPN;MSN;DDR1;CTGF;AKT1;RAB17;BCAR1;CLDN1;GAS6;LZTS1;SH3BP4;UNC119;PARVB
19907,GO:1904031,0.000108479260098874,0.999992685642876,5,35,positive regulation of cyclin-dependent protein kinase activity,BP,FGF10;PDGFB;PSRC1;CDKN1A;AKT1
2435,GO:0005085,0.000108728136570463,0.99997033985446,15,320,guanyl-nucleotide exchange factor activity,MF,ARTN;RIN3;ACTN2;RABIF;SPTBN5;SPTBN4;FGF10;FGF17;PDGFB;FGF8;SPTB;HBEGF;NRTN;KITLG;GDNF
11312,GO:0043276,0.000109692525943079,0.999992654388803,5,32,anoikis,BP,ITGA5;NOTCH1;AKT1;TLE1;PIK3CA
18169,GO:0098797,0.000110162108901309,0.999975051247437,12,230,plasma membrane protein complex,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8;CDH2;GJB1;GJB2;GJB6;CDH1;GJA3;FZD8
8369,GO:0032268,0.000110226972432115,0.999943664640188,53,2281,regulation of cellular protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;SERPINA5;WNT7A;WNT7B;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;MSN;CTGF;AKT1;KITLG;CST9L;INHBB;PIK3CA;PIK3CG;GAS6;PM20D2;ARAF;UNC119;FZD8;DUSP5;RNF144A
13323,GO:0048639,0.000110583662928201,0.99997912823763,10,155,positive regulation of developmental growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;FGF8;WT1;DLL1;AKT1
15210,GO:0060828,0.000111313606457364,0.999974752044893,12,234,regulation of canonical Wnt signaling pathway,BP,WNT2;WNT4;NOTCH1;WNT7A;DKK3;CDH2;FGF10;WNT5B;WNT5A;AXIN1;BMP2;WNT2B
861,GO:0002066,0.000113074169895554,0.999989260020359,6,52,columnar/cuboidal epithelial cell development,BP,WNT5A;BMP6;BMP4;CDKN1A;DLL1;MYO7A
13307,GO:0048609,0.000115711845659928,0.999956899711496,24,755,multicellular organismal reproductive process,BP,ITGA3;LIF;WNT3;WNT4;NOTCH1;DHH;SERPINA5;ACVR1;EDN1;TYRO3;FSTL3;JAM3;BMP4;WT1;SLC2A14;GJB2;AKT1;KITLG;NPPC;JAG2;INHBB;VDR;ACSL4;CLDN11
14218,GO:0051704,0.000116399446589649,0.999941290488643,50,2241,multi-organism process,BP,ITGA3;ITGA5;LIF;ADRA2C;WNT3;WNT4;NOTCH1;IGSF8;ITGB5;PMAIP1;DHH;SERPINA5;ACVR1;NMT2;EDN1;RAB40B;MFGE8;CCL20;SPTBN4;TYRO3;FSTL3;FGF10;PIK3R1;HRAS;WNT5A;JAM3;BMP6;BMP4;WT1;SLC2A14;CHGA;DDR1;GJB2;GJB6;AKT1;PTGES;NPPC;JAG2;CDH1;EPN1;INHBB;CLDN1;GAS6;VDR;ACSL4;ACTA2;CLDN11;PIM2;EFNB2;PDE4B
4680,GO:0009913,0.000117168265201706,0.999971193749149,13,335,epidermal cell differentiation,BP,POU3F1;NOTCH1;DSC2;WNT5A;BMP4;DLL1;DSG3;PKP3;PKP1;JAG2;MYO7A;DSC3;VDR
5866,GO:0016301,0.000117249236598561,0.999953597777333,27,816,kinase activity,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;NPR1;NUAK2;PFKFB3;FGF8;HBEGF;CDKN1A;PKN3;WNK4;DDR1;AKT1;KITLG;PIK3CA;PIK3CG;ARAF;PIM2
3547,GO:0006941,0.000117956781565635,0.999977523955702,10,163,striated muscle contraction,BP,ACTN3;DSC2;ADORA1;CASQ2;KCNH2;CHGA;CTGF;PIK3CA;PIK3CG;PDE4B
21092,GO:2000270,0.000119572946790976,0.999998169559361,3,7,negative regulation of fibroblast apoptotic process,BP,PIK3CA;PIK3CG;GAS6
2878,GO:0005922,0.000119842008288609,0.999995016859124,4,20,connexin complex,CC,GJB1;GJB2;GJB6;GJA3
15366,GO:0061101,0.000120716077335278,0.999998020492543,3,8,neuroendocrine cell differentiation,BP,WNT4;FGF8;BMP2
4671,GO:0009891,0.000122720146998755,0.999940457167451,44,1746,positive regulation of biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;CCL20;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;CTGF;AKT1;KITLG;NPPC;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
17914,GO:0097435,0.000124261124071265,0.999958148170449,20,534,supramolecular fiber organization,BP,FHOD3;WNT4;TUBG2;ACTN2;ITGB5;CASQ2;EDN1;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;AXIN1;PSRC1;SDC4;SPTB;ESPN;CTGF;PKP1;BCAR1;MYH11
19650,GO:1903531,0.00012562281883856,0.999975850812248,10,169,negative regulation of secretion by cell,BP,LIF;ADRA2B;ADRA2C;NOTCH1;ADORA1;EDN1;CHGA;INHBB;RAB11FIP1;GAS6
11867,GO:0044706,0.000125889592139903,0.999973309516035,11,210,multi-multicellular organism process,BP,ITGA3;LIF;ADRA2C;WNT4;EDN1;DDR1;GJB2;AKT1;EPN1;VDR;ACSL4
1476,GO:0003190,0.000126654775308598,0.999998022638998,3,7,atrioventricular valve formation,BP,NOTCH1;ZFPM1;HEY1
12854,GO:0046885,0.000127281174622467,0.999994775992321,4,17,regulation of hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
16831,GO:0072074,0.000129973157857785,0.999994577565492,4,18,kidney mesenchyme development,BP,WNT4;BMP7;BMP4;WT1
10591,GO:0040019,0.000130293762764243,0.999990915351573,5,33,positive regulation of embryonic development,BP,WNT2;WNT4;WNT2B;AMOT;GDNF
3733,GO:0007254,0.000130507542925495,0.999972286116984,11,190,JNK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;CTGF;AKT1;FZD8
15095,GO:0060638,0.000131398530318309,0.999997782004273,3,8,mesenchymal-epithelial cell signaling,BP,FGF10;WNT5A;WNT2B
6534,GO:0019216,0.000132001363224775,0.999967284200132,13,269,regulation of lipid metabolic process,BP,WNT4;DHH;ADORA1;DKK3;PIK3R2;PIK3R1;PDGFB;SESN2;BMP6;BMP2;AKT1;PIK3CG;VDR
628,GO:0001755,0.000132394978786335,0.999990681714384,5,35,neural crest cell migration,BP,ACVR1;NRTN;KITLG;LAMA5;GDNF
13837,GO:0051050,0.000133191702731195,0.999946815057752,27,889,positive regulation of transport,BP,ACTN2;RAB27A;TF;PMAIP1;ADORA1;EDN1;MFGE8;CDH2;PRR5L;PIK3R2;PIK3R1;PDGFB;KCNH2;WNT5A;RHOQ;NPR1;SDC4;BMP6;BMP4;DLL1;MSN;AKT1;CDH1;INHBB;GAS6;RAB3D;GDNF
10443,GO:0038030,0.000133595199513284,0.999997875881002,3,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,WNT4;FZD7;WNT5A
17809,GO:0097205,0.000134468243307608,0.999994339737428,4,18,renal filtration,BP,ITGA3;ADORA1;PDGFB;GAS6
12756,GO:0046649,0.000136107681812309,0.999952431405005,21,613,lymphocyte activation,BP,WNT4;RAB27A;ZFPM1;FZD7;TYRO3;FGF10;PIK3R1;SDC4;CLCF1;BMP4;CDKN1A;DLL1;MSN;TPD52;AKT1;JAG2;PIK3CA;PIK3CG;GAS6;FZD8;EFNB2
8552,GO:0032504,0.000136345131971583,0.999948637465557,24,764,multicellular organism reproduction,BP,ITGA3;LIF;WNT3;WNT4;NOTCH1;DHH;SERPINA5;ACVR1;EDN1;TYRO3;FSTL3;JAM3;BMP4;WT1;SLC2A14;GJB2;AKT1;KITLG;NPPC;JAG2;INHBB;VDR;ACSL4;CLDN11
8195,GO:0031946,0.000136371970565186,0.999997816417994,3,7,regulation of glucocorticoid biosynthetic process,BP,WNT4;DKK3;BMP2
17488,GO:0090257,0.00013724064896386,0.999970643670957,11,201,regulation of muscle system process,BP,ADRA2B;ADRA2C;ACTN3;DSC2;ADORA1;CASQ2;EDN1;CHGA;CTGF;PIK3CG;PDE4B
4691,GO:0009952,0.000138831511624613,0.99997026758439,11,200,anterior/posterior pattern specification,BP,WNT3;WNT2;NOTCH1;WNT5A;AXIN1;FGF8;BMP4;BMP2;WT1;DLL1;WNT2B
2507,GO:0005178,0.000139154017521873,0.99997911522093,8,100,integrin binding,MF,ITGA3;ITGA5;ACTN3;ACTN2;MFGE8;JAM3;CTGF;LAMA5
6458,GO:0019003,0.000142838423453037,0.999985745587802,6,57,GDP binding,MF,RAB27A;RALB;HRAS;RHOB;RAB12;RAB17
2799,GO:0005788,0.000144573169585552,0.999968908266436,11,196,endoplasmic reticulum lumen,CC,WNT3;WNT4;WNT6;WNT7A;WNT7B;CASQ2;EDN1;PDGFB;WNT5B;WNT5A;GAS6
14733,GO:0060128,0.000145431661483358,1,2,2,corticotropin hormone secreting cell differentiation,BP,FGF8;BMP2
4069,GO:0008305,0.000145748062379341,0.999989622892425,5,32,integrin complex,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8
9699,GO:0035137,0.000146767692811346,0.999989409198286,5,36,hindlimb morphogenesis,BP,WNT3;NOTCH1;WNT7A;FGF8;BMP4
16834,GO:0072077,0.000146889498190831,0.999993611213346,4,19,renal vesicle morphogenesis,BP,LIF;WNT4;BMP4;GDNF
13109,GO:0048144,0.000148009377927487,0.999981156751975,7,84,fibroblast proliferation,BP,WNT2;WNT7B;FGF10;PDGFB;WNT5A;CDKN1A;GAS6
16521,GO:0071496,0.000148480468167422,0.999962756182429,13,268,cellular response to external stimulus,BP,WNT4;PMAIP1;GADD45A;DSC2;RALB;NUAK2;BMP6;CDKN1A;AKT1;WNT2B;INHBB;GAS6;VDR
13271,GO:0048534,0.000148734715819282,0.999943645437917,24,752,hematopoietic or lymphoid organ development,BP,ARTN;LIF;WNT4;NOTCH1;ZFPM1;FZD7;TYRO3;FSTL3;FGF10;PIK3R1;WNT5A;JAM3;CLCF1;BMP4;DLL1;SFXN1;TPD52;WNT2B;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
1552,GO:0003323,0.000151721104739126,0.999993344698737,4,19,type B pancreatic cell development,BP,WNT5A;BMP6;BMP4;DLL1
13838,GO:0051051,0.000152253755093106,0.999953035150596,17,442,negative regulation of transport,BP,LIF;ADRA2B;ADRA2C;ACTN2;NOTCH1;ADORA1;CASQ2;EDN1;KCNH2;BMP7;WNK4;CHGA;AKT1;INHBB;RAB11FIP1;GAS6;UNC119
4849,GO:0010557,0.000152999876006832,0.999926757888368,41,1587,positive regulation of macromolecule biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;CCL20;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;CTGF;AKT1;KITLG;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
1503,GO:0003230,0.000159514213644389,0.999988345201606,5,34,cardiac atrium development,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A
19990,GO:1904238,0.000162656203317163,0.999997046496783,3,8,pericyte cell differentiation,BP,NOTCH1;PDGFB;ACTA2
1380,GO:0003007,0.000163619530035095,0.99996132846217,12,228,heart morphogenesis,BP,WNT2;NOTCH1;ZFPM1;ACVR1;WNT5A;FGF8;BMP7;BMP4;BMP2;DLL1;CLDN5;HEY1
14737,GO:0060135,0.000164101855772533,0.999983160240049,6,59,maternal process involved in female pregnancy,BP,ITGA3;LIF;WNT4;GJB2;AKT1;VDR
4761,GO:0010243,0.00016615329884315,0.99993522187726,25,792,response to organonitrogen compound,BP,ACTN2;NOTCH1;CASQ2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;KHK;SESN2;RHOQ;BMP7;WT1;CDKN1A;CTGF;GJB2;AKT1;CDH1;BCAR1;INHBB;PIK3CA;PIK3CG;SH3BP4;PDE4B
3842,GO:0007565,0.000166294950736731,0.999966832663378,10,182,female pregnancy,BP,ITGA3;LIF;ADRA2C;WNT4;DDR1;GJB2;AKT1;EPN1;VDR;ACSL4
3853,GO:0007589,0.000166403370232348,0.999978370072059,7,87,body fluid secretion,BP,ADORA1;EDN1;FGF10;NPR1;WNK4;DDR1;VDR
3206,GO:0006464,0.000168359383552646,0.999904072187484,78,3744,cellular protein modification process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;MARK4;GADD45A;FBXO41;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EDN1;RAB40B;RAB40A;PRKACB;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;PKN3;WNK4;DDR1;CTGF;AKT1;NRTN;KITLG;INHBB;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;RNF144A;PIM2
10278,GO:0036211,0.000168359383552646,0.999904072187484,78,3744,protein modification process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;MARK4;GADD45A;FBXO41;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EDN1;RAB40B;RAB40A;PRKACB;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;PKN3;WNK4;DDR1;CTGF;AKT1;NRTN;KITLG;INHBB;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;RNF144A;PIM2
15215,GO:0060837,0.000170551293067597,0.99999685246974,3,8,blood vessel endothelial cell differentiation,BP,NOTCH1;DLL1;HEY1
11803,GO:0044433,0.000171189231426542,0.999921377031205,36,1367,cytoplasmic vesicle part,CC,TMEM163;SYT5;WNT3;WNT4;ACTN2;TSPAN15;RAB27A;TF;CRISPLD2;SERPINA5;WNT6;WNT7A;WNT7B;PLAU;RAB39A;SYCN;FZD7;PDGFB;WNT5B;WNT5A;SNX18;RHOQ;RHOB;HBEGF;RAB20;VAMP1;CHGA;PKP1;RAB12;RAB17;RAB44;RAB11FIP1;GAS6;RAB38;RAB3D;RNF144A
6278,GO:0017111,0.000171824574320982,0.999932877374739,25,772,nucleoside-triphosphatase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
13457,GO:0048878,0.000176227470384882,0.999925930715227,29,1004,chemical homeostasis,BP,CDH23;TF;WNT7B;ADORA1;CASQ2;EDN1;PRKACB;RAB39A;PRND;LPAR2;PIK3R2;PIK3R1;KCNH2;PRKAR1B;SESN2;NPR1;BMP6;RAB20;SFXN1;WNK4;GJB6;AKT1;CLDN1;PIK3CA;PIK3CG;GAS6;VDR;RAB38;CLDN16
16840,GO:0072087,0.000177125765303321,0.999991839031212,4,20,renal vesicle development,BP,LIF;WNT4;BMP4;GDNF
18041,GO:0097756,0.000177439963513197,0.999976783123873,7,80,negative regulation of blood vessel diameter,BP,ADRA2B;ADRA2C;ADORA1;EDN1;CHGA;AKT1;ACTA2
14027,GO:0051345,0.000178010312095986,0.999926349781249,28,925,positive regulation of hydrolase activity,BP,ARTN;WNT4;RIN3;ACTN2;PMAIP1;RABIF;CCL20;SPTBN5;SPTBN4;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;SPTB;HBEGF;BMP2;CTGF;AKT1;NRTN;KITLG;GDNF
8952,GO:0033138,0.000181182312604801,0.999976059863697,7,92,positive regulation of peptidyl-serine phosphorylation,BP,LIF;WNT5A;AXIN1;AKT1;PIK3CA;GAS6;ARAF
13384,GO:0048736,0.000185513755659613,0.999962599147636,10,164,appendage development,BP,WNT3;NOTCH1;ITGB4;WNT7A;SALL4;FGF10;WNT5A;FGF8;BMP7;BMP4
14764,GO:0060173,0.000185513755659613,0.999962599147636,10,164,limb development,BP,WNT3;NOTCH1;ITGB4;WNT7A;SALL4;FGF10;WNT5A;FGF8;BMP7;BMP4
5191,GO:0014032,0.000188598678514587,0.999980160186538,6,58,neural crest cell development,BP,ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
8071,GO:0031669,0.00019161768764143,0.999961178226909,10,169,cellular response to nutrient levels,BP,WNT4;PMAIP1;DSC2;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6;VDR
13833,GO:0051046,0.000191798231226554,0.999929389804496,22,673,regulation of secretion,BP,LIF;ADRA2B;ADRA2C;SYT5;NOTCH1;RAB27A;ADORA1;EDN1;FGF10;RALB;WNT5A;NPR1;SDC4;BMP6;WNK4;CHGA;INHBB;RAB11FIP1;KCNG2;GAS6;RAB3D;GDNF
12763,GO:0046660,0.000192732657631633,0.999969542638832,8,109,female sex differentiation,BP,WNT4;STRA6;TYRO3;FGF10;WNT5A;WT1;KITLG;INHBB
20466,GO:1905330,0.000194402948201816,0.999960486347356,10,178,regulation of morphogenesis of an epithelium,BP,LIF;WNT2;WNT4;FZD7;FGF10;WNT5A;BMP7;BMP4;WNT2B;GDNF
3783,GO:0007368,0.000199575954804968,0.999968286518128,8,110,determination of left/right symmetry,BP,NOTCH1;ACVR1;FGF10;WNT5A;AXIN1;FGF8;DAAM2;DLL1
2451,GO:0005111,0.000200595253133783,0.999999452178915,2,3,type 2 fibroblast growth factor receptor binding,MF,FGF10;FGF17
1430,GO:0003130,0.000203392262022917,1,2,2,BMP signaling pathway involved in heart induction,BP,BMP4;BMP2
1432,GO:0003133,0.000203392262022917,1,2,2,endodermal-mesodermal cell signaling,BP,BMP4;BMP2
1433,GO:0003134,0.000203392262022917,1,2,2,endodermal-mesodermal cell signaling involved in heart induction,BP,BMP4;BMP2
7721,GO:0031032,0.00020353343043149,0.999958487117017,10,164,actomyosin structure organization,BP,FHOD3;WNT4;ACTN2;ITGB5;CASQ2;EDN1;PIK3R1;SDC4;CTGF;MYH11
12441,GO:0045944,0.000209010392672328,0.999909902731876,30,1031,positive regulation of transcription from RNA polymerase II promoter,BP,LIF;WNT2;POU3F1;NOTCH1;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;RHOQ;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;AKT1;VDR;GDNF;FZD8;HEY1
16450,GO:0071396,0.000209704431032065,0.999928634985449,19,522,cellular response to lipid,BP,WNT3;WNT2;WNT6;WNT7B;EDN1;CCL20;FZD7;WNT5B;WNT5A;BMP7;BMP6;BMP4;MSN;GJB2;AKT1;CLDN1;VDR;HEY1;PDE4B
2887,GO:0005942,0.000210896405004342,0.999989910386772,4,19,phosphatidylinositol 3-kinase complex,CC,PIK3R2;PIK3R1;PIK3CA;PIK3CG
3798,GO:0007409,0.000214282505368828,0.99993198953553,17,416,axonogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;PIK3CA;GDNF
14083,GO:0051445,0.00021483304958334,0.999983042273226,5,39,regulation of meiotic cell cycle,BP,LIF;WNT4;PRKACB;WNT5A;NPPC
3527,GO:0006909,0.000217293777930649,0.999950919766797,11,209,phagocytosis,BP,RAB27A;ADORA1;MFGE8;RAB39A;TYRO3;PIK3R2;PIK3R1;RAB20;MYO7A;PIK3CA;GAS6
3937,GO:0008104,0.000219270972113285,0.999882657285991,56,2482,protein localization,BP,ITGA3;LIF;ADRA2C;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;PMAIP1;WNT7A;RABIF;ADORA1;RAB40B;RAB40A;SPTBN4;RAB39B;RAB39A;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SNX18;SESN2;RHOQ;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;WNK4;MSN;AKT1;PKP3;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;AMOT;LAMA5;SH3BP4;UNC119;RAB38;RAB3D;CLDN18
11473,GO:0043547,0.000219746580372772,0.99991833689549,22,640,positive regulation of GTPase activity,BP,ARTN;WNT4;RIN3;ACTN2;RABIF;CCL20;SPTBN5;SPTBN4;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;SPTB;HBEGF;NRTN;KITLG;GDNF
4663,GO:0009880,0.000220052959255812,0.999976079847429,6,62,embryonic pattern specification,BP,WNT7A;FGF10;WNT5A;BMP7;WT1;DLL1
18098,GO:0098636,0.000220442162092977,0.999982672436184,5,35,protein complex involved in cell adhesion,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8
8580,GO:0032555,0.000223323983616545,0.999886864649082,46,1791,purine ribonucleotide binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
13432,GO:0048844,0.000224573603572702,0.999975620181309,6,57,artery morphogenesis,BP,NOTCH1;STRA6;FGF8;BMP4;HEY1;EFNB2
8949,GO:0033135,0.000225345008627936,0.999963413837841,8,121,regulation of peptidyl-serine phosphorylation,BP,LIF;SPTBN4;WNT5A;AXIN1;AKT1;PIK3CA;GAS6;ARAF
14920,GO:0060393,0.000226644557237806,0.999975274854146,6,60,regulation of pathway-restricted SMAD protein phosphorylation,BP,ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
16078,GO:0070673,0.000231332962551345,0.999995035687658,3,9,response to interleukin-18,BP,PDGFB;AKT1;CLDN1
8192,GO:0031943,0.000232836885059338,0.999994992289259,3,9,regulation of glucocorticoid metabolic process,BP,WNT4;DKK3;BMP2
7484,GO:0030539,0.000234939070283394,0.9999881717433,4,22,male genitalia development,BP,FGF10;FGF8;BMP6;WT1
20416,GO:1905207,0.000234983093269062,0.999981128599607,5,38,regulation of cardiocyte differentiation,BP,EDN1;FZD7;BMP4;BMP2;EFNB2
7355,GO:0030278,0.000236542328055907,0.999950715022711,10,179,regulation of ossification,BP,WNT4;NOTCH1;WNT7B;ACVR1;WNT5A;BMP7;BMP6;BMP4;BMP2;NPPC
3932,GO:0008091,0.000237244775740181,0.999995096789055,3,8,spectrin,CC,SPTBN5;SPTBN4;SPTB
3933,GO:0008092,0.00024562331162142,0.999899805300972,26,823,cytoskeletal protein binding,MF,TAGLN;FHOD3;ACTN3;ACTN2;MARK4;RAB27A;SPTBN5;SPTBN4;RAB39B;CGN;REEP1;PLEKHH2;PSTPIP2;PSRC1;SPTB;CAMSAP3;DAAM2;ESPN;MSN;CDH1;MYO7A;MYH11;LZTS1;RAB3D;PARVB;PDE4B
7284,GO:0030177,0.000245754803966574,0.99995382055802,9,151,positive regulation of Wnt signaling pathway,BP,WNT3;WNT2;WNT4;WNT7A;FGF10;WNT5A;AXIN1;BMP2;WNT2B
3803,GO:0007417,0.000252876947472232,0.999894777917723,27,886,central nervous system development,BP,LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;WNT7A;WNT7B;SPTBN4;TYRO3;CDH2;FGF10;WNT5A;AXIN1;PFKFB3;FGF8;CLCF1;BMP7;BMP4;BMP2;DLL1;DRP2;AKT1;WNT2B;CDH1;HAPLN3;TSPAN2
8466,GO:0032403,0.000253007048361478,0.999902688843836,23,710,protein complex binding,MF,ITGA3;ITGA5;TAGLN;ACTN3;ACTN2;ACVR1;ADORA1;MFGE8;FSTL3;PIK3R1;PDGFB;JAM3;SPTB;MB21D2;CDKN1A;ESPN;DDR1;CTGF;PKP1;MYO7A;MYH11;LAMA5;RAB38
13300,GO:0048592,0.000258311782802172,0.999951254063902,9,139,eye morphogenesis,BP,WNT2;STRA6;WNT5A;AXIN1;BMP7;BMP4;DLL1;WNT2B;MYO7A
13286,GO:0048562,0.000259313900962741,0.999931006871865,13,283,embryonic organ morphogenesis,BP,NOTCH1;STRA6;ACVR1;EDN1;FGF10;WNT5A;AXIN1;FGF8;BMP7;BMP4;DLL1;GJB6;MYO7A
6260,GO:0017076,0.000260800275208149,0.999866883502596,46,1804,purine nucleotide binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
10853,GO:0042482,0.000261346445956785,0.999993946061184,3,10,positive regulation of odontogenesis,BP,WNT6;EDN1;BMP2
14878,GO:0060341,0.000263275979564497,0.999894081100609,25,811,regulation of cellular localization,BP,ITGA3;LIF;ACTN2;PMAIP1;CASQ2;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SESN2;RHOQ;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;CDH1;GAS6;GDNF;CLDN18
8414,GO:0032346,0.000268961173719622,1,2,2,positive regulation of aldosterone metabolic process,BP,WNT4;BMP6
8417,GO:0032349,0.000268961173719622,1,2,2,positive regulation of aldosterone biosynthetic process,BP,WNT4;BMP6
3396,GO:0006700,0.000273655752056971,0.999985568705858,4,23,C21-steroid hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
2888,GO:0005943,0.000274051043093201,1,2,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3R1;PIK3CA
19812,GO:1903847,0.000274215381777431,1,2,2,regulation of aorta morphogenesis,BP,NOTCH1;EFNB2
19813,GO:1903849,0.000274215381777431,1,2,2,positive regulation of aorta morphogenesis,BP,NOTCH1;EFNB2
20581,GO:1905651,0.000274215381777431,1,2,2,regulation of artery morphogenesis,BP,NOTCH1;EFNB2
20582,GO:1905653,0.000274215381777431,1,2,2,positive regulation of artery morphogenesis,BP,NOTCH1;EFNB2
1491,GO:0003213,0.000274215381782982,1,2,2,cardiac right atrium morphogenesis,BP,NOTCH1;WNT5A
2669,GO:0005578,0.000274375995251143,0.999918242724254,15,351,proteinaceous extracellular matrix,CC,WNT3;WNT2;WNT4;CRISPLD2;WNT6;WNT7A;WNT7B;WNT5B;WNT5A;BMP4;CTGF;WNT2B;HAPLN3;LAMA1;LAMA5
8578,GO:0032553,0.000275678843225097,0.999858909262421,46,1808,ribonucleotide binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
9744,GO:0035265,0.000277780780772985,0.999947020830852,9,142,organ growth,BP,WNT2;NOTCH1;EDN1;FGF10;FGF8;WT1;DLL1;AKT1;NPPC
9689,GO:0035107,0.000279275392283551,0.999946696638158,9,142,appendage morphogenesis,BP,WNT3;NOTCH1;WNT7A;SALL4;FGF10;WNT5A;FGF8;BMP7;BMP4
9690,GO:0035108,0.000279275392283551,0.999946696638158,9,142,limb morphogenesis,BP,WNT3;NOTCH1;WNT7A;SALL4;FGF10;WNT5A;FGF8;BMP7;BMP4
14948,GO:0060428,0.000279363135001027,0.999976600166699,5,40,lung epithelium development,BP,WNT2;STRA6;WNT7B;FGF10;BMP4
13371,GO:0048708,0.000279517005147108,0.99996822379432,6,62,astrocyte differentiation,BP,LIF;NOTCH1;CLCF1;BMP2;DLL1;TSPAN2
14347,GO:0051953,0.00028189479857815,0.999985106689892,4,22,negative regulation of amine transport,BP,ADRA2B;ADRA2C;ADORA1;CHGA
15315,GO:0061028,0.000283559558360778,0.999976274265694,5,38,establishment of endothelial barrier,BP,WNT7A;WNT7B;MSN;CLDN1;CLDN5
1649,GO:0003779,0.000284024960663772,0.999911189984713,16,393,actin binding,MF,TAGLN;FHOD3;ACTN3;ACTN2;SPTBN5;SPTBN4;CGN;PLEKHH2;PSTPIP2;SPTB;DAAM2;ESPN;MSN;MYO7A;MYH11;PARVB
1120,GO:0002521,0.000296007172891092,0.999903217971969,17,462,leukocyte differentiation,BP,LIF;WNT4;ZFPM1;FZD7;TYRO3;FSTL3;PIK3R1;CLCF1;BMP4;DLL1;TPD52;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
8204,GO:0031960,0.000296798258594604,0.999942687637249,9,159,response to corticosteroid,BP,NOTCH1;WNT7B;EDN1;BMP6;CDKN1A;CTGF;GJB2;CLDN1;HEY1
1569,GO:0003344,0.000299638227361688,0.999992971997374,3,9,pericardium morphogenesis,BP,NOTCH1;WNT5A;BMP7
731,GO:0001892,0.000306298821736345,0.999955943604936,7,88,embryonic placenta development,BP,LIF;WNT2;WNT7B;PDGFB;BMP7;AKT1;HEY1
14916,GO:0060389,0.000307725376870074,0.999964346402493,6,63,pathway-restricted SMAD protein phosphorylation,BP,ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
14965,GO:0060445,0.000308739905443914,0.999983189618186,4,23,branching involved in salivary gland morphogenesis,BP,FGF10;FGF8;BMP7;LAMA5
1119,GO:0002520,0.000314124557871488,0.999874566971662,24,789,immune system development,BP,ARTN;LIF;WNT4;NOTCH1;ZFPM1;FZD7;TYRO3;FSTL3;FGF10;PIK3R1;WNT5A;JAM3;CLCF1;BMP4;DLL1;SFXN1;TPD52;WNT2B;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
14578,GO:0055025,0.00031532215603146,0.99997287932176,5,40,positive regulation of cardiac muscle tissue development,BP,WNT2;NOTCH1;EDN1;BMP4;EFNB2
4239,GO:0008593,0.000315947600920186,0.999963179217193,6,64,regulation of Notch signaling pathway,BP,NOTCH1;FGF10;BMP7;DLL1;JAG2;HEY1
7458,GO:0030500,0.000318073318350971,0.999962853070298,6,65,regulation of bone mineralization,BP,WNT4;ACVR1;BMP7;BMP6;BMP4;BMP2
8838,GO:0032940,0.000320321765391362,0.999849256298045,35,1364,secretion by cell,BP,LIF;ADRA2B;ADRA2C;SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;WNT7A;ADORA1;EDN1;PLAU;RAB40B;RAB40A;SYCN;TYRO3;FGF10;PDGFB;RALB;WNT5A;SDC4;BMP6;VAMP1;CHGA;CTGF;PKP1;INHBB;RAB44;PIK3CG;RAB11FIP1;KCNG2;GAS6;RAB3D;GDNF
16433,GO:0071375,0.000320643523790721,0.999912707088877,13,293,cellular response to peptide hormone stimulus,BP,ACTN2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RHOQ;GJB2;AKT1;BCAR1;INHBB;PIK3CA
14059,GO:0051403,0.000321807889216542,0.999917900614141,12,247,stress-activated MAPK cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
4662,GO:0009855,0.000322662844687991,0.999944774523378,8,118,determination of bilateral symmetry,BP,NOTCH1;ACVR1;FGF10;WNT5A;AXIN1;FGF8;DAAM2;DLL1
9537,GO:0034650,0.000322669361739279,0.999992236377834,3,9,cortisol metabolic process,BP,WNT4;DKK3;BMP2
9538,GO:0034651,0.000322669361739279,0.999992236377834,3,9,cortisol biosynthetic process,BP,WNT4;DKK3;BMP2
1391,GO:0003018,0.000323117893330776,0.999936953780312,9,152,vascular process in circulatory system,BP,ADRA2B;ADRA2C;ADORA1;EDN1;NPR1;CHGA;AKT1;NPPC;ACTA2
13339,GO:0048667,0.00032663407512924,0.999884795655489,19,512,cell morphogenesis involved in neuron differentiation,BP,ARTN;WNT3;NOTCH1;WNT7A;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;NRTN;SEMA6C;MYO7A;PIK3CA;LZTS1;GDNF
7658,GO:0030900,0.000332438564348803,0.999899066340873,15,360,forebrain development,BP,WNT4;POU3F1;NOTCH1;WNT7A;WNT7B;TYRO3;CDH2;FGF10;WNT5A;AXIN1;FGF8;BMP4;BMP2;WNT2B;CDH1
11922,GO:0044802,0.000332569611966839,0.999869519541066,23,717,single-organism membrane organization,BP,ITGA3;SYT5;WNT4;ACTN2;TSPAN15;PMAIP1;SERPINA5;RAB40B;RAB40A;SPTBN4;RAB39A;CDH2;PIK3R1;REEP1;RHOQ;RAB20;VAMP1;AKT1;PKP3;CDH1;GAS6;LAMA5;GDNF
5939,GO:0016462,0.000333020743850127,0.999863839673942,25,810,pyrophosphatase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
21062,GO:2000209,0.00033533855184768,0.999981336393954,4,23,regulation of anoikis,BP,ITGA5;NOTCH1;TLE1;PIK3CA
14667,GO:0060037,0.000335890686103504,0.999981195676067,4,24,pharyngeal system development,BP,ACVR1;FGF8;BMP7;BMP4
17160,GO:0072676,0.000336429809974454,0.999959828093951,6,83,lymphocyte migration,BP,ARTN;CCL20;WNT5A;MSN;PIK3CG;GAS6
7341,GO:0030258,0.000337224070906157,0.99991346675208,12,254,lipid modification,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;SESN2;FGF8;HBEGF;AKT1;KITLG;PIK3CA;PIK3CG
14964,GO:0060444,0.000338499834744474,0.999981113431714,4,23,branching involved in mammary gland duct morphogenesis,BP,WNT4;WNT5A;DDR1;VDR
6135,GO:0016818,0.000339010340536845,0.999861216423847,25,812,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
14561,GO:0055006,0.000347137806357876,0.999958819809286,6,64,cardiac cell development,BP,FHOD3;ACTN2;NOTCH1;EDN1;BMP4;MYH11
6134,GO:0016817,0.000349353150161994,0.999856680958626,25,814,hydrolase activity, acting on acid anhydrides,MF,TUBG2;RAB6C;RAB27A;RASL11B;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;CGN;RALB;HRAS;RHOQ;RHOJ;RHOB;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;MYH11;RAB38;RAB3D
1545,GO:0003309,0.000349663928838877,0.999980321574324,4,23,type B pancreatic cell differentiation,BP,WNT5A;BMP6;BMP4;DLL1
7886,GO:0031328,0.000349840277779202,0.999823823731446,42,1717,positive regulation of cellular biosynthetic process,BP,LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;CCL20;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;BMP7;BMP6;BMP4;BMP2;WT1;DLL1;HMGN5;AKT1;KITLG;NPPC;CDH1;VDR;GDNF;FZD8;HEY1;PIM2
7622,GO:0030856,0.000350722752248555,0.999939161698115,8,121,regulation of epithelial cell differentiation,BP,LIF;NOTCH1;BMP6;BMP4;DLL1;CLDN5;VDR;GDNF
863,GO:0002068,0.000352773170683531,0.999980099814987,4,23,glandular epithelial cell development,BP,WNT5A;BMP6;BMP4;DLL1
6717,GO:0019827,0.000354832397881792,0.999929922393564,9,148,stem cell population maintenance,BP,LIF;NOTCH1;WNT7A;SALL4;FZD7;CDH2;FGF10;BMP7;DLL1
3615,GO:0007044,0.000360892210909565,0.999946733892423,7,85,cell-substrate junction assembly,BP,ITGA5;WNT4;ACTN3;ACTN2;ITGB4;SDC4;LAMA5
6756,GO:0019898,0.000365427048705498,0.999905382825427,12,254,extrinsic component of membrane,CC,TF;NMT2;MFGE8;CDH2;PIK3R2;PIK3R1;SNX18;MSN;CDH1;PIK3CA;PIK3CG;MYZAP
13418,GO:0048812,0.000369567036025439,0.999864393460753,20,561,neuron projection morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;LZTS1;GDNF
13064,GO:0048010,0.00037012976859386,0.999944975831473,7,91,vascular endothelial growth factor receptor signaling pathway,BP,ITGA5;MAPK12;FGF10;PIK3R2;PIK3R1;BCAR1;PIK3CA
1504,GO:0003231,0.000370502276653586,0.999935291807023,8,116,cardiac ventricle development,BP,NOTCH1;STRA6;ZFPM1;ACVR1;SALL4;WNT5A;BMP4;HEY1
761,GO:0001936,0.000377585987444847,0.9999435805789,7,95,regulation of endothelial cell proliferation,BP,WNT2;PDGFB;WNT5A;BMP6;BMP4;BMP2;AKT1
13964,GO:0051246,0.000380084116278608,0.999793341631482,54,2455,regulation of protein metabolic process,BP,ITGA5;LIF;ADRA2B;ADRA2C;PMAIP1;GADD45A;SERPINA5;WNT7A;WNT7B;ZFPM1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FGF10;PDGFB;PRKAR1B;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CDKN1A;MSN;CTGF;AKT1;KITLG;CST9L;INHBB;PIK3CA;PIK3CG;GAS6;PM20D2;ARAF;UNC119;FZD8;DUSP5;RNF144A
5192,GO:0014033,0.000380274950298065,0.999954028403432,6,66,neural crest cell differentiation,BP,ACVR1;EDN1;NRTN;KITLG;LAMA5;GDNF
7717,GO:0031018,0.000384302516013661,0.99996522505241,5,44,endocrine pancreas development,BP,WNT5A;BMP6;BMP4;DLL1;AKT1
12297,GO:0045682,0.000393928586679273,0.999951948276666,6,69,regulation of epidermis development,BP,NOTCH1;WNT5A;BMP4;DLL1;NAB2;VDR
18132,GO:0098727,0.000394905504462965,0.999920815765761,9,150,maintenance of cell number,BP,LIF;NOTCH1;WNT7A;SALL4;FZD7;CDH2;FGF10;BMP7;DLL1
4692,GO:0009953,0.000396314423293204,0.999940325750019,7,94,dorsal/ventral pattern formation,BP,WNT3;WNT7A;ACVR1;EDN1;PRKACB;FGF8;BMP4
8797,GO:0032880,0.000396700753741676,0.99982987715759,27,937,regulation of protein localization,BP,ITGA3;LIF;ADRA2C;ACTN2;PMAIP1;WNT7A;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;RALB;WNT5A;SESN2;RHOQ;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6;CLDN18
8775,GO:0032835,0.000397338926542714,0.999951687677784,6,63,glomerulus development,BP,NOTCH1;PDGFB;BMP7;BMP4;WT1;ACTA2
700,GO:0001845,0.000398340631186023,0.999989043272796,3,11,phagolysosome assembly,BP,RAB39A;RAB20;MYO7A
7766,GO:0031098,0.000398557061125834,0.999895802515959,12,253,stress-activated protein kinase signaling cascade,BP,GADD45A;WNT7A;WNT7B;EDN1;FZD7;HRAS;WNT5A;AXIN1;BMP2;CTGF;AKT1;FZD8
1471,GO:0003183,0.000399141824690759,0.999989303422563,3,10,mitral valve morphogenesis,BP,NOTCH1;ZFPM1;ACVR1
15046,GO:0060561,0.000405173623092017,0.999976156898868,4,24,apoptotic process involved in morphogenesis,BP,NOTCH1;BMP7;JAG2;VDR
7815,GO:0031214,0.000409096094183823,0.999927270424873,8,126,biomineral tissue development,BP,WNT4;WNT6;ACVR1;BMP7;BMP6;BMP4;BMP2;GAS6
15362,GO:0061097,0.000409211474619431,0.999949922020536,6,64,regulation of protein tyrosine kinase activity,BP,ADRA2B;ADRA2C;ADORA1;PDGFB;GAS6;UNC119
502,GO:0001533,0.000419688739841444,0.999960441935545,5,63,cornified envelope,CC,DSC2;DSG3;PKP3;PKP1;DSC3
3545,GO:0006939,0.000424773681432556,0.999935292561506,7,94,smooth muscle contraction,BP,ADRA2B;ADRA2C;ADORA1;EDN1;MYH11;GDNF;ACTA2
18352,GO:0099568,0.00043085407915862,0.999879013964021,13,287,cytoplasmic region,CC,ACTN2;SPTBN5;SPTBN4;CDH2;PLEKHH2;RALB;SPTB;CTGF;CYTIP;CDH1;MYO7A;CLDN5;MYZAP
15907,GO:0070372,0.000434640982044762,0.999893095782639,11,240,regulation of ERK1 and ERK2 cascade,BP,LIF;CCL20;FGF10;PDGFB;HRAS;FGF8;BMP4;BMP2;CTGF;GAS6;ARAF
7223,GO:0030097,0.000435173811042466,0.999829629714282,22,712,hemopoiesis,BP,LIF;WNT4;NOTCH1;ZFPM1;FZD7;TYRO3;FSTL3;PIK3R1;WNT5A;JAM3;CLCF1;BMP4;DLL1;SFXN1;TPD52;WNT2B;KITLG;JAG2;GAS6;TSPAN2;FZD8;CLDN18
14019,GO:0051336,0.000445169689601211,0.999788772080531,34,1321,regulation of hydrolase activity,BP,ARTN;WNT4;RIN3;ACTN2;PMAIP1;SERPINA5;RABIF;CCL20;SPTBN5;SPTBN4;MAPK12;LPAR2;FGF10;FGF17;PIK3R2;PDGFB;HRAS;WNT5A;SNX18;AXIN1;FGF8;SPTB;HBEGF;BMP2;CAMSAP3;CTGF;AKT1;NRTN;KITLG;CST9L;GAS6;AMOT;SH3BP4;GDNF
7509,GO:0030595,0.000447000535137625,0.999908295790834,9,187,leukocyte chemotaxis,BP,EDN1;CCL20;PDGFB;WNT5A;JAM3;CHGA;PIK3CG;GAS6;PDE4B
4015,GO:0008217,0.000453840218429553,0.999906981982753,9,165,regulation of blood pressure,BP,ADORA1;EDN1;KCNK6;PDGFB;NPR1;DLL1;CHGA;GAS6;ACTA2
13373,GO:0048710,0.000453930800412052,0.999972330098695,4,25,regulation of astrocyte differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
3719,GO:0007219,0.00045878287729641,0.999905920486898,9,159,Notch signaling pathway,BP,NOTCH1;FGF10;BMP7;BMP2;DLL1;JAG2;EPN1;DTX4;HEY1
10935,GO:0042594,0.000467982429703143,0.999903819174677,9,156,response to starvation,BP,WNT4;PMAIP1;DSC2;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6
19230,GO:1902589,0.000469734241012576,0.999765485347649,39,1542,single-organism organelle organization,BP,FHOD3;SYT5;WNT4;TUBG2;ACTN2;NOTCH1;MARK4;ITGB5;PMAIP1;CASQ2;EDN1;SPTBN5;SPTBN4;RAB39A;FGF10;PIK3R1;PLEKHH2;HRAS;JAM3;AXIN1;RHOQ;RHOJ;NUAK2;PSRC1;SDC4;SPTB;DAAM2;RAB20;ESPN;VAMP1;RND3;CTGF;PKP1;RAB17;BCAR1;MYH11;AMOT;LAMA5;PARVB
7394,GO:0030326,0.000470691924192252,0.99991461212891,8,122,embryonic limb morphogenesis,BP,WNT3;NOTCH1;WNT7A;SALL4;WNT5A;FGF8;BMP7;BMP4
9692,GO:0035113,0.000470691924192252,0.99991461212891,8,122,embryonic appendage morphogenesis,BP,WNT3;NOTCH1;WNT7A;SALL4;WNT5A;FGF8;BMP7;BMP4
12326,GO:0045741,0.000473030273215448,0.999986193847266,3,11,positive regulation of epidermal growth factor-activated receptor activity,BP,ADRA2B;ADRA2C;ADORA1
16348,GO:0071241,0.000489728120436587,0.999898558471341,9,165,cellular response to inorganic substance,BP,TF;GUCY1B3;EDN1;FSTL3;WNT5A;BMP6;AKT1;CDH1;CLDN1
12859,GO:0046890,0.000490490693651811,0.999910299801308,8,129,regulation of lipid biosynthetic process,BP,WNT4;DHH;DKK3;PDGFB;BMP6;BMP2;AKT1;VDR
9960,GO:0035639,0.000491655259688354,0.999744385899569,44,1749,purine ribonucleoside triphosphate binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2
18536,GO:1900182,0.000497404752194504,0.999908932891867,8,125,positive regulation of protein localization to nucleus,BP,LIF;PIK3R2;PIK3R1;SESN2;BMP6;BMP4;AKT1;CDH1
13442,GO:0048858,0.000501829403214101,0.999811223470277,20,575,cell projection morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;LZTS1;GDNF
1417,GO:0003093,0.000506959054605685,0.99998451853834,3,12,regulation of glomerular filtration,BP,ADORA1;PDGFB;GAS6
15426,GO:0061217,0.000529314208017338,0.999966231595665,4,26,regulation of mesonephros development,BP,BMP4;WT1;WNT2B;GDNF
7616,GO:0030850,0.000533635040806036,0.99994800272974,5,45,prostate gland development,BP,NOTCH1;FGF10;WNT5A;BMP7;BMP4
8418,GO:0032350,0.000534795948187885,0.999965787702148,4,26,regulation of hormone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
13288,GO:0048565,0.000548355168951309,0.999898101219934,8,125,digestive tract development,BP,NOTCH1;STRA6;ITGB4;FGF10;WNT5A;BMP4;CDKN1A;CLDN18
1464,GO:0003174,0.000551377761769693,0.999983031230962,3,11,mitral valve development,BP,NOTCH1;ZFPM1;ACVR1
10107,GO:0035883,0.000556218526146122,0.999964041190762,4,26,enteroendocrine cell differentiation,BP,WNT5A;BMP6;BMP4;DLL1
11734,GO:0044319,0.000558321913106725,0.999963868709791,4,26,wound healing, spreading of cells,BP,ITGA5;WNT7A;HBEGF;DDR1
17610,GO:0090505,0.000558321913106725,0.999963868709791,4,26,epiboly involved in wound healing,BP,ITGA5;WNT7A;HBEGF;DDR1
7464,GO:0030507,0.000569223394622702,0.999963137575462,4,25,spectrin binding,MF,SPTBN5;SPTBN4;CAMSAP3;MYO7A
790,GO:0001968,0.000573351596496177,0.99996263113903,4,26,fibronectin binding,MF,ITGA3;FSTL3;SDC4;CTGF
7067,GO:0021984,0.000575792251832254,0.999981029081308,3,14,adenohypophysis development,BP,WNT4;FGF8;BMP2
16929,GO:0072207,0.000577456225983864,0.999962291610603,4,26,metanephric epithelium development,BP,LIF;WNT4;WNT7B;WT1
3806,GO:0007422,0.000585553086666034,0.999922980114811,6,69,peripheral nervous system development,BP,ARTN;POU3F1;AKT1;NAB2;CLDN1;GDNF
7715,GO:0031016,0.000587644674101617,0.999922491218265,6,72,pancreas development,BP,FGF10;WNT5A;BMP6;BMP4;DLL1;AKT1
2159,GO:0004672,0.00059888194311732,0.999765505623469,21,624,protein kinase activity,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;FGF10;FGF17;KCNH2;NPR1;NUAK2;FGF8;HBEGF;CDKN1A;PKN3;WNK4;DDR1;AKT1;PIK3CA;PIK3CG;ARAF;PIM2
11809,GO:0044444,0.000604970093327385,0.999621689717975,147,8745,cytoplasmic part,CC,ITGA3;ITGA5;FHOD3;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT4;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;PNMT;TF;ITGB5;FASN;PMAIP1;CRISPLD2;FBXO41;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;HMGCS2;RABIF;NMT2;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;PSRC1;SDC4;SPTB;HBEGF;LGALS4;B3GNT2;WT1;CDKN1A;DLL1;PKN3;RAB20;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP1;RAB12;RAB17;CYTIP;PTGES;NPPC;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;RAB44;TLE1;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;DTX4;MYH11;GPSM1;AMOT;ARAF;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;ACTA2;RNF144A;PARVB;PDE4B
15140,GO:0060711,0.000607155599685011,0.999938939859652,5,47,labyrinthine layer development,BP,WNT2;WNT7B;BMP7;AKT1;HEY1
16878,GO:0072138,0.000608969688451793,0.999997084289073,2,3,mesenchymal cell proliferation involved in ureteric bud development,BP,BMP4;BMP2
12428,GO:0045927,0.000610176015914767,0.999843689985816,11,237,positive regulation of growth,BP,WNT3;WNT2;ACTN3;NOTCH1;EDN1;SPTBN4;FGF8;HBEGF;WT1;DLL1;AKT1
14823,GO:0060272,0.0006111648180401,0.999980089270623,3,12,embryonic skeletal joint morphogenesis,BP,AXIN1;BMP7;BMP4
7606,GO:0030834,0.000611787703299642,0.999938459816383,5,46,regulation of actin filament depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB
4764,GO:0010256,0.000615885032060652,0.999770792347219,19,553,endomembrane system organization,BP,ITGA3;WNT4;ACTN2;TSPAN15;RAB27A;RAB40B;RAB40A;SPTBN5;SPTBN4;CDH2;PIK3R1;REEP1;RHOQ;AKT1;PKP3;CDH1;GAS6;LAMA5;RAB38
8070,GO:0031668,0.000617668435484118,0.999854131339226,10,198,cellular response to extracellular stimulus,BP,WNT4;PMAIP1;DSC2;RALB;NUAK2;CDKN1A;WNT2B;INHBB;GAS6;VDR
12244,GO:0045608,0.000622010887020413,0.999996989660069,2,3,negative regulation of auditory receptor cell differentiation,BP,NOTCH1;DLL1
18875,GO:1901653,0.000622606937174384,0.999817812082047,13,315,cellular response to peptide,BP,ACTN2;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RHOQ;GJB2;AKT1;BCAR1;INHBB;PIK3CA
19343,GO:1902903,0.000625881546307614,0.999827534539504,12,272,regulation of supramolecular fiber organization,BP,FHOD3;WNT4;ACTN2;EDN1;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;PSRC1;SDC4;SPTB;CTGF
6536,GO:0019218,0.000632697562099187,0.999915199717102,6,75,regulation of steroid metabolic process,BP,WNT4;DHH;DKK3;BMP6;BMP2;VDR
9130,GO:0033604,0.000633382246986183,0.999979108572689,3,12,negative regulation of catecholamine secretion,BP,ADRA2B;ADRA2C;CHGA
8877,GO:0033002,0.000646176572245579,0.999860879968779,9,164,muscle cell proliferation,BP,WNT2;NOTCH1;EDN1;PDGFB;NPR1;HBEGF;BMP4;AKT1;NPPC
1041,GO:0002376,0.000647410630965787,0.999639011673399,54,2604,immune system process,BP,ITGA3;ITGA5;ARTN;LIF;WNT4;NOTCH1;RAB27A;ITGB5;PMAIP1;CRISPLD2;ZFPM1;ADORA1;EDN1;PLAU;PRKACB;CCL20;FZD7;TYRO3;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;HRAS;WNT5A;JAM3;SDC4;CLCF1;BMP6;BMP4;CDKN1A;DLL1;SFXN1;CHGA;MSN;TPD52;AKT1;PKP1;RAB17;WNT2B;KITLG;JAG2;BCAR1;RAB44;CLDN1;PIK3CA;PIK3CG;GAS6;TSPAN2;RAB3D;FZD8;CLDN18;EFNB2;PDE4B
17383,GO:0090100,0.000648579947102693,0.999893666373039,7,99,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,NOTCH1;ACVR1;BMP7;BMP6;BMP4;BMP2;INHBB
4247,GO:0008610,0.000651641309194783,0.999749353883092,20,628,lipid biosynthetic process,BP,WNT4;FASN;DHH;HMGCS2;DKK3;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;BMP6;BMP2;AKT1;PTGES;PIK3CA;PIK3CG;VDR
20323,GO:1904953,0.000653076738677264,0.99997822909792,3,12,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2;WNT5A
17609,GO:0090504,0.000657893393154801,0.999955326294609,4,27,epiboly,BP,ITGA5;WNT7A;HBEGF;DDR1
8181,GO:0031929,0.000660006668220374,0.999891512961989,7,98,TOR signaling,BP,PRR5L;SESN2;AKT1;PIK3CA;GAS6;ARAF;SH3BP4
527,GO:0001570,0.000677321707224815,0.999908260675963,6,71,vasculogenesis,BP,NOTCH1;WNT7A;WNT7B;WT1;AMOT;HEY1
8902,GO:0033036,0.000678069443419443,0.999613109259311,59,2775,macromolecule localization,BP,ITGA3;LIF;ADRA2C;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;PMAIP1;SERPINA5;WNT7A;RABIF;ADORA1;EDN1;RAB40B;RAB40A;SPTBN4;RAB39B;RAB39A;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SNX18;SESN2;RHOQ;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;WNK4;MSN;AKT1;PKP3;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;AMOT;LAMA5;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;CLDN18
10855,GO:0042487,0.000681102882564476,0.999976557608245,3,13,regulation of odontogenesis of dentin-containing tooth,BP,FGF8;BMP4;BMP2
17514,GO:0090287,0.000681657158682875,0.999823053513439,11,234,regulation of cellular response to growth factor stimulus,BP,ITGA3;ITGA5;WNT4;NOTCH1;RASL11B;DKK3;FSTL3;FGF10;WNT5A;BMP4;DLL1
15866,GO:0070307,0.000691656536686416,0.99997606709286,3,13,lens fiber cell development,BP,WNT7A;WNT7B;WNT5B
1562,GO:0003337,0.000693764730912083,0.999975968791777,3,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF;BMP4;GDNF
2346,GO:0004938,0.000697648722358313,0.999996421072497,2,3,alpha2-adrenergic receptor activity,MF,ADRA2B;ADRA2C
8870,GO:0032990,0.000698375318198515,0.999730016749623,20,593,cell part morphogenesis,BP,ARTN;WNT3;NOTCH1;WNT7A;WNT7B;SPTBN5;SPTBN4;PIK3R1;HRAS;WNT5A;FGF8;SPTB;BMP7;B3GNT2;DDR1;NRTN;SEMA6C;PIK3CA;LZTS1;GDNF
10752,GO:0042306,0.000703981273718383,0.99984654687479,9,166,regulation of protein import into nucleus,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CDH1;GAS6
2877,GO:0005921,0.000704247231504909,0.999950781595587,4,30,gap junction,CC,GJB1;GJB2;GJB6;GJA3
15466,GO:0061351,0.00071070010005343,0.99986250704029,8,127,neural precursor cell proliferation,BP,ARTN;WNT2;NOTCH1;WNT7A;LIMS2;CDH2;WNT5A;FGF8
14944,GO:0060423,0.000717423582029063,0.999996267009173,2,3,foregut regionalization,BP,WNT2;WNT2B
14945,GO:0060424,0.000717423582029063,0.999996267009173,2,3,lung field specification,BP,WNT2;WNT2B
15002,GO:0060492,0.000717423582029063,0.999996267009173,2,3,lung induction,BP,WNT2;WNT2B
15420,GO:0061205,0.000723230390463811,0.999996221352992,2,3,paramesonephric duct development,BP,WNT4;STRA6
11392,GO:0043412,0.000725583362449247,0.999560763373404,79,3985,macromolecule modification,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;MARK4;GADD45A;FBXO41;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EDN1;RAB40B;RAB40A;PRKACB;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;HMGN5;PKN3;WNK4;DDR1;CTGF;AKT1;NRTN;KITLG;INHBB;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;RNF144A;PIM2
16353,GO:0071248,0.000739454798482191,0.999855590717147,8,142,cellular response to metal ion,BP,TF;EDN1;FSTL3;WNT5A;BMP6;AKT1;CDH1;CLDN1
18077,GO:0098588,0.000742769298494805,0.999605355420932,44,1865,bounding membrane of organelle,CC,TMEM163;SYT5;WNT3;WNT4;TSPAN15;NOTCH1;RAB27A;TF;PMAIP1;SERPINA5;WNT6;WNT7A;WNT7B;CASQ2;PLAU;SPTBN5;TTYH1;RAB39A;SYCN;FZD7;PDGFB;HRAS;WNT5B;WNT5A;SNX18;RHOQ;RHOB;HBEGF;B3GNT2;RAB20;VAMP1;RND3;CHGA;PKP1;RAB12;RAB17;MYO7A;RAB44;RAB11FIP1;GPSM1;RAB38;RAB3D;ACSL4;RNF144A
8568,GO:0032535,0.000746655347868267,0.999777179186101,13,313,regulation of cellular component size,BP,FHOD3;WNT3;ACTN2;WNT7A;WNT7B;EDN1;SPTBN5;SPTBN4;PLEKHH2;WNT5A;SPTB;MSN;AKT1
4805,GO:0010463,0.000746688494645632,0.999921370219269,5,47,mesenchymal cell proliferation,BP,WNT2;WNT5A;BMP7;BMP4;BMP2
3671,GO:0007163,0.000754091985601801,0.99983415167219,9,161,establishment or maintenance of cell polarity,BP,MARK4;WNT7A;WNT7B;FGF10;WNT5A;JAM3;MSN;AMOT;PARVB
17340,GO:0090031,0.000756813331005527,0.999995953648826,2,3,positive regulation of steroid hormone biosynthetic process,BP,WNT4;BMP6
10633,GO:0042063,0.000761474396186798,0.999799554737823,11,239,gliogenesis,BP,LIF;POU3F1;NOTCH1;CDH2;FGF10;CLCF1;BMP2;DLL1;AKT1;NAB2;TSPAN2
14961,GO:0060441,0.000764155764459032,0.999945585045486,4,29,epithelial tube branching involved in lung morphogenesis,BP,WNT2;FGF10;BMP4;WNT2B
15089,GO:0060627,0.000768139561753016,0.999736058559193,16,441,regulation of vesicle-mediated transport,BP,SYT5;ACTN2;NOTCH1;RAB27A;TF;MFGE8;RALB;WNT5A;SDC4;DLL1;RAB20;MSN;RAB17;GAS6;UNC119;RAB3D
9569,GO:0034698,0.000771595562290773,0.999945309840128,4,27,response to gonadotropin,BP,ITGA3;NOTCH1;WT1;GJB2
14830,GO:0060284,0.000772329701743295,0.99967729611652,23,747,regulation of cell development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;EDN1;CDH2;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;NPPC;CLDN5;LZTS1;CLDN18
20141,GO:1904589,0.000779751418041102,0.999827479455274,9,169,regulation of protein import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CDH1;GAS6
15906,GO:0070371,0.000783125148410208,0.999792873770834,11,256,ERK1 and ERK2 cascade,BP,LIF;CCL20;FGF10;PDGFB;HRAS;FGF8;BMP4;BMP2;CTGF;GAS6;ARAF
12072,GO:0045184,0.000788282650572338,0.999574420566179,46,2049,establishment of protein localization,BP,ITGA3;ADRA2C;WNT4;ACTN2;TSPAN15;TSPAN17;NOTCH1;RAB27A;TF;PMAIP1;RABIF;ADORA1;RAB40B;RAB40A;SPTBN4;RAB39B;RAB39A;FZD7;CDH2;PRR5L;PIK3R2;PIK3R1;REEP1;WNT5A;SNX18;RHOQ;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;AKT1;PKP3;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;LAMA5;UNC119;RAB38;RAB3D
13279,GO:0048546,0.000788510143771987,0.999915722225223,5,49,digestive tract morphogenesis,BP,NOTCH1;STRA6;FGF10;WNT5A;BMP4
2441,GO:0005092,0.000799195020044669,0.999970499818803,3,14,GDP-dissociation inhibitor activity,MF,SESN2;GPSM1;SH3BP4
8545,GO:0032496,0.000799903671863931,0.999772899901104,12,299,response to lipopolysaccharide,BP,NOTCH1;EDN1;CCL20;FGF10;WNT5A;BMP6;GJB2;GJB6;AKT1;PTGES;CLDN1;PDE4B
14255,GO:0051783,0.000802419808315608,0.9998217157903,9,170,regulation of nuclear division,BP,LIF;WNT4;EDN1;PDGFB;WNT5A;PSRC1;FGF8;BMP7;BMP4
12133,GO:0045321,0.000805412852368533,0.999626722641974,29,1129,leukocyte activation,BP,WNT4;RAB27A;CRISPLD2;ZFPM1;EDN1;PLAU;FZD7;TYRO3;FGF10;PIK3R1;WNT5A;SDC4;CLCF1;BMP4;CDKN1A;DLL1;CHGA;MSN;TPD52;AKT1;PKP1;JAG2;RAB44;PIK3CA;PIK3CG;GAS6;RAB3D;FZD8;EFNB2
1477,GO:0003192,0.000807361764559002,0.999995539169077,2,3,mitral valve formation,BP,NOTCH1;ZFPM1
12917,GO:0046983,0.000808881281303438,0.999624944547004,29,1157,protein dimerization activity,MF,ITGA3;ADRA2C;SYT5;ACTN3;ACTN2;NOTCH1;GLDC;FASN;GADD45A;ACVR1;ADORA1;CASQ2;TYRO3;PIK3R2;PIK3R1;PDGFB;KCNH2;JAM3;AXIN1;CLCF1;BMP6;BMP2;GJB1;TPD52;NPPC;MYO7A;INHBB;GDNF;HEY1
1205,GO:0002685,0.000816114532655021,0.999837772531671,8,156,regulation of leukocyte migration,BP,ADORA1;EDN1;CCL20;WNT5A;JAM3;MSN;KITLG;GAS6
2533,GO:0005243,0.000818394172550098,0.999969540945468,3,14,gap junction channel activity,MF,GJB1;GJB2;GJA3
1475,GO:0003188,0.000827390881930368,0.999969532279921,3,13,heart valve formation,BP,NOTCH1;ZFPM1;HEY1
18291,GO:0099068,0.000829532130645545,0.999969951617051,3,12,postsynapse assembly,BP,WNT7A;CDH2;WNT5A
7204,GO:0030042,0.000843721663189311,0.999908446608057,5,49,actin filament depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB
10636,GO:0042074,0.000850875500219201,0.999967900707022,3,14,cell migration involved in gastrulation,BP,WNT5A;FGF8;AMOT
3805,GO:0007420,0.000862293371069678,0.999652157245072,21,666,brain development,BP,WNT3;WNT2;WNT4;POU3F1;NOTCH1;WNT7A;WNT7B;TYRO3;CDH2;FGF10;WNT5A;AXIN1;PFKFB3;FGF8;BMP7;BMP4;BMP2;DLL1;WNT2B;CDH1;TSPAN2
5880,GO:0016324,0.000874758443228085,0.999749441269272,12,274,apical plasma membrane,CC,NOTCH1;RAB27A;TF;SLC52A3;CDH2;DLL1;MSN;GJB6;RAB17;MYO7A;CLDN1;LZTS1
16814,GO:0072044,0.000878071719173541,0.999966990347355,3,13,collecting duct development,BP,NOTCH1;WNT7B;BMP4
14631,GO:0055123,0.000880603993659694,0.999823534926019,8,136,digestive system development,BP,NOTCH1;STRA6;ITGB4;FGF10;WNT5A;BMP4;CDKN1A;CLDN18
18721,GO:1901213,0.000885058298933668,0.999966635795141,3,13,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,NOTCH1;ACVR1;BMP4
520,GO:0001558,0.000888899004538174,0.999715272570223,14,373,regulation of cell growth,BP,WNT3;EDN1;WNT5A;SESN2;NPR1;PSRC1;HBEGF;WT1;CDKN1A;DDR1;CTGF;AKT1;BCAR1;SH3BP4
12322,GO:0045737,0.00089189251414188,0.999933187040128,4,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,FGF10;PDGFB;PSRC1;AKT1
7183,GO:0030010,0.000894982220878642,0.999844859861759,7,101,establishment of cell polarity,BP,MARK4;WNT7A;FGF10;WNT5A;JAM3;MSN;AMOT
40,GO:0000079,0.000897787550156867,0.999870856762613,6,81,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,GADD45A;FGF10;PDGFB;PSRC1;CDKN1A;AKT1
19287,GO:1902742,0.00090648451156103,0.999932406706744,4,29,apoptotic process involved in development,BP,NOTCH1;BMP7;JAG2;VDR
13328,GO:0048644,0.000906908374179306,0.999869497651513,6,78,muscle organ morphogenesis,BP,LIF;WNT2;NOTCH1;ZFPM1;WNT5A;BMP2
12232,GO:0045596,0.000909508447643107,0.999649758877584,19,603,negative regulation of cell differentiation,BP,WNT3;WNT4;NOTCH1;WNT7A;ZFPM1;FZD7;FSTL3;FGF10;PIK3R1;PDGFB;FOXO4;WNT5A;AXIN1;BMP7;BMP4;BMP2;DLL1;NPPC;CLDN18
15109,GO:0060674,0.000912425518727803,0.999931843503932,4,29,placenta blood vessel development,BP,WNT2;ITGB8;AKT1;HEY1
732,GO:0001893,0.000913271739398821,0.999931338170123,4,31,maternal placenta development,BP,LIF;GJB2;AKT1;VDR
2628,GO:0005488,0.000925474529630755,0.999500387287858,208,13522,binding,MF,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;RHBDL3;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;RABIF;SALL4;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;TTYH1;MPZL1;RRAS2;RAB39B;RAB39A;PRND;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;MB21D2;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;CAMSAP3;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;ESPN;VAMP1;WNK4;RND3;MSN;DDR1;DSG3;CTGF;GJB1;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;HPCAL1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;HAPLN3;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;SHC4;DSC3;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
15457,GO:0061337,0.00092890327222566,0.999812306898534,8,136,cardiac conduction,BP,DSC2;CASQ2;KCNK6;SPTBN4;KCNH2;NPR1;NPPC;KCND1
2666,GO:0005575,0.000930579962173117,1,240,16973,cellular_component,CC,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;RHBDL3;FBXO41;SLC45A4;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;HRCT1;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;OLFML2B;SDC4;CLCF1;SPTB;HBEGF;PGBD5;LGALS4;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;SEMA6C;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;TPBGL;SPSB1;HPCAL1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;HAPLN3;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;PM20D2;SHC4;SLC18B1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
13110,GO:0048145,0.000931271237492076,0.999864953546019,6,83,regulation of fibroblast proliferation,BP,WNT2;FGF10;PDGFB;WNT5A;CDKN1A;GAS6
11051,GO:0042802,0.000933021399977576,0.999541927047526,33,1331,identical protein binding,MF,ADRA2C;ACTN3;ACTN2;FASN;GADD45A;ACVR1;CASQ2;PDGFB;KCNH2;PLEKHH2;FOXO4;JAM3;AXIN1;GJB1;TPD52;AKT1;NPPC;NAB2;MYO7A;INHBB;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;CLDN23;SH3BP4;GDNF;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18
17059,GO:0072498,0.000940905436731432,0.999963240117351,3,14,embryonic skeletal joint development,BP,AXIN1;BMP7;BMP4
13301,GO:0048593,0.000945331781348825,0.999834467218485,7,103,camera-type eye morphogenesis,BP,WNT2;STRA6;WNT5A;BMP7;BMP4;DLL1;WNT2B
15323,GO:0061036,0.000960355599444387,0.999927263262956,4,29,positive regulation of cartilage development,BP,WNT5A;BMP6;BMP4;BMP2
20628,GO:1905867,0.000980645349038692,0.999991558611486,2,4,epididymis development,BP,GJB1;GJB2
12299,GO:0045684,0.000983193910142228,0.999924185249346,4,33,positive regulation of epidermis development,BP,NOTCH1;WNT5A;BMP4;VDR
12302,GO:0045687,0.000984613864845648,0.999924243316349,4,32,positive regulation of glial cell differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
12237,GO:0045601,0.000987807909800421,0.999924368571496,4,30,regulation of endothelial cell differentiation,BP,NOTCH1;BMP6;BMP4;CLDN5
10119,GO:0035909,0.000988563080567183,0.999924537974984,4,29,aorta morphogenesis,BP,NOTCH1;FGF8;HEY1;EFNB2
11796,GO:0044425,0.000994706249045958,0.999367194225111,109,6187,membrane part,CC,ITGA3;ITGA5;TMEM163;ADRA2B;ADRA2C;SYT5;TSPAN15;TSPAN17;NOTCH1;RAB27A;CDH23;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;RHBDL3;SLC45A4;DSC2;SERPINA5;SLC52A3;TMEM206;ACVR1;NMT2;ADORA1;CASQ2;KCNK6;MFGE8;FLVCR2;SPTBN5;MBOAT2;SLC25A53;TTYH1;MPZL1;TSPAN13;PRND;FZD7;TYRO3;LPAR2;CDH2;HRCT1;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;PTPN7;JAM3;SNX18;AXIN1;RHOQ;NPR1;FGF8;SDC4;SPTB;HBEGF;PGBD5;BMP2;B3GNT2;DLL1;DRP2;SLC2A14;VAMP1;SFXN1;MSN;DDR1;DSG3;GJB1;GJB2;GJB6;RAB17;PTGES;KITLG;SEMA6C;JAG2;CDH1;EPN1;MYO7A;GJA3;TPBGL;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;KCNG2;LZTS1;CLDN23;SHC4;SLC18B1;DSC3;GPSM1;AMOT;SH3BP4;KCND1;TSPAN2;ACSL4;MYZAP;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;EFNB2;PDE4B
14184,GO:0051641,0.000996061344713685,0.999435612240649,53,2455,cellular localization,BP,ITGA3;LIF;SYT5;WNT4;ACTN2;RAB6C;TSPAN15;TSPAN17;RAB27A;PMAIP1;WNT7A;NMT2;ADORA1;CASQ2;RAB40B;RAB40A;SPTBN5;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;GPRASP1;SESN2;RHOQ;RHOB;PSRC1;SPTB;BMP7;BMP6;BMP4;CDKN1A;CHGA;MSN;AKT1;PKP3;RAB12;RAB17;CDH1;MYO7A;PIK3CG;GAS6;AMOT;LAMA5;SH3BP4;RAB38;GDNF;CLDN18
760,GO:0001935,0.0010013231448,0.999822465796416,7,111,endothelial cell proliferation,BP,WNT2;PDGFB;WNT5A;BMP6;BMP4;BMP2;AKT1
10859,GO:0042491,0.00102456236854892,0.999920537907674,4,31,auditory receptor cell differentiation,BP,NOTCH1;DLL1;JAG2;MYO7A
12262,GO:0045632,0.00103209238491997,0.999990881802162,2,4,negative regulation of mechanoreceptor differentiation,BP,NOTCH1;DLL1
21528,GO:2000981,0.00103209238491997,0.999990881802162,2,4,negative regulation of inner ear receptor cell differentiation,BP,NOTCH1;DLL1
3815,GO:0007492,0.00103725636908256,0.999846888913181,6,77,endoderm development,BP,ITGA5;NOTCH1;ITGB5;FGF8;BMP4;DUSP5
12351,GO:0045787,0.00104505499071724,0.999676052703475,13,334,positive regulation of cell cycle,BP,WNT4;GADD45A;EDN1;FGF10;PDGFB;FOXO4;WNT5A;PSRC1;FGF8;CDKN1A;HMGN5;CTGF;AKT1
12916,GO:0046982,0.0010534967438567,0.999640507270225,15,466,protein heterodimerization activity,MF,ITGA3;ADRA2C;SYT5;NOTCH1;GADD45A;ADORA1;TYRO3;PIK3R2;PIK3R1;PDGFB;JAM3;CLCF1;BMP6;BMP2;TPD52
21181,GO:2000379,0.00105506131786374,0.99984317922131,6,84,positive regulation of reactive oxygen species metabolic process,BP,RAB27A;GADD45A;EDN1;PDGFB;CDKN1A;AKT1
16732,GO:0071880,0.00105781785505401,0.999956950569582,3,14,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,ADRA2B;ADRA2C;CHGA
11624,GO:0044087,0.00106018049797758,0.999546038891608,23,771,regulation of cellular component biogenesis,BP,FHOD3;WNT4;NOTCH1;PMAIP1;WNT7A;EDN1;SPTBN5;SPTBN4;PIK3R1;RALB;HRAS;WNT5A;RHOQ;PSRC1;SDC4;SPTB;BMP7;ESPN;CHGA;MSN;CTGF;RAB17;CLDN1
14257,GO:0051785,0.0010622949017386,0.99987778452873,5,55,positive regulation of nuclear division,BP,WNT4;EDN1;PDGFB;WNT5A;FGF8
98,GO:0000187,0.00106307067304825,0.999780285011896,8,144,activation of MAPK activity,BP,ADRA2B;ADRA2C;WNT7B;FGF10;WNT5A;AXIN1;BMP2;DUSP5
13332,GO:0048660,0.00107678736981914,0.999806623004983,7,112,regulation of smooth muscle cell proliferation,BP,EDN1;PDGFB;NPR1;HBEGF;BMP4;AKT1;NPPC
3592,GO:0007015,0.00107739640004203,0.999664991653911,13,328,actin filament organization,BP,FHOD3;WNT4;ACTN2;ITGB5;SPTBN5;SPTBN4;PIK3R1;PLEKHH2;SDC4;SPTB;ESPN;CTGF;BCAR1
17493,GO:0090263,0.0010786787180503,0.999805857096085,7,119,positive regulation of canonical Wnt signaling pathway,BP,WNT2;WNT4;WNT7A;FGF10;WNT5A;AXIN1;WNT2B
12332,GO:0045747,0.00108082991645333,0.999914492589038,4,33,positive regulation of Notch signaling pathway,BP,NOTCH1;FGF10;DLL1;JAG2
19905,GO:1904029,0.00109379846189236,0.999836277781341,6,84,regulation of cyclin-dependent protein kinase activity,BP,GADD45A;FGF10;PDGFB;PSRC1;CDKN1A;AKT1
19649,GO:1903530,0.00110954233729148,0.999565226487669,19,617,regulation of secretion by cell,BP,LIF;ADRA2B;ADRA2C;SYT5;NOTCH1;RAB27A;ADORA1;EDN1;RALB;WNT5A;SDC4;BMP6;CHGA;INHBB;RAB11FIP1;KCNG2;GAS6;RAB3D;GDNF
16858,GO:0072108,0.00111147338627425,0.999989803363864,2,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF;GDNF
8758,GO:0032811,0.00112734296672991,0.999989582904407,2,4,negative regulation of epinephrine secretion,BP,ADRA2B;ADRA2C
3363,GO:0006661,0.00114091786702556,0.999761760458379,8,140,phosphatidylinositol biosynthetic process,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;PIK3CA;PIK3CG
6102,GO:0016772,0.001145845500551,0.999471551528289,27,955,transferase activity, transferring phosphorus-containing groups,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;NPR1;NUAK2;PFKFB3;FGF8;HBEGF;CDKN1A;PKN3;WNK4;DDR1;AKT1;KITLG;PIK3CA;PIK3CG;ARAF;PIM2
4006,GO:0008207,0.00114736856056173,0.999907521793555,4,34,C21-steroid hormone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
3741,GO:0007264,0.00115205494126084,0.999573846398486,17,482,small GTPase mediated signal transduction,BP,ITGA3;RAB6C;RABIF;RRAS2;FGF10;PIK3R2;RALB;HRAS;RHOQ;RHOJ;RHOB;CDKN1A;RND3;RRAD;KITLG;AMOT;RAB38
17125,GO:0072593,0.00115414473561101,0.999703186021259,10,228,reactive oxygen species metabolic process,BP,RAB27A;PMAIP1;GADD45A;EDN1;PDGFB;SESN2;BMP7;CDKN1A;CTGF;AKT1
10229,GO:0036094,0.00118313873910607,0.999327115572056,52,2314,small molecule binding,MF,TUBG2;RAB6C;GLDC;MARK4;RAB27A;RASL11B;FASN;SERPINA5;ACVR1;GUCY1B3;ADORA1;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;SESN2;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;VDR;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
21487,GO:2000826,0.00118323524725395,0.99990431187026,4,32,regulation of heart morphogenesis,BP,NOTCH1;ACVR1;BMP4;BMP2
12327,GO:0045742,0.00119136154533042,0.999902990199107,4,34,positive regulation of epidermal growth factor receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;AKT1
877,GO:0002085,0.00119642503954898,0.99998860478054,2,4,inhibition of neuroepithelial cell differentiation,BP,NOTCH1;DLL1
10982,GO:0042693,0.00120007192226502,0.999947320601907,3,17,muscle cell fate commitment,BP,ACVR1;FGF10;WT1
20324,GO:1904954,0.00121478753307871,0.999988339814042,2,4,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
12668,GO:0046488,0.00121977863140657,0.999684411789482,10,213,phosphatidylinositol metabolic process,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
724,GO:0001885,0.00121994741559798,0.999855502027958,5,53,endothelial cell development,BP,WNT7A;WNT7B;MSN;CLDN1;CLDN5
5009,GO:0010810,0.00123083813651631,0.999709126713953,9,174,regulation of cell-substrate adhesion,BP,ITGA3;ITGA5;WNT4;NOTCH1;PLAU;FZD7;PIK3R1;SDC4;DDR1
7193,GO:0030027,0.00123613091941485,0.999707776247616,9,172,lamellipodium,CC,CDH2;PLEKHH2;KITLG;CDH1;BCAR1;PIK3CA;AMOT;ACTA2;PARVB
11702,GO:0044267,0.00125843381014321,0.999210022854925,87,4698,cellular protein metabolic process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN17;MARK4;PMAIP1;GADD45A;FBXO41;SERPINA5;WNT7A;WNT7B;ACVR1;NMT2;ADORA1;EDN1;RAB40B;RAB40A;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;DLL1;PKN3;WNK4;MSN;DDR1;CTGF;AKT1;RAB12;NRTN;KITLG;CST9L;JAG2;INHBB;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;PM20D2;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;RNF144A;PIM2
12732,GO:0046620,0.0012708309030326,0.999804418338383,6,81,regulation of organ growth,BP,WNT2;NOTCH1;EDN1;FGF8;WT1;AKT1
955,GO:0002237,0.00127663218913916,0.999616930022607,12,314,response to molecule of bacterial origin,BP,NOTCH1;EDN1;CCL20;FGF10;WNT5A;BMP6;GJB2;GJB6;AKT1;PTGES;CLDN1;PDE4B
13331,GO:0048659,0.00127897337023901,0.999763168640247,7,115,smooth muscle cell proliferation,BP,EDN1;PDGFB;NPR1;HBEGF;BMP4;AKT1;NPPC
15422,GO:0061209,0.00128629334642139,0.999987288505601,2,4,cell proliferation involved in mesonephros development,BP,BMP4;BMP2
3749,GO:0007272,0.00128862496358115,0.99976140879327,7,110,ensheathment of neurons,BP,POU3F1;DHH;JAM3;AKT1;NAB2;TSPAN2;CLDN11
4104,GO:0008366,0.00128862496358115,0.99976140879327,7,110,axon ensheathment,BP,POU3F1;DHH;JAM3;AKT1;NAB2;TSPAN2;CLDN11
16842,GO:0072089,0.00128902609085246,0.99976161675799,7,106,stem cell proliferation,BP,ARTN;WNT3;NOTCH1;WNT7B;WNT5A;WNT2B;KITLG
8788,GO:0032870,0.0012906603619311,0.999487606515302,19,610,cellular response to hormone stimulus,BP,ACTN2;NOTCH1;EDN1;PRKACB;PIK3R2;PIK3R1;PRKAR1B;FOXO4;RHOQ;BMP7;BMP4;WT1;GJB2;AKT1;BCAR1;INHBB;PIK3CA;VDR;HEY1
15218,GO:0060840,0.00130121898408064,0.999799130757821,6,78,artery development,BP,NOTCH1;STRA6;FGF8;BMP4;HEY1;EFNB2
5280,GO:0014834,0.00134227962798789,0.999986444109268,2,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A;FZD7
19739,GO:1903707,0.00134895386510205,0.999746930942217,7,131,negative regulation of hemopoiesis,BP,NOTCH1;ZFPM1;FSTL3;PIK3R1;BMP4;DLL1;CLDN18
7285,GO:0030178,0.00134997342747455,0.999675935336193,9,193,negative regulation of Wnt signaling pathway,BP,WNT4;NOTCH1;DKK3;CDH2;WNT5B;WNT5A;AXIN1;BMP2;TLE1
14922,GO:0060395,0.00136174596723049,0.999834139405774,5,56,SMAD protein signal transduction,BP,BMP7;BMP6;BMP4;BMP2;INHBB
9512,GO:0034613,0.00137472720712447,0.999270461859755,39,1682,cellular protein localization,BP,ITGA3;LIF;WNT4;ACTN2;TSPAN15;TSPAN17;RAB27A;PMAIP1;ADORA1;RAB40B;RAB40A;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SESN2;RHOQ;RHOB;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;PKP3;CDH1;MYO7A;GAS6;AMOT;LAMA5;SH3BP4;RAB38;CLDN18
5202,GO:0014045,0.00137578931583771,0.999985929948786,2,4,establishment of endothelial blood-brain barrier,BP,WNT7A;WNT7B
7079,GO:0022009,0.00137578931583771,0.999985929948786,2,4,central nervous system vasculogenesis,BP,WNT7A;WNT7B
7111,GO:0022607,0.00138594483334451,0.999198243080565,54,2570,cellular component assembly,BP,ITGA5;FHOD3;WNT4;TUBG2;ACTN3;ACTN2;NOTCH1;MARK4;ITGB5;ITGB4;PMAIP1;WNT7A;CASQ2;EDN1;SPTBN5;SPTBN4;TTYH1;RAB39A;PRND;LIMS2;CDH2;PIK3R1;RALB;HRAS;WNT5A;AXIN1;RHOQ;PSRC1;SDC4;SPTB;BMP7;RAB20;ESPN;VAMP1;MSN;CTGF;GJB1;GJB2;PKP3;PKP1;RAB17;CDH1;MYO7A;TLE1;CLDN1;CLDN3;CLDN5;KCNG2;GAS6;MYH11;LAMA5;KCND1;RAB38;PARVB
16832,GO:0072075,0.00140634919525793,0.999936001022849,3,15,metanephric mesenchyme development,BP,WNT4;BMP7;WT1
10701,GO:0042181,0.00140833163605829,0.999879452778685,4,36,ketone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
14085,GO:0051447,0.00140936463424353,0.999934556469144,3,17,negative regulation of meiotic cell cycle,BP,LIF;PRKACB;NPPC
14942,GO:0060421,0.00141547948027534,0.999879497298029,4,33,positive regulation of heart growth,BP,WNT2;NOTCH1;EDN1;WT1
16974,GO:0072283,0.00141558594903024,0.999934757301169,3,16,metanephric renal vesicle morphogenesis,BP,LIF;BMP4;GDNF
83,GO:0000166,0.00143114654481257,0.999198479506203,47,2024,nucleotide binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;FASN;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
8413,GO:0032345,0.00143362069113452,0.999985027436195,2,4,negative regulation of aldosterone metabolic process,BP,DKK3;BMP2
8416,GO:0032348,0.00143362069113452,0.999985027436195,2,4,negative regulation of aldosterone biosynthetic process,BP,DKK3;BMP2
20985,GO:2000065,0.00143362069113452,0.999985027436195,2,4,negative regulation of cortisol biosynthetic process,BP,DKK3;BMP2
9951,GO:0035625,0.00143493007511329,0.999985006781982,2,4,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C
14862,GO:0060323,0.00143652866965792,0.999877211930598,4,33,head morphogenesis,BP,WNT3;STRA6;CRISPLD2;CLDN5
16735,GO:0071883,0.00143663603402011,0.99998497985768,2,4,activation of MAPK activity by adrenergic receptor signaling pathway,BP,ADRA2B;ADRA2C
3810,GO:0007435,0.00143685461628311,0.999876879529461,4,34,salivary gland morphogenesis,BP,FGF10;FGF8;BMP7;LAMA5
21091,GO:2000269,0.00143801346418208,0.999934047461794,3,15,regulation of fibroblast apoptotic process,BP,PIK3CA;PIK3CG;GAS6
18748,GO:1901265,0.00143866847641664,0.999194041887334,47,2025,nucleoside phosphate binding,MF,TUBG2;RAB6C;MARK4;RAB27A;RASL11B;FASN;ACVR1;GUCY1B3;RAB40B;RAB40A;PRKACB;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;RALB;HRAS;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;MYH11;ARAF;RAB38;RAB3D;ACSL4;ACTA2;PIM2;PDE4B
17162,GO:0072678,0.00143920236937146,0.999874962073186,4,41,T cell migration,BP,CCL20;WNT5A;MSN;PIK3CG
2976,GO:0006081,0.00144696372536224,0.999770647427315,6,90,cellular aldehyde metabolic process,BP,WNT4;GLDC;DKK3;KHK;BMP6;BMP2
13091,GO:0048048,0.00145188511340746,0.999875859283864,4,32,embryonic eye morphogenesis,BP,STRA6;WNT5A;AXIN1;BMP7
18206,GO:0098858,0.00146077402028278,0.999645943843094,9,178,actin-based cell projection,CC,ITGA3;ACTN2;CDH23;TTYH1;ESPN;MSN;KITLG;MYO7A;ACTA2
1424,GO:0003104,0.001467903988132,0.999984483471883,2,4,positive regulation of glomerular filtration,BP,PDGFB;GAS6
7976,GO:0031489,0.00148128878992027,0.999930007021235,3,17,myosin V binding,MF,RAB27A;RAB39B;RAB3D
18706,GO:1901186,0.00150243515288987,0.999869108973282,4,36,positive regulation of ERBB signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;AKT1
5216,GO:0014060,0.00151266445516588,0.999981161802561,2,5,regulation of epinephrine secretion,BP,ADRA2B;ADRA2C
13150,GO:0048242,0.00151266445516588,0.999981161802561,2,5,epinephrine secretion,BP,ADRA2B;ADRA2C
16101,GO:0070727,0.001532740131965,0.999181419756508,39,1692,cellular macromolecule localization,BP,ITGA3;LIF;WNT4;ACTN2;TSPAN15;TSPAN17;RAB27A;PMAIP1;ADORA1;RAB40B;RAB40A;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;RALB;WNT5A;SESN2;RHOQ;RHOB;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;PKP3;CDH1;MYO7A;GAS6;AMOT;LAMA5;SH3BP4;RAB38;CLDN18
8069,GO:0031667,0.00153377865657071,0.999478934101351,14,403,response to nutrient levels,BP,WNT4;PMAIP1;DSC2;FOXO4;RALB;NUAK2;BMP7;CDKN1A;AKT1;WNT2B;INHBB;GAS6;VDR;ACSL4
799,GO:0001977,0.00153435594682587,0.999926599482776,3,17,renal system process involved in regulation of blood volume,BP,ADORA1;PDGFB;GAS6
7379,GO:0030308,0.00154300497812159,0.999661215031731,8,155,negative regulation of cell growth,BP,WNT3;WNT5A;SESN2;NPR1;PSRC1;WT1;CDKN1A;SH3BP4
13318,GO:0048633,0.00156846761879144,0.999982850248201,2,4,positive regulation of skeletal muscle tissue growth,BP,ACTN3;DLL1
17377,GO:0090090,0.00157962250454692,0.999651565328596,8,161,negative regulation of canonical Wnt signaling pathway,BP,WNT4;NOTCH1;DKK3;CDH2;WNT5B;WNT5A;AXIN1;BMP2
14557,GO:0055001,0.00160134207235142,0.99964668401931,8,149,muscle cell development,BP,FHOD3;ACTN2;NOTCH1;CASQ2;EDN1;AXIN1;BMP4;MYH11
8907,GO:0033043,0.00163895268956594,0.999203138717692,29,1117,regulation of organelle organization,BP,FHOD3;LIF;WNT4;ACTN2;RAB6C;PMAIP1;EDN1;SPTBN5;SPTBN4;CDH2;PIK3R1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;RHOQ;PSRC1;FGF8;SDC4;SPTB;BMP7;BMP4;CAMSAP3;ESPN;MSN;CTGF;AKT1
14568,GO:0055013,0.00165524623674464,0.999788681218859,5,59,cardiac muscle cell development,BP,FHOD3;ACTN2;EDN1;BMP4;MYH11
13906,GO:0051153,0.00165770448993895,0.999730122138286,6,90,regulation of striated muscle cell differentiation,BP,NOTCH1;EDN1;FZD7;BMP4;BMP2;EFNB2
1429,GO:0003129,0.00166995081374477,0.999978127319083,2,5,heart induction,BP,BMP4;BMP2
3400,GO:0006704,0.00170657468052311,0.99991525520473,3,17,glucocorticoid biosynthetic process,BP,WNT4;DKK3;BMP2
7224,GO:0030098,0.00171286199839345,0.999467777156879,12,314,lymphocyte differentiation,BP,WNT4;ZFPM1;FZD7;TYRO3;PIK3R1;CLCF1;BMP4;DLL1;TPD52;JAG2;GAS6;FZD8
12067,GO:0045177,0.00171793736628784,0.999436849966643,13,339,apical part of cell,CC,NOTCH1;RAB27A;TF;SLC52A3;ACVR1;CDH2;DLL1;MSN;GJB6;RAB17;MYO7A;CLDN1;LZTS1
13238,GO:0048471,0.00176767727190026,0.999278349534892,19,621,perinuclear region of cytoplasm,CC,ITGA3;SYT5;TF;RAB40B;PRKACB;PIK3R1;KCNH2;HRAS;AXIN1;CDKN1A;PKN3;CHGA;MSN;CTGF;GJB2;TPD52;PTGES;CDH1;INHBB
7600,GO:0030825,0.00177494206516283,0.999908234600975,3,21,positive regulation of cGMP metabolic process,BP,WNT5A;NPR1;NPPC
7331,GO:0030239,0.0017961527842879,0.999766380586931,5,59,myofibril assembly,BP,FHOD3;ACTN2;CASQ2;EDN1;MYH11
15440,GO:0061302,0.00180560052624732,0.999975389131839,2,5,smooth muscle cell-matrix adhesion,BP,PLAU;DDR1
18789,GO:1901380,0.00181593759626303,0.999907833892724,3,17,negative regulation of potassium ion transmembrane transport,BP,ACTN2;CASQ2;KCNH2
9769,GO:0035313,0.001821382351237,0.999908287994448,3,16,wound healing, spreading of epidermal cells,BP,ITGA5;WNT7A;HBEGF
16544,GO:0071542,0.00182962100121514,0.999831439414706,4,37,dopaminergic neuron differentiation,BP,WNT3;WNT2;WNT5A;FGF8
15081,GO:0060606,0.00190916857178312,0.999680920050069,6,86,tube closure,BP,SALL4;PRKACB;FGF10;WNT5A;SDC4;BMP4
4055,GO:0008286,0.00192163000766232,0.999617403945011,7,120,insulin receptor signaling pathway,BP,PIK3R2;PIK3R1;FOXO4;RHOQ;AKT1;BCAR1;PIK3CA
11956,GO:0044877,0.00192334032943756,0.999121007045386,24,880,macromolecular complex binding,MF,ITGA3;ITGA5;TAGLN;ACTN3;ACTN2;ACVR1;ADORA1;MFGE8;FSTL3;PIK3R1;PDGFB;JAM3;SPTB;MB21D2;CDKN1A;HMGN5;ESPN;DDR1;CTGF;PKP1;MYO7A;MYH11;LAMA5;RAB38
13790,GO:0050995,0.00192801520705778,0.999897944839746,3,20,negative regulation of lipid catabolic process,BP,ADORA1;AKT1;PIK3CG
19645,GO:1903524,0.00193120351527814,0.999743807374222,5,63,positive regulation of blood circulation,BP,ADRA2C;EDN1;CHGA;CTGF;AKT1
1418,GO:0003094,0.00198073963829037,0.99989634781507,3,17,glomerular filtration,BP,ADORA1;PDGFB;GAS6
7796,GO:0031143,0.00199405440688747,0.999895404434464,3,17,pseudopodium,CC,ACTN3;ACTN2;MSN
19804,GO:1903829,0.00199749060930839,0.999333385229858,13,357,positive regulation of cellular protein localization,BP,ITGA3;LIF;PMAIP1;PRR5L;PIK3R2;PIK3R1;SESN2;BMP6;BMP4;MSN;AKT1;CDH1;GAS6
21417,GO:2000727,0.00200881190850379,0.999893523477444,3,18,positive regulation of cardiac muscle cell differentiation,BP,EDN1;BMP4;EFNB2
9958,GO:0035637,0.00201169736891128,0.999488339937337,9,190,multicellular organismal signaling,BP,DSC2;CASQ2;KCNK6;SPTBN4;KCNH2;JAM3;NPR1;NPPC;KCND1
13179,GO:0048286,0.00204083183960707,0.999806637999748,4,36,lung alveolus development,BP,LIF;STRA6;FGF10;BMP4
7507,GO:0030593,0.00204755862690182,0.999721316307754,5,86,neutrophil chemotaxis,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
14563,GO:0055008,0.00205850504387313,0.99972310654427,5,62,cardiac muscle tissue morphogenesis,BP,WNT2;NOTCH1;ZFPM1;WNT5A;BMP2
9970,GO:0035655,0.00206886274553831,0.999969770369115,2,5,interleukin-18-mediated signaling pathway,BP,PDGFB;AKT1
17575,GO:0090382,0.0020712369928958,0.999801194603344,4,41,phagosome maturation,BP,RAB39A;RAB20;MYO7A;RAB38
12382,GO:0045843,0.00207429388982043,0.999801821756302,4,38,negative regulation of striated muscle tissue development,BP,FZD7;FGF8;BMP4;BMP2
3809,GO:0007431,0.0020886141970187,0.999800075435498,4,38,salivary gland development,BP,FGF10;FGF8;BMP7;LAMA5
8828,GO:0032924,0.0020937973963531,0.999799086818166,4,39,activin receptor signaling pathway,BP,ACVR1;FSTL3;FGF10;INHBB
17439,GO:0090185,0.00209562944603305,0.99988725292246,3,18,negative regulation of kidney development,BP,BMP7;BMP4;WT1
9485,GO:0034504,0.00210866746690032,0.999291990554208,13,354,protein localization to nucleus,BP,LIF;FZD7;PIK3R2;PIK3R1;SESN2;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6;CLDN18
7747,GO:0031076,0.00211798639579968,0.999797694796119,4,35,embryonic camera-type eye development,BP,STRA6;FGF10;WNT5A;BMP7
15322,GO:0061035,0.00212638128251172,0.999712294731028,5,60,regulation of cartilage development,BP,WNT5A;BMP6;BMP4;BMP2;CTGF
9376,GO:0034332,0.00213205025710204,0.999568309695992,7,114,adherens junction organization,BP,WNT4;ACTN3;ACTN2;CDH2;SDC4;CDH1;LAMA5
6350,GO:0018105,0.00214392569855651,0.99935598810736,11,272,peptidyl-serine phosphorylation,BP,LIF;SPTBN4;MAPK12;PDGFB;WNT5A;AXIN1;PKN3;AKT1;PIK3CA;GAS6;ARAF
7343,GO:0030260,0.00215565376403087,0.999561592289187,7,124,entry into host cell,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
11785,GO:0044409,0.00215565376403087,0.999561592289187,7,124,entry into host,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
14274,GO:0051806,0.00215565376403087,0.999561592289187,7,124,entry into cell of other organism involved in symbiotic interaction,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
14281,GO:0051828,0.00215565376403087,0.999561592289187,7,124,entry into other organism involved in symbiotic interaction,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
10068,GO:0035812,0.00216374060228481,0.999880060017196,3,21,renal sodium excretion,BP,ADORA1;EDN1;NPR1
10069,GO:0035813,0.00216374060228481,0.999880060017196,3,21,regulation of renal sodium excretion,BP,ADORA1;EDN1;NPR1
14951,GO:0060431,0.00219803115179953,0.999966872695804,2,5,primary lung bud formation,BP,WNT2;WNT2B
9770,GO:0035315,0.0022027054768795,0.99978604326963,4,38,hair cell differentiation,BP,NOTCH1;DLL1;JAG2;MYO7A
11626,GO:0044089,0.002222256999062,0.999181864166102,15,441,positive regulation of cellular component biogenesis,BP,WNT4;PMAIP1;WNT7A;EDN1;RALB;HRAS;RHOQ;PSRC1;SDC4;BMP7;ESPN;CHGA;MSN;CTGF;CLDN1
13149,GO:0048241,0.00225788433790868,0.999962481993732,2,6,epinephrine transport,BP,ADRA2B;ADRA2C
12366,GO:0045822,0.00226478860451749,0.999873121574189,3,20,negative regulation of heart contraction,BP,ADORA1;SPTBN4;PIK3CG
18704,GO:1901184,0.00226842884018893,0.999606845513604,6,91,regulation of ERBB signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;HBEGF;AKT1;EPN1
20319,GO:1904948,0.00227153112756124,0.999874263380586,3,18,midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2;WNT5A
3787,GO:0007386,0.00228102491150701,0.999964963665639,2,5,compartment pattern specification,BP,NOTCH1;DLL1
13335,GO:0048663,0.0022851907467865,0.999684253519322,5,66,neuron fate commitment,BP,NOTCH1;AXIN1;BMP4;DLL1;JAG2
15397,GO:0061156,0.0022859117524921,0.999964850124302,2,5,pulmonary artery morphogenesis,BP,STRA6;BMP4
7607,GO:0030835,0.00229860224491937,0.999774511263868,4,37,negative regulation of actin filament depolymerization,BP,SPTBN5;SPTBN4;PLEKHH2;SPTB
11814,GO:0044449,0.00230169502276698,0.999402027520398,9,203,contractile fiber part,CC,FHOD3;ACTN2;CASQ2;SDC4;MYH11;MYZAP;ACTA2;PARVB;PDE4B
4679,GO:0009912,0.00230621651357922,0.999961261678895,2,6,auditory receptor cell fate commitment,BP,NOTCH1;JAG2
14726,GO:0060120,0.00230621651357922,0.999961261678895,2,6,inner ear receptor cell fate commitment,BP,NOTCH1;JAG2
13155,GO:0048247,0.00231857930723234,0.999766575463932,4,56,lymphocyte chemotaxis,BP,CCL20;WNT5A;PIK3CG;GAS6
4950,GO:0010720,0.00233488252821667,0.999136029240734,15,437,positive regulation of cell development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;EDN1;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;CLDN5
7038,GO:0021915,0.00234275849634927,0.999450144674309,8,155,neural tube development,BP,NOTCH1;SALL4;PRKACB;WNT5A;FGF8;SDC4;BMP7;BMP4
13452,GO:0048871,0.002344976508658,0.999243035867285,12,320,multicellular organismal homeostasis,BP,CDH23;TF;ADORA1;PRKACB;PRKAR1B;BMP6;DLL1;CTGF;CLDN1;PIK3CA;RAB3D;CLDN18
10499,GO:0038128,0.00234739339612268,0.999767952296873,4,38,ERBB2 signaling pathway,BP,PIK3R1;HRAS;HBEGF;PIK3CA
17007,GO:0072341,0.0023479338358961,0.999673342473421,5,67,modified amino acid binding,MF,SYT5;FASN;MFGE8;PTGES;GAS6
3614,GO:0007043,0.00235831334436916,0.99958824664464,6,90,cell-cell junction assembly,BP,GJB1;GJB2;PKP3;CLDN1;CLDN3;CLDN5
7767,GO:0031099,0.00237919167367821,0.999439010663727,8,170,regeneration,BP,NOTCH1;WNT7A;FZD7;FGF10;JAM3;CDKN1A;CLDN1;GAS6
20467,GO:1905331,0.00239901412925609,0.99986461959497,3,18,negative regulation of morphogenesis of an epithelium,BP,WNT5A;BMP7;BMP4
12286,GO:0045662,0.00240352698585777,0.999861734306869,3,21,negative regulation of myoblast differentiation,BP,NOTCH1;BMP4;DLL1
20659,GO:1905940,0.00240742642252964,0.999961986864696,2,5,negative regulation of gonad development,BP,WNT4;WT1
8193,GO:0031944,0.00242069187997493,0.999961669679271,2,5,negative regulation of glucocorticoid metabolic process,BP,DKK3;BMP2
8196,GO:0031947,0.00242069187997493,0.999961669679271,2,5,negative regulation of glucocorticoid biosynthetic process,BP,DKK3;BMP2
8421,GO:0032353,0.00242069187997493,0.999961669679271,2,5,negative regulation of hormone biosynthetic process,BP,DKK3;BMP2
17341,GO:0090032,0.00242069187997493,0.999961669679271,2,5,negative regulation of steroid hormone biosynthetic process,BP,DKK3;BMP2
9950,GO:0035624,0.0024228380864378,0.999961618277594,2,5,receptor transactivation,BP,ADRA2B;ADRA2C
8933,GO:0033093,0.00242805121873371,0.999961493325079,2,5,Weibel-Palade body,CC,RAB27A;EDN1
13320,GO:0048635,0.00245934675327972,0.999752888310929,4,40,negative regulation of muscle organ development,BP,FZD7;FGF8;BMP4;BMP2
13518,GO:0050433,0.00245994724827684,0.999751355361162,4,44,regulation of catecholamine secretion,BP,ADRA2B;ADRA2C;CHGA;GDNF
11758,GO:0044346,0.00246901224818701,0.999859244976582,3,18,fibroblast apoptotic process,BP,PIK3CA;PIK3CG;GAS6
1466,GO:0003176,0.00249565417740385,0.999956352127854,2,6,aortic valve development,BP,NOTCH1;BMP4
1469,GO:0003180,0.00249565417740385,0.999956352127854,2,6,aortic valve morphogenesis,BP,NOTCH1;BMP4
18945,GO:1901862,0.00249690240825557,0.999748061478171,4,40,negative regulation of muscle tissue development,BP,FZD7;FGF8;BMP4;BMP2
16941,GO:0072223,0.0025104246913384,0.999959500622717,2,5,metanephric glomerular mesangium development,BP,PDGFB;WT1
18318,GO:0099503,0.00251074370870974,0.998847718042322,23,905,secretory vesicle,CC,TMEM163;SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;SERPINA5;EDN1;PLAU;RAB40B;RAB40A;SYCN;FSTL3;PDGFB;VAMP1;CHGA;PKP1;NPPC;RAB44;GAS6;RAB3D;PDE4B
12782,GO:0046697,0.00252058443556679,0.999853350317796,3,20,decidualization,BP,LIF;GJB2;VDR
14628,GO:0055118,0.00252876292895727,0.9999590523454,2,5,negative regulation of cardiac muscle contraction,BP,ADORA1;PIK3CG
12242,GO:0045606,0.00253494228831394,0.999852218336908,3,20,positive regulation of epidermal cell differentiation,BP,NOTCH1;BMP4;VDR
7226,GO:0030100,0.00255476718082595,0.99932586695423,9,204,regulation of endocytosis,BP,RAB27A;TF;MFGE8;WNT5A;DLL1;RAB20;RAB17;GAS6;UNC119
14346,GO:0051952,0.00258859888147211,0.999630774717671,5,71,regulation of amine transport,BP,ADRA2B;ADRA2C;ADORA1;CHGA;GDNF
1440,GO:0003143,0.00259704085866342,0.999630936043523,5,64,embryonic heart tube morphogenesis,BP,NOTCH1;ACVR1;WNT5A;FGF8;DLL1
7358,GO:0030282,0.00260326152689558,0.999535374863165,6,96,bone mineralization,BP,WNT4;ACVR1;BMP7;BMP6;BMP4;BMP2
5186,GO:0014020,0.00261838330708657,0.99953298567161,6,91,primary neural tube formation,BP,SALL4;PRKACB;WNT5A;SDC4;BMP7;BMP4
15167,GO:0060745,0.00262840955435692,0.999956587214664,2,5,mammary gland branching involved in pregnancy,BP,WNT4;VDR
12592,GO:0046326,0.00265036900843122,0.999728125639974,4,40,positive regulation of glucose import,BP,PIK3R2;PIK3R1;RHOQ;AKT1
12431,GO:0045932,0.00265745830378016,0.999842466108926,3,20,negative regulation of muscle contraction,BP,ADRA2C;ADORA1;PIK3CG
16416,GO:0071351,0.00269501896617139,0.999950973553324,2,6,cellular response to interleukin-18,BP,PDGFB;AKT1
7130,GO:0022829,0.0026974269564116,0.999838365086068,3,21,wide pore channel activity,MF,GJB1;GJB2;GJA3
8786,GO:0032868,0.00271102421089379,0.999216113614182,10,244,response to insulin,BP,PIK3R2;PIK3R1;FOXO4;KHK;SESN2;RHOQ;AKT1;BCAR1;INHBB;PIK3CA
7102,GO:0022412,0.00274936779691614,0.999202939768059,10,254,cellular process involved in reproduction in multicellular organism,BP,WNT4;DHH;SERPINA5;ACVR1;JAM3;BMP4;WT1;AKT1;NPPC;INHBB
552,GO:0001618,0.00278767988262093,0.999597300710073,5,64,virus receptor activity,MF,ITGA5;ITGB5;TYRO3;CLDN1;EFNB2
7177,GO:0030001,0.00280311794765345,0.998726289077736,22,797,metal ion transport,BP,ACTN2;CDH23;TF;ADORA1;CASQ2;KCNK6;SPTBN4;TTYH1;TSPAN13;PDGFB;KCNH2;SFXN1;WNK4;CTGF;AKT1;PIK3CG;KCNG2;GAS6;VDR;KCND1;CLDN16;PDE4B
11623,GO:0044085,0.00282212643256836,0.998294522930766,56,2815,cellular component biogenesis,BP,ITGA5;FHOD3;WNT4;TUBG2;ACTN3;ACTN2;NOTCH1;MARK4;RAB27A;ITGB5;ITGB4;PMAIP1;WNT7A;CASQ2;EDN1;SPTBN5;SPTBN4;TTYH1;RAB39A;PRND;LIMS2;CDH2;PIK3R1;RALB;HRAS;WNT5A;AXIN1;RHOQ;PSRC1;SDC4;SPTB;BMP7;RAB20;ESPN;VAMP1;CHGA;MSN;CTGF;GJB1;GJB2;PKP3;PKP1;RAB17;CDH1;MYO7A;TLE1;CLDN1;CLDN3;CLDN5;KCNG2;GAS6;MYH11;LAMA5;KCND1;RAB38;PARVB
18951,GO:1901879,0.00285691149955354,0.999584379929872,5,66,regulation of protein depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB
4128,GO:0008406,0.00286769764351857,0.999229927267782,9,207,gonad development,BP,WNT4;DHH;FSTL3;WNT5A;FGF8;WT1;WNT2B;KITLG;INHBB
15447,GO:0061312,0.00287442764481137,0.999945953973757,2,6,BMP signaling pathway involved in heart development,BP,ACVR1;BMP4
11440,GO:0043507,0.0028804151847264,0.999581038166381,5,63,positive regulation of JUN kinase activity,BP,WNT7B;EDN1;WNT5A;AXIN1;FZD8
4706,GO:0009991,0.00290502888049776,0.998940904620103,14,433,response to extracellular stimulus,BP,WNT4;PMAIP1;DSC2;FOXO4;RALB;NUAK2;BMP7;CDKN1A;AKT1;WNT2B;INHBB;GAS6;VDR;ACSL4
15078,GO:0060602,0.002914969173111,0.999821441767337,3,20,branch elongation of an epithelium,BP,FGF10;WNT5A;BMP4
7282,GO:0030175,0.0029375700473885,0.999463598614621,6,92,filopodium,CC,ITGA3;ACTN2;TTYH1;MSN;KITLG;ACTA2
8856,GO:0032967,0.00297408997406366,0.999814598921481,3,22,positive regulation of collagen biosynthetic process,BP,WNT4;BMP4;CTGF
3863,GO:0007605,0.00297434472506719,0.999358402194198,7,131,sensory perception of sound,BP,CDH23;SLC52A3;SPTBN4;ESPN;GJB2;GJB6;MYO7A
6777,GO:0019953,0.00297533218826139,0.998695391094413,20,747,sexual reproduction,BP,WNT3;WNT4;NOTCH1;IGSF8;DHH;SERPINA5;ACVR1;MFGE8;SPTBN4;TYRO3;FSTL3;JAM3;BMP4;WT1;SLC2A14;AKT1;NPPC;JAG2;INHBB;CLDN11
14947,GO:0060426,0.00299080179912649,0.99994260963742,2,6,lung vasculature development,BP,LIF;STRA6
4234,GO:0008584,0.00301466033600786,0.99934787542817,7,133,male gonad development,BP,WNT4;DHH;FSTL3;WNT5A;WT1;WNT2B;KITLG
12703,GO:0046546,0.00301466033600786,0.99934787542817,7,133,development of primary male sexual characteristics,BP,WNT4;DHH;FSTL3;WNT5A;WT1;WNT2B;KITLG
3753,GO:0007281,0.00302314019586781,0.9991810297598,9,217,germ cell development,BP,WNT4;DHH;ACVR1;JAM3;BMP4;WT1;AKT1;NPPC;INHBB
7463,GO:0030506,0.00308728399003076,0.999808166551282,3,19,ankyrin binding,MF,SPTBN4;SPTB;CDH1
15144,GO:0060716,0.00308760623589626,0.99980696309742,3,20,labyrinthine layer blood vessel development,BP,WNT2;AKT1;HEY1
4944,GO:0010714,0.00309887102461706,0.999803105997535,3,23,positive regulation of collagen metabolic process,BP,WNT4;BMP4;CTGF
11690,GO:0044253,0.00309887102461706,0.999803105997535,3,23,positive regulation of multicellular organismal metabolic process,BP,WNT4;BMP4;CTGF
15325,GO:0061038,0.00309912952825927,0.999939435380689,2,6,uterus morphogenesis,BP,STRA6;WNT7A
8419,GO:0032351,0.00310805354056127,0.999939171288648,2,6,negative regulation of hormone metabolic process,BP,DKK3;BMP2
14232,GO:0051726,0.00311628174212703,0.99849666740423,25,969,regulation of cell cycle,BP,LIF;WNT4;RAB6C;GADD45A;EDN1;PRKACB;MAPK12;FGF10;PDGFB;FOXO4;HRAS;WNT5A;RHOB;PSRC1;FGF8;BMP7;BMP4;BMP2;CDKN1A;HMGN5;CTGF;AKT1;NPPC;GAS6;PIM2
4856,GO:0010564,0.00312421545975021,0.998726045115949,17,568,regulation of cell cycle process,BP,LIF;WNT4;RAB6C;GADD45A;EDN1;FGF10;PDGFB;FOXO4;WNT5A;PSRC1;FGF8;BMP7;BMP4;CDKN1A;HMGN5;CTGF;AKT1
12427,GO:0045926,0.00312509028671455,0.999149119254456,9,218,negative regulation of growth,BP,WNT3;WNT5A;SESN2;NPR1;PSRC1;BMP4;WT1;CDKN1A;SH3BP4
14693,GO:0060065,0.00315816339497884,0.999800959964374,3,20,uterus development,BP,STRA6;WNT7A;WNT5A
4704,GO:0009987,0.00319570225231374,0.998280113776753,216,14598,cellular process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;FBXO41;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;PTGES;KITLG;SEMA6C;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;MYH11;LZTS1;PM20D2;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN11;CLDN16;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
12816,GO:0046822,0.00319813360640954,0.999127117879706,9,206,regulation of nucleocytoplasmic transport,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CDH1;GAS6
13887,GO:0051130,0.00320652797914693,0.998384633391166,28,1116,positive regulation of cellular component organization,BP,ITGA3;LIF;WNT3;WNT4;ACTN2;RAB27A;TF;PMAIP1;WNT7A;EDN1;MFGE8;PIK3R1;PDGFB;RALB;HRAS;WNT5A;RHOQ;PSRC1;FGF8;SDC4;BMP7;DLL1;ESPN;MSN;CTGF;AKT1;CLDN1;GAS6
8919,GO:0033077,0.00322184042414835,0.999517405549463,5,68,T cell differentiation in thymus,BP,WNT4;FZD7;BMP4;JAG2;FZD8
2344,GO:0004936,0.00322625611755863,0.999935636402084,2,6,alpha-adrenergic receptor activity,MF,ADRA2B;ADRA2C
16469,GO:0071425,0.00323198578924645,0.999794626902447,3,20,hematopoietic stem cell proliferation,BP,WNT5A;WNT2B;KITLG
4674,GO:0009894,0.00324666092368049,0.998565676015711,20,723,regulation of catabolic process,BP,ACTN3;ADORA1;PRR5L;PIK3R2;RALB;WNT5A;SESN2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;PIK3CA;PIK3CG;LZTS1;ARAF;SH3BP4;RNF144A;PIM2
19897,GO:1904018,0.00325196963470229,0.999286616456124,7,135,positive regulation of vasculature development,BP,ITGA5;NOTCH1;PDGFB;WNT5A;RHOB;DLL1;EFNB2
11282,GO:0043235,0.00325882874427604,0.998904732526537,12,320,receptor complex,CC,ITGA3;ITGA5;NOTCH1;TF;ITGB5;ITGB4;ITGB8;ACVR1;NPR1;BMP2;DDR1;VDR
14047,GO:0051384,0.00326304407396686,0.99928261972655,7,144,response to glucocorticoid,BP,WNT7B;EDN1;BMP6;CDKN1A;GJB2;CLDN1;HEY1
1571,GO:0003348,0.0032648215238789,0.999934468376777,2,6,cardiac endothelial cell differentiation,BP,NOTCH1;ACVR1
15265,GO:0060956,0.0032648215238789,0.999934468376777,2,6,endocardial cell differentiation,BP,NOTCH1;ACVR1
14043,GO:0051379,0.00329606817529513,0.999933516752251,2,6,epinephrine binding,MF,ADRA2B;ADRA2C
6384,GO:0018209,0.00330525393235659,0.9989488423223,11,288,peptidyl-serine modification,BP,LIF;SPTBN4;MAPK12;PDGFB;WNT5A;AXIN1;PKN3;AKT1;PIK3CA;GAS6;ARAF
5083,GO:0010894,0.00330843374616806,0.999786852096291,3,21,negative regulation of steroid biosynthetic process,BP,WNT4;DKK3;BMP2
15352,GO:0061082,0.00333472075712231,0.999783490944971,3,22,myeloid leukocyte cytokine production,BP,WNT5A;CHGA;GAS6
3685,GO:0007179,0.00333603636523973,0.999169321063265,8,167,transforming growth factor beta receptor signaling pathway,BP,ITGA3;RASL11B;ITGB5;ACVR1;DKK3;CGN;PDGFB;CLDN5
13517,GO:0050432,0.0033440584603722,0.999630575794696,4,47,catecholamine secretion,BP,ADRA2B;ADRA2C;CHGA;GDNF
20743,GO:1990266,0.00335122695831719,0.99948772810888,5,93,neutrophil migration,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
12049,GO:0045137,0.00335914103600885,0.999075873997471,9,212,development of primary sexual characteristics,BP,WNT4;DHH;FSTL3;WNT5A;FGF8;WT1;WNT2B;KITLG;INHBB
17970,GO:0097529,0.0033634584815405,0.999254553666015,7,162,myeloid leukocyte migration,BP,EDN1;CCL20;PDGFB;JAM3;CHGA;PIK3CG;PDE4B
16975,GO:0072284,0.00341620184875303,0.999929814575834,2,6,metanephric S-shaped body morphogenesis,BP,BMP4;WT1
12243,GO:0045607,0.00345393321204707,0.999924680318294,2,7,regulation of auditory receptor cell differentiation,BP,NOTCH1;DLL1
12261,GO:0045631,0.00345393321204707,0.999924680318294,2,7,regulation of mechanoreceptor differentiation,BP,NOTCH1;DLL1
21527,GO:2000980,0.00345393321204707,0.999924680318294,2,7,regulation of inner ear receptor cell differentiation,BP,NOTCH1;DLL1
4723,GO:0010038,0.0034562704319943,0.998893261165971,11,308,response to metal ion,BP,TF;CASQ2;EDN1;FSTL3;WNT5A;KHK;BMP6;AKT1;PTGES;CDH1;CLDN1
11619,GO:0044062,0.00348216707188779,0.999768452852588,3,24,regulation of excretion,BP,ADORA1;EDN1;NPR1
16728,GO:0071875,0.00350496980000872,0.999769503027958,3,21,adrenergic receptor signaling pathway,BP,ADRA2B;ADRA2C;CHGA
14035,GO:0051353,0.00350914577094818,0.999607093601218,4,47,positive regulation of oxidoreductase activity,BP,EDN1;AKT1;VDR;GDNF
6641,GO:0019538,0.00354136583782775,0.997661216131974,93,5268,protein metabolic process,BP,ITGA5;ARTN;LIF;ADRA2B;ADRA2C;ACTN2;TSPAN15;TSPAN17;MARK4;PMAIP1;GADD45A;RHBDL3;FBXO41;DHH;SERPINA5;WNT7A;WNT7B;ZFPM1;ACVR1;NMT2;ADORA1;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FGF10;FGF17;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CDKN1A;DLL1;PKN3;WNK4;MSN;DDR1;CTGF;AKT1;RAB12;NRTN;KITLG;CST9L;JAG2;INHBB;SPSB1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;PM20D2;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;RNF144A;PIM2
15139,GO:0060710,0.00354146313521059,0.999925881817945,2,6,chorio-allantoic fusion,BP,WNT7B;BMP7
13842,GO:0051055,0.00356348708113665,0.999600761997956,4,44,negative regulation of lipid biosynthetic process,BP,WNT4;DKK3;PDGFB;BMP2
13333,GO:0048661,0.00356458800140625,0.999452061456911,5,72,positive regulation of smooth muscle cell proliferation,BP,EDN1;PDGFB;HBEGF;BMP4;AKT1
2452,GO:0005112,0.00357339198226074,0.999764665773334,3,20,Notch binding,MF,NOTCH1;DLL1;JAG2
10444,GO:0038031,0.00359130007626813,0.999924296784855,2,6,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD7;WNT5A
15217,GO:0060839,0.00359863258152523,0.999924062610149,2,6,endothelial cell fate commitment,BP,ACVR1;DLL1
15970,GO:0070482,0.00360600313641405,0.998771280380188,12,349,response to oxygen levels,BP,NOTCH1;PMAIP1;ADORA1;EDN1;PLAU;BMP7;BMP2;CDKN1A;CTGF;AKT1;NPPC;CLDN3
14602,GO:0055082,0.00364146961277141,0.998410861468133,19,690,cellular chemical homeostasis,BP,CDH23;TF;CASQ2;EDN1;RAB39A;PRND;LPAR2;PIK3R2;PIK3R1;SESN2;BMP6;RAB20;GJB6;PIK3CA;PIK3CG;GAS6;VDR;RAB38;CLDN16
17767,GO:0097150,0.00364436067156453,0.999758302802977,3,20,neuronal stem cell population maintenance,BP,NOTCH1;CDH2;DLL1
21043,GO:2000181,0.00365759820274145,0.99943437078729,5,72,negative regulation of blood vessel morphogenesis,BP,WNT4;NOTCH1;FOXO4;NPR1;AMOT
11319,GO:0043292,0.00367943516878706,0.998973221219392,9,218,contractile fiber,CC,FHOD3;ACTN2;CASQ2;SDC4;MYH11;MYZAP;ACTA2;PARVB;PDE4B
1446,GO:0003151,0.00368166499831388,0.999430751188922,5,69,outflow tract morphogenesis,BP,ZFPM1;WNT5A;FGF8;BMP4;CLDN5
1265,GO:0002762,0.00369271993108707,0.999582143447451,4,44,negative regulation of myeloid leukocyte differentiation,BP,ZFPM1;FSTL3;PIK3R1;CLDN18
8829,GO:0032925,0.00369372859004864,0.999750181073474,3,23,regulation of activin receptor signaling pathway,BP,ACVR1;FSTL3;FGF10
12885,GO:0046935,0.00369385854128907,0.999920998997122,2,6,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R2;PIK3R1
5027,GO:0010828,0.00369992261639749,0.999581100191474,4,44,positive regulation of glucose transport,BP,PIK3R2;PIK3R1;RHOQ;AKT1
14969,GO:0060449,0.00371732448471591,0.999915817532736,2,7,bud elongation involved in lung branching,BP,FGF10;BMP4
17577,GO:0090385,0.0037226041935992,0.999915636445819,2,7,phagosome-lysosome fusion,BP,RAB39A;RAB20
7671,GO:0030916,0.00372682518231146,0.999912238472448,2,8,otic vesicle formation,BP,FGF10;FGF8
843,GO:0002040,0.00377708088705024,0.999413214083724,5,67,sprouting angiogenesis,BP,ITGA5;NOTCH1;BMP4;DLL1;EFNB2
10658,GO:0042110,0.00377780838561202,0.998581147479644,14,446,T cell activation,BP,WNT4;RAB27A;ZFPM1;FZD7;PIK3R1;SDC4;BMP4;MSN;AKT1;JAG2;PIK3CA;PIK3CG;FZD8;EFNB2
12461,GO:0045988,0.00378295582737404,0.99991809514435,2,6,negative regulation of striated muscle contraction,BP,ADORA1;PIK3CG
10845,GO:0042470,0.00378808409775369,0.999268884123803,6,104,melanosome,CC,RAB27A;FASN;RAB17;MYO7A;MYH11;RAB38
13404,GO:0048770,0.00378808409775369,0.999268884123803,6,104,pigment granule,CC,RAB27A;FASN;RAB17;MYO7A;MYH11;RAB38
18425,GO:0120025,0.00378963330983803,0.997877539925794,38,1661,plasma membrane bounded cell projection,CC,ITGA3;ITGA5;ADRA2C;SYT5;ACTN3;ACTN2;MARK4;RAB27A;CDH23;ADORA1;PRKACB;SPTBN5;SPTBN4;TTYH1;RAB39B;CDH2;FSTL3;PRKAR1B;PLEKHH2;DRP2;ESPN;VAMP1;MSN;GJB2;AKT1;RAB17;NRTN;KITLG;CDH1;MYO7A;BCAR1;PIK3CA;LZTS1;AMOT;KCND1;ACTA2;PARVB;PDE4B
4001,GO:0008201,0.00378964716885727,0.999143600429557,7,147,heparin binding,MF,CRISPLD2;SERPINA5;FGF10;HBEGF;BMP7;BMP4;CTGF
13316,GO:0048631,0.00381350520154046,0.999917091228182,2,6,regulation of skeletal muscle tissue growth,BP,ACTN3;DLL1
12093,GO:0045214,0.00381479607432191,0.999564967576022,4,43,sarcomere organization,BP,FHOD3;ACTN2;CASQ2;EDN1
4220,GO:0008543,0.00385218948083926,0.999253547800714,6,106,fibroblast growth factor receptor signaling pathway,BP,WNT4;FGF10;FGF17;WNT5A;FGF8;CTGF
3752,GO:0007276,0.0038602895044475,0.998391590864762,17,603,gamete generation,BP,WNT3;WNT4;NOTCH1;DHH;SERPINA5;ACVR1;TYRO3;FSTL3;JAM3;BMP4;WT1;SLC2A14;AKT1;NPPC;JAG2;INHBB;CLDN11
21079,GO:2000243,0.00386717182995371,0.999555087166391,4,47,positive regulation of reproductive process,BP,WNT4;WNT5A;WT1;INHBB
2447,GO:0005104,0.00388978498879324,0.99972903410982,3,26,fibroblast growth factor receptor binding,MF,FGF10;FGF17;FGF8
15116,GO:0060684,0.00390257400426139,0.99990938457055,2,7,epithelial-mesenchymal cell signaling,BP,WNT6;BMP4
7313,GO:0030216,0.00390430173805744,0.998895965073132,9,287,keratinocyte differentiation,BP,POU3F1;NOTCH1;DSC2;WNT5A;DSG3;PKP3;PKP1;DSC3;VDR
4937,GO:0010700,0.00394161673122374,0.999908008167511,2,7,negative regulation of norepinephrine secretion,BP,ADRA2B;ADRA2C
4009,GO:0008211,0.00395462597292819,0.999724835599739,3,24,glucocorticoid metabolic process,BP,WNT4;DKK3;BMP2
17328,GO:0090003,0.00400799802459192,0.999535941969587,4,44,regulation of establishment of protein localization to plasma membrane,BP,ITGA3;PIK3R1;RHOQ;AKT1
18723,GO:1901215,0.00403176816654768,0.99896303085191,8,177,negative regulation of neuron death,BP,TYRO3;HRAS;FGF8;CLCF1;CHGA;AKT1;PIK3CA;GDNF
18174,GO:0098802,0.00403538227845687,0.998962953569158,8,169,plasma membrane receptor complex,CC,ITGA3;ITGA5;TF;ITGB5;ITGB4;ITGB8;ACVR1;BMP2
14320,GO:0051904,0.00403734760043254,0.999718133040766,3,23,pigment granule transport,BP,RAB27A;RAB17;MYO7A
15423,GO:0061213,0.00404944103416947,0.999718237512046,3,22,positive regulation of mesonephros development,BP,WT1;WNT2B;GDNF
12267,GO:0045638,0.0040669568577948,0.999351398889598,5,85,negative regulation of myeloid cell differentiation,BP,ZFPM1;FSTL3;PIK3R1;DLL1;CLDN18
15070,GO:0060592,0.00407092343394031,0.999903399098811,2,7,mammary gland formation,BP,FGF10;BMP4
11307,GO:0043269,0.00407547639669824,0.998293241659895,17,582,regulation of ion transport,BP,ACTN2;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;TTYH1;TSPAN13;PDGFB;KCNH2;WNK4;AKT1;PIK3CG;KCNG2;KCND1;GDNF;PDE4B
13644,GO:0050767,0.00409528093296697,0.998194118230165,19,647,regulation of neurogenesis,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;CDH2;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;LZTS1
5183,GO:0014015,0.0041275506565906,0.999516940432138,4,46,positive regulation of gliogenesis,BP,LIF;NOTCH1;CLCF1;BMP2
696,GO:0001841,0.00413458084476714,0.999188614254378,6,100,neural tube formation,BP,SALL4;PRKACB;WNT5A;SDC4;BMP7;BMP4
16895,GO:0072170,0.00413768748971825,0.999709869653042,3,22,metanephric tubule development,BP,LIF;WNT4;WNT7B
14950,GO:0060430,0.00415920501545403,0.999900208203053,2,7,lung saccule development,BP,STRA6;FGF10
8062,GO:0031659,0.00416111946796177,0.999900138612501,2,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,FGF10;AKT1
2804,GO:0005794,0.00416454499600605,0.997745879316372,33,1399,Golgi apparatus,CC,ITGA5;WNT3;WNT4;RAB6C;NOTCH1;RAB27A;FASN;WNT6;WNT7A;WNT7B;NMT2;RAB39B;RAB39A;FSTL3;PDGFB;HRAS;WNT5B;WNT5A;RHOQ;SDC4;SPTB;B3GNT2;PKN3;RAB20;RND3;CTGF;RAB12;CDH1;GAS6;GPSM1;RAB38;FZD8;RNF144A
14938,GO:0060415,0.004169134384549,0.999334825661184,5,73,muscle tissue morphogenesis,BP,WNT2;NOTCH1;ZFPM1;WNT5A;BMP2
8922,GO:0033080,0.00418074690273719,0.999899424193366,2,7,immature T cell proliferation in thymus,BP,WNT4;BMP4
11429,GO:0043491,0.0042027530876896,0.999032670543817,7,144,protein kinase B signaling,BP,TYRO3;SESN2;HBEGF;AKT1;PIK3CA;PIK3CG;GAS6
5635,GO:0015837,0.00420951609816427,0.999324895293199,5,79,amine transport,BP,ADRA2B;ADRA2C;ADORA1;CHGA;GDNF
21095,GO:2000273,0.00422631748262275,0.999502087144936,4,46,positive regulation of receptor activity,BP,ADRA2B;ADRA2C;ACTN2;ADORA1
14727,GO:0060122,0.00425904200217941,0.999695695684204,3,24,inner ear receptor stereocilium organization,BP,CDH23;SDC4;MYO7A
6371,GO:0018193,0.00427808091747617,0.997797791215081,28,1149,peptidyl-amino acid modification,BP,ITGA5;LIF;ADRA2B;ADRA2C;ACVR1;NMT2;ADORA1;SPTBN4;MAPK12;TYRO3;FGF10;FGF17;PDGFB;WNT5A;AXIN1;FGF8;CLCF1;HBEGF;BMP7;PKN3;DDR1;AKT1;KITLG;PIK3CA;GAS6;ARAF;UNC119;RAB3D
12082,GO:0045198,0.00428502301808919,0.99989559945128,2,7,establishment of epithelial cell apical/basal polarity,BP,WNT5A;MSN
12438,GO:0045939,0.00432808895858053,0.999690226452543,3,23,negative regulation of steroid metabolic process,BP,WNT4;DKK3;BMP2
2638,GO:0005509,0.00433752429750842,0.998076212382517,19,676,calcium ion binding,MF,SYT5;ACTN3;ACTN2;NOTCH1;CDH23;RHBDL3;DHH;DSC2;CASQ2;TTYH1;CDH2;DLL1;DSG3;TPD52;JAG2;CDH1;HPCAL1;GAS6;DSC3
14579,GO:0055026,0.00434959126620336,0.999688134717214,3,23,negative regulation of cardiac muscle tissue development,BP,FZD7;FGF8;BMP2
3616,GO:0007045,0.00436600833689012,0.999297389437475,5,69,cell-substrate adherens junction assembly,BP,WNT4;ACTN3;ACTN2;SDC4;LAMA5
13090,GO:0048041,0.00436600833689012,0.999297389437475,5,69,focal adhesion assembly,BP,WNT4;ACTN3;ACTN2;SDC4;LAMA5
20418,GO:1905209,0.00441054775079363,0.999682184407211,3,23,positive regulation of cardiocyte differentiation,BP,EDN1;BMP4;EFNB2
14590,GO:0055067,0.00441945617309942,0.998973752680477,7,142,monovalent inorganic cation homeostasis,BP,ADORA1;EDN1;RAB39A;KCNH2;NPR1;RAB20;RAB38
12240,GO:0045604,0.00443137050263235,0.999469730155695,4,48,regulation of epidermal cell differentiation,BP,NOTCH1;BMP4;DLL1;VDR
17443,GO:0090189,0.00445961666771764,0.999677372635049,3,23,regulation of branching involved in ureteric bud morphogenesis,BP,BMP4;WNT2B;GDNF
3837,GO:0007530,0.00446199390782567,0.999677139026267,3,23,sex determination,BP,WNT4;DHH;WT1
1409,GO:0003071,0.00448409260916242,0.999673656325222,3,24,renal system process involved in regulation of systemic arterial blood pressure,BP,ADORA1;PDGFB;GAS6
14884,GO:0060348,0.00450614391964599,0.998819871965603,8,174,bone development,BP,ZFPM1;FGF8;BMP6;BMP4;BMP2;NPPC;NAB2;CLDN18
13453,GO:0048872,0.00454758467538714,0.998688649866591,9,225,homeostasis of number of cells,BP,PMAIP1;ZFPM1;CDH2;JAM3;BMP4;SFXN1;AKT1;KITLG;PDE4B
17576,GO:0090383,0.00458630630888496,0.999660086663847,3,27,phagosome acidification,BP,RAB39A;RAB20;RAB38
18960,GO:1901897,0.00460170658689037,0.999883687250721,2,7,regulation of relaxation of cardiac muscle,BP,CHGA;PDE4B
1564,GO:0003339,0.00461054264267545,0.999878868078464,2,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF;GDNF
5133,GO:0010959,0.00461531292808482,0.99846402994814,11,313,regulation of metal ion transport,BP,ACTN2;ADORA1;CASQ2;SPTBN4;TSPAN13;PDGFB;KCNH2;WNK4;AKT1;PIK3CG;PDE4B
13759,GO:0050921,0.00465201577828249,0.999059004633379,6,125,positive regulation of chemotaxis,BP,ARTN;EDN1;FGF10;PDGFB;WNT5A;GAS6
1146,GO:0002573,0.00465344728211492,0.998773251285023,8,185,myeloid leukocyte differentiation,BP,LIF;ZFPM1;FSTL3;PIK3R1;BMP4;KITLG;TSPAN2;CLDN18
14321,GO:0051905,0.00465735775430176,0.999656409938627,3,24,establishment of pigment granule localization,BP,RAB27A;RAB17;MYO7A
1264,GO:0002761,0.00471802521755664,0.999046070428512,6,110,regulation of myeloid leukocyte differentiation,BP,LIF;ZFPM1;FSTL3;PIK3R1;KITLG;CLDN18
9663,GO:0035050,0.00472660859027214,0.999222858947004,5,74,embryonic heart tube development,BP,NOTCH1;ACVR1;WNT5A;FGF8;DLL1
12350,GO:0045786,0.00473795846525826,0.998043274955191,16,544,negative regulation of cell cycle,BP,LIF;GADD45A;PRKACB;MAPK12;FGF10;FOXO4;HRAS;RHOB;BMP7;BMP4;BMP2;CDKN1A;HMGN5;AKT1;NPPC;GAS6
12589,GO:0046323,0.00474781124559402,0.999218547463668,5,74,glucose import,BP,PIK3R2;PIK3R1;SESN2;RHOQ;AKT1
15441,GO:0061303,0.00475555706548592,0.999873047972754,2,8,cornea development in camera-type eye,BP,WNT6;WNT2B
7609,GO:0030837,0.00475992937135173,0.999419468964883,4,47,negative regulation of actin filament polymerization,BP,FHOD3;SPTBN5;SPTBN4;SPTB
4688,GO:0009948,0.00480404693834012,0.999410693971656,4,50,anterior/posterior axis specification,BP,WNT3;WNT5A;BMP4;WT1
13575,GO:0050674,0.00483512399269604,1,1,1,urothelial cell proliferation,BP,FGF10
13576,GO:0050675,0.00483512399269604,1,1,1,regulation of urothelial cell proliferation,BP,FGF10
13577,GO:0050677,0.00483512399269604,1,1,1,positive regulation of urothelial cell proliferation,BP,FGF10
14952,GO:0060432,0.00483512399269604,1,1,1,lung pattern specification process,BP,FGF10
14956,GO:0060436,0.00483512399269604,1,1,1,bronchiole morphogenesis,BP,FGF10
15003,GO:0060495,0.00483512399269604,1,1,1,cell-cell signaling involved in lung development,BP,FGF10
15004,GO:0060496,0.00483512399269604,1,1,1,mesenchymal-epithelial cell signaling involved in lung development,BP,FGF10
15234,GO:0060879,0.00483512399269604,1,1,1,semicircular canal fusion,BP,FGF10
15377,GO:0061115,0.00483512399269604,1,1,1,lung proximal/distal axis specification,BP,FGF10
21179,GO:2000377,0.00483868802112071,0.998856169108084,7,150,regulation of reactive oxygen species metabolic process,BP,RAB27A;GADD45A;EDN1;PDGFB;BMP7;CDKN1A;AKT1
9749,GO:0035272,0.00485332038213378,0.999404168206,4,48,exocrine system development,BP,FGF10;FGF8;BMP7;LAMA5
11460,GO:0043534,0.00486183427187797,0.999194482694729,5,76,blood vessel endothelial cell migration,BP,NOTCH1;PDGFB;AKT1;AMOT;EFNB2
15119,GO:0060687,0.00488412474578488,0.999872696451929,2,7,regulation of branching involved in prostate gland morphogenesis,BP,BMP7;BMP4
13646,GO:0050769,0.00488683397812574,0.998187607668271,13,378,positive regulation of neurogenesis,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2
10756,GO:0042310,0.00489164514975879,0.999189175971991,5,74,vasoconstriction,BP,ADRA2B;ADRA2C;EDN1;AKT1;ACTA2
12794,GO:0046718,0.00489847807756722,0.999002169216184,6,109,viral entry into host cell,BP,ITGA5;ITGB5;TYRO3;CLDN1;GAS6;EFNB2
3083,GO:0006275,0.00490321419031595,0.999000500453533,6,111,regulation of DNA replication,BP,FGF10;PDGFB;HRAS;BMP6;BMP4;KITLG
13103,GO:0048103,0.00494320592202665,0.999630567037323,3,22,somatic stem cell division,BP,NOTCH1;WNT7A;FZD7
12359,GO:0045807,0.00497764561811842,0.998981926964388,6,112,positive regulation of endocytosis,BP,RAB27A;TF;MFGE8;WNT5A;DLL1;GAS6
2892,GO:0005952,0.00497980260962648,0.999868896163268,2,7,cAMP-dependent protein kinase complex,CC,PRKACB;PRKAR1B
19174,GO:1902473,0.00498342903394444,0.999868751367465,2,7,regulation of protein localization to synapse,BP,WNT7A;WNT5A
19175,GO:1902474,0.00498342903394444,0.999868751367465,2,7,positive regulation of protein localization to synapse,BP,WNT7A;WNT5A
13776,GO:0050957,0.00503372615596428,0.999866737440154,2,7,equilibrioception,BP,CDH23;MYO7A
2655,GO:0005539,0.00505882865488203,0.99864672298206,8,192,glycosaminoglycan binding,MF,CRISPLD2;SERPINA5;FGF10;HBEGF;BMP7;BMP4;CTGF;HAPLN3
8914,GO:0033059,0.00506471211451422,0.999369385052713,4,50,cellular pigmentation,BP,RAB27A;RAB17;MYO7A;RAB38
7598,GO:0030823,0.00506719946713918,0.999609661636296,3,28,regulation of cGMP metabolic process,BP,WNT5A;NPR1;NPPC
16458,GO:0071407,0.00507610697945145,0.997888982478525,16,527,cellular response to organic cyclic compound,BP,CASQ2;EDN1;PDGFB;RALB;BMP7;BMP4;BMP2;WT1;MSN;GJB2;AKT1;CDH1;PIK3CG;VDR;HEY1;PDE4B
9643,GO:0035014,0.00511554188080094,0.999863439005471,2,7,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R2;PIK3R1
4749,GO:0010171,0.00514802182932235,0.999358826553299,4,46,body morphogenesis,BP,WNT3;STRA6;CRISPLD2;CLDN5
7249,GO:0030133,0.00517651318608658,0.99815334713211,12,361,transport vesicle,CC,TMEM163;SYT5;RAB27A;CRISPLD2;EDN1;RAB40B;RAB40A;SYCN;VAMP1;CHGA;RAB3D;PDE4B
13694,GO:0050839,0.00518587781504343,0.997981140339405,14,438,cell adhesion molecule binding,MF,ITGA3;ITGA5;ACTN3;ACTN2;FASN;MFGE8;CGN;JAM3;MB21D2;MSN;CTGF;PKP3;CDH1;LAMA5
16819,GO:0072050,0.0052240772443186,0.99985361348553,2,8,S-shaped body morphogenesis,BP,BMP4;WT1
10904,GO:0042552,0.00523192663140063,0.998920250271979,6,107,myelination,BP,POU3F1;DHH;JAM3;AKT1;NAB2;TSPAN2
13774,GO:0050954,0.00531773868670945,0.998721677933244,7,146,sensory perception of mechanical stimulus,BP,CDH23;SLC52A3;SPTBN4;ESPN;GJB2;GJB6;MYO7A
4266,GO:0008643,0.00540352657496977,0.998540112378752,8,181,carbohydrate transport,BP,SLC45A4;EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;SLC2A14;AKT1
14651,GO:0060019,0.00540682967416836,0.999841424026847,2,9,radial glial cell differentiation,BP,CDH2;FGF10
9642,GO:0035005,0.00543057566058419,0.999850481636447,2,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,PIK3CA;PIK3CG
14863,GO:0060324,0.0054571450605056,0.999309013116364,4,46,face development,BP,STRA6;CRISPLD2;WNT5A;CLDN5
11305,GO:0043267,0.00546703446701308,0.999571202513407,3,25,negative regulation of potassium ion transport,BP,ACTN2;CASQ2;KCNH2
16599,GO:0071621,0.00547484568732367,0.999057713667108,5,105,granulocyte chemotaxis,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
10717,GO:0042246,0.00548178166323273,0.999300058543225,4,53,tissue regeneration,BP,NOTCH1;WNT7A;FZD7;FGF10
15251,GO:0060923,0.00549584515040152,0.999841910741677,2,8,cardiac muscle cell fate commitment,BP,ACVR1;WT1
5832,GO:0016242,0.00553665263522336,0.999565348792523,3,24,negative regulation of macroautophagy,BP,AKT1;PIK3CA;LZTS1
1202,GO:0002682,0.00555986708728275,0.997046162111119,29,1306,regulation of immune system process,BP,LIF;NOTCH1;ZFPM1;ADORA1;EDN1;PRKACB;CCL20;TYRO3;FSTL3;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;JAM3;SDC4;CLCF1;BMP4;CDKN1A;DLL1;MSN;AKT1;KITLG;BCAR1;PIK3CA;GAS6;CLDN18;EFNB2;PDE4B
11870,GO:0044710,0.00556453831490543,0.996351682305276,74,4067,single-organism metabolic process,BP,ARTN;LIF;ADRA2B;ADRA2C;WNT4;ACTN3;ACTN2;GLDC;STRA6;ITGB8;FASN;PMAIP1;GADD45A;DHH;WNT7A;WNT7B;SLC52A3;HMGCS2;ACVR1;GUCY1B3;ADORA1;DKK3;EDN1;CCL20;SPTBN5;SPTBN4;MBOAT2;MAPK12;FZD7;TYRO3;CDH2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;HRAS;WNT5A;KHK;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;CHGA;CTGF;AKT1;NRTN;PTGES;KITLG;NPPC;INHBB;PIK3CA;PIK3CG;GAS6;SIN3B;VDR;ARAF;GDNF;ACSL4;FZD8;DUSP5;PDE4B
15870,GO:0070316,0.00559113235425212,0.999837734618121,2,8,regulation of G0 to G1 transition,BP,FOXO4;CTGF
13789,GO:0050994,0.00559562861047474,0.99928073458416,4,54,regulation of lipid catabolic process,BP,ADORA1;SESN2;AKT1;PIK3CG
21403,GO:2000698,0.00559687352883471,0.999837481804712,2,8,positive regulation of epithelial cell differentiation involved in kidney development,BP,LIF;GDNF
13302,GO:0048596,0.0056196312121687,0.999558232705677,3,23,embryonic camera-type eye morphogenesis,BP,STRA6;WNT5A;BMP7
12234,GO:0045598,0.00562066489388165,0.998821793448228,6,110,regulation of fat cell differentiation,BP,ZFPM1;WNT5B;WNT5A;AXIN1;BMP2;AKT1
14134,GO:0051549,0.00562512537147031,0.999836235756484,2,8,positive regulation of keratinocyte migration,BP,FGF10;HBEGF
9388,GO:0034350,0.0056528379023461,0.999835010311326,2,8,regulation of glial cell apoptotic process,BP,DLL1;GAS6
9389,GO:0034351,0.0056528379023461,0.999835010311326,2,8,negative regulation of glial cell apoptotic process,BP,DLL1;GAS6
7887,GO:0031329,0.00566429235349315,0.997546458288177,17,606,regulation of cellular catabolic process,BP,PRR5L;PIK3R2;RALB;SESN2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;PIK3CA;PIK3CG;LZTS1;ARAF;SH3BP4;RNF144A;PIM2
8060,GO:0031657,0.00569556467458586,0.999833114776965,2,8,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,FGF10;AKT1
16886,GO:0072161,0.0057425931887805,0.999831019785763,2,8,mesenchymal cell differentiation involved in kidney development,BP,WNT4;BMP4
21533,GO:2001012,0.0057425931887805,0.999831019785763,2,8,mesenchymal cell differentiation involved in renal system development,BP,WNT4;BMP4
4721,GO:0010035,0.00574465567510897,0.9977351981547,14,473,response to inorganic substance,BP,TF;GUCY1B3;CASQ2;EDN1;FSTL3;WNT5A;KHK;RHOB;BMP7;BMP6;AKT1;PTGES;CDH1;CLDN1
16923,GO:0072201,0.00576096973726906,0.999830198715196,2,8,negative regulation of mesenchymal cell proliferation,BP,WNT5A;BMP4
12295,GO:0045671,0.00581057344817943,0.999534138568212,3,25,negative regulation of osteoclast differentiation,BP,FSTL3;PIK3R1;CLDN18
10630,GO:0042058,0.00582240624205652,0.998992239224754,5,78,regulation of epidermal growth factor receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;AKT1;EPN1
3323,GO:0006606,0.00583400215716661,0.998117286120145,10,267,protein import into nucleus,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
11889,GO:0044744,0.00583400215716661,0.998117286120145,10,267,protein targeting to nucleus,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
13903,GO:0051150,0.00590784224740655,0.999523494826347,3,25,regulation of smooth muscle cell differentiation,BP,PDGFB;FOXO4;BMP4
14295,GO:0051875,0.00596281600249633,0.999515835658285,3,26,pigment granule localization,BP,RAB27A;RAB17;MYO7A
14886,GO:0060350,0.0060285256851608,0.999213012795174,4,48,endochondral bone morphogenesis,BP,BMP6;BMP4;NPPC;NAB2
15029,GO:0060539,0.00606127095357312,0.999816588253262,2,8,diaphragm development,BP,STRA6;WT1
646,GO:0001776,0.00608079747207863,0.998934310368134,5,83,leukocyte homeostasis,BP,PMAIP1;JAM3;AKT1;KITLG;PDE4B
18811,GO:1901522,0.0060853941431971,0.999502240021765,3,26,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,NOTCH1;SESN2;BMP2
19032,GO:1902106,0.00611123795407053,0.998927278456056,5,84,negative regulation of leukocyte differentiation,BP,ZFPM1;FSTL3;PIK3R1;BMP4;CLDN18
9032,GO:0033278,0.00613524511461593,0.999813180291866,2,8,cell proliferation in midbrain,BP,WNT2;WNT5A
3511,GO:0006887,0.00615150266244986,0.997060366547432,21,833,exocytosis,BP,SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;PLAU;RAB40B;RAB40A;SYCN;PDGFB;RALB;SDC4;VAMP1;CHGA;PKP1;RAB44;PIK3CG;RAB11FIP1;GAS6;RAB3D
11289,GO:0043244,0.00620487413884185,0.998909137003116,5,79,regulation of protein complex disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB
3683,GO:0007176,0.00623834939548326,0.999486848318177,3,25,regulation of epidermal growth factor-activated receptor activity,BP,ADRA2B;ADRA2C;ADORA1
13315,GO:0048630,0.00624382073588502,0.99980813917326,2,8,skeletal muscle tissue growth,BP,ACTN3;DLL1
14356,GO:0051962,0.0062716720787889,0.997504336063134,14,434,positive regulation of nervous system development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2
14108,GO:0051494,0.00630195836669411,0.998646233606023,6,113,negative regulation of cytoskeleton organization,BP,FHOD3;SPTBN5;SPTBN4;PLEKHH2;SPTB;ESPN
19233,GO:1902593,0.00630395691575313,0.997942324911316,10,270,single-organism nuclear import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
16950,GO:0072239,0.00632807423828251,0.999804195492776,2,8,metanephric glomerulus vasculature development,BP,PDGFB;WT1
10846,GO:0042471,0.00633189230920374,0.99863782881977,6,115,ear morphogenesis,BP,EDN1;FGF10;WNT5A;FGF8;GJB6;MYO7A
14600,GO:0055080,0.00635257777645295,0.997214947161669,17,624,cation homeostasis,BP,CDH23;TF;ADORA1;CASQ2;EDN1;RAB39A;PRND;LPAR2;KCNH2;NPR1;BMP6;RAB20;SFXN1;PIK3CG;VDR;RAB38;CLDN16
5592,GO:0015758,0.00635283160398105,0.998421213791201,7,148,glucose transport,BP,EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;SLC2A14;AKT1
13431,GO:0048843,0.0063730271071567,0.999802080055889,2,8,negative regulation of axon extension involved in axon guidance,BP,WNT3;WNT5A
13616,GO:0050719,0.00640077420937896,1,1,1,interleukin-1 alpha biosynthetic process,BP,CCL20
13618,GO:0050721,0.00640077420937896,1,1,1,regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
13621,GO:0050726,0.00640077420937896,1,1,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
14696,GO:0060068,0.00645782626469703,0.999792380350864,2,9,vagina development,BP,TYRO3;WNT5A
11825,GO:0044464,0.00648199357431711,0.996769491318579,225,15425,cell part,CC,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;FBXO41;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;LGALS4;BMP6;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;PM20D2;SHC4;SLC18B1;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
16927,GO:0072205,0.0066017771104312,0.999791194376035,2,8,metanephric collecting duct development,BP,WNT7B;BMP4
19146,GO:1902373,0.0066146636205304,0.999790575162231,2,8,negative regulation of mRNA catabolic process,BP,PKP3;PKP1
1411,GO:0003073,0.00662112169800117,0.998815308064396,5,84,regulation of systemic arterial blood pressure,BP,ADORA1;EDN1;KCNK6;PDGFB;GAS6
14941,GO:0060420,0.00663517081484529,0.999107152257039,4,51,regulation of heart growth,BP,WNT2;NOTCH1;EDN1;WT1
8830,GO:0032926,0.00669353294261679,0.999780768539055,2,9,negative regulation of activin receptor signaling pathway,BP,ACVR1;FSTL3
3676,GO:0007168,0.00671630512146637,0.999774871900716,2,10,receptor guanylyl cyclase signaling pathway,BP,NPR1;NPPC
8854,GO:0032965,0.00674983182953649,0.999421909940133,3,29,regulation of collagen biosynthetic process,BP,WNT4;BMP4;CTGF
12818,GO:0046824,0.00675969850678254,0.998526166592234,6,114,positive regulation of nucleocytoplasmic transport,BP,PIK3R2;PIK3R1;BMP6;BMP4;CDH1;GAS6
3551,GO:0006950,0.0068088695323442,0.995588005564654,64,3506,response to stress,BP,ITGA5;ADRA2B;ADRA2C;WNT4;NOTCH1;RAB27A;ITGB4;PMAIP1;GADD45A;DSC2;SERPINA5;WNT7A;WNT7B;ZFPM1;SLC52A3;ACVR1;GUCY1B3;ADORA1;EDN1;PLAU;PRKACB;CCL20;MAPK12;FZD7;TYRO3;PRR5L;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;SESN2;AXIN1;RHOB;NUAK2;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP2;CDKN1A;CHGA;DDR1;CTGF;GJB2;AKT1;WNT2B;PTGES;NPPC;INHBB;CLDN1;CLDN3;PIK3CA;PIK3CG;GAS6;TSPAN2;FZD8
16584,GO:0071600,0.00681761018241913,0.999769697064428,2,10,otic vesicle morphogenesis,BP,FGF10;FGF8
4267,GO:0008645,0.00683407540241378,0.998277821772998,7,150,hexose transport,BP,EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;SLC2A14;AKT1
10116,GO:0035904,0.00684976343622492,0.999072650094732,4,48,aorta development,BP,NOTCH1;FGF8;HEY1;EFNB2
8921,GO:0033079,0.00685391762406186,0.999772743376258,2,9,immature T cell proliferation,BP,WNT4;BMP4
19644,GO:1903523,0.00685592158621806,0.999411043298256,3,28,negative regulation of blood circulation,BP,ADORA1;SPTBN4;PIK3CG
3546,GO:0006940,0.00691583394971298,0.999055811753243,4,54,regulation of smooth muscle contraction,BP,ADRA2B;ADRA2C;ADORA1;EDN1
12855,GO:0046886,0.00693749107889374,0.999774857557888,2,8,positive regulation of hormone biosynthetic process,BP,WNT4;BMP6
5262,GO:0014807,0.00695602389611217,0.999767582549965,2,9,regulation of somitogenesis,BP,NOTCH1;DLL1
7832,GO:0031252,0.00695657810661182,0.997423675968433,12,347,cell leading edge,CC,ITGA5;ITGB4;ADORA1;CDH2;PLEKHH2;KITLG;CDH1;BCAR1;PIK3CA;AMOT;ACTA2;PARVB
8787,GO:0032869,0.00699860081050597,0.998022658489894,8,191,cellular response to insulin stimulus,BP,PIK3R2;PIK3R1;FOXO4;RHOQ;AKT1;BCAR1;INHBB;PIK3CA
13714,GO:0050865,0.00701320895119411,0.997169640662328,14,479,regulation of cell activation,BP,TYRO3;FGF10;PIK3R1;PDGFB;WNT5A;SDC4;CLCF1;BMP4;CDKN1A;CTGF;AKT1;PIK3CA;GAS6;EFNB2
10300,GO:0036293,0.00703277678784099,0.99752007033413,11,334,response to decreased oxygen levels,BP,NOTCH1;PMAIP1;ADORA1;EDN1;PLAU;BMP7;BMP2;CTGF;AKT1;NPPC;CLDN3
12852,GO:0046883,0.00705923863096804,0.997818113455055,9,243,regulation of hormone secretion,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;BMP6;INHBB;RAB11FIP1;KCNG2
4675,GO:0009895,0.00708223571384294,0.99799368261501,8,198,negative regulation of catabolic process,BP,ACTN3;ADORA1;AKT1;PKP3;PKP1;PIK3CA;PIK3CG;LZTS1
781,GO:0001958,0.00711646815146599,0.999383976361622,3,26,endochondral ossification,BP,BMP6;BMP4;NAB2
10219,GO:0036075,0.00711646815146599,0.999383976361622,3,26,replacement ossification,BP,BMP6;BMP4;NAB2
14354,GO:0051960,0.00711994588818949,0.996618809996421,20,729,regulation of nervous system development,BP,ITGA3;LIF;ADRA2B;ADRA2C;WNT3;WNT2;NOTCH1;WNT7A;PRKACB;CDH2;WNT5A;CLCF1;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;LZTS1
5035,GO:0010837,0.00712180199620689,0.99937970822875,3,28,regulation of keratinocyte proliferation,BP,FGF10;VDR;EFNB2
13716,GO:0050867,0.00714332400174833,0.997622651909148,10,294,positive regulation of cell activation,BP,FGF10;PIK3R1;WNT5A;CLCF1;CDKN1A;CTGF;AKT1;PIK3CA;GAS6;EFNB2
11309,GO:0043271,0.00716494194273831,0.998416587641576,6,120,negative regulation of ion transport,BP,ACTN2;ADORA1;CASQ2;KCNH2;WNK4;AKT1
11298,GO:0043256,0.00718783232577618,0.999762400738458,2,8,laminin complex,CC,LAMA1;LAMA5
20953,GO:2000018,0.00721466098217595,0.999754331989035,2,9,regulation of male gonad development,BP,WNT4;WT1
12502,GO:0046068,0.00723513113930277,0.998998573333276,4,55,cGMP metabolic process,BP,GUCY1B3;WNT5A;NPR1;NPPC
2601,GO:0005381,0.00729624063416662,0.999750099994706,2,9,iron ion transmembrane transporter activity,MF,TF;TTYH1
7694,GO:0030971,0.00731633007626712,0.998986672825087,4,52,receptor tyrosine kinase binding,MF,PIK3R2;PIK3R1;GAS6;SHC4
15344,GO:0061072,0.00732787073650038,0.999748452444512,2,9,iris morphogenesis,BP,WNT2;WNT2B
2700,GO:0005623,0.00734553863741038,0.996307795791339,225,15450,cell,CC,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;FBXO41;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;TMEM206;HMGCS2;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;LGALS4;BMP6;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;SEMA6C;NPPC;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;PM20D2;SHC4;SLC18B1;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
5590,GO:0015749,0.00736142440670537,0.998118393299334,7,152,monosaccharide transport,BP,EDN1;PIK3R2;PIK3R1;SESN2;RHOQ;SLC2A14;AKT1
13278,GO:0048545,0.00737864418586972,0.997243740901607,12,376,response to steroid hormone,BP,NOTCH1;WNT7B;EDN1;BMP7;BMP6;BMP4;CDKN1A;CTGF;GJB2;CLDN1;VDR;HEY1
2873,GO:0005913,0.00739102571438544,0.998643798271326,5,81,cell-cell adherens junction,CC,DSC2;CDH2;CAMSAP3;PKP3;CDH1
7466,GO:0030510,0.00739667486240952,0.998642512092361,5,81,regulation of BMP signaling pathway,BP,ITGA3;NOTCH1;FSTL3;WNT5A;BMP4
19356,GO:1902936,0.00740417019873427,0.998641375494488,5,80,phosphatidylinositol bisphosphate binding,MF,SYT5;ACTN2;FZD7;SNX18;AKT1
13386,GO:0048739,0.00741010375968562,0.999744151587095,2,9,cardiac muscle fiber development,BP,BMP4;MYH11
3392,GO:0006694,0.00741072720989494,0.998100924631389,7,162,steroid biosynthetic process,BP,WNT4;DHH;HMGCS2;DKK3;BMP6;BMP2;VDR
8291,GO:0032102,0.00741576748884296,0.997689664185001,9,246,negative regulation of response to external stimulus,BP,WNT3;WNT4;NOTCH1;ADORA1;EDN1;PLAU;TYRO3;PDGFB;WNT5A
16937,GO:0072217,0.00742500915591145,0.999743369323077,2,9,negative regulation of metanephros development,BP,BMP4;WT1
7189,GO:0030018,0.00742718084535025,0.99834726808793,6,117,Z disc,CC,FHOD3;ACTN2;CASQ2;MYZAP;PARVB;PDE4B
2854,GO:0005884,0.00749786019279612,0.998619433100456,5,81,actin filament,CC,ACTN3;ACTN2;RHOQ;ESPN;AMOT
10592,GO:0040020,0.00750937811035217,0.999333250471073,3,28,regulation of meiotic nuclear division,BP,LIF;WNT4;WNT5A
11439,GO:0043506,0.00754741948381799,0.998608684275374,5,80,regulation of JUN kinase activity,BP,WNT7B;EDN1;WNT5A;AXIN1;FZD8
5002,GO:0010800,0.00756410520294019,0.999328513169895,3,27,positive regulation of peptidyl-threonine phosphorylation,BP,WNT5A;AXIN1;BMP7
5169,GO:0012505,0.00759669151947598,0.994943498572893,74,4018,endomembrane system,CC,ITGA5;TMEM163;ADRA2C;SYT5;WNT3;WNT4;RIN3;ACTN2;RAB6C;TSPAN15;NOTCH1;RAB27A;TF;FASN;CRISPLD2;SERPINA5;WNT6;WNT7A;WNT7B;NMT2;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;MBOAT2;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;FZD7;TYRO3;FSTL3;PIK3R1;REEP1;PDGFB;HRAS;WNT5B;WNT5A;SNX18;RHOQ;RHOB;SDC4;SPTB;B3GNT2;PKN3;RAB20;VAMP1;RND3;CHGA;CTGF;GJB1;TPD52;PKP1;RAB12;RAB17;CYTIP;PTGES;NPPC;CDH1;EPN1;RAB44;RAB11FIP1;GAS6;GPSM1;SH3BP4;RAB38;RAB3D;ACSL4;FZD8;RNF144A;PDE4B
9377,GO:0034333,0.00764625792666031,0.998586645317754,5,79,adherens junction assembly,BP,WNT4;ACTN3;ACTN2;SDC4;LAMA5
967,GO:0002262,0.00766472808644079,0.998280625350881,6,124,myeloid cell homeostasis,BP,ZFPM1;JAM3;BMP4;SFXN1;KITLG;PDE4B
7202,GO:0030038,0.00772573131841865,0.998567174180517,5,81,contractile actin filament bundle assembly,BP,WNT4;ITGB5;PIK3R1;SDC4;CTGF
11223,GO:0043149,0.00772573131841865,0.998567174180517,5,81,stress fiber assembly,BP,WNT4;ITGB5;PIK3R1;SDC4;CTGF
6676,GO:0019725,0.00776494494245959,0.996279596744945,20,797,cellular homeostasis,BP,CDH23;TF;CASQ2;EDN1;RAB39A;PRND;TYRO3;LPAR2;PIK3R2;PIK3R1;SESN2;BMP6;RAB20;GJB6;PIK3CA;PIK3CG;GAS6;VDR;RAB38;CLDN16
17363,GO:0090075,0.00778393127727887,0.999297965098262,3,29,relaxation of muscle,BP,ADORA1;CHGA;PDE4B
8646,GO:0032649,0.00780370396324138,0.998543415332443,5,92,regulation of interferon-gamma production,BP,ZFPM1;HRAS;WNT5A;GAS6;PDE4B
18952,GO:1901880,0.00781843433185856,0.998895349629608,4,53,negative regulation of protein depolymerization,BP,SPTBN5;SPTBN4;PLEKHH2;SPTB
17403,GO:0090133,0.00783370545386641,1,1,1,mesendoderm migration,BP,FGF8
17404,GO:0090134,0.00783370545386641,1,1,1,cell migration involved in mesendoderm migration,BP,FGF8
15914,GO:0070382,0.00783641064782228,0.997971410541059,7,159,exocytic vesicle,CC,TMEM163;SYT5;RAB27A;RAB40B;RAB40A;VAMP1;PDE4B
15448,GO:0061314,0.00789710272028699,0.999718169162715,2,9,Notch signaling involved in heart development,BP,NOTCH1;HEY1
8423,GO:0032355,0.00790036602079295,0.998216100663994,6,125,response to estradiol,BP,DHH;WNT7A;FGF10;BMP7;CTGF;GJB2
18856,GO:1901617,0.00791022778574868,0.997716179677747,8,199,organic hydroxy compound biosynthetic process,BP,WNT4;PNMT;HMGCS2;DKK3;WNT5A;BMP6;BMP2;VDR
20703,GO:1990124,0.00792910703743195,0.999716431346033,2,9,messenger ribonucleoprotein complex,CC,PKP3;PKP1
13907,GO:0051154,0.00800386336236944,0.999270775934303,3,29,negative regulation of striated muscle cell differentiation,BP,NOTCH1;FZD7;BMP2
18154,GO:0098771,0.00803482982166928,0.996389436169777,17,638,inorganic ion homeostasis,BP,CDH23;TF;ADORA1;CASQ2;EDN1;RAB39A;PRND;LPAR2;KCNH2;NPR1;BMP6;RAB20;SFXN1;PIK3CG;VDR;RAB38;CLDN16
13768,GO:0050930,0.00807449438281546,0.999692917356347,2,12,induction of positive chemotaxis,BP,ARTN;FGF10
14332,GO:0051930,0.00813117320374561,0.999253104119185,3,30,regulation of sensory perception of pain,BP,ADRA2C;ADORA1;EDN1
14333,GO:0051931,0.00813117320374561,0.999253104119185,3,30,regulation of sensory perception,BP,ADRA2C;ADORA1;EDN1
7093,GO:0022402,0.00816238101290468,0.995535667363025,29,1261,cell cycle process,BP,LIF;WNT4;RAB6C;MARK4;GADD45A;ACVR1;EDN1;PHLDA1;TTYH1;MAPK12;FGF10;PDGFB;FOXO4;RALB;HRAS;WNT5A;SNX18;RHOB;PSRC1;FGF8;BMP7;BMP4;CDKN1A;HMGN5;CTGF;AKT1;GAS6;LZTS1;PIM2
17329,GO:0090004,0.00817791894150422,0.999249059647588,3,29,positive regulation of establishment of protein localization to plasma membrane,BP,ITGA3;PIK3R1;AKT1
6234,GO:0017022,0.00819570408974129,0.998822510667626,4,57,myosin binding,MF,RAB27A;SPTBN5;RAB39B;RAB3D
4600,GO:0009617,0.0082646005979431,0.996722082180737,13,497,response to bacterium,BP,NOTCH1;EDN1;CCL20;FGF10;WNT5A;BMP6;CHGA;GJB2;GJB6;AKT1;PTGES;CLDN1;PDE4B
8230,GO:0032006,0.00829586996896856,0.998433481705152,5,83,regulation of TOR signaling,BP,SESN2;PIK3CA;GAS6;ARAF;SH3BP4
12185,GO:0045444,0.0083001863639223,0.997583709436068,8,199,fat cell differentiation,BP,ZFPM1;FGF10;WNT5B;WNT5A;AXIN1;BMP2;AKT1;INHBB
11676,GO:0044233,0.00833391621696221,0.999687543120731,2,10,ER-mitochondrion membrane contact site,CC,RAB38;ACSL4
20271,GO:1904861,0.00834682160138608,0.999693412781445,2,9,excitatory synapse assembly,BP,WNT7A;WNT5A
13841,GO:0051054,0.00835336279511733,0.997564930994291,8,202,positive regulation of DNA metabolic process,BP,FGF10;PDGFB;HRAS;CLCF1;BMP6;BMP4;AKT1;KITLG
14338,GO:0051937,0.00836982600317904,0.998787661719094,4,60,catecholamine transport,BP,ADRA2B;ADRA2C;CHGA;GDNF
5741,GO:0016049,0.00837968626860898,0.996546698389611,14,473,cell growth,BP,WNT3;EDN1;WNT5A;SESN2;NPR1;PSRC1;HBEGF;WT1;CDKN1A;DDR1;CTGF;AKT1;BCAR1;SH3BP4
7208,GO:0030048,0.00840252171432194,0.998080187328264,6,119,actin filament-based movement,BP,ACTN3;ACTN2;DSC2;KCNH2;MYO7A;PDE4B
12830,GO:0046847,0.00845003867706134,0.998781315402742,4,51,filopodium assembly,BP,TTYH1;RHOQ;ESPN;RAB17
16372,GO:0071281,0.00847425746572669,0.999679509211149,2,10,cellular response to iron ion,BP,TF;BMP6
14765,GO:0060174,0.0084859732703474,0.999678835338647,2,10,limb bud formation,BP,WNT3;FGF10
1542,GO:0003306,0.00850339125778552,0.999677832579254,2,10,Wnt signaling pathway involved in heart development,BP,WNT5A;BMP2
587,GO:0001678,0.00853213768604123,0.998042296742247,6,124,cellular glucose homeostasis,BP,PIK3R2;PIK3R1;SESN2;GJB6;PIK3CA;GAS6
14864,GO:0060325,0.0085327219317238,0.999206325745549,3,28,face morphogenesis,BP,STRA6;CRISPLD2;CLDN5
12300,GO:0045685,0.00855361376124334,0.998756808448228,4,56,regulation of glial cell differentiation,BP,LIF;NOTCH1;CLCF1;BMP2
2107,GO:0004603,0.00857529489301073,1,1,1,phenylethanolamine N-methyltransferase activity,MF,PNMT
598,GO:0001702,0.00859093243893881,0.999198926824509,3,28,gastrulation with mouth forming second,BP,ACVR1;WNT5A;AMOT
831,GO:0002027,0.00859787326544092,0.998359318523861,5,88,regulation of heart rate,BP,DSC2;CASQ2;EDN1;SPTBN4;KCNH2
14048,GO:0051385,0.0086466641644105,0.999185933479007,3,31,response to mineralocorticoid,BP,EDN1;CDKN1A;CTGF
11972,GO:0045023,0.00865206448470514,0.999669229392496,2,10,G0 to G1 transition,BP,FOXO4;CTGF
19723,GO:1903670,0.00872894727979884,0.999181309399743,3,28,regulation of sprouting angiogenesis,BP,ITGA5;NOTCH1;DLL1
5891,GO:0016342,0.00875301971992208,0.999670437806031,2,9,catenin complex,CC,CDH2;CDH1
13902,GO:0051149,0.00875692772124403,0.998320951201614,5,89,positive regulation of muscle cell differentiation,BP,EDN1;MAPK12;CDH2;BMP4;EFNB2
15716,GO:0070075,0.00877438535258247,0.999980748598166,1,2,tear secretion,BP,FGF10
2343,GO:0004935,0.00880303228281132,0.999660413225601,2,10,adrenergic receptor activity,MF,ADRA2B;ADRA2C
13915,GO:0051170,0.00880723234275051,0.99697791716947,10,288,nuclear import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
17357,GO:0090068,0.00887266404467284,0.997156141414102,9,246,positive regulation of cell cycle process,BP,WNT4;GADD45A;EDN1;PDGFB;FOXO4;WNT5A;FGF8;CDKN1A;CTGF
10576,GO:0039706,0.00888003021403998,0.999655885804137,2,10,co-receptor binding,MF,BMP4;BMP2
14971,GO:0060452,0.00890262108362458,0.999648662085009,2,11,positive regulation of cardiac muscle contraction,BP,CHGA;CTGF
14582,GO:0055038,0.00894047477251238,0.998683897401258,4,56,recycling endosome membrane,CC,SYT5;FZD7;RAB12;RAB17
14576,GO:0055023,0.0089547739128146,0.999150052973981,3,29,positive regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1;EDN1
15865,GO:0070306,0.00895672782794865,0.999147746382638,3,30,lens fiber cell differentiation,BP,WNT7A;WNT7B;WNT5B
16153,GO:0070851,0.00897183202706514,0.99791711736779,6,130,growth factor receptor binding,MF,ITGA5;FGF10;FGF17;PDGFB;FGF8;HBEGF
2756,GO:0005737,0.00901410987521577,0.993825186544329,165,10558,cytoplasm,CC,ITGA3;ITGA5;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT2;WNT4;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;PNMT;TF;ITGB5;FASN;PMAIP1;GADD45A;CRISPLD2;FBXO41;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;PIK3R2;PIK3R1;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;SDC4;SPTB;HBEGF;LGALS4;BMP6;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;PKN3;RAB20;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP1;RAB12;RAB17;CYTIP;PTGES;KITLG;NPPC;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;DTX4;MYH11;LZTS1;DSC3;GPSM1;AMOT;ARAF;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;HEY1;ACTA2;RNF144A;PIM2;PARVB;PDE4B
7256,GO:0030141,0.00902406039220213,0.995699248250009,19,787,secretory granule,CC,SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;SERPINA5;EDN1;PLAU;SYCN;FSTL3;PDGFB;VAMP1;CHGA;PKP1;NPPC;RAB44;GAS6;RAB3D
13669,GO:0050801,0.00905944855584822,0.995775921493127,18,698,ion homeostasis,BP,CDH23;TF;ADORA1;CASQ2;EDN1;RAB39A;PRND;LPAR2;KCNH2;NPR1;BMP6;RAB20;SFXN1;WNK4;PIK3CG;VDR;RAB38;CLDN16
11287,GO:0043242,0.00906754711318956,0.998659740175477,4,56,negative regulation of protein complex disassembly,BP,SPTBN5;SPTBN4;PLEKHH2;SPTB
16066,GO:0070661,0.00917751267265222,0.997038957967912,9,268,leukocyte proliferation,BP,WNT4;FGF10;SDC4;CLCF1;BMP4;CDKN1A;MSN;KITLG;PIK3CG
3579,GO:0006996,0.00924953584548454,0.99389545322219,65,3492,organelle organization,BP,FHOD3;LIF;SYT5;WNT4;TUBG2;ACTN2;RAB6C;NOTCH1;MARK4;RAB27A;ITGB5;PMAIP1;GADD45A;ZFPM1;CASQ2;EDN1;SPTBN5;SPTBN4;TTYH1;RAB39A;CDH2;FGF10;PIK3R1;REEP1;PDGFB;PLEKHH2;RALB;HRAS;WNT5A;JAM3;PSTPIP2;SNX18;SESN2;AXIN1;RHOQ;RHOJ;NUAK2;PSRC1;FGF8;SDC4;SPTB;BMP7;BMP4;CAMSAP3;DAAM2;HMGN5;RAB20;ESPN;VAMP1;RND3;CHGA;MSN;CTGF;AKT1;PKP1;RAB17;MYO7A;BCAR1;SIN3B;MYH11;AMOT;LAMA5;RAB38;PIM2;PARVB
17971,GO:0097530,0.00925275524050756,0.998189875389945,5,115,granulocyte migration,BP,EDN1;CCL20;JAM3;PIK3CG;PDE4B
12340,GO:0045765,0.00925727687632259,0.997252038625102,8,207,regulation of angiogenesis,BP,ITGA5;NOTCH1;FOXO4;WNT5A;RHOB;NPR1;DLL1;AMOT
19134,GO:1902337,0.00929516897619618,0.999631119848333,2,10,regulation of apoptotic process involved in morphogenesis,BP,BMP7;VDR
20221,GO:1904748,0.00929516897619618,0.999631119848333,2,10,regulation of apoptotic process involved in development,BP,BMP7;VDR
14132,GO:0051547,0.00933338062270386,0.999628810318581,2,10,regulation of keratinocyte migration,BP,FGF10;HBEGF
14953,GO:0060433,0.00937577696693947,0.999619873307236,2,11,bronchus development,BP,WNT7B;BMP4
4811,GO:0010469,0.00939242120012721,0.997800569290712,6,124,regulation of receptor activity,BP,ADRA2B;ADRA2C;ACTN2;ADORA1;CASQ2;PLAU
3340,GO:0006629,0.00943639198322052,0.994779297651422,29,1307,lipid metabolic process,BP,WNT4;STRA6;ITGB8;FASN;DHH;HMGCS2;ADORA1;DKK3;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;SESN2;FGF8;SDC4;HBEGF;BMP6;BMP2;AKT1;PTGES;KITLG;PIK3CA;PIK3CG;SIN3B;VDR;ACSL4
16739,GO:0071887,0.00950306889013388,0.998136736188341,5,97,leukocyte apoptotic process,BP,WNT5A;BMP4;AKT1;KITLG;GAS6
16925,GO:0072203,0.009538979902872,0.999616298082532,2,10,cell proliferation involved in metanephros development,BP,BMP7;WT1
15327,GO:0061041,0.0095410418977403,0.997757455092128,6,126,regulation of wound healing,BP,WNT4;EDN1;PLAU;PDGFB;HRAS;HBEGF
17797,GO:0097191,0.00955359762524612,0.997148104426025,8,209,extrinsic apoptotic signaling pathway,BP,PMAIP1;ACVR1;FGF10;PIK3R1;BMP4;AKT1;KITLG;GDNF
4986,GO:0010762,0.00955500474143088,0.999071306830621,3,29,regulation of fibroblast migration,BP,PRR5L;SDC4;AKT1
698,GO:0001843,0.00956449474907453,0.99812900386879,5,85,neural tube closure,BP,SALL4;PRKACB;WNT5A;SDC4;BMP4
17239,GO:0085029,0.00959593107386161,0.999065868306873,3,29,extracellular matrix assembly,BP,NOTCH1;GAS6;MYH11
15228,GO:0060856,0.00962777631895842,0.999610849692309,2,10,establishment of blood-brain barrier,BP,WNT7A;WNT7B
18687,GO:1901099,0.00968547237082464,0.999045677580651,3,33,negative regulation of signal transduction in absence of ligand,BP,FGF10;AKT1;GDNF
21642,GO:2001240,0.00968547237082464,0.999045677580651,3,33,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,FGF10;AKT1;GDNF
8373,GO:0032272,0.00972717449185322,0.998530581886056,4,58,negative regulation of protein polymerization,BP,FHOD3;SPTBN5;SPTBN4;SPTB
13433,GO:0048845,0.00973709125373811,0.999604105707732,2,10,venous blood vessel morphogenesis,BP,NOTCH1;EFNB2
18898,GO:1901681,0.00973712768845691,0.997082380327081,8,215,sulfur compound binding,MF,CRISPLD2;SERPINA5;FGF10;HBEGF;BMP7;BMP4;CTGF;PTGES
526,GO:0001569,0.00973897596196439,0.999044495358233,3,30,branching involved in blood vessel morphogenesis,BP,ACVR1;EDN1;FGF8
4942,GO:0010712,0.00975970514474037,0.999033901623062,3,34,regulation of collagen metabolic process,BP,WNT4;BMP4;CTGF
13369,GO:0048705,0.00981069009756964,0.997059001351639,8,204,skeletal system morphogenesis,BP,WNT7A;AXIN1;BMP7;BMP6;BMP4;CTGF;NPPC;NAB2
11125,GO:0042995,0.00989543140708489,0.994096657425753,38,1762,cell projection,CC,ITGA3;ITGA5;ADRA2C;SYT5;ACTN3;ACTN2;MARK4;RAB27A;CDH23;ADORA1;PRKACB;SPTBN5;SPTBN4;TTYH1;RAB39B;CDH2;FSTL3;PRKAR1B;PLEKHH2;DRP2;ESPN;VAMP1;MSN;GJB2;AKT1;RAB17;NRTN;KITLG;CDH1;MYO7A;BCAR1;PIK3CA;LZTS1;AMOT;KCND1;ACTA2;PARVB;PDE4B
15006,GO:0060502,0.0100153252500234,0.99958675956793,2,10,epithelial cell proliferation involved in lung morphogenesis,BP,WNT2;BMP4
13979,GO:0051261,0.0100625395470206,0.998004914974642,5,88,protein depolymerization,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB
13255,GO:0048505,0.0101172818688035,0.999573197295546,2,11,regulation of timing of cell differentiation,BP,NOTCH1;DLL1
15823,GO:0070243,0.0101326081482221,0.999572212828865,2,11,regulation of thymocyte apoptotic process,BP,WNT5A;BMP4
18956,GO:1901890,0.0102190906819032,0.998979546176884,3,30,positive regulation of cell junction assembly,BP,WNT4;SDC4;CLDN1
7064,GO:0021978,0.0102660380942046,0.99956360881102,2,11,telencephalon regionalization,BP,BMP4;BMP2
19260,GO:1902668,0.0102821616251734,0.99956988220029,2,10,negative regulation of axon guidance,BP,WNT3;WNT5A
12367,GO:0045823,0.010326907488783,0.998958283867232,3,33,positive regulation of heart contraction,BP,EDN1;CHGA;CTGF
3354,GO:0006650,0.0103427777631086,0.99615160057506,11,337,glycerophospholipid metabolic process,BP,MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
19145,GO:1902369,0.0104198497036628,0.999561081759542,2,10,negative regulation of RNA catabolic process,BP,PKP3;PKP1
8694,GO:0032729,0.010457006994381,0.998381602491987,4,63,positive regulation of interferon-gamma production,BP,ZFPM1;HRAS;WNT5A;PDE4B
8972,GO:0033162,0.0105637700480863,0.999537901250752,2,12,melanosome membrane,CC,RAB27A;RAB38
11964,GO:0045009,0.0105637700480863,0.999537901250752,2,12,chitosome,CC,RAB27A;RAB38
5181,GO:0014013,0.0105683282005787,0.997876572375046,5,92,regulation of gliogenesis,BP,LIF;NOTCH1;CDH2;CLCF1;BMP2
11005,GO:0042733,0.0106178675064756,0.998354713559002,4,58,embryonic digit morphogenesis,BP,NOTCH1;WNT7A;WNT5A;BMP4
12126,GO:0045294,0.01064979607507,0.999546246640522,2,10,alpha-catenin binding,MF,CDH2;PKP3
16828,GO:0072070,0.0106542657794722,0.999538237449972,2,11,loop of Henle development,BP,WNT7B;DLL1
14959,GO:0060439,0.0106796401967998,0.999536561850894,2,11,trachea morphogenesis,BP,WNT7B;BMP4
14692,GO:0060064,0.0107000416070331,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
20523,GO:1905474,0.0107000416070331,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
771,GO:0001947,0.0107279279192012,0.998332664312002,4,58,heart looping,BP,NOTCH1;WNT5A;FGF8;DLL1
12375,GO:0045836,0.0107549190708642,0.999531578379836,2,11,positive regulation of meiotic nuclear division,BP,WNT4;WNT5A
5806,GO:0016197,0.0107633593114546,0.996441639467557,9,246,endosomal transport,BP,ACTN2;RAB6C;SNX18;GPRASP1;RHOB;MSN;RAB12;RAB17;RAB38
11685,GO:0044246,0.0107956934395606,0.998889169209606,3,35,regulation of multicellular organismal metabolic process,BP,WNT4;BMP4;CTGF
2661,GO:0005546,0.0108015803274659,0.998319073997234,4,57,phosphatidylinositol-4,5-bisphosphate binding,MF,SYT5;ACTN2;FZD7;SNX18
17228,GO:0080135,0.0108561324585156,0.995092560325474,16,579,regulation of cellular response to stress,BP,PMAIP1;GADD45A;WNT7A;WNT7B;EDN1;FZD7;FGF10;PIK3R1;HRAS;WNT5A;AXIN1;BMP7;BMP2;CTGF;AKT1;FZD8
6544,GO:0019229,0.0108820992170864,0.998301663233066,4,58,regulation of vasoconstriction,BP,ADRA2B;ADRA2C;EDN1;AKT1
8290,GO:0032101,0.0109647654077755,0.994905019617056,17,672,regulation of response to external stimulus,BP,ARTN;WNT3;WNT4;NOTCH1;NMT2;ADORA1;EDN1;PLAU;TYRO3;FGF10;PDGFB;WNT5A;JAM3;BMP6;PIK3CG;GAS6;EFNB2
19039,GO:1902117,0.0109953185138048,0.998280042366672,4,57,positive regulation of organelle assembly,BP,EDN1;RALB;SDC4;MSN
1590,GO:0003401,0.0110077339916936,0.998867833501957,3,31,axis elongation,BP,FGF10;WNT5A;BMP4
18674,GO:1901077,0.0110697842513682,0.999503780068149,2,12,regulation of relaxation of muscle,BP,CHGA;PDE4B
13904,GO:0051151,0.0111791127746181,0.999503151511844,2,11,negative regulation of smooth muscle cell differentiation,BP,PDGFB;FOXO4
1448,GO:0003157,0.0112610015303678,0.999497596827563,2,11,endocardium development,BP,NOTCH1;ACVR1
12127,GO:0045295,0.01129397653259,0.999503780896566,2,10,gamma-catenin binding,MF,CDH2;CDH1
10599,GO:0040034,0.0114071609729771,0.999480563373483,2,12,regulation of development, heterochronic,BP,NOTCH1;DLL1
20524,GO:1905475,0.011414407222951,0.997209855683055,6,131,regulation of protein localization to membrane,BP,ITGA3;PMAIP1;CDH2;PIK3R1;RHOQ;AKT1
21197,GO:2000401,0.0114272111056878,0.998792209287896,3,39,regulation of lymphocyte migration,BP,CCL20;WNT5A;MSN
18156,GO:0098773,0.0114594143811059,0.997649222348153,5,95,skin epidermis development,BP,NOTCH1;FGF10;WNT5A;DLL1;LAMA5
21416,GO:2000726,0.0115047929302682,0.999480932833344,2,11,negative regulation of cardiac muscle cell differentiation,BP,FZD7;BMP2
9676,GO:0035089,0.0115475056073765,0.999477993772263,2,11,establishment of apical/basal cell polarity,BP,WNT5A;MSN
20876,GO:1990782,0.0115655827272073,0.998161379027794,4,59,protein tyrosine kinase binding,MF,PIK3R2;PIK3R1;GAS6;SHC4
11756,GO:0044344,0.0116117946964084,0.997150180651717,6,133,cellular response to fibroblast growth factor stimulus,BP,WNT4;FGF10;FGF17;WNT5A;FGF8;CTGF
5095,GO:0010907,0.0116726219031292,0.998770685636422,3,32,positive regulation of glucose metabolic process,BP,ACTN3;PMAIP1;AKT1
13676,GO:0050808,0.0116840832192277,0.996087515830862,9,238,synapse organization,BP,WNT7A;WNT7B;RAB39B;CDH2;WNT5A;DRP2;RAB17;CDH1;GDNF
8839,GO:0032941,0.0117010090465534,0.998754138691187,3,38,secretion by tissue,BP,ADORA1;FGF10;WNK4
11418,GO:0043473,0.011818760648381,0.997557015442785,5,95,pigmentation,BP,RAB27A;RAB17;KITLG;MYO7A;RAB38
12266,GO:0045637,0.0118293932403853,0.99667888136241,7,184,regulation of myeloid cell differentiation,BP,LIF;ZFPM1;FSTL3;PIK3R1;DLL1;KITLG;CLDN18
3463,GO:0006812,0.0118636513409323,0.993690104837269,24,1043,cation transport,BP,ACTN2;CDH23;TF;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;TTYH1;TSPAN13;PDGFB;KCNH2;SFXN1;WNK4;CTGF;AKT1;PIK3CG;KCNG2;GAS6;VDR;KCND1;GDNF;CLDN16;PDE4B
5831,GO:0016241,0.0118962774003965,0.997066576352265,6,130,regulation of macroautophagy,BP,RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1
9971,GO:0035659,0.0119012313386519,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
20291,GO:1904889,0.0119012313386519,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
20292,GO:1904891,0.0119012313386519,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
8618,GO:0032609,0.0119199563721294,0.997526880563843,5,101,interferon-gamma production,BP,ZFPM1;HRAS;WNT5A;GAS6;PDE4B
15242,GO:0060911,0.011976998587858,0.999440516784162,2,12,cardiac cell fate commitment,BP,ACVR1;WT1
12590,GO:0046324,0.0120653372970325,0.998055535079817,4,61,regulation of glucose import,BP,PIK3R2;PIK3R1;RHOQ;AKT1
8075,GO:0031674,0.0120784588953809,0.997011375751244,6,131,I band,CC,FHOD3;ACTN2;CASQ2;MYZAP;PARVB;PDE4B
8853,GO:0032964,0.0120872170685706,0.998703452417567,3,35,collagen biosynthetic process,BP,WNT4;BMP4;CTGF
1207,GO:0002687,0.0120934594273592,0.997475052107269,5,113,positive regulation of leukocyte migration,BP,EDN1;CCL20;WNT5A;KITLG;GAS6
13204,GO:0048333,0.0121012659716741,0.998708476256292,3,32,mesodermal cell differentiation,BP,ITGA3;ITGB4;BMP4
13807,GO:0051017,0.0121349514146738,0.996996995691866,6,126,actin filament bundle assembly,BP,WNT4;ITGB5;PIK3R1;SDC4;ESPN;CTGF
15551,GO:0061572,0.0121349514146738,0.996996995691866,6,126,actin filament bundle organization,BP,WNT4;ITGB5;PIK3R1;SDC4;ESPN;CTGF
20934,GO:1990967,0.0121389753734115,1,1,1,multi-organism toxin transport,BP,RAB40B
9755,GO:0035282,0.0121873205974386,0.997461692442526,5,95,segmentation,BP,NOTCH1;WNT5A;BMP4;WT1;DLL1
10071,GO:0035815,0.012238004317989,0.999415232956298,2,13,positive regulation of renal sodium excretion,BP,EDN1;NPR1
13229,GO:0048390,0.0122606155910515,1,1,1,intermediate mesoderm morphogenesis,BP,BMP4
13230,GO:0048391,0.0122606155910515,1,1,1,intermediate mesoderm formation,BP,BMP4
13231,GO:0048392,0.0122606155910515,1,1,1,intermediate mesodermal cell differentiation,BP,BMP4
14572,GO:0055018,0.0122606155910515,1,1,1,regulation of cardiac muscle fiber development,BP,BMP4
14573,GO:0055020,0.0122606155910515,1,1,1,positive regulation of cardiac muscle fiber development,BP,BMP4
15007,GO:0060503,0.0122606155910515,1,1,1,bud dilation involved in lung branching,BP,BMP4
15390,GO:0061149,0.0122606155910515,1,1,1,BMP signaling pathway involved in ureter morphogenesis,BP,BMP4
15391,GO:0061150,0.0122606155910515,1,1,1,renal system segmentation,BP,BMP4
15392,GO:0061151,0.0122606155910515,1,1,1,BMP signaling pathway involved in renal system segmentation,BP,BMP4
15396,GO:0061155,0.0122606155910515,1,1,1,pulmonary artery endothelial tube morphogenesis,BP,BMP4
15425,GO:0061216,0.0122606155910515,1,1,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,BMP4
16743,GO:0071893,0.0122606155910515,1,1,1,BMP signaling pathway involved in nephric duct formation,BP,BMP4
16847,GO:0072096,0.0122606155910515,1,1,1,negative regulation of branch elongation involved in ureteric bud branching,BP,BMP4
16848,GO:0072097,0.0122606155910515,1,1,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,BMP4
16850,GO:0072099,0.0122606155910515,1,1,1,anterior/posterior pattern specification involved in ureteric bud development,BP,BMP4
16851,GO:0072100,0.0122606155910515,1,1,1,specification of ureteric bud anterior/posterior symmetry,BP,BMP4
16852,GO:0072101,0.0122606155910515,1,1,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,BMP4
16915,GO:0072192,0.0122606155910515,1,1,1,ureter epithelial cell differentiation,BP,BMP4
16922,GO:0072200,0.0122606155910515,1,1,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
18971,GO:1901964,0.0122606155910515,1,1,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
20942,GO:2000004,0.0122606155910515,1,1,1,regulation of metanephric S-shaped body morphogenesis,BP,BMP4
20943,GO:2000005,0.0122606155910515,1,1,1,negative regulation of metanephric S-shaped body morphogenesis,BP,BMP4
20944,GO:2000006,0.0122606155910515,1,1,1,regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
20945,GO:2000007,0.0122606155910515,1,1,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
13760,GO:0050922,0.0123065799231935,0.998671131689989,3,35,negative regulation of chemotaxis,BP,WNT3;NOTCH1;WNT5A
3852,GO:0007588,0.0123200169292539,0.997996525242823,4,66,excretion,BP,ADORA1;EDN1;NPR1;CLDN16
12241,GO:0045605,0.0123675196620524,0.999405775426542,2,13,negative regulation of epidermal cell differentiation,BP,NOTCH1;DLL1
1203,GO:0002683,0.0123858028529484,0.995266725666807,11,373,negative regulation of immune system process,BP,NOTCH1;ZFPM1;ADORA1;TYRO3;FSTL3;PIK3R1;SDC4;BMP4;DLL1;KITLG;CLDN18
15841,GO:0070268,0.0124345502325822,0.997387603125741,5,110,cornification,BP,DSC2;DSG3;PKP3;PKP1;DSC3
15487,GO:0061384,0.0124776924206318,0.998650535379296,3,33,heart trabecula morphogenesis,BP,NOTCH1;BMP7;HEY1
15307,GO:0061013,0.0124842290029803,0.99865218373247,3,32,regulation of mRNA catabolic process,BP,PRR5L;PKP3;PKP1
10753,GO:0042307,0.0125184527659062,0.997376180628345,5,94,positive regulation of protein import into nucleus,BP,PIK3R2;PIK3R1;BMP6;BMP4;CDH1
8111,GO:0031731,0.0125629884321388,0.999947315827435,1,3,CCR6 chemokine receptor binding,MF,CCL20
2857,GO:0005887,0.0125773348562885,0.992629396571753,33,1513,integral component of plasma membrane,CC,ITGA3;ITGA5;ADRA2B;ADRA2C;TSPAN15;TSPAN17;ITGB5;ITGB4;ITGB8;SLC52A3;ACVR1;ADORA1;KCNK6;MPZL1;TSPAN13;TYRO3;LPAR2;KCNH2;NPR1;SDC4;HBEGF;BMP2;DLL1;VAMP1;DDR1;JAG2;CLDN1;CLDN3;KCNG2;SLC18B1;KCND1;TSPAN2;EFNB2
10836,GO:0042446,0.0125949510192565,0.997939648946465,4,65,hormone biosynthetic process,BP,WNT4;DKK3;BMP6;BMP2
245,GO:0000578,0.0125965247402632,0.998628075087749,3,35,embryonic axis specification,BP,WNT7A;WNT5A;WT1
8184,GO:0031932,0.0126622749681395,0.999390998425626,2,12,TORC2 complex,CC,PRR5L;SESN2
20912,GO:1990909,0.0126640482596024,0.999399137128991,2,11,Wnt signalosome,CC,WNT3;WNT2
4676,GO:0009896,0.0127070803211642,0.994894413051628,12,406,positive regulation of catabolic process,BP,ACTN3;PRR5L;RALB;WNT5A;SESN2;AXIN1;MSN;AKT1;RAB12;SH3BP4;RNF144A;PIM2
7819,GO:0031226,0.0127846019866556,0.992441557286488,34,1576,intrinsic component of plasma membrane,CC,ITGA3;ITGA5;ADRA2B;ADRA2C;TSPAN15;TSPAN17;ITGB5;ITGB4;ITGB8;SLC52A3;ACVR1;ADORA1;KCNK6;MPZL1;TSPAN13;TYRO3;LPAR2;KCNH2;NPR1;SDC4;SPTB;HBEGF;BMP2;DLL1;VAMP1;DDR1;JAG2;CLDN1;CLDN3;KCNG2;SLC18B1;KCND1;TSPAN2;EFNB2
8420,GO:0032352,0.0128590193256222,0.999384973045424,2,11,positive regulation of hormone metabolic process,BP,WNT4;BMP6
5037,GO:0010839,0.012925291832086,0.99937160561513,2,12,negative regulation of keratinocyte proliferation,BP,VDR;EFNB2
11454,GO:0043524,0.0129583218323985,0.996743505214233,6,133,negative regulation of neuron apoptotic process,BP,TYRO3;HRAS;FGF8;CLCF1;PIK3CA;GDNF
9985,GO:0035690,0.0129769696553924,0.997858472606651,4,65,cellular response to drug,BP,EDN1;KCNH2;GAS6;PDE4B
2782,GO:0005768,0.0129894738647498,0.993456922042597,20,803,endosome,CC,TMEM163;ADRA2C;SYT5;RIN3;TSPAN15;RAB27A;TF;RAB40B;RAB40A;FZD7;SNX18;RHOB;RAB20;RAB12;RAB17;CYTIP;CDH1;RAB11FIP1;RAB38;RNF144A
5111,GO:0010927,0.0129929686490205,0.997251547672925,5,94,cellular component assembly involved in morphogenesis,BP,FHOD3;ACTN2;CASQ2;EDN1;MYH11
13130,GO:0048185,0.0130336285993523,0.999363556015651,2,12,activin binding,MF,ACVR1;FSTL3
13438,GO:0048854,0.0130567132814088,0.998564027321911,3,33,brain morphogenesis,BP,CDH2;WNT5A;FGF8
784,GO:0001961,0.0130575699187453,0.998561288799793,3,34,positive regulation of cytokine-mediated signaling pathway,BP,EDN1;WNT5A;GAS6
15964,GO:0070473,0.0130700514409852,1,1,1,negative regulation of uterine smooth muscle contraction,BP,ADRA2C
11483,GO:0043560,0.0131013218065351,0.999367210065789,2,11,insulin receptor substrate binding,MF,PIK3R1;PIK3CA
14211,GO:0051693,0.0131212592210522,0.998554291883943,3,33,actin filament capping,BP,SPTBN5;SPTBN4;SPTB
18876,GO:1901654,0.0131702554265569,0.996226196604153,7,180,response to ketone,BP,EDN1;CDKN1A;MSN;GJB2;AKT1;CLDN1;GAS6
775,GO:0001952,0.0132044014673078,0.997195631084482,5,94,regulation of cell-matrix adhesion,BP,WNT4;PLAU;PIK3R1;SDC4;DDR1
12414,GO:0045913,0.0132899585952369,0.997795231504096,4,62,positive regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1;PDGFB;AKT1
6242,GO:0017046,0.0132926953734976,0.998523158533726,3,35,peptide hormone binding,MF,ACVR1;PIK3R1;NPR1
19738,GO:1903706,0.0132975856184289,0.995138397978247,10,323,regulation of hemopoiesis,BP,LIF;NOTCH1;ZFPM1;FSTL3;PIK3R1;BMP4;DLL1;KITLG;GAS6;CLDN18
20143,GO:1904591,0.013301531643343,0.997168232844063,5,96,positive regulation of protein import,BP,PIK3R2;PIK3R1;BMP6;BMP4;CDH1
16903,GO:0072178,0.013318140516713,0.999342246161121,2,12,nephric duct morphogenesis,BP,BMP4;EFNB2
3134,GO:0006357,0.0133875904781244,0.991843096375669,38,1840,regulation of transcription from RNA polymerase II promoter,BP,ITGA3;LIF;WNT2;POU3F1;NOTCH1;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;TLE1;SIN3B;ZCCHC12;VDR;GDNF;FZD8;HEY1
11306,GO:0043268,0.0133953164551415,0.998512753114953,3,33,positive regulation of potassium ion transport,BP,ACTN2;ADORA1;KCNH2
17268,GO:0086030,0.0134755525944761,1,1,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,CHGA
16509,GO:0071479,0.0135399875089771,0.997738764321738,4,64,cellular response to ionizing radiation,BP,GADD45A;HRAS;RHOB;CDKN1A
13769,GO:0050931,0.0136663785249017,0.998468575333563,3,34,pigment cell differentiation,BP,RAB27A;KITLG;RAB38
15331,GO:0061045,0.0136819584714754,0.997708031689268,4,64,negative regulation of wound healing,BP,WNT4;EDN1;PLAU;PDGFB
8019,GO:0031583,0.0136998060325298,1,1,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,EDN1
8096,GO:0031707,0.0136998060325298,1,1,1,endothelin A receptor binding,MF,EDN1
9568,GO:0034696,0.0136998060325298,1,1,1,response to prostaglandin F,BP,EDN1
10758,GO:0042313,0.0136998060325298,1,1,1,protein kinase C deactivation,BP,EDN1
11243,GO:0043179,0.0136998060325298,1,1,1,rhythmic excitation,BP,EDN1
15177,GO:0060760,0.0137177090371081,0.998458062486339,3,35,positive regulation of response to cytokine stimulus,BP,EDN1;WNT5A;GAS6
18079,GO:0098590,0.0137664943468547,0.992683648729735,23,932,plasma membrane region,CC,ITGA3;ITGA5;NOTCH1;RAB27A;TF;SLC52A3;ADORA1;SPTBN5;TTYH1;CDH2;PDGFB;DLL1;DRP2;MSN;GJB6;RAB17;CDH1;MYO7A;CLDN1;CLDN3;CLDN5;LZTS1;SHC4
16675,GO:0071774,0.0137891448661249,0.996484428432916,6,139,response to fibroblast growth factor,BP,WNT4;FGF10;FGF17;WNT5A;FGF8;CTGF
18722,GO:1901214,0.0137914219581303,0.995248654344646,9,262,regulation of neuron death,BP,RRAS2;TYRO3;HRAS;FGF8;CLCF1;CHGA;AKT1;PIK3CA;GDNF
15479,GO:0061371,0.0137920527156663,0.997685462412265,4,63,determination of heart left/right asymmetry,BP,NOTCH1;WNT5A;FGF8;DLL1
6759,GO:0019901,0.0138523398896553,0.993740015975056,15,528,protein kinase binding,MF,CDH2;PIK3R2;PIK3R1;PRKAR1B;AXIN1;NPR1;SDC4;CDKN1A;MSN;AKT1;BCAR1;GAS6;SHC4;ARAF;ACTA2
5195,GO:0014037,0.0138618066071703,0.998441300799383,3,33,Schwann cell differentiation,BP,POU3F1;AKT1;NAB2
21639,GO:2001237,0.0138633915823069,0.997014935621787,5,100,negative regulation of extrinsic apoptotic signaling pathway,BP,ACVR1;FGF10;BMP4;AKT1;GDNF
12288,GO:0045664,0.0140191391847803,0.993655530098326,15,529,regulation of neuron differentiation,BP,ITGA3;ADRA2B;ADRA2C;WNT3;NOTCH1;WNT7A;WNT5A;BMP7;BMP6;BMP4;BMP2;DLL1;AKT1;RAB17;LZTS1
7055,GO:0021953,0.0140783319709191,0.99591654009007,7,172,central nervous system neuron differentiation,BP,WNT3;WNT2;WNT7A;SPTBN4;WNT5A;AXIN1;FGF8
11313,GO:0043277,0.0140979322708023,0.998399169715863,3,35,apoptotic cell clearance,BP,MFGE8;TYRO3;GAS6
7252,GO:0030136,0.0141128766916318,0.995902893142639,7,176,clathrin-coated vesicle,CC,RAB27A;TF;EDN1;WNT5A;SNX18;HBEGF;SH3BP4
14962,GO:0060442,0.0141689113123852,0.999277072763126,2,12,branching involved in prostate gland morphogenesis,BP,BMP7;BMP4
7625,GO:0030859,0.0141947965662779,0.999275056143132,2,12,polarized epithelial cell differentiation,BP,WNT5A;MSN
15895,GO:0070352,0.014206089179969,0.999949397410705,1,2,positive regulation of white fat cell proliferation,BP,FGF10
12462,GO:0045989,0.0142579238397572,0.999254759410358,2,14,positive regulation of striated muscle contraction,BP,CHGA;CTGF
10601,GO:0040037,0.0142711690657757,0.999269094779376,2,12,negative regulation of fibroblast growth factor receptor signaling pathway,BP,WNT4;WNT5A
755,GO:0001928,0.0143208805656651,1,1,1,regulation of exocyst assembly,BP,RALB
14768,GO:0060178,0.0143208805656651,1,1,1,regulation of exocyst localization,BP,RALB
14558,GO:0055002,0.0143367174312907,0.996316524915961,6,134,striated muscle cell development,BP,FHOD3;ACTN2;CASQ2;EDN1;BMP4;MYH11
12141,GO:0045335,0.0144059496020886,0.996866769364465,5,102,phagocytic vesicle,CC,ITGB5;RAB39A;RAB20;RAB11FIP1;RAB38
7322,GO:0030225,0.0144257262515457,0.998345263257514,3,36,macrophage differentiation,BP,LIF;BMP4;TSPAN2
14918,GO:0060391,0.0144683436637674,0.999253625003754,2,12,positive regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
13437,GO:0048853,0.0145117447919136,0.999234420829329,2,14,forebrain morphogenesis,BP,WNT5A;FGF8
10188,GO:0036024,0.0145156595431163,1,1,1,protein C inhibitor-TMPRSS7 complex,CC,SERPINA5
10189,GO:0036025,0.0145156595431163,1,1,1,protein C inhibitor-TMPRSS11E complex,CC,SERPINA5
10190,GO:0036026,0.0145156595431163,1,1,1,protein C inhibitor-PLAT complex,CC,SERPINA5
10191,GO:0036027,0.0145156595431163,1,1,1,protein C inhibitor-PLAU complex,CC,SERPINA5
10192,GO:0036028,0.0145156595431163,1,1,1,protein C inhibitor-thrombin complex,CC,SERPINA5
10193,GO:0036029,0.0145156595431163,1,1,1,protein C inhibitor-KLK3 complex,CC,SERPINA5
10194,GO:0036030,0.0145156595431163,1,1,1,protein C inhibitor-plasma kallikrein complex,CC,SERPINA5
17789,GO:0097179,0.0145156595431163,1,1,1,protease inhibitor complex,CC,SERPINA5
17790,GO:0097180,0.0145156595431163,1,1,1,serine protease inhibitor complex,CC,SERPINA5
17791,GO:0097181,0.0145156595431163,1,1,1,protein C inhibitor-coagulation factor V complex,CC,SERPINA5
17792,GO:0097182,0.0145156595431163,1,1,1,protein C inhibitor-coagulation factor Xa complex,CC,SERPINA5
17793,GO:0097183,0.0145156595431163,1,1,1,protein C inhibitor-coagulation factor XI complex,CC,SERPINA5
10446,GO:0038034,0.0146013627991844,0.997500165167114,4,69,signal transduction in absence of ligand,BP,FGF10;AKT1;KITLG;GDNF
17798,GO:0097192,0.0146013627991844,0.997500165167114,4,69,extrinsic apoptotic signaling pathway in absence of ligand,BP,FGF10;AKT1;KITLG;GDNF
10066,GO:0035810,0.0146578779958097,0.999229994669616,2,13,positive regulation of urine volume,BP,EDN1;NPR1
14129,GO:0051543,0.0146680918626825,1,1,1,regulation of elastin biosynthetic process,BP,HBEGF
14130,GO:0051545,0.0146680918626825,1,1,1,negative regulation of elastin biosynthetic process,BP,HBEGF
5845,GO:0016264,0.0146790880520956,0.999236965214491,2,12,gap junction assembly,BP,GJB1;GJB2
6296,GO:0017145,0.0147296310131791,0.998302864123168,3,34,stem cell division,BP,NOTCH1;WNT7A;FZD7
13063,GO:0048009,0.0147558302410947,0.998293106091784,3,36,insulin-like growth factor receptor signaling pathway,BP,PIK3R1;BMP2;AKT1
7541,GO:0030670,0.0147919119416964,0.997457829316032,4,69,phagocytic vesicle membrane,CC,RAB39A;RAB20;RAB11FIP1;RAB38
16800,GO:0072017,0.0147982124364784,0.999227491169885,2,12,distal tubule development,BP,NOTCH1;WNK4
7888,GO:0031330,0.0148060515451562,0.9961650940509,6,141,negative regulation of cellular catabolic process,BP,AKT1;PKP3;PKP1;PIK3CA;PIK3CG;LZTS1
1992,GO:0004454,0.0148615613346579,1,1,1,ketohexokinase activity,MF,KHK
8481,GO:0032420,0.0149315129295193,0.998265164372588,3,36,stereocilium,CC,CDH23;ESPN;MYO7A
14109,GO:0051495,0.014943744239053,0.995610354361155,7,182,positive regulation of cytoskeleton organization,BP,WNT4;ACTN2;EDN1;HRAS;PSRC1;SDC4;CTGF
2925,GO:0006000,0.0149974005721744,0.999194973266629,2,14,fructose metabolic process,BP,KHK;PFKFB3
18509,GO:1900141,0.0151277931503116,1,1,1,regulation of oligodendrocyte apoptotic process,BP,GAS6
18510,GO:1900142,0.0151277931503116,1,1,1,negative regulation of oligodendrocyte apoptotic process,BP,GAS6
21282,GO:2000533,0.0151277931503116,1,1,1,negative regulation of renal albumin absorption,BP,GAS6
4457,GO:0009187,0.0151837228729906,0.995521999032385,7,192,cyclic nucleotide metabolic process,BP,GUCY1B3;EDN1;WNT5A;NPR1;CHGA;NPPC;PDE4B
15237,GO:0060900,0.0152072073721871,0.999194652360327,2,12,embryonic camera-type eye formation,BP,STRA6;WNT5A
3735,GO:0007257,0.0152178047508558,0.998225210985077,3,34,activation of JUN kinase activity,BP,WNT7B;WNT5A;AXIN1
650,GO:0001780,0.0152402225781612,0.999182805320202,2,13,neutrophil homeostasis,BP,JAM3;PDE4B
4271,GO:0008654,0.0152762350440078,0.994646597465566,9,266,phospholipid biosynthetic process,BP,MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;PIK3CA;PIK3CG
7225,GO:0030099,0.0152926760464335,0.994286543120907,10,329,myeloid cell differentiation,BP,LIF;ZFPM1;FSTL3;PIK3R1;BMP4;DLL1;SFXN1;KITLG;TSPAN2;CLDN18
18062,GO:0098552,0.0153718356664916,0.993660443472026,12,412,side of membrane,CC,ITGA3;ITGA5;TF;SERPINA5;MFGE8;PTPN7;SNX18;FGF8;SPTB;CDH1;AMOT;MYZAP
578,GO:0001666,0.015411560223732,0.994235832737124,10,326,response to hypoxia,BP,NOTCH1;PMAIP1;ADORA1;EDN1;PLAU;BMP7;BMP2;AKT1;NPPC;CLDN3
11176,GO:0043068,0.0154462008271141,0.992924486319935,15,566,positive regulation of programmed cell death,BP,NOTCH1;MARK4;PMAIP1;GADD45A;PIK3R2;WNT5A;RHOB;BMP7;BMP4;BMP2;CDKN1A;CTGF;AKT1;INHBB;VDR
16239,GO:0070986,0.0154793108038533,0.999163147153552,2,13,left/right axis specification,BP,NOTCH1;DLL1
12459,GO:0045986,0.0154813646091228,0.999154975914791,2,14,negative regulation of smooth muscle contraction,BP,ADRA2C;ADORA1
5639,GO:0015844,0.0156543669036098,0.997260358275912,4,72,monoamine transport,BP,ADRA2B;ADRA2C;CHGA;GDNF
16307,GO:0071156,0.0157131661639453,0.996505045827977,5,105,regulation of cell cycle arrest,BP,GADD45A;FGF10;FOXO4;CDKN1A;HMGN5
6238,GO:0017038,0.0157505576354797,0.994091305318306,10,316,protein import,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
19614,GO:1903435,0.0158305426417452,1,1,1,positive regulation of constitutive secretory pathway,BP,RAB27A
19444,GO:1903076,0.0158912689003721,0.997214539686376,4,66,regulation of protein localization to plasma membrane,BP,ITGA3;PIK3R1;RHOQ;AKT1
8361,GO:0032242,0.0158996412384785,1,1,1,regulation of nucleoside transport,BP,ADORA1
8362,GO:0032244,0.0158996412384785,1,1,1,positive regulation of nucleoside transport,BP,ADORA1
8808,GO:0032900,0.0158996412384785,1,1,1,negative regulation of neurotrophin production,BP,ADORA1
15386,GO:0061143,0.0159138200454265,1,1,1,alveolar primary septum development,BP,STRA6
15138,GO:0060709,0.0159433052516372,1,1,1,glycogen cell differentiation involved in embryonic placenta development,BP,AKT1
18383,GO:0100002,0.0159433052516372,1,1,1,negative regulation of protein kinase activity by protein phosphorylation,BP,AKT1
3002,GO:0006113,0.0159568801301764,1,1,1,fermentation,BP,ACTN3
6659,GO:0019659,0.0159568801301764,1,1,1,glucose catabolic process to lactate,BP,ACTN3
6660,GO:0019660,0.0159568801301764,1,1,1,glycolytic fermentation,BP,ACTN3
6661,GO:0019661,0.0159568801301764,1,1,1,glucose catabolic process to lactate via pyruvate,BP,ACTN3
11414,GO:0043465,0.0159568801301764,1,1,1,regulation of fermentation,BP,ACTN3
19269,GO:1902690,0.0159568801301764,1,1,1,positive regulation of NAD metabolic process,BP,ACTN3
19901,GO:1904023,0.0159568801301764,1,1,1,regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
19902,GO:1904025,0.0159568801301764,1,1,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
16957,GO:0072255,0.0159661022898472,1,1,1,metanephric glomerular mesangial cell development,BP,PDGFB
17668,GO:0090677,0.0159661022898472,1,1,1,reversible differentiation,BP,PDGFB
17669,GO:0090678,0.0159661022898472,1,1,1,cell dedifferentiation involved in phenotypic switching,BP,PDGFB
18568,GO:1900241,0.0159661022898472,1,1,1,positive regulation of phenotypic switching,BP,PDGFB
20409,GO:1905174,0.0159661022898472,1,1,1,regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
20410,GO:1905176,0.0159661022898472,1,1,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
20926,GO:1990936,0.0159661022898472,1,1,1,vascular smooth muscle cell dedifferentiation,BP,PDGFB
16435,GO:0071377,0.0160187225015341,0.998081309228549,3,39,cellular response to glucagon stimulus,BP,PRKACB;PRKAR1B;GJB2
15266,GO:0060957,0.0160932128778903,1,1,1,endocardial cell fate commitment,BP,ACVR1
15507,GO:0061445,0.0160932128778903,1,1,1,endocardial cushion cell fate commitment,BP,ACVR1
5323,GO:0014909,0.0161227043480209,0.997164905639924,4,64,smooth muscle cell migration,BP,PLAU;PDGFB;FOXO4;DDR1
16981,GO:0072299,0.0161523980843032,1,1,1,negative regulation of metanephric glomerulus development,BP,WT1
16984,GO:0072302,0.0161523980843032,1,1,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,WT1
4903,GO:0010639,0.0162532670163444,0.993874112468628,10,311,negative regulation of organelle organization,BP,FHOD3;LIF;SPTBN5;SPTBN4;PLEKHH2;SPTB;BMP7;BMP4;ESPN;AKT1
19725,GO:1903672,0.0162778314847582,0.999096311057991,2,13,positive regulation of sprouting angiogenesis,BP,ITGA5;DLL1
1216,GO:0002696,0.0163037286789799,0.994219241637576,9,286,positive regulation of leukocyte activation,BP,FGF10;PIK3R1;WNT5A;CLCF1;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
13829,GO:0051042,0.016316837107346,1,1,1,negative regulation of calcium-independent cell-cell adhesion,BP,BMP2
15200,GO:0060804,0.016316837107346,1,1,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,BMP2
12248,GO:0045618,0.0163202417536456,0.999084048543119,2,14,positive regulation of keratinocyte differentiation,BP,NOTCH1;VDR
15829,GO:0070252,0.0163247067119112,0.996336751676434,5,102,actin-mediated cell contraction,BP,ACTN3;ACTN2;DSC2;KCNH2;PDE4B
12432,GO:0045933,0.0163326294879501,0.998029493776172,3,39,positive regulation of muscle contraction,BP,EDN1;CHGA;CTGF
8614,GO:0032605,0.0163640928740197,1,1,1,hepatocyte growth factor production,BP,INHBB
8643,GO:0032646,0.0163640928740197,1,1,1,regulation of hepatocyte growth factor production,BP,INHBB
8668,GO:0032686,0.0163640928740197,1,1,1,negative regulation of hepatocyte growth factor production,BP,INHBB
12809,GO:0046789,0.0163640928740197,1,1,1,host cell surface receptor binding,MF,INHBB
12813,GO:0046812,0.0163640928740197,1,1,1,host cell surface binding,MF,INHBB
13125,GO:0048175,0.0163640928740197,1,1,1,hepatocyte growth factor biosynthetic process,BP,INHBB
13126,GO:0048176,0.0163640928740197,1,1,1,regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
13127,GO:0048178,0.0163640928740197,1,1,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
5175,GO:0014004,0.0163749986765976,1,1,1,microglia differentiation,BP,TSPAN2
5176,GO:0014005,0.0163749986765976,1,1,1,microglia development,BP,TSPAN2
12171,GO:0045403,0.0164003573027892,1,1,1,negative regulation of interleukin-4 biosynthetic process,BP,ZFPM1
14906,GO:0060377,0.0164003573027892,1,1,1,negative regulation of mast cell differentiation,BP,ZFPM1
12085,GO:0045202,0.0164068782557242,0.991539849772291,20,797,synapse,CC,ITGA3;ITGA5;TMEM163;ADRA2C;SYT5;ACTN2;RAB27A;WNT7A;ADORA1;RAB40B;RAB40A;CDH2;DRP2;VAMP1;AKT1;MYO7A;LZTS1;SHC4;LAMA5;PDE4B
6910,GO:0021679,0.0164481909689286,1,1,1,cerebellar molecular layer development,BP,DLL1
6918,GO:0021687,0.0164481909689286,1,1,1,cerebellar molecular layer morphogenesis,BP,DLL1
6919,GO:0021688,0.0164481909689286,1,1,1,cerebellar molecular layer formation,BP,DLL1
15227,GO:0060853,0.0164481909689286,1,1,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,DLL1
15400,GO:0061162,0.0164866204349194,0.999078539069207,2,13,establishment of monopolar cell polarity,BP,WNT5A;MSN
15458,GO:0061339,0.0164866204349194,0.999078539069207,2,13,establishment or maintenance of monopolar cell polarity,BP,WNT5A;MSN
7016,GO:0021881,0.0164955649349323,1,1,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,AXIN1
15647,GO:0061772,0.0165042280933937,1,1,1,drug transport across blood-nerve barrier,BP,CLDN1
19660,GO:1903544,0.0165042280933937,1,1,1,response to butyrate,BP,CLDN1
19661,GO:1903545,0.0165042280933937,1,1,1,cellular response to butyrate,BP,CLDN1
18995,GO:1902010,0.016532719622089,1,1,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
17407,GO:0090138,0.0165764583037123,1,1,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,JAM3
3845,GO:0007568,0.0165823592335898,0.994105905021949,9,278,aging,BP,EDN1;FOXO4;HRAS;CDKN1A;CTGF;GJB2;GJB6;AKT1;CLDN1
1950,GO:0004375,0.0165907178551939,1,1,1,glycine dehydrogenase (decarboxylating) activity,MF,GLDC
6040,GO:0016642,0.0165907178551939,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,GLDC
609,GO:0001715,0.0165914710319069,1,1,1,ectodermal cell fate specification,BP,FZD7
10973,GO:0042665,0.0165914710319069,1,1,1,regulation of ectodermal cell fate specification,BP,FZD7
10974,GO:0042666,0.0165914710319069,1,1,1,negative regulation of ectodermal cell fate specification,BP,FZD7
21185,GO:2000383,0.0165914710319069,1,1,1,regulation of ectoderm development,BP,FZD7
21186,GO:2000384,0.0165914710319069,1,1,1,negative regulation of ectoderm development,BP,FZD7
8194,GO:0031945,0.0165927576164568,1,1,1,positive regulation of glucocorticoid metabolic process,BP,WNT4
8197,GO:0031948,0.0165927576164568,1,1,1,positive regulation of glucocorticoid biosynthetic process,BP,WNT4
15477,GO:0061369,0.0165927576164568,1,1,1,negative regulation of testicular blood vessel morphogenesis,BP,WNT4
20954,GO:2000019,0.0165927576164568,1,1,1,negative regulation of male gonad development,BP,WNT4
20986,GO:2000066,0.0165927576164568,1,1,1,positive regulation of cortisol biosynthetic process,BP,WNT4
21068,GO:2000225,0.0165927576164568,1,1,1,negative regulation of testosterone biosynthetic process,BP,WNT4
5884,GO:0016332,0.0165928612814836,1,1,1,establishment or maintenance of polarity of embryonic epithelium,BP,WNT7B
16825,GO:0072060,0.0165928612814836,1,1,1,outer medullary collecting duct development,BP,WNT7B
18893,GO:1901676,0.0165929284526478,1,1,1,positive regulation of histone H3-K27 acetylation,BP,LIF
14213,GO:0051695,0.0165932406479928,1,1,1,actin filament uncapping,BP,ACTN2
4147,GO:0008434,0.0165932406480242,1,1,1,calcitriol receptor activity,MF,VDR
10529,GO:0038186,0.0165932406480242,1,1,1,lithocholic acid receptor activity,MF,VDR
19025,GO:1902098,0.0165932406480242,1,1,1,calcitriol binding,MF,VDR
19041,GO:1902121,0.0165932406480242,1,1,1,lithocholic acid binding,MF,VDR
20707,GO:1990134,0.016593240648093,1,1,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,JAG2
13014,GO:0047676,0.0165932406481286,1,1,1,arachidonate-CoA ligase activity,MF,ACSL4
20812,GO:1990578,0.0165932406482874,1,1,1,perinuclear endoplasmic reticulum membrane,CC,PIK3R1
2455,GO:0005115,0.0165932406482946,1,1,1,receptor tyrosine kinase-like orphan receptor binding,MF,WNT5A
10418,GO:0036517,0.0165932406482946,1,1,1,chemoattraction of serotonergic neuron axon,BP,WNT5A
15462,GO:0061347,0.0165932406482946,1,1,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,WNT5A
15463,GO:0061348,0.0165932406482946,1,1,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,WNT5A
15464,GO:0061349,0.0165932406482946,1,1,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,WNT5A
15465,GO:0061350,0.0165932406482946,1,1,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,WNT5A
15467,GO:0061354,0.0165932406482946,1,1,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,WNT5A
15586,GO:0061642,0.0165932406482946,1,1,1,chemoattraction of axon,BP,WNT5A
19148,GO:1902379,0.0165932406482946,1,1,1,chemoattractant activity involved in axon guidance,MF,WNT5A
20314,GO:1904934,0.0165932406482946,1,1,1,negative regulation of cell proliferation in midbrain,BP,WNT5A
20325,GO:1904955,0.0165932406482946,1,1,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
20718,GO:1990172,0.0165932406483045,1,1,1,G-protein coupled receptor catabolic process,BP,GPRASP1
905,GO:0002140,0.0165932406486918,1,1,1,stereocilia tip link,CC,MYO7A
7975,GO:0031477,0.0165932406486918,1,1,1,myosin VII complex,CC,MYO7A
20778,GO:1990427,0.0165932406486918,1,1,1,stereocilia tip-link density,CC,MYO7A
20782,GO:1990435,0.0165932406486918,1,1,1,upper tip-link density,CC,MYO7A
1901,GO:0004313,0.0165932406489674,1,1,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,FASN
1904,GO:0004316,0.0165932406489674,1,1,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,FASN
1905,GO:0004317,0.0165932406489674,1,1,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,FASN
1906,GO:0004319,0.0165932406489674,1,1,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,FASN
6514,GO:0019171,0.0165932406489674,1,1,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,FASN
12939,GO:0047117,0.0165932406489674,1,1,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,FASN
12990,GO:0047451,0.0165932406489674,1,1,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,FASN
18400,GO:0102132,0.0165932406489674,1,1,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,FASN
1523,GO:0003270,0.0165932406491675,1,1,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
15221,GO:0060843,0.0165932406491675,1,1,1,venous endothelial cell differentiation,BP,NOTCH1
8245,GO:0032029,0.0165932406497359,1,1,1,myosin tail binding,MF,SPTBN5
13305,GO:0048599,0.0167806166449673,0.997954880371888,3,39,oocyte development,BP,WNT4;NPPC;INHBB
4825,GO:0010508,0.0168100042004497,0.996201906462597,5,100,positive regulation of autophagy,BP,RALB;SESN2;RAB12;SH3BP4;PIM2
20041,GO:1904375,0.0168160330772284,0.997000962109239,4,67,regulation of protein localization to cell periphery,BP,ITGA3;PIK3R1;RHOQ;AKT1
18651,GO:1901017,0.0168229865666319,0.99904058555754,2,14,negative regulation of potassium ion transmembrane transporter activity,BP,ACTN2;CASQ2
8569,GO:0032536,0.0168270980689821,0.999049297340604,2,13,regulation of cell projection size,BP,WNT7A;WNT7B
15141,GO:0060712,0.0168740852619588,0.999028277401094,2,15,spongiotrophoblast layer development,BP,LIF;AKT1
16714,GO:0071850,0.0168869938808108,0.99903500125373,2,14,mitotic cell cycle arrest,BP,GADD45A;CDKN1A
13405,GO:0048771,0.016899545949802,0.995492203891569,6,144,tissue remodeling,BP,LIF;FGF10;FGF8;VDR;RAB3D;CLDN18
14589,GO:0055065,0.0169195285100032,0.99239353096253,14,537,metal ion homeostasis,BP,CDH23;TF;ADORA1;CASQ2;EDN1;PRND;LPAR2;KCNH2;NPR1;BMP6;SFXN1;PIK3CG;VDR;CLDN16
4806,GO:0010464,0.0169510037269842,0.99793837360697,3,35,regulation of mesenchymal cell proliferation,BP,WNT2;WNT5A;BMP4
10126,GO:0035924,0.0170001195187059,0.997923762635077,3,37,cellular response to vascular endothelial growth factor stimulus,BP,NOTCH1;DLL1;AKT1
4823,GO:0010506,0.0170624807180743,0.993909452216181,9,267,regulation of autophagy,BP,PIK3R2;RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1;SH3BP4;PIM2
3034,GO:0006182,0.0171625277958327,0.997885445296788,3,41,cGMP biosynthetic process,BP,GUCY1B3;NPR1;NPPC
6830,GO:0021532,0.0171783244230493,0.997890816809563,3,38,neural tube patterning,BP,PRKACB;FGF8;BMP4
11511,GO:0043616,0.0172169212912069,0.997884301882704,3,38,keratinocyte proliferation,BP,FGF10;VDR;EFNB2
13839,GO:0051052,0.0172621269575378,0.993080603833451,11,364,regulation of DNA metabolic process,BP,FGF10;PDGFB;HRAS;CLCF1;BMP6;BMP4;CDKN1A;AKT1;KITLG;NPPC;PIK3CA
3894,GO:0008021,0.0172703566635258,0.995370586351538,6,145,synaptic vesicle,CC,TMEM163;SYT5;RAB40B;RAB40A;VAMP1;PDE4B
3779,GO:0007351,0.0173123075824385,0.998997605919247,2,14,tripartite regional subdivision,BP,WNT5A;WT1
4241,GO:0008595,0.0173123075824385,0.998997605919247,2,14,anterior/posterior axis specification, embryo,BP,WNT5A;WT1
5115,GO:0010934,0.0173768857617699,0.998991884216269,2,14,macrophage cytokine production,BP,WNT5A;GAS6
17384,GO:0090101,0.0174345472330809,0.996022483669388,5,102,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,NOTCH1;RASL11B;ACVR1;FSTL3;WNT5A
21003,GO:2000107,0.0174804397540073,0.997828959023386,3,42,negative regulation of leukocyte apoptotic process,BP,BMP4;KITLG;GAS6
8292,GO:0032103,0.0175178397343793,0.994160864233232,8,258,positive regulation of response to external stimulus,BP,ARTN;EDN1;FGF10;PDGFB;WNT5A;BMP6;PIK3CG;GAS6
5973,GO:0016525,0.0175468938647097,0.996826109370512,4,70,negative regulation of angiogenesis,BP,NOTCH1;FOXO4;NPR1;AMOT
5082,GO:0010893,0.0177046942280334,0.998962663400213,2,14,positive regulation of steroid biosynthetic process,BP,WNT4;BMP6
5217,GO:0014061,0.0177155085518329,0.998953247535719,2,15,regulation of norepinephrine secretion,BP,ADRA2B;ADRA2C
12349,GO:0045785,0.0177284454690336,0.992863061393989,11,378,positive regulation of cell adhesion,BP,ITGA3;ITGA5;WNT4;FSTL3;PIK3R1;WNT5A;SDC4;BMP7;AKT1;PIK3CA;EFNB2
19446,GO:1903078,0.0177439775819594,0.997794775779014,3,38,positive regulation of protein localization to plasma membrane,BP,ITGA3;PIK3R1;AKT1
20043,GO:1904377,0.0177439775819594,0.997794775779014,3,38,positive regulation of protein localization to cell periphery,BP,ITGA3;PIK3R1;AKT1
15798,GO:0070201,0.0177472937021541,0.990936601995576,19,791,regulation of establishment of protein localization,BP,ITGA3;ADRA2C;PMAIP1;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;RHOQ;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6
11675,GO:0044232,0.0177765855157184,0.998956215711851,2,14,organelle membrane contact site,CC,RAB38;ACSL4
16550,GO:0071548,0.0178461133386294,0.997768841499234,3,41,response to dexamethasone,BP,EDN1;GJB2;CLDN1
14725,GO:0060119,0.0178518282355649,0.9977763280189,3,38,inner ear receptor cell development,BP,CDH23;SDC4;MYO7A
7681,GO:0030949,0.0179189921228675,0.998934809024731,2,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,ITGA5;FGF10
14084,GO:0051446,0.017945514556315,0.998941009635039,2,14,positive regulation of meiotic cell cycle,BP,WNT4;WNT5A
9610,GO:0034766,0.0180004645292837,0.99671482986805,4,73,negative regulation of ion transmembrane transport,BP,ACTN2;CASQ2;KCNH2;AKT1
16583,GO:0071599,0.0180446714050926,0.998923364048062,2,15,otic vesicle development,BP,FGF10;FGF8
13805,GO:0051015,0.0180775770613252,0.99510912270419,6,139,actin filament binding,MF,TAGLN;ACTN2;SPTB;ESPN;MYO7A;MYH11
12659,GO:0046474,0.0180861682412096,0.993946827989576,8,227,glycerophospholipid biosynthetic process,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;PIK3CA;PIK3CG
21243,GO:2000479,0.018153464299609,0.998922184776275,2,14,regulation of cAMP-dependent protein kinase activity,BP,PRKAR1B;SESN2
6758,GO:0019900,0.0181834475328303,0.991279562744055,16,596,kinase binding,MF,GADD45A;CDH2;PIK3R2;PIK3R1;PRKAR1B;AXIN1;NPR1;SDC4;CDKN1A;MSN;AKT1;BCAR1;GAS6;SHC4;ARAF;ACTA2
21671,GO:2001275,0.018299656887262,0.998908880573764,2,14,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R2;PIK3R1
12666,GO:0046486,0.0184458479313956,0.992196301053161,12,423,glycerolipid metabolic process,BP,MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG;ACSL4
656,GO:0001786,0.0184509496968264,0.997676343870535,3,37,phosphatidylserine binding,MF,SYT5;MFGE8;GAS6
12757,GO:0046651,0.0185210122149852,0.993765430539023,8,253,lymphocyte proliferation,BP,WNT4;FGF10;SDC4;CLCF1;BMP4;CDKN1A;MSN;PIK3CG
15855,GO:0070293,0.0185664160111905,0.998875391929348,2,15,renal absorption,BP,WNK4;GAS6
21001,GO:2000105,0.0186859744032313,0.998873447423165,2,14,positive regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
19344,GO:1902904,0.0187324202536553,0.995645124740612,5,105,negative regulation of supramolecular fiber organization,BP,FHOD3;SPTBN5;SPTBN4;PLEKHH2;SPTB
15098,GO:0060661,0.0187500149293606,0.999911645201098,1,2,submandibular salivary gland formation,BP,FGF10
16404,GO:0071335,0.0187500149293606,0.999911645201098,1,2,hair follicle cell proliferation,BP,FGF10
16405,GO:0071336,0.0187500149293606,0.999911645201098,1,2,regulation of hair follicle cell proliferation,BP,FGF10
16406,GO:0071338,0.0187500149293606,0.999911645201098,1,2,positive regulation of hair follicle cell proliferation,BP,FGF10
4708,GO:0009994,0.0188694329725338,0.997591042551164,3,41,oocyte differentiation,BP,WNT4;NPPC;INHBB
10371,GO:0036461,0.0189525965237604,0.999909716341439,1,2,BLOC-2 complex binding,MF,RAB38
14581,GO:0055037,0.0189861089633929,0.994804987845532,6,142,recycling endosome,CC,SYT5;TF;FZD7;RAB12;RAB17;RAB11FIP1
13967,GO:0051249,0.019027580527969,0.992257460815113,11,390,regulation of lymphocyte activation,BP,TYRO3;FGF10;PIK3R1;SDC4;CLCF1;BMP4;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
3618,GO:0007050,0.0190327303544914,0.993568367508008,8,233,cell cycle arrest,BP,GADD45A;MAPK12;FGF10;FOXO4;HRAS;CDKN1A;HMGN5;GAS6
7862,GO:0031295,0.0191415774892363,0.996437467025126,4,76,T cell costimulation,BP,PIK3R1;AKT1;PIK3CA;EFNB2
7603,GO:0030828,0.0191577546406991,0.998792406364805,2,19,positive regulation of cGMP biosynthetic process,BP,NPR1;NPPC
11495,GO:0043584,0.0191674921518241,0.998819216213846,2,15,nose development,BP,STRA6;AXIN1
1450,GO:0003159,0.0192545760265605,0.998810997450007,2,15,morphogenesis of an endothelium,BP,RHOB;BMP4
15395,GO:0061154,0.0192545760265605,0.998810997450007,2,15,endothelial tube morphogenesis,BP,RHOB;BMP4
8840,GO:0032943,0.0194762589949766,0.993382969322338,8,255,mononuclear cell proliferation,BP,WNT4;FGF10;SDC4;CLCF1;BMP4;CDKN1A;MSN;PIK3CG
8741,GO:0032794,0.019541229363042,0.99879359078571,2,14,GTPase activating protein binding,MF,AKT1;CDH1
12848,GO:0046879,0.0195935267299488,0.992835981136397,9,285,hormone secretion,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;BMP6;INHBB;RAB11FIP1;KCNG2
14103,GO:0051489,0.0196357933466561,0.997468578663656,3,37,regulation of filopodium assembly,BP,RHOQ;ESPN;RAB17
19652,GO:1903533,0.019636636153122,0.992817858663722,9,284,regulation of protein targeting,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CDH1;GAS6
15233,GO:0060876,0.0196959689509449,0.999902458169643,1,2,semicircular canal formation,BP,FGF10
11052,GO:0042803,0.0197182679670374,0.99022026960817,17,705,protein homodimerization activity,MF,ADRA2C;ACTN3;ACTN2;FASN;GADD45A;ACVR1;CASQ2;PDGFB;KCNH2;JAM3;AXIN1;GJB1;TPD52;NPPC;MYO7A;INHBB;GDNF
6755,GO:0019897,0.0197691981134739,0.994538271516421,6,147,extrinsic component of plasma membrane,CC,TF;MFGE8;CDH2;SNX18;CDH1;MYZAP
5001,GO:0010799,0.0198010242433983,0.997435607521119,3,38,regulation of peptidyl-threonine phosphorylation,BP,WNT5A;AXIN1;BMP7
7768,GO:0031100,0.0198951125366661,0.996252692410211,4,77,animal organ regeneration,BP,NOTCH1;CDKN1A;CLDN1;GAS6
9269,GO:0034109,0.0199038890019139,0.996259762120974,4,71,homotypic cell-cell adhesion,BP,DSC2;TYRO3;PIK3CG;GAS6
3638,GO:0007088,0.0199173515784625,0.994487485167241,6,148,regulation of mitotic nuclear division,BP,EDN1;PDGFB;PSRC1;FGF8;BMP7;BMP4
14131,GO:0051546,0.0199760146512468,0.998742138738333,2,15,keratinocyte migration,BP,FGF10;HBEGF
10539,GO:0038201,0.0200578687951719,0.998734239677829,2,15,TOR complex,CC,PRR5L;SESN2
9644,GO:0035019,0.020108947492224,0.996207914207043,4,72,somatic stem cell population maintenance,BP,WNT7A;SALL4;FGF10;BMP7
19031,GO:1902105,0.0202093239457337,0.99309323697671,8,239,regulation of leukocyte differentiation,BP,LIF;ZFPM1;FSTL3;PIK3R1;BMP4;KITLG;GAS6;CLDN18
11743,GO:0044331,0.0202133520666566,0.998719187129105,2,15,cell-cell adhesion mediated by cadherin,BP,CDH2;WNT5A
4985,GO:0010761,0.020512496563157,0.997307880601193,3,38,fibroblast migration,BP,PRR5L;SDC4;AKT1
9387,GO:0034349,0.0205178485203897,0.99868952631008,2,15,glial cell apoptotic process,BP,DLL1;GAS6
13151,GO:0048243,0.0205405057762772,0.998678121309153,2,16,norepinephrine secretion,BP,ADRA2B;ADRA2C
21638,GO:2001236,0.020609293480644,0.994250248276633,6,151,regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1;ACVR1;FGF10;BMP4;AKT1;GDNF
19419,GO:1903034,0.0206751686970183,0.994229169048976,6,149,regulation of response to wounding,BP,WNT4;EDN1;PLAU;PDGFB;HRAS;HBEGF
7861,GO:0031294,0.0207013422592173,0.996051139301889,4,79,lymphocyte costimulation,BP,PIK3R1;AKT1;PIK3CA;EFNB2
20658,GO:1905939,0.0207283921691965,0.99865137718039,2,17,regulation of gonad development,BP,WNT4;WT1
1214,GO:0002694,0.0207386220768277,0.991076725685451,12,446,regulation of leukocyte activation,BP,TYRO3;FGF10;PIK3R1;WNT5A;SDC4;CLCF1;BMP4;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
15822,GO:0070242,0.0207916539960547,0.998653292473034,2,16,thymocyte apoptotic process,BP,WNT5A;BMP4
16901,GO:0072176,0.0207933414663801,0.998662483993897,2,15,nephric duct development,BP,BMP4;EFNB2
11618,GO:0044060,0.0208146411390911,0.997236619991759,3,43,regulation of endocrine process,BP,BMP6;INHBB;RAB11FIP1
14599,GO:0055078,0.0208797732018125,0.997224703521751,3,43,sodium ion homeostasis,BP,ADORA1;EDN1;NPR1
5271,GO:0014821,0.0209215013519297,0.998632091781256,2,17,phasic smooth muscle contraction,BP,EDN1;GDNF
21002,GO:2000106,0.020964360604048,0.995985751751091,4,79,regulation of leukocyte apoptotic process,BP,WNT5A;BMP4;KITLG;GAS6
11821,GO:0044456,0.0209812176598403,0.98952447566995,17,663,synapse part,CC,ITGA3;TMEM163;ADRA2C;SYT5;ACTN2;WNT7A;ADORA1;RAB40B;RAB40A;CDH2;DRP2;VAMP1;AKT1;LZTS1;SHC4;LAMA5;PDE4B
8894,GO:0033026,0.0210993207301249,0.999887983005439,1,2,negative regulation of mast cell apoptotic process,BP,KITLG
16779,GO:0071963,0.0211805808898042,0.999887113838183,1,2,establishment or maintenance of cell polarity regulating cell shape,BP,PARVB
7097,GO:0022407,0.0212401682055835,0.991215044807728,11,389,regulation of cell-cell adhesion,BP,WNT4;FSTL3;PIK3R1;WNT5A;SDC4;BMP7;BMP4;AKT1;CDH1;PIK3CA;EFNB2
10819,GO:0042418,0.021323448265604,0.999885577480683,1,2,epinephrine biosynthetic process,BP,PNMT
15320,GO:0061033,0.0213483023325346,0.999885309134767,1,2,secretion by lung epithelial cell involved in lung growth,BP,FGF10
15072,GO:0060595,0.0213484673512266,0.999885307352022,1,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,FGF10
15085,GO:0060615,0.0213484673512266,0.999885307352022,1,2,mammary gland bud formation,BP,FGF10
15103,GO:0060667,0.0213484673512266,0.999885307352022,1,2,branch elongation involved in salivary gland morphogenesis,BP,FGF10
15246,GO:0060915,0.0213484673512266,0.999885307352022,1,2,mesenchymal cell differentiation involved in lung development,BP,FGF10
12298,GO:0045683,0.0213655551257469,0.998587378312817,2,17,negative regulation of epidermis development,BP,NOTCH1;DLL1
14106,GO:0051492,0.0214034351823771,0.995890977707958,4,70,regulation of stress fiber assembly,BP,WNT4;PIK3R1;SDC4;CTGF
2492,GO:0005161,0.0214777169524837,0.998605746500821,2,14,platelet-derived growth factor receptor binding,MF,ITGA5;PDGFB
21202,GO:2000406,0.0215224809544271,0.998550807010694,2,20,positive regulation of T cell migration,BP,CCL20;WNT5A
20417,GO:1905208,0.0216010249475794,0.99858208050077,2,15,negative regulation of cardiocyte differentiation,BP,FZD7;BMP2
7805,GO:0031177,0.0216326781023895,0.999882216150837,1,2,phosphopantetheine binding,MF,FASN
6965,GO:0021784,0.0216406652804132,0.999882128678396,1,2,postganglionic parasympathetic fiber development,BP,GDNF
14215,GO:0051701,0.0216986933203027,0.993131366547978,7,190,interaction with host,BP,ITGA5;ITGB5;TYRO3;CDH1;CLDN1;GAS6;EFNB2
4948,GO:0010718,0.0217189333501792,0.997083472130848,3,39,positive regulation of epithelial to mesenchymal transition,BP,NOTCH1;ACVR1;BMP2
3776,GO:0007346,0.0218363577913852,0.990181079588294,13,492,regulation of mitotic cell cycle,BP,GADD45A;EDN1;FGF10;PDGFB;FOXO4;HRAS;PSRC1;FGF8;BMP7;BMP4;CDKN1A;AKT1;PIM2
3917,GO:0008064,0.0219863612248962,0.99377589209324,6,152,regulation of actin polymerization or depolymerization,BP,FHOD3;ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB
21019,GO:2000136,0.0220451524464492,0.998526944124856,2,16,regulation of cell proliferation involved in heart morphogenesis,BP,NOTCH1;BMP4
11477,GO:0043551,0.0223159393747919,0.996972385038798,3,39,regulation of phosphatidylinositol 3-kinase activity,BP,PIK3R2;PIK3R1;PDGFB
14936,GO:0060413,0.0223918812935573,0.998501750876612,2,15,atrial septum morphogenesis,BP,ZFPM1;ACVR1
9099,GO:0033554,0.0224483320000772,0.98605219200371,35,1745,cellular response to stress,BP,WNT4;NOTCH1;PMAIP1;GADD45A;DSC2;WNT7A;WNT7B;SLC52A3;GUCY1B3;EDN1;MAPK12;FZD7;PRR5L;FGF10;PIK3R2;PIK3R1;FOXO4;RALB;HRAS;WNT5A;JAM3;SESN2;AXIN1;RHOB;NUAK2;BMP7;BMP2;CDKN1A;CTGF;GJB2;AKT1;WNT2B;INHBB;GAS6;FZD8
9607,GO:0034763,0.0225134139909788,0.995595465268372,4,79,negative regulation of transmembrane transport,BP,ACTN2;CASQ2;KCNH2;AKT1
15285,GO:0060986,0.022526517918485,0.996915502045719,3,44,endocrine hormone secretion,BP,BMP6;INHBB;RAB11FIP1
13886,GO:0051129,0.0225364641672214,0.989188612517223,15,581,negative regulation of cellular component organization,BP,ITGA3;FHOD3;LIF;WNT3;SPTBN5;SPTBN4;PLEKHH2;WNT5A;RHOQ;SPTB;BMP7;BMP4;ESPN;AKT1;UNC119
7604,GO:0030832,0.0227241459522196,0.993518411531847,6,153,regulation of actin filament length,BP,FHOD3;ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB
19227,GO:1902582,0.0227792474677174,0.988515409499603,17,694,single-organism intracellular transport,BP,SYT5;RAB27A;WNT7A;FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CHGA;AKT1;RAB17;CDH1;MYO7A;PIK3CG;GAS6
14220,GO:0051707,0.0230480808895856,0.988354761144359,17,790,response to other organism,BP,NOTCH1;PMAIP1;EDN1;CCL20;FGF10;HRAS;WNT5A;BMP6;CHGA;GJB2;GJB6;AKT1;PTGES;CLDN1;ACTA2;PIM2;PDE4B
14940,GO:0060419,0.0230630393593995,0.995465381312307,4,73,heart growth,BP,WNT2;NOTCH1;EDN1;WT1
14247,GO:0051767,0.0230731329302559,0.998410743462286,2,17,nitric-oxide synthase biosynthetic process,BP,EDN1;CCL20
14248,GO:0051769,0.0230731329302559,0.998410743462286,2,17,regulation of nitric-oxide synthase biosynthetic process,BP,EDN1;CCL20
5121,GO:0010942,0.0231886128853687,0.988833944704151,15,598,positive regulation of cell death,BP,NOTCH1;MARK4;PMAIP1;GADD45A;PIK3R2;WNT5A;RHOB;BMP7;BMP4;BMP2;CDKN1A;CTGF;AKT1;INHBB;VDR
18771,GO:1901338,0.0232184120189734,0.998379115124466,2,19,catecholamine binding,MF,ADRA2B;ADRA2C
13643,GO:0050766,0.0232675206733707,0.996771576638091,3,45,positive regulation of phagocytosis,BP,RAB27A;MFGE8;GAS6
19420,GO:1903035,0.0233164474467298,0.995396622716494,4,75,negative regulation of response to wounding,BP,WNT4;EDN1;PLAU;PDGFB
11262,GO:0043207,0.0233735203701979,0.988171142918209,17,791,response to external biotic stimulus,BP,NOTCH1;PMAIP1;EDN1;CCL20;FGF10;HRAS;WNT5A;BMP6;CHGA;GJB2;GJB6;AKT1;PTGES;CLDN1;ACTA2;PIM2;PDE4B
5017,GO:0010818,0.0235649397913231,0.998334849841047,2,20,T cell chemotaxis,BP,WNT5A;PIK3CG
15721,GO:0070080,0.0237180671102397,0.999858261978833,1,2,titin Z domain binding,MF,ACTN2
16015,GO:0070557,0.0237234892384433,0.999858196773624,1,2,PCNA-p21 complex,CC,CDKN1A
16003,GO:0070542,0.0237680823349739,0.995274726498419,4,78,response to fatty acid,BP,EDN1;CTGF;AKT1;CLDN1
11056,GO:0042813,0.0238015472314742,0.998354709946619,2,15,Wnt-activated receptor activity,MF,FZD7;FZD8
17406,GO:0090136,0.0239062660950392,0.998343592311914,2,15,epithelial cell-cell adhesion,BP,ITGB5;CAMSAP3
14917,GO:0060390,0.0239123171142746,0.998331402176069,2,16,regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
796,GO:0001974,0.0239175862109888,0.996656739210657,3,42,blood vessel remodeling,BP,LIF;FGF10;FGF8
4071,GO:0008307,0.0240316529219841,0.996621268124525,3,46,structural constituent of muscle,MF,ACTN3;ACTN2;MYH11
5881,GO:0016327,0.0240629608063623,0.998295938845654,2,18,apicolateral plasma membrane,CC,CLDN3;CLDN5
13701,GO:0050852,0.0241913661955852,0.992990864665933,6,168,T cell receptor signaling pathway,BP,PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
21040,GO:2000177,0.024305315528449,0.995146525047265,4,72,regulation of neural precursor cell proliferation,BP,NOTCH1;LIMS2;CDH2;WNT5A
13732,GO:0050886,0.0244369110060358,0.995098911274667,4,79,endocrine process,BP,EDN1;BMP6;INHBB;RAB11FIP1
15812,GO:0070231,0.0244399800994837,0.996535790816868,3,48,T cell apoptotic process,BP,WNT5A;BMP4;AKT1
3720,GO:0007220,0.0246768748367018,0.998248856516742,2,16,Notch receptor processing,BP,DLL1;JAG2
4681,GO:0009914,0.0247854603519107,0.990562922138488,9,297,hormone transport,BP,LIF;ADRA2B;ADRA2C;ADORA1;EDN1;BMP6;INHBB;RAB11FIP1;KCNG2
14110,GO:0051496,0.0248459754091022,0.996472531445166,3,43,positive regulation of stress fiber assembly,BP,WNT4;SDC4;CTGF
13228,GO:0048389,0.0248919386037217,0.999843791036444,1,2,intermediate mesoderm development,BP,BMP4
15428,GO:0061227,0.0248919386037217,0.999843791036444,1,2,pattern specification involved in mesonephros development,BP,BMP4
16849,GO:0072098,0.0248919386037217,0.999843791036444,1,2,anterior/posterior pattern specification involved in kidney development,BP,BMP4
15219,GO:0060841,0.0249019369701667,0.998224287947409,2,16,venous blood vessel development,BP,NOTCH1;EFNB2
6352,GO:0018107,0.0249364175647909,0.993759253422714,5,108,peptidyl-threonine phosphorylation,BP,ACVR1;WNT5A;AXIN1;BMP7;AKT1
19268,GO:1902688,0.0250230993115995,0.999842129910701,1,2,regulation of NAD metabolic process,BP,ACTN3
14088,GO:0051452,0.0250714502272369,0.996411635831148,3,48,intracellular pH reduction,BP,RAB39A;RAB20;RAB38
12379,GO:0045840,0.0250937385126319,0.996416759798264,3,45,positive regulation of mitotic nuclear division,BP,EDN1;PDGFB;FGF8
12235,GO:0045599,0.02517236583346,0.996412218816285,3,42,negative regulation of fat cell differentiation,BP,ZFPM1;WNT5A;AXIN1
9356,GO:0034260,0.0252940265487034,0.996384393343667,3,43,negative regulation of GTPase activity,BP,HRAS;AMOT;SH3BP4
20723,GO:1990182,0.0252985455635814,0.99815987572887,2,18,exosomal secretion,BP,RAB27A;SDC4
16942,GO:0072224,0.0253276249720196,0.998177485511951,2,16,metanephric glomerulus development,BP,PDGFB;WT1
5868,GO:0016307,0.0253487496903511,0.998175151646062,2,16,phosphatidylinositol phosphate kinase activity,MF,PIK3CA;PIK3CG
19754,GO:1903729,0.025355049658012,0.994863062338929,4,76,regulation of plasma membrane organization,BP,ITGA3;PIK3R1;RHOQ;AKT1
21641,GO:2001239,0.0253743105471621,0.996354731176101,3,47,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,FGF10;AKT1;GDNF
4087,GO:0008333,0.0253905007609213,0.996369209839188,3,42,endosome to lysosome transport,BP,GPRASP1;RHOB;RAB12
17722,GO:0097059,0.0253981036171847,0.999837331452946,1,2,CNTFR-CLCF1 complex,CC,CLCF1
12458,GO:0045981,0.0254582736527655,0.993569789065697,5,130,positive regulation of nucleotide metabolic process,BP,ACTN3;WNT5A;NPR1;CHGA;NPPC
18621,GO:1900544,0.0254582736527655,0.993569789065697,5,130,positive regulation of purine nucleotide metabolic process,BP,ACTN3;WNT5A;NPR1;CHGA;NPPC
21067,GO:2000224,0.0254824283878661,0.999836242433121,1,2,regulation of testosterone biosynthetic process,BP,WNT4
13580,GO:0050680,0.0254899672555761,0.993577972809272,5,113,negative regulation of epithelial cell proliferation,BP,LIMS2;WNT5A;BMP4;VDR;EFNB2
5266,GO:0014812,0.0254990481310053,0.994829027710208,4,74,muscle cell migration,BP,PLAU;PDGFB;FOXO4;DDR1
19345,GO:1902905,0.0255693367611285,0.992504960946315,6,159,positive regulation of supramolecular fiber organization,BP,WNT4;ACTN2;EDN1;PSRC1;SDC4;CTGF
32,GO:0000060,0.025667275251921,0.99629648059411,3,47,protein import into nucleus, translocation,BP,CDKN1A;AKT1;GAS6
10861,GO:0042493,0.0256713322824274,0.989071134434713,11,405,response to drug,BP,ITGA3;RAB6C;EDN1;KCNH2;FGF8;CDKN1A;NPPC;CDH1;CLDN1;GAS6;PDE4B
14629,GO:0055119,0.0256737057186554,0.998127827140015,2,17,relaxation of cardiac muscle,BP,CHGA;PDE4B
8482,GO:0032421,0.0257155124846414,0.996297156749931,3,44,stereocilium bundle,CC,CDH23;ESPN;MYO7A
15028,GO:0060538,0.0257682635160984,0.992437519226103,6,154,skeletal muscle organ development,BP,ACTN3;NOTCH1;STRA6;IGSF8;WT1;DLL1
12186,GO:0045445,0.0257888057357269,0.994742332223035,4,79,myoblast differentiation,BP,NOTCH1;MAPK12;BMP4;DLL1
1903,GO:0004315,0.0257978223646473,0.999832136616487,1,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,FASN
13698,GO:0050849,0.0258424362813101,0.998098809192018,2,18,negative regulation of calcium-mediated signaling,BP,ACTN3;CASQ2
13834,GO:0051047,0.0259150093611738,0.989468786705505,10,358,positive regulation of secretion,BP,RAB27A;ADORA1;EDN1;WNT5A;NPR1;SDC4;BMP6;INHBB;RAB3D;GDNF
3778,GO:0007350,0.0259451112626842,0.998097357970593,2,17,blastoderm segmentation,BP,WNT5A;WT1
13429,GO:0048841,0.0259635477293863,0.998106763096058,2,16,regulation of axon extension involved in axon guidance,BP,WNT3;WNT5A
3969,GO:0008150,0.0259727487331523,0.986350663895019,228,16026,biological_process,BP,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;RHBDL3;FBXO41;SLC45A4;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;RALB;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;SEMA6C;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;HAPLN3;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;PM20D2;SHC4;SLC18B1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
19607,GO:1903428,0.0260549987423177,0.99621898363432,3,47,positive regulation of reactive oxygen species biosynthetic process,BP,RAB27A;EDN1;AKT1
3524,GO:0006904,0.0262883159457623,0.996186595927015,3,43,vesicle docking involved in exocytosis,BP,RAB40B;RAB40A;RALB
10167,GO:0035993,0.026323459026764,0.999825179363067,1,2,deltoid tuberosity development,BP,BMP4
20313,GO:1904933,0.0264773046729778,0.999823115997922,1,2,regulation of cell proliferation in midbrain,BP,WNT5A
12385,GO:0045851,0.0265170105758519,0.996119638118097,3,49,pH reduction,BP,RAB39A;RAB20;RAB38
13362,GO:0048697,0.0265786989004664,0.999821749398584,1,2,positive regulation of collateral sprouting in absence of injury,BP,WNT3
10763,GO:0042323,0.0266688272139321,0.999820530166947,1,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADORA1
15833,GO:0070256,0.0266688272139321,0.999820530166947,1,2,negative regulation of mucus secretion,BP,ADORA1
7601,GO:0030826,0.0267085266489936,0.997967550953054,2,22,regulation of cGMP biosynthetic process,BP,NPR1;NPPC
12063,GO:0045168,0.0267183964440152,0.999819857812214,1,2,cell-cell signaling involved in cell fate commitment,BP,DLL1
12597,GO:0046331,0.0267183964440152,0.999819857812214,1,2,lateral inhibition,BP,DLL1
18287,GO:0099054,0.0268672600023204,0.998004615597867,2,16,presynapse assembly,BP,WNT7A;WNT5A
13969,GO:0051251,0.0268732217097688,0.990307836061949,8,261,positive regulation of lymphocyte activation,BP,FGF10;PIK3R1;CLCF1;CDKN1A;AKT1;PIK3CA;GAS6;EFNB2
8281,GO:0032092,0.0268758043832661,0.994451237872523,4,79,positive regulation of protein binding,BP,RALB;WNT5A;BMP4;BMP2
18635,GO:1900745,0.0268806145597129,0.997980283947139,2,18,positive regulation of p38MAPK cascade,BP,GADD45A;BMP2
20507,GO:1905438,0.0269260182908803,0.999817027791067,1,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
9086,GO:0033500,0.0269480941629223,0.991076531657663,7,204,carbohydrate homeostasis,BP,PIK3R2;PIK3R1;SESN2;GJB6;AKT1;PIK3CA;GAS6
10934,GO:0042593,0.0269480941629223,0.991076531657663,7,204,glucose homeostasis,BP,PIK3R2;PIK3R1;SESN2;GJB6;AKT1;PIK3CA;GAS6
10108,GO:0035886,0.026975333762762,0.997969343121596,2,18,vascular smooth muscle cell differentiation,BP,NOTCH1;PDGFB
14023,GO:0051341,0.0270473655573017,0.99439234431386,4,86,regulation of oxidoreductase activity,BP,EDN1;AKT1;VDR;GDNF
11750,GO:0044338,0.0271164610895923,0.999814412267241,1,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
2898,GO:0005960,0.0271682837629403,0.999813697282015,1,2,glycine cleavage complex,CC,GLDC
10065,GO:0035809,0.0271908520930539,0.997925931715351,2,20,regulation of urine volume,BP,EDN1;NPR1
21675,GO:2001287,0.027234235829476,0.999812785341246,1,2,negative regulation of caveolin-mediated endocytosis,BP,UNC119
5123,GO:0010948,0.0272603082871898,0.990141407300507,8,262,negative regulation of cell cycle process,BP,LIF;GADD45A;FGF10;FOXO4;BMP7;BMP4;CDKN1A;HMGN5
9325,GO:0034199,0.0272654994828948,0.997946638348213,2,17,activation of protein kinase A activity,BP,PRKACB;PRKAR1B
8407,GO:0032330,0.0273650840041998,0.995969018329171,3,43,regulation of chondrocyte differentiation,BP,BMP6;BMP4;CTGF
12712,GO:0046579,0.027549029420544,0.995923454642631,3,45,positive regulation of Ras protein signal transduction,BP,FGF10;HRAS;KITLG
7996,GO:0031527,0.0277519082559114,0.997890086555737,2,17,filopodium membrane,CC,ITGA3;TTYH1
16250,GO:0070997,0.0277546974021804,0.989223957480929,9,296,neuron death,BP,RRAS2;TYRO3;HRAS;FGF8;CLCF1;CHGA;AKT1;PIK3CA;GDNF
20490,GO:1905384,0.0277636797126657,0.999805382719845,1,2,regulation of protein localization to presynapse,BP,WNT7A
20491,GO:1905386,0.0277636797126657,0.999805382719845,1,2,positive regulation of protein localization to presynapse,BP,WNT7A
21401,GO:2000696,0.0278153668039401,0.997871391860228,2,18,regulation of epithelial cell differentiation involved in kidney development,BP,LIF;GDNF
8803,GO:0032891,0.0278345763993488,0.997880420644656,2,17,negative regulation of organic acid transport,BP,ADORA1;AKT1
13094,GO:0048066,0.0278746424615202,0.995856676656707,3,45,developmental pigmentation,BP,RAB27A;KITLG;RAB38
7889,GO:0031331,0.0278908001222117,0.988532113091251,10,352,positive regulation of cellular catabolic process,BP,PRR5L;RALB;SESN2;AXIN1;MSN;AKT1;RAB12;SH3BP4;RNF144A;PIM2
16308,GO:0071157,0.0279610568660763,0.997835007527014,2,20,negative regulation of cell cycle arrest,BP,FGF10;HMGN5
2479,GO:0005146,0.0280181172193802,0.999801773408737,1,2,leukemia inhibitory factor receptor binding,MF,LIF
18962,GO:1901899,0.0280276658853693,0.999801637301702,1,2,positive regulation of relaxation of cardiac muscle,BP,CHGA
9189,GO:0033762,0.0280633791388708,0.995806771375761,3,48,response to glucagon,BP,PRKACB;PRKAR1B;GJB2
19242,GO:1902612,0.0281855307826259,0.999799380221918,1,2,regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
19243,GO:1902613,0.0281855307826259,0.999799380221918,1,2,negative regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
20741,GO:1990262,0.0281855307826259,0.999799380221918,1,2,anti-Mullerian hormone signaling pathway,BP,DKK3
21567,GO:2001074,0.0282306313922253,0.999798733015139,1,2,regulation of metanephric ureteric bud development,BP,WT1
21568,GO:2001076,0.0282306313922253,0.999798733015139,1,2,positive regulation of metanephric ureteric bud development,BP,WT1
13416,GO:0048807,0.0282337616761133,0.999732012395778,1,3,female genitalia morphogenesis,BP,FGF10
10061,GO:0035801,0.0282454521457862,0.999798520102215,1,2,adrenal cortex development,BP,WT1
10062,GO:0035802,0.0282454521457862,0.999798520102215,1,2,adrenal cortex formation,BP,WT1
16100,GO:0070724,0.028291121911056,0.999797863298516,1,2,BMP receptor complex,CC,BMP2
18036,GO:0097734,0.0283737944736885,0.997795007456248,2,19,extracellular exosome biogenesis,BP,RAB27A;SDC4
7615,GO:0030849,0.0284256091070936,0.999795922860753,1,2,autosome,CC,SIN3B
6767,GO:0019912,0.028484058367619,0.999795076598365,1,2,cyclin-dependent protein kinase activating kinase activity,MF,CDKN1A
14955,GO:0060435,0.0285124727129815,0.999726660662363,1,3,bronchiole development,BP,FGF10
1907,GO:0004320,0.0285265948385266,0.999794459613659,1,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,FASN
5861,GO:0016295,0.0285265948385266,0.999794459613659,1,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,FASN
5862,GO:0016296,0.0285265948385266,0.999794459613659,1,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,FASN
5863,GO:0016297,0.0285265948385266,0.999794459613659,1,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,FASN
18970,GO:1901963,0.0285668569366456,0.999793874751485,1,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
20869,GO:1990769,0.028602066148636,0.999793362598365,1,2,proximal neuron projection,CC,SYT5
6757,GO:0019899,0.0286381778752973,0.981756110531888,36,1773,enzyme binding,MF,ITGA3;RIN3;TSPAN15;TSPAN17;NOTCH1;GLDC;GADD45A;SERPINA5;PRKACB;SPTBN4;CDH2;PRR5L;PIK3R2;PIK3R1;KCNH2;PRKAR1B;FOXO4;RALB;MAGEC2;AXIN1;NPR1;SDC4;DAAM2;CDKN1A;MSN;AKT1;PKP3;BCAR1;RAB11FIP1;GAS6;SHC4;ARAF;SH3BP4;FZD8;ACTA2;RNF144A
15291,GO:0060994,0.0286395447204315,0.999792816726648,1,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,BMP4
21020,GO:2000137,0.0286512445693872,0.999792646169851,1,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
19108,GO:1902271,0.0286660841184241,0.99979242974104,1,2,D3 vitamins binding,MF,VDR
7187,GO:0030016,0.0286974327317327,0.99037108369166,7,208,myofibril,CC,FHOD3;ACTN2;CASQ2;SDC4;MYZAP;PARVB;PDE4B
1404,GO:0003064,0.0287109688154433,0.999791774418662,1,2,regulation of heart rate by hormone,BP,KCNH2
16891,GO:0072166,0.0287341560268067,0.999791435471819,1,2,posterior mesonephric tubule development,BP,WT1
21041,GO:2000178,0.0287510539643873,0.997760356093313,2,18,negative regulation of neural precursor cell proliferation,BP,LIMS2;WNT5A
11123,GO:0042993,0.0288093893470538,0.995655453011269,3,47,positive regulation of transcription factor import into nucleus,BP,PIK3R2;PIK3R1;CDH1
6385,GO:0018210,0.0288599907837264,0.992492291442486,5,112,peptidyl-threonine modification,BP,ACVR1;WNT5A;AXIN1;BMP7;AKT1
7470,GO:0030514,0.0289016499185927,0.995644022233627,3,45,negative regulation of BMP signaling pathway,BP,NOTCH1;FSTL3;WNT5A
12285,GO:0045661,0.0290165314293102,0.995608487242925,3,48,regulation of myoblast differentiation,BP,NOTCH1;BMP4;DLL1
11308,GO:0043270,0.0290259381359171,0.990232992400472,7,216,positive regulation of ion transport,BP,ACTN2;ADORA1;EDN1;PDGFB;KCNH2;AKT1;GDNF
16836,GO:0072079,0.029083196201196,0.997709705143497,2,19,nephron tubule formation,BP,WNT6;GDNF
8969,GO:0033158,0.0291068411991269,0.997706841996869,2,19,regulation of protein import into nucleus, translocation,BP,CDKN1A;GAS6
1048,GO:0002386,0.0293187881000353,0.999782796954133,1,2,immune response in mucosal-associated lymphoid tissue,BP,RAB17
1055,GO:0002415,0.0293187881000353,0.999782796954133,1,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,RAB17
14662,GO:0060031,0.0293301550122611,0.999782627233419,1,2,mediolateral intercalation,BP,WNT5A
15188,GO:0060775,0.0293301550122611,0.999782627233419,1,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,WNT5A
17831,GO:0097241,0.0293439095201585,0.999782421773267,1,2,hematopoietic stem cell migration to bone marrow,BP,GAS6
12163,GO:0045360,0.029358697720576,0.999710083135101,1,3,regulation of interleukin-1 biosynthetic process,BP,CCL20
12164,GO:0045362,0.029358697720576,0.999710083135101,1,3,positive regulation of interleukin-1 biosynthetic process,BP,CCL20
1902,GO:0004314,0.0294316469849118,0.999781108862317,1,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,FASN
5915,GO:0016419,0.0294316469849118,0.999781108862317,1,2,S-malonyltransferase activity,MF,FASN
5916,GO:0016420,0.0294316469849118,0.999781108862317,1,2,malonyltransferase activity,MF,FASN
14574,GO:0055021,0.0296317411022066,0.995486857948719,3,46,regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1;EDN1
16997,GO:0072320,0.0297123288606811,0.99977688178374,1,2,volume-sensitive chloride channel activity,MF,TTYH1
10308,GO:0036304,0.0297920050262898,0.999775674378741,1,2,umbilical cord morphogenesis,BP,HEY1
15314,GO:0061027,0.0297920050262898,0.999775674378741,1,2,umbilical cord development,BP,HEY1
12373,GO:0045834,0.0298261552436698,0.992158788461926,5,123,positive regulation of lipid metabolic process,BP,WNT4;PDGFB;SESN2;BMP6;AKT1
21410,GO:2000707,0.0298461030495825,0.9997748526969,1,2,positive regulation of dense core granule biogenesis,BP,CHGA
11304,GO:0043266,0.0300044383843371,0.993588112331055,4,81,regulation of potassium ion transport,BP,ACTN2;ADORA1;CASQ2;KCNH2
5016,GO:0010817,0.0300805925712742,0.986343381949955,12,465,regulation of hormone levels,BP,LIF;ADRA2B;ADRA2C;WNT4;ADORA1;DKK3;EDN1;BMP6;BMP2;INHBB;RAB11FIP1;KCNG2
14825,GO:0060279,0.0301299304030626,0.999770516716397,1,2,positive regulation of ovulation,BP,INHBB
3617,GO:0007049,0.0302352204509984,0.981012188134469,33,1635,cell cycle,BP,LIF;WNT4;RAB6C;MARK4;GADD45A;ACVR1;EDN1;PHLDA1;PRKACB;TTYH1;MAPK12;FGF10;PDGFB;FOXO4;RALB;HRAS;WNT5A;SNX18;RHOB;PSRC1;FGF8;BMP7;BMP4;BMP2;CDKN1A;HMGN5;CTGF;AKT1;NPPC;JAG2;GAS6;LZTS1;PIM2
1005,GO:0002320,0.0303198170233065,0.997558253192211,2,19,lymphoid progenitor cell differentiation,BP,NOTCH1;BMP4
8487,GO:0032427,0.0303443924600435,0.99976721256007,1,2,GBD domain binding,MF,RHOQ
20379,GO:1905069,0.0303520567328413,0.999767094034878,1,2,allantois development,BP,BMP7
649,GO:0001779,0.0304050817813746,0.997537369096528,2,20,natural killer cell differentiation,BP,TYRO3;GAS6
15319,GO:0061032,0.0306073075131882,0.999763129171498,1,2,visceral serous pericardium development,BP,WT1
305,GO:0000806,0.0306218284897785,0.999762902592315,1,2,Y chromosome,CC,SIN3B
21199,GO:2000403,0.0306861935420164,0.997462792281244,2,25,positive regulation of lymphocyte migration,BP,CCL20;WNT5A
14304,GO:0051885,0.0307200343846918,0.999761367340764,1,2,positive regulation of timing of anagen,BP,WNT5A
20451,GO:1905276,0.030753658084925,0.997515991800901,2,18,regulation of epithelial tube formation,BP,WNT5A;GDNF
14695,GO:0060067,0.0307656659936407,0.99976065226982,1,2,cervix development,BP,WNT5A
7294,GO:0030195,0.0308392281796132,0.995222056883525,3,48,negative regulation of blood coagulation,BP,EDN1;PLAU;PDGFB
18456,GO:1900047,0.0308392281796132,0.995222056883525,3,48,negative regulation of hemostasis,BP,EDN1;PLAU;PDGFB
15222,GO:0060844,0.0308776345397427,0.999758893059839,1,2,arterial endothelial cell fate commitment,BP,DLL1
17315,GO:0086097,0.0309129610932769,0.999758336663596,1,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,ACTN2
4048,GO:0008277,0.0309376702449808,0.991788361610959,5,123,regulation of G-protein coupled receptor protein signaling pathway,BP,NMT2;EDN1;GPRASP1;CHGA;GPSM1
8802,GO:0032890,0.0309816792619271,0.995191461221287,3,48,regulation of organic acid transport,BP,ADORA1;EDN1;AKT1
14128,GO:0051542,0.031018933850787,0.999756663675181,1,2,elastin biosynthetic process,BP,HBEGF
11801,GO:0044431,0.0310203635387393,0.982890806695842,20,878,Golgi apparatus part,CC,WNT3;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;RAB39A;PDGFB;HRAS;WNT5B;WNT5A;RHOQ;SDC4;B3GNT2;RND3;RAB12;CDH1;GAS6;GPSM1;RAB38
1976,GO:0004421,0.0311125705088849,0.999755180557193,1,2,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS2
17740,GO:0097102,0.0312657226317644,0.999752744900938,1,2,endothelial tip cell fate specification,BP,DLL1
16386,GO:0071307,0.0312672646606012,0.999752720314978,1,2,cellular response to vitamin K,BP,GAS6
16751,GO:0071901,0.031281578878261,0.99167299195396,5,123,negative regulation of protein serine/threonine kinase activity,BP,PRKAR1B;BMP7;BMP4;CDKN1A;DUSP5
16931,GO:0072209,0.0313722767272072,0.999751043090325,1,2,metanephric mesangial cell differentiation,BP,PDGFB
16956,GO:0072254,0.0313722767272072,0.999751043090325,1,2,metanephric glomerular mesangial cell differentiation,BP,PDGFB
6963,GO:0021782,0.0314031305615379,0.993189887383771,4,83,glial cell development,BP,POU3F1;DLL1;AKT1;TSPAN2
1958,GO:0004383,0.0314597044093316,0.997441256171408,2,17,guanylate cyclase activity,MF,GUCY1B3;NPR1
3922,GO:0008074,0.0314597044093316,0.997441256171408,2,17,guanylate cyclase complex, soluble,CC,GUCY1B3;NPR1
481,GO:0001502,0.0314680843970916,0.997393871623083,2,21,cartilage condensation,BP,WNT7A;CTGF
17694,GO:0097018,0.0314710378709623,0.999749460447299,1,2,renal albumin absorption,BP,GAS6
21281,GO:2000532,0.0314710378709623,0.999749460447299,1,2,regulation of renal albumin absorption,BP,GAS6
4829,GO:0010512,0.0314863957226626,0.999749213880573,1,2,negative regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
8571,GO:0032542,0.0315556773090947,0.999748100048933,1,2,sulfiredoxin activity,MF,SESN2
11969,GO:0045017,0.0316574366791735,0.988227830816671,8,254,glycerolipid biosynthetic process,BP,FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;PIK3CA;PIK3CG
21507,GO:2000857,0.0316702397170151,0.999746252740207,1,2,positive regulation of mineralocorticoid secretion,BP,BMP6
21509,GO:2000860,0.0316702397170151,0.999746252740207,1,2,positive regulation of aldosterone secretion,BP,BMP6
1479,GO:0003195,0.0316988998774321,0.999745789525062,1,2,tricuspid valve formation,BP,ZFPM1
15142,GO:0060713,0.0317908538609211,0.997373601285592,2,19,labyrinthine layer morphogenesis,BP,WNT7B;BMP7
4603,GO:0009628,0.0318091822710641,0.981446210120778,24,1129,response to abiotic stimulus,BP,NOTCH1;STRA6;PMAIP1;GADD45A;SLC52A3;NMT2;ADORA1;EDN1;PLAU;PIK3R1;HRAS;RHOB;BMP7;BMP6;BMP2;CDKN1A;CTGF;GJB6;AKT1;NPPC;INHBB;CLDN1;CLDN3;UNC119
17444,GO:0090190,0.0318242487995874,0.997369353400528,2,19,positive regulation of branching involved in ureteric bud morphogenesis,BP,WNT2B;GDNF
4677,GO:0009897,0.0318256566684182,0.989086921025613,7,213,external side of plasma membrane,CC,ITGA3;ITGA5;TF;SERPINA5;MFGE8;FGF8;AMOT
6305,GO:0017157,0.0319043848370011,0.990158951737669,6,162,regulation of exocytosis,BP,SYT5;NOTCH1;RAB27A;RALB;SDC4;RAB3D
16508,GO:0071478,0.0319850028038133,0.990126370151429,6,164,cellular response to radiation,BP,GADD45A;NMT2;PIK3R1;HRAS;RHOB;CDKN1A
14958,GO:0060438,0.0320088898006937,0.997345822244837,2,19,trachea development,BP,WNT7B;BMP4
16529,GO:0071505,0.0320089721741165,0.99974075058103,1,2,response to mycophenolic acid,BP,PDGFB
16530,GO:0071506,0.0320089721741165,0.99974075058103,1,2,cellular response to mycophenolic acid,BP,PDGFB
11692,GO:0044255,0.0320225945496,0.981760825311196,22,1021,cellular lipid metabolic process,BP,STRA6;ITGB8;FASN;HMGCS2;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;SESN2;FGF8;SDC4;HBEGF;AKT1;PTGES;KITLG;PIK3CA;PIK3CG;SIN3B;ACSL4
15203,GO:0060809,0.0320287488639822,0.999740427487378,1,2,mesodermal to mesenchymal transition involved in gastrulation,BP,WNT5A
11341,GO:0043316,0.032096907586749,0.999739312404769,1,2,cytotoxic T cell degranulation,BP,RAB27A
4931,GO:0010676,0.0321564373197132,0.994937003880186,3,48,positive regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1;AKT1
17861,GO:0097325,0.0321574888998727,0.999738319249848,1,2,melanocyte proliferation,BP,WNT5A
19612,GO:1903433,0.0321607961013377,0.999738264977159,1,2,regulation of constitutive secretory pathway,BP,RAB27A
5362,GO:0015091,0.0321612379961778,0.99973825772503,1,2,ferric iron transmembrane transporter activity,MF,TF
17067,GO:0072510,0.0321612379961778,0.99973825772503,1,2,trivalent inorganic cation transmembrane transporter activity,MF,TF
16983,GO:0072301,0.0321922431562854,0.999737748630788,1,2,regulation of metanephric glomerular mesangial cell proliferation,BP,WT1
8807,GO:0032899,0.0322294162227181,0.9997371375988,1,2,regulation of neurotrophin production,BP,ADORA1
18613,GO:1900453,0.0322301299570053,0.999737125859726,1,2,negative regulation of long term synaptic depression,BP,ADORA1
14967,GO:0060447,0.0322580286223145,0.999649530404104,1,3,bud outgrowth involved in lung branching,BP,FGF10
15890,GO:0070346,0.0322778574434142,0.99960559394398,1,4,positive regulation of fat cell proliferation,BP,FGF10
5241,GO:0014728,0.0322864228848603,0.999736199148046,1,2,regulation of the force of skeletal muscle contraction,BP,ACTN3
5298,GO:0014862,0.0322864228848603,0.999736199148046,1,2,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,ACTN3
5658,GO:0015874,0.0323171664159926,0.997295063816867,2,20,norepinephrine transport,BP,ADRA2B;ADRA2C
19121,GO:1902303,0.0323234675540206,0.999735588402795,1,2,negative regulation of potassium ion export,BP,KCNH2
20952,GO:2000017,0.0323364410069132,0.999735374343314,1,2,positive regulation of determination of dorsal identity,BP,ACVR1
7329,GO:0030237,0.0323483734567536,0.999735177382443,1,2,female sex determination,BP,WNT4
8968,GO:0033157,0.0323597573120619,0.986365487183703,10,356,regulation of intracellular protein transport,BP,FZD7;PRR5L;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;CDH1;GAS6
2450,GO:0005110,0.032377694883136,0.999734693077084,1,2,frizzled-2 binding,MF,WNT5A
6570,GO:0019320,0.0323925162621742,0.994881324524183,3,49,hexose catabolic process,BP,ACTN3;KHK;PFKFB3
10419,GO:0036518,0.0323990337305344,0.999734340338099,1,2,chemorepulsion of dopaminergic neuron axon,BP,WNT5A
15505,GO:0061443,0.0324205025149717,0.99973398521078,1,2,endocardial cushion cell differentiation,BP,ACVR1
13827,GO:0051040,0.0324680673011121,0.999733197555669,1,2,regulation of calcium-independent cell-cell adhesion,BP,BMP2
6520,GO:0019200,0.0325250686448586,0.997279639870207,2,19,carbohydrate kinase activity,MF,KHK;PFKFB3
15169,GO:0060748,0.0325268820706986,0.999732221968033,1,2,tertiary branching involved in mammary gland duct morphogenesis,BP,WNT4
15075,GO:0060599,0.0325273573079406,0.999732214077682,1,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,WNT5A
16071,GO:0070666,0.0325531205508015,0.999731786154363,1,2,regulation of mast cell proliferation,BP,KITLG
16073,GO:0070668,0.0325531205508015,0.999731786154363,1,2,positive regulation of mast cell proliferation,BP,KITLG
10460,GO:0038060,0.0326064760920139,0.999730898822761,1,2,nitric oxide-cGMP-mediated signaling pathway,BP,GUCY1B3
16198,GO:0070925,0.0326472946070997,0.983188783858375,16,664,organelle assembly,BP,FHOD3;ACTN2;NOTCH1;MARK4;CASQ2;EDN1;RAB39A;RALB;SDC4;RAB20;MSN;RAB17;MYO7A;MYH11;LAMA5;RAB38
10462,GO:0038062,0.0326910095602643,0.999729489934896,1,2,protein tyrosine kinase collagen receptor activity,MF,DDR1
491,GO:0001516,0.0326958921227856,0.997217741416668,2,23,prostaglandin biosynthetic process,BP,EDN1;PTGES
12645,GO:0046457,0.0326958921227856,0.997217741416668,2,23,prostanoid biosynthetic process,BP,EDN1;PTGES
11871,GO:0044711,0.0327018557425818,0.980095261482357,28,1404,single-organism biosynthetic process,BP,WNT4;FASN;DHH;HMGCS2;GUCY1B3;DKK3;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;WNT5A;SESN2;NPR1;FGF8;BMP6;BMP4;BMP2;B3GNT2;CTGF;AKT1;PTGES;NPPC;PIK3CA;PIK3CG;VDR
14905,GO:0060375,0.0327225708800939,0.999728962955146,1,2,regulation of mast cell differentiation,BP,ZFPM1
6922,GO:0021693,0.0327696140173533,0.999728176507422,1,2,cerebellar Purkinje cell layer structural organization,BP,DLL1
6927,GO:0021698,0.0327696140173533,0.999728176507422,1,2,cerebellar cortex structural organization,BP,DLL1
9561,GO:0034684,0.0328071493974607,0.999727548175448,1,2,integrin alphav-beta5 complex,CC,ITGB5
15207,GO:0060823,0.0328162050503143,0.999727396475857,1,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,AXIN1
16821,GO:0072053,0.0328278744238126,0.99972720092811,1,2,renal inner medulla development,BP,WNT7B
16822,GO:0072054,0.0328278744238126,0.99972720092811,1,2,renal outer medulla development,BP,WNT7B
17613,GO:0090526,0.0328527456956196,0.999726783913651,1,2,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,SESN2
1460,GO:0003169,0.0328629686586048,0.999726612412194,1,2,coronary vein morphogenesis,BP,NOTCH1
4634,GO:0009749,0.0328814876269252,0.989778748032973,6,170,response to glucose,BP,KHK;SESN2;CTGF;GJB6;PIK3CA;GAS6
17865,GO:0097338,0.0328953173299239,0.999726069367088,1,2,response to clozapine,BP,PRKACB
11606,GO:0044028,0.0329012051776284,0.999725970467399,1,2,DNA hypomethylation,BP,PIK3CA
11607,GO:0044029,0.0329012051776284,0.999725970467399,1,2,hypomethylation of CpG island,BP,PIK3CA
9549,GO:0034667,0.0329062216074235,0.999725886190818,1,2,integrin alpha3-beta1 complex,CC,ITGA3
11586,GO:0043974,0.0329119594766548,0.999725789777819,1,2,histone H3-K27 acetylation,BP,LIF
18891,GO:1901674,0.0329119594766548,0.999725789777819,1,2,regulation of histone H3-K27 acetylation,BP,LIF
1954,GO:0004379,0.0329122665121007,0.999725784618239,1,2,glycylpeptide N-tetradecanoyltransferase activity,MF,NMT2
6329,GO:0018008,0.0329122665121007,0.999725784618239,1,2,N-terminal peptidyl-glycine N-myristoylation,BP,NMT2
6502,GO:0019107,0.0329122665121007,0.999725784618239,1,2,myristoyltransferase activity,MF,NMT2
15459,GO:0061341,0.0329122665124115,0.999725784618234,1,2,non-canonical Wnt signaling pathway involved in heart development,BP,WNT5A
15461,GO:0061346,0.0329122665124115,0.999725784618234,1,2,planar cell polarity pathway involved in heart morphogenesis,BP,WNT5A
12089,GO:0045210,0.0329122665124553,0.999725784618233,1,2,FasL biosynthetic process,BP,PHLDA1
18961,GO:1901898,0.0329122665127742,0.999725784618227,1,2,negative regulation of relaxation of cardiac muscle,BP,PDE4B
5914,GO:0016418,0.0329122665128727,0.999725784618226,1,2,S-acetyltransferase activity,MF,FASN
16833,GO:0072076,0.0329122665129061,0.999725784618225,1,2,nephrogenic mesenchyme development,BP,BMP7
16874,GO:0072134,0.0329122665129061,0.999725784618225,1,2,nephrogenic mesenchyme morphogenesis,BP,BMP7
2695,GO:0005608,0.0329122665134521,0.999725784618216,1,2,laminin-3 complex,CC,LAMA1
9563,GO:0034686,0.0329122665135489,0.999725784618214,1,2,integrin alphav-beta8 complex,CC,ITGB8
1582,GO:0003365,0.0329122665135491,0.999725784618214,1,2,establishment of cell polarity involved in ameboidal cell migration,BP,AMOT
3141,GO:0006366,0.0330422735320502,0.978368039830448,39,2029,transcription from RNA polymerase II promoter,BP,ITGA3;LIF;WNT2;POU3F1;NOTCH1;WNT7A;ZFPM1;ACVR1;SALL4;EDN1;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;TLE1;SIN3B;ZCCHC12;VDR;GDNF;FZD8;HEY1
338,GO:0000930,0.0330657890475169,0.997209683455071,2,19,gamma-tubulin complex,CC,TUBG2;PDE4B
3612,GO:0007041,0.0331867401489969,0.992688633969492,4,79,lysosomal transport,BP,SPTBN5;GPRASP1;RHOB;RAB12
7176,GO:0023061,0.033204326667031,0.985293291539974,11,407,signal release,BP,LIF;ADRA2B;ADRA2C;SYT5;WNT7A;ADORA1;EDN1;BMP6;INHBB;RAB11FIP1;KCNG2
16429,GO:0071371,0.0332175178981559,0.997203066511252,2,18,cellular response to gonadotropin stimulus,BP,NOTCH1;WT1
5945,GO:0016480,0.0332932540516292,0.999626498175973,1,3,negative regulation of transcription from RNA polymerase III promoter,BP,NAB2
4687,GO:0009946,0.0332971943405941,0.99962640908891,1,3,proximal/distal axis specification,BP,FGF10
15486,GO:0061383,0.0333668331079459,0.994675319724572,3,47,trabecula morphogenesis,BP,NOTCH1;BMP7;HEY1
18877,GO:1901655,0.0335440148180945,0.992575587144144,4,83,cellular response to ketone,BP,MSN;GJB2;AKT1;GAS6
5277,GO:0014829,0.0337201536867842,0.997124171353514,2,19,vascular smooth muscle contraction,BP,EDN1;ACTA2
15097,GO:0060648,0.0337382396653699,0.999616369195577,1,3,mammary gland bud morphogenesis,BP,FGF10
21669,GO:2001273,0.0337503119212316,0.99712020788141,2,19,regulation of glucose import in response to insulin stimulus,BP,PIK3R2;PIK3R1
12068,GO:0045178,0.0337645501174686,0.994587086556559,3,47,basal part of cell,CC,TF;EDN1;CLDN11
7289,GO:0030185,0.0339048749856846,0.999612540744971,1,3,nitric oxide transport,BP,EDN1
15451,GO:0061318,0.033987241911954,0.997089001495563,2,19,renal filtration cell differentiation,BP,BMP4;WT1
16862,GO:0072112,0.033987241911954,0.997089001495563,2,19,glomerular visceral epithelial cell differentiation,BP,BMP4;WT1
18140,GO:0098743,0.0342621164537962,0.997019074848321,2,22,cell aggregation,BP,WNT7A;CTGF
15045,GO:0060560,0.0342703140414766,0.988074554609885,7,202,developmental growth involved in morphogenesis,BP,WNT3;NOTCH1;WNT7B;FGF10;WNT5A;BMP4;DDR1
5879,GO:0016323,0.0343179616773719,0.988055335680176,7,201,basolateral plasma membrane,CC,ITGA3;TF;ADORA1;CDH2;PDGFB;MSN;RAB17
20489,GO:1905383,0.0343643624039959,0.999601883987966,1,3,protein localization to presynapse,BP,WNT7A
21200,GO:2000404,0.0343674902100448,0.99697948379018,2,25,regulation of T cell migration,BP,CCL20;WNT5A
1611,GO:0003674,0.0343786134246317,0.981461034259696,228,16005,molecular_function,MF,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;TMEM163;LIF;ADRA2B;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;CDH23;PNMT;STRA6;RASL11B;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;RHBDL3;FBXO41;SLC45A4;DHH;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;RHPN1;PRKACB;KCNK6;MFGE8;CCL20;FLVCR2;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;MPZL1;RRAS2;TSPAN13;RAB39B;RAB39A;PRND;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;JAM3;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;MB21D2;HBEGF;LGALS4;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;EPN1;MYO7A;BCAR1;INHBB;GJA3;SPSB1;HPCAL1;RAB44;TLE1;CLDN1;CLDN2;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;HAPLN3;DTX4;ZCCHC12;MYH11;LZTS1;CLDN23;PM20D2;SHC4;SLC18B1;DSC3;GPSM1;VDR;AMOT;LAMA1;LAMA5;ARAF;SH3BP4;UNC119;KCND1;TSPAN2;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FZD8;DUSP5;HEY1;ACTA2;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;PIM2;PARVB;EFNB2;PDE4B
15339,GO:0061053,0.0343984899611888,0.992324395196407,4,84,somite development,BP,WNT4;NOTCH1;WNT5A;DLL1
8354,GO:0032231,0.034515118876849,0.992295062581934,4,82,regulation of actin filament bundle assembly,BP,WNT4;PIK3R1;SDC4;CTGF
9968,GO:0035650,0.0345882394116826,0.999596638463847,1,3,AP-1 adaptor complex binding,MF,RAB38
13765,GO:0050927,0.0347274744198025,0.996956467397145,2,22,positive regulation of positive chemotaxis,BP,ARTN;FGF10
18631,GO:1900738,0.0348006122023966,0.99959163025145,1,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA
1531,GO:0003283,0.0348313278957918,0.996976842945888,2,19,atrial septum development,BP,ZFPM1;ACVR1
2161,GO:0004674,0.0348513229456868,0.983841178614428,12,431,protein serine/threonine kinase activity,MF,MARK4;ACVR1;PRKACB;MAPK12;NUAK2;PKN3;WNK4;AKT1;PIK3CA;PIK3CG;ARAF;PIM2
1208,GO:0002688,0.0348996559858615,0.992144012933846,4,101,regulation of leukocyte chemotaxis,BP,EDN1;WNT5A;JAM3;GAS6
10165,GO:0035990,0.0349068951946692,0.999589112080154,1,3,tendon cell differentiation,BP,BMP4
10166,GO:0035992,0.0349068951946692,0.999589112080154,1,3,tendon formation,BP,BMP4
19339,GO:1902895,0.0349537719583198,0.996960446203847,2,19,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB;BMP2
16141,GO:0070838,0.0351645972025912,0.984283595276981,11,411,divalent metal ion transport,BP,CDH23;TF;CASQ2;TSPAN13;PDGFB;CTGF;PIK3CG;GAS6;VDR;CLDN16;PDE4B
3889,GO:0008013,0.0351837605364508,0.992109369283236,4,78,beta-catenin binding,MF,CDH2;FOXO4;AXIN1;CDH1
10709,GO:0042222,0.0351847696627867,0.999530771045527,1,4,interleukin-1 biosynthetic process,BP,CCL20
4594,GO:0009607,0.0351927247350567,0.981305090371425,17,827,response to biotic stimulus,BP,NOTCH1;PMAIP1;EDN1;CCL20;FGF10;HRAS;WNT5A;BMP6;CHGA;GJB2;GJB6;AKT1;PTGES;CLDN1;ACTA2;PIM2;PDE4B
9969,GO:0035651,0.0352326362589541,0.999581345278672,1,3,AP-3 adaptor complex binding,MF,RAB38
9273,GO:0034113,0.0353251293116395,0.994227460378802,3,49,heterotypic cell-cell adhesion,BP,ITGA5;DSC2;BMP7
18541,GO:1900194,0.0353547390364298,0.999578414881064,1,3,negative regulation of oocyte maturation,BP,NPPC
13684,GO:0050819,0.0353555167528603,0.994211938535807,3,51,negative regulation of coagulation,BP,EDN1;PLAU;PDGFB
13390,GO:0048745,0.0354092815327983,0.996899167141081,2,19,smooth muscle tissue development,BP,STRA6;BMP4
12439,GO:0045940,0.0357643220451847,0.996805483349722,2,23,positive regulation of steroid metabolic process,BP,WNT4;BMP6
2541,GO:0005251,0.0359049533015963,0.99681874506376,2,20,delayed rectifier potassium channel activity,MF,KCNH2;KCNG2
6926,GO:0021697,0.0359508180758077,0.996812476883091,2,20,cerebellar cortex formation,BP,WNT7A;DLL1
13490,GO:0050220,0.0359625079317691,0.999563674224347,1,3,prostaglandin-E synthase activity,MF,PTGES
11736,GO:0044321,0.0360008279367477,0.996805637123168,2,20,response to leptin,BP,EDN1;INHBB
10954,GO:0042629,0.036086343381628,0.996770978699922,2,22,mast cell granule,CC,CHGA;PIK3CG
13146,GO:0048237,0.0361169579974434,0.999559887203834,1,3,rough endoplasmic reticulum lumen,CC,EDN1
20517,GO:1905457,0.0361368750342609,0.999559397639479,1,3,negative regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
21523,GO:2000974,0.0361368750342609,0.999559397639479,1,3,negative regulation of pro-B cell differentiation,BP,NOTCH1
16946,GO:0072234,0.0361536686560465,0.996784700521163,2,20,metanephric nephron tubule development,BP,LIF;WNT7B
14250,GO:0051771,0.0362041337912235,0.99955774236253,1,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,EDN1
14256,GO:0051784,0.0364373659416925,0.993964581180372,3,51,negative regulation of nuclear division,BP,LIF;BMP7;BMP4
767,GO:0001942,0.0366693561694677,0.991648150198044,4,86,hair follicle development,BP,NOTCH1;FGF10;WNT5A;LAMA5
15274,GO:0060972,0.036770543795372,0.9966873172384,2,21,left/right pattern formation,BP,NOTCH1;DLL1
14885,GO:0060349,0.0368993712705493,0.991581784961042,4,85,bone morphogenesis,BP,BMP6;BMP4;NPPC;NAB2
7483,GO:0030538,0.0369118042955413,0.999540134883021,1,3,embryonic genitalia morphogenesis,BP,FGF10
3664,GO:0007156,0.0369716379441489,0.988210901957054,6,152,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDH23;DSC2;CDH2;DSG3;CDH1;DSC3
17721,GO:0097058,0.0370178261428633,0.999537466858068,1,3,CRLF-CLCF1 complex,CC,CLCF1
17515,GO:0090288,0.0370646541445926,0.989680136862584,5,124,negative regulation of cellular response to growth factor stimulus,BP,WNT4;NOTCH1;RASL11B;FSTL3;WNT5A
17068,GO:0072511,0.0370922675406996,0.9832811254344,11,415,divalent inorganic cation transport,BP,CDH23;TF;CASQ2;TSPAN13;PDGFB;CTGF;PIK3CG;GAS6;VDR;CLDN16;PDE4B
16653,GO:0071702,0.037094446217679,0.97468229126073,47,2596,organic substance transport,BP,ADRA2B;ADRA2C;NOTCH1;RAB27A;TF;SLC45A4;SERPINA5;SLC52A3;RABIF;ADORA1;EDN1;RAB40B;RAB40A;FLVCR2;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;SESN2;RHOQ;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;SLC2A14;CHGA;GJB1;AKT1;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;UNC119;RAB38;RAB3D;GDNF;ACSL4
15887,GO:0070343,0.0371566013690591,0.999476260762789,1,4,white fat cell proliferation,BP,FGF10
15893,GO:0070350,0.0371566013690591,0.999476260762789,1,4,regulation of white fat cell proliferation,BP,FGF10
11476,GO:0043550,0.0372076320394813,0.993800775271617,3,48,regulation of lipid kinase activity,BP,PIK3R2;PIK3R1;PDGFB
16670,GO:0071733,0.0372476224732828,0.999531657122112,1,3,transcriptional activation by promoter-enhancer looping,BP,ZFPM1
17456,GO:0090202,0.0372476224732828,0.999531657122112,1,3,gene looping,BP,ZFPM1
17634,GO:0090579,0.0372476224732828,0.999531657122112,1,3,dsDNA loop formation,BP,ZFPM1
8891,GO:0033023,0.0373070947280525,0.99953014753046,1,3,mast cell homeostasis,BP,KITLG
8892,GO:0033024,0.0373070947280525,0.99953014753046,1,3,mast cell apoptotic process,BP,KITLG
8893,GO:0033025,0.0373070947280525,0.99953014753046,1,3,regulation of mast cell apoptotic process,BP,KITLG
16992,GO:0072311,0.037403249182942,0.996611681697395,2,20,glomerular epithelial cell differentiation,BP,BMP4;WT1
4633,GO:0009746,0.0374594477757055,0.987991651969491,6,175,response to hexose,BP,KHK;SESN2;CTGF;GJB6;PIK3CA;GAS6
10815,GO:0042414,0.0375643051843073,0.999523590273679,1,3,epinephrine metabolic process,BP,PNMT
4713,GO:0010008,0.037571863773829,0.983032025691989,11,411,endosome membrane,CC,TMEM163;SYT5;TSPAN15;RAB27A;TF;FZD7;SNX18;RHOB;RAB12;RAB17;RNF144A
15071,GO:0060594,0.0375889107800002,0.999522960562492,1,3,mammary gland specification,BP,FGF10
8356,GO:0032233,0.037681061879947,0.993676509896164,3,51,positive regulation of actin filament bundle assembly,BP,WNT4;SDC4;CTGF
15737,GO:0070101,0.0377087196410117,0.999519888345161,1,3,positive regulation of chemokine-mediated signaling pathway,BP,EDN1
8097,GO:0031708,0.0377272022199146,0.999519413509587,1,3,endothelin B receptor binding,MF,EDN1
8465,GO:0032402,0.0378156471653864,0.996529241273068,2,22,melanosome transport,BP,RAB27A;RAB17
7761,GO:0031091,0.0378355059530442,0.99128824689968,4,90,platelet alpha granule,CC,ACTN2;SERPINA5;PDGFB;GAS6
11120,GO:0042990,0.0380819806151826,0.991215980047347,4,89,regulation of transcription factor import into nucleus,BP,PIK3R2;PIK3R1;BMP7;CDH1
11800,GO:0044430,0.0383383914371388,0.976128258639643,29,1452,cytoskeletal part,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;PRKACB;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;RHOQ;PSRC1;SPTB;CAMSAP3;ESPN;AKT1;PKP1;CDH1;MYO7A;CLDN5;MYH11;AMOT;UNC119;RAB3D;MYZAP;FAM110B;PDE4B
6208,GO:0016936,0.0383557768761983,0.999441621573737,1,4,galactoside binding,MF,LGALS4
5011,GO:0010812,0.0383834955360553,0.993526819033166,3,48,negative regulation of cell-substrate adhesion,BP,NOTCH1;FZD7;PIK3R1
13764,GO:0050926,0.0384127292837921,0.996433396024975,2,23,regulation of positive chemotaxis,BP,ARTN;FGF10
7452,GO:0030485,0.0384262286755584,0.999501279499919,1,3,smooth muscle contractile fiber,CC,ACTA2
16920,GO:0072198,0.038490232495162,0.999499602046577,1,3,mesenchymal cell proliferation involved in ureter development,BP,BMP4
16921,GO:0072199,0.038490232495162,0.999499602046577,1,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
12826,GO:0046835,0.0385256875303597,0.996440206644874,2,21,carbohydrate phosphorylation,BP,KHK;PFKFB3
8649,GO:0032652,0.0385811941517084,0.993437037548096,3,58,regulation of interleukin-1 production,BP,CCL20;WNT5A;GAS6
13908,GO:0051155,0.0387106301065123,0.993417787040876,3,55,positive regulation of striated muscle cell differentiation,BP,EDN1;BMP4;EFNB2
14687,GO:0060057,0.0388985226517803,0.999488833843405,1,3,apoptotic process involved in mammary gland involution,BP,VDR
14688,GO:0060058,0.0388985226517803,0.999488833843405,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,VDR
19136,GO:1902339,0.0388985226517803,0.999488833843405,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,VDR
19641,GO:1903519,0.0388985226517803,0.999488833843405,1,3,regulation of mammary gland involution,BP,VDR
19642,GO:1903521,0.0388985226517803,0.999488833843405,1,3,positive regulation of mammary gland involution,BP,VDR
20220,GO:1904747,0.0388985226517803,0.999488833843405,1,3,positive regulation of apoptotic process involved in development,BP,VDR
19104,GO:1902263,0.0388985226530164,0.999488833843372,1,3,apoptotic process involved in embryonic digit morphogenesis,BP,NOTCH1
15062,GO:0060584,0.0389225225550464,0.999488197241401,1,3,regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
15063,GO:0060585,0.0389225225550464,0.999488197241401,1,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
20950,GO:2000015,0.0390018500004578,0.999486090196466,1,3,regulation of determination of dorsal identity,BP,ACVR1
19746,GO:1903719,0.0390516088701823,0.999484766284485,1,3,regulation of I-kappaB phosphorylation,BP,AKT1
19747,GO:1903721,0.0390516088701823,0.999484766284485,1,3,positive regulation of I-kappaB phosphorylation,BP,AKT1
3971,GO:0008154,0.0390689291608794,0.987352564690889,6,174,actin polymerization or depolymerization,BP,FHOD3;ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB
728,GO:0001889,0.0393735690980707,0.988849517052595,5,130,liver development,BP,WNT4;NOTCH1;LIMS2;CLDN1;PIK3CA
20996,GO:2000097,0.0394041771955107,0.999475335986819,1,3,regulation of smooth muscle cell-matrix adhesion,BP,PLAU
16655,GO:0071705,0.0395081774368133,0.97353172946008,41,2230,nitrogen compound transport,BP,ADRA2B;ADRA2C;NOTCH1;RAB27A;TF;SLC52A3;RABIF;ADORA1;EDN1;RAB40B;RAB40A;FLVCR2;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;CHGA;GJB1;AKT1;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;UNC119;RAB38;RAB3D;GDNF
461,GO:0001191,0.0396027527316964,0.990757396150478,4,87,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,POU3F1;NOTCH1;TLE1;SIN3B
11121,GO:0042991,0.0396509935586398,0.990735101668916,4,90,transcription factor import into nucleus,BP,PIK3R2;PIK3R1;BMP7;CDH1
6357,GO:0018125,0.0396905859812508,0.99946761118346,1,3,peptidyl-cysteine methylation,BP,RAB3D
97,GO:0000186,0.0397736691103092,0.993193119938417,3,49,activation of MAPKK activity,BP,ADORA1;BMP4;ARAF
7094,GO:0022404,0.0397776442701268,0.990701153600129,4,88,molting cycle process,BP,NOTCH1;FGF10;WNT5A;LAMA5
7095,GO:0022405,0.0397776442701268,0.990701153600129,4,88,hair cycle process,BP,NOTCH1;FGF10;WNT5A;LAMA5
3473,GO:0006826,0.0398548819881462,0.993137667616744,3,57,iron ion transport,BP,TF;TTYH1;SFXN1
7333,GO:0030241,0.0399193480281795,0.99946139988757,1,3,skeletal muscle myosin thick filament assembly,BP,MYH11
12851,GO:0046882,0.0400723444363587,0.999457225289929,1,3,negative regulation of follicle-stimulating hormone secretion,BP,INHBB
9703,GO:0035162,0.0402837019425527,0.996186290051639,2,21,embryonic hemopoiesis,BP,ZFPM1;KITLG
17422,GO:0090162,0.0403220763003568,0.996180676856175,2,21,establishment of epithelial cell polarity,BP,WNT5A;MSN
3269,GO:0006546,0.0403944442773586,0.999448382946922,1,3,glycine catabolic process,BP,GLDC
6619,GO:0019464,0.0403944442773586,0.999448382946922,1,3,glycine decarboxylation via glycine cleavage system,BP,GLDC
9106,GO:0033563,0.0404891990446446,0.999445767868319,1,3,dorsal/ventral axon guidance,BP,FGF8
10173,GO:0036003,0.0406169399935423,0.996112537036135,2,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1;SESN2
10524,GO:0038181,0.0406258265979914,0.99944198607775,1,3,bile acid receptor activity,MF,VDR
10526,GO:0038183,0.0406258265979914,0.99944198607775,1,3,bile acid signaling pathway,BP,VDR
16452,GO:0071398,0.0406400173197384,0.992970686691297,3,52,cellular response to fatty acid,BP,EDN1;AKT1;CLDN1
15992,GO:0070527,0.040714428861226,0.992948063958239,3,53,platelet aggregation,BP,TYRO3;PIK3CG;GAS6
4701,GO:0009975,0.0409176447676078,0.99610771084333,2,20,cyclase activity,MF,GUCY1B3;NPR1
16913,GO:0072190,0.0410735803334585,0.999429500626095,1,3,ureter urothelium development,BP,BMP4
13844,GO:0051057,0.0410744206962513,0.992865903346167,3,52,positive regulation of small GTPase mediated signal transduction,BP,FGF10;HRAS;KITLG
14691,GO:0060061,0.0411343979834275,0.999427793890113,1,3,Spemann organizer formation,BP,WNT3
11774,GO:0044381,0.0411351722558751,0.996061037774319,2,21,glucose import in response to insulin stimulus,BP,PIK3R2;PIK3R1
7569,GO:0030742,0.0411525797289857,0.996021981168906,2,24,GTP-dependent protein binding,MF,RAB38;RAB3D
21050,GO:2000191,0.0411988189979618,0.996026170049854,2,23,regulation of fatty acid transport,BP,EDN1;AKT1
13843,GO:0051056,0.0412242126347195,0.982832429468908,9,295,regulation of small GTPase mediated signal transduction,BP,ITGA3;FGF10;PIK3R2;HRAS;RHOQ;RHOJ;RHOB;KITLG;AMOT
14776,GO:0060197,0.0412326263812981,0.999425031804201,1,3,cloacal septation,BP,BMP4
6154,GO:0016849,0.0412344199357823,0.996061046521871,2,20,phosphorus-oxygen lyase activity,MF,GUCY1B3;NPR1
7576,GO:0030801,0.0413113549102785,0.99019109534462,4,104,positive regulation of cyclic nucleotide metabolic process,BP,WNT5A;NPR1;CHGA;NPPC
4902,GO:0010638,0.0413282167351489,0.979094489107132,14,584,positive regulation of organelle organization,BP,LIF;WNT4;ACTN2;PMAIP1;EDN1;PDGFB;RALB;HRAS;WNT5A;PSRC1;FGF8;SDC4;MSN;CTGF
2692,GO:0005605,0.0414172904125418,0.996019213854185,2,21,basal lamina,CC,LAMA1;LAMA5
12236,GO:0045600,0.0415445940707014,0.992742493054413,3,54,positive regulation of fat cell differentiation,BP,WNT5B;BMP2;AKT1
8719,GO:0032768,0.0415584941526704,0.992730315116218,3,56,regulation of monooxygenase activity,BP,AKT1;VDR;GDNF
8464,GO:0032401,0.0416238236305269,0.995962652399567,2,23,establishment of melanosome localization,BP,RAB27A;RAB17
14653,GO:0060021,0.0416979727684287,0.990109227785635,4,87,palate development,BP,WNT7A;WNT5A;JAG2;CLDN5
15105,GO:0060669,0.0417928232004968,0.995949686947793,2,22,embryonic placenta morphogenesis,BP,WNT7B;BMP7
3822,GO:0007500,0.0418945158734172,0.999406243392151,1,3,mesodermal cell fate determination,BP,BMP4
2836,GO:0005856,0.0419154228815897,0.972318890653842,37,1934,cytoskeleton,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;PRKACB;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;PTPN7;FRMPD1;PSTPIP2;RHOQ;PSRC1;SPTB;CAMSAP3;ESPN;MSN;AKT1;PKP1;KITLG;CDH1;MYO7A;BCAR1;CLDN5;MYH11;AMOT;UNC119;RAB3D;MYZAP;FAM110B;ACTA2;PARVB;PDE4B
10620,GO:0042035,0.0419539845576888,0.990004446025304,4,97,regulation of cytokine biosynthetic process,BP,ZFPM1;CCL20;WNT5A;INHBB
4951,GO:0010721,0.0420522104958764,0.983475732974547,8,264,negative regulation of cell development,BP,WNT3;NOTCH1;WNT7A;WNT5A;BMP7;DLL1;NPPC;CLDN18
9362,GO:0034284,0.0420804134970881,0.986130204994275,6,180,response to monosaccharide,BP,KHK;SESN2;CTGF;GJB6;PIK3CA;GAS6
16826,GO:0072061,0.0422092042307838,0.999397202633753,1,3,inner medullary collecting duct development,BP,WNT7B
12290,GO:0045666,0.0422172582120777,0.9823367949869,9,305,positive regulation of neuron differentiation,BP,ITGA3;ADRA2B;ADRA2C;WNT3;WNT5A;BMP7;BMP6;BMP4;BMP2
14694,GO:0060066,0.0422190286906008,0.999396919263464,1,3,oviduct development,BP,WNT7A
20526,GO:1905477,0.0422625721513016,0.98991698547689,4,93,positive regulation of protein localization to membrane,BP,ITGA3;PMAIP1;PIK3R1;AKT1
17696,GO:0097021,0.0422869435156561,0.99939495851597,1,3,lymphocyte migration into lymphoid organs,BP,ARTN
11461,GO:0043535,0.0423333169169846,0.992549950442709,3,54,regulation of blood vessel endothelial cell migration,BP,NOTCH1;PDGFB;AKT1
1603,GO:0003419,0.0424571726514918,0.999314611937967,1,4,growth plate cartilage chondrocyte proliferation,BP,NPPC
5094,GO:0010906,0.0424669420878976,0.98986306816215,4,89,regulation of glucose metabolic process,BP,ACTN3;PMAIP1;SESN2;AKT1
1204,GO:0002684,0.042544567841605,0.976057651924892,19,904,positive regulation of immune system process,BP,LIF;EDN1;PRKACB;CCL20;TYRO3;FGF10;PIK3R2;PIK3R1;HRAS;WNT5A;CLCF1;CDKN1A;AKT1;KITLG;BCAR1;PIK3CA;GAS6;EFNB2;PDE4B
13361,GO:0048696,0.0427327014608306,0.999382008634887,1,3,regulation of collateral sprouting in absence of injury,BP,WNT3
15372,GO:0061107,0.0428364456613623,0.999378974664399,1,3,seminal vesicle development,BP,SERPINA5
1443,GO:0003148,0.0429349656127782,0.995777306302437,2,22,outflow tract septum morphogenesis,BP,FGF8;BMP4
1052,GO:0002407,0.0429490812849501,0.995739592338836,2,25,dendritic cell chemotaxis,BP,PIK3CG;GAS6
15303,GO:0061008,0.0429837480418011,0.987532371878734,5,133,hepaticobiliary system development,BP,WNT4;NOTCH1;LIMS2;CLDN1;PIK3CA
17855,GO:0097305,0.042985955829484,0.985752547434174,6,187,response to alcohol,BP,AKT1;NPPC;CDH1;CLDN1;CLDN3;CLDN18
13435,GO:0048850,0.0430685634518282,0.999372159002711,1,3,hypophysis morphogenesis,BP,WNT5A
19259,GO:1902667,0.0431999417335141,0.995751239395395,2,21,regulation of axon guidance,BP,WNT3;WNT5A
18537,GO:1900186,0.0432905382017604,0.999365605681704,1,3,negative regulation of clathrin-dependent endocytosis,BP,UNC119
15531,GO:0061515,0.0434253919708725,0.992285840844735,3,53,myeloid cell development,BP,ZFPM1;TSPAN2;CLDN18
3670,GO:0007162,0.0434772025399655,0.984068698232216,7,223,negative regulation of cell adhesion,BP,NOTCH1;FZD7;PIK3R1;SDC4;BMP4;BMP2;CDH1
6568,GO:0019318,0.0434994744499699,0.984057911266234,7,224,hexose metabolic process,BP,ACTN3;PMAIP1;KHK;SESN2;PFKFB3;AKT1;PIK3CA
18977,GO:1901981,0.0435086576471802,0.987353032980723,5,125,phosphatidylinositol phosphate binding,MF,SYT5;ACTN2;FZD7;SNX18;AKT1
8450,GO:0032386,0.0436342217196631,0.9790565386601,12,480,regulation of intracellular transport,BP,FZD7;PRR5L;PIK3R2;PIK3R1;REEP1;BMP7;BMP6;BMP4;CDKN1A;MSN;CDH1;GAS6
20773,GO:1990418,0.043639698086797,0.999355227259029,1,3,response to insulin-like growth factor stimulus,BP,AKT1
16875,GO:0072135,0.0436586116691663,0.999354662619374,1,3,kidney mesenchymal cell proliferation,BP,BMP7
16876,GO:0072136,0.0436586116691663,0.999354662619374,1,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,BMP7
13076,GO:0048022,0.04394076820086,0.999346209276729,1,3,negative regulation of melanin biosynthetic process,BP,WNT5A
18598,GO:1900377,0.04394076820086,0.999346209276729,1,3,negative regulation of secondary metabolite biosynthetic process,BP,WNT5A
13434,GO:0048846,0.0440132525207086,0.995626876557188,2,21,axon extension involved in axon guidance,BP,WNT3;WNT5A
19112,GO:1902284,0.0440132525207086,0.995626876557188,2,21,neuron projection extension involved in neuron projection guidance,BP,WNT3;WNT5A
13976,GO:0051258,0.044069437793319,0.983801311007113,7,227,protein polymerization,BP,FHOD3;TUBG2;CASQ2;SPTBN5;SPTBN4;PSRC1;SPTB
18676,GO:1901079,0.0441577208032824,0.999339671258203,1,3,positive regulation of relaxation of muscle,BP,CHGA
14824,GO:0060278,0.0442367358721512,0.999337281837966,1,3,regulation of ovulation,BP,INHBB
16284,GO:0071062,0.0442445289803333,0.999337045935357,1,3,alphav-beta3 integrin-vitronectin complex,CC,ITGA5
13128,GO:0048179,0.04429497198519,0.999335517955776,1,3,activin receptor complex,CC,ACVR1
4235,GO:0008585,0.0443645871443159,0.989257089279779,4,91,female gonad development,BP,WNT4;WT1;KITLG;INHBB
3923,GO:0008076,0.0443822634960565,0.989262809804072,4,87,voltage-gated potassium channel complex,CC,KCNK6;KCNH2;KCNG2;KCND1
16919,GO:0072197,0.0443946745569449,0.999332492564543,1,3,ureter morphogenesis,BP,BMP4
2532,GO:0005242,0.0444233095954112,0.995548769075887,2,22,inward rectifier potassium channel activity,MF,KCNK6;KCNH2
15389,GO:0061146,0.0445842906200118,0.999326719471709,1,3,Peyer's patch morphogenesis,BP,ARTN
4744,GO:0010159,0.0445901812849147,0.999326539716907,1,3,specification of animal organ position,BP,BMP4
7637,GO:0030878,0.0445992303029785,0.995495305390267,2,24,thyroid gland development,BP,FGF10;FGF8
3918,GO:0008065,0.0446356885000595,0.999325150229962,1,3,establishment of blood-nerve barrier,BP,CLDN1
7030,GO:0021898,0.044682270368589,0.999323726416622,1,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,AXIN1
7081,GO:0022011,0.0446962217547228,0.995506387480695,2,22,myelination in peripheral nervous system,BP,POU3F1;AKT1
8389,GO:0032292,0.0446962217547228,0.995506387480695,2,22,peripheral nervous system axon ensheathment,BP,POU3F1;AKT1
10241,GO:0036118,0.0447284485991142,0.99932231342925,1,3,hyaluranon cable assembly,BP,BMP7
18481,GO:1900104,0.0447284485991142,0.99932231342925,1,3,regulation of hyaluranon cable assembly,BP,BMP7
18482,GO:1900106,0.0447284485991142,0.99932231342925,1,3,positive regulation of hyaluranon cable assembly,BP,BMP7
7179,GO:0030003,0.0448196768264691,0.977696105684006,13,556,cellular cation homeostasis,BP,CDH23;TF;CASQ2;EDN1;RAB39A;PRND;LPAR2;BMP6;RAB20;PIK3CG;VDR;RAB38;CLDN16
3351,GO:0006644,0.0449743793909131,0.979092123002821,11,427,phospholipid metabolic process,BP,MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FGF8;HBEGF;KITLG;PIK3CA;PIK3CG
11376,GO:0043393,0.0450310095225216,0.98491695993406,6,180,regulation of protein binding,BP,ZFPM1;PDGFB;RALB;WNT5A;BMP4;BMP2
8095,GO:0031705,0.0451284467465829,0.999224759977029,1,4,bombesin receptor binding,MF,EDN1
8343,GO:0032217,0.0451298192300831,0.999309968662241,1,3,riboflavin transporter activity,MF,SLC52A3
8344,GO:0032218,0.0451298192300831,0.999309968662241,1,3,riboflavin transport,BP,SLC52A3
13926,GO:0051183,0.0453121386918518,0.995383410247154,2,24,vitamin transporter activity,MF,STRA6;SLC52A3
11411,GO:0043457,0.0453316428828885,0.995393142013216,2,23,regulation of cellular respiration,BP,ACTN3;PIK3CA
14675,GO:0060045,0.0453703560759085,0.99540107107497,2,22,positive regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1
19341,GO:1902897,0.0453983557446425,0.999301645894316,1,3,regulation of postsynaptic density protein 95 clustering,BP,CDH2
1453,GO:0003162,0.0454163072856884,0.999301087704714,1,3,atrioventricular node development,BP,NOTCH1
12613,GO:0046365,0.0454579405601245,0.991753609353931,3,58,monosaccharide catabolic process,BP,ACTN3;KHK;PFKFB3
15223,GO:0060846,0.0454786695480197,0.999299146828023,1,3,blood vessel endothelial cell fate commitment,BP,DLL1
15224,GO:0060847,0.0454786695480197,0.999299146828023,1,3,endothelial cell fate specification,BP,DLL1
17739,GO:0097101,0.0454786695480197,0.999299146828023,1,3,blood vessel endothelial cell fate specification,BP,DLL1
5173,GO:0014002,0.0455862377202138,0.995340122315283,2,24,astrocyte development,BP,DLL1;TSPAN2
10656,GO:0042108,0.0456082558090444,0.991706941107721,3,60,positive regulation of cytokine biosynthetic process,BP,ZFPM1;CCL20;WNT5A
9144,GO:0033627,0.0457701313770916,0.991688733366699,3,55,cell adhesion mediated by integrin,BP,ITGA5;PLAU;PIK3CG
11543,GO:0043696,0.0457900860418451,0.999289413606084,1,3,dedifferentiation,BP,PDGFB
11544,GO:0043697,0.0457900860418451,0.999289413606084,1,3,cell dedifferentiation,BP,PDGFB
15312,GO:0061025,0.045855967262882,0.983003875372482,7,223,membrane fusion,BP,SYT5;SERPINA5;RABIF;RAB39A;RAB20;VAMP1;GAS6
904,GO:0002139,0.0458712734479813,0.999286864855774,1,3,stereocilia coupling link,CC,MYO7A
10140,GO:0035939,0.0458928998262004,0.999286185143894,1,3,microsatellite binding,MF,HEY1
21481,GO:2000820,0.0458928998265805,0.999286185143882,1,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,HEY1
15374,GO:0061110,0.0459286343171584,0.999285061292861,1,3,dense core granule biogenesis,BP,CHGA
21408,GO:2000705,0.0459286343171584,0.999285061292861,1,3,regulation of dense core granule biogenesis,BP,CHGA
19428,GO:1903047,0.0459302609998266,0.973925591407128,19,874,mitotic cell cycle process,BP,MARK4;GADD45A;ACVR1;EDN1;PHLDA1;TTYH1;FGF10;PDGFB;FOXO4;HRAS;SNX18;PSRC1;FGF8;BMP7;BMP4;CDKN1A;AKT1;LZTS1;PIM2
14310,GO:0051894,0.0459515866294721,0.995295264956618,2,23,positive regulation of focal adhesion assembly,BP,WNT4;SDC4
3611,GO:0007040,0.0459711018747499,0.991637792854639,3,55,lysosome organization,BP,RAB39A;RAB20;MYO7A
17234,GO:0080171,0.0459711018747499,0.991637792854639,3,55,lytic vacuole organization,BP,RAB39A;RAB20;MYO7A
11458,GO:0043532,0.0459800073267002,0.999194930432149,1,4,angiostatin binding,MF,AMOT
13199,GO:0048320,0.0460142494402817,0.999282365021442,1,3,axial mesoderm formation,BP,AXIN1
9665,GO:0035054,0.0461195186650743,0.999279042680511,1,3,embryonic heart tube anterior/posterior pattern specification,BP,BMP2
7760,GO:0031090,0.046216392269203,0.967846172501303,48,2705,organelle membrane,CC,TMEM163;SYT5;WNT3;WNT4;TSPAN15;NOTCH1;RAB27A;TF;PMAIP1;SERPINA5;WNT6;WNT7A;WNT7B;HMGCS2;CASQ2;PLAU;SPTBN5;SLC25A53;TTYH1;RAB39A;SYCN;FZD7;REEP1;PDGFB;HRAS;WNT5B;WNT5A;SNX18;RHOQ;RHOB;HBEGF;B3GNT2;RAB20;VAMP1;SFXN1;RND3;CHGA;PKP1;RAB12;RAB17;MYO7A;RAB44;RAB11FIP1;GPSM1;RAB38;RAB3D;ACSL4;RNF144A
8452,GO:0032388,0.0462864018501792,0.981455674627532,8,278,positive regulation of intracellular transport,BP,PRR5L;PIK3R2;PIK3R1;BMP6;BMP4;MSN;CDH1;GAS6
17833,GO:0097252,0.0463189222237897,0.9992727279378,1,3,oligodendrocyte apoptotic process,BP,GAS6
15408,GO:0061184,0.0463196652266578,0.999272704355678,1,3,positive regulation of dermatome development,BP,WNT4
6807,GO:0021502,0.0464436952308986,0.999268762301153,1,3,neural fold elevation formation,BP,BMP7
17847,GO:0097278,0.0464555235948855,0.999178023496656,1,4,complement-dependent cytotoxicity,BP,RAB27A
4192,GO:0008506,0.0464798743445625,0.999267610367439,1,3,sucrose:proton symporter activity,MF,SLC45A4
4200,GO:0008515,0.0464798743445625,0.999267610367439,1,3,sucrose transmembrane transporter activity,MF,SLC45A4
5396,GO:0015154,0.0464798743445625,0.999267610367439,1,3,disaccharide transmembrane transporter activity,MF,SLC45A4
5397,GO:0015157,0.0464798743445625,0.999267610367439,1,3,oligosaccharide transmembrane transporter activity,MF,SLC45A4
5595,GO:0015766,0.0464798743445625,0.999267610367439,1,3,disaccharide transport,BP,SLC45A4
5596,GO:0015770,0.0464798743445625,0.999267610367439,1,3,sucrose transport,BP,SLC45A4
5597,GO:0015772,0.0464798743445625,0.999267610367439,1,3,oligosaccharide transport,BP,SLC45A4
7033,GO:0021904,0.0464897617936382,0.995209688775373,2,23,dorsal/ventral neural tube patterning,BP,PRKACB;BMP4
11891,GO:0044752,0.0466482650955509,0.999262236661702,1,3,response to human chorionic gonadotropin,BP,GJB2
17693,GO:0097017,0.0466750036442173,0.999261381531841,1,3,renal protein absorption,BP,GAS6
754,GO:0001927,0.0467637210884909,0.999258540620105,1,3,exocyst assembly,BP,RALB
16952,GO:0072243,0.0468749337777375,0.99514809591045,2,23,metanephric nephron epithelium development,BP,LIF;WNT7B
21381,GO:2000669,0.0469129627719179,0.999253749031008,1,3,negative regulation of dendritic cell apoptotic process,BP,GAS6
16441,GO:0071385,0.0469362365703589,0.991377192065401,3,58,cellular response to glucocorticoid stimulus,BP,EDN1;GJB2;HEY1
9250,GO:0034059,0.0470445644600012,0.999249510712771,1,3,response to anoxia,BP,CTGF
5148,GO:0010979,0.0470883961863712,0.999248096361034,1,3,regulation of vitamin D 24-hydroxylase activity,BP,VDR
5149,GO:0010980,0.0470883961863712,0.999248096361034,1,3,positive regulation of vitamin D 24-hydroxylase activity,BP,VDR
935,GO:0002193,0.0471011545793806,0.999247684420602,1,3,MAML1-RBP-Jkappa- ICN1 complex,CC,NOTCH1
607,GO:0001712,0.0471474389097136,0.999246189033806,1,3,ectodermal cell fate commitment,BP,FZD7
16794,GO:0072010,0.0472972520214716,0.995080232377697,2,23,glomerular epithelium development,BP,BMP4;WT1
20374,GO:1905064,0.0473232985602843,0.999240493401868,1,3,negative regulation of vascular smooth muscle cell differentiation,BP,PDGFB
6657,GO:0019637,0.0473285854605311,0.971897935314263,22,1112,organophosphate metabolic process,BP,ACTN3;GUCY1B3;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;WNT5A;KHK;RHOQ;NPR1;PFKFB3;FGF8;HBEGF;CHGA;KITLG;NPPC;PIK3CA;PIK3CG;PDE4B
3924,GO:0008078,0.0473546508206429,0.99914556508286,1,4,mesodermal cell migration,BP,FGF8
601,GO:0001706,0.0473620679445603,0.991288024176447,3,54,endoderm formation,BP,ITGA5;ITGB5;DUSP5
7188,GO:0030017,0.0473811999346764,0.983928538417297,6,186,sarcomere,CC,FHOD3;ACTN2;CASQ2;MYZAP;PARVB;PDE4B
8970,GO:0033159,0.0474963728487247,0.999234866590421,1,3,negative regulation of protein import into nucleus, translocation,BP,GAS6
7015,GO:0021879,0.0475260506120164,0.991240545546251,3,55,forebrain neuron differentiation,BP,WNT5A;AXIN1;FGF8
10056,GO:0035793,0.0475592862743049,0.999232815954891,1,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
18566,GO:1900238,0.0475592862743049,0.999232815954891,1,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
21327,GO:2000591,0.0475592862743049,0.999232815954891,1,3,positive regulation of metanephric mesenchymal cell migration,BP,PDGFB
12096,GO:0045218,0.0475810232623459,0.999232106795363,1,3,zonula adherens maintenance,BP,CAMSAP3
6379,GO:0018201,0.0476860380557902,0.999228676018169,1,3,peptidyl-glycine modification,BP,NMT2
6211,GO:0016941,0.0478209963386002,0.999224255526222,1,3,natriuretic peptide receptor activity,MF,NPR1
3689,GO:0007184,0.0478456177993161,0.994991599639792,2,23,SMAD protein import into nucleus,BP,BMP6;BMP4
10648,GO:0042097,0.0478653617988699,0.999222799537753,1,3,interleukin-4 biosynthetic process,BP,ZFPM1
12170,GO:0045402,0.0478653617988699,0.999222799537753,1,3,regulation of interleukin-4 biosynthetic process,BP,ZFPM1
19559,GO:1903348,0.0478834157995486,0.999222206640977,1,3,positive regulation of bicellular tight junction assembly,BP,CLDN1
15264,GO:0060948,0.0479065010816624,0.999221448179329,1,3,cardiac vascular smooth muscle cell development,BP,NOTCH1
8742,GO:0032795,0.0482455876204345,0.999112769406551,1,4,heterotrimeric G-protein binding,MF,ADORA1
11886,GO:0044729,0.0482534665333803,0.99921000318856,1,3,hemi-methylated DNA-binding,MF,WT1
16961,GO:0072262,0.0482534676695173,0.999210003150944,1,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,WT1
17796,GO:0097190,0.0483013024907457,0.975697167225345,13,565,apoptotic signaling pathway,BP,WNT4;PMAIP1;ACVR1;ADORA1;FGF10;PIK3R1;HRAS;BMP4;CDKN1A;AKT1;KITLG;INHBB;GDNF
11496,GO:0043585,0.0483044422971465,0.999208314510437,1,3,nose morphogenesis,BP,STRA6
10274,GO:0036166,0.0483550106676128,0.999206637506814,1,3,phenotypic switching,BP,PDGFB
18567,GO:1900239,0.0483550106676128,0.999206637506814,1,3,regulation of phenotypic switching,BP,PDGFB
15587,GO:0061643,0.048365778125217,0.999206280190351,1,3,chemorepulsion of axon,BP,WNT5A
3782,GO:0007356,0.0484449959821208,0.99910534275552,1,4,thorax and anterior abdomen determination,BP,WT1
2539,GO:0005249,0.0484731996361598,0.987936249914173,4,88,voltage-gated potassium channel activity,MF,KCNK6;KCNH2;KCNG2;KCND1
1526,GO:0003274,0.0484779544169004,0.999202552744797,1,3,endocardial cushion fusion,BP,ACVR1
17333,GO:0090022,0.0485073412920663,0.994796535303791,2,31,regulation of neutrophil chemotaxis,BP,EDN1;JAM3
625,GO:0001743,0.0485189115873466,0.999201189576061,1,3,optic placode formation,BP,AXIN1
1595,GO:0003408,0.0485216631564904,0.999201097953506,1,3,optic cup formation involved in camera-type eye development,BP,WNT5A
16809,GO:0072034,0.0485864486893687,0.999198939153461,1,3,renal vesicle induction,BP,WNT4
2889,GO:0005944,0.0485975829352809,0.999198567835354,1,3,phosphatidylinositol 3-kinase complex, class IB,CC,PIK3CG
16067,GO:0070662,0.0486083805752352,0.999198207658757,1,3,mast cell proliferation,BP,KITLG
16374,GO:0071284,0.0486446438923931,0.999196997418666,1,3,cellular response to lead ion,BP,CLDN1
7473,GO:0030517,0.0487645466978796,0.994827486818118,2,24,negative regulation of axon extension,BP,WNT3;WNT5A
20878,GO:1990785,0.0487886521892832,0.999192182120278,1,3,response to water-immersion restraint stress,BP,FOXO4
20272,GO:1904862,0.0488157532804451,0.999191274277829,1,3,inhibitory synapse assembly,BP,WNT5A
9506,GO:0034599,0.0488450855675181,0.981631658780889,7,240,cellular response to oxidative stress,BP,GUCY1B3;PRR5L;SESN2;RHOB;BMP7;GJB2;AKT1
15281,GO:0060979,0.0489424588568286,0.999187022929872,1,3,vasculogenesis involved in coronary vascular morphogenesis,BP,NOTCH1
16059,GO:0070644,0.0489615906554562,0.999186380010833,1,3,vitamin D response element binding,MF,VDR
2503,GO:0005173,0.0489615906560374,0.999186380010814,1,3,stem cell factor receptor binding,MF,KITLG
8363,GO:0032252,0.0489615906572919,0.999186380010772,1,3,secretory granule localization,BP,PIK3CG
2693,GO:0005606,0.0489615906575497,0.999186380010763,1,3,laminin-1 complex,CC,LAMA1
2696,GO:0005610,0.0489615906576478,0.99918638001076,1,3,laminin-5 complex,CC,LAMA5
16884,GO:0072156,0.048961590657924,0.99918638001075,1,3,distal tubule morphogenesis,BP,WNK4
11301,GO:0043260,0.0489615906579702,0.999186380010749,1,3,laminin-11 complex,CC,LAMA5
11300,GO:0043259,0.0489615906579809,0.999186380010748,1,3,laminin-10 complex,CC,LAMA5
13327,GO:0048643,0.0490584013509361,0.994779105741658,2,24,positive regulation of skeletal muscle tissue development,BP,ACTN3;DLL1
8463,GO:0032400,0.0490908154477404,0.994760506735843,2,25,melanosome localization,BP,RAB27A;RAB17
9574,GO:0034705,0.049107669642802,0.987721038823938,4,90,potassium channel complex,CC,KCNK6;KCNH2;KCNG2;KCND1
5085,GO:0010897,0.0492188063086273,0.999076224024632,1,4,negative regulation of triglyceride catabolic process,BP,PIK3CG
2448,GO:0005105,0.0494371335263266,0.999067922145023,1,4,type 1 fibroblast growth factor receptor binding,MF,FGF17
5829,GO:0016239,0.0495251534907712,0.990721838835501,3,55,positive regulation of macroautophagy,BP,RALB;SESN2;RAB12
18321,GO:0099512,0.0497550405024274,0.971933930129868,18,861,supramolecular fiber,CC,FHOD3;TUBG2;ACTN3;ACTN2;CASQ2;RHOQ;PSRC1;SDC4;CAMSAP3;ESPN;PKP1;MYH11;AMOT;RAB3D;MYZAP;ACTA2;PARVB;PDE4B
7141,GO:0022843,0.0499274028986051,0.984924680942378,5,130,voltage-gated cation channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
13417,GO:0048808,0.0500279255474782,0.999045267048922,1,4,male genitalia morphogenesis,BP,FGF10
17637,GO:0090598,0.0500279255474782,0.999045267048922,1,4,male anatomical structure morphogenesis,BP,FGF10
19785,GO:1903792,0.0500366088164383,0.994631714950093,2,23,negative regulation of anion transport,BP,ADORA1;AKT1
11629,GO:0044092,0.0500835303359879,0.970448321717438,21,1056,negative regulation of molecular function,BP,ACTN2;NOTCH1;GADD45A;SERPINA5;ZFPM1;CASQ2;PDGFB;PRKAR1B;RALB;HRAS;BMP7;BMP4;CAMSAP3;CDKN1A;AKT1;CST9L;GAS6;AMOT;SH3BP4;DUSP5;HEY1
12702,GO:0046545,0.0502211754757176,0.987336939188526,4,95,development of primary female sexual characteristics,BP,WNT4;WT1;KITLG;INHBB
10847,GO:0042472,0.0503490656428778,0.987294351395651,4,95,inner ear morphogenesis,BP,FGF10;WNT5A;FGF8;MYO7A
15101,GO:0060665,0.0504141690847482,0.999030305488488,1,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,FGF10
8721,GO:0032770,0.0504873794575132,0.994503158379621,2,27,positive regulation of monooxygenase activity,BP,AKT1;GDNF
3464,GO:0006813,0.0504939426453215,0.98088976054603,7,224,potassium ion transport,BP,ACTN2;ADORA1;CASQ2;KCNK6;KCNH2;KCNG2;KCND1
1054,GO:0002414,0.0505324399936693,0.999025700363279,1,4,immunoglobulin transcytosis in epithelial cells,BP,RAB17
15053,GO:0060574,0.0506365244237022,0.999021638394751,1,4,intestinal epithelial cell maturation,BP,CDKN1A
12858,GO:0046889,0.0506679333546387,0.990395192776973,3,60,positive regulation of lipid biosynthetic process,BP,WNT4;BMP6;AKT1
18629,GO:1900736,0.0507422906801102,0.999017501944985,1,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA
16510,GO:0071480,0.05074688243969,0.994471158137216,2,26,cellular response to gamma radiation,BP,HRAS;CDKN1A
1544,GO:0003308,0.0509132253355134,0.999010797945728,1,4,negative regulation of Wnt signaling pathway involved in heart development,BP,BMP2
3667,GO:0007159,0.0512567232181944,0.977752555943739,9,346,leukocyte cell-cell adhesion,BP,ITGA5;PIK3R1;SDC4;BMP7;BMP4;MSN;AKT1;PIK3CA;EFNB2
13185,GO:0048295,0.0512785932661737,0.998996390201088,1,4,positive regulation of isotype switching to IgE isotypes,BP,CLCF1
7387,GO:0030318,0.0513093218473374,0.994403056467545,2,24,melanocyte differentiation,BP,RAB27A;KITLG
17930,GO:0097460,0.0513108218703728,0.998995114202568,1,4,ferrous iron import into cell,BP,TF
12845,GO:0046875,0.0513280049548384,0.994385727065779,2,25,ephrin receptor binding,MF,PIK3CG;EFNB2
7679,GO:0030947,0.0513496122189316,0.994368998440016,2,26,regulation of vascular endothelial growth factor receptor signaling pathway,BP,ITGA5;FGF10
14829,GO:0060283,0.0513637005178072,0.998993018829798,1,4,negative regulation of oocyte development,BP,NPPC
20634,GO:1905880,0.0513637005178072,0.998993018829798,1,4,negative regulation of oogenesis,BP,NPPC
8084,GO:0031694,0.0513769385027199,0.998992493911338,1,4,alpha-2A adrenergic receptor binding,MF,ADRA2C
16440,GO:0071384,0.0515532678260627,0.990155012062778,3,61,cellular response to corticosteroid stimulus,BP,EDN1;GJB2;HEY1
2998,GO:0006109,0.0517783513260434,0.984195209763152,5,137,regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1;PDGFB;SESN2;AKT1
1507,GO:0003241,0.0518758586393551,0.99897260853651,1,4,growth involved in heart morphogenesis,BP,NOTCH1
3531,GO:0006914,0.0520335664233901,0.975226453780781,11,438,autophagy,BP,ITGB4;RAB39A;PIK3R2;RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1;SH3BP4;PIM2
957,GO:0002244,0.052061032304557,0.986720725418917,4,95,hematopoietic progenitor cell differentiation,BP,NOTCH1;FSTL3;JAM3;BMP4
2930,GO:0006006,0.0521412283815501,0.981900766930128,6,187,glucose metabolic process,BP,ACTN3;PMAIP1;SESN2;PFKFB3;AKT1;PIK3CA
19926,GO:1904063,0.052192371661481,0.989974655439477,3,63,negative regulation of cation transmembrane transport,BP,ACTN2;CASQ2;KCNH2
18467,GO:1900078,0.0522856371180233,0.994222408610069,2,25,positive regulation of cellular response to insulin stimulus,BP,PIK3R2;PIK3R1
12435,GO:0045936,0.0522931285824121,0.973386788192537,13,541,negative regulation of phosphate metabolic process,BP,LIF;ACTN3;GADD45A;EDN1;PRR5L;PDGFB;PRKAR1B;BMP7;BMP4;CAMSAP3;CDKN1A;AKT1;DUSP5
11142,GO:0043015,0.0523933053400483,0.994218549975479,2,24,gamma-tubulin binding,MF,MARK4;PDE4B
7099,GO:0022409,0.0524149430803922,0.979981048404894,7,244,positive regulation of cell-cell adhesion,BP,FSTL3;PIK3R1;WNT5A;BMP7;AKT1;PIK3CA;EFNB2
16068,GO:0070663,0.0526064447823486,0.981681928294152,6,202,regulation of leukocyte proliferation,BP,FGF10;SDC4;CLCF1;BMP4;CDKN1A;KITLG
16856,GO:0072106,0.0526110558510598,0.998942943626258,1,4,regulation of ureteric bud formation,BP,GDNF
16857,GO:0072107,0.0526110558510598,0.998942943626258,1,4,positive regulation of ureteric bud formation,BP,GDNF
20453,GO:1905278,0.0526110558510598,0.998942943626258,1,4,positive regulation of epithelial tube formation,BP,GDNF
5324,GO:0014910,0.0528037562400187,0.989846187493389,3,56,regulation of smooth muscle cell migration,BP,PLAU;PDGFB;FOXO4
15916,GO:0070384,0.0528283853321153,0.998934091759477,1,4,Harderian gland development,BP,FGF10
4855,GO:0010563,0.0528958004518014,0.973034002707191,13,542,negative regulation of phosphorus metabolic process,BP,LIF;ACTN3;GADD45A;EDN1;PRR5L;PDGFB;PRKAR1B;BMP7;BMP4;CAMSAP3;CDKN1A;AKT1;DUSP5
18675,GO:1901078,0.0530296426036931,0.998925860840486,1,4,negative regulation of relaxation of muscle,BP,PDE4B
15137,GO:0060708,0.0531520638809571,0.998920838272695,1,4,spongiotrophoblast differentiation,BP,LIF
13222,GO:0048382,0.0531543539424018,0.99892074420432,1,4,mesendoderm development,BP,FGF8
8151,GO:0031849,0.0531800075685646,0.998848720144694,1,5,olfactory receptor binding,MF,REEP1
3499,GO:0006873,0.0533437004176204,0.972762684087418,13,570,cellular ion homeostasis,BP,CDH23;TF;CASQ2;EDN1;RAB39A;PRND;LPAR2;BMP6;RAB20;PIK3CG;VDR;RAB38;CLDN16
17227,GO:0080134,0.0534682285913148,0.966792934055553,25,1266,regulation of response to stress,BP,WNT4;PMAIP1;GADD45A;WNT7A;WNT7B;ADORA1;EDN1;PLAU;PRKACB;FZD7;TYRO3;FGF10;PIK3R1;PDGFB;HRAS;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP2;CTGF;AKT1;PIK3CG;FZD8
11988,GO:0045054,0.0534968996820751,0.99890662627805,1,4,constitutive secretory pathway,BP,RAB27A
8276,GO:0032079,0.0536732919200869,0.998899319700197,1,4,positive regulation of endodeoxyribonuclease activity,BP,AKT1
18298,GO:0099081,0.0536779206385376,0.969437556896446,18,868,supramolecular polymer,CC,FHOD3;TUBG2;ACTN3;ACTN2;CASQ2;RHOQ;PSRC1;SDC4;CAMSAP3;ESPN;PKP1;MYH11;AMOT;RAB3D;MYZAP;ACTA2;PARVB;PDE4B
7381,GO:0030311,0.0536912109510403,0.998898576058812,1,4,poly-N-acetyllactosamine biosynthetic process,BP,B3GNT2
5275,GO:0014826,0.0536969515336999,0.998898337769763,1,4,vein smooth muscle contraction,BP,EDN1
10621,GO:0042036,0.053769508583729,0.993927024281652,2,28,negative regulation of cytokine biosynthetic process,BP,ZFPM1;INHBB
10070,GO:0035814,0.0538177265001808,0.998820629090919,1,5,negative regulation of renal sodium excretion,BP,ADORA1
10910,GO:0042562,0.0539128604300938,0.989514213325732,3,62,hormone binding,MF,ACVR1;PIK3R1;NPR1
7743,GO:0031069,0.0539551596163765,0.993919510163962,2,26,hair follicle morphogenesis,BP,NOTCH1;FGF10
1495,GO:0003219,0.0539602487969415,0.998887380063923,1,4,cardiac right ventricle formation,BP,NOTCH1
16337,GO:0071222,0.0539939826476979,0.983307802348128,5,148,cellular response to lipopolysaccharide,BP,CCL20;WNT5A;BMP6;AKT1;PDE4B
21544,GO:2001027,0.0540324426079123,0.998884365860857,1,4,negative regulation of endothelial cell chemotaxis,BP,NOTCH1
2188,GO:0004713,0.0540888848602659,0.981067038770299,6,180,protein tyrosine kinase activity,MF,TYRO3;FGF10;FGF17;FGF8;HBEGF;DDR1
20631,GO:1905874,0.0542005397589121,0.998877331372059,1,4,regulation of postsynaptic density organization,BP,CDH2
18297,GO:0099080,0.0542614628408233,0.969064020469378,18,869,supramolecular complex,CC,FHOD3;TUBG2;ACTN3;ACTN2;CASQ2;RHOQ;PSRC1;SDC4;CAMSAP3;ESPN;PKP1;MYH11;AMOT;RAB3D;MYZAP;ACTA2;PARVB;PDE4B
19585,GO:1903393,0.0542678977518407,0.99387889872871,2,25,positive regulation of adherens junction organization,BP,WNT4;SDC4
11385,GO:0043403,0.0543651577741385,0.993822279566543,2,28,skeletal muscle tissue regeneration,BP,WNT7A;FZD7
7539,GO:0030667,0.0544053271191675,0.97748211650546,8,288,secretory granule membrane,CC,RAB27A;SERPINA5;PLAU;SYCN;VAMP1;PKP1;RAB44;RAB3D
16914,GO:0072191,0.054447135248661,0.998866970949115,1,4,ureter smooth muscle development,BP,BMP4
16916,GO:0072193,0.054447135248661,0.998866970949115,1,4,ureter smooth muscle cell differentiation,BP,BMP4
15993,GO:0070528,0.0544492007459782,0.993832853885643,2,26,protein kinase C signaling,BP,PDGFB;WNT5A
7817,GO:0031224,0.0546508438475828,0.959072861336598,82,5117,intrinsic component of membrane,CC,ITGA3;ITGA5;TMEM163;ADRA2B;ADRA2C;SYT5;TSPAN15;TSPAN17;NOTCH1;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;RHBDL3;SLC45A4;DSC2;SLC52A3;TMEM206;ACVR1;ADORA1;CASQ2;KCNK6;FLVCR2;MBOAT2;SLC25A53;TTYH1;MPZL1;TSPAN13;PRND;FZD7;TYRO3;LPAR2;CDH2;HRCT1;REEP1;KCNH2;JAM3;NPR1;SDC4;SPTB;HBEGF;PGBD5;BMP2;B3GNT2;DLL1;SLC2A14;VAMP1;SFXN1;DDR1;DSG3;GJB1;GJB2;GJB6;PTGES;KITLG;SEMA6C;JAG2;CDH1;GJA3;TPBGL;CLDN1;CLDN2;CLDN3;CLDN5;KCNG2;CLDN23;SLC18B1;DSC3;KCND1;TSPAN2;ACSL4;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;EFNB2;PDE4B
4857,GO:0010565,0.0547168768259253,0.983009031882884,5,156,regulation of cellular ketone metabolic process,BP,WNT4;DKK3;BMP6;BMP2;AKT1
21636,GO:2001234,0.0548999764308805,0.980690597905011,6,197,negative regulation of apoptotic signaling pathway,BP,WNT4;ACVR1;FGF10;BMP4;AKT1;GDNF
5201,GO:0014044,0.0551705448461825,0.993720063534115,2,25,Schwann cell development,BP,POU3F1;AKT1
11206,GO:0043125,0.055310331795371,0.998830320874804,1,4,ErbB-3 class receptor binding,MF,PIK3R1
15872,GO:0070318,0.0553817469560239,0.998827261930554,1,4,positive regulation of G0 to G1 transition,BP,CTGF
19803,GO:1903828,0.0555870082622951,0.982688481738956,5,142,negative regulation of cellular protein localization,BP,ACTN2;RHOQ;BMP7;GAS6;CLDN18
11579,GO:0043954,0.0556512739862173,0.993620122643865,2,26,cellular component maintenance,BP,ITGA3;CAMSAP3
11807,GO:0044440,0.0556514082462218,0.97320739315646,11,443,endosomal part,CC,TMEM163;SYT5;TSPAN15;RAB27A;TF;FZD7;SNX18;RHOB;RAB12;RAB17;RNF144A
11698,GO:0044262,0.055661708685545,0.978469600603171,7,234,cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1;KHK;SESN2;PFKFB3;B3GNT2;AKT1
3509,GO:0006885,0.0557450410731497,0.985451821344901,4,99,regulation of pH,BP,EDN1;RAB39A;RAB20;RAB38
3742,GO:0007265,0.0558292569514332,0.975398662535487,9,318,Ras protein signal transduction,BP,ITGA3;RRAS2;FGF10;RALB;HRAS;RHOJ;RHOB;CDKN1A;KITLG
15135,GO:0060706,0.0558472613233906,0.993585186517401,2,26,cell differentiation involved in embryonic placenta development,BP,LIF;AKT1
21366,GO:2000653,0.0558699996163047,0.99880623885067,1,4,regulation of genetic imprinting,BP,PIK3CA
7494,GO:0030552,0.0559533258810352,0.993597231940218,2,24,cAMP binding,MF,PRKAR1B;PDE4B
10761,GO:0042321,0.0559535605182016,0.998724023331731,1,5,negative regulation of circadian sleep/wake cycle, sleep,BP,ADORA1
6762,GO:0019904,0.0559881502113345,0.969740784149289,15,652,protein domain specific binding,MF,ITGA3;WNT3;ACTN2;RAB27A;FZD7;KCNH2;WNT5A;AXIN1;RHOQ;WT1;ESPN;MYO7A;BCAR1;SHC4;FZD8
19505,GO:1903232,0.0560262316931235,0.998720667886139,1,5,melanosome assembly,BP,RAB38
4798,GO:0010453,0.0560932089767427,0.99351468033981,2,28,regulation of cell fate commitment,BP,FZD7;BMP4
7574,GO:0030799,0.0562813746157334,0.982383769840682,5,158,regulation of cyclic nucleotide metabolic process,BP,EDN1;WNT5A;NPR1;CHGA;NPPC
3209,GO:0006469,0.0562906147895326,0.978168324379426,7,238,negative regulation of protein kinase activity,BP,GADD45A;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
3694,GO:0007189,0.0563105290396328,0.988855685745578,3,62,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C;CHGA
11173,GO:0043065,0.0563982991800211,0.970966539645259,13,560,positive regulation of apoptotic process,BP,NOTCH1;PMAIP1;GADD45A;PIK3R2;WNT5A;RHOB;BMP7;BMP4;BMP2;CTGF;AKT1;INHBB;VDR
4824,GO:0010507,0.0564368512556325,0.988836948624605,3,59,negative regulation of autophagy,BP,AKT1;PIK3CA;LZTS1
13436,GO:0048852,0.0564398008910694,0.998781462483441,1,4,diencephalon morphogenesis,BP,WNT5A
1281,GO:0002790,0.0564456748954001,0.971796650659978,12,511,peptide secretion,BP,ADRA2C;NOTCH1;ADORA1;EDN1;RAB40B;RAB40A;WNT5A;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6
15454,GO:0061325,0.056469351457917,0.998780170439436,1,4,cell proliferation involved in outflow tract morphogenesis,BP,BMP4
19751,GO:1903725,0.0564759095103815,0.988826126035884,3,59,regulation of phospholipid metabolic process,BP,PIK3R2;PIK3R1;PDGFB
14841,GO:0060298,0.056489247049491,0.998779300146248,1,4,positive regulation of sarcomere organization,BP,EDN1
18790,GO:1901381,0.0565586264463025,0.993457789167149,2,26,positive regulation of potassium ion transmembrane transport,BP,ACTN2;KCNH2
2644,GO:0005520,0.0566601279246431,0.993412568059826,2,28,insulin-like growth factor binding,MF,ITGB4;CTGF
17445,GO:0090191,0.0567639837214484,0.998767249815993,1,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,BMP4
10641,GO:0042089,0.056824320758952,0.985052432200495,4,108,cytokine biosynthetic process,BP,ZFPM1;CCL20;WNT5A;INHBB
8621,GO:0032612,0.0568555740467561,0.988675834960554,3,68,interleukin-1 production,BP,CCL20;WNT5A;GAS6
4894,GO:0010629,0.0569540729490754,0.962935197846252,30,1614,negative regulation of gene expression,BP,WNT4;NOTCH1;ITGB8;ZFPM1;SALL4;DKK3;EDN1;PRR5L;PDGFB;HRAS;WNT5A;SESN2;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;CTGF;AKT1;PKP3;PKP1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
11462,GO:0043536,0.0569590409683884,0.993371567931715,2,27,positive regulation of blood vessel endothelial cell migration,BP,PDGFB;AKT1
10429,GO:0038001,0.0570036602187074,0.998756687729883,1,4,paracrine signaling,BP,PDGFB
139,GO:0000278,0.0571416041628777,0.966229872476309,20,952,mitotic cell cycle,BP,RAB6C;MARK4;GADD45A;ACVR1;EDN1;PHLDA1;TTYH1;FGF10;PDGFB;FOXO4;HRAS;SNX18;PSRC1;FGF8;BMP7;BMP4;CDKN1A;AKT1;LZTS1;PIM2
10078,GO:0035844,0.0571444371812161,0.998750462429366,1,4,cloaca development,BP,BMP4
15777,GO:0070172,0.0571564291149962,0.998667902564713,1,5,positive regulation of tooth mineralization,BP,WNT6
17928,GO:0097458,0.0573091492775905,0.963830439760822,26,1285,neuron part,CC,ITGA3;TMEM163;ADRA2C;SYT5;ACTN2;MARK4;RAB27A;CDH23;WNT7A;ADORA1;RAB40B;RAB40A;SPTBN5;SPTBN4;RAB39B;FSTL3;DRP2;ESPN;VAMP1;RAB17;NRTN;MYO7A;LZTS1;KCND1;ACSL4;PDE4B
4212,GO:0008532,0.0574065090409918,0.998738830896567,1,4,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT2
21152,GO:2000346,0.0574267731165359,0.998737929215523,1,4,negative regulation of hepatocyte proliferation,BP,LIMS2
4953,GO:0010724,0.057592774862907,0.9987305302769,1,4,regulation of definitive erythrocyte differentiation,BP,ZFPM1
15171,GO:0060750,0.0576211769599617,0.998729262133154,1,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,WNT5A
8038,GO:0031625,0.0576493459332946,0.975860977525517,8,286,ubiquitin protein ligase binding,MF,PRKACB;PRR5L;KCNH2;RALB;MAGEC2;AXIN1;CDKN1A;FZD8
15703,GO:0070053,0.0576732939895732,0.998726933437681,1,4,thrombospondin receptor activity,MF,SDC4
8929,GO:0033088,0.0577467949556093,0.998723645549429,1,4,negative regulation of immature T cell proliferation in thymus,BP,BMP4
18165,GO:0098793,0.0577703000849169,0.974366128466484,9,337,presynapse,CC,TMEM163;ADRA2C;SYT5;WNT7A;ADORA1;RAB40B;RAB40A;VAMP1;PDE4B
13641,GO:0050764,0.0578837292348922,0.988406745482774,3,64,regulation of phagocytosis,BP,RAB27A;MFGE8;GAS6
15025,GO:0060535,0.0579173902542125,0.998715997624578,1,4,trachea cartilage morphogenesis,BP,WNT7B
17540,GO:0090316,0.0579238427915222,0.977389796574126,7,241,positive regulation of intracellular protein transport,BP,PRR5L;PIK3R2;PIK3R1;BMP6;BMP4;CDH1;GAS6
4754,GO:0010193,0.0582384201959526,0.998616364394906,1,5,response to ozone,BP,EDN1
13700,GO:0050851,0.0582766994608166,0.9791925192326,6,205,antigen receptor-mediated signaling pathway,BP,PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
3693,GO:0007188,0.0583565640705631,0.981566425343884,5,149,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C;ADORA1;PRKACB;CHGA
16972,GO:0072278,0.0585379423483211,0.9986879801467,1,4,metanephric comma-shaped body morphogenesis,BP,BMP4
2926,GO:0006001,0.0585537600757271,0.998687261934353,1,4,fructose catabolic process,BP,KHK
15576,GO:0061624,0.0585537600757271,0.998687261934353,1,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,KHK
11453,GO:0043523,0.0585921581187932,0.979070644362043,6,191,regulation of neuron apoptotic process,BP,TYRO3;HRAS;FGF8;CLCF1;PIK3CA;GDNF
15871,GO:0070317,0.0587091983558059,0.998680193453215,1,4,negative regulation of G0 to G1 transition,BP,FOXO4
16846,GO:0072095,0.0589225264189457,0.998670460766871,1,4,regulation of branch elongation involved in ureteric bud branching,BP,BMP4
15340,GO:0061054,0.0589409460882108,0.998669618684418,1,4,dermatome development,BP,WNT4
15407,GO:0061183,0.0589409460882108,0.998669618684418,1,4,regulation of dermatome development,BP,WNT4
5726,GO:0016021,0.0589530628495493,0.95573560928117,80,4993,integral component of membrane,CC,ITGA3;ITGA5;TMEM163;ADRA2B;ADRA2C;SYT5;TSPAN15;TSPAN17;NOTCH1;CDH23;STRA6;IGSF8;ITGB5;ITGB4;ITGB8;RHBDL3;SLC45A4;DSC2;SLC52A3;TMEM206;ACVR1;ADORA1;CASQ2;KCNK6;FLVCR2;MBOAT2;SLC25A53;TTYH1;MPZL1;TSPAN13;FZD7;TYRO3;LPAR2;CDH2;HRCT1;REEP1;KCNH2;JAM3;NPR1;SDC4;HBEGF;PGBD5;BMP2;B3GNT2;DLL1;SLC2A14;VAMP1;SFXN1;DDR1;DSG3;GJB1;GJB2;GJB6;PTGES;KITLG;SEMA6C;JAG2;CDH1;GJA3;TPBGL;CLDN1;CLDN2;CLDN3;CLDN5;KCNG2;CLDN23;SLC18B1;DSC3;KCND1;TSPAN2;ACSL4;FZD8;CLDN12;CLDN11;CLDN16;CLDN15;CLDN18;RNF144A;EFNB2;PDE4B
7398,GO:0030330,0.0590399544145132,0.984287253425685,4,104,DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1;GADD45A;SESN2;CDKN1A
11751,GO:0044339,0.0591398512895175,0.998660508016284,1,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
15769,GO:0070164,0.0591537333004661,0.998659870972981,1,4,negative regulation of adiponectin secretion,BP,RAB11FIP1
5026,GO:0010827,0.059191048355055,0.984249440386483,4,99,regulation of glucose transport,BP,PIK3R2;PIK3R1;RHOQ;AKT1
10655,GO:0042107,0.0592229709389296,0.984206003785424,4,110,cytokine metabolic process,BP,ZFPM1;CCL20;WNT5A;INHBB
20781,GO:1990430,0.0592387709278565,0.998655965218461,1,4,extracellular matrix protein binding,MF,ITGB8
14798,GO:0060235,0.0592566936592166,0.998655141288446,1,4,lens induction in camera-type eye,BP,BMP4
16871,GO:0072131,0.0592998001977105,0.998653158567144,1,4,kidney mesenchyme morphogenesis,BP,BMP7
16873,GO:0072133,0.0592998001977105,0.998653158567144,1,4,metanephric mesenchyme morphogenesis,BP,BMP7
11622,GO:0044070,0.0593478967999376,0.984187723188435,4,101,regulation of anion transport,BP,ADORA1;EDN1;TTYH1;AKT1
14731,GO:0060126,0.0593691438786911,0.998561433634304,1,5,somatotropin secreting cell differentiation,BP,WNT4
8325,GO:0032190,0.0594102215296604,0.998559417443792,1,5,acrosin binding,MF,SERPINA5
2820,GO:0005829,0.0594512670741145,0.955535681534441,76,4626,cytosol,CC,LIF;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;NOTCH1;MARK4;RAB27A;PNMT;FASN;PMAIP1;FBXO41;RABIF;NMT2;GUCY1B3;PHLDA1;RHPN1;PRKACB;SPTBN5;SPTBN4;RAB39A;MAPK12;LIMS2;PIK3R2;PIK3R1;PRKAR1B;PTPN7;FOXO4;FRMPD1;HRAS;MAGEC2;PSTPIP2;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;PFKFB3;PSRC1;SPTB;LGALS4;WT1;CDKN1A;VAMP1;WNK4;MSN;DSG3;CTGF;GJB2;GJB6;AKT1;RAB12;CYTIP;EPN1;MYO7A;BCAR1;SPSB1;TLE1;PIK3CA;PIK3CG;RAB11FIP1;DTX4;MYH11;GPSM1;AMOT;ARAF;UNC119;RAB38;FAM110B;ACTA2;PARVB;PDE4B
14127,GO:0051541,0.0595812445554593,0.998551007663674,1,5,elastin metabolic process,BP,HBEGF
18436,GO:1900019,0.0595871302212286,0.99863990429629,1,4,regulation of protein kinase C activity,BP,WNT5A
18437,GO:1900020,0.0595871302212286,0.99863990429629,1,4,positive regulation of protein kinase C activity,BP,WNT5A
12331,GO:0045746,0.0596357052353928,0.992881012383269,2,27,negative regulation of Notch signaling pathway,BP,BMP7;HEY1
10600,GO:0040036,0.0596391984518445,0.992895474485574,2,26,regulation of fibroblast growth factor receptor signaling pathway,BP,WNT4;WNT5A
13444,GO:0048861,0.0597904228990535,0.998630486361814,1,4,leukemia inhibitory factor signaling pathway,BP,LIF
15009,GO:0060510,0.0598255690762303,0.998538949873305,1,5,Type II pneumocyte differentiation,BP,FGF10
8360,GO:0032241,0.060031957028045,0.998619253467024,1,4,positive regulation of nucleobase-containing compound transport,BP,ADORA1
17243,GO:0086003,0.060110396628147,0.987818181948048,3,57,cardiac muscle cell contraction,BP,DSC2;KCNH2;PDE4B
5894,GO:0016361,0.0601561668747032,0.998613458573978,1,4,activin receptor activity, type I,MF,ACVR1
13601,GO:0050704,0.0603130302251802,0.992692657816518,2,32,regulation of interleukin-1 secretion,BP,WNT5A;GAS6
9599,GO:0034754,0.0603475753783354,0.983807420050872,4,110,cellular hormone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
1682,GO:0003873,0.0603682040536976,0.998603537398577,1,4,6-phosphofructo-2-kinase activity,MF,PFKFB3
1914,GO:0004331,0.0603682040536976,0.998603537398577,1,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,PFKFB3
2928,GO:0006003,0.0603682040536976,0.998603537398577,1,4,fructose 2,6-bisphosphate metabolic process,BP,PFKFB3
12294,GO:0045670,0.0603777302451251,0.98770581129037,3,63,regulation of osteoclast differentiation,BP,FSTL3;PIK3R1;CLDN18
432,GO:0001106,0.0604692500476535,0.992725608959687,2,27,RNA polymerase II transcription corepressor activity,MF,TLE1;SIN3B
17163,GO:0072679,0.0604835959145383,0.998506220432633,1,5,thymocyte migration,BP,CCL20
6526,GO:0019207,0.0605841049049494,0.978173924664707,6,196,kinase regulator activity,MF,PIK3R2;PIK3R1;PRKAR1B;CDKN1A;PIK3CA;GAS6
15856,GO:0070294,0.0605861672764004,0.998593301100848,1,4,renal sodium ion absorption,BP,WNK4
8695,GO:0032730,0.0606560203344354,0.998497582779875,1,5,positive regulation of interleukin-1 alpha production,BP,CCL20
18619,GO:1900542,0.0608385218846188,0.978041469031973,6,210,regulation of purine nucleotide metabolic process,BP,ACTN3;EDN1;WNT5A;NPR1;CHGA;NPPC
600,GO:0001705,0.0608813139985035,0.998579378832974,1,4,ectoderm formation,BP,FZD7
16380,GO:0071295,0.0609237764691151,0.992625880805492,2,28,cellular response to vitamin,BP,GAS6;VDR
10586,GO:0040014,0.0609341769996328,0.987535856184193,3,65,regulation of multicellular organism growth,BP,SPTBN4;NPPC;PIK3CA
21054,GO:2000195,0.060938899641125,0.998576654273335,1,4,negative regulation of female gonad development,BP,WT1
19665,GO:1903553,0.0609422285705006,0.998576496689175,1,4,positive regulation of extracellular exosome assembly,BP,SDC4
8051,GO:0031644,0.0609649704042968,0.987527018497686,3,65,regulation of neurological system process,BP,ADRA2C;ADORA1;EDN1
16329,GO:0071214,0.0610836385143699,0.97411911021974,8,288,cellular response to abiotic stimulus,BP,GADD45A;NMT2;PIK3R1;HRAS;RHOB;BMP6;CDKN1A;AKT1
17980,GO:0097546,0.0610920691815914,0.992608680946798,2,27,ciliary base,CC,PRKACB;PRKAR1B
19247,GO:1902622,0.0611377104980426,0.992516570394026,2,34,regulation of neutrophil migration,BP,EDN1;JAM3
14703,GO:0060076,0.0612151898031798,0.992618196405956,2,25,excitatory synapse,CC,ITGA3;PDE4B
6996,GO:0021846,0.0616922908563347,0.992495341014875,2,27,cell proliferation in forebrain,BP,WNT7A;FGF8
1525,GO:0003273,0.0617130163284837,0.998539768106134,1,4,cell migration involved in endocardial cushion formation,BP,NOTCH1
7940,GO:0031424,0.0618395880322062,0.980053552332312,5,220,keratinization,BP,DSC2;DSG3;PKP3;PKP1;DSC3
13198,GO:0048319,0.0618470270016745,0.998533333369141,1,4,axial mesoderm morphogenesis,BP,AXIN1
14750,GO:0060157,0.0618611525423019,0.998436497958372,1,5,urinary bladder development,BP,WNT5A
17401,GO:0090131,0.0618728391474084,0.998435899482455,1,5,mesenchyme migration,BP,ACTA2
16334,GO:0071219,0.0618950463521599,0.9801167336973,5,154,cellular response to molecule of bacterial origin,BP,CCL20;WNT5A;BMP6;AKT1;PDE4B
17116,GO:0072583,0.0619299015553605,0.987284224764211,3,59,clathrin-dependent endocytosis,BP,SYT5;DLL1;UNC119
11777,GO:0044389,0.0619382627378523,0.973679957305758,8,291,ubiquitin-like protein ligase binding,MF,PRKACB;PRR5L;KCNH2;RALB;MAGEC2;AXIN1;CDKN1A;FZD8
12633,GO:0046427,0.0619542441336216,0.987208630403357,3,72,positive regulation of JAK-STAT cascade,BP,LIF;NOTCH1;CLCF1
20295,GO:1904894,0.0619542441336216,0.987208630403357,3,72,positive regulation of STAT cascade,BP,LIF;NOTCH1;CLCF1
14656,GO:0060024,0.0619930999377502,0.998526302890852,1,4,rhythmic synaptic transmission,BP,EDN1
16172,GO:0070885,0.0620206963708233,0.99852497273754,1,4,negative regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
3850,GO:0007585,0.0620328066149964,0.987224772305319,3,64,respiratory gaseous exchange,BP,ADORA1;EDN1;JAG2
2540,GO:0005250,0.0620948914614128,0.998521393463771,1,4,A-type (transient outward) potassium channel activity,MF,KCND1
14597,GO:0055076,0.0622044601619562,0.983149317432552,4,108,transition metal ion homeostasis,BP,TF;PRND;BMP6;SFXN1
16712,GO:0071847,0.0622607493667575,0.998513376134922,1,4,TNFSF11-mediated signaling pathway,BP,CLDN18
10325,GO:0036336,0.0625134688711603,0.992297207764128,2,30,dendritic cell migration,BP,PIK3CG;GAS6
14303,GO:0051884,0.0625438407686669,0.998499640459653,1,4,regulation of timing of anagen,BP,WNT5A
8226,GO:0031999,0.0625497684950752,0.998499352150989,1,4,negative regulation of fatty acid beta-oxidation,BP,AKT1
14105,GO:0051491,0.0626281051505958,0.992333614142503,2,26,positive regulation of filopodium assembly,BP,RHOQ;ESPN
140,GO:0000280,0.062752695212311,0.967172127049106,13,560,nuclear division,BP,LIF;WNT4;MARK4;EDN1;TTYH1;PDGFB;WNT5A;SNX18;PSRC1;FGF8;BMP7;BMP4;PIM2
15021,GO:0060528,0.0627755056882486,0.998488351721708,1,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,NOTCH1
15495,GO:0061419,0.0628681923626758,0.998483823040301,1,4,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1
8274,GO:0032077,0.0628978576138474,0.998382950530571,1,5,positive regulation of deoxyribonuclease activity,BP,AKT1
15808,GO:0070227,0.0629911401018511,0.98692094032711,3,69,lymphocyte apoptotic process,BP,WNT5A;BMP4;AKT1
10442,GO:0038028,0.0630115504662016,0.998476804837612,1,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,PIK3CA
19432,GO:1903053,0.0631218798958465,0.992222817307045,2,27,regulation of extracellular matrix organization,BP,NOTCH1;DDR1
17374,GO:0090087,0.0632915071013024,0.964481867516727,16,747,regulation of peptide transport,BP,ADRA2C;ADORA1;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;BMP7;BMP6;BMP4;CDKN1A;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6
16287,GO:0071072,0.0633279227026669,0.99846125765868,1,4,negative regulation of phospholipid biosynthetic process,BP,PDGFB
9609,GO:0034765,0.063331113791766,0.970041332372647,10,397,regulation of ion transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TSPAN13;KCNH2;AKT1;PIK3CG;KCNG2;KCND1;PDE4B
7666,GO:0030910,0.0633462678044203,0.99846035365397,1,4,olfactory placode formation,BP,AXIN1
16650,GO:0071698,0.0633462678044203,0.99846035365397,1,4,olfactory placode development,BP,AXIN1
16651,GO:0071699,0.0633462678044203,0.99846035365397,1,4,olfactory placode morphogenesis,BP,AXIN1
10052,GO:0035788,0.0633665262898286,0.998459355045049,1,4,cell migration involved in metanephros development,BP,PDGFB
10053,GO:0035789,0.0633665262898286,0.998459355045049,1,4,metanephric mesenchymal cell migration,BP,PDGFB
21325,GO:2000589,0.0633665262898286,0.998459355045049,1,4,regulation of metanephric mesenchymal cell migration,BP,PDGFB
5634,GO:0015833,0.0634732594893776,0.957020643923516,35,1934,peptide transport,BP,ADRA2C;NOTCH1;RAB27A;TF;RABIF;ADORA1;EDN1;RAB40B;RAB40A;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;AKT1;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;UNC119;RAB38;RAB3D
7763,GO:0031093,0.0635787385382629,0.986764570199913,3,66,platelet alpha granule lumen,CC,ACTN2;PDGFB;GAS6
10226,GO:0036091,0.063622782731439,0.99834495700561,1,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2
3231,GO:0006499,0.0636435846406649,0.99844566450811,1,4,N-terminal protein myristoylation,BP,NMT2
13175,GO:0048278,0.0636753189083347,0.986759049913785,3,62,vesicle docking,BP,RAB40B;RAB40A;RALB
18634,GO:1900744,0.0637567521728378,0.992085151237767,2,28,regulation of p38MAPK cascade,BP,GADD45A;BMP2
4631,GO:0009743,0.0638177906921396,0.976706926621782,6,200,response to carbohydrate,BP,KHK;SESN2;CTGF;GJB6;PIK3CA;GAS6
11390,GO:0043409,0.0638948869337934,0.979309970739764,5,145,negative regulation of MAPK cascade,BP,LIF;BMP7;BMP4;AKT1;DUSP5
917,GO:0002159,0.063936575115829,0.998431118967197,1,4,desmosome assembly,BP,PKP3
8806,GO:0032898,0.0639404289826883,0.998430927177524,1,4,neurotrophin production,BP,ADORA1
7199,GO:0030035,0.0639711583064822,0.998429397485709,1,4,microspike assembly,BP,ACTN2
18501,GO:1900127,0.0639856958334957,0.998428673547205,1,4,positive regulation of hyaluronan biosynthetic process,BP,PDGFB
20899,GO:1990851,0.0639955783403278,0.998428181321073,1,4,Wnt-Frizzled-LRP5/6 complex,CC,FZD8
16812,GO:0072039,0.0640145862684266,0.998427234354777,1,4,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
16813,GO:0072040,0.0640145862684266,0.998427234354777,1,4,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
18694,GO:1901145,0.0640145862684266,0.998427234354777,1,4,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
20177,GO:1904673,0.0640145862684266,0.998427234354777,1,4,negative regulation of somatic stem cell population maintenance,BP,BMP7
3607,GO:0007034,0.0640680073839678,0.982498862099669,4,101,vacuolar transport,BP,SPTBN5;GPRASP1;RHOB;RAB12
3781,GO:0007354,0.0640928666747748,0.99832007760152,1,5,zygotic determination of anterior/posterior axis, embryo,BP,WT1
4972,GO:0010746,0.0641274130110683,0.998421607342363,1,4,regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
4973,GO:0010748,0.0641274130110683,0.998421607342363,1,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,AKT1
3802,GO:0007416,0.0641303122917748,0.979233545011048,5,136,synapse assembly,BP,WNT7A;CDH2;WNT5A;RAB17;CDH1
1534,GO:0003289,0.0641817927215942,0.99841889157116,1,4,atrial septum primum morphogenesis,BP,ACVR1
5053,GO:0010861,0.0642343553225478,0.998416264266707,1,4,thyroid hormone receptor activator activity,MF,ACTN2
7419,GO:0030375,0.0642343553225478,0.998416264266707,1,4,thyroid hormone receptor coactivator activity,MF,ACTN2
2413,GO:0005025,0.0642700099060388,0.998414480820951,1,4,transforming growth factor beta receptor activity, type I,MF,ACVR1
15460,GO:0061343,0.0642700099062168,0.998414480820942,1,4,cell adhesion involved in heart morphogenesis,BP,ACVR1
2642,GO:0005518,0.0643498468882682,0.986567842413357,3,61,collagen binding,MF,ITGA3;PDGFB;DDR1
5237,GO:0014719,0.064431079894651,0.99830205958312,1,5,skeletal muscle satellite cell activation,BP,WNT7A
19380,GO:1902965,0.0644748285421013,0.998404215779598,1,4,regulation of protein localization to early endosome,BP,MSN
19381,GO:1902966,0.0644748285421013,0.998404215779598,1,4,positive regulation of protein localization to early endosome,BP,MSN
20586,GO:1905666,0.0644748285421013,0.998404215779598,1,4,regulation of protein localization to endosome,BP,MSN
20587,GO:1905668,0.0644748285421013,0.998404215779598,1,4,positive regulation of protein localization to endosome,BP,MSN
7227,GO:0030101,0.06450901124135,0.98644478297338,3,76,natural killer cell activation,BP,RAB27A;TYRO3;GAS6
10464,GO:0038064,0.0645316487948837,0.998401362043127,1,4,collagen receptor activity,MF,DDR1
2931,GO:0006007,0.0645567612875508,0.991901553242402,2,30,glucose catabolic process,BP,ACTN3;PFKFB3
21577,GO:2001137,0.0646453999338974,0.998395641135352,1,4,positive regulation of endocytic recycling,BP,ACTN2
11714,GO:0044291,0.0646693328891481,0.986480547770173,3,60,cell-cell contact zone,CC,DSC2;CDH2;JAM3
10417,GO:0036515,0.0647453135298391,0.998390607492453,1,4,serotonergic neuron axon guidance,BP,WNT5A
17755,GO:0097118,0.064745652171735,0.9983905904179,1,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,CDH2
13380,GO:0048730,0.0647932101162422,0.991869036238436,2,29,epidermis morphogenesis,BP,NOTCH1;FGF10
1543,GO:0003307,0.0648390881002738,0.998280191885759,1,5,regulation of Wnt signaling pathway involved in heart development,BP,BMP2
14040,GO:0051373,0.064994672678676,0.998271815279238,1,5,FATZ binding,MF,ACTN2
10984,GO:0042695,0.0649973345185445,0.998271671785007,1,5,thelarche,BP,WNT5A
15166,GO:0060744,0.0649973345185445,0.998271671785007,1,5,mammary gland branching involved in thelarche,BP,WNT5A
9566,GO:0034694,0.0650605735588158,0.991802866094105,2,30,response to prostaglandin,BP,EDN1;AKT1
18788,GO:1901379,0.0653818145204195,0.986257799508483,3,62,regulation of potassium ion transmembrane transport,BP,ACTN2;CASQ2;KCNH2
1389,GO:0003016,0.0654339116967519,0.991743396364127,2,29,respiratory system process,BP,ADORA1;JAG2
13422,GO:0048818,0.0658684485748317,0.998224382965358,1,5,positive regulation of hair follicle maturation,BP,WNT5A
411,GO:0001076,0.0658746119636898,0.978483601594969,5,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,LIF;POU3F1;NOTCH1;TLE1;SIN3B
16688,GO:0071804,0.0660391410112015,0.975708381654457,6,189,cellular potassium ion transport,BP,ACTN2;CASQ2;KCNK6;KCNH2;KCNG2;KCND1
16689,GO:0071805,0.0660391410112015,0.975708381654457,6,189,potassium ion transmembrane transport,BP,ACTN2;CASQ2;KCNK6;KCNH2;KCNG2;KCND1
7368,GO:0030295,0.066073983303783,0.986034697208584,3,65,protein kinase activator activity,MF,CDKN1A;PIK3CA;GAS6
15606,GO:0061695,0.0661623348500576,0.973390999707136,7,248,transferase complex, transferring phosphorus-containing groups,CC,ACVR1;PIK3R2;PIK3R1;SESN2;CDKN1A;PIK3CA;PIK3CG
19605,GO:1903426,0.0662498884951165,0.985965805126459,3,68,regulation of reactive oxygen species biosynthetic process,BP,RAB27A;EDN1;AKT1
14957,GO:0060437,0.0662973744069257,0.998200857462876,1,5,lung growth,BP,FGF10
7287,GO:0030183,0.066554209375085,0.981552758476861,4,113,B cell differentiation,BP,PIK3R1;CLCF1;DLL1;TPD52
5010,GO:0010811,0.0665608482657028,0.981578429390635,4,104,positive regulation of cell-substrate adhesion,BP,ITGA3;ITGA5;WNT4;SDC4
10164,GO:0035989,0.0666749018429974,0.998180019314961,1,5,tendon development,BP,BMP4
19199,GO:1902532,0.0666958549172882,0.966900818339132,11,451,negative regulation of intracellular signal transduction,BP,ITGA3;LIF;ACTN3;CASQ2;SESN2;BMP7;BMP4;AKT1;TLE1;SH3BP4;DUSP5
8590,GO:0032571,0.0667261298408829,0.998177182208971,1,5,response to vitamin K,BP,GAS6
7881,GO:0031323,0.0667589547856705,0.948984922747663,92,5697,regulation of cellular metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;RAB27A;FASN;PMAIP1;GADD45A;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;DKK3;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;CHGA;MSN;CTGF;AKT1;PKP3;PKP1;RAB12;KITLG;NPPC;CST9L;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;PM20D2;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
9423,GO:0034392,0.0667979698751442,0.998173199741166,1,5,negative regulation of smooth muscle cell apoptotic process,BP,EDN1
15813,GO:0070232,0.0669050631716411,0.991399854536276,2,33,regulation of T cell apoptotic process,BP,WNT5A;BMP4
16051,GO:0070627,0.0670560590373029,0.998158855646136,1,5,ferrous iron import,BP,TF
19337,GO:1902893,0.0674565322901655,0.991374577963284,2,27,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB;BMP2
15100,GO:0060664,0.0674836970891217,0.998058759503802,1,6,epithelial cell proliferation involved in salivary gland morphogenesis,BP,FGF10
850,GO:0002053,0.0675151369052065,0.991362886071757,2,27,positive regulation of mesenchymal cell proliferation,BP,WNT2;WNT5A
6925,GO:0021696,0.0678646501490419,0.991276033457503,2,28,cerebellar cortex morphogenesis,BP,WNT7A;DLL1
3390,GO:0006692,0.067880584102031,0.991203540620459,2,33,prostanoid metabolic process,BP,EDN1;PTGES
3391,GO:0006693,0.067880584102031,0.991203540620459,2,33,prostaglandin metabolic process,BP,EDN1;PTGES
3013,GO:0006140,0.0678937500964512,0.974812410997449,6,217,regulation of nucleotide metabolic process,BP,ACTN3;EDN1;WNT5A;NPR1;CHGA;NPPC
1423,GO:0003100,0.0678996992881897,0.99811156513814,1,5,regulation of systemic arterial blood pressure by endothelin,BP,EDN1
630,GO:0001757,0.0680669764319588,0.998102115076318,1,5,somite specification,BP,DLL1
7011,GO:0021872,0.0681463306155364,0.985427282578514,3,63,forebrain generation of neurons,BP,WNT5A;AXIN1;FGF8
11257,GO:0043200,0.0681784085491497,0.9809743190181,4,106,response to amino acid,BP,EDN1;SESN2;CTGF;SH3BP4
13734,GO:0050891,0.0683345185156685,0.985377171430238,3,62,multicellular organismal water homeostasis,BP,PRKACB;PRKAR1B;CLDN1
8884,GO:0033010,0.0683868392614516,0.998083977351828,1,5,paranodal junction,CC,JAM3
9693,GO:0035115,0.0684829555764717,0.991120762327283,2,30,embryonic forelimb morphogenesis,BP,WNT3;WNT7A
2461,GO:0005127,0.0684971454023389,0.998077701893095,1,5,ciliary neurotrophic factor receptor binding,MF,CLCF1
17144,GO:0072656,0.0685621210984286,0.998074000400579,1,5,maintenance of protein location in mitochondrion,BP,AKT1
21674,GO:2001286,0.068610073016978,0.998071266357733,1,5,regulation of caveolin-mediated endocytosis,BP,UNC119
4916,GO:0010656,0.068810596895702,0.991054396509434,2,30,negative regulation of muscle cell apoptotic process,BP,EDN1;BMP7
8928,GO:0033087,0.0689585872078759,0.998051335388063,1,5,negative regulation of immature T cell proliferation,BP,BMP4
21556,GO:2001046,0.0689800071267749,0.998050106977577,1,5,positive regulation of integrin-mediated signaling pathway,BP,LIMS2
16194,GO:0070915,0.0691174078542243,0.998042217711722,1,5,lysophosphatidic acid receptor activity,MF,LPAR2
10750,GO:0042303,0.0691390759665034,0.98061038707023,4,108,molting cycle,BP,NOTCH1;FGF10;WNT5A;LAMA5
10957,GO:0042633,0.0691390759665034,0.98061038707023,4,108,hair cycle,BP,NOTCH1;FGF10;WNT5A;LAMA5
7380,GO:0030309,0.0692615867406775,0.998033921629522,1,5,poly-N-acetyllactosamine metabolic process,BP,B3GNT2
7882,GO:0031324,0.0693868153824667,0.951375954775033,41,2336,negative regulation of cellular metabolic process,BP,LIF;WNT4;ACTN3;NOTCH1;GADD45A;SERPINA5;ZFPM1;SALL4;DKK3;EDN1;PRR5L;PDGFB;PRKAR1B;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;AKT1;PKP3;PKP1;NPPC;CST9L;NAB2;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;LZTS1;VDR;FZD8;DUSP5;HEY1
16904,GO:0072179,0.069428541927128,0.998024292434222,1,5,nephric duct formation,BP,BMP4
629,GO:0001756,0.0694412433994935,0.985017327058854,3,66,somitogenesis,BP,NOTCH1;WNT5A;DLL1
14848,GO:0060306,0.0699155992040929,0.99084461124255,2,29,regulation of membrane repolarization,BP,CASQ2;KCNH2
15825,GO:0070245,0.070113274719734,0.997984546858404,1,5,positive regulation of thymocyte apoptotic process,BP,WNT5A
19120,GO:1902302,0.0702380380816313,0.997977261021259,1,5,regulation of potassium ion export,BP,KCNH2
2783,GO:0005769,0.0703099003434927,0.969331782488025,8,293,early endosome,CC,TMEM163;RIN3;TF;RHOB;RAB20;RAB17;CYTIP;RAB38
8647,GO:0032650,0.0703544440032992,0.997887599712007,1,6,regulation of interleukin-1 alpha production,BP,CCL20
14993,GO:0060482,0.0703836145655959,0.997885822319012,1,6,lobar bronchus development,BP,WNT7B
14593,GO:0055072,0.0706428559731903,0.984639225707981,3,68,iron ion homeostasis,BP,TF;BMP6;SFXN1
21349,GO:2000630,0.0706567324235214,0.997952711463661,1,5,positive regulation of miRNA metabolic process,BP,HRAS
19004,GO:1902035,0.0707385834436,0.997947894420497,1,5,positive regulation of hematopoietic stem cell proliferation,BP,KITLG
9160,GO:0033673,0.0708681521912222,0.971050902256895,7,251,negative regulation of kinase activity,BP,GADD45A;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
15172,GO:0060751,0.0709206864691212,0.997937156494921,1,5,branch elongation involved in mammary gland duct branching,BP,WNT5A
6971,GO:0021797,0.0710291284998377,0.997930748366491,1,5,forebrain anterior/posterior pattern specification,BP,AXIN1
14738,GO:0060136,0.071082160214247,0.997927610853775,1,5,embryonic process involved in female pregnancy,BP,ACSL4
12081,GO:0045197,0.0711120475534155,0.990583029743127,2,30,establishment or maintenance of epithelial cell apical/basal polarity,BP,WNT5A;MSN
11076,GO:0042886,0.0713149317971814,0.95120479302862,35,1954,amide transport,BP,ADRA2C;NOTCH1;RAB27A;TF;RABIF;ADORA1;EDN1;RAB40B;RAB40A;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;AKT1;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;UNC119;RAB38;RAB3D
11286,GO:0043241,0.0715271369154139,0.973104324836916,6,227,protein complex disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;AXIN1;SPTB
16797,GO:0072014,0.0717497306980096,0.997887905942966,1,5,proximal tubule development,BP,DLL1
5207,GO:0014050,0.0717725749969036,0.997886540368682,1,5,negative regulation of glutamate secretion,BP,ADORA1
18168,GO:0098796,0.0719402333793404,0.961544201590157,13,631,membrane protein complex,CC,ITGA3;ITGA5;ITGB5;ITGB4;ITGB8;CDH2;VAMP1;GJB1;GJB2;GJB6;CDH1;GJA3;FZD8
10114,GO:0035900,0.0724239401378981,0.99775959318954,1,6,response to isolation stress,BP,HRAS
16948,GO:0072236,0.0727304709584994,0.997828870277094,1,5,metanephric loop of Henle development,BP,WNT7B
4672,GO:0009892,0.072822852047325,0.94804110047536,45,2643,negative regulation of metabolic process,BP,LIF;WNT4;ACTN3;NOTCH1;ITGB8;GADD45A;SERPINA5;ZFPM1;SALL4;ADORA1;DKK3;EDN1;PRR5L;PDGFB;PRKAR1B;HRAS;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;CTGF;AKT1;PKP3;PKP1;NPPC;CST9L;NAB2;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;LZTS1;VDR;FZD8;DUSP5;HEY1
1420,GO:0003096,0.0730857702935718,0.997807275997622,1,5,renal sodium ion transport,BP,WNK4
18826,GO:1901552,0.0730937689922067,0.997806788586919,1,5,positive regulation of endothelial cell development,BP,CLDN5
19467,GO:1903142,0.0730937689922067,0.997806788586919,1,5,positive regulation of establishment of endothelial barrier,BP,CLDN5
12814,GO:0046813,0.0731716205084969,0.997802041690194,1,5,receptor-mediated virion attachment to host cell,BP,GAS6
18095,GO:0098632,0.0731914362016774,0.990133971787482,2,31,protein binding involved in cell-cell adhesion,MF,DSC2;PKP3
7365,GO:0030291,0.0731974118702508,0.990104743067877,2,33,protein serine/threonine kinase inhibitor activity,MF,PRKAR1B;CDKN1A
14859,GO:0060318,0.0732341756641758,0.997798223635598,1,5,definitive erythrocyte differentiation,BP,ZFPM1
9606,GO:0034762,0.0732764474223858,0.964407844451666,10,411,regulation of transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TSPAN13;KCNH2;AKT1;PIK3CG;KCNG2;KCND1;PDE4B
5889,GO:0016339,0.0734567147783027,0.99012790723369,2,28,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,CDH23;CDH2
16866,GO:0072126,0.0734602206159093,0.997784398498786,1,5,positive regulation of glomerular mesangial cell proliferation,BP,PDGFB
20104,GO:1904502,0.0736443048938781,0.997773106751467,1,5,regulation of lipophagy,BP,SESN2
20105,GO:1904504,0.0736443048938781,0.997773106751467,1,5,positive regulation of lipophagy,BP,SESN2
766,GO:0001941,0.0738348908466431,0.990013708801443,2,30,postsynaptic membrane organization,BP,CDH2;GDNF
11232,GO:0043167,0.0738485831679098,0.943054854047147,97,5840,ion binding,MF,ITGA3;ITGA5;TMEM163;SYT5;TUBG2;ACTN3;ACTN2;RAB6C;NOTCH1;GLDC;MARK4;RAB27A;CDH23;RASL11B;TF;FASN;CRISPLD2;RHBDL3;DHH;DSC2;SERPINA5;ZFPM1;ACVR1;RABIF;SALL4;GUCY1B3;CASQ2;RAB40B;RAB40A;PRKACB;MFGE8;SPTBN4;TTYH1;RRAS2;RAB39B;RAB39A;PRND;MAPK12;FZD7;TYRO3;LIMS2;CDH2;FGF10;PRKAR1B;RALB;HRAS;SNX18;KHK;SESN2;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;HBEGF;BMP7;BMP4;WT1;CDKN1A;DLL1;PKN3;RAB20;DRP2;WNK4;RND3;DDR1;DSG3;CTGF;RRAD;TPD52;AKT1;RAB12;RAB17;PTGES;JAG2;CDH1;MYO7A;HPCAL1;RAB44;PIK3CA;PIK3CG;GAS6;DTX4;ZCCHC12;MYH11;DSC3;VDR;ARAF;KCND1;RAB38;RAB3D;ACSL4;ACTA2;RNF144A;PIM2;PDE4B
864,GO:0002069,0.0738668642817698,0.997668046769278,1,6,columnar/cuboidal epithelial cell maturation,BP,CDKN1A
16854,GO:0072103,0.0740013525121671,0.997751121019975,1,5,glomerulus vasculature morphogenesis,BP,BMP4
16855,GO:0072104,0.0740013525121671,0.997751121019975,1,5,glomerular capillary formation,BP,BMP4
14860,GO:0060319,0.0740040999106948,0.997750951412986,1,5,primitive erythrocyte differentiation,BP,ZFPM1
12410,GO:0045907,0.0741389886569491,0.989933638675293,2,31,positive regulation of vasoconstriction,BP,ADRA2C;AKT1
13341,GO:0048669,0.074182752510942,0.997739908369988,1,5,collateral sprouting in absence of injury,BP,WNT3
19332,GO:1902882,0.0743050554007739,0.983499493134967,3,69,regulation of response to oxidative stress,BP,SESN2;BMP7;AKT1
2508,GO:0005179,0.0743051578905588,0.983344678057863,3,111,hormone activity,MF,EDN1;NPPC;INHBB
16887,GO:0072162,0.0744612270176259,0.997722639398669,1,5,metanephric mesenchymal cell differentiation,BP,WNT4
15114,GO:0060681,0.0745391746646835,0.997717793503793,1,5,branch elongation involved in ureteric bud branching,BP,BMP4
12246,GO:0045616,0.074549019302156,0.989831649888014,2,32,regulation of keratinocyte differentiation,BP,NOTCH1;VDR
21500,GO:2000848,0.0745556009052012,0.997557290685107,1,7,positive regulation of corticosteroid hormone secretion,BP,BMP6
14191,GO:0051649,0.07460356104055,0.94874668637432,35,1947,establishment of localization in cell,BP,SYT5;RAB6C;RAB27A;PMAIP1;WNT7A;NMT2;ADORA1;CASQ2;SPTBN5;SPTBN4;FZD7;CDH2;PRR5L;FGF10;PIK3R2;PIK3R1;REEP1;GPRASP1;RHOB;PSRC1;SPTB;BMP7;BMP6;BMP4;CDKN1A;CHGA;MSN;AKT1;RAB12;RAB17;CDH1;MYO7A;PIK3CG;GAS6;GDNF
7794,GO:0031133,0.0746067274431975,0.99771358954512,1,5,regulation of axon diameter,BP,WNT7A
15973,GO:0070487,0.0746159071649941,0.997713017962712,1,5,monocyte aggregation,BP,BMP7
6540,GO:0019222,0.0746756846277096,0.942375732052451,97,6101,regulation of metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;RAB27A;ITGB8;FASN;PMAIP1;GADD45A;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;DKK3;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;WT1;CDKN1A;DLL1;HMGN5;CHGA;MSN;CTGF;AKT1;PKP3;PKP1;RAB12;KITLG;NPPC;CST9L;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;PM20D2;SHC4;VDR;ARAF;SH3BP4;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
8619,GO:0032610,0.0747192682447217,0.997546392218993,1,7,interleukin-1 alpha production,BP,CCL20
19540,GO:1903305,0.0748770396862056,0.978439778560258,4,108,regulation of regulated secretory pathway,BP,SYT5;NOTCH1;RAB27A;RAB3D
17442,GO:0090188,0.0749458340780691,0.997692425875194,1,5,negative regulation of pancreatic juice secretion,BP,WNK4
3466,GO:0006816,0.0750432555117213,0.964976778380304,9,362,calcium ion transport,BP,CDH23;CASQ2;TSPAN13;PDGFB;CTGF;PIK3CG;GAS6;VDR;PDE4B
4724,GO:0010039,0.0751019802328204,0.989713497350565,2,32,response to iron ion,BP,TF;BMP6
4598,GO:0009612,0.0751125492711853,0.971444567626808,6,202,response to mechanical stimulus,BP,STRA6;GADD45A;EDN1;BMP6;AKT1;INHBB
12200,GO:0045505,0.0752602723005305,0.997459500818861,1,8,dynein intermediate chain binding,MF,SPTBN5
18540,GO:1900193,0.0753251077490357,0.997573607948343,1,6,regulation of oocyte maturation,BP,NPPC
2631,GO:0005499,0.0753276760862454,0.997573439912362,1,6,vitamin D binding,MF,VDR
11989,GO:0045055,0.0756550194824895,0.957326023847564,15,723,regulated exocytosis,BP,SYT5;ACTN2;NOTCH1;RAB27A;TF;CRISPLD2;PLAU;PDGFB;CHGA;PKP1;RAB44;PIK3CG;RAB11FIP1;GAS6;RAB3D
4787,GO:0010385,0.0758528863319883,0.997635322014119,1,5,double-stranded methylated DNA binding,MF,WT1
1210,GO:0002690,0.0759151426885287,0.982917669321699,3,84,positive regulation of leukocyte chemotaxis,BP,EDN1;WNT5A;GAS6
17546,GO:0090324,0.0761512098879763,0.997616383454774,1,5,negative regulation of oxidative phosphorylation,BP,ACTN3
4693,GO:0009954,0.0761597996411437,0.989501353525755,2,31,proximal/distal pattern formation,BP,FGF10;DLL1
4103,GO:0008361,0.0762654250616557,0.97402854781473,5,149,regulation of cell size,BP,WNT3;EDN1;WNT5A;MSN;AKT1
5338,GO:0015031,0.0762910005779939,0.947743803678799,34,1900,protein transport,BP,ADRA2C;NOTCH1;RAB27A;TF;RABIF;ADORA1;RAB40B;RAB40A;RAB39B;RAB39A;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;SNX18;RHOB;BMP7;BMP6;BMP4;CDKN1A;RAB20;AKT1;RAB12;RAB17;CDH1;MYO7A;INHBB;RAB11FIP1;KCNG2;GAS6;UNC119;RAB38;RAB3D
14712,GO:0060087,0.0764139163361685,0.997501833457731,1,6,relaxation of vascular smooth muscle,BP,ADORA1
8632,GO:0032633,0.0764198516291553,0.989429837191815,2,32,interleukin-4 production,BP,NOTCH1;ZFPM1
6298,GO:0017147,0.0766761056684764,0.989406330736465,2,30,Wnt-protein binding,MF,FZD7;FZD8
6972,GO:0021798,0.0768808703646106,0.997470720996231,1,6,forebrain dorsal/ventral pattern formation,BP,FGF8
17130,GO:0072602,0.077000805937321,0.997562020834929,1,5,interleukin-4 secretion,BP,NOTCH1
18660,GO:1901031,0.0772305346467228,0.989253903265985,2,32,regulation of response to reactive oxygen species,BP,SESN2;BMP7
16818,GO:0072049,0.0772513508938322,0.997445895052295,1,6,comma-shaped body morphogenesis,BP,BMP4
17731,GO:0097070,0.0775982755983568,0.997523411640389,1,5,ductus arteriosus closure,BP,STRA6
13289,GO:0048566,0.0776798482334594,0.989141123682375,2,33,embryonic digestive tract development,BP,STRA6;FGF10
21621,GO:2001205,0.0777866754083861,0.997511172031362,1,5,negative regulation of osteoclast development,BP,CLDN18
14571,GO:0055017,0.0778078687669581,0.982404767689646,3,67,cardiac muscle tissue growth,BP,WNT2;NOTCH1;EDN1
2658,GO:0005543,0.0778764349617627,0.963399007930662,9,353,phospholipid binding,MF,SYT5;ACTN2;SERPINA5;MFGE8;SPTBN4;FZD7;SNX18;AKT1;GAS6
5677,GO:0015911,0.0778956808235918,0.997504076133951,1,5,plasma membrane long-chain fatty acid transport,BP,AKT1
10962,GO:0042640,0.078087383523403,0.997491571593097,1,5,anagen,BP,WNT5A
12871,GO:0046912,0.0781165660550469,0.997489665219373,1,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS2
7251,GO:0030135,0.0781309029578451,0.96736083936049,7,257,coated vesicle,CC,RAB27A;TF;EDN1;WNT5A;SNX18;HBEGF;SH3BP4
11824,GO:0044463,0.078222162182603,0.951999946992929,20,964,cell projection part,CC,ITGA3;ITGA5;ADRA2C;ACTN2;MARK4;RAB27A;ADORA1;PRKACB;SPTBN5;SPTBN4;TTYH1;FSTL3;PRKAR1B;ESPN;VAMP1;MSN;AKT1;MYO7A;LZTS1;PDE4B
154,GO:0000302,0.0782652631470729,0.969901229499681,6,224,response to reactive oxygen species,BP,GUCY1B3;EDN1;SESN2;RHOB;BMP7;AKT1
7229,GO:0030104,0.0784435183156611,0.98220840484902,3,66,water homeostasis,BP,PRKACB;PRKAR1B;CLDN1
11617,GO:0044058,0.0785104434440908,0.98889575422957,2,38,regulation of digestive system process,BP,FGF10;WNK4
134,GO:0000271,0.0785263001056752,0.982174970434172,3,67,polysaccharide biosynthetic process,BP,PDGFB;B3GNT2;AKT1
15478,GO:0061370,0.0785432724582485,0.997358343735052,1,6,testosterone biosynthetic process,BP,WNT4
20287,GO:1904885,0.0786511579159015,0.997454610111609,1,5,beta-catenin destruction complex assembly,BP,AXIN1
4709,GO:0009996,0.0787663103517613,0.997343074611551,1,6,negative regulation of cell fate specification,BP,FZD7
14160,GO:0051592,0.0788011956145911,0.976901852736481,4,113,response to calcium ion,BP,CASQ2;EDN1;WNT5A;PTGES
10051,GO:0035787,0.0789124884559559,0.997437382296078,1,5,cell migration involved in kidney development,BP,PDGFB
1474,GO:0003186,0.0790915628641655,0.997425542407104,1,5,tricuspid valve morphogenesis,BP,ZFPM1
7018,GO:0021884,0.0791225602313799,0.98885525955952,2,31,forebrain neuron development,BP,WNT5A;FGF8
6416,GO:0018377,0.0791445063364187,0.997422036532487,1,5,protein myristoylation,BP,NMT2
7206,GO:0030046,0.0792597360249555,0.997414397588862,1,5,parallel actin filament bundle assembly,BP,ESPN
7115,GO:0022614,0.0793627763900201,0.997407556818771,1,5,membrane to membrane docking,BP,MSN
13241,GO:0048477,0.0793837597458117,0.981867376580241,3,72,oogenesis,BP,WNT4;NPPC;INHBB
15179,GO:0060762,0.0794166880817139,0.997298290383768,1,6,regulation of branching involved in mammary gland duct morphogenesis,BP,WNT5A
1532,GO:0003284,0.0794693115930507,0.997400474204016,1,5,septum primum development,BP,ACVR1
14355,GO:0051961,0.0795091158611901,0.966659745147161,7,251,negative regulation of nervous system development,BP,WNT3;NOTCH1;WNT7A;PRKACB;WNT5A;BMP7;DLL1
20349,GO:1905007,0.0795317896361188,0.997396315925817,1,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,ACVR1
8697,GO:0032732,0.0795324007006434,0.988692280751753,2,36,positive regulation of interleukin-1 production,BP,CCL20;WNT5A
8683,GO:0032713,0.0797225470127182,0.997277095621218,1,6,negative regulation of interleukin-4 production,BP,ZFPM1
8352,GO:0032229,0.0797467727296754,0.99727541322234,1,6,negative regulation of synaptic transmission, GABAergic,BP,ADORA1
14904,GO:0060374,0.079749932103087,0.997381770326694,1,5,mast cell differentiation,BP,ZFPM1
10416,GO:0036514,0.0797802825645911,0.997379743257271,1,5,dopaminergic neuron axon guidance,BP,WNT5A
20317,GO:1904938,0.0797802825645911,0.997379743257271,1,5,planar cell polarity pathway involved in axon guidance,BP,WNT5A
3554,GO:0006954,0.0799495180629364,0.956553955264591,13,635,inflammatory response,BP,NOTCH1;ACVR1;ADORA1;CCL20;TYRO3;WNT5A;JAM3;BMP6;BMP2;AKT1;PTGES;PIK3CG;TSPAN2
1602,GO:0003418,0.0800230084986535,0.997256191565449,1,6,growth plate cartilage chondrocyte differentiation,BP,NPPC
16639,GO:0071680,0.0800778311886575,0.99735982739392,1,5,response to indole-3-methanol,BP,CDH1
16640,GO:0071681,0.0800778311886575,0.99735982739392,1,5,cellular response to indole-3-methanol,BP,CDH1
10502,GO:0038132,0.0801185159396335,0.99735709817535,1,5,neuregulin binding,MF,ITGB4
2487,GO:0005154,0.0801250414856203,0.988616839377802,2,32,epidermal growth factor receptor binding,MF,ITGA5;HBEGF
15111,GO:0060676,0.0802386995813748,0.997241134322994,1,6,ureteric bud formation,BP,GDNF
19780,GO:1903779,0.0802486197597074,0.981600192227799,3,70,regulation of cardiac conduction,BP,CASQ2;NPR1;NPPC
13923,GO:0051180,0.0802619274988392,0.988556219271814,2,34,vitamin transport,BP,STRA6;SLC52A3
12265,GO:0045636,0.0802671462677014,0.997347115345746,1,5,positive regulation of melanocyte differentiation,BP,KITLG
21473,GO:2000809,0.0802685969208835,0.997347017815993,1,5,positive regulation of synaptic vesicle clustering,BP,CDH2
14358,GO:0051964,0.0802688173844978,0.997347002993706,1,5,negative regulation of synapse assembly,BP,WNT5A
15568,GO:0061614,0.0803377834557791,0.988603768524146,2,30,pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB;BMP2
10879,GO:0042517,0.0804015748028805,0.98849821009847,2,36,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,LIF;CLCF1
17245,GO:0086005,0.0804144628778944,0.988586725828032,2,30,ventricular cardiac muscle cell action potential,BP,DSC2;KCNH2
9129,GO:0033603,0.08069071232177,0.997209441501237,1,6,positive regulation of dopamine secretion,BP,GDNF
17587,GO:0090407,0.0808064303520445,0.956022419459629,13,615,organophosphate biosynthetic process,BP,GUCY1B3;EDN1;MBOAT2;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;NPR1;FGF8;NPPC;PIK3CA;PIK3CG
9824,GO:0035418,0.0808292212346883,0.988476499764929,2,31,protein localization to synapse,BP,WNT7A;WNT5A
15824,GO:0070244,0.0810357916406595,0.997185120362096,1,6,negative regulation of thymocyte apoptotic process,BP,BMP4
10649,GO:0042098,0.0813310992920037,0.971736517088588,5,171,T cell proliferation,BP,WNT4;SDC4;BMP4;MSN;PIK3CG
9572,GO:0034703,0.0815452964477481,0.968357299468202,6,197,cation channel complex,CC,CASQ2;KCNK6;KCNH2;KCNG2;KCND1;PDE4B
19473,GO:1903169,0.0816175045394431,0.975775889091212,4,118,regulation of calcium ion transmembrane transport,BP,CASQ2;TSPAN13;PIK3CG;PDE4B
5936,GO:0016459,0.0816352925977896,0.981149329528771,3,70,myosin complex,CC,CGN;MYO7A;MYH11
8428,GO:0032364,0.0816782325604237,0.997139550559595,1,6,oxygen homeostasis,BP,WNT7B
7891,GO:0031333,0.08172686527453,0.975746531746114,4,114,negative regulation of protein complex assembly,BP,FHOD3;SPTBN5;SPTBN4;SPTB
8926,GO:0033084,0.0818513016033569,0.997127209681722,1,6,regulation of immature T cell proliferation in thymus,BP,BMP4
1451,GO:0003160,0.0820611294702879,0.997112210832398,1,6,endocardium morphogenesis,BP,NOTCH1
2921,GO:0005996,0.0820838115455896,0.965312595644901,7,262,monosaccharide metabolic process,BP,ACTN3;PMAIP1;KHK;SESN2;PFKFB3;AKT1;PIK3CA
4632,GO:0009744,0.0821756004367122,0.997104011227645,1,6,response to sucrose,BP,KHK
9363,GO:0034285,0.0821756004367122,0.997104011227645,1,6,response to disaccharide,BP,KHK
19651,GO:1903532,0.0823733158497829,0.96282350980563,8,327,positive regulation of secretion by cell,BP,RAB27A;EDN1;WNT5A;SDC4;BMP6;INHBB;RAB3D;GDNF
11388,GO:0043407,0.0823960780933557,0.980893980424428,3,71,negative regulation of MAP kinase activity,BP,BMP7;BMP4;DUSP5
21522,GO:2000973,0.0824645014159914,0.997083263660425,1,6,regulation of pro-B cell differentiation,BP,NOTCH1
16444,GO:0071389,0.0825391064767854,0.997077893416213,1,6,cellular response to mineralocorticoid stimulus,BP,EDN1
8232,GO:0032008,0.0827272273201273,0.988032339984045,2,32,positive regulation of TOR signaling,BP,PIK3CA;GAS6
13971,GO:0051253,0.0828537311235594,0.947065545446757,23,1206,negative regulation of RNA metabolic process,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;PKP3;PKP1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
13866,GO:0051098,0.0829717207996038,0.962504760703632,8,318,regulation of binding,BP,LIF;ZFPM1;PDGFB;RALB;WNT5A;BMP4;BMP2;HEY1
14634,GO:0055131,0.0832958254310026,0.997023134228069,1,6,C3HC4-type RING finger domain binding,MF,KCNH2
5325,GO:0014911,0.0833442054647207,0.987892132764739,2,32,positive regulation of smooth muscle cell migration,BP,PDGFB;FOXO4
7469,GO:0030513,0.0834249675688201,0.987873733868249,2,32,positive regulation of BMP signaling pathway,BP,NOTCH1;BMP4
2870,GO:0005905,0.0836372431696978,0.980513669500335,3,67,clathrin-coated pit,CC,TF;EPN1;SH3BP4
21021,GO:2000138,0.0838741465040442,0.996980929938639,1,6,positive regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
8755,GO:0032808,0.084032886722565,0.996969291729391,1,6,lacrimal gland development,BP,FGF10
7209,GO:0030049,0.0842196608562266,0.987593491776858,2,39,muscle filament sliding,BP,ACTN3;ACTN2
9029,GO:0033275,0.0842196608562266,0.987593491776858,2,39,actin-myosin filament sliding,BP,ACTN3;ACTN2
7649,GO:0030890,0.0842587956561006,0.987596292285451,2,38,positive regulation of B cell proliferation,BP,CLCF1;CDKN1A
6528,GO:0019209,0.0843083755344939,0.98025734752046,3,72,kinase activator activity,MF,CDKN1A;PIK3CA;GAS6
14661,GO:0060029,0.0843608754617336,0.996945171467,1,6,convergent extension involved in organogenesis,BP,WNT5A
12846,GO:0046877,0.0845497919667098,0.99678174139997,1,8,regulation of saliva secretion,BP,FGF10
7075,GO:0021999,0.0846215045754653,0.996925934251846,1,6,neural plate anterior/posterior regionalization,BP,AXIN1
10929,GO:0042587,0.0849207866641876,0.996903766916868,1,6,glycogen granule,CC,FASN
20642,GO:1905898,0.0851446857190458,0.987446511181597,2,34,positive regulation of response to endoplasmic reticulum stress,BP,PMAIP1;PIK3R1
10133,GO:0035931,0.0851839472246048,0.99688420690451,1,6,mineralocorticoid secretion,BP,BMP6
10134,GO:0035932,0.0851839472246048,0.99688420690451,1,6,aldosterone secretion,BP,BMP6
21506,GO:2000855,0.0851839472246048,0.99688420690451,1,6,regulation of mineralocorticoid secretion,BP,BMP6
21508,GO:2000858,0.0851839472246048,0.99688420690451,1,6,regulation of aldosterone secretion,BP,BMP6
697,GO:0001842,0.0852757990668433,0.996877364789585,1,6,neural fold formation,BP,BMP7
3417,GO:0006734,0.0853075072037137,0.987393764697012,2,35,NADH metabolic process,BP,ACTN3;PFKFB3
16411,GO:0071346,0.0853089827996292,0.974245561408174,4,136,cellular response to interferon-gamma,BP,EDN1;CCL20;WNT5A;CLDN1
4930,GO:0010675,0.0853898161806662,0.974283225772625,4,114,regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1;SESN2;AKT1
6479,GO:0019064,0.0855196938906957,0.996859159157055,1,6,fusion of virus membrane with host plasma membrane,BP,GAS6
10570,GO:0039663,0.0855196938906957,0.996859159157055,1,6,membrane fusion involved in viral entry into host cell,BP,GAS6
11920,GO:0044800,0.0855196938906957,0.996859159157055,1,6,multi-organism membrane fusion,BP,GAS6
15847,GO:0070278,0.0856506511904732,0.996849361178125,1,6,extracellular matrix constituent secretion,BP,CTGF
11474,GO:0043548,0.0857178421975885,0.98734696804198,2,32,phosphatidylinositol 3-kinase binding,MF,TYRO3;PIK3R1
4828,GO:0010511,0.0857698225577058,0.996840431264884,1,6,regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
18818,GO:1901533,0.0858253733936981,0.996748185621124,1,7,negative regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
17156,GO:0072672,0.0859137101228556,0.996829631838754,1,6,neutrophil extravasation,BP,PIK3CG
13949,GO:0051223,0.0861265518857172,0.950502162267185,15,719,regulation of protein transport,BP,ADRA2C;FZD7;PRR5L;PIK3R2;PIK3R1;WNT5A;BMP7;BMP6;BMP4;CDKN1A;CDH1;INHBB;RAB11FIP1;KCNG2;GAS6
19664,GO:1903551,0.0861858542162151,0.996809153975166,1,6,regulation of extracellular exosome assembly,BP,SDC4
18145,GO:0098751,0.0862428937598048,0.98722514702759,2,32,bone cell development,BP,ZFPM1;CLDN18
15337,GO:0061051,0.0862869694693606,0.996712495489016,1,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
12849,GO:0046880,0.0864679237571407,0.996787857171777,1,6,regulation of follicle-stimulating hormone secretion,BP,INHBB
12850,GO:0046881,0.0864679237571407,0.996787857171777,1,6,positive regulation of follicle-stimulating hormone secretion,BP,INHBB
8258,GO:0032052,0.0865171532220461,0.996575476490209,1,9,bile acid binding,MF,VDR
11030,GO:0042770,0.0866228403648643,0.97377040064904,4,118,signal transduction in response to DNA damage,BP,PMAIP1;GADD45A;SESN2;CDKN1A
16811,GO:0072038,0.0867393322531296,0.996767296004752,1,6,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,BMP7
14960,GO:0060440,0.0867419464731646,0.996767097628054,1,6,trachea formation,BP,BMP4
15427,GO:0061218,0.0867674404682744,0.996765162718617,1,6,negative regulation of mesonephros development,BP,BMP4
6761,GO:0019903,0.0867951171249352,0.973736059631908,4,109,protein phosphatase binding,MF,CDH2;PIK3R2;PIK3R1;AKT1
8378,GO:0032277,0.0868149498686896,0.996671425276737,1,7,negative regulation of gonadotropin secretion,BP,INHBB
9861,GO:0035502,0.0868150568725757,0.996761547185412,1,6,metanephric part of ureteric bud development,BP,WT1
15619,GO:0061724,0.0868298308761866,0.996760424963853,1,6,lipophagy,BP,SESN2
5798,GO:0016176,0.0868526282888486,0.996668484278288,1,7,superoxide-generating NADPH oxidase activator activity,MF,PDGFB
8372,GO:0032271,0.0873470709072491,0.969026687948901,5,166,regulation of protein polymerization,BP,FHOD3;SPTBN5;SPTBN4;PSRC1;SPTB
12095,GO:0045217,0.0874542392144552,0.996712811165541,1,6,cell-cell junction maintenance,BP,CAMSAP3
10476,GO:0038095,0.0874774181288246,0.973402742574494,4,124,Fc-epsilon receptor signaling pathway,BP,PIK3R2;PIK3R1;HRAS;PIK3CA
10541,GO:0038203,0.0875306493345419,0.996706959840896,1,6,TORC2 signaling,BP,PRR5L
16477,GO:0071438,0.0876078589763521,0.99670104181183,1,6,invadopodium membrane,CC,ITGA3
1403,GO:0003062,0.0876340920586457,0.996699029823083,1,6,regulation of heart rate by chemical signal,BP,KCNH2
12694,GO:0046533,0.0876657662606446,0.996696599671501,1,6,negative regulation of photoreceptor cell differentiation,BP,NOTCH1
10766,GO:0042326,0.0876880312135737,0.955973440302202,10,421,negative regulation of phosphorylation,BP,LIF;ACTN3;GADD45A;PRR5L;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
17267,GO:0086029,0.0877596158569015,0.996689393771394,1,6,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,CASQ2
17297,GO:0086068,0.0877596158569015,0.996689393771394,1,6,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,CASQ2
14018,GO:0051321,0.0880252502464235,0.965141544948804,6,211,meiotic cell cycle,BP,LIF;WNT4;PRKACB;WNT5A;NPPC;PIM2
3230,GO:0006498,0.0880889236644087,0.996664044675549,1,6,N-terminal protein lipidation,BP,NMT2
17262,GO:0086023,0.0883219833097253,0.996646043883421,1,6,adrenergic receptor signaling pathway involved in heart process,BP,CHGA
8512,GO:0032456,0.0883764275186975,0.986725573087089,2,32,endocytic recycling,BP,ACTN2;RAB17
19167,GO:1902455,0.088405158591407,0.996639607525627,1,6,negative regulation of stem cell population maintenance,BP,BMP7
9033,GO:0033280,0.0887100715090805,0.986595797677192,2,35,response to vitamin D,BP,BMP7;VDR
17712,GO:0097048,0.0887221294252572,0.996615020694045,1,6,dendritic cell apoptotic process,BP,GAS6
21380,GO:2000668,0.0887221294252572,0.996615020694045,1,6,regulation of dendritic cell apoptotic process,BP,GAS6
3687,GO:0007182,0.08874881152027,0.996612946772667,1,6,common-partner SMAD protein phosphorylation,BP,BMP4
15760,GO:0070141,0.0887645480339488,0.996611723310564,1,6,response to UV-A,BP,AKT1
6760,GO:0019902,0.0888339544631854,0.968379442550825,5,153,phosphatase binding,MF,SPTBN4;CDH2;PIK3R2;PIK3R1;AKT1
15767,GO:0070162,0.0888897746107288,0.99660197918951,1,6,adiponectin secretion,BP,RAB11FIP1
15768,GO:0070163,0.0888897746107288,0.99660197918951,1,6,regulation of adiponectin secretion,BP,RAB11FIP1
12341,GO:0045766,0.0889840669022541,0.972805646575029,4,119,positive regulation of angiogenesis,BP,ITGA5;WNT5A;RHOB;DLL1
1591,GO:0003402,0.0890801305319002,0.996587139430853,1,6,planar cell polarity pathway involved in axis elongation,BP,WNT5A
11752,GO:0044340,0.0891497859572495,0.996581700854139,1,6,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,WNT3
13876,GO:0051119,0.0892884660554302,0.986474439263876,2,34,sugar transmembrane transporter activity,MF,SLC45A4;SLC2A14
15950,GO:0070444,0.0893520164842636,0.996565885587649,1,6,oligodendrocyte progenitor proliferation,BP,CDH2
15951,GO:0070445,0.0893520164842636,0.996565885587649,1,6,regulation of oligodendrocyte progenitor proliferation,BP,CDH2
15577,GO:0061626,0.0894903133083334,0.99645925289368,1,7,pharyngeal arch artery morphogenesis,BP,BMP4
1465,GO:0003175,0.0894912440159254,0.996554975406377,1,6,tricuspid valve development,BP,ZFPM1
16899,GO:0072174,0.0895751713481442,0.996548389999877,1,6,metanephric tubule formation,BP,WNT4
7633,GO:0030868,0.0895764468309858,0.996452309070398,1,7,smooth endoplasmic reticulum membrane,CC,TTYH1
17909,GO:0097425,0.0895764468309858,0.996452309070398,1,7,smooth endoplasmic reticulum part,CC,TTYH1
1034,GO:0002367,0.0895924330244711,0.978444125035563,3,78,cytokine production involved in immune response,BP,WNT5A;CHGA;GAS6
14190,GO:0051648,0.0896519205451178,0.961343148970612,7,255,vesicle localization,BP,SYT5;RAB27A;WNT7A;CDH2;RAB17;MYO7A;PIK3CG
10466,GO:0038066,0.0897159040795158,0.986372601941306,2,34,p38MAPK cascade,BP,GADD45A;BMP2
9995,GO:0035701,0.0897835999811954,0.996532007304497,1,6,hematopoietic stem cell migration,BP,GAS6
845,GO:0002042,0.089819359872244,0.986365193611879,2,33,cell migration involved in sprouting angiogenesis,BP,NOTCH1;EFNB2
8799,GO:0032885,0.0898420872540244,0.986359773423479,2,33,regulation of polysaccharide biosynthetic process,BP,PDGFB;AKT1
7351,GO:0030274,0.0898746712087373,0.996524836381492,1,6,LIM domain binding,MF,ACTN2
15963,GO:0070472,0.0899995378830319,0.99641809833697,1,7,regulation of uterine smooth muscle contraction,BP,ADRA2C
7542,GO:0030672,0.0900415422784128,0.978316101988935,3,74,synaptic vesicle membrane,CC,TMEM163;SYT5;VAMP1
18317,GO:0099501,0.0900415422784128,0.978316101988935,3,74,exocytic vesicle membrane,CC,TMEM163;SYT5;VAMP1
17686,GO:0097009,0.0902225864448366,0.986268907140898,2,33,energy homeostasis,BP,DLL1;PIK3CA
12031,GO:0045110,0.0902419271070393,0.996495840759677,1,6,intermediate filament bundle assembly,BP,PKP1
19135,GO:1902338,0.0902507530034303,0.99649514239835,1,6,negative regulation of apoptotic process involved in morphogenesis,BP,BMP7
20219,GO:1904746,0.0902507530034303,0.99649514239835,1,6,negative regulation of apoptotic process involved in development,BP,BMP7
10681,GO:0042149,0.0902954178761561,0.986234067290626,2,34,cellular response to glucose starvation,BP,PMAIP1;NUAK2
14939,GO:0060416,0.0903257424997981,0.986210387034818,2,35,response to growth hormone,BP,PIK3R1;AKT1
14058,GO:0051402,0.0905836745940096,0.963855734427439,6,215,neuron apoptotic process,BP,TYRO3;HRAS;FGF8;CLCF1;PIK3CA;GDNF
12191,GO:0045471,0.0908125159732173,0.972016922831379,4,130,response to ethanol,BP,NPPC;CLDN1;CLDN3;CLDN18
3344,GO:0006636,0.0908533221169625,0.986039267482988,2,38,unsaturated fatty acid biosynthetic process,BP,EDN1;PTGES
16077,GO:0070672,0.0909063126423937,0.99644306838468,1,6,response to interleukin-15,BP,ACSL4
7056,GO:0021954,0.0910297486650137,0.978006588789852,3,70,central nervous system neuron development,BP,SPTBN4;WNT5A;FGF8
1125,GO:0002526,0.0910416368220796,0.97191919337222,4,131,acute inflammatory response,BP,ACVR1;ADORA1;PTGES;PIK3CG
17440,GO:0090186,0.091168896794875,0.996322659284139,1,7,regulation of pancreatic juice secretion,BP,WNK4
20347,GO:1905005,0.0912932064487859,0.996412148603111,1,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,ACVR1
15005,GO:0060501,0.0913079918884584,0.996410964224066,1,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
8714,GO:0032762,0.0913549035278364,0.996307358037312,1,7,mast cell cytokine production,BP,CHGA
15043,GO:0060558,0.0914406688626934,0.996300291724409,1,7,regulation of calcidiol 1-monooxygenase activity,BP,VDR
8379,GO:0032278,0.0914668032198357,0.996298137088922,1,7,positive regulation of gonadotropin secretion,BP,INHBB
11260,GO:0043203,0.0915102526729629,0.996294553477579,1,7,axon hillock,CC,SPTBN4
11518,GO:0043624,0.0915319549582899,0.967041869236965,5,192,cellular protein complex disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;SPTB
5306,GO:0014883,0.0915527116488405,0.996291049820612,1,7,transition between fast and slow fiber,BP,ACTN3
18443,GO:1900029,0.0918511951894832,0.996266370869714,1,7,positive regulation of ruffle assembly,BP,HRAS
14702,GO:0060075,0.092088314467714,0.996348168855754,1,6,regulation of resting membrane potential,BP,KCNK6
8068,GO:0031666,0.0920907950021913,0.996170499642932,1,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
18859,GO:1901621,0.0922003185664466,0.996339109058502,1,6,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
13274,GO:0048537,0.0924975240979291,0.99621264055562,1,7,mucosal-associated lymphoid tissue development,BP,ARTN
13277,GO:0048541,0.0924975240979291,0.99621264055562,1,7,Peyer's patch development,BP,ARTN
14673,GO:0060043,0.0925308910612624,0.985694670704321,2,34,regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1
16360,GO:0071260,0.0925806399470307,0.977444030239177,3,74,cellular response to mechanical stimulus,BP,GADD45A;BMP6;AKT1
16102,GO:0070728,0.0927845543091305,0.996291662283464,1,6,leucine binding,MF,SESN2
4803,GO:0010459,0.092855609721525,0.996045390995709,1,9,negative regulation of heart rate,BP,SPTBN4
1067,GO:0002433,0.0929550129861808,0.977336262985339,3,71,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3R2;PIK3R1;PIK3CA
10477,GO:0038096,0.0929550129861808,0.977336262985339,3,71,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3R2;PIK3R1;PIK3CA
5299,GO:0014866,0.0931381985648884,0.996158986950947,1,7,skeletal myofibril assembly,BP,MYH11
21493,GO:2000833,0.0931505144068927,0.996019765267229,1,9,positive regulation of steroid hormone secretion,BP,BMP6
13393,GO:0048752,0.0932019970862427,0.996153622658789,1,7,semicircular canal morphogenesis,BP,FGF10
8454,GO:0032391,0.0934227312268651,0.985477271566538,2,34,photoreceptor connecting cilium,CC,SPTBN5;MYO7A
15195,GO:0060795,0.0934929028872085,0.985442829903855,2,35,cell fate commitment involved in formation of primary germ layer,BP,FZD7;BMP4
11482,GO:0043559,0.0935205475139387,0.996231439117936,1,6,insulin binding,MF,PIK3R1
603,GO:0001708,0.093549217082753,0.9770883317407,3,77,cell fate specification,BP,NOTCH1;FZD7;DLL1
7824,GO:0031232,0.093665132858291,0.996114564842153,1,7,extrinsic component of external side of plasma membrane,CC,TF
12433,GO:0045934,0.0937026469021199,0.938191862254784,25,1347,negative regulation of nucleobase-containing compound metabolic process,BP,WNT4;ACTN3;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;PKP3;PKP1;NPPC;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
19362,GO:1902946,0.0938663422617296,0.996202970116888,1,6,protein localization to early endosome,BP,MSN
549,GO:0001609,0.0939164207896134,0.9960932871129,1,7,G-protein coupled adenosine receptor activity,MF,ADORA1
304,GO:0000805,0.0939221491987456,0.996092801358046,1,7,X chromosome,CC,SIN3B
12076,GO:0045188,0.0939601742200479,0.996010447970577,1,8,regulation of circadian sleep/wake cycle, non-REM sleep,BP,ADORA1
3570,GO:0006979,0.0940083778955828,0.954102437703659,9,397,response to oxidative stress,BP,GUCY1B3;EDN1;PRR5L;SESN2;RHOB;FGF8;BMP7;GJB2;AKT1
13598,GO:0050701,0.0942211192576002,0.985189996042936,2,40,interleukin-1 secretion,BP,WNT5A;GAS6
20750,GO:1990316,0.0942662869664629,0.996169904093103,1,6,ATG1/ULK1 kinase complex,CC,SESN2
13075,GO:0048021,0.0942876840212385,0.996061740046461,1,7,regulation of melanin biosynthetic process,BP,WNT5A
18597,GO:1900376,0.0942876840212385,0.996061740046461,1,7,regulation of secondary metabolite biosynthetic process,BP,WNT5A
16980,GO:0072298,0.0943093545237739,0.996166334530145,1,6,regulation of metanephric glomerulus development,BP,WT1
20176,GO:1904672,0.0943347526552801,0.996164228649727,1,6,regulation of somatic stem cell population maintenance,BP,BMP7
20322,GO:1904951,0.0943607567489491,0.950241508616758,11,498,positive regulation of establishment of protein localization,BP,ITGA3;PMAIP1;PRR5L;PIK3R2;PIK3R1;WNT5A;BMP6;BMP4;AKT1;CDH1;GAS6
13675,GO:0050807,0.094520118497678,0.970540447510563,4,113,regulation of synapse organization,BP,WNT7A;CDH2;WNT5A;RAB17
21290,GO:2000542,0.0945583499003065,0.996038657890275,1,7,negative regulation of gastrulation,BP,FZD7
12700,GO:0046543,0.094565810053424,0.996038020702462,1,7,development of secondary female sexual characteristics,BP,WNT5A
1147,GO:0002576,0.0945844062897649,0.970462304552759,4,126,platelet degranulation,BP,ACTN2;TF;PDGFB;GAS6
17462,GO:0090209,0.0947071540142438,0.995945541994342,1,8,negative regulation of triglyceride metabolic process,BP,PIK3CG
13178,GO:0048285,0.0948220695789317,0.947073508486819,13,599,organelle fission,BP,LIF;WNT4;MARK4;EDN1;TTYH1;PDGFB;WNT5A;SNX18;PSRC1;FGF8;BMP7;BMP4;PIM2
12644,GO:0046456,0.0949467943542061,0.984973720195656,2,43,icosanoid biosynthetic process,BP,EDN1;PTGES
18838,GO:1901570,0.0949467943542061,0.984973720195656,2,43,fatty acid derivative biosynthetic process,BP,EDN1;PTGES
3692,GO:0007187,0.094997590492326,0.965455477818466,5,176,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,ADRA2B;ADRA2C;ADORA1;PRKACB;CHGA
78,GO:0000155,0.0950231414587195,0.996106922013,1,6,phosphorelay sensor kinase activity,MF,KCNH2
7532,GO:0030658,0.0950758805824655,0.965428281299405,5,172,transport vesicle membrane,CC,TMEM163;SYT5;SYCN;VAMP1;CHGA
7314,GO:0030217,0.095086169619332,0.961578526634477,6,216,T cell differentiation,BP,WNT4;ZFPM1;FZD7;BMP4;JAG2;FZD8
13608,GO:0050711,0.0951269282698904,0.99590882857759,1,8,negative regulation of interleukin-1 secretion,BP,GAS6
4143,GO:0008429,0.0952309620380921,0.995899703218712,1,8,phosphatidylethanolamine binding,MF,MFGE8
2498,GO:0005168,0.0952310247327767,0.996089529371871,1,6,neurotrophin TRKA receptor binding,MF,PIK3R1
11246,GO:0043184,0.0952350603209053,0.995980641910833,1,7,vascular endothelial growth factor receptor 2 binding,MF,ITGA5
17301,GO:0086073,0.0952386965488382,0.996088886734746,1,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,DSC2
17309,GO:0086083,0.0952386965488382,0.996088886734746,1,6,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,DSC2
7623,GO:0030857,0.0952624744488638,0.984974459159554,2,37,negative regulation of epithelial cell differentiation,BP,NOTCH1;DLL1
14153,GO:0051584,0.0952654134790896,0.995896678971096,1,8,regulation of dopamine uptake involved in synaptic transmission,BP,GDNF
14341,GO:0051940,0.0952654134790896,0.995896678971096,1,8,regulation of catecholamine uptake involved in synaptic transmission,BP,GDNF
7213,GO:0030056,0.0955353810516868,0.996063992537386,1,6,hemidesmosome,CC,ITGB4
12399,GO:0045892,0.0956959086893762,0.939076266303057,21,1103,negative regulation of transcription, DNA-templated,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
13180,GO:0048289,0.0958319420868295,0.995929105935146,1,7,isotype switching to IgE isotypes,BP,CLCF1
13183,GO:0048293,0.0958319420868295,0.995929105935146,1,7,regulation of isotype switching to IgE isotypes,BP,CLCF1
4243,GO:0008603,0.0958553325889261,0.995927079403091,1,7,cAMP-dependent protein kinase regulator activity,MF,PRKAR1B
19752,GO:1903726,0.0958746629715221,0.995925404240502,1,7,negative regulation of phospholipid metabolic process,BP,PDGFB
5701,GO:0015939,0.0959372537973093,0.995919977690003,1,7,pantothenate metabolic process,BP,FASN
6872,GO:0021587,0.0960205686064799,0.984836877288236,2,34,cerebellum morphogenesis,BP,WNT7A;DLL1
9675,GO:0035088,0.0960445602423224,0.984795946857835,2,36,establishment or maintenance of apical/basal cell polarity,BP,WNT5A;MSN
15431,GO:0061245,0.0960445602423224,0.984795946857835,2,36,establishment or maintenance of bipolar cell polarity,BP,WNT5A;MSN
12422,GO:0045921,0.0960650870901477,0.976208806397739,3,77,positive regulation of exocytosis,BP,RAB27A;SDC4;RAB3D
1200,GO:0002679,0.0961625039399157,0.995817521952371,1,8,respiratory burst involved in defense response,BP,PIK3CG
13324,GO:0048640,0.0963667002683932,0.976123638926424,3,74,negative regulation of developmental growth,BP,WNT3;WNT5A;BMP4
16070,GO:0070665,0.0964158924023408,0.969668710982758,4,133,positive regulation of leukocyte proliferation,BP,FGF10;CLCF1;CDKN1A;KITLG
10897,GO:0042538,0.0964491330286956,0.995792064861477,1,8,hyperosmotic salinity response,BP,CLDN1
13070,GO:0048016,0.0964751760439667,0.984705611876619,2,35,inositol phosphate-mediated signaling,BP,ACTN3;EDN1
14840,GO:0060297,0.0966257158786266,0.995860041029327,1,7,regulation of sarcomere organization,BP,EDN1
15241,GO:0060907,0.096929863050042,0.995833417597433,1,7,positive regulation of macrophage cytokine production,BP,WNT5A
16600,GO:0071622,0.0969316854595718,0.984433977952989,2,47,regulation of granulocyte chemotaxis,BP,EDN1;JAM3
8768,GO:0032825,0.0969430450723836,0.995832261706515,1,7,positive regulation of natural killer cell differentiation,BP,GAS6
4947,GO:0010717,0.0969510429911445,0.975925173904775,3,73,regulation of epithelial to mesenchymal transition,BP,NOTCH1;ACVR1;BMP2
694,GO:0001839,0.0969582875322579,0.995830924934323,1,7,neural plate morphogenesis,BP,FGF8
4678,GO:0009898,0.0970394122921787,0.964523441680888,5,164,cytoplasmic side of plasma membrane,CC,PTPN7;SNX18;SPTB;CDH1;MYZAP
3691,GO:0007186,0.0974959500959426,0.940003801372262,18,1157,G-protein coupled receptor signaling pathway,BP,ADRA2B;ADRA2C;ACTN2;NMT2;ADORA1;EDN1;PRKACB;CCL20;FZD7;LPAR2;GPRASP1;NPR1;CHGA;AKT1;BCAR1;PIK3CG;GPSM1;FZD8
5554,GO:0015684,0.0976597090664157,0.995769168639918,1,7,ferrous iron transport,BP,TF
1416,GO:0003091,0.0978995016178816,0.984348603938787,2,35,renal water homeostasis,BP,PRKACB;PRKAR1B
5274,GO:0014824,0.0980069578109873,0.995738420471501,1,7,artery smooth muscle contraction,BP,EDN1
17993,GO:0097623,0.0980377035373985,0.99573569241781,1,7,potassium ion export across plasma membrane,BP,KCNH2
18121,GO:0098668,0.0980377035373985,0.99573569241781,1,7,potassium ion export from cell,BP,KCNH2
3437,GO:0006771,0.0980428490823938,0.995735235767326,1,7,riboflavin metabolic process,BP,SLC52A3
14749,GO:0060155,0.0980492899108778,0.995648470404242,1,8,platelet dense granule organization,BP,RAB38
14007,GO:0051301,0.0982075858519654,0.946275818697702,12,547,cell division,BP,NOTCH1;MARK4;WNT7A;FZD7;PDGFB;RALB;SNX18;RHOB;PSRC1;FGF8;DLL1;BCAR1
9059,GO:0033365,0.098850661197255,0.939989693657114,17,884,protein localization to organelle,BP,LIF;TSPAN17;PMAIP1;FZD7;PIK3R2;PIK3R1;SESN2;BMP7;BMP6;BMP4;CDKN1A;MSN;AKT1;CDH1;GAS6;SH3BP4;CLDN18
1501,GO:0003228,0.0988516232800124,0.995663143314495,1,7,atrial cardiac muscle tissue development,BP,WNT2
14564,GO:0055009,0.0988516232800124,0.995663143314495,1,7,atrial cardiac muscle tissue morphogenesis,BP,WNT2
13287,GO:0048563,0.0989153096091222,0.995569710566753,1,8,post-embryonic animal organ morphogenesis,BP,MYO7A
16518,GO:0071493,0.099136294894411,0.99554949545655,1,8,cellular response to UV-B,BP,CDKN1A
16331,GO:0071216,0.0993079818502056,0.963417312679134,5,175,cellular response to biotic stimulus,BP,CCL20;WNT5A;BMP6;AKT1;PDE4B
19609,GO:1903430,0.0993411913891011,0.995530709328657,1,8,negative regulation of cell maturation,BP,NPPC
1255,GO:0002741,0.0994659371065603,0.995607964263505,1,7,positive regulation of cytokine secretion involved in immune response,BP,WNT5A
16490,GO:0071456,0.0995362189977486,0.963293947504396,5,181,cellular response to hypoxia,BP,NOTCH1;PMAIP1;EDN1;BMP7;AKT1
7309,GO:0030212,0.0996380074529548,0.983908566105658,2,35,hyaluronan metabolic process,BP,PDGFB;AKT1
13370,GO:0048706,0.0997532067270643,0.968295820688422,4,121,embryonic skeletal system development,BP,WNT5A;AXIN1;BMP7;BMP4
15236,GO:0060897,0.09979356910899,0.995578387105438,1,7,neural plate regionalization,BP,AXIN1
8384,GO:0032287,0.099818239332466,0.995576155803241,1,7,peripheral nervous system myelin maintenance,BP,AKT1
16154,GO:0070852,0.0998554367940178,0.99557279036494,1,7,cell body fiber,CC,SPTBN4
21348,GO:2000628,0.0998826097098061,0.995570331054613,1,7,regulation of miRNA metabolic process,BP,HRAS
17453,GO:0090199,0.0998917040203671,0.983723740702152,2,43,regulation of release of cytochrome c from mitochondria,BP,PMAIP1;AKT1
8269,GO:0032071,0.0999884615348999,0.995471093254829,1,8,regulation of endodeoxyribonuclease activity,BP,AKT1
10224,GO:0036089,0.100080957550673,0.995552357854614,1,7,cleavage furrow formation,BP,SNX18
2160,GO:0004673,0.100101270990379,0.995550515022157,1,7,protein histidine kinase activity,MF,KCNH2
18954,GO:1901888,0.100146094446567,0.974789748247452,3,73,regulation of cell junction assembly,BP,WNT4;SDC4;CLDN1
17313,GO:0086091,0.100254745363418,0.983770516136498,2,34,regulation of heart rate by cardiac conduction,BP,DSC2;KCNH2
2171,GO:0004691,0.100262649694774,0.995535860643942,1,7,cAMP-dependent protein kinase activity,MF,PRKACB
19003,GO:1902033,0.100350918157928,0.995527834599418,1,7,regulation of hematopoietic stem cell proliferation,BP,KITLG
10034,GO:0035754,0.100352504177181,0.995437382883305,1,8,B cell chemotaxis,BP,GAS6
16781,GO:0071971,0.100497013526673,0.995514533991703,1,7,extracellular exosome assembly,BP,SDC4
626,GO:0001750,0.10055643550624,0.974605726593358,3,78,photoreceptor outer segment,CC,RAB27A;SPTBN5;MYO7A
11726,GO:0044306,0.100703009021407,0.967877543335492,4,124,neuron projection terminus,CC,ADRA2C;ADORA1;FSTL3;VAMP1
18912,GO:1901724,0.101017109936275,0.995467017105131,1,7,positive regulation of cell proliferation involved in kidney development,BP,PDGFB
18535,GO:1900181,0.101150288650554,0.974399236302226,3,77,negative regulation of protein localization to nucleus,BP,BMP7;GAS6;CLDN18
12874,GO:0046916,0.101201511922685,0.974347209519838,3,82,cellular transition metal ion homeostasis,BP,TF;PRND;BMP6
20969,GO:2000049,0.101248686118749,0.995445775980181,1,7,positive regulation of cell-cell adhesion mediated by cadherin,BP,WNT5A
8798,GO:0032881,0.101398398957433,0.98343980966593,2,36,regulation of polysaccharide metabolic process,BP,PDGFB;AKT1
8890,GO:0033018,0.101403112604511,0.995431582590737,1,7,sarcoplasmic reticulum lumen,CC,CASQ2
11344,GO:0043320,0.101621918414814,0.99541143267309,1,7,natural killer cell degranulation,BP,RAB27A
12853,GO:0046884,0.101632013288743,0.995410501916876,1,7,follicle-stimulating hormone secretion,BP,INHBB
13209,GO:0048341,0.101659307770277,0.995407984849252,1,7,paraxial mesoderm formation,BP,WNT5A
4002,GO:0008202,0.101682813642112,0.95478934346257,7,288,steroid metabolic process,BP,WNT4;DHH;HMGCS2;DKK3;BMP6;BMP2;VDR
10475,GO:0038094,0.101770017205921,0.97419064314205,3,75,Fc-gamma receptor signaling pathway,BP,PIK3R2;PIK3R1;PIK3CA
9145,GO:0033628,0.101983987594442,0.98323889149236,2,39,regulation of cell adhesion mediated by integrin,BP,PLAU;PIK3CG
15263,GO:0060947,0.10225851341749,0.99535254552292,1,7,cardiac vascular smooth muscle cell differentiation,BP,NOTCH1
17803,GO:0097197,0.102273049987644,0.995351196271363,1,7,tetraspanin-enriched microdomain,CC,TSPAN15
621,GO:0001738,0.102387704911247,0.967126733828064,4,131,morphogenesis of a polarized epithelium,BP,FZD7;WNT5A;MSN;LAMA5
654,GO:0001784,0.102397213024684,0.9832005677577,2,35,phosphotyrosine binding,MF,PIK3R2;PIK3R1
14313,GO:0051897,0.102439273616328,0.973906225458546,3,81,positive regulation of protein kinase B signaling,BP,HBEGF;PIK3CG;GAS6
1623,GO:0003696,0.102489032370737,0.995331125224537,1,7,satellite DNA binding,MF,HEY1
14660,GO:0060028,0.102631051654939,0.99531790293718,1,7,convergent extension involved in axis elongation,BP,WNT5A
12693,GO:0046532,0.102810053426315,0.995301209735224,1,7,regulation of photoreceptor cell differentiation,BP,NOTCH1
6915,GO:0021684,0.102913062034969,0.995291589401348,1,7,cerebellar granular layer formation,BP,WNT7A
6932,GO:0021707,0.102913062034969,0.995291589401348,1,7,cerebellar granule cell differentiation,BP,WNT7A
17244,GO:0086004,0.102928922402374,0.98306278508077,2,35,regulation of cardiac muscle cell contraction,BP,DSC2;PDE4B
10801,GO:0042391,0.10296813752919,0.948819619167024,9,373,regulation of membrane potential,BP,ACTN2;PMAIP1;DSC2;WNT7A;ADORA1;CASQ2;EDN1;KCNK6;KCNH2
15501,GO:0061438,0.10309478798495,0.995274592365473,1,7,renal system vasculature morphogenesis,BP,BMP4
15502,GO:0061439,0.10309478798495,0.995274592365473,1,7,kidney vasculature morphogenesis,BP,BMP4
3813,GO:0007442,0.103131297385599,0.995271173747161,1,7,hindgut morphogenesis,BP,WNT5A
13167,GO:0048263,0.103326125195074,0.99515714748281,1,8,determination of dorsal identity,BP,ACVR1
12264,GO:0045634,0.103349404664623,0.995250724054788,1,7,regulation of melanocyte differentiation,BP,KITLG
13197,GO:0048318,0.10341380946601,0.995148751960547,1,8,axial mesoderm development,BP,AXIN1
9720,GO:0035234,0.103432227471785,0.995146987525244,1,8,ectopic germ cell programmed cell death,BP,KITLG
17732,GO:0097084,0.10349901039791,0.99514058695157,1,8,vascular smooth muscle cell development,BP,NOTCH1
16389,GO:0071313,0.103499028141117,0.995236668777195,1,7,cellular response to caffeine,BP,CASQ2
15962,GO:0070471,0.103950580826706,0.995097192388054,1,8,uterine smooth muscle contraction,BP,ADRA2C
21265,GO:2000510,0.104016266802276,0.995015467983299,1,9,positive regulation of dendritic cell chemotaxis,BP,GAS6
21362,GO:2000648,0.104062148358228,0.982748550339864,2,36,positive regulation of stem cell proliferation,BP,NOTCH1;KITLG
14981,GO:0060462,0.104416183343458,0.995150039890911,1,7,lung lobe development,BP,LIF
14982,GO:0060463,0.104416183343458,0.995150039890911,1,7,lung lobe morphogenesis,BP,LIF
13671,GO:0050803,0.104531970834989,0.966255590887781,4,117,regulation of synapse structure or activity,BP,WNT7A;CDH2;WNT5A;RAB17
3723,GO:0007224,0.10456557240929,0.966231888126949,4,119,smoothened signaling pathway,BP,DHH;PRKACB;FGF10;BMP4
19743,GO:1903715,0.104597492874079,0.995132818065599,1,7,regulation of aerobic respiration,BP,ACTN3
20373,GO:1905063,0.104650398115632,0.995127786817837,1,7,regulation of vascular smooth muscle cell differentiation,BP,PDGFB
672,GO:0001816,0.104676930168751,0.940609775064198,13,635,cytokine production,BP,NOTCH1;ZFPM1;CCL20;PIK3R1;HRAS;WNT5A;DLL1;CHGA;INHBB;PIK3CG;GAS6;DTX4;PDE4B
4152,GO:0008443,0.104927249786052,0.99510141420181,1,7,phosphofructokinase activity,MF,PFKFB3
1437,GO:0003139,0.105035056532766,0.994992155782866,1,8,secondary heart field specification,BP,BMP4
8927,GO:0033085,0.105097888350824,0.994986034639183,1,8,negative regulation of T cell differentiation in thymus,BP,BMP4
12598,GO:0046332,0.105290238270681,0.972926917196651,3,73,SMAD binding,MF,ACVR1;AXIN1;BMP2
11489,GO:0043569,0.105369777213406,0.995059105176378,1,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2
7672,GO:0030917,0.105472811729619,0.994871898734202,1,9,midbrain-hindbrain boundary development,BP,FGF8
13158,GO:0048251,0.105477996265355,0.995048729703954,1,7,elastic fiber assembly,BP,MYH11
7096,GO:0022406,0.105742159841633,0.960334409630891,5,169,membrane docking,BP,MARK4;RAB40B;RAB40A;RALB;MSN
12873,GO:0046915,0.10593094111573,0.982220950207813,2,38,transition metal ion transmembrane transporter activity,MF,TF;TTYH1
9698,GO:0035136,0.105998811473745,0.982202966484525,2,38,forelimb morphogenesis,BP,WNT3;WNT7A
2868,GO:0005902,0.10617695154998,0.972561814818562,3,78,microvillus,CC,ESPN;MSN;MYO7A
6223,GO:0017002,0.106183947016641,0.994980768031423,1,7,activin-activated receptor activity,MF,ACVR1
3999,GO:0008199,0.10639815701967,0.994716523470265,1,10,ferric iron binding,MF,TF
11153,GO:0043029,0.106512496754321,0.982033891464149,2,40,T cell homeostasis,BP,PMAIP1;AKT1
8280,GO:0032091,0.106550958946931,0.972402473784781,3,81,negative regulation of protein binding,BP,ZFPM1;PDGFB;RALB
18094,GO:0098631,0.106558401966235,0.982054422682141,2,38,protein binding involved in cell adhesion,MF,DSC2;PKP3
19206,GO:1902554,0.106596988893581,0.972392488244732,3,80,serine/threonine protein kinase complex,CC,ACVR1;SESN2;CDKN1A
8925,GO:0033083,0.106712081195211,0.994827440388118,1,8,regulation of immature T cell proliferation,BP,BMP4
11841,GO:0044557,0.106821080075063,0.994816638366688,1,8,relaxation of smooth muscle,BP,ADORA1
8072,GO:0031670,0.106824954769054,0.981966630705949,2,39,cellular response to nutrient,BP,GAS6;VDR
15919,GO:0070391,0.106940247378875,0.994725105546624,1,9,response to lipoteichoic acid,BP,CCL20
16338,GO:0071223,0.106940247378875,0.994725105546624,1,9,cellular response to lipoteichoic acid,BP,CCL20
5242,GO:0014731,0.106950463853633,0.994906427757871,1,7,spectrin-associated cytoskeleton,CC,SPTB
19413,GO:1903025,0.107095546633324,0.994645550837079,1,10,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,LIF
7445,GO:0030432,0.107116661355961,0.994707312653347,1,9,peristalsis,BP,GDNF
17218,GO:0080090,0.10714056673118,0.915856533431706,88,5552,regulation of primary metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;PMAIP1;GADD45A;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;DKK3;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;MSN;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;CST9L;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;PM20D2;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
12184,GO:0045429,0.107217798266283,0.981845713826466,2,40,positive regulation of nitric oxide biosynthetic process,BP,EDN1;AKT1
20065,GO:1904407,0.107217798266283,0.981845713826466,2,40,positive regulation of nitric oxide metabolic process,BP,EDN1;AKT1
21218,GO:2000427,0.107283095552892,0.994770721048948,1,8,positive regulation of apoptotic cell clearance,BP,MFGE8
12060,GO:0045162,0.107390227627188,0.994863519740351,1,7,clustering of voltage-gated sodium channels,BP,SPTBN4
1516,GO:0003256,0.107421506947068,0.994860460635847,1,7,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,NOTCH1
18499,GO:1900125,0.107520226402597,0.99485079967406,1,7,regulation of hyaluronan biosynthetic process,BP,PDGFB
13801,GO:0051011,0.107629961510044,0.994840049566212,1,7,microtubule minus-end binding,MF,CAMSAP3
21051,GO:2000192,0.107703994772538,0.994832790343051,1,7,negative regulation of fatty acid transport,BP,AKT1
1004,GO:0002318,0.107803786712368,0.994822996953247,1,7,myeloid progenitor cell differentiation,BP,JAM3
8399,GO:0032306,0.10783868187116,0.99456937906962,1,10,regulation of prostaglandin secretion,BP,EDN1
8400,GO:0032308,0.10783868187116,0.99456937906962,1,10,positive regulation of prostaglandin secretion,BP,EDN1
20792,GO:1990459,0.108023050119226,0.994696740280854,1,8,transferrin receptor binding,MF,TF
15735,GO:0070099,0.10815516731704,0.994683474084303,1,8,regulation of chemokine-mediated signaling pathway,BP,EDN1
13771,GO:0050942,0.108159795479797,0.994787979989349,1,7,positive regulation of pigment cell differentiation,BP,KITLG
9113,GO:0033574,0.108214090909296,0.981534260904088,2,43,response to testosterone,BP,EDN1;MSN
10028,GO:0035747,0.108241384793578,0.994474504368376,1,11,natural killer cell chemotaxis,BP,PIK3CG
7493,GO:0030551,0.108247781442556,0.98162122774789,2,37,cyclic nucleotide binding,MF,PRKAR1B;PDE4B
4928,GO:0010668,0.108302323616407,0.994773926367176,1,7,ectodermal cell differentiation,BP,FZD7
12430,GO:0045931,0.108373987056522,0.964535275045587,4,126,positive regulation of mitotic cell cycle,BP,EDN1;FGF10;PDGFB;FGF8
9781,GO:0035338,0.108435716344895,0.981503420863245,2,41,long-chain fatty-acyl-CoA biosynthetic process,BP,FASN;ACSL4
18281,GO:0099024,0.108654102378161,0.981460156396092,2,40,plasma membrane invagination,BP,MFGE8;SNX18
5243,GO:0014732,0.108701569477238,0.994628424720438,1,8,skeletal muscle atrophy,BP,ACTN3
3721,GO:0007221,0.108732874398617,0.994731352889259,1,7,positive regulation of transcription of Notch receptor target,BP,NOTCH1
20848,GO:1990712,0.10873439977811,0.994625107674166,1,8,HFE-transferrin receptor complex,CC,TF
17274,GO:0086042,0.108839294910813,0.99472080204881,1,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,DSC2
13978,GO:0051260,0.108851814026288,0.950817413263994,7,283,protein homooligomerization,BP,ACTN2;SPTBN5;PRND;CLDN1;CLDN3;KCNG2;KCND1
11254,GO:0043197,0.108941055089889,0.964311540262517,4,120,dendritic spine,CC,ACTN2;ADORA1;LZTS1;PDE4B
11015,GO:0042748,0.10900041405664,0.994515369318788,1,9,circadian sleep/wake cycle, non-REM sleep,BP,ADORA1
11351,GO:0043331,0.109128217927083,0.971419037787953,3,85,response to dsRNA,BP,PMAIP1;RALB;BMP4
21264,GO:2000508,0.109148769678293,0.994433726754575,1,10,regulation of dendritic cell chemotaxis,BP,GAS6
2875,GO:0005915,0.109150478524925,0.99468988709069,1,7,zonula adherens,CC,CAMSAP3
6867,GO:0021575,0.109188434187883,0.981349888284358,2,38,hindbrain morphogenesis,BP,WNT7A;DLL1
11297,GO:0043255,0.109198071044659,0.971450172441071,3,77,regulation of carbohydrate biosynthetic process,BP,PDGFB;SESN2;AKT1
7383,GO:0030314,0.109648273621557,0.994640236707552,1,7,junctional membrane complex,CC,CASQ2
3567,GO:0006975,0.109794109502088,0.994517464021271,1,8,DNA damage induced protein phosphorylation,BP,MAPK12
1065,GO:0002431,0.109827150841258,0.971215321494404,3,77,Fc receptor mediated stimulatory signaling pathway,BP,PIK3R2;PIK3R1;PIK3CA
20955,GO:2000020,0.10984332088419,0.994512438105109,1,8,positive regulation of male gonad development,BP,WT1
15384,GO:0061140,0.109849723115751,0.994360429412076,1,10,lung secretory cell differentiation,BP,FGF10
18612,GO:1900452,0.109915538935955,0.994613479809607,1,7,regulation of long term synaptic depression,BP,ADORA1
10748,GO:0042297,0.10991613122488,0.994613420436042,1,7,vocal learning,BP,STRA6
18083,GO:0098596,0.10991613122488,0.994613420436042,1,7,imitative learning,BP,STRA6
80,GO:0000160,0.110035495785106,0.994601447839319,1,7,phosphorelay signal transduction system,BP,KCNH2
21244,GO:2000480,0.110156698055388,0.994480376701008,1,8,negative regulation of cAMP-dependent protein kinase activity,BP,PRKAR1B
12563,GO:0046189,0.110182802927002,0.981046350990713,2,40,phenol-containing compound biosynthetic process,BP,PNMT;WNT5A
2497,GO:0005167,0.110250242901622,0.994579873102548,1,7,neurotrophin TRK receptor binding,MF,PIK3R1
19405,GO:1903011,0.110399749837759,0.994455443018844,1,8,negative regulation of bone development,BP,CLDN18
1138,GO:0002548,0.110447606937697,0.980764128983392,2,59,monocyte chemotaxis,BP,CCL20;PDGFB
16346,GO:0071233,0.110494806126934,0.994555248050155,1,7,cellular response to leucine,BP,SESN2
15700,GO:0070050,0.110498640823983,0.994445281387352,1,8,neuron cellular homeostasis,BP,TYRO3
16958,GO:0072257,0.110515895078541,0.994553121870749,1,7,metanephric nephron tubule epithelial cell differentiation,BP,LIF
16988,GO:0072307,0.110515895078541,0.994553121870749,1,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,LIF
19792,GO:1903800,0.110529356222048,0.994442123219687,1,8,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
21471,GO:2000807,0.110549354269016,0.994549747638001,1,7,regulation of synaptic vesicle clustering,BP,CDH2
5036,GO:0010838,0.110651587083772,0.994344186561128,1,9,positive regulation of keratinocyte proliferation,BP,FGF10
11415,GO:0043467,0.110789025217656,0.970831775317804,3,80,regulation of generation of precursor metabolites and energy,BP,ACTN3;AKT1;PIK3CA
2453,GO:0005113,0.110848025046947,0.994409302208631,1,8,patched binding,MF,DHH
12344,GO:0045776,0.110992863335079,0.980779588293608,2,43,negative regulation of blood pressure,BP,ADORA1;KCNK6
14357,GO:0051963,0.11132263569327,0.970671189456337,3,75,regulation of synapse assembly,BP,WNT7A;WNT5A;RAB17
12588,GO:0046322,0.111368402657246,0.994355489146687,1,8,negative regulation of fatty acid oxidation,BP,AKT1
9953,GO:0035630,0.111476568887712,0.994344269668092,1,8,bone mineralization involved in bone maturation,BP,BMP2
10625,GO:0042045,0.111506558486189,0.994341156951828,1,8,epithelial fluid transport,BP,EDN1
13423,GO:0048819,0.111540404984567,0.994337642839797,1,8,regulation of hair follicle maturation,BP,WNT5A
832,GO:0002028,0.111571316235033,0.97052279227674,3,82,regulation of sodium ion transport,BP,SPTBN4;WNK4;AKT1
19110,GO:1902282,0.11164036467154,0.994327257867125,1,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,KCNH2
16309,GO:0071158,0.111713785865927,0.970461985208907,3,83,positive regulation of cell cycle arrest,BP,GADD45A;FOXO4;CDKN1A
8486,GO:0032426,0.11177751194111,0.994312993222345,1,8,stereocilium tip,CC,ESPN
2860,GO:0005891,0.112178730521474,0.980536106734377,2,38,voltage-gated calcium channel complex,CC,CASQ2;PDE4B
12892,GO:0046949,0.112285502024227,0.980439399023389,2,42,fatty-acyl-CoA biosynthetic process,BP,FASN;ACSL4
20516,GO:1905456,0.112482150731209,0.994239408450536,1,8,regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
5647,GO:0015858,0.112587792400559,0.994228333726643,1,8,nucleoside transport,BP,ADORA1
10878,GO:0042516,0.112603983266671,0.98033667099599,2,43,regulation of tyrosine phosphorylation of Stat3 protein,BP,LIF;CLCF1
12868,GO:0046907,0.112687285257807,0.921970228118063,29,1646,intracellular transport,BP,SYT5;RAB6C;RAB27A;WNT7A;NMT2;ADORA1;SPTBN5;SPTBN4;FZD7;PRR5L;PIK3R2;PIK3R1;REEP1;GPRASP1;RHOB;SPTB;BMP7;BMP6;BMP4;CDKN1A;CHGA;MSN;AKT1;RAB12;RAB17;CDH1;MYO7A;PIK3CG;GAS6
15775,GO:0070170,0.112713830629197,0.99412652307185,1,9,regulation of tooth mineralization,BP,WNT6
5270,GO:0014820,0.112980288929499,0.994187089676315,1,8,tonic smooth muscle contraction,BP,EDN1
10999,GO:0042726,0.113014608154769,0.994183476061131,1,8,flavin-containing compound metabolic process,BP,SLC52A3
4057,GO:0008289,0.113055597245572,0.935039872716355,13,631,lipid binding,MF,SYT5;ACTN2;SERPINA5;MFGE8;SPTBN4;FZD7;LPAR2;SNX18;AKT1;EPN1;GAS6;VDR;UNC119
3501,GO:0006875,0.113122130293468,0.94035099000389,10,472,cellular metal ion homeostasis,BP,CDH23;TF;CASQ2;EDN1;PRND;LPAR2;BMP6;PIK3CG;VDR;CLDN16
6742,GO:0019869,0.113346807169251,0.994058852043091,1,9,chloride channel inhibitor activity,MF,WNK4
3665,GO:0007157,0.113436831293184,0.980171250673967,2,39,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ITGA5;CDH2
6478,GO:0019062,0.113673479597277,0.994113872818782,1,8,virion attachment to host cell,BP,GAS6
11858,GO:0044650,0.113673479597277,0.994113872818782,1,8,adhesion of symbiont to host cell,BP,GAS6
14686,GO:0060056,0.113776592695344,0.994012672838114,1,9,mammary gland involution,BP,VDR
4424,GO:0009150,0.113832020068651,0.9398793656133,10,507,purine ribonucleotide metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
4635,GO:0009750,0.114071295196684,0.994071637681104,1,8,response to fructose,BP,KHK
2305,GO:0004872,0.114190376037252,0.922932931981746,25,1537,receptor activity,MF,ITGA5;ADRA2B;ADRA2C;NOTCH1;STRA6;ITGB5;ITGB4;ITGB8;ACVR1;GUCY1B3;ADORA1;KCNK6;FZD7;TYRO3;LPAR2;KCNH2;NPR1;SDC4;DDR1;CLDN1;CLDN3;VDR;AMOT;FZD8;EFNB2
14714,GO:0060089,0.114190376037252,0.922932931981746,25,1537,molecular transducer activity,MF,ITGA5;ADRA2B;ADRA2C;NOTCH1;STRA6;ITGB5;ITGB4;ITGB8;ACVR1;GUCY1B3;ADORA1;KCNK6;FZD7;TYRO3;LPAR2;KCNH2;NPR1;SDC4;DDR1;CLDN1;CLDN3;VDR;AMOT;FZD8;EFNB2
10301,GO:0036294,0.114339089967014,0.956043563453369,5,188,cellular response to decreased oxygen levels,BP,NOTCH1;PMAIP1;EDN1;BMP7;AKT1
11729,GO:0044309,0.114383784895264,0.961877556725042,4,122,neuron spine,CC,ACTN2;ADORA1;LZTS1;PDE4B
5102,GO:0010917,0.114394865268402,0.993945913066844,1,9,negative regulation of mitochondrial membrane potential,BP,PMAIP1
17345,GO:0090037,0.114399705250855,0.994036652029061,1,8,positive regulation of protein kinase C signaling,BP,WNT5A
15041,GO:0060556,0.114438644361134,0.99394117120646,1,9,regulation of vitamin D biosynthetic process,BP,VDR
12011,GO:0045080,0.11447136212304,0.993864598246915,1,10,positive regulation of chemokine biosynthetic process,BP,WNT5A
19544,GO:1903312,0.114669724088121,0.979847920177424,2,38,negative regulation of mRNA metabolic process,BP,PKP3;PKP1
2809,GO:0005801,0.11469259765774,0.979805009543951,2,40,cis-Golgi network,CC,PIK3R1;CTGF
15610,GO:0061700,0.11484302492384,0.993989254026595,1,8,GATOR2 complex,CC,SESN2
9453,GO:0034446,0.114970256717474,0.969263762998789,3,78,substrate adhesion-dependent cell spreading,BP,FZD7;TYRO3;LAMA5
12048,GO:0045136,0.115109516047738,0.993868263777921,1,9,development of secondary sexual characteristics,BP,WNT5A
758,GO:0001933,0.115606700104644,0.941140457449592,9,389,negative regulation of protein phosphorylation,BP,LIF;GADD45A;PRR5L;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
3854,GO:0007595,0.115694650009174,0.979525037886242,2,40,lactation,BP,DDR1;VDR
8596,GO:0032585,0.115733459144114,0.993800046530618,1,9,multivesicular body membrane,CC,RAB27A
16897,GO:0072172,0.115772717139029,0.993795741142072,1,9,mesonephric tubule formation,BP,GDNF
8866,GO:0032984,0.115850867541276,0.950609844847745,6,258,macromolecular complex disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;AXIN1;SPTB
2548,GO:0005267,0.115871935995765,0.961197249011558,4,124,potassium channel activity,MF,KCNK6;KCNH2;KCNG2;KCND1
10925,GO:0042583,0.115945532624179,0.993870525788508,1,8,chromaffin granule,CC,CHGA
14811,GO:0060255,0.116559209697338,0.907879208899388,89,5664,regulation of macromolecule metabolic process,BP,ITGA3;ITGA5;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;ITGB8;PMAIP1;GADD45A;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;SALL4;ADORA1;DKK3;EDN1;PRKACB;CCL20;SPTBN4;MAPK12;FZD7;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;PSRC1;FGF8;SDC4;CLCF1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;MSN;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;CST9L;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;PM20D2;SHC4;VDR;ARAF;UNC119;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
18864,GO:1901626,0.11663974765141,0.993700255616589,1,9,regulation of postsynaptic membrane organization,BP,CDH2
13571,GO:0050670,0.116646024291882,0.954871773176626,5,194,regulation of lymphocyte proliferation,BP,FGF10;SDC4;CLCF1;BMP4;CDKN1A
19594,GO:1903409,0.116768887362284,0.968513450976983,3,86,reactive oxygen species biosynthetic process,BP,RAB27A;EDN1;AKT1
2707,GO:0005641,0.116924460197512,0.993764085571379,1,8,nuclear envelope lumen,CC,PTGES
604,GO:0001709,0.117005082661002,0.979139211931122,2,41,cell fate determination,BP,BMP4;DLL1
15284,GO:0060982,0.11716370752003,0.993737925788975,1,8,coronary artery morphogenesis,BP,NOTCH1
18854,GO:1901615,0.117245986922539,0.937757838774807,10,457,organic hydroxy compound metabolic process,BP,WNT4;ACTN3;PNMT;HMGCS2;DKK3;WNT5A;NPR1;BMP6;BMP2;VDR
9080,GO:0033483,0.117417374309561,0.993613966083107,1,9,gas homeostasis,BP,WNT7B
14739,GO:0060137,0.117455118923472,0.993609762090238,1,9,maternal process involved in parturition,BP,EDN1
9375,GO:0034331,0.117499385630232,0.993701125279309,1,8,cell junction maintenance,BP,CAMSAP3
5019,GO:0010820,0.117623627558689,0.993513856800742,1,10,positive regulation of T cell chemotaxis,BP,WNT5A
13166,GO:0048262,0.117822527155905,0.993568764437365,1,9,determination of dorsal/ventral asymmetry,BP,ACVR1
12378,GO:0045839,0.117834455632289,0.978904543061977,2,41,negative regulation of mitotic nuclear division,BP,BMP7;BMP4
10869,GO:0042503,0.117864586665767,0.978848020332828,2,44,tyrosine phosphorylation of Stat3 protein,BP,LIF;CLCF1
19453,GO:1903115,0.117942320504665,0.978910135730785,2,39,regulation of actin filament-based movement,BP,DSC2;PDE4B
15536,GO:0061525,0.118019909303087,0.993643836459606,1,8,hindgut development,BP,WNT5A
15301,GO:0061004,0.118125568118791,0.993534845861524,1,9,pattern specification involved in kidney development,BP,BMP4
16817,GO:0072048,0.118125568118791,0.993534845861524,1,9,renal system pattern specification,BP,BMP4
17584,GO:0090400,0.118152489825634,0.9936292011852,1,8,stress-induced premature senescence,BP,CDKN1A
15024,GO:0060534,0.118169120670642,0.9936273640965,1,8,trachea cartilage development,BP,WNT7B
5441,GO:0015232,0.118255072600996,0.993617865183024,1,8,heme transporter activity,MF,FLVCR2
14894,GO:0060363,0.118353436507055,0.993509279552666,1,9,cranial suture morphogenesis,BP,BMP4
16462,GO:0071415,0.118381560398319,0.993603872983126,1,8,cellular response to purine-containing compound,BP,CASQ2
10394,GO:0036490,0.118410681512889,0.993600649301776,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,SESN2
2525,GO:0005225,0.118694605946591,0.993569174469448,1,8,volume-sensitive anion channel activity,MF,TTYH1
8841,GO:0032944,0.118730747931898,0.953817098010522,5,195,regulation of mononuclear cell proliferation,BP,FGF10;SDC4;CLCF1;BMP4;CDKN1A
15124,GO:0060693,0.118913333912338,0.993446235659183,1,9,regulation of branching involved in salivary gland morphogenesis,BP,FGF10
10860,GO:0042492,0.119077685795984,0.99352657922547,1,8,gamma-delta T cell differentiation,BP,JAG2
16853,GO:0072102,0.11912100654361,0.993521753038814,1,8,glomerulus morphogenesis,BP,BMP4
5674,GO:0015908,0.119235852953868,0.967544291165756,3,88,fatty acid transport,BP,EDN1;AKT1;ACSL4
15064,GO:0060586,0.119245288265084,0.993408707037924,1,9,multicellular organismal iron ion homeostasis,BP,BMP6
6723,GO:0019838,0.119278854652428,0.959634529474203,4,127,growth factor binding,MF,ITGB4;ACVR1;PDGFB;CTGF
18858,GO:1901620,0.119382514547853,0.993492579423095,1,8,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
6523,GO:0019203,0.119402065059007,0.993390943794235,1,9,carbohydrate phosphatase activity,MF,PFKFB3
13501,GO:0050308,0.119402065059007,0.993390943794235,1,9,sugar-phosphatase activity,MF,PFKFB3
21323,GO:2000587,0.119529327580103,0.993476170934793,1,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
7105,GO:0022600,0.119685989500441,0.967349204031555,3,91,digestive system process,BP,FGF10;WNK4;VDR
15112,GO:0060677,0.119865386396308,0.993438529845732,1,8,ureteric bud elongation,BP,BMP4
16783,GO:0071985,0.119944998358501,0.993329234160458,1,9,multivesicular body sorting pathway,BP,RAB27A
7605,GO:0030833,0.119989643205004,0.95928265743618,4,133,regulation of actin filament polymerization,BP,FHOD3;SPTBN5;SPTBN4;SPTB
17058,GO:0072497,0.120054993758263,0.993417242253386,1,8,mesenchymal stem cell differentiation,BP,WNT3
14659,GO:0060027,0.120135904555476,0.993408147221331,1,8,convergent extension involved in gastrulation,BP,WNT5A
2298,GO:0004862,0.120305248214239,0.993288122219232,1,9,cAMP-dependent protein kinase inhibitor activity,MF,PRKAR1B
10121,GO:0035912,0.12040372151332,0.993377995394081,1,8,dorsal aorta morphogenesis,BP,HEY1
8231,GO:0032007,0.120435555485351,0.978180118034552,2,40,negative regulation of TOR signaling,BP,SESN2;SH3BP4
19820,GO:1903867,0.120496068502166,0.993367581878695,1,8,extraembryonic membrane development,BP,BMP7
14827,GO:0060281,0.120612998586863,0.993252896582943,1,9,regulation of oocyte development,BP,NPPC
20633,GO:1905879,0.120612998586863,0.993252896582943,1,9,regulation of oogenesis,BP,NPPC
13344,GO:0048672,0.120656129824324,0.993247951977582,1,9,positive regulation of collateral sprouting,BP,WNT3
13977,GO:0051259,0.120672680054045,0.935560652130073,10,478,protein oligomerization,BP,ACTN2;PMAIP1;SPTBN5;PRND;HRAS;GJB1;CLDN1;CLDN3;KCNG2;KCND1
11321,GO:0043295,0.120712930123313,0.993093790902591,1,11,glutathione binding,MF,PTGES
18650,GO:1901016,0.12078622272198,0.978061041630483,2,41,regulation of potassium ion transmembrane transporter activity,BP,ACTN2;CASQ2
5392,GO:0015144,0.120828482439745,0.978048871502025,2,41,carbohydrate transmembrane transporter activity,MF,SLC45A4;SLC2A14
18804,GO:1901476,0.120828482439745,0.978048871502025,2,41,carbohydrate transporter activity,MF,SLC45A4;SLC2A14
15832,GO:0070255,0.120845848308045,0.993226179904866,1,9,regulation of mucus secretion,BP,ADORA1
7292,GO:0030193,0.120887951127659,0.966935616253365,3,83,regulation of blood coagulation,BP,EDN1;PLAU;PDGFB
18455,GO:1900046,0.120887951127659,0.966935616253365,3,83,regulation of hemostasis,BP,EDN1;PLAU;PDGFB
17249,GO:0086009,0.120956232510914,0.978030374422704,2,40,membrane repolarization,BP,CASQ2;KCNH2
7023,GO:0021891,0.121041475259554,0.993305903817662,1,8,olfactory bulb interneuron development,BP,WNT5A
21463,GO:2000794,0.121226549253493,0.99328490634579,1,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
17688,GO:0097011,0.12123307518569,0.993181627625686,1,9,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,AKT1
17689,GO:0097012,0.12123307518569,0.993181627625686,1,9,response to granulocyte macrophage colony-stimulating factor,BP,AKT1
9839,GO:0035457,0.121365664014865,0.99326910041852,1,8,cellular response to interferon-alpha,BP,GAS6
18527,GO:1900165,0.121401083556446,0.993265073007571,1,8,negative regulation of interleukin-6 secretion,BP,GAS6
18411,GO:0102391,0.12159174968156,0.993243371405702,1,8,decanoate--CoA ligase activity,MF,ACSL4
1522,GO:0003266,0.121717108118609,0.993125721753305,1,9,regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
677,GO:0001821,0.121922137747553,0.993019089824619,1,10,histamine secretion,BP,EDN1
41,GO:0000082,0.121992770821299,0.947309192428533,6,236,G1/S transition of mitotic cell cycle,BP,GADD45A;ACVR1;FGF10;CDKN1A;AKT1;PIM2
60,GO:0000122,0.122093881019366,0.926043173263349,15,742,negative regulation of transcription from RNA polymerase II promoter,BP,NOTCH1;ZFPM1;SALL4;EDN1;PDGFB;AXIN1;BMP6;BMP4;BMP2;WT1;TLE1;SIN3B;VDR;FZD8;HEY1
20660,GO:1905941,0.122098605936972,0.992998370175627,1,10,positive regulation of gonad development,BP,WT1
14182,GO:0051639,0.122154852892848,0.993179064931981,1,8,actin filament network formation,BP,FHOD3
21635,GO:2001233,0.122548793700206,0.939651706876704,8,362,regulation of apoptotic signaling pathway,BP,WNT4;PMAIP1;ACVR1;FGF10;BMP4;AKT1;INHBB;GDNF
5311,GO:0014891,0.122697953444874,0.993011698841793,1,9,striated muscle atrophy,BP,ACTN3
8268,GO:0032070,0.122717531742244,0.992925445505159,1,10,regulation of deoxyribonuclease activity,BP,AKT1
3530,GO:0006913,0.122845018586734,0.934188612405319,10,457,nucleocytoplasmic transport,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
18067,GO:0098562,0.122845317735582,0.951772832634331,5,177,cytoplasmic side of membrane,CC,PTPN7;SNX18;SPTB;CDH1;MYZAP
15230,GO:0060872,0.12296054806794,0.992981005128564,1,9,semicircular canal development,BP,FGF10
8260,GO:0032055,0.122984655788911,0.992978183725491,1,9,negative regulation of translation in response to stress,BP,SESN2
13941,GO:0051205,0.1230076415233,0.977351097982059,2,45,protein insertion into membrane,BP,PMAIP1;REEP1
4365,GO:0009071,0.123029345999566,0.992888555858009,1,10,serine family amino acid catabolic process,BP,GLDC
21421,GO:2000736,0.123595143936969,0.977265275701351,2,40,regulation of stem cell differentiation,BP,NOTCH1;GDNF
19632,GO:1903507,0.123622169236679,0.918706360304222,21,1143,negative regulation of nucleic acid-templated transcription,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
10876,GO:0042511,0.123678487584589,0.992741712902636,1,11,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,LIF
438,GO:0001135,0.123726163847599,0.992997927441537,1,8,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,LIF
1444,GO:0003149,0.123746253590629,0.992888744830917,1,9,membranous septum morphogenesis,BP,BMP4
21357,GO:2000643,0.123862573444706,0.992982084680135,1,8,positive regulation of early endosome to late endosome transport,BP,MSN
3462,GO:0006811,0.124036736069496,0.914294378017777,27,1514,ion transport,BP,ACTN2;CDH23;TF;SLC52A3;ADORA1;CASQ2;EDN1;KCNK6;SPTBN4;TTYH1;TSPAN13;PDGFB;KCNH2;SFXN1;WNK4;CTGF;AKT1;PIK3CG;KCNG2;GAS6;VDR;KCND1;GDNF;ACSL4;CLDN16;CLDN15;PDE4B
9571,GO:0034702,0.124289231594875,0.942025541574852,7,275,ion channel complex,CC,CASQ2;KCNK6;TTYH1;KCNH2;KCNG2;KCND1;PDE4B
733,GO:0001894,0.124568867504027,0.950853503346346,5,189,tissue homeostasis,BP,CDH23;TF;CTGF;RAB3D;CLDN18
18084,GO:0098597,0.124692568437576,0.992885282275921,1,8,observational learning,BP,STRA6
867,GO:0002072,0.124724011767454,0.99288160132537,1,8,optic cup morphogenesis involved in camera-type eye development,BP,WNT5A
16808,GO:0072033,0.124887146651598,0.992862487671797,1,8,renal vesicle formation,BP,WNT4
11182,GO:0043086,0.125031830338016,0.923954725528225,15,811,negative regulation of catalytic activity,BP,NOTCH1;GADD45A;SERPINA5;PRKAR1B;HRAS;BMP7;BMP4;CAMSAP3;CDKN1A;AKT1;CST9L;GAS6;AMOT;SH3BP4;DUSP5
17626,GO:0090557,0.125066519548749,0.992841440376938,1,8,establishment of endothelial intestinal barrier,BP,CLDN1
16448,GO:0071394,0.125155494085088,0.992721680079431,1,9,cellular response to testosterone stimulus,BP,MSN
5018,GO:0010819,0.125293053949765,0.992546161914472,1,11,regulation of T cell chemotaxis,BP,WNT5A
17741,GO:0097104,0.125315322129176,0.99281219235315,1,8,postsynaptic membrane assembly,BP,CDH2
13868,GO:0051100,0.12583684942534,0.956559075849034,4,137,negative regulation of binding,BP,ZFPM1;PDGFB;RALB;HEY1
15055,GO:0060576,0.125869020926175,0.992547962988703,1,10,intestinal epithelial cell development,BP,CDKN1A
17318,GO:0086103,0.126036752583612,0.992616170488138,1,9,G-protein coupled receptor signaling pathway involved in heart process,BP,CHGA
17921,GO:0097449,0.12610815247555,0.992607587087441,1,9,astrocyte projection,CC,GJB2
8000,GO:0031532,0.126176067802813,0.964828795330774,3,85,actin cytoskeleton reorganization,BP,FGF10;HRAS;PARVB
5084,GO:0010896,0.12625492267507,0.992367855493322,1,12,regulation of triglyceride catabolic process,BP,PIK3CG
11940,GO:0044851,0.12627480858326,0.992587531968145,1,9,hair cycle phase,BP,WNT5A
19542,GO:1903307,0.126348740516906,0.976383254198569,2,44,positive regulation of regulated secretory pathway,BP,RAB27A;RAB3D
6546,GO:0019233,0.126670048519262,0.964608530587804,3,88,sensory perception of pain,BP,ADRA2C;ADORA1;EDN1
12894,GO:0046951,0.126777186527247,0.992526903684039,1,9,ketone body biosynthetic process,BP,HMGCS2
17929,GO:0097459,0.127363681897554,0.992455795088754,1,9,iron ion import into cell,BP,TF
2434,GO:0005080,0.127417328836428,0.976100329121066,2,42,protein kinase C binding,MF,SDC4;AKT1
14168,GO:0051601,0.127553397115732,0.992432717542992,1,9,exocyst localization,BP,RALB
2303,GO:0004869,0.127632113091644,0.975833572524007,2,57,cysteine-type endopeptidase inhibitor activity,MF,CST9L;GAS6
6589,GO:0019371,0.127732068140823,0.992245572854262,1,11,cyclooxygenase pathway,BP,PTGES
20966,GO:2000045,0.127792939707691,0.955646625117166,4,136,regulation of G1/S transition of mitotic cell cycle,BP,GADD45A;FGF10;CDKN1A;AKT1
13645,GO:0050768,0.127870594005469,0.944073712245401,6,232,negative regulation of neurogenesis,BP,WNT3;NOTCH1;WNT7A;WNT5A;BMP7;DLL1
9027,GO:0033273,0.128056571179222,0.964037319482316,3,90,response to vitamin,BP,BMP7;GAS6;VDR
977,GO:0002279,0.128113545787367,0.975840744137183,2,45,mast cell activation involved in immune response,BP,CHGA;PIK3CG
11328,GO:0043303,0.128113545787367,0.975840744137183,2,45,mast cell degranulation,BP,CHGA;PIK3CG
7385,GO:0030316,0.128124397081345,0.964039717307013,3,86,osteoclast differentiation,BP,FSTL3;PIK3R1;CLDN18
13099,GO:0048087,0.128396311782761,0.992329734097892,1,9,positive regulation of developmental pigmentation,BP,KITLG
18085,GO:0098598,0.128437986877106,0.992324623413451,1,9,learned vocalization behavior or vocal learning,BP,STRA6
6929,GO:0021700,0.128488507777314,0.943718892346161,6,237,developmental maturation,BP,SPTBN4;WNT5A;BMP2;CDKN1A;NPPC;RAB38
4799,GO:0010454,0.128504624765618,0.992149057921291,1,11,negative regulation of cell fate commitment,BP,FZD7
15885,GO:0070341,0.128512969029807,0.992148012050586,1,11,fat cell proliferation,BP,FGF10
15888,GO:0070344,0.128512969029807,0.992148012050586,1,11,regulation of fat cell proliferation,BP,FGF10
17527,GO:0090303,0.128579015167431,0.975685321473388,2,46,positive regulation of wound healing,BP,HRAS;HBEGF
7328,GO:0030235,0.128696625508854,0.992292866060386,1,9,nitric-oxide synthase regulator activity,MF,AKT1
9779,GO:0035336,0.128797315279985,0.97563557440944,2,45,long-chain fatty-acyl-CoA metabolic process,BP,FASN;ACSL4
11517,GO:0043623,0.128965903817394,0.927975776181709,11,548,cellular protein complex assembly,BP,FHOD3;TUBG2;CASQ2;SPTBN5;SPTBN4;RALB;AXIN1;PSRC1;SPTB;VAMP1;MYH11
9967,GO:0035646,0.129040309223546,0.992157684272062,1,10,endosome to melanosome transport,BP,RAB38
11423,GO:0043485,0.129040309223546,0.992157684272062,1,10,endosome to pigment granule transport,BP,RAB38
13397,GO:0048757,0.129040309223546,0.992157684272062,1,10,pigment granule maturation,BP,RAB38
15235,GO:0060896,0.129434093543725,0.992201935673565,1,9,neural plate pattern specification,BP,AXIN1
8246,GO:0032036,0.129565840210638,0.991951723515061,1,12,myosin heavy chain binding,MF,SPTBN5
19090,GO:1902237,0.129591209419801,0.992088817848451,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
14269,GO:0051798,0.129686836785959,0.99200014871936,1,11,positive regulation of hair follicle development,BP,WNT5A
3843,GO:0007566,0.129748503460822,0.975302926786016,2,48,embryo implantation,BP,LIF;DDR1
9382,GO:0034341,0.129767372570845,0.954632089465093,4,158,response to interferon-gamma,BP,EDN1;CCL20;WNT5A;CLDN1
2170,GO:0004690,0.129771366534751,0.99216016242507,1,9,cyclic nucleotide-dependent protein kinase activity,MF,PRKACB
21016,GO:2000121,0.129786876526961,0.992064281782466,1,10,regulation of removal of superoxide radicals,BP,BMP7
5667,GO:0015886,0.129789508142329,0.992157912148121,1,9,heme transport,BP,FLVCR2
7608,GO:0030836,0.130028991650186,0.992128174830174,1,9,positive regulation of actin filament depolymerization,BP,ACTN2
19925,GO:1904062,0.130275286084647,0.942704944803975,6,245,regulation of cation transmembrane transport,BP,ACTN2;CASQ2;TSPAN13;KCNH2;PIK3CG;PDE4B
1428,GO:0003128,0.130296012238471,0.99200025018609,1,10,heart field specification,BP,BMP4
7032,GO:0021903,0.130425388559779,0.991906374642137,1,11,rostrocaudal neural tube patterning,BP,FGF8
6914,GO:0021683,0.130456789594076,0.992074906404288,1,9,cerebellar granular layer morphogenesis,BP,WNT7A
13770,GO:0050932,0.130544864305242,0.992063916042701,1,9,regulation of pigment cell differentiation,BP,KITLG
12289,GO:0045665,0.130546975414131,0.947778249924671,5,181,negative regulation of neuron differentiation,BP,WNT3;NOTCH1;WNT5A;BMP7;DLL1
3021,GO:0006163,0.130752010558204,0.929032413702434,10,523,purine nucleotide metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
16687,GO:0071803,0.130885407298852,0.99192578623073,1,10,positive regulation of podosome assembly,BP,MSN
5938,GO:0016461,0.130949689301558,0.991917642885958,1,10,unconventional myosin complex,CC,MYO7A
11802,GO:0044432,0.131024544173054,0.913188048024182,21,1135,endoplasmic reticulum part,CC,WNT3;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;CASQ2;EDN1;MBOAT2;TTYH1;TYRO3;PIK3R1;REEP1;PDGFB;WNT5B;WNT5A;GJB1;PTGES;GAS6;GPSM1;ACSL4
10374,GO:0036465,0.131103709727375,0.97501173222814,2,41,synaptic vesicle recycling,BP,SYT5;WNT7A
14152,GO:0051583,0.131237437822055,0.991802604328078,1,11,dopamine uptake involved in synaptic transmission,BP,GDNF
14336,GO:0051934,0.131237437822055,0.991802604328078,1,11,catecholamine uptake involved in synaptic transmission,BP,GDNF
17602,GO:0090493,0.131237437822055,0.991802604328078,1,11,catecholamine uptake,BP,GDNF
17603,GO:0090494,0.131237437822055,0.991802604328078,1,11,dopamine uptake,BP,GDNF
9513,GO:0034614,0.131288117598121,0.953961086512596,4,144,cellular response to reactive oxygen species,BP,GUCY1B3;RHOB;BMP7;AKT1
1001,GO:0002315,0.131362241984181,0.991961536956428,1,9,marginal zone B cell differentiation,BP,DLL1
4853,GO:0010561,0.131699377075959,0.991822351871599,1,10,negative regulation of glycoprotein biosynthetic process,BP,HBEGF
12376,GO:0045837,0.131796456072315,0.991730763708273,1,11,negative regulation of membrane potential,BP,PMAIP1
3504,GO:0006879,0.131817557607158,0.974704732433244,2,46,cellular iron ion homeostasis,BP,TF;BMP6
12064,GO:0045171,0.131829048702558,0.974752834921967,2,43,intercellular bridge,CC,PRKACB;UNC119
18636,GO:1900746,0.131840975684709,0.991804287529301,1,10,regulation of vascular endothelial growth factor signaling pathway,BP,DLL1
13914,GO:0051169,0.131926761725537,0.928314179073996,10,465,nuclear transport,BP,FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
7688,GO:0030957,0.132025616956831,0.991780700494033,1,10,Tat protein binding,MF,DLL1
14787,GO:0060215,0.132207406443662,0.991854949803063,1,9,primitive hemopoiesis,BP,ZFPM1
15437,GO:0061299,0.132310222277338,0.991841932762192,1,9,retina vasculature morphogenesis in camera-type eye,BP,RHOJ
15831,GO:0070254,0.132325738059279,0.991662440180566,1,11,mucus secretion,BP,ADORA1
16017,GO:0070561,0.13248641784157,0.991819599959522,1,9,vitamin D receptor signaling pathway,BP,VDR
4512,GO:0009259,0.132528413404587,0.927876169514782,10,522,ribonucleotide metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
14856,GO:0060315,0.132610478953571,0.991625561226406,1,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,CASQ2
11179,GO:0043083,0.132611811967166,0.991803686630814,1,9,synaptic cleft,CC,LAMA5
21053,GO:2000194,0.132706040446842,0.991613165109833,1,11,regulation of female gonad development,BP,WT1
9131,GO:0033605,0.132706526482768,0.991613102037169,1,11,positive regulation of catecholamine secretion,BP,GDNF
10514,GO:0038166,0.132715114529468,0.991692304620588,1,10,angiotensin-activated signaling pathway,BP,ACTN2
15972,GO:0070486,0.132718004589981,0.991611612455701,1,11,leukocyte aggregation,BP,BMP7
11409,GO:0043455,0.132767558068371,0.991605180009403,1,11,regulation of secondary metabolic process,BP,WNT5A
2502,GO:0005172,0.132916726179701,0.991666363140761,1,10,vascular endothelial growth factor receptor binding,MF,ITGA5
13683,GO:0050818,0.132935129960397,0.962078272529524,3,87,regulation of coagulation,BP,EDN1;PLAU;PDGFB
15185,GO:0060768,0.133003475621019,0.991655187921959,1,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
12944,GO:0047144,0.133121308845969,0.991738860352082,1,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
9349,GO:0034244,0.133172133033202,0.991633438571784,1,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
14584,GO:0055056,0.133454311899597,0.991696344808289,1,9,D-glucose transmembrane transporter activity,MF,SLC2A14
18935,GO:1901841,0.133674774387965,0.991568442975688,1,10,regulation of high voltage-gated calcium channel activity,BP,PDE4B
13264,GO:0048521,0.133829710305588,0.99134116301304,1,13,negative regulation of behavior,BP,ADORA1
14028,GO:0051346,0.133869875865462,0.932720813062545,8,384,negative regulation of hydrolase activity,BP,SERPINA5;HRAS;CAMSAP3;AKT1;CST9L;GAS6;AMOT;SH3BP4
2646,GO:0005522,0.133889719478073,0.991640581216815,1,9,profilin binding,MF,RHOQ
16487,GO:0071453,0.133984580947939,0.945926226477283,5,197,cellular response to oxygen levels,BP,NOTCH1;PMAIP1;EDN1;BMP7;AKT1
1490,GO:0003211,0.134157168270279,0.991505816043763,1,10,cardiac ventricle formation,BP,NOTCH1
15351,GO:0061081,0.134159450080182,0.991423438957456,1,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,WNT5A
18639,GO:1900750,0.134245101235378,0.99134375558864,1,12,oligopeptide binding,MF,PTGES
5300,GO:0014870,0.134335122242042,0.991482651383735,1,10,response to muscle inactivity,BP,ACTN3
5304,GO:0014877,0.134335122242042,0.991482651383735,1,10,response to muscle inactivity involved in regulation of muscle adaptation,BP,ACTN3
5312,GO:0014894,0.134335122242042,0.991482651383735,1,10,response to denervation involved in regulation of muscle adaptation,BP,ACTN3
4018,GO:0008227,0.13456718104439,0.973772422155868,2,52,G-protein coupled amine receptor activity,MF,ADRA2B;ADRA2C
14713,GO:0060088,0.1347909395444,0.991423164812622,1,10,auditory receptor cell stereocilium organization,BP,MYO7A
21575,GO:2001135,0.134792370605238,0.991524349079474,1,9,regulation of endocytic recycling,BP,ACTN2
10118,GO:0035907,0.134857534181634,0.99151592533489,1,9,dorsal aorta development,BP,HEY1
14463,GO:0052652,0.135165431784163,0.952075961454273,4,152,cyclic purine nucleotide metabolic process,BP,GUCY1B3;EDN1;NPR1;NPPC
9049,GO:0033327,0.135171122650201,0.991373381787516,1,10,Leydig cell differentiation,BP,DHH
6018,GO:0016600,0.135207150240748,0.991470654756897,1,9,flotillin complex,CC,CDH1
19262,GO:1902679,0.135222755585063,0.910029639639496,21,1159,negative regulation of RNA biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
19868,GO:1903960,0.135261672207876,0.991463583429133,1,9,negative regulation of anion transmembrane transport,BP,AKT1
9037,GO:0033293,0.135366297410833,0.973487201539207,2,55,monocarboxylic acid binding,MF,SERPINA5;VDR
1521,GO:0003264,0.135457675762414,0.99133575862405,1,10,regulation of cardioblast proliferation,BP,NOTCH1
9458,GO:0034452,0.13563587694862,0.99141496673729,1,9,dynactin binding,MF,SPTBN5
8377,GO:0032276,0.135716673142976,0.9912176762473,1,11,regulation of gonadotropin secretion,BP,INHBB
777,GO:0001954,0.135734673193329,0.973515435246448,2,45,positive regulation of cell-matrix adhesion,BP,WNT4;SDC4
21216,GO:2000425,0.13579428109702,0.99129145343283,1,10,regulation of apoptotic cell clearance,BP,MFGE8
2412,GO:0005024,0.135959052759067,0.991372862367315,1,9,transforming growth factor beta-activated receptor activity,MF,ACVR1
14329,GO:0051924,0.136039559886091,0.944839391601277,5,197,regulation of calcium ion transport,BP,CASQ2;TSPAN13;PDGFB;PIK3CG;PDE4B
13985,GO:0051271,0.136086896395889,0.93944623076392,6,239,negative regulation of cellular component movement,BP,WNT3;WNT4;NOTCH1;ADORA1;WNT5A;RHOB
1195,GO:0002674,0.136178901873304,0.991085680574765,1,12,negative regulation of acute inflammatory response,BP,ADORA1
17550,GO:0090329,0.136209198616356,0.973404792948429,2,43,regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
14174,GO:0051608,0.136500086159476,0.991113186989467,1,11,histamine transport,BP,EDN1
1369,GO:0002934,0.136530169355009,0.991298189383844,1,9,desmosome organization,BP,PKP3
17756,GO:0097119,0.136602447686566,0.99128871481804,1,9,postsynaptic density protein 95 clustering,BP,CDH2
6530,GO:0019211,0.13662143623516,0.991182073418834,1,10,phosphatase activator activity,MF,BMP2
17117,GO:0072584,0.136623600390321,0.991181786293153,1,10,caveolin-mediated endocytosis,BP,UNC119
1139,GO:0002551,0.136767633585105,0.991077352885786,1,11,mast cell chemotaxis,BP,CHGA
6519,GO:0019199,0.136962914830298,0.960479532759416,3,80,transmembrane receptor protein kinase activity,MF,ACVR1;TYRO3;DDR1
5060,GO:0010870,0.137018883517196,0.991043632282242,1,11,positive regulation of receptor biosynthetic process,BP,EDN1
16898,GO:0072173,0.13705625213831,0.991124285774161,1,10,metanephric tubule morphogenesis,BP,WNT4
7659,GO:0030901,0.137076410734877,0.960330018409741,3,92,midbrain development,BP,WNT3;WNT2;WNT5A
21560,GO:2001054,0.137145093004239,0.991112454168729,1,10,negative regulation of mesenchymal cell apoptotic process,BP,BMP7
8900,GO:0033033,0.137161512921551,0.990953013302344,1,12,negative regulation of myeloid cell apoptotic process,BP,KITLG
1597,GO:0003413,0.13743607678884,0.991073643377376,1,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,NPPC
8432,GO:0032368,0.137558147215372,0.960107808293352,3,95,regulation of lipid transport,BP,EDN1;BMP6;AKT1
8065,GO:0031663,0.137739582409461,0.972823934387537,2,49,lipopolysaccharide-mediated signaling pathway,BP,BMP6;AKT1
4460,GO:0009190,0.13789389034313,0.950754229296459,4,153,cyclic nucleotide biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
1081,GO:0002448,0.137945547652602,0.972790718864685,2,47,mast cell mediated immunity,BP,CHGA;PIK3CG
3773,GO:0007342,0.138095475561054,0.990825955127964,1,12,fusion of sperm to egg plasma membrane,BP,SERPINA5
11991,GO:0045058,0.13821387893069,0.97272321636262,2,46,T cell selection,BP,ZFPM1;JAG2
12352,GO:0045792,0.138333656436325,0.990866079061507,1,11,negative regulation of cell size,BP,AKT1
10791,GO:0042368,0.138343381686616,0.990864758857742,1,11,vitamin D biosynthetic process,BP,VDR
2191,GO:0004716,0.138367858107721,0.991055604206869,1,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,TYRO3
19720,GO:1903651,0.13840842661231,0.991050209149345,1,9,positive regulation of cytoplasmic transport,BP,MSN
17736,GO:0097091,0.138480702374429,0.991040593196881,1,9,synaptic vesicle clustering,BP,CDH2
2304,GO:0004871,0.138554959925402,0.903649396695233,26,1637,signal transducer activity,MF,ADRA2B;ADRA2C;WNT3;WNT2;WNT4;WNT7A;ACVR1;ADORA1;MAPK12;FZD7;TYRO3;LPAR2;PIK3R1;KCNH2;WNT5A;AXIN1;NPR1;SDC4;DDR1;PKP1;BCAR1;CLDN3;GAS6;VDR;ARAF;FZD8
12004,GO:0045073,0.138565629666435,0.990699981133523,1,13,regulation of chemokine biosynthetic process,BP,WNT5A
15278,GO:0060976,0.138822629350309,0.972607643805852,2,42,coronary vasculature development,BP,NOTCH1;BMP4
5230,GO:0014701,0.138965624711363,0.990975935301096,1,9,junctional sarcoplasmic reticulum membrane,CC,CASQ2
13378,GO:0048715,0.138977198565618,0.990778500758769,1,11,negative regulation of oligodendrocyte differentiation,BP,NOTCH1
13723,GO:0050877,0.139002210573392,0.909074821332388,19,1203,neurological system process,BP,ITGA3;ITGA5;ADRA2C;CDH23;STRA6;SLC52A3;ADORA1;EDN1;SPTBN4;PRKAR1B;JAM3;B3GNT2;ESPN;GJB2;GJB6;MYO7A;GJA3;CLDN5;UNC119
21388,GO:2000677,0.139225553362123,0.972387348865021,2,47,regulation of transcription regulatory region DNA binding,BP,LIF;HEY1
20947,GO:2000009,0.139301624337224,0.990734182896865,1,11,negative regulation of protein localization to cell surface,BP,ACTN2
10463,GO:0038063,0.139640472168188,0.99088554408234,1,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,DDR1
3398,GO:0006702,0.139661337440358,0.990684913357327,1,11,androgen biosynthetic process,BP,WNT4
14877,GO:0060340,0.139710842090581,0.990767158141466,1,10,positive regulation of type I interferon-mediated signaling pathway,BP,WNT5A
16439,GO:0071383,0.139784437907141,0.937339819837462,6,240,cellular response to steroid hormone stimulus,BP,EDN1;BMP7;BMP4;GJB2;VDR;HEY1
14350,GO:0051956,0.140349785322674,0.990680087195441,1,10,negative regulation of amino acid transport,BP,ADORA1
19898,GO:1904019,0.140368626346611,0.958984317168897,3,88,epithelial cell apoptotic process,BP,JAG2;PIK3CG;GAS6
4529,GO:0009306,0.140634861699413,0.922586608149714,10,480,protein secretion,BP,ADRA2C;NOTCH1;RAB40B;RAB40A;WNT5A;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6
9911,GO:0035579,0.140643673213234,0.958860311340163,3,89,specific granule membrane,CC,PLAU;VAMP1;RAB44
12699,GO:0046541,0.140696672912031,0.990403571305955,1,13,saliva secretion,BP,FGF10
14089,GO:0051453,0.140799850250283,0.958786433404724,3,90,regulation of intracellular pH,BP,RAB39A;RAB20;RAB38
12496,GO:0046058,0.14081693981026,0.9493424093026,4,150,cAMP metabolic process,BP,EDN1;CHGA;NPPC;PDE4B
21554,GO:2001044,0.141002854790745,0.990499948508146,1,11,regulation of integrin-mediated signaling pathway,BP,LIMS2
691,GO:0001836,0.141041942160157,0.971707508472457,2,54,release of cytochrome c from mitochondria,BP,PMAIP1;AKT1
695,GO:0001840,0.141116219458129,0.99057507218293,1,10,neural plate development,BP,FGF8
17126,GO:0072594,0.141177362366055,0.917641572990386,12,641,establishment of protein localization to organelle,BP,TSPAN17;PMAIP1;FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
10103,GO:0035878,0.141277898100472,0.990552839829942,1,10,nail development,BP,ITGB4
17941,GO:0097479,0.141411953464519,0.949133643929616,4,132,synaptic vesicle localization,BP,SYT5;RAB27A;WNT7A;CDH2
13293,GO:0048570,0.141450642528115,0.99052905519604,1,10,notochord morphogenesis,BP,WNT5A
16137,GO:0070830,0.141847093003264,0.971589697171601,2,45,bicellular tight junction assembly,BP,CLDN1;CLDN3
1011,GO:0002328,0.141890227225039,0.99046838740523,1,10,pro-B cell differentiation,BP,NOTCH1
4647,GO:0009791,0.142333755008703,0.958163732593604,3,87,post-embryonic development,BP,BMP4;NPPC;MYO7A
11513,GO:0043619,0.142706735761026,0.990262247296244,1,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,SESN2
96,GO:0000185,0.142865199276054,0.990239982706338,1,11,activation of MAPKKK activity,BP,GADD45A
1900,GO:0004312,0.143108725467669,0.990205714096018,1,11,fatty acid synthase activity,MF,FASN
2430,GO:0005068,0.143145413050178,0.990200545968452,1,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PIK3R1
9600,GO:0034755,0.14321041457358,0.990191385752695,1,11,iron ion transmembrane transport,BP,TTYH1
5269,GO:0014819,0.143450452516329,0.990157519603564,1,11,regulation of skeletal muscle contraction,BP,ACTN3
9780,GO:0035337,0.143644444913868,0.970959618171001,2,48,fatty-acyl-CoA metabolic process,BP,FASN;ACSL4
11718,GO:0044297,0.143651961739392,0.920594769220083,10,472,cell body,CC,SYT5;ADORA1;SPTBN4;DRP2;GJB2;RAB17;LZTS1;KCND1;ACSL4;ACTA2
17447,GO:0090193,0.14402073185761,0.990171445441687,1,10,positive regulation of glomerulus development,BP,PDGFB
7014,GO:0021877,0.144123523099786,0.990156996732838,1,10,forebrain neuron fate commitment,BP,AXIN1
10959,GO:0042635,0.144136404241439,0.989981481322179,1,12,positive regulation of hair cycle,BP,WNT5A
21620,GO:2001204,0.144297099125242,0.990037575521486,1,11,regulation of osteoclast development,BP,CLDN18
12374,GO:0045835,0.144397317896089,0.990023326637924,1,11,negative regulation of meiotic nuclear division,BP,LIF
7531,GO:0030656,0.144512372272841,0.989927622853878,1,12,regulation of vitamin metabolic process,BP,VDR
8201,GO:0031957,0.144665758660595,0.990080591981211,1,10,very long-chain fatty acid-CoA ligase activity,MF,ACSL4
2297,GO:0004861,0.144714710003899,0.989898574126099,1,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1A
14668,GO:0060038,0.144738196032615,0.970679904900149,2,44,cardiac muscle cell proliferation,BP,WNT2;NOTCH1
8023,GO:0031588,0.144867474206151,0.990052088958932,1,10,nucleotide-activated protein kinase complex,CC,SESN2
2495,GO:0005165,0.145350423321736,0.989887276951673,1,11,neurotrophin receptor binding,MF,PIK3R1
3535,GO:0006924,0.145473296841401,0.989869666492822,1,11,activation-induced cell death of T cells,BP,AKT1
4777,GO:0010324,0.145556428105388,0.970340253779717,2,48,membrane invagination,BP,MFGE8;SNX18
13208,GO:0048340,0.145641140280894,0.989942365522017,1,10,paraxial mesoderm morphogenesis,BP,WNT5A
11296,GO:0043254,0.145653046447578,0.925399812465248,8,360,regulation of protein complex assembly,BP,FHOD3;PMAIP1;SPTBN5;SPTBN4;RALB;PSRC1;SPTB;MSN
9765,GO:0035306,0.145672914605061,0.970357085729716,2,45,positive regulation of dephosphorylation,BP,ADORA1;BMP2
11937,GO:0044843,0.145706423413067,0.933912609514776,6,249,cell cycle G1/S phase transition,BP,GADD45A;ACVR1;FGF10;CDKN1A;AKT1;PIM2
11903,GO:0044773,0.145722706089232,0.956662931719503,3,94,mitotic DNA damage checkpoint,BP,GADD45A;FOXO4;CDKN1A
20967,GO:2000047,0.145728533011088,0.989833033681047,1,11,regulation of cell-cell adhesion mediated by cadherin,BP,WNT5A
4607,GO:0009636,0.14577644820182,0.93956571031345,5,214,response to toxic substance,BP,SESN2;BMP7;CDKN1A;CDH1;CLDN1
12132,GO:0045309,0.145893413287557,0.9703053813985,2,44,protein phosphorylated amino acid binding,MF,PIK3R2;PIK3R1
10619,GO:0042033,0.145905960792205,0.989599696062685,1,14,chemokine biosynthetic process,BP,WNT5A
8776,GO:0032836,0.145981814862345,0.989893847742819,1,10,glomerular basement membrane development,BP,WT1
688,GO:0001833,0.146108596092447,0.989875760356596,1,10,inner cell mass cell proliferation,BP,SALL4
11921,GO:0044801,0.146115736385398,0.939444443719178,5,192,single-organism membrane fusion,BP,SYT5;SERPINA5;RAB39A;RAB20;VAMP1
19204,GO:1902547,0.146254918793596,0.989757262753325,1,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,DLL1
7357,GO:0030280,0.146327438976386,0.989537764086644,1,14,structural constituent of epidermis,MF,PKP1
3812,GO:0007440,0.146427489322763,0.989830189264944,1,10,foregut morphogenesis,BP,NOTCH1
4920,GO:0010660,0.146475186046943,0.970058376420396,2,47,regulation of muscle cell apoptotic process,BP,EDN1;BMP7
12448,GO:0045955,0.146538600960939,0.989814285477576,1,10,negative regulation of calcium ion-dependent exocytosis,BP,NOTCH1
7540,GO:0030669,0.146978562413034,0.969842956261248,2,50,clathrin-coated endocytic vesicle membrane,CC,WNT5A;HBEGF
12347,GO:0045779,0.147067246719576,0.989557576243115,1,12,negative regulation of bone resorption,BP,CLDN18
12009,GO:0045078,0.147106038082947,0.989551903186677,1,12,positive regulation of interferon-gamma biosynthetic process,BP,ZFPM1
8766,GO:0032823,0.147126231678822,0.989548949320856,1,12,regulation of natural killer cell differentiation,BP,GAS6
15184,GO:0060767,0.147397984546134,0.989591696063723,1,11,epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
7315,GO:0030218,0.147546304637765,0.955878903674379,3,94,erythrocyte differentiation,BP,ZFPM1;BMP4;SFXN1
9174,GO:0033690,0.147901528230457,0.98951831376838,1,11,positive regulation of osteoblast proliferation,BP,BMP2
7526,GO:0030641,0.148097222431686,0.955657132725998,3,92,regulation of cellular pH,BP,RAB39A;RAB20;RAB38
6448,GO:0018958,0.148331029169801,0.955548008394237,3,93,phenol-containing compound metabolic process,BP,PNMT;WNT5A;NPR1
17331,GO:0090009,0.148387856307261,0.989447180679121,1,11,primitive streak formation,BP,WNT5A
21322,GO:2000586,0.148522637812199,0.989528082725977,1,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
6668,GO:0019693,0.148541467905134,0.917279522369216,10,535,ribose phosphate metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
10162,GO:0035987,0.148872538177698,0.969310199099904,2,45,endodermal cell differentiation,BP,ITGA5;ITGB5
7786,GO:0031122,0.149330633268928,0.969179798513263,2,44,cytoplasmic microtubule organization,BP,TUBG2;AXIN1
21459,GO:2000786,0.149340235533318,0.989408916716158,1,10,positive regulation of autophagosome assembly,BP,RALB
6924,GO:0021695,0.149447356607244,0.969120582460004,2,45,cerebellar cortex development,BP,WNT7A;DLL1
12364,GO:0045820,0.149769495585243,0.989243700866198,1,11,negative regulation of glycolytic process,BP,ACTN3
13936,GO:0051195,0.149769495585243,0.989243700866198,1,11,negative regulation of cofactor metabolic process,BP,ACTN3
13939,GO:0051198,0.149769495585243,0.989243700866198,1,11,negative regulation of coenzyme metabolic process,BP,ACTN3
14149,GO:0051580,0.149865219542312,0.989144191507673,1,12,regulation of neurotransmitter uptake,BP,GDNF
15336,GO:0061050,0.149992617040956,0.989125166521042,1,12,regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
13368,GO:0048704,0.150123374231698,0.954770959668401,3,93,embryonic skeletal system morphogenesis,BP,AXIN1;BMP7;BMP4
11270,GO:0043220,0.150390062039503,0.98915163587364,1,11,Schmidt-Lanterman incisure,CC,JAM3
13917,GO:0051172,0.150416227244756,0.894399811997412,26,1487,negative regulation of nitrogen compound metabolic process,BP,WNT4;ACTN3;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;SESN2;AXIN1;BMP7;BMP6;BMP4;BMP2;WT1;PKP3;PKP1;NPPC;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
21009,GO:2000113,0.150831084969502,0.8963773827923,23,1293,negative regulation of cellular macromolecule biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
19338,GO:1902894,0.151010614892909,0.98916322922177,1,10,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,PDGFB
1063,GO:0002429,0.151342699277568,0.92578183906583,7,318,immune response-activating cell surface receptor signaling pathway,BP,PRKACB;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
2851,GO:0005881,0.151360413566702,0.968446691937998,2,47,cytoplasmic microtubule,CC,TUBG2;RAB3D
9902,GO:0035567,0.151361277752276,0.944114823228578,4,149,non-canonical Wnt signaling pathway,BP,WNT4;WNT7A;FZD7;WNT5A
4987,GO:0010763,0.151370685504162,0.98900530437064,1,11,positive regulation of fibroblast migration,BP,AKT1
8402,GO:0032310,0.151466363029852,0.988830092262727,1,13,prostaglandin secretion,BP,EDN1
13325,GO:0048641,0.151513563805857,0.968414939050987,2,46,regulation of skeletal muscle tissue development,BP,ACTN3;DLL1
2876,GO:0005916,0.151521816024002,0.989087440789443,1,10,fascia adherens,CC,CDH2
13244,GO:0048484,0.151532205954915,0.988981101902297,1,11,enteric nervous system development,BP,GDNF
17353,GO:0090051,0.151713852444555,0.988953849938021,1,11,negative regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
1122,GO:0002523,0.151778401980662,0.988719217118169,1,14,leukocyte migration involved in inflammatory response,BP,JAM3
13636,GO:0050755,0.151858327096467,0.988652001883387,1,15,chemokine metabolic process,BP,WNT5A
12893,GO:0046950,0.151936769076066,0.988920357435277,1,11,cellular ketone body metabolic process,BP,HMGCS2
10313,GO:0036312,0.152038592665154,0.989010540333006,1,10,phosphatidylinositol 3-kinase regulatory subunit binding,MF,PIK3R1
6674,GO:0019722,0.152205806389469,0.943698293430471,4,147,calcium-mediated signaling,BP,ACTN3;CASQ2;EDN1;CCL20
7764,GO:0031094,0.152225284733528,0.988982688475194,1,10,platelet dense tubular network,CC,SERPINA5
21248,GO:2000484,0.152297586192675,0.988703377379997,1,13,positive regulation of interleukin-8 secretion,BP,WNT5A
2982,GO:0006089,0.152385135854374,0.988764591285469,1,12,lactate metabolic process,BP,ACTN3
3306,GO:0006584,0.152840992860416,0.967914837841138,2,49,catecholamine metabolic process,BP,PNMT;NPR1
4621,GO:0009712,0.152840992860416,0.967914837841138,2,49,catechol-containing compound metabolic process,BP,PNMT;NPR1
3641,GO:0007093,0.152864965353999,0.943365527940218,4,147,mitotic cell cycle checkpoint,BP,GADD45A;FOXO4;HRAS;CDKN1A
430,GO:0001104,0.152889715701404,0.953562764460598,3,93,RNA polymerase II transcription cofactor activity,MF,POU3F1;TLE1;SIN3B
15689,GO:0070016,0.152894552934631,0.988882534838277,1,10,armadillo repeat domain binding,MF,AXIN1
20001,GO:1904262,0.152921911019849,0.988771697572486,1,11,negative regulation of TORC1 signaling,BP,SESN2
12353,GO:0045793,0.152989841650529,0.988761407886432,1,11,positive regulation of cell size,BP,EDN1
17248,GO:0086008,0.153098282692026,0.988744971565169,1,11,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,KCNH2
17709,GO:0097038,0.153409115586726,0.988697788101537,1,11,perinuclear endoplasmic reticulum,CC,PIK3R1
11783,GO:0044406,0.153476114026365,0.988687604197765,1,11,adhesion of symbiont to host,BP,GAS6
846,GO:0002043,0.153717426738145,0.988650883736185,1,11,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,BMP4
7203,GO:0030041,0.153743122960816,0.942925958469035,4,146,actin filament polymerization,BP,FHOD3;SPTBN5;SPTBN4;SPTB
3593,GO:0007016,0.153776620257482,0.988749799968762,1,10,cytoskeletal anchoring at plasma membrane,BP,SPTBN4
2178,GO:0004702,0.153850952710058,0.95319442756773,3,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,ACVR1;MAPK12;ARAF
11712,GO:0044283,0.153919720858939,0.913694975243404,10,496,small molecule biosynthetic process,BP,WNT4;FASN;HMGCS2;DKK3;EDN1;SESN2;BMP6;BMP2;PTGES;VDR
4102,GO:0008360,0.15402667218647,0.942806669341187,4,141,regulation of cell shape,BP,RHOQ;RHOJ;MSN;PARVB
16474,GO:0071435,0.1540366898829,0.98851203864124,1,12,potassium ion export,BP,KCNH2
19411,GO:1903019,0.154050937275187,0.988433598573627,1,13,negative regulation of glycoprotein metabolic process,BP,HBEGF
5231,GO:0014704,0.154245148326902,0.96749894409899,2,46,intercalated disc,CC,DSC2;CDH2
3503,GO:0006878,0.154367079620637,0.98838459532836,1,13,cellular copper ion homeostasis,BP,PRND
10700,GO:0042180,0.154395588202827,0.934824785452724,5,217,cellular ketone metabolic process,BP,WNT4;DKK3;BMP6;BMP2;AKT1
5827,GO:0016236,0.15452238169586,0.928752619943899,6,252,macroautophagy,BP,RALB;SESN2;AKT1;RAB12;PIK3CA;LZTS1
11938,GO:0044848,0.154554364420897,0.988523036715944,1,11,biological phase,BP,WNT5A
3456,GO:0006801,0.154705400033453,0.967205082504665,2,54,superoxide metabolic process,BP,EDN1;BMP7
15809,GO:0070228,0.154814022028884,0.967168225639323,2,54,regulation of lymphocyte apoptotic process,BP,WNT5A;BMP4
1266,GO:0002763,0.15503343161466,0.967157555508988,2,50,positive regulation of myeloid leukocyte differentiation,BP,LIF;KITLG
9276,GO:0034116,0.155323911501877,0.988313128277194,1,12,positive regulation of heterotypic cell-cell adhesion,BP,BMP7
12429,GO:0045930,0.155447713391472,0.928179173023906,6,264,negative regulation of mitotic cell cycle,BP,GADD45A;FOXO4;HRAS;BMP7;BMP4;CDKN1A
2842,GO:0005865,0.155577440325085,0.988021189080142,1,16,striated muscle thin filament,CC,FHOD3
19348,GO:1902911,0.156140346284976,0.952120873522097,3,94,protein kinase complex,CC,ACVR1;SESN2;CDKN1A
16424,GO:0071360,0.156681073291255,0.988101442079128,1,12,cellular response to exogenous dsRNA,BP,RALB
8434,GO:0032370,0.157003761667572,0.966436990489141,2,53,positive regulation of lipid transport,BP,EDN1;BMP6
8018,GO:0031581,0.157144566091994,0.988122535622078,1,11,hemidesmosome assembly,BP,ITGB4
19037,GO:1902115,0.157261149099848,0.941161064020932,4,141,regulation of organelle assembly,BP,EDN1;RALB;SDC4;MSN
11420,GO:0043476,0.157721712100368,0.987937755619333,1,12,pigment accumulation,BP,RAB38
11421,GO:0043482,0.157721712100368,0.987937755619333,1,12,cellular pigment accumulation,BP,RAB38
15001,GO:0060491,0.157853020804468,0.940853270742951,4,142,regulation of cell projection assembly,BP,HRAS;RHOQ;ESPN;RAB17
1486,GO:0003207,0.158059424175158,0.987884379478663,1,12,cardiac chamber formation,BP,NOTCH1
19307,GO:1902806,0.158180113683195,0.940656268197285,4,148,regulation of cell cycle G1/S phase transition,BP,GADD45A;FGF10;CDKN1A;AKT1
981,GO:0002285,0.158346087102615,0.94053962747759,4,155,lymphocyte activation involved in immune response,BP,RAB27A;ZFPM1;CLCF1;DLL1
795,GO:0001973,0.158476800525265,0.987818238773846,1,12,adenosine receptor signaling pathway,BP,ADORA1
4755,GO:0010212,0.158846577077429,0.940333989543684,4,144,response to ionizing radiation,BP,GADD45A;HRAS;RHOB;CDKN1A
13989,GO:0051280,0.15905461812224,0.987645062383831,1,13,negative regulation of release of sequestered calcium ion into cytosol,BP,CASQ2
10151,GO:0035970,0.159100201336074,0.987815300855735,1,11,peptidyl-threonine dephosphorylation,BP,DUSP5
20972,GO:2000052,0.159371087971716,0.987772414123138,1,11,positive regulation of non-canonical Wnt signaling pathway,BP,WNT5A
17725,GO:0097062,0.159517322480446,0.987652514038724,1,12,dendritic spine maintenance,BP,ITGA3
14196,GO:0051656,0.159559498419464,0.912961036540755,9,416,establishment of organelle localization,BP,SYT5;RAB27A;WNT7A;FGF10;PSRC1;CHGA;RAB17;MYO7A;PIK3CG
13721,GO:0050872,0.159896003658125,0.987509746308527,1,13,white fat cell differentiation,BP,FGF10
3817,GO:0007494,0.160255382607645,0.987631853354329,1,11,midgut development,BP,WNT5A
21559,GO:2001053,0.160384338859437,0.987513511830985,1,12,regulation of mesenchymal cell apoptotic process,BP,BMP7
18895,GO:1901678,0.160427739126865,0.987506531989907,1,12,iron coordination entity transport,BP,FLVCR2
6912,GO:0021681,0.160511383946167,0.987493073958833,1,12,cerebellar granular layer development,BP,WNT7A
5116,GO:0010935,0.16059802876776,0.98747912509657,1,12,regulation of macrophage cytokine production,BP,WNT5A
4850,GO:0010558,0.160599885703876,0.887910679419905,24,1374,negative regulation of macromolecule biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;INHBB;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
4877,GO:0010605,0.160720917369238,0.879279466992296,39,2423,negative regulation of macromolecule metabolic process,BP,LIF;WNT4;NOTCH1;ITGB8;GADD45A;SERPINA5;ZFPM1;SALL4;DKK3;EDN1;PRR5L;PDGFB;PRKAR1B;HRAS;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;CTGF;AKT1;PKP3;PKP1;NPPC;CST9L;NAB2;INHBB;TLE1;GAS6;SIN3B;VDR;FZD8;DUSP5;HEY1
16375,GO:0071285,0.160746936220795,0.987372095765162,1,13,cellular response to lithium ion,BP,CDH1
13733,GO:0050890,0.160855375532563,0.925007298752066,6,246,cognition,BP,ITGA3;ITGA5;STRA6;ADORA1;PRKAR1B;CLDN5
15026,GO:0060536,0.160948978509227,0.987422541246735,1,12,cartilage morphogenesis,BP,WNT7B
3555,GO:0006955,0.161325592088008,0.883718530030927,29,1821,immune response,BP,LIF;NOTCH1;RAB27A;CRISPLD2;ZFPM1;EDN1;PLAU;PRKACB;CCL20;TYRO3;PIK3R2;PIK3R1;HRAS;WNT5A;JAM3;CLCF1;BMP6;DLL1;CHGA;PKP1;RAB17;BCAR1;RAB44;CLDN1;PIK3CA;PIK3CG;GAS6;RAB3D;PDE4B
7266,GO:0030157,0.161379201369965,0.987269296932865,1,13,pancreatic juice secretion,BP,WNK4
12189,GO:0045453,0.161389967734892,0.964955723841745,2,51,bone resorption,BP,RAB3D;CLDN18
12183,GO:0045428,0.161506346921201,0.964897929447419,2,52,regulation of nitric oxide biosynthetic process,BP,EDN1;AKT1
8221,GO:0031994,0.161663464263234,0.987306923678451,1,12,insulin-like growth factor I binding,MF,ITGB4
8733,GO:0032785,0.161707155463121,0.987299835289712,1,12,negative regulation of DNA-templated transcription, elongation,BP,AXIN1
6140,GO:0016829,0.161713086740261,0.938809772976994,4,154,lyase activity,MF,GLDC;FASN;GUCY1B3;NPR1
10668,GO:0042130,0.161976705599325,0.964751183880867,2,51,negative regulation of T cell proliferation,BP,SDC4;BMP4
16286,GO:0071071,0.162041819145144,0.987245469978102,1,12,regulation of phospholipid biosynthetic process,BP,PDGFB
9148,GO:0033631,0.162175407022629,0.987223734347821,1,12,cell-cell adhesion mediated by integrin,BP,ITGA5
17307,GO:0086080,0.162180965674423,0.987322810500109,1,11,protein binding involved in heterotypic cell-cell adhesion,MF,DSC2
10890,GO:0042531,0.16218711224284,0.964568852227203,2,58,positive regulation of tyrosine phosphorylation of STAT protein,BP,LIF;CLCF1
20618,GO:1905809,0.162453232456001,0.987178467069578,1,12,negative regulation of synapse organization,BP,WNT5A
9026,GO:0033270,0.16253858711246,0.987264966381915,1,11,paranode region of axon,CC,SPTBN4
10787,GO:0042362,0.162565304152453,0.987075251319841,1,13,fat-soluble vitamin biosynthetic process,BP,VDR
7636,GO:0030877,0.162621866826891,0.987251475973866,1,11,beta-catenin destruction complex,CC,AXIN1
16430,GO:0071372,0.162650363456842,0.987246858078622,1,11,cellular response to follicle-stimulating hormone stimulus,BP,NOTCH1
15136,GO:0060707,0.162676540400544,0.987142020620347,1,12,trophoblast giant cell differentiation,BP,LIF
15922,GO:0070402,0.162811421350068,0.987034790524262,1,13,NADPH binding,MF,FASN
4890,GO:0010623,0.162821920336592,0.98703306302761,1,13,programmed cell death involved in cell development,BP,KITLG
14908,GO:0060379,0.162845167218721,0.987215266099722,1,11,cardiac muscle cell myoblast differentiation,BP,NOTCH1
7378,GO:0030307,0.162850085264135,0.938234580437393,4,151,positive regulation of cell growth,BP,WNT3;EDN1;HBEGF;AKT1
14361,GO:0051967,0.162914288365492,0.986944799554095,1,14,negative regulation of synaptic transmission, glutamatergic,BP,ADORA1
19421,GO:1903036,0.163111441211227,0.964319877647775,2,53,positive regulation of response to wounding,BP,HRAS;HBEGF
20321,GO:1904950,0.163199525646481,0.929928209746685,5,205,negative regulation of establishment of protein localization,BP,RHOQ;BMP7;INHBB;RAB11FIP1;GAS6
15930,GO:0070411,0.163202461778742,0.987157213955759,1,11,I-SMAD binding,MF,AXIN1
2429,GO:0005057,0.163399422365464,0.938016550279377,4,138,signal transducer activity, downstream of receptor,MF,ACVR1;MAPK12;TYRO3;ARAF
17850,GO:0097286,0.163733470460667,0.986968767946799,1,12,iron ion import,BP,TF
9691,GO:0035112,0.163946017058091,0.986847394145221,1,13,genitalia morphogenesis,BP,FGF10
10585,GO:0040013,0.163950082073217,0.92313470035373,6,253,negative regulation of locomotion,BP,WNT3;WNT4;NOTCH1;ADORA1;WNT5A;RHOB
6105,GO:0016775,0.164002659924179,0.986838001062731,1,13,phosphotransferase activity, nitrogenous group as acceptor,MF,KCNH2
15018,GO:0060525,0.164336601131563,0.986972011456067,1,11,prostate glandular acinus development,BP,NOTCH1
18824,GO:1901550,0.164414448977542,0.98685648548062,1,12,regulation of endothelial cell development,BP,CLDN5
19465,GO:1903140,0.164414448977542,0.98685648548062,1,12,regulation of establishment of endothelial barrier,BP,CLDN5
5742,GO:0016050,0.164498285124791,0.913308023022463,8,365,vesicle organization,BP,SYT5;RAB27A;RAB39A;SDC4;RAB20;VAMP1;MYO7A;RAB38
11990,GO:0045056,0.164780619187017,0.986795897132494,1,12,transcytosis,BP,RAB17
13391,GO:0048747,0.164804407257085,0.963777180843338,2,50,muscle fiber development,BP,BMP4;MYH11
13504,GO:0050321,0.164809320340531,0.986791141805686,1,12,tau-protein kinase activity,MF,MARK4
20227,GO:1904754,0.165104948034125,0.986845736757619,1,11,positive regulation of vascular associated smooth muscle cell migration,BP,PDGFB
17972,GO:0097531,0.165195605833967,0.986639342961719,1,13,mast cell migration,BP,CHGA
4917,GO:0010657,0.165306695819865,0.96358120431408,2,51,muscle cell apoptotic process,BP,EDN1;BMP7
4666,GO:0009886,0.165347217213854,0.986613981684045,1,13,post-embryonic animal morphogenesis,BP,MYO7A
16395,GO:0071320,0.165439938398962,0.963613336413375,2,47,cellular response to cAMP,BP,WT1;PIK3CG
19078,GO:1902224,0.165485499091407,0.986678845003811,1,12,ketone body metabolic process,BP,HMGCS2
641,GO:0001771,0.165603356900454,0.986571076735149,1,13,immunological synapse formation,BP,MSN
10089,GO:0035859,0.16568398886876,0.986645784240597,1,12,Seh1-associated complex,CC,SESN2
7725,GO:0031045,0.165784735779393,0.986628986924415,1,12,dense core granule,CC,SYT5
6811,GO:0021510,0.16600399409303,0.947646154773621,3,98,spinal cord development,BP,NOTCH1;DLL1;AKT1
8955,GO:0033141,0.166118047837017,0.986080067463897,1,21,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
4778,GO:0010332,0.166137524092653,0.963268882400895,2,52,response to gamma radiation,BP,HRAS;CDKN1A
2534,GO:0005244,0.166179830547111,0.928282229468047,5,192,voltage-gated ion channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
7131,GO:0022832,0.166179830547111,0.928282229468047,5,192,voltage-gated channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
11449,GO:0043517,0.166361503608436,0.986443652625346,1,13,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
17583,GO:0090399,0.166536420027995,0.986503303932657,1,12,replicative senescence,BP,CDKN1A
13998,GO:0051291,0.166571870429792,0.947247483122006,3,118,protein heterooligomerization,BP,HRAS;CLDN1;CLDN3
18078,GO:0098589,0.166579244512016,0.911965396535087,8,355,membrane region,CC,TF;CDH2;RHOQ;SDC4;DLL1;CDH1;EPN1;SH3BP4
15815,GO:0070234,0.166626289226017,0.986256362473843,1,15,positive regulation of T cell apoptotic process,BP,WNT5A
4584,GO:0009566,0.166693236238797,0.936165862424744,4,166,fertilization,BP,IGSF8;SERPINA5;MFGE8;SPTBN4
11258,GO:0043201,0.166729862307654,0.986576542947371,1,11,response to leucine,BP,SESN2
11267,GO:0043217,0.166747558256943,0.986467888141942,1,12,myelin maintenance,BP,AKT1
16677,GO:0071786,0.166778167309192,0.986462749738978,1,12,endoplasmic reticulum tubular network organization,BP,REEP1
13234,GO:0048407,0.166937411197257,0.986541948965408,1,11,platelet-derived growth factor binding,MF,PDGFB
10923,GO:0042581,0.167224187987973,0.93592993256933,4,156,specific granule,CC,RAB27A;PLAU;VAMP1;RAB44
18480,GO:1900103,0.167242153226093,0.986294831490858,1,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
10132,GO:0035930,0.167278771683311,0.986211589608074,1,14,corticosteroid hormone secretion,BP,BMP6
21498,GO:2000846,0.167278771683311,0.986211589608074,1,14,regulation of corticosteroid hormone secretion,BP,BMP6
6773,GO:0019934,0.167326051976301,0.986370598786225,1,12,cGMP-mediated signaling,BP,GUCY1B3
5643,GO:0015850,0.167499882085822,0.927462502353906,5,212,organic hydroxy compound transport,BP,ADRA2B;ADRA2C;BMP6;CHGA;GDNF
12276,GO:0045651,0.167642690468049,0.986226857227654,1,13,positive regulation of macrophage differentiation,BP,LIF
865,GO:0002070,0.167748633794135,0.986208847756984,1,13,epithelial cell maturation,BP,CDKN1A
3830,GO:0007519,0.167814305904907,0.93566366007856,4,147,skeletal muscle tissue development,BP,ACTN3;NOTCH1;IGSF8;DLL1
10465,GO:0038065,0.16797419664169,0.986368425354661,1,11,collagen-activated signaling pathway,BP,DDR1
6231,GO:0017017,0.16810692863303,0.986147847411873,1,13,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP5
7310,GO:0030213,0.168131590419324,0.98623450466058,1,12,hyaluronan biosynthetic process,BP,PDGFB
4913,GO:0010649,0.168181610150328,0.986226030071793,1,12,regulation of cell communication by electrical coupling,BP,CASQ2
14809,GO:0060253,0.168420089095362,0.986094413355088,1,13,negative regulation of glial cell proliferation,BP,NOTCH1
9265,GO:0034101,0.168553135105078,0.946443617729549,3,102,erythrocyte homeostasis,BP,ZFPM1;BMP4;SFXN1
3322,GO:0006605,0.168873986089543,0.898171545922342,12,662,protein targeting,BP,RAB27A;ADORA1;FZD7;PIK3R2;PIK3R1;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;GAS6
18239,GO:0098915,0.168877801063959,0.986107788211375,1,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,KCNH2
1073,GO:0002440,0.168905578082222,0.935028247560782,4,160,production of molecular mediator of immune response,BP,WNT5A;CLCF1;CHGA;GAS6
624,GO:0001741,0.169006228608106,0.985994105563359,1,13,XY body,CC,SIN3B
7901,GO:0031344,0.169516076512234,0.900251801168977,11,527,regulation of cell projection organization,BP,ITGA3;WNT3;WNT7A;HRAS;WNT5A;RHOQ;BMP7;ESPN;AKT1;RAB17;LZTS1
5455,GO:0015271,0.169591186579983,0.985986064748787,1,12,outward rectifier potassium channel activity,MF,KCND1
8474,GO:0032413,0.169608941827513,0.9619765861753,2,55,negative regulation of ion transmembrane transporter activity,BP,ACTN2;CASQ2
5291,GO:0014854,0.169763597118454,0.985863923494695,1,13,response to inactivity,BP,ACTN3
17242,GO:0086002,0.169766236434551,0.962072468639135,2,47,cardiac muscle cell action potential involved in contraction,BP,DSC2;KCNH2
5310,GO:0014889,0.17000124765128,0.985822941504593,1,13,muscle atrophy,BP,ACTN3
7816,GO:0031223,0.170213246531829,0.985879459899521,1,12,auditory behavior,BP,STRA6
17330,GO:0090005,0.170411567625502,0.985845381886808,1,12,negative regulation of establishment of protein localization to plasma membrane,BP,RHOQ
13062,GO:0048008,0.170742552742002,0.961721143472412,2,47,platelet-derived growth factor receptor signaling pathway,BP,PDGFB;BCAR1
7196,GO:0030031,0.171049234737166,0.902000895836491,10,474,cell projection assembly,BP,ACTN2;NOTCH1;MARK4;TTYH1;HRAS;RHOQ;ESPN;RAB17;LAMA5;PARVB
14883,GO:0060347,0.171053842488149,0.985560103456708,1,14,heart trabecula formation,BP,HEY1
13648,GO:0050771,0.171093994437459,0.961550980608549,2,49,negative regulation of axonogenesis,BP,WNT3;WNT5A
2639,GO:0005513,0.171224445168757,0.985611000420655,1,13,detection of calcium ion,BP,CASQ2
1253,GO:0002739,0.171311443404363,0.985515060952134,1,14,regulation of cytokine secretion involved in immune response,BP,WNT5A
16369,GO:0071277,0.171325996565463,0.96142709474102,2,51,cellular response to calcium ion,BP,EDN1;WNT5A
6229,GO:0017015,0.17137204096996,0.945181090965263,3,97,regulation of transforming growth factor beta receptor signaling pathway,BP,ITGA3;RASL11B;DKK3
11904,GO:0044774,0.171513298825448,0.945081377279399,3,101,mitotic DNA integrity checkpoint,BP,GADD45A;FOXO4;CDKN1A
7647,GO:0030888,0.172026408005027,0.961085280357912,2,56,regulation of B cell proliferation,BP,CLCF1;CDKN1A
12059,GO:0045161,0.172057871365866,0.985560793927851,1,12,neuronal ion channel clustering,BP,SPTBN4
11019,GO:0042754,0.172619743724643,0.985367182265197,1,13,negative regulation of circadian rhythm,BP,ADORA1
11251,GO:0043194,0.17266076861304,0.985455814547976,1,12,axon initial segment,CC,SPTBN4
1415,GO:0003085,0.1727724197712,0.985258181997415,1,14,negative regulation of systemic arterial blood pressure,BP,KCNK6
7656,GO:0030898,0.172852216781038,0.985422393382378,1,12,actin-dependent ATPase activity,MF,MYO7A
5225,GO:0014069,0.172890483879391,0.924444276087481,5,190,postsynaptic density,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
13993,GO:0051284,0.173018567689944,0.985214664441222,1,14,positive regulation of sequestering of calcium ion,BP,CASQ2
18747,GO:1901264,0.173265514811593,0.960666984680413,2,54,carbohydrate derivative transport,BP,ADORA1;GJB1
756,GO:0001931,0.173412928940879,0.985227600004627,1,13,uropod,CC,MSN
7834,GO:0031254,0.173412928940879,0.985227600004627,1,13,cell trailing edge,CC,MSN
17747,GO:0097110,0.173441599102604,0.960677985905068,2,50,scaffold protein binding,MF,KCNH2;DLL1
9425,GO:0034394,0.173744120434697,0.960528323580518,2,52,protein localization to cell surface,BP,ACTN2;FGF10
13744,GO:0050905,0.173836012813845,0.944032635495886,3,97,neuromuscular process,BP,CDH23;STRA6;MYO7A
4990,GO:0010766,0.174061456527492,0.985112946183571,1,13,negative regulation of sodium ion transport,BP,WNK4
16476,GO:0071437,0.174062593114879,0.985210145225747,1,12,invadopodium,CC,ITGA3
13867,GO:0051099,0.174149028302313,0.932281029509991,4,153,positive regulation of binding,BP,RALB;WNT5A;BMP4;BMP2
17769,GO:0097152,0.174326292986466,0.985065988798726,1,13,mesenchymal cell apoptotic process,BP,BMP7
13606,GO:0050709,0.174340885722947,0.943729352422572,3,105,negative regulation of protein secretion,BP,INHBB;RAB11FIP1;GAS6
16798,GO:0072015,0.174380608409445,0.985154105937091,1,12,glomerular visceral epithelial cell development,BP,BMP4
3761,GO:0007292,0.174453759234136,0.943684217526895,3,104,female gamete generation,BP,WNT4;NPPC;INHBB
885,GO:0002093,0.174492564855651,0.985036467090322,1,13,auditory receptor cell morphogenesis,BP,MYO7A
18040,GO:0097755,0.174505650268364,0.960195750361005,2,55,positive regulation of blood vessel diameter,BP,ADORA1;NPPC
22,GO:0000041,0.174560279995374,0.943618775992886,3,106,transition metal ion transport,BP,TF;TTYH1;SFXN1
9916,GO:0035584,0.174764342903287,0.984767515719821,1,16,calcium-mediated signaling using intracellular calcium source,BP,CCL20
7930,GO:0031406,0.174925409460576,0.931824308584045,4,162,carboxylic acid binding,MF,GLDC;SERPINA5;SESN2;VDR
989,GO:0002295,0.175053129240347,0.984779253770406,1,15,T-helper cell lineage commitment,BP,ZFPM1
12834,GO:0046851,0.175157407610829,0.984833634061444,1,14,negative regulation of bone remodeling,BP,CLDN18
12217,GO:0045576,0.175234058141964,0.959928000187951,2,55,mast cell activation,BP,CHGA;PIK3CG
5005,GO:0010804,0.175349077858974,0.984661786160863,1,16,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
18033,GO:0097731,0.175605621521501,0.943176137270772,3,100,9+0 non-motile cilium,CC,RAB27A;SPTBN5;MYO7A
18035,GO:0097733,0.175605621521501,0.943176137270772,3,100,photoreceptor cell cilium,CC,RAB27A;SPTBN5;MYO7A
7022,GO:0021889,0.175610409358328,0.984837180787818,1,13,olfactory bulb interneuron differentiation,BP,WNT5A
7418,GO:0030374,0.175629815103945,0.959876373141767,2,50,ligand-dependent nuclear receptor transcription coactivator activity,MF,ACTN2;ZCCHC12
11156,GO:0043032,0.17567159364061,0.984667661540858,1,15,positive regulation of macrophage activation,BP,WNT5A
14976,GO:0060457,0.175742019189407,0.984590515741189,1,16,negative regulation of digestive system process,BP,WNK4
18711,GO:1901201,0.176121799723226,0.984845263725565,1,12,regulation of extracellular matrix assembly,BP,NOTCH1
1452,GO:0003161,0.176445918101494,0.984687304379464,1,13,cardiac conduction system development,BP,NOTCH1
8398,GO:0032305,0.176566902641679,0.984505342344442,1,15,positive regulation of icosanoid secretion,BP,EDN1
21052,GO:2000193,0.176566902641679,0.984505342344442,1,15,positive regulation of fatty acid transport,BP,EDN1
18355,GO:0099572,0.176587401497545,0.922294290319236,5,192,postsynaptic specialization,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
17074,GO:0072521,0.176590647606215,0.898068508059957,10,555,purine-containing compound metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
13666,GO:0050795,0.176954169001461,0.959185600411456,2,62,regulation of behavior,BP,STRA6;ADORA1
11880,GO:0044723,0.176978691063927,0.901192176899742,9,436,single-organism carbohydrate metabolic process,BP,ACTN3;PMAIP1;PDGFB;KHK;SESN2;PFKFB3;B3GNT2;AKT1;PIK3CA
5549,GO:0015672,0.177586397594823,0.897410820749099,10,513,monovalent inorganic cation transport,BP,ACTN2;ADORA1;CASQ2;KCNK6;SPTBN4;KCNH2;WNK4;AKT1;KCNG2;KCND1
14183,GO:0051640,0.177778195940067,0.897309308863409,10,482,organelle localization,BP,SYT5;RAB27A;WNT7A;CDH2;FGF10;PSRC1;CHGA;RAB17;MYO7A;PIK3CG
14309,GO:0051893,0.177793620422686,0.959077193078044,2,50,regulation of focal adhesion assembly,BP,WNT4;SDC4
17390,GO:0090109,0.177793620422686,0.959077193078044,2,50,regulation of cell-substrate junction assembly,BP,WNT4;SDC4
15164,GO:0060742,0.17781925880163,0.984540889539506,1,12,epithelial cell differentiation involved in prostate gland development,BP,NOTCH1
8375,GO:0032274,0.178057229702076,0.984308723073672,1,14,gonadotropin secretion,BP,INHBB
21081,GO:2000251,0.178076014440291,0.984229664127715,1,15,positive regulation of actin cytoskeleton reorganization,BP,HRAS
19809,GO:1903844,0.17817447241686,0.941972303338315,3,99,regulation of cellular response to transforming growth factor beta stimulus,BP,ITGA3;RASL11B;DKK3
11241,GO:0043177,0.178181530247671,0.930072082063063,4,163,organic acid binding,MF,GLDC;SERPINA5;SESN2;VDR
5244,GO:0014733,0.178215690066723,0.984367221499331,1,13,regulation of skeletal muscle adaptation,BP,ACTN3
3704,GO:0007200,0.178281886653138,0.941840191007005,3,109,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,ACTN2;EDN1;CHGA
10967,GO:0042659,0.178632932266894,0.984291240371725,1,13,regulation of cell fate specification,BP,FZD7
7327,GO:0030234,0.178892795221989,0.881464868661737,17,961,enzyme regulator activity,MF,RIN3;NOTCH1;SERPINA5;PIK3R2;PIK3R1;PDGFB;PRKAR1B;SESN2;AXIN1;BMP2;CDKN1A;AKT1;CST9L;PIK3CA;GAS6;GPSM1;SH3BP4
16643,GO:0071688,0.178940321523774,0.984235137170634,1,13,striated muscle myosin thick filament assembly,BP,MYH11
879,GO:0002087,0.179208317929977,0.984186136051711,1,13,regulation of respiratory gaseous exchange by neurological system process,BP,ADORA1
6533,GO:0019215,0.179369170970574,0.984156686038127,1,13,intermediate filament binding,MF,PKP1
5580,GO:0015732,0.179412240769604,0.983983388282305,1,15,prostaglandin transport,BP,EDN1
7903,GO:0031346,0.179440188698954,0.908095510364728,7,305,positive regulation of cell projection organization,BP,ITGA3;WNT3;HRAS;WNT5A;RHOQ;BMP7;ESPN
19724,GO:1903671,0.179571850302014,0.984119536262066,1,13,negative regulation of sprouting angiogenesis,BP,NOTCH1
18652,GO:1901018,0.17964550032385,0.98401715507394,1,14,positive regulation of potassium ion transmembrane transporter activity,BP,ACTN2
14069,GO:0051428,0.180027105437704,0.983641840011314,1,19,peptide hormone receptor binding,MF,NPPC
21625,GO:2001212,0.180480983433593,0.98386262247908,1,14,regulation of vasculogenesis,BP,HEY1
18953,GO:1901881,0.180590869968639,0.983842238171183,1,14,positive regulation of protein depolymerization,BP,ACTN2
7945,GO:0031432,0.180838822915499,0.9837961912693,1,14,titin binding,MF,ACTN2
15316,GO:0061029,0.180878404007748,0.983878930518817,1,13,eyelid development in camera-type eye,BP,STRA6
14592,GO:0055070,0.181192225245468,0.983583665721934,1,16,copper ion homeostasis,BP,PRND
12741,GO:0046629,0.181216584353326,0.983816336545341,1,13,gamma-delta T cell activation,BP,JAG2
6004,GO:0016580,0.181332810810303,0.983794794002021,1,13,Sin3 complex,CC,SIN3B
11102,GO:0042953,0.181468435562029,0.983678950368611,1,14,lipoprotein transport,BP,UNC119
11955,GO:0044872,0.181468435562029,0.983678950368611,1,14,lipoprotein localization,BP,UNC119
17582,GO:0090398,0.181583745953451,0.957581183964565,2,54,cellular senescence,BP,HRAS;CDKN1A
10659,GO:0042113,0.181588665733266,0.919276602863673,5,218,B cell activation,BP,PIK3R1;CLCF1;CDKN1A;DLL1;TPD52
16912,GO:0072189,0.181683578221239,0.983729685874756,1,13,ureter development,BP,BMP4
5654,GO:0015868,0.181815583144163,0.983614113183823,1,14,purine ribonucleotide transport,BP,GJB1
7537,GO:0030665,0.181906139107741,0.940143216820379,3,105,clathrin-coated vesicle membrane,CC,TF;WNT5A;HBEGF
9096,GO:0033549,0.181921174279667,0.983594364371517,1,14,MAP kinase phosphatase activity,MF,DUSP5
18705,GO:1901185,0.181945834404805,0.957483533688723,2,52,negative regulation of ERBB signaling pathway,BP,HBEGF;EPN1
5893,GO:0016358,0.182023024923879,0.919106542021899,5,194,dendrite development,BP,WNT7A;BMP7;RAB17;LZTS1;ACSL4
3528,GO:0006910,0.182147183687157,0.983472920546022,1,15,phagocytosis, recognition,BP,MFGE8
13731,GO:0050885,0.182419821817471,0.957325393850816,2,51,neuromuscular process controlling balance,BP,CDH23;MYO7A
21151,GO:2000345,0.182617635916211,0.983463783858778,1,14,regulation of hepatocyte proliferation,BP,LIMS2
19017,GO:1902074,0.182764104052154,0.983436251461316,1,14,response to salt,BP,EDN1
508,GO:0001541,0.1828419847827,0.957087620383235,2,55,ovarian follicle development,BP,KITLG;INHBB
4945,GO:0010715,0.182938786914709,0.983495547505493,1,13,regulation of extracellular matrix disassembly,BP,DDR1
19183,GO:1902495,0.182987866253248,0.905786320608922,7,310,transmembrane transporter complex,CC,CASQ2;KCNK6;TTYH1;KCNH2;KCNG2;KCND1;PDE4B
13778,GO:0050961,0.183155801076946,0.983362500973272,1,14,detection of temperature stimulus involved in sensory perception,BP,ADORA1
13780,GO:0050965,0.183155801076946,0.983362500973272,1,14,detection of temperature stimulus involved in sensory perception of pain,BP,ADORA1
16423,GO:0071359,0.183396458583701,0.95693535308177,2,52,cellular response to dsRNA,BP,RALB;BMP4
10985,GO:0042698,0.183398961601834,0.939443328539628,3,103,ovulation cycle,BP,TYRO3;KITLG;INHBB
14249,GO:0051770,0.183432814936076,0.983310237087288,1,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
8380,GO:0032279,0.183628264824223,0.918160678645144,5,194,asymmetric synapse,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
11268,GO:0043218,0.183643278096763,0.983270470257794,1,14,compact myelin,CC,JAM3
5205,GO:0014048,0.183667405529211,0.983265908145647,1,14,regulation of glutamate secretion,BP,ADORA1
16685,GO:0071801,0.184162694880053,0.983172108847115,1,14,regulation of podosome assembly,BP,MSN
8493,GO:0032433,0.184558569517381,0.983190740575369,1,13,filopodium tip,CC,TTYH1
12042,GO:0045125,0.184689025547406,0.982990764250126,1,15,bioactive lipid receptor activity,MF,LPAR2
2906,GO:0005976,0.184788603494591,0.938809684835572,3,99,polysaccharide metabolic process,BP,PDGFB;B3GNT2;AKT1
6921,GO:0021692,0.185023471183738,0.98310270135347,1,13,cerebellar Purkinje cell layer morphogenesis,BP,DLL1
15275,GO:0060973,0.185067461515765,0.983000032429938,1,14,cell migration involved in heart development,BP,NOTCH1
10055,GO:0035791,0.185298802105745,0.983050444611061,1,13,platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
2849,GO:0005876,0.185697769296379,0.956059769251698,2,52,spindle microtubule,CC,TUBG2;PSRC1
17455,GO:0090201,0.185818342613883,0.982702132850323,1,16,negative regulation of release of cytochrome c from mitochondria,BP,AKT1
2514,GO:0005200,0.186083475732539,0.938138720841706,3,104,structural constituent of cytoskeleton,MF,SPTBN4;SPTB;MSN
9421,GO:0034390,0.1861753941387,0.9827053573649,1,15,smooth muscle cell apoptotic process,BP,EDN1
9422,GO:0034391,0.1861753941387,0.9827053573649,1,15,regulation of smooth muscle cell apoptotic process,BP,EDN1
3629,GO:0007067,0.186229202937056,0.894826638170213,9,438,mitotic nuclear division,BP,MARK4;EDN1;TTYH1;PDGFB;SNX18;PSRC1;FGF8;BMP7;BMP4
3525,GO:0006906,0.186448333488322,0.925629794983029,4,152,vesicle fusion,BP,SYT5;RAB39A;RAB20;VAMP1
17743,GO:0097106,0.186473031486041,0.982826603672033,1,13,postsynaptic density organization,BP,CDH2
18300,GO:0099084,0.186473031486041,0.982826603672033,1,13,postsynaptic specialization organization,BP,CDH2
874,GO:0002082,0.186513180349869,0.98264014007773,1,15,regulation of oxidative phosphorylation,BP,ACTN3
7330,GO:0030238,0.186667235661737,0.982693464033661,1,14,male sex determination,BP,DHH
10930,GO:0042588,0.186671282450381,0.982609569437337,1,15,zymogen granule,CC,RAB3D
5273,GO:0014823,0.186722677067243,0.95557197383902,2,57,response to activity,BP,EDN1;BMP6
13715,GO:0050866,0.18699492764377,0.92528330251995,4,161,negative regulation of cell activation,BP,TYRO3;PDGFB;SDC4;BMP4
11362,GO:0043373,0.187099445004885,0.98245361917992,1,16,CD4-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
16991,GO:0072310,0.187162297651469,0.982694472505221,1,13,glomerular epithelial cell development,BP,BMP4
15279,GO:0060977,0.187186752131558,0.982689774588854,1,13,coronary vasculature morphogenesis,BP,NOTCH1
10875,GO:0042510,0.187284448236705,0.982353056069929,1,17,regulation of tyrosine phosphorylation of Stat1 protein,BP,LIF
3859,GO:0007600,0.187419840547957,0.882265679030726,13,886,sensory perception,BP,ADRA2C;CDH23;SLC52A3;ADORA1;EDN1;SPTBN4;B3GNT2;ESPN;GJB2;GJB6;MYO7A;GJA3;UNC119
2002,GO:0004467,0.187957164497522,0.982541419466267,1,13,long-chain fatty acid-CoA ligase activity,MF,ACSL4
18270,GO:0098984,0.18804761553961,0.915532560698845,5,196,neuron to neuron synapse,CC,ADORA1;CDH2;DRP2;LZTS1;PDE4B
16725,GO:0071872,0.188120529515784,0.982509873150988,1,13,cellular response to epinephrine stimulus,BP,PDE4B
16907,GO:0072182,0.188127992070314,0.982508431373535,1,13,regulation of nephron tubule epithelial cell differentiation,BP,LIF
8852,GO:0032963,0.188252657018536,0.937084418245689,3,104,collagen metabolic process,BP,WNT4;BMP4;CTGF
17434,GO:0090179,0.188445332563459,0.982447061327928,1,13,planar cell polarity pathway involved in neural tube closure,BP,WNT5A
10163,GO:0035988,0.188604031101656,0.982318355755016,1,14,chondrocyte proliferation,BP,CTGF
8358,GO:0032239,0.188715834476511,0.982394657738678,1,13,regulation of nucleobase-containing compound transport,BP,ADORA1
2183,GO:0004707,0.188835208552519,0.982273292609705,1,14,MAP kinase activity,MF,MAPK12
5031,GO:0010832,0.189178738921505,0.982120848010786,1,15,negative regulation of myotube differentiation,BP,NOTCH1
19657,GO:1903541,0.18923392886646,0.982110008903286,1,15,regulation of exosomal secretion,BP,SDC4
19659,GO:1903543,0.18923392886646,0.982110008903286,1,15,positive regulation of exosomal secretion,BP,SDC4
8272,GO:0032075,0.189273802543605,0.982102175650687,1,15,positive regulation of nuclease activity,BP,AKT1
12856,GO:0046887,0.189426453771938,0.936446335488811,3,112,positive regulation of hormone secretion,BP,EDN1;BMP6;INHBB
13935,GO:0051194,0.189545458300851,0.982134457186141,1,14,positive regulation of cofactor metabolic process,BP,ACTN3
13938,GO:0051197,0.189545458300851,0.982134457186141,1,14,positive regulation of coenzyme metabolic process,BP,ACTN3
8953,GO:0033139,0.189694309867378,0.981602307175007,1,23,regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
15213,GO:0060831,0.190104263092887,0.982124353399231,1,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
4188,GO:0008499,0.190677290008492,0.98191200470157,1,14,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,B3GNT2
11323,GO:0043297,0.1907286148189,0.95407874087613,2,54,apical junction assembly,BP,CLDN1;CLDN3
460,GO:0001190,0.190797899752402,0.954032090839344,2,55,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,POU3F1;NOTCH1
18180,GO:0098811,0.190797899752402,0.954032090839344,2,55,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,POU3F1;NOTCH1
17849,GO:0097284,0.191030237219107,0.98184233163931,1,14,hepatocyte apoptotic process,BP,PIK3CG
10178,GO:0036010,0.191222293163163,0.981905073666522,1,13,protein localization to endosome,BP,MSN
16647,GO:0071695,0.191595328924918,0.953761397898833,2,53,anatomical structure maturation,BP,WNT5A;BMP2
2490,GO:0005159,0.192114964090491,0.981462270164469,1,16,insulin-like growth factor receptor binding,MF,PIK3R1
1492,GO:0003214,0.192218809123546,0.981606638732126,1,14,cardiac left ventricle morphogenesis,BP,NOTCH1
1283,GO:0002792,0.192268550251217,0.935057649776061,3,111,negative regulation of peptide secretion,BP,INHBB;RAB11FIP1;GAS6
16633,GO:0071674,0.192472458603321,0.953071597645719,2,77,mononuclear cell migration,BP,CCL20;PDGFB
7723,GO:0031034,0.192564400551585,0.981537799919075,1,14,myosin filament assembly,BP,MYH11
15734,GO:0070098,0.192752621797411,0.952971181933966,2,76,chemokine-mediated signaling pathway,BP,EDN1;CCL20
17294,GO:0086065,0.192758283275094,0.953328123678405,2,52,cell communication involved in cardiac conduction,BP,DSC2;CASQ2
14030,GO:0051348,0.1929006604799,0.899221626465198,7,345,negative regulation of transferase activity,BP,GADD45A;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
12003,GO:0045072,0.192914208459877,0.981301575727473,1,16,regulation of interferon-gamma biosynthetic process,BP,ZFPM1
9909,GO:0035577,0.193386990583067,0.952981017510033,2,57,azurophil granule membrane,CC,RAB44;RAB3D
20753,GO:1990351,0.193548049413988,0.898848477017797,7,317,transporter complex,CC,CASQ2;KCNK6;TTYH1;KCNH2;KCNG2;KCND1;PDE4B
3568,GO:0006977,0.193586808134799,0.952866945357806,2,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,GADD45A;CDKN1A
9342,GO:0034236,0.193689714539644,0.981312683524907,1,14,protein kinase A catalytic subunit binding,MF,PRKAR1B
3267,GO:0006544,0.193761143594511,0.981208787017695,1,15,glycine metabolic process,BP,GLDC
3861,GO:0007602,0.193768056471437,0.952795531688648,2,59,phototransduction,BP,NMT2;UNC119
5302,GO:0014874,0.193894327664292,0.98118191180952,1,15,response to stimulus involved in regulation of muscle adaptation,BP,ACTN3
8173,GO:0031902,0.194591320098232,0.933924773140575,3,109,late endosome membrane,CC,TSPAN15;RAB27A;RHOB
19790,GO:1903798,0.194615685197635,0.98112633833425,1,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
21491,GO:2000831,0.194927842428153,0.980823498997689,1,17,regulation of steroid hormone secretion,BP,BMP6
5651,GO:0015865,0.195403112475679,0.980876003087317,1,15,purine nucleotide transport,BP,GJB1
13292,GO:0048569,0.19557737839328,0.980840498437621,1,15,post-embryonic animal organ development,BP,MYO7A
19583,GO:1903391,0.19578496464126,0.952114208228556,2,53,regulation of adherens junction organization,BP,WNT4;SDC4
3643,GO:0007095,0.195867979894194,0.980872730613349,1,14,mitotic G2 DNA damage checkpoint,BP,FOXO4
7947,GO:0031434,0.196000518747457,0.980845782351392,1,14,mitogen-activated protein kinase kinase binding,MF,ARAF
8675,GO:0032693,0.196161209672517,0.980641023765969,1,16,negative regulation of interleukin-10 production,BP,DLL1
734,GO:0001895,0.196363579907384,0.951750759735808,2,60,retina homeostasis,BP,CDH23;TF
12315,GO:0045725,0.196623348261675,0.980626645163609,1,15,positive regulation of glycogen biosynthetic process,BP,AKT1
10344,GO:0036379,0.196941155248576,0.9802890847965,1,19,myofilament,CC,FHOD3
37,GO:0000075,0.196957116205534,0.910109770070615,5,214,cell cycle checkpoint,BP,GADD45A;FOXO4;HRAS;CDKN1A;AKT1
2214,GO:0004745,0.197311330894928,0.98026883151788,1,18,retinol dehydrogenase activity,MF,BMP2
528,GO:0001573,0.197338866630805,0.980479613817266,1,15,ganglioside metabolic process,BP,ITGB8
3887,GO:0007638,0.197544169380008,0.980530408246155,1,14,mechanosensory behavior,BP,STRA6
5292,GO:0014855,0.197855565805701,0.951269740224209,2,54,striated muscle cell proliferation,BP,WNT2;NOTCH1
1601,GO:0003417,0.198073901755463,0.980327944974559,1,15,growth plate cartilage development,BP,NPPC
15193,GO:0060788,0.198708541766054,0.980196480230037,1,15,ectodermal placode formation,BP,AXIN1
16649,GO:0071697,0.198708541766054,0.980196480230037,1,15,ectodermal placode morphogenesis,BP,AXIN1
8544,GO:0032495,0.198776901122662,0.980276551328631,1,14,response to muramyl dipeptide,BP,NOTCH1
12807,GO:0046785,0.199085083385468,0.950737000132215,2,56,microtubule polymerization,BP,TUBG2;PSRC1
12075,GO:0045187,0.199265128153799,0.979749787691635,1,20,regulation of circadian sleep/wake cycle, sleep,BP,ADORA1
17298,GO:0086069,0.199418651180196,0.980143689769804,1,14,bundle of His cell to Purkinje myocyte communication,BP,DSC2
437,GO:0001134,0.199433784057712,0.980140550972457,1,14,transcription factor activity, transcription factor recruiting,MF,LIF
8763,GO:0032816,0.19961522965974,0.979924717699495,1,16,positive regulation of natural killer cell activation,BP,GAS6
17052,GO:0072431,0.199621903018435,0.950447319331162,2,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
19151,GO:1902400,0.199621903018435,0.950447319331162,2,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
11205,GO:0043124,0.199719567406866,0.950482310416404,2,56,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,BMP7;TLE1
10647,GO:0042095,0.199793287367562,0.979813980050426,1,17,interferon-gamma biosynthetic process,BP,ZFPM1
6013,GO:0016594,0.19982203394495,0.979964674921781,1,15,glycine binding,MF,GLDC
10097,GO:0035869,0.199901604420774,0.95040913725788,2,56,ciliary transition zone,CC,SPTBN5;MYO7A
10016,GO:0035729,0.200069902133196,0.979912875034214,1,15,cellular response to hepatocyte growth factor stimulus,BP,BCAR1
16403,GO:0071333,0.200476089521651,0.930974109589456,3,110,cellular response to glucose stimulus,BP,GJB6;PIK3CA;GAS6
1032,GO:0002363,0.200598139781887,0.979644277601178,1,17,alpha-beta T cell lineage commitment,BP,ZFPM1
16110,GO:0070742,0.200633713067886,0.979794778785857,1,15,C2H2 zinc finger domain binding,MF,WT1
8348,GO:0032225,0.201149546035563,0.979601999390719,1,16,regulation of synaptic transmission, dopaminergic,BP,GDNF
17429,GO:0090174,0.201330408615754,0.917293672518095,4,157,organelle membrane fusion,BP,SYT5;RAB39A;RAB20;VAMP1
11538,GO:0043679,0.201393784060617,0.930519692221032,3,109,axon terminus,CC,ADRA2C;ADORA1;VAMP1
15814,GO:0070233,0.201404594944036,0.979473464619844,1,17,negative regulation of T cell apoptotic process,BP,BMP4
3606,GO:0007033,0.20151329451766,0.917189851695201,4,157,vacuole organization,BP,RAB39A;RALB;RAB20;MYO7A
9573,GO:0034704,0.20154363322714,0.949767607033674,2,55,calcium channel complex,CC,CASQ2;PDE4B
17893,GO:0097386,0.201583809878873,0.979594921076916,1,15,glial cell projection,CC,GJB2
8674,GO:0032692,0.201646562021523,0.979355610721107,1,18,negative regulation of interleukin-1 production,BP,GAS6
20215,GO:1904738,0.201817495914056,0.97964276951359,1,14,vascular associated smooth muscle cell migration,BP,PDGFB
20225,GO:1904752,0.201817495914056,0.97964276951359,1,14,regulation of vascular associated smooth muscle cell migration,BP,PDGFB
17433,GO:0090178,0.201923204492468,0.979620539896826,1,14,regulation of establishment of planar polarity involved in neural tube closure,BP,WNT5A
6475,GO:0019058,0.201996024320953,0.888017323608743,8,438,viral life cycle,BP,ITGA5;NOTCH1;ITGB5;NMT2;TYRO3;CLDN1;GAS6;EFNB2
11620,GO:0044065,0.202046120647341,0.97949728555237,1,15,regulation of respiratory system process,BP,ADORA1
7180,GO:0030004,0.202320529157428,0.930077831832577,3,106,cellular monovalent inorganic cation homeostasis,BP,RAB39A;RAB20;RAB38
16512,GO:0071482,0.202395681514414,0.930030720326035,3,107,cellular response to light stimulus,BP,NMT2;PIK3R1;CDKN1A
8479,GO:0032418,0.202671626731949,0.949214209112548,2,60,lysosome localization,BP,CHGA;PIK3CG
2590,GO:0005351,0.202741573508944,0.979349936151877,1,15,sugar:proton symporter activity,MF,SLC45A4
2607,GO:0005402,0.202741573508944,0.979349936151877,1,15,cation:sugar symporter activity,MF,SLC45A4
7706,GO:0031000,0.202950336783164,0.979305592545275,1,15,response to caffeine,BP,CASQ2
20050,GO:1904385,0.202984460551018,0.979212387639316,1,16,cellular response to angiotensin,BP,ACTN2
12902,GO:0046965,0.203154288248232,0.979262221146167,1,15,retinoid X receptor binding,MF,VDR
8396,GO:0032303,0.203203151094708,0.979089727674093,1,17,regulation of icosanoid secretion,BP,EDN1
7827,GO:0031235,0.203403334555497,0.979307897004996,1,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,SPTB
12692,GO:0046530,0.203470749356185,0.948986181585067,2,55,photoreceptor cell differentiation,BP,NOTCH1;MYO7A
2645,GO:0005521,0.203560351398285,0.979175722766975,1,15,lamin binding,MF,PKP1
3204,GO:0006461,0.203607222430894,0.855508832650339,22,1312,protein complex assembly,BP,FHOD3;TUBG2;ACTN2;PMAIP1;CASQ2;SPTBN5;SPTBN4;PRND;RALB;HRAS;AXIN1;PSRC1;SPTB;VAMP1;MSN;GJB1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;KCND1
15843,GO:0070271,0.203607222430894,0.855508832650339,22,1312,protein complex biogenesis,BP,FHOD3;TUBG2;ACTN2;PMAIP1;CASQ2;SPTBN5;SPTBN4;PRND;RALB;HRAS;AXIN1;PSRC1;SPTB;VAMP1;MSN;GJB1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;KCND1
7722,GO:0031033,0.203670615731956,0.979152200826454,1,15,myosin filament organization,BP,MYH11
66,GO:0000132,0.204094258085957,0.978974799099129,1,16,establishment of mitotic spindle orientation,BP,FGF10
1040,GO:0002374,0.204113223119668,0.978894086100591,1,17,cytokine secretion involved in immune response,BP,WNT5A
8494,GO:0032434,0.204113770901689,0.929168275418677,3,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,AKT1;ARAF;RNF144A
14658,GO:0060026,0.204446042699413,0.978986376820914,1,15,convergent extension,BP,WNT5A
16669,GO:0071732,0.20481404881212,0.978819920210094,1,16,cellular response to nitric oxide,BP,GUCY1B3
3796,GO:0007405,0.204904221158862,0.94844618030685,2,53,neuroblast proliferation,BP,ARTN;NOTCH1
3731,GO:0007252,0.205179068273406,0.978828963833081,1,15,I-kappaB phosphorylation,BP,AKT1
17045,GO:0072413,0.205509421534086,0.948037656191813,2,61,signal transduction involved in mitotic cell cycle checkpoint,BP,GADD45A;CDKN1A
19152,GO:1902402,0.205509421534086,0.948037656191813,2,61,signal transduction involved in mitotic DNA damage checkpoint,BP,GADD45A;CDKN1A
19153,GO:1902403,0.205509421534086,0.948037656191813,2,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,GADD45A;CDKN1A
18861,GO:1901623,0.205750515214767,0.978352899221509,1,20,regulation of lymphocyte chemotaxis,BP,WNT5A
8225,GO:0031998,0.206074369562778,0.978635836636419,1,15,regulation of fatty acid beta-oxidation,BP,AKT1
6085,GO:0016740,0.20640832207186,0.841399639544019,38,2269,transferase activity,MF,TSPAN17;MARK4;PNMT;FASN;FBXO41;HMGCS2;ACVR1;NMT2;PRKACB;MBOAT2;MAPK12;TYRO3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;KHK;NPR1;NUAK2;PFKFB3;FGF8;HBEGF;B3GNT2;CDKN1A;PKN3;WNK4;DDR1;AKT1;KITLG;SPSB1;PIK3CA;PIK3CG;DTX4;ARAF;RNF144A;PIM2
14596,GO:0055075,0.206527164100692,0.978537800313809,1,15,potassium ion homeostasis,BP,KCNH2
11571,GO:0043931,0.206580539994344,0.97852622760722,1,15,ossification involved in bone maturation,BP,BMP2
15452,GO:0061323,0.206885087124175,0.978370843177872,1,16,cell proliferation involved in heart morphogenesis,BP,BMP4
17856,GO:0097306,0.207195622471147,0.947483685344194,2,54,cellular response to alcohol,BP,AKT1;CDH1
9615,GO:0034774,0.207256432465795,0.895867988151888,6,312,secretory granule lumen,CC,ACTN2;RAB27A;TF;CRISPLD2;PDGFB;GAS6
11696,GO:0044259,0.207483153707703,0.927420409566105,3,109,multicellular organismal macromolecule metabolic process,BP,WNT4;BMP4;CTGF
18236,GO:0098911,0.207532994556851,0.978421906974346,1,14,regulation of ventricular cardiac muscle cell action potential,BP,DSC2
794,GO:0001972,0.207660064317488,0.978122154471975,1,17,retinoic acid binding,MF,SERPINA5
4837,GO:0010523,0.207724316147042,0.978108031716671,1,17,negative regulation of calcium ion transport into cytosol,BP,CASQ2
16196,GO:0070920,0.20799150503481,0.978219077947238,1,15,regulation of production of small RNA involved in gene silencing by RNA,BP,BMP4
18817,GO:1901532,0.208044401050731,0.978117223813025,1,16,regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
6127,GO:0016805,0.208217549507218,0.978079206623986,1,16,dipeptidase activity,MF,PM20D2
4690,GO:0009950,0.208790612201375,0.97795312650364,1,16,dorsal/ventral axis specification,BP,WNT3
18118,GO:0098662,0.208966188701215,0.868755371322996,12,648,inorganic cation transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TTYH1;TSPAN13;KCNH2;PIK3CG;KCNG2;GAS6;KCND1;CLDN16;PDE4B
7361,GO:0030285,0.209019272418171,0.97799385072474,1,15,integral component of synaptic vesicle membrane,CC,TMEM163
17432,GO:0090177,0.209097296417358,0.977976700853974,1,15,establishment of planar polarity involved in neural tube closure,BP,WNT5A
13165,GO:0048261,0.209126431370669,0.977798607509509,1,17,negative regulation of receptor-mediated endocytosis,BP,UNC119
10874,GO:0042509,0.209426714349947,0.946321598012739,2,67,regulation of tyrosine phosphorylation of STAT protein,BP,LIF;CLCF1
4757,GO:0010224,0.209590764254653,0.977695615769913,1,17,response to UV-B,BP,CDKN1A
6263,GO:0017081,0.209726288739685,0.977665506737124,1,17,chloride channel regulator activity,MF,WNK4
16166,GO:0070875,0.20996583260572,0.977693333429443,1,16,positive regulation of glycogen metabolic process,BP,AKT1
3786,GO:0007379,0.210072460170454,0.97758849859034,1,17,segment specification,BP,DLL1
8471,GO:0032410,0.210166366298434,0.946076778209975,2,63,negative regulation of transporter activity,BP,ACTN2;CASQ2
18179,GO:0098810,0.210564262691625,0.977478845666131,1,17,neurotransmitter reuptake,BP,GDNF
16648,GO:0071696,0.210790443332822,0.977510056126646,1,16,ectodermal placode development,BP,AXIN1
11869,GO:0044708,0.210817471841076,0.881944382480892,8,396,single-organism behavior,BP,ITGA3;ITGA5;STRA6;ADORA1;SPTBN4;PRKAR1B;CLDN5;GDNF
7812,GO:0031210,0.210820358295233,0.977284035818197,1,19,phosphatidylcholine binding,MF,SERPINA5
13792,GO:0050997,0.210820358295233,0.977284035818197,1,19,quaternary ammonium group binding,MF,SERPINA5
13269,GO:0048531,0.211106225865614,0.977439654218801,1,16,beta-1,3-galactosyltransferase activity,MF,B3GNT2
11740,GO:0044325,0.211139927581158,0.925554772285865,3,107,ion channel binding,MF,ACTN3;ACTN2;PDE4B
15773,GO:0070168,0.211155367345046,0.977273799053608,1,18,negative regulation of biomineral tissue development,BP,GAS6
6771,GO:0019932,0.211384589517697,0.90120117569249,5,225,second-messenger-mediated signaling,BP,ACTN3;GUCY1B3;CASQ2;EDN1;CCL20
8066,GO:0031664,0.211437624206194,0.977144999607495,1,19,regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
11066,GO:0042832,0.211449116771642,0.977142406581664,1,19,defense response to protozoan,BP,HRAS
7161,GO:0023019,0.211603693986847,0.977172956329653,1,18,signal transduction involved in regulation of gene expression,BP,FGF8
3650,GO:0007126,0.211711373175843,0.911301987484212,4,163,meiotic nuclear division,BP,LIF;WNT4;WNT5A;PIM2
9024,GO:0033268,0.211755993465244,0.97738796045265,1,15,node of Ranvier,CC,SPTBN4
5356,GO:0015079,0.211928550924805,0.911209998685383,4,157,potassium ion transmembrane transporter activity,MF,KCNK6;KCNH2;KCNG2;KCND1
17344,GO:0090036,0.212023306150121,0.977328298404382,1,15,regulation of protein kinase C signaling,BP,WNT5A
14118,GO:0051531,0.212085816426549,0.977220497064102,1,16,NFAT protein import into nucleus,BP,PIK3R1
999,GO:0002313,0.212247398923953,0.97710136453668,1,17,mature B cell differentiation involved in immune response,BP,DLL1
16401,GO:0071331,0.212254329476516,0.924923019927932,3,113,cellular response to hexose stimulus,BP,GJB6;PIK3CA;GAS6
13066,GO:0048012,0.212301695470437,0.977172044614356,1,16,hepatocyte growth factor receptor signaling pathway,BP,BCAR1
3207,GO:0006465,0.212627927665466,0.976875584545209,1,19,signal peptide processing,BP,GAS6
9176,GO:0033692,0.212633855589055,0.945137277513997,2,58,cellular polysaccharide biosynthetic process,BP,B3GNT2;AKT1
11134,GO:0043005,0.212905162733037,0.854973242502675,17,931,neuron projection,CC,ITGA3;ADRA2C;SYT5;ACTN2;MARK4;RAB27A;ADORA1;SPTBN4;RAB39B;FSTL3;DRP2;VAMP1;RAB17;NRTN;LZTS1;KCND1;PDE4B
18102,GO:0098641,0.213162841584514,0.976820360547743,1,18,cadherin binding involved in cell-cell adhesion,MF,PKP3
9854,GO:0035493,0.213487631596956,0.97690486860493,1,16,SNARE complex assembly,BP,VAMP1
1270,GO:0002768,0.213911485187068,0.885096205665892,7,350,immune response-regulating cell surface receptor signaling pathway,BP,PRKACB;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
3569,GO:0006978,0.214115616548657,0.976678367662311,1,17,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,CDKN1A
3892,GO:0008017,0.214323506629127,0.899430326061636,5,208,microtubule binding,MF,MARK4;REEP1;PSRC1;CAMSAP3;LZTS1
11016,GO:0042749,0.214553602138609,0.976271076284669,1,22,regulation of circadian sleep/wake cycle,BP,ADORA1
19010,GO:1902043,0.214763613377954,0.976615511873949,1,16,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1
3754,GO:0007283,0.214859400428653,0.874536809891377,9,488,spermatogenesis,BP,NOTCH1;DHH;SERPINA5;TYRO3;FSTL3;JAM3;SLC2A14;JAG2;CLDN11
16885,GO:0072160,0.214871224674651,0.976687338054268,1,15,nephron tubule epithelial cell differentiation,BP,LIF
11735,GO:0044320,0.214896171484407,0.976585338686815,1,16,cellular response to leptin stimulus,BP,INHBB
15170,GO:0060749,0.215010826151783,0.976474179586487,1,17,mammary gland alveolus development,BP,DDR1
15482,GO:0061377,0.215010826151783,0.976474179586487,1,17,mammary gland lobule development,BP,DDR1
11264,GO:0043209,0.215246159215095,0.909221166228762,4,167,myelin sheath,CC,JAM3;MSN;TSPAN2;CLDN11
16132,GO:0070822,0.215337821728426,0.97648465596469,1,16,Sin3-type complex,CC,SIN3B
3342,GO:0006633,0.215396261848648,0.923243416671219,3,118,fatty acid biosynthetic process,BP,FASN;EDN1;PTGES
966,GO:0002260,0.215579423619965,0.943799830206957,2,63,lymphocyte homeostasis,BP,PMAIP1;AKT1
13246,GO:0048486,0.21585773637738,0.976203965468849,1,18,parasympathetic nervous system development,BP,GDNF
15096,GO:0060644,0.215967276516429,0.976254949558816,1,17,mammary gland epithelial cell differentiation,BP,AKT1
16399,GO:0071326,0.216551241934459,0.922671121652112,3,114,cellular response to monosaccharide stimulus,BP,GJB6;PIK3CA;GAS6
13096,GO:0048070,0.2166046243373,0.976194554761981,1,16,regulation of developmental pigmentation,BP,KITLG
14268,GO:0051797,0.216755572470352,0.975996644956811,1,18,regulation of hair follicle development,BP,WNT5A
17043,GO:0072401,0.216803816311382,0.943279294509937,2,63,signal transduction involved in DNA integrity checkpoint,BP,GADD45A;CDKN1A
17047,GO:0072422,0.216803816311382,0.943279294509937,2,63,signal transduction involved in DNA damage checkpoint,BP,GADD45A;CDKN1A
13145,GO:0048232,0.216892832105054,0.873069119324378,9,489,male gamete generation,BP,NOTCH1;DHH;SERPINA5;TYRO3;FSTL3;JAM3;SLC2A14;JAG2;CLDN11
8251,GO:0032042,0.217104026526846,0.976079656291542,1,16,mitochondrial DNA metabolic process,BP,SESN2
11252,GO:0043195,0.217292203278336,0.943107777382548,2,61,terminal bouton,CC,ADORA1;VAMP1
9837,GO:0035455,0.217372071608614,0.975853719638448,1,18,response to interferon-alpha,BP,GAS6
10088,GO:0035855,0.217455287781099,0.976097310624663,1,15,megakaryocyte development,BP,ZFPM1
687,GO:0001832,0.217568111006391,0.975972612447668,1,16,blastocyst growth,BP,SALL4
3460,GO:0006809,0.217633707861382,0.942925321949865,2,63,nitric oxide biosynthetic process,BP,EDN1;AKT1
15054,GO:0060575,0.21766046445185,0.975864126433264,1,17,intestinal epithelial cell differentiation,BP,CDKN1A
19055,GO:1902176,0.217735129918358,0.975700046347569,1,19,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1
3867,GO:0007611,0.217817602268556,0.897210883013482,5,214,learning or memory,BP,ITGA3;ITGA5;STRA6;PRKAR1B;CLDN5
18925,GO:1901798,0.21790701712506,0.975659928982158,1,19,positive regulation of signal transduction by p53 class mediator,BP,PMAIP1
1282,GO:0002791,0.21803197191974,0.876845663202498,8,412,regulation of peptide secretion,BP,ADRA2C;ADORA1;WNT5A;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6
3849,GO:0007584,0.218122863591191,0.907507864310357,4,172,response to nutrient,BP,BMP7;GAS6;VDR;ACSL4
21474,GO:2000810,0.21823696763607,0.975817877096919,1,16,regulation of bicellular tight junction assembly,BP,CLDN1
4906,GO:0010642,0.21828010393291,0.975807879175943,1,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFB
17737,GO:0097094,0.21857462160024,0.975651670370508,1,17,craniofacial suture morphogenesis,BP,BMP4
13424,GO:0048820,0.218814003758952,0.975683947415071,1,16,hair follicle maturation,BP,WNT5A
8054,GO:0031647,0.218910831963368,0.896461372575995,5,230,regulation of protein stability,BP,TF;PIK3R1;BMP2;CDKN1A;PIM2
17110,GO:0072574,0.218951113658771,0.975563875264253,1,17,hepatocyte proliferation,BP,LIMS2
17111,GO:0072575,0.218951113658771,0.975563875264253,1,17,epithelial cell proliferation involved in liver morphogenesis,BP,LIMS2
7301,GO:0030203,0.219039589152907,0.907039729145438,4,159,glycosaminoglycan metabolic process,BP,PDGFB;SDC4;B3GNT2;AKT1
16421,GO:0071356,0.219230481793699,0.896167062705553,5,260,cellular response to tumor necrosis factor,BP,EDN1;CCL20;CLDN1;GAS6;CLDN18
10131,GO:0035929,0.219388176637363,0.975312737505271,1,19,steroid hormone secretion,BP,BMP6
8081,GO:0031690,0.219390007023297,0.975461310546972,1,17,adrenergic receptor binding,MF,ADRA2C
1839,GO:0004115,0.219675211552903,0.975583985048104,1,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,PDE4B
18992,GO:1902001,0.219887011610768,0.975433827250346,1,16,fatty acid transmembrane transport,BP,AKT1
15811,GO:0070230,0.220175955792382,0.975063248893836,1,20,positive regulation of lymphocyte apoptotic process,BP,WNT5A
16724,GO:0071871,0.220493765667316,0.975291771808652,1,16,response to epinephrine,BP,PDE4B
11032,GO:0042772,0.220775612778918,0.975056310737934,1,18,DNA damage response, signal transduction resulting in transcription,BP,CDKN1A
16843,GO:0072091,0.221095350502395,0.941537762391423,2,58,regulation of stem cell proliferation,BP,NOTCH1;KITLG
16715,GO:0071855,0.221247885180047,0.974492051929531,1,27,neuropeptide receptor binding,MF,EDN1
3070,GO:0006260,0.221279211513712,0.886710065004508,6,281,DNA replication,BP,FGF10;PDGFB;HRAS;BMP6;BMP4;KITLG
9678,GO:0035091,0.22129939355054,0.8950221641923,5,211,phosphatidylinositol binding,MF,SYT5;ACTN2;FZD7;SNX18;AKT1
10198,GO:0036035,0.221376949625837,0.974994041941837,1,17,osteoclast development,BP,CLDN18
8842,GO:0032945,0.221958559500242,0.94104754443343,2,64,negative regulation of mononuclear cell proliferation,BP,SDC4;BMP4
13573,GO:0050672,0.221958559500242,0.94104754443343,2,64,negative regulation of lymphocyte proliferation,BP,SDC4;BMP4
18604,GO:1900407,0.222389764996282,0.940878754014017,2,63,regulation of cellular response to oxidative stress,BP,BMP7;AKT1
20197,GO:1904707,0.222602153491423,0.974703505667717,1,17,positive regulation of vascular smooth muscle cell proliferation,BP,PDGFB
12140,GO:0045334,0.222828805758043,0.940652603801818,2,65,clathrin-coated endocytic vesicle,CC,WNT5A;HBEGF
17041,GO:0072395,0.222911951220288,0.940634055236821,2,64,signal transduction involved in cell cycle checkpoint,BP,GADD45A;CDKN1A
10873,GO:0042508,0.222957713211673,0.974399607361849,1,20,tyrosine phosphorylation of Stat1 protein,BP,LIF
10831,GO:0042438,0.222968507434534,0.974535028371589,1,18,melanin biosynthetic process,BP,WNT5A
2175,GO:0004697,0.223007744950235,0.974698408867362,1,16,protein kinase C activity,MF,PKN3
8516,GO:0032461,0.223146008197981,0.974419804509763,1,19,positive regulation of protein oligomerization,BP,PMAIP1
12036,GO:0045117,0.223194726834883,0.974480916865901,1,18,azole transport,BP,EDN1
14442,GO:0052547,0.223783310849699,0.878244606131149,7,384,regulation of peptidase activity,BP,PMAIP1;SERPINA5;MAPK12;CTGF;AKT1;CST9L;GAS6
21355,GO:2000641,0.223906906775357,0.97439208380511,1,17,regulation of early endosome to late endosome transport,BP,MSN
14559,GO:0055003,0.223944992640216,0.974382962011975,1,17,cardiac myofibril assembly,BP,FHOD3
16232,GO:0070977,0.223967750095997,0.974377510615186,1,17,bone maturation,BP,BMP2
16676,GO:0071782,0.224123516440879,0.974432585604387,1,16,endoplasmic reticulum tubular network,CC,REEP1
21543,GO:2001026,0.224165701424137,0.974174508684513,1,19,regulation of endothelial cell chemotaxis,BP,NOTCH1
3844,GO:0007567,0.22440668454231,0.974189945821424,1,18,parturition,BP,EDN1
2162,GO:0004675,0.224658724008486,0.974304536305537,1,16,transmembrane receptor protein serine/threonine kinase activity,MF,ACVR1
10015,GO:0035728,0.224771817794382,0.9741844934722,1,17,response to hepatocyte growth factor,BP,BCAR1
6663,GO:0019674,0.224891839270536,0.939771446841383,2,64,NAD metabolic process,BP,ACTN3;PFKFB3
1498,GO:0003222,0.224977801071873,0.974228029684969,1,16,ventricular trabecula myocardium morphogenesis,BP,NOTCH1
5071,GO:0010881,0.224990626177161,0.97404910567958,1,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,CASQ2
3512,GO:0006888,0.225223392740932,0.90331611015193,4,169,ER to Golgi vesicle-mediated transport,BP,SPTBN5;SPTBN4;SPTB;GAS6
15436,GO:0061298,0.225233211987076,0.974166698709141,1,16,retina vasculature development in camera-type eye,BP,RHOJ
13283,GO:0048557,0.225251375510839,0.973986080203626,1,18,embryonic digestive tract morphogenesis,BP,FGF10
8422,GO:0032354,0.225251440848531,0.97416231841646,1,16,response to follicle-stimulating hormone,BP,NOTCH1
998,GO:0002312,0.225647191712198,0.939459415262281,2,63,B cell activation involved in immune response,BP,CLCF1;DLL1
7369,GO:0030296,0.225685682145875,0.973964155097952,1,17,protein tyrosine kinase activator activity,MF,GAS6
11281,GO:0043234,0.225849273071078,0.821582608313078,45,2889,protein complex,CC,ITGA3;ITGA5;WNT3;WNT2;POU3F1;TUBG2;NOTCH1;STRA6;ITGB5;ITGB4;ITGB8;SERPINA5;ZFPM1;SALL4;GUCY1B3;CASQ2;CDH2;PRR5L;PIK3R1;CGN;RALB;SESN2;AXIN1;NPR1;CLCF1;SPTB;CDKN1A;ESPN;VAMP1;GJB1;GJB2;GJB6;AKT1;NPPC;CDH1;MYO7A;GJA3;MYH11;VDR;AMOT;LAMA1;LAMA5;FZD8;ACTA2;PDE4B
7885,GO:0031327,0.22588988779017,0.83504640157801,24,1445,negative regulation of cellular biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;INHBB;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
16171,GO:0070884,0.226504745269204,0.973765800929984,1,17,regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
9806,GO:0035384,0.226543083351644,0.93906654107422,2,63,thioester biosynthetic process,BP,FASN;ACSL4
16596,GO:0071616,0.226543083351644,0.93906654107422,2,63,acyl-CoA biosynthetic process,BP,FASN;ACSL4
4773,GO:0010288,0.226563620022186,0.973667626053493,1,18,response to lead ion,BP,CLDN1
9267,GO:0034104,0.226851672088021,0.973522231483946,1,19,negative regulation of tissue remodeling,BP,CLDN18
9957,GO:0035635,0.227097571461356,0.97362171968431,1,17,entry of bacterium into host cell,BP,CDH1
5740,GO:0016048,0.227978584617235,0.973321861234619,1,18,detection of temperature stimulus,BP,ADORA1
4847,GO:0010544,0.228520929960404,0.973274015628768,1,17,negative regulation of platelet activation,BP,PDGFB
17724,GO:0097061,0.228786069018729,0.938182219689331,2,58,dendritic spine organization,BP,ITGA3;WNT7A
13263,GO:0048520,0.2289078484105,0.972777404275631,1,23,positive regulation of behavior,BP,STRA6
20873,GO:1990776,0.229240310961503,0.973011453079374,1,18,response to angiotensin,BP,ACTN2
3938,GO:0008105,0.229615308746645,0.973004975067531,1,17,asymmetric protein localization,BP,WNT7A
13270,GO:0048532,0.230015641483156,0.972906187906716,1,17,anatomical structure arrangement,BP,DLL1
7543,GO:0030673,0.230194889429713,0.972959369251235,1,16,axolemma,CC,ADORA1
8639,GO:0032642,0.230205536416842,0.937393912880224,2,66,regulation of chemokine production,BP,ZFPM1;WNT5A
16053,GO:0070633,0.230265668108854,0.972757743081757,1,18,transepithelial transport,BP,EDN1
13572,GO:0050671,0.230647225987204,0.915037030634971,3,127,positive regulation of lymphocyte proliferation,BP,FGF10;CLCF1;CDKN1A
6666,GO:0019682,0.230718306555564,0.972497564623491,1,20,glyceraldehyde-3-phosphate metabolic process,BP,KHK
18620,GO:1900543,0.230821785585263,0.937137699961445,2,65,negative regulation of purine nucleotide metabolic process,BP,ACTN3;EDN1
8408,GO:0032331,0.23085455238813,0.972611442277095,1,18,negative regulation of chondrocyte differentiation,BP,BMP4
5365,GO:0015095,0.231980416461292,0.972418477585656,1,17,magnesium ion transmembrane transporter activity,MF,CLDN16
19805,GO:1903830,0.231980416461292,0.972418477585656,1,17,magnesium ion transmembrane transport,BP,CLDN16
20662,GO:1905952,0.232013239420657,0.914324715034732,3,123,regulation of lipid localization,BP,EDN1;BMP6;AKT1
1666,GO:0003841,0.232025952161945,0.972407117649146,1,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
10695,GO:0042171,0.232025952161945,0.972407117649146,1,17,lysophosphatidic acid acyltransferase activity,MF,MBOAT2
16597,GO:0071617,0.232025952161945,0.972407117649146,1,17,lysophospholipid acyltransferase activity,MF,MBOAT2
7317,GO:0030220,0.232125378782014,0.972294253359986,1,18,platelet formation,BP,ZFPM1
13720,GO:0050871,0.232341751873077,0.936390350137513,2,69,positive regulation of B cell activation,BP,CLCF1;CDKN1A
10754,GO:0042308,0.23265204646279,0.936339411776616,2,64,negative regulation of protein import into nucleus,BP,BMP7;GAS6
20142,GO:1904590,0.23265204646279,0.936339411776616,2,64,negative regulation of protein import,BP,BMP7;GAS6
9649,GO:0035024,0.232861384727406,0.972198242805965,1,17,negative regulation of Rho protein signal transduction,BP,ITGA3
1047,GO:0002385,0.23286574767129,0.971507329240753,1,30,mucosal immune response,BP,RAB17
10328,GO:0036342,0.232925937425976,0.972093408334079,1,18,post-anal tail morphogenesis,BP,WNT5A
10168,GO:0035994,0.233008399177842,0.971993336035245,1,19,response to muscle stretch,BP,EDN1
16668,GO:0071731,0.233021064905432,0.971990142114362,1,19,response to nitric oxide,BP,GUCY1B3
10719,GO:0042249,0.233165013063849,0.972122114870625,1,17,establishment of planar polarity of embryonic epithelium,BP,WNT5A
3738,GO:0007260,0.233188690044513,0.935978945291676,2,71,tyrosine phosphorylation of STAT protein,BP,LIF;CLCF1
8047,GO:0031640,0.233233435533757,0.971412947477888,1,30,killing of cells of other organism,BP,CHGA
11767,GO:0044364,0.233233435533757,0.971412947477888,1,30,disruption of cells of other organism,BP,CHGA
9266,GO:0034103,0.233279555370063,0.936021366831247,2,66,regulation of tissue remodeling,BP,VDR;CLDN18
5533,GO:0015631,0.233455873118369,0.878544140954813,6,275,tubulin binding,MF,MARK4;REEP1;PSRC1;CAMSAP3;LZTS1;PDE4B
17509,GO:0090281,0.233472749070819,0.971739654817245,1,21,negative regulation of calcium ion import,BP,CASQ2
12457,GO:0045980,0.233501888105843,0.935921601246968,2,66,negative regulation of nucleotide metabolic process,BP,ACTN3;EDN1
17889,GO:0097381,0.233807031634877,0.971791552558361,1,19,photoreceptor disc membrane,CC,SPTBN5
2939,GO:0006022,0.234071345950856,0.898018972830337,4,164,aminoglycan metabolic process,BP,PDGFB;SDC4;B3GNT2;AKT1
3769,GO:0007338,0.234079577088594,0.913127601165749,3,132,single fertilization,BP,IGSF8;SERPINA5;MFGE8
4867,GO:0010586,0.234152235668232,0.971873798958038,1,17,miRNA metabolic process,BP,HRAS
6611,GO:0019430,0.234300400518746,0.971469772982249,1,22,removal of superoxide radicals,BP,BMP7
8843,GO:0032946,0.234586907854206,0.912878656000976,3,128,positive regulation of mononuclear cell proliferation,BP,FGF10;CLCF1;CDKN1A
6726,GO:0019842,0.234700835258652,0.912863660686622,3,122,vitamin binding,MF,GLDC;FASN;VDR
1538,GO:0003298,0.234702870570891,0.971564259923511,1,19,physiological muscle hypertrophy,BP,EDN1
1541,GO:0003301,0.234702870570891,0.971564259923511,1,19,physiological cardiac muscle hypertrophy,BP,EDN1
15335,GO:0061049,0.234702870570891,0.971564259923511,1,19,cell growth involved in cardiac muscle cell development,BP,EDN1
16438,GO:0071380,0.234765962915672,0.971718816940001,1,17,cellular response to prostaglandin E stimulus,BP,AKT1
14782,GO:0060205,0.235031878159675,0.877336235826728,6,329,cytoplasmic vesicle lumen,CC,ACTN2;RAB27A;TF;CRISPLD2;PDGFB;GAS6
18350,GO:0099565,0.235086900922557,0.912762836711966,3,110,chemical synaptic transmission, postsynaptic,BP,WNT7A;ADORA1;AKT1
11358,GO:0043369,0.235165486161585,0.971373796468009,1,20,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
7781,GO:0031116,0.235573908964765,0.971342296555002,1,19,positive regulation of microtubule polymerization,BP,PSRC1
3408,GO:0006720,0.235834074358923,0.912201296946546,3,127,isoprenoid metabolic process,BP,STRA6;HMGCS2;SDC4
3304,GO:0006582,0.235873962203476,0.971265615026775,1,19,melanin metabolic process,BP,WNT5A
13712,GO:0050863,0.236089149401247,0.876678852393965,6,302,regulation of T cell activation,BP,PIK3R1;SDC4;BMP4;AKT1;PIK3CA;EFNB2
8781,GO:0032845,0.236183187164761,0.89666063507457,4,177,negative regulation of homeostatic process,BP,ADORA1;CASQ2;KITLG;CLDN18
13342,GO:0048670,0.236217115067269,0.971259316822504,1,18,regulation of collateral sprouting,BP,WNT3
21389,GO:2000678,0.236344730107229,0.971005251270965,1,21,negative regulation of transcription regulatory region DNA binding,BP,HEY1
523,GO:0001562,0.236494776374336,0.970966597274883,1,21,response to protozoan,BP,HRAS
16069,GO:0070664,0.236899504613236,0.934370676010701,2,67,negative regulation of leukocyte proliferation,BP,SDC4;BMP4
11627,GO:0044090,0.236953536994502,0.971162578402867,1,17,positive regulation of vacuole organization,BP,RALB
4616,GO:0009651,0.237021342659945,0.970897504097642,1,20,response to salt stress,BP,CLDN1
13692,GO:0050832,0.237244937236964,0.970341950676787,1,31,defense response to fungus,BP,CHGA
5224,GO:0014068,0.237324966273624,0.934253452542274,2,63,positive regulation of phosphatidylinositol 3-kinase signaling,BP,PRR5L;PDGFB
14312,GO:0051896,0.237388051788353,0.911402700578986,3,120,regulation of protein kinase B signaling,BP,HBEGF;PIK3CG;GAS6
10849,GO:0042474,0.237398469410978,0.970800187762489,1,20,middle ear morphogenesis,BP,EDN1
8215,GO:0031983,0.23752769628768,0.875632143617389,6,330,vesicle lumen,CC,ACTN2;RAB27A;TF;CRISPLD2;PDGFB;GAS6
881,GO:0002089,0.23781529133349,0.97084940159152,1,18,lens morphogenesis in camera-type eye,BP,BMP4
1222,GO:0002702,0.238299428591806,0.933651043879617,2,72,positive regulation of production of molecular mediator of immune response,BP,WNT5A;CLCF1
12371,GO:0045830,0.238399613538291,0.970540976967655,1,20,positive regulation of isotype switching,BP,CLCF1
11724,GO:0044304,0.238406789530399,0.933803861771863,2,61,main axon,CC,ADORA1;SPTBN4
2941,GO:0006024,0.238417449033173,0.910929864709488,3,110,glycosaminoglycan biosynthetic process,BP,PDGFB;SDC4;B3GNT2
6751,GO:0019887,0.238432955011337,0.895290782141022,4,176,protein kinase regulator activity,MF,PRKAR1B;CDKN1A;PIK3CA;GAS6
19404,GO:1903010,0.238616988077415,0.970559369800831,1,19,regulation of bone development,BP,CLDN18
605,GO:0001710,0.238683922122816,0.970542018133442,1,19,mesodermal cell fate commitment,BP,BMP4
14849,GO:0060307,0.238739394792913,0.970610917698834,1,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,KCNH2
1136,GO:0002544,0.238787477169063,0.970310843253109,1,22,chronic inflammatory response,BP,PTGES
21246,GO:2000482,0.238883616919197,0.970347374979305,1,21,regulation of interleukin-8 secretion,BP,WNT5A
13074,GO:0048020,0.238900206181408,0.969778839833721,1,36,CCR chemokine receptor binding,MF,CCL20
18068,GO:0098563,0.239141109914563,0.97050691252153,1,18,intrinsic component of synaptic vesicle membrane,CC,TMEM163
13968,GO:0051250,0.240333239987171,0.909746596954134,3,123,negative regulation of lymphocyte activation,BP,TYRO3;SDC4;BMP4
14723,GO:0060117,0.240350411508141,0.970192596532019,1,18,auditory receptor cell development,BP,MYO7A
7565,GO:0030728,0.240361299986336,0.970029402607597,1,20,ovulation,BP,INHBB
5145,GO:0010975,0.240404059234536,0.860833950088488,8,391,regulation of neuron projection development,BP,ITGA3;WNT3;WNT7A;WNT5A;BMP7;AKT1;RAB17;LZTS1
13670,GO:0050802,0.240475749087711,0.969758952138917,1,24,circadian sleep/wake cycle, sleep,BP,ADORA1
21422,GO:2000737,0.240650071770805,0.970114425810551,1,18,negative regulation of stem cell differentiation,BP,NOTCH1
12567,GO:0046209,0.241568283213153,0.932238405032102,2,67,nitric oxide metabolic process,BP,EDN1;AKT1
10330,GO:0036344,0.241648215225141,0.969767906764945,1,19,platelet morphogenesis,BP,ZFPM1
2940,GO:0006023,0.241799364067022,0.909043768734679,3,111,aminoglycan biosynthetic process,BP,PDGFB;SDC4;B3GNT2
10303,GO:0036296,0.242054345624658,0.969660983787471,1,19,response to increased oxygen levels,BP,CDKN1A
14612,GO:0055093,0.242054345624658,0.969660983787471,1,19,response to hyperoxia,BP,CDKN1A
13207,GO:0048339,0.242121320201201,0.969728988153244,1,18,paraxial mesoderm development,BP,WNT5A
13516,GO:0050431,0.24212272937576,0.969824408108869,1,17,transforming growth factor beta binding,MF,ACVR1
16384,GO:0071305,0.242744678909339,0.969478759377569,1,19,cellular response to vitamin D,BP,VDR
1194,GO:0002673,0.243013536874466,0.931519449429711,2,70,regulation of acute inflammatory response,BP,ADORA1;PIK3CG
12274,GO:0045649,0.243265596499115,0.969263075535011,1,20,regulation of macrophage differentiation,BP,LIF
8012,GO:0031571,0.243333588693435,0.931406317094083,2,68,mitotic G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
11929,GO:0044819,0.243333588693435,0.931406317094083,2,68,mitotic G1/S transition checkpoint,BP,GADD45A;CDKN1A
7661,GO:0030903,0.243695839465561,0.969226697277104,1,19,notochord development,BP,WNT5A
19050,GO:1902170,0.243783686225885,0.969203359649375,1,19,cellular response to reactive nitrogen species,BP,GUCY1B3
16344,GO:0071230,0.243837910668802,0.931291495395083,2,62,cellular response to amino acid stimulus,BP,SESN2;SH3BP4
19681,GO:1903579,0.243899110802666,0.969172680748339,1,19,negative regulation of ATP metabolic process,BP,ACTN3
6016,GO:0016597,0.244079509610236,0.931117647186144,2,65,amino acid binding,MF,GLDC;SESN2
10835,GO:0042445,0.24430381149317,0.891627226202933,4,185,hormone metabolic process,BP,WNT4;DKK3;BMP6;BMP2
5453,GO:0015267,0.244406490483534,0.852894242579384,9,461,channel activity,MF,KCNK6;TTYH1;KCNH2;GJB1;GJB2;GJA3;KCNG2;GAS6;KCND1
17112,GO:0072576,0.244683096828143,0.968963856629545,1,19,liver morphogenesis,BP,LIMS2
4670,GO:0009890,0.244710668102509,0.819289879929702,24,1465,negative regulation of biosynthetic process,BP,WNT4;NOTCH1;ZFPM1;SALL4;DKK3;EDN1;PDGFB;WNT5A;SESN2;AXIN1;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;NAB2;INHBB;TLE1;GAS6;SIN3B;VDR;FZD8;HEY1
5559,GO:0015693,0.244738171319894,0.969036673009344,1,18,magnesium ion transport,BP,CLDN16
6037,GO:0016638,0.2447405178491,0.968948531200939,1,19,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,GLDC
17351,GO:0090049,0.245292256946109,0.968801061018607,1,19,regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
10867,GO:0042501,0.245416075202279,0.968259721872474,1,28,serine phosphorylation of STAT protein,BP,LIF
16397,GO:0071322,0.245562507885317,0.90684209340681,3,121,cellular response to carbohydrate stimulus,BP,GJB6;PIK3CA;GAS6
8078,GO:0031683,0.245885184140144,0.968562690036176,1,20,G-protein beta/gamma-subunit complex binding,MF,ADORA1
17334,GO:0090023,0.246288403289975,0.968105030019241,1,26,positive regulation of neutrophil chemotaxis,BP,EDN1
9274,GO:0034114,0.246292865187737,0.968452905221613,1,20,regulation of heterotypic cell-cell adhesion,BP,BMP7
2592,GO:0005355,0.246366666350951,0.968512780337379,1,19,glucose transmembrane transporter activity,MF,SLC2A14
9828,GO:0035428,0.246366666350951,0.968512780337379,1,19,hexose transmembrane transport,BP,SLC2A14
20172,GO:1904659,0.246366666350951,0.968512780337379,1,19,glucose transmembrane transport,BP,SLC2A14
20661,GO:1905950,0.246366666350951,0.968512780337379,1,19,monosaccharide transmembrane transport,BP,SLC2A14
7125,GO:0022803,0.246523008232377,0.851309680209877,9,462,passive transmembrane transporter activity,MF,KCNK6;TTYH1;KCNH2;GJB1;GJB2;GJA3;KCNG2;GAS6;KCND1
8242,GO:0032026,0.246612609809564,0.968535442205506,1,18,response to magnesium ion,BP,BMP6
19427,GO:1903046,0.246638844019553,0.890236109384247,4,174,meiotic cell cycle process,BP,LIF;WNT4;WNT5A;PIM2
13615,GO:0050718,0.246706128669751,0.968203328241662,1,22,positive regulation of interleukin-1 beta secretion,BP,WNT5A
19608,GO:1903429,0.246891178212627,0.968291401325056,1,20,regulation of cell maturation,BP,NPPC
19568,GO:1903364,0.24817702229925,0.889213426134433,4,186,positive regulation of cellular protein catabolic process,BP,AXIN1;MSN;AKT1;RNF144A
70,GO:0000145,0.248181981697249,0.968112356574349,1,18,exocyst,CC,RALB
21540,GO:2001022,0.248215701990943,0.9291518148237,2,67,positive regulation of response to DNA damage stimulus,BP,PMAIP1;FGF10
13927,GO:0051184,0.24840775033594,0.967961079357769,1,19,cofactor transporter activity,MF,FLVCR2
19635,GO:1903510,0.248437195409215,0.905309650122338,3,112,mucopolysaccharide metabolic process,BP,PDGFB;B3GNT2;AKT1
2986,GO:0006096,0.248538883912744,0.929000235603532,2,67,glycolytic process,BP,ACTN3;PFKFB3
3432,GO:0006757,0.248538883912744,0.929000235603532,2,67,ATP generation from ADP,BP,ACTN3;PFKFB3
16485,GO:0071450,0.24856248477987,0.967580987330397,1,24,cellular response to oxygen radical,BP,BMP7
16486,GO:0071451,0.24856248477987,0.967580987330397,1,24,cellular response to superoxide,BP,BMP7
3565,GO:0006972,0.248582041427612,0.967759072757575,1,21,hyperosmotic response,BP,CLDN1
14001,GO:0051294,0.248989291372472,0.967721442274195,1,20,establishment of spindle orientation,BP,FGF10
10784,GO:0042359,0.249380032107608,0.967614674713085,1,20,vitamin D metabolic process,BP,VDR
11908,GO:0044783,0.249453543542975,0.928533280761073,2,69,G1 DNA damage checkpoint,BP,GADD45A;CDKN1A
19718,GO:1903649,0.249476278046637,0.967670139873624,1,19,regulation of cytoplasmic transport,BP,MSN
3434,GO:0006766,0.249556751606548,0.904543560383388,3,126,vitamin metabolic process,BP,FASN;SLC52A3;VDR
3866,GO:0007610,0.249816398060288,0.844452675214475,10,547,behavior,BP,ITGA3;ITGA5;CDH23;STRA6;ADORA1;SPTBN4;PRKAR1B;ESPN;CLDN5;GDNF
532,GO:0001578,0.250211256660248,0.928253298844917,2,65,microtubule bundle formation,BP,MARK4;PSRC1
15499,GO:0061436,0.250235747550326,0.967462464188748,1,19,establishment of skin barrier,BP,CLDN1
18465,GO:1900076,0.250877658737349,0.927938951513836,2,65,regulation of cellular response to insulin stimulus,BP,PIK3R2;PIK3R1
13795,GO:0051000,0.250995049933915,0.967171306254671,1,20,positive regulation of nitric-oxide synthase activity,BP,AKT1
9459,GO:0034453,0.25108144209331,0.967322444336346,1,18,microtubule anchoring,BP,CAMSAP3
3492,GO:0006862,0.2510887341187,0.967145484655858,1,20,nucleotide transport,BP,GJB1
7589,GO:0030814,0.251393863333912,0.903443176571358,3,133,regulation of cAMP metabolic process,BP,EDN1;CHGA;NPPC
4924,GO:0010664,0.252163203553772,0.966848529557552,1,20,negative regulation of striated muscle cell apoptotic process,BP,BMP7
962,GO:0002251,0.252219755980836,0.966238458419838,1,32,organ or tissue specific immune response,BP,RAB17
14171,GO:0051604,0.252248783119218,0.874705548661969,5,251,protein maturation,BP,TSPAN15;RHBDL3;PLAU;PRKACB;GAS6
11158,GO:0043034,0.252621646354961,0.966805241031061,1,19,costamere,CC,SDC4
11436,GO:0043502,0.252729686833281,0.927021929146172,2,67,regulation of muscle adaptation,BP,ACTN3;EDN1
6541,GO:0019226,0.252926076790423,0.926909384322587,2,68,transmission of nerve impulse,BP,SPTBN4;JAM3
1493,GO:0003215,0.253308219632712,0.966614764009386,1,19,cardiac right ventricle morphogenesis,BP,NOTCH1
6831,GO:0021533,0.253436059585247,0.966579230329138,1,19,cell differentiation in hindbrain,BP,WNT7A
4622,GO:0009713,0.253515860224778,0.966472580969978,1,20,catechol-containing compound biosynthetic process,BP,PNMT
10822,GO:0042423,0.253515860224778,0.966472580969978,1,20,catecholamine biosynthetic process,BP,PNMT
16684,GO:0071800,0.253609382352968,0.966446501017803,1,20,podosome assembly,BP,MSN
3343,GO:0006635,0.254065532215714,0.926348165198974,2,69,fatty acid beta-oxidation,BP,SESN2;AKT1
5059,GO:0010869,0.254139363089369,0.966298495675647,1,20,regulation of receptor biosynthetic process,BP,EDN1
21656,GO:2001257,0.254272975712591,0.901890049680286,3,122,regulation of cation channel activity,BP,ACTN2;CASQ2;PDE4B
12821,GO:0046827,0.254280681117979,0.966258969307124,1,20,positive regulation of protein export from nucleus,BP,GAS6
10579,GO:0040001,0.254370129343829,0.966233937515247,1,20,establishment of mitotic spindle localization,BP,FGF10
8553,GO:0032506,0.254734111560317,0.966217241322775,1,19,cytokinetic process,BP,SNX18
7100,GO:0022410,0.254980545987663,0.96568876639751,1,26,circadian sleep/wake cycle process,BP,ADORA1
18441,GO:1900027,0.255124998787253,0.965944932217134,1,21,regulation of ruffle assembly,BP,HRAS
8046,GO:0031639,0.255254771153639,0.965838037780231,1,22,plasminogen activation,BP,PLAU
11608,GO:0044030,0.255594668512683,0.965890216572154,1,20,regulation of DNA methylation,BP,PIK3CA
21261,GO:2000505,0.255663039640904,0.965956859041369,1,19,regulation of energy homeostasis,BP,DLL1
19445,GO:1903077,0.255786813881778,0.965922080683621,1,19,negative regulation of protein localization to plasma membrane,BP,RHOQ
2656,GO:0005540,0.256251621462633,0.965705015855628,1,20,hyaluronic acid binding,MF,HAPLN3
11288,GO:0043243,0.256751315669421,0.965485441184964,1,21,positive regulation of protein complex disassembly,BP,ACTN2
10474,GO:0038093,0.256805036632162,0.883790019338812,4,185,Fc receptor signaling pathway,BP,PIK3R2;PIK3R1;HRAS;PIK3CA
14062,GO:0051412,0.256862843902761,0.965453805096731,1,21,response to corticosterone,BP,CDKN1A
519,GO:0001556,0.257129039414646,0.96537823094176,1,21,oocyte maturation,BP,NPPC
3042,GO:0006198,0.257467361799535,0.965544756932064,1,18,cAMP catabolic process,BP,PDE4B
5394,GO:0015149,0.257665664644848,0.965304491542678,1,20,hexose transmembrane transporter activity,MF,SLC2A14
3998,GO:0008198,0.2578745319787,0.965094291233717,1,22,ferrous iron binding,MF,TF
6306,GO:0017158,0.257903047840842,0.924588667261152,2,65,regulation of calcium ion-dependent exocytosis,BP,SYT5;NOTCH1
8611,GO:0032602,0.257934907009964,0.924421205548442,2,73,chemokine production,BP,ZFPM1;WNT5A
1016,GO:0002335,0.257992597360592,0.965132430169581,1,21,mature B cell differentiation,BP,DLL1
13772,GO:0050951,0.258102145842017,0.96518033647401,1,20,sensory perception of temperature stimulus,BP,ADORA1
21563,GO:2001057,0.258308390028788,0.924293940672174,2,70,reactive nitrogen species metabolic process,BP,EDN1;AKT1
20664,GO:1905954,0.258377904579899,0.924207325464075,2,73,positive regulation of lipid localization,BP,EDN1;BMP6
19566,GO:1903362,0.258538311020315,0.8704774289139,5,251,regulation of cellular protein catabolic process,BP,AXIN1;MSN;AKT1;ARAF;RNF144A
8409,GO:0032332,0.258805109666144,0.965067871969267,1,19,positive regulation of chondrocyte differentiation,BP,BMP6
9486,GO:0034505,0.258849804221079,0.964887479778472,1,21,tooth mineralization,BP,WNT6
14788,GO:0060216,0.259100677747322,0.964983589924192,1,19,definitive hemopoiesis,BP,ZFPM1
1007,GO:0002323,0.259632605304408,0.964183188251232,1,30,natural killer cell activation involved in immune response,BP,RAB27A
16602,GO:0071624,0.259805327395913,0.964171506904019,1,29,positive regulation of granulocyte chemotaxis,BP,EDN1
2794,GO:0005783,0.260006736407327,0.804142075154867,26,1601,endoplasmic reticulum,CC,ITGA5;WNT3;WNT4;NOTCH1;WNT6;WNT7A;WNT7B;ADORA1;CASQ2;EDN1;MBOAT2;TTYH1;RRAS2;TYRO3;PIK3R1;REEP1;PDGFB;WNT5B;WNT5A;GJB1;TPD52;PTGES;GAS6;GPSM1;RAB38;ACSL4
13672,GO:0050804,0.260187703589969,0.859986913322763,6,292,modulation of synaptic transmission,BP,WNT7A;ADORA1;EDN1;HRAS;LZTS1;GDNF
11840,GO:0044550,0.260412872247178,0.964438367463425,1,21,secondary metabolite biosynthetic process,BP,WNT5A
12423,GO:0045922,0.261294817289441,0.964109843784631,1,22,negative regulation of fatty acid metabolic process,BP,AKT1
4804,GO:0010460,0.261606767880106,0.964019296926779,1,22,positive regulation of heart rate,BP,EDN1
9532,GO:0034644,0.262123237934115,0.922461796889753,2,69,cellular response to UV,BP,PIK3R1;CDKN1A
7577,GO:0030802,0.262138367958131,0.897210237596337,3,138,regulation of cyclic nucleotide biosynthetic process,BP,EDN1;NPR1;NPPC
11487,GO:0043567,0.262404938698201,0.963719195141288,1,23,regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2
11994,GO:0045061,0.262595770982755,0.96380583364509,1,21,thymic T cell selection,BP,JAG2
1600,GO:0003416,0.262787807989874,0.963749889822514,1,21,endochondral bone growth,BP,NPPC
13613,GO:0050716,0.262832620854738,0.963531812666537,1,24,positive regulation of interleukin-1 secretion,BP,WNT5A
4536,GO:0009314,0.262883217369602,0.844180691660127,8,421,response to radiation,BP,GADD45A;NMT2;PIK3R1;HRAS;RHOB;CDKN1A;AKT1;UNC119
17253,GO:0086013,0.262940925290971,0.963787392923939,1,20,membrane repolarization during cardiac muscle cell action potential,BP,KCNH2
10775,GO:0042347,0.263483889439013,0.963471756060267,1,22,negative regulation of NF-kappaB import into nucleus,BP,BMP7
4712,GO:0010002,0.263743065985003,0.963644923432585,1,19,cardioblast differentiation,BP,NOTCH1
7777,GO:0031112,0.263785230793106,0.963383427489524,1,22,positive regulation of microtubule polymerization or depolymerization,BP,PSRC1
20641,GO:1905897,0.264095507021082,0.9214972249313,2,69,regulation of response to endoplasmic reticulum stress,BP,PMAIP1;PIK3R1
18186,GO:0098827,0.264166068682354,0.963429870846805,1,20,endoplasmic reticulum subcompartment,CC,REEP1
17241,GO:0086001,0.264425476901404,0.921441311664233,2,64,cardiac muscle cell action potential,BP,DSC2;KCNH2
21352,GO:2000637,0.264460360653629,0.963343698247475,1,20,positive regulation of gene silencing by miRNA,BP,BMP4
5539,GO:0015645,0.264797855715932,0.96324473577986,1,20,fatty acid ligase activity,MF,ACSL4
15245,GO:0060914,0.264875241810085,0.96306293120239,1,22,heart formation,BP,BMP4
17794,GO:0097186,0.264920703443646,0.963125295604874,1,21,amelogenesis,BP,ITGB4
19611,GO:1903432,0.265225501800588,0.963035552263461,1,21,regulation of TORC1 signaling,BP,SESN2
18166,GO:0098794,0.265763977824221,0.842060078052827,8,400,postsynapse,CC,ACTN2;ADORA1;CDH2;DRP2;AKT1;LZTS1;SHC4;PDE4B
4563,GO:0009411,0.266120728803625,0.895004696496679,3,123,response to UV,BP,PIK3R1;CDKN1A;AKT1
10115,GO:0035902,0.266158784383788,0.962549786070243,1,24,response to immobilization stress,BP,FOXO4
12320,GO:0045732,0.266376253328592,0.865148780501024,5,251,positive regulation of protein catabolic process,BP,WNT5A;AXIN1;MSN;AKT1;RNF144A
11480,GO:0043555,0.26674758646338,0.962585572542023,1,21,regulation of translation in response to stress,BP,SESN2
14923,GO:0060396,0.266872790331369,0.96247154067721,1,22,growth hormone receptor signaling pathway,BP,PIK3R1
9511,GO:0034612,0.267136072920409,0.864540972463434,5,278,response to tumor necrosis factor,BP,EDN1;CCL20;CLDN1;GAS6;CLDN18
18653,GO:1901019,0.267262627391389,0.919861964661941,2,73,regulation of calcium ion transmembrane transporter activity,BP,CASQ2;PDE4B
20042,GO:1904376,0.268079187004177,0.962274783350539,1,20,negative regulation of protein localization to cell periphery,BP,RHOQ
11317,GO:0043281,0.268655581027969,0.876156509361502,4,192,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;CTGF;AKT1;GAS6
11521,GO:0043627,0.268951087365099,0.919024146890514,2,73,response to estrogen,BP,DHH;WNT7A
18114,GO:0098657,0.269009352283786,0.919112734654195,2,67,import into cell,BP,TF;GDNF
11897,GO:0044766,0.26904397102725,0.91901491055177,2,71,multi-organism transport,BP,NMT2;RAB40B
19224,GO:1902579,0.26904397102725,0.91901491055177,2,71,multi-organism localization,BP,NMT2;RAB40B
849,GO:0002052,0.269173514407113,0.961948159072974,1,20,positive regulation of neuroblast proliferation,BP,NOTCH1
4388,GO:0009110,0.269308743981687,0.961743244980758,1,22,vitamin biosynthetic process,BP,VDR
19422,GO:1903037,0.270371282662938,0.852673050606274,6,317,regulation of leukocyte cell-cell adhesion,BP,PIK3R1;SDC4;BMP4;AKT1;PIK3CA;EFNB2
12832,GO:0046849,0.270501199005455,0.918269961483924,2,72,bone remodeling,BP,RAB3D;CLDN18
16131,GO:0070821,0.270594242581947,0.918242393560037,2,71,tertiary granule membrane,CC,PLAU;VAMP1
116,GO:0000242,0.270605690713919,0.961518314391611,1,20,pericentriolar material,CC,TUBG2
5743,GO:0016051,0.270958175216229,0.874693669039857,4,186,carbohydrate biosynthetic process,BP,PDGFB;SESN2;B3GNT2;AKT1
17544,GO:0090322,0.271359705817189,0.960984974682441,1,24,regulation of superoxide metabolic process,BP,BMP7
483,GO:0001504,0.271710025731135,0.961017641425949,1,22,neurotransmitter uptake,BP,GDNF
18319,GO:0099504,0.27208657331864,0.891527332349463,3,118,synaptic vesicle cycle,BP,SYT5;WNT7A;CDH2
9961,GO:0035640,0.272106124517051,0.960897217015874,1,22,exploration behavior,BP,ITGA3
20956,GO:2000021,0.272458975465196,0.873699707638126,4,189,regulation of ion homeostasis,BP,ADORA1;CASQ2;EDN1;NPR1
11348,GO:0043325,0.272511253578285,0.960853983713228,1,21,phosphatidylinositol-3,4-bisphosphate binding,MF,AKT1
19541,GO:1903306,0.272654417367067,0.960810413880987,1,21,negative regulation of regulated secretory pathway,BP,NOTCH1
12319,GO:0045730,0.272761447379213,0.960495336766431,1,25,respiratory burst,BP,PIK3CG
4587,GO:0009583,0.272834640612591,0.917082542037413,2,73,detection of light stimulus,BP,NMT2;UNC119
20970,GO:2000050,0.272858417594787,0.960836716235437,1,20,regulation of non-canonical Wnt signaling pathway,BP,WNT5A
18478,GO:1900101,0.273234197146671,0.960553112446339,1,22,regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
12479,GO:0046031,0.27329735350193,0.916868490171206,2,72,ADP metabolic process,BP,ACTN3;PFKFB3
12301,GO:0045686,0.273379046445089,0.960435191085206,1,23,negative regulation of glial cell differentiation,BP,NOTCH1
4237,GO:0008589,0.273620277393051,0.916830003550585,2,66,regulation of smoothened signaling pathway,BP,PRKACB;FGF10
9105,GO:0033561,0.273630207160345,0.960512722349353,1,21,regulation of water loss via skin,BP,CLDN1
13414,GO:0048799,0.273869881860279,0.960439409692662,1,21,animal organ maturation,BP,BMP2
11902,GO:0044772,0.274500336132059,0.829953530083619,9,501,mitotic cell cycle phase transition,BP,GADD45A;ACVR1;PHLDA1;FGF10;FOXO4;CDKN1A;AKT1;LZTS1;PIM2
2185,GO:0004709,0.274668893880332,0.960284060180633,1,20,MAP kinase kinase kinase activity,MF,ARAF
12412,GO:0045911,0.274882151309009,0.95997296160212,1,23,positive regulation of DNA recombination,BP,CLCF1
10905,GO:0042554,0.274895802727891,0.959900550191052,1,24,superoxide anion generation,BP,EDN1
14008,GO:0051302,0.275046911198957,0.889634044414514,3,131,regulation of cell division,BP,PDGFB;FGF8;DLL1
11012,GO:0042745,0.275206438932696,0.959580089038663,1,28,circadian sleep/wake cycle,BP,ADORA1
2189,GO:0004714,0.275220292325177,0.916070636475347,2,64,transmembrane receptor protein tyrosine kinase activity,MF,TYRO3;DDR1
12817,GO:0046823,0.276272297349343,0.915346906977003,2,73,negative regulation of nucleocytoplasmic transport,BP,BMP7;GAS6
13245,GO:0048485,0.276487626921072,0.959633711046151,1,21,sympathetic nervous system development,BP,GDNF
872,GO:0002080,0.276581816007405,0.959314133092986,1,25,acrosomal membrane,CC,SERPINA5
14744,GO:0060148,0.276680752893027,0.959573908672765,1,21,positive regulation of posttranscriptional gene silencing,BP,BMP4
7833,GO:0031253,0.276713302761658,0.848172353563556,6,295,cell projection membrane,CC,ITGA3;ITGA5;ADORA1;SPTBN5;TTYH1;MSN
5072,GO:0010882,0.277048331585658,0.959301522606223,1,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,CASQ2
9920,GO:0035588,0.277222949097766,0.959247124166802,1,23,G-protein coupled purinergic receptor signaling pathway,BP,ADORA1
6835,GO:0021537,0.277423035034618,0.857591166914682,5,235,telencephalon development,BP,CDH2;WNT5A;FGF8;BMP4;BMP2
3740,GO:0007263,0.277920092445182,0.959029536897747,1,23,nitric oxide mediated signal transduction,BP,GUCY1B3
16436,GO:0071378,0.278288516368715,0.958914284177042,1,23,cellular response to growth hormone stimulus,BP,PIK3R1
11677,GO:0044236,0.278397137604108,0.887637798000562,3,129,multicellular organism metabolic process,BP,WNT4;BMP4;CTGF
18209,GO:0098869,0.278583295630474,0.913911143228224,2,90,cellular oxidant detoxification,BP,SESN2;BMP7
6034,GO:0016628,0.278836928373931,0.958607707926719,1,25,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,FASN
12030,GO:0045109,0.279049543207574,0.958752324229365,1,22,intermediate filament organization,BP,PKP1
3791,GO:0007398,0.279277616963921,0.958764941378572,1,21,ectoderm development,BP,FZD7
7997,GO:0031528,0.279299651480171,0.95867386161059,1,22,microvillus membrane,CC,MSN
12330,GO:0045745,0.279307426760543,0.958524199196894,1,24,positive regulation of G-protein coupled receptor protein signaling pathway,BP,CHGA
11928,GO:0044818,0.279314188150725,0.958669298666328,1,22,mitotic G2/M transition checkpoint,BP,FOXO4
4759,GO:0010226,0.279368458832872,0.958575400943937,1,23,response to lithium ion,BP,CDH1
18032,GO:0097730,0.27987348718608,0.886774229918181,3,126,non-motile cilium,CC,RAB27A;SPTBN5;MYO7A
1487,GO:0003208,0.280179629582117,0.913393976482247,2,71,cardiac ventricle morphogenesis,BP,NOTCH1;HEY1
8899,GO:0033032,0.280188631439191,0.958246148975993,1,24,regulation of myeloid cell apoptotic process,BP,KITLG
155,GO:0000303,0.280261648085012,0.958042067496242,1,27,response to superoxide,BP,BMP7
18370,GO:0099623,0.28026520799092,0.958370165371748,1,22,regulation of cardiac muscle cell membrane repolarization,BP,KCNH2
13966,GO:0051248,0.280557550115965,0.799694169411005,17,1048,negative regulation of protein metabolic process,BP,LIF;GADD45A;SERPINA5;ZFPM1;EDN1;PRR5L;PRKAR1B;SESN2;HBEGF;BMP7;BMP4;CDKN1A;AKT1;CST9L;INHBB;GAS6;DUSP5
1029,GO:0002360,0.280570315794241,0.958125390189247,1,24,T cell lineage commitment,BP,ZFPM1
5393,GO:0015145,0.280722510421302,0.958225893507796,1,22,monosaccharide transmembrane transporter activity,MF,SLC2A14
11808,GO:0044441,0.281349259023535,0.836776050760571,7,364,ciliary part,CC,MARK4;RAB27A;PRKACB;SPTBN5;PRKAR1B;AKT1;MYO7A
673,GO:0001817,0.281758691785435,0.819563267824175,10,576,regulation of cytokine production,BP,ZFPM1;CCL20;PIK3R1;HRAS;WNT5A;DLL1;INHBB;GAS6;DTX4;PDE4B
6842,GO:0021544,0.281963927337095,0.957832828618498,1,22,subpallium development,BP,FGF8
5163,GO:0010996,0.282024725887479,0.957735203582828,1,23,response to auditory stimulus,BP,STRA6
11435,GO:0043501,0.282594955989436,0.957553596849219,1,23,skeletal muscle adaptation,BP,ACTN3
19249,GO:1902624,0.282634255333858,0.957183469210479,1,29,positive regulation of neutrophil migration,BP,EDN1
1033,GO:0002366,0.282822610005295,0.814575413017429,11,663,leukocyte activation involved in immune response,BP,RAB27A;CRISPLD2;ZFPM1;PLAU;CLCF1;DLL1;CHGA;PKP1;RAB44;PIK3CG;RAB3D
9528,GO:0034637,0.282946797798317,0.91195111143999,2,72,cellular carbohydrate biosynthetic process,BP,B3GNT2;AKT1
21173,GO:2000369,0.283027122960405,0.957580972829739,1,21,regulation of clathrin-dependent endocytosis,BP,UNC119
13697,GO:0050848,0.283899051635368,0.91136576178139,2,77,regulation of calcium-mediated signaling,BP,ACTN3;CASQ2
17133,GO:0072606,0.284202101146735,0.956899506292043,1,25,interleukin-8 secretion,BP,WNT5A
19033,GO:1902107,0.284724296490275,0.883768570195833,3,132,positive regulation of leukocyte differentiation,BP,LIF;KITLG;GAS6
13948,GO:0051222,0.284952112892538,0.827395873959286,8,443,positive regulation of protein transport,BP,PRR5L;PIK3R2;PIK3R1;WNT5A;BMP6;BMP4;CDH1;GAS6
8498,GO:0032438,0.284964399833958,0.956653641663026,1,25,melanosome organization,BP,RAB38
14192,GO:0051650,0.284985202002439,0.85228340282709,5,239,establishment of vesicle localization,BP,SYT5;RAB27A;WNT7A;RAB17;MYO7A
18372,GO:0099625,0.285090108198422,0.956833802236348,1,22,ventricular cardiac muscle cell membrane repolarization,BP,KCNH2
13950,GO:0051224,0.285094137640186,0.865345079539995,4,193,negative regulation of protein transport,BP,BMP7;INHBB;RAB11FIP1;GAS6
7109,GO:0022604,0.285490764591201,0.827035990097885,8,414,regulation of cell morphogenesis,BP,WNT3;WNT7A;WNT5A;RHOQ;RHOJ;MSN;LZTS1;PARVB
8780,GO:0032844,0.285517618597229,0.82696806019431,8,439,regulation of homeostatic process,BP,ZFPM1;ADORA1;CASQ2;EDN1;NPR1;DLL1;KITLG;CLDN18
16412,GO:0071347,0.285596892006145,0.910315567729165,2,88,cellular response to interleukin-1,BP,EDN1;CCL20
9567,GO:0034695,0.286064091342682,0.956365459086385,1,24,response to prostaglandin E,BP,AKT1
17386,GO:0090103,0.286103581736705,0.956426504283868,1,23,cochlea morphogenesis,BP,WNT5A
968,GO:0002263,0.286320569008351,0.811762466861778,11,665,cell activation involved in immune response,BP,RAB27A;CRISPLD2;ZFPM1;PLAU;CLCF1;DLL1;CHGA;PKP1;RAB44;PIK3CG;RAB3D
14799,GO:0060236,0.286368729358764,0.956340652364937,1,23,regulation of mitotic spindle organization,BP,PSRC1
9005,GO:0033218,0.286397662560411,0.851205962007488,5,260,amide binding,MF,FASN;ACVR1;PIK3R1;NPR1;PTGES
8748,GO:0032801,0.28655106767102,0.956362400240591,1,22,receptor catabolic process,BP,GPRASP1
16437,GO:0071379,0.286578393138061,0.956353555709567,1,22,cellular response to prostaglandin stimulus,BP,AKT1
3902,GO:0008037,0.286656937493533,0.882594206083771,3,131,cell recognition,BP,MFGE8;MSN;LAMA5
11492,GO:0043576,0.286694087207914,0.956316097388558,1,22,regulation of respiratory gaseous exchange,BP,ADORA1
4585,GO:0009581,0.286822350333979,0.882502001350324,3,130,detection of external stimulus,BP,NMT2;ADORA1;UNC119
18208,GO:0098868,0.287018953331327,0.956129713162931,1,23,bone growth,BP,NPPC
10266,GO:0036152,0.287248365003769,0.955849106368527,1,26,phosphatidylethanolamine acyl-chain remodeling,BP,MBOAT2
11151,GO:0043027,0.287552210792532,0.955813106215142,1,25,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,GAS6
20288,GO:1904886,0.287626933573836,0.956013406269415,1,22,beta-catenin destruction complex disassembly,BP,AXIN1
20863,GO:1990748,0.28785312715541,0.909084680935632,2,92,cellular detoxification,BP,SESN2;BMP7
9348,GO:0034243,0.288026991773453,0.95580156037027,1,23,regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
8433,GO:0032369,0.28813363633765,0.95562300221439,1,25,negative regulation of lipid transport,BP,AKT1
13121,GO:0048169,0.288343440074277,0.955780111603086,1,22,regulation of long-term neuronal synaptic plasticity,BP,HRAS
20195,GO:1904705,0.289711754207771,0.955174316724024,1,24,regulation of vascular smooth muscle cell proliferation,BP,PDGFB
20903,GO:1990874,0.289711754207771,0.955174316724024,1,24,vascular smooth muscle cell proliferation,BP,PDGFB
18689,GO:1901135,0.290010457439626,0.787880139657047,19,1210,carbohydrate derivative metabolic process,BP,ACTN3;ITGB8;GUCY1B3;EDN1;PHLDA1;PDGFB;WNT5A;KHK;RHOQ;NPR1;PFKFB3;SDC4;HBEGF;BMP2;B3GNT2;CHGA;AKT1;NPPC;PDE4B
12631,GO:0046425,0.290075059572788,0.880371648818022,3,145,regulation of JAK-STAT cascade,BP,LIF;NOTCH1;CLCF1
20293,GO:1904892,0.290075059572788,0.880371648818022,3,145,regulation of STAT cascade,BP,LIF;NOTCH1;CLCF1
5203,GO:0014046,0.29058383852957,0.954692361697394,1,27,dopamine secretion,BP,GDNF
5215,GO:0014059,0.29058383852957,0.954692361697394,1,27,regulation of dopamine secretion,BP,GDNF
368,GO:0000983,0.290633294580447,0.955029854929103,1,22,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,HEY1
4481,GO:0009214,0.290871466567429,0.955042669723779,1,21,cyclic nucleotide catabolic process,BP,PDE4B
12803,GO:0046777,0.291089472968537,0.848009137022022,5,230,protein autophosphorylation,BP,TYRO3;PDGFB;DDR1;AKT1;PIM2
9268,GO:0034105,0.291163938678987,0.95455985415072,1,26,positive regulation of tissue remodeling,BP,VDR
782,GO:0001959,0.291172917672828,0.879723643627693,3,141,regulation of cytokine-mediated signaling pathway,BP,EDN1;WNT5A;GAS6
4904,GO:0010640,0.291395209476412,0.954778634712963,1,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFB
8923,GO:0033081,0.291701133572904,0.954517039322712,1,24,regulation of T cell differentiation in thymus,BP,BMP4
13650,GO:0050773,0.291739326128309,0.879551146552491,3,122,regulation of dendrite development,BP,BMP7;RAB17;LZTS1
13249,GO:0048489,0.29292912274696,0.87878126948097,3,125,synaptic vesicle transport,BP,SYT5;RAB27A;WNT7A
17942,GO:0097480,0.29292912274696,0.87878126948097,3,125,establishment of synaptic vesicle localization,BP,SYT5;RAB27A;WNT7A
18276,GO:0099003,0.29292912274696,0.87878126948097,3,125,vesicle-mediated transport in synapse,BP,SYT5;RAB27A;WNT7A
17454,GO:0090200,0.29336615440814,0.953707963941522,1,28,positive regulation of release of cytochrome c from mitochondria,BP,PMAIP1
10468,GO:0038084,0.293409129068355,0.954026048096252,1,23,vascular endothelial growth factor signaling pathway,BP,DLL1
3881,GO:0007626,0.293424045003194,0.859792614772377,4,186,locomotory behavior,BP,CDH23;SPTBN4;ESPN;GDNF
112,GO:0000226,0.293501564946466,0.820838545779025,8,418,microtubule cytoskeleton organization,BP,TUBG2;RAB6C;MARK4;GADD45A;FGF10;AXIN1;PSRC1;CAMSAP3
4066,GO:0008299,0.293529314389523,0.953836785960736,1,25,isoprenoid biosynthetic process,BP,HMGCS2
12487,GO:0046039,0.29372440611374,0.953705430009785,1,26,GTP metabolic process,BP,RHOQ
16741,GO:0071889,0.293900745541854,0.953861894718192,1,23,14-3-3 protein binding,MF,AKT1
9918,GO:0035586,0.29410785222514,0.953642894344773,1,25,purinergic receptor activity,MF,ADORA1
8747,GO:0032800,0.294362262755425,0.953629347333809,1,24,receptor biosynthetic process,BP,EDN1
12321,GO:0045736,0.295316983809403,0.953308504113183,1,24,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN1A
10650,GO:0042100,0.295414091362195,0.905135542719199,2,88,B cell proliferation,BP,CLCF1;CDKN1A
14887,GO:0060351,0.295903130670117,0.95318986020093,1,23,cartilage development involved in endochondral bone morphogenesis,BP,NPPC
13757,GO:0050919,0.296239393197761,0.953162833187627,1,22,negative chemotaxis,BP,WNT5A
13298,GO:0048588,0.296310508269239,0.857861559845463,4,182,developmental cell growth,BP,WNT3;EDN1;WNT5A;DDR1
15324,GO:0061037,0.296702909483993,0.952840517768598,1,24,negative regulation of cartilage development,BP,BMP4
13394,GO:0048753,0.296844249163344,0.952652147074178,1,26,pigment granule organization,BP,RAB38
17001,GO:0072331,0.29689443162538,0.84376213100477,5,255,signal transduction by p53 class mediator,BP,PMAIP1;GADD45A;SESN2;CDKN1A;AKT1
17002,GO:0072332,0.296904078022242,0.904462954788075,2,80,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PMAIP1;CDKN1A
20960,GO:2000036,0.29707764486243,0.952879963155446,1,22,regulation of stem cell population maintenance,BP,BMP7
14807,GO:0060251,0.29712349157141,0.952697975929775,1,24,regulation of glial cell proliferation,BP,NOTCH1
14855,GO:0060314,0.297542371400652,0.952482355562263,1,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,CASQ2
18594,GO:1900371,0.297571366077094,0.875686838802098,3,147,regulation of purine nucleotide biosynthetic process,BP,EDN1;NPR1;NPPC
13791,GO:0050996,0.297571462860697,0.952341990328145,1,27,positive regulation of lipid catabolic process,BP,SESN2
17251,GO:0086011,0.29764321582475,0.952601379254004,1,23,membrane repolarization during action potential,BP,KCNH2
4586,GO:0009582,0.297654456648927,0.875753161250539,3,133,detection of abiotic stimulus,BP,NMT2;ADORA1;UNC119
9172,GO:0033688,0.297868748941004,0.952524800520909,1,23,regulation of osteoblast proliferation,BP,BMP2
10040,GO:0035767,0.29894338391668,0.951935894686537,1,26,endothelial cell chemotaxis,BP,NOTCH1
13605,GO:0050708,0.298955036517206,0.8234015600042,7,386,regulation of protein secretion,BP,ADRA2C;WNT5A;BMP6;INHBB;RAB11FIP1;KCNG2;GAS6
1196,GO:0002675,0.298983801533896,0.951858738928364,1,27,positive regulation of acute inflammatory response,BP,PIK3CG
13603,GO:0050706,0.298989037030319,0.951798176490704,1,28,regulation of interleukin-1 beta secretion,BP,WNT5A
7400,GO:0030332,0.299212306870611,0.951986424307455,1,24,cyclin binding,MF,CDKN1A
12460,GO:0045987,0.299495358630392,0.951815165758782,1,25,positive regulation of smooth muscle contraction,BP,EDN1
5070,GO:0010880,0.299519111413109,0.951807018691738,1,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,CASQ2
7583,GO:0030808,0.300087695703339,0.874096097432004,3,148,regulation of nucleotide biosynthetic process,BP,EDN1;NPR1;NPPC
8864,GO:0032982,0.300310067811074,0.951780109384194,1,22,myosin filament,CC,MYH11
7054,GO:0021952,0.301202278731928,0.951473987043446,1,22,central nervous system projection neuron axonogenesis,BP,SPTBN4
13924,GO:0051181,0.301500688428434,0.951124591934437,1,25,cofactor transport,BP,FLVCR2
10958,GO:0042634,0.301624037469148,0.95108193193862,1,25,regulation of hair cycle,BP,WNT5A
4885,GO:0010613,0.302119432556403,0.95098606046098,1,24,positive regulation of cardiac muscle hypertrophy,BP,EDN1
5253,GO:0014742,0.302119432556403,0.95098606046098,1,24,positive regulation of muscle hypertrophy,BP,EDN1
10624,GO:0042044,0.302295772477772,0.95077933636746,1,26,fluid transport,BP,EDN1
19682,GO:1903580,0.302421555179878,0.950735637559845,1,26,positive regulation of ATP metabolic process,BP,ACTN3
16368,GO:0071276,0.302521457018647,0.950418881141945,1,31,cellular response to cadmium ion,BP,AKT1
8978,GO:0033173,0.30257091976179,0.950829647546823,1,24,calcineurin-NFAT signaling cascade,BP,ACTN3
7098,GO:0022408,0.303094971059333,0.872285551952079,3,137,negative regulation of cell-cell adhesion,BP,SDC4;BMP4;CDH1
14880,GO:0060343,0.303540712319198,0.950416332673116,1,25,trabecula formation,BP,HEY1
5126,GO:0010951,0.303708070953547,0.852578166499242,4,225,negative regulation of endopeptidase activity,BP,SERPINA5;AKT1;CST9L;GAS6
19906,GO:1904030,0.303887076352807,0.950295505420568,1,25,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
3418,GO:0006735,0.303934400672232,0.95020832328913,1,26,NADH regeneration,BP,PFKFB3
15573,GO:0061621,0.303934400672232,0.95020832328913,1,26,canonical glycolysis,BP,PFKFB3
15617,GO:0061718,0.303934400672232,0.95020832328913,1,26,glucose catabolic process to pyruvate,BP,PFKFB3
11226,GO:0043154,0.303945066680641,0.900639855207831,2,81,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,AKT1;GAS6
10265,GO:0036151,0.304635297086047,0.949897234542636,1,27,phosphatidylcholine acyl-chain remodeling,BP,MBOAT2
7268,GO:0030159,0.304672396520062,0.950097878485854,1,24,receptor signaling complex scaffold activity,MF,AXIN1
2301,GO:0004866,0.305026795809435,0.870853869704906,3,164,endopeptidase inhibitor activity,MF,SERPINA5;CST9L;GAS6
1838,GO:0004114,0.30503520470773,0.949970919334921,1,24,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
16531,GO:0071514,0.305566712810932,0.949707197166006,1,25,genetic imprinting,BP,PIK3CA
4257,GO:0008625,0.30569361430039,0.899720101295955,2,79,extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;PIK3R1
14835,GO:0060292,0.305809215238184,0.949783747610235,1,23,long term synaptic depression,BP,ADORA1
3341,GO:0006631,0.306039360278053,0.826446210039884,6,330,fatty acid metabolic process,BP,FASN;EDN1;SESN2;AKT1;PTGES;ACSL4
1260,GO:0002757,0.306112625032924,0.810910436986552,8,454,immune response-activating signal transduction,BP,PRKACB;TYRO3;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
15983,GO:0070507,0.30628484145918,0.870324172629646,3,130,regulation of microtubule cytoskeleton organization,BP,RAB6C;PSRC1;CAMSAP3
8761,GO:0032814,0.306569523603425,0.949215658038744,1,27,regulation of natural killer cell activation,BP,GAS6
3597,GO:0007020,0.306692765641854,0.949473321883936,1,23,microtubule nucleation,BP,TUBG2
12667,GO:0046487,0.307088339850088,0.948969979355684,1,28,glyoxylate metabolic process,BP,GLDC
11463,GO:0043537,0.307361037886222,0.949074357528778,1,25,negative regulation of blood vessel endothelial cell migration,BP,NOTCH1
21230,GO:2000463,0.307528545337162,0.949178675364489,1,23,positive regulation of excitatory postsynaptic potential,BP,WNT7A
769,GO:0001945,0.307595863018317,0.949069624040816,1,24,lymph vessel development,BP,EFNB2
15810,GO:0070229,0.308114587287174,0.948605062007389,1,28,negative regulation of lymphocyte apoptotic process,BP,BMP4
71,GO:0000146,0.308145020372985,0.949054118803009,1,22,microfilament motor activity,MF,MYO7A
11105,GO:0042974,0.308217320750128,0.948849499961144,1,24,retinoic acid receptor binding,MF,VDR
743,GO:0001913,0.308402240481922,0.948502511021401,1,28,T cell mediated cytotoxicity,BP,RAB27A
13340,GO:0048668,0.308836782611631,0.948629543565253,1,24,collateral sprouting,BP,WNT3
12268,GO:0045639,0.309023536529474,0.897889277976647,2,79,positive regulation of myeloid cell differentiation,BP,LIF;KITLG
14443,GO:0052548,0.309162654205655,0.824021483997015,6,358,regulation of endopeptidase activity,BP,PMAIP1;SERPINA5;CTGF;AKT1;CST9L;GAS6
17470,GO:0090224,0.3095230598933,0.94830583427761,1,25,regulation of spindle organization,BP,PSRC1
14253,GO:0051781,0.309732931950577,0.897443145091699,2,82,positive regulation of cell division,BP,PDGFB;FGF8
8267,GO:0032069,0.309951036973941,0.948079460620297,1,26,regulation of nuclease activity,BP,AKT1
8496,GO:0032436,0.30996353625143,0.897448828791759,2,75,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,AKT1;RNF144A
18027,GO:0097720,0.310087189513811,0.948104224561137,1,25,calcineurin-mediated signaling,BP,ACTN3
9821,GO:0035412,0.310161997850665,0.948157180419585,1,24,regulation of catenin import into nucleus,BP,FZD7
18146,GO:0098754,0.310207868097311,0.89697217676697,2,96,detoxification,BP,SESN2;BMP7
19543,GO:1903311,0.3102889974701,0.867750606576977,3,131,regulation of mRNA metabolic process,BP,PRR5L;PKP3;PKP1
830,GO:0002026,0.31043530800194,0.947837690810713,1,27,regulation of the force of heart contraction,BP,CHGA
15569,GO:0061615,0.310838003393234,0.947692937614975,1,27,glycolytic process through fructose-6-phosphate,BP,PFKFB3
15572,GO:0061620,0.310838003393234,0.947692937614975,1,27,glycolytic process through glucose-6-phosphate,BP,PFKFB3
17149,GO:0072661,0.31097997605192,0.947864385006103,1,24,protein targeting to plasma membrane,BP,GAS6
14997,GO:0060487,0.311161590821059,0.94764497901584,1,26,lung epithelial cell differentiation,BP,FGF10
21158,GO:2000352,0.311338680701044,0.947581245991665,1,26,negative regulation of endothelial cell apoptotic process,BP,GAS6
4995,GO:0010771,0.311535481889358,0.896599160275666,2,74,negative regulation of cell morphogenesis involved in differentiation,BP,WNT3;WNT5A
3888,GO:0008009,0.311807236924732,0.946583966604158,1,47,chemokine activity,MF,CCL20
5981,GO:0016538,0.312029520845527,0.947139800810132,1,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN1A
7270,GO:0030162,0.312048858080857,0.790765582929126,11,693,regulation of proteolysis,BP,PMAIP1;SERPINA5;PRKACB;MAPK12;AXIN1;CTGF;AKT1;CST9L;GAS6;ARAF;RNF144A
99,GO:0000188,0.312119170350861,0.947299826838785,1,26,inactivation of MAPK activity,BP,DUSP5
21011,GO:2000116,0.31222070303847,0.846768901572692,4,206,regulation of cysteine-type endopeptidase activity,BP,PMAIP1;CTGF;AKT1;GAS6
6117,GO:0016790,0.312450716576402,0.946987111590575,1,29,thiolester hydrolase activity,MF,FASN
6613,GO:0019433,0.31246806979407,0.946778347826979,1,33,triglyceride catabolic process,BP,PIK3CG
8895,GO:0033028,0.312552864615725,0.947009771887473,1,28,myeloid cell apoptotic process,BP,KITLG
6376,GO:0018198,0.31263430680034,0.947044444327488,1,27,peptidyl-cysteine modification,BP,RAB3D
156,GO:0000305,0.312726032838561,0.946831378702629,1,30,response to oxygen radical,BP,BMP7
4394,GO:0009117,0.31310605519038,0.794280086260776,10,641,nucleotide metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
8938,GO:0033120,0.313268876668101,0.946958742148537,1,25,positive regulation of RNA splicing,BP,PIK3R1
303,GO:0000803,0.313379036921721,0.946843741626114,1,26,sex chromosome,CC,SIN3B
8804,GO:0032892,0.313619330097489,0.946622287614385,1,28,positive regulation of organic acid transport,BP,EDN1
785,GO:0001963,0.313756995087489,0.94645581012584,1,30,synaptic transmission, dopaminergic,BP,GDNF
3135,GO:0006359,0.313948772942283,0.946712107727555,1,25,regulation of transcription from RNA polymerase III promoter,BP,NAB2
15176,GO:0060759,0.314045188781133,0.865181197861529,3,147,regulation of response to cytokine stimulus,BP,EDN1;WNT5A;GAS6
7559,GO:0030695,0.314052185267109,0.820482566086073,6,300,GTPase regulator activity,MF,RIN3;PIK3R2;SESN2;AXIN1;GPSM1;SH3BP4
3552,GO:0006952,0.314184826793241,0.763584133287758,21,1444,defense response,BP,NOTCH1;RAB27A;PMAIP1;ACVR1;ADORA1;EDN1;PRKACB;CCL20;TYRO3;HRAS;WNT5A;JAM3;BMP6;BMP2;CHGA;AKT1;PTGES;INHBB;CLDN1;PIK3CG;TSPAN2
1,GO:0000002,0.314253253663894,0.946601444131948,1,25,mitochondrial genome maintenance,BP,SESN2
4092,GO:0008344,0.314334837161983,0.89495725464849,2,78,adult locomotory behavior,BP,SPTBN4;GDNF
3906,GO:0008045,0.314385819543485,0.946553221968484,1,25,motor neuron axon guidance,BP,FGF8
5907,GO:0016411,0.314455846444907,0.946452142364104,1,26,acylglycerol O-acyltransferase activity,MF,MBOAT2
13719,GO:0050870,0.314820117836719,0.844941056347524,4,208,positive regulation of T cell activation,BP,PIK3R1;AKT1;PIK3CA;EFNB2
9334,GO:0034219,0.314923744966544,0.946281470672903,1,26,carbohydrate transmembrane transport,BP,SLC2A14
3705,GO:0007202,0.315001543018655,0.946253062738998,1,26,activation of phospholipase C activity,BP,LPAR2
1215,GO:0002695,0.315262736769778,0.864425207312005,3,143,negative regulation of leukocyte activation,BP,TYRO3;SDC4;BMP4
6911,GO:0021680,0.31575644977219,0.946135783043181,1,24,cerebellar Purkinje cell layer development,BP,DLL1
2515,GO:0005201,0.315987159717023,0.894093154355216,2,75,extracellular matrix structural constituent,MF,HAPLN3;LAMA1
13686,GO:0050821,0.316161248907724,0.863841366999052,3,143,protein stabilization,BP,PIK3R1;CDKN1A;PIM2
2838,GO:0005859,0.316240628189886,0.945728691313787,1,27,muscle myosin complex,CC,MYH11
6172,GO:0016878,0.316448173617626,0.945799807869337,1,25,acid-thiol ligase activity,MF,ACSL4
1836,GO:0004112,0.316584171423264,0.945749913082159,1,25,cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
18654,GO:1901020,0.316748856574973,0.945357336574061,1,30,negative regulation of calcium ion transmembrane transporter activity,BP,CASQ2
8659,GO:0032673,0.316834207853141,0.945510352900827,1,27,regulation of interleukin-4 production,BP,ZFPM1
7472,GO:0030516,0.317144644768259,0.893442676052606,2,75,regulation of axon extension,BP,WNT3;WNT5A
2632,GO:0005501,0.317351447632329,0.945080830035612,1,31,retinoid binding,MF,SERPINA5
11881,GO:0044724,0.318424084624281,0.862412085091405,3,138,single-organism carbohydrate catabolic process,BP,ACTN3;KHK;PFKFB3
2641,GO:0005516,0.318719081998062,0.84231143839135,4,189,calmodulin binding,MF,CAMSAP3;RRAD;MYO7A;MYH11
11002,GO:0042730,0.319375057111979,0.944570060036673,1,27,fibrinolysis,BP,PLAU
4007,GO:0008209,0.320221698237063,0.944187360805612,1,28,androgen metabolic process,BP,WNT4
11448,GO:0043516,0.320278370098392,0.944166190665268,1,28,regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
9762,GO:0035303,0.320403389440394,0.861187374119086,3,131,regulation of dephosphorylation,BP,ADORA1;BMP2;CAMSAP3
6537,GO:0019219,0.320848806982915,0.731154768336616,60,3966,regulation of nucleobase-containing compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
8200,GO:0031954,0.320911844014894,0.944148409597999,1,25,positive regulation of protein autophosphorylation,BP,PDGFB
3023,GO:0006165,0.321314435686891,0.890925822378401,2,83,nucleoside diphosphate phosphorylation,BP,ACTN3;PFKFB3
1234,GO:0002714,0.321388205153996,0.943628661096324,1,30,positive regulation of B cell mediated immunity,BP,CLCF1
1346,GO:0002891,0.321388205153996,0.943628661096324,1,30,positive regulation of immunoglobulin mediated immune response,BP,CLCF1
13163,GO:0048259,0.32186704738874,0.890666873272434,2,80,regulation of receptor-mediated endocytosis,BP,TF;UNC119
1647,GO:0003774,0.322083105461945,0.860095913868573,3,130,motor activity,MF,CGN;MYO7A;MYH11
14990,GO:0060479,0.322550234514878,0.943382026875636,1,27,lung cell differentiation,BP,FGF10
15381,GO:0061135,0.323123773748792,0.859081041702323,3,170,endopeptidase regulator activity,MF,SERPINA5;CST9L;GAS6
9124,GO:0033598,0.323350099377316,0.94308046323808,1,27,mammary gland epithelial cell proliferation,BP,WNT5A
11154,GO:0043030,0.323487460913635,0.942836286586592,1,30,regulation of macrophage activation,BP,WNT5A
11711,GO:0044282,0.323567449099658,0.813099288820873,6,336,small molecule catabolic process,BP,ACTN3;GLDC;KHK;SESN2;PFKFB3;AKT1
14227,GO:0051721,0.323658622738583,0.943118030841036,1,25,protein phosphatase 2A binding,MF,AKT1
11434,GO:0043500,0.32399641963577,0.88941275449808,2,82,muscle adaptation,BP,ACTN3;EDN1
15308,GO:0061014,0.324056060807302,0.94288780509257,1,26,positive regulation of mRNA catabolic process,BP,PRR5L
3430,GO:0006753,0.324261529420831,0.78511075577222,10,647,nucleoside phosphate metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
14102,GO:0051482,0.324558568189682,0.94255395054287,1,28,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,EDN1
19054,GO:1902175,0.324924125152543,0.942350527978164,1,29,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,AKT1
3860,GO:0007601,0.325392138158748,0.837482170643734,4,206,visual perception,BP,CDH23;MYO7A;GJA3;UNC119
2909,GO:0005979,0.32542567876424,0.942368522090883,1,26,regulation of glycogen biosynthetic process,BP,AKT1
5136,GO:0010962,0.32542567876424,0.942368522090883,1,26,regulation of glucan biosynthetic process,BP,AKT1
497,GO:0001523,0.326071351184843,0.88810091332624,2,89,retinoid metabolic process,BP,STRA6;SDC4
3707,GO:0007205,0.326227422493467,0.941918177054259,1,28,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,EDN1
9523,GO:0034629,0.326446972266285,0.941904185387609,1,27,cellular protein complex localization,BP,RALB
9731,GO:0035250,0.326524841989889,0.941874429719021,1,27,UDP-galactosyltransferase activity,MF,B3GNT2
9171,GO:0033687,0.326600875511014,0.941920794508529,1,26,osteoblast proliferation,BP,BMP2
8696,GO:0032731,0.326612012906334,0.941645118489262,1,30,positive regulation of interleukin-1 beta production,BP,WNT5A
7107,GO:0022602,0.326674069188342,0.887893236999332,2,81,ovulation cycle process,BP,KITLG;INHBB
18207,GO:0098862,0.326860198781366,0.856879633327202,3,136,cluster of actin-based cell projections,CC,CDH23;ESPN;MYO7A
17799,GO:0097193,0.3269441209694,0.821690159550118,5,273,intrinsic apoptotic signaling pathway,BP,PMAIP1;PIK3R1;HRAS;CDKN1A;AKT1
3435,GO:0006767,0.326991567955739,0.8876545347611,2,84,water-soluble vitamin metabolic process,BP,FASN;SLC52A3
9743,GO:0035264,0.327036480606865,0.856723738202531,3,140,multicellular organism growth,BP,SPTBN4;NPPC;PIK3CA
12079,GO:0045191,0.32703678643856,0.941608387098886,1,28,regulation of isotype switching,BP,CLCF1
7091,GO:0022400,0.327172011593893,0.941556536132097,1,28,regulation of rhodopsin mediated signaling pathway,BP,NMT2
7617,GO:0030851,0.3275225831573,0.941356460851913,1,29,granulocyte differentiation,BP,ZFPM1
14609,GO:0055090,0.327536724575631,0.941179100401287,1,32,acylglycerol homeostasis,BP,SESN2
15878,GO:0070328,0.327536724575631,0.941179100401287,1,32,triglyceride homeostasis,BP,SESN2
14349,GO:0051955,0.327539202375203,0.941486019037464,1,27,regulation of amino acid transport,BP,ADORA1
4766,GO:0010259,0.327559942753816,0.941478061747436,1,27,multicellular organism aging,BP,EDN1
21012,GO:2000117,0.328570435301937,0.886706664057255,2,86,negative regulation of cysteine-type endopeptidase activity,BP,AKT1;GAS6
9057,GO:0033363,0.328809906862858,0.940860352865563,1,29,secretory granule organization,BP,RAB38
10540,GO:0038202,0.328976404795265,0.940933142861877,1,27,TORC1 signaling,BP,SESN2
20525,GO:1905476,0.329073975918379,0.940972062034872,1,26,negative regulation of protein localization to membrane,BP,RHOQ
330,GO:0000910,0.329192172871955,0.855319526142854,3,137,cytokinesis,BP,RALB;SNX18;RHOB
13065,GO:0048011,0.329200477252165,0.940923295099986,1,26,neurotrophin TRK receptor signaling pathway,BP,BCAR1
16038,GO:0070588,0.329421109030448,0.819889907136588,5,259,calcium ion transmembrane transport,BP,CASQ2;TSPAN13;PIK3CG;GAS6;PDE4B
21004,GO:2000108,0.329459372300501,0.940547290002578,1,30,positive regulation of leukocyte apoptotic process,BP,WNT5A
982,GO:0002286,0.329597753931636,0.886014147205813,2,92,T cell activation involved in immune response,BP,RAB27A;ZFPM1
4922,GO:0010662,0.329881428287334,0.940583450775664,1,27,regulation of striated muscle cell apoptotic process,BP,BMP7
13946,GO:0051219,0.329970316013037,0.886068162823396,2,77,phosphoprotein binding,MF,PIK3R2;PIK3R1
12586,GO:0046320,0.330378786048907,0.940390769423004,1,27,regulation of fatty acid oxidation,BP,AKT1
12396,GO:0045879,0.330523017972843,0.940495499512628,1,25,negative regulation of smoothened signaling pathway,BP,PRKACB
4808,GO:0010466,0.330714301574418,0.833532048516776,4,235,negative regulation of peptidase activity,BP,SERPINA5;AKT1;CST9L;GAS6
11900,GO:0044770,0.3307545895019,0.785055457721045,9,530,cell cycle phase transition,BP,GADD45A;ACVR1;PHLDA1;FGF10;FOXO4;CDKN1A;AKT1;LZTS1;PIM2
7908,GO:0031365,0.330946105500077,0.940098674473531,1,28,N-terminal protein amino acid modification,BP,NMT2
7434,GO:0030414,0.331567998975469,0.853453947517794,3,172,peptidase inhibitor activity,MF,SERPINA5;CST9L;GAS6
13372,GO:0048709,0.331731773473781,0.884941449809431,2,82,oligodendrocyte differentiation,BP,NOTCH1;TSPAN2
18632,GO:1900739,0.331790646555981,0.939702375342599,1,29,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
18633,GO:1900740,0.331790646555981,0.939702375342599,1,29,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
9820,GO:0035411,0.331980577882919,0.939845677038381,1,26,catenin import into nucleus,BP,FZD7
8191,GO:0031941,0.333232386254125,0.939278286593781,1,27,filamentous actin,CC,ESPN
18304,GO:0099106,0.333338850902612,0.883946401070668,2,85,ion channel regulator activity,MF,TSPAN13;WNK4
2294,GO:0004857,0.333425380164566,0.805375405761197,6,373,enzyme inhibitor activity,MF,NOTCH1;SERPINA5;PRKAR1B;CDKN1A;CST9L;GAS6
5263,GO:0014808,0.333440035077597,0.9390560330475,1,29,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,CASQ2
16700,GO:0071822,0.334504301821362,0.742620764865748,23,1516,protein complex subunit organization,BP,FHOD3;TUBG2;ACTN2;PMAIP1;CASQ2;SPTBN5;SPTBN4;PRND;PLEKHH2;RALB;HRAS;AXIN1;PSRC1;SPTB;VAMP1;MSN;GJB1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;KCND1
12773,GO:0046685,0.334690609023186,0.938563316896481,1,29,response to arsenic-containing substance,BP,CDKN1A
13337,GO:0048665,0.334864646271231,0.938430684659885,1,30,neuron fate specification,BP,DLL1
15382,GO:0061136,0.335037263881637,0.851346178213358,3,143,regulation of proteasomal protein catabolic process,BP,AKT1;ARAF;RNF144A
11283,GO:0043236,0.335067145654395,0.938483063088507,1,28,laminin binding,MF,ITGA3
7979,GO:0031492,0.335301639399566,0.938257695093259,1,30,nucleosomal DNA binding,MF,HMGN5
14348,GO:0051954,0.33587472626697,0.938030405333652,1,30,positive regulation of amine transport,BP,GDNF
17907,GO:0097421,0.335969818939061,0.937876154750011,1,32,liver regeneration,BP,CLDN1
13773,GO:0050953,0.336471276639505,0.829502935025361,4,209,sensory perception of light stimulus,BP,CDH23;MYO7A;GJA3;UNC119
19088,GO:1902235,0.337019910185916,0.937639466261498,1,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
5107,GO:0010922,0.33732454417597,0.937662151901618,1,27,positive regulation of phosphatase activity,BP,BMP2
5572,GO:0015718,0.337621759239027,0.849573528992543,3,146,monocarboxylic acid transport,BP,EDN1;AKT1;ACSL4
13956,GO:0051233,0.337655374769369,0.937455639740764,1,28,spindle midzone,CC,UNC119
7579,GO:0030804,0.337687411497974,0.88120835897105,2,96,positive regulation of cyclic nucleotide biosynthetic process,BP,NPR1;NPPC
7118,GO:0022617,0.33823649751813,0.881060967847424,2,85,extracellular matrix disassembly,BP,DDR1;CDH1
8735,GO:0032787,0.338307741186324,0.778816696037701,9,540,monocarboxylic acid metabolic process,BP,ACTN3;GLDC;FASN;EDN1;SESN2;PFKFB3;AKT1;PTGES;ACSL4
17132,GO:0072604,0.338373367603061,0.937098985685496,1,29,interleukin-6 secretion,BP,GAS6
15515,GO:0061462,0.338387708352524,0.937238244397174,1,27,protein localization to lysosome,BP,SH3BP4
6724,GO:0019840,0.338757721525404,0.936707443443271,1,33,isoprenoid binding,MF,SERPINA5
4000,GO:0008200,0.34040616856305,0.93615443784462,1,31,ion channel inhibitor activity,MF,WNK4
19637,GO:1903514,0.341866390382176,0.935625044573286,1,30,calcium ion transport from endoplasmic reticulum to cytosol,BP,CASQ2
14000,GO:0051293,0.341932184423373,0.935736262021617,1,28,establishment of spindle localization,BP,FGF10
7902,GO:0031345,0.342031074585329,0.846614705767037,3,142,negative regulation of cell projection organization,BP,ITGA3;WNT3;WNT5A
11198,GO:0043114,0.342254002424534,0.935534302826895,1,29,regulation of vascular permeability,BP,NPR1
8671,GO:0032689,0.342292963978426,0.93538937935316,1,31,negative regulation of interferon-gamma production,BP,GAS6
7977,GO:0031490,0.342306449027659,0.878601659598763,2,87,chromatin DNA binding,MF,NOTCH1;HMGN5
13160,GO:0048255,0.342582715758745,0.935472359629312,1,28,mRNA stabilization,BP,GDNF
4908,GO:0010644,0.342710671355285,0.935497388212688,1,27,cell communication by electrical coupling,BP,CASQ2
13177,GO:0048284,0.342850397524193,0.82488461979763,4,204,organelle fusion,BP,SYT5;RAB39A;RAB20;VAMP1
12886,GO:0046939,0.342872188792839,0.878245364704452,2,88,nucleotide phosphorylation,BP,ACTN3;PFKFB3
3646,GO:0007098,0.343070986113868,0.878279649985188,2,80,centrosome cycle,BP,RAB6C;GADD45A
2699,GO:0005622,0.343200877855127,0.713446722045051,192,13536,intracellular,CC,ITGA3;ITGA5;ARTN;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;PNMT;TF;ITGB5;ITGB4;FASN;PMAIP1;GADD45A;CRISPLD2;FBXO41;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;RHPN1;PRKACB;CCL20;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;LGALS4;BMP6;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DSG3;CTGF;GJB1;GJB2;GJB6;RRAD;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;NRTN;WNT2B;CYTIP;PTGES;KITLG;NPPC;NAB2;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;DTX4;ZCCHC12;MYH11;LZTS1;PM20D2;SHC4;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;RAB3D;GDNF;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;PARVB;PDE4B
9281,GO:0034122,0.343386860664298,0.935145271686942,1,28,negative regulation of toll-like receptor signaling pathway,BP,TYRO3
5562,GO:0015696,0.343959413404329,0.877558982796404,2,90,ammonium transport,BP,EDN1;GDNF
12421,GO:0045920,0.344116797404969,0.934847535453025,1,28,negative regulation of exocytosis,BP,NOTCH1
9670,GO:0035066,0.344190785941026,0.934745025158286,1,29,positive regulation of histone acetylation,BP,LIF
7774,GO:0031109,0.344578596063319,0.877313950343841,2,83,microtubule polymerization or depolymerization,BP,TUBG2;PSRC1
17460,GO:0090207,0.345196693330716,0.934086327997772,1,33,regulation of triglyceride metabolic process,BP,PIK3CG
19424,GO:1903039,0.345271594508066,0.823035855239092,4,217,positive regulation of leukocyte cell-cell adhesion,BP,PIK3R1;AKT1;PIK3CA;EFNB2
18793,GO:1901385,0.345426881558755,0.934047390653622,1,32,regulation of voltage-gated calcium channel activity,BP,PDE4B
10757,GO:0042311,0.345657108958387,0.934075738764377,1,30,vasodilation,BP,ADORA1
11357,GO:0043368,0.345687249508702,0.933999717796459,1,31,positive T cell selection,BP,ZFPM1
699,GO:0001844,0.345808508921618,0.933949754449952,1,31,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
17788,GO:0097178,0.346183770007654,0.933858790496905,1,30,ruffle assembly,BP,HRAS
3851,GO:0007586,0.346250319701213,0.843516695024879,3,167,digestion,BP,FGF10;WNK4;VDR
3882,GO:0007628,0.346310406267483,0.933947999244496,1,28,adult walking behavior,BP,SPTBN4
6360,GO:0018146,0.347026771789751,0.933652682124864,1,28,keratan sulfate biosynthetic process,BP,B3GNT2
19271,GO:1902692,0.347075387321557,0.933711573353365,1,27,regulation of neuroblast proliferation,BP,NOTCH1
2789,GO:0005776,0.347246383170627,0.875725584882165,2,82,autophagosome,CC,RALB;RAB12
13237,GO:0048469,0.347435320069078,0.842835271983689,3,150,cell maturation,BP,SPTBN4;CDKN1A;NPPC
5468,GO:0015295,0.347498159457966,0.933457936863798,1,28,solute:proton symporter activity,MF,SLC45A4
13376,GO:0048713,0.347676725699366,0.933241538514569,1,30,regulation of oligodendrocyte differentiation,BP,NOTCH1
5228,GO:0014074,0.348047758019594,0.84248791291207,3,142,response to purine-containing compound,BP,CASQ2;WT1;PIK3CG
5744,GO:0016052,0.348132498986024,0.842390969407979,3,146,carbohydrate catabolic process,BP,ACTN3;KHK;PFKFB3
10383,GO:0036477,0.348247762949415,0.760454584681285,11,644,somatodendritic compartment,CC,SYT5;ACTN2;RAB27A;ADORA1;SPTBN4;DRP2;RAB17;LZTS1;KCND1;ACSL4;PDE4B
6763,GO:0019905,0.348304010581152,0.875106021730631,2,81,syntaxin binding,MF,SYT5;VAMP1
19474,GO:1903170,0.348609480779859,0.932671966391238,1,33,negative regulation of calcium ion transmembrane transport,BP,CASQ2
18226,GO:0098901,0.348823877592567,0.932988204506949,1,27,regulation of cardiac muscle cell action potential,BP,DSC2
7444,GO:0030431,0.349264020610725,0.93229425672426,1,35,sleep,BP,ADORA1
13132,GO:0048193,0.349894155343083,0.792548382502739,6,326,Golgi vesicle transport,BP,RAB6C;RABIF;SPTBN5;SPTBN4;SPTB;GAS6
10289,GO:0036257,0.349929520788786,0.932238640307673,1,31,multivesicular body organization,BP,RAB27A
12843,GO:0046873,0.34995387617168,0.775587678314531,8,436,metal ion transmembrane transporter activity,MF,TF;KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1;CLDN16
8554,GO:0032507,0.350027856389759,0.873978456060533,2,85,maintenance of protein location in cell,BP,SPTBN4;AKT1
16658,GO:0071709,0.350138135530001,0.932361123585729,1,28,membrane assembly,BP,CDH2
16164,GO:0070873,0.350192752722686,0.932263524604395,1,29,regulation of glycogen metabolic process,BP,AKT1
20709,GO:1990138,0.350497103851846,0.840846859947114,3,137,neuron projection extension,BP,WNT3;WNT5A;DDR1
11974,GO:0045026,0.35055432096988,0.931915693565459,1,32,plasma membrane fusion,BP,SERPINA5
39,GO:0000077,0.351291591064376,0.840215057258624,3,145,DNA damage checkpoint,BP,GADD45A;FOXO4;CDKN1A
11923,GO:0044803,0.351354387245656,0.931641070032812,1,31,multi-organism membrane organization,BP,GAS6
5836,GO:0016248,0.351368525376801,0.931573553652521,1,32,channel inhibitor activity,MF,WNK4
8283,GO:0032094,0.351426587021776,0.931337105553323,1,36,response to food,BP,AKT1
16418,GO:0071353,0.352535747466345,0.931143299807059,1,31,cellular response to interleukin-4,BP,FASN
3529,GO:0006911,0.352677575051019,0.931083398447233,1,31,phagocytosis, engulfment,BP,MFGE8
21657,GO:2001258,0.3532992665474,0.930644774391015,1,34,negative regulation of cation channel activity,BP,CASQ2
21080,GO:2000249,0.353466659783395,0.930687271177527,1,32,regulation of actin cytoskeleton reorganization,BP,HRAS
1587,GO:0003382,0.353526952110787,0.930861622779271,1,29,epithelial cell morphogenesis,BP,CLDN3
12345,GO:0045777,0.353944526360716,0.930370621929943,1,34,positive regulation of blood pressure,BP,ADORA1
15858,GO:0070296,0.354198449775155,0.930376584487442,1,32,sarcoplasmic reticulum calcium ion transport,BP,CASQ2
5127,GO:0010952,0.354585321017165,0.837841324297645,3,154,positive regulation of peptidase activity,BP,PMAIP1;MAPK12;CTGF
4918,GO:0010658,0.354925758749901,0.930196816962791,1,30,striated muscle cell apoptotic process,BP,BMP7
21436,GO:2000758,0.355091663984379,0.930126204249006,1,30,positive regulation of peptidyl-lysine acetylation,BP,LIF
10590,GO:0040018,0.355203301305952,0.929948643603025,1,32,positive regulation of multicellular organism growth,BP,SPTBN4
9919,GO:0035587,0.355350895778701,0.929948613122223,1,31,purinergic receptor signaling pathway,BP,ADORA1
776,GO:0001953,0.356003774641248,0.929886600466703,1,28,negative regulation of cell-matrix adhesion,BP,PIK3R1
674,GO:0001818,0.356099393632332,0.815006901121664,4,218,negative regulation of cytokine production,BP,ZFPM1;DLL1;INHBB;GAS6
7631,GO:0030866,0.356195776202887,0.929804721409148,1,28,cortical actin cytoskeleton organization,BP,RHOQ
13940,GO:0051204,0.356682615190282,0.929315848317055,1,32,protein insertion into mitochondrial membrane,BP,PMAIP1
737,GO:0001906,0.356776605050515,0.869506510642104,2,106,cell killing,BP,RAB27A;CHGA
4846,GO:0010543,0.357010113934789,0.929379127422892,1,29,regulation of platelet activation,BP,PDGFB
17657,GO:0090659,0.357176191289641,0.929307981841317,1,29,walking behavior,BP,SPTBN4
5913,GO:0016417,0.35736733817469,0.929153409611003,1,30,S-acyltransferase activity,MF,FASN
1172,GO:0002639,0.357532757126429,0.928781461709385,1,35,positive regulation of immunoglobulin production,BP,CLCF1
20895,GO:1990841,0.357671505154776,0.929173527580676,1,28,promoter-specific chromatin binding,MF,FOXO4
2784,GO:0005770,0.35827472166411,0.813406948163874,4,213,late endosome,CC,TSPAN15;RAB27A;TF;RHOB
18302,GO:0099094,0.35837023229147,0.868934650683544,2,81,ligand-gated cation channel activity,MF,KCNK6;KCNH2
15293,GO:0060996,0.358835073000828,0.868646265211685,2,81,dendritic spine development,BP,WNT7A;ACSL4
14806,GO:0060249,0.358917707795319,0.785256818508256,6,354,anatomical structure homeostasis,BP,CDH23;TF;TYRO3;CTGF;RAB3D;CLDN18
7778,GO:0031113,0.35897221327421,0.928394094929044,1,31,regulation of microtubule polymerization,BP,PSRC1
15267,GO:0060964,0.359097201116496,0.928481990857894,1,29,regulation of gene silencing by miRNA,BP,BMP4
370,GO:0000988,0.359337758033016,0.755731032171062,10,590,transcription factor activity, protein binding,MF,LIF;WNT4;POU3F1;ACTN2;NOTCH1;NAB2;TLE1;SIN3B;ZCCHC12;HEY1
16551,GO:0071549,0.359349538805276,0.928106169705594,1,33,cellular response to dexamethasone stimulus,BP,GJB2
17127,GO:0072595,0.359637295221893,0.928175201334672,1,30,maintenance of protein localization in organelle,BP,AKT1
1206,GO:0002686,0.35977610525647,0.927921203070684,1,33,negative regulation of leukocyte migration,BP,ADORA1
4426,GO:0009152,0.360228027255492,0.811808057686801,4,239,purine ribonucleotide biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
7660,GO:0030902,0.360339432457509,0.833928490747741,3,141,hindbrain development,BP,WNT7A;BMP7;DLL1
20946,GO:2000008,0.36052998842639,0.927719234033589,1,31,regulation of protein localization to cell surface,BP,ACTN2
13717,GO:0050868,0.361548892524997,0.866759589999053,2,91,negative regulation of T cell activation,BP,SDC4;BMP4
8514,GO:0032459,0.361681478131019,0.927033995421131,1,34,regulation of protein oligomerization,BP,PMAIP1
4685,GO:0009925,0.361869989990086,0.927279817412279,1,29,basal plasma membrane,CC,TF
5672,GO:0015893,0.362117087205419,0.927172114428429,1,29,drug transport,BP,CLDN1
18333,GO:0099531,0.362384006684076,0.832443999619756,3,145,presynaptic process involved in chemical synaptic transmission,BP,SYT5;WNT7A;GDNF
5768,GO:0016101,0.362597825941069,0.866019646398427,2,96,diterpenoid metabolic process,BP,STRA6;SDC4
4409,GO:0009135,0.362798441175671,0.866031823560378,2,88,purine nucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
4449,GO:0009179,0.362798441175671,0.866031823560378,2,88,purine ribonucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
2536,GO:0005246,0.363370128432426,0.926351686637651,1,33,calcium channel regulator activity,MF,TSPAN13
7057,GO:0021955,0.363619086716967,0.926595976013212,1,28,central nervous system neuron axonogenesis,BP,SPTBN4
14604,GO:0055085,0.363727796014466,0.71954158306991,21,1348,transmembrane transport,BP,ACTN2;CASQ2;KCNK6;FLVCR2;SLC25A53;TTYH1;TSPAN13;KCNH2;SLC2A14;SFXN1;GJB1;GJB2;AKT1;GJA3;PIK3CG;KCNG2;GAS6;SLC18B1;KCND1;CLDN16;PDE4B
11895,GO:0044764,0.364237957774339,0.735337317964218,14,934,multi-organism cellular process,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;NMT2;MFGE8;TYRO3;PIK3R1;INHBB;CLDN1;GAS6;ACTA2;PIM2;EFNB2
5947,GO:0016485,0.364315557550762,0.808809045302847,4,222,protein processing,BP,RHBDL3;PLAU;PRKACB;GAS6
4109,GO:0008378,0.36455147761821,0.925959833006562,1,31,galactosyltransferase activity,MF,B3GNT2
11562,GO:0043902,0.364846793018843,0.830570062785143,3,159,positive regulation of multi-organism process,BP,NOTCH1;BMP6;INHBB
7403,GO:0030336,0.364881487868649,0.808448730108018,4,210,negative regulation of cell migration,BP,WNT4;NOTCH1;ADORA1;RHOB
17541,GO:0090317,0.365241741655046,0.864459026678937,2,90,negative regulation of intracellular protein transport,BP,BMP7;GAS6
14100,GO:0051480,0.36525365511543,0.792206626123636,5,291,regulation of cytosolic calcium ion concentration,BP,CDH23;CASQ2;EDN1;LPAR2;PIK3CG
11941,GO:0044853,0.365258854099953,0.864607912549218,2,82,plasma membrane raft,CC,CDH2;CDH1
12648,GO:0046461,0.365274387382825,0.925205002821185,1,39,neutral lipid catabolic process,BP,PIK3CG
12651,GO:0046464,0.365274387382825,0.925205002821185,1,39,acylglycerol catabolic process,BP,PIK3CG
8048,GO:0031641,0.365373195872873,0.925668226053431,1,30,regulation of myelination,BP,AKT1
9103,GO:0033559,0.365473614288511,0.864210608981781,2,96,unsaturated fatty acid metabolic process,BP,EDN1;PTGES
18112,GO:0098655,0.365612977603972,0.741262543635675,12,745,cation transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TTYH1;TSPAN13;KCNH2;PIK3CG;KCNG2;GAS6;KCND1;CLDN16;PDE4B
4989,GO:0010765,0.365682953449023,0.925460324649206,1,31,positive regulation of sodium ion transport,BP,AKT1
13735,GO:0050892,0.365882491298609,0.925242722304208,1,33,intestinal absorption,BP,VDR
12390,GO:0045862,0.365976000655704,0.779554652023242,6,357,positive regulation of proteolysis,BP,PMAIP1;MAPK12;AXIN1;CTGF;AKT1;RNF144A
8704,GO:0032743,0.366573271825054,0.925137306167069,1,30,positive regulation of interleukin-2 production,BP,PDE4B
2759,GO:0005741,0.36675251189131,0.829265259326208,3,153,mitochondrial outer membrane,CC,PMAIP1;VAMP1;ACSL4
18973,GO:1901976,0.367227986419794,0.924775050156443,1,31,regulation of cell cycle checkpoint,BP,AKT1
7101,GO:0022411,0.367412230102955,0.760922143418003,8,500,cellular component disassembly,BP,ACTN2;SPTBN5;SPTBN4;PLEKHH2;AXIN1;SPTB;DDR1;CDH1
6115,GO:0016787,0.367529920753413,0.699123268938762,36,2385,hydrolase activity,MF,TUBG2;RAB6C;RAB27A;RASL11B;FASN;RHBDL3;DHH;ADORA1;PLAU;RAB40B;RAB40A;RRAS2;RAB39B;RAB39A;CGN;PTPN7;RALB;HRAS;RHOQ;RHOJ;RHOB;PFKFB3;RAB20;RND3;RRAD;RAB12;RAB17;MYO7A;RAB44;SIN3B;MYH11;PM20D2;RAB38;RAB3D;DUSP5;PDE4B
17259,GO:0086019,0.368215161509182,0.924484361104803,1,29,cell-cell signaling involved in cardiac conduction,BP,CASQ2
5748,GO:0016056,0.368352214432815,0.924206520892626,1,32,rhodopsin mediated signaling pathway,BP,NMT2
3987,GO:0008180,0.368406166038705,0.92418241128472,1,32,COP9 signalosome,CC,AMOT
11699,GO:0044264,0.368982344053506,0.862168483912518,2,86,cellular polysaccharide metabolic process,BP,B3GNT2;AKT1
4261,GO:0008630,0.369611998512162,0.861603390713827,2,95,intrinsic apoptotic signaling pathway in response to DNA damage,BP,PIK3R1;CDKN1A
13067,GO:0048013,0.369772750996808,0.861645872548971,2,87,ephrin receptor signaling pathway,BP,HRAS;EFNB2
3022,GO:0006164,0.369789897837078,0.804552156367282,4,242,purine nucleotide biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
586,GO:0001676,0.370054396274318,0.861372930547002,2,92,long-chain fatty acid metabolic process,BP,PTGES;ACSL4
4519,GO:0009266,0.370065159263399,0.804486758192749,4,214,response to temperature stimulus,BP,SLC52A3;ADORA1;CDKN1A;AKT1
7439,GO:0030425,0.370191361370573,0.758669641678903,8,454,dendrite,CC,ACTN2;RAB27A;ADORA1;DRP2;RAB17;LZTS1;KCND1;PDE4B
7272,GO:0030165,0.370845808865964,0.861023834256472,2,84,PDZ domain binding,MF,FZD7;FZD8
8351,GO:0032228,0.370863844617357,0.923147821470415,1,31,regulation of synaptic transmission, GABAergic,BP,ADORA1
16130,GO:0070820,0.371007491578773,0.826150075791111,3,161,tertiary granule,CC,PLAU;VAMP1;PKP1
12222,GO:0045581,0.371119357778395,0.922839124214343,1,34,negative regulation of T cell differentiation,BP,BMP4
11427,GO:0043489,0.371200761131481,0.922995993721168,1,31,RNA stabilization,BP,GDNF
3737,GO:0007259,0.371267428069506,0.825923089525295,3,166,JAK-STAT cascade,BP,LIF;NOTCH1;CLCF1
18021,GO:0097696,0.371267428069506,0.825923089525295,3,166,STAT cascade,BP,LIF;NOTCH1;CLCF1
11478,GO:0043552,0.371677970946623,0.922854029086809,1,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,PDGFB
4455,GO:0009185,0.371776787290247,0.860309699049644,2,90,ribonucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
16075,GO:0070670,0.372155295395098,0.92237024890651,1,34,response to interleukin-4,BP,FASN
580,GO:0001669,0.372885706731589,0.859401917135112,2,102,acrosomal vesicle,CC,NOTCH1;SERPINA5
7585,GO:0030810,0.373219276768697,0.859173350064038,2,103,positive regulation of nucleotide biosynthetic process,BP,NPR1;NPPC
18596,GO:1900373,0.373219276768697,0.859173350064038,2,103,positive regulation of purine nucleotide biosynthetic process,BP,NPR1;NPPC
2489,GO:0005158,0.373695887563812,0.921866078359968,1,31,insulin receptor binding,MF,PIK3R1
19429,GO:1903050,0.373892015705649,0.801477023560553,4,229,regulation of proteolysis involved in cellular protein catabolic process,BP,AXIN1;AKT1;ARAF;RNF144A
2999,GO:0006110,0.373899369928836,0.921703913106516,1,32,regulation of glycolytic process,BP,ACTN3
13599,GO:0050702,0.374216506922845,0.921374273696673,1,35,interleukin-1 beta secretion,BP,WNT5A
13411,GO:0048791,0.37452528090726,0.921562830036309,1,30,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT5
12001,GO:0045070,0.375020723835237,0.921192169409844,1,32,positive regulation of viral genome replication,BP,NOTCH1
9263,GO:0034097,0.375267102084657,0.732762348715533,12,798,response to cytokine,BP,FASN;EDN1;CCL20;PDGFB;WNT5A;CLCF1;AKT1;PTGES;CLDN1;GAS6;ACSL4;CLDN18
3345,GO:0006637,0.375445770838441,0.857899062198515,2,93,acyl-CoA metabolic process,BP,FASN;ACSL4
9805,GO:0035383,0.375445770838441,0.857899062198515,2,93,thioester metabolic process,BP,FASN;ACSL4
10844,GO:0042462,0.37560415425752,0.920995347878546,1,31,eye photoreceptor cell development,BP,MYO7A
9112,GO:0033572,0.375666091837135,0.920710231457902,1,35,transferrin transport,BP,TF
12711,GO:0046578,0.375816601087733,0.800177521568483,4,199,regulation of Ras protein signal transduction,BP,ITGA3;FGF10;HRAS;KITLG
5937,GO:0016460,0.375840524375236,0.920750774420543,1,33,myosin II complex,CC,MYH11
13623,GO:0050728,0.376776776026097,0.856939466691846,2,99,negative regulation of inflammatory response,BP,ADORA1;TYRO3
13119,GO:0048167,0.376789405097234,0.822134696392535,3,144,regulation of synaptic plasticity,BP,ADORA1;HRAS;LZTS1
17507,GO:0090279,0.377013083493198,0.856834972130247,2,96,regulation of calcium ion import,BP,CASQ2;PDGFB
7321,GO:0030224,0.377019528020667,0.920208665979629,1,33,monocyte differentiation,BP,BMP4
19462,GO:1903131,0.377019528020667,0.920208665979629,1,33,mononuclear cell differentiation,BP,BMP4
963,GO:0002252,0.377036323694739,0.718177261555344,16,1065,immune effector process,BP,RAB27A;PMAIP1;CRISPLD2;ZFPM1;PLAU;PIK3R2;PIK3R1;WNT5A;CLCF1;DLL1;CHGA;PKP1;RAB44;PIK3CA;PIK3CG;RAB3D
2296,GO:0004860,0.377053583455671,0.856878351167276,2,92,protein kinase inhibitor activity,MF,PRKAR1B;CDKN1A
2801,GO:0005790,0.377138809050736,0.920153698377216,1,33,smooth endoplasmic reticulum,CC,TTYH1
18116,GO:0098660,0.377170701520988,0.731138307557359,12,744,inorganic ion transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TTYH1;TSPAN13;KCNH2;PIK3CG;KCNG2;GAS6;KCND1;CLDN16;PDE4B
1267,GO:0002764,0.377419125376797,0.752490825813269,8,487,immune response-regulating signaling pathway,BP,PRKACB;TYRO3;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
13624,GO:0050729,0.377477453519188,0.856470162148411,2,100,positive regulation of inflammatory response,BP,WNT5A;PIK3CG
14081,GO:0051443,0.377520772237576,0.85638296522909,2,104,positive regulation of ubiquitin-protein transferase activity,BP,MAGEC2;AXIN1
4356,GO:0009062,0.377737832336175,0.856435252963308,2,92,fatty acid catabolic process,BP,SESN2;AKT1
18927,GO:1901800,0.378399360680612,0.85604356283461,2,90,positive regulation of proteasomal protein catabolic process,BP,AKT1;RNF144A
1367,GO:0002931,0.379172727284405,0.919280140181718,1,32,response to ischemia,BP,GJB2
21018,GO:2000134,0.379435710967815,0.855332904890906,2,92,negative regulation of G1/S transition of mitotic cell cycle,BP,GADD45A;CDKN1A
3388,GO:0006690,0.379545048139778,0.855111648101002,2,101,icosanoid metabolic process,BP,EDN1;PTGES
18836,GO:1901568,0.379545048139778,0.855111648101002,2,101,fatty acid derivative metabolic process,BP,EDN1;PTGES
2125,GO:0004629,0.379750184693788,0.91916036264878,1,30,phospholipase C activity,MF,ADORA1
18369,GO:0099622,0.380632417593793,0.918601478560003,1,32,cardiac muscle cell membrane repolarization,BP,KCNH2
12041,GO:0045124,0.381243425725889,0.918184615223894,1,34,regulation of bone resorption,BP,CLDN18
12595,GO:0046329,0.382107580979867,0.917912193510474,1,32,negative regulation of JNK cascade,BP,AKT1
19867,GO:1903959,0.382307730609557,0.917818405489519,1,32,regulation of anion transmembrane transport,BP,AKT1
13690,GO:0050829,0.382814941728756,0.917129075728326,1,40,defense response to Gram-negative bacterium,BP,CHGA
1382,GO:0003009,0.382863231598846,0.917252614220249,1,37,skeletal muscle contraction,BP,ACTN3
13248,GO:0048488,0.382910048124003,0.91760870457416,1,31,synaptic vesicle endocytosis,BP,SYT5
21094,GO:2000272,0.383074936252435,0.9173252832097,1,34,negative regulation of receptor activity,BP,CASQ2
18322,GO:0099513,0.383236052083709,0.735042662072351,10,647,polymeric cytoskeletal fiber,CC,TUBG2;ACTN3;ACTN2;RHOQ;PSRC1;CAMSAP3;ESPN;PKP1;AMOT;RAB3D
6955,GO:0021772,0.383622168047133,0.91720089146831,1,32,olfactory bulb development,BP,WNT5A
4601,GO:0009620,0.383953237288457,0.916354408103536,1,46,response to fungus,BP,CHGA
11628,GO:0044091,0.384230477220604,0.916914181064707,1,32,membrane biogenesis,BP,CDH2
14875,GO:0060338,0.384489271661944,0.916336774556797,1,40,regulation of type I interferon-mediated signaling pathway,BP,WNT5A
3000,GO:0006111,0.384563357955094,0.916687973765095,1,33,regulation of gluconeogenesis,BP,SESN2
12768,GO:0046676,0.384672388290078,0.916452259772931,1,36,negative regulation of insulin secretion,BP,INHBB
19353,GO:1902930,0.384715806243445,0.916550862514824,1,34,regulation of alcohol biosynthetic process,BP,VDR
5177,GO:0014009,0.384753594224374,0.916598021870445,1,33,glial cell proliferation,BP,NOTCH1
11457,GO:0043531,0.384954795265575,0.916572023683079,1,32,ADP binding,MF,MYO7A
10798,GO:0042379,0.385074916130847,0.915515070987572,1,57,chemokine receptor binding,MF,CCL20
4428,GO:0009154,0.385192325685845,0.916390350509633,1,33,purine ribonucleotide catabolic process,BP,PDE4B
11150,GO:0043025,0.385768378136717,0.753468824757611,7,412,neuronal cell body,CC,SYT5;ADORA1;SPTBN4;DRP2;RAB17;KCND1;ACSL4
3846,GO:0007569,0.386436930387306,0.850725688527377,2,93,cell aging,BP,HRAS;CDKN1A
1240,GO:0002720,0.387911333785437,0.914968059390713,1,35,positive regulation of cytokine production involved in immune response,BP,WNT5A
2905,GO:0005975,0.388404256442469,0.736340775255445,9,549,carbohydrate metabolic process,BP,ACTN3;PMAIP1;PDGFB;KHK;SESN2;PFKFB3;B3GNT2;AKT1;PIK3CA
1631,GO:0003714,0.388686346035079,0.790077448231801,4,216,transcription corepressor activity,MF,WNT4;NAB2;TLE1;SIN3B
10818,GO:0042417,0.388784947153415,0.914611826182473,1,34,dopamine metabolic process,BP,NPR1
19423,GO:1903038,0.389340793419128,0.848713797227157,2,98,negative regulation of leukocyte cell-cell adhesion,BP,SDC4;BMP4
12073,GO:0045185,0.389449506328406,0.848729628000782,2,93,maintenance of protein location,BP,SPTBN4;AKT1
6599,GO:0019395,0.390015524869733,0.848316712670065,2,95,fatty acid oxidation,BP,SESN2;AKT1
18980,GO:1901985,0.390034417449526,0.914011092177705,1,34,positive regulation of protein acetylation,BP,LIF
8011,GO:0031570,0.390367933528113,0.812058776092379,3,155,DNA integrity checkpoint,BP,GADD45A;FOXO4;CDKN1A
14743,GO:0060147,0.3905332532301,0.913908710331634,1,32,regulation of posttranscriptional gene silencing,BP,BMP4
15269,GO:0060966,0.3905332532301,0.913908710331634,1,32,regulation of gene silencing by RNA,BP,BMP4
8664,GO:0032680,0.390841648838117,0.84768139205393,2,100,regulation of tumor necrosis factor production,BP,PIK3R1;GAS6
4932,GO:0010677,0.391450483865215,0.913327219315917,1,34,negative regulation of cellular carbohydrate metabolic process,BP,ACTN3
2785,GO:0005771,0.391708191472504,0.91296854842205,1,38,multivesicular body,CC,RAB27A
9766,GO:0035307,0.392664149172957,0.912806209102513,1,33,positive regulation of protein dephosphorylation,BP,ADORA1
15489,GO:0061387,0.392812051831662,0.846565041306922,2,89,regulation of extent of cell growth,BP,WNT3;WNT5A
20260,GO:1904837,0.392871333913857,0.912170299673927,1,43,beta-catenin-TCF complex assembly,BP,TLE1
13334,GO:0048662,0.393001055653719,0.912450415053581,1,36,negative regulation of smooth muscle cell proliferation,BP,NPR1
1305,GO:0002833,0.393007516752802,0.91233614217401,1,38,positive regulation of response to biotic stimulus,BP,BMP6
14194,GO:0051653,0.393076925748043,0.912605583505246,1,33,spindle localization,BP,FGF10
19308,GO:1902807,0.393082541329775,0.846268437446668,2,95,negative regulation of cell cycle G1/S phase transition,BP,GADD45A;CDKN1A
166,GO:0000323,0.393090110303538,0.726441912726379,10,624,lytic vacuole,CC,RAB27A;RAB39A;SDC4;CHGA;RAB12;MYO7A;RAB44;PIK3CG;RAB38;RAB3D
2778,GO:0005764,0.393090110303538,0.726441912726379,10,624,lysosome,CC,RAB27A;RAB39A;SDC4;CHGA;RAB12;MYO7A;RAB44;PIK3CG;RAB38;RAB3D
7147,GO:0022857,0.393100901571633,0.703706735896056,16,1011,transmembrane transporter activity,MF,TF;SLC45A4;KCNK6;SLC25A53;TTYH1;KCNH2;SLC2A14;SFXN1;GJB1;GJB2;GJA3;KCNG2;GAS6;SLC18B1;KCND1;CLDN16
13655,GO:0050778,0.393237493582055,0.726287936753283,10,643,positive regulation of immune response,BP,PRKACB;TYRO3;PIK3R2;PIK3R1;HRAS;WNT5A;CLCF1;BCAR1;PIK3CA;PDE4B
12329,GO:0045744,0.39361412216019,0.912211949916271,1,35,negative regulation of G-protein coupled receptor protein signaling pathway,BP,GPRASP1
7071,GO:0021988,0.393790718166842,0.912258001463776,1,33,olfactory lobe development,BP,WNT5A
4851,GO:0010559,0.393880669156531,0.912021233238431,1,36,regulation of glycoprotein biosynthetic process,BP,HBEGF
10771,GO:0042339,0.394182762667112,0.912066743693287,1,33,keratan sulfate metabolic process,BP,B3GNT2
17466,GO:0090218,0.394476620879853,0.911923222386783,1,33,positive regulation of lipid kinase activity,BP,PDGFB
2979,GO:0006084,0.394899752245121,0.911647868111698,1,34,acetyl-CoA metabolic process,BP,FASN
3348,GO:0006641,0.39491165736188,0.844891457049927,2,104,triglyceride metabolic process,BP,PIK3CG;ACSL4
4514,GO:0009261,0.395080476884484,0.91155934651981,1,34,ribonucleotide catabolic process,BP,PDE4B
21458,GO:2000785,0.395571568060687,0.91131853471084,1,34,regulation of autophagosome assembly,BP,RALB
10737,GO:0042277,0.395746649945961,0.784430243143873,4,231,peptide binding,MF,ACVR1;PIK3R1;NPR1;PTGES
19927,GO:1904064,0.396061402767149,0.844213220609629,2,98,positive regulation of cation transmembrane transport,BP,ACTN2;KCNH2
18659,GO:1901030,0.396482028846622,0.910686556629156,1,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
6529,GO:0019210,0.397130867424661,0.843526143124275,2,96,kinase inhibitor activity,MF,PRKAR1B;CDKN1A
9447,GO:0034440,0.397341829286603,0.843365799800783,2,97,lipid oxidation,BP,SESN2;AKT1
11324,GO:0043299,0.397618630347744,0.735108246985725,8,519,leukocyte degranulation,BP,RAB27A;CRISPLD2;PLAU;CHGA;PKP1;RAB44;PIK3CG;RAB3D
7535,GO:0030662,0.397944792336298,0.806322590056072,3,163,coated vesicle membrane,CC,TF;WNT5A;HBEGF
8800,GO:0032886,0.398561186637966,0.805962099159524,3,152,regulation of microtubule-based process,BP,RAB6C;PSRC1;CAMSAP3
6847,GO:0021549,0.398614623294658,0.842657668681156,2,89,cerebellum development,BP,WNT7A;DLL1
13406,GO:0048786,0.398654603929152,0.910020519955004,1,31,presynaptic active zone,CC,ADORA1
11971,GO:0045022,0.398747532129748,0.909751681437208,1,34,early endosome to late endosome transport,BP,MSN
17701,GO:0097028,0.398750561495052,0.909405167230383,1,40,dendritic cell differentiation,BP,GAS6
12368,GO:0045824,0.3988538451458,0.909571039919935,1,36,negative regulation of innate immune response,BP,TYRO3
3927,GO:0008081,0.398949267505634,0.842410101315956,2,90,phosphoric diester hydrolase activity,MF,ADORA1;PDE4B
5657,GO:0015872,0.399221743356693,0.909220721325864,1,39,dopamine transport,BP,GDNF
4560,GO:0009408,0.399972836895009,0.804849121542509,3,157,response to heat,BP,SLC52A3;CDKN1A;AKT1
8637,GO:0032640,0.400329161311536,0.841255006267315,2,102,tumor necrosis factor production,BP,PIK3R1;GAS6
5553,GO:0015682,0.4007460909226,0.908512703850123,1,38,ferric iron transport,BP,TF
17069,GO:0072512,0.4007460909226,0.908512703850123,1,38,trivalent inorganic cation transport,BP,TF
13647,GO:0050770,0.401600127962294,0.803699764437942,3,149,regulation of axonogenesis,BP,WNT3;WNT7A;WNT5A
9431,GO:0034405,0.402154015673521,0.908052765703591,1,34,response to fluid shear stress,BP,AKT1
19740,GO:1903708,0.402173834068021,0.803138689173571,3,162,positive regulation of hemopoiesis,BP,LIF;KITLG;GAS6
18991,GO:1901998,0.40255377285752,0.907721906936215,1,36,toxin transport,BP,RAB40B
4513,GO:0009260,0.402588638953214,0.778880915805327,4,252,ribonucleotide biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
16721,GO:0071868,0.403320398662962,0.907538009525232,1,33,cellular response to monoamine stimulus,BP,PDE4B
16723,GO:0071870,0.403320398662962,0.907538009525232,1,33,cellular response to catecholamine stimulus,BP,PDE4B
2691,GO:0005604,0.403760642874946,0.839152013504212,2,89,basement membrane,CC,LAMA1;LAMA5
4747,GO:0010165,0.403922752987615,0.907163121940777,1,34,response to X-ray,BP,CDKN1A
2626,GO:0005484,0.403993830317271,0.906878829846004,1,38,SNAP receptor activity,MF,VAMP1
10640,GO:0042088,0.404141593444261,0.906804079234717,1,38,T-helper 1 type immune response,BP,HRAS
14159,GO:0051591,0.404456652238395,0.838593120572846,2,93,response to cAMP,BP,WT1;PIK3CG
6061,GO:0016684,0.404850728896973,0.906076556456741,1,46,oxidoreductase activity, acting on peroxide as acceptor,MF,SESN2
7316,GO:0030219,0.404942465486194,0.905992656095054,1,47,megakaryocyte differentiation,BP,ZFPM1
7630,GO:0030865,0.405040381199189,0.906670245515998,1,33,cortical cytoskeleton organization,BP,RHOQ
12195,GO:0045494,0.405543552280004,0.906343356587615,1,34,photoreceptor cell maintenance,BP,CDH23
10697,GO:0042176,0.405649461495861,0.746619228846792,6,371,regulation of protein catabolic process,BP,WNT5A;AXIN1;MSN;AKT1;ARAF;RNF144A
19666,GO:1903555,0.405938047845275,0.837397592629423,2,103,regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1;GAS6
7220,GO:0030072,0.406139031841025,0.776139967956708,4,231,peptide hormone secretion,BP,ADRA2C;EDN1;INHBB;KCNG2
11255,GO:0043198,0.406432122139788,0.905964508307337,1,33,dendritic shaft,CC,LZTS1
9324,GO:0034198,0.406720888874784,0.905612273707896,1,36,cellular response to amino acid starvation,BP,CDKN1A
8685,GO:0032715,0.406816649147231,0.905563456473115,1,36,negative regulation of interleukin-6 production,BP,GAS6
16014,GO:0070555,0.407018256290145,0.836506272999774,2,113,response to interleukin-1,BP,EDN1;CCL20
20663,GO:1905953,0.407535089520855,0.905077420871714,1,38,negative regulation of lipid localization,BP,AKT1
10522,GO:0038179,0.40755114458149,0.90532193200259,1,34,neurotrophin signaling pathway,BP,BCAR1
21026,GO:2000146,0.407651364299361,0.774963282709762,4,224,negative regulation of cell motility,BP,WNT4;NOTCH1;ADORA1;RHOB
15067,GO:0060589,0.408025014427264,0.744703394890546,6,338,nucleoside-triphosphatase regulator activity,MF,RIN3;PIK3R2;SESN2;AXIN1;GPSM1;SH3BP4
10214,GO:0036064,0.408076621816988,0.836119610860246,2,92,ciliary basal body,CC,MARK4;AKT1
4566,GO:0009416,0.408257394743972,0.757384472735413,5,289,response to light stimulus,BP,NMT2;PIK3R1;CDKN1A;AKT1;UNC119
5182,GO:0014014,0.408396441944654,0.904636109879708,1,38,negative regulation of gliogenesis,BP,NOTCH1
17075,GO:0072522,0.408413492624142,0.774193491555672,4,254,purine-containing compound biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
15083,GO:0060612,0.408414149543729,0.904880796267718,1,34,adipose tissue development,BP,PIK3CA
13667,GO:0050796,0.408990298868376,0.797927121903432,3,164,regulation of insulin secretion,BP,ADRA2C;INHBB;KCNG2
13273,GO:0048536,0.409363674355417,0.904259425323594,1,36,spleen development,BP,FGF10
973,GO:0002275,0.409396095764315,0.724836410702935,8,524,myeloid cell activation involved in immune response,BP,RAB27A;CRISPLD2;PLAU;CHGA;PKP1;RAB44;PIK3CG;RAB3D
3908,GO:0008047,0.409450322217282,0.724862055597449,8,484,enzyme activator activity,MF,RIN3;PIK3R2;PDGFB;AXIN1;BMP2;CDKN1A;PIK3CA;GAS6
19431,GO:1903052,0.409645167978335,0.797356960173713,3,172,positive regulation of proteolysis involved in cellular protein catabolic process,BP,AXIN1;AKT1;RNF144A
14605,GO:0055086,0.40970695988357,0.711633094803499,10,695,nucleobase-containing small molecule metabolic process,BP,ACTN3;GUCY1B3;EDN1;WNT5A;RHOQ;NPR1;PFKFB3;CHGA;NPPC;PDE4B
19909,GO:1904036,0.409816347541055,0.90402653435172,1,36,negative regulation of epithelial cell apoptotic process,BP,GAS6
3409,GO:0006721,0.409853627808333,0.834641641814562,2,106,terpenoid metabolic process,BP,STRA6;SDC4
21099,GO:2000278,0.409994593448196,0.834751043734051,2,94,regulation of DNA biosynthetic process,BP,PDGFB;CDKN1A
8871,GO:0032991,0.410201459892045,0.645647145635452,65,4576,macromolecular complex,CC,ITGA3;ITGA5;WNT3;WNT2;POU3F1;TUBG2;TSPAN17;NOTCH1;GLDC;STRA6;TF;ITGB5;ITGB4;ITGB8;SERPINA5;ZFPM1;ACVR1;SALL4;GUCY1B3;CASQ2;PRKACB;KCNK6;TTYH1;CDH2;PRR5L;PIK3R2;PIK3R1;CGN;KCNH2;PRKAR1B;RALB;SESN2;AXIN1;NPR1;CLCF1;SPTB;BMP2;CDKN1A;ESPN;VAMP1;DDR1;GJB1;GJB2;GJB6;AKT1;PKP3;PKP1;NPPC;CDH1;MYO7A;GJA3;PIK3CA;PIK3CG;KCNG2;SIN3B;MYH11;VDR;AMOT;LAMA1;LAMA5;KCND1;FZD8;ACTA2;RNF144A;PDE4B
9714,GO:0035196,0.410418361282427,0.903851537379314,1,34,production of miRNAs involved in gene silencing by miRNA,BP,BMP4
11350,GO:0043330,0.410640831434747,0.90318346369308,1,44,response to exogenous dsRNA,BP,RALB
5055,GO:0010863,0.41092917054246,0.903518402025566,1,35,positive regulation of phospholipase C activity,BP,LPAR2
18605,GO:1900408,0.41117817484498,0.903202450216717,1,38,negative regulation of cellular response to oxidative stress,BP,AKT1
19333,GO:1902883,0.41117817484498,0.903202450216717,1,38,negative regulation of response to oxidative stress,BP,AKT1
19489,GO:1903202,0.41117817484498,0.903202450216717,1,38,negative regulation of oxidative stress-induced cell death,BP,AKT1
18183,GO:0098815,0.411259693422776,0.903491581698796,1,33,modulation of excitatory postsynaptic potential,BP,WNT7A
12622,GO:0046390,0.411263287417525,0.771886033030455,4,255,ribose phosphate biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
972,GO:0002274,0.4115590474278,0.715953692196345,9,596,myeloid leukocyte activation,BP,RAB27A;CRISPLD2;PLAU;WNT5A;CHGA;PKP1;RAB44;PIK3CG;RAB3D
11512,GO:0043618,0.411713886403266,0.833287375021742,2,110,regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1;SESN2
14315,GO:0051899,0.412033888732402,0.83331275476065,2,95,membrane depolarization,BP,EDN1;KCNH2
8037,GO:0031624,0.412230573228117,0.902989556447588,1,33,ubiquitin conjugating enzyme binding,MF,RNF144A
16388,GO:0071312,0.413117384920946,0.902254947351375,1,37,cellular response to alkaloid,BP,CASQ2
3500,GO:0006874,0.413710387609739,0.73972777726887,6,379,cellular calcium ion homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;PIK3CG;VDR
964,GO:0002253,0.413857720816717,0.72094736009056,8,507,activation of immune response,BP,PRKACB;TYRO3;PIK3R2;PIK3R1;HRAS;BCAR1;PIK3CA;PDE4B
612,GO:0001726,0.413925594595783,0.794226273334619,3,154,ruffle,CC,ITGA5;BCAR1;AMOT
1077,GO:0002444,0.413991262688251,0.720793128091966,8,528,myeloid leukocyte mediated immunity,BP,RAB27A;CRISPLD2;PLAU;CHGA;PKP1;RAB44;PIK3CG;RAB3D
4812,GO:0010470,0.414240940962078,0.901732129564997,1,36,regulation of gastrulation,BP,FZD7
11782,GO:0044403,0.414261560901194,0.690380333496983,14,968,symbiosis, encompassing mutualism through parasitism,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;NMT2;MFGE8;TYRO3;PIK3R1;CDH1;CLDN1;GAS6;ACTA2;PIM2;EFNB2
12039,GO:0045121,0.414376056833105,0.752307719829154,5,281,membrane raft,CC,CDH2;RHOQ;SDC4;DLL1;CDH1
1070,GO:0002437,0.415278678240746,0.900902580646394,1,41,inflammatory response to antigenic stimulus,BP,NOTCH1
13858,GO:0051090,0.415291485948237,0.738421723948503,6,362,regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2;EDN1;WNT5A;BMP7;AKT1;GAS6
8013,GO:0031572,0.415754481286439,0.901078438478848,1,34,G2 DNA damage checkpoint,BP,FOXO4
806,GO:0001990,0.416398299897004,0.900477080560772,1,38,regulation of systemic arterial blood pressure by hormone,BP,EDN1
158,GO:0000307,0.41644336068305,0.900395943474707,1,39,cyclin-dependent protein kinase holoenzyme complex,CC,CDKN1A
18205,GO:0098857,0.417652325942165,0.749550739157483,5,282,membrane microdomain,CC,CDH2;RHOQ;SDC4;DLL1;CDH1
572,GO:0001659,0.417717587514085,0.899841917550112,1,37,temperature homeostasis,BP,ADORA1
11790,GO:0044419,0.418035911137719,0.686920541724508,14,970,interspecies interaction between organisms,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;NMT2;MFGE8;TYRO3;PIK3R1;CDH1;CLDN1;GAS6;ACTA2;PIM2;EFNB2
8055,GO:0031648,0.418932981449104,0.89919841538272,1,37,protein destabilization,BP,BMP2
18115,GO:0098659,0.418966928676894,0.899385878444043,1,34,inorganic cation import into cell,BP,TF
18358,GO:0099587,0.418966928676894,0.899385878444043,1,34,inorganic ion import into cell,BP,TF
13859,GO:0051091,0.418987113888197,0.765727199438361,4,230,positive regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2;EDN1;WNT5A;AKT1
3869,GO:0007613,0.419438378231211,0.828109726276552,2,95,memory,BP,ITGA3;ITGA5
8661,GO:0032675,0.419464343236685,0.827980259606029,2,101,regulation of interleukin-6 production,BP,WNT5A;GAS6
12413,GO:0045912,0.419803810417298,0.898735806231521,1,37,negative regulation of carbohydrate metabolic process,BP,ACTN3
431,GO:0001105,0.420165221187087,0.898543436419034,1,37,RNA polymerase II transcription coactivator activity,MF,POU3F1
7729,GO:0031050,0.42022268115712,0.898646657183457,1,35,dsRNA fragmentation,BP,BMP4
16195,GO:0070918,0.42022268115712,0.898646657183457,1,35,production of small RNA involved in gene silencing by RNA,BP,BMP4
4363,GO:0009069,0.420477657848762,0.898315277682794,1,38,serine family amino acid metabolic process,BP,GLDC
12324,GO:0045739,0.420512307587348,0.898296794538655,1,38,positive regulation of DNA repair,BP,FGF10
12819,GO:0046825,0.42135899591393,0.897844512109097,1,38,regulation of protein export from nucleus,BP,GAS6
13257,GO:0048512,0.421498082464613,0.897457680680179,1,44,circadian behavior,BP,ADORA1
8889,GO:0033017,0.421806478975624,0.897667040925588,1,37,sarcoplasmic reticulum membrane,CC,CASQ2
17506,GO:0090278,0.42193982640434,0.897365506782322,1,41,negative regulation of peptide hormone secretion,BP,INHBB
5023,GO:0010824,0.422155116675663,0.897545913708485,1,36,regulation of centrosome duplication,BP,RAB6C
2662,GO:0005547,0.422256974866463,0.897560773748338,1,35,phosphatidylinositol-3,4,5-trisphosphate binding,MF,AKT1
18985,GO:1901990,0.422261235823409,0.745549660124703,5,309,regulation of mitotic cell cycle phase transition,BP,GADD45A;FGF10;FOXO4;CDKN1A;AKT1
9778,GO:0035335,0.422441028313613,0.825938077079133,2,97,peptidyl-tyrosine dephosphorylation,BP,PTPN7;DUSP5
6539,GO:0019221,0.422811955774865,0.712955133751526,8,552,cytokine-mediated signaling pathway,BP,EDN1;CCL20;PDGFB;WNT5A;CLCF1;AKT1;GAS6;CLDN18
14698,GO:0060071,0.422928465798004,0.825386871452665,2,109,Wnt signaling pathway, planar cell polarity pathway,BP,FZD7;WNT5A
16656,GO:0071706,0.42307367568567,0.825313943766744,2,107,tumor necrosis factor superfamily cytokine production,BP,PIK3R1;GAS6
19786,GO:1903793,0.423339826260841,0.896666043560095,1,40,positive regulation of anion transport,BP,EDN1
12553,GO:0046165,0.423374079137304,0.825181675392396,2,102,alcohol biosynthetic process,BP,HMGCS2;VDR
3862,GO:0007603,0.423438975654598,0.896728242368588,1,38,phototransduction, visible light,BP,NMT2
141,GO:0000281,0.423651350694266,0.896742519696579,1,36,mitotic cytokinesis,BP,SNX18
12292,GO:0045668,0.423732899354545,0.896510520735324,1,39,negative regulation of osteoblast differentiation,BP,NOTCH1
12271,GO:0045646,0.424038674431455,0.896405027047081,1,38,regulation of erythrocyte differentiation,BP,ZFPM1
8729,GO:0032781,0.424069721951844,0.896118676898851,1,43,positive regulation of ATPase activity,BP,FGF10
4874,GO:0010596,0.424394569384901,0.896212921826702,1,38,negative regulation of endothelial cell migration,BP,NOTCH1
18247,GO:0098927,0.425237546851716,0.895820076828,1,37,vesicle-mediated transport between endosomal compartments,BP,MSN
3439,GO:0006775,0.425393929809846,0.895501607493048,1,41,fat-soluble vitamin metabolic process,BP,VDR
8401,GO:0032309,0.425459799130378,0.895365313077191,1,43,icosanoid secretion,BP,EDN1
772,GO:0001948,0.425943706432535,0.823377001364439,2,100,glycoprotein binding,MF,ITGA3;CDH1
428,GO:0001102,0.425979375558542,0.895294839109065,1,39,RNA polymerase II activating transcription factor binding,MF,ZFPM1
19410,GO:1903018,0.426116205561974,0.895109267257665,1,41,regulation of glycoprotein metabolic process,BP,HBEGF
21157,GO:2000351,0.426394097148641,0.895069465011345,1,39,regulation of endothelial cell apoptotic process,BP,GAS6
1220,GO:0002700,0.426398050612737,0.82288577734148,2,110,regulation of production of molecular mediator of immune response,BP,WNT5A;CLCF1
12250,GO:0045620,0.427087366148311,0.894528456763261,1,42,negative regulation of lymphocyte differentiation,BP,BMP4
7593,GO:0030818,0.427128253520418,0.894612489729827,1,40,negative regulation of cAMP biosynthetic process,BP,EDN1
16720,GO:0071867,0.427142453645615,0.89485309087813,1,36,response to monoamine,BP,PDE4B
16722,GO:0071869,0.427142453645615,0.89485309087813,1,36,response to catecholamine,BP,PDE4B
3069,GO:0006259,0.427720618589624,0.678034194374754,14,927,DNA metabolic process,BP,GADD45A;FGF10;PDGFB;HRAS;SESN2;CLCF1;BMP6;BMP4;CDKN1A;CTGF;AKT1;KITLG;NPPC;PIK3CA
2197,GO:0004725,0.427725313663263,0.822132836142618,2,98,protein tyrosine phosphatase activity,MF,PTPN7;DUSP5
6146,GO:0016836,0.4284010734731,0.893760305857709,1,43,hydro-lyase activity,MF,FASN
8599,GO:0032589,0.428495316482904,0.894115274499425,1,36,neuron projection membrane,CC,ADORA1
8732,GO:0032784,0.42858804341842,0.89393298652853,1,38,regulation of DNA-templated transcription, elongation,BP,AXIN1
17430,GO:0090175,0.428634103372554,0.821274149431154,2,110,regulation of establishment of planar polarity,BP,FZD7;WNT5A
12128,GO:0045296,0.428997403485868,0.739860134583428,5,299,cadherin binding,MF,FASN;CGN;MB21D2;PKP3;CDH1
8589,GO:0032570,0.429033706554084,0.893515336118337,1,41,response to progesterone,BP,GJB2
6753,GO:0019894,0.429055947043559,0.893880219363123,1,35,kinesin binding,MF,SPTBN5
11203,GO:0043122,0.429096777093537,0.757374235599268,4,234,regulation of I-kappaB kinase/NF-kappaB signaling,BP,BMP7;AKT1;TLE1;PIM2
14193,GO:0051651,0.429333326391645,0.820899175424067,2,102,maintenance of location in cell,BP,SPTBN4;AKT1
11152,GO:0043028,0.429483691803018,0.893268185609126,1,41,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,GAS6
14169,GO:0051602,0.429720758639062,0.893192958790733,1,40,response to electrical stimulus,BP,GJB6
13713,GO:0050864,0.429803284566456,0.820491391890966,2,106,regulation of B cell activation,BP,CLCF1;CDKN1A
18583,GO:1900274,0.430312690515809,0.893051038193076,1,37,regulation of phospholipase C activity,BP,LPAR2
12090,GO:0045211,0.430647984273227,0.756190024954711,4,217,postsynaptic membrane,CC,ADORA1;DRP2;LZTS1;SHC4
3877,GO:0007622,0.430736636857959,0.89238138602461,1,45,rhythmic behavior,BP,ADORA1
783,GO:0001960,0.430739524161646,0.892523849831647,1,42,negative regulation of cytokine-mediated signaling pathway,BP,GAS6
9774,GO:0035329,0.430849709393912,0.89289592447995,1,35,hippo signaling,BP,AMOT
17103,GO:0072562,0.431314838927443,0.819273617509521,2,114,blood microparticle,CC,TF;MSN
6028,GO:0016616,0.431669615790056,0.819001723921037,2,115,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,FASN;BMP2
12993,GO:0047485,0.432386707824052,0.818616270158855,2,106,protein N-terminus binding,MF,GADD45A;MYO7A
13565,GO:0050663,0.432416908824722,0.779538352854006,3,174,cytokine secretion,BP,NOTCH1;WNT5A;GAS6
8045,GO:0031638,0.432618734367284,0.891536550407953,1,41,zymogen activation,BP,PLAU
747,GO:0001917,0.432854984689788,0.891461270392124,1,40,photoreceptor inner segment,CC,MYO7A
16428,GO:0071364,0.433109106444587,0.891506266801348,1,37,cellular response to epidermal growth factor stimulus,BP,AKT1
7925,GO:0031400,0.433204669990084,0.69659056105229,9,580,negative regulation of protein modification process,BP,LIF;GADD45A;PRR5L;PRKAR1B;BMP7;BMP4;CDKN1A;AKT1;DUSP5
8687,GO:0032720,0.433709899749454,0.890876405142358,1,42,negative regulation of tumor necrosis factor production,BP,GAS6
14334,GO:0051932,0.434412075476007,0.890716136156991,1,38,synaptic transmission, GABAergic,BP,ADORA1
2983,GO:0006090,0.435135890902662,0.816661208054576,2,103,pyruvate metabolic process,BP,ACTN3;PFKFB3
6486,GO:0019079,0.435976957272544,0.816010755452151,2,105,viral genome replication,BP,NOTCH1;GAS6
8710,GO:0032757,0.437564621606605,0.888663704141954,1,43,positive regulation of interleukin-8 production,BP,WNT5A
12358,GO:0045806,0.438122874984081,0.888454912033497,1,41,negative regulation of endocytosis,BP,UNC119
11031,GO:0042771,0.438141604853445,0.888337884926694,1,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CDKN1A
11514,GO:0043620,0.438152131351707,0.814257172410762,2,115,regulation of DNA-templated transcription in response to stress,BP,NOTCH1;SESN2
13869,GO:0051101,0.438389256221448,0.814188420162722,2,108,regulation of DNA binding,BP,LIF;HEY1
940,GO:0002204,0.438927901170774,0.888057181047891,1,40,somatic recombination of immunoglobulin genes involved in immune response,BP,CLCF1
941,GO:0002208,0.438927901170774,0.888057181047891,1,40,somatic diversification of immunoglobulins involved in immune response,BP,CLCF1
12078,GO:0045190,0.438927901170774,0.888057181047891,1,40,isotype switching,BP,CLCF1
3636,GO:0007080,0.439980121624371,0.887460796259342,1,40,mitotic metaphase plate congression,BP,PSRC1
1232,GO:0002712,0.440088175784761,0.887234343800297,1,43,regulation of B cell mediated immunity,BP,CLCF1
1344,GO:0002889,0.440088175784761,0.887234343800297,1,43,regulation of immunoglobulin mediated immune response,BP,CLCF1
8650,GO:0032653,0.440129397800363,0.887263311711284,1,42,regulation of interleukin-10 production,BP,DLL1
2786,GO:0005773,0.440535742750121,0.678512922403945,11,715,vacuole,CC,RAB27A;RAB39A;RALB;SDC4;CHGA;RAB12;MYO7A;RAB44;PIK3CG;RAB38;RAB3D
14706,GO:0060079,0.440613836180551,0.812724914915158,2,98,excitatory postsynaptic potential,BP,WNT7A;ADORA1
7578,GO:0030803,0.441168875598703,0.886671442168533,1,42,negative regulation of cyclic nucleotide biosynthetic process,BP,EDN1
3656,GO:0007140,0.441726926241279,0.886466417625165,1,40,male meiosis,BP,PIM2
7770,GO:0031103,0.44191429121024,0.886359438797315,1,40,axon regeneration,BP,JAM3
675,GO:0001819,0.443203166952147,0.714036816038799,6,387,positive regulation of cytokine production,BP,ZFPM1;CCL20;PIK3R1;HRAS;WNT5A;PDE4B
11778,GO:0044390,0.443241303533411,0.885726339350094,1,38,ubiquitin-like protein conjugating enzyme binding,MF,RNF144A
3498,GO:0006869,0.443512141243554,0.727316554271878,5,309,lipid transport,BP,SERPINA5;EDN1;BMP6;AKT1;ACSL4
7998,GO:0031529,0.443738664788094,0.885255873796205,1,41,ruffle organization,BP,HRAS
5309,GO:0014888,0.443772216227703,0.885295263007608,1,40,striated muscle adaptation,BP,ACTN3
7089,GO:0022037,0.443871884612834,0.810307617259961,2,98,metencephalon development,BP,WNT7A;DLL1
3142,GO:0006367,0.444374429751887,0.769933155893823,3,173,transcription initiation from RNA polymerase II promoter,BP,NOTCH1;CTGF;VDR
16662,GO:0071715,0.444411997646947,0.884659489224579,1,45,icosanoid transport,BP,EDN1
18839,GO:1901571,0.444411997646947,0.884659489224579,1,45,fatty acid derivative transport,BP,EDN1
8209,GO:0031968,0.444676220900091,0.769679404698143,3,174,organelle outer membrane,CC,PMAIP1;VAMP1;ACSL4
9611,GO:0034767,0.444897234158707,0.809378744962887,2,107,positive regulation of ion transmembrane transport,BP,ACTN2;KCNH2
402,GO:0001047,0.445557146758896,0.769085784264294,3,161,core promoter binding,MF,NOTCH1;GADD45A;ZFPM1
11416,GO:0043470,0.446517125205227,0.88365244621162,1,41,regulation of carbohydrate catabolic process,BP,ACTN3
4264,GO:0008637,0.447049983809965,0.807672648550309,2,113,apoptotic mitochondrial changes,BP,PMAIP1;AKT1
4728,GO:0010043,0.447158504807024,0.882777142604691,1,52,response to zinc ion,BP,KHK
21658,GO:2001259,0.447640543294077,0.883000221732894,1,41,positive regulation of cation channel activity,BP,ACTN2
11122,GO:0042992,0.448009505750032,0.882785520356345,1,41,negative regulation of transcription factor import into nucleus,BP,BMP7
6160,GO:0016860,0.44808957088647,0.882526468568368,1,45,intramolecular oxidoreductase activity,MF,PTGES
19667,GO:1903556,0.448188306846129,0.882518358619581,1,44,negative regulation of tumor necrosis factor superfamily cytokine production,BP,GAS6
14595,GO:0055074,0.448285961976602,0.709513944378862,6,392,calcium ion homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;PIK3CG;VDR
17152,GO:0072665,0.448403203396795,0.882616016375437,1,40,protein localization to vacuole,BP,SH3BP4
8634,GO:0032635,0.449037379311862,0.806275649064103,2,107,interleukin-6 production,BP,WNT5A;GAS6
8648,GO:0032651,0.449463091342077,0.881676017968984,1,46,regulation of interleukin-1 beta production,BP,WNT5A
3961,GO:0008138,0.450144325161226,0.881374060619538,1,44,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP5
13970,GO:0051252,0.450151869885859,0.611130101466708,53,3624,regulation of RNA metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;PKP3;PKP1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
4406,GO:0009132,0.450292797453062,0.805296174331054,2,109,nucleoside diphosphate metabolic process,BP,ACTN3;PFKFB3
17723,GO:0097060,0.450636034808519,0.721200659555561,5,285,synaptic membrane,CC,ITGA3;ADORA1;DRP2;LZTS1;SHC4
10631,GO:0042059,0.450874402490177,0.881170613630272,1,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,EPN1
6171,GO:0016877,0.451097687439513,0.88110315219713,1,39,ligase activity, forming carbon-sulfur bonds,MF,ACSL4
7826,GO:0031234,0.451156194206077,0.804712402414873,2,105,extrinsic component of cytoplasmic side of plasma membrane,CC,SNX18;MYZAP
16410,GO:0071345,0.451826593301399,0.673340621977987,10,704,cellular response to cytokine stimulus,BP,FASN;EDN1;CCL20;PDGFB;WNT5A;CLCF1;AKT1;CLDN1;GAS6;CLDN18
5022,GO:0010823,0.45232366721918,0.880143739769165,1,43,negative regulation of mitochondrion organization,BP,AKT1
825,GO:0002020,0.452897623576893,0.80334211073105,2,108,protease binding,MF,ITGA3;SERPINA5
19753,GO:1903727,0.452997160269426,0.879859192061124,1,41,positive regulation of phospholipid metabolic process,BP,PDGFB
13346,GO:0048675,0.45304268107825,0.803397626782911,2,99,axon extension,BP,WNT3;WNT5A
6741,GO:0019867,0.453352509592546,0.762566973847829,3,176,outer membrane,CC,PMAIP1;VAMP1;ACSL4
5146,GO:0010976,0.453563676033653,0.736771108660247,4,227,positive regulation of neuron projection development,BP,ITGA3;WNT3;WNT5A;BMP7
4883,GO:0010611,0.454589775009654,0.878915333691065,1,41,regulation of cardiac muscle hypertrophy,BP,EDN1
1968,GO:0004407,0.455342377346225,0.878529369380675,1,40,histone deacetylase activity,MF,SIN3B
9102,GO:0033558,0.455342377346225,0.878529369380675,1,40,protein deacetylase activity,MF,SIN3B
2187,GO:0004712,0.456077934353811,0.878091080251688,1,40,protein serine/threonine/tyrosine kinase activity,MF,AKT1
20697,GO:1990090,0.45618133779423,0.877908586010277,1,42,cellular response to nerve growth factor stimulus,BP,AKT1
12833,GO:0046850,0.456226728830094,0.877881475389602,1,42,regulation of bone remodeling,BP,CLDN18
5106,GO:0010921,0.45681898622386,0.800483729775993,2,101,regulation of phosphatase activity,BP,BMP2;CAMSAP3
15380,GO:0061134,0.456855768649573,0.759444517545689,3,207,peptidase regulator activity,MF,SERPINA5;CST9L;GAS6
10843,GO:0042461,0.457361903491043,0.877323657515516,1,40,photoreceptor cell development,BP,MYO7A
3161,GO:0006402,0.457741082324928,0.758650358607162,3,217,mRNA catabolic process,BP,PRR5L;PKP3;PKP1
3602,GO:0007029,0.457761178219941,0.877084401005886,1,40,endoplasmic reticulum organization,BP,REEP1
8622,GO:0032613,0.457820048149929,0.876816930070496,1,44,interleukin-10 production,BP,DLL1
3470,GO:0006821,0.457961286526679,0.799571586029477,2,103,chloride transport,BP,TTYH1;WNK4
3722,GO:0007223,0.458208889702317,0.876881404540069,1,39,Wnt signaling pathway, calcium modulating pathway,BP,WNT5A
7590,GO:0030815,0.458215252419323,0.876579397579219,1,44,negative regulation of cAMP metabolic process,BP,EDN1
10773,GO:0042345,0.458366781273536,0.876436564827183,1,45,regulation of NF-kappaB import into nucleus,BP,BMP7
10776,GO:0042348,0.458366781273536,0.876436564827183,1,45,NF-kappaB import into nucleus,BP,BMP7
12793,GO:0046717,0.459054881420975,0.79859313615492,2,111,acid secretion,BP,ADORA1;EDN1
18657,GO:1901028,0.459942010148158,0.87548617808639,1,45,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
3743,GO:0007266,0.460046808751752,0.757128819888872,3,165,Rho protein signal transduction,BP,ITGA3;RHOJ;RHOB
11316,GO:0043280,0.46006045764962,0.797788156979619,2,113,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;CTGF
6090,GO:0016746,0.460622463310139,0.730568144451422,4,247,transferase activity, transferring acyl groups,MF,FASN;HMGCS2;NMT2;MBOAT2
13947,GO:0051220,0.460758722774168,0.875098486231618,1,43,cytoplasmic sequestering of protein,BP,AKT1
947,GO:0002223,0.460763159970642,0.797157434966812,2,119,stimulatory C-type lectin receptor signaling pathway,BP,PRKACB;HRAS
4262,GO:0008631,0.461285203398995,0.874724513015623,1,44,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,AKT1
2535,GO:0005245,0.461340858303301,0.874863111464571,1,41,voltage-gated calcium channel activity,MF,GAS6
8790,GO:0032873,0.461676628465049,0.874659395840492,1,41,negative regulation of stress-activated MAPK cascade,BP,AKT1
15862,GO:0070303,0.461676628465049,0.874659395840492,1,41,negative regulation of stress-activated protein kinase signaling cascade,BP,AKT1
5932,GO:0016447,0.462500768321925,0.874040323536021,1,43,somatic recombination of immunoglobulin gene segments,BP,CLCF1
9608,GO:0034764,0.463360139564245,0.795256427942286,2,112,positive regulation of transmembrane transport,BP,ACTN2;KCNH2
15178,GO:0060761,0.463371069437889,0.873351104053671,1,46,negative regulation of response to cytokine stimulus,BP,GAS6
14077,GO:0051438,0.463502155381569,0.794984934795507,2,123,regulation of ubiquitin-protein transferase activity,BP,MAGEC2;AXIN1
13243,GO:0048483,0.463738475419126,0.873285115571,1,43,autonomic nervous system development,BP,GDNF
5730,GO:0016032,0.465844499458322,0.645985156421654,13,928,viral process,BP,ITGA5;NOTCH1;ITGB5;PMAIP1;NMT2;MFGE8;TYRO3;PIK3R1;CLDN1;GAS6;ACTA2;PIM2;EFNB2
627,GO:0001754,0.466000704372087,0.87201737486766,1,41,eye photoreceptor cell differentiation,BP,MYO7A
13794,GO:0050999,0.466714403021301,0.871348202394159,1,45,regulation of nitric-oxide synthase activity,BP,AKT1
16152,GO:0070849,0.466955527208557,0.871429317703031,1,41,response to epidermal growth factor,BP,AKT1
7584,GO:0030809,0.467576425474793,0.870815415563387,1,45,negative regulation of nucleotide biosynthetic process,BP,EDN1
18595,GO:1900372,0.467576425474793,0.870815415563387,1,45,negative regulation of purine nucleotide biosynthetic process,BP,EDN1
8198,GO:0031952,0.468312289159755,0.870655892626603,1,40,regulation of protein autophosphorylation,BP,PDGFB
945,GO:0002220,0.468326984643572,0.791254163107109,2,121,innate immune response activating cell surface receptor signaling pathway,BP,PRKACB;HRAS
6304,GO:0017156,0.468397297855969,0.791476314743395,2,104,calcium ion regulated exocytosis,BP,SYT5;NOTCH1
3706,GO:0007204,0.46850728227762,0.723642819760081,4,258,positive regulation of cytosolic calcium ion concentration,BP,CASQ2;EDN1;LPAR2;PIK3CG
12769,GO:0046677,0.469221561229028,0.869743074703814,1,46,response to antibiotic,BP,GJB2
13563,GO:0050661,0.469956992985106,0.869336883602999,1,45,NADP binding,MF,FASN
3347,GO:0006639,0.470413922736812,0.789646252708091,2,119,acylglycerol metabolic process,BP,PIK3CG;ACSL4
7575,GO:0030800,0.471496996106262,0.868322592369639,1,46,negative regulation of cyclic nucleotide metabolic process,BP,EDN1
5254,GO:0014743,0.472188396227758,0.868053383587877,1,43,regulation of muscle hypertrophy,BP,EDN1
12026,GO:0045104,0.473404237099937,0.867289632174933,1,43,intermediate filament cytoskeleton organization,BP,PKP1
5204,GO:0014047,0.473450382732812,0.867320918849878,1,42,glutamate secretion,BP,ADORA1
17062,GO:0072503,0.473669191043896,0.686586804665786,6,403,cellular divalent inorganic cation homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;PIK3CG;VDR
13702,GO:0050853,0.473694707669257,0.867049127109585,1,44,B cell receptor signaling pathway,BP,BCAR1
18666,GO:1901068,0.474177829585047,0.866636579238937,1,46,guanosine-containing compound metabolic process,BP,RHOQ
10903,GO:0042551,0.474200559469569,0.866848414922364,1,42,neuron maturation,BP,SPTBN4
13725,GO:0050879,0.474390058632968,0.866451985445573,1,47,multicellular organismal movement,BP,ACTN3
13727,GO:0050881,0.474390058632968,0.866451985445573,1,47,musculoskeletal movement,BP,ACTN3
17000,GO:0072330,0.474718360266471,0.74459701091899,3,185,monocarboxylic acid biosynthetic process,BP,FASN;EDN1;PTGES
3346,GO:0006638,0.475766709435962,0.785403754134303,2,120,neutral lipid metabolic process,BP,PIK3CG;ACSL4
17508,GO:0090280,0.476139860288377,0.865247613630113,1,49,positive regulation of calcium ion import,BP,PDGFB
371,GO:0000989,0.476269496817353,0.656882507261339,9,582,transcription factor activity, transcription factor binding,MF,LIF;WNT4;POU3F1;ACTN2;NOTCH1;NAB2;TLE1;SIN3B;ZCCHC12
16999,GO:0072329,0.477041341825292,0.784482489302786,2,114,monocarboxylic acid catabolic process,BP,SESN2;AKT1
3895,GO:0008022,0.477139036391875,0.742609737373288,3,176,protein C-terminus binding,MF,HRAS;CTGF;LAMA1
12040,GO:0045123,0.477497094059917,0.86453028125797,1,46,cellular extravasation,BP,PIK3CG
620,GO:0001736,0.478356975340471,0.783341814227236,2,120,establishment of planar polarity,BP,FZD7;WNT5A
3672,GO:0007164,0.478356975340471,0.783341814227236,2,120,establishment of tissue polarity,BP,FZD7;WNT5A
9023,GO:0033267,0.478566398726234,0.741406943588483,3,174,axon part,CC,ADORA1;SPTBN4;VAMP1
3040,GO:0006195,0.479108392298395,0.863500280002988,1,46,purine nucleotide catabolic process,BP,PDE4B
18982,GO:1901987,0.479352359236864,0.695406125182022,5,330,regulation of cell cycle phase transition,BP,GADD45A;FGF10;FOXO4;CDKN1A;AKT1
20696,GO:1990089,0.479847516630265,0.863080122556699,1,45,response to nerve growth factor,BP,AKT1
11235,GO:0043170,0.480464618211066,0.570902133811338,122,8633,macromolecule metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN2;TSPAN15;TSPAN17;NOTCH1;MARK4;RAB27A;ITGB8;PMAIP1;GADD45A;RHBDL3;FBXO41;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;NMT2;SALL4;ADORA1;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;VDR;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2
11682,GO:0044242,0.480753104421467,0.739400538802013,3,189,cellular lipid catabolic process,BP,SESN2;AKT1;PIK3CG
1045,GO:0002381,0.48162037245149,0.86188467317789,1,46,immunoglobulin production involved in immunoglobulin mediated immune response,BP,CLCF1
8473,GO:0032412,0.481786445785943,0.738552472922519,3,184,regulation of ion transmembrane transporter activity,BP,ACTN2;CASQ2;PDE4B
2517,GO:0005215,0.482033984661787,0.612766719932666,19,1294,transporter activity,MF,STRA6;TF;SLC45A4;SLC52A3;KCNK6;FLVCR2;SLC25A53;TTYH1;KCNH2;SLC2A14;SFXN1;GJB1;GJB2;GJA3;KCNG2;GAS6;SLC18B1;KCND1;CLDN16
12025,GO:0045103,0.482126012908068,0.861669417941819,1,44,intermediate filament-based process,BP,PKP1
13164,GO:0048260,0.482219155435015,0.861552262250864,1,45,positive regulation of receptor-mediated endocytosis,BP,TF
11697,GO:0044260,0.482386505728231,0.569113191056818,113,7982,cellular macromolecule metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN2;TSPAN17;NOTCH1;MARK4;PMAIP1;GADD45A;FBXO41;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;ACVR1;NMT2;SALL4;ADORA1;DKK3;EDN1;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;VDR;ARAF;UNC119;RAB3D;GDNF;FZD8;DUSP5;HEY1;RNF144A;PIM2
21042,GO:2000179,0.483109037015023,0.861093221876252,1,43,positive regulation of neural precursor cell proliferation,BP,NOTCH1
11625,GO:0044088,0.483743865802744,0.860621645164583,1,44,regulation of vacuole organization,BP,RALB
13691,GO:0050830,0.48447365704854,0.859312964703684,1,65,defense response to Gram-positive bacterium,BP,CHGA
17113,GO:0072577,0.484686633948978,0.859896220316386,1,46,endothelial cell apoptotic process,BP,GAS6
13808,GO:0051018,0.485290787064129,0.859738725119352,1,42,protein kinase A binding,MF,PRKAR1B
2659,GO:0005544,0.486859138326018,0.858476425832437,1,46,calcium-dependent phospholipid binding,MF,SYT5
4810,GO:0010468,0.486944122897953,0.572223364517105,61,4258,regulation of gene expression,BP,ITGA3;LIF;WNT3;WNT2;WNT4;POU3F1;NOTCH1;RAB27A;ITGB8;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;PRKACB;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;MSN;CTGF;AKT1;PKP3;PKP1;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;SHC4;VDR;GDNF;FZD8;HEY1;ACTA2;PIM2
3745,GO:0007268,0.487350849459208,0.646416030528898,9,584,chemical synaptic transmission,BP,SYT5;WNT7A;ADORA1;EDN1;HRAS;AKT1;LZTS1;UNC119;GDNF
18240,GO:0098916,0.487350849459208,0.646416030528898,9,584,anterograde trans-synaptic signaling,BP,SYT5;WNT7A;ADORA1;EDN1;HRAS;AKT1;LZTS1;UNC119;GDNF
12774,GO:0046686,0.487566725752482,0.857602682086462,1,55,response to cadmium ion,BP,AKT1
3958,GO:0008134,0.487923646303981,0.653380244892824,8,517,transcription factor binding,MF,ZFPM1;PIK3R1;FOXO4;DLL1;NAB2;TLE1;VDR;HEY1
14004,GO:0051297,0.488096884222666,0.775676736389689,2,109,centrosome organization,BP,RAB6C;GADD45A
961,GO:0002250,0.488490594366317,0.687041263457314,5,338,adaptive immune response,BP,RAB27A;HRAS;JAM3;CLCF1;PIK3CG
4107,GO:0008375,0.488652586631819,0.857353365379161,1,45,acetylglucosaminyltransferase activity,MF,B3GNT2
18986,GO:1901991,0.488712919744242,0.732474970112855,3,194,negative regulation of mitotic cell cycle phase transition,BP,GADD45A;FOXO4;CDKN1A
4106,GO:0008374,0.488914907311937,0.857124526916583,1,46,O-acyltransferase activity,MF,MBOAT2
13607,GO:0050710,0.48945857809813,0.856660565589501,1,48,negative regulation of cytokine secretion,BP,GAS6
15584,GO:0061640,0.490022867663338,0.856507441804199,1,44,cytoskeleton-dependent cytokinesis,BP,SNX18
9681,GO:0035094,0.490149900167433,0.85625463985441,1,47,response to nicotine,BP,EDN1
3756,GO:0007286,0.490611892208298,0.773371898934536,2,125,spermatid development,BP,DHH;JAM3
8584,GO:0032559,0.490644568534334,0.596699559992494,23,1461,adenyl ribonucleotide binding,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;PRKAR1B;KHK;NPR1;NUAK2;PFKFB3;PKN3;WNK4;DDR1;AKT1;MYO7A;PIK3CA;PIK3CG;MYH11;ARAF;ACSL4;ACTA2;PIM2;PDE4B
6677,GO:0019730,0.491650981846137,0.854252150397913,1,79,antimicrobial humoral response,BP,CHGA
21646,GO:2001244,0.491740667739718,0.854917027025727,1,53,positive regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1
12713,GO:0046580,0.491970802945974,0.855277523682032,1,43,negative regulation of Ras protein signal transduction,BP,ITGA3
8451,GO:0032387,0.491987028886627,0.772349903436656,2,118,negative regulation of intracellular transport,BP,BMP7;GAS6
18335,GO:0099536,0.492010654952981,0.641982485339957,9,586,synaptic signaling,BP,SYT5;WNT7A;ADORA1;EDN1;HRAS;AKT1;LZTS1;UNC119;GDNF
18336,GO:0099537,0.492010654952981,0.641982485339957,9,586,trans-synaptic signaling,BP,SYT5;WNT7A;ADORA1;EDN1;HRAS;AKT1;LZTS1;UNC119;GDNF
1397,GO:0003044,0.493254835955134,0.854136951085708,1,48,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,EDN1
1170,GO:0002637,0.493451542385535,0.853861122764031,1,51,regulation of immunoglobulin production,BP,CLCF1
11383,GO:0043401,0.493468764924061,0.728455415634878,3,178,steroid hormone mediated signaling pathway,BP,BMP7;BMP4;VDR
13275,GO:0048538,0.493548583525089,0.854104202200824,1,45,thymus development,BP,FGF10
9510,GO:0034605,0.493960323816227,0.770865374812068,2,110,cellular response to heat,BP,SLC52A3;CDKN1A
12679,GO:0046503,0.49469974843349,0.852895217633606,1,54,glycerolipid catabolic process,BP,PIK3CG
2908,GO:0005978,0.495016983632303,0.853063319604176,1,46,glycogen biosynthetic process,BP,AKT1
4506,GO:0009250,0.495016983632303,0.853063319604176,1,46,glucan biosynthetic process,BP,AKT1
17385,GO:0090102,0.495205976899894,0.852993687842607,1,45,cochlea development,BP,WNT5A
6052,GO:0016667,0.495503760294476,0.852354001466532,1,54,oxidoreductase activity, acting on a sulfur group of donors,MF,SESN2
2637,GO:0005507,0.496331602765128,0.851795414749751,1,54,copper ion binding,MF,PRND
7277,GO:0030170,0.496403026483201,0.852075571541087,1,47,pyridoxal phosphate binding,MF,GLDC
15848,GO:0070279,0.496403026483201,0.852075571541087,1,47,vitamin B6 binding,MF,GLDC
14565,GO:0055010,0.496682392004859,0.851887077075532,1,47,ventricular cardiac muscle tissue morphogenesis,BP,NOTCH1
8370,GO:0032269,0.496844893694196,0.612513729352622,14,986,negative regulation of cellular protein metabolic process,BP,LIF;GADD45A;SERPINA5;EDN1;PRR5L;PRKAR1B;SESN2;BMP7;BMP4;CDKN1A;AKT1;CST9L;GAS6;DUSP5
13365,GO:0048701,0.497901499575441,0.851176058205077,1,45,embryonic cranial skeleton morphogenesis,BP,BMP4
5004,GO:0010803,0.499083914107887,0.850106736164718,1,50,regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
7156,GO:0022898,0.499283206939021,0.72323008530969,3,190,regulation of transmembrane transporter activity,BP,ACTN2;CASQ2;PDE4B
17504,GO:0090276,0.499837385011434,0.722731395918732,3,191,regulation of peptide hormone secretion,BP,ADRA2C;INHBB;KCNG2
9629,GO:0034976,0.50011582757667,0.695395647814785,4,254,response to endoplasmic reticulum stress,BP,PMAIP1;PIK3R2;PIK3R1;SESN2
13845,GO:0051058,0.50042412890442,0.849523156631818,1,44,negative regulation of small GTPase mediated signal transduction,BP,ITGA3
6805,GO:0020037,0.501151369501756,0.764697353261322,2,123,heme binding,MF,GUCY1B3;FLVCR2
8688,GO:0032722,0.501489592121193,0.848464345364015,1,50,positive regulation of chemokine production,BP,WNT5A
7985,GO:0031503,0.501497422759512,0.764469730216302,2,119,protein complex localization,BP,RALB;BMP7
72,GO:0000149,0.501985668092961,0.764144677742821,2,114,SNARE binding,MF,SYT5;VAMP1
5930,GO:0016445,0.502298170752365,0.848011235142613,1,48,somatic diversification of immunoglobulins,BP,CLCF1
14015,GO:0051310,0.502619073769087,0.847790886199298,1,48,metaphase plate congression,BP,PSRC1
484,GO:0001505,0.502892686000664,0.720115081866118,3,180,regulation of neurotransmitter levels,BP,SYT5;WNT7A;GDNF
12549,GO:0046148,0.503145480781869,0.847279250044378,1,51,pigment biosynthetic process,BP,WNT5A
21562,GO:2001056,0.504115456975661,0.762232851816038,2,122,positive regulation of cysteine-type endopeptidase activity,BP,PMAIP1;CTGF
7496,GO:0030554,0.504294663397054,0.583308447683383,23,1472,adenyl nucleotide binding,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;PRKAR1B;KHK;NPR1;NUAK2;PFKFB3;PKN3;WNK4;DDR1;AKT1;MYO7A;PIK3CA;PIK3CG;MYH11;ARAF;ACSL4;ACTA2;PIM2;PDE4B
7978,GO:0031491,0.504602599471226,0.846372084724394,1,49,nucleosome binding,MF,HMGN5
6587,GO:0019369,0.50481971615964,0.846123588335443,1,51,arachidonic acid metabolic process,BP,PTGES
14672,GO:0060042,0.505453291392901,0.845947519724008,1,46,retina morphogenesis in camera-type eye,BP,DLL1
3729,GO:0007249,0.505589418194329,0.69034668078251,4,260,I-kappaB kinase/NF-kappaB signaling,BP,BMP7;AKT1;TLE1;PIM2
5835,GO:0016247,0.505702187534466,0.760869908052312,2,124,channel regulator activity,MF,TSPAN13;WNK4
7769,GO:0031102,0.505812914980219,0.845534125570868,1,49,neuron projection regeneration,BP,JAM3
2312,GO:0004879,0.505940523561476,0.845610007375746,1,46,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,VDR
18053,GO:0098531,0.505940523561476,0.845610007375746,1,46,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,VDR
3393,GO:0006695,0.506353015885192,0.84510876503347,1,50,cholesterol biosynthetic process,BP,HMGCS2
21640,GO:2001238,0.506798736635802,0.844798862247415,1,50,positive regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1
10727,GO:0042267,0.507067565004691,0.844471439787169,1,53,natural killer cell mediated cytotoxicity,BP,RAB27A
6683,GO:0019748,0.507569398508991,0.84416655876505,1,52,secondary metabolic process,BP,WNT5A
10645,GO:0042093,0.507676229850342,0.844187585788637,1,50,T-helper cell differentiation,BP,ZFPM1
11375,GO:0043392,0.508339758926072,0.843675483343402,1,51,negative regulation of DNA binding,BP,HEY1
7807,GO:0031201,0.508433445736142,0.843609985364977,1,51,SNARE complex,CC,VAMP1
12727,GO:0046605,0.509202540584292,0.843280215715732,1,47,regulation of centrosome cycle,BP,RAB6C
3150,GO:0006383,0.50955388457394,0.842825293383524,1,51,transcription from RNA polymerase III promoter,BP,NAB2
12738,GO:0046626,0.509844290183993,0.842775025896896,1,48,regulation of insulin receptor signaling pathway,BP,PIK3R1
11710,GO:0044281,0.510660735783616,0.571018467189721,27,1974,small molecule metabolic process,BP,WNT4;ACTN3;GLDC;FASN;PMAIP1;SLC52A3;HMGCS2;GUCY1B3;DKK3;EDN1;WNT5A;KHK;SESN2;RHOQ;NPR1;PFKFB3;BMP6;BMP2;B3GNT2;CHGA;AKT1;PTGES;NPPC;PIK3CA;VDR;ACSL4;PDE4B
19545,GO:1903313,0.510980726362439,0.841923011665678,1,49,positive regulation of mRNA metabolic process,BP,PRR5L
2546,GO:0005261,0.511308142166069,0.665932542152028,5,312,cation channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
17076,GO:0072523,0.511705253843037,0.841360924777705,1,50,purine-containing compound catabolic process,BP,PDE4B
19255,GO:1902653,0.511747825025749,0.841281414847532,1,51,secondary alcohol biosynthetic process,BP,HMGCS2
11197,GO:0043113,0.511821300714826,0.8414401616926,1,47,receptor clustering,BP,CDH2
14330,GO:0051926,0.511883413293858,0.841092324575951,1,53,negative regulation of calcium ion transport,BP,CASQ2
4993,GO:0010769,0.512163572505143,0.684365443587792,4,244,regulation of cell morphogenesis involved in differentiation,BP,WNT3;WNT7A;WNT5A;LZTS1
9280,GO:0034121,0.512352805969486,0.84100893080463,1,48,regulation of toll-like receptor signaling pathway,BP,TYRO3
13695,GO:0050840,0.512691535523566,0.840769471471301,1,48,extracellular matrix binding,MF,ITGA3
13260,GO:0048515,0.512936334556262,0.754654583805747,2,130,spermatid differentiation,BP,DHH;JAM3
18983,GO:1901988,0.512973469749143,0.710894544521061,3,202,negative regulation of cell cycle phase transition,BP,GADD45A;FOXO4;CDKN1A
5029,GO:0010830,0.513314198837777,0.84012533694049,1,52,regulation of myotube differentiation,BP,NOTCH1
8316,GO:0032154,0.513857053794422,0.839943740410676,1,48,cleavage furrow,CC,RHOB
17991,GO:0097610,0.513857053794422,0.839943740410676,1,48,cell surface furrow,CC,RHOB
7534,GO:0030660,0.513874762688466,0.839825196659103,1,50,Golgi-associated vesicle membrane,CC,RHOQ
19680,GO:1903578,0.514870100784514,0.839019268598312,1,52,regulation of ATP metabolic process,BP,ACTN3
7221,GO:0030073,0.515168792077355,0.708977898652352,3,193,insulin secretion,BP,ADRA2C;INHBB;KCNG2
4832,GO:0010518,0.515229753953181,0.838861165092743,1,50,positive regulation of phospholipase activity,BP,LPAR2
3514,GO:0006891,0.51699083425678,0.837766818825499,1,47,intra-Golgi vesicle-mediated transport,BP,RAB6C
19631,GO:1903506,0.51710969153075,0.54659118875226,50,3489,regulation of nucleic acid-templated transcription,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
988,GO:0002294,0.517802938769358,0.836920864946306,1,52,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,ZFPM1
3478,GO:0006836,0.518028280244706,0.70646697343399,3,183,neurotransmitter transport,BP,SYT5;WNT7A;GDNF
6279,GO:0017112,0.518061170499484,0.836887252856897,1,49,Rab guanyl-nucleotide exchange factor activity,MF,RIN3
18225,GO:0098900,0.518317048964663,0.836758302029007,1,48,regulation of action potential,BP,DSC2
5147,GO:0010977,0.518574118125671,0.74999971755011,2,118,negative regulation of neuron projection development,BP,WNT3;WNT5A
7720,GO:0031023,0.518953675925742,0.749723999921118,2,115,microtubule organizing center organization,BP,RAB6C;GADD45A
15294,GO:0060997,0.519615799524707,0.835940691008769,1,46,dendritic spine morphogenesis,BP,WNT7A
9576,GO:0034707,0.519632549123904,0.835702697948404,1,50,chloride channel complex,CC,TTYH1
8656,GO:0032663,0.520175756061523,0.835310243017003,1,50,regulation of interleukin-2 production,BP,PDE4B
6816,GO:0021515,0.520600022364041,0.834903082350646,1,52,cell differentiation in spinal cord,BP,NOTCH1
17871,GO:0097345,0.521127343327102,0.834473518402086,1,53,mitochondrial outer membrane permeabilization,BP,PMAIP1
8620,GO:0032611,0.521308842693488,0.834209860920571,1,56,interleukin-1 beta production,BP,WNT5A
13622,GO:0050727,0.522712767255341,0.67431665297445,4,280,regulation of inflammatory response,BP,ADORA1;TYRO3;WNT5A;PIK3CG
5872,GO:0016311,0.523421200553419,0.639892441858479,6,389,dephosphorylation,BP,ADORA1;PTPN7;PFKFB3;BMP2;CAMSAP3;DUSP5
7152,GO:0022890,0.523883577613884,0.618817026132325,8,540,inorganic cation transmembrane transporter activity,MF,TF;KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1;CLDN16
17065,GO:0072507,0.524036222194356,0.639205050980234,6,422,divalent inorganic cation homeostasis,BP,CDH23;CASQ2;EDN1;LPAR2;PIK3CG;VDR
13674,GO:0050806,0.525254190799685,0.744153719315685,2,121,positive regulation of synaptic transmission,BP,WNT7A;ADORA1
983,GO:0002287,0.525393698167866,0.831359139978475,1,53,alpha-beta T cell activation involved in immune response,BP,ZFPM1
987,GO:0002293,0.525393698167866,0.831359139978475,1,53,alpha-beta T cell differentiation involved in immune response,BP,ZFPM1
6026,GO:0016614,0.52576644268411,0.743502967324567,2,135,oxidoreductase activity, acting on CH-OH group of donors,MF,FASN;BMP2
13120,GO:0048168,0.525995314727567,0.831177999133524,1,48,regulation of neuronal synaptic plasticity,BP,HRAS
5066,GO:0010876,0.527284152624161,0.650627609686081,5,341,lipid localization,BP,SERPINA5;EDN1;BMP6;AKT1;ACSL4
19036,GO:1902110,0.527747923990088,0.829577610164369,1,54,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
19267,GO:1902686,0.527747923990088,0.829577610164369,1,54,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,PMAIP1
143,GO:0000287,0.52782368404596,0.697419627143209,3,190,magnesium ion binding,MF,PRKACB;MAPK12;NUAK2
16747,GO:0071897,0.527832304592793,0.697411660321065,3,190,DNA biosynthetic process,BP,PDGFB;CDKN1A;CTGF
9669,GO:0035065,0.527845537225114,0.829703456346272,1,50,regulation of histone acetylation,BP,LIF
9912,GO:0035580,0.528457641013885,0.828804321722583,1,60,specific granule lumen,CC,RAB27A
1654,GO:0003824,0.52887026695673,0.526371099325166,78,5495,catalytic activity,MF,TUBG2;RAB6C;TSPAN17;GLDC;MARK4;RAB27A;PNMT;RASL11B;FASN;RHBDL3;FBXO41;DHH;HMGCS2;ACVR1;NMT2;GUCY1B3;ADORA1;PLAU;RAB40B;RAB40A;PRKACB;MBOAT2;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;FGF10;FGF17;PIK3R2;PIK3R1;CGN;PDGFB;KCNH2;PTPN7;RALB;HRAS;KHK;SESN2;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;FGF8;HBEGF;BMP2;B3GNT2;CDKN1A;PKN3;RAB20;WNK4;RND3;DDR1;RRAD;AKT1;RAB12;RAB17;PTGES;KITLG;MYO7A;SPSB1;RAB44;PIK3CA;PIK3CG;SIN3B;DTX4;MYH11;PM20D2;ARAF;RAB38;RAB3D;ACSL4;DUSP5;RNF144A;PIM2;PDE4B
6284,GO:0017124,0.529084912147359,0.740846358593388,2,118,SH3 domain binding,MF,ESPN;BCAR1
21580,GO:2001141,0.529927068147339,0.533783931835063,50,3508,regulation of RNA biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
17250,GO:0086010,0.530809890280554,0.827616025443133,1,48,membrane depolarization during action potential,BP,KCNH2
13934,GO:0051193,0.532522038212352,0.826119629223315,1,52,regulation of cofactor metabolic process,BP,ACTN3
13937,GO:0051196,0.532522038212352,0.826119629223315,1,52,regulation of coenzyme metabolic process,BP,ACTN3
12389,GO:0045861,0.532523795820188,0.664920871491167,4,304,negative regulation of proteolysis,BP,SERPINA5;AKT1;CST9L;GAS6
13916,GO:0051171,0.533004884407956,0.526744255799676,60,4223,regulation of nitrogen compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
19488,GO:1903201,0.533214013747886,0.825503597188062,1,54,regulation of oxidative stress-induced cell death,BP,AKT1
8712,GO:0032760,0.5336403604425,0.825050261875544,1,57,positive regulation of tumor necrosis factor production,BP,PIK3R1
1142,GO:0002562,0.533749689340518,0.825198132509852,1,52,somatic diversification of immune receptors via germline recombination within a single locus,BP,CLCF1
5929,GO:0016444,0.533749689340518,0.825198132509852,1,52,somatic cell DNA recombination,BP,CLCF1
10682,GO:0042157,0.533769566917676,0.691763091281582,3,207,lipoprotein metabolic process,BP,NMT2;PRKACB;PRND
1502,GO:0003229,0.533876259617703,0.825102944001579,1,52,ventricular cardiac muscle tissue development,BP,NOTCH1
5780,GO:0016126,0.534676884753667,0.824356431243927,1,55,sterol biosynthetic process,BP,HMGCS2
951,GO:0002228,0.534716334840632,0.824239356975894,1,57,natural killer cell mediated immunity,BP,RAB27A
11403,GO:0043433,0.534971491311861,0.735494248320739,2,127,negative regulation of sequence-specific DNA binding transcription factor activity,BP,BMP7;GAS6
13192,GO:0048306,0.535119283389442,0.823814864091662,1,60,calcium-dependent protein binding,MF,CASQ2
7775,GO:0031110,0.536723135930872,0.822902836024756,1,53,regulation of microtubule polymerization or depolymerization,BP,PSRC1
11413,GO:0043462,0.537351954912499,0.82208373543371,1,61,regulation of ATPase activity,BP,FGF10
10660,GO:0042116,0.53749596202629,0.822176318064395,1,56,macrophage activation,BP,WNT5A
6532,GO:0019213,0.537553177663133,0.822322724394713,1,52,deacetylase activity,MF,SIN3B
11273,GO:0043226,0.537704124224003,0.519955929118251,174,12482,organelle,CC,ITGA3;ITGA5;FHOD3;BEX4;TMEM163;ADRA2C;SYT5;WNT3;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;CDH23;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;NMT2;SALL4;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;PRKACB;MFGE8;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NUAK2;PFKFB3;PSRC1;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP2;CAMSAP3;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;DRP2;SLC2A14;ESPN;VAMP1;SFXN1;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;WNT2B;CYTIP;PTGES;KITLG;NPPC;NAB2;CDH1;EPN1;MYO7A;BCAR1;HPCAL1;RAB44;TLE1;CLDN2;CLDN3;CLDN5;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;ZCCHC12;MYH11;LZTS1;PM20D2;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;CLDN11;RNF144A;PARVB;PDE4B
11426,GO:0043488,0.537841496372238,0.732806792781034,2,136,regulation of mRNA stability,BP,AKT1;GDNF
11791,GO:0044420,0.537942997832071,0.733043414494587,2,115,extracellular matrix component,CC,LAMA1;LAMA5
6033,GO:0016627,0.538314702687027,0.821552856879925,1,56,oxidoreductase activity, acting on the CH-CH group of donors,MF,FASN
12867,GO:0046906,0.539311133497446,0.73154428154191,2,132,tetrapyrrole binding,MF,GUCY1B3;FLVCR2
10057,GO:0035794,0.539983280312463,0.820277780697286,1,56,positive regulation of mitochondrial membrane permeability,BP,PMAIP1
2883,GO:0005929,0.540690349963434,0.61155674722283,7,479,cilium,CC,MARK4;RAB27A;PRKACB;SPTBN5;PRKAR1B;AKT1;MYO7A
20597,GO:1905710,0.54205646028151,0.818641151835862,1,57,positive regulation of membrane permeability,BP,PMAIP1
4669,GO:0009889,0.542649380902653,0.517388815014379,59,4178,regulation of biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;DHH;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;CCL20;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;NPPC;NAB2;CDH1;INHBB;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
8470,GO:0032409,0.544255616390793,0.681934414608677,3,203,regulation of transporter activity,BP,ACTN2;CASQ2;PDE4B
4897,GO:0010633,0.544353177871933,0.817003441845497,1,54,negative regulation of epithelial cell migration,BP,NOTCH1
14300,GO:0051881,0.544717992581826,0.816458195821149,1,60,regulation of mitochondrial membrane potential,BP,PMAIP1
11580,GO:0043966,0.545186013174922,0.816357112318172,1,54,histone H3 acetylation,BP,LIF
8782,GO:0032846,0.545246708996416,0.680994491161389,3,203,positive regulation of homeostatic process,BP,CASQ2;EDN1;NPR1
6582,GO:0019362,0.546176217152959,0.725388442261556,2,129,pyridine nucleotide metabolic process,BP,ACTN3;PFKFB3
12673,GO:0046496,0.546176217152959,0.725388442261556,2,129,nicotinamide nucleotide metabolic process,BP,ACTN3;PFKFB3
4588,GO:0009584,0.547480187729687,0.814568840969247,1,54,detection of visible light,BP,NMT2
15706,GO:0070059,0.548270919468234,0.813901507052389,1,55,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PMAIP1
19668,GO:1903557,0.548478131236053,0.81356217600603,1,59,positive regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1
2812,GO:0005813,0.548905706872366,0.603439709121062,7,467,centrosome,CC,TUBG2;RAB6C;MARK4;PRKACB;CAMSAP3;UNC119;PDE4B
11515,GO:0043621,0.551053376768613,0.81181112088566,1,53,protein self-association,MF,SPTBN5
7135,GO:0022836,0.552149415949049,0.62646906910462,5,327,gated channel activity,MF,KCNK6;KCNH2;KCNG2;GAS6;KCND1
8662,GO:0032677,0.552572584286066,0.810288579937585,1,60,regulation of interleukin-8 production,BP,WNT5A
21434,GO:2000756,0.552647558652528,0.810498472925379,1,54,regulation of peptidyl-lysine acetylation,BP,LIF
13419,GO:0048813,0.552842598162096,0.71947397135181,2,118,dendrite morphogenesis,BP,WNT7A;LZTS1
6145,GO:0016835,0.552972873706571,0.809892245021596,1,62,carbon-oxygen lyase activity,MF,FASN
15908,GO:0070373,0.555245667995294,0.808429524551903,1,54,negative regulation of ERK1 and ERK2 cascade,BP,LIF
14928,GO:0060401,0.555478180851054,0.716845253601917,2,130,cytosolic calcium ion transport,BP,CASQ2;CTGF
4354,GO:0009060,0.555486845426422,0.80784820571301,1,63,aerobic respiration,BP,ACTN3
19008,GO:1902041,0.556524689027228,0.807307946870345,1,56,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1
5125,GO:0010950,0.556569720854517,0.715748568967937,2,136,positive regulation of endopeptidase activity,BP,PMAIP1;CTGF
3160,GO:0006401,0.556636490580736,0.669808452575342,3,246,RNA catabolic process,BP,PRR5L;PKP3;PKP1
12139,GO:0045333,0.558141237528811,0.713961242216243,2,165,cellular respiration,BP,ACTN3;PIK3CA
10467,GO:0038083,0.559006213879575,0.805514027998922,1,52,peptidyl-tyrosine autophosphorylation,BP,DDR1
3132,GO:0006355,0.559501542989126,0.504458045829765,49,3465,regulation of transcription, DNA-templated,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
5675,GO:0015909,0.560067465390441,0.804193396933973,1,62,long-chain fatty acid transport,BP,AKT1
2791,GO:0005778,0.560100746791989,0.804377319366714,1,57,peroxisomal membrane,CC,ACSL4
8174,GO:0031903,0.560100746791989,0.804377319366714,1,57,microbody membrane,CC,ACSL4
19034,GO:1902108,0.561206678458397,0.803390421820314,1,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
680,GO:0001824,0.561731121428229,0.803007313787241,1,58,blastocyst development,BP,SALL4
986,GO:0002292,0.562156995367528,0.802616373406574,1,59,T cell differentiation involved in immune response,BP,ZFPM1
4473,GO:0009205,0.564155070357382,0.662493180165561,3,248,purine ribonucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
12771,GO:0046683,0.564287176578455,0.708645764466882,2,129,response to organophosphorus,BP,WT1;PIK3CG
8628,GO:0032623,0.564351025160412,0.800911366667287,1,57,interleukin-2 production,BP,PDE4B
1087,GO:0002460,0.565645530796292,0.66125583290832,3,213,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,RAB27A;HRAS;CLCF1
5846,GO:0016266,0.565720629508983,0.799882647048668,1,55,O-glycan processing,BP,B3GNT2
15672,GO:0065003,0.565844543320985,0.523333337552872,22,1645,macromolecular complex assembly,BP,FHOD3;TUBG2;ACTN2;PMAIP1;CASQ2;SPTBN5;SPTBN4;PRND;RALB;HRAS;AXIN1;PSRC1;SPTB;VAMP1;MSN;GJB1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;KCND1
6774,GO:0019935,0.566443122639481,0.799099654855898,1,59,cyclic-nucleotide-mediated signaling,BP,GUCY1B3
5946,GO:0016482,0.566984305069387,0.706151282033262,2,126,cytosolic transport,BP,RAB6C;MSN
3327,GO:0006612,0.567414549233733,0.705143748904911,2,178,protein targeting to membrane,BP,ADORA1;GAS6
21644,GO:2001242,0.567700758674786,0.705216241840998,2,144,regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1;AKT1
7197,GO:0030032,0.567828040405318,0.798142871095308,1,55,lamellipodium assembly,BP,PARVB
3510,GO:0006886,0.568604850402544,0.537584534241876,15,1108,intracellular protein transport,BP,RAB27A;ADORA1;FZD7;PRR5L;PIK3R2;PIK3R1;RHOB;BMP7;BMP6;BMP4;CDKN1A;AKT1;CDH1;MYO7A;GAS6
17077,GO:0072524,0.568609231648113,0.704490203594868,2,134,pyridine-containing compound metabolic process,BP,ACTN3;PFKFB3
3520,GO:0006898,0.5687478518936,0.629689840580374,4,278,receptor-mediated endocytosis,BP,SYT5;TF;DLL1;UNC119
11706,GO:0044272,0.569320687125709,0.657678377955228,3,209,sulfur compound biosynthetic process,BP,FASN;B3GNT2;ACSL4
13348,GO:0048678,0.569961774711232,0.796054878040503,1,62,response to axon injury,BP,JAM3
7892,GO:0031334,0.570270284324007,0.656735381305467,3,210,positive regulation of protein complex assembly,BP,PMAIP1;PSRC1;MSN
5736,GO:0016042,0.570442280332395,0.627908819191605,4,296,lipid catabolic process,BP,ADORA1;SESN2;AKT1;PIK3CG
4438,GO:0009165,0.57285350116191,0.625434467143174,4,309,nucleotide biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
11315,GO:0043279,0.572967214422153,0.700298877429215,2,137,response to alkaloid,BP,CASQ2;EDN1
10921,GO:0042578,0.573342502772279,0.605221441055625,5,340,phosphoric ester hydrolase activity,MF,ADORA1;PTPN7;PFKFB3;DUSP5;PDE4B
1097,GO:0002479,0.573745546335926,0.792475809658819,1,74,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGB5
3229,GO:0006497,0.574408336944327,0.698864988979611,2,141,protein lipidation,BP,NMT2;PRND
5975,GO:0016529,0.574427761734236,0.792435433070722,1,59,sarcoplasmic reticulum,CC,CASQ2
11425,GO:0043487,0.574996709936834,0.698261775769448,2,144,regulation of RNA stability,BP,AKT1;GDNF
12018,GO:0045087,0.57510870888692,0.553116879671224,10,808,innate immune response,BP,RAB27A;EDN1;PRKACB;CCL20;TYRO3;HRAS;WNT5A;CHGA;CLDN1;PIK3CG
18387,GO:0101003,0.575113489929131,0.791811975877438,1,60,ficolin-1-rich granule membrane,CC,PKP1
939,GO:0002200,0.575479478035141,0.791592360187022,1,58,somatic diversification of immune receptors,BP,CLCF1
1238,GO:0002718,0.576464759271458,0.790542414795967,1,63,regulation of cytokine production involved in immune response,BP,WNT5A
6091,GO:0016747,0.577824500245618,0.649238878518281,3,211,transferase activity, transferring acyl groups other than amino-acyl groups,MF,FASN;NMT2;MBOAT2
3071,GO:0006261,0.579001889989713,0.694571150995355,2,132,DNA-dependent DNA replication,BP,BMP6;BMP4
18011,GO:0097659,0.579964613707664,0.482691854617233,51,3636,nucleic acid-templated transcription,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
2814,GO:0005815,0.579991574457151,0.554823223117727,9,620,microtubule organizing center,CC,TUBG2;RAB6C;MARK4;PRKACB;CAMSAP3;AKT1;UNC119;FAM110B;PDE4B
8315,GO:0032153,0.580033698938581,0.78776203232806,1,57,cell division site,CC,RHOB
8317,GO:0032155,0.580033698938581,0.78776203232806,1,57,cell division site part,CC,RHOB
18753,GO:1901293,0.58066834675648,0.61753235144262,4,312,nucleoside phosphate biosynthetic process,BP,GUCY1B3;EDN1;NPR1;NPPC
4831,GO:0010517,0.581140536442889,0.786672265618024,1,60,regulation of phospholipase activity,BP,LPAR2
3868,GO:0007612,0.581270382120538,0.692436979916145,2,128,learning,BP,STRA6;CLDN5
3747,GO:0007270,0.582881833714339,0.690807182094177,2,132,neuron-neuron synaptic transmission,BP,ADORA1;GDNF
4418,GO:0009144,0.583314590173453,0.643462913700255,3,255,purine nucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
4467,GO:0009199,0.583342023625445,0.64344059291285,3,254,ribonucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
14360,GO:0051966,0.583610466778459,0.784633437117511,1,58,regulation of synaptic transmission, glutamatergic,BP,ADORA1
15271,GO:0060968,0.583635992540852,0.784351599560243,1,64,regulation of gene silencing,BP,BMP4
4705,GO:0009988,0.584024606097079,0.784014726803747,1,64,cell-cell recognition,BP,MSN
10667,GO:0042129,0.584385880174406,0.689133349292266,2,147,regulation of T cell proliferation,BP,SDC4;BMP4
336,GO:0000922,0.584842578919399,0.688910176872842,2,131,spindle pole,CC,PSRC1;UNC119
10932,GO:0042590,0.586021223488114,0.781851708661948,1,77,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,ITGB5
5813,GO:0016209,0.586301505681694,0.781553646441276,1,79,antioxidant activity,MF,SESN2
14775,GO:0060193,0.586898878451317,0.781552117002883,1,63,positive regulation of lipase activity,BP,LPAR2
8635,GO:0032637,0.588092111056023,0.780389887830287,1,66,interleukin-8 production,BP,WNT5A
2943,GO:0006027,0.588347075609444,0.780413081709811,1,60,glycosaminoglycan catabolic process,BP,SDC4
7353,GO:0030276,0.588505764864021,0.780367627361434,1,58,clathrin binding,MF,SYT5
7905,GO:0031348,0.588648494676988,0.684991426319179,2,144,negative regulation of defense response,BP,ADORA1;TYRO3
1627,GO:0003707,0.588743352429162,0.780159118912211,1,58,steroid hormone receptor activity,MF,VDR
4439,GO:0009166,0.589287640031756,0.779416619334119,1,64,nucleotide catabolic process,BP,PDE4B
364,GO:0000979,0.58938510299561,0.779547411166193,1,59,RNA polymerase II core promoter sequence-specific DNA binding,MF,ZFPM1
486,GO:0001508,0.589585593511284,0.684254803661798,2,131,action potential,BP,DSC2;KCNH2
8277,GO:0032088,0.58966146949484,0.779087469991905,1,64,negative regulation of NF-kappaB transcription factor activity,BP,BMP7
14359,GO:0051965,0.589950843516213,0.779146889865397,1,57,positive regulation of synapse assembly,BP,WNT7A
18978,GO:1901983,0.590203433428634,0.778735655854363,1,61,regulation of protein acetylation,BP,LIF
635,GO:0001764,0.590693527782276,0.683177342655553,2,130,neuron migration,BP,ITGA3;GAS6
3105,GO:0006305,0.592632846118983,0.776677852380071,1,59,DNA alkylation,BP,PIK3CA
3106,GO:0006306,0.592632846118983,0.776677852380071,1,59,DNA methylation,BP,PIK3CA
10833,GO:0042440,0.592771151904303,0.77625805460097,1,66,pigment metabolic process,BP,WNT5A
3233,GO:0006501,0.592983589930886,0.775960355155217,1,69,C-terminal protein lipidation,BP,PRND
6230,GO:0017016,0.59442936460401,0.603657148876026,4,268,Ras GTPase binding,MF,RIN3;DAAM2;RAB11FIP1;SH3BP4
4386,GO:0009108,0.594784448398547,0.678929056744965,2,143,coenzyme biosynthetic process,BP,FASN;ACSL4
11356,GO:0043367,0.595142676664515,0.774263462974835,1,63,CD4-positive, alpha-beta T cell differentiation,BP,ZFPM1
12537,GO:0046128,0.595418240461195,0.773935625033653,1,65,purine ribonucleoside metabolic process,BP,RHOQ
3416,GO:0006733,0.596133007439623,0.677584424532853,2,143,oxidoreduction coenzyme metabolic process,BP,ACTN3;PFKFB3
9763,GO:0035304,0.597281183629442,0.772432677148986,1,61,regulation of protein dephosphorylation,BP,ADORA1
4080,GO:0008324,0.597304720856344,0.536840694241761,9,649,cation transmembrane transporter activity,MF,TF;SLC45A4;KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1;CLDN16
4350,GO:0009056,0.597361900142348,0.479640613693434,30,2223,catabolic process,BP,ACTN3;GLDC;ITGB4;PMAIP1;ADORA1;RAB39A;PRR5L;PIK3R2;RALB;WNT5A;MAGEC2;KHK;GPRASP1;SESN2;AXIN1;PFKFB3;SDC4;MSN;AKT1;PKP3;PKP1;RAB12;PIK3CA;PIK3CG;LZTS1;ARAF;SH3BP4;RNF144A;PIM2;PDE4B
7019,GO:0021885,0.597407421447728,0.772461285182745,1,58,forebrain cell migration,BP,TYRO3
3129,GO:0006352,0.597892604561807,0.628794660992762,3,229,DNA-templated transcription, initiation,BP,NOTCH1;CTGF;VDR
2780,GO:0005766,0.597969840432561,0.675645599228359,2,151,primary lysosome,CC,RAB44;RAB3D
10924,GO:0042582,0.597969840432561,0.675645599228359,2,151,azurophil granule,CC,RAB44;RAB3D
12249,GO:0045619,0.598070282349768,0.675646852411141,2,143,regulation of lymphocyte differentiation,BP,BMP4;GAS6
6293,GO:0017137,0.598130874153845,0.675795163954696,2,129,Rab GTPase binding,MF,RIN3;RAB11FIP1
7482,GO:0030534,0.598171393380956,0.675586780293758,2,140,adult behavior,BP,SPTBN4;GDNF
14156,GO:0051588,0.598660739593185,0.77114527025729,1,62,regulation of neurotransmitter transport,BP,GDNF
15925,GO:0070405,0.598791450532376,0.770787879206408,1,68,ammonium ion binding,MF,SERPINA5
4848,GO:0010556,0.599137252668389,0.461352872131165,55,3946,regulation of macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;CCL20;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;NAB2;CDH1;INHBB;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
9713,GO:0035195,0.600226163812435,0.769819807293194,1,60,gene silencing by miRNA,BP,BMP4
8709,GO:0032755,0.60071293688954,0.769161328538283,1,65,positive regulation of interleukin-6 production,BP,WNT5A
10683,GO:0042158,0.600722234585619,0.672892897744664,2,150,lipoprotein biosynthetic process,BP,NMT2;PRND
19908,GO:1904035,0.601429402387455,0.768592723966839,1,63,regulation of epithelial cell apoptotic process,BP,GAS6
3746,GO:0007269,0.602442623264949,0.671362969558867,2,135,neurotransmitter secretion,BP,SYT5;WNT7A
18380,GO:0099643,0.602442623264949,0.671362969558867,2,135,signal release from synapse,BP,SYT5;WNT7A
4638,GO:0009755,0.604113450085771,0.62244803291551,3,218,hormone-mediated signaling pathway,BP,BMP7;BMP4;VDR
2802,GO:0005791,0.604350349248969,0.765724836792653,1,68,rough endoplasmic reticulum,CC,EDN1
20290,GO:1904888,0.605091318402186,0.765333311884938,1,61,cranial skeletal system development,BP,BMP4
8999,GO:0033209,0.605115948499628,0.668312302791249,2,162,tumor necrosis factor-mediated signaling pathway,BP,GAS6;CLDN18
2942,GO:0006026,0.605264526836109,0.765084860693401,1,63,aminoglycan catabolic process,BP,SDC4
5746,GO:0016054,0.605876455123977,0.620573199579661,3,224,organic acid catabolic process,BP,GLDC;SESN2;AKT1
12625,GO:0046395,0.605876455123977,0.620573199579661,3,224,carboxylic acid catabolic process,BP,GLDC;SESN2;AKT1
17209,GO:0075733,0.606088194394107,0.764242685804242,1,65,intracellular transport of virus,BP,NMT2
10122,GO:0035914,0.606122869630274,0.764338702564242,1,62,skeletal muscle cell differentiation,BP,NOTCH1
9335,GO:0034220,0.606470230166619,0.501895569139208,14,1015,ion transmembrane transport,BP,ACTN2;CASQ2;KCNK6;TTYH1;TSPAN13;KCNH2;SFXN1;AKT1;PIK3CG;KCNG2;GAS6;KCND1;CLDN16;PDE4B
3385,GO:0006687,0.606646506866222,0.763811709277954,1,63,glycosphingolipid metabolic process,BP,ITGB8
57,GO:0000118,0.606700859319166,0.763851184907464,1,61,histone deacetylase complex,CC,SIN3B
15494,GO:0061418,0.607206016002364,0.762826967036679,1,76,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1
3006,GO:0006119,0.607620196248361,0.76191680617856,1,99,oxidative phosphorylation,BP,ACTN3
8210,GO:0031970,0.60786549148046,0.762215874759837,1,76,organelle envelope lumen,CC,PTGES
9,GO:0000018,0.607903948003832,0.762649077448937,1,63,regulation of DNA recombination,BP,CLCF1
1636,GO:0003725,0.608043052590167,0.762657475851557,1,60,double-stranded RNA binding,MF,MSN
5709,GO:0015980,0.608994441697285,0.617146404998251,3,252,energy derivation by oxidation of organic compounds,BP,ACTN3;AKT1;PIK3CA
9135,GO:0033613,0.609205235467551,0.761398639096041,1,64,activating transcription factor binding,MF,ZFPM1
21318,GO:2000573,0.609215293605927,0.76143231574137,1,63,positive regulation of DNA biosynthetic process,BP,PDGFB
7835,GO:0031256,0.609580950242006,0.66412064018436,2,134,leading edge membrane,CC,ITGA5;ADORA1
14671,GO:0060041,0.609699055390632,0.663984196240152,2,135,retina development in camera-type eye,BP,RHOJ;DLL1
7356,GO:0030279,0.609845667778848,0.760643051143477,1,68,negative regulation of ossification,BP,NOTCH1
3415,GO:0006732,0.610508797363205,0.586695924140694,4,303,coenzyme metabolic process,BP,ACTN3;FASN;PFKFB3;ACSL4
8475,GO:0032414,0.610578657161666,0.760036979277972,1,66,positive regulation of ion transmembrane transporter activity,BP,ACTN2
14705,GO:0060078,0.611276221709702,0.66239856293467,2,133,regulation of postsynaptic membrane potential,BP,WNT7A;ADORA1
19226,GO:1902581,0.611714818928796,0.758974827072867,1,66,multi-organism cellular localization,BP,NMT2
19228,GO:1902583,0.611714818928796,0.758974827072867,1,66,multi-organism intracellular transport,BP,NMT2
10738,GO:0042278,0.611902147063798,0.758721506582357,1,68,purine nucleoside metabolic process,BP,RHOQ
2518,GO:0005216,0.612178676889259,0.550026829335716,6,423,ion channel activity,MF,KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1
980,GO:0002283,0.612777907512423,0.549262264184159,6,474,neutrophil activation involved in immune response,BP,RAB27A;CRISPLD2;PLAU;PKP1;RAB44;RAB3D
11337,GO:0043312,0.612777907512423,0.549262264184159,6,474,neutrophil degranulation,BP,RAB27A;CRISPLD2;PLAU;PKP1;RAB44;RAB3D
13996,GO:0051289,0.613056642258263,0.757600634343675,1,69,protein homotetramerization,BP,ACTN2
14009,GO:0051303,0.613997372153005,0.756914182239788,1,64,establishment of chromosome localization,BP,PSRC1
14005,GO:0051298,0.614388979772132,0.756680450249446,1,61,centrosome duplication,BP,RAB6C
1284,GO:0002793,0.614569522727674,0.611415357647524,3,232,positive regulation of peptide secretion,BP,ADORA1;WNT5A;BMP6
5974,GO:0016528,0.61561122998816,0.755306945615204,1,66,sarcoplasm,CC,CASQ2
43,GO:0000086,0.616698408289821,0.6092015717638,3,227,G2/M transition of mitotic cell cycle,BP,PHLDA1;FOXO4;CDKN1A
13604,GO:0050707,0.617229919940661,0.6559962429951,2,151,regulation of cytokine secretion,BP,WNT5A;GAS6
7468,GO:0030512,0.617740435615858,0.753370141906617,1,64,negative regulation of transforming growth factor beta receptor signaling pathway,BP,RASL11B
18280,GO:0099023,0.617804495812635,0.753353276362048,1,63,tethering complex,CC,RALB
13988,GO:0051279,0.617977551874249,0.752980932481585,1,68,regulation of release of sequestered calcium ion into cytosol,BP,CASQ2
10663,GO:0042119,0.619111668719775,0.542514816162161,6,477,neutrophil activation,BP,RAB27A;CRISPLD2;PLAU;PKP1;RAB44;RAB3D
12864,GO:0046902,0.61925527279771,0.751723364894614,1,69,regulation of mitochondrial membrane permeability,BP,PMAIP1
13465,GO:0050000,0.620427501136212,0.750760329692795,1,65,chromosome localization,BP,PSRC1
2648,GO:0005524,0.621269845649265,0.467877676231947,21,1426,ATP binding,MF,MARK4;ACVR1;PRKACB;MAPK12;TYRO3;KHK;NPR1;NUAK2;PFKFB3;PKN3;WNK4;DDR1;AKT1;MYO7A;PIK3CA;PIK3CG;MYH11;ARAF;ACSL4;ACTA2;PIM2
7456,GO:0030496,0.622451888459815,0.650666111872397,2,142,midbody,CC,RALB;PSRC1
9712,GO:0035194,0.623976116305478,0.747384519027334,1,64,posttranscriptional gene silencing by RNA,BP,BMP4
12811,GO:0046794,0.624963400024613,0.746260665959099,1,68,transport of virus,BP,NMT2
3563,GO:0006970,0.625058841941702,0.746167957418963,1,68,response to osmotic stress,BP,CLDN1
3128,GO:0006351,0.625238433402412,0.436437680262602,50,3617,transcription, DNA-templated,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
17818,GO:0097223,0.625335590737244,0.647372221247118,2,163,sperm part,CC,NOTCH1;SERPINA5
5144,GO:0010972,0.625624397803697,0.745217625069605,1,80,negative regulation of G2/M transition of mitotic cell cycle,BP,FOXO4
14874,GO:0060337,0.625794230092224,0.745052150471835,1,80,type I interferon signaling pathway,BP,WNT5A
16422,GO:0071357,0.625794230092224,0.745052150471835,1,80,cellular response to type I interferon,BP,WNT5A
10379,GO:0036473,0.627630526784984,0.743621824874168,1,69,cell death in response to oxidative stress,BP,AKT1
15985,GO:0070509,0.627804247175928,0.64492900105862,2,149,calcium ion import,BP,CASQ2;PDGFB
10285,GO:0036230,0.627984174577692,0.532983646256034,6,482,granulocyte activation,BP,RAB27A;CRISPLD2;PLAU;PKP1;RAB44;RAB3D
12888,GO:0046942,0.628091928728005,0.567959486129655,4,297,carboxylic acid transport,BP,ADORA1;EDN1;AKT1;ACSL4
19810,GO:1903845,0.628220878604316,0.743164273409968,1,66,negative regulation of cellular response to transforming growth factor beta stimulus,BP,RASL11B
1296,GO:0002824,0.628425634879274,0.74266376410335,1,74,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,CLCF1
18752,GO:1901292,0.629032041773258,0.74217298049631,1,71,nucleoside phosphate catabolic process,BP,PDE4B
1540,GO:0003300,0.629087749315599,0.74231396513599,1,66,cardiac muscle hypertrophy,BP,EDN1
1228,GO:0002708,0.630180756973943,0.740971682006314,1,73,positive regulation of lymphocyte mediated immunity,BP,CLCF1
5927,GO:0016441,0.630240686525987,0.741222828916905,1,65,posttranscriptional gene silencing,BP,BMP4
5108,GO:0010923,0.630643436909878,0.740825878139583,1,65,negative regulation of phosphatase activity,BP,CAMSAP3
13673,GO:0050805,0.631667839298951,0.739771166232758,1,66,negative regulation of synaptic transmission,BP,ADORA1
10000,GO:0035710,0.631729960501316,0.739549736700065,1,70,CD4-positive, alpha-beta T cell activation,BP,ZFPM1
10679,GO:0042147,0.632203577007568,0.739199060156926,1,67,retrograde transport, endosome to Golgi,BP,RAB6C
2984,GO:0006091,0.632508709525935,0.562990653683211,4,342,generation of precursor metabolites and energy,BP,ACTN3;PFKFB3;AKT1;PIK3CA
7136,GO:0022838,0.632587724346693,0.528128782342751,6,433,substrate-specific channel activity,MF,KCNK6;TTYH1;KCNH2;KCNG2;GAS6;KCND1
6423,GO:0018410,0.633601904065314,0.737483073914072,1,76,C-terminal protein amino acid modification,BP,PRND
12020,GO:0045089,0.634123163595243,0.561349828748955,4,313,positive regulation of innate immune response,BP,PRKACB;TYRO3;HRAS;WNT5A
1629,GO:0003712,0.634180180977343,0.514768098383611,7,521,transcription cofactor activity,MF,WNT4;POU3F1;ACTN2;NAB2;TLE1;SIN3B;ZCCHC12
2811,GO:0005811,0.634999482761273,0.736377828655151,1,68,lipid particle,CC,ACSL4
1076,GO:0002443,0.635432198763823,0.496270627174245,9,717,leukocyte mediated immunity,BP,RAB27A;CRISPLD2;PLAU;CLCF1;CHGA;PKP1;RAB44;PIK3CG;RAB3D
1079,GO:0002446,0.635588334148643,0.524742907036289,6,486,neutrophil mediated immunity,BP,RAB27A;CRISPLD2;PLAU;PKP1;RAB44;RAB3D
19295,GO:1902750,0.635799189725875,0.73510983531108,1,82,negative regulation of cell cycle G2/M phase transition,BP,FOXO4
13256,GO:0048511,0.636345984219033,0.558958279584985,4,306,rhythmic process,BP,ADORA1;TYRO3;KITLG;INHBB
13875,GO:0051117,0.636779297810752,0.73437330659465,1,74,ATPase binding,MF,RALB
3559,GO:0006959,0.637053419158946,0.634549920722881,2,199,humoral immune response,BP,NOTCH1;CHGA
3605,GO:0007032,0.638746825894768,0.732577216889469,1,69,endosome organization,BP,RAB27A
18430,GO:1900006,0.638948962577544,0.732541343093428,1,65,positive regulation of dendrite development,BP,BMP7
3978,GO:0008170,0.639695172027749,0.731580210803457,1,70,N-methyltransferase activity,MF,PNMT
2816,GO:0005819,0.640017805704948,0.55499285990749,4,295,spindle,CC,TUBG2;PSRC1;AKT1;UNC119
5315,GO:0014897,0.640198246882578,0.731150425201794,1,68,striated muscle hypertrophy,BP,EDN1
5458,GO:0015276,0.641031030329043,0.630838363382519,2,142,ligand-gated ion channel activity,MF,KCNK6;KCNH2
7133,GO:0022834,0.641031030329043,0.630838363382519,2,142,ligand-gated channel activity,MF,KCNK6;KCNH2
8724,GO:0032774,0.642383691437075,0.418069010414911,51,3751,RNA biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
4415,GO:0009141,0.642615474395165,0.580964276292123,3,275,nucleoside triphosphate metabolic process,BP,ACTN3;RHOQ;PFKFB3
1219,GO:0002699,0.643644464106932,0.627735230613699,2,162,positive regulation of immune effector process,BP,WNT5A;CLCF1
3465,GO:0006814,0.643936105583969,0.579844610000043,3,220,sodium ion transport,BP,SPTBN4;WNK4;AKT1
11936,GO:0044839,0.644024106164688,0.579633897013083,3,236,cell cycle G2/M phase transition,BP,PHLDA1;FOXO4;CDKN1A
2985,GO:0006094,0.645285674999619,0.725699290945796,1,75,gluconeogenesis,BP,SESN2
11196,GO:0043112,0.645289086238463,0.626097166602305,2,149,receptor metabolic process,BP,EDN1;GPRASP1
20730,GO:1990204,0.645491632356021,0.72492935785122,1,96,oxidoreductase complex,CC,GLDC
17628,GO:0090559,0.645608527490086,0.725401899468789,1,74,regulation of membrane permeability,BP,PMAIP1
12656,GO:0046470,0.646208227507541,0.724651617434668,1,78,phosphatidylcholine metabolic process,BP,MBOAT2
8844,GO:0032947,0.646855156641973,0.724346979549556,1,68,protein complex scaffold,MF,AXIN1
5642,GO:0015849,0.647608611222644,0.54657862472275,4,305,organic acid transport,BP,ADORA1;EDN1;AKT1;ACSL4
5314,GO:0014896,0.647812380652058,0.723277356610952,1,70,muscle hypertrophy,BP,EDN1
6908,GO:0021675,0.647982463726491,0.723062570920975,1,71,nerve development,BP,NRTN
9381,GO:0034340,0.648211371923944,0.722405089504858,1,84,response to type I interferon,BP,WNT5A
4349,GO:0009055,0.648908283738018,0.721373992964081,1,97,electron carrier activity,MF,GLDC
1293,GO:0002821,0.649016556397028,0.721746428270133,1,78,positive regulation of adaptive immune response,BP,CLCF1
24,GO:0000045,0.649611478130956,0.721452047157176,1,69,autophagosome assembly,BP,RALB
8472,GO:0032411,0.651139556221875,0.719670025553402,1,74,positive regulation of transporter activity,BP,ACTN2
739,GO:0001909,0.651297518901025,0.719277935808208,1,81,leukocyte mediated cytotoxicity,BP,RAB27A
7906,GO:0031349,0.651419718203215,0.52221992106159,5,406,positive regulation of defense response,BP,PRKACB;TYRO3;HRAS;WNT5A;PIK3CG
11795,GO:0044424,0.651445893973108,0.406322029385677,183,13251,intracellular part,CC,ITGA3;ITGA5;TAGLN;FHOD3;BEX4;TMEM163;LIF;ADRA2C;SYT5;WNT3;WNT2;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;PNMT;TF;ITGB5;ITGB4;FASN;PMAIP1;GADD45A;CRISPLD2;FBXO41;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;RABIF;NMT2;SALL4;GUCY1B3;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;RHPN1;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;KCNH2;PRKAR1B;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;KHK;GPRASP1;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;PSRC1;SDC4;SPTB;HBEGF;LGALS4;BMP6;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SLC2A14;ESPN;VAMP1;SFXN1;WNK4;RND3;CHGA;MSN;DSG3;CTGF;GJB1;GJB2;GJB6;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;WNT2B;CYTIP;PTGES;KITLG;NPPC;NAB2;CDH1;EPN1;MYO7A;BCAR1;INHBB;SPSB1;RAB44;TLE1;CLDN1;CLDN3;CLDN5;PIK3CA;PIK3CG;RAB11FIP1;GAS6;SIN3B;DTX4;ZCCHC12;MYH11;LZTS1;PM20D2;DSC3;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;PARVB;PDE4B
21538,GO:2001020,0.651617981655102,0.619048265517813,2,155,regulation of response to DNA damage stimulus,BP,PMAIP1;FGF10
292,GO:0000792,0.652888701629931,0.717950734169023,1,71,heterochromatin,CC,SALL4
1084,GO:0002456,0.652925661630844,0.717730912990853,1,76,T cell mediated immunity,BP,RAB27A
7844,GO:0031267,0.653787675013855,0.53978296347277,4,289,small GTPase binding,MF,RIN3;DAAM2;RAB11FIP1;SH3BP4
11009,GO:0042742,0.654797590295701,0.614928186714484,2,222,defense response to bacterium,BP,CCL20;CHGA
11815,GO:0044450,0.655468857709968,0.614871375485037,2,147,microtubule organizing center part,CC,TUBG2;PDE4B
14068,GO:0051427,0.656029131254514,0.614127080554365,2,156,hormone receptor binding,MF,NPPC;VDR
6299,GO:0017148,0.657794393813541,0.612228850756755,2,150,negative regulation of translation,BP,SESN2;BMP4
17986,GO:0097581,0.658220131691519,0.712357023289865,1,70,lamellipodium organization,BP,PARVB
11006,GO:0042734,0.658273997339503,0.712471333642636,1,66,presynaptic membrane,CC,ADORA1
7591,GO:0030816,0.658615735164051,0.71146385218895,1,84,positive regulation of cAMP metabolic process,BP,CHGA
2867,GO:0005901,0.659157961988778,0.711398692483436,1,69,caveola,CC,CDH1
3533,GO:0006919,0.659891522116339,0.710250306706794,1,79,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1
6569,GO:0019319,0.660018794111179,0.710146363090568,1,78,hexose biosynthetic process,BP,SESN2
2907,GO:0005977,0.66018018018919,0.710186210109151,1,72,glycogen metabolic process,BP,AKT1
9541,GO:0034655,0.660989811473678,0.531392646606494,4,364,nucleobase-containing compound catabolic process,BP,PRR5L;PKP3;PKP1;PDE4B
8207,GO:0031966,0.661714686838134,0.484337936768059,7,634,mitochondrial membrane,CC,PMAIP1;HMGCS2;SLC25A53;REEP1;VAMP1;SFXN1;ACSL4
3697,GO:0007193,0.662438781722108,0.707686144892529,1,74,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,ADORA1
14773,GO:0060191,0.662647964714969,0.707289505748408,1,79,regulation of lipase activity,BP,LPAR2
3374,GO:0006672,0.664606942329913,0.705343687269138,1,74,ceramide metabolic process,BP,ITGB8
11885,GO:0044728,0.665574562786202,0.704293755560974,1,74,DNA methylation or demethylation,BP,PIK3CA
7438,GO:0030424,0.665735440124942,0.50628136549203,5,378,axon,CC,ADRA2C;ADORA1;SPTBN4;VAMP1;NRTN
14822,GO:0060271,0.665804643547907,0.526173571876716,4,305,cilium assembly,BP,NOTCH1;MARK4;RAB17;LAMA5
2975,GO:0006073,0.665843946989748,0.704038334623165,1,73,cellular glucan metabolic process,BP,AKT1
11614,GO:0044042,0.665843946989748,0.704038334623165,1,73,glucan metabolic process,BP,AKT1
12000,GO:0045069,0.665892102282379,0.703775946652522,1,79,regulation of viral genome replication,BP,NOTCH1
20360,GO:1905037,0.666235570562268,0.703650779281594,1,72,autophagosome organization,BP,RALB
2302,GO:0004867,0.666814781692842,0.702433484324793,1,91,serine-type endopeptidase inhibitor activity,MF,SERPINA5
6535,GO:0019217,0.66906283953639,0.700344408755268,1,78,regulation of fatty acid metabolic process,BP,AKT1
4820,GO:0010498,0.669750179642662,0.501673447134504,5,398,proteasomal protein catabolic process,BP,PMAIP1;AXIN1;AKT1;ARAF;RNF144A
20980,GO:2000060,0.672909705255749,0.695749720299656,1,90,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1
21637,GO:2001235,0.673681581851598,0.593881932400883,2,172,positive regulation of apoptotic signaling pathway,BP,PMAIP1;INHBB
15860,GO:0070301,0.673715103792279,0.695140329128936,1,80,cellular response to hydrogen peroxide,BP,RHOB
9730,GO:0035249,0.67374658182672,0.695313905811067,1,74,synaptic transmission, glutamatergic,BP,ADORA1
1092,GO:0002474,0.67481732197778,0.693552972713888,1,93,antigen processing and presentation of peptide antigen via MHC class I,BP,ITGB5
17800,GO:0097194,0.674957513485046,0.69375675881612,1,80,execution phase of apoptosis,BP,AKT1
18691,GO:1901137,0.675634605223294,0.452061241717662,9,723,carbohydrate derivative biosynthetic process,BP,GUCY1B3;EDN1;PHLDA1;PDGFB;NPR1;SDC4;HBEGF;B3GNT2;NPPC
11907,GO:0044782,0.676876368485542,0.513492642670805,4,309,cilium organization,BP,NOTCH1;MARK4;RAB17;LAMA5
9764,GO:0035305,0.678189131841657,0.690346463012267,1,74,negative regulation of dephosphorylation,BP,CAMSAP3
13649,GO:0050772,0.678754612026584,0.689748355317691,1,73,positive regulation of axonogenesis,BP,WNT3
21645,GO:2001243,0.679383101667793,0.688665454310146,1,84,negative regulation of intrinsic apoptotic signaling pathway,BP,AKT1
18923,GO:1901796,0.681476845116809,0.584903993087775,2,163,regulation of signal transduction by p53 class mediator,BP,PMAIP1;AKT1
7884,GO:0031326,0.681530271450901,0.374743558651563,56,4131,regulation of cellular biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;CCL20;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;KITLG;NPPC;NAB2;CDH1;INHBB;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
3086,GO:0006282,0.681917677409972,0.686019457375185,1,77,regulation of DNA repair,BP,FGF10
3594,GO:0007017,0.682006420499979,0.452515350462601,8,608,microtubule-based process,BP,TUBG2;RAB6C;MARK4;GADD45A;FGF10;AXIN1;PSRC1;CAMSAP3
11687,GO:0044248,0.68263857634863,0.39697688219445,24,1867,cellular catabolic process,BP,GLDC;ITGB4;PMAIP1;RAB39A;PRR5L;PIK3R2;RALB;MAGEC2;GPRASP1;SESN2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;PIK3CA;PIK3CG;LZTS1;ARAF;SH3BP4;RNF144A;PIM2;PDE4B
12612,GO:0046364,0.684554392240085,0.682782121564399,1,84,monosaccharide biosynthetic process,BP,SESN2
13420,GO:0048814,0.686508670365968,0.68087793274753,1,74,regulation of dendrite morphogenesis,BP,LZTS1
6129,GO:0016811,0.688144109513877,0.678678766862495,1,83,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,SIN3B
1888,GO:0004252,0.689822949118914,0.57479410425069,2,186,serine-type endopeptidase activity,MF,RHBDL3;PLAU
18690,GO:1901136,0.690144543579263,0.574559185518772,2,171,carbohydrate derivative catabolic process,BP,SDC4;PDE4B
7923,GO:0031398,0.690300723188849,0.57432040939672,2,176,positive regulation of protein ubiquitination,BP,MAGEC2;AXIN1
5589,GO:0015748,0.690650196326008,0.675799887768446,1,82,organophosphate ester transport,BP,GJB1
16046,GO:0070613,0.69079373569006,0.67563259043705,1,82,regulation of protein processing,BP,PRKACB
2779,GO:0005765,0.691669812723537,0.496215883485932,4,322,lysosomal membrane,CC,RAB12;MYO7A;RAB44;RAB3D
18202,GO:0098852,0.691669812723537,0.496215883485932,4,322,lytic vacuole membrane,CC,RAB12;MYO7A;RAB44;RAB3D
12251,GO:0045621,0.693795971698092,0.672055476566797,1,84,positive regulation of lymphocyte differentiation,BP,GAS6
6527,GO:0019208,0.694183682217761,0.671694556694238,1,81,phosphatase regulator activity,MF,BMP2
17143,GO:0072655,0.695048562097386,0.568558829757508,2,183,establishment of protein localization to mitochondrion,BP,PMAIP1;AKT1
14762,GO:0060170,0.695203995068956,0.670492215504864,1,81,ciliary membrane,CC,SPTBN5
19547,GO:1903317,0.695765866652851,0.669764210520968,1,83,regulation of protein maturation,BP,PRKACB
14203,GO:0051668,0.696429512775052,0.669077010181833,1,80,localization within membrane,BP,CDH2
9353,GO:0034249,0.696583702193708,0.566931959616215,2,162,negative regulation of cellular amide metabolic process,BP,SESN2;BMP4
1225,GO:0002705,0.697026459451577,0.668151192235563,1,87,positive regulation of leukocyte mediated immunity,BP,CLCF1
9518,GO:0034622,0.697172622020825,0.415955653549358,11,947,cellular macromolecular complex assembly,BP,FHOD3;TUBG2;CASQ2;SPTBN5;SPTBN4;RALB;AXIN1;PSRC1;SPTB;VAMP1;MYH11
9923,GO:0035591,0.697609912087221,0.667746790652984,1,78,signaling adaptor activity,MF,PIK3R1
4836,GO:0010522,0.697740878977851,0.667361489026351,1,85,regulation of calcium ion transport into cytosol,BP,CASQ2
3210,GO:0006470,0.699789808955266,0.515380702124774,3,241,protein dephosphorylation,BP,ADORA1;PTPN7;DUSP5
5999,GO:0016575,0.700889303535003,0.66376338224104,1,80,histone deacetylation,BP,SIN3B
1042,GO:0002377,0.700954038248101,0.663436817269472,1,88,immunoglobulin production,BP,CLCF1
11678,GO:0044237,0.701194300675735,0.34561441456061,134,9871,cellular metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;PNMT;STRA6;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;FBXO41;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;ADORA1;DKK3;EDN1;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;RAB39A;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;KHK;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;CHGA;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;VDR;ARAF;SH3BP4;UNC119;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;RNF144A;PIM2;PDE4B
2544,GO:0005254,0.701689580446943,0.66280285915168,1,80,chloride channel activity,MF,TTYH1
2808,GO:0005798,0.701765917734942,0.662611938374364,1,83,Golgi-associated vesicle,CC,RHOQ
16035,GO:0070585,0.702248497890953,0.559805822449219,2,185,protein localization to mitochondrion,BP,PMAIP1;AKT1
6841,GO:0021543,0.702928164324848,0.559232846962794,2,161,pallium development,BP,CDH2;FGF8
2341,GO:0004930,0.704694035380146,0.435227880212042,7,775,G-protein coupled receptor activity,MF,ADRA2B;ADRA2C;ADORA1;FZD7;LPAR2;NPR1;FZD8
7736,GO:0031058,0.70558171084958,0.658066382119482,1,81,positive regulation of histone modification,BP,LIF
5760,GO:0016079,0.705587506007588,0.658093510503447,1,80,synaptic vesicle exocytosis,BP,SYT5
8597,GO:0032587,0.706591914885191,0.656871651004329,1,80,ruffle membrane,CC,ITGA5
2629,GO:0005496,0.707605127422544,0.655299747350046,1,91,steroid binding,MF,VDR
11810,GO:0044445,0.708335535853554,0.551997836017785,2,228,cytosolic part,CC,GUCY1B3;NPR1
10437,GO:0038023,0.709337656527916,0.389755255618002,14,1290,signaling receptor activity,MF,ADRA2B;ADRA2C;ACVR1;ADORA1;FZD7;TYRO3;LPAR2;KCNH2;NPR1;SDC4;DDR1;CLDN3;VDR;FZD8
3513,GO:0006890,0.709611650257756,0.653076420422453,1,83,retrograde vesicle-mediated transport, Golgi to ER,BP,RAB6C
6118,GO:0016791,0.710294663079733,0.502599200715889,3,247,phosphatase activity,MF,PTPN7;PFKFB3;DUSP5
1261,GO:0002758,0.712335116145908,0.499997685998354,3,264,innate immune response-activating signal transduction,BP,PRKACB;TYRO3;HRAS
2758,GO:0005740,0.713559275942636,0.424965263134854,7,669,mitochondrial envelope,CC,PMAIP1;HMGCS2;SLC25A53;REEP1;VAMP1;SFXN1;ACSL4
4395,GO:0009119,0.714044563727301,0.647303195340569,1,93,ribonucleoside metabolic process,BP,RHOQ
5992,GO:0016567,0.714095655286289,0.402018036439581,10,800,protein ubiquitination,BP,TSPAN17;FBXO41;RAB40B;RAB40A;MAGEC2;AXIN1;AKT1;SPSB1;DTX4;RNF144A
3001,GO:0006112,0.714516472141091,0.646943532922738,1,85,energy reserve metabolic process,BP,AKT1
17647,GO:0090630,0.71501834498451,0.646414945600451,1,82,activation of GTPase activity,BP,WNT5A
20732,GO:1990234,0.715048437395513,0.40711116093088,9,719,transferase complex,CC,TSPAN17;ACVR1;PIK3R2;PIK3R1;SESN2;CDKN1A;PIK3CA;PIK3CG;RNF144A
13931,GO:0051188,0.716098000781783,0.542664332300164,2,184,cofactor biosynthetic process,BP,FASN;ACSL4
11805,GO:0044438,0.717303942733496,0.643280544482685,1,91,microbody part,CC,ACSL4
11806,GO:0044439,0.717303942733496,0.643280544482685,1,91,peroxisomal part,CC,ACSL4
14331,GO:0051928,0.718106031731031,0.642166686579105,1,95,positive regulation of calcium ion transport,BP,PDGFB
13810,GO:0051020,0.719919914886791,0.46235793043065,4,317,GTPase binding,MF,RIN3;DAAM2;RAB11FIP1;SH3BP4
11204,GO:0043123,0.723420849440009,0.533464257892875,2,178,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,AKT1;PIM2
2194,GO:0004721,0.723823259229087,0.533037865582598,2,170,phosphoprotein phosphatase activity,MF,PTPN7;DUSP5
5564,GO:0015698,0.725277938623278,0.531203884966197,2,168,inorganic anion transport,BP,TTYH1;WNK4
6243,GO:0017048,0.725313833928244,0.633347210268286,1,83,Rho GTPase binding,MF,DAAM2
2944,GO:0006029,0.725897616047765,0.632630581806953,1,82,proteoglycan metabolic process,BP,BMP2
11694,GO:0044257,0.726091676472552,0.401457293896969,8,652,cellular protein catabolic process,BP,PMAIP1;MAGEC2;AXIN1;MSN;AKT1;RAB12;ARAF;RNF144A
18848,GO:1901606,0.726818881156952,0.631109964444106,1,93,alpha-amino acid catabolic process,BP,GLDC
944,GO:0002218,0.728160944778084,0.480282913941854,3,271,activation of innate immune response,BP,PRKACB;TYRO3;HRAS
12743,GO:0046632,0.729254078180217,0.628039050839147,1,90,alpha-beta T cell differentiation,BP,ZFPM1
20978,GO:2000058,0.729626814078115,0.62718552700435,1,105,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1
3477,GO:0006835,0.730012774163521,0.627172287666425,1,86,dicarboxylic acid transport,BP,ADORA1
3469,GO:0006820,0.730827203415319,0.404603999256256,7,573,anion transport,BP,SLC52A3;ADORA1;EDN1;TTYH1;WNK4;AKT1;ACSL4
11700,GO:0044265,0.730921602734232,0.377191979678311,11,927,cellular macromolecule catabolic process,BP,PMAIP1;PRR5L;MAGEC2;AXIN1;MSN;AKT1;PKP3;PKP1;RAB12;ARAF;RNF144A
6246,GO:0017053,0.731709325792749,0.624989682972189,1,85,transcriptional repressor complex,CC,ZFPM1
3620,GO:0007052,0.731835463339302,0.624761413088493,1,87,mitotic spindle organization,BP,PSRC1
19319,GO:1902850,0.731835463339302,0.624761413088493,1,87,microtubule cytoskeleton organization involved in mitosis,BP,PSRC1
13653,GO:0050776,0.732111960714283,0.38098625687509,10,860,regulation of immune response,BP,PRKACB;TYRO3;PIK3R2;PIK3R1;HRAS;WNT5A;CLCF1;BCAR1;PIK3CA;PDE4B
3515,GO:0006892,0.732156780217935,0.624340603802896,1,87,post-Golgi vesicle-mediated transport,BP,RABIF
4351,GO:0009057,0.732509806042228,0.36336797763633,14,1153,macromolecule catabolic process,BP,PMAIP1;PRR5L;WNT5A;MAGEC2;GPRASP1;AXIN1;SDC4;MSN;AKT1;PKP3;PKP1;RAB12;ARAF;RNF144A
19838,GO:1903902,0.73283830952545,0.623246458898978,1,94,positive regulation of viral life cycle,BP,NOTCH1
18361,GO:0099600,0.734093721457029,0.364960611003812,13,1234,transmembrane receptor activity,MF,ADRA2B;ADRA2C;ACVR1;ADORA1;KCNK6;FZD7;TYRO3;LPAR2;KCNH2;NPR1;DDR1;CLDN3;FZD8
19552,GO:1903322,0.734702694544257,0.51880494106174,2,191,positive regulation of protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1
3566,GO:0006974,0.734872587412014,0.383814724945364,9,751,cellular response to DNA damage stimulus,BP,PMAIP1;GADD45A;MAPK12;FGF10;PIK3R1;FOXO4;SESN2;CDKN1A;AKT1
3966,GO:0008144,0.734910900223034,0.620464597296341,1,96,drug binding,MF,FASN
17780,GO:0097164,0.73561488514608,0.517624346004085,2,190,ammonium ion metabolic process,BP,MBOAT2;NPR1
5354,GO:0015077,0.735979794562775,0.442339647641752,4,354,monovalent inorganic cation transmembrane transporter activity,MF,KCNK6;KCNH2;KCNG2;KCND1
11573,GO:0043933,0.736423011456206,0.338902915987243,23,1895,macromolecular complex subunit organization,BP,FHOD3;TUBG2;ACTN2;PMAIP1;CASQ2;SPTBN5;SPTBN4;PRND;PLEKHH2;RALB;HRAS;AXIN1;PSRC1;SPTB;VAMP1;MSN;GJB1;TLE1;CLDN1;CLDN3;KCNG2;MYH11;KCND1
20447,GO:1905269,0.736792098855276,0.618195858873753,1,88,positive regulation of chromatin organization,BP,LIF
6778,GO:0019955,0.736836936453761,0.618047959417649,1,91,cytokine binding,MF,ACVR1
3883,GO:0007631,0.736856371055719,0.617634917639649,1,107,feeding behavior,BP,STRA6
11541,GO:0043687,0.737171011232933,0.617418878476684,1,98,post-translational protein modification,BP,PRND
11259,GO:0043202,0.737784949387159,0.616815949323844,1,90,lysosomal lumen,CC,SDC4
3143,GO:0006368,0.738763271340407,0.615321486414692,1,97,transcription elongation from RNA polymerase II promoter,BP,AXIN1
11560,GO:0043900,0.739876400416324,0.437384580402104,4,373,regulation of multi-organism process,BP,NOTCH1;BMP6;NPPC;INHBB
5750,GO:0016064,0.741127831019859,0.612126942684271,1,98,immunoglobulin mediated immune response,BP,CLCF1
3104,GO:0006304,0.741311918641025,0.611955861702263,1,95,DNA modification,BP,PIK3CA
12482,GO:0046034,0.741451491582732,0.509695882188403,2,224,ATP metabolic process,BP,ACTN3;PFKFB3
2810,GO:0005802,0.743662938776638,0.507098919723672,2,183,trans-Golgi network,CC,CDH1;RAB38
2121,GO:0004620,0.74385205724335,0.608525188778836,1,95,phospholipase activity,MF,ADORA1
21008,GO:2000112,0.744170338200911,0.308912869718693,51,3834,regulation of cellular macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;AKT1;KITLG;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
12783,GO:0046700,0.744594133020051,0.431328833530621,4,406,heterocycle catabolic process,BP,PRR5L;PKP3;PKP1;PDE4B
14715,GO:0060090,0.745451658433648,0.504772116047944,2,178,binding, bridging,MF,PIK3R1;GAS6
11017,GO:0042752,0.745636493926967,0.606073751428986,1,96,regulation of circadian rhythm,BP,ADORA1
16654,GO:0071704,0.746320281230549,0.29743200855146,137,10155,organic substance metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;PNMT;STRA6;ITGB8;FASN;PMAIP1;GADD45A;RHBDL3;FBXO41;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;ADORA1;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;KHK;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;CHGA;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;VDR;ARAF;UNC119;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;PDE4B
3215,GO:0006476,0.748652575110499,0.602055051710228,1,92,protein deacetylation,BP,SIN3B
6675,GO:0019724,0.748969878825225,0.60140909419888,1,100,B cell mediated immunity,BP,CLCF1
4023,GO:0008236,0.749631929212546,0.49891921770573,2,207,serine-type peptidase activity,MF,RHBDL3;PLAU
13929,GO:0051186,0.749640960782992,0.425003297629061,4,373,cofactor metabolic process,BP,ACTN3;FASN;PFKFB3;ACSL4
7745,GO:0031072,0.749765633915332,0.600466901059528,1,94,heat shock protein binding,MF,ADORA1
13612,GO:0050715,0.750215985098348,0.599667332234676,1,101,positive regulation of cytokine secretion,BP,WNT5A
18025,GO:0097711,0.750332865152523,0.599711702130912,1,93,ciliary basal body docking,BP,MARK4
11704,GO:0044270,0.750605683968467,0.423666510332693,4,409,cellular nitrogen compound catabolic process,BP,PRR5L;PKP3;PKP1;PDE4B
3586,GO:0007006,0.751824009076908,0.597394682219638,1,103,mitochondrial membrane organization,BP,PMAIP1
5371,GO:0015108,0.752032594113313,0.597415481991736,1,91,chloride transmembrane transporter activity,MF,TTYH1
19177,GO:1902476,0.752032594113313,0.597415481991736,1,91,chloride transmembrane transport,BP,TTYH1
5903,GO:0016407,0.752838529546276,0.596079932248945,1,99,acetyltransferase activity,MF,FASN
3228,GO:0006493,0.753719630675214,0.594982801787431,1,94,protein O-linked glycosylation,BP,B3GNT2
17066,GO:0072509,0.754084880785879,0.493215365057902,2,174,divalent inorganic cation transmembrane transporter activity,MF,GAS6;CLDN16
11275,GO:0043228,0.754630823626997,0.29859511596803,48,3749,non-membrane-bounded organelle,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;SALL4;CASQ2;PHLDA1;MRO;PRKACB;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;PTPN7;FRMPD1;MAGEC2;PSTPIP2;RHOQ;PSRC1;SDC4;SPTB;CAMSAP3;WT1;CDKN1A;HMGN5;ESPN;MSN;AKT1;PKP1;KITLG;CDH1;MYO7A;BCAR1;CLDN5;SIN3B;MYH11;AMOT;UNC119;RAB3D;ACSL4;MYZAP;FAM110B;ACTA2;PARVB;PDE4B
11279,GO:0043232,0.754630823626997,0.29859511596803,48,3749,intracellular non-membrane-bounded organelle,CC,FHOD3;TUBG2;ACTN3;ACTN2;RAB6C;MARK4;SALL4;CASQ2;PHLDA1;MRO;PRKACB;SPTBN5;SPTBN4;CDH2;CGN;PLEKHH2;PTPN7;FRMPD1;MAGEC2;PSTPIP2;RHOQ;PSRC1;SDC4;SPTB;CAMSAP3;WT1;CDKN1A;HMGN5;ESPN;MSN;AKT1;PKP1;KITLG;CDH1;MYO7A;BCAR1;CLDN5;SIN3B;MYH11;AMOT;UNC119;RAB3D;ACSL4;MYZAP;FAM110B;ACTA2;PARVB;PDE4B
2543,GO:0005253,0.755570663390481,0.592393582656737,1,94,anion channel activity,MF,TTYH1
13943,GO:0051209,0.757225627629807,0.589935252451687,1,99,release of sequestered calcium ion into cytosol,BP,CASQ2
13992,GO:0051283,0.757225627629807,0.589935252451687,1,99,negative regulation of sequestering of calcium ion,BP,CASQ2
6314,GO:0017171,0.757546246223754,0.488176566550554,2,210,serine hydrolase activity,MF,RHBDL3;PLAU
5570,GO:0015711,0.757796326833043,0.395959913506998,5,437,organic anion transport,BP,SLC52A3;ADORA1;EDN1;AKT1;ACSL4
5319,GO:0014902,0.758165337096336,0.588634000716739,1,98,myotube differentiation,BP,NOTCH1
5745,GO:0016053,0.75855269706655,0.440944434766294,3,285,organic acid biosynthetic process,BP,FASN;EDN1;PTGES
12624,GO:0046394,0.75855269706655,0.440944434766294,3,285,carboxylic acid biosynthetic process,BP,FASN;EDN1;PTGES
12019,GO:0045088,0.760870901937717,0.410527842398145,4,377,regulation of innate immune response,BP,PRKACB;TYRO3;HRAS;WNT5A
13991,GO:0051282,0.761260610332184,0.584188512064073,1,100,regulation of sequestering of calcium ion,BP,CASQ2
6023,GO:0016605,0.761528774226091,0.583935494556818,1,95,PML body,CC,SPTBN4
5906,GO:0016410,0.762276462988636,0.582737158697786,1,100,N-acyltransferase activity,MF,NMT2
11040,GO:0042787,0.764089989681747,0.479258584816177,2,200,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A
18782,GO:1901362,0.764472600540851,0.284502936020489,57,4382,organic cyclic compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;PNMT;DHH;WNT6;WNT7A;ZFPM1;HMGCS2;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
2284,GO:0004842,0.764722652312071,0.387163423454907,5,423,ubiquitin-protein transferase activity,MF,TSPAN17;FBXO41;SPSB1;DTX4;RNF144A
4025,GO:0008238,0.764945089287806,0.578954189385573,1,98,exopeptidase activity,MF,PM20D2
4789,GO:0010389,0.765213889234252,0.578270295225862,1,111,regulation of G2/M transition of mitotic cell cycle,BP,FOXO4
9929,GO:0035601,0.765472805529199,0.578218650418055,1,97,protein deacylation,BP,SIN3B
8374,GO:0032273,0.76623538472046,0.576966872279367,1,103,positive regulation of protein polymerization,BP,PSRC1
14607,GO:0055088,0.767728385396921,0.574732038620787,1,106,lipid homeostasis,BP,SESN2
6024,GO:0016607,0.768216348696186,0.401006427009721,4,355,nuclear speck,CC,GADD45A;FOXO4;WT1;ZCCHC12
18134,GO:0098732,0.768335604891389,0.574039904557601,1,98,macromolecule deacylation,BP,SIN3B
13958,GO:0051235,0.769269851472135,0.426609573175802,3,284,maintenance of location,BP,CASQ2;SPTBN4;AKT1
6615,GO:0019439,0.770258125254529,0.398129703697246,4,420,aromatic compound catabolic process,BP,PRR5L;PKP3;PKP1;PDE4B
18840,GO:1901575,0.770575820509833,0.301433479253599,22,1816,organic substance catabolic process,BP,ACTN3;GLDC;PMAIP1;ADORA1;PRR5L;WNT5A;MAGEC2;KHK;GPRASP1;SESN2;AXIN1;PFKFB3;SDC4;MSN;AKT1;PKP3;PKP1;RAB12;PIK3CG;ARAF;RNF144A;PDE4B
10072,GO:0035821,0.771011712303034,0.569787127356404,1,113,modification of morphology or physiology of other organism,BP,CHGA
101,GO:0000209,0.771573951113718,0.423491432892308,3,284,protein polyubiquitination,BP,FBXO41;SPSB1;RNF144A
13942,GO:0051208,0.771977864274441,0.568580948014693,1,103,sequestering of calcium ion,BP,CASQ2
11261,GO:0043204,0.772179098534213,0.568261068908038,1,104,perikaryon,CC,DRP2
11229,GO:0043161,0.773378003892707,0.394150146447917,4,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,AXIN1;AKT1;ARAF;RNF144A
2869,GO:0005903,0.773864939159571,0.565918077300005,1,98,brush border,CC,ESPN
13267,GO:0048524,0.775101883010122,0.563888779783047,1,106,positive regulation of viral process,BP,NOTCH1
5896,GO:0016363,0.777086811536677,0.561096992930802,1,99,nuclear matrix,CC,SPTBN4
6614,GO:0019438,0.778273603152382,0.269810026198299,55,4252,aromatic compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;PNMT;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
2787,GO:0005774,0.77872378995498,0.387053235017223,4,367,vacuolar membrane,CC,RAB12;MYO7A;RAB44;RAB3D
11210,GO:0043130,0.77924772332598,0.557803947192492,1,101,ubiquitin binding,MF,MARK4
17982,GO:0097553,0.779675191750246,0.557064389549368,1,105,calcium ion transmembrane import into cytosol,BP,CASQ2
19256,GO:1902656,0.779675191750246,0.557064389549368,1,105,calcium ion import into cytosol,BP,CASQ2
6746,GO:0019882,0.781409791000655,0.454658694517132,2,223,antigen processing and presentation,BP,RAB27A;ITGB5
4357,GO:0009063,0.781732953874481,0.553885273559575,1,108,cellular amino acid catabolic process,BP,GLDC
9540,GO:0034654,0.782717938560591,0.265170363067004,54,4183,nucleobase-containing compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
19759,GO:1903749,0.783935142169715,0.55046933094648,1,111,positive regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
3603,GO:0007030,0.784297851194105,0.550219978580615,1,98,Golgi organization,BP,SPTBN5
11422,GO:0043484,0.784850295873053,0.549248224314845,1,103,regulation of RNA splicing,BP,PIK3R1
4599,GO:0009615,0.786895475698416,0.402312979957707,3,310,response to virus,BP,PMAIP1;ACTA2;PIM2
69,GO:0000139,0.786902449500936,0.327107495463273,8,678,Golgi membrane,CC,NOTCH1;RAB39A;PDGFB;HRAS;B3GNT2;RND3;RAB12;GPSM1
10461,GO:0038061,0.787228564954064,0.54527674026008,1,118,NIK/NF-kappaB signaling,BP,AKT1
4393,GO:0009116,0.787633375328498,0.544689126935027,1,116,nucleoside metabolic process,BP,RHOQ
18059,GO:0098542,0.788635258269928,0.373498383046294,4,451,defense response to other organism,BP,PMAIP1;CCL20;HRAS;CHGA
7153,GO:0022891,0.789064125519121,0.307510508504571,11,925,substrate-specific transmembrane transporter activity,MF,TF;SLC45A4;KCNK6;TTYH1;KCNH2;SLC2A14;SFXN1;KCNG2;GAS6;KCND1;CLDN16
7592,GO:0030817,0.78932119198973,0.542037300656159,1,118,regulation of cAMP biosynthetic process,BP,EDN1
1082,GO:0002449,0.789521180757314,0.442979411889252,2,212,lymphocyte mediated immunity,BP,RAB27A;CLCF1
20362,GO:1905039,0.789827109051524,0.541617661997762,1,101,carboxylic acid transmembrane transport,BP,AKT1
5020,GO:0010821,0.790191991100065,0.441997637540604,2,212,regulation of mitochondrion organization,BP,PMAIP1;AKT1
19294,GO:1902749,0.791032707073539,0.539353958912182,1,119,regulation of cell cycle G2/M phase transition,BP,FOXO4
2803,GO:0005793,0.79164350033683,0.538598042427061,1,109,endoplasmic reticulum-Golgi intermediate compartment,CC,GJB2
3366,GO:0006664,0.793310137632342,0.535942116847443,1,111,glycolipid metabolic process,BP,ITGB8
2445,GO:0005096,0.793905189668748,0.392662104967559,3,271,GTPase activator activity,MF,RIN3;PIK3R2;AXIN1
6701,GO:0019787,0.795107126641158,0.347340807947636,5,443,ubiquitin-like protein transferase activity,MF,TSPAN17;FBXO41;SPSB1;DTX4;RNF144A
1226,GO:0002706,0.795363155743486,0.532603781622527,1,116,regulation of lymphocyte mediated immunity,BP,CLCF1
1294,GO:0002822,0.795570629541724,0.532256322669805,1,117,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,CLCF1
3028,GO:0006171,0.796629423747256,0.530503922394797,1,121,cAMP biosynthetic process,BP,EDN1
19634,GO:1903509,0.796762055211589,0.530465359665889,1,112,liposaccharide metabolic process,BP,ITGB8
13611,GO:0050714,0.796991132651695,0.43194880214783,2,214,positive regulation of protein secretion,BP,WNT5A;BMP6
11469,GO:0043543,0.797155589496685,0.431781735914748,2,204,protein acylation,BP,LIF;NMT2
5467,GO:0015294,0.799293069337578,0.526630519151068,1,103,solute:cation symporter activity,MF,SLC45A4
17632,GO:0090575,0.800238569152863,0.52485010521861,1,115,RNA polymerase II transcription factor complex,CC,VDR
7271,GO:0030163,0.80532208018443,0.297179768807001,9,792,protein catabolic process,BP,PMAIP1;WNT5A;MAGEC2;AXIN1;MSN;AKT1;RAB12;ARAF;RNF144A
7070,GO:0021987,0.805625395378071,0.516292558317651,1,107,cerebral cortex development,BP,CDH2
13654,GO:0050777,0.806323032387687,0.514885769729981,1,120,negative regulation of immune response,BP,TYRO3
12742,GO:0046631,0.806685754000345,0.514386423951805,1,115,alpha-beta T cell activation,BP,ZFPM1
18386,GO:0101002,0.806742969538127,0.514127005870761,1,124,ficolin-1-rich granule,CC,CRISPLD2
20249,GO:1904813,0.806742969538127,0.514127005870761,1,124,ficolin-1-rich granule lumen,CC,CRISPLD2
1630,GO:0003713,0.806804800039182,0.374117418528702,3,294,transcription coactivator activity,MF,POU3F1;ACTN2;ZCCHC12
11274,GO:0043227,0.807109195952348,0.232432710038596,156,11597,membrane-bounded organelle,CC,ITGA3;ITGA5;BEX4;TMEM163;ADRA2C;SYT5;WNT3;WNT4;POU3F1;RIN3;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;RAB27A;TF;IGSF8;ITGB5;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;NMT2;SALL4;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;PRKACB;MFGE8;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;SNX18;KHK;SESN2;AXIN1;RHOQ;RHOJ;RHOB;NUAK2;PFKFB3;PSRC1;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP2;B3GNT2;DAAM2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SLC2A14;VAMP1;SFXN1;RND3;CHGA;MSN;DDR1;DSG3;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;WNT2B;CYTIP;PTGES;NPPC;NAB2;CDH1;EPN1;MYO7A;HPCAL1;RAB44;TLE1;CLDN2;CLDN3;CLDN5;PIK3CG;RAB11FIP1;KCNG2;GAS6;SIN3B;ZCCHC12;MYH11;PM20D2;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;RAB38;RAB3D;ACSL4;FAM110B;FZD8;DUSP5;HEY1;ACTA2;CLDN11;RNF144A;PDE4B
4210,GO:0008528,0.80888655998827,0.510616515343535,1,123,G-protein coupled peptide receptor activity,MF,NPR1
5353,GO:0015075,0.809429998448736,0.286646527750883,10,861,ion transmembrane transporter activity,MF,TF;SLC45A4;KCNK6;TTYH1;KCNH2;SFXN1;KCNG2;GAS6;KCND1;CLDN16
2721,GO:0005667,0.810705338136861,0.368411688467544,3,304,transcription factor complex,CC,POU3F1;ZFPM1;VDR
566,GO:0001653,0.812064601466899,0.505324454835761,1,124,peptide receptor activity,MF,NPR1
12221,GO:0045580,0.812352386262136,0.504952387630535,1,118,regulation of T cell differentiation,BP,BMP4
13960,GO:0051238,0.812381275432801,0.504866856475065,1,120,sequestering of metal ion,BP,CASQ2
10900,GO:0042542,0.813240237262814,0.503376810075184,1,123,response to hydrogen peroxide,BP,RHOB
418,GO:0001085,0.813669932356716,0.502826475491902,1,114,RNA polymerase II transcription factor binding,MF,ZFPM1
401,GO:0001046,0.813981998065619,0.502409463807073,1,109,core promoter sequence-specific DNA binding,MF,ZFPM1
2847,GO:0005874,0.814242939462027,0.338230610767518,4,376,microtubule,CC,TUBG2;PSRC1;CAMSAP3;RAB3D
8530,GO:0032479,0.815437748425872,0.499833679232633,1,115,regulation of type I interferon production,BP,DTX4
19757,GO:1903747,0.815506560176549,0.499567803690596,1,123,regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
3131,GO:0006354,0.815706862708213,0.499247462073164,1,122,DNA-templated transcription, elongation,BP,AXIN1
5864,GO:0016298,0.815813343001159,0.499122448344366,1,119,lipase activity,MF,ADORA1
4003,GO:0008203,0.816028744778878,0.498758621390417,1,119,cholesterol metabolic process,BP,HMGCS2
19800,GO:1903825,0.817191784845021,0.496950538980075,1,111,organic acid transmembrane transport,BP,AKT1
13980,GO:0051262,0.817361195734505,0.496168068668808,1,140,protein tetramerization,BP,ACTN2
8615,GO:0032606,0.817372796101535,0.49654036407088,1,116,type I interferon production,BP,DTX4
6359,GO:0018130,0.817707744273675,0.225721958604295,54,4246,heterocycle biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
11679,GO:0044238,0.817711052733729,0.218763040729683,130,9787,primary metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT2;WNT4;POU3F1;ACTN3;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;STRA6;ITGB8;FASN;PMAIP1;GADD45A;RHBDL3;FBXO41;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;ADORA1;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;KHK;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;CHGA;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;VDR;ARAF;UNC119;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;RNF144A;PIM2;PDE4B
7691,GO:0030968,0.817958267139303,0.495488156729112,1,119,endoplasmic reticulum unfolded protein response,BP,PIK3R1
10696,GO:0042175,0.818487809822458,0.270653705377245,11,971,nuclear outer membrane-endoplasmic reticulum membrane network,CC,NOTCH1;CASQ2;MBOAT2;TTYH1;TYRO3;PIK3R1;REEP1;GJB1;PTGES;GPSM1;ACSL4
8503,GO:0032446,0.818909888900967,0.27452539482965,10,882,protein modification by small protein conjugation,BP,TSPAN17;FBXO41;RAB40B;RAB40A;MAGEC2;AXIN1;AKT1;SPSB1;DTX4;RNF144A
2790,GO:0005777,0.819074139537242,0.493497331542063,1,124,peroxisome,CC,ACSL4
10922,GO:0042579,0.819074139537242,0.493497331542063,1,124,microbody,CC,ACSL4
8216,GO:0031984,0.819700206621033,0.355207206054499,3,300,organelle subcompartment,CC,REEP1;CDH1;RAB38
4288,GO:0008757,0.820428184229301,0.491290562033995,1,118,S-adenosylmethionine-dependent methyltransferase activity,MF,PNMT
18781,GO:1901361,0.82188095642699,0.327167741649615,4,452,organic cyclic compound catabolic process,BP,PRR5L;PKP3;PKP1;PDE4B
8172,GO:0031901,0.823123199303431,0.486709662166141,1,115,early endosome membrane,CC,TMEM163
1291,GO:0002819,0.824923537403839,0.483351117536772,1,128,regulation of adaptive immune response,BP,CLCF1
12634,GO:0046434,0.826199784596671,0.481228768766186,1,122,organophosphate catabolic process,BP,PDE4B
2757,GO:0005739,0.826971215740988,0.242900442060691,17,1569,mitochondrion,CC,GLDC;FASN;PMAIP1;HMGCS2;SLC25A53;MAPK12;PRR5L;REEP1;SESN2;VAMP1;SFXN1;AKT1;ARAF;RAB38;RAB3D;ACSL4;FAM110B
10800,GO:0042383,0.827329039493043,0.479345967615541,1,117,sarcolemma,CC,CDH2
413,GO:0001078,0.828146362862513,0.477910763008881,1,117,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,ZFPM1
9517,GO:0034620,0.828160717451823,0.477773784568641,1,123,cellular response to unfolded protein,BP,PIK3R1
19254,GO:1902652,0.82859307573776,0.476995336728924,1,124,secondary alcohol metabolic process,BP,HMGCS2
13840,GO:0051053,0.830305533985776,0.474061799306002,1,119,negative regulation of DNA metabolic process,BP,NPPC
14929,GO:0060402,0.830972826936137,0.472787576487845,1,124,calcium ion transport into cytosol,BP,CASQ2
2547,GO:0005262,0.831115464174635,0.472724355034165,1,114,calcium channel activity,MF,GAS6
8364,GO:0032259,0.831961315275026,0.336749188203413,3,313,methylation,BP,PNMT;PIK3CA;RAB3D
4381,GO:0009100,0.833212041266556,0.310896976344465,4,396,glycoprotein metabolic process,BP,PHLDA1;HBEGF;BMP2;B3GNT2
3970,GO:0008152,0.83651544040757,0.198174599164392,141,10623,metabolic process,BP,ITGA3;ITGA5;ARTN;LIF;ADRA2B;ADRA2C;WNT3;WNT2;WNT4;POU3F1;ACTN3;ACTN2;TSPAN15;TSPAN17;NOTCH1;GLDC;MARK4;RAB27A;PNMT;STRA6;ITGB4;ITGB8;FASN;PMAIP1;GADD45A;RHBDL3;FBXO41;DHH;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;SLC52A3;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;ADORA1;DKK3;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;PRKACB;MFGE8;CCL20;SPTBN5;SPTBN4;MBOAT2;RAB39A;PRND;MAPK12;FZD7;TYRO3;CDH2;PRR5L;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;KCNH2;PRKAR1B;PTPN7;FOXO4;RALB;HRAS;WNT5A;MAGEC2;KHK;GPRASP1;SESN2;AXIN1;RHOQ;NPR1;NUAK2;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;SPTB;HBEGF;BMP7;BMP6;BMP4;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;WNK4;CHGA;MSN;DDR1;CTGF;AKT1;PKP3;PKP1;RAB12;NRTN;PTGES;KITLG;NPPC;CST9L;NAB2;JAG2;CDH1;INHBB;SPSB1;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;DTX4;ZCCHC12;LZTS1;PM20D2;SHC4;VDR;ARAF;SH3BP4;UNC119;RAB3D;GDNF;ACSL4;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PIM2;PDE4B
5694,GO:0015931,0.837371731765464,0.368934878126613,2,224,nucleobase-containing compound transport,BP,ADORA1;GJB1
4440,GO:0009167,0.839347217803528,0.365455959075684,2,267,purine ribonucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
8321,GO:0032182,0.839557880121569,0.457377234063883,1,121,ubiquitin-like protein binding,MF,MARK4
4400,GO:0009126,0.840378817830489,0.363753741733098,2,268,purine nucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
6155,GO:0016853,0.84107621343229,0.454277911893841,1,141,isomerase activity,MF,PTGES
2317,GO:0004888,0.842199947359876,0.239999222524383,11,1184,transmembrane signaling receptor activity,MF,ADRA2B;ADRA2C;ACVR1;ADORA1;FZD7;TYRO3;LPAR2;NPR1;DDR1;CLDN3;FZD8
9429,GO:0034399,0.842429387411331,0.452102489598608,1,121,nuclear periphery,CC,SPTBN4
948,GO:0002224,0.842733738294742,0.451451582524416,1,126,toll-like receptor signaling pathway,BP,TYRO3
1303,GO:0002831,0.845410213020461,0.446353755960774,1,134,regulation of response to biotic stimulus,BP,BMP6
18879,GO:1901657,0.846719131963003,0.443819727832849,1,140,glycosyl compound metabolic process,BP,RHOQ
4809,GO:0010467,0.848768621870167,0.18782540312653,64,5049,gene expression,BP,ITGA3;LIF;WNT3;WNT2;WNT4;POU3F1;TSPAN15;NOTCH1;RAB27A;ITGB8;RHBDL3;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;PLAU;PRKACB;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;MSN;CTGF;AKT1;PKP3;PKP1;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;SHC4;VDR;GDNF;FZD8;HEY1;ACTA2;PIM2
18117,GO:0098661,0.851012876818264,0.435979478301991,1,123,inorganic anion transmembrane transport,BP,TTYH1
13860,GO:0051092,0.851245083718471,0.435386911703642,1,132,positive regulation of NF-kappaB transcription factor activity,BP,WNT5A
36,GO:0000070,0.853020908730738,0.4320422395256,1,129,mitotic sister chromatid segregation,BP,PSRC1
3173,GO:0006417,0.85415410685263,0.302169095078185,3,329,regulation of translation,BP,SESN2;BMP4;AKT1
9648,GO:0035023,0.855437664098782,0.427493260914038,1,123,regulation of Rho protein signal transduction,BP,ITGA3
7734,GO:0031056,0.856063701686908,0.426195227200878,1,128,regulation of histone modification,BP,LIF
5779,GO:0016125,0.856327679549428,0.425543929887531,1,137,sterol metabolic process,BP,HMGCS2
4434,GO:0009161,0.858694505160869,0.332806311842463,2,279,ribonucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
6128,GO:0016810,0.859834404964576,0.418670423873165,1,139,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,SIN3B
11804,GO:0044437,0.861343831640224,0.253858848395392,5,517,vacuolar part,CC,SDC4;RAB12;MYO7A;RAB44;RAB3D
10150,GO:0035967,0.861480209246685,0.415441630166889,1,138,cellular response to topologically incorrect protein,BP,PIK3R1
11919,GO:0044798,0.861607792041728,0.415161247578886,1,140,nuclear transcription factor complex,CC,VDR
11793,GO:0044422,0.861665493129856,0.16906539484463,110,8458,organelle part,CC,FHOD3;TMEM163;SYT5;WNT3;WNT4;POU3F1;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;CDH23;TF;PMAIP1;GADD45A;CRISPLD2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;SALL4;CASQ2;EDN1;PLAU;RAB40B;PHLDA1;MRO;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RAB39A;SYCN;MAPK12;FZD7;TYRO3;CDH2;FSTL3;PIK3R1;CGN;REEP1;PDGFB;PRKAR1B;PLEKHH2;FOXO4;HRAS;WNT5B;WNT5A;MAGEC2;SNX18;RHOQ;RHOB;PFKFB3;PSRC1;SDC4;SPTB;HBEGF;CAMSAP3;B3GNT2;WT1;CDKN1A;HMGN5;RAB20;ESPN;VAMP1;SFXN1;RND3;CHGA;GJB1;AKT1;PKP3;PKP1;RAB12;RAB17;CYTIP;PTGES;CDH1;MYO7A;RAB44;TLE1;CLDN5;RAB11FIP1;GAS6;SIN3B;ZCCHC12;MYH11;PM20D2;GPSM1;VDR;AMOT;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;DUSP5;HEY1;ACTA2;RNF144A;PARVB;PDE4B
7921,GO:0031396,0.86213375260792,0.326961574734318,2,252,regulation of protein ubiquitination,BP,MAGEC2;AXIN1
18833,GO:1901565,0.862770714992736,0.288256816664969,3,346,organonitrogen compound catabolic process,BP,GLDC;SDC4;PDE4B
3996,GO:0008194,0.863801150429277,0.410908823436021,1,133,UDP-glycosyltransferase activity,MF,B3GNT2
7818,GO:0031225,0.863852811875181,0.410550123113649,1,152,anchored component of membrane,CC,PRND
3367,GO:0006665,0.864170160100797,0.410157415595357,1,134,sphingolipid metabolic process,BP,ITGB8
4994,GO:0010770,0.864606242440645,0.409348691897832,1,130,positive regulation of cell morphogenesis involved in differentiation,BP,WNT3
9738,GO:0035257,0.864965255236127,0.408583115249161,1,133,nuclear hormone receptor binding,MF,VDR
2852,GO:0005882,0.865761728968796,0.406380421993671,1,189,intermediate filament,CC,PKP1
2636,GO:0005506,0.866022492731757,0.406267254294515,1,147,iron ion binding,MF,TF
4382,GO:0009101,0.867822461107936,0.28004919112094,3,332,glycoprotein biosynthetic process,BP,PHLDA1;HBEGF;B3GNT2
14172,GO:0051606,0.869189356717814,0.256110395184957,4,625,detection of stimulus,BP,NMT2;ADORA1;CASQ2;UNC119
13086,GO:0048037,0.871738229608743,0.309986633518539,2,252,cofactor binding,MF,GLDC;FASN
7726,GO:0031047,0.871798583647685,0.39439996176836,1,158,gene silencing by RNA,BP,BMP4
3495,GO:0006865,0.872564458638019,0.393117130583083,1,135,amino acid transport,BP,ADORA1
2800,GO:0005789,0.872642744184446,0.203186991782446,10,951,endoplasmic reticulum membrane,CC,NOTCH1;CASQ2;MBOAT2;TTYH1;TYRO3;REEP1;GJB1;PTGES;GPSM1;ACSL4
5368,GO:0015103,0.873174724274142,0.391858005196942,1,135,inorganic anion transmembrane transporter activity,MF,TTYH1
5997,GO:0016573,0.873955661908377,0.390198613717271,1,138,histone acetylation,BP,LIF
4397,GO:0009123,0.874256628961555,0.305288992945163,2,291,nucleoside monophosphate metabolic process,BP,ACTN3;PFKFB3
3452,GO:0006790,0.875629970580834,0.267024896762823,3,358,sulfur compound metabolic process,BP,FASN;B3GNT2;ACSL4
11561,GO:0043901,0.875783332021249,0.386193851062732,1,154,negative regulation of multi-organism process,BP,NPPC
4880,GO:0010608,0.876210597407677,0.245266313993002,4,450,posttranscriptional regulation of gene expression,BP,SESN2;BMP4;AKT1;GDNF
5358,GO:0015085,0.876772650311793,0.384403972937087,1,133,calcium ion transmembrane transporter activity,MF,GAS6
3619,GO:0007051,0.877825645679576,0.382105403714554,1,139,spindle organization,BP,PSRC1
1096,GO:0002478,0.880638296809899,0.375848733300114,1,165,antigen processing and presentation of exogenous peptide antigen,BP,ITGB5
1223,GO:0002703,0.881075291471397,0.375047218752847,1,153,regulation of leukocyte mediated immunity,BP,CLCF1
6417,GO:0018393,0.881407325900257,0.374463147213314,1,143,internal peptidyl-lysine acetylation,BP,LIF
6685,GO:0019752,0.882939826994892,0.192976371999326,9,909,carboxylic acid metabolic process,BP,ACTN3;GLDC;FASN;EDN1;SESN2;PFKFB3;AKT1;PTGES;ACSL4
18832,GO:1901564,0.884318496272928,0.162687619451141,23,2159,organonitrogen compound metabolic process,BP,ACTN3;GLDC;PNMT;ITGB8;FASN;SLC52A3;GUCY1B3;EDN1;MBOAT2;PDGFB;WNT5A;SESN2;RHOQ;NPR1;PFKFB3;SDC4;BMP4;B3GNT2;CHGA;AKT1;NPPC;GAS6;PDE4B
11394,GO:0043414,0.885018636562367,0.28574089782404,2,251,macromolecule methylation,BP,PIK3CA;RAB3D
7440,GO:0030426,0.886493096482883,0.363526953966184,1,141,growth cone,CC,ITGA3
3297,GO:0006575,0.887118862911714,0.361924365234294,1,161,cellular modified amino acid metabolic process,BP,FASN
5466,GO:0015293,0.88791101160917,0.360429717864989,1,141,symporter activity,MF,SLC45A4
7904,GO:0031347,0.888128740530609,0.20337551443612,6,661,regulation of defense response,BP,ADORA1;PRKACB;TYRO3;HRAS;WNT5A;PIK3CG
6418,GO:0018394,0.888174232205087,0.359762203061727,1,148,peptidyl-lysine acetylation,BP,LIF
3214,GO:0006475,0.888332988822764,0.359413926414714,1,148,internal protein amino acid acetylation,BP,LIF
11276,GO:0043229,0.88909151591989,0.138728413746465,153,11553,intracellular organelle,CC,ITGA5;FHOD3;BEX4;TMEM163;ADRA2C;SYT5;WNT3;WNT4;POU3F1;RIN3;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;TF;ITGB5;ITGB4;FASN;PMAIP1;GADD45A;CRISPLD2;DSC2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;NMT2;SALL4;ADORA1;CASQ2;EDN1;PLAU;RAB40B;RAB40A;PHLDA1;MRO;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;SYCN;MAPK12;FZD7;TYRO3;LPAR2;LIMS2;CDH2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;CGN;REEP1;PDGFB;PLEKHH2;PTPN7;FOXO4;FRMPD1;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;PSTPIP2;SNX18;SESN2;AXIN1;RHOQ;RHOB;NUAK2;PFKFB3;PSRC1;SDC4;SPTB;HBEGF;BMP2;CAMSAP3;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;PKN3;RAB20;SLC2A14;ESPN;VAMP1;SFXN1;RND3;CHGA;MSN;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;RAB17;WNT2B;CYTIP;PTGES;KITLG;NPPC;NAB2;CDH1;EPN1;MYO7A;BCAR1;RAB44;TLE1;CLDN5;PIK3CG;RAB11FIP1;GAS6;SIN3B;ZCCHC12;MYH11;PM20D2;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;FZD8;DUSP5;HEY1;ACTA2;RNF144A;PARVB;PDE4B
11811,GO:0044446,0.89165219992262,0.134563469698665,106,8256,intracellular organelle part,CC,FHOD3;TMEM163;SYT5;WNT3;WNT4;POU3F1;TUBG2;ACTN3;ACTN2;RAB6C;TSPAN15;NOTCH1;GLDC;MARK4;RAB27A;TF;PMAIP1;GADD45A;CRISPLD2;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;SALL4;CASQ2;EDN1;PLAU;RAB40B;PHLDA1;MRO;PRKACB;SPTBN5;SPTBN4;MBOAT2;SLC25A53;TTYH1;RAB39A;SYCN;MAPK12;FZD7;TYRO3;CDH2;FSTL3;PIK3R1;CGN;REEP1;PDGFB;PLEKHH2;FOXO4;HRAS;WNT5B;WNT5A;MAGEC2;SNX18;RHOQ;RHOB;PFKFB3;PSRC1;SDC4;SPTB;HBEGF;CAMSAP3;B3GNT2;WT1;CDKN1A;HMGN5;RAB20;ESPN;VAMP1;SFXN1;RND3;CHGA;GJB1;AKT1;PKP3;PKP1;RAB12;RAB17;CYTIP;PTGES;CDH1;MYO7A;RAB44;TLE1;CLDN5;RAB11FIP1;GAS6;SIN3B;ZCCHC12;MYH11;PM20D2;GPSM1;VDR;AMOT;UNC119;RAB38;RAB3D;ACSL4;MYZAP;FAM110B;DUSP5;HEY1;RNF144A;PDE4B
6748,GO:0019884,0.892372891481138,0.350220033535234,1,172,antigen processing and presentation of exogenous antigen,BP,ITGB5
5021,GO:0010822,0.892851115414055,0.34924811961322,1,162,positive regulation of mitochondrion organization,BP,PMAIP1
19550,GO:1903320,0.893299015557658,0.270021699601448,2,274,regulation of protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1
8208,GO:0031967,0.893488313316072,0.174049915872942,10,1063,organelle envelope,CC,PMAIP1;HMGCS2;RAB40B;SLC25A53;TYRO3;REEP1;VAMP1;SFXN1;PTGES;ACSL4
8212,GO:0031975,0.893488313316072,0.174049915872942,10,1063,envelope,CC,PMAIP1;HMGCS2;RAB40B;SLC25A53;TYRO3;REEP1;VAMP1;SFXN1;PTGES;ACSL4
21653,GO:2001252,0.894512058889311,0.345677463846599,1,148,positive regulation of chromosome organization,BP,LIF
3585,GO:0007005,0.894734249841002,0.21512325890579,4,495,mitochondrion organization,BP,PMAIP1;SESN2;AKT1;RAB38
7441,GO:0030427,0.895683215616479,0.343058004645503,1,146,site of polarized growth,CC,ITGA3
2788,GO:0005775,0.896585167403228,0.340811205403632,1,164,vacuolar lumen,CC,SDC4
2761,GO:0005743,0.896594638337901,0.230802710348686,3,454,mitochondrial inner membrane,CC,HMGCS2;SLC25A53;SFXN1
9352,GO:0034248,0.89723957933463,0.229838561055758,3,366,regulation of cellular amide metabolic process,BP,SESN2;BMP4;AKT1
3574,GO:0006986,0.899317321762246,0.334596863415509,1,161,response to unfolded protein,BP,PIK3R1
11799,GO:0044429,0.899448146610236,0.173682867944449,8,919,mitochondrial part,CC,GLDC;PMAIP1;HMGCS2;SLC25A53;REEP1;VAMP1;SFXN1;ACSL4
13058,GO:0048002,0.899811531672705,0.333301251597779,1,178,antigen processing and presentation of peptide antigen,BP,ITGB5
7867,GO:0031301,0.90086133754156,0.331045019958985,1,160,integral component of organelle membrane,CC,TMEM163
11872,GO:0044712,0.903031348415041,0.164065901664663,9,922,single-organism catabolic process,BP,ACTN3;GLDC;ADORA1;KHK;SESN2;PFKFB3;AKT1;PIK3CG;PDE4B
3480,GO:0006839,0.903813796718262,0.24951313158054,2,296,mitochondrial transport,BP,PMAIP1;SLC25A53
11406,GO:0043436,0.904070386950904,0.158938618626616,10,1016,oxoacid metabolic process,BP,ACTN3;GLDC;FASN;EDN1;SESN2;PFKFB3;B3GNT2;AKT1;PTGES;ACSL4
19109,GO:1902275,0.904798918832838,0.321913835644897,1,154,regulation of chromatin organization,BP,LIF
3218,GO:0006479,0.905782099394426,0.319538164471754,1,159,protein methylation,BP,RAB3D
4011,GO:0008213,0.905782099394426,0.319538164471754,1,159,protein alkylation,BP,RAB3D
5532,GO:0015630,0.906397458316942,0.152582167057221,11,1035,microtubule cytoskeleton,CC,TUBG2;RAB6C;MARK4;PRKACB;PSRC1;CAMSAP3;AKT1;UNC119;RAB3D;FAM110B;PDE4B
6003,GO:0016579,0.906765869549026,0.243722387422894,2,276,protein deubiquitination,BP,FOXO4;AXIN1
7544,GO:0030674,0.910704517210922,0.307735566877241,1,161,protein binding, bridging,MF,PIK3R1
19836,GO:1903900,0.911211469592337,0.306376729157007,1,175,regulation of viral life cycle,BP,NOTCH1
18113,GO:0098656,0.911436326790356,0.234378998826987,2,262,anion transmembrane transport,BP,TTYH1;AKT1
5752,GO:0016070,0.911521565367229,0.115567046811064,54,4437,RNA metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;PKP3;PKP1;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
946,GO:0002221,0.91225415557241,0.303930840939424,1,165,pattern recognition receptor signaling pathway,BP,TYRO3
16061,GO:0070647,0.912605232587472,0.1436560478384,11,1072,protein modification by small protein conjugation or removal,BP,TSPAN17;FBXO41;RAB40B;RAB40A;FOXO4;MAGEC2;AXIN1;AKT1;SPSB1;DTX4;RNF144A
2977,GO:0006082,0.913286274805239,0.145530790330087,10,1031,organic acid metabolic process,BP,ACTN3;GLDC;FASN;EDN1;SESN2;PFKFB3;B3GNT2;AKT1;PTGES;ACSL4
7866,GO:0031300,0.914643769478886,0.298023684565778,1,170,intrinsic component of organelle membrane,CC,TMEM163
2969,GO:0006066,0.916409136119699,0.224094906736512,2,289,alcohol metabolic process,BP,HMGCS2;VDR
12032,GO:0045111,0.917017035270046,0.291780238412618,1,222,intermediate filament cytoskeleton,CC,PKP1
3212,GO:0006473,0.919086650024996,0.286919190816307,1,173,protein acetylation,BP,LIF
1616,GO:0003682,0.919300550203792,0.173152439232953,4,470,chromatin binding,MF,NOTCH1;FOXO4;HMGN5;SIN3B
18163,GO:0098791,0.920718187016494,0.215146446690516,2,282,Golgi subcompartment,CC,CDH1;RAB38
10149,GO:0035966,0.921274163483143,0.281333111697054,1,178,response to topologically incorrect protein,BP,PIK3R1
13564,GO:0050662,0.921564403596216,0.280600997044437,1,177,coenzyme binding,MF,FASN
16060,GO:0070646,0.921941277132037,0.212542187112905,2,291,protein modification by small protein removal,BP,FOXO4;AXIN1
6168,GO:0016874,0.922160688347563,0.279136152591968,1,170,ligase activity,MF,ACSL4
3326,GO:0006611,0.922503686901613,0.278206130736012,1,176,protein export from nucleus,BP,GAS6
3976,GO:0008168,0.92254503315811,0.278100085661282,1,176,methyltransferase activity,MF,PNMT
4353,GO:0009059,0.924908191819532,0.0982797367560528,60,4943,macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;NMT2;SALL4;DKK3;EDN1;PHLDA1;CCL20;PRND;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;NAB2;CDH1;INHBB;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
74,GO:0000151,0.925993088104913,0.203945961686863,2,286,ubiquitin ligase complex,CC,TSPAN17;RNF144A
7154,GO:0022892,0.92918465410351,0.119347486533925,11,1110,substrate-specific transporter activity,MF,TF;SLC45A4;KCNK6;TTYH1;KCNH2;SLC2A14;SFXN1;KCNG2;GAS6;KCND1;CLDN16
471,GO:0001227,0.930048356485889,0.258448101613465,1,179,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,ZFPM1
3350,GO:0006643,0.93211259523652,0.252863651583373,1,185,membrane lipid metabolic process,BP,ITGB8
3878,GO:0007623,0.933033385903474,0.250344110808629,1,189,circadian rhythm,BP,ADORA1
4352,GO:0009058,0.934413794568302,0.0852399016526478,74,6057,biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;RAB27A;PNMT;FASN;DHH;WNT6;WNT7A;ZFPM1;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;DKK3;EDN1;PHLDA1;CCL20;MBOAT2;PRND;MAPK12;FZD7;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;PTGES;KITLG;NPPC;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;ACSL4;FZD8;HEY1;PIM2
6086,GO:0016741,0.934490874023091,0.246388199164917,1,187,transferase activity, transferring one-carbon groups,MF,PNMT
18841,GO:1901576,0.935304120429644,0.0842256657951051,73,5982,organic substance biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;PNMT;FASN;DHH;WNT6;WNT7A;ZFPM1;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;DKK3;EDN1;PHLDA1;CCL20;MBOAT2;PRND;MAPK12;FZD7;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;SDC4;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;PTGES;KITLG;NPPC;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;ACSL4;FZD8;HEY1;PIM2
6116,GO:0016788,0.936910776271398,0.125192143309232,6,697,hydrolase activity, acting on ester bonds,MF,FASN;ADORA1;PTPN7;PFKFB3;DUSP5;PDE4B
286,GO:0000785,0.938511466403117,0.151957963459826,3,459,chromatin,CC,SALL4;HMGN5;SIN3B
13913,GO:0051168,0.938977337562032,0.233924524878011,1,192,nuclear export,BP,GAS6
1217,GO:0002697,0.938992415831059,0.175224225240314,2,324,regulation of immune effector process,BP,WNT5A;CLCF1
2702,GO:0005635,0.939197492757005,0.150638987727034,3,412,nuclear envelope,CC,RAB40B;TYRO3;PTGES
6740,GO:0019866,0.939967507742482,0.148960068867877,3,506,organelle inner membrane,CC,HMGCS2;SLC25A53;SFXN1
14626,GO:0055114,0.940313677441152,0.110580952209407,8,940,oxidation-reduction process,BP,ACTN3;GLDC;FASN;SESN2;PFKFB3;BMP2;AKT1;PIK3CA
17528,GO:0090304,0.941051890776034,0.0784414235055608,59,4910,nucleic acid metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;GADD45A;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
6022,GO:0016604,0.941791151903879,0.11684477601125,6,686,nuclear body,CC,GADD45A;SPTBN4;FOXO4;WT1;CDKN1A;ZCCHC12
11663,GO:0044212,0.942389868706092,0.111029667090369,7,771,transcription regulatory region DNA binding,MF,NOTCH1;GADD45A;ZFPM1;SALL4;WNT5A;WT1;VDR
6097,GO:0016758,0.942416133393718,0.22416514102688,1,193,transferase activity, transferring hexosyl groups,MF,B3GNT2
360,GO:0000975,0.943358948925938,0.109406775176174,7,773,regulatory region DNA binding,MF,NOTCH1;GADD45A;ZFPM1;SALL4;WNT5A;WT1;VDR
406,GO:0001067,0.943890773691592,0.108514275374956,7,774,regulatory region nucleic acid binding,MF,NOTCH1;GADD45A;ZFPM1;SALL4;WNT5A;WT1;VDR
14170,GO:0051603,0.945150842053724,0.117095680029912,5,617,proteolysis involved in cellular protein catabolic process,BP,PMAIP1;AXIN1;AKT1;ARAF;RNF144A
18847,GO:1901605,0.946004187734615,0.213690217554638,1,206,alpha-amino acid metabolic process,BP,GLDC
15581,GO:0061630,0.94614473575623,0.21334136811796,1,195,ubiquitin protein ligase activity,MF,RNF144A
3202,GO:0006457,0.94732535232671,0.209725783108439,1,221,protein folding,BP,NPPC
11688,GO:0044249,0.948629328056496,0.0679126412484211,71,5897,cellular biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;PNMT;FASN;WNT6;WNT7A;ZFPM1;HMGCS2;ACVR1;NMT2;SALL4;GUCY1B3;DKK3;EDN1;PHLDA1;CCL20;MBOAT2;PRND;MAPK12;FZD7;FSTL3;FGF10;FGF17;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;PTGES;KITLG;NPPC;NAB2;CDH1;INHBB;TLE1;PIK3CA;PIK3CG;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;ACSL4;FZD8;HEY1;PIM2
3237,GO:0006508,0.949746760952711,0.0812758550579005,16,1634,proteolysis,BP,PMAIP1;RHBDL3;DHH;SERPINA5;PLAU;PRKACB;MAPK12;FOXO4;AXIN1;CTGF;AKT1;CST9L;GAS6;PM20D2;ARAF;RNF144A
15593,GO:0061659,0.950004666205436,0.201843121452231,1,200,ubiquitin-like protein ligase activity,MF,RNF144A
4041,GO:0008270,0.95034652715204,0.0890485295341609,10,1061,zinc ion binding,MF,TMEM163;DHH;RABIF;LIMS2;WT1;DRP2;DTX4;ZCCHC12;VDR;RNF144A
312,GO:0000819,0.950958028719319,0.198931987009464,1,206,sister chromatid segregation,BP,PSRC1
5935,GO:0016458,0.956345381623748,0.182124207680814,1,248,gene silencing,BP,BMP4
9533,GO:0034645,0.95722505820266,0.0583081884670452,56,4781,cellular macromolecule biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;NMT2;SALL4;DKK3;EDN1;PHLDA1;PRND;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;PSRC1;FGF8;HBEGF;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;KITLG;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
14173,GO:0051607,0.957262012254446,0.179293916122467,1,231,defense response to virus,BP,PMAIP1
3239,GO:0006511,0.958933092775809,0.098370119560163,4,548,ubiquitin-dependent protein catabolic process,BP,AXIN1;AKT1;ARAF;RNF144A
3012,GO:0006139,0.961433643850435,0.0521769622780206,65,5512,nucleobase-containing compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;GADD45A;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
6775,GO:0019941,0.961593931186387,0.0929293338146344,4,555,modification-dependent protein catabolic process,BP,AXIN1;AKT1;ARAF;RNF144A
3865,GO:0007608,0.961648779959968,0.164781728766295,1,402,sensory perception of smell,BP,B3GNT2
18834,GO:1901566,0.962160274109584,0.0682708733675406,11,1317,organonitrogen compound biosynthetic process,BP,PNMT;GUCY1B3;EDN1;PDGFB;SESN2;NPR1;SDC4;BMP4;B3GNT2;AKT1;NPPC
11705,GO:0044271,0.963616716211917,0.0502492583494055,54,4709,cellular nitrogen compound biosynthetic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN2;NOTCH1;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PSRC1;FGF8;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CTGF;AKT1;NPPC;NAB2;CDH1;TLE1;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2
11524,GO:0043632,0.963779491964054,0.0884083539690827,4,561,modification-dependent macromolecule catabolic process,BP,AXIN1;AKT1;ARAF;RNF144A
10594,GO:0040029,0.964429538874566,0.15583438522889,1,262,regulation of gene expression, epigenetic,BP,BMP4
2773,GO:0005759,0.966419732602771,0.108448704974219,2,410,mitochondrial matrix,CC,GLDC;HMGCS2
19182,GO:1902494,0.966425296336332,0.0613284097245998,11,1259,catalytic complex,CC,TSPAN17;GLDC;ACVR1;PIK3R2;PIK3R1;SESN2;CDKN1A;PIK3CA;PIK3CG;SIN3B;RNF144A
12872,GO:0046914,0.967293652267564,0.0586585320327515,12,1303,transition metal ion binding,MF,TMEM163;TF;DHH;RABIF;PRND;LIMS2;WT1;DRP2;DTX4;ZCCHC12;VDR;RNF144A
7335,GO:0030246,0.970516562780567,0.134870256470162,1,256,carbohydrate binding,MF,LGALS4
5464,GO:0015291,0.970694302902672,0.134331110542661,1,227,secondary active transmembrane transporter activity,MF,SLC45A4
11486,GO:0043565,0.971278132811422,0.0580291536509685,8,957,sequence-specific DNA binding,MF,POU3F1;NOTCH1;ZFPM1;SALL4;FOXO4;WT1;VDR;HEY1
11234,GO:0043169,0.971590875389189,0.0404254941227909,47,4015,cation binding,MF,ITGA3;ITGA5;TMEM163;SYT5;ACTN3;ACTN2;NOTCH1;GLDC;CDH23;TF;RHBDL3;DHH;DSC2;SERPINA5;ZFPM1;ACVR1;RABIF;SALL4;GUCY1B3;CASQ2;PRKACB;TTYH1;PRND;MAPK12;LIMS2;CDH2;SESN2;NUAK2;WT1;CDKN1A;DLL1;DRP2;DDR1;DSG3;TPD52;JAG2;CDH1;HPCAL1;GAS6;DTX4;ZCCHC12;DSC3;VDR;ARAF;KCND1;RNF144A;PDE4B
366,GO:0000981,0.972290041465567,0.0650428321392134,5,676,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,ZFPM1;FOXO4;WT1;VDR;HEY1
11504,GO:0043603,0.97248836469776,0.0608713821541481,6,882,cellular amide metabolic process,BP,ITGB8;FASN;SESN2;BMP4;AKT1;GAS6
12664,GO:0046483,0.97268208719558,0.0376094381410175,66,5674,heterocycle metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;GADD45A;WNT6;WNT7A;ZFPM1;SLC52A3;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
13663,GO:0050792,0.972917506540526,0.126249241791926,1,258,regulation of viral process,BP,NOTCH1
367,GO:0000982,0.97314821372677,0.0903600365815258,2,366,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,ZFPM1;WT1
4020,GO:0008233,0.973228251599198,0.0682374693330872,4,614,peptidase activity,MF,RHBDL3;DHH;PLAU;PM20D2
18780,GO:1901360,0.973796402028978,0.0360178359708117,69,5915,organic cyclic compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;PNMT;GADD45A;DHH;WNT6;WNT7A;ZFPM1;SLC52A3;HMGCS2;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
3110,GO:0006310,0.974554715155332,0.120272149634677,1,250,DNA recombination,BP,CLCF1
1878,GO:0004175,0.975124092086734,0.0848033774605344,2,405,endopeptidase activity,MF,RHBDL3;PLAU
4111,GO:0008380,0.976472997134042,0.080990519629416,2,401,RNA splicing,BP,PIK3R1;WT1
3411,GO:0006725,0.976649619740173,0.0324126198969545,66,5710,cellular aromatic compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;PNMT;GADD45A;WNT6;WNT7A;ZFPM1;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
3169,GO:0006412,0.97692535297891,0.0670522137603944,3,581,translation,BP,SESN2;BMP4;AKT1
412,GO:0001077,0.977786733637123,0.108093267090613,1,255,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,WT1
6096,GO:0016757,0.977953840450823,0.107437221841823,1,261,transferase activity, transferring glycosyl groups,MF,B3GNT2
4590,GO:0009593,0.978265922788846,0.105975477100671,1,454,detection of chemical stimulus,BP,CASQ2
3222,GO:0006486,0.978525573236468,0.105232720300874,1,261,protein glycosylation,BP,B3GNT2
11393,GO:0043413,0.978525573236468,0.105232720300874,1,261,macromolecule glycosylation,BP,B3GNT2
18181,GO:0098813,0.979341502011393,0.102050526509487,1,265,nuclear chromosome segregation,BP,PSRC1
11563,GO:0043903,0.979881715808403,0.0999004919752117,1,280,regulation of symbiosis, encompassing mutualism through parasitism,BP,NOTCH1
290,GO:0000790,0.980037929199735,0.099248582556263,1,300,nuclear chromatin,CC,SIN3B
7477,GO:0030522,0.980423204483485,0.0977995172989818,1,262,intracellular receptor signaling pathway,BP,VDR
15724,GO:0070085,0.98099587042664,0.0955059398430007,1,269,glycosylation,BP,B3GNT2
11163,GO:0043043,0.982140353354252,0.0538873558394968,3,605,peptide biosynthetic process,BP,SESN2;BMP4;AKT1
3864,GO:0007606,0.982987002869333,0.0872156249890388,1,473,sensory perception of chemical stimulus,BP,B3GNT2
13745,GO:0050906,0.983069693608391,0.0868795292352233,1,468,detection of stimulus involved in sensory perception,BP,ADORA1
5951,GO:0016491,0.983144215424624,0.0457063570706876,4,701,oxidoreductase activity,MF,GLDC;FASN;SESN2;BMP2
1625,GO:0003700,0.983553709200778,0.0330150913584946,10,1183,transcription factor activity, sequence-specific DNA binding,MF,POU3F1;NOTCH1;ZFPM1;SALL4;FOXO4;WNT5A;WT1;LZTS1;VDR;HEY1
409,GO:0001071,0.983697047752032,0.0327540559265503,10,1184,nucleic acid binding transcription factor activity,MF,POU3F1;NOTCH1;ZFPM1;SALL4;FOXO4;WNT5A;WT1;LZTS1;VDR;HEY1
3244,GO:0006518,0.983788209283814,0.0441737265138345,4,735,peptide metabolic process,BP,SESN2;BMP4;AKT1;GAS6
5993,GO:0016569,0.984377681863318,0.0480805746230676,3,516,covalent chromatin modification,BP,LIF;HMGN5;SIN3B
5994,GO:0016570,0.985777476030956,0.0532033647053942,2,410,histone modification,BP,LIF;SIN3B
8908,GO:0033044,0.985783215374546,0.0756877736923481,1,281,regulation of chromosome organization,BP,LIF
12842,GO:0046872,0.986629346016191,0.0200171653970889,44,3929,metal ion binding,MF,ITGA3;ITGA5;TMEM163;SYT5;ACTN3;ACTN2;NOTCH1;CDH23;TF;RHBDL3;DHH;DSC2;ZFPM1;ACVR1;RABIF;SALL4;GUCY1B3;CASQ2;PRKACB;TTYH1;PRND;MAPK12;LIMS2;CDH2;NUAK2;WT1;CDKN1A;DLL1;DRP2;DDR1;DSG3;TPD52;JAG2;CDH1;HPCAL1;GAS6;DTX4;ZCCHC12;DSC3;VDR;ARAF;KCND1;RNF144A;PDE4B
17776,GO:0097159,0.987611034799432,0.0177488523305387,66,5716,organic cyclic compound binding,MF,ADRA2B;ADRA2C;POU3F1;TUBG2;RAB6C;NOTCH1;GLDC;MARK4;RAB27A;RASL11B;FASN;GADD45A;ZFPM1;ACVR1;SALL4;GUCY1B3;ADORA1;RAB40B;RAB40A;PRKACB;FLVCR2;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;WT1;HMGN5;PKN3;RAB20;WNK4;RND3;MSN;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;ZCCHC12;MYH11;LZTS1;VDR;ARAF;RAB38;RAB3D;ACSL4;HEY1;ACTA2;PIM2;PDE4B
3115,GO:0006325,0.988593139742425,0.0324871604953461,4,709,chromatin organization,BP,LIF;ZFPM1;HMGN5;SIN3B
3623,GO:0007059,0.989267217530686,0.0602257514314343,1,308,chromosome segregation,BP,PSRC1
15686,GO:0070011,0.990323515358384,0.0317608865841491,3,596,peptidase activity, acting on L-amino acid peptides,MF,RHBDL3;PLAU;PM20D2
4195,GO:0008509,0.99044722569032,0.0547596873401885,1,304,anion transmembrane transporter activity,MF,TTYH1
10948,GO:0042623,0.990537970243443,0.0543318810018539,1,305,ATPase activity, coupled,MF,MYO7A
18783,GO:1901363,0.991619813154159,0.0122662475424447,64,5633,heterocyclic compound binding,MF,POU3F1;TUBG2;RAB6C;NOTCH1;GLDC;MARK4;RAB27A;RASL11B;FASN;GADD45A;ZFPM1;ACVR1;SALL4;GUCY1B3;ADORA1;RAB40B;RAB40A;PRKACB;FLVCR2;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;PRKAR1B;FOXO4;RALB;HRAS;WNT5A;KHK;RHOQ;RHOJ;RHOB;NPR1;NUAK2;PFKFB3;WT1;HMGN5;PKN3;RAB20;WNK4;RND3;MSN;DDR1;RRAD;AKT1;RAB12;RAB17;MYO7A;RAB44;PIK3CA;PIK3CG;ZCCHC12;MYH11;LZTS1;VDR;ARAF;RAB38;RAB3D;ACSL4;HEY1;ACTA2;PIM2;PDE4B
3245,GO:0006520,0.991853490476774,0.0480019196669138,1,349,cellular amino acid metabolic process,BP,GLDC
11505,GO:0043604,0.992154142697694,0.026441415467248,3,676,amide biosynthetic process,BP,SESN2;BMP4;AKT1
9530,GO:0034641,0.992692200170896,0.0106970896109398,68,6132,cellular nitrogen compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;ITGB8;FASN;GADD45A;WNT6;WNT7A;ZFPM1;SLC52A3;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;CLCF1;BMP7;BMP6;BMP4;BMP2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
3085,GO:0006281,0.992694199844622,0.0301655388654319,2,493,DNA repair,BP,GADD45A;FGF10
11816,GO:0044451,0.992798829254681,0.0174731591764186,7,1010,nucleoplasm part,CC,GADD45A;SPTBN4;FOXO4;WT1;CDKN1A;SIN3B;ZCCHC12
2752,GO:0005730,0.993517702520334,0.0180054161324557,5,861,nucleolus,CC,PHLDA1;MRO;MAGEC2;WT1;CDKN1A
6381,GO:0018205,0.994089745063558,0.0367935318891163,1,342,peptidyl-lysine modification,BP,LIF
5753,GO:0016071,0.994321073023824,0.019920257865379,3,674,mRNA metabolic process,BP,PRR5L;PKP3;PKP1
3458,GO:0006807,0.994619204822209,0.00792921448148959,73,6563,nitrogen compound metabolic process,BP,ITGA3;LIF;WNT2;WNT4;POU3F1;ACTN3;ACTN2;NOTCH1;GLDC;PNMT;ITGB8;FASN;GADD45A;WNT6;WNT7A;ZFPM1;SLC52A3;ACVR1;SALL4;GUCY1B3;DKK3;EDN1;MBOAT2;MAPK12;FZD7;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;PDGFB;FOXO4;HRAS;WNT5A;SESN2;AXIN1;RHOQ;NPR1;PFKFB3;PSRC1;FGF8;SDC4;CLCF1;BMP7;BMP6;BMP4;BMP2;B3GNT2;WT1;CDKN1A;DLL1;HMGN5;CHGA;CTGF;AKT1;PKP3;PKP1;KITLG;NPPC;NAB2;CDH1;TLE1;PIK3CA;GAS6;SIN3B;ZCCHC12;LZTS1;VDR;GDNF;FZD8;HEY1;PIM2;PDE4B
472,GO:0001228,0.994781134612426,0.0331568622056647,1,352,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,WT1
7126,GO:0022804,0.995044066443519,0.031753331398314,1,350,active transmembrane transporter activity,MF,SLC45A4
8211,GO:0031974,0.997582395617009,0.00389534978180407,47,4694,membrane-enclosed lumen,CC,WNT3;WNT4;POU3F1;ACTN2;NOTCH1;GLDC;RAB27A;TF;GADD45A;CRISPLD2;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;SALL4;CASQ2;EDN1;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;FSTL3;PDGFB;FOXO4;WNT5B;WNT5A;MAGEC2;PFKFB3;PSRC1;SDC4;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;PTGES;TLE1;GAS6;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
11280,GO:0043233,0.997582395617009,0.00389534978180407,47,4694,organelle lumen,CC,WNT3;WNT4;POU3F1;ACTN2;NOTCH1;GLDC;RAB27A;TF;GADD45A;CRISPLD2;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;SALL4;CASQ2;EDN1;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;FSTL3;PDGFB;FOXO4;WNT5B;WNT5A;MAGEC2;PFKFB3;PSRC1;SDC4;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;PTGES;TLE1;GAS6;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
15688,GO:0070013,0.997582395617009,0.00389534978180407,47,4694,intracellular organelle lumen,CC,WNT3;WNT4;POU3F1;ACTN2;NOTCH1;GLDC;RAB27A;TF;GADD45A;CRISPLD2;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;SALL4;CASQ2;EDN1;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;FSTL3;PDGFB;FOXO4;WNT5B;WNT5A;MAGEC2;PFKFB3;PSRC1;SDC4;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;PTGES;TLE1;GAS6;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
6180,GO:0016887,0.998162600227306,0.0136565473631395,1,406,ATPase activity,MF,MYO7A
11819,GO:0044454,0.998535197106091,0.0112221586952448,1,476,nuclear chromosome part,CC,SIN3B
1620,GO:0003690,0.998706380480099,0.00533961748776778,3,723,double-stranded DNA binding,MF,ZFPM1;WT1;HEY1
11797,GO:0044427,0.998808231634287,0.00495740362465072,3,793,chromosomal part,CC,SALL4;HMGN5;SIN3B
9544,GO:0034660,0.998974099660015,0.00823548679055205,1,529,ncRNA metabolic process,BP,HRAS
113,GO:0000228,0.999114109686071,0.00724882602665168,1,508,nuclear chromosome,CC,SIN3B
7480,GO:0030529,0.999433893613095,0.00317050400802632,2,756,intracellular ribonucleoprotein complex,CC,PKP3;PKP1
20893,GO:1990837,0.999436140239173,0.00316181787322088,2,653,sequence-specific double-stranded DNA binding,MF,ZFPM1;HEY1
20910,GO:1990904,0.999442764066024,0.0031258636941677,2,757,ribonucleoprotein complex,CC,PKP3;PKP1
3155,GO:0006396,0.999449758824227,0.00246358371208948,3,872,RNA processing,BP,PIK3R1;BMP4;WT1
13987,GO:0051276,0.99955914992872,0.00155709629452688,5,1106,chromosome organization,BP,LIF;ZFPM1;PSRC1;HMGN5;SIN3B
362,GO:0000977,0.999697791741244,0.00281198459769316,1,542,RNA polymerase II regulatory region sequence-specific DNA binding,MF,ZFPM1
388,GO:0001012,0.999702976092267,0.00276910711047371,1,543,RNA polymerase II regulatory region DNA binding,MF,ZFPM1
2742,GO:0005694,0.999703556600005,0.00140243565050349,3,897,chromosome,CC,SALL4;HMGN5;SIN3B
2711,GO:0005654,0.999862987009883,0.000285796454787117,25,3159,nucleoplasm,CC,POU3F1;NOTCH1;GADD45A;ZFPM1;SALL4;PRKACB;SPTBN4;MAPK12;FSTL3;FOXO4;PFKFB3;PSRC1;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;TLE1;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
11278,GO:0043231,0.999898498144519,0.000168304292070276,111,9934,intracellular membrane-bounded organelle,CC,ITGA5;BEX4;WNT3;WNT4;POU3F1;RAB6C;NOTCH1;GLDC;RAB27A;ITGB4;FASN;PMAIP1;GADD45A;SERPINA5;WNT6;WNT7A;WNT7B;ZFPM1;HMGCS2;NMT2;SALL4;ADORA1;CASQ2;EDN1;RAB40B;PHLDA1;MRO;PRKACB;SPTBN4;MBOAT2;SLC25A53;TTYH1;RRAS2;RAB39B;RAB39A;MAPK12;TYRO3;LIMS2;PRR5L;FSTL3;FGF10;PIK3R2;PIK3R1;REEP1;PDGFB;FOXO4;RALB;TJP3;HRAS;WNT5B;WNT5A;MAGEC2;SESN2;AXIN1;RHOQ;RHOB;NUAK2;PFKFB3;PSRC1;SDC4;SPTB;BMP2;B3GNT2;WT1;CDKN1A;HMGN5;PKN3;RAB20;SLC2A14;VAMP1;SFXN1;RND3;CHGA;MSN;CTGF;GJB1;GJB2;TPD52;AKT1;PKP3;PKP1;RAB12;WNT2B;CYTIP;PTGES;NAB2;CDH1;EPN1;MYO7A;RAB44;TLE1;PIK3CG;RAB11FIP1;GAS6;SIN3B;ZCCHC12;PM20D2;GPSM1;VDR;AMOT;LAMA5;ARAF;SH3BP4;RAB38;RAB3D;ACSL4;FAM110B;FZD8;DUSP5;HEY1;RNF144A
361,GO:0000976,0.999912275881171,0.000929697890953865,1,618,transcription regulatory region sequence-specific DNA binding,MF,ZFPM1
11798,GO:0044428,0.999984267393244,3.34072173577698e-05,32,4050,nuclear part,CC,POU3F1;NOTCH1;GADD45A;ZFPM1;SALL4;RAB40B;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;TYRO3;FSTL3;FOXO4;MAGEC2;PFKFB3;PSRC1;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;PTGES;TLE1;SIN3B;ZCCHC12;PM20D2;VDR;AMOT;DUSP5;HEY1
8213,GO:0031981,0.999986174368888,3.05838956550818e-05,28,3713,nuclear lumen,CC,POU3F1;NOTCH1;GADD45A;ZFPM1;SALL4;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;FSTL3;FOXO4;MAGEC2;PFKFB3;PSRC1;WT1;CDKN1A;AKT1;PKP3;PKP1;CYTIP;TLE1;SIN3B;ZCCHC12;PM20D2;VDR;DUSP5;HEY1
1613,GO:0003677,0.999999058918484,3.12759177164808e-06,12,2382,DNA binding,MF,POU3F1;NOTCH1;GADD45A;ZFPM1;SALL4;FOXO4;WNT5A;WT1;HMGN5;LZTS1;VDR;HEY1
1634,GO:0003723,0.999999453609646,3.31423954080024e-06,4,1541,RNA binding,MF,FASN;WT1;HMGN5;MSN
2701,GO:0005634,0.999999971981807,6.25907492582099e-08,55,6684,nucleus,CC,BEX4;POU3F1;RAB6C;NOTCH1;GLDC;ITGB4;PMAIP1;GADD45A;ZFPM1;SALL4;RAB40B;PHLDA1;MRO;PRKACB;SPTBN4;MAPK12;TYRO3;LIMS2;FSTL3;FGF10;PIK3R2;PIK3R1;FOXO4;TJP3;HRAS;MAGEC2;SESN2;AXIN1;RHOB;NUAK2;PFKFB3;PSRC1;WT1;CDKN1A;HMGN5;PKN3;SLC2A14;MSN;AKT1;PKP3;PKP1;CYTIP;PTGES;NAB2;EPN1;TLE1;SIN3B;ZCCHC12;PM20D2;VDR;AMOT;LAMA5;SH3BP4;DUSP5;HEY1
15399,GO:0061158,0.999999999999997,0.825565947939195,0,12,3'-UTR-mediated mRNA destabilization,BP,
3648,GO:0007100,1,0.82144033448291,0,13,mitotic centrosome separation,BP,
3,GO:0000009,1,0.985272691223766,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.972216461946577,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000012,1,0.89270507033136,0,8,single strand break repair,BP,
6,GO:0000014,1,0.894734902511607,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
7,GO:0000015,1,0.947670781001656,0,4,phosphopyruvate hydratase complex,CC,
8,GO:0000016,1,0.983406759351575,0,1,lactase activity,MF,
10,GO:0000019,1,0.924135643194005,0,5,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.862315797476884,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.951065741678,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.953328053134241,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.790392349522275,0,22,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.89498197811605,0,15,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.742084901140866,0,23,mannosyltransferase activity,MF,
17,GO:0000032,1,0.987784806077991,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.961741113711561,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.978764634116489,0,2,acyl binding,MF,
20,GO:0000036,1,0.994875889508817,0,1,ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process,MF,
21,GO:0000038,1,0.685817950648404,0,26,very long-chain fatty acid metabolic process,BP,
23,GO:0000042,1,0.72815944441298,0,19,protein targeting to Golgi,BP,
25,GO:0000049,1,0.486084857290003,0,49,tRNA binding,MF,
26,GO:0000050,1,0.865745256492873,0,11,urea cycle,BP,
27,GO:0000052,1,0.88907622174065,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.987523128423052,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.863627364480595,0,12,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.915156287102213,0,7,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.929925824121039,0,6,ribosomal small subunit export from nucleus,BP,
33,GO:0000062,1,0.805970074466795,0,16,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.957220350084556,0,3,L-ornithine transmembrane transporter activity,MF,
35,GO:0000066,1,0.973373563672801,0,2,mitochondrial ornithine transport,BP,
38,GO:0000076,1,0.793079494174775,0,17,DNA replication checkpoint,BP,
42,GO:0000083,1,0.690432065346381,0,25,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
44,GO:0000095,1,0.98578926837925,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
45,GO:0000096,1,0.574673833135526,0,38,sulfur amino acid metabolic process,BP,
46,GO:0000097,1,0.79494191878082,0,16,sulfur amino acid biosynthetic process,BP,
47,GO:0000098,1,0.862859613662669,0,10,sulfur amino acid catabolic process,BP,
48,GO:0000099,1,0.896186343645213,0,7,sulfur amino acid transmembrane transporter activity,MF,
49,GO:0000101,1,0.911313760578422,0,6,sulfur amino acid transport,BP,
50,GO:0000103,1,0.95965709193667,0,3,sulfate assimilation,BP,
51,GO:0000104,1,0.951992044001775,0,4,succinate dehydrogenase activity,MF,
52,GO:0000105,1,0.969039888476289,0,2,histidine biosynthetic process,BP,
53,GO:0000109,1,0.811049267343476,0,15,nucleotide-excision repair complex,CC,
54,GO:0000110,1,0.95638796533979,0,3,nucleotide-excision repair factor 1 complex,CC,
55,GO:0000111,1,0.983432360355796,0,1,nucleotide-excision repair factor 2 complex,CC,
56,GO:0000117,1,0.983406759351775,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
58,GO:0000120,1,0.932683541732651,0,5,RNA polymerase I transcription factor complex,CC,
59,GO:0000121,1,0.983697909677509,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000123,1,0.318849716395135,0,78,histone acetyltransferase complex,CC,
62,GO:0000124,1,0.862912718552335,0,11,SAGA complex,CC,
63,GO:0000125,1,0.941918134078098,0,5,PCAF complex,CC,
64,GO:0000126,1,0.967111480802227,0,2,transcription factor TFIIIB complex,CC,
65,GO:0000127,1,0.915175980621265,0,6,transcription factor TFIIIC complex,CC,
67,GO:0000137,1,0.9129468655662,0,6,Golgi cis cisterna,CC,
68,GO:0000138,1,0.929090140800184,0,5,Golgi trans cisterna,CC,
73,GO:0000150,1,0.892768188981343,0,8,recombinase activity,MF,
75,GO:0000152,1,0.585161576198952,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.848964207514881,0,12,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.713365301172487,0,27,rRNA modification,BP,
79,GO:0000159,1,0.734735990604357,0,20,protein phosphatase type 2A complex,CC,
81,GO:0000164,1,0.860295781061009,0,10,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.989852633883451,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.968595716073957,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.968595716073957,0,2,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.988431419314424,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.669776170157091,0,28,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.887951696267122,0,11,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.877765783336895,0,10,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.751929554031273,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.94876163968384,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.854871665028384,0,10,rDNA binding,MF,
94,GO:0000183,1,0.763960468579573,0,39,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.327745227855251,0,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
100,GO:0000189,1,0.954785709320522,0,3,MAPK import into nucleus,BP,
102,GO:0000210,1,0.983467280377892,0,1,NAD+ diphosphatase activity,MF,
103,GO:0000212,1,0.852958799076687,0,11,meiotic spindle organization,BP,
104,GO:0000213,1,0.946768345171208,0,4,tRNA-intron endonuclease activity,MF,
105,GO:0000214,1,0.947733711779776,0,4,tRNA-intron endonuclease complex,CC,
106,GO:0000215,1,0.992426565083806,0,1,tRNA 2'-phosphotransferase activity,MF,
107,GO:0000217,1,0.704233193828644,0,23,DNA secondary structure binding,MF,
108,GO:0000220,1,0.922136157024817,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
109,GO:0000221,1,0.95404998578644,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
110,GO:0000224,1,0.984785340412547,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
111,GO:0000225,1,0.991437917127923,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
114,GO:0000229,1,0.980599092799878,0,2,cytoplasmic chromosome,CC,
115,GO:0000235,1,0.92192242783043,0,5,astral microtubule,CC,
117,GO:0000243,1,0.905453915596102,0,8,commitment complex,CC,
118,GO:0000244,1,0.826737407337043,0,12,spliceosomal tri-snRNP complex assembly,BP,
119,GO:0000245,1,0.460809489575554,0,55,spliceosomal complex assembly,BP,
120,GO:0000246,1,0.98340675935207,0,1,delta24(24-1) sterol reductase activity,MF,
121,GO:0000247,1,0.991424705107005,0,1,C-8 sterol isomerase activity,MF,
122,GO:0000248,1,0.983406759352021,0,1,C-5 sterol desaturase activity,MF,
123,GO:0000250,1,0.98340675935207,0,1,lanosterol synthase activity,MF,
124,GO:0000252,1,0.988708213662624,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
125,GO:0000253,1,0.971775308184179,0,3,3-keto sterol reductase activity,MF,
126,GO:0000254,1,0.984725543253726,0,1,C-4 methylsterol oxidase activity,MF,
127,GO:0000255,1,0.941123281495055,0,4,allantoin metabolic process,BP,
128,GO:0000256,1,0.989576581289443,0,1,allantoin catabolic process,BP,
129,GO:0000257,1,0.990090677622663,0,1,nitrilase activity,MF,
130,GO:0000262,1,0.988736001529085,0,1,mitochondrial chromosome,CC,
131,GO:0000266,1,0.600171178943318,0,33,mitochondrial fission,BP,
132,GO:0000268,1,0.929293381135476,0,5,peroxisome targeting sequence binding,MF,
133,GO:0000270,1,0.940093979077931,0,7,peptidoglycan metabolic process,BP,
135,GO:0000272,1,0.648419409921579,0,29,polysaccharide catabolic process,BP,
136,GO:0000274,1,0.995451832282456,0,1,mitochondrial proton-transporting ATP synthase, stator stalk,CC,
137,GO:0000275,1,0.969601200072378,0,4,mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),CC,
138,GO:0000276,1,0.92571632062131,0,10,mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),CC,
142,GO:0000285,1,0.942516208859505,0,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
144,GO:0000288,1,0.371275962601798,0,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
145,GO:0000289,1,0.594099791716373,0,34,nuclear-transcribed mRNA poly(A) tail shortening,BP,
146,GO:0000290,1,0.881500348750547,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
147,GO:0000291,1,0.653145678020831,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
148,GO:0000293,1,0.952451004552008,0,3,ferric-chelate reductase activity,MF,
149,GO:0000294,1,0.968013582603194,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
150,GO:0000295,1,0.85525024843359,0,11,adenine nucleotide transmembrane transporter activity,MF,
151,GO:0000296,1,0.985564663058066,0,1,spermine transport,BP,
152,GO:0000298,1,0.946675313860854,0,4,endopolyphosphatase activity,MF,
153,GO:0000301,1,0.673934727720794,0,24,retrograde transport, vesicle recycling within Golgi,BP,
157,GO:0000306,1,0.953324876174232,0,3,extrinsic component of vacuolar membrane,CC,
159,GO:0000308,1,0.967087814754631,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
160,GO:0000309,1,0.954890586254582,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
161,GO:0000313,1,0.494922771490844,0,78,organellar ribosome,CC,
162,GO:0000314,1,0.787378663709322,0,26,organellar small ribosomal subunit,CC,
163,GO:0000315,1,0.637922141857871,0,49,organellar large ribosomal subunit,CC,
164,GO:0000320,1,0.951038409344209,0,3,re-entry into mitotic cell cycle,BP,
165,GO:0000322,1,0.959885559747881,0,3,storage vacuole,CC,
167,GO:0000333,1,0.967087733487774,0,2,telomerase catalytic core complex,CC,
168,GO:0000334,1,0.990564716460073,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
169,GO:0000338,1,0.878112060634675,0,10,protein deneddylation,BP,
170,GO:0000339,1,0.811091284950613,0,15,RNA cap binding,MF,
171,GO:0000340,1,0.898741323853125,0,7,RNA 7-methylguanosine cap binding,MF,
172,GO:0000346,1,0.83446339859447,0,13,transcription export complex,CC,
173,GO:0000347,1,0.926612972657108,0,6,THO complex,CC,
174,GO:0000349,1,0.985358549378959,0,1,generation of catalytic spliceosome for first transesterification step,BP,
175,GO:0000350,1,0.962588758256398,0,3,generation of catalytic spliceosome for second transesterification step,BP,
176,GO:0000354,1,0.967253815747029,0,2,cis assembly of pre-catalytic spliceosome,BP,
177,GO:0000375,1,0.0129124532959279,0,309,RNA splicing, via transesterification reactions,BP,
178,GO:0000377,1,0.0134314835506696,0,306,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
179,GO:0000379,1,0.959321944537479,0,3,tRNA-type intron splice site recognition and cleavage,BP,
180,GO:0000380,1,0.486435945573007,0,48,alternative mRNA splicing, via spliceosome,BP,
181,GO:0000381,1,0.573658294992107,0,37,regulation of alternative mRNA splicing, via spliceosome,BP,
182,GO:0000384,1,0.977082260991933,0,2,first spliceosomal transesterification activity,MF,
183,GO:0000386,1,0.971758696638726,0,2,second spliceosomal transesterification activity,MF,
184,GO:0000387,1,0.608051751581604,0,38,spliceosomal snRNP assembly,BP,
185,GO:0000389,1,0.914273999252131,0,6,mRNA 3'-splice site recognition,BP,
186,GO:0000390,1,0.975279231834399,0,2,spliceosomal complex disassembly,BP,
187,GO:0000393,1,0.948492848598302,0,4,spliceosomal conformational changes to generate catalytic conformation,BP,
188,GO:0000394,1,0.809856744959159,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
189,GO:0000395,1,0.915961380060351,0,6,mRNA 5'-splice site recognition,BP,
190,GO:0000398,1,0.0134314835506696,0,306,mRNA splicing, via spliceosome,BP,
191,GO:0000400,1,0.786082108767325,0,16,four-way junction DNA binding,MF,
192,GO:0000403,1,0.936034523061817,0,4,Y-form DNA binding,MF,
193,GO:0000404,1,0.983432360355796,0,1,heteroduplex DNA loop binding,MF,
194,GO:0000405,1,0.891152162011527,0,7,bubble DNA binding,MF,
195,GO:0000407,1,0.650292605301201,0,27,pre-autophagosomal structure,CC,
196,GO:0000408,1,0.958534436928153,0,3,EKC/KEOPS complex,CC,
197,GO:0000409,1,0.983406759351429,0,1,regulation of transcription by galactose,BP,
198,GO:0000411,1,0.983406759351429,0,1,positive regulation of transcription by galactose,BP,
199,GO:0000413,1,0.651048965008239,0,38,protein peptidyl-prolyl isomerization,BP,
200,GO:0000414,1,0.935675897609655,0,4,regulation of histone H3-K36 methylation,BP,
201,GO:0000415,1,0.983406759351575,0,1,negative regulation of histone H3-K36 methylation,BP,
202,GO:0000416,1,0.983416289398154,0,1,positive regulation of histone H3-K36 methylation,BP,
203,GO:0000421,1,0.676020885899569,0,28,autophagosome membrane,CC,
204,GO:0000422,1,0.330343774506784,0,77,mitophagy,BP,
205,GO:0000423,1,0.771536632683299,0,17,macromitophagy,BP,
206,GO:0000428,1,0.17482875175298,0,125,DNA-directed RNA polymerase complex,CC,
207,GO:0000429,1,0.946033436922638,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
208,GO:0000430,1,0.961998655171537,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
209,GO:0000431,1,0.983406759351429,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
210,GO:0000432,1,0.961998655171537,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
211,GO:0000433,1,0.985154132624775,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
212,GO:0000435,1,0.983406759351429,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
213,GO:0000436,1,0.946033436922638,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
214,GO:0000437,1,0.985154132624775,0,1,carbon catabolite repression of transcription from RNA polymerase II promoter,BP,
215,GO:0000438,1,0.964560327358931,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
216,GO:0000439,1,0.892903601597061,0,8,core TFIIH complex,CC,
217,GO:0000444,1,0.946988635101955,0,4,MIS12/MIND type complex,CC,
218,GO:0000445,1,0.926612972657108,0,6,THO complex part of transcription export complex,CC,
219,GO:0000447,1,0.890417172124987,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
220,GO:0000448,1,0.968897261966854,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
221,GO:0000451,1,0.971109564460838,0,2,rRNA 2'-O-methylation,BP,
222,GO:0000453,1,0.971109564460838,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
223,GO:0000454,1,0.975383790688815,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
224,GO:0000459,1,0.935354921984849,0,5,exonucleolytic trimming involved in rRNA processing,BP,
225,GO:0000460,1,0.683705474196048,0,29,maturation of 5.8S rRNA,BP,
226,GO:0000461,1,0.988575805784523,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000462,1,0.638386657385215,0,36,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000463,1,0.902525278228695,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000466,1,0.783811597934285,0,18,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
230,GO:0000467,1,0.935354921984849,0,5,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000469,1,0.734687151832646,0,23,cleavage involved in rRNA processing,BP,
232,GO:0000470,1,0.783921356044493,0,21,maturation of LSU-rRNA,BP,
233,GO:0000472,1,0.953791390928245,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000478,1,0.820456661523327,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
235,GO:0000479,1,0.820456661523327,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
236,GO:0000480,1,0.911124720849334,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
237,GO:0000481,1,0.983432958183734,0,1,maturation of 5S rRNA,BP,
238,GO:0000491,1,0.923205436389834,0,6,small nucleolar ribonucleoprotein complex assembly,BP,
239,GO:0000492,1,0.949739525283887,0,4,box C/D snoRNP assembly,BP,
240,GO:0000493,1,0.972067614998671,0,2,box H/ACA snoRNP assembly,BP,
241,GO:0000494,1,0.991339022669521,0,1,box C/D snoRNA 3'-end processing,BP,
242,GO:0000495,1,0.984676451729454,0,1,box H/ACA snoRNA 3'-end processing,BP,
243,GO:0000502,1,0.474167277004128,0,65,proteasome complex,CC,
244,GO:0000506,1,0.907531676723381,0,8,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
246,GO:0000700,1,0.947319340688756,0,4,mismatch base pair DNA N-glycosylase activity,MF,
247,GO:0000701,1,0.977816462743755,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
248,GO:0000702,1,0.968323476219785,0,3,oxidized base lesion DNA N-glycosylase activity,MF,
249,GO:0000703,1,0.980976743498474,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
250,GO:0000706,1,0.941496040154711,0,4,meiotic DNA double-strand break processing,BP,
251,GO:0000707,1,0.918352041890671,0,6,meiotic DNA recombinase assembly,BP,
252,GO:0000710,1,0.967230385983359,0,2,meiotic mismatch repair,BP,
253,GO:0000711,1,0.973386351450561,0,2,meiotic DNA repair synthesis,BP,
254,GO:0000712,1,0.830694119467339,0,12,resolution of meiotic recombination intermediates,BP,
255,GO:0000715,1,0.743044104947612,0,23,nucleotide-excision repair, DNA damage recognition,BP,
256,GO:0000717,1,0.743356658674789,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
257,GO:0000718,1,0.988025773396631,0,1,nucleotide-excision repair, DNA damage removal,BP,
258,GO:0000720,1,0.958037719254325,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
259,GO:0000722,1,0.607428100299433,0,36,telomere maintenance via recombination,BP,
260,GO:0000723,1,0.137594913889424,0,147,telomere maintenance,BP,
261,GO:0000724,1,0.230516943713918,0,97,double-strand break repair via homologous recombination,BP,
262,GO:0000725,1,0.2269746116002,0,98,recombinational repair,BP,
263,GO:0000726,1,0.391093549473551,0,74,non-recombinational repair,BP,
264,GO:0000727,1,0.932397177260235,0,5,double-strand break repair via break-induced replication,BP,
265,GO:0000729,1,0.697721139971027,0,23,DNA double-strand break processing,BP,
266,GO:0000730,1,0.864895659315495,0,10,DNA recombinase assembly,BP,
267,GO:0000731,1,0.369940552412999,0,68,DNA synthesis involved in DNA repair,BP,
268,GO:0000732,1,0.674011676527093,0,25,strand displacement,BP,
269,GO:0000733,1,0.867692738497995,0,9,DNA strand renaturation,BP,
270,GO:0000737,1,0.729919431631109,0,23,DNA catabolic process, endonucleolytic,BP,
271,GO:0000738,1,0.97638011047765,0,2,DNA catabolic process, exonucleolytic,BP,
272,GO:0000741,1,0.987922462885514,0,1,karyogamy,BP,
273,GO:0000768,1,0.519940729087713,0,47,syncytium formation by plasma membrane fusion,BP,
274,GO:0000773,1,0.992519644739583,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
275,GO:0000774,1,0.869228173856236,0,10,adenyl-nucleotide exchange factor activity,MF,
276,GO:0000775,1,0.0731725214873545,0,176,chromosome, centromeric region,CC,
277,GO:0000776,1,0.171520508989503,0,121,kinetochore,CC,
278,GO:0000777,1,0.257456484565933,0,94,condensed chromosome kinetochore,CC,
279,GO:0000778,1,0.890928580583824,0,8,condensed nuclear chromosome kinetochore,CC,
280,GO:0000779,1,0.223646276510505,0,104,condensed chromosome, centromeric region,CC,
281,GO:0000780,1,0.821293831774103,0,14,condensed nuclear chromosome, centromeric region,CC,
282,GO:0000781,1,0.124665998674669,0,161,chromosome, telomeric region,CC,
283,GO:0000782,1,0.845192206133737,0,11,telomere cap complex,CC,
284,GO:0000783,1,0.845192206133737,0,11,nuclear telomere cap complex,CC,
285,GO:0000784,1,0.20559578293814,0,126,nuclear chromosome, telomeric region,CC,
287,GO:0000786,1,0.536595916434293,0,101,nucleosome,CC,
288,GO:0000788,1,0.827594919200588,0,37,nuclear nucleosome,CC,
289,GO:0000789,1,0.991770780535169,0,1,cytoplasmic chromatin,CC,
291,GO:0000791,1,0.64427538677651,0,32,euchromatin,CC,
293,GO:0000793,1,0.0619222290182231,0,192,condensed chromosome,CC,
294,GO:0000794,1,0.323066575805055,0,78,condensed nuclear chromosome,CC,
295,GO:0000795,1,0.639486615223701,0,32,synaptonemal complex,CC,
296,GO:0000796,1,0.889450486185255,0,7,condensin complex,CC,
297,GO:0000797,1,0.983406759351971,0,1,condensin core heterodimer,CC,
298,GO:0000798,1,0.925646148725976,0,5,nuclear cohesin complex,CC,
299,GO:0000799,1,0.951038409344445,0,3,nuclear condensin complex,CC,
300,GO:0000800,1,0.83377049170527,0,12,lateral element,CC,
301,GO:0000801,1,0.898666792386738,0,8,central element,CC,
302,GO:0000802,1,0.983458607178778,0,1,transverse filament,CC,
306,GO:0000808,1,0.869677145420501,0,9,origin recognition complex,CC,
307,GO:0000811,1,0.958798652619795,0,3,GINS complex,CC,
308,GO:0000812,1,0.882708433435472,0,9,Swr1 complex,CC,
309,GO:0000813,1,0.86897185332486,0,10,ESCRT I complex,CC,
310,GO:0000814,1,0.966585530494068,0,3,ESCRT II complex,CC,
311,GO:0000815,1,0.86371284196167,0,11,ESCRT III complex,CC,
313,GO:0000820,1,0.931789531185422,0,5,regulation of glutamine family amino acid metabolic process,BP,
314,GO:0000821,1,0.969283496849305,0,2,regulation of arginine metabolic process,BP,
315,GO:0000822,1,0.951766037001357,0,3,inositol hexakisphosphate binding,MF,
316,GO:0000823,1,0.987684184735078,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
317,GO:0000824,1,0.987684184735078,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
318,GO:0000825,1,0.987684184735078,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
319,GO:0000827,1,0.926957851736841,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
320,GO:0000828,1,0.926957851736841,0,5,inositol hexakisphosphate kinase activity,MF,
321,GO:0000829,1,0.926957851736841,0,5,inositol heptakisphosphate kinase activity,MF,
322,GO:0000831,1,0.984253152378988,0,1,inositol hexakisphosphate 6-kinase activity,MF,
323,GO:0000832,1,0.926957851736841,0,5,inositol hexakisphosphate 5-kinase activity,MF,
324,GO:0000835,1,0.910420924934603,0,6,ER ubiquitin ligase complex,CC,
325,GO:0000836,1,0.925787607141687,0,5,Hrd1p ubiquitin ligase complex,CC,
326,GO:0000839,1,0.95647978444969,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
327,GO:0000900,1,0.811728829162035,0,13,translation repressor activity, nucleic acid binding,MF,
331,GO:0000912,1,0.951233388312996,0,3,assembly of actomyosin apparatus involved in cytokinesis,BP,
332,GO:0000915,1,0.951233388312996,0,3,actomyosin contractile ring assembly,BP,
333,GO:0000917,1,0.987413413405493,0,1,barrier septum assembly,BP,
334,GO:0000920,1,0.79462538297813,0,17,cell separation after cytokinesis,BP,
335,GO:0000921,1,0.983406759351968,0,1,septin ring assembly,BP,
337,GO:0000923,1,0.906217624100177,0,6,equatorial microtubule organizing center,CC,
339,GO:0000931,1,0.893366985580217,0,7,gamma-tubulin large complex,CC,
340,GO:0000932,1,0.233245092370417,0,101,P-body,CC,
341,GO:0000938,1,0.936978972931536,0,4,GARP complex,CC,
342,GO:0000939,1,0.974828278864884,0,2,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.827372517884136,0,12,condensed chromosome outer kinetochore,CC,
344,GO:0000942,1,0.942991086093723,0,4,condensed nuclear chromosome outer kinetochore,CC,
345,GO:0000956,1,0.108466959596163,0,198,nuclear-transcribed mRNA catabolic process,BP,
346,GO:0000957,1,0.93796791826355,0,4,mitochondrial RNA catabolic process,BP,
347,GO:0000958,1,0.968594277933987,0,2,mitochondrial mRNA catabolic process,BP,
348,GO:0000959,1,0.657564865813045,0,29,mitochondrial RNA metabolic process,BP,
349,GO:0000960,1,0.93796791826355,0,4,regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000961,1,0.968384722375726,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000962,1,0.968594277933987,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000963,1,0.806183062550307,0,15,mitochondrial RNA processing,BP,
353,GO:0000964,1,0.96838472237626,0,2,mitochondrial RNA 5'-end processing,BP,
354,GO:0000965,1,0.954658591510251,0,3,mitochondrial RNA 3'-end processing,BP,
355,GO:0000966,1,0.908302211736804,0,6,RNA 5'-end processing,BP,
356,GO:0000967,1,0.953791390928245,0,3,rRNA 5'-end processing,BP,
357,GO:0000972,1,0.911323381002723,0,6,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
358,GO:0000973,1,0.955847105431752,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000974,1,0.859329564298966,0,11,Prp19 complex,CC,
363,GO:0000978,1,0.00731418231038603,0,330,RNA polymerase II core promoter proximal region sequence-specific DNA binding,MF,
365,GO:0000980,1,0.382673317372549,0,65,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
369,GO:0000987,1,0.00601464294237314,0,342,core promoter proximal region sequence-specific DNA binding,MF,
372,GO:0000990,1,0.881755729124386,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.973126389151754,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.968738891493215,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.718154415327418,0,23,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.987764589990723,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.935773034254262,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0000997,1,0.983409775239993,0,1,mitochondrial RNA polymerase core promoter sequence-specific DNA binding,MF,
379,GO:0000999,1,0.985085663920662,0,1,RNA polymerase III type 1 promoter transcriptional preinitiation complex assembly,BP,
380,GO:0001002,1,0.968738891493215,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
381,GO:0001003,1,0.968738891493215,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
382,GO:0001004,1,0.985085663920662,0,1,transcription factor activity, RNA polymerase III promoter sequence-specific binding, TFIIIB recruiting,MF,
383,GO:0001005,1,0.985085663920662,0,1,transcription factor activity, RNA polymerase III type 1 promoter sequence-specific binding, TFIIIB recruiting,MF,
384,GO:0001007,1,0.92452890092204,0,5,transcription factor activity, RNA polymerase III transcription factor binding,MF,
385,GO:0001009,1,0.985085663920662,0,1,transcription from RNA polymerase III type 2 promoter,BP,
386,GO:0001010,1,0.956100439191933,0,3,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
387,GO:0001011,1,0.983406759351085,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
389,GO:0001013,1,0.887472187066578,0,8,RNA polymerase I regulatory region DNA binding,MF,
390,GO:0001016,1,0.907926911741738,0,7,RNA polymerase III regulatory region DNA binding,MF,
391,GO:0001018,1,0.983409775239993,0,1,mitochondrial RNA polymerase regulatory region DNA binding,MF,
392,GO:0001022,1,0.985085663920662,0,1,transcription initiation from RNA polymerase III type 1 promoter,BP,
393,GO:0001025,1,0.919731182613132,0,5,RNA polymerase III transcription factor binding,MF,
394,GO:0001026,1,0.967111480802227,0,2,TFIIIB-type transcription factor activity,MF,
395,GO:0001030,1,0.925385531328306,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
396,GO:0001031,1,0.925385531328306,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
397,GO:0001032,1,0.942666724279175,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
398,GO:0001034,1,0.972901190562805,0,2,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
399,GO:0001042,1,0.919737622847598,0,5,RNA polymerase I core binding,MF,
400,GO:0001044,1,0.983409775239993,0,1,mitochondrial RNA polymerase regulatory region sequence-specific DNA binding,MF,
403,GO:0001054,1,0.893400356042461,0,9,RNA polymerase I activity,MF,
404,GO:0001055,1,0.885999269977854,0,10,RNA polymerase II activity,MF,
405,GO:0001056,1,0.832047925389309,0,14,RNA polymerase III activity,MF,
407,GO:0001069,1,0.98340675935187,0,1,regulatory region RNA binding,MF,
408,GO:0001070,1,0.984755249504008,0,1,RNA binding transcription factor activity,MF,
410,GO:0001075,1,0.869301670501873,0,9,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
414,GO:0001079,1,0.98609242153372,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
415,GO:0001080,1,0.98609242153372,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
416,GO:0001082,1,0.985505137178381,0,1,transcription factor activity, RNA polymerase I transcription factor binding,MF,
417,GO:0001083,1,0.923683760513537,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
419,GO:0001087,1,0.983406759351085,0,1,transcription factor activity, TFIIB-class binding,MF,
420,GO:0001091,1,0.85028921657412,0,11,RNA polymerase II basal transcription factor binding,MF,
421,GO:0001093,1,0.955124966904597,0,3,TFIIB-class transcription factor binding,MF,
422,GO:0001094,1,0.905271671827926,0,7,TFIID-class transcription factor binding,MF,
423,GO:0001096,1,0.98342251866506,0,1,TFIIF-class transcription factor binding,MF,
424,GO:0001098,1,0.605020731064131,0,35,basal transcription machinery binding,MF,
425,GO:0001099,1,0.605020731064131,0,35,basal RNA polymerase II transcription machinery binding,MF,
426,GO:0001100,1,0.984725543253726,0,1,negative regulation of exit from mitosis,BP,
429,GO:0001103,1,0.661032100605408,0,28,RNA polymerase II repressing transcription factor binding,MF,
433,GO:0001128,1,0.99020175279965,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
434,GO:0001129,1,0.939273359616599,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
435,GO:0001132,1,0.939273359616599,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
436,GO:0001133,1,0.986410205054556,0,1,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
439,GO:0001147,1,0.967157834459359,0,2,transcription termination site sequence-specific DNA binding,MF,
440,GO:0001153,1,0.985085663920662,0,1,transcription factor activity, RNA polymerase III transcription factor recruiting,MF,
441,GO:0001156,1,0.951038409341685,0,3,TFIIIC-class transcription factor binding,MF,
442,GO:0001158,1,0.290619740628198,0,83,enhancer sequence-specific DNA binding,MF,
443,GO:0001159,1,0.00573635683696295,0,345,core promoter proximal region DNA binding,MF,
444,GO:0001160,1,0.967157834459359,0,2,transcription termination site DNA binding,MF,
445,GO:0001161,1,0.855037331461809,0,11,intronic transcription regulatory region sequence-specific DNA binding,MF,
446,GO:0001162,1,0.896947734004811,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
447,GO:0001163,1,0.887472187066578,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
448,GO:0001164,1,0.887472187066578,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
449,GO:0001165,1,0.983406759352018,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
450,GO:0001167,1,0.985505137178381,0,1,RNA polymerase I transcription factor activity, sequence-specific DNA binding,MF,
451,GO:0001169,1,0.985505137178381,0,1,transcription factor activity, RNA polymerase I CORE element sequence-specific binding,MF,
452,GO:0001172,1,0.967087733487673,0,2,transcription, RNA-templated,BP,
453,GO:0001179,1,0.987355497898684,0,1,RNA polymerase I transcription factor binding,MF,
454,GO:0001180,1,0.956902008149645,0,3,transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript,BP,
455,GO:0001181,1,0.983413537398471,0,1,transcription factor activity, core RNA polymerase I binding,MF,
456,GO:0001186,1,0.985505137178381,0,1,transcription factor activity, RNA polymerase I transcription factor recruiting,MF,
457,GO:0001187,1,0.985505137178381,0,1,transcription factor activity, RNA polymerase I CORE element binding transcription factor recruiting,MF,
458,GO:0001188,1,0.973043165060007,0,2,RNA polymerase I transcriptional preinitiation complex assembly,BP,
459,GO:0001189,1,0.973043165060007,0,2,RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript,BP,
462,GO:0001205,1,0.686315147039005,0,26,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
463,GO:0001206,1,0.858929638453971,0,10,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
464,GO:0001207,1,0.983591033443995,0,1,histone displacement,BP,
465,GO:0001221,1,0.595771823998065,0,34,transcription cofactor binding,MF,
466,GO:0001222,1,0.869000273944452,0,10,transcription corepressor binding,MF,
467,GO:0001223,1,0.744334689548053,0,19,transcription coactivator binding,MF,
468,GO:0001224,1,0.95119380556666,0,3,RNA polymerase II transcription cofactor binding,MF,
469,GO:0001225,1,0.967087733486853,0,2,RNA polymerase II transcription coactivator binding,MF,
470,GO:0001226,1,0.983567422310223,0,1,RNA polymerase II transcription corepressor binding,MF,
473,GO:0001300,1,0.967629467468297,0,2,chronological cell aging,BP,
474,GO:0001302,1,0.920233114644808,0,6,replicative cell aging,BP,
475,GO:0001306,1,0.975847018750108,0,2,age-dependent response to oxidative stress,BP,
476,GO:0001315,1,0.992313236079646,0,1,age-dependent response to reactive oxygen species,BP,
477,GO:0001325,1,0.783480211420798,0,15,formation of extrachromosomal circular DNA,BP,
478,GO:0001401,1,0.987830459906291,0,1,mitochondrial sorting and assembly machinery complex,CC,
479,GO:0001405,1,0.957982153332618,0,3,presequence translocase-associated import motor,CC,
485,GO:0001507,1,0.968751942143426,0,2,acetylcholine catabolic process in synaptic cleft,BP,
487,GO:0001510,1,0.482997847570889,0,51,RNA methylation,BP,
488,GO:0001512,1,0.991517356609453,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
489,GO:0001514,1,0.884913740156815,0,9,selenocysteine incorporation,BP,
490,GO:0001515,1,0.95421610852736,0,4,opioid peptide activity,MF,
492,GO:0001517,1,0.895186853219354,0,7,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
493,GO:0001518,1,0.796886219886834,0,14,voltage-gated sodium channel complex,CC,
494,GO:0001519,1,0.97089570495633,0,2,peptide amidation,BP,
495,GO:0001520,1,0.909514622494115,0,8,outer dense fiber,CC,
496,GO:0001522,1,0.804463596885653,0,18,pseudouridine synthesis,BP,
499,GO:0001527,1,0.860511791846423,0,10,microfibril,CC,
500,GO:0001530,1,0.751201922207579,0,21,lipopolysaccharide binding,MF,
501,GO:0001532,1,0.983583400093628,0,1,interleukin-21 receptor activity,MF,
503,GO:0001534,1,0.953114942388319,0,3,radial spoke,CC,
504,GO:0001536,1,0.968390479418343,0,2,radial spoke stalk,CC,
505,GO:0001537,1,0.930821968206944,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
506,GO:0001539,1,0.706759021452898,0,24,cilium or flagellum-dependent cell motility,BP,
507,GO:0001540,1,0.619577213835478,0,33,beta-amyloid binding,MF,
509,GO:0001542,1,0.879126919504807,0,8,ovulation from ovarian follicle,BP,
510,GO:0001543,1,0.983406759351282,0,1,ovarian follicle rupture,BP,
511,GO:0001544,1,0.983406759351328,0,1,initiation of primordial ovarian follicle growth,BP,
512,GO:0001545,1,0.968291872253044,0,2,primary ovarian follicle growth,BP,
513,GO:0001546,1,0.96103493005771,0,3,preantral ovarian follicle growth,BP,
514,GO:0001547,1,0.912360704796616,0,6,antral ovarian follicle growth,BP,
515,GO:0001550,1,0.96708773348782,0,2,ovarian cumulus expansion,BP,
516,GO:0001553,1,0.862365369506678,0,10,luteinization,BP,
517,GO:0001554,1,0.919903227832501,0,5,luteolysis,BP,
518,GO:0001555,1,0.970833646490952,0,2,oocyte growth,BP,
521,GO:0001560,1,0.951038409343727,0,3,regulation of cell growth by extracellular stimulus,BP,
522,GO:0001561,1,0.904857563947396,0,7,fatty acid alpha-oxidation,BP,
524,GO:0001567,1,0.977508182766201,0,2,cholesterol 25-hydroxylase activity,MF,
529,GO:0001574,1,0.899221526222818,0,7,ganglioside biosynthetic process,BP,
530,GO:0001575,1,0.973659198008185,0,2,globoside metabolic process,BP,
531,GO:0001576,1,0.986335251764542,0,1,globoside biosynthetic process,BP,
533,GO:0001579,1,0.967627106921414,0,2,medium-chain fatty acid transport,BP,
534,GO:0001580,1,0.749561626400751,0,33,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
535,GO:0001581,1,0.967449747326673,0,2,detection of chemical stimulus involved in sensory perception of sour taste,BP,
536,GO:0001582,1,0.969788752974161,0,2,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
537,GO:0001587,1,0.983406759351968,0,1,Gq/11-coupled serotonin receptor activity,MF,
538,GO:0001588,1,0.951323400249151,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
539,GO:0001591,1,0.927893566976567,0,8,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
540,GO:0001594,1,0.94344454622299,0,7,trace-amine receptor activity,MF,
541,GO:0001595,1,0.95311806723355,0,4,angiotensin receptor activity,MF,
542,GO:0001596,1,0.985439661683852,0,1,angiotensin type I receptor activity,MF,
543,GO:0001601,1,0.955808269299977,0,3,peptide YY receptor activity,MF,
544,GO:0001602,1,0.955199292005508,0,4,pancreatic polypeptide receptor activity,MF,
545,GO:0001604,1,0.99135876533335,0,1,urotensin II receptor activity,MF,
546,GO:0001605,1,0.983406759351921,0,1,adrenomedullin receptor activity,MF,
547,GO:0001607,1,0.970246052829517,0,2,neuromedin U receptor activity,MF,
548,GO:0001608,1,0.824998064817819,0,14,G-protein coupled nucleotide receptor activity,MF,
550,GO:0001614,1,0.748298297491773,0,21,purinergic nucleotide receptor activity,MF,
551,GO:0001616,1,0.992599184191449,0,1,growth hormone secretagogue receptor activity,MF,
553,GO:0001621,1,0.989361272306657,0,1,ADP receptor activity,MF,
554,GO:0001626,1,0.983575632517515,0,1,nociceptin receptor activity,MF,
555,GO:0001631,1,0.984768879537809,0,1,cysteinyl leukotriene receptor activity,MF,
556,GO:0001632,1,0.972909085971934,0,2,leukotriene B4 receptor activity,MF,
557,GO:0001635,1,0.968046169843001,0,2,calcitonin gene-related peptide receptor activity,MF,
558,GO:0001637,1,0.727317497901264,0,23,G-protein coupled chemoattractant receptor activity,MF,
559,GO:0001640,1,0.920771407167316,0,5,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
560,GO:0001641,1,0.968181292598207,0,2,group II metabotropic glutamate receptor activity,MF,
561,GO:0001642,1,0.98340675935207,0,1,group III metabotropic glutamate receptor activity,MF,
563,GO:0001650,1,0.169902059726215,0,121,fibrillar center,CC,
564,GO:0001651,1,0.991339022669521,0,1,dense fibrillar component,CC,
565,GO:0001652,1,0.956334535133995,0,4,granular component,CC,
573,GO:0001660,1,0.860750875994449,0,10,fever generation,BP,
574,GO:0001661,1,0.907239949393015,0,6,conditioned taste aversion,BP,
575,GO:0001662,1,0.649258104403931,0,30,behavioral fear response,BP,
577,GO:0001665,1,0.91993150401963,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
581,GO:0001671,1,0.722161836500962,0,23,ATPase activator activity,MF,
582,GO:0001672,1,0.864811380278819,0,9,regulation of chromatin assembly or disassembly,BP,
583,GO:0001673,1,0.837258298124952,0,14,male germ cell nucleus,CC,
584,GO:0001674,1,0.955123212416909,0,3,female germ cell nucleus,CC,
585,GO:0001675,1,0.854202143401569,0,12,acrosome assembly,BP,
588,GO:0001680,1,0.985614351305629,0,1,tRNA 3'-terminal CCA addition,BP,
589,GO:0001681,1,0.984095018807551,0,1,sialate O-acetylesterase activity,MF,
590,GO:0001682,1,0.882313697959974,0,11,tRNA 5'-leader removal,BP,
591,GO:0001692,1,0.9589990812569,0,4,histamine metabolic process,BP,
592,GO:0001694,1,0.978646991632039,0,2,histamine biosynthetic process,BP,
593,GO:0001695,1,0.993140998787335,0,1,histamine catabolic process,BP,
594,GO:0001696,1,0.805611304251123,0,17,gastric acid secretion,BP,
595,GO:0001697,1,0.984135743636259,0,1,histamine-induced gastric acid secretion,BP,
596,GO:0001698,1,0.980202806002624,0,2,gastrin-induced gastric acid secretion,BP,
606,GO:0001711,1,0.791480634042815,0,16,endodermal cell fate commitment,BP,
608,GO:0001714,1,0.884906922756925,0,9,endodermal cell fate specification,BP,
610,GO:0001716,1,0.986475523130299,0,1,L-amino-acid oxidase activity,MF,
611,GO:0001725,1,0.474224907523567,0,49,stress fiber,CC,
613,GO:0001727,1,0.924375914879219,0,5,lipid kinase activity,MF,
614,GO:0001729,1,0.967614881352648,0,2,ceramide kinase activity,MF,
615,GO:0001730,1,0.956397607787409,0,3,2'-5'-oligoadenylate synthetase activity,MF,
616,GO:0001731,1,0.885975093754399,0,8,formation of translation preinitiation complex,BP,
617,GO:0001732,1,0.97052593942292,0,2,formation of cytoplasmic translation initiation complex,BP,
618,GO:0001733,1,0.946705516173557,0,4,galactosylceramide sulfotransferase activity,MF,
619,GO:0001735,1,0.968405932332871,0,2,prenylcysteine oxidase activity,MF,
622,GO:0001739,1,0.915478071960777,0,6,sex chromatin,CC,
623,GO:0001740,1,0.934708217099009,0,5,Barr body,CC,
631,GO:0001758,1,0.912566717736271,0,7,retinal dehydrogenase activity,MF,
633,GO:0001760,1,0.99078737987985,0,1,aminocarboxymuconate-semialdehyde decarboxylase activity,MF,
636,GO:0001765,1,0.872179082905674,0,10,membrane raft assembly,BP,
637,GO:0001766,1,0.888035642351843,0,9,membrane raft polarization,BP,
638,GO:0001767,1,0.883030865664265,0,9,establishment of lymphocyte polarity,BP,
639,GO:0001768,1,0.897937147806151,0,8,establishment of T cell polarity,BP,
640,GO:0001770,1,0.983406759351379,0,1,establishment of natural killer cell polarity,BP,
642,GO:0001772,1,0.625405056533328,0,33,immunological synapse,CC,
643,GO:0001773,1,0.695805639812049,0,29,myeloid dendritic cell activation,BP,
644,GO:0001774,1,0.782568718765741,0,18,microglial cell activation,BP,
647,GO:0001777,1,0.962525065275101,0,4,T cell homeostatic proliferation,BP,
648,GO:0001778,1,0.882990553285514,0,8,plasma membrane repair,BP,
651,GO:0001781,1,0.910847713563114,0,7,neutrophil apoptotic process,BP,
652,GO:0001782,1,0.673616398965814,0,28,B cell homeostasis,BP,
653,GO:0001783,1,0.728199615343798,0,23,B cell apoptotic process,BP,
655,GO:0001785,1,0.968909620234345,0,2,prostaglandin J receptor activity,MF,
657,GO:0001787,1,0.843670771207284,0,12,natural killer cell proliferation,BP,
658,GO:0001791,1,0.990186280614321,0,1,IgM binding,MF,
659,GO:0001792,1,0.98340675935207,0,1,polymeric immunoglobulin receptor activity,MF,
660,GO:0001794,1,0.978900679269921,0,2,type IIa hypersensitivity,BP,
661,GO:0001796,1,0.978900679269921,0,2,regulation of type IIa hypersensitivity,BP,
662,GO:0001798,1,0.978900679269921,0,2,positive regulation of type IIa hypersensitivity,BP,
663,GO:0001802,1,0.980046555321313,0,2,type III hypersensitivity,BP,
664,GO:0001803,1,0.980046555321313,0,2,regulation of type III hypersensitivity,BP,
665,GO:0001805,1,0.980046555321313,0,2,positive regulation of type III hypersensitivity,BP,
666,GO:0001806,1,0.944796020037306,0,4,type IV hypersensitivity,BP,
667,GO:0001807,1,0.960387172230464,0,3,regulation of type IV hypersensitivity,BP,
668,GO:0001808,1,0.970162304403503,0,2,negative regulation of type IV hypersensitivity,BP,
669,GO:0001809,1,0.98992549238389,0,1,positive regulation of type IV hypersensitivity,BP,
670,GO:0001810,1,0.971577033228296,0,3,regulation of type I hypersensitivity,BP,
671,GO:0001812,1,0.971577033228296,0,3,positive regulation of type I hypersensitivity,BP,
676,GO:0001820,1,0.871489186184263,0,11,serotonin secretion,BP,
681,GO:0001825,1,0.668459766048668,0,28,blastocyst formation,BP,
682,GO:0001826,1,0.880287863693189,0,8,inner cell mass cell differentiation,BP,
683,GO:0001827,1,0.953415317148237,0,3,inner cell mass cell fate commitment,BP,
684,GO:0001828,1,0.952939173331783,0,3,inner cell mass cellular morphogenesis,BP,
685,GO:0001829,1,0.816985650868151,0,14,trophectodermal cell differentiation,BP,
686,GO:0001831,1,0.969988208782527,0,2,trophectodermal cellular morphogenesis,BP,
689,GO:0001834,1,0.983406759351328,0,1,trophectodermal cell proliferation,BP,
690,GO:0001835,1,0.983595118214331,0,1,blastocyst hatching,BP,
701,GO:0001846,1,0.849807301657428,0,12,opsonin binding,MF,
702,GO:0001847,1,0.943524592139778,0,4,opsonin receptor activity,MF,
703,GO:0001848,1,0.767396076132858,0,19,complement binding,MF,
704,GO:0001849,1,0.899947243367149,0,8,complement component C1q binding,MF,
705,GO:0001850,1,0.987515768568437,0,1,complement component C3a binding,MF,
706,GO:0001851,1,0.971128835145697,0,2,complement component C3b binding,MF,
707,GO:0001855,1,0.972386510013107,0,2,complement component C4b binding,MF,
708,GO:0001856,1,0.985398882868201,0,1,complement component C5a binding,MF,
709,GO:0001861,1,0.983406759350836,0,1,complement component C4b receptor activity,MF,
710,GO:0001865,1,0.882129734439,0,8,NK T cell differentiation,BP,
711,GO:0001866,1,0.926438894430183,0,6,NK T cell proliferation,BP,
712,GO:0001867,1,0.878090755169614,0,10,complement activation, lectin pathway,BP,
713,GO:0001868,1,0.970823653680205,0,2,regulation of complement activation, lectin pathway,BP,
714,GO:0001869,1,0.970823653680205,0,2,negative regulation of complement activation, lectin pathway,BP,
715,GO:0001871,1,0.744332554818808,0,21,pattern binding,MF,
716,GO:0001872,1,0.987007608471373,0,1,(1->3)-beta-D-glucan binding,MF,
717,GO:0001875,1,0.932025285343373,0,5,lipopolysaccharide receptor activity,MF,
718,GO:0001878,1,0.927012564349735,0,6,response to yeast,BP,
719,GO:0001880,1,0.942100301233743,0,4,Mullerian duct regression,BP,
720,GO:0001881,1,0.619829425278526,0,32,receptor recycling,BP,
723,GO:0001884,1,0.968424655254934,0,2,pyrimidine nucleoside binding,MF,
725,GO:0001886,1,0.860545226569348,0,10,endothelial cell morphogenesis,BP,
726,GO:0001887,1,0.939006689261101,0,4,selenium compound metabolic process,BP,
727,GO:0001888,1,0.967720228882744,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
730,GO:0001891,1,0.773414295350615,0,18,phagocytic cup,CC,
735,GO:0001897,1,0.970300521909226,0,2,cytolysis by symbiont of host cells,BP,
736,GO:0001905,1,0.951058110350431,0,3,activation of membrane attack complex,BP,
738,GO:0001907,1,0.946398730395589,0,4,killing by symbiont of host cells,BP,
740,GO:0001910,1,0.505523289346248,0,50,regulation of leukocyte mediated cytotoxicity,BP,
741,GO:0001911,1,0.832839771218483,0,13,negative regulation of leukocyte mediated cytotoxicity,BP,
742,GO:0001912,1,0.65058379734037,0,32,positive regulation of leukocyte mediated cytotoxicity,BP,
744,GO:0001914,1,0.758299158370743,0,21,regulation of T cell mediated cytotoxicity,BP,
745,GO:0001915,1,0.924609569381889,0,5,negative regulation of T cell mediated cytotoxicity,BP,
746,GO:0001916,1,0.839150035621732,0,14,positive regulation of T cell mediated cytotoxicity,BP,
748,GO:0001918,1,0.984193471542078,0,1,farnesylated protein binding,MF,
749,GO:0001919,1,0.714019625049478,0,22,regulation of receptor recycling,BP,
750,GO:0001920,1,0.940486230297212,0,4,negative regulation of receptor recycling,BP,
751,GO:0001921,1,0.818463611796742,0,13,positive regulation of receptor recycling,BP,
752,GO:0001922,1,0.951038409345729,0,3,B-1 B cell homeostasis,BP,
753,GO:0001923,1,0.957882396734297,0,3,B-1 B cell differentiation,BP,
762,GO:0001937,1,0.639420698582525,0,31,negative regulation of endothelial cell proliferation,BP,
764,GO:0001939,1,0.888919010549954,0,8,female pronucleus,CC,
765,GO:0001940,1,0.926316219954385,0,5,male pronucleus,CC,
770,GO:0001946,1,0.779616503130912,0,16,lymphangiogenesis,BP,
773,GO:0001949,1,0.985110386459961,0,1,sebaceous gland cell differentiation,BP,
774,GO:0001951,1,0.936356874573403,0,4,intestinal D-glucose absorption,BP,
778,GO:0001955,1,0.889073228848552,0,8,blood vessel maturation,BP,
779,GO:0001956,1,0.842351139622908,0,11,positive regulation of neurotransmitter secretion,BP,
780,GO:0001957,1,0.914238347601417,0,6,intramembranous ossification,BP,
786,GO:0001964,1,0.689574838952014,0,25,startle response,BP,
787,GO:0001965,1,0.765048970327739,0,19,G-protein alpha-subunit binding,MF,
788,GO:0001966,1,0.990115295674954,0,1,thigmotaxis,BP,
789,GO:0001967,1,0.823367172842623,0,13,suckling behavior,BP,
791,GO:0001969,1,0.951058110350431,0,3,regulation of activation of membrane attack complex,BP,
792,GO:0001970,1,0.9671077655805,0,2,positive regulation of activation of membrane attack complex,BP,
793,GO:0001971,1,0.983406759351231,0,1,negative regulation of activation of membrane attack complex,BP,
797,GO:0001975,1,0.684520209005063,0,27,response to amphetamine,BP,
798,GO:0001976,1,0.83890586628772,0,13,neurological system process involved in regulation of systemic arterial blood pressure,BP,
800,GO:0001978,1,0.979951324986026,0,2,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
801,GO:0001979,1,0.988169684514756,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
802,GO:0001980,1,0.993581347532036,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
803,GO:0001983,1,0.979951324986026,0,2,baroreceptor response to increased systemic arterial blood pressure,BP,
804,GO:0001984,1,0.993904549651105,0,1,artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,BP,
805,GO:0001985,1,0.985961559158191,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
807,GO:0001991,1,0.761211295596811,0,19,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
808,GO:0001992,1,0.93049137686735,0,5,regulation of systemic arterial blood pressure by vasopressin,BP,
809,GO:0001993,1,0.875163214775544,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
810,GO:0001994,1,0.942689878526846,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
811,GO:0001996,1,0.942420397860244,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
812,GO:0001997,1,0.970256443639351,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
813,GO:0001999,1,0.921424183114893,0,5,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
814,GO:0002001,1,0.921424183114893,0,5,renin secretion into blood stream,BP,
815,GO:0002002,1,0.839616095730306,0,13,regulation of angiotensin levels in blood,BP,
816,GO:0002003,1,0.853792489464222,0,12,angiotensin maturation,BP,
817,GO:0002005,1,0.951199052316363,0,3,angiotensin catabolic process in blood,BP,
818,GO:0002007,1,0.988169684514756,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
821,GO:0002016,1,0.883966636549338,0,9,regulation of blood volume by renin-angiotensin,BP,
822,GO:0002017,1,0.971405164741643,0,2,regulation of blood volume by renal aldosterone,BP,
823,GO:0002018,1,0.944743234466903,0,4,renin-angiotensin regulation of aldosterone production,BP,
824,GO:0002019,1,0.963314996094008,0,3,regulation of renal output by angiotensin,BP,
826,GO:0002021,1,0.741379789501358,0,22,response to dietary excess,BP,
827,GO:0002023,1,0.968135133936463,0,3,reduction of food intake in response to dietary excess,BP,
828,GO:0002024,1,0.881564135635525,0,9,diet induced thermogenesis,BP,
829,GO:0002025,1,0.955808201849196,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
833,GO:0002029,1,0.825201589244794,0,14,desensitization of G-protein coupled receptor protein signaling pathway,BP,
834,GO:0002031,1,0.84784951455413,0,12,G-protein coupled receptor internalization,BP,
835,GO:0002032,1,0.973873251636209,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
836,GO:0002033,1,0.98400676700382,0,1,angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
837,GO:0002034,1,0.941108822052539,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
838,GO:0002035,1,0.937257366758029,0,4,brain renin-angiotensin system,BP,
839,GO:0002036,1,0.940047530721414,0,4,regulation of L-glutamate transport,BP,
840,GO:0002037,1,0.986192286296392,0,1,negative regulation of L-glutamate transport,BP,
841,GO:0002038,1,0.985653813887015,0,1,positive regulation of L-glutamate transport,BP,
842,GO:0002039,1,0.356231020426322,0,68,p53 binding,MF,
844,GO:0002041,1,0.98556113693202,0,1,intussusceptive angiogenesis,BP,
847,GO:0002046,1,0.971132794953589,0,3,opsin binding,MF,
848,GO:0002051,1,0.935723875568603,0,4,osteoblast fate commitment,BP,
851,GO:0002054,1,0.950722915222988,0,4,nucleobase binding,MF,
852,GO:0002055,1,0.994332601825609,0,1,adenine binding,MF,
853,GO:0002058,1,0.986180203205732,0,1,uracil binding,MF,
854,GO:0002059,1,0.986180203205732,0,1,thymine binding,MF,
855,GO:0002060,1,0.96404787281499,0,3,purine nucleobase binding,MF,
856,GO:0002061,1,0.986180203205732,0,1,pyrimidine nucleobase binding,MF,
858,GO:0002063,1,0.692614797311084,0,23,chondrocyte development,BP,
866,GO:0002071,1,0.975535832326748,0,2,glandular epithelial cell maturation,BP,
868,GO:0002074,1,0.922472983513231,0,5,extraocular skeletal muscle development,BP,
869,GO:0002076,1,0.769590101091219,0,18,osteoblast development,BP,
870,GO:0002077,1,0.990059957830177,0,1,acrosome matrix dispersal,BP,
871,GO:0002079,1,0.948122961125903,0,4,inner acrosomal membrane,CC,
873,GO:0002081,1,0.948880770733899,0,4,outer acrosomal membrane,CC,
875,GO:0002083,1,0.988482947792151,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
876,GO:0002084,1,0.946886748512049,0,4,protein depalmitoylation,BP,
878,GO:0002086,1,0.978163553391702,0,2,diaphragm contraction,BP,
882,GO:0002090,1,0.592998536290294,0,34,regulation of receptor internalization,BP,
883,GO:0002091,1,0.894126114060308,0,7,negative regulation of receptor internalization,BP,
884,GO:0002092,1,0.711792594776199,0,22,positive regulation of receptor internalization,BP,
886,GO:0002094,1,0.972232615214613,0,2,polyprenyltransferase activity,MF,
887,GO:0002097,1,0.827251625171128,0,13,tRNA wobble base modification,BP,
888,GO:0002098,1,0.877847699073658,0,9,tRNA wobble uridine modification,BP,
889,GO:0002100,1,0.983406759351575,0,1,tRNA wobble adenosine to inosine editing,BP,
890,GO:0002101,1,0.958297756422834,0,3,tRNA wobble cytosine modification,BP,
891,GO:0002102,1,0.619971157300813,0,30,podosome,CC,
892,GO:0002113,1,0.98557879828845,0,1,interleukin-33 binding,MF,
893,GO:0002114,1,0.969227163590814,0,2,interleukin-33 receptor activity,MF,
894,GO:0002115,1,0.864716408649057,0,10,store-operated calcium entry,BP,
895,GO:0002116,1,0.890919141533902,0,7,semaphorin receptor complex,CC,
896,GO:0002118,1,0.892534135914067,0,9,aggressive behavior,BP,
897,GO:0002121,1,0.967425165619255,0,2,inter-male aggressive behavior,BP,
898,GO:0002125,1,0.962604460913549,0,4,maternal aggressive behavior,BP,
899,GO:0002127,1,0.989654070168948,0,1,wobble base cytosine methylation,BP,
900,GO:0002133,1,0.967087733485738,0,2,polycystin complex,CC,
901,GO:0002134,1,0.968424655254934,0,2,UTP binding,MF,
902,GO:0002135,1,0.984766147175537,0,1,CTP binding,MF,
903,GO:0002138,1,0.896669488714387,0,8,retinoic acid biosynthetic process,BP,
906,GO:0002141,1,0.970229984790712,0,2,stereocilia ankle link,CC,
907,GO:0002142,1,0.983406759350094,0,1,stereocilia ankle link complex,CC,
908,GO:0002143,1,0.960567915577279,0,3,tRNA wobble position uridine thiolation,BP,
909,GO:0002148,1,0.983617657530074,0,1,hypochlorous acid metabolic process,BP,
910,GO:0002149,1,0.983617657530074,0,1,hypochlorous acid biosynthetic process,BP,
911,GO:0002151,1,0.89503437838359,0,7,G-quadruplex RNA binding,MF,
912,GO:0002152,1,0.983492411185385,0,1,bile acid conjugation,BP,
913,GO:0002153,1,0.985130620981145,0,1,steroid receptor RNA activator RNA binding,MF,
914,GO:0002154,1,0.936483261705002,0,5,thyroid hormone mediated signaling pathway,BP,
915,GO:0002155,1,0.952287983384967,0,4,regulation of thyroid hormone mediated signaling pathway,BP,
916,GO:0002158,1,0.897588663816585,0,8,osteoclast proliferation,BP,
918,GO:0002161,1,0.843554517539971,0,11,aminoacyl-tRNA editing activity,MF,
919,GO:0002162,1,0.87775301066289,0,9,dystroglycan binding,MF,
920,GO:0002169,1,0.968433844632033,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
921,GO:0002174,1,0.983942765591477,0,1,mammary stem cell proliferation,BP,
922,GO:0002175,1,0.935813613904334,0,4,protein localization to paranode region of axon,BP,
923,GO:0002176,1,0.931437649978679,0,6,male germ cell proliferation,BP,
924,GO:0002177,1,0.928012193176229,0,6,manchette,CC,
925,GO:0002178,1,0.852267920867612,0,11,palmitoyltransferase complex,CC,
926,GO:0002181,1,0.551720788151379,0,47,cytoplasmic translation,BP,
927,GO:0002182,1,0.967087733487527,0,2,cytoplasmic translational elongation,BP,
928,GO:0002183,1,0.735220165687438,0,22,cytoplasmic translational initiation,BP,
929,GO:0002184,1,0.967769870042315,0,2,cytoplasmic translational termination,BP,
930,GO:0002188,1,0.951393309914948,0,3,translation reinitiation,BP,
931,GO:0002189,1,0.958612430150225,0,3,ribose phosphate diphosphokinase complex,CC,
932,GO:0002190,1,0.811381574731041,0,15,cap-independent translational initiation,BP,
933,GO:0002191,1,0.958018224308293,0,3,cap-dependent translational initiation,BP,
934,GO:0002192,1,0.846351243900045,0,12,IRES-dependent translational initiation,BP,
936,GO:0002194,1,0.983766730501423,0,1,hepatocyte cell migration,BP,
937,GO:0002196,1,0.987177207290076,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
938,GO:0002199,1,0.879383176245127,0,9,zona pellucida receptor complex,CC,
942,GO:0002209,1,0.649258104403931,0,30,behavioral defense response,BP,
943,GO:0002215,1,0.961735499898939,0,3,defense response to nematode,BP,
949,GO:0002225,1,0.962085290604191,0,5,positive regulation of antimicrobial peptide production,BP,
950,GO:0002227,1,0.870147953466247,0,21,innate immune response in mucosa,BP,
952,GO:0002230,1,0.767953405422203,0,19,positive regulation of defense response to virus by host,BP,
953,GO:0002232,1,0.961219385162478,0,3,leukocyte chemotaxis involved in inflammatory response,BP,
954,GO:0002236,1,0.985473983702695,0,1,detection of misfolded protein,BP,
956,GO:0002238,1,0.953810531524633,0,3,response to molecule of fungal origin,BP,
958,GO:0002246,1,0.918744353530701,0,6,wound healing involved in inflammatory response,BP,
959,GO:0002248,1,0.92897630305546,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
960,GO:0002249,1,0.923397878431663,0,6,lymphocyte anergy,BP,
965,GO:0002254,1,0.958709387974757,0,3,kinin cascade,BP,
969,GO:0002264,1,0.987510865608086,0,1,endothelial cell activation involved in immune response,BP,
970,GO:0002266,1,0.97130173952771,0,2,follicular dendritic cell activation,BP,
971,GO:0002268,1,0.97130173952771,0,2,follicular dendritic cell differentiation,BP,
974,GO:0002276,1,0.986246994830835,0,1,basophil activation involved in immune response,BP,
975,GO:0002277,1,0.963745091817504,0,3,myeloid dendritic cell activation involved in immune response,BP,
976,GO:0002278,1,0.925846113005238,0,6,eosinophil activation involved in immune response,BP,
978,GO:0002281,1,0.878563037325515,0,9,macrophage activation involved in immune response,BP,
979,GO:0002282,1,0.968558964862539,0,2,microglial cell activation involved in immune response,BP,
984,GO:0002290,1,0.984058405067898,0,1,gamma-delta T cell activation involved in immune response,BP,
985,GO:0002291,1,0.89447232466764,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
990,GO:0002296,1,0.976720129833441,0,2,T-helper 1 cell lineage commitment,BP,
991,GO:0002298,1,0.979490687952011,0,2,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
992,GO:0002299,1,0.98892392660798,0,1,alpha-beta intraepithelial T cell differentiation,BP,
993,GO:0002300,1,0.98892392660798,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
994,GO:0002302,1,0.975515736178554,0,2,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
995,GO:0002304,1,0.973981397670421,0,2,gamma-delta intraepithelial T cell differentiation,BP,
996,GO:0002305,1,0.973981397670421,0,2,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
997,GO:0002309,1,0.94112551275268,0,5,T cell proliferation involved in immune response,BP,
1000,GO:0002314,1,0.958355453682584,0,3,germinal center B cell differentiation,BP,
1002,GO:0002316,1,0.98340675935207,0,1,follicular B cell differentiation,BP,
1003,GO:0002317,1,0.958104025213371,0,4,plasma cell differentiation,BP,
1006,GO:0002322,1,0.922895975507307,0,5,B cell proliferation involved in immune response,BP,
1008,GO:0002325,1,0.960391178964028,0,4,natural killer cell differentiation involved in immune response,BP,
1009,GO:0002326,1,0.936930203477131,0,4,B cell lineage commitment,BP,
1010,GO:0002327,1,0.87625063031884,0,8,immature B cell differentiation,BP,
1012,GO:0002329,1,0.921377662288775,0,5,pre-B cell differentiation,BP,
1013,GO:0002331,1,0.952740699667701,0,3,pre-B cell allelic exclusion,BP,
1014,GO:0002332,1,0.983406759351775,0,1,transitional stage B cell differentiation,BP,
1015,GO:0002333,1,0.983406759351775,0,1,transitional one stage B cell differentiation,BP,
1017,GO:0002337,1,0.974046736057146,0,2,B-1a B cell differentiation,BP,
1018,GO:0002339,1,0.964687151137469,0,3,B cell selection,BP,
1019,GO:0002343,1,0.984557888005925,0,1,peripheral B cell selection,BP,
1020,GO:0002344,1,0.984557888005925,0,1,B cell affinity maturation,BP,
1021,GO:0002347,1,0.802537865257792,0,16,response to tumor cell,BP,
1022,GO:0002349,1,0.920584071897416,0,6,histamine production involved in inflammatory response,BP,
1023,GO:0002351,1,0.963289055554731,0,3,serotonin production involved in inflammatory response,BP,
1024,GO:0002352,1,0.979818896447577,0,2,B cell negative selection,BP,
1025,GO:0002353,1,0.958709387974757,0,3,plasma kallikrein-kinin cascade,BP,
1026,GO:0002355,1,0.985116598391772,0,1,detection of tumor cell,BP,
1027,GO:0002357,1,0.969797178192441,0,2,defense response to tumor cell,BP,
1028,GO:0002358,1,0.979069049380736,0,2,B cell homeostatic proliferation,BP,
1030,GO:0002361,1,0.936197826851541,0,5,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1031,GO:0002362,1,0.985409035850243,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1035,GO:0002368,1,0.970255268317599,0,2,B cell cytokine production,BP,
1036,GO:0002369,1,0.675155073910775,0,29,T cell cytokine production,BP,
1037,GO:0002370,1,0.968190853054159,0,2,natural killer cell cytokine production,BP,
1038,GO:0002371,1,0.913568257482138,0,6,dendritic cell cytokine production,BP,
1039,GO:0002373,1,0.992902080858833,0,1,plasmacytoid dendritic cell cytokine production,BP,
1043,GO:0002378,1,0.952313961944261,0,3,immunoglobulin biosynthetic process,BP,
1044,GO:0002380,1,0.983406759352021,0,1,immunoglobulin secretion involved in immune response,BP,
1046,GO:0002384,1,0.974798532830812,0,2,hepatic immune response,BP,
1049,GO:0002396,1,0.952121877990298,0,5,MHC protein complex assembly,BP,
1050,GO:0002397,1,0.987100057091306,0,1,MHC class I protein complex assembly,BP,
1051,GO:0002399,1,0.964566590112797,0,4,MHC class II protein complex assembly,BP,
1053,GO:0002408,1,0.958141983087096,0,4,myeloid dendritic cell chemotaxis,BP,
1056,GO:0002416,1,0.98784318268749,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1057,GO:0002418,1,0.834022303286744,0,13,immune response to tumor cell,BP,
1058,GO:0002420,1,0.894271616075838,0,8,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1059,GO:0002423,1,0.894271616075838,0,8,natural killer cell mediated immune response to tumor cell,BP,
1060,GO:0002424,1,0.969205861988691,0,2,T cell mediated immune response to tumor cell,BP,
1061,GO:0002426,1,0.976949668546252,0,2,immunoglobulin production in mucosal tissue,BP,
1062,GO:0002428,1,0.964661721329795,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1064,GO:0002430,1,0.858309370063751,0,11,complement receptor mediated signaling pathway,BP,
1066,GO:0002432,1,0.983406759352021,0,1,granuloma formation,BP,
1068,GO:0002434,1,0.979274202728636,0,2,immune complex clearance,BP,
1069,GO:0002436,1,0.979274202728636,0,2,immune complex clearance by monocytes and macrophages,BP,
1071,GO:0002438,1,0.776311411788221,0,20,acute inflammatory response to antigenic stimulus,BP,
1072,GO:0002439,1,0.953037069452945,0,4,chronic inflammatory response to antigenic stimulus,BP,
1074,GO:0002441,1,0.920584071897416,0,6,histamine secretion involved in inflammatory response,BP,
1075,GO:0002442,1,0.963289055554731,0,3,serotonin secretion involved in inflammatory response,BP,
1078,GO:0002445,1,0.978900679269921,0,2,type II hypersensitivity,BP,
1080,GO:0002447,1,0.925846113005238,0,6,eosinophil mediated immunity,BP,
1083,GO:0002455,1,0.56805122133461,0,42,humoral immune response mediated by circulating immunoglobulin,BP,
1085,GO:0002457,1,0.927470658837038,0,5,T cell antigen processing and presentation,BP,
1086,GO:0002458,1,0.971839849186762,0,2,peripheral T cell tolerance induction,BP,
1088,GO:0002461,1,0.957701176023199,0,3,tolerance induction dependent upon immune response,BP,
1089,GO:0002465,1,0.971839849186762,0,2,peripheral tolerance induction,BP,
1090,GO:0002467,1,0.807428212707211,0,15,germinal center formation,BP,
1091,GO:0002468,1,0.902478522273709,0,8,dendritic cell antigen processing and presentation,BP,
1093,GO:0002475,1,0.870602340871393,0,10,antigen processing and presentation via MHC class Ib,BP,
1094,GO:0002476,1,0.971878823553379,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1095,GO:0002477,1,0.992574952411202,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1098,GO:0002480,1,0.914062284859368,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1099,GO:0002481,1,0.992574952411202,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1100,GO:0002483,1,0.890930678953573,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1101,GO:0002488,1,0.983406759352069,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1102,GO:0002489,1,0.983406759352069,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1103,GO:0002495,1,0.277159083005007,0,93,antigen processing and presentation of peptide antigen via MHC class II,BP,
1104,GO:0002501,1,0.960256018993336,0,4,peptide antigen assembly with MHC protein complex,BP,
1105,GO:0002502,1,0.987100057091306,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1106,GO:0002503,1,0.972806600469372,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1107,GO:0002504,1,0.272535798414559,0,94,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1108,GO:0002505,1,0.982414753652273,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1109,GO:0002506,1,0.982414753652273,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1110,GO:0002507,1,0.707433359650956,0,24,tolerance induction,BP,
1111,GO:0002508,1,0.970973710936143,0,2,central tolerance induction,BP,
1112,GO:0002509,1,0.986230727841008,0,1,central tolerance induction to self antigen,BP,
1113,GO:0002510,1,0.984530854415234,0,1,central B cell tolerance induction,BP,
1114,GO:0002513,1,0.926930863594486,0,5,tolerance induction to self antigen,BP,
1115,GO:0002514,1,0.968193251074717,0,2,B cell tolerance induction,BP,
1116,GO:0002517,1,0.834360772609193,0,13,T cell tolerance induction,BP,
1117,GO:0002518,1,0.991123064544678,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1118,GO:0002519,1,0.973938364562793,0,2,natural killer cell tolerance induction,BP,
1121,GO:0002522,1,0.971419556661784,0,2,leukocyte migration involved in immune response,BP,
1123,GO:0002524,1,0.890068384385953,0,9,hypersensitivity,BP,
1124,GO:0002525,1,0.959079374071993,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1126,GO:0002528,1,0.967554536080396,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1127,GO:0002532,1,0.530946542120348,0,46,production of molecular mediator involved in inflammatory response,BP,
1128,GO:0002534,1,0.680857738543154,0,27,cytokine production involved in inflammatory response,BP,
1129,GO:0002536,1,0.963616989093186,0,4,respiratory burst involved in inflammatory response,BP,
1130,GO:0002537,1,0.96708773348709,0,2,nitric oxide production involved in inflammatory response,BP,
1131,GO:0002538,1,0.968646458051597,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1132,GO:0002540,1,0.968646458051597,0,2,leukotriene production involved in inflammatory response,BP,
1133,GO:0002541,1,0.958099590741319,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1134,GO:0002542,1,0.972344259869883,0,2,Factor XII activation,BP,
1135,GO:0002543,1,0.969000698580778,0,2,activation of blood coagulation via clotting cascade,BP,
1137,GO:0002545,1,0.971116020353581,0,2,chronic inflammatory response to non-antigenic stimulus,BP,
1140,GO:0002553,1,0.920584071897416,0,6,histamine secretion by mast cell,BP,
1141,GO:0002554,1,0.963289055554731,0,3,serotonin secretion by platelet,BP,
1143,GO:0002566,1,0.831663432843877,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1144,GO:0002568,1,0.920430563820922,0,5,somatic diversification of T cell receptor genes,BP,
1145,GO:0002572,1,0.96744347135469,0,2,pro-T cell differentiation,BP,
1148,GO:0002577,1,0.819972134298805,0,16,regulation of antigen processing and presentation,BP,
1149,GO:0002578,1,0.918288317805682,0,6,negative regulation of antigen processing and presentation,BP,
1150,GO:0002579,1,0.904296334345139,0,9,positive regulation of antigen processing and presentation,BP,
1151,GO:0002580,1,0.943522267017284,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1152,GO:0002581,1,0.957517064954939,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1153,GO:0002582,1,0.985386911478045,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1154,GO:0002583,1,0.935151591115319,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1155,GO:0002584,1,0.949022752633378,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1156,GO:0002585,1,0.985386911478045,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1157,GO:0002586,1,0.959445288795723,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1158,GO:0002587,1,0.973675264858631,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1159,GO:0002588,1,0.985386911478045,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1160,GO:0002589,1,0.974683739957469,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1161,GO:0002590,1,0.974683739957469,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1162,GO:0002604,1,0.902478522273709,0,8,regulation of dendritic cell antigen processing and presentation,BP,
1163,GO:0002605,1,0.983406759351724,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1164,GO:0002606,1,0.917711713355642,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1165,GO:0002625,1,0.974601375535804,0,2,regulation of T cell antigen processing and presentation,BP,
1166,GO:0002626,1,0.986957261121186,0,1,negative regulation of T cell antigen processing and presentation,BP,
1167,GO:0002634,1,0.881924472639563,0,9,regulation of germinal center formation,BP,
1168,GO:0002635,1,0.968193251073216,0,2,negative regulation of germinal center formation,BP,
1169,GO:0002636,1,0.973526966446825,0,3,positive regulation of germinal center formation,BP,
1171,GO:0002638,1,0.886196994611569,0,8,negative regulation of immunoglobulin production,BP,
1173,GO:0002640,1,0.984725543253726,0,1,regulation of immunoglobulin biosynthetic process,BP,
1174,GO:0002642,1,0.984725543253726,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1175,GO:0002643,1,0.782068514805937,0,17,regulation of tolerance induction,BP,
1176,GO:0002644,1,0.970806460794791,0,2,negative regulation of tolerance induction,BP,
1177,GO:0002645,1,0.878078631417754,0,9,positive regulation of tolerance induction,BP,
1178,GO:0002646,1,0.984530854415234,0,1,regulation of central tolerance induction,BP,
1179,GO:0002648,1,0.984530854415234,0,1,positive regulation of central tolerance induction,BP,
1180,GO:0002649,1,0.983406759351972,0,1,regulation of tolerance induction to self antigen,BP,
1181,GO:0002651,1,0.983406759351972,0,1,positive regulation of tolerance induction to self antigen,BP,
1182,GO:0002652,1,0.971073771730549,0,2,regulation of tolerance induction dependent upon immune response,BP,
1183,GO:0002654,1,0.985409035850243,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1184,GO:0002658,1,0.985409035850243,0,1,regulation of peripheral tolerance induction,BP,
1185,GO:0002660,1,0.985409035850243,0,1,positive regulation of peripheral tolerance induction,BP,
1186,GO:0002661,1,0.968193251074717,0,2,regulation of B cell tolerance induction,BP,
1187,GO:0002663,1,0.968193251074717,0,2,positive regulation of B cell tolerance induction,BP,
1188,GO:0002664,1,0.859329696148122,0,11,regulation of T cell tolerance induction,BP,
1189,GO:0002665,1,0.984347074825103,0,1,negative regulation of T cell tolerance induction,BP,
1190,GO:0002666,1,0.906936838365126,0,7,positive regulation of T cell tolerance induction,BP,
1191,GO:0002667,1,0.923397878431663,0,6,regulation of T cell anergy,BP,
1192,GO:0002668,1,0.984347074825103,0,1,negative regulation of T cell anergy,BP,
1193,GO:0002669,1,0.958574192811788,0,3,positive regulation of T cell anergy,BP,
1197,GO:0002676,1,0.870966804916631,0,11,regulation of chronic inflammatory response,BP,
1198,GO:0002677,1,0.920354203427588,0,6,negative regulation of chronic inflammatory response,BP,
1199,GO:0002678,1,0.954984329689549,0,4,positive regulation of chronic inflammatory response,BP,
1201,GO:0002681,1,0.920430563820922,0,5,somatic recombination of T cell receptor gene segments,BP,
1209,GO:0002689,1,0.823124357571609,0,14,negative regulation of leukocyte chemotaxis,BP,
1211,GO:0002691,1,0.733742299122032,0,23,regulation of cellular extravasation,BP,
1212,GO:0002692,1,0.905201688981068,0,8,negative regulation of cellular extravasation,BP,
1213,GO:0002693,1,0.830122209284426,0,13,positive regulation of cellular extravasation,BP,
1218,GO:0002698,1,0.247134316422548,0,102,negative regulation of immune effector process,BP,
1221,GO:0002701,1,0.673051762264126,0,30,negative regulation of production of molecular mediator of immune response,BP,
1224,GO:0002704,1,0.54683741760066,0,44,negative regulation of leukocyte mediated immunity,BP,
1227,GO:0002707,1,0.638849498480913,0,33,negative regulation of lymphocyte mediated immunity,BP,
1229,GO:0002709,1,0.502458413240126,0,51,regulation of T cell mediated immunity,BP,
1230,GO:0002710,1,0.809853816170108,0,16,negative regulation of T cell mediated immunity,BP,
1231,GO:0002711,1,0.652541943872191,0,31,positive regulation of T cell mediated immunity,BP,
1233,GO:0002713,1,0.877754333501012,0,9,negative regulation of B cell mediated immunity,BP,
1235,GO:0002715,1,0.627784017202349,0,33,regulation of natural killer cell mediated immunity,BP,
1236,GO:0002716,1,0.857281772585992,0,11,negative regulation of natural killer cell mediated immunity,BP,
1237,GO:0002717,1,0.754372691527193,0,20,positive regulation of natural killer cell mediated immunity,BP,
1239,GO:0002719,1,0.748514432344001,0,23,negative regulation of cytokine production involved in immune response,BP,
1241,GO:0002721,1,0.984557888005925,0,1,regulation of B cell cytokine production,BP,
1242,GO:0002724,1,0.744541164939418,0,22,regulation of T cell cytokine production,BP,
1243,GO:0002725,1,0.921700492855501,0,7,negative regulation of T cell cytokine production,BP,
1244,GO:0002726,1,0.818068808077765,0,14,positive regulation of T cell cytokine production,BP,
1245,GO:0002727,1,0.968190853054159,0,2,regulation of natural killer cell cytokine production,BP,
1246,GO:0002728,1,0.983406759352021,0,1,negative regulation of natural killer cell cytokine production,BP,
1247,GO:0002729,1,0.984528416097605,0,1,positive regulation of natural killer cell cytokine production,BP,
1248,GO:0002730,1,0.9289878415733,0,5,regulation of dendritic cell cytokine production,BP,
1249,GO:0002731,1,0.976426132271139,0,2,negative regulation of dendritic cell cytokine production,BP,
1250,GO:0002732,1,0.983406759352021,0,1,positive regulation of dendritic cell cytokine production,BP,
1251,GO:0002736,1,0.992902080858833,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1252,GO:0002737,1,0.992902080858833,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1254,GO:0002740,1,0.935600671277914,0,6,negative regulation of cytokine secretion involved in immune response,BP,
1256,GO:0002752,1,0.977240575281028,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1257,GO:0002753,1,0.444910552370773,0,53,cytoplasmic pattern recognition receptor signaling pathway,BP,
1258,GO:0002755,1,0.591769914049685,0,36,MyD88-dependent toll-like receptor signaling pathway,BP,
1259,GO:0002756,1,0.623210131050141,0,33,MyD88-independent toll-like receptor signaling pathway,BP,
1262,GO:0002759,1,0.934260482878249,0,7,regulation of antimicrobial humoral response,BP,
1263,GO:0002760,1,0.962085290604191,0,5,positive regulation of antimicrobial humoral response,BP,
1268,GO:0002765,1,0.918702231321437,0,6,immune response-inhibiting signal transduction,BP,
1269,GO:0002767,1,0.931247020360602,0,5,immune response-inhibiting cell surface receptor signaling pathway,BP,
1271,GO:0002769,1,0.988702664278225,0,1,natural killer cell inhibitory signaling pathway,BP,
1272,GO:0002774,1,0.952547680524133,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1273,GO:0002775,1,0.93688592349869,0,7,antimicrobial peptide production,BP,
1274,GO:0002777,1,0.994095158928263,0,2,antimicrobial peptide biosynthetic process,BP,
1275,GO:0002778,1,0.93688592349869,0,7,antibacterial peptide production,BP,
1276,GO:0002780,1,0.994095158928263,0,2,antibacterial peptide biosynthetic process,BP,
1277,GO:0002784,1,0.946135065543074,0,6,regulation of antimicrobial peptide production,BP,
1278,GO:0002785,1,0.983423841912682,0,1,negative regulation of antimicrobial peptide production,BP,
1279,GO:0002786,1,0.946135065543074,0,6,regulation of antibacterial peptide production,BP,
1280,GO:0002787,1,0.983423841912682,0,1,negative regulation of antibacterial peptide production,BP,
1285,GO:0002803,1,0.962085290604191,0,5,positive regulation of antibacterial peptide production,BP,
1286,GO:0002805,1,0.994095158928263,0,2,regulation of antimicrobial peptide biosynthetic process,BP,
1287,GO:0002807,1,0.994095158928263,0,2,positive regulation of antimicrobial peptide biosynthetic process,BP,
1288,GO:0002808,1,0.994095158928263,0,2,regulation of antibacterial peptide biosynthetic process,BP,
1289,GO:0002815,1,0.994095158928263,0,2,biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
1290,GO:0002816,1,0.994095158928263,0,2,regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
1292,GO:0002820,1,0.596471188376247,0,38,negative regulation of adaptive immune response,BP,
1295,GO:0002823,1,0.623869105378426,0,35,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1297,GO:0002825,1,0.739311262987489,0,22,regulation of T-helper 1 type immune response,BP,
1298,GO:0002826,1,0.902905738466762,0,7,negative regulation of T-helper 1 type immune response,BP,
1299,GO:0002827,1,0.817910709882227,0,15,positive regulation of T-helper 1 type immune response,BP,
1300,GO:0002828,1,0.687807314604115,0,27,regulation of type 2 immune response,BP,
1301,GO:0002829,1,0.857561620039386,0,11,negative regulation of type 2 immune response,BP,
1302,GO:0002830,1,0.81282507695833,0,15,positive regulation of type 2 immune response,BP,
1304,GO:0002832,1,0.612834667479639,0,34,negative regulation of response to biotic stimulus,BP,
1306,GO:0002834,1,0.855382024908565,0,11,regulation of response to tumor cell,BP,
1307,GO:0002835,1,0.969165854945369,0,2,negative regulation of response to tumor cell,BP,
1308,GO:0002836,1,0.8974308506614,0,8,positive regulation of response to tumor cell,BP,
1309,GO:0002837,1,0.855382024908565,0,11,regulation of immune response to tumor cell,BP,
1310,GO:0002838,1,0.969165854945369,0,2,negative regulation of immune response to tumor cell,BP,
1311,GO:0002839,1,0.8974308506614,0,8,positive regulation of immune response to tumor cell,BP,
1312,GO:0002840,1,0.969205861988691,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1313,GO:0002842,1,0.985473983702695,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1314,GO:0002849,1,0.985409035850243,0,1,regulation of peripheral T cell tolerance induction,BP,
1315,GO:0002851,1,0.985409035850243,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1316,GO:0002855,1,0.894271616075838,0,8,regulation of natural killer cell mediated immune response to tumor cell,BP,
1317,GO:0002856,1,0.969165854945369,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1318,GO:0002857,1,0.922732629752484,0,6,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1319,GO:0002858,1,0.894271616075838,0,8,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1320,GO:0002859,1,0.969165854945369,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1321,GO:0002860,1,0.922732629752484,0,6,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1322,GO:0002861,1,0.768140477346252,0,21,regulation of inflammatory response to antigenic stimulus,BP,
1323,GO:0002862,1,0.87693773014384,0,10,negative regulation of inflammatory response to antigenic stimulus,BP,
1324,GO:0002863,1,0.875998340109693,0,11,positive regulation of inflammatory response to antigenic stimulus,BP,
1325,GO:0002864,1,0.858106314463748,0,12,regulation of acute inflammatory response to antigenic stimulus,BP,
1326,GO:0002865,1,0.942337712376181,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1327,GO:0002866,1,0.910635454945785,0,8,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1328,GO:0002870,1,0.923397878431663,0,6,T cell anergy,BP,
1329,GO:0002874,1,0.96700485976066,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1330,GO:0002875,1,0.988548397282744,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1331,GO:0002876,1,0.978207929760086,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1332,GO:0002877,1,0.959079374071993,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1333,GO:0002878,1,0.983661989983942,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1334,GO:0002879,1,0.975010768052567,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1335,GO:0002880,1,0.971116020353581,0,2,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1336,GO:0002881,1,0.983653385348909,0,1,negative regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1337,GO:0002882,1,0.987255151267588,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1338,GO:0002883,1,0.904760080489801,0,8,regulation of hypersensitivity,BP,
1339,GO:0002884,1,0.970162304403503,0,2,negative regulation of hypersensitivity,BP,
1340,GO:0002885,1,0.932594493909209,0,6,positive regulation of hypersensitivity,BP,
1341,GO:0002886,1,0.588809368316542,0,38,regulation of myeloid leukocyte mediated immunity,BP,
1342,GO:0002887,1,0.866651203185999,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1343,GO:0002888,1,0.791176138917854,0,18,positive regulation of myeloid leukocyte mediated immunity,BP,
1345,GO:0002890,1,0.877754333501012,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1347,GO:0002892,1,0.978900679269921,0,2,regulation of type II hypersensitivity,BP,
1348,GO:0002894,1,0.978900679269921,0,2,positive regulation of type II hypersensitivity,BP,
1349,GO:0002895,1,0.984530854415234,0,1,regulation of central B cell tolerance induction,BP,
1350,GO:0002897,1,0.984530854415234,0,1,positive regulation of central B cell tolerance induction,BP,
1351,GO:0002901,1,0.95944657861196,0,4,mature B cell apoptotic process,BP,
1352,GO:0002902,1,0.788605396218011,0,18,regulation of B cell apoptotic process,BP,
1353,GO:0002903,1,0.857006746059871,0,12,negative regulation of B cell apoptotic process,BP,
1354,GO:0002904,1,0.96612697149986,0,3,positive regulation of B cell apoptotic process,BP,
1355,GO:0002905,1,0.95944657861196,0,4,regulation of mature B cell apoptotic process,BP,
1356,GO:0002906,1,0.95944657861196,0,4,negative regulation of mature B cell apoptotic process,BP,
1357,GO:0002911,1,0.923397878431663,0,6,regulation of lymphocyte anergy,BP,
1358,GO:0002912,1,0.984347074825103,0,1,negative regulation of lymphocyte anergy,BP,
1359,GO:0002913,1,0.958574192811788,0,3,positive regulation of lymphocyte anergy,BP,
1360,GO:0002920,1,0.520099109349611,0,49,regulation of humoral immune response,BP,
1361,GO:0002921,1,0.848717226241652,0,11,negative regulation of humoral immune response,BP,
1362,GO:0002922,1,0.847451285123928,0,15,positive regulation of humoral immune response,BP,
1363,GO:0002923,1,0.892822053213544,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1364,GO:0002924,1,0.933948427199938,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1365,GO:0002925,1,0.95597727378081,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1366,GO:0002930,1,0.970446292569371,0,2,trabecular meshwork development,BP,
1368,GO:0002933,1,0.932215722836493,0,5,lipid hydroxylation,BP,
1370,GO:0002940,1,0.985940398800112,0,1,tRNA N2-guanine methylation,BP,
1371,GO:0002943,1,0.961400644954375,0,3,tRNA dihydrouridine synthesis,BP,
1372,GO:0002944,1,0.969267630033,0,2,cyclin K-CDK12 complex,CC,
1373,GO:0002945,1,0.969267630033338,0,2,cyclin K-CDK13 complex,CC,
1374,GO:0002946,1,0.989654070168948,0,1,tRNA C5-cytosine methylation,BP,
1375,GO:0002947,1,0.983406759352069,0,1,tumor necrosis factor receptor superfamily complex,CC,
1376,GO:0002949,1,0.96239104120643,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1377,GO:0002950,1,0.95670555546659,0,3,ceramide phosphoethanolamine synthase activity,MF,
1383,GO:0003010,1,0.935798159624287,0,5,voluntary skeletal muscle contraction,BP,
1384,GO:0003011,1,0.961931174794472,0,3,involuntary skeletal muscle contraction,BP,
1390,GO:0003017,1,0.983406759350889,0,1,lymph circulation,BP,
1392,GO:0003025,1,0.948967325786269,0,4,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1393,GO:0003026,1,0.984725543253726,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1394,GO:0003027,1,0.988169684514756,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1395,GO:0003029,1,0.988169684514756,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1396,GO:0003032,1,0.969568400513674,0,2,detection of oxygen,BP,
1398,GO:0003050,1,0.9673198689535,0,2,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1399,GO:0003051,1,0.952493869120721,0,3,angiotensin-mediated drinking behavior,BP,
1400,GO:0003056,1,0.907761414441266,0,6,regulation of vascular smooth muscle contraction,BP,
1401,GO:0003057,1,0.932237064927368,0,5,regulation of the force of heart contraction by chemical signal,BP,
1402,GO:0003058,1,0.990870761894025,0,1,hormonal regulation of the force of heart contraction,BP,
1405,GO:0003065,1,0.98770421713424,0,1,positive regulation of heart rate by epinephrine,BP,
1406,GO:0003068,1,0.992313236079646,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1407,GO:0003069,1,0.992313236079646,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1408,GO:0003070,1,0.992313236079646,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1410,GO:0003072,1,0.941108822052539,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1412,GO:0003081,1,0.704440151273276,0,25,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1413,GO:0003083,1,0.994698943007998,0,1,negative regulation of renal output by angiotensin,BP,
1414,GO:0003084,1,0.891416693418421,0,9,positive regulation of systemic arterial blood pressure,BP,
1419,GO:0003095,1,0.958606305124392,0,3,pressure natriuresis,BP,
1421,GO:0003097,1,0.911698855342481,0,6,renal water transport,BP,
1422,GO:0003099,1,0.961397633630255,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1425,GO:0003105,1,0.933706615847933,0,6,negative regulation of glomerular filtration,BP,
1426,GO:0003106,1,0.994698943007998,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1427,GO:0003127,1,0.967087733486853,0,2,detection of nodal flow,BP,
1431,GO:0003131,1,0.984121084602615,0,1,mesodermal-endodermal cell signaling,BP,
1434,GO:0003136,1,0.983950314107376,0,1,negative regulation of heart induction by canonical Wnt signaling pathway,BP,
1435,GO:0003137,1,0.991411501090547,0,1,Notch signaling pathway involved in heart induction,BP,
1436,GO:0003138,1,0.983406759351575,0,1,primary heart field specification,BP,
1438,GO:0003140,1,0.899530626959351,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1439,GO:0003142,1,0.985371944351204,0,1,cardiogenic plate morphogenesis,BP,
1441,GO:0003144,1,0.987989484991945,0,1,embryonic heart tube formation,BP,
1442,GO:0003147,1,0.992156073995558,0,1,neural crest cell migration involved in heart formation,BP,
1445,GO:0003150,1,0.923890309515198,0,5,muscular septum morphogenesis,BP,
1454,GO:0003163,1,0.958780749744373,0,3,sinoatrial node development,BP,
1455,GO:0003164,1,0.929478127350243,0,5,His-Purkinje system development,BP,
1456,GO:0003165,1,0.970692596794289,0,2,Purkinje myocyte development,BP,
1457,GO:0003166,1,0.945165114514416,0,4,bundle of His development,BP,
1458,GO:0003167,1,0.983406759351968,0,1,atrioventricular bundle cell differentiation,BP,
1459,GO:0003168,1,0.987072199627865,0,1,Purkinje myocyte differentiation,BP,
1463,GO:0003172,1,0.983406759351575,0,1,sinoatrial valve development,BP,
1473,GO:0003185,1,0.983406759351575,0,1,sinoatrial valve morphogenesis,BP,
1478,GO:0003193,1,0.972563058367712,0,2,pulmonary valve formation,BP,
1482,GO:0003199,1,0.946424029792525,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1489,GO:0003210,1,0.991411501090547,0,1,cardiac atrium formation,BP,
1494,GO:0003218,1,0.971614266376161,0,2,cardiac left ventricle formation,BP,
1496,GO:0003220,1,0.967087733484337,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1497,GO:0003221,1,0.9545836927143,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1499,GO:0003223,1,0.89293227602706,0,7,ventricular compact myocardium morphogenesis,BP,
1500,GO:0003226,1,0.983406759350544,0,1,right ventricular compact myocardium morphogenesis,BP,
1505,GO:0003235,1,0.991411501090547,0,1,sinus venosus development,BP,
1506,GO:0003236,1,0.991411501090547,0,1,sinus venosus morphogenesis,BP,
1508,GO:0003245,1,0.972477585263194,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1509,GO:0003247,1,0.988499272489636,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1510,GO:0003249,1,0.967087733485253,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1511,GO:0003250,1,0.967087733485253,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1512,GO:0003251,1,0.98340675935099,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1513,GO:0003252,1,0.9834067593502,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1514,GO:0003253,1,0.952456307132088,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1515,GO:0003254,1,0.551888610298649,0,41,regulation of membrane depolarization,BP,
1517,GO:0003257,1,0.93660798413874,0,4,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1518,GO:0003259,1,0.991411501090547,0,1,cardioblast anterior-lateral migration,BP,
1519,GO:0003260,1,0.991411501090547,0,1,cardioblast migration,BP,
1520,GO:0003263,1,0.87913779220451,0,9,cardioblast proliferation,BP,
1527,GO:0003275,1,0.955846912533053,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1528,GO:0003278,1,0.916196556236873,0,6,apoptotic process involved in heart morphogenesis,BP,
1533,GO:0003285,1,0.970784096314489,0,2,septum secundum development,BP,
1535,GO:0003290,1,0.983499452362297,0,1,atrial septum secundum morphogenesis,BP,
1536,GO:0003292,1,0.970692596794287,0,2,cardiac septum cell differentiation,BP,
1537,GO:0003294,1,0.983668456749255,0,1,atrial ventricular junction remodeling,BP,
1539,GO:0003299,1,0.749366761877429,0,19,muscle hypertrophy in response to stress,BP,
1546,GO:0003310,1,0.899561029067349,0,7,pancreatic A cell differentiation,BP,
1547,GO:0003311,1,0.983462499175671,0,1,pancreatic D cell differentiation,BP,
1548,GO:0003312,1,0.971166403391051,0,2,pancreatic PP cell differentiation,BP,
1549,GO:0003318,1,0.991411501090547,0,1,cell migration to the midline involved in heart development,BP,
1550,GO:0003321,1,0.90105207120374,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1551,GO:0003322,1,0.983406759351429,0,1,pancreatic A cell development,BP,
1553,GO:0003326,1,0.971166403391051,0,2,pancreatic A cell fate commitment,BP,
1554,GO:0003327,1,0.98640182911472,0,1,type B pancreatic cell fate commitment,BP,
1555,GO:0003329,1,0.971166403391051,0,2,pancreatic PP cell fate commitment,BP,
1556,GO:0003330,1,0.95821253844059,0,3,regulation of extracellular matrix constituent secretion,BP,
1557,GO:0003331,1,0.95821253844059,0,3,positive regulation of extracellular matrix constituent secretion,BP,
1558,GO:0003333,1,0.356697754371387,0,67,amino acid transmembrane transport,BP,
1559,GO:0003334,1,0.85088487152314,0,11,keratinocyte development,BP,
1560,GO:0003335,1,0.975238235802881,0,2,corneocyte development,BP,
1561,GO:0003336,1,0.984771615077026,0,1,corneocyte desquamation,BP,
1565,GO:0003340,1,0.96049361414884,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1566,GO:0003341,1,0.512572448229833,0,48,cilium movement,BP,
1567,GO:0003342,1,0.97110789246316,0,2,proepicardium development,BP,
1568,GO:0003343,1,0.97110789246316,0,2,septum transversum development,BP,
1570,GO:0003345,1,0.983407808304194,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1572,GO:0003350,1,0.956871465775078,0,3,pulmonary myocardium development,BP,
1573,GO:0003351,1,0.774656835536551,0,19,epithelial cilium movement,BP,
1574,GO:0003352,1,0.838355213562318,0,11,regulation of cilium movement,BP,
1575,GO:0003353,1,0.983846284233559,0,1,positive regulation of cilium movement,BP,
1576,GO:0003356,1,0.852129318839161,0,10,regulation of cilium beat frequency,BP,
1577,GO:0003357,1,0.8979658706764,0,7,noradrenergic neuron differentiation,BP,
1578,GO:0003358,1,0.953650039934191,0,3,noradrenergic neuron development,BP,
1579,GO:0003359,1,0.984968016038942,0,1,noradrenergic neuron fate commitment,BP,
1580,GO:0003360,1,0.895564932726255,0,7,brainstem development,BP,
1581,GO:0003363,1,0.983406759351676,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1583,GO:0003366,1,0.967878752188904,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1584,GO:0003373,1,0.89029542620833,0,7,dynamin family protein polymerization involved in membrane fission,BP,
1585,GO:0003374,1,0.89029542620833,0,7,dynamin family protein polymerization involved in mitochondrial fission,BP,
1586,GO:0003376,1,0.8385947457544,0,12,sphingosine-1-phosphate signaling pathway,BP,
1588,GO:0003383,1,0.95103840934368,0,3,apical constriction,BP,
1589,GO:0003400,1,0.986017784658162,0,1,regulation of COPII vesicle coating,BP,
1592,GO:0003404,1,0.968646595624919,0,2,optic vesicle morphogenesis,BP,
1593,GO:0003406,1,0.936467455225827,0,4,retinal pigment epithelium development,BP,
1594,GO:0003407,1,0.416503202646452,0,57,neural retina development,BP,
1596,GO:0003409,1,0.983560134074922,0,1,optic cup structural organization,BP,
1598,GO:0003414,1,0.983409117130476,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1599,GO:0003415,1,0.935924592092879,0,4,chondrocyte hypertrophy,BP,
1604,GO:0003420,1,0.968991535576422,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1605,GO:0003421,1,0.983407728180071,0,1,growth plate cartilage axis specification,BP,
1606,GO:0003422,1,0.967091005119224,0,2,growth plate cartilage morphogenesis,BP,
1607,GO:0003429,1,0.983409117130476,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1608,GO:0003430,1,0.967780454857863,0,2,growth plate cartilage chondrocyte growth,BP,
1609,GO:0003431,1,0.93828889450544,0,4,growth plate cartilage chondrocyte development,BP,
1610,GO:0003433,1,0.90969110814769,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1614,GO:0003678,1,0.473575007979655,0,47,DNA helicase activity,MF,
1615,GO:0003680,1,0.901170122700377,0,8,AT DNA binding,MF,
1617,GO:0003684,1,0.39788844399467,0,62,damaged DNA binding,MF,
1618,GO:0003688,1,0.818173730674582,0,13,DNA replication origin binding,MF,
1619,GO:0003689,1,0.893170915093693,0,8,DNA clamp loader activity,MF,
1621,GO:0003691,1,0.87180481078024,0,9,double-stranded telomeric DNA binding,MF,
1622,GO:0003692,1,0.985953853875729,0,1,left-handed Z-DNA binding,MF,
1624,GO:0003697,1,0.259447339881948,0,91,single-stranded DNA binding,MF,
1626,GO:0003705,1,0.250717136742818,0,94,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1628,GO:0003708,1,0.898108702918994,0,7,retinoic acid receptor activity,MF,
1632,GO:0003720,1,0.895169378218696,0,7,telomerase activity,MF,
1633,GO:0003721,1,0.983406759352117,0,1,telomerase RNA reverse transcriptase activity,MF,
1635,GO:0003724,1,0.338683143946646,0,68,RNA helicase activity,MF,
1637,GO:0003726,1,0.953502007296054,0,3,double-stranded RNA adenosine deaminase activity,MF,
1638,GO:0003727,1,0.339983159314441,0,72,single-stranded RNA binding,MF,
1639,GO:0003729,1,0.0789053394590111,0,176,mRNA binding,MF,
1640,GO:0003730,1,0.417155935075642,0,57,mRNA 3'-UTR binding,MF,
1641,GO:0003735,1,0.304664678985725,0,154,structural constituent of ribosome,MF,
1642,GO:0003743,1,0.505495499178998,0,50,translation initiation factor activity,MF,
1643,GO:0003746,1,0.814590617121804,0,15,translation elongation factor activity,MF,
1644,GO:0003747,1,0.912283551475792,0,6,translation release factor activity,MF,
1645,GO:0003755,1,0.651048965008239,0,38,peptidyl-prolyl cis-trans isomerase activity,MF,
1646,GO:0003756,1,0.761828112530574,0,18,protein disulfide isomerase activity,MF,
1648,GO:0003777,1,0.300774965414475,0,76,microtubule motor activity,MF,
1650,GO:0003785,1,0.73005734102709,0,26,actin monomer binding,MF,
1651,GO:0003796,1,0.925186456402199,0,11,lysozyme activity,MF,
1652,GO:0003810,1,0.868577580168086,0,9,protein-glutamine gamma-glutamyltransferase activity,MF,
1653,GO:0003823,1,0.460631000692789,0,64,antigen binding,MF,
1655,GO:0003826,1,0.972495171606339,0,2,alpha-ketoacid dehydrogenase activity,MF,
1656,GO:0003827,1,0.983965623204124,0,1,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1657,GO:0003828,1,0.911477856795213,0,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1658,GO:0003829,1,0.953456006441042,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1659,GO:0003830,1,0.983406759351921,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1660,GO:0003831,1,0.886438462286737,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1661,GO:0003835,1,0.967087733487574,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1662,GO:0003836,1,0.915452346930505,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1663,GO:0003837,1,0.986410205054556,0,1,beta-ureidopropionase activity,MF,
1664,GO:0003839,1,0.956794680005604,0,4,gamma-glutamylcyclotransferase activity,MF,
1665,GO:0003840,1,0.927550808547416,0,6,gamma-glutamyltransferase activity,MF,
1667,GO:0003842,1,0.983595118214331,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1668,GO:0003844,1,0.983721525814145,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1669,GO:0003845,1,0.97720120009366,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1670,GO:0003846,1,0.930741833852878,0,6,2-acylglycerol O-acyltransferase activity,MF,
1671,GO:0003847,1,0.942934754055701,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1672,GO:0003854,1,0.93674005244279,0,5,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1673,GO:0003857,1,0.889718373442002,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1674,GO:0003858,1,0.967731084465443,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1675,GO:0003860,1,0.98703291513635,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1676,GO:0003863,1,0.972495171606339,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1677,GO:0003865,1,0.955855760037396,0,3,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1678,GO:0003867,1,0.983406759351921,0,1,4-aminobutyrate transaminase activity,MF,
1679,GO:0003868,1,0.988331803727591,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1680,GO:0003870,1,0.97218367390541,0,2,5-aminolevulinate synthase activity,MF,
1681,GO:0003872,1,0.952590119727347,0,3,6-phosphofructokinase activity,MF,
1683,GO:0003874,1,0.992937098316418,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1684,GO:0003875,1,0.971395893233617,0,2,ADP-ribosylarginine hydrolase activity,MF,
1685,GO:0003876,1,0.95274978971535,0,3,AMP deaminase activity,MF,
1686,GO:0003878,1,0.983406759352021,0,1,ATP citrate synthase activity,MF,
1687,GO:0003880,1,0.974099432878204,0,2,protein C-terminal carboxyl O-methyltransferase activity,MF,
1688,GO:0003881,1,0.987293227484874,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1689,GO:0003882,1,0.985036820424895,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1690,GO:0003883,1,0.968384808079036,0,2,CTP synthase activity,MF,
1691,GO:0003884,1,0.977434131926749,0,2,D-amino-acid oxidase activity,MF,
1692,GO:0003886,1,0.95103845435099,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1693,GO:0003887,1,0.685122724354846,0,26,DNA-directed DNA polymerase activity,MF,
1694,GO:0003896,1,0.959016593156292,0,3,DNA primase activity,MF,
1695,GO:0003899,1,0.593450618856079,0,40,DNA-directed 5'-3' RNA polymerase activity,MF,
1696,GO:0003905,1,0.991885055232925,0,1,alkylbase DNA N-glycosylase activity,MF,
1697,GO:0003906,1,0.839246326862162,0,14,DNA-(apurinic or apyrimidinic site) lyase activity,MF,
1698,GO:0003908,1,0.9907107361571,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1699,GO:0003909,1,0.897645032147398,0,7,DNA ligase activity,MF,
1700,GO:0003910,1,0.910180563995063,0,6,DNA ligase (ATP) activity,MF,
1701,GO:0003912,1,0.986530857840023,0,1,DNA nucleotidylexotransferase activity,MF,
1702,GO:0003916,1,0.897088563549976,0,7,DNA topoisomerase activity,MF,
1703,GO:0003917,1,0.939066387688388,0,4,DNA topoisomerase type I activity,MF,
1704,GO:0003918,1,0.955309721541157,0,3,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1705,GO:0003919,1,0.986837428914268,0,1,FMN adenylyltransferase activity,MF,
1706,GO:0003920,1,0.976570686515648,0,2,GMP reductase activity,MF,
1707,GO:0003921,1,0.984994741437184,0,1,GMP synthase activity,MF,
1708,GO:0003922,1,0.984994741437184,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1709,GO:0003923,1,0.929153192970106,0,5,GPI-anchor transamidase activity,MF,
1711,GO:0003933,1,0.98692313693549,0,1,GTP cyclohydrolase activity,MF,
1712,GO:0003934,1,0.98692313693549,0,1,GTP cyclohydrolase I activity,MF,
1713,GO:0003937,1,0.986298138481011,0,1,IMP cyclohydrolase activity,MF,
1714,GO:0003938,1,0.973226670797772,0,2,IMP dehydrogenase activity,MF,
1715,GO:0003939,1,0.98481024597292,0,1,L-iditol 2-dehydrogenase activity,MF,
1716,GO:0003940,1,0.985917419369727,0,1,L-iduronidase activity,MF,
1717,GO:0003941,1,0.963930205392808,0,3,L-serine ammonia-lyase activity,MF,
1718,GO:0003943,1,0.968938905939717,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1719,GO:0003944,1,0.985868005436853,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1720,GO:0003945,1,0.943382027494711,0,4,N-acetyllactosamine synthase activity,MF,
1721,GO:0003947,1,0.983831319221429,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1722,GO:0003948,1,0.986335251764542,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1723,GO:0003950,1,0.72295170400369,0,22,NAD+ ADP-ribosyltransferase activity,MF,
1724,GO:0003951,1,0.769950260315631,0,16,NAD+ kinase activity,MF,
1725,GO:0003952,1,0.985058090684018,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1726,GO:0003953,1,0.969037418289426,0,3,NAD+ nucleosidase activity,MF,
1727,GO:0003954,1,0.758696640551463,0,38,NADH dehydrogenase activity,MF,
1728,GO:0003955,1,0.968655742805805,0,2,NAD(P)H dehydrogenase (quinone) activity,MF,
1729,GO:0003956,1,0.949086275829829,0,5,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1730,GO:0003957,1,0.983406759351972,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1731,GO:0003958,1,0.907417243577388,0,6,NADPH-hemoprotein reductase activity,MF,
1732,GO:0003960,1,0.95127086549177,0,4,NADPH:quinone reductase activity,MF,
1733,GO:0003962,1,0.987935314300946,0,1,cystathionine gamma-synthase activity,MF,
1734,GO:0003963,1,0.984725543253726,0,1,RNA-3'-phosphate cyclase activity,MF,
1735,GO:0003964,1,0.895169378218696,0,7,RNA-directed DNA polymerase activity,MF,
1736,GO:0003968,1,0.967087733487673,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1737,GO:0003973,1,0.97681406979208,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1738,GO:0003974,1,0.988636285343882,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1739,GO:0003975,1,0.986108273388071,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1740,GO:0003976,1,0.960828206330755,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1741,GO:0003977,1,0.969182313446229,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1742,GO:0003978,1,0.988636285343882,0,1,UDP-glucose 4-epimerase activity,MF,
1743,GO:0003979,1,0.98363933440899,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1744,GO:0003980,1,0.967087733486465,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1745,GO:0003983,1,0.98611224388859,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1746,GO:0003985,1,0.959443921592556,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1747,GO:0003986,1,0.959197143742076,0,4,acetyl-CoA hydrolase activity,MF,
1748,GO:0003987,1,0.95185659750754,0,3,acetate-CoA ligase activity,MF,
1749,GO:0003988,1,0.921965025445789,0,6,acetyl-CoA C-acyltransferase activity,MF,
1750,GO:0003989,1,0.967087733485641,0,2,acetyl-CoA carboxylase activity,MF,
1751,GO:0003990,1,0.9699599875213,0,2,acetylcholinesterase activity,MF,
1752,GO:0003993,1,0.886802488576018,0,9,acid phosphatase activity,MF,
1753,GO:0003994,1,0.96797199517123,0,2,aconitate hydratase activity,MF,
1754,GO:0003995,1,0.788300038551931,0,16,acyl-CoA dehydrogenase activity,MF,
1755,GO:0003996,1,0.905579940668251,0,7,acyl-CoA ligase activity,MF,
1756,GO:0003997,1,0.913878922732207,0,6,acyl-CoA oxidase activity,MF,
1757,GO:0003998,1,0.986081998809683,0,2,acylphosphatase activity,MF,
1758,GO:0003999,1,0.994332601825609,0,1,adenine phosphoribosyltransferase activity,MF,
1759,GO:0004000,1,0.859934359322515,0,10,adenosine deaminase activity,MF,
1760,GO:0004001,1,0.986477642086532,0,1,adenosine kinase activity,MF,
1761,GO:0004003,1,0.589703218129888,0,33,ATP-dependent DNA helicase activity,MF,
1762,GO:0004004,1,0.344288884532171,0,67,ATP-dependent RNA helicase activity,MF,
1763,GO:0004008,1,0.967087733486655,0,2,copper-exporting ATPase activity,MF,
1764,GO:0004012,1,0.727528453819879,0,19,phospholipid-translocating ATPase activity,MF,
1765,GO:0004013,1,0.985557613879444,0,1,adenosylhomocysteinase activity,MF,
1766,GO:0004014,1,0.983585198051488,0,1,adenosylmethionine decarboxylase activity,MF,
1767,GO:0004016,1,0.846008626557052,0,10,adenylate cyclase activity,MF,
1768,GO:0004017,1,0.896849235290744,0,7,adenylate kinase activity,MF,
1769,GO:0004018,1,0.989393501185617,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1770,GO:0004019,1,0.972144638564943,0,2,adenylosuccinate synthase activity,MF,
1771,GO:0004020,1,0.968418076297561,0,2,adenylylsulfate kinase activity,MF,
1772,GO:0004021,1,0.970830875297921,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1773,GO:0004022,1,0.8875031701238,0,9,alcohol dehydrogenase (NAD) activity,MF,
1774,GO:0004024,1,0.924772241010799,0,6,alcohol dehydrogenase activity, zinc-dependent,MF,
1775,GO:0004027,1,0.984073514377899,0,2,alcohol sulfotransferase activity,MF,
1776,GO:0004028,1,0.927222164938332,0,5,3-chloroallyl aldehyde dehydrogenase activity,MF,
1777,GO:0004029,1,0.801684495909872,0,14,aldehyde dehydrogenase (NAD) activity,MF,
1778,GO:0004030,1,0.899966331285738,0,7,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1779,GO:0004031,1,0.969540021681503,0,2,aldehyde oxidase activity,MF,
1780,GO:0004032,1,0.928687579377228,0,7,alditol:NADP+ 1-oxidoreductase activity,MF,
1781,GO:0004033,1,0.743848554806988,0,25,aldo-keto reductase (NADP) activity,MF,
1782,GO:0004034,1,0.984938620238289,0,1,aldose 1-epimerase activity,MF,
1783,GO:0004035,1,0.939755670466894,0,4,alkaline phosphatase activity,MF,
1784,GO:0004037,1,0.989576581289443,0,1,allantoicase activity,MF,
1785,GO:0004040,1,0.960261007666103,0,3,amidase activity,MF,
1786,GO:0004042,1,0.98640182911472,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1787,GO:0004043,1,0.983444592055299,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1788,GO:0004044,1,0.983414210805075,0,1,amidophosphoribosyltransferase activity,MF,
1789,GO:0004045,1,0.972657860888486,0,3,aminoacyl-tRNA hydrolase activity,MF,
1790,GO:0004046,1,0.942439662314446,0,5,aminoacylase activity,MF,
1791,GO:0004047,1,0.975796349340223,0,2,aminomethyltransferase activity,MF,
1792,GO:0004051,1,0.984728227912546,0,1,arachidonate 5-lipoxygenase activity,MF,
1793,GO:0004052,1,0.95525767953657,0,3,arachidonate 12-lipoxygenase activity,MF,
1794,GO:0004053,1,0.976507175499536,0,2,arginase activity,MF,
1795,GO:0004055,1,0.987523128423052,0,1,argininosuccinate synthase activity,MF,
1796,GO:0004056,1,0.986746146968489,0,1,argininosuccinate lyase activity,MF,
1797,GO:0004057,1,0.985837852115415,0,1,arginyltransferase activity,MF,
1798,GO:0004058,1,0.986625645402232,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1799,GO:0004059,1,0.989458188743017,0,1,aralkylamine N-acetyltransferase activity,MF,
1800,GO:0004060,1,0.966867506365901,0,3,arylamine N-acetyltransferase activity,MF,
1801,GO:0004061,1,0.988182873842877,0,1,arylformamidase activity,MF,
1802,GO:0004062,1,0.88277006332427,0,11,aryl sulfotransferase activity,MF,
1803,GO:0004063,1,0.979168243905463,0,2,aryldialkylphosphatase activity,MF,
1804,GO:0004064,1,0.933231780278498,0,6,arylesterase activity,MF,
1805,GO:0004065,1,0.830904067424338,0,12,arylsulfatase activity,MF,
1806,GO:0004066,1,0.970627680804132,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1807,GO:0004067,1,0.972827665061887,0,2,asparaginase activity,MF,
1808,GO:0004068,1,0.983424145688257,0,1,aspartate 1-decarboxylase activity,MF,
1809,GO:0004069,1,0.961679714757001,0,3,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1810,GO:0004070,1,0.983406759351379,0,1,aspartate carbamoyltransferase activity,MF,
1811,GO:0004074,1,0.985466040882494,0,2,biliverdin reductase activity,MF,
1812,GO:0004075,1,0.922470076426391,0,5,biotin carboxylase activity,MF,
1813,GO:0004077,1,0.983406759351672,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1814,GO:0004078,1,0.983406759351672,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1815,GO:0004079,1,0.983406759351672,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1816,GO:0004080,1,0.983406759351672,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1817,GO:0004081,1,0.976926140728303,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1818,GO:0004082,1,0.957531351123574,0,4,bisphosphoglycerate mutase activity,MF,
1819,GO:0004084,1,0.972190230503299,0,2,branched-chain-amino-acid transaminase activity,MF,
1820,GO:0004085,1,0.987072199627865,0,1,butyryl-CoA dehydrogenase activity,MF,
1821,GO:0004087,1,0.983406759351724,0,1,carbamoyl-phosphate synthase (ammonia) activity,MF,
1822,GO:0004088,1,0.967087733487142,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1823,GO:0004089,1,0.852736652513068,0,13,carbonate dehydratase activity,MF,
1824,GO:0004090,1,0.962012668183496,0,4,carbonyl reductase (NADPH) activity,MF,
1825,GO:0004092,1,0.984131141338345,0,1,carnitine O-acetyltransferase activity,MF,
1826,GO:0004095,1,0.937283167391839,0,4,carnitine O-palmitoyltransferase activity,MF,
1827,GO:0004096,1,0.963840045359777,0,3,catalase activity,MF,
1828,GO:0004098,1,0.987151402271142,0,1,cerebroside-sulfatase activity,MF,
1829,GO:0004102,1,0.984985804656315,0,1,choline O-acetyltransferase activity,MF,
1830,GO:0004103,1,0.973087751599786,0,2,choline kinase activity,MF,
1831,GO:0004104,1,0.954820538746449,0,3,cholinesterase activity,MF,
1832,GO:0004105,1,0.972394763708649,0,2,choline-phosphate cytidylyltransferase activity,MF,
1833,GO:0004108,1,0.9838765730806,0,1,citrate (Si)-synthase activity,MF,
1834,GO:0004109,1,0.969480405429325,0,2,coproporphyrinogen oxidase activity,MF,
1835,GO:0004111,1,0.929020419188829,0,6,creatine kinase activity,MF,
1837,GO:0004113,1,0.983406759351872,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1840,GO:0004117,1,0.954446222934253,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1841,GO:0004118,1,0.951038409343064,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1842,GO:0004119,1,0.967087733487774,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1843,GO:0004122,1,0.984615667407723,0,1,cystathionine beta-synthase activity,MF,
1844,GO:0004123,1,0.987935314300946,0,1,cystathionine gamma-lyase activity,MF,
1845,GO:0004126,1,0.915565221250472,0,8,cytidine deaminase activity,MF,
1846,GO:0004127,1,0.938598639737019,0,4,cytidylate kinase activity,MF,
1847,GO:0004128,1,0.90545878932522,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1848,GO:0004129,1,0.835658595399198,0,26,cytochrome-c oxidase activity,MF,
1849,GO:0004131,1,0.99323283792893,0,1,cytosine deaminase activity,MF,
1850,GO:0004132,1,0.986582382029099,0,1,dCMP deaminase activity,MF,
1851,GO:0004133,1,0.98340675935133,0,1,glycogen debranching enzyme activity,MF,
1852,GO:0004134,1,0.98340675935133,0,1,4-alpha-glucanotransferase activity,MF,
1853,GO:0004135,1,0.98340675935133,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1854,GO:0004137,1,0.968269155962149,0,2,deoxycytidine kinase activity,MF,
1855,GO:0004138,1,0.992395609449106,0,1,deoxyguanosine kinase activity,MF,
1856,GO:0004139,1,0.988025773396631,0,1,deoxyribose-phosphate aldolase activity,MF,
1857,GO:0004140,1,0.972259304730068,0,2,dephospho-CoA kinase activity,MF,
1858,GO:0004142,1,0.958616666722707,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1859,GO:0004143,1,0.833043439148125,0,11,diacylglycerol kinase activity,MF,
1860,GO:0004144,1,0.939676529059021,0,5,diacylglycerol O-acyltransferase activity,MF,
1861,GO:0004145,1,0.970748170002122,0,3,diamine N-acetyltransferase activity,MF,
1862,GO:0004146,1,0.983407061187744,0,1,dihydrofolate reductase activity,MF,
1863,GO:0004148,1,0.983438992748238,0,1,dihydrolipoyl dehydrogenase activity,MF,
1864,GO:0004149,1,0.984079163645405,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1865,GO:0004151,1,0.983406759351379,0,1,dihydroorotase activity,MF,
1866,GO:0004152,1,0.986418592932794,0,1,dihydroorotate dehydrogenase activity,MF,
1867,GO:0004155,1,0.988428714313238,0,1,6,7-dihydropteridine reductase activity,MF,
1868,GO:0004157,1,0.969815341883839,0,2,dihydropyrimidinase activity,MF,
1869,GO:0004161,1,0.973673941280527,0,2,dimethylallyltranstransferase activity,MF,
1870,GO:0004163,1,0.987654222367057,0,1,diphosphomevalonate decarboxylase activity,MF,
1871,GO:0004164,1,0.987694195188049,0,1,diphthine synthase activity,MF,
1872,GO:0004165,1,0.953591580487392,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1873,GO:0004167,1,0.976206182176278,0,3,dopachrome isomerase activity,MF,
1874,GO:0004168,1,0.985898353279622,0,1,dolichol kinase activity,MF,
1875,GO:0004169,1,0.945783376351053,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1876,GO:0004170,1,0.987298000092628,0,1,dUTP diphosphatase activity,MF,
1877,GO:0004174,1,0.969184960236034,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1879,GO:0004176,1,0.937369649049323,0,4,ATP-dependent peptidase activity,MF,
1880,GO:0004177,1,0.539691072030058,0,40,aminopeptidase activity,MF,
1881,GO:0004180,1,0.589107901425097,0,37,carboxypeptidase activity,MF,
1882,GO:0004181,1,0.701820064766893,0,25,metallocarboxypeptidase activity,MF,
1883,GO:0004185,1,0.931909232090696,0,5,serine-type carboxypeptidase activity,MF,
1884,GO:0004190,1,0.725034134741963,0,24,aspartic-type endopeptidase activity,MF,
1885,GO:0004197,1,0.316462079098277,0,80,cysteine-type endopeptidase activity,MF,
1886,GO:0004198,1,0.754719987908011,0,19,calcium-dependent cysteine-type endopeptidase activity,MF,
1887,GO:0004222,1,0.176910211836153,0,112,metalloendopeptidase activity,MF,
1889,GO:0004298,1,0.833135404013818,0,21,threonine-type endopeptidase activity,MF,
1890,GO:0004300,1,0.899075256952306,0,8,enoyl-CoA hydratase activity,MF,
1891,GO:0004301,1,0.93703930610151,0,5,epoxide hydrolase activity,MF,
1892,GO:0004303,1,0.891554791907275,0,10,estradiol 17-beta-dehydrogenase activity,MF,
1893,GO:0004304,1,0.974674213530538,0,2,estrone sulfotransferase activity,MF,
1894,GO:0004305,1,0.942190481286947,0,4,ethanolamine kinase activity,MF,
1895,GO:0004306,1,0.987369937642802,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1896,GO:0004307,1,0.977793001689623,0,2,ethanolaminephosphotransferase activity,MF,
1897,GO:0004308,1,0.920878285147598,0,6,exo-alpha-sialidase activity,MF,
1898,GO:0004310,1,0.986257186080042,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1899,GO:0004311,1,0.939791724383923,0,4,farnesyltranstransferase activity,MF,
1908,GO:0004321,1,0.918714588655285,0,6,fatty-acyl-CoA synthase activity,MF,
1909,GO:0004322,1,0.920675663094066,0,6,ferroxidase activity,MF,
1910,GO:0004324,1,0.987179557575313,0,1,ferredoxin-NADP+ reductase activity,MF,
1911,GO:0004325,1,0.983406759351328,0,1,ferrochelatase activity,MF,
1912,GO:0004326,1,0.984918230711999,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1913,GO:0004329,1,0.967178128446868,0,2,formate-tetrahydrofolate ligase activity,MF,
1915,GO:0004332,1,0.963035409113811,0,3,fructose-bisphosphate aldolase activity,MF,
1916,GO:0004333,1,0.987694195188049,0,1,fumarate hydratase activity,MF,
1917,GO:0004334,1,0.989535030186473,0,1,fumarylacetoacetase activity,MF,
1918,GO:0004335,1,0.973920861327488,0,2,galactokinase activity,MF,
1919,GO:0004336,1,0.983982792429525,0,1,galactosylceramidase activity,MF,
1920,GO:0004337,1,0.973673941280527,0,2,geranyltranstransferase activity,MF,
1921,GO:0004339,1,0.983406759351527,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1922,GO:0004340,1,0.921293224150784,0,5,glucokinase activity,MF,
1923,GO:0004341,1,0.987042139523325,0,1,gluconolactonase activity,MF,
1924,GO:0004342,1,0.972814483376737,0,2,glucosamine-6-phosphate deaminase activity,MF,
1925,GO:0004343,1,0.98340696990532,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1926,GO:0004345,1,0.969038633940188,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1927,GO:0004346,1,0.956695897806699,0,3,glucose-6-phosphatase activity,MF,
1928,GO:0004347,1,0.986339390427225,0,1,glucose-6-phosphate isomerase activity,MF,
1929,GO:0004348,1,0.957472195513349,0,3,glucosylceramidase activity,MF,
1930,GO:0004349,1,0.983473444283871,0,1,glutamate 5-kinase activity,MF,
1931,GO:0004350,1,0.983473444283871,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1932,GO:0004351,1,0.953958587263492,0,3,glutamate decarboxylase activity,MF,
1933,GO:0004352,1,0.969138360337431,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1934,GO:0004353,1,0.969138360337431,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1935,GO:0004356,1,0.967087733487917,0,2,glutamate-ammonia ligase activity,MF,
1936,GO:0004357,1,0.967443258148103,0,2,glutamate-cysteine ligase activity,MF,
1937,GO:0004359,1,0.953727037901403,0,3,glutaminase activity,MF,
1938,GO:0004360,1,0.967493994633408,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1939,GO:0004361,1,0.98810400393685,0,1,glutaryl-CoA dehydrogenase activity,MF,
1940,GO:0004362,1,0.985635830374349,0,1,glutathione-disulfide reductase activity,MF,
1941,GO:0004363,1,0.987137364004211,0,1,glutathione synthase activity,MF,
1942,GO:0004364,1,0.819216358444962,0,23,glutathione transferase activity,MF,
1943,GO:0004365,1,0.979791773872411,0,2,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1944,GO:0004366,1,0.96776987004251,0,2,glycerol-3-phosphate O-acyltransferase activity,MF,
1945,GO:0004367,1,0.967707322521919,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1946,GO:0004368,1,0.967706972178188,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1947,GO:0004370,1,0.954876591004031,0,3,glycerol kinase activity,MF,
1948,GO:0004372,1,0.970966727516621,0,2,glycine hydroxymethyltransferase activity,MF,
1949,GO:0004373,1,0.967442330844359,0,2,glycogen (starch) synthase activity,MF,
1951,GO:0004376,1,0.941312340676307,0,4,glycolipid mannosyltransferase activity,MF,
1952,GO:0004377,1,0.984793613710715,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1953,GO:0004378,1,0.983989121954792,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1955,GO:0004380,1,0.988814169145597,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1956,GO:0004381,1,0.988814169145597,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1957,GO:0004382,1,0.970162768530904,0,2,guanosine-diphosphatase activity,MF,
1959,GO:0004385,1,0.81513925218244,0,13,guanylate kinase activity,MF,
1960,GO:0004386,1,0.0953769441162835,0,147,helicase activity,MF,
1961,GO:0004392,1,0.977069470666568,0,2,heme oxygenase (decyclizing) activity,MF,
1962,GO:0004394,1,0.983406759352069,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1963,GO:0004395,1,0.990704363325434,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1964,GO:0004396,1,0.921293224150784,0,5,hexokinase activity,MF,
1965,GO:0004397,1,0.983676454999591,0,1,histidine ammonia-lyase activity,MF,
1966,GO:0004398,1,0.985160432073427,0,1,histidine decarboxylase activity,MF,
1967,GO:0004402,1,0.444027075553765,0,54,histone acetyltransferase activity,MF,
1969,GO:0004408,1,0.985571724528833,0,1,holocytochrome-c synthase activity,MF,
1970,GO:0004411,1,0.987039832328744,0,1,homogentisate 1,2-dioxygenase activity,MF,
1971,GO:0004415,1,0.917052566408844,0,6,hyalurononglucosaminidase activity,MF,
1972,GO:0004416,1,0.972950869596186,0,2,hydroxyacylglutathione hydrolase activity,MF,
1973,GO:0004418,1,0.989458188743017,0,1,hydroxymethylbilane synthase activity,MF,
1974,GO:0004419,1,0.974258172616007,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1975,GO:0004420,1,0.983406759352021,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1977,GO:0004422,1,0.98976807092467,0,1,hypoxanthine phosphoribosyltransferase activity,MF,
1978,GO:0004423,1,0.983406759351724,0,1,iduronate-2-sulfatase activity,MF,
1979,GO:0004427,1,0.968032338731852,0,3,inorganic diphosphatase activity,MF,
1980,GO:0004430,1,0.935342349791984,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1981,GO:0004435,1,0.649942000175247,0,27,phosphatidylinositol phospholipase C activity,MF,
1982,GO:0004438,1,0.794511901831205,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1983,GO:0004439,1,0.878159570843092,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1984,GO:0004441,1,0.986324918197955,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1985,GO:0004445,1,0.922699154948968,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1986,GO:0004446,1,0.98408794163048,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1987,GO:0004447,1,0.96758161688106,0,2,iodide peroxidase activity,MF,
1988,GO:0004448,1,0.937294800830971,0,5,isocitrate dehydrogenase activity,MF,
1989,GO:0004449,1,0.962739484131993,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1990,GO:0004450,1,0.973574653380987,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1991,GO:0004452,1,0.976409805234678,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
1993,GO:0004457,1,0.915132446959128,0,7,lactate dehydrogenase activity,MF,
1994,GO:0004458,1,0.971401834768343,0,2,D-lactate dehydrogenase (cytochrome) activity,MF,
1995,GO:0004459,1,0.942080809102248,0,5,L-lactate dehydrogenase activity,MF,
1996,GO:0004461,1,0.964498584397214,0,3,lactose synthase activity,MF,
1997,GO:0004462,1,0.986520177499673,0,1,lactoylglutathione lyase activity,MF,
1998,GO:0004463,1,0.986397645622698,0,1,leukotriene-A4 hydrolase activity,MF,
1999,GO:0004464,1,0.988789682247843,0,2,leukotriene-C4 synthase activity,MF,
2000,GO:0004465,1,0.898904662420367,0,8,lipoprotein lipase activity,MF,
2001,GO:0004466,1,0.946409213496639,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
2003,GO:0004468,1,0.923246375103676,0,6,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
2004,GO:0004470,1,0.944486307986809,0,4,malic enzyme activity,MF,
2005,GO:0004471,1,0.953386814813389,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
2006,GO:0004473,1,0.953386814813389,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
2007,GO:0004474,1,0.983406759351724,0,1,malate synthase activity,MF,
2008,GO:0004475,1,0.988680494091708,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
2009,GO:0004476,1,0.987784806077991,0,1,mannose-6-phosphate isomerase activity,MF,
2010,GO:0004477,1,0.939404309701361,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
2011,GO:0004478,1,0.967896375361172,0,2,methionine adenosyltransferase activity,MF,
2012,GO:0004479,1,0.984275768717627,0,1,methionyl-tRNA formyltransferase activity,MF,
2013,GO:0004482,1,0.983406759351624,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2014,GO:0004484,1,0.983406759352021,0,1,mRNA guanylyltransferase activity,MF,
2015,GO:0004485,1,0.968433844632033,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2016,GO:0004486,1,0.983473070617362,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2017,GO:0004487,1,0.955233247248618,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2018,GO:0004488,1,0.939404309701361,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2019,GO:0004489,1,0.983406759351379,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2020,GO:0004490,1,0.988758280857567,0,1,methylglutaconyl-CoA hydratase activity,MF,
2021,GO:0004491,1,0.985951929448957,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2022,GO:0004492,1,0.98622464010204,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2023,GO:0004493,1,0.993395968098118,0,1,methylmalonyl-CoA epimerase activity,MF,
2024,GO:0004494,1,0.983903209158954,0,1,methylmalonyl-CoA mutase activity,MF,
2025,GO:0004496,1,0.986399736995498,0,1,mevalonate kinase activity,MF,
2026,GO:0004497,1,0.267627428188034,0,91,monooxygenase activity,MF,
2027,GO:0004498,1,0.984918230711999,0,1,calcidiol 1-monooxygenase activity,MF,
2028,GO:0004499,1,0.929050757681211,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2029,GO:0004500,1,0.968286448699606,0,2,dopamine beta-monooxygenase activity,MF,
2030,GO:0004502,1,0.983406759351921,0,1,kynurenine 3-monooxygenase activity,MF,
2031,GO:0004503,1,0.98643961483798,0,1,monophenol monooxygenase activity,MF,
2032,GO:0004504,1,0.983416035861832,0,1,peptidylglycine monooxygenase activity,MF,
2033,GO:0004505,1,0.962571028237507,0,3,phenylalanine 4-monooxygenase activity,MF,
2034,GO:0004506,1,0.983861596996454,0,1,squalene monooxygenase activity,MF,
2035,GO:0004507,1,0.967687740650048,0,2,steroid 11-beta-monooxygenase activity,MF,
2036,GO:0004508,1,0.98730755402416,0,1,steroid 17-alpha-monooxygenase activity,MF,
2037,GO:0004509,1,0.986593170059687,0,1,steroid 21-monooxygenase activity,MF,
2038,GO:0004510,1,0.973042684889441,0,2,tryptophan 5-monooxygenase activity,MF,
2039,GO:0004511,1,0.987142040508027,0,1,tyrosine 3-monooxygenase activity,MF,
2040,GO:0004512,1,0.985661028735059,0,1,inositol-3-phosphate synthase activity,MF,
2041,GO:0004513,1,0.98549472495242,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2042,GO:0004514,1,0.972589037057462,0,2,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2043,GO:0004515,1,0.939042852958382,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2044,GO:0004517,1,0.95257433551999,0,3,nitric-oxide synthase activity,MF,
2045,GO:0004518,1,0.0614651167104248,0,199,nuclease activity,MF,
2046,GO:0004519,1,0.184691331593236,0,125,endonuclease activity,MF,
2047,GO:0004520,1,0.496050354876955,0,50,endodeoxyribonuclease activity,MF,
2048,GO:0004521,1,0.526931783443965,0,50,endoribonuclease activity,MF,
2049,GO:0004522,1,0.973218546889519,0,4,ribonuclease A activity,MF,
2050,GO:0004523,1,0.929672131884582,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2051,GO:0004525,1,0.940819828510553,0,4,ribonuclease III activity,MF,
2052,GO:0004526,1,0.892613360865732,0,10,ribonuclease P activity,MF,
2053,GO:0004527,1,0.337656873690103,0,73,exonuclease activity,MF,
2054,GO:0004528,1,0.926945956712134,0,5,phosphodiesterase I activity,MF,
2055,GO:0004529,1,0.761083217978196,0,19,exodeoxyribonuclease activity,MF,
2056,GO:0004530,1,0.983731103812819,0,1,deoxyribonuclease I activity,MF,
2057,GO:0004531,1,0.978351534886959,0,2,deoxyribonuclease II activity,MF,
2058,GO:0004532,1,0.630769612003628,0,32,exoribonuclease activity,MF,
2059,GO:0004534,1,0.96715783445955,0,2,5'-3' exoribonuclease activity,MF,
2060,GO:0004535,1,0.826062547709109,0,12,poly(A)-specific ribonuclease activity,MF,
2061,GO:0004536,1,0.382541286597657,0,69,deoxyribonuclease activity,MF,
2062,GO:0004540,1,0.303031364773294,0,90,ribonuclease activity,MF,
2063,GO:0004549,1,0.831046408060593,0,15,tRNA-specific ribonuclease activity,MF,
2064,GO:0004550,1,0.820500453973986,0,16,nucleoside diphosphate kinase activity,MF,
2065,GO:0004551,1,0.8259602465475,0,14,nucleotide diphosphatase activity,MF,
2066,GO:0004553,1,0.288794697316583,0,88,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
2067,GO:0004555,1,0.987345885905482,0,1,alpha,alpha-trehalase activity,MF,
2068,GO:0004556,1,0.93835879310993,0,5,alpha-amylase activity,MF,
2069,GO:0004557,1,0.973335386616889,0,2,alpha-galactosidase activity,MF,
2070,GO:0004558,1,0.935281228389458,0,4,alpha-1,4-glucosidase activity,MF,
2071,GO:0004559,1,0.808662603720357,0,13,alpha-mannosidase activity,MF,
2072,GO:0004560,1,0.972710871902025,0,2,alpha-L-fucosidase activity,MF,
2073,GO:0004561,1,0.984211070597279,0,1,alpha-N-acetylglucosaminidase activity,MF,
2074,GO:0004563,1,0.927037567464291,0,5,beta-N-acetylhexosaminidase activity,MF,
2075,GO:0004564,1,0.983406759351625,0,1,beta-fructofuranosidase activity,MF,
2076,GO:0004565,1,0.912981704921894,0,6,beta-galactosidase activity,MF,
2077,GO:0004566,1,0.957369310771966,0,3,beta-glucuronidase activity,MF,
2078,GO:0004567,1,0.983546838826684,0,1,beta-mannosidase activity,MF,
2079,GO:0004568,1,0.959051476133879,0,3,chitinase activity,MF,
2080,GO:0004569,1,0.983406759352018,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2081,GO:0004571,1,0.893785815366425,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2082,GO:0004572,1,0.967087733487527,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2083,GO:0004573,1,0.984314695119386,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2084,GO:0004574,1,0.967115525155997,0,2,oligo-1,6-glucosidase activity,MF,
2085,GO:0004575,1,0.983406759351625,0,1,sucrose alpha-glucosidase activity,MF,
2086,GO:0004576,1,0.882396496707205,0,10,oligosaccharyl transferase activity,MF,
2087,GO:0004577,1,0.97600722935627,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2088,GO:0004578,1,0.983406887266048,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2089,GO:0004579,1,0.890124205923097,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2090,GO:0004581,1,0.991322584352734,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2091,GO:0004582,1,0.977806361183351,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2092,GO:0004583,1,0.940103171865015,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2093,GO:0004584,1,0.985315358120536,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2094,GO:0004585,1,0.988428714313238,0,1,ornithine carbamoyltransferase activity,MF,
2095,GO:0004586,1,0.986418592932794,0,1,ornithine decarboxylase activity,MF,
2096,GO:0004587,1,0.986792746302191,0,1,ornithine-oxo-acid transaminase activity,MF,
2097,GO:0004588,1,0.984480325526317,0,1,orotate phosphoribosyltransferase activity,MF,
2098,GO:0004590,1,0.984480325526317,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2099,GO:0004591,1,0.95106533514987,0,3,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2100,GO:0004594,1,0.941531355449558,0,4,pantothenate kinase activity,MF,
2101,GO:0004595,1,0.985536540128593,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2102,GO:0004596,1,0.858307256933222,0,11,peptide alpha-N-acetyltransferase activity,MF,
2103,GO:0004597,1,0.983429598774477,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2104,GO:0004598,1,0.983416035861832,0,1,peptidylamidoglycolate lyase activity,MF,
2105,GO:0004601,1,0.619262043140727,0,43,peroxidase activity,MF,
2106,GO:0004602,1,0.8307494738208,0,20,glutathione peroxidase activity,MF,
2108,GO:0004605,1,0.953236343680105,0,3,phosphatidate cytidylyltransferase activity,MF,
2109,GO:0004607,1,0.990146120840743,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2110,GO:0004608,1,0.992519644739583,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2111,GO:0004609,1,0.970802506851425,0,2,phosphatidylserine decarboxylase activity,MF,
2112,GO:0004610,1,0.986715261609845,0,1,phosphoacetylglucosamine mutase activity,MF,
2113,GO:0004611,1,0.971481249581945,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2114,GO:0004613,1,0.971481249581945,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2115,GO:0004614,1,0.955933869353365,0,3,phosphoglucomutase activity,MF,
2116,GO:0004615,1,0.976157048142887,0,2,phosphomannomutase activity,MF,
2117,GO:0004616,1,0.95779116332995,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2118,GO:0004617,1,0.986623475189904,0,1,phosphoglycerate dehydrogenase activity,MF,
2119,GO:0004618,1,0.97378019862123,0,2,phosphoglycerate kinase activity,MF,
2120,GO:0004619,1,0.957531351123574,0,4,phosphoglycerate mutase activity,MF,
2122,GO:0004621,1,0.985566427273525,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2123,GO:0004622,1,0.753404923708049,0,19,lysophospholipase activity,MF,
2124,GO:0004623,1,0.665856560115862,0,32,phospholipase A2 activity,MF,
2126,GO:0004630,1,0.916947886703361,0,6,phospholipase D activity,MF,
2127,GO:0004631,1,0.990501594766783,0,1,phosphomevalonate kinase activity,MF,
2128,GO:0004632,1,0.990720299495725,0,1,phosphopantothenate--cysteine ligase activity,MF,
2129,GO:0004633,1,0.985822848464919,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2130,GO:0004634,1,0.947670781001656,0,4,phosphopyruvate hydratase activity,MF,
2131,GO:0004637,1,0.98348345345403,0,1,phosphoribosylamine-glycine ligase activity,MF,
2132,GO:0004638,1,0.983533759023357,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2133,GO:0004639,1,0.983533759023357,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2134,GO:0004641,1,0.98348345345403,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2135,GO:0004642,1,0.983406759351821,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2136,GO:0004643,1,0.986298138481011,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2137,GO:0004644,1,0.98348345345403,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2138,GO:0004645,1,0.911004038783679,0,6,phosphorylase activity,MF,
2139,GO:0004647,1,0.961882382168826,0,3,phosphoserine phosphatase activity,MF,
2140,GO:0004648,1,0.986206417426949,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2141,GO:0004649,1,0.97181611797306,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2142,GO:0004651,1,0.972074684313398,0,2,polynucleotide 5'-phosphatase activity,MF,
2143,GO:0004652,1,0.875460059851636,0,8,polynucleotide adenylyltransferase activity,MF,
2144,GO:0004653,1,0.737371286389921,0,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2145,GO:0004654,1,0.983406759352018,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2146,GO:0004655,1,0.983645414098226,0,1,porphobilinogen synthase activity,MF,
2147,GO:0004656,1,0.94140893807676,0,4,procollagen-proline 4-dioxygenase activity,MF,
2148,GO:0004657,1,0.974245708837992,0,2,proline dehydrogenase activity,MF,
2149,GO:0004658,1,0.972700260287315,0,2,propionyl-CoA carboxylase activity,MF,
2150,GO:0004659,1,0.802792955784094,0,15,prenyltransferase activity,MF,
2151,GO:0004660,1,0.972997805444944,0,2,protein farnesyltransferase activity,MF,
2152,GO:0004661,1,0.933848786736477,0,5,protein geranylgeranyltransferase activity,MF,
2153,GO:0004662,1,0.973183973955053,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2154,GO:0004663,1,0.948732149451253,0,4,Rab geranylgeranyltransferase activity,MF,
2155,GO:0004666,1,0.967087733487964,0,2,prostaglandin-endoperoxide synthase activity,MF,
2156,GO:0004667,1,0.982479436924718,0,2,prostaglandin-D synthase activity,MF,
2157,GO:0004668,1,0.923820443599718,0,5,protein-arginine deiminase activity,MF,
2158,GO:0004671,1,0.983406759351971,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2163,GO:0004676,1,0.98340675935138,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2164,GO:0004677,1,0.951729318132803,0,3,DNA-dependent protein kinase activity,MF,
2165,GO:0004679,1,0.897432235671029,0,7,AMP-activated protein kinase activity,MF,
2166,GO:0004683,1,0.64956849004636,0,28,calmodulin-dependent protein kinase activity,MF,
2167,GO:0004686,1,0.983406759351281,0,1,elongation factor-2 kinase activity,MF,
2168,GO:0004687,1,0.935982566620887,0,4,myosin light chain kinase activity,MF,
2169,GO:0004689,1,0.925575751423426,0,5,phosphorylase kinase activity,MF,
2172,GO:0004692,1,0.967217077926882,0,2,cGMP-dependent protein kinase activity,MF,
2173,GO:0004693,1,0.694423895851232,0,27,cyclin-dependent protein serine/threonine kinase activity,MF,
2174,GO:0004694,1,0.936164466827848,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2176,GO:0004698,1,0.945546803405169,0,4,calcium-dependent protein kinase C activity,MF,
2177,GO:0004699,1,0.951849506772236,0,3,calcium-independent protein kinase C activity,MF,
2179,GO:0004703,1,0.930634972257424,0,5,G-protein coupled receptor kinase activity,MF,
2180,GO:0004704,1,0.914409710347392,0,6,NF-kappaB-inducing kinase activity,MF,
2181,GO:0004705,1,0.957176665878615,0,3,JUN kinase activity,MF,
2182,GO:0004706,1,0.951148666211525,0,3,JUN kinase kinase kinase activity,MF,
2184,GO:0004708,1,0.819907160549051,0,13,MAP kinase kinase activity,MF,
2186,GO:0004711,1,0.955525562041307,0,3,ribosomal protein S6 kinase activity,MF,
2190,GO:0004715,1,0.457859115064063,0,50,non-membrane spanning protein tyrosine kinase activity,MF,
2192,GO:0004719,1,0.955461947640742,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2193,GO:0004720,1,0.951326137592287,0,3,protein-lysine 6-oxidase activity,MF,
2195,GO:0004722,1,0.3666564428854,0,67,protein serine/threonine phosphatase activity,MF,
2196,GO:0004723,1,0.905118385124028,0,6,calcium-dependent protein serine/threonine phosphatase activity,MF,
2198,GO:0004726,1,0.887107046502496,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2199,GO:0004727,1,0.977132031474563,0,2,prenylated protein tyrosine phosphatase activity,MF,
2200,GO:0004728,1,0.984643899909647,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2201,GO:0004729,1,0.987930171593581,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2202,GO:0004730,1,0.988342526418377,0,1,pseudouridylate synthase activity,MF,
2203,GO:0004731,1,0.968803135584683,0,2,purine-nucleoside phosphorylase activity,MF,
2204,GO:0004733,1,0.983475715800253,0,1,pyridoxamine-phosphate oxidase activity,MF,
2205,GO:0004735,1,0.960663457025068,0,3,pyrroline-5-carboxylate reductase activity,MF,
2206,GO:0004736,1,0.983406759352069,0,1,pyruvate carboxylase activity,MF,
2207,GO:0004738,1,0.916895101534733,0,6,pyruvate dehydrogenase activity,MF,
2208,GO:0004739,1,0.963039419533272,0,3,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2209,GO:0004740,1,0.93730225446242,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2210,GO:0004741,1,0.95104084943638,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2211,GO:0004742,1,0.983406759352021,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2212,GO:0004743,1,0.968775570094333,0,2,pyruvate kinase activity,MF,
2213,GO:0004744,1,0.984577792821529,0,1,retinal isomerase activity,MF,
2215,GO:0004747,1,0.991136089127553,0,1,ribokinase activity,MF,
2216,GO:0004748,1,0.951372534454334,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2217,GO:0004749,1,0.936895163280127,0,5,ribose phosphate diphosphokinase activity,MF,
2218,GO:0004750,1,0.985533038601372,0,1,ribulose-phosphate 3-epimerase activity,MF,
2219,GO:0004751,1,0.987471745925945,0,1,ribose-5-phosphate isomerase activity,MF,
2220,GO:0004753,1,0.983406759351673,0,1,saccharopine dehydrogenase activity,MF,
2221,GO:0004756,1,0.970502461701088,0,2,selenide, water dikinase activity,MF,
2222,GO:0004757,1,0.989529104285034,0,1,sepiapterin reductase activity,MF,
2223,GO:0004758,1,0.925822781015883,0,5,serine C-palmitoyltransferase activity,MF,
2224,GO:0004760,1,0.988691573711516,0,1,serine-pyruvate transaminase activity,MF,
2225,GO:0004766,1,0.990640755393025,0,1,spermidine synthase activity,MF,
2226,GO:0004767,1,0.918803541508808,0,6,sphingomyelin phosphodiesterase activity,MF,
2227,GO:0004768,1,0.952496507618286,0,3,stearoyl-CoA 9-desaturase activity,MF,
2228,GO:0004769,1,0.967976111819597,0,3,steroid delta-isomerase activity,MF,
2229,GO:0004771,1,0.941128527774392,0,4,sterol esterase activity,MF,
2230,GO:0004772,1,0.970091073434178,0,2,sterol O-acyltransferase activity,MF,
2231,GO:0004773,1,0.983406759351575,0,1,steryl-sulfatase activity,MF,
2232,GO:0004774,1,0.961359364813292,0,3,succinate-CoA ligase activity,MF,
2233,GO:0004775,1,0.97566548782218,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2234,GO:0004776,1,0.974997209737826,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2235,GO:0004777,1,0.983406759351872,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2236,GO:0004778,1,0.988553869511422,0,1,succinyl-CoA hydrolase activity,MF,
2237,GO:0004779,1,0.968418076297561,0,2,sulfate adenylyltransferase activity,MF,
2238,GO:0004781,1,0.968418076297561,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2239,GO:0004782,1,0.968050164438198,0,2,sulfinoalanine decarboxylase activity,MF,
2240,GO:0004784,1,0.952250782116253,0,5,superoxide dismutase activity,MF,
2241,GO:0004788,1,0.985325278825704,0,1,thiamine diphosphokinase activity,MF,
2242,GO:0004790,1,0.98473360677907,0,1,thioether S-methyltransferase activity,MF,
2243,GO:0004791,1,0.897120480791826,0,10,thioredoxin-disulfide reductase activity,MF,
2244,GO:0004792,1,0.966446738675683,0,3,thiosulfate sulfurtransferase activity,MF,
2245,GO:0004793,1,0.970966727516621,0,2,threonine aldolase activity,MF,
2246,GO:0004794,1,0.978660015212631,0,2,L-threonine ammonia-lyase activity,MF,
2247,GO:0004796,1,0.986238855333363,0,1,thromboxane-A synthase activity,MF,
2248,GO:0004797,1,0.972317962643004,0,2,thymidine kinase activity,MF,
2249,GO:0004798,1,0.975549463919345,0,2,thymidylate kinase activity,MF,
2250,GO:0004799,1,0.988791781330131,0,1,thymidylate synthase activity,MF,
2251,GO:0004800,1,0.958506569266432,0,3,thyroxine 5'-deiodinase activity,MF,
2252,GO:0004801,1,0.990838648869179,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2253,GO:0004802,1,0.955618808855274,0,3,transketolase activity,MF,
2254,GO:0004803,1,0.952313961944452,0,3,transposase activity,MF,
2255,GO:0004806,1,0.754701286209495,0,21,triglyceride lipase activity,MF,
2256,GO:0004807,1,0.989511341572342,0,1,triose-phosphate isomerase activity,MF,
2257,GO:0004809,1,0.958166800747455,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2258,GO:0004810,1,0.985614351305629,0,1,tRNA adenylyltransferase activity,MF,
2259,GO:0004812,1,0.517622890678688,0,44,aminoacyl-tRNA ligase activity,MF,
2260,GO:0004813,1,0.954799842084587,0,3,alanine-tRNA ligase activity,MF,
2261,GO:0004814,1,0.953396277807833,0,4,arginine-tRNA ligase activity,MF,
2262,GO:0004815,1,0.969179893710261,0,2,aspartate-tRNA ligase activity,MF,
2263,GO:0004816,1,0.969879157643878,0,2,asparagine-tRNA ligase activity,MF,
2264,GO:0004817,1,0.971993463183418,0,2,cysteine-tRNA ligase activity,MF,
2265,GO:0004818,1,0.967088020374865,0,2,glutamate-tRNA ligase activity,MF,
2266,GO:0004819,1,0.985045917426215,0,1,glutamine-tRNA ligase activity,MF,
2267,GO:0004820,1,0.973167816712704,0,2,glycine-tRNA ligase activity,MF,
2268,GO:0004821,1,0.971942863108805,0,2,histidine-tRNA ligase activity,MF,
2269,GO:0004822,1,0.967125959360278,0,2,isoleucine-tRNA ligase activity,MF,
2270,GO:0004823,1,0.967087733488061,0,2,leucine-tRNA ligase activity,MF,
2271,GO:0004824,1,0.986246994830835,0,1,lysine-tRNA ligase activity,MF,
2272,GO:0004825,1,0.96823295023159,0,2,methionine-tRNA ligase activity,MF,
2273,GO:0004826,1,0.930812138342592,0,5,phenylalanine-tRNA ligase activity,MF,
2274,GO:0004827,1,0.969033663019404,0,2,proline-tRNA ligase activity,MF,
2275,GO:0004828,1,0.973739041728352,0,2,serine-tRNA ligase activity,MF,
2276,GO:0004829,1,0.953597771260728,0,3,threonine-tRNA ligase activity,MF,
2277,GO:0004830,1,0.968784430234546,0,2,tryptophan-tRNA ligase activity,MF,
2278,GO:0004831,1,0.969985312934487,0,2,tyrosine-tRNA ligase activity,MF,
2279,GO:0004832,1,0.95106094615064,0,3,valine-tRNA ligase activity,MF,
2280,GO:0004833,1,0.963021625433459,0,3,tryptophan 2,3-dioxygenase activity,MF,
2281,GO:0004835,1,0.983406759351872,0,1,tubulin-tyrosine ligase activity,MF,
2282,GO:0004838,1,0.984245026222994,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2283,GO:0004839,1,0.936799324496439,0,4,ubiquitin activating enzyme activity,MF,
2285,GO:0004843,1,0.32235720533672,0,73,thiol-dependent ubiquitin-specific protease activity,MF,
2286,GO:0004844,1,0.939502358734182,0,5,uracil DNA N-glycosylase activity,MF,
2287,GO:0004849,1,0.935042102635755,0,5,uridine kinase activity,MF,
2288,GO:0004850,1,0.972938588902751,0,2,uridine phosphorylase activity,MF,
2289,GO:0004852,1,0.990127618737726,0,1,uroporphyrinogen-III synthase activity,MF,
2290,GO:0004853,1,0.989943760877651,0,1,uroporphyrinogen decarboxylase activity,MF,
2291,GO:0004854,1,0.967087733487721,0,2,xanthine dehydrogenase activity,MF,
2292,GO:0004855,1,0.983406759351724,0,1,xanthine oxidase activity,MF,
2293,GO:0004856,1,0.983419700639195,0,1,xylulokinase activity,MF,
2295,GO:0004859,1,0.8924910425938,0,11,phospholipase inhibitor activity,MF,
2299,GO:0004864,1,0.631131986688019,0,33,protein phosphatase inhibitor activity,MF,
2300,GO:0004865,1,0.899912025186756,0,8,protein serine/threonine phosphatase inhibitor activity,MF,
2306,GO:0004873,1,0.979089757217264,0,2,asialoglycoprotein receptor activity,MF,
2307,GO:0004874,1,0.967087733487625,0,2,aryl hydrocarbon receptor activity,MF,
2308,GO:0004875,1,0.870886531824144,0,10,complement receptor activity,MF,
2309,GO:0004876,1,0.986929948559013,0,1,complement component C3a receptor activity,MF,
2310,GO:0004877,1,0.983406759350836,0,1,complement component C3b receptor activity,MF,
2311,GO:0004878,1,0.970346539678431,0,2,complement component C5a receptor activity,MF,
2313,GO:0004882,1,0.95879202432968,0,3,androgen receptor activity,MF,
2314,GO:0004883,1,0.983406759351528,0,1,glucocorticoid receptor activity,MF,
2315,GO:0004886,1,0.958911688092845,0,3,9-cis retinoic acid receptor activity,MF,
2316,GO:0004887,1,0.904278825679445,0,7,thyroid hormone receptor activity,MF,
2318,GO:0004890,1,0.749247064487036,0,19,GABA-A receptor activity,MF,
2319,GO:0004896,1,0.276737474619127,0,88,cytokine receptor activity,MF,
2320,GO:0004897,1,0.938677338007445,0,4,ciliary neurotrophic factor receptor activity,MF,
2321,GO:0004900,1,0.987403731843185,0,1,erythropoietin receptor activity,MF,
2322,GO:0004904,1,0.931326615287312,0,5,interferon receptor activity,MF,
2323,GO:0004905,1,0.973361697164472,0,2,type I interferon receptor activity,MF,
2324,GO:0004906,1,0.972206978044596,0,2,interferon-gamma receptor activity,MF,
2325,GO:0004908,1,0.900710684322103,0,7,interleukin-1 receptor activity,MF,
2326,GO:0004909,1,0.970472737311096,0,2,interleukin-1, Type I, activating receptor activity,MF,
2327,GO:0004910,1,0.973708162700548,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2328,GO:0004911,1,0.956717005183079,0,3,interleukin-2 receptor activity,MF,
2329,GO:0004912,1,0.971686770884834,0,2,interleukin-3 receptor activity,MF,
2330,GO:0004913,1,0.974454680712479,0,2,interleukin-4 receptor activity,MF,
2331,GO:0004914,1,0.970247021654019,0,2,interleukin-5 receptor activity,MF,
2332,GO:0004915,1,0.967315619071654,0,2,interleukin-6 receptor activity,MF,
2333,GO:0004917,1,0.976827335329865,0,2,interleukin-7 receptor activity,MF,
2334,GO:0004918,1,0.969429615636244,0,2,interleukin-8 receptor activity,MF,
2335,GO:0004919,1,0.986053003073054,0,1,interleukin-9 receptor activity,MF,
2336,GO:0004920,1,0.92830112811653,0,5,interleukin-10 receptor activity,MF,
2337,GO:0004921,1,0.983638474406083,0,1,interleukin-11 receptor activity,MF,
2338,GO:0004923,1,0.967315619070248,0,2,leukemia inhibitory factor receptor activity,MF,
2339,GO:0004924,1,0.951282316360793,0,3,oncostatin-M receptor activity,MF,
2340,GO:0004925,1,0.983406759350245,0,1,prolactin receptor activity,MF,
2342,GO:0004931,1,0.907101001348616,0,7,extracellular ATP-gated cation channel activity,MF,
2345,GO:0004937,1,0.956767406031214,0,3,alpha1-adrenergic receptor activity,MF,
2347,GO:0004939,1,0.955808201849196,0,3,beta-adrenergic receptor activity,MF,
2348,GO:0004940,1,0.984072195840504,0,1,beta1-adrenergic receptor activity,MF,
2349,GO:0004941,1,0.986554419989759,0,1,beta2-adrenergic receptor activity,MF,
2350,GO:0004945,1,0.95311806723355,0,4,angiotensin type II receptor activity,MF,
2351,GO:0004946,1,0.980074879049148,0,2,bombesin receptor activity,MF,
2352,GO:0004947,1,0.974146061543772,0,2,bradykinin receptor activity,MF,
2353,GO:0004948,1,0.960471737805097,0,3,calcitonin receptor activity,MF,
2354,GO:0004949,1,0.955290209529829,0,3,cannabinoid receptor activity,MF,
2355,GO:0004950,1,0.727317497901264,0,23,chemokine receptor activity,MF,
2356,GO:0004951,1,0.974636035586167,0,2,cholecystokinin receptor activity,MF,
2357,GO:0004952,1,0.882713127205034,0,12,dopamine neurotransmitter receptor activity,MF,
2358,GO:0004953,1,0.807123805164453,0,15,icosanoid receptor activity,MF,
2359,GO:0004954,1,0.851649623340719,0,11,prostanoid receptor activity,MF,
2360,GO:0004955,1,0.864067145796716,0,10,prostaglandin receptor activity,MF,
2361,GO:0004956,1,0.968909620234345,0,2,prostaglandin D receptor activity,MF,
2362,GO:0004957,1,0.916208194583027,0,6,prostaglandin E receptor activity,MF,
2363,GO:0004958,1,0.968384722376066,0,2,prostaglandin F receptor activity,MF,
2364,GO:0004960,1,0.985637625278431,0,1,thromboxane receptor activity,MF,
2365,GO:0004961,1,0.985637625278431,0,1,thromboxane A2 receptor activity,MF,
2366,GO:0004962,1,0.967090341150694,0,2,endothelin receptor activity,MF,
2367,GO:0004963,1,0.968291872253044,0,2,follicle-stimulating hormone receptor activity,MF,
2368,GO:0004964,1,0.983741971792908,0,1,luteinizing hormone receptor activity,MF,
2369,GO:0004965,1,0.951038409344538,0,3,G-protein coupled GABA receptor activity,MF,
2370,GO:0004966,1,0.930582268416781,0,7,galanin receptor activity,MF,
2371,GO:0004967,1,0.959048095323329,0,3,glucagon receptor activity,MF,
2372,GO:0004968,1,0.96708773348782,0,2,gonadotropin-releasing hormone receptor activity,MF,
2373,GO:0004969,1,0.909739969225927,0,6,histamine receptor activity,MF,
2374,GO:0004970,1,0.728347336383062,0,19,ionotropic glutamate receptor activity,MF,
2375,GO:0004971,1,0.935254347829705,0,4,AMPA glutamate receptor activity,MF,
2376,GO:0004972,1,0.889450432495563,0,7,NMDA glutamate receptor activity,MF,
2377,GO:0004974,1,0.9477520446941,0,4,leukotriene receptor activity,MF,
2378,GO:0004977,1,0.930793864319136,0,6,melanocortin receptor activity,MF,
2379,GO:0004978,1,0.983426706542317,0,1,corticotropin receptor activity,MF,
2380,GO:0004979,1,0.987336285518239,0,1,beta-endorphin receptor activity,MF,
2381,GO:0004980,1,0.965710105492043,0,3,melanocyte-stimulating hormone receptor activity,MF,
2382,GO:0004982,1,0.954949512722883,0,4,N-formyl peptide receptor activity,MF,
2383,GO:0004983,1,0.898251146080741,0,8,neuropeptide Y receptor activity,MF,
2384,GO:0004984,1,0.0559533344278704,0,376,olfactory receptor activity,MF,
2385,GO:0004985,1,0.905125375547332,0,8,opioid receptor activity,MF,
2386,GO:0004990,1,0.983406759352021,0,1,oxytocin receptor activity,MF,
2387,GO:0004991,1,0.970710423395241,0,2,parathyroid hormone receptor activity,MF,
2388,GO:0004992,1,0.956699039762243,0,3,platelet activating factor receptor activity,MF,
2389,GO:0004993,1,0.743891628668888,0,26,G-protein coupled serotonin receptor activity,MF,
2390,GO:0004994,1,0.933390366489372,0,5,somatostatin receptor activity,MF,
2391,GO:0004995,1,0.957246091397039,0,3,tachykinin receptor activity,MF,
2392,GO:0004996,1,0.974391565265069,0,2,thyroid-stimulating hormone receptor activity,MF,
2393,GO:0004997,1,0.990263785993729,0,1,thyrotropin-releasing hormone receptor activity,MF,
2394,GO:0004998,1,0.967668316700936,0,2,transferrin receptor activity,MF,
2395,GO:0004999,1,0.956629912978155,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2396,GO:0005000,1,0.904671739753082,0,7,vasopressin receptor activity,MF,
2397,GO:0005001,1,0.767146303712841,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2398,GO:0005003,1,0.739398348196527,0,19,ephrin receptor activity,MF,
2399,GO:0005004,1,0.891093616639503,0,7,GPI-linked ephrin receptor activity,MF,
2400,GO:0005005,1,0.886319755843018,0,8,transmembrane-ephrin receptor activity,MF,
2401,GO:0005006,1,0.969276725901575,0,2,epidermal growth factor-activated receptor activity,MF,
2402,GO:0005007,1,0.920410343695971,0,5,fibroblast growth factor-activated receptor activity,MF,
2403,GO:0005008,1,0.983406759351479,0,1,hepatocyte growth factor-activated receptor activity,MF,
2404,GO:0005009,1,0.983406759350887,0,1,insulin-activated receptor activity,MF,
2405,GO:0005010,1,0.951038409341876,0,3,insulin-like growth factor-activated receptor activity,MF,
2406,GO:0005011,1,0.967087733489271,0,2,macrophage colony-stimulating factor receptor activity,MF,
2407,GO:0005017,1,0.956699039761719,0,3,platelet-derived growth factor-activated receptor activity,MF,
2408,GO:0005018,1,0.983406759351528,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2409,GO:0005019,1,0.972843492674742,0,2,platelet-derived growth factor beta-receptor activity,MF,
2410,GO:0005020,1,0.983406759351872,0,1,stem cell factor receptor activity,MF,
2411,GO:0005021,1,0.890835108361884,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2414,GO:0005026,1,0.97095231829983,0,2,transforming growth factor beta receptor activity, type II,MF,
2415,GO:0005030,1,0.936900386450226,0,4,neurotrophin receptor activity,MF,
2416,GO:0005031,1,0.71953097856539,0,24,tumor necrosis factor-activated receptor activity,MF,
2417,GO:0005034,1,0.983674085893709,0,1,osmosensor activity,MF,
2418,GO:0005035,1,0.71953097856539,0,24,death receptor activity,MF,
2419,GO:0005041,1,0.811688896267693,0,13,low-density lipoprotein receptor activity,MF,
2420,GO:0005042,1,0.967106062922593,0,2,netrin receptor activity,MF,
2421,GO:0005044,1,0.524359765141474,0,41,scavenger receptor activity,MF,
2422,GO:0005046,1,0.973433554266325,0,2,KDEL sequence binding,MF,
2423,GO:0005047,1,0.942580227664161,0,4,signal recognition particle binding,MF,
2424,GO:0005048,1,0.533572444956774,0,43,signal sequence binding,MF,
2425,GO:0005049,1,0.893333704001192,0,7,nuclear export signal receptor activity,MF,
2426,GO:0005052,1,0.967361112611999,0,2,peroxisome matrix targeting signal-1 binding,MF,
2427,GO:0005053,1,0.989358346220811,0,1,peroxisome matrix targeting signal-2 binding,MF,
2428,GO:0005055,1,0.976848383060839,0,2,laminin receptor activity,MF,
2431,GO:0005070,1,0.425661655371613,0,57,SH3/SH2 adaptor activity,MF,
2432,GO:0005072,1,0.848905414415753,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2433,GO:0005078,1,0.889948485478734,0,7,MAP-kinase scaffold activity,MF,
2436,GO:0005086,1,0.745639181406119,0,19,ARF guanyl-nucleotide exchange factor activity,MF,
2437,GO:0005087,1,0.952375867916283,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2439,GO:0005089,1,0.274791593403976,0,78,Rho guanyl-nucleotide exchange factor activity,MF,
2440,GO:0005090,1,0.986017784658162,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2442,GO:0005093,1,0.970517203859021,0,2,Rab GDP-dissociation inhibitor activity,MF,
2443,GO:0005094,1,0.971502941821799,0,3,Rho GDP-dissociation inhibitor activity,MF,
2444,GO:0005095,1,0.819161879801351,0,14,GTPase inhibitor activity,MF,
2454,GO:0005114,1,0.896394520115202,0,7,type II transforming growth factor beta receptor binding,MF,
2456,GO:0005119,1,0.951141293967252,0,3,smoothened binding,MF,
2457,GO:0005123,1,0.806547249153921,0,15,death receptor binding,MF,
2458,GO:0005124,1,0.986240889082363,0,1,scavenger receptor binding,MF,
2462,GO:0005128,1,0.974053223128537,0,2,erythropoietin receptor binding,MF,
2463,GO:0005129,1,0.994034637748439,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
2464,GO:0005130,1,0.989178179665123,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2465,GO:0005131,1,0.932537674523249,0,5,growth hormone receptor binding,MF,
2466,GO:0005132,1,0.884360095379399,0,17,type I interferon receptor binding,MF,
2467,GO:0005133,1,0.991071049420841,0,1,interferon-gamma receptor binding,MF,
2468,GO:0005134,1,0.945663855091474,0,5,interleukin-2 receptor binding,MF,
2469,GO:0005135,1,0.976695944623897,0,2,interleukin-3 receptor binding,MF,
2470,GO:0005136,1,0.965152214988952,0,3,interleukin-4 receptor binding,MF,
2471,GO:0005137,1,0.97988325956092,0,2,interleukin-5 receptor binding,MF,
2472,GO:0005138,1,0.90925439754328,0,7,interleukin-6 receptor binding,MF,
2473,GO:0005139,1,0.986380941516767,0,1,interleukin-7 receptor binding,MF,
2474,GO:0005140,1,0.995418209170563,0,1,interleukin-9 receptor binding,MF,
2475,GO:0005141,1,0.988548397282744,0,1,interleukin-10 receptor binding,MF,
2476,GO:0005142,1,0.985345203965664,0,1,interleukin-11 receptor binding,MF,
2477,GO:0005143,1,0.931273367591284,0,5,interleukin-12 receptor binding,MF,
2478,GO:0005144,1,0.990609033835784,0,1,interleukin-13 receptor binding,MF,
2480,GO:0005147,1,0.987360308246559,0,1,oncostatin-M receptor binding,MF,
2481,GO:0005148,1,0.985843046329031,0,2,prolactin receptor binding,MF,
2482,GO:0005149,1,0.784729763246446,0,17,interleukin-1 receptor binding,MF,
2483,GO:0005150,1,0.971381830499471,0,2,interleukin-1, Type I receptor binding,MF,
2484,GO:0005151,1,0.971353707594301,0,2,interleukin-1, Type II receptor binding,MF,
2485,GO:0005152,1,0.95651503355488,0,3,interleukin-1 receptor antagonist activity,MF,
2486,GO:0005153,1,0.983705984872474,0,1,interleukin-8 receptor binding,MF,
2488,GO:0005157,1,0.962524540489372,0,3,macrophage colony-stimulating factor receptor binding,MF,
2493,GO:0005163,1,0.992149262571447,0,1,nerve growth factor receptor binding,MF,
2494,GO:0005164,1,0.681184594451219,0,30,tumor necrosis factor receptor binding,MF,
2496,GO:0005166,1,0.968171145195771,0,3,neurotrophin p75 receptor binding,MF,
2499,GO:0005169,1,0.967087733487964,0,2,neurotrophin TRKB receptor binding,MF,
2500,GO:0005170,1,0.983406759351821,0,1,neurotrophin TRKC receptor binding,MF,
2501,GO:0005171,1,0.973372556802439,0,2,hepatocyte growth factor receptor binding,MF,
2504,GO:0005174,1,0.973268561883025,0,2,CD40 receptor binding,MF,
2505,GO:0005175,1,0.994824208439125,0,1,CD27 receptor binding,MF,
2506,GO:0005176,1,0.960632303126445,0,3,ErbB-2 class receptor binding,MF,
2509,GO:0005183,1,0.98810400393685,0,1,gonadotropin hormone-releasing hormone activity,MF,
2510,GO:0005184,1,0.812935937583628,0,27,neuropeptide hormone activity,MF,
2511,GO:0005185,1,0.991277255404731,0,2,neurohypophyseal hormone activity,MF,
2513,GO:0005199,1,0.983519914615201,0,1,structural constituent of cell wall,MF,
2516,GO:0005212,1,0.849564136100279,0,20,structural constituent of eye lens,MF,
2519,GO:0005217,1,0.640891287387607,0,28,intracellular ligand-gated ion channel activity,MF,
2520,GO:0005219,1,0.944071054500354,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2521,GO:0005220,1,0.951038409340494,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2522,GO:0005221,1,0.864720606358808,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2523,GO:0005222,1,0.935360771076504,0,4,intracellular cAMP activated cation channel activity,MF,
2524,GO:0005223,1,0.936093779676893,0,4,intracellular cGMP activated cation channel activity,MF,
2526,GO:0005227,1,0.643406266460659,0,30,calcium activated cation channel activity,MF,
2527,GO:0005229,1,0.770770006303919,0,16,intracellular calcium activated chloride channel activity,MF,
2528,GO:0005230,1,0.321293886381555,0,75,extracellular ligand-gated ion channel activity,MF,
2529,GO:0005231,1,0.477696234048052,0,48,excitatory extracellular ligand-gated ion channel activity,MF,
2530,GO:0005234,1,0.72869572816151,0,19,extracellular-glutamate-gated ion channel activity,MF,
2531,GO:0005237,1,0.912951017776217,0,6,inhibitory extracellular ligand-gated ion channel activity,MF,
2537,GO:0005247,1,0.833622966947821,0,12,voltage-gated chloride channel activity,MF,
2538,GO:0005248,1,0.687940318758404,0,23,voltage-gated sodium channel activity,MF,
2542,GO:0005252,1,0.983406772879133,0,1,open rectifier potassium channel activity,MF,
2545,GO:0005260,1,0.983406759351627,0,1,intracellular ATPase-gated chloride channel activity,MF,
2549,GO:0005272,1,0.482167744736528,0,45,sodium channel activity,MF,
2550,GO:0005275,1,0.956008555445203,0,3,amine transmembrane transporter activity,MF,
2551,GO:0005276,1,0.984693575781511,0,1,vesicular hydrogen:amino acid antiporter activity,MF,
2552,GO:0005277,1,0.957989366921874,0,3,acetylcholine transmembrane transporter activity,MF,
2553,GO:0005280,1,0.909704721934713,0,6,hydrogen:amino acid symporter activity,MF,
2554,GO:0005283,1,0.837662316998076,0,11,sodium:amino acid symporter activity,MF,
2555,GO:0005287,1,0.983406759351282,0,1,high-affinity basic amino acid transmembrane transporter activity,MF,
2556,GO:0005289,1,0.983406759351282,0,1,high-affinity arginine transmembrane transporter activity,MF,
2557,GO:0005290,1,0.969449584215117,0,2,L-histidine transmembrane transporter activity,MF,
2558,GO:0005292,1,0.983406759351282,0,1,high-affinity lysine transmembrane transporter activity,MF,
2559,GO:0005294,1,0.951861222277752,0,3,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2560,GO:0005298,1,0.967095233948012,0,2,proline:sodium symporter activity,MF,
2561,GO:0005302,1,0.983676454999591,0,1,L-tyrosine transmembrane transporter activity,MF,
2562,GO:0005307,1,0.983406759351872,0,1,choline:sodium symporter activity,MF,
2563,GO:0005308,1,0.967130495088187,0,2,creatine transmembrane transporter activity,MF,
2564,GO:0005309,1,0.983450239533627,0,1,creatine:sodium symporter activity,MF,
2565,GO:0005310,1,0.601587141955344,0,32,dicarboxylic acid transmembrane transporter activity,MF,
2566,GO:0005313,1,0.79992906163599,0,14,L-glutamate transmembrane transporter activity,MF,
2567,GO:0005314,1,0.898023678801688,0,7,high-affinity glutamate transmembrane transporter activity,MF,
2568,GO:0005315,1,0.935872721052648,0,4,inorganic phosphate transmembrane transporter activity,MF,
2569,GO:0005316,1,0.983568771766829,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2570,GO:0005319,1,0.186146008029361,0,116,lipid transporter activity,MF,
2571,GO:0005324,1,0.941703028399726,0,5,long-chain fatty acid transporter activity,MF,
2572,GO:0005325,1,0.98342354169628,0,1,peroxisomal fatty-acyl-CoA transporter activity,MF,
2573,GO:0005326,1,0.676096817620536,0,25,neurotransmitter transporter activity,MF,
2574,GO:0005328,1,0.735199538808969,0,19,neurotransmitter:sodium symporter activity,MF,
2575,GO:0005329,1,0.92481658215915,0,5,dopamine transmembrane transporter activity,MF,
2576,GO:0005330,1,0.96708783789524,0,2,dopamine:sodium symporter activity,MF,
2577,GO:0005332,1,0.94097218605396,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2578,GO:0005333,1,0.956410860348948,0,3,norepinephrine transmembrane transporter activity,MF,
2579,GO:0005334,1,0.983524776113773,0,1,norepinephrine:sodium symporter activity,MF,
2580,GO:0005335,1,0.983406759352021,0,1,serotonin:sodium symporter activity,MF,
2581,GO:0005337,1,0.874315318305221,0,9,nucleoside transmembrane transporter activity,MF,
2582,GO:0005338,1,0.883102642198636,0,9,nucleotide-sugar transmembrane transporter activity,MF,
2583,GO:0005342,1,0.117422290983102,0,141,organic acid transmembrane transporter activity,MF,
2584,GO:0005343,1,0.682002222150565,0,25,organic acid:sodium symporter activity,MF,
2585,GO:0005344,1,0.904824525922837,0,14,oxygen transporter activity,MF,
2586,GO:0005345,1,0.921781654038051,0,6,purine nucleobase transmembrane transporter activity,MF,
2587,GO:0005346,1,0.85525024843359,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2588,GO:0005347,1,0.878859536018644,0,9,ATP transmembrane transporter activity,MF,
2589,GO:0005350,1,0.956795349724992,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2591,GO:0005353,1,0.985456784122933,0,1,fructose transmembrane transporter activity,MF,
2593,GO:0005362,1,0.969423700808649,0,2,low-affinity glucose:sodium symporter activity,MF,
2594,GO:0005365,1,0.967087733485785,0,2,myo-inositol transmembrane transporter activity,MF,
2595,GO:0005366,1,0.98340675935138,0,1,myo-inositol:proton symporter activity,MF,
2596,GO:0005367,1,0.983406759350296,0,1,myo-inositol:sodium symporter activity,MF,
2597,GO:0005368,1,0.983406759351527,0,1,taurine transmembrane transporter activity,MF,
2598,GO:0005369,1,0.983406759351527,0,1,taurine:sodium symporter activity,MF,
2599,GO:0005372,1,0.845561652054547,0,12,water transmembrane transporter activity,MF,
2600,GO:0005375,1,0.92032504476523,0,6,copper ion transmembrane transporter activity,MF,
2602,GO:0005384,1,0.94145724938947,0,4,manganese ion transmembrane transporter activity,MF,
2603,GO:0005385,1,0.717624283951051,0,22,zinc ion transmembrane transporter activity,MF,
2604,GO:0005388,1,0.791249285482465,0,14,calcium-transporting ATPase activity,MF,
2605,GO:0005391,1,0.864998412498162,0,10,sodium:potassium-exchanging ATPase activity,MF,
2606,GO:0005395,1,0.983406759351331,0,1,eye pigment precursor transporter activity,MF,
2608,GO:0005412,1,0.913942230335664,0,6,glucose:sodium symporter activity,MF,
2609,GO:0005415,1,0.957902663805033,0,3,nucleoside:sodium symporter activity,MF,
2610,GO:0005416,1,0.761972429737587,0,17,cation:amino acid symporter activity,MF,
2611,GO:0005427,1,0.967375371250215,0,2,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2612,GO:0005432,1,0.924362306335846,0,5,calcium:sodium antiporter activity,MF,
2613,GO:0005436,1,0.860380658843138,0,10,sodium:phosphate symporter activity,MF,
2614,GO:0005451,1,0.798108237035138,0,14,monovalent cation:proton antiporter activity,MF,
2615,GO:0005452,1,0.69001046947791,0,24,inorganic anion exchanger activity,MF,
2616,GO:0005456,1,0.987584713029126,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2617,GO:0005457,1,0.952526934294867,0,3,GDP-fucose transmembrane transporter activity,MF,
2618,GO:0005459,1,0.979341034141075,0,2,UDP-galactose transmembrane transporter activity,MF,
2619,GO:0005461,1,0.983406759351527,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2620,GO:0005462,1,0.969717349664978,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2621,GO:0005464,1,0.983406759351429,0,1,UDP-xylose transmembrane transporter activity,MF,
2622,GO:0005471,1,0.963411824572547,0,3,ATP:ADP antiporter activity,MF,
2623,GO:0005476,1,0.98730755402416,0,1,carnitine:acyl carnitine antiporter activity,MF,
2624,GO:0005477,1,0.983451089488994,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2625,GO:0005483,1,0.954929527016794,0,3,soluble NSF attachment protein activity,MF,
2627,GO:0005487,1,0.651428749033264,0,28,nucleocytoplasmic transporter activity,MF,
2630,GO:0005497,1,0.956088497188597,0,4,androgen binding,MF,
2633,GO:0005502,1,0.957202307831957,0,3,11-cis retinal binding,MF,
2634,GO:0005503,1,0.986799429902972,0,1,all-trans retinal binding,MF,
2635,GO:0005504,1,0.782097959595965,0,25,fatty acid binding,MF,
2643,GO:0005519,1,0.983406769360567,0,1,cytoskeletal regulatory protein binding,MF,
2647,GO:0005523,1,0.839476196761464,0,14,tropomyosin binding,MF,
2650,GO:0005527,1,0.840091389469327,0,14,macrolide binding,MF,
2651,GO:0005528,1,0.840091389469327,0,14,FK506 binding,MF,
2652,GO:0005534,1,0.946871749507881,0,4,galactose binding,MF,
2653,GO:0005536,1,0.84033448826477,0,11,glucose binding,MF,
2654,GO:0005537,1,0.786001967103085,0,17,mannose binding,MF,
2657,GO:0005542,1,0.894791542734424,0,10,folic acid binding,MF,
2660,GO:0005545,1,0.743643327702614,0,18,1-phosphatidylinositol binding,MF,
2663,GO:0005548,1,0.484042104202452,0,47,phospholipid transporter activity,MF,
2664,GO:0005549,1,0.539631155460977,0,84,odorant binding,MF,
2665,GO:0005550,1,0.995913430856783,0,1,pheromone binding,MF,
2668,GO:0005577,1,0.87688180163,0,9,fibrinogen complex,CC,
2670,GO:0005579,1,0.903841047072387,0,7,membrane attack complex,CC,
2671,GO:0005581,1,0.267061917716053,0,88,collagen trimer,CC,
2672,GO:0005582,1,0.983406759351821,0,1,collagen type XV trimer,CC,
2673,GO:0005583,1,0.820621060323964,0,12,fibrillar collagen trimer,CC,
2674,GO:0005584,1,0.967087733487527,0,2,collagen type I trimer,CC,
2675,GO:0005585,1,0.983406759351921,0,1,collagen type II trimer,CC,
2676,GO:0005586,1,0.983406759351773,0,1,collagen type III trimer,CC,
2677,GO:0005587,1,0.904464618950666,0,6,collagen type IV trimer,CC,
2678,GO:0005588,1,0.951038409342826,0,3,collagen type V trimer,CC,
2679,GO:0005589,1,0.95674687945929,0,3,collagen type VI trimer,CC,
2680,GO:0005590,1,0.983406759350836,0,1,collagen type VII trimer,CC,
2681,GO:0005591,1,0.984554178720758,0,1,collagen type VIII trimer,CC,
2682,GO:0005592,1,0.967087733486995,0,2,collagen type XI trimer,CC,
2683,GO:0005593,1,0.906483645458415,0,6,FACIT collagen trimer,CC,
2684,GO:0005594,1,0.953160962811389,0,3,collagen type IX trimer,CC,
2685,GO:0005595,1,0.983406759350691,0,1,collagen type XII trimer,CC,
2686,GO:0005596,1,0.983406759351527,0,1,collagen type XIV trimer,CC,
2687,GO:0005597,1,0.983406759351775,0,1,collagen type XVI trimer,CC,
2688,GO:0005598,1,0.984554178720758,0,1,short-chain collagen trimer,CC,
2689,GO:0005600,1,0.983777200604435,0,1,collagen type XIII trimer,CC,
2690,GO:0005602,1,0.984078230859101,0,2,complement component C1 complex,CC,
2694,GO:0005607,1,0.967087733487623,0,2,laminin-2 complex,CC,
2697,GO:0005614,1,0.816717409368859,0,13,interstitial matrix,CC,
2703,GO:0005637,1,0.476104071683031,0,51,nuclear inner membrane,CC,
2704,GO:0005638,1,0.940665411928767,0,4,lamin filament,CC,
2705,GO:0005639,1,0.80796195082747,0,14,integral component of nuclear inner membrane,CC,
2706,GO:0005640,1,0.722747607403946,0,23,nuclear outer membrane,CC,
2708,GO:0005642,1,0.926426021082729,0,5,annulate lamellae,CC,
2709,GO:0005643,1,0.341730327950954,0,72,nuclear pore,CC,
2710,GO:0005652,1,0.885135671640515,0,8,nuclear lamina,CC,
2712,GO:0005655,1,0.923751754727114,0,7,nucleolar ribonuclease P complex,CC,
2713,GO:0005656,1,0.971985278910257,0,2,nuclear pre-replicative complex,CC,
2714,GO:0005657,1,0.393587416845395,0,65,replication fork,CC,
2715,GO:0005658,1,0.913843942439603,0,6,alpha DNA polymerase:primase complex,CC,
2716,GO:0005662,1,0.8087268266617,0,15,DNA replication factor A complex,CC,
2717,GO:0005663,1,0.92705039219053,0,6,DNA replication factor C complex,CC,
2718,GO:0005664,1,0.869677145420501,0,9,nuclear origin of replication recognition complex,CC,
2719,GO:0005665,1,0.803653235480169,0,18,DNA-directed RNA polymerase II, core complex,CC,
2720,GO:0005666,1,0.806341573795886,0,17,DNA-directed RNA polymerase III complex,CC,
2722,GO:0005668,1,0.976312313609924,0,2,RNA polymerase transcription factor SL1 complex,CC,
2723,GO:0005669,1,0.622356978358451,0,35,transcription factor TFIID complex,CC,
2724,GO:0005671,1,0.822213269640292,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2725,GO:0005672,1,0.945400050957387,0,5,transcription factor TFIIA complex,CC,
2726,GO:0005673,1,0.989057545717563,0,1,transcription factor TFIIE complex,CC,
2727,GO:0005674,1,0.974434100092121,0,2,transcription factor TFIIF complex,CC,
2728,GO:0005675,1,0.851276919516337,0,12,holo TFIIH complex,CC,
2729,GO:0005677,1,0.868376878968723,0,9,chromatin silencing complex,CC,
2730,GO:0005680,1,0.76019075846114,0,21,anaphase-promoting complex,CC,
2731,GO:0005681,1,0.0902634546389344,0,174,spliceosomal complex,CC,
2732,GO:0005682,1,0.766511434816662,0,20,U5 snRNP,CC,
2733,GO:0005683,1,0.940213170436143,0,7,U7 snRNP,CC,
2734,GO:0005684,1,0.651029640528349,0,33,U2-type spliceosomal complex,CC,
2735,GO:0005685,1,0.801807666462123,0,19,U1 snRNP,CC,
2736,GO:0005686,1,0.830429632175894,0,17,U2 snRNP,CC,
2737,GO:0005687,1,0.906296951517028,0,10,U4 snRNP,CC,
2738,GO:0005688,1,0.946871766888164,0,6,U6 snRNP,CC,
2739,GO:0005689,1,0.7631564258042,0,25,U12-type spliceosomal complex,CC,
2740,GO:0005690,1,0.985925067047608,0,1,U4atac snRNP,CC,
2741,GO:0005691,1,0.983406759352021,0,1,U6atac snRNP,CC,
2743,GO:0005697,1,0.749979590293904,0,21,telomerase holoenzyme complex,CC,
2744,GO:0005712,1,0.968637759047363,0,2,chiasma,CC,
2745,GO:0005713,1,0.968848697574295,0,2,recombination nodule,CC,
2746,GO:0005715,1,0.984982832020166,0,1,late recombination nodule,CC,
2747,GO:0005719,1,0.726820055393132,0,24,nuclear euchromatin,CC,
2748,GO:0005720,1,0.619577910273194,0,33,nuclear heterochromatin,CC,
2749,GO:0005721,1,0.755318679578423,0,18,pericentric heterochromatin,CC,
2750,GO:0005724,1,0.988499272489636,0,1,nuclear telomeric heterochromatin,CC,
2751,GO:0005726,1,0.951095964033064,0,3,perichromatin fibrils,CC,
2753,GO:0005731,1,0.988072634922144,0,1,nucleolus organizer region,CC,
2754,GO:0005732,1,0.840496267690329,0,16,small nucleolar ribonucleoprotein complex,CC,
2755,GO:0005736,1,0.867599454561899,0,11,DNA-directed RNA polymerase I complex,CC,
2760,GO:0005742,1,0.91099572573327,0,9,mitochondrial outer membrane translocase complex,CC,
2762,GO:0005744,1,0.88889483794388,0,10,mitochondrial inner membrane presequence translocase complex,CC,
2763,GO:0005745,1,0.968519322833289,0,2,m-AAA complex,CC,
2764,GO:0005746,1,0.54141178984315,0,77,mitochondrial respiratory chain,CC,
2765,GO:0005747,1,0.729688227960272,0,42,mitochondrial respiratory chain complex I,CC,
2766,GO:0005749,1,0.951992044001775,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2767,GO:0005750,1,0.893500716373712,0,11,mitochondrial respiratory chain complex III,CC,
2768,GO:0005751,1,0.940307991941059,0,12,mitochondrial respiratory chain complex IV,CC,
2769,GO:0005753,1,0.855142414307095,0,20,mitochondrial proton-transporting ATP synthase complex,CC,
2770,GO:0005754,1,0.987427957467423,0,1,mitochondrial proton-transporting ATP synthase, catalytic core,CC,
2771,GO:0005757,1,0.993810880445406,0,1,mitochondrial permeability transition pore complex,CC,
2772,GO:0005758,1,0.44424180575522,0,68,mitochondrial intermembrane space,CC,
2774,GO:0005760,1,0.967087733488108,0,2,gamma DNA polymerase complex,CC,
2775,GO:0005761,1,0.494922771490844,0,78,mitochondrial ribosome,CC,
2776,GO:0005762,1,0.637922141857871,0,49,mitochondrial large ribosomal subunit,CC,
2777,GO:0005763,1,0.787378663709322,0,26,mitochondrial small ribosomal subunit,CC,
2781,GO:0005767,1,0.830369417507967,0,14,secondary lysosome,CC,
2792,GO:0005779,1,0.82996806118951,0,14,integral component of peroxisomal membrane,CC,
2793,GO:0005782,1,0.561613328162341,0,43,peroxisomal matrix,CC,
2795,GO:0005784,1,0.965885786396732,0,4,Sec61 translocon complex,CC,
2796,GO:0005785,1,0.926132599684691,0,6,signal recognition particle receptor complex,CC,
2797,GO:0005786,1,0.929910444183741,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2798,GO:0005787,1,0.944891954932749,0,5,signal peptidase complex,CC,
2805,GO:0005795,1,0.158622938807234,0,120,Golgi stack,CC,
2807,GO:0005797,1,0.941818505361153,0,4,Golgi medial cisterna,CC,
2813,GO:0005814,1,0.200292436022977,0,105,centriole,CC,
2815,GO:0005818,1,0.92192242783043,0,5,aster,CC,
2817,GO:0005826,1,0.937881068078488,0,4,actomyosin contractile ring,CC,
2818,GO:0005827,1,0.924227898730724,0,5,polar microtubule,CC,
2819,GO:0005828,1,0.906750218144858,0,6,kinetochore microtubule,CC,
2821,GO:0005832,1,0.854605115285832,0,11,chaperonin-containing T-complex,CC,
2822,GO:0005833,1,0.933386343850138,0,12,hemoglobin complex,CC,
2823,GO:0005834,1,0.634607057709913,0,35,heterotrimeric G-protein complex,CC,
2824,GO:0005838,1,0.775689558113863,0,21,proteasome regulatory particle,CC,
2825,GO:0005839,1,0.825821020437049,0,21,proteasome core complex,CC,
2826,GO:0005840,1,0.131148164602858,0,219,ribosome,CC,
2827,GO:0005844,1,0.545809547915878,0,44,polysome,CC,
2828,GO:0005845,1,0.828755482258798,0,13,mRNA cap binding complex,CC,
2829,GO:0005846,1,0.969965794010984,0,2,nuclear cap binding complex,CC,
2830,GO:0005847,1,0.816815813871436,0,14,mRNA cleavage and polyadenylation specificity factor complex,CC,
2831,GO:0005849,1,0.754671485026567,0,19,mRNA cleavage factor complex,CC,
2832,GO:0005850,1,0.936488730451424,0,4,eukaryotic translation initiation factor 2 complex,CC,
2833,GO:0005851,1,0.921918548992822,0,6,eukaryotic translation initiation factor 2B complex,CC,
2834,GO:0005852,1,0.805463841963874,0,17,eukaryotic translation initiation factor 3 complex,CC,
2835,GO:0005853,1,0.954652783715966,0,4,eukaryotic translation elongation factor 1 complex,CC,
2837,GO:0005858,1,0.822315914608847,0,12,axonemal dynein complex,CC,
2839,GO:0005861,1,0.937578730107867,0,8,troponin complex,CC,
2840,GO:0005862,1,0.947878415605749,0,4,muscle thin filament tropomyosin,CC,
2841,GO:0005863,1,0.951048920321179,0,3,striated muscle myosin thick filament,CC,
2843,GO:0005868,1,0.751022568356782,0,22,cytoplasmic dynein complex,CC,
2844,GO:0005869,1,0.899782057540651,0,8,dynactin complex,CC,
2845,GO:0005871,1,0.432539969416142,0,52,kinesin complex,CC,
2846,GO:0005873,1,0.967087733487625,0,2,plus-end kinesin complex,CC,
2848,GO:0005875,1,0.119221463678369,0,141,microtubule associated complex,CC,
2850,GO:0005879,1,0.957443854577891,0,3,axonemal microtubule,CC,
2853,GO:0005883,1,0.877287567716297,0,8,neurofilament,CC,
2855,GO:0005885,1,0.880738248381035,0,11,Arp2/3 protein complex,CC,
2858,GO:0005889,1,0.967153897334521,0,2,hydrogen:potassium-exchanging ATPase complex,CC,
2859,GO:0005890,1,0.866571731286616,0,11,sodium:potassium-exchanging ATPase complex,CC,
2861,GO:0005892,1,0.779048244311167,0,17,acetylcholine-gated channel complex,CC,
2862,GO:0005895,1,0.986021685726174,0,1,interleukin-5 receptor complex,CC,
2863,GO:0005896,1,0.958847667232075,0,3,interleukin-6 receptor complex,CC,
2864,GO:0005898,1,0.983406759352069,0,1,interleukin-13 receptor complex,CC,
2865,GO:0005899,1,0.951038409342349,0,3,insulin receptor complex,CC,
2866,GO:0005900,1,0.967335739492003,0,2,oncostatin-M receptor complex,CC,
2874,GO:0005914,1,0.983534335108998,0,1,spot adherens junction,CC,
2882,GO:0005927,1,0.966047924711994,0,3,muscle tendon junction,CC,
2884,GO:0005930,1,0.279415390162894,0,84,axoneme,CC,
2886,GO:0005940,1,0.983851570765422,0,1,septin ring,CC,
2890,GO:0005945,1,0.967549849148058,0,2,6-phosphofructokinase complex,CC,
2891,GO:0005947,1,0.93399229761094,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2893,GO:0005953,1,0.973183973955053,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2894,GO:0005954,1,0.984959164224607,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2895,GO:0005955,1,0.935919771431633,0,4,calcineurin complex,CC,
2896,GO:0005956,1,0.976043912758796,0,2,protein kinase CK2 complex,CC,
2897,GO:0005958,1,0.955859182836043,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2899,GO:0005964,1,0.925575751423426,0,5,phosphorylase kinase complex,CC,
2900,GO:0005965,1,0.972997805444944,0,2,protein farnesyltransferase complex,CC,
2901,GO:0005967,1,0.953108551577292,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2902,GO:0005968,1,0.943660068657162,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2903,GO:0005969,1,0.983406759351133,0,1,serine-pyruvate aminotransferase complex,CC,
2904,GO:0005971,1,0.967427473745998,0,2,ribonucleoside-diphosphate reductase complex,CC,
2910,GO:0005980,1,0.676372696440725,0,26,glycogen catabolic process,BP,
2911,GO:0005981,1,0.922095969339429,0,6,regulation of glycogen catabolic process,BP,
2912,GO:0005982,1,0.983406759351527,0,1,starch metabolic process,BP,
2913,GO:0005983,1,0.983406759351527,0,1,starch catabolic process,BP,
2914,GO:0005984,1,0.87217850231982,0,10,disaccharide metabolic process,BP,
2915,GO:0005985,1,0.963385308396413,0,3,sucrose metabolic process,BP,
2916,GO:0005986,1,0.979613973101819,0,2,sucrose biosynthetic process,BP,
2917,GO:0005988,1,0.961706408261513,0,3,lactose metabolic process,BP,
2918,GO:0005989,1,0.961706408261513,0,3,lactose biosynthetic process,BP,
2919,GO:0005991,1,0.987345885905482,0,1,trehalose metabolic process,BP,
2920,GO:0005993,1,0.987345885905482,0,1,trehalose catabolic process,BP,
2922,GO:0005997,1,0.954915385248943,0,4,xylulose metabolic process,BP,
2923,GO:0005998,1,0.983419700639195,0,1,xylulose catabolic process,BP,
2924,GO:0005999,1,0.977213139410781,0,2,xylulose biosynthetic process,BP,
2927,GO:0006002,1,0.883617909798865,0,9,fructose 6-phosphate metabolic process,BP,
2929,GO:0006004,1,0.788776119706332,0,15,fucose metabolic process,BP,
2932,GO:0006011,1,0.915849349579152,0,6,UDP-glucose metabolic process,BP,
2933,GO:0006012,1,0.842735775896854,0,12,galactose metabolic process,BP,
2934,GO:0006013,1,0.887154909210465,0,8,mannose metabolic process,BP,
2935,GO:0006014,1,0.969985074089021,0,3,D-ribose metabolic process,BP,
2936,GO:0006015,1,0.947949035426248,0,4,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2937,GO:0006020,1,0.847857941303359,0,11,inositol metabolic process,BP,
2938,GO:0006021,1,0.943071904866373,0,4,inositol biosynthetic process,BP,
2945,GO:0006030,1,0.959051476133879,0,3,chitin metabolic process,BP,
2946,GO:0006032,1,0.959051476133879,0,3,chitin catabolic process,BP,
2947,GO:0006037,1,0.989276674890875,0,1,cell wall chitin metabolic process,BP,
2948,GO:0006040,1,0.606202685908749,0,34,amino sugar metabolic process,BP,
2949,GO:0006041,1,0.956315739433113,0,3,glucosamine metabolic process,BP,
2950,GO:0006043,1,0.985547063166251,0,1,glucosamine catabolic process,BP,
2951,GO:0006044,1,0.799862408023262,0,15,N-acetylglucosamine metabolic process,BP,
2952,GO:0006045,1,0.967091851055718,0,2,N-acetylglucosamine biosynthetic process,BP,
2953,GO:0006047,1,0.816729107895704,0,14,UDP-N-acetylglucosamine metabolic process,BP,
2954,GO:0006048,1,0.879019163771956,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2955,GO:0006049,1,0.983965623204124,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2956,GO:0006050,1,0.978371244486081,0,2,mannosamine metabolic process,BP,
2957,GO:0006051,1,0.978371244486081,0,2,N-acetylmannosamine metabolic process,BP,
2958,GO:0006054,1,0.882785127113355,0,9,N-acetylneuraminate metabolic process,BP,
2959,GO:0006055,1,0.990870761894025,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2960,GO:0006056,1,0.987784806077991,0,1,mannoprotein metabolic process,BP,
2961,GO:0006057,1,0.987784806077991,0,1,mannoprotein biosynthetic process,BP,
2962,GO:0006059,1,0.965161589658678,0,3,hexitol metabolic process,BP,
2963,GO:0006060,1,0.974816383285237,0,2,sorbitol metabolic process,BP,
2964,GO:0006061,1,0.989852633883451,0,1,sorbitol biosynthetic process,BP,
2965,GO:0006062,1,0.98481024597292,0,1,sorbitol catabolic process,BP,
2966,GO:0006063,1,0.73304554121576,0,22,uronic acid metabolic process,BP,
2967,GO:0006064,1,0.941944323047372,0,5,glucuronate catabolic process,BP,
2968,GO:0006065,1,0.953880772510519,0,3,UDP-glucuronate biosynthetic process,BP,
2970,GO:0006067,1,0.756264669672871,0,21,ethanol metabolic process,BP,
2971,GO:0006068,1,0.858278790725999,0,12,ethanol catabolic process,BP,
2972,GO:0006069,1,0.842043556204828,0,12,ethanol oxidation,BP,
2973,GO:0006071,1,0.808787387516288,0,16,glycerol metabolic process,BP,
2974,GO:0006072,1,0.894243903366604,0,7,glycerol-3-phosphate metabolic process,BP,
2978,GO:0006083,1,0.95147964076251,0,3,acetate metabolic process,BP,
2980,GO:0006085,1,0.733052078667362,0,20,acetyl-CoA biosynthetic process,BP,
2981,GO:0006086,1,0.792489436910579,0,15,acetyl-CoA biosynthetic process from pyruvate,BP,
2987,GO:0006097,1,0.973574653380987,0,2,glyoxylate cycle,BP,
2988,GO:0006098,1,0.81716891769978,0,16,pentose-phosphate shunt,BP,
2989,GO:0006099,1,0.662623208361214,0,30,tricarboxylic acid cycle,BP,
2990,GO:0006101,1,0.61965041592914,0,34,citrate metabolic process,BP,
2991,GO:0006102,1,0.937121236843093,0,5,isocitrate metabolic process,BP,
2992,GO:0006103,1,0.784044686367925,0,16,2-oxoglutarate metabolic process,BP,
2993,GO:0006104,1,0.944495395433799,0,4,succinyl-CoA metabolic process,BP,
2994,GO:0006105,1,0.860980248527915,0,10,succinate metabolic process,BP,
2995,GO:0006106,1,0.959452716586576,0,3,fumarate metabolic process,BP,
2996,GO:0006107,1,0.845353097797917,0,12,oxaloacetate metabolic process,BP,
2997,GO:0006108,1,0.900678566957811,0,8,malate metabolic process,BP,
3003,GO:0006114,1,0.939205189725571,0,4,glycerol biosynthetic process,BP,
3004,GO:0006116,1,0.956635038635785,0,3,NADH oxidation,BP,
3005,GO:0006117,1,0.984676451729454,0,1,acetaldehyde metabolic process,BP,
3007,GO:0006120,1,0.685805579117691,0,46,mitochondrial electron transport, NADH to ubiquinone,BP,
3008,GO:0006121,1,0.966756014709898,0,3,mitochondrial electron transport, succinate to ubiquinone,BP,
3009,GO:0006122,1,0.865265249974623,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
3010,GO:0006123,1,0.890738473421555,0,17,mitochondrial electron transport, cytochrome c to oxygen,BP,
3011,GO:0006127,1,0.984036403941389,0,1,glycerophosphate shuttle,BP,
3014,GO:0006144,1,0.758240834244259,0,19,purine nucleobase metabolic process,BP,
3015,GO:0006145,1,0.935538012778197,0,4,purine nucleobase catabolic process,BP,
3016,GO:0006147,1,0.983406759351824,0,1,guanine catabolic process,BP,
3017,GO:0006148,1,0.985150987584955,0,1,inosine catabolic process,BP,
3018,GO:0006152,1,0.924565908424069,0,6,purine nucleoside catabolic process,BP,
3019,GO:0006154,1,0.989057545717563,0,1,adenosine catabolic process,BP,
3020,GO:0006157,1,0.989057545717563,0,1,deoxyadenosine catabolic process,BP,
3024,GO:0006166,1,0.942353159293373,0,5,purine ribonucleoside salvage,BP,
3025,GO:0006167,1,0.9161345337262,0,7,AMP biosynthetic process,BP,
3026,GO:0006168,1,0.984158419585502,0,2,adenine salvage,BP,
3027,GO:0006169,1,0.986477642086532,0,1,adenosine salvage,BP,
3029,GO:0006172,1,0.969256802571366,0,2,ADP biosynthetic process,BP,
3030,GO:0006173,1,0.983436631854148,0,1,dADP biosynthetic process,BP,
3031,GO:0006175,1,0.986477642086532,0,1,dATP biosynthetic process,BP,
3032,GO:0006177,1,0.958621521589172,0,3,GMP biosynthetic process,BP,
3033,GO:0006178,1,0.98976807092467,0,1,guanine salvage,BP,
3035,GO:0006183,1,0.891349954450351,0,11,GTP biosynthetic process,BP,
3036,GO:0006185,1,0.992540372159341,0,1,dGDP biosynthetic process,BP,
3037,GO:0006188,1,0.86079319099123,0,10,IMP biosynthetic process,BP,
3038,GO:0006189,1,0.912845033740768,0,6,'de novo' IMP biosynthetic process,BP,
3039,GO:0006193,1,0.99178755111599,0,1,ITP catabolic process,BP,
3041,GO:0006196,1,0.967087733488158,0,2,AMP catabolic process,BP,
3043,GO:0006203,1,0.965158259965845,0,3,dGTP catabolic process,BP,
3044,GO:0006206,1,0.76225223346455,0,19,pyrimidine nucleobase metabolic process,BP,
3045,GO:0006207,1,0.908841142375912,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3046,GO:0006208,1,0.956479576716435,0,3,pyrimidine nucleobase catabolic process,BP,
3047,GO:0006210,1,0.956479576716435,0,3,thymine catabolic process,BP,
3048,GO:0006211,1,0.983406759350788,0,1,5-methylcytosine catabolic process,BP,
3049,GO:0006212,1,0.970109445349199,0,2,uracil catabolic process,BP,
3050,GO:0006213,1,0.562137079506852,0,47,pyrimidine nucleoside metabolic process,BP,
3051,GO:0006214,1,0.983704967407228,0,1,thymidine catabolic process,BP,
3052,GO:0006216,1,0.908009652279371,0,9,cytidine catabolic process,BP,
3053,GO:0006218,1,0.987599560370927,0,1,uridine catabolic process,BP,
3054,GO:0006220,1,0.569163091691133,0,45,pyrimidine nucleotide metabolic process,BP,
3055,GO:0006221,1,0.689798141994885,0,30,pyrimidine nucleotide biosynthetic process,BP,
3056,GO:0006222,1,0.868771643087135,0,10,UMP biosynthetic process,BP,
3057,GO:0006226,1,0.987298000092628,0,1,dUMP biosynthetic process,BP,
3058,GO:0006227,1,0.975549463919345,0,2,dUDP biosynthetic process,BP,
3059,GO:0006228,1,0.900677036241773,0,10,UTP biosynthetic process,BP,
3060,GO:0006231,1,0.973971773613311,0,2,dTMP biosynthetic process,BP,
3061,GO:0006233,1,0.975549463919345,0,2,dTDP biosynthetic process,BP,
3062,GO:0006235,1,0.955323328130025,0,4,dTTP biosynthetic process,BP,
3063,GO:0006238,1,0.990832232705604,0,1,CMP salvage,BP,
3064,GO:0006241,1,0.85574231062498,0,14,CTP biosynthetic process,BP,
3065,GO:0006244,1,0.8630518482053,0,12,pyrimidine nucleotide catabolic process,BP,
3066,GO:0006253,1,0.991683767070938,0,1,dCTP catabolic process,BP,
3067,GO:0006256,1,0.98394879876846,0,1,UDP catabolic process,BP,
3068,GO:0006258,1,0.976339676961947,0,2,UDP-glucose catabolic process,BP,
3072,GO:0006264,1,0.860381791755368,0,10,mitochondrial DNA replication,BP,
3073,GO:0006265,1,0.869822342146371,0,9,DNA topological change,BP,
3074,GO:0006266,1,0.722118682716907,0,24,DNA ligation,BP,
3075,GO:0006267,1,0.971985278910257,0,2,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3076,GO:0006268,1,0.896462542262854,0,7,DNA unwinding involved in DNA replication,BP,
3077,GO:0006269,1,0.943206664991509,0,4,DNA replication, synthesis of RNA primer,BP,
3078,GO:0006270,1,0.563367022994694,0,39,DNA replication initiation,BP,
3079,GO:0006271,1,0.795525069819724,0,16,DNA strand elongation involved in DNA replication,BP,
3080,GO:0006272,1,0.967087733487045,0,2,leading strand elongation,BP,
3081,GO:0006273,1,0.886787040840525,0,8,lagging strand elongation,BP,
3082,GO:0006274,1,0.984725543253726,0,1,DNA replication termination,BP,
3084,GO:0006278,1,0.403359577247294,0,62,RNA-dependent DNA biosynthetic process,BP,
3087,GO:0006283,1,0.384282870999091,0,73,transcription-coupled nucleotide-excision repair,BP,
3088,GO:0006284,1,0.566212643828796,0,41,base-excision repair,BP,
3089,GO:0006285,1,0.882400598416933,0,10,base-excision repair, AP site formation,BP,
3090,GO:0006286,1,0.980119663008863,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3091,GO:0006287,1,0.927761920359366,0,5,base-excision repair, gap-filling,BP,
3092,GO:0006288,1,0.960936059968909,0,3,base-excision repair, DNA ligation,BP,
3093,GO:0006289,1,0.214928090790802,0,114,nucleotide-excision repair,BP,
3094,GO:0006290,1,0.90629931792949,0,7,pyrimidine dimer repair,BP,
3095,GO:0006293,1,0.740111337095247,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3096,GO:0006294,1,0.680777965679623,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3097,GO:0006295,1,0.740111337095247,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3098,GO:0006296,1,0.607501885831402,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3099,GO:0006297,1,0.733633882569629,0,23,nucleotide-excision repair, DNA gap filling,BP,
3100,GO:0006298,1,0.628764099436127,0,31,mismatch repair,BP,
3101,GO:0006301,1,0.496781667929128,0,50,postreplication repair,BP,
3102,GO:0006302,1,0.0591687367939605,0,199,double-strand break repair,BP,
3103,GO:0006303,1,0.43583597715721,0,67,double-strand break repair via nonhomologous end joining,BP,
3107,GO:0006307,1,0.877113824443419,0,10,DNA dealkylation involved in DNA repair,BP,
3108,GO:0006308,1,0.657874130804181,0,31,DNA catabolic process,BP,
3109,GO:0006309,1,0.773506903085109,0,19,apoptotic DNA fragmentation,BP,
3111,GO:0006311,1,0.952548066338423,0,3,meiotic gene conversion,BP,
3112,GO:0006312,1,0.510099878203189,0,47,mitotic recombination,BP,
3113,GO:0006313,1,0.968384722376302,0,2,transposition, DNA-mediated,BP,
3114,GO:0006323,1,0.129626848306725,0,185,DNA packaging,BP,
3116,GO:0006333,1,0.148005749484029,0,174,chromatin assembly or disassembly,BP,
3117,GO:0006334,1,0.276219053855083,0,132,nucleosome assembly,BP,
3118,GO:0006335,1,0.818609862007187,0,32,DNA replication-dependent nucleosome assembly,BP,
3119,GO:0006336,1,0.602191436034815,0,48,DNA replication-independent nucleosome assembly,BP,
3120,GO:0006337,1,0.788114568444691,0,18,nucleosome disassembly,BP,
3121,GO:0006338,1,0.136471759573008,0,149,chromatin remodeling,BP,
3122,GO:0006342,1,0.331908338720406,0,114,chromatin silencing,BP,
3123,GO:0006343,1,0.983408648114669,0,1,establishment of chromatin silencing,BP,
3124,GO:0006344,1,0.936337064364023,0,4,maintenance of chromatin silencing,BP,
3125,GO:0006346,1,0.770144662621814,0,20,methylation-dependent chromatin silencing,BP,
3126,GO:0006348,1,0.898250368544573,0,9,chromatin silencing at telomere,BP,
3127,GO:0006349,1,0.77944321862957,0,16,regulation of gene expression by genetic imprinting,BP,
3130,GO:0006353,1,0.243352285685619,0,104,DNA-templated transcription, termination,BP,
3133,GO:0006356,1,0.630897504727286,0,31,regulation of transcription from RNA polymerase I promoter,BP,
3136,GO:0006360,1,0.437271979918227,0,59,transcription from RNA polymerase I promoter,BP,
3137,GO:0006361,1,0.66138880868348,0,32,transcription initiation from RNA polymerase I promoter,BP,
3138,GO:0006362,1,0.669734680627888,0,31,transcription elongation from RNA polymerase I promoter,BP,
3139,GO:0006363,1,0.681248902671849,0,30,termination of RNA polymerase I transcription,BP,
3140,GO:0006364,1,0.0648053796647047,0,242,rRNA processing,BP,
3144,GO:0006369,1,0.384149837603211,0,69,termination of RNA polymerase II transcription,BP,
3145,GO:0006370,1,0.68592399001344,0,30,7-methylguanosine mRNA capping,BP,
3146,GO:0006376,1,0.676769670057108,0,26,mRNA splice site selection,BP,
3147,GO:0006378,1,0.557218362456085,0,39,mRNA polyadenylation,BP,
3148,GO:0006379,1,0.716250465116351,0,25,mRNA cleavage,BP,
3149,GO:0006382,1,0.938571233808915,0,4,adenosine to inosine editing,BP,
3151,GO:0006384,1,0.886520747651468,0,8,transcription initiation from RNA polymerase III promoter,BP,
3152,GO:0006388,1,0.849787886012111,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3153,GO:0006390,1,0.911730650173578,0,7,transcription from mitochondrial promoter,BP,
3154,GO:0006391,1,0.958716236375543,0,3,transcription initiation from mitochondrial promoter,BP,
3156,GO:0006397,1,0.00134959223494599,0,461,mRNA processing,BP,
3157,GO:0006398,1,0.927685923922185,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3158,GO:0006399,1,0.101700488898273,0,166,tRNA metabolic process,BP,
3159,GO:0006400,1,0.418572349474597,0,62,tRNA modification,BP,
3162,GO:0006403,1,0.0423047244551888,0,218,RNA localization,BP,
3163,GO:0006404,1,0.955655107777084,0,3,RNA import into nucleus,BP,
3164,GO:0006405,1,0.138144550862742,0,137,RNA export from nucleus,BP,
3165,GO:0006406,1,0.203593753090556,0,108,mRNA export from nucleus,BP,
3166,GO:0006407,1,0.975201686065936,0,2,rRNA export from nucleus,BP,
3167,GO:0006408,1,0.974399785429556,0,2,snRNA export from nucleus,BP,
3168,GO:0006409,1,0.624167024427032,0,31,tRNA export from nucleus,BP,
3170,GO:0006413,1,0.129005372827613,0,188,translational initiation,BP,
3171,GO:0006414,1,0.246778936341853,0,130,translational elongation,BP,
3172,GO:0006415,1,0.35936710930076,0,100,translational termination,BP,
3174,GO:0006418,1,0.499153925456938,0,48,tRNA aminoacylation for protein translation,BP,
3175,GO:0006419,1,0.954799842084587,0,3,alanyl-tRNA aminoacylation,BP,
3176,GO:0006420,1,0.953396277807833,0,4,arginyl-tRNA aminoacylation,BP,
3177,GO:0006421,1,0.953898173901576,0,3,asparaginyl-tRNA aminoacylation,BP,
3178,GO:0006422,1,0.985415819962233,0,1,aspartyl-tRNA aminoacylation,BP,
3179,GO:0006423,1,0.971993463183418,0,2,cysteinyl-tRNA aminoacylation,BP,
3180,GO:0006424,1,0.967088020374865,0,2,glutamyl-tRNA aminoacylation,BP,
3181,GO:0006425,1,0.985045917426215,0,1,glutaminyl-tRNA aminoacylation,BP,
3182,GO:0006426,1,0.973167816712704,0,2,glycyl-tRNA aminoacylation,BP,
3183,GO:0006427,1,0.971942863108805,0,2,histidyl-tRNA aminoacylation,BP,
3184,GO:0006428,1,0.967125959360278,0,2,isoleucyl-tRNA aminoacylation,BP,
3185,GO:0006429,1,0.967087733488061,0,2,leucyl-tRNA aminoacylation,BP,
3186,GO:0006430,1,0.986246994830835,0,1,lysyl-tRNA aminoacylation,BP,
3187,GO:0006431,1,0.96823295023159,0,2,methionyl-tRNA aminoacylation,BP,
3188,GO:0006432,1,0.945473179871713,0,4,phenylalanyl-tRNA aminoacylation,BP,
3189,GO:0006433,1,0.969033663019404,0,2,prolyl-tRNA aminoacylation,BP,
3190,GO:0006434,1,0.973739041728352,0,2,seryl-tRNA aminoacylation,BP,
3191,GO:0006435,1,0.953597771260728,0,3,threonyl-tRNA aminoacylation,BP,
3192,GO:0006436,1,0.968784430234546,0,2,tryptophanyl-tRNA aminoacylation,BP,
3193,GO:0006437,1,0.969985312934487,0,2,tyrosyl-tRNA aminoacylation,BP,
3194,GO:0006438,1,0.95106094615064,0,3,valyl-tRNA aminoacylation,BP,
3195,GO:0006446,1,0.374004340864636,0,70,regulation of translational initiation,BP,
3196,GO:0006447,1,0.955817567002493,0,3,regulation of translational initiation by iron,BP,
3197,GO:0006448,1,0.707357435565503,0,26,regulation of translational elongation,BP,
3198,GO:0006449,1,0.884290063248834,0,8,regulation of translational termination,BP,
3199,GO:0006450,1,0.810056809513476,0,16,regulation of translational fidelity,BP,
3200,GO:0006451,1,0.884913740156815,0,9,translational readthrough,BP,
3201,GO:0006452,1,0.95782396190528,0,3,translational frameshifting,BP,
3203,GO:0006458,1,0.642740643484859,0,32,'de novo' protein folding,BP,
3205,GO:0006463,1,0.983414653530329,0,1,steroid hormone receptor complex assembly,BP,
3211,GO:0006471,1,0.739909998143906,0,22,protein ADP-ribosylation,BP,
3213,GO:0006474,1,0.794231935613637,0,16,N-terminal protein amino acid acetylation,BP,
3216,GO:0006477,1,0.89890626144816,0,7,protein sulfation,BP,
3217,GO:0006478,1,0.97361831394926,0,2,peptidyl-tyrosine sulfation,BP,
3219,GO:0006480,1,0.977742487336825,0,2,N-terminal protein amino acid methylation,BP,
3220,GO:0006481,1,0.974099432878204,0,2,C-terminal protein methylation,BP,
3221,GO:0006482,1,0.631592874085598,0,28,protein demethylation,BP,
3223,GO:0006487,1,0.400328133317026,0,67,protein N-linked glycosylation,BP,
3224,GO:0006488,1,0.749189383620738,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3225,GO:0006489,1,0.901722874262242,0,7,dolichyl diphosphate biosynthetic process,BP,
3226,GO:0006490,1,0.737783379623167,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3232,GO:0006500,1,0.973900149284738,0,2,N-terminal protein palmitoylation,BP,
3234,GO:0006505,1,0.642663167358437,0,33,GPI anchor metabolic process,BP,
3235,GO:0006506,1,0.652091771199959,0,32,GPI anchor biosynthetic process,BP,
3236,GO:0006507,1,0.985566427273525,0,1,GPI anchor release,BP,
3238,GO:0006509,1,0.563705476902294,0,39,membrane protein ectodomain proteolysis,BP,
3240,GO:0006513,1,0.427892825062163,0,57,protein monoubiquitination,BP,
3241,GO:0006515,1,0.714973154565468,0,23,misfolded or incompletely synthesized protein catabolic process,BP,
3242,GO:0006516,1,0.788237470263734,0,17,glycoprotein catabolic process,BP,
3243,GO:0006517,1,0.601038987097777,0,34,protein deglycosylation,BP,
3246,GO:0006521,1,0.516361120515292,0,60,regulation of cellular amino acid metabolic process,BP,
3247,GO:0006522,1,0.935436007811469,0,5,alanine metabolic process,BP,
3248,GO:0006524,1,0.935436007811469,0,5,alanine catabolic process,BP,
3249,GO:0006525,1,0.794077110429301,0,17,arginine metabolic process,BP,
3250,GO:0006526,1,0.950058098097111,0,4,arginine biosynthetic process,BP,
3251,GO:0006527,1,0.880441600030247,0,9,arginine catabolic process,BP,
3252,GO:0006528,1,0.93541667305938,0,5,asparagine metabolic process,BP,
3253,GO:0006529,1,0.970627680804132,0,2,asparagine biosynthetic process,BP,
3254,GO:0006530,1,0.972827665061887,0,2,asparagine catabolic process,BP,
3255,GO:0006531,1,0.862755095275892,0,11,aspartate metabolic process,BP,
3256,GO:0006532,1,0.961679714757001,0,3,aspartate biosynthetic process,BP,
3257,GO:0006533,1,0.961655990254831,0,3,aspartate catabolic process,BP,
3258,GO:0006534,1,0.82672294730458,0,13,cysteine metabolic process,BP,
3259,GO:0006535,1,0.984615667407723,0,1,cysteine biosynthetic process from serine,BP,
3260,GO:0006536,1,0.645770354093827,0,29,glutamate metabolic process,BP,
3261,GO:0006537,1,0.907613005206068,0,6,glutamate biosynthetic process,BP,
3262,GO:0006538,1,0.898070169915933,0,7,glutamate catabolic process,BP,
3263,GO:0006540,1,0.970056986256568,0,2,glutamate decarboxylation to succinate,BP,
3264,GO:0006541,1,0.696366888721142,0,24,glutamine metabolic process,BP,
3265,GO:0006542,1,0.967087733487917,0,2,glutamine biosynthetic process,BP,
3266,GO:0006543,1,0.952135232127261,0,3,glutamine catabolic process,BP,
3268,GO:0006545,1,0.930554787237092,0,5,glycine biosynthetic process,BP,
3270,GO:0006547,1,0.878100063819731,0,9,histidine metabolic process,BP,
3271,GO:0006548,1,0.906166357877489,0,7,histidine catabolic process,BP,
3272,GO:0006549,1,0.927147841878361,0,5,isoleucine metabolic process,BP,
3273,GO:0006550,1,0.974884655337789,0,2,isoleucine catabolic process,BP,
3274,GO:0006551,1,0.905621320431609,0,7,leucine metabolic process,BP,
3275,GO:0006552,1,0.931534598314756,0,5,leucine catabolic process,BP,
3276,GO:0006553,1,0.846754857522155,0,11,lysine metabolic process,BP,
3277,GO:0006554,1,0.860477766850294,0,10,lysine catabolic process,BP,
3278,GO:0006555,1,0.751847644333922,0,20,methionine metabolic process,BP,
3279,GO:0006556,1,0.954682573144848,0,3,S-adenosylmethionine biosynthetic process,BP,
3280,GO:0006557,1,0.983585198051488,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3281,GO:0006558,1,0.883005937873557,0,10,L-phenylalanine metabolic process,BP,
3282,GO:0006559,1,0.883005937873557,0,10,L-phenylalanine catabolic process,BP,
3283,GO:0006560,1,0.883282015954718,0,9,proline metabolic process,BP,
3284,GO:0006561,1,0.917004715660358,0,6,proline biosynthetic process,BP,
3285,GO:0006562,1,0.947433898296673,0,4,proline catabolic process,BP,
3286,GO:0006563,1,0.869381504243034,0,10,L-serine metabolic process,BP,
3287,GO:0006564,1,0.920544274074862,0,6,L-serine biosynthetic process,BP,
3288,GO:0006565,1,0.958872925708143,0,3,L-serine catabolic process,BP,
3289,GO:0006566,1,0.9755700864159,0,2,threonine metabolic process,BP,
3290,GO:0006567,1,0.988797374227199,0,1,threonine catabolic process,BP,
3291,GO:0006568,1,0.843692043760874,0,13,tryptophan metabolic process,BP,
3292,GO:0006569,1,0.868271959574948,0,11,tryptophan catabolic process,BP,
3293,GO:0006570,1,0.887737047275173,0,9,tyrosine metabolic process,BP,
3294,GO:0006572,1,0.940837533935195,0,5,tyrosine catabolic process,BP,
3295,GO:0006573,1,0.875345116130389,0,9,valine metabolic process,BP,
3296,GO:0006574,1,0.946760822324993,0,4,valine catabolic process,BP,
3298,GO:0006576,1,0.528425958389031,0,49,cellular biogenic amine metabolic process,BP,
3299,GO:0006577,1,0.766169992412942,0,17,amino-acid betaine metabolic process,BP,
3300,GO:0006578,1,0.897423969252463,0,7,amino-acid betaine biosynthetic process,BP,
3301,GO:0006579,1,0.954248417241756,0,3,amino-acid betaine catabolic process,BP,
3302,GO:0006580,1,0.984393633848452,0,1,ethanolamine metabolic process,BP,
3303,GO:0006581,1,0.968751942143426,0,2,acetylcholine catabolic process,BP,
3305,GO:0006583,1,0.971997545080955,0,2,melanin biosynthetic process from tyrosine,BP,
3307,GO:0006585,1,0.987142040508027,0,1,dopamine biosynthetic process from tyrosine,BP,
3308,GO:0006586,1,0.793578716726286,0,18,indolalkylamine metabolic process,BP,
3309,GO:0006589,1,0.968286448699606,0,2,octopamine biosynthetic process,BP,
3310,GO:0006590,1,0.783134578136132,0,16,thyroid hormone generation,BP,
3311,GO:0006591,1,0.910954053078291,0,7,ornithine metabolic process,BP,
3312,GO:0006592,1,0.983473444283871,0,1,ornithine biosynthetic process,BP,
3313,GO:0006593,1,0.988428714313238,0,1,ornithine catabolic process,BP,
3314,GO:0006595,1,0.839674739339128,0,15,polyamine metabolic process,BP,
3315,GO:0006596,1,0.865387653064933,0,12,polyamine biosynthetic process,BP,
3316,GO:0006597,1,0.971982048363638,0,2,spermine biosynthetic process,BP,
3317,GO:0006598,1,0.937911600952018,0,6,polyamine catabolic process,BP,
3318,GO:0006599,1,0.988938071724141,0,1,phosphagen metabolic process,BP,
3319,GO:0006600,1,0.863401914041703,0,11,creatine metabolic process,BP,
3320,GO:0006601,1,0.97719738152521,0,2,creatine biosynthetic process,BP,
3321,GO:0006603,1,0.988938071724141,0,1,phosphocreatine metabolic process,BP,
3324,GO:0006607,1,0.704908782753369,0,22,NLS-bearing protein import into nucleus,BP,
3325,GO:0006610,1,0.885522684816463,0,8,ribosomal protein import into nucleus,BP,
3328,GO:0006613,1,0.483309455017553,0,96,cotranslational protein targeting to membrane,BP,
3329,GO:0006614,1,0.519875525777526,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3330,GO:0006616,1,0.939124713752683,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3331,GO:0006617,1,0.979102880600592,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3332,GO:0006620,1,0.925920736426701,0,6,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3333,GO:0006621,1,0.879835409717356,0,9,protein retention in ER lumen,BP,
3334,GO:0006622,1,0.764780521018807,0,17,protein targeting to lysosome,BP,
3335,GO:0006623,1,0.65941933885962,0,28,protein targeting to vacuole,BP,
3336,GO:0006624,1,0.980351395140305,0,2,vacuolar protein processing,BP,
3337,GO:0006625,1,0.771626363420461,0,17,protein targeting to peroxisome,BP,
3338,GO:0006626,1,0.158995526408236,0,141,protein targeting to mitochondrion,BP,
3339,GO:0006627,1,0.920374258615041,0,7,protein processing involved in protein targeting to mitochondrion,BP,
3349,GO:0006642,1,0.937049751724858,0,4,triglyceride mobilization,BP,
3353,GO:0006649,1,0.96736434756503,0,2,phospholipid transfer to membrane,BP,
3355,GO:0006651,1,0.960841074825163,0,4,diacylglycerol biosynthetic process,BP,
3356,GO:0006654,1,0.600242596244129,0,35,phosphatidic acid biosynthetic process,BP,
3357,GO:0006655,1,0.869194890398353,0,9,phosphatidylglycerol biosynthetic process,BP,
3358,GO:0006656,1,0.623699872653247,0,35,phosphatidylcholine biosynthetic process,BP,
3359,GO:0006657,1,0.907055803960686,0,7,CDP-choline pathway,BP,
3360,GO:0006658,1,0.662855912599025,0,30,phosphatidylserine metabolic process,BP,
3361,GO:0006659,1,0.940553281163778,0,4,phosphatidylserine biosynthetic process,BP,
3362,GO:0006660,1,0.98774441978744,0,1,phosphatidylserine catabolic process,BP,
3364,GO:0006662,1,0.880530546195382,0,11,glycerol ether metabolic process,BP,
3365,GO:0006663,1,0.944607035000643,0,4,platelet activating factor biosynthetic process,BP,
3368,GO:0006666,1,0.983406759351872,0,1,3-keto-sphinganine metabolic process,BP,
3369,GO:0006667,1,0.961031085735739,0,3,sphinganine metabolic process,BP,
3370,GO:0006668,1,0.967723573955816,0,2,sphinganine-1-phosphate metabolic process,BP,
3371,GO:0006669,1,0.98390178276889,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3372,GO:0006670,1,0.86942856969514,0,10,sphingosine metabolic process,BP,
3373,GO:0006671,1,0.983406759352021,0,1,phytosphingosine metabolic process,BP,
3375,GO:0006677,1,0.817509945587604,0,14,glycosylceramide metabolic process,BP,
3376,GO:0006678,1,0.899849344734452,0,7,glucosylceramide metabolic process,BP,
3377,GO:0006679,1,0.97212289847767,0,2,glucosylceramide biosynthetic process,BP,
3378,GO:0006680,1,0.953541433367102,0,3,glucosylceramide catabolic process,BP,
3379,GO:0006681,1,0.928365798633719,0,5,galactosylceramide metabolic process,BP,
3380,GO:0006682,1,0.971894908170225,0,2,galactosylceramide biosynthetic process,BP,
3381,GO:0006683,1,0.983982792429525,0,1,galactosylceramide catabolic process,BP,
3382,GO:0006684,1,0.822897059967203,0,14,sphingomyelin metabolic process,BP,
3383,GO:0006685,1,0.91502842673109,0,6,sphingomyelin catabolic process,BP,
3384,GO:0006686,1,0.921895054209003,0,6,sphingomyelin biosynthetic process,BP,
3386,GO:0006688,1,0.800402218134923,0,15,glycosphingolipid biosynthetic process,BP,
3387,GO:0006689,1,0.920872401646753,0,6,ganglioside catabolic process,BP,
3389,GO:0006691,1,0.71756223812209,0,27,leukotriene metabolic process,BP,
3394,GO:0006696,1,0.975509687259949,0,2,ergosterol biosynthetic process,BP,
3395,GO:0006699,1,0.603509379387174,0,34,bile acid biosynthetic process,BP,
3397,GO:0006701,1,0.910757660888147,0,7,progesterone biosynthetic process,BP,
3399,GO:0006703,1,0.86230108943235,0,12,estrogen biosynthetic process,BP,
3402,GO:0006706,1,0.686647007555193,0,27,steroid catabolic process,BP,
3403,GO:0006707,1,0.859895216184948,0,11,cholesterol catabolic process,BP,
3404,GO:0006710,1,0.949669387192483,0,4,androgen catabolic process,BP,
3405,GO:0006711,1,0.97418953094798,0,2,estrogen catabolic process,BP,
3406,GO:0006713,1,0.987709232416293,0,1,glucocorticoid catabolic process,BP,
3407,GO:0006714,1,0.979770821705243,0,2,sesquiterpenoid metabolic process,BP,
3410,GO:0006722,1,0.985174651492059,0,1,triterpenoid metabolic process,BP,
3412,GO:0006726,1,0.942944951255989,0,4,eye pigment biosynthetic process,BP,
3413,GO:0006729,1,0.921651164248646,0,7,tetrahydrobiopterin biosynthetic process,BP,
3414,GO:0006730,1,0.634661489150553,0,33,one-carbon metabolic process,BP,
3419,GO:0006738,1,0.985150987584955,0,1,nicotinamide riboside catabolic process,BP,
3420,GO:0006739,1,0.661119986028556,0,31,NADP metabolic process,BP,
3421,GO:0006740,1,0.954904171390189,0,3,NADPH regeneration,BP,
3422,GO:0006741,1,0.955772873241274,0,3,NADP biosynthetic process,BP,
3423,GO:0006742,1,0.976431204174188,0,2,NADP catabolic process,BP,
3424,GO:0006743,1,0.838317887745483,0,14,ubiquinone metabolic process,BP,
3425,GO:0006744,1,0.852472458527443,0,13,ubiquinone biosynthetic process,BP,
3426,GO:0006747,1,0.986837428914268,0,1,FAD biosynthetic process,BP,
3427,GO:0006749,1,0.595327300868723,0,46,glutathione metabolic process,BP,
3428,GO:0006750,1,0.816644013728617,0,15,glutathione biosynthetic process,BP,
3429,GO:0006751,1,0.909075869357752,0,8,glutathione catabolic process,BP,
3431,GO:0006754,1,0.625449457585082,0,42,ATP biosynthetic process,BP,
3433,GO:0006760,1,0.697013705572201,0,25,folic acid-containing compound metabolic process,BP,
3436,GO:0006768,1,0.846889583685197,0,11,biotin metabolic process,BP,
3438,GO:0006772,1,0.943564558446595,0,4,thiamine metabolic process,BP,
3440,GO:0006776,1,0.898990510032803,0,8,vitamin A metabolic process,BP,
3441,GO:0006777,1,0.914333788301599,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3442,GO:0006778,1,0.618731214715942,0,36,porphyrin-containing compound metabolic process,BP,
3443,GO:0006779,1,0.722078145713184,0,24,porphyrin-containing compound biosynthetic process,BP,
3444,GO:0006780,1,0.97627901406532,0,2,uroporphyrinogen III biosynthetic process,BP,
3445,GO:0006781,1,0.986013886613784,0,1,succinyl-CoA pathway,BP,
3446,GO:0006782,1,0.901900905396793,0,8,protoporphyrinogen IX biosynthetic process,BP,
3447,GO:0006783,1,0.768558697700195,0,20,heme biosynthetic process,BP,
3448,GO:0006784,1,0.967525846480413,0,2,heme a biosynthetic process,BP,
3449,GO:0006787,1,0.925101853984493,0,7,porphyrin-containing compound catabolic process,BP,
3450,GO:0006788,1,0.977069470666568,0,2,heme oxidation,BP,
3451,GO:0006789,1,0.970829443720238,0,2,bilirubin conjugation,BP,
3455,GO:0006797,1,0.98408794163048,0,1,polyphosphate metabolic process,BP,
3457,GO:0006805,1,0.256794263701728,0,103,xenobiotic metabolic process,BP,
3459,GO:0006808,1,0.963728223872851,0,3,regulation of nitrogen utilization,BP,
3467,GO:0006817,1,0.694234177932739,0,24,phosphate ion transport,BP,
3468,GO:0006818,1,0.162860860893346,0,154,hydrogen transport,BP,
3471,GO:0006824,1,0.936099288531607,0,5,cobalt ion transport,BP,
3472,GO:0006825,1,0.785741251330306,0,18,copper ion transport,BP,
3474,GO:0006828,1,0.838993871479445,0,11,manganese ion transport,BP,
3475,GO:0006829,1,0.679489900084168,0,26,zinc II ion transport,BP,
3476,GO:0006833,1,0.772749123485144,0,19,water transport,BP,
3479,GO:0006837,1,0.809118494001949,0,16,serotonin transport,BP,
3481,GO:0006842,1,0.940486611673458,0,4,tricarboxylic acid transport,BP,
3482,GO:0006843,1,0.988691573711516,0,1,mitochondrial citrate transport,BP,
3483,GO:0006844,1,0.972795515795962,0,2,acyl carnitine transport,BP,
3484,GO:0006848,1,0.939065122190732,0,4,pyruvate transport,BP,
3485,GO:0006850,1,0.954870180769942,0,3,mitochondrial pyruvate transport,BP,
3486,GO:0006851,1,0.897849776081253,0,8,mitochondrial calcium ion transport,BP,
3488,GO:0006855,1,0.711792998408411,0,22,drug transmembrane transport,BP,
3489,GO:0006857,1,0.86931290647013,0,9,oligopeptide transport,BP,
3490,GO:0006858,1,0.970665303259473,0,2,extracellular transport,BP,
3491,GO:0006860,1,0.987044447449686,0,1,extracellular amino acid transport,BP,
3493,GO:0006863,1,0.912250020637865,0,7,purine nucleobase transport,BP,
3494,GO:0006864,1,0.97307979491638,0,2,pyrimidine nucleotide transport,BP,
3496,GO:0006867,1,0.969449584215117,0,2,asparagine transport,BP,
3497,GO:0006868,1,0.925470035590954,0,5,glutamine transport,BP,
3502,GO:0006876,1,0.983408102448569,0,1,cellular cadmium ion homeostasis,BP,
3505,GO:0006880,1,0.958932363807995,0,5,intracellular sequestering of iron ion,BP,
3506,GO:0006882,1,0.702809727451065,0,25,cellular zinc ion homeostasis,BP,
3507,GO:0006883,1,0.814808994499106,0,13,cellular sodium ion homeostasis,BP,
3508,GO:0006884,1,0.770845468387523,0,17,cell volume homeostasis,BP,
3516,GO:0006893,1,0.510366465837192,0,45,Golgi to plasma membrane transport,BP,
3517,GO:0006895,1,0.746649898053483,0,18,Golgi to endosome transport,BP,
3518,GO:0006896,1,0.855530755651859,0,10,Golgi to vacuole transport,BP,
3521,GO:0006900,1,0.209607010429736,0,109,membrane budding,BP,
3522,GO:0006901,1,0.400561172777605,0,64,vesicle coating,BP,
3523,GO:0006903,1,0.310455303918099,0,80,vesicle targeting,BP,
3526,GO:0006907,1,0.764273298408095,0,18,pinocytosis,BP,
3534,GO:0006921,1,0.656929109303319,0,30,cellular component disassembly involved in execution phase of apoptosis,BP,
3536,GO:0006925,1,0.795173998549267,0,17,inflammatory cell apoptotic process,BP,
3538,GO:0006929,1,0.662186082861445,0,27,substrate-dependent cell migration,BP,
3539,GO:0006930,1,0.885842657418405,0,8,substrate-dependent cell migration, cell extension,BP,
3540,GO:0006931,1,0.945795912368816,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3541,GO:0006933,1,0.945698500878688,0,4,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3549,GO:0006948,1,0.983723637727737,0,1,induction by virus of host cell-cell fusion,BP,
3550,GO:0006949,1,0.50353320956803,0,49,syncytium formation,BP,
3553,GO:0006953,1,0.570807946427085,0,46,acute-phase response,BP,
3556,GO:0006956,1,0.475396719360245,0,55,complement activation,BP,
3557,GO:0006957,1,0.820317161551832,0,14,complement activation, alternative pathway,BP,
3558,GO:0006958,1,0.642870263820346,0,32,complement activation, classical pathway,BP,
3560,GO:0006963,1,0.994095158928263,0,2,positive regulation of antibacterial peptide biosynthetic process,BP,
3561,GO:0006965,1,0.994095158928263,0,2,positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
3562,GO:0006968,1,0.477426565708338,0,59,cellular defense response,BP,
3564,GO:0006971,1,0.884667080702172,0,8,hypotonic response,BP,
3571,GO:0006982,1,0.970724697888131,0,3,response to lipid hydroperoxide,BP,
3572,GO:0006983,1,0.857086069904356,0,10,ER overload response,BP,
3573,GO:0006984,1,0.538608168932195,0,42,ER-nucleus signaling pathway,BP,
3575,GO:0006987,1,0.887599436123427,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3576,GO:0006990,1,0.944498648938845,0,4,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3577,GO:0006991,1,0.866731223934061,0,9,response to sterol depletion,BP,
3578,GO:0006995,1,0.939247370480361,0,4,cellular response to nitrogen starvation,BP,
3580,GO:0006997,1,0.138887648093816,0,136,nucleus organization,BP,
3581,GO:0006998,1,0.302349968481592,0,81,nuclear envelope organization,BP,
3582,GO:0006999,1,0.806894140744873,0,14,nuclear pore organization,BP,
3583,GO:0007000,1,0.917121728631388,0,6,nucleolus organization,BP,
3584,GO:0007004,1,0.416198373938209,0,60,telomere maintenance via telomerase,BP,
3587,GO:0007007,1,0.809116823974824,0,18,inner mitochondrial membrane organization,BP,
3588,GO:0007008,1,0.916752900242986,0,8,outer mitochondrial membrane organization,BP,
3591,GO:0007014,1,0.983417626569944,0,1,actin ubiquitination,BP,
3595,GO:0007018,1,0.0287965436855797,0,237,microtubule-based movement,BP,
3596,GO:0007019,1,0.655173112224988,0,29,microtubule depolymerization,BP,
3598,GO:0007021,1,0.934763898299507,0,6,tubulin complex assembly,BP,
3599,GO:0007023,1,0.95435769458318,0,4,post-chaperonin tubulin folding pathway,BP,
3600,GO:0007026,1,0.785134048157746,0,17,negative regulation of microtubule depolymerization,BP,
3601,GO:0007028,1,0.852956978843873,0,10,cytoplasm organization,BP,
3604,GO:0007031,1,0.648572798308447,0,31,peroxisome organization,BP,
3608,GO:0007035,1,0.77875903275857,0,18,vacuolar acidification,BP,
3609,GO:0007037,1,0.983406759351775,0,1,vacuolar phosphate transport,BP,
3610,GO:0007039,1,0.889711080669539,0,8,protein catabolic process in the vacuole,BP,
3613,GO:0007042,1,0.928692081586244,0,6,lysosomal lumen acidification,BP,
3621,GO:0007056,1,0.961244194438599,0,3,spindle assembly involved in female meiosis,BP,
3622,GO:0007057,1,0.97196418973137,0,2,spindle assembly involved in female meiosis I,BP,
3624,GO:0007060,1,0.954152438287166,0,3,male meiosis chromosome segregation,BP,
3625,GO:0007062,1,0.187189113810828,0,115,sister chromatid cohesion,BP,
3626,GO:0007063,1,0.767147914298162,0,17,regulation of sister chromatid cohesion,BP,
3627,GO:0007064,1,0.744270151554293,0,19,mitotic sister chromatid cohesion,BP,
3628,GO:0007066,1,0.985474784771317,0,2,female meiosis sister chromatid cohesion,BP,
3630,GO:0007068,1,0.967087733487819,0,2,negative regulation of transcription during mitotic cell cycle,BP,
3631,GO:0007070,1,0.967087733487819,0,2,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
3632,GO:0007072,1,0.988072634922144,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3633,GO:0007076,1,0.797391827845906,0,14,mitotic chromosome condensation,BP,
3634,GO:0007077,1,0.532997820714671,0,42,mitotic nuclear envelope disassembly,BP,
3635,GO:0007079,1,0.951407028510014,0,3,mitotic chromosome movement towards spindle pole,BP,
3637,GO:0007084,1,0.87367660413927,0,10,mitotic nuclear envelope reassembly,BP,
3639,GO:0007089,1,0.940274572539006,0,4,traversing start control point of mitotic cell cycle,BP,
3640,GO:0007091,1,0.514697505380418,0,46,metaphase/anaphase transition of mitotic cell cycle,BP,
3642,GO:0007094,1,0.674070802415265,0,27,mitotic spindle assembly checkpoint,BP,
3644,GO:0007096,1,0.781226837532421,0,18,regulation of exit from mitosis,BP,
3645,GO:0007097,1,0.862458131660699,0,9,nuclear migration,BP,
3647,GO:0007099,1,0.658881780853682,0,27,centriole replication,BP,
3649,GO:0007113,1,0.964585434065313,0,3,endomitotic cell cycle,BP,
3651,GO:0007127,1,0.26679703718486,0,93,meiosis I,BP,
3652,GO:0007129,1,0.59512532048288,0,37,synapsis,BP,
3653,GO:0007130,1,0.771480368365896,0,19,synaptonemal complex assembly,BP,
3654,GO:0007131,1,0.531452373786156,0,43,reciprocal meiotic recombination,BP,
3655,GO:0007135,1,0.900000808991401,0,8,meiosis II,BP,
3657,GO:0007141,1,0.795692184854603,0,17,male meiosis I,BP,
3658,GO:0007143,1,0.701277710011561,0,24,female meiotic division,BP,
3659,GO:0007144,1,0.913570127886314,0,6,female meiosis I,BP,
3660,GO:0007146,1,0.984725543253726,0,1,meiotic recombination nodule assembly,BP,
3661,GO:0007147,1,0.983430059982292,0,1,female meiosis II,BP,
3666,GO:0007158,1,0.785085758693253,0,15,neuron cell-cell adhesion,BP,
3669,GO:0007161,1,0.935746148352933,0,4,calcium-independent cell-matrix adhesion,BP,
3678,GO:0007171,1,0.813173098327578,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3679,GO:0007172,1,0.885210064739265,0,8,signal complex assembly,BP,
3681,GO:0007174,1,0.985770719433395,0,1,epidermal growth factor catabolic process,BP,
3682,GO:0007175,1,0.841505724351113,0,11,negative regulation of epidermal growth factor-activated receptor activity,BP,
3686,GO:0007181,1,0.95782900207425,0,3,transforming growth factor beta receptor complex assembly,BP,
3688,GO:0007183,1,0.810664293799509,0,14,SMAD protein complex assembly,BP,
3690,GO:0007185,1,0.894527300210476,0,7,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3695,GO:0007190,1,0.568310287554818,0,38,activation of adenylate cyclase activity,BP,
3696,GO:0007191,1,0.862053817565111,0,10,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3698,GO:0007194,1,0.690855753150844,0,28,negative regulation of adenylate cyclase activity,BP,
3699,GO:0007195,1,0.88394473288053,0,11,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3700,GO:0007196,1,0.8611559325672,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3701,GO:0007197,1,0.928712815255303,0,5,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3702,GO:0007198,1,0.951723842382339,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3703,GO:0007199,1,0.968926001766089,0,2,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3708,GO:0007206,1,0.967087733487287,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3709,GO:0007207,1,0.915848188966402,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3710,GO:0007208,1,0.967319441607041,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3711,GO:0007210,1,0.743891628668888,0,26,serotonin receptor signaling pathway,BP,
3712,GO:0007212,1,0.544995346098876,0,45,dopamine receptor signaling pathway,BP,
3713,GO:0007213,1,0.812768612900091,0,15,G-protein coupled acetylcholine receptor signaling pathway,BP,
3714,GO:0007214,1,0.704560423573006,0,23,gamma-aminobutyric acid signaling pathway,BP,
3715,GO:0007215,1,0.305595266895383,0,76,glutamate receptor signaling pathway,BP,
3716,GO:0007216,1,0.799452735328069,0,14,G-protein coupled glutamate receptor signaling pathway,BP,
3717,GO:0007217,1,0.924320856457576,0,7,tachykinin receptor signaling pathway,BP,
3718,GO:0007218,1,0.325154961644327,0,98,neuropeptide signaling pathway,BP,
3724,GO:0007225,1,0.983406759351968,0,1,patched ligand maturation,BP,
3725,GO:0007227,1,0.940443216515482,0,4,signal transduction downstream of smoothened,BP,
3726,GO:0007228,1,0.956314408613777,0,3,positive regulation of hh target transcription factor activity,BP,
3728,GO:0007231,1,0.959858991729692,0,3,osmosensory signaling pathway,BP,
3730,GO:0007250,1,0.764723688883262,0,18,activation of NF-kappaB-inducing kinase activity,BP,
3732,GO:0007253,1,0.868636700456814,0,11,cytoplasmic sequestering of NF-kappaB,BP,
3734,GO:0007256,1,0.904569498048484,0,6,activation of JNKK activity,BP,
3736,GO:0007258,1,0.941650304172982,0,4,JUN phosphorylation,BP,
3739,GO:0007262,1,0.887260077575886,0,8,STAT protein import into nucleus,BP,
3748,GO:0007271,1,0.60779901866118,0,35,synaptic transmission, cholinergic,BP,
3750,GO:0007274,1,0.649765103038463,0,29,neuromuscular synaptic transmission,BP,
3755,GO:0007284,1,0.983406759352018,0,1,spermatogonial cell division,BP,
3757,GO:0007288,1,0.889023691721458,0,8,sperm axoneme assembly,BP,
3758,GO:0007289,1,0.810127042962013,0,17,spermatid nucleus differentiation,BP,
3759,GO:0007290,1,0.958961292036343,0,4,spermatid nucleus elongation,BP,
3760,GO:0007291,1,0.992616505470012,0,1,sperm individualization,BP,
3762,GO:0007296,1,0.939949408085329,0,4,vitellogenesis,BP,
3763,GO:0007308,1,0.968400394610989,0,2,oocyte construction,BP,
3764,GO:0007309,1,0.968400394610989,0,2,oocyte axis specification,BP,
3765,GO:0007314,1,0.968400394610989,0,2,oocyte anterior/posterior axis specification,BP,
3766,GO:0007315,1,0.968400394610989,0,2,pole plasm assembly,BP,
3767,GO:0007320,1,0.848042925215027,0,13,insemination,BP,
3768,GO:0007321,1,0.993346233364737,0,1,sperm displacement,BP,
3770,GO:0007339,1,0.631696223587444,0,34,binding of sperm to zona pellucida,BP,
3771,GO:0007340,1,0.659102944993545,0,35,acrosome reaction,BP,
3772,GO:0007341,1,0.932690312545041,0,6,penetration of zona pellucida,BP,
3774,GO:0007343,1,0.93317147368454,0,5,egg activation,BP,
3775,GO:0007344,1,0.987922462885514,0,1,pronuclear fusion,BP,
3777,GO:0007349,1,0.992616505470012,0,1,cellularization,BP,
3780,GO:0007352,1,0.962189833216054,0,3,zygotic specification of dorsal/ventral axis,BP,
3785,GO:0007371,1,0.983414835417473,0,1,ventral midline determination,BP,
3788,GO:0007387,1,0.984355832896009,0,1,anterior compartment pattern formation,BP,
3789,GO:0007388,1,0.984355832896009,0,1,posterior compartment specification,BP,
3793,GO:0007400,1,0.984968016038942,0,1,neuroblast fate determination,BP,
3794,GO:0007402,1,0.978234355062551,0,2,ganglion mother cell fate determination,BP,
3795,GO:0007403,1,0.983492190195988,0,1,glial cell fate determination,BP,
3797,GO:0007406,1,0.922612487496065,0,5,negative regulation of neuroblast proliferation,BP,
3800,GO:0007412,1,0.964950046206228,0,3,axon target recognition,BP,
3801,GO:0007413,1,0.713503587874597,0,21,axonal fasciculation,BP,
3804,GO:0007418,1,0.940503066517688,0,4,ventral midline development,BP,
3808,GO:0007424,1,0.984730915754465,0,1,open tracheal system development,BP,
3811,GO:0007439,1,0.968876099326227,0,2,ectodermal digestive tract development,BP,
3814,GO:0007468,1,0.958500304673003,0,3,regulation of rhodopsin gene expression,BP,
3816,GO:0007493,1,0.969077691904096,0,2,endodermal cell fate determination,BP,
3818,GO:0007495,1,0.983648935320606,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3819,GO:0007497,1,0.967087733488009,0,2,posterior midgut development,BP,
3821,GO:0007499,1,0.983406759351972,0,1,ectoderm and mesoderm interaction,BP,
3823,GO:0007501,1,0.817222189358452,0,14,mesodermal cell fate specification,BP,
3824,GO:0007506,1,0.924240020052121,0,7,gonadal mesoderm development,BP,
3826,GO:0007509,1,0.968487250749608,0,2,mesoderm migration involved in gastrulation,BP,
3827,GO:0007512,1,0.842878307034454,0,12,adult heart development,BP,
3829,GO:0007518,1,0.973114272063307,0,2,myoblast fate determination,BP,
3831,GO:0007520,1,0.598895676184774,0,38,myoblast fusion,BP,
3832,GO:0007521,1,0.967193355676294,0,2,muscle cell fate determination,BP,
3833,GO:0007522,1,0.983406759351676,0,1,visceral muscle development,BP,
3834,GO:0007525,1,0.968304428311226,0,2,somatic muscle development,BP,
3835,GO:0007528,1,0.52663830334813,0,41,neuromuscular junction development,BP,
3836,GO:0007529,1,0.983410275827822,0,1,establishment of synaptic specificity at neuromuscular junction,BP,
3838,GO:0007538,1,0.951356534876678,0,3,primary sex determination,BP,
3839,GO:0007542,1,0.967087973900934,0,2,primary sex determination, germ-line,BP,
3841,GO:0007549,1,0.874601038346287,0,9,dosage compensation,BP,
3847,GO:0007571,1,0.975847018750108,0,2,age-dependent general metabolic decline,BP,
3848,GO:0007576,1,0.984763417990627,0,1,nucleolar fragmentation,BP,
3856,GO:0007597,1,0.778045438443153,0,19,blood coagulation, intrinsic pathway,BP,
3857,GO:0007598,1,0.929192940532284,0,5,blood coagulation, extrinsic pathway,BP,
3870,GO:0007614,1,0.879400937937216,0,9,short-term memory,BP,
3871,GO:0007616,1,0.624473349183302,0,30,long-term memory,BP,
3872,GO:0007617,1,0.745068007466267,0,21,mating behavior,BP,
3873,GO:0007618,1,0.598025149965977,0,38,mating,BP,
3874,GO:0007619,1,0.956315844219099,0,3,courtship behavior,BP,
3875,GO:0007620,1,0.777578042925601,0,20,copulation,BP,
3876,GO:0007621,1,0.95123596405048,0,4,negative regulation of female receptivity,BP,
3879,GO:0007624,1,0.983406759352069,0,1,ultradian rhythm,BP,
3880,GO:0007625,1,0.799762135311089,0,18,grooming behavior,BP,
3884,GO:0007632,1,0.469357483543071,0,50,visual behavior,BP,
3885,GO:0007634,1,0.985067253555091,0,1,optokinetic behavior,BP,
3886,GO:0007635,1,0.779725561237093,0,17,chemosensory behavior,BP,
3893,GO:0008020,1,0.944787286769367,0,4,G-protein coupled photoreceptor activity,MF,
3896,GO:0008023,1,0.508606830514187,0,45,transcription elongation factor complex,CC,
3897,GO:0008024,1,0.881609099148083,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3898,GO:0008026,1,0.206096562190199,0,99,ATP-dependent helicase activity,MF,
3899,GO:0008028,1,0.576044018115624,0,37,monocarboxylic acid transmembrane transporter activity,MF,
3900,GO:0008033,1,0.233124335479646,0,108,tRNA processing,BP,
3901,GO:0008035,1,0.894285097390279,0,9,high-density lipoprotein particle binding,MF,
3903,GO:0008038,1,0.580403660455595,0,34,neuron recognition,BP,
3904,GO:0008039,1,0.989160875801517,0,1,synaptic target recognition,BP,
3905,GO:0008043,1,0.984409330669437,0,2,intracellular ferritin complex,CC,
3907,GO:0008046,1,0.892721079389322,0,7,axon guidance receptor activity,MF,
3909,GO:0008048,1,0.953352664496531,0,5,calcium sensitive guanylate cyclase activator activity,MF,
3910,GO:0008049,1,0.987132690419356,0,1,male courtship behavior,BP,
3911,GO:0008050,1,0.968783105569457,0,2,female courtship behavior,BP,
3912,GO:0008052,1,0.992512739064815,0,1,sensory organ boundary specification,BP,
3913,GO:0008053,1,0.768698060934582,0,19,mitochondrial fusion,BP,
3914,GO:0008057,1,0.983406759351281,0,1,eye pigment granule organization,BP,
3915,GO:0008061,1,0.893506718486844,0,8,chitin binding,MF,
3916,GO:0008063,1,0.908989111428483,0,6,Toll signaling pathway,BP,
3919,GO:0008066,1,0.637698544471276,0,27,glutamate receptor activity,MF,
3920,GO:0008068,1,0.9838765730806,0,1,extracellular-glutamate-gated chloride channel activity,MF,
3921,GO:0008073,1,0.972228208677445,0,3,ornithine decarboxylase inhibitor activity,MF,
3925,GO:0008079,1,0.912283551475792,0,6,translation termination factor activity,MF,
3926,GO:0008080,1,0.305366028084084,0,83,N-acetyltransferase activity,MF,
3929,GO:0008088,1,0.513922894537535,0,45,axo-dendritic transport,BP,
3930,GO:0008089,1,0.651346174508332,0,30,anterograde axonal transport,BP,
3931,GO:0008090,1,0.878970335801713,0,9,retrograde axonal transport,BP,
3934,GO:0008093,1,0.843841085063115,0,11,cytoskeletal adaptor activity,MF,
3935,GO:0008094,1,0.320946967582506,0,74,DNA-dependent ATPase activity,MF,
3936,GO:0008097,1,0.947309442258654,0,6,5S rRNA binding,MF,
3939,GO:0008106,1,0.826779396362147,0,16,alcohol dehydrogenase (NADP+) activity,MF,
3940,GO:0008107,1,0.967418487781962,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3941,GO:0008108,1,0.990251360910938,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3942,GO:0008109,1,0.953456006441277,0,3,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3943,GO:0008111,1,0.986828468817881,0,1,alpha-methylacyl-CoA racemase activity,MF,
3944,GO:0008112,1,0.98884221466863,0,1,nicotinamide N-methyltransferase activity,MF,
3945,GO:0008113,1,0.979748860006426,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3946,GO:0008115,1,0.98514784566868,0,1,sarcosine oxidase activity,MF,
3947,GO:0008116,1,0.983406759351773,0,1,prostaglandin-I synthase activity,MF,
3948,GO:0008117,1,0.983406759351724,0,1,sphinganine-1-phosphate aldolase activity,MF,
3949,GO:0008118,1,0.985802297981742,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3950,GO:0008119,1,0.983595867326286,0,1,thiopurine S-methyltransferase activity,MF,
3951,GO:0008120,1,0.988526536177453,0,1,ceramide glucosyltransferase activity,MF,
3952,GO:0008121,1,0.928942723257778,0,8,ubiquinol-cytochrome-c reductase activity,MF,
3953,GO:0008123,1,0.984039755963948,0,1,cholesterol 7-alpha-monooxygenase activity,MF,
3954,GO:0008124,1,0.977820507642304,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3955,GO:0008126,1,0.984095018807551,0,1,acetylesterase activity,MF,
3956,GO:0008127,1,0.990495294871004,0,1,quercetin 2,3-dioxygenase activity,MF,
3957,GO:0008131,1,0.922405904737245,0,5,primary amine oxidase activity,MF,
3959,GO:0008135,1,0.325816384999685,0,80,translation factor activity, RNA binding,MF,
3960,GO:0008137,1,0.758696640551463,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3962,GO:0008139,1,0.669124384965891,0,26,nuclear localization sequence binding,MF,
3963,GO:0008140,1,0.892589064637096,0,8,cAMP response element binding protein binding,MF,
3964,GO:0008142,1,0.924158808401959,0,5,oxysterol binding,MF,
3965,GO:0008143,1,0.827762214005336,0,12,poly(A) binding,MF,
3967,GO:0008146,1,0.481178739727688,0,52,sulfotransferase activity,MF,
3968,GO:0008147,1,0.9907796571119,0,2,structural constituent of bone,MF,
3972,GO:0008156,1,0.605367684130692,0,34,negative regulation of DNA replication,BP,
3973,GO:0008157,1,0.758156613637945,0,18,protein phosphatase 1 binding,MF,
3974,GO:0008158,1,0.960283461875091,0,3,hedgehog receptor activity,MF,
3975,GO:0008160,1,0.98458029535975,0,1,protein tyrosine phosphatase activator activity,MF,
3977,GO:0008169,1,0.95903335509696,0,3,C-methyltransferase activity,MF,
3979,GO:0008171,1,0.81526967094395,0,15,O-methyltransferase activity,MF,
3980,GO:0008172,1,0.908120579904768,0,7,S-methyltransferase activity,MF,
3981,GO:0008173,1,0.518847500020848,0,45,RNA methyltransferase activity,MF,
3982,GO:0008174,1,0.957165896170909,0,3,mRNA methyltransferase activity,MF,
3983,GO:0008175,1,0.690709288585713,0,25,tRNA methyltransferase activity,MF,
3984,GO:0008176,1,0.978670653350822,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3985,GO:0008177,1,0.967140070475663,0,3,succinate dehydrogenase (ubiquinone) activity,MF,
3986,GO:0008179,1,0.833705513185907,0,12,adenylate cyclase binding,MF,
3988,GO:0008184,1,0.951821032271625,0,3,glycogen phosphorylase activity,MF,
3989,GO:0008186,1,0.338550985843899,0,68,RNA-dependent ATPase activity,MF,
3990,GO:0008187,1,0.729394100365043,0,21,poly-pyrimidine tract binding,MF,
3991,GO:0008188,1,0.571583551864698,0,44,neuropeptide receptor activity,MF,
3992,GO:0008190,1,0.885435363928074,0,9,eukaryotic initiation factor 4E binding,MF,
3993,GO:0008191,1,0.819896595034284,0,15,metalloendopeptidase inhibitor activity,MF,
3994,GO:0008192,1,0.957858062221458,0,3,RNA guanylyltransferase activity,MF,
3995,GO:0008193,1,0.974021992601829,0,2,tRNA guanylyltransferase activity,MF,
3997,GO:0008195,1,0.951038409344209,0,3,phosphatidate phosphatase activity,MF,
4004,GO:0008204,1,0.975509687259949,0,2,ergosterol metabolic process,BP,
4005,GO:0008206,1,0.52068013247564,0,45,bile acid metabolic process,BP,
4008,GO:0008210,1,0.735261389757509,0,23,estrogen metabolic process,BP,
4012,GO:0008214,1,0.631592874085598,0,28,protein dealkylation,BP,
4013,GO:0008215,1,0.91970933185858,0,7,spermine metabolic process,BP,
4014,GO:0008216,1,0.91341386095354,0,8,spermidine metabolic process,BP,
4016,GO:0008218,1,0.955560031071397,0,3,bioluminescence,BP,
4019,GO:0008228,1,0.8506595315519,0,12,opsonization,BP,
4021,GO:0008234,1,0.0698564098967916,0,179,cysteine-type peptidase activity,MF,
4022,GO:0008235,1,0.439438547215347,0,55,metalloexopeptidase activity,MF,
4024,GO:0008237,1,0.061523685264693,0,183,metallopeptidase activity,MF,
4026,GO:0008239,1,0.878838814890612,0,9,dipeptidyl-peptidase activity,MF,
4027,GO:0008240,1,0.951193319819917,0,3,tripeptidyl-peptidase activity,MF,
4028,GO:0008241,1,0.972531620519102,0,2,peptidyl-dipeptidase activity,MF,
4029,GO:0008242,1,0.853318702023901,0,12,omega peptidase activity,MF,
4030,GO:0008250,1,0.869520529072433,0,12,oligosaccharyltransferase complex,CC,
4031,GO:0008251,1,0.967975426694723,0,2,tRNA-specific adenosine deaminase activity,MF,
4032,GO:0008252,1,0.831065348242381,0,13,nucleotidase activity,MF,
4033,GO:0008253,1,0.857975092232243,0,11,5'-nucleotidase activity,MF,
4034,GO:0008254,1,0.98340675935133,0,1,3'-nucleotidase activity,MF,
4035,GO:0008260,1,0.971203623969209,0,2,3-oxoacid CoA-transferase activity,MF,
4036,GO:0008263,1,0.968813854909755,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
4037,GO:0008265,1,0.984303005945753,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
4038,GO:0008266,1,0.766147681349334,0,18,poly(U) RNA binding,MF,
4039,GO:0008267,1,0.983406759351133,0,1,poly-glutamine tract binding,MF,
4040,GO:0008269,1,0.973238186303644,0,2,JAK pathway signal transduction adaptor activity,MF,
4042,GO:0008271,1,0.809598345832436,0,13,secondary active sulfate transmembrane transporter activity,MF,
4043,GO:0008272,1,0.786074908559514,0,15,sulfate transport,BP,
4044,GO:0008273,1,0.926835465690679,0,5,calcium, potassium:sodium antiporter activity,MF,
4045,GO:0008274,1,0.893366985580217,0,7,gamma-tubulin ring complex,CC,
4046,GO:0008275,1,0.951251512741983,0,3,gamma-tubulin small complex,CC,
4047,GO:0008276,1,0.368393545068889,0,67,protein methyltransferase activity,MF,
4049,GO:0008278,1,0.870283269869158,0,9,cohesin complex,CC,
4050,GO:0008281,1,0.967087733487914,0,2,sulfonylurea receptor activity,MF,
4051,GO:0008282,1,0.937356354436359,0,4,ATP-sensitive potassium channel complex,CC,
4056,GO:0008287,1,0.501319804218167,0,45,protein serine/threonine phosphatase complex,CC,
4058,GO:0008290,1,0.894633814268146,0,8,F-actin capping protein complex,CC,
4059,GO:0008291,1,0.9379097171519,0,4,acetylcholine metabolic process,BP,
4060,GO:0008292,1,0.968167046838403,0,2,acetylcholine biosynthetic process,BP,
4061,GO:0008294,1,0.967087733486221,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4062,GO:0008295,1,0.949286948636443,0,4,spermidine biosynthetic process,BP,
4063,GO:0008296,1,0.876032010831386,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4064,GO:0008297,1,0.902410484979277,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4065,GO:0008298,1,0.842521938527495,0,12,intracellular mRNA localization,BP,
4067,GO:0008300,1,0.904707020096434,0,8,isoprenoid catabolic process,BP,
4068,GO:0008301,1,0.759394053125157,0,19,DNA binding, bending,MF,
4070,GO:0008306,1,0.339370392655933,0,72,associative learning,BP,
4072,GO:0008308,1,0.775076796576075,0,18,voltage-gated anion channel activity,MF,
4073,GO:0008309,1,0.946605862598793,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4074,GO:0008310,1,0.931664296213698,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4075,GO:0008311,1,0.97628649879829,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4076,GO:0008312,1,0.91679678746156,0,7,7S RNA binding,MF,
4077,GO:0008318,1,0.90376722721618,0,7,protein prenyltransferase activity,MF,
4078,GO:0008320,1,0.838190035017997,0,17,protein transmembrane transporter activity,MF,
4079,GO:0008321,1,0.952298446703982,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4081,GO:0008327,1,0.766105791578102,0,21,methyl-CpG binding,MF,
4082,GO:0008328,1,0.504362720237124,0,45,ionotropic glutamate receptor complex,CC,
4083,GO:0008329,1,0.799529095416042,0,17,signaling pattern recognition receptor activity,MF,
4084,GO:0008330,1,0.959403675984298,0,3,protein tyrosine/threonine phosphatase activity,MF,
4085,GO:0008331,1,0.823156359626979,0,12,high voltage-gated calcium channel activity,MF,
4086,GO:0008332,1,0.951038409341873,0,3,low voltage-gated calcium channel activity,MF,
4088,GO:0008334,1,0.73326754133004,0,24,histone mRNA metabolic process,BP,
4089,GO:0008336,1,0.987217261229828,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4090,GO:0008340,1,0.831306115938554,0,12,determination of adult lifespan,BP,
4091,GO:0008343,1,0.909968015316172,0,10,adult feeding behavior,BP,
4093,GO:0008347,1,0.529414891762643,0,44,glial cell migration,BP,
4094,GO:0008348,1,0.983423841912682,0,1,negative regulation of antimicrobial humoral response,BP,
4095,GO:0008349,1,0.93651486772582,0,4,MAP kinase kinase kinase kinase activity,MF,
4096,GO:0008352,1,0.98447086204243,0,1,katanin complex,CC,
4097,GO:0008353,1,0.804114016624594,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4098,GO:0008354,1,0.895388129260703,0,7,germ cell migration,BP,
4099,GO:0008355,1,0.967087733488112,0,2,olfactory learning,BP,
4100,GO:0008356,1,0.781472194090272,0,17,asymmetric cell division,BP,
4101,GO:0008358,1,0.968400394610989,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4105,GO:0008373,1,0.733883159561916,0,21,sialyltransferase activity,MF,
4108,GO:0008376,1,0.582234481852447,0,34,acetylgalactosaminyltransferase activity,MF,
4110,GO:0008379,1,0.961302405239491,0,5,thioredoxin peroxidase activity,MF,
4112,GO:0008381,1,0.881423416557325,0,8,mechanically-gated ion channel activity,MF,
4113,GO:0008384,1,0.951243732571546,0,3,IkappaB kinase activity,MF,
4114,GO:0008385,1,0.861981803483414,0,11,IkappaB kinase complex,CC,
4115,GO:0008386,1,0.986841913380399,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4116,GO:0008387,1,0.985603653174881,0,1,steroid 7-alpha-hydroxylase activity,MF,
4117,GO:0008389,1,0.975874042881961,0,2,coumarin 7-hydroxylase activity,MF,
4118,GO:0008391,1,0.805658572020047,0,16,arachidonic acid monooxygenase activity,MF,
4119,GO:0008392,1,0.805658572020047,0,16,arachidonic acid epoxygenase activity,MF,
4120,GO:0008395,1,0.75325219491499,0,20,steroid hydroxylase activity,MF,
4121,GO:0008396,1,0.971023808655131,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4122,GO:0008397,1,0.983406860491098,0,1,sterol 12-alpha-hydroxylase activity,MF,
4123,GO:0008398,1,0.983759861238514,0,1,sterol 14-demethylase activity,MF,
4124,GO:0008401,1,0.944006619863664,0,4,retinoic acid 4-hydroxylase activity,MF,
4125,GO:0008403,1,0.983659251457671,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4126,GO:0008404,1,0.987360308246559,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4127,GO:0008405,1,0.987360308246559,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4129,GO:0008408,1,0.498960750820822,0,48,3'-5' exonuclease activity,MF,
4130,GO:0008409,1,0.827568332707505,0,12,5'-3' exonuclease activity,MF,
4131,GO:0008410,1,0.95909173568726,0,3,CoA-transferase activity,MF,
4132,GO:0008413,1,0.981216229000929,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4133,GO:0008417,1,0.814327455212621,0,13,fucosyltransferase activity,MF,
4134,GO:0008418,1,0.991697132543431,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4135,GO:0008419,1,0.984492227410872,0,1,RNA lariat debranching enzyme activity,MF,
4136,GO:0008420,1,0.919024821347402,0,6,CTD phosphatase activity,MF,
4137,GO:0008422,1,0.926869280139058,0,5,beta-glucosidase activity,MF,
4138,GO:0008424,1,0.983567422310223,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4139,GO:0008425,1,0.990704363325434,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4140,GO:0008426,1,0.967380204511568,0,3,protein kinase C inhibitor activity,MF,
4141,GO:0008427,1,0.968448484676017,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4142,GO:0008428,1,0.955036019070301,0,3,ribonuclease inhibitor activity,MF,
4144,GO:0008430,1,0.932859523038561,0,5,selenium binding,MF,
4145,GO:0008431,1,0.95568300604008,0,3,vitamin E binding,MF,
4146,GO:0008432,1,0.905678343879495,0,7,JUN kinase binding,MF,
4148,GO:0008437,1,0.986693289315737,0,1,thyrotropin-releasing hormone activity,MF,
4149,GO:0008440,1,0.868331388269001,0,10,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4150,GO:0008441,1,0.968655346497457,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4151,GO:0008442,1,0.986808351690338,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4153,GO:0008444,1,0.985917419369727,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4154,GO:0008445,1,0.988603244367643,0,1,D-aspartate oxidase activity,MF,
4155,GO:0008446,1,0.988289025981634,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4156,GO:0008448,1,0.987479066778075,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4157,GO:0008449,1,0.951038409344444,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4158,GO:0008453,1,0.974557144417809,0,2,alanine-glyoxylate transaminase activity,MF,
4159,GO:0008454,1,0.955492438478563,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4160,GO:0008455,1,0.984367960048915,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4161,GO:0008456,1,0.983416086204809,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4162,GO:0008457,1,0.983406759352069,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4163,GO:0008458,1,0.983594371083701,0,1,carnitine O-octanoyltransferase activity,MF,
4164,GO:0008459,1,0.969151432319654,0,2,chondroitin 6-sulfotransferase activity,MF,
4165,GO:0008460,1,0.987132690419356,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4166,GO:0008465,1,0.990877190928817,0,1,glycerate dehydrogenase activity,MF,
4167,GO:0008466,1,0.971350038668485,0,2,glycogenin glucosyltransferase activity,MF,
4168,GO:0008467,1,0.908991308942215,0,7,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4169,GO:0008469,1,0.903870810183364,0,7,histone-arginine N-methyltransferase activity,MF,
4170,GO:0008470,1,0.983406759351972,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4171,GO:0008474,1,0.935394757852282,0,5,palmitoyl-(protein) hydrolase activity,MF,
4172,GO:0008475,1,0.95189184599814,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4173,GO:0008476,1,0.97361831394926,0,2,protein-tyrosine sulfotransferase activity,MF,
4174,GO:0008478,1,0.983406759351331,0,1,pyridoxal kinase activity,MF,
4175,GO:0008479,1,0.941712333273235,0,6,queuine tRNA-ribosyltransferase activity,MF,
4176,GO:0008480,1,0.983553385989877,0,1,sarcosine dehydrogenase activity,MF,
4177,GO:0008481,1,0.97144109814238,0,2,sphinganine kinase activity,MF,
4178,GO:0008482,1,0.985412426360754,0,1,sulfite oxidase activity,MF,
4179,GO:0008483,1,0.783806413037652,0,17,transaminase activity,MF,
4180,GO:0008484,1,0.766268893723887,0,17,sulfuric ester hydrolase activity,MF,
4181,GO:0008486,1,0.946675313860854,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4182,GO:0008488,1,0.983661532194309,0,1,gamma-glutamyl carboxylase activity,MF,
4183,GO:0008489,1,0.983994698202427,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4184,GO:0008493,1,0.987343484720486,0,1,tetracycline transporter activity,MF,
4185,GO:0008494,1,0.899958986999959,0,7,translation activator activity,MF,
4186,GO:0008495,1,0.983852234548494,0,1,protoheme IX farnesyltransferase activity,MF,
4187,GO:0008496,1,0.98340675935207,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4189,GO:0008502,1,0.967161635883838,0,3,melatonin receptor activity,MF,
4190,GO:0008503,1,0.917571885576219,0,6,benzodiazepine receptor activity,MF,
4191,GO:0008504,1,0.869441906857473,0,9,monoamine transmembrane transporter activity,MF,
4193,GO:0008507,1,0.983439456094266,0,1,sodium:iodide symporter activity,MF,
4194,GO:0008508,1,0.927347318696477,0,6,bile acid:sodium symporter activity,MF,
4196,GO:0008510,1,0.935408459167597,0,4,sodium:bicarbonate symporter activity,MF,
4197,GO:0008511,1,0.96708773348748,0,2,sodium:potassium:chloride symporter activity,MF,
4198,GO:0008513,1,0.958734096892829,0,3,secondary active organic cation transmembrane transporter activity,MF,
4199,GO:0008514,1,0.0585963511780434,0,186,organic anion transmembrane transporter activity,MF,
4201,GO:0008517,1,0.921224819173751,0,6,folic acid transporter activity,MF,
4202,GO:0008518,1,0.984102144869068,0,1,reduced folate carrier activity,MF,
4203,GO:0008519,1,0.673835433015724,0,27,ammonium transmembrane transporter activity,MF,
4204,GO:0008520,1,0.968977804748556,0,2,L-ascorbate:sodium symporter activity,MF,
4205,GO:0008521,1,0.98447322307645,0,1,acetyl-CoA transporter activity,MF,
4206,GO:0008523,1,0.967236339114127,0,2,sodium-dependent multivitamin transmembrane transporter activity,MF,
4207,GO:0008525,1,0.906923570200425,0,6,phosphatidylcholine transporter activity,MF,
4208,GO:0008526,1,0.894450169036785,0,7,phosphatidylinositol transporter activity,MF,
4209,GO:0008527,1,0.783537911263069,0,25,taste receptor activity,MF,
4211,GO:0008531,1,0.984367960048915,0,1,riboflavin kinase activity,MF,
4213,GO:0008534,1,0.979211699242738,0,2,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4214,GO:0008535,1,0.767865208820911,0,20,respiratory chain complex IV assembly,BP,
4215,GO:0008536,1,0.611195063399439,0,32,Ran GTPase binding,MF,
4216,GO:0008537,1,0.969442410423555,0,3,proteasome activator complex,CC,
4217,GO:0008540,1,0.889813120931644,0,10,proteasome regulatory particle, base subcomplex,CC,
4218,GO:0008541,1,0.92024463125528,0,7,proteasome regulatory particle, lid subcomplex,CC,
4219,GO:0008542,1,0.503230935028998,0,45,visual learning,BP,
4222,GO:0008545,1,0.983414297989996,0,1,JUN kinase kinase activity,MF,
4223,GO:0008553,1,0.918977706357774,0,7,hydrogen-exporting ATPase activity, phosphorylative mechanism,MF,
4224,GO:0008554,1,0.983406759351968,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4225,GO:0008555,1,0.983406759351821,0,1,chloride-transporting ATPase activity,MF,
4226,GO:0008556,1,0.855787878421204,0,11,potassium-transporting ATPase activity,MF,
4227,GO:0008559,1,0.889619687736633,0,7,xenobiotic-transporting ATPase activity,MF,
4228,GO:0008565,1,0.262801019485693,0,95,protein transporter activity,MF,
4229,GO:0008568,1,0.881388684793662,0,8,microtubule-severing ATPase activity,MF,
4230,GO:0008569,1,0.941501215786648,0,4,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4231,GO:0008574,1,0.765085620365428,0,16,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4232,GO:0008579,1,0.98340675935187,0,1,JUN kinase phosphatase activity,MF,
4233,GO:0008582,1,0.922457378620515,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4236,GO:0008588,1,0.947042179107029,0,4,release of cytoplasmic sequestered NF-kappaB,BP,
4238,GO:0008592,1,0.983604239074011,0,1,regulation of Toll signaling pathway,BP,
4240,GO:0008594,1,0.983406759352069,0,1,photoreceptor cell morphogenesis,BP,
4242,GO:0008597,1,0.957526359290358,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4244,GO:0008607,1,0.940920077856669,0,4,phosphorylase kinase regulator activity,MF,
4245,GO:0008608,1,0.677922844414388,0,26,attachment of spindle microtubules to kinetochore,BP,
4246,GO:0008609,1,0.983406759351231,0,1,alkylglycerone-phosphate synthase activity,MF,
4248,GO:0008611,1,0.941869820187888,0,4,ether lipid biosynthetic process,BP,
4249,GO:0008612,1,0.953100365808395,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4250,GO:0008613,1,0.994647465757837,0,1,diuretic hormone activity,MF,
4251,GO:0008614,1,0.969909131996071,0,2,pyridoxine metabolic process,BP,
4252,GO:0008615,1,0.969909131996071,0,2,pyridoxine biosynthetic process,BP,
4253,GO:0008616,1,0.941712333273235,0,6,queuosine biosynthetic process,BP,
4254,GO:0008617,1,0.992395609449106,0,1,guanosine metabolic process,BP,
4255,GO:0008622,1,0.93827578242107,0,5,epsilon DNA polymerase complex,CC,
4256,GO:0008623,1,0.968763205455043,0,2,CHRAC,CC,
4258,GO:0008626,1,0.949038150456924,0,4,granzyme-mediated apoptotic signaling pathway,BP,
4259,GO:0008627,1,0.904512188845864,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4260,GO:0008628,1,0.966217906047339,0,4,hormone-mediated apoptotic signaling pathway,BP,
4263,GO:0008635,1,0.880979747898425,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4265,GO:0008641,1,0.856158360122019,0,10,small protein activating enzyme activity,MF,
4268,GO:0008649,1,0.83880081935687,0,13,rRNA methyltransferase activity,MF,
4269,GO:0008652,1,0.3368662911774,0,75,cellular amino acid biosynthetic process,BP,
4270,GO:0008653,1,0.983406887266048,0,1,lipopolysaccharide metabolic process,BP,
4272,GO:0008655,1,0.868404468816989,0,11,pyrimidine-containing compound salvage,BP,
4273,GO:0008656,1,0.814086595603669,0,15,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4274,GO:0008665,1,0.992426565083806,0,1,2'-phosphotransferase activity,MF,
4275,GO:0008670,1,0.979657477309854,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4276,GO:0008689,1,0.990704363325434,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4277,GO:0008700,1,0.984725543253726,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4278,GO:0008705,1,0.983406759350544,0,1,methionine synthase activity,MF,
4279,GO:0008709,1,0.992814717333676,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4280,GO:0008721,1,0.984950340754611,0,1,D-serine ammonia-lyase activity,MF,
4281,GO:0008725,1,0.991885055232925,0,1,DNA-3-methyladenine glycosylase activity,MF,
4282,GO:0008732,1,0.970966727516621,0,2,L-allo-threonine aldolase activity,MF,
4283,GO:0008745,1,0.959473861307335,0,4,N-acetylmuramoyl-L-alanine amidase activity,MF,
4284,GO:0008746,1,0.975445802810265,0,2,NAD(P)+ transhydrogenase activity,MF,
4285,GO:0008747,1,0.988938071724141,0,1,N-acetylneuraminate lyase activity,MF,
4286,GO:0008750,1,0.983406759351972,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4287,GO:0008753,1,0.983480813168941,0,1,NADPH dehydrogenase (quinone) activity,MF,
4289,GO:0008761,1,0.983406759351821,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4290,GO:0008768,1,0.993424421568501,0,1,UDP-sugar diphosphatase activity,MF,
4291,GO:0008775,1,0.987530494773408,0,1,acetate CoA-transferase activity,MF,
4292,GO:0008781,1,0.978923412655991,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4293,GO:0008783,1,0.985902160426923,0,1,agmatinase activity,MF,
4294,GO:0008785,1,0.988904151473304,0,1,alkyl hydroperoxide reductase activity,MF,
4295,GO:0008794,1,0.993098701691907,0,1,arsenate reductase (glutaredoxin) activity,MF,
4296,GO:0008796,1,0.976926140728303,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4297,GO:0008798,1,0.968908422971999,0,2,beta-aspartyl-peptidase activity,MF,
4298,GO:0008802,1,0.983444592055299,0,1,betaine-aldehyde dehydrogenase activity,MF,
4299,GO:0008803,1,0.992554199085501,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4300,GO:0008808,1,0.983410518075759,0,1,cardiolipin synthase activity,MF,
4301,GO:0008811,1,0.993631429938524,0,1,chloramphenicol O-acetyltransferase activity,MF,
4302,GO:0008812,1,0.983427383816485,0,1,choline dehydrogenase activity,MF,
4303,GO:0008817,1,0.983406759352069,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4304,GO:0008821,1,0.882491228343782,0,9,crossover junction endodeoxyribonuclease activity,MF,
4305,GO:0008823,1,0.951038556798296,0,3,cupric reductase activity,MF,
4306,GO:0008829,1,0.98755017012104,0,1,dCTP deaminase activity,MF,
4307,GO:0008832,1,0.98363590712598,0,1,dGTPase activity,MF,
4308,GO:0008843,1,0.985484340456906,0,1,endochitinase activity,MF,
4309,GO:0008852,1,0.984112925989126,0,1,exodeoxyribonuclease I activity,MF,
4310,GO:0008853,1,0.949768898261582,0,4,exodeoxyribonuclease III activity,MF,
4311,GO:0008859,1,0.992783329919151,0,1,exoribonuclease II activity,MF,
4312,GO:0008865,1,0.935597904174762,0,4,fructokinase activity,MF,
4313,GO:0008887,1,0.983605012166373,0,1,glycerate kinase activity,MF,
4314,GO:0008889,1,0.908598483575419,0,6,glycerophosphodiester phosphodiesterase activity,MF,
4315,GO:0008890,1,0.988797374227199,0,1,glycine C-acetyltransferase activity,MF,
4316,GO:0008891,1,0.987912194602553,0,1,glycolate oxidase activity,MF,
4317,GO:0008892,1,0.983406759351824,0,1,guanine deaminase activity,MF,
4318,GO:0008893,1,0.992183337888335,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4319,GO:0008894,1,0.984300891223285,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4320,GO:0008897,1,0.984061834709197,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4321,GO:0008898,1,0.983406759350544,0,1,S-adenosylmethionine-homocysteine S-methyltransferase activity,MF,
4322,GO:0008900,1,0.956861296934554,0,3,hydrogen:potassium-exchanging ATPase activity,MF,
4323,GO:0008903,1,0.991730580032462,0,1,hydroxypyruvate isomerase activity,MF,
4324,GO:0008905,1,0.988680494091708,0,1,mannose-phosphate guanylyltransferase activity,MF,
4325,GO:0008934,1,0.94118100943791,0,4,inositol monophosphate 1-phosphatase activity,MF,
4326,GO:0008940,1,0.953591218330664,0,3,nitrate reductase activity,MF,
4327,GO:0008941,1,0.972002401272172,0,2,nitric oxide dioxygenase activity,MF,
4328,GO:0008948,1,0.942204274960437,0,4,oxaloacetate decarboxylase activity,MF,
4329,GO:0008955,1,0.98340681868598,0,1,peptidoglycan glycosyltransferase activity,MF,
4330,GO:0008962,1,0.984655561072892,0,1,phosphatidylglycerophosphatase activity,MF,
4331,GO:0008963,1,0.986108273388071,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4332,GO:0008967,1,0.970538559586227,0,2,phosphoglycolate phosphatase activity,MF,
4333,GO:0008969,1,0.964005327949665,0,3,phosphohistidine phosphatase activity,MF,
4334,GO:0008970,1,0.86253858013236,0,10,phosphatidylcholine 1-acylhydrolase activity,MF,
4335,GO:0008973,1,0.983598126576069,0,1,phosphopentomutase activity,MF,
4336,GO:0008988,1,0.969683443564638,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4337,GO:0008995,1,0.984643899909647,0,1,ribonuclease E activity,MF,
4338,GO:0009000,1,0.984991759365261,0,1,selenocysteine lyase activity,MF,
4339,GO:0009007,1,0.983422376003528,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4340,GO:0009008,1,0.926578877835423,0,5,DNA-methyltransferase activity,MF,
4341,GO:0009013,1,0.983406759351872,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4342,GO:0009019,1,0.939022784748772,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4343,GO:0009020,1,0.986898217540882,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4344,GO:0009032,1,0.988374762250607,0,1,thymidine phosphorylase activity,MF,
4345,GO:0009041,1,0.960009520045869,0,3,uridylate kinase activity,MF,
4346,GO:0009048,1,0.898685700492974,0,7,dosage compensation by inactivation of X chromosome,BP,
4347,GO:0009051,1,0.965009941322965,0,3,pentose-phosphate shunt, oxidative branch,BP,
4348,GO:0009052,1,0.935225341418848,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4355,GO:0009061,1,0.985204877732082,0,1,anaerobic respiration,BP,
4358,GO:0009064,1,0.363020247935107,0,70,glutamine family amino acid metabolic process,BP,
4359,GO:0009065,1,0.693752340016237,0,25,glutamine family amino acid catabolic process,BP,
4360,GO:0009066,1,0.476712989692225,0,52,aspartate family amino acid metabolic process,BP,
4361,GO:0009067,1,0.735250521915725,0,21,aspartate family amino acid biosynthetic process,BP,
4362,GO:0009068,1,0.78279152301898,0,17,aspartate family amino acid catabolic process,BP,
4364,GO:0009070,1,0.795172086437149,0,16,serine family amino acid biosynthetic process,BP,
4366,GO:0009072,1,0.683863077730179,0,29,aromatic amino acid family metabolic process,BP,
4367,GO:0009074,1,0.766633287833419,0,21,aromatic amino acid family catabolic process,BP,
4368,GO:0009078,1,0.935436007811469,0,5,pyruvate family amino acid metabolic process,BP,
4369,GO:0009080,1,0.935436007811469,0,5,pyruvate family amino acid catabolic process,BP,
4370,GO:0009081,1,0.715961985792758,0,23,branched-chain amino acid metabolic process,BP,
4371,GO:0009082,1,0.972190230503299,0,2,branched-chain amino acid biosynthetic process,BP,
4372,GO:0009083,1,0.752865798893664,0,20,branched-chain amino acid catabolic process,BP,
4373,GO:0009084,1,0.777379749957377,0,17,glutamine family amino acid biosynthetic process,BP,
4374,GO:0009085,1,0.984061834709197,0,1,lysine biosynthetic process,BP,
4375,GO:0009086,1,0.84099951721752,0,12,methionine biosynthetic process,BP,
4376,GO:0009087,1,0.983500858265144,0,1,methionine catabolic process,BP,
4377,GO:0009092,1,0.946539930032596,0,4,homoserine metabolic process,BP,
4378,GO:0009093,1,0.962422288376796,0,3,cysteine catabolic process,BP,
4379,GO:0009098,1,0.972190230503299,0,2,leucine biosynthetic process,BP,
4380,GO:0009099,1,0.972190230503299,0,2,valine biosynthetic process,BP,
4383,GO:0009103,1,0.983406887266048,0,1,lipopolysaccharide biosynthetic process,BP,
4384,GO:0009106,1,0.964907348450242,0,3,lipoate metabolic process,BP,
4385,GO:0009107,1,0.981157580575079,0,2,lipoate biosynthetic process,BP,
4387,GO:0009109,1,0.858397709361488,0,12,coenzyme catabolic process,BP,
4389,GO:0009111,1,0.862942980498919,0,11,vitamin catabolic process,BP,
4390,GO:0009112,1,0.587382894906463,0,37,nucleobase metabolic process,BP,
4391,GO:0009113,1,0.856734900636575,0,11,purine nucleobase biosynthetic process,BP,
4392,GO:0009115,1,0.967087733487721,0,2,xanthine catabolic process,BP,
4396,GO:0009120,1,0.927564218765207,0,6,deoxyribonucleoside metabolic process,BP,
4398,GO:0009124,1,0.345433152342069,0,85,nucleoside monophosphate biosynthetic process,BP,
4399,GO:0009125,1,0.865426980439377,0,11,nucleoside monophosphate catabolic process,BP,
4401,GO:0009127,1,0.452504973030039,0,65,purine nucleoside monophosphate biosynthetic process,BP,
4402,GO:0009128,1,0.888830229009915,0,9,purine nucleoside monophosphate catabolic process,BP,
4403,GO:0009129,1,0.826015991405579,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4404,GO:0009130,1,0.835390869804234,0,13,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4405,GO:0009131,1,0.988786191140326,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4407,GO:0009133,1,0.925366735927723,0,6,nucleoside diphosphate biosynthetic process,BP,
4408,GO:0009134,1,0.910836553446274,0,7,nucleoside diphosphate catabolic process,BP,
4410,GO:0009136,1,0.962025569564241,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4411,GO:0009137,1,0.949055262849585,0,4,purine nucleoside diphosphate catabolic process,BP,
4412,GO:0009138,1,0.959889128006262,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4413,GO:0009139,1,0.975549463919345,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4414,GO:0009140,1,0.98394879876846,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4416,GO:0009142,1,0.439201581669169,0,70,nucleoside triphosphate biosynthetic process,BP,
4417,GO:0009143,1,0.866593483658632,0,11,nucleoside triphosphate catabolic process,BP,
4419,GO:0009145,1,0.549813722353562,0,54,purine nucleoside triphosphate biosynthetic process,BP,
4420,GO:0009146,1,0.931041165136021,0,6,purine nucleoside triphosphate catabolic process,BP,
4421,GO:0009147,1,0.774884014353746,0,22,pyrimidine nucleoside triphosphate metabolic process,BP,
4422,GO:0009148,1,0.803910351105654,0,19,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4423,GO:0009149,1,0.991683767070938,0,1,pyrimidine nucleoside triphosphate catabolic process,BP,
4425,GO:0009151,1,0.88731660570109,0,10,purine deoxyribonucleotide metabolic process,BP,
4427,GO:0009153,1,0.962899560172205,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4429,GO:0009155,1,0.92858014382761,0,6,purine deoxyribonucleotide catabolic process,BP,
4430,GO:0009156,1,0.383636965805883,0,77,ribonucleoside monophosphate biosynthetic process,BP,
4431,GO:0009157,1,0.913577791816678,0,7,deoxyribonucleoside monophosphate biosynthetic process,BP,
4432,GO:0009158,1,0.89623897317961,0,8,ribonucleoside monophosphate catabolic process,BP,
4433,GO:0009159,1,0.973682317338116,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4435,GO:0009162,1,0.882886873636642,0,10,deoxyribonucleoside monophosphate metabolic process,BP,
4436,GO:0009163,1,0.562801699621808,0,47,nucleoside biosynthetic process,BP,
4437,GO:0009164,1,0.718961094963078,0,27,nucleoside catabolic process,BP,
4441,GO:0009168,1,0.452504973030039,0,65,purine ribonucleoside monophosphate biosynthetic process,BP,
4442,GO:0009169,1,0.89623897317961,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4443,GO:0009170,1,0.992540372159341,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4444,GO:0009173,1,0.868771643087135,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4445,GO:0009174,1,0.868771643087135,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4446,GO:0009176,1,0.950814104351979,0,4,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4447,GO:0009177,1,0.961599037824821,0,3,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4448,GO:0009178,1,0.988786191140326,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4450,GO:0009180,1,0.962025569564241,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4451,GO:0009181,1,0.949055262849585,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4452,GO:0009182,1,0.965524551002584,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4453,GO:0009183,1,0.97610005174218,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4454,GO:0009184,1,0.989166641157437,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4456,GO:0009186,1,0.94191355665156,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4458,GO:0009188,1,0.962025569564241,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4459,GO:0009189,1,0.952231511888769,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4461,GO:0009191,1,0.925484188730898,0,6,ribonucleoside diphosphate catabolic process,BP,
4462,GO:0009192,1,0.989166641157437,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
4463,GO:0009193,1,0.98394879876846,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4464,GO:0009195,1,0.98394879876846,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4465,GO:0009196,1,0.975549463919345,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4466,GO:0009197,1,0.975549463919345,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4468,GO:0009200,1,0.838986288402912,0,15,deoxyribonucleoside triphosphate metabolic process,BP,
4469,GO:0009201,1,0.512035044176862,0,59,ribonucleoside triphosphate biosynthetic process,BP,
4470,GO:0009202,1,0.94240266697184,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,
4471,GO:0009203,1,0.99178755111599,0,1,ribonucleoside triphosphate catabolic process,BP,
4472,GO:0009204,1,0.930943712406063,0,6,deoxyribonucleoside triphosphate catabolic process,BP,
4474,GO:0009206,1,0.557368874829065,0,53,purine ribonucleoside triphosphate biosynthetic process,BP,
4475,GO:0009207,1,0.99178755111599,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4476,GO:0009208,1,0.828494321433153,0,16,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4477,GO:0009209,1,0.841533663297859,0,15,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4478,GO:0009211,1,0.93534085447296,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4479,GO:0009212,1,0.955323328130025,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4480,GO:0009213,1,0.991683767070938,0,1,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4482,GO:0009215,1,0.912152964667315,0,8,purine deoxyribonucleoside triphosphate metabolic process,BP,
4483,GO:0009216,1,0.986477642086532,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4484,GO:0009217,1,0.938752647525512,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4485,GO:0009218,1,0.733962970663718,0,24,pyrimidine ribonucleotide metabolic process,BP,
4486,GO:0009219,1,0.814870521283396,0,17,pyrimidine deoxyribonucleotide metabolic process,BP,
4487,GO:0009220,1,0.757696193358977,0,22,pyrimidine ribonucleotide biosynthetic process,BP,
4488,GO:0009221,1,0.929047293005767,0,6,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4489,GO:0009222,1,0.98394879876846,0,1,pyrimidine ribonucleotide catabolic process,BP,
4490,GO:0009223,1,0.877138575090101,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4491,GO:0009224,1,0.990832232705604,0,1,CMP biosynthetic process,BP,
4492,GO:0009225,1,0.62279761274089,0,34,nucleotide-sugar metabolic process,BP,
4493,GO:0009226,1,0.751626363125843,0,21,nucleotide-sugar biosynthetic process,BP,
4494,GO:0009227,1,0.960683135672497,0,3,nucleotide-sugar catabolic process,BP,
4495,GO:0009229,1,0.985325278825704,0,1,thiamine diphosphate biosynthetic process,BP,
4496,GO:0009231,1,0.984367960048915,0,1,riboflavin biosynthetic process,BP,
4497,GO:0009233,1,0.953116840555796,0,3,menaquinone metabolic process,BP,
4498,GO:0009234,1,0.98342653957286,0,1,menaquinone biosynthetic process,BP,
4499,GO:0009235,1,0.768921213184731,0,21,cobalamin metabolic process,BP,
4500,GO:0009236,1,0.951697261629785,0,3,cobalamin biosynthetic process,BP,
4501,GO:0009237,1,0.983961000675291,0,1,siderophore metabolic process,BP,
4502,GO:0009240,1,0.942199541342896,0,5,isopentenyl diphosphate biosynthetic process,BP,
4503,GO:0009245,1,0.994875889508817,0,1,lipid A biosynthetic process,BP,
4504,GO:0009247,1,0.472140628551458,0,55,glycolipid biosynthetic process,BP,
4505,GO:0009249,1,0.967171818729165,0,4,protein lipoylation,BP,
4507,GO:0009251,1,0.665131441457379,0,27,glucan catabolic process,BP,
4508,GO:0009253,1,0.940093979077931,0,7,peptidoglycan catabolic process,BP,
4509,GO:0009256,1,0.921875785338916,0,5,10-formyltetrahydrofolate metabolic process,BP,
4510,GO:0009257,1,0.967178128446868,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4511,GO:0009258,1,0.967364347564981,0,2,10-formyltetrahydrofolate catabolic process,BP,
4515,GO:0009262,1,0.679523640660479,0,31,deoxyribonucleotide metabolic process,BP,
4516,GO:0009263,1,0.851048655042532,0,12,deoxyribonucleotide biosynthetic process,BP,
4517,GO:0009264,1,0.80469975135101,0,18,deoxyribonucleotide catabolic process,BP,
4518,GO:0009265,1,0.894568884246667,0,9,2'-deoxyribonucleotide biosynthetic process,BP,
4521,GO:0009268,1,0.565303795508908,0,40,response to pH,BP,
4522,GO:0009295,1,0.578341415456773,0,38,nucleoid,CC,
4523,GO:0009298,1,0.953315638599971,0,4,GDP-mannose biosynthetic process,BP,
4524,GO:0009299,1,0.712191109008619,0,23,mRNA transcription,BP,
4525,GO:0009301,1,0.406455399052754,0,65,snRNA transcription,BP,
4526,GO:0009303,1,0.679017585248992,0,28,rRNA transcription,BP,
4527,GO:0009304,1,0.900006820854012,0,7,tRNA transcription,BP,
4528,GO:0009305,1,0.983406759351672,0,1,protein biotinylation,BP,
4530,GO:0009308,1,0.210857590441979,0,125,amine metabolic process,BP,
4531,GO:0009309,1,0.764517405149894,0,22,amine biosynthetic process,BP,
4532,GO:0009310,1,0.720739499190897,0,25,amine catabolic process,BP,
4533,GO:0009311,1,0.460106964542832,0,54,oligosaccharide metabolic process,BP,
4534,GO:0009312,1,0.807341409917013,0,16,oligosaccharide biosynthetic process,BP,
4535,GO:0009313,1,0.827071245690484,0,13,oligosaccharide catabolic process,BP,
4537,GO:0009328,1,0.957499102430324,0,3,phenylalanine-tRNA ligase complex,CC,
4538,GO:0009330,1,0.96709523394772,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4539,GO:0009331,1,0.951647757960367,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4540,GO:0009346,1,0.983406759352021,0,1,citrate lyase complex,CC,
4541,GO:0009353,1,0.990326049080474,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4542,GO:0009360,1,0.984381301587911,0,1,DNA polymerase III complex,CC,
4543,GO:0009368,1,0.976898122235275,0,2,endopeptidase Clp complex,CC,
4544,GO:0009372,1,0.98357355435276,0,1,quorum sensing,BP,
4545,GO:0009374,1,0.922470076427272,0,5,biotin binding,MF,
4546,GO:0009378,1,0.919758250762834,0,5,four-way junction helicase activity,MF,
4547,GO:0009383,1,0.968033048794125,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4548,GO:0009384,1,0.972427838266973,0,2,N-acylmannosamine kinase activity,MF,
4549,GO:0009386,1,0.974444262561393,0,2,translational attenuation,BP,
4550,GO:0009394,1,0.722974518390939,0,27,2'-deoxyribonucleotide metabolic process,BP,
4551,GO:0009395,1,0.595051347176156,0,36,phospholipid catabolic process,BP,
4552,GO:0009396,1,0.865185634810736,0,10,folic acid-containing compound biosynthetic process,BP,
4553,GO:0009397,1,0.960878797059327,0,3,folic acid-containing compound catabolic process,BP,
4554,GO:0009398,1,0.984367960048915,0,1,FMN biosynthetic process,BP,
4555,GO:0009399,1,0.991633715656112,0,1,nitrogen fixation,BP,
4556,GO:0009400,1,0.98408970635106,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4557,GO:0009403,1,0.983701928859783,0,1,toxin biosynthetic process,BP,
4558,GO:0009404,1,0.831572605606333,0,12,toxin metabolic process,BP,
4559,GO:0009405,1,0.967087733487527,0,2,pathogenesis,BP,
4561,GO:0009409,1,0.534267781224622,0,44,response to cold,BP,
4562,GO:0009410,1,0.225622666819776,0,113,response to xenobiotic stimulus,BP,
4564,GO:0009414,1,0.893111361979951,0,8,response to water deprivation,BP,
4565,GO:0009415,1,0.813991724741559,0,14,response to water,BP,
4567,GO:0009435,1,0.71879154797641,0,23,NAD biosynthetic process,BP,
4568,GO:0009436,1,0.959669734083091,0,3,glyoxylate catabolic process,BP,
4569,GO:0009437,1,0.817697998355454,0,13,carnitine metabolic process,BP,
4570,GO:0009438,1,0.940031932256781,0,5,methylglyoxal metabolic process,BP,
4571,GO:0009439,1,0.98113773131458,0,2,cyanate metabolic process,BP,
4572,GO:0009440,1,0.98113773131458,0,2,cyanate catabolic process,BP,
4573,GO:0009441,1,0.964656143718643,0,3,glycolate metabolic process,BP,
4574,GO:0009443,1,0.983406759351331,0,1,pyridoxal 5'-phosphate salvage,BP,
4575,GO:0009444,1,0.983406759351821,0,1,pyruvate oxidation,BP,
4576,GO:0009445,1,0.930367798408219,0,6,putrescine metabolic process,BP,
4577,GO:0009446,1,0.945068818473593,0,4,putrescine biosynthetic process,BP,
4578,GO:0009447,1,0.972814029117056,0,3,putrescine catabolic process,BP,
4579,GO:0009448,1,0.924527978278539,0,5,gamma-aminobutyric acid metabolic process,BP,
4580,GO:0009449,1,0.952880530469652,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4581,GO:0009450,1,0.967087733487869,0,2,gamma-aminobutyric acid catabolic process,BP,
4582,GO:0009451,1,0.198371113165763,0,116,RNA modification,BP,
4583,GO:0009452,1,0.657162137535536,0,34,7-methylguanosine RNA capping,BP,
4589,GO:0009590,1,0.986490371457807,0,1,detection of gravity,BP,
4591,GO:0009595,1,0.742900727730301,0,21,detection of biotic stimulus,BP,
4592,GO:0009597,1,0.925984952656765,0,5,detection of virus,BP,
4595,GO:0009608,1,0.975746109145683,0,2,response to symbiont,BP,
4596,GO:0009609,1,0.975746109145683,0,2,response to symbiotic bacterium,BP,
4602,GO:0009624,1,0.967115462886216,0,3,response to nematode,BP,
4604,GO:0009629,1,0.888127002504158,0,9,response to gravity,BP,
4605,GO:0009631,1,0.983406759351869,0,1,cold acclimation,BP,
4606,GO:0009635,1,0.911766135185899,0,7,response to herbicide,BP,
4608,GO:0009637,1,0.967262868591393,0,2,response to blue light,BP,
4609,GO:0009642,1,0.829875647037572,0,12,response to light intensity,BP,
4610,GO:0009644,1,0.969980047661859,0,2,response to high light intensity,BP,
4611,GO:0009645,1,0.983468694959197,0,1,response to low light intensity stimulus,BP,
4612,GO:0009646,1,0.983565412210262,0,1,response to absence of light,BP,
4613,GO:0009648,1,0.725174146566302,0,23,photoperiodism,BP,
4614,GO:0009649,1,0.701860001297655,0,25,entrainment of circadian clock,BP,
4615,GO:0009650,1,0.829949000852189,0,13,UV protection,BP,
4618,GO:0009673,1,0.983424145688257,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4619,GO:0009692,1,0.98459790289113,0,1,ethylene metabolic process,BP,
4620,GO:0009698,1,0.914217495218237,0,7,phenylpropanoid metabolic process,BP,
4624,GO:0009720,1,0.983871772840128,0,1,detection of hormone stimulus,BP,
4626,GO:0009726,1,0.951488179110679,0,3,detection of endogenous stimulus,BP,
4627,GO:0009730,1,0.947316746879277,0,4,detection of carbohydrate stimulus,BP,
4628,GO:0009732,1,0.947316746879277,0,4,detection of hexose stimulus,BP,
4629,GO:0009737,1,0.983406759352021,0,1,response to abscisic acid,BP,
4630,GO:0009738,1,0.983406759352021,0,1,abscisic acid-activated signaling pathway,BP,
4636,GO:0009751,1,0.984849498336284,0,1,response to salicylic acid,BP,
4637,GO:0009753,1,0.961960127897768,0,4,response to jasmonic acid,BP,
4639,GO:0009756,1,0.908788031037406,0,7,carbohydrate mediated signaling,BP,
4640,GO:0009757,1,0.937817034749506,0,5,hexose mediated signaling,BP,
4641,GO:0009758,1,0.98340675935099,0,1,carbohydrate utilization,BP,
4642,GO:0009785,1,0.967262868591393,0,2,blue light signaling pathway,BP,
4643,GO:0009786,1,0.963216422919428,0,3,regulation of asymmetric cell division,BP,
4644,GO:0009787,1,0.983406759352021,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4645,GO:0009789,1,0.983406759352021,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4649,GO:0009794,1,0.942397573022423,0,4,regulation of mitotic cell cycle, embryonic,BP,
4652,GO:0009804,1,0.914217495218237,0,7,coumarin metabolic process,BP,
4653,GO:0009810,1,0.985864225629554,0,1,stilbene metabolic process,BP,
4654,GO:0009812,1,0.846995330151426,0,12,flavonoid metabolic process,BP,
4655,GO:0009814,1,0.985890748093858,0,1,defense response, incompatible interaction,BP,
4656,GO:0009817,1,0.985890748093858,0,1,defense response to fungus, incompatible interaction,BP,
4657,GO:0009820,1,0.907497997369807,0,7,alkaloid metabolic process,BP,
4658,GO:0009822,1,0.961600333788455,0,3,alkaloid catabolic process,BP,
4659,GO:0009826,1,0.962075154113612,0,3,unidimensional cell growth,BP,
4660,GO:0009838,1,0.920745913033967,0,6,abscission,BP,
4661,GO:0009841,1,0.985328591930967,0,1,mitochondrial endopeptidase Clp complex,CC,
4664,GO:0009881,1,0.831511110668776,0,14,photoreceptor activity,MF,
4665,GO:0009882,1,0.967262868591393,0,2,blue light photoreceptor activity,MF,
4682,GO:0009917,1,0.985055042664757,0,1,sterol 5-alpha reductase activity,MF,
4683,GO:0009918,1,0.984483887631901,0,1,sterol delta7 reductase activity,MF,
4684,GO:0009922,1,0.902186315265529,0,7,fatty acid elongase activity,MF,
4686,GO:0009931,1,0.849035266084224,0,11,calcium-dependent protein serine/threonine kinase activity,MF,
4689,GO:0009949,1,0.988853451736982,0,1,polarity specification of anterior/posterior axis,BP,
4694,GO:0009955,1,0.985879363093538,0,1,adaxial/abaxial pattern specification,BP,
4695,GO:0009956,1,0.983407132784863,0,1,radial pattern formation,BP,
4696,GO:0009957,1,0.952898845421299,0,3,epidermal cell fate specification,BP,
4700,GO:0009972,1,0.908009652279371,0,9,cytidine deamination,BP,
4702,GO:0009982,1,0.838166596264756,0,13,pseudouridine synthase activity,MF,
4707,GO:0009992,1,0.985973139802016,0,1,cellular water homeostasis,BP,
4710,GO:0009997,1,0.983950314107376,0,1,negative regulation of cardioblast cell fate specification,BP,
4714,GO:0010009,1,0.969599923385928,0,2,cytoplasmic side of endosome membrane,CC,
4715,GO:0010015,1,0.99404187805355,0,1,root morphogenesis,BP,
4716,GO:0010021,1,0.983677406548395,0,1,amylopectin biosynthetic process,BP,
4717,GO:0010025,1,0.946822959677684,0,4,wax biosynthetic process,BP,
4718,GO:0010032,1,0.912836170311417,0,6,meiotic chromosome condensation,BP,
4720,GO:0010034,1,0.983451375249606,0,1,response to acetate,BP,
4722,GO:0010037,1,0.983738140813592,0,1,response to carbon dioxide,BP,
4725,GO:0010040,1,0.932595065149368,0,5,response to iron(II) ion,BP,
4726,GO:0010041,1,0.934074167171172,0,5,response to iron(III) ion,BP,
4727,GO:0010042,1,0.800250467662656,0,15,response to manganese ion,BP,
4729,GO:0010044,1,0.928595507410848,0,5,response to aluminum ion,BP,
4730,GO:0010045,1,0.983406759351282,0,1,response to nickel cation,BP,
4731,GO:0010046,1,0.948742999379805,0,4,response to mycotoxin,BP,
4732,GO:0010053,1,0.99404187805355,0,1,root epidermal cell differentiation,BP,
4733,GO:0010054,1,0.99404187805355,0,1,trichoblast differentiation,BP,
4734,GO:0010070,1,0.98514784566868,0,1,zygote asymmetric cell division,BP,
4735,GO:0010085,1,0.986355974988371,0,1,polarity specification of proximal/distal axis,BP,
4737,GO:0010106,1,0.986957261121186,0,1,cellular response to iron ion starvation,BP,
4738,GO:0010107,1,0.653675689945022,0,28,potassium ion import,BP,
4739,GO:0010124,1,0.99117521259016,0,1,phenylacetate catabolic process,BP,
4740,GO:0010133,1,0.958261608259227,0,3,proline catabolic process to glutamate,BP,
4741,GO:0010138,1,0.93875658605913,0,5,pyrimidine ribonucleotide salvage,BP,
4742,GO:0010155,1,0.82511895904802,0,17,regulation of proton transport,BP,
4743,GO:0010157,1,0.968358491736484,0,2,response to chlorate,BP,
4745,GO:0010160,1,0.992512739064815,0,1,formation of animal organ boundary,BP,
4746,GO:0010164,1,0.988619752444679,0,1,response to cesium ion,BP,
4748,GO:0010166,1,0.946822959677684,0,4,wax metabolic process,BP,
4750,GO:0010172,1,0.836791329382161,0,11,embryonic body morphogenesis,BP,
4751,GO:0010181,1,0.78593733752343,0,16,FMN binding,MF,
4752,GO:0010182,1,0.937817034749506,0,5,sugar mediated signaling pathway,BP,
4753,GO:0010189,1,0.988286358379468,0,1,vitamin E biosynthetic process,BP,
4756,GO:0010216,1,0.904774751104812,0,6,maintenance of DNA methylation,BP,
4758,GO:0010225,1,0.830931362229973,0,12,response to UV-C,BP,
4760,GO:0010232,1,0.983704967407228,0,1,vascular transport,BP,
4762,GO:0010248,1,0.836840144728928,0,13,establishment or maintenance of transmembrane electrochemical gradient,BP,
4763,GO:0010255,1,0.937817034749506,0,5,glucose mediated signaling pathway,BP,
4765,GO:0010257,1,0.610796593016403,0,55,NADH dehydrogenase complex assembly,BP,
4767,GO:0010260,1,0.984698871827951,0,1,animal organ senescence,BP,
4768,GO:0010265,1,0.918012148954452,0,6,SCF complex assembly,BP,
4769,GO:0010266,1,0.961698591533735,0,3,response to vitamin B1,BP,
4770,GO:0010269,1,0.930031763382235,0,6,response to selenium ion,BP,
4771,GO:0010273,1,0.976460571029606,0,2,detoxification of copper ion,BP,
4772,GO:0010286,1,0.957199211131806,0,3,heat acclimation,BP,
4774,GO:0010309,1,0.988305046438691,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4775,GO:0010310,1,0.846952151079575,0,13,regulation of hydrogen peroxide metabolic process,BP,
4776,GO:0010314,1,0.848861298691465,0,11,phosphatidylinositol-5-phosphate binding,MF,
4779,GO:0010335,1,0.983406759352021,0,1,response to non-ionic osmotic stress,BP,
4780,GO:0010340,1,0.93071032479391,0,5,carboxyl-O-methyltransferase activity,MF,
4781,GO:0010348,1,0.984725543253726,0,1,lithium:proton antiporter activity,MF,
4782,GO:0010359,1,0.920295531145529,0,5,regulation of anion channel activity,BP,
4783,GO:0010360,1,0.967681017415782,0,2,negative regulation of anion channel activity,BP,
4784,GO:0010369,1,0.809481880272141,0,14,chromocenter,CC,
4785,GO:0010370,1,0.970283425248034,0,2,perinucleolar chromocenter,CC,
4786,GO:0010383,1,0.989276674890875,0,1,cell wall polysaccharide metabolic process,BP,
4788,GO:0010387,1,0.954924673220629,0,3,COP9 signalosome assembly,BP,
4790,GO:0010390,1,0.704304885908306,0,23,histone monoubiquitination,BP,
4791,GO:0010420,1,0.990704363325434,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4792,GO:0010421,1,0.849689231581323,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4793,GO:0010428,1,0.983406759351673,0,1,methyl-CpNpG binding,MF,
4794,GO:0010430,1,0.969540021681546,0,2,fatty acid omega-oxidation,BP,
4795,GO:0010446,1,0.963309334378662,0,3,response to alkaline pH,BP,
4796,GO:0010447,1,0.728832715097252,0,22,response to acidic pH,BP,
4797,GO:0010452,1,0.869414602098951,0,9,histone H3-K36 methylation,BP,
4800,GO:0010455,1,0.886774511571858,0,9,positive regulation of cell fate commitment,BP,
4801,GO:0010457,1,0.862643739609168,0,9,centriole-centriole cohesion,BP,
4802,GO:0010458,1,0.667812402912121,0,30,exit from mitosis,BP,
4807,GO:0010465,1,0.968164683624356,0,2,nerve growth factor receptor activity,MF,
4813,GO:0010477,1,0.983597371504519,0,1,response to sulfur dioxide,BP,
4814,GO:0010481,1,0.973984943776237,0,2,epidermal cell division,BP,
4815,GO:0010482,1,0.973984943776237,0,2,regulation of epidermal cell division,BP,
4816,GO:0010484,1,0.951527994819879,0,3,H3 histone acetyltransferase activity,MF,
4817,GO:0010485,1,0.765152187130763,0,17,H4 histone acetyltransferase activity,MF,
4818,GO:0010494,1,0.549499139459308,0,39,cytoplasmic stress granule,CC,
4819,GO:0010496,1,0.986706463820984,0,1,intercellular transport,BP,
4821,GO:0010499,1,0.937309720979034,0,4,proteasomal ubiquitin-independent protein catabolic process,BP,
4822,GO:0010501,1,0.498454713106239,0,45,RNA secondary structure unwinding,BP,
4826,GO:0010509,1,0.983406759351773,0,1,polyamine homeostasis,BP,
4827,GO:0010510,1,0.825565602277205,0,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4830,GO:0010513,1,0.943959037145893,0,4,positive regulation of phosphatidylinositol biosynthetic process,BP,
4833,GO:0010519,1,0.906903929310498,0,7,negative regulation of phospholipase activity,BP,
4834,GO:0010520,1,0.968218279356946,0,2,regulation of reciprocal meiotic recombination,BP,
4835,GO:0010521,1,0.960512583041083,0,3,telomerase inhibitor activity,MF,
4838,GO:0010524,1,0.545186559372145,0,45,positive regulation of calcium ion transport into cytosol,BP,
4839,GO:0010528,1,0.834800745668016,0,13,regulation of transposition,BP,
4840,GO:0010529,1,0.834800745668016,0,13,negative regulation of transposition,BP,
4841,GO:0010531,1,0.983707004650127,0,1,activation of JAK1 kinase activity,BP,
4842,GO:0010533,1,0.913601079538402,0,8,regulation of activation of Janus kinase activity,BP,
4843,GO:0010534,1,0.913601079538402,0,8,regulation of activation of JAK2 kinase activity,BP,
4844,GO:0010535,1,0.933794444827236,0,6,positive regulation of activation of JAK2 kinase activity,BP,
4845,GO:0010536,1,0.933794444827236,0,6,positive regulation of activation of Janus kinase activity,BP,
4852,GO:0010560,1,0.787428577439348,0,17,positive regulation of glycoprotein biosynthetic process,BP,
4859,GO:0010569,1,0.739849072645448,0,20,regulation of double-strand break repair via homologous recombination,BP,
4860,GO:0010571,1,0.905342669988861,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4861,GO:0010572,1,0.951921549345632,0,3,positive regulation of platelet activation,BP,
4862,GO:0010573,1,0.621756291807442,0,33,vascular endothelial growth factor production,BP,
4863,GO:0010574,1,0.632267438402214,0,32,regulation of vascular endothelial growth factor production,BP,
4864,GO:0010575,1,0.664839347345066,0,27,positive regulation of vascular endothelial growth factor production,BP,
4865,GO:0010578,1,0.913946881626786,0,6,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4866,GO:0010579,1,0.913946881626786,0,6,positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4868,GO:0010587,1,0.906592479077132,0,6,miRNA catabolic process,BP,
4869,GO:0010591,1,0.662778783525393,0,28,regulation of lamellipodium assembly,BP,
4870,GO:0010592,1,0.781637154222809,0,17,positive regulation of lamellipodium assembly,BP,
4871,GO:0010593,1,0.945640996437369,0,4,negative regulation of lamellipodium assembly,BP,
4875,GO:0010603,1,0.877930088155727,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4878,GO:0010606,1,0.919881484059365,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4879,GO:0010607,1,0.986889177987485,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4881,GO:0010609,1,0.969891831151308,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4882,GO:0010610,1,0.983406759351035,0,1,regulation of mRNA stability involved in response to stress,BP,
4884,GO:0010612,1,0.909785950179112,0,6,regulation of cardiac muscle adaptation,BP,
4886,GO:0010614,1,0.795679531572457,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4887,GO:0010615,1,0.967163564975404,0,2,positive regulation of cardiac muscle adaptation,BP,
4888,GO:0010616,1,0.951325859886589,0,3,negative regulation of cardiac muscle adaptation,BP,
4889,GO:0010621,1,0.964533724011176,0,3,negative regulation of transcription by transcription factor localization,BP,
4891,GO:0010624,1,0.924737694887375,0,5,regulation of Schwann cell proliferation,BP,
4892,GO:0010626,1,0.924737694887375,0,5,negative regulation of Schwann cell proliferation,BP,
4899,GO:0010635,1,0.887272894321195,0,8,regulation of mitochondrial fusion,BP,
4900,GO:0010636,1,0.968353283215801,0,2,positive regulation of mitochondrial fusion,BP,
4901,GO:0010637,1,0.93085230722214,0,5,negative regulation of mitochondrial fusion,BP,
4905,GO:0010641,1,0.921861470390668,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4907,GO:0010643,1,0.951999056741241,0,3,cell communication by chemical coupling,BP,
4909,GO:0010645,1,0.967638463318763,0,2,regulation of cell communication by chemical coupling,BP,
4914,GO:0010650,1,0.967087733486753,0,2,positive regulation of cell communication by electrical coupling,BP,
4915,GO:0010652,1,0.967638463318763,0,2,positive regulation of cell communication by chemical coupling,BP,
4919,GO:0010659,1,0.666181186899205,0,28,cardiac muscle cell apoptotic process,BP,
4921,GO:0010661,1,0.792780217662479,0,16,positive regulation of muscle cell apoptotic process,BP,
4923,GO:0010663,1,0.881316867881949,0,8,positive regulation of striated muscle cell apoptotic process,BP,
4925,GO:0010665,1,0.692041452782497,0,25,regulation of cardiac muscle cell apoptotic process,BP,
4926,GO:0010666,1,0.881316867881949,0,8,positive regulation of cardiac muscle cell apoptotic process,BP,
4927,GO:0010667,1,0.785335128119462,0,17,negative regulation of cardiac muscle cell apoptotic process,BP,
4929,GO:0010669,1,0.712475558969383,0,24,epithelial structure maintenance,BP,
4933,GO:0010692,1,0.866386435278577,0,9,regulation of alkaline phosphatase activity,BP,
4934,GO:0010693,1,0.955817567002588,0,3,negative regulation of alkaline phosphatase activity,BP,
4935,GO:0010694,1,0.90645160637426,0,6,positive regulation of alkaline phosphatase activity,BP,
4936,GO:0010698,1,0.979164414432852,0,2,acetyltransferase activator activity,MF,
4938,GO:0010701,1,0.950015612058288,0,4,positive regulation of norepinephrine secretion,BP,
4939,GO:0010705,1,0.96789043333706,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4940,GO:0010710,1,0.962116277414335,0,3,regulation of collagen catabolic process,BP,
4941,GO:0010711,1,0.994078100203671,0,1,negative regulation of collagen catabolic process,BP,
4943,GO:0010713,1,0.901968720726438,0,8,negative regulation of collagen metabolic process,BP,
4946,GO:0010716,1,0.948533727766949,0,4,negative regulation of extracellular matrix disassembly,BP,
4949,GO:0010719,1,0.690177979609232,0,26,negative regulation of epithelial to mesenchymal transition,BP,
4952,GO:0010722,1,0.983406759351379,0,1,regulation of ferrochelatase activity,BP,
4954,GO:0010725,1,0.957278890499147,0,3,regulation of primitive erythrocyte differentiation,BP,
4955,GO:0010726,1,0.970483621699411,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4956,GO:0010727,1,0.927851813832191,0,6,negative regulation of hydrogen peroxide metabolic process,BP,
4957,GO:0010728,1,0.956284743804038,0,3,regulation of hydrogen peroxide biosynthetic process,BP,
4958,GO:0010729,1,0.986601813837513,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4959,GO:0010730,1,0.969272912189198,0,2,negative regulation of hydrogen peroxide biosynthetic process,BP,
4960,GO:0010731,1,0.985390443310591,0,1,protein glutathionylation,BP,
4961,GO:0010732,1,0.985390443310591,0,1,regulation of protein glutathionylation,BP,
4962,GO:0010734,1,0.985390443310591,0,1,negative regulation of protein glutathionylation,BP,
4963,GO:0010735,1,0.938741248766075,0,4,positive regulation of transcription via serum response element binding,BP,
4964,GO:0010736,1,0.97069259679458,0,2,serum response element binding,MF,
4965,GO:0010737,1,0.653224253490236,0,29,protein kinase A signaling,BP,
4966,GO:0010738,1,0.748628633520537,0,19,regulation of protein kinase A signaling,BP,
4967,GO:0010739,1,0.919869372678745,0,6,positive regulation of protein kinase A signaling,BP,
4968,GO:0010742,1,0.620714496144424,0,34,macrophage derived foam cell differentiation,BP,
4969,GO:0010743,1,0.671163641012856,0,29,regulation of macrophage derived foam cell differentiation,BP,
4970,GO:0010744,1,0.812459140861248,0,16,positive regulation of macrophage derived foam cell differentiation,BP,
4971,GO:0010745,1,0.826225119010502,0,13,negative regulation of macrophage derived foam cell differentiation,BP,
4974,GO:0010749,1,0.947763554103061,0,4,regulation of nitric oxide mediated signal transduction,BP,
4975,GO:0010750,1,0.983406759352021,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
4976,GO:0010751,1,0.963757848440067,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4977,GO:0010752,1,0.967087733487816,0,2,regulation of cGMP-mediated signaling,BP,
4978,GO:0010754,1,0.983406759351724,0,1,negative regulation of cGMP-mediated signaling,BP,
4979,GO:0010755,1,0.86370692814774,0,11,regulation of plasminogen activation,BP,
4980,GO:0010756,1,0.940107402652782,0,5,positive regulation of plasminogen activation,BP,
4981,GO:0010757,1,0.918752154821505,0,6,negative regulation of plasminogen activation,BP,
4982,GO:0010758,1,0.774414477604129,0,20,regulation of macrophage chemotaxis,BP,
4983,GO:0010759,1,0.833281452228505,0,15,positive regulation of macrophage chemotaxis,BP,
4984,GO:0010760,1,0.945092563966274,0,4,negative regulation of macrophage chemotaxis,BP,
4988,GO:0010764,1,0.887228593106693,0,8,negative regulation of fibroblast migration,BP,
4991,GO:0010767,1,0.952013758994445,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4992,GO:0010768,1,0.983406759351574,0,1,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4996,GO:0010792,1,0.909409463697367,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4997,GO:0010793,1,0.922902260986369,0,5,regulation of mRNA export from nucleus,BP,
4998,GO:0010795,1,0.990704363325434,0,1,regulation of ubiquinone biosynthetic process,BP,
4999,GO:0010796,1,0.964374935656414,0,3,regulation of multivesicular body size,BP,
5000,GO:0010797,1,0.991038607842323,0,1,regulation of multivesicular body size involved in endosome transport,BP,
5003,GO:0010801,1,0.808029559058713,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
5006,GO:0010805,1,0.984675140077779,0,1,regulation of lysine import,BP,
5007,GO:0010807,1,0.926165519996686,0,5,regulation of synaptic vesicle priming,BP,
5008,GO:0010808,1,0.983406759351574,0,1,positive regulation of synaptic vesicle priming,BP,
5012,GO:0010813,1,0.973007307472733,0,2,neuropeptide catabolic process,BP,
5013,GO:0010814,1,0.983406759351869,0,1,substance P catabolic process,BP,
5014,GO:0010815,1,0.931003498489875,0,5,bradykinin catabolic process,BP,
5015,GO:0010816,1,0.983406759351869,0,1,calcitonin catabolic process,BP,
5024,GO:0010825,1,0.906981805084175,0,6,positive regulation of centrosome duplication,BP,
5025,GO:0010826,1,0.867604634490421,0,10,negative regulation of centrosome duplication,BP,
5028,GO:0010829,1,0.808601094198639,0,15,negative regulation of glucose transport,BP,
5030,GO:0010831,1,0.670529329214589,0,30,positive regulation of myotube differentiation,BP,
5032,GO:0010833,1,0.349746318007605,0,71,telomere maintenance via telomere lengthening,BP,
5033,GO:0010835,1,0.930902386070986,0,5,regulation of protein ADP-ribosylation,BP,
5034,GO:0010836,1,0.986653925583247,0,1,negative regulation of protein ADP-ribosylation,BP,
5038,GO:0010840,1,0.946945986877327,0,6,regulation of circadian sleep/wake cycle, wakefulness,BP,
5039,GO:0010841,1,0.958862086484098,0,5,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
5040,GO:0010842,1,0.708239825302614,0,22,retina layer formation,BP,
5041,GO:0010845,1,0.968218279356946,0,2,positive regulation of reciprocal meiotic recombination,BP,
5042,GO:0010847,1,0.940145701722726,0,4,regulation of chromatin assembly,BP,
5043,GO:0010848,1,0.967253815747707,0,2,regulation of chromatin disassembly,BP,
5044,GO:0010849,1,0.985909783828412,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
5045,GO:0010851,1,0.908228585899131,0,9,cyclase regulator activity,MF,
5046,GO:0010852,1,0.985554093900647,0,1,cyclase inhibitor activity,MF,
5047,GO:0010853,1,0.937099318607165,0,7,cyclase activator activity,MF,
5048,GO:0010854,1,0.98340675935207,0,1,adenylate cyclase regulator activity,MF,
5049,GO:0010855,1,0.98340675935207,0,1,adenylate cyclase inhibitor activity,MF,
5050,GO:0010857,1,0.835839602200403,0,12,calcium-dependent protein kinase activity,MF,
5051,GO:0010858,1,0.968448484676017,0,3,calcium-dependent protein kinase regulator activity,MF,
5052,GO:0010859,1,0.983406759352021,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5056,GO:0010866,1,0.795542906796881,0,16,regulation of triglyceride biosynthetic process,BP,
5057,GO:0010867,1,0.849986308820619,0,11,positive regulation of triglyceride biosynthetic process,BP,
5058,GO:0010868,1,0.967095857691287,0,2,negative regulation of triglyceride biosynthetic process,BP,
5061,GO:0010871,1,0.908878155709666,0,6,negative regulation of receptor biosynthetic process,BP,
5062,GO:0010872,1,0.884568166205733,0,11,regulation of cholesterol esterification,BP,
5063,GO:0010873,1,0.913026224079034,0,9,positive regulation of cholesterol esterification,BP,
5064,GO:0010874,1,0.754355679671807,0,20,regulation of cholesterol efflux,BP,
5065,GO:0010875,1,0.816947797567475,0,14,positive regulation of cholesterol efflux,BP,
5067,GO:0010877,1,0.977051838262063,0,2,lipid transport involved in lipid storage,BP,
5068,GO:0010878,1,0.793444877017667,0,15,cholesterol storage,BP,
5069,GO:0010879,1,0.985653813887015,0,1,cholesterol transport involved in cholesterol storage,BP,
5073,GO:0010883,1,0.555127695332285,0,42,regulation of lipid storage,BP,
5074,GO:0010884,1,0.739577528052864,0,22,positive regulation of lipid storage,BP,
5075,GO:0010885,1,0.818518335256559,0,13,regulation of cholesterol storage,BP,
5076,GO:0010886,1,0.893185859050127,0,7,positive regulation of cholesterol storage,BP,
5077,GO:0010887,1,0.916440596031238,0,6,negative regulation of cholesterol storage,BP,
5078,GO:0010888,1,0.785318049989835,0,17,negative regulation of lipid storage,BP,
5079,GO:0010889,1,0.857828640939679,0,12,regulation of sequestering of triglyceride,BP,
5080,GO:0010890,1,0.926160992606907,0,7,positive regulation of sequestering of triglyceride,BP,
5081,GO:0010891,1,0.926242410112601,0,5,negative regulation of sequestering of triglyceride,BP,
5086,GO:0010898,1,0.918992284915168,0,8,positive regulation of triglyceride catabolic process,BP,
5087,GO:0010899,1,0.964601201155302,0,3,regulation of phosphatidylcholine catabolic process,BP,
5088,GO:0010900,1,0.996405217884173,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5089,GO:0010901,1,0.967335444796474,0,5,regulation of very-low-density lipoprotein particle remodeling,BP,
5090,GO:0010902,1,0.981628650584026,0,2,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5091,GO:0010903,1,0.985440423963261,0,3,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5092,GO:0010904,1,0.985951929448957,0,1,regulation of UDP-glucose catabolic process,BP,
5093,GO:0010905,1,0.985951929448957,0,1,negative regulation of UDP-glucose catabolic process,BP,
5096,GO:0010908,1,0.967171757277233,0,2,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5097,GO:0010909,1,0.967171757277233,0,2,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5098,GO:0010911,1,0.924510823730587,0,5,regulation of isomerase activity,BP,
5099,GO:0010912,1,0.924510823730587,0,5,positive regulation of isomerase activity,BP,
5100,GO:0010915,1,0.975800249497722,0,4,regulation of very-low-density lipoprotein particle clearance,BP,
5101,GO:0010916,1,0.975800249497722,0,4,negative regulation of very-low-density lipoprotein particle clearance,BP,
5103,GO:0010918,1,0.952601321875272,0,4,positive regulation of mitochondrial membrane potential,BP,
5104,GO:0010919,1,0.820853684888078,0,14,regulation of inositol phosphate biosynthetic process,BP,
5105,GO:0010920,1,0.984073933253676,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5109,GO:0010924,1,0.984073933253676,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5110,GO:0010925,1,0.984073933253676,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5112,GO:0010931,1,0.983406759351084,0,1,macrophage tolerance induction,BP,
5113,GO:0010932,1,0.983406759351084,0,1,regulation of macrophage tolerance induction,BP,
5114,GO:0010933,1,0.983406759351084,0,1,positive regulation of macrophage tolerance induction,BP,
5117,GO:0010936,1,0.929526819790235,0,5,negative regulation of macrophage cytokine production,BP,
5118,GO:0010939,1,0.719337029827324,0,26,regulation of necrotic cell death,BP,
5119,GO:0010940,1,0.941273824511699,0,6,positive regulation of necrotic cell death,BP,
5122,GO:0010944,1,0.883446252380889,0,9,negative regulation of transcription by competitive promoter binding,BP,
5124,GO:0010949,1,0.968968553918727,0,2,negative regulation of intestinal phytosterol absorption,BP,
5128,GO:0010954,1,0.770870250067918,0,18,positive regulation of protein processing,BP,
5129,GO:0010955,1,0.596864031767092,0,37,negative regulation of protein processing,BP,
5130,GO:0010956,1,0.953440050922468,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5131,GO:0010957,1,0.929310802555308,0,5,negative regulation of vitamin D biosynthetic process,BP,
5132,GO:0010958,1,0.942331684888768,0,4,regulation of amino acid import,BP,
5134,GO:0010960,1,0.835105139306636,0,11,magnesium ion homeostasis,BP,
5135,GO:0010961,1,0.92211306207952,0,5,cellular magnesium ion homeostasis,BP,
5137,GO:0010963,1,0.974404950951122,0,2,regulation of L-arginine import,BP,
5138,GO:0010965,1,0.514697505380418,0,46,regulation of mitotic sister chromatid separation,BP,
5139,GO:0010966,1,0.922716020369615,0,5,regulation of phosphate transport,BP,
5140,GO:0010967,1,0.988182873842877,0,1,regulation of polyamine biosynthetic process,BP,
5141,GO:0010968,1,0.924809129736837,0,5,regulation of microtubule nucleation,BP,
5142,GO:0010970,1,0.165913347662645,0,121,transport along microtubule,BP,
5143,GO:0010971,1,0.742201063660667,0,20,positive regulation of G2/M transition of mitotic cell cycle,BP,
5150,GO:0010982,1,0.965199325782353,0,3,regulation of high-density lipoprotein particle clearance,BP,
5151,GO:0010983,1,0.96921170950478,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5152,GO:0010984,1,0.838540815277353,0,15,regulation of lipoprotein particle clearance,BP,
5153,GO:0010985,1,0.92980886996785,0,7,negative regulation of lipoprotein particle clearance,BP,
5154,GO:0010986,1,0.944271183467419,0,4,positive regulation of lipoprotein particle clearance,BP,
5155,GO:0010987,1,0.995860701704935,0,1,negative regulation of high-density lipoprotein particle clearance,BP,
5156,GO:0010988,1,0.89589354723113,0,9,regulation of low-density lipoprotein particle clearance,BP,
5157,GO:0010989,1,0.948927725709701,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5158,GO:0010990,1,0.911150894693971,0,6,regulation of SMAD protein complex assembly,BP,
5159,GO:0010991,1,0.926529846617291,0,5,negative regulation of SMAD protein complex assembly,BP,
5160,GO:0010992,1,0.937497259710296,0,4,ubiquitin homeostasis,BP,
5161,GO:0010993,1,0.938167051596099,0,5,regulation of ubiquitin homeostasis,BP,
5162,GO:0010994,1,0.938167051596099,0,5,free ubiquitin chain polymerization,BP,
5164,GO:0010997,1,0.911851821742709,0,6,anaphase-promoting complex binding,MF,
5165,GO:0010998,1,0.844870184561469,0,11,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5166,GO:0010999,1,0.983406759352021,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5168,GO:0012502,1,0.975369653398164,0,2,induction of programmed cell death,BP,
5171,GO:0012507,1,0.476862065363495,0,56,ER to Golgi transport vesicle membrane,CC,
5172,GO:0012510,1,0.82213343923795,0,14,trans-Golgi network transport vesicle membrane,CC,
5174,GO:0014003,1,0.591129909190857,0,37,oligodendrocyte development,BP,
5178,GO:0014010,1,0.909388368551056,0,6,Schwann cell proliferation,BP,
5179,GO:0014011,1,0.984725543253726,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5180,GO:0014012,1,0.93245602261542,0,6,peripheral nervous system axon regeneration,BP,
5184,GO:0014016,1,0.955537255069318,0,3,neuroblast differentiation,BP,
5185,GO:0014017,1,0.984968016038942,0,1,neuroblast fate commitment,BP,
5187,GO:0014022,1,0.951959761363184,0,3,neural plate elongation,BP,
5188,GO:0014028,1,0.942031904891268,0,4,notochord formation,BP,
5189,GO:0014029,1,0.845514755840459,0,12,neural crest formation,BP,
5193,GO:0014034,1,0.964324544760743,0,3,neural crest cell fate commitment,BP,
5194,GO:0014036,1,0.991220950504445,0,1,neural crest cell fate specification,BP,
5196,GO:0014038,1,0.956639770877323,0,3,regulation of Schwann cell differentiation,BP,
5197,GO:0014040,1,0.968336442164433,0,2,positive regulation of Schwann cell differentiation,BP,
5198,GO:0014041,1,0.844389037014813,0,11,regulation of neuron maturation,BP,
5199,GO:0014042,1,0.935256047033903,0,4,positive regulation of neuron maturation,BP,
5200,GO:0014043,1,0.939275775115718,0,4,negative regulation of neuron maturation,BP,
5206,GO:0014049,1,0.894101018145999,0,8,positive regulation of glutamate secretion,BP,
5208,GO:0014051,1,0.878147936405874,0,8,gamma-aminobutyric acid secretion,BP,
5209,GO:0014052,1,0.923069757392406,0,5,regulation of gamma-aminobutyric acid secretion,BP,
5210,GO:0014053,1,0.983406759351921,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5211,GO:0014054,1,0.938649036569335,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5212,GO:0014055,1,0.954993428787652,0,3,acetylcholine secretion, neurotransmission,BP,
5213,GO:0014056,1,0.954993428787652,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5214,GO:0014057,1,0.970088314463376,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5218,GO:0014062,1,0.912604745882008,0,7,regulation of serotonin secretion,BP,
5219,GO:0014063,1,0.945557591420004,0,4,negative regulation of serotonin secretion,BP,
5220,GO:0014064,1,0.983406759352021,0,1,positive regulation of serotonin secretion,BP,
5223,GO:0014067,1,0.85424712455341,0,11,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5227,GO:0014072,1,0.6533954396035,0,31,response to isoquinoline alkaloid,BP,
5229,GO:0014075,1,0.58522050283941,0,38,response to amine,BP,
5232,GO:0014705,1,0.98340675935207,0,1,C zone,CC,
5234,GO:0014707,1,0.95809705953066,0,3,branchiomeric skeletal muscle development,BP,
5235,GO:0014717,1,0.962818797914774,0,3,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5236,GO:0014718,1,0.973689683183518,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5238,GO:0014721,1,0.935798159624287,0,5,twitch skeletal muscle contraction,BP,
5239,GO:0014722,1,0.940030037327184,0,5,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5240,GO:0014724,1,0.967133468273641,0,2,regulation of twitch skeletal muscle contraction,BP,
5245,GO:0014734,1,0.954066303318944,0,3,skeletal muscle hypertrophy,BP,
5246,GO:0014735,1,0.961834293472261,0,3,regulation of muscle atrophy,BP,
5247,GO:0014736,1,0.973558705800993,0,2,negative regulation of muscle atrophy,BP,
5248,GO:0014737,1,0.987958491802573,0,1,positive regulation of muscle atrophy,BP,
5249,GO:0014738,1,0.964404598502569,0,3,regulation of muscle hyperplasia,BP,
5250,GO:0014739,1,0.995068352617493,0,1,positive regulation of muscle hyperplasia,BP,
5251,GO:0014740,1,0.969184903009102,0,2,negative regulation of muscle hyperplasia,BP,
5252,GO:0014741,1,0.770045013219535,0,18,negative regulation of muscle hypertrophy,BP,
5255,GO:0014744,1,0.935022517008688,0,5,positive regulation of muscle adaptation,BP,
5256,GO:0014745,1,0.88271660637331,0,8,negative regulation of muscle adaptation,BP,
5257,GO:0014801,1,0.992568032913338,0,1,longitudinal sarcoplasmic reticulum,CC,
5258,GO:0014802,1,0.948443420230667,0,4,terminal cisterna,CC,
5259,GO:0014804,1,0.986884662621452,0,1,terminal cisterna lumen,CC,
5260,GO:0014805,1,0.958591749144639,0,4,smooth muscle adaptation,BP,
5261,GO:0014806,1,0.97414841683001,0,2,smooth muscle hyperplasia,BP,
5264,GO:0014809,1,0.955267095466714,0,4,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5265,GO:0014810,1,0.994012925112929,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5267,GO:0014813,1,0.985664640752396,0,1,skeletal muscle satellite cell commitment,BP,
5268,GO:0014816,1,0.907928362754824,0,6,skeletal muscle satellite cell differentiation,BP,
5272,GO:0014822,1,0.984730915754465,0,1,detection of wounding,BP,
5276,GO:0014827,1,0.943025015434916,0,4,intestine smooth muscle contraction,BP,
5278,GO:0014831,1,0.896842066928174,0,7,gastro-intestinal system smooth muscle contraction,BP,
5279,GO:0014832,1,0.900521895180211,0,7,urinary bladder smooth muscle contraction,BP,
5281,GO:0014835,1,0.969279965615617,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5282,GO:0014839,1,0.977369336724702,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5283,GO:0014841,1,0.855642928844276,0,10,skeletal muscle satellite cell proliferation,BP,
5284,GO:0014842,1,0.870088774860632,0,9,regulation of skeletal muscle satellite cell proliferation,BP,
5285,GO:0014843,1,0.983406759351477,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5286,GO:0014846,1,0.967087733487869,0,2,esophagus smooth muscle contraction,BP,
5287,GO:0014848,1,0.900521895180211,0,7,urinary tract smooth muscle contraction,BP,
5288,GO:0014850,1,0.795277566850937,0,16,response to muscle activity,BP,
5289,GO:0014852,1,0.984052432056505,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5290,GO:0014853,1,0.984052432056505,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5293,GO:0014856,1,0.846099321590797,0,11,skeletal muscle cell proliferation,BP,
5294,GO:0014857,1,0.86038471322641,0,10,regulation of skeletal muscle cell proliferation,BP,
5295,GO:0014858,1,0.988853451736982,0,1,positive regulation of skeletal muscle cell proliferation,BP,
5296,GO:0014859,1,0.967947138412916,0,2,negative regulation of skeletal muscle cell proliferation,BP,
5297,GO:0014861,1,0.983406759351821,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5301,GO:0014873,1,0.972817410903796,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5303,GO:0014876,1,0.989986470737502,0,1,response to injury involved in regulation of muscle adaptation,BP,
5305,GO:0014878,1,0.943796901238401,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5307,GO:0014886,1,0.96726357827833,0,2,transition between slow and fast fiber,BP,
5308,GO:0014887,1,0.749366761877429,0,19,cardiac muscle adaptation,BP,
5313,GO:0014895,1,0.994698943007998,0,1,smooth muscle hypertrophy,BP,
5316,GO:0014898,1,0.749366761877429,0,19,cardiac muscle hypertrophy in response to stress,BP,
5317,GO:0014900,1,0.953784074139725,0,4,muscle hyperplasia,BP,
5318,GO:0014901,1,0.962818797914774,0,3,satellite cell activation involved in skeletal muscle regeneration,BP,
5320,GO:0014904,1,0.62497751182538,0,32,myotube cell development,BP,
5321,GO:0014905,1,0.993753357775697,0,1,myoblast fusion involved in skeletal muscle regeneration,BP,
5322,GO:0014908,1,0.965182514394939,0,3,myotube differentiation involved in skeletal muscle regeneration,BP,
5326,GO:0014912,1,0.746331228745419,0,20,negative regulation of smooth muscle cell migration,BP,
5327,GO:0014916,1,0.954439516414501,0,3,regulation of lung blood pressure,BP,
5328,GO:0015002,1,0.835658595399198,0,26,heme-copper terminal oxidase activity,MF,
5329,GO:0015012,1,0.67732287445857,0,24,heparan sulfate proteoglycan biosynthetic process,BP,
5330,GO:0015014,1,0.95115789381545,0,3,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5331,GO:0015015,1,0.923541366421502,0,5,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5332,GO:0015016,1,0.935372978472663,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5333,GO:0015018,1,0.960641576788642,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5334,GO:0015019,1,0.983406759351872,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5335,GO:0015020,1,0.630757607698069,0,31,glucuronosyltransferase activity,MF,
5336,GO:0015026,1,0.594204202019641,0,36,coreceptor activity,MF,
5337,GO:0015030,1,0.51285636097219,0,49,Cajal body,CC,
5339,GO:0015035,1,0.786651584358974,0,21,protein disulfide oxidoreductase activity,MF,
5340,GO:0015036,1,0.628633104471847,0,39,disulfide oxidoreductase activity,MF,
5341,GO:0015037,1,0.860158264254736,0,13,peptide disulfide oxidoreductase activity,MF,
5342,GO:0015038,1,0.953049835388586,0,5,glutathione disulfide oxidoreductase activity,MF,
5343,GO:0015039,1,0.987179557575313,0,1,NADPH-adrenodoxin reductase activity,MF,
5344,GO:0015052,1,0.984518694985009,0,1,beta3-adrenergic receptor activity,MF,
5345,GO:0015054,1,0.98621248489368,0,1,gastrin receptor activity,MF,
5346,GO:0015055,1,0.987510865608086,0,1,secretin receptor activity,MF,
5347,GO:0015056,1,0.97306465365889,0,2,corticotrophin-releasing factor receptor activity,MF,
5348,GO:0015057,1,0.922668026554665,0,5,thrombin-activated receptor activity,MF,
5349,GO:0015065,1,0.961546422634693,0,3,uridine nucleotide receptor activity,MF,
5350,GO:0015067,1,0.984651666829039,0,1,amidinotransferase activity,MF,
5351,GO:0015068,1,0.984651666829039,0,1,glycine amidinotransferase activity,MF,
5352,GO:0015074,1,0.863234471725528,0,10,DNA integration,BP,
5355,GO:0015078,1,0.325962598518384,0,101,hydrogen ion transmembrane transporter activity,MF,
5357,GO:0015081,1,0.0921669694320686,0,151,sodium ion transmembrane transporter activity,MF,
5359,GO:0015086,1,0.983406759352069,0,1,cadmium ion transmembrane transporter activity,MF,
5360,GO:0015087,1,0.983406759352069,0,1,cobalt ion transmembrane transporter activity,MF,
5361,GO:0015088,1,0.983406759351968,0,1,copper uptake transmembrane transporter activity,MF,
5363,GO:0015093,1,0.951154689721993,0,3,ferrous iron transmembrane transporter activity,MF,
5364,GO:0015094,1,0.983406759352069,0,1,lead ion transmembrane transporter activity,MF,
5366,GO:0015098,1,0.987177207290076,0,1,molybdate ion transmembrane transporter activity,MF,
5367,GO:0015101,1,0.819323341247121,0,14,organic cation transmembrane transporter activity,MF,
5369,GO:0015105,1,0.990596360661074,0,1,arsenite transmembrane transporter activity,MF,
5370,GO:0015106,1,0.73272153974965,0,19,bicarbonate transmembrane transporter activity,MF,
5372,GO:0015111,1,0.951070034246113,0,3,iodide transmembrane transporter activity,MF,
5373,GO:0015112,1,0.984489840589118,0,1,nitrate transmembrane transporter activity,MF,
5374,GO:0015114,1,0.771484079320408,0,17,phosphate ion transmembrane transporter activity,MF,
5375,GO:0015116,1,0.799240450814351,0,14,sulfate transmembrane transporter activity,MF,
5376,GO:0015117,1,0.987217261229828,0,1,thiosulfate transmembrane transporter activity,MF,
5377,GO:0015119,1,0.954105695326802,0,3,hexose phosphate transmembrane transporter activity,MF,
5378,GO:0015125,1,0.832841796946892,0,13,bile acid transmembrane transporter activity,MF,
5379,GO:0015126,1,0.983406759351968,0,1,canalicular bile acid transmembrane transporter activity,MF,
5380,GO:0015127,1,0.983406759351921,0,1,bilirubin transmembrane transporter activity,MF,
5381,GO:0015129,1,0.926283699552262,0,5,lactate transmembrane transporter activity,MF,
5382,GO:0015130,1,0.983406759352069,0,1,mevalonate transmembrane transporter activity,MF,
5383,GO:0015131,1,0.987217261229828,0,1,oxaloacetate transmembrane transporter activity,MF,
5384,GO:0015132,1,0.98340675935207,0,1,prostaglandin transmembrane transporter activity,MF,
5385,GO:0015136,1,0.983548689119741,0,1,sialic acid transmembrane transporter activity,MF,
5386,GO:0015137,1,0.940486611673458,0,4,citrate transmembrane transporter activity,MF,
5387,GO:0015139,1,0.984058405067898,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5388,GO:0015140,1,0.975127649192592,0,2,malate transmembrane transporter activity,MF,
5389,GO:0015141,1,0.954932315913588,0,3,succinate transmembrane transporter activity,MF,
5390,GO:0015142,1,0.940486611673458,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5391,GO:0015143,1,0.870581944916769,0,10,urate transmembrane transporter activity,MF,
5395,GO:0015152,1,0.986261267829129,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5398,GO:0015165,1,0.922321665655412,0,6,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5399,GO:0015166,1,0.876892099159076,0,9,polyol transmembrane transporter activity,MF,
5400,GO:0015168,1,0.920256234084608,0,6,glycerol transmembrane transporter activity,MF,
5401,GO:0015171,1,0.303664613352651,0,78,amino acid transmembrane transporter activity,MF,
5402,GO:0015172,1,0.79992906163599,0,14,acidic amino acid transmembrane transporter activity,MF,
5403,GO:0015173,1,0.95341339640789,0,3,aromatic amino acid transmembrane transporter activity,MF,
5404,GO:0015174,1,0.873298202317026,0,9,basic amino acid transmembrane transporter activity,MF,
5405,GO:0015175,1,0.622473784508776,0,31,neutral amino acid transmembrane transporter activity,MF,
5406,GO:0015179,1,0.4539258793379,0,52,L-amino acid transmembrane transporter activity,MF,
5407,GO:0015180,1,0.893630375729438,0,7,L-alanine transmembrane transporter activity,MF,
5408,GO:0015181,1,0.941117199376225,0,4,arginine transmembrane transporter activity,MF,
5409,GO:0015182,1,0.969449584215117,0,2,L-asparagine transmembrane transporter activity,MF,
5410,GO:0015183,1,0.940656002065271,0,4,L-aspartate transmembrane transporter activity,MF,
5411,GO:0015184,1,0.941554622161597,0,4,L-cystine transmembrane transporter activity,MF,
5412,GO:0015185,1,0.926565662880023,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5413,GO:0015186,1,0.94100747182138,0,4,L-glutamine transmembrane transporter activity,MF,
5414,GO:0015187,1,0.88259364850179,0,8,glycine transmembrane transporter activity,MF,
5415,GO:0015189,1,0.956999794871821,0,3,L-lysine transmembrane transporter activity,MF,
5416,GO:0015190,1,0.984213042107821,0,1,L-leucine transmembrane transporter activity,MF,
5417,GO:0015191,1,0.984213042107821,0,1,L-methionine transmembrane transporter activity,MF,
5418,GO:0015193,1,0.891459428890825,0,7,L-proline transmembrane transporter activity,MF,
5419,GO:0015194,1,0.881067810087849,0,9,L-serine transmembrane transporter activity,MF,
5420,GO:0015195,1,0.983406759352021,0,1,L-threonine transmembrane transporter activity,MF,
5421,GO:0015196,1,0.984982832020166,0,1,L-tryptophan transmembrane transporter activity,MF,
5422,GO:0015197,1,0.219467035569046,0,106,peptide transporter activity,MF,
5423,GO:0015198,1,0.920047351825271,0,5,oligopeptide transporter activity,MF,
5424,GO:0015199,1,0.944801593847067,0,4,amino-acid betaine transmembrane transporter activity,MF,
5425,GO:0015203,1,0.993392413129631,0,1,polyamine transmembrane transporter activity,MF,
5426,GO:0015204,1,0.939735741512671,0,4,urea transmembrane transporter activity,MF,
5427,GO:0015205,1,0.893176456083014,0,8,nucleobase transmembrane transporter activity,MF,
5428,GO:0015207,1,0.963411824572547,0,3,adenine transmembrane transporter activity,MF,
5429,GO:0015211,1,0.941444311078173,0,4,purine nucleoside transmembrane transporter activity,MF,
5430,GO:0015215,1,0.795845574728139,0,16,nucleotide transmembrane transporter activity,MF,
5431,GO:0015216,1,0.841049754412374,0,12,purine nucleotide transmembrane transporter activity,MF,
5432,GO:0015217,1,0.878859536018644,0,9,ADP transmembrane transporter activity,MF,
5433,GO:0015218,1,0.97307979491638,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5434,GO:0015220,1,0.90748231066571,0,6,choline transmembrane transporter activity,MF,
5435,GO:0015222,1,0.95530859580211,0,3,serotonin transmembrane transporter activity,MF,
5436,GO:0015226,1,0.944801593847067,0,4,carnitine transmembrane transporter activity,MF,
5437,GO:0015227,1,0.972795515795962,0,2,acyl carnitine transmembrane transporter activity,MF,
5438,GO:0015228,1,0.969582674838051,0,2,coenzyme A transmembrane transporter activity,MF,
5439,GO:0015229,1,0.968977804748556,0,2,L-ascorbic acid transporter activity,MF,
5440,GO:0015230,1,0.969704837623964,0,2,FAD transmembrane transporter activity,MF,
5442,GO:0015234,1,0.94310419814714,0,4,thiamine transmembrane transporter activity,MF,
5443,GO:0015235,1,0.96059550475344,0,3,cobalamin transporter activity,MF,
5444,GO:0015238,1,0.739294786507714,0,20,drug transmembrane transporter activity,MF,
5445,GO:0015245,1,0.83210080889627,0,13,fatty acid transporter activity,MF,
5446,GO:0015247,1,0.967087733486077,0,2,aminophospholipid transporter activity,MF,
5447,GO:0015248,1,0.673748935198852,0,28,sterol transporter activity,MF,
5448,GO:0015250,1,0.859838009058529,0,11,water channel activity,MF,
5449,GO:0015252,1,0.91310109839037,0,6,hydrogen ion channel activity,MF,
5450,GO:0015254,1,0.950748999462197,0,4,glycerol channel activity,MF,
5451,GO:0015265,1,0.955595119773985,0,3,urea channel activity,MF,
5452,GO:0015266,1,0.885850090758414,0,11,protein channel activity,MF,
5454,GO:0015269,1,0.763993123812922,0,19,calcium-activated potassium channel activity,MF,
5456,GO:0015272,1,0.922992603134987,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5457,GO:0015275,1,0.95129841072171,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5459,GO:0015277,1,0.920456436062274,0,5,kainate selective glutamate receptor activity,MF,
5460,GO:0015278,1,0.753810560836047,0,18,calcium-release channel activity,MF,
5461,GO:0015279,1,0.845618707725052,0,11,store-operated calcium channel activity,MF,
5462,GO:0015280,1,0.867075009542179,0,9,ligand-gated sodium channel activity,MF,
5463,GO:0015288,1,0.92531391117793,0,6,porin activity,MF,
5465,GO:0015292,1,0.984725543253726,0,1,uniporter activity,MF,
5469,GO:0015296,1,0.464309280177307,0,49,anion:cation symporter activity,MF,
5470,GO:0015297,1,0.294681795360323,0,79,antiporter activity,MF,
5471,GO:0015298,1,0.605182845116266,0,32,solute:cation antiporter activity,MF,
5472,GO:0015299,1,0.74096437589474,0,19,solute:proton antiporter activity,MF,
5473,GO:0015301,1,0.616659047803822,0,31,anion:anion antiporter activity,MF,
5474,GO:0015307,1,0.958642764495135,0,3,drug:proton antiporter activity,MF,
5475,GO:0015315,1,0.954105695326802,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5476,GO:0015319,1,0.9838765730806,0,1,sodium:inorganic phosphate symporter activity,MF,
5477,GO:0015320,1,0.988257061428659,0,1,phosphate ion carrier activity,MF,
5478,GO:0015321,1,0.898244918193682,0,7,sodium-dependent phosphate transmembrane transporter activity,MF,
5479,GO:0015322,1,0.967375371250215,0,2,secondary active oligopeptide transmembrane transporter activity,MF,
5480,GO:0015327,1,0.983406759350742,0,1,cystine:glutamate antiporter activity,MF,
5481,GO:0015328,1,0.983406759350742,0,1,cystine secondary active transmembrane transporter activity,MF,
5482,GO:0015333,1,0.939276422461688,0,4,peptide:proton symporter activity,MF,
5483,GO:0015347,1,0.787891460844706,0,16,sodium-independent organic anion transmembrane transporter activity,MF,
5484,GO:0015349,1,0.921926048576,0,5,thyroid hormone transmembrane transporter activity,MF,
5485,GO:0015350,1,0.967771626631759,0,2,methotrexate transporter activity,MF,
5486,GO:0015361,1,0.985091825770778,0,1,low-affinity sodium:dicarboxylate symporter activity,MF,
5487,GO:0015362,1,0.983406759352069,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5488,GO:0015367,1,0.987754499152002,0,1,oxoglutarate:malate antiporter activity,MF,
5489,GO:0015368,1,0.856710550155545,0,10,calcium:cation antiporter activity,MF,
5490,GO:0015370,1,0.433109047946153,0,54,solute:sodium symporter activity,MF,
5491,GO:0015373,1,0.983439456094266,0,1,monovalent anion:sodium symporter activity,MF,
5492,GO:0015375,1,0.96792437421183,0,2,glycine:sodium symporter activity,MF,
5493,GO:0015377,1,0.860341126324464,0,9,cation:chloride symporter activity,MF,
5494,GO:0015378,1,0.983406759351773,0,1,sodium:chloride symporter activity,MF,
5495,GO:0015379,1,0.904652260332481,0,6,potassium:chloride symporter activity,MF,
5496,GO:0015382,1,0.967674935141435,0,2,sodium:sulfate symporter activity,MF,
5497,GO:0015385,1,0.811454517197848,0,13,sodium:proton antiporter activity,MF,
5498,GO:0015386,1,0.83684315923868,0,11,potassium:proton antiporter activity,MF,
5499,GO:0015389,1,0.972529124735272,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5500,GO:0015390,1,0.985807893522371,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5501,GO:0015399,1,0.189219677267461,0,117,primary active transmembrane transporter activity,MF,
5502,GO:0015403,1,0.95411042296654,0,3,thiamine uptake transmembrane transporter activity,MF,
5503,GO:0015405,1,0.189219677267461,0,117,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
5504,GO:0015410,1,0.983407580382724,0,1,manganese-transporting ATPase activity,MF,
5505,GO:0015420,1,0.983406759351574,0,1,cobalamin-transporting ATPase activity,MF,
5506,GO:0015421,1,0.983452239894892,0,1,oligopeptide-transporting ATPase activity,MF,
5507,GO:0015431,1,0.983406759351574,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5508,GO:0015432,1,0.967131190928779,0,2,bile acid-exporting ATPase activity,MF,
5509,GO:0015433,1,0.967142226068687,0,2,peptide antigen-transporting ATPase activity,MF,
5510,GO:0015439,1,0.983871089773647,0,1,heme-transporting ATPase activity,MF,
5511,GO:0015440,1,0.935830802565907,0,4,peptide-transporting ATPase activity,MF,
5512,GO:0015450,1,0.928491857861318,0,8,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5513,GO:0015459,1,0.529749605884763,0,44,potassium channel regulator activity,MF,
5514,GO:0015464,1,0.726465312793665,0,22,acetylcholine receptor activity,MF,
5515,GO:0015467,1,0.852105508803826,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5516,GO:0015485,1,0.571840948118305,0,43,cholesterol binding,MF,
5517,GO:0015489,1,0.993392413129631,0,1,putrescine transmembrane transporter activity,MF,
5518,GO:0015491,1,0.641060536538124,0,28,cation:cation antiporter activity,MF,
5519,GO:0015495,1,0.984693575781511,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5520,GO:0015499,1,0.984483887631901,0,1,formate transmembrane transporter activity,MF,
5521,GO:0015501,1,0.967096906197535,0,2,glutamate:sodium symporter activity,MF,
5522,GO:0015526,1,0.954105695326802,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5523,GO:0015538,1,0.983548689119741,0,1,sialic acid:proton symporter activity,MF,
5524,GO:0015556,1,0.887247893015646,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5525,GO:0015562,1,0.925785755289095,0,5,efflux transmembrane transporter activity,MF,
5526,GO:0015563,1,0.939303479634,0,4,uptake transmembrane transporter activity,MF,
5527,GO:0015578,1,0.985024735033645,0,1,mannose transmembrane transporter activity,MF,
5528,GO:0015605,1,0.759287011694511,0,19,organophosphate ester transmembrane transporter activity,MF,
5529,GO:0015607,1,0.98342354169628,0,1,fatty-acyl-CoA transporter activity,MF,
5530,GO:0015616,1,0.951429584993527,0,3,DNA translocase activity,MF,
5534,GO:0015633,1,0.986310482630928,0,1,zinc-transporting ATPase activity,MF,
5535,GO:0015635,1,0.985491260372201,0,1,short-chain fatty acid transporter activity,MF,
5536,GO:0015636,1,0.985491260372201,0,1,short-chain fatty acid uptake transporter activity,MF,
5537,GO:0015639,1,0.983406759352069,0,1,ferrous iron uptake transmembrane transporter activity,MF,
5538,GO:0015643,1,0.856190766931812,0,11,toxic substance binding,MF,
5540,GO:0015651,1,0.890215515311194,0,8,quaternary ammonium group transmembrane transporter activity,MF,
5541,GO:0015658,1,0.984213042107821,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5542,GO:0015659,1,0.984483887631901,0,1,formate uptake transmembrane transporter activity,MF,
5543,GO:0015660,1,0.984483887631901,0,1,formate efflux transmembrane transporter activity,MF,
5544,GO:0015662,1,0.572069363868828,0,37,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5545,GO:0015665,1,0.876892099159076,0,9,alcohol transmembrane transporter activity,MF,
5546,GO:0015669,1,0.845348229024647,0,19,gas transport,BP,
5547,GO:0015670,1,0.948218281493622,0,4,carbon dioxide transport,BP,
5548,GO:0015671,1,0.891534985553613,0,15,oxygen transport,BP,
5550,GO:0015677,1,0.904464759214624,0,6,copper ion import,BP,
5551,GO:0015679,1,0.983406759351034,0,1,plasma membrane copper ion transport,BP,
5552,GO:0015680,1,0.972065123617809,0,3,intracellular copper ion transport,BP,
5555,GO:0015688,1,0.964812110728132,0,3,iron chelate transport,BP,
5556,GO:0015689,1,0.987177207290076,0,1,molybdate ion transport,BP,
5557,GO:0015691,1,0.938532093123473,0,4,cadmium ion transport,BP,
5558,GO:0015692,1,0.983406759352069,0,1,lead ion transport,BP,
5560,GO:0015694,1,0.983406759351921,0,1,mercury ion transport,BP,
5561,GO:0015695,1,0.746596964788307,0,21,organic cation transport,BP,
5563,GO:0015697,1,0.863385060788535,0,10,quaternary ammonium group transport,BP,
5565,GO:0015701,1,0.53862479469262,0,44,bicarbonate transport,BP,
5566,GO:0015705,1,0.919761770670937,0,5,iodide transport,BP,
5567,GO:0015706,1,0.984489840589118,0,1,nitrate transport,BP,
5568,GO:0015707,1,0.983408102448569,0,1,nitrite transport,BP,
5569,GO:0015709,1,0.987217261229828,0,1,thiosulfate transport,BP,
5571,GO:0015712,1,0.91682868842013,0,6,hexose phosphate transport,BP,
5573,GO:0015721,1,0.653458093448645,0,30,bile acid and bile salt transport,BP,
5574,GO:0015722,1,0.951441631960282,0,3,canalicular bile acid transport,BP,
5575,GO:0015723,1,0.983406759351921,0,1,bilirubin transport,BP,
5576,GO:0015724,1,0.984483887631901,0,1,formate transport,BP,
5577,GO:0015727,1,0.910908816577429,0,6,lactate transport,BP,
5578,GO:0015728,1,0.983406759352069,0,1,mevalonate transport,BP,
5579,GO:0015729,1,0.987217261229828,0,1,oxaloacetate transport,BP,
5581,GO:0015734,1,0.983406759351527,0,1,taurine transport,BP,
5582,GO:0015739,1,0.983548689119741,0,1,sialic acid transport,BP,
5583,GO:0015740,1,0.826143708429603,0,12,C4-dicarboxylate transport,BP,
5584,GO:0015742,1,0.958621919659795,0,3,alpha-ketoglutarate transport,BP,
5585,GO:0015743,1,0.987217261229828,0,1,malate transport,BP,
5586,GO:0015744,1,0.954932315913588,0,3,succinate transport,BP,
5587,GO:0015746,1,0.940486611673458,0,4,citrate transport,BP,
5588,GO:0015747,1,0.868279586950162,0,10,urate transport,BP,
5591,GO:0015755,1,0.970525719719735,0,2,fructose transport,BP,
5593,GO:0015760,1,0.91682868842013,0,6,glucose-6-phosphate transport,BP,
5594,GO:0015761,1,0.985024735033645,0,1,mannose transport,BP,
5598,GO:0015780,1,0.893352383010859,0,8,nucleotide-sugar transport,BP,
5599,GO:0015781,1,0.922321665655412,0,6,pyrimidine nucleotide-sugar transport,BP,
5600,GO:0015782,1,0.987584713029126,0,1,CMP-N-acetylneuraminate transport,BP,
5601,GO:0015783,1,0.952526934294867,0,3,GDP-fucose transport,BP,
5602,GO:0015785,1,0.979341034141075,0,2,UDP-galactose transport,BP,
5603,GO:0015787,1,0.983406759351527,0,1,UDP-glucuronic acid transport,BP,
5604,GO:0015788,1,0.969717349664978,0,2,UDP-N-acetylglucosamine transport,BP,
5605,GO:0015790,1,0.983406759351429,0,1,UDP-xylose transport,BP,
5606,GO:0015791,1,0.84894554357258,0,11,polyol transport,BP,
5607,GO:0015793,1,0.920256234084608,0,6,glycerol transport,BP,
5608,GO:0015797,1,0.984483887631901,0,1,mannitol transport,BP,
5609,GO:0015798,1,0.95103840934097,0,3,myo-inositol transport,BP,
5610,GO:0015800,1,0.673711057037183,0,25,acidic amino acid transport,BP,
5611,GO:0015801,1,0.924186024447178,0,5,aromatic amino acid transport,BP,
5612,GO:0015802,1,0.826044075652221,0,13,basic amino acid transport,BP,
5613,GO:0015803,1,0.938163957961063,0,4,branched-chain amino acid transport,BP,
5614,GO:0015804,1,0.582893470463199,0,35,neutral amino acid transport,BP,
5615,GO:0015805,1,0.98578926837925,0,1,S-adenosyl-L-methionine transport,BP,
5616,GO:0015807,1,0.38494225667387,0,63,L-amino acid transport,BP,
5617,GO:0015808,1,0.893630375729438,0,7,L-alanine transport,BP,
5618,GO:0015809,1,0.890208748015693,0,8,arginine transport,BP,
5619,GO:0015810,1,0.865157207782821,0,9,aspartate transport,BP,
5620,GO:0015811,1,0.941554622161597,0,4,L-cystine transport,BP,
5621,GO:0015812,1,0.827367707046425,0,12,gamma-aminobutyric acid transport,BP,
5622,GO:0015813,1,0.696673948721991,0,23,L-glutamate transport,BP,
5623,GO:0015816,1,0.85353071339984,0,10,glycine transport,BP,
5624,GO:0015817,1,0.969449584215117,0,2,histidine transport,BP,
5625,GO:0015819,1,0.942331255719099,0,4,lysine transport,BP,
5626,GO:0015820,1,0.95321529059241,0,3,leucine transport,BP,
5627,GO:0015821,1,0.984213042107821,0,1,methionine transport,BP,
5628,GO:0015822,1,0.957220350084556,0,3,ornithine transport,BP,
5629,GO:0015824,1,0.862105751294133,0,9,proline transport,BP,
5630,GO:0015825,1,0.881067810087849,0,9,L-serine transport,BP,
5631,GO:0015826,1,0.983406759352021,0,1,threonine transport,BP,
5632,GO:0015827,1,0.954791693802975,0,3,tryptophan transport,BP,
5633,GO:0015828,1,0.983676454999591,0,1,tyrosine transport,BP,
5636,GO:0015838,1,0.9163328702259,0,6,amino-acid betaine transport,BP,
5637,GO:0015840,1,0.921932242675903,0,6,urea transport,BP,
5638,GO:0015842,1,0.946110197643002,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5640,GO:0015846,1,0.926650358453009,0,6,polyamine transport,BP,
5641,GO:0015847,1,0.993392413129631,0,1,putrescine transport,BP,
5644,GO:0015851,1,0.883939409611137,0,9,nucleobase transport,BP,
5645,GO:0015853,1,0.953451536223095,0,4,adenine transport,BP,
5646,GO:0015855,1,0.956795349724992,0,3,pyrimidine nucleobase transport,BP,
5648,GO:0015860,1,0.970982552623197,0,2,purine nucleoside transmembrane transport,BP,
5649,GO:0015862,1,0.985422616436221,0,1,uridine transport,BP,
5650,GO:0015864,1,0.971436548181889,0,2,pyrimidine nucleoside transport,BP,
5652,GO:0015866,1,0.878859536018644,0,9,ADP transport,BP,
5653,GO:0015867,1,0.850504549421024,0,11,ATP transport,BP,
5655,GO:0015870,1,0.926224826136992,0,5,acetylcholine transport,BP,
5656,GO:0015871,1,0.877603203051701,0,8,choline transport,BP,
5659,GO:0015876,1,0.98447322307645,0,1,acetyl-CoA transport,BP,
5660,GO:0015878,1,0.983557862200963,0,1,biotin transport,BP,
5661,GO:0015879,1,0.931798922637735,0,5,carnitine transport,BP,
5662,GO:0015880,1,0.969582674838051,0,2,coenzyme A transport,BP,
5663,GO:0015881,1,0.967130495088187,0,2,creatine transport,BP,
5664,GO:0015882,1,0.968977804748556,0,2,L-ascorbic acid transport,BP,
5665,GO:0015883,1,0.969704837623964,0,2,FAD transport,BP,
5666,GO:0015884,1,0.915290015226159,0,7,folic acid transport,BP,
5668,GO:0015887,1,0.983557862200963,0,1,pantothenate transmembrane transport,BP,
5669,GO:0015888,1,0.928018810428973,0,5,thiamine transport,BP,
5670,GO:0015889,1,0.901707004737889,0,8,cobalamin transport,BP,
5671,GO:0015891,1,0.964812110728132,0,3,siderophore transport,BP,
5673,GO:0015904,1,0.987343484720486,0,1,tetracycline transport,BP,
5676,GO:0015910,1,0.96918681710622,0,2,peroxisomal long-chain fatty acid import,BP,
5678,GO:0015912,1,0.985491260372201,0,1,short-chain fatty acid transport,BP,
5679,GO:0015913,1,0.985491260372201,0,1,short-chain fatty acid import,BP,
5680,GO:0015914,1,0.443762683588874,0,57,phospholipid transport,BP,
5681,GO:0015916,1,0.98447322307645,0,1,fatty-acyl-CoA transport,BP,
5682,GO:0015917,1,0.951038409342163,0,3,aminophospholipid transport,BP,
5683,GO:0015918,1,0.314283679681558,0,83,sterol transport,BP,
5684,GO:0015919,1,0.895157544036196,0,7,peroxisomal membrane transport,BP,
5685,GO:0015920,1,0.972102852366495,0,2,lipopolysaccharide transport,BP,
5686,GO:0015922,1,0.988603244367643,0,1,aspartate oxidase activity,MF,
5687,GO:0015923,1,0.795345940414997,0,14,mannosidase activity,MF,
5688,GO:0015924,1,0.864355845768017,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5689,GO:0015925,1,0.888628330564237,0,8,galactosidase activity,MF,
5690,GO:0015926,1,0.82515965287887,0,12,glucosidase activity,MF,
5691,GO:0015927,1,0.987345885905482,0,1,trehalase activity,MF,
5692,GO:0015928,1,0.972710871902025,0,2,fucosidase activity,MF,
5693,GO:0015929,1,0.824862701214432,0,13,hexosaminidase activity,MF,
5695,GO:0015932,1,0.592498358077011,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5696,GO:0015934,1,0.396607298969477,0,110,large ribosomal subunit,CC,
5697,GO:0015935,1,0.582126604224194,0,68,small ribosomal subunit,CC,
5698,GO:0015936,1,0.82316588981211,0,14,coenzyme A metabolic process,BP,
5699,GO:0015937,1,0.872027144683044,0,10,coenzyme A biosynthetic process,BP,
5700,GO:0015938,1,0.992395609449106,0,1,coenzyme A catabolic process,BP,
5702,GO:0015942,1,0.91998884224413,0,6,formate metabolic process,BP,
5703,GO:0015949,1,0.751681598031305,0,22,nucleobase-containing small molecule interconversion,BP,
5704,GO:0015959,1,0.903705451314084,0,7,diadenosine polyphosphate metabolic process,BP,
5705,GO:0015960,1,0.954619790470824,0,3,diadenosine polyphosphate biosynthetic process,BP,
5706,GO:0015961,1,0.946675313860854,0,4,diadenosine polyphosphate catabolic process,BP,
5707,GO:0015965,1,0.954619790470824,0,3,diadenosine tetraphosphate metabolic process,BP,
5708,GO:0015966,1,0.954619790470824,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5710,GO:0015985,1,0.786182322557275,0,25,energy coupled proton transport, down electrochemical gradient,BP,
5711,GO:0015986,1,0.786182322557275,0,25,ATP synthesis coupled proton transport,BP,
5712,GO:0015988,1,0.706177653894465,0,27,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5713,GO:0015991,1,0.706177653894465,0,27,ATP hydrolysis coupled proton transport,BP,
5714,GO:0015992,1,0.167799961988339,0,152,proton transport,BP,
5715,GO:0015993,1,0.970779709028788,0,2,molecular hydrogen transport,BP,
5716,GO:0016004,1,0.873131193992647,0,11,phospholipase activator activity,MF,
5717,GO:0016005,1,0.968306971358815,0,2,phospholipase A2 activator activity,MF,
5718,GO:0016010,1,0.737411251072944,0,21,dystrophin-associated glycoprotein complex,CC,
5719,GO:0016011,1,0.907344559053069,0,7,dystroglycan complex,CC,
5720,GO:0016012,1,0.922659537512303,0,6,sarcoglycan complex,CC,
5721,GO:0016013,1,0.944321040926424,0,4,syntrophin complex,CC,
5722,GO:0016015,1,0.913284773465069,0,7,morphogen activity,MF,
5723,GO:0016018,1,0.876624630328767,0,10,cyclosporin A binding,MF,
5724,GO:0016019,1,0.948696583085213,0,5,peptidoglycan receptor activity,MF,
5727,GO:0016024,1,0.841745439893825,0,11,CDP-diacylglycerol biosynthetic process,BP,
5728,GO:0016028,1,0.983428251747412,0,1,rhabdomere,CC,
5729,GO:0016031,1,0.978866660160089,0,2,tRNA import into mitochondrion,BP,
5731,GO:0016034,1,0.990251360910938,0,1,maleylacetoacetate isomerase activity,MF,
5732,GO:0016035,1,0.958899177447795,0,3,zeta DNA polymerase complex,CC,
5733,GO:0016036,1,0.985637625278431,0,1,cellular response to phosphate starvation,BP,
5734,GO:0016037,1,0.9842389658803,0,1,light absorption,BP,
5735,GO:0016038,1,0.9842389658803,0,1,absorption of visible light,BP,
5738,GO:0016045,1,0.839983616414935,0,12,detection of bacterium,BP,
5739,GO:0016046,1,0.983406759351775,0,1,detection of fungus,BP,
5749,GO:0016062,1,0.968775743558609,0,2,adaptation of rhodopsin mediated signaling,BP,
5751,GO:0016068,1,0.971577033228296,0,3,type I hypersensitivity,BP,
5754,GO:0016072,1,0.0411051413702945,0,273,rRNA metabolic process,BP,
5755,GO:0016073,1,0.35606572124055,0,77,snRNA metabolic process,BP,
5756,GO:0016074,1,0.874357674159212,0,13,snoRNA metabolic process,BP,
5757,GO:0016075,1,0.815613995700973,0,15,rRNA catabolic process,BP,
5758,GO:0016077,1,0.983406759351672,0,1,snoRNA catabolic process,BP,
5759,GO:0016078,1,0.961300490524181,0,3,tRNA catabolic process,BP,
5761,GO:0016080,1,0.935298723435284,0,4,synaptic vesicle targeting,BP,
5762,GO:0016081,1,0.881610498192043,0,8,synaptic vesicle docking,BP,
5763,GO:0016082,1,0.816131544662966,0,13,synaptic vesicle priming,BP,
5764,GO:0016093,1,0.902710837390673,0,8,polyprenol metabolic process,BP,
5765,GO:0016094,1,0.967239537827426,0,2,polyprenol biosynthetic process,BP,
5766,GO:0016095,1,0.964556856678327,0,3,polyprenol catabolic process,BP,
5767,GO:0016098,1,0.92427452826968,0,6,monoterpenoid metabolic process,BP,
5769,GO:0016102,1,0.896669488714387,0,8,diterpenoid biosynthetic process,BP,
5770,GO:0016103,1,0.953147815621575,0,4,diterpenoid catabolic process,BP,
5771,GO:0016107,1,0.979770821705243,0,2,sesquiterpenoid catabolic process,BP,
5772,GO:0016108,1,0.984068730074366,0,1,tetraterpenoid metabolic process,BP,
5773,GO:0016114,1,0.873053167857418,0,10,terpenoid biosynthetic process,BP,
5774,GO:0016115,1,0.93386260510853,0,6,terpenoid catabolic process,BP,
5775,GO:0016116,1,0.984068730074366,0,1,carotenoid metabolic process,BP,
5776,GO:0016119,1,0.984068730074366,0,1,carotene metabolic process,BP,
5777,GO:0016121,1,0.984068730074366,0,1,carotene catabolic process,BP,
5778,GO:0016122,1,0.984068730074366,0,1,xanthophyll metabolic process,BP,
5781,GO:0016127,1,0.859895216184948,0,11,sterol catabolic process,BP,
5782,GO:0016128,1,0.960372024167385,0,3,phytosteroid metabolic process,BP,
5783,GO:0016129,1,0.960372024167385,0,3,phytosteroid biosynthetic process,BP,
5784,GO:0016131,1,0.984483887631901,0,1,brassinosteroid metabolic process,BP,
5785,GO:0016132,1,0.984483887631901,0,1,brassinosteroid biosynthetic process,BP,
5786,GO:0016137,1,0.79599391254237,0,18,glycoside metabolic process,BP,
5787,GO:0016139,1,0.892456307088568,0,8,glycoside catabolic process,BP,
5788,GO:0016149,1,0.953542775391313,0,3,translation release factor activity, codon specific,MF,
5789,GO:0016151,1,0.973869775234413,0,2,nickel cation binding,MF,
5790,GO:0016153,1,0.983519117580024,0,1,urocanate hydratase activity,MF,
5791,GO:0016154,1,0.988374762250607,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5792,GO:0016155,1,0.967364347564981,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5793,GO:0016160,1,0.922784305576343,0,6,amylase activity,MF,
5794,GO:0016165,1,0.970084470009214,0,2,linoleate 13S-lipoxygenase activity,MF,
5795,GO:0016167,1,0.95728787647556,0,3,glial cell-derived neurotrophic factor receptor activity,MF,
5796,GO:0016174,1,0.90881772168932,0,6,NAD(P)H oxidase activity,MF,
5797,GO:0016175,1,0.882820620862665,0,9,superoxide-generating NADPH oxidase activity,MF,
5799,GO:0016180,1,0.773820285720125,0,18,snRNA processing,BP,
5800,GO:0016182,1,0.983406759351971,0,1,synaptic vesicle budding from endosome,BP,
5801,GO:0016185,1,0.967273716142487,0,2,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5802,GO:0016188,1,0.874988797528729,0,9,synaptic vesicle maturation,BP,
5803,GO:0016189,1,0.983406759351133,0,1,synaptic vesicle to endosome fusion,BP,
5804,GO:0016191,1,0.922119265031247,0,5,synaptic vesicle uncoating,BP,
5807,GO:0016198,1,0.894241027510888,0,7,axon choice point recognition,BP,
5808,GO:0016199,1,0.92097638297471,0,5,axon midline choice point recognition,BP,
5810,GO:0016203,1,0.983406759351331,0,1,muscle attachment,BP,
5811,GO:0016206,1,0.969652692165568,0,2,catechol O-methyltransferase activity,MF,
5812,GO:0016208,1,0.86433022766528,0,11,AMP binding,MF,
5814,GO:0016211,1,0.967087733487917,0,2,ammonia ligase activity,MF,
5815,GO:0016212,1,0.971047709946888,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5816,GO:0016213,1,0.983675505684426,0,1,linoleoyl-CoA desaturase activity,MF,
5817,GO:0016215,1,0.952496507618286,0,3,acyl-CoA desaturase activity,MF,
5818,GO:0016222,1,0.968980991421985,0,2,procollagen-proline 4-dioxygenase complex,CC,
5819,GO:0016226,1,0.815763234426403,0,18,iron-sulfur cluster assembly,BP,
5820,GO:0016229,1,0.725725772004707,0,27,steroid dehydrogenase activity,MF,
5821,GO:0016230,1,0.973536442842662,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5822,GO:0016231,1,0.983406759351869,0,1,beta-N-acetylglucosaminidase activity,MF,
5823,GO:0016232,1,0.984144076856531,0,1,HNK-1 sulfotransferase activity,MF,
5824,GO:0016233,1,0.532461726932206,0,53,telomere capping,BP,
5825,GO:0016234,1,0.322681239699205,0,75,inclusion body,CC,
5826,GO:0016235,1,0.560076863520831,0,38,aggresome,CC,
5828,GO:0016237,1,0.967094359503926,0,2,lysosomal microautophagy,BP,
5830,GO:0016240,1,0.94690877118634,0,4,autophagosome docking,BP,
5833,GO:0016243,1,0.983406759353248,0,1,regulation of autophagosome size,BP,
5834,GO:0016246,1,0.860982966233179,0,10,RNA interference,BP,
5837,GO:0016250,1,0.984234941936482,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5838,GO:0016254,1,0.820114218414435,0,15,preassembly of GPI anchor in ER membrane,BP,
5839,GO:0016255,1,0.904257573683776,0,7,attachment of GPI anchor to protein,BP,
5840,GO:0016256,1,0.974365271220782,0,2,N-glycan processing to lysosome,BP,
5841,GO:0016259,1,0.956866081922853,0,3,selenocysteine metabolic process,BP,
5842,GO:0016260,1,0.985664640752396,0,1,selenocysteine biosynthetic process,BP,
5843,GO:0016262,1,0.956091924171367,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5844,GO:0016263,1,0.974779851685205,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5847,GO:0016267,1,0.974779851685205,0,2,O-glycan processing, core 1,BP,
5848,GO:0016269,1,0.98491243352299,0,1,O-glycan processing, core 3,BP,
5849,GO:0016272,1,0.946086800269724,0,7,prefoldin complex,CC,
5850,GO:0016273,1,0.850101825140613,0,11,arginine N-methyltransferase activity,MF,
5851,GO:0016274,1,0.850101825140613,0,11,protein-arginine N-methyltransferase activity,MF,
5852,GO:0016277,1,0.985182578475753,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5853,GO:0016278,1,0.515774215853415,0,43,lysine N-methyltransferase activity,MF,
5854,GO:0016279,1,0.523796219508159,0,42,protein-lysine N-methyltransferase activity,MF,
5855,GO:0016281,1,0.878231848041945,0,9,eukaryotic translation initiation factor 4F complex,CC,
5856,GO:0016282,1,0.983406759352021,0,1,eukaryotic 43S preinitiation complex,CC,
5857,GO:0016286,1,0.94309607950892,0,4,small conductance calcium-activated potassium channel activity,MF,
5858,GO:0016287,1,0.984403796766486,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5859,GO:0016289,1,0.784773862595082,0,19,CoA hydrolase activity,MF,
5860,GO:0016290,1,0.882819837127039,0,10,palmitoyl-CoA hydrolase activity,MF,
5865,GO:0016300,1,0.938015451777706,0,4,tRNA (uracil) methyltransferase activity,MF,
5869,GO:0016308,1,0.896675729778074,0,7,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5870,GO:0016309,1,0.95133136123605,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5873,GO:0016312,1,0.938232942879047,0,4,inositol bisphosphate phosphatase activity,MF,
5874,GO:0016314,1,0.954984309613055,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5875,GO:0016316,1,0.967087733487576,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5876,GO:0016320,1,0.974236557165995,0,2,endoplasmic reticulum membrane fusion,BP,
5877,GO:0016321,1,0.955462979110819,0,3,female meiosis chromosome segregation,BP,
5878,GO:0016322,1,0.857846441559199,0,10,neuron remodeling,BP,
5885,GO:0016333,1,0.9839360319995,0,1,morphogenesis of follicular epithelium,BP,
5886,GO:0016334,1,0.9839360319995,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5890,GO:0016340,1,0.967087733487142,0,2,calcium-dependent cell-matrix adhesion,BP,
5892,GO:0016344,1,0.951940725410212,0,3,meiotic chromosome movement towards spindle pole,BP,
5895,GO:0016362,1,0.967087733484676,0,2,activin receptor activity, type II,MF,
5897,GO:0016401,1,0.972627434929923,0,2,palmitoyl-CoA oxidase activity,MF,
5898,GO:0016402,1,0.955462049007511,0,3,pristanoyl-CoA oxidase activity,MF,
5899,GO:0016403,1,0.973855904726319,0,2,dimethylargininase activity,MF,
5900,GO:0016404,1,0.967922144499445,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5901,GO:0016405,1,0.828637758812031,0,13,CoA-ligase activity,MF,
5902,GO:0016406,1,0.90726793106662,0,6,carnitine O-acyltransferase activity,MF,
5904,GO:0016408,1,0.767375525156422,0,19,C-acyltransferase activity,MF,
5905,GO:0016409,1,0.57406935709607,0,37,palmitoyltransferase activity,MF,
5908,GO:0016412,1,0.988380144766829,0,1,serine O-acyltransferase activity,MF,
5909,GO:0016413,1,0.905106085177447,0,7,O-acetyltransferase activity,MF,
5910,GO:0016414,1,0.983594371083701,0,1,O-octanoyltransferase activity,MF,
5911,GO:0016415,1,0.976488750608917,0,2,octanoyltransferase activity,MF,
5912,GO:0016416,1,0.921726465835681,0,5,O-palmitoyltransferase activity,MF,
5917,GO:0016421,1,0.910981733286182,0,6,CoA carboxylase activity,MF,
5918,GO:0016422,1,0.973318194656017,0,2,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5919,GO:0016423,1,0.854561181823149,0,11,tRNA (guanine) methyltransferase activity,MF,
5920,GO:0016426,1,0.956415442393763,0,3,tRNA (adenine) methyltransferase activity,MF,
5921,GO:0016427,1,0.903790990396252,0,7,tRNA (cytosine) methyltransferase activity,MF,
5922,GO:0016428,1,0.943160363354929,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5923,GO:0016429,1,0.956415442393763,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5924,GO:0016433,1,0.922531363283964,0,6,rRNA (adenine) methyltransferase activity,MF,
5925,GO:0016434,1,0.968033048794125,0,2,rRNA (cytosine) methyltransferase activity,MF,
5926,GO:0016435,1,0.971109564460838,0,2,rRNA (guanine) methyltransferase activity,MF,
5928,GO:0016442,1,0.855811196947818,0,10,RISC complex,CC,
5931,GO:0016446,1,0.845706099965489,0,11,somatic hypermutation of immunoglobulin genes,BP,
5933,GO:0016453,1,0.948693791357205,0,4,C-acetyltransferase activity,MF,
5934,GO:0016454,1,0.925822781015883,0,5,C-palmitoyltransferase activity,MF,
5940,GO:0016469,1,0.620432137153034,0,46,proton-transporting two-sector ATPase complex,CC,
5941,GO:0016471,1,0.81832396836682,0,16,vacuolar proton-transporting V-type ATPase complex,CC,
5942,GO:0016476,1,0.953685407781838,0,3,regulation of embryonic cell shape,BP,
5944,GO:0016479,1,0.941180901779158,0,4,negative regulation of transcription from RNA polymerase I promoter,BP,
5948,GO:0016486,1,0.662035634776834,0,32,peptide hormone processing,BP,
5949,GO:0016487,1,0.979770821705243,0,2,farnesol metabolic process,BP,
5950,GO:0016488,1,0.979770821705243,0,2,farnesol catabolic process,BP,
5952,GO:0016492,1,0.972268867822951,0,2,G-protein coupled neurotensin receptor activity,MF,
5953,GO:0016493,1,0.859659905434825,0,11,C-C chemokine receptor activity,MF,
5954,GO:0016494,1,0.90713273408623,0,7,C-X-C chemokine receptor activity,MF,
5955,GO:0016495,1,0.983653385348909,0,1,C-X3-C chemokine receptor activity,MF,
5956,GO:0016496,1,0.983592882755861,0,1,substance P receptor activity,MF,
5957,GO:0016497,1,0.98514470687641,0,1,substance K receptor activity,MF,
5958,GO:0016499,1,0.974432778829845,0,2,orexin receptor activity,MF,
5959,GO:0016500,1,0.8470627859444,0,11,protein-hormone receptor activity,MF,
5960,GO:0016501,1,0.98636012860423,0,1,prostacyclin receptor activity,MF,
5961,GO:0016502,1,0.748298297491773,0,21,nucleotide receptor activity,MF,
5962,GO:0016503,1,0.966465150847198,0,4,pheromone receptor activity,MF,
5963,GO:0016504,1,0.614420151686645,0,36,peptidase activator activity,MF,
5964,GO:0016505,1,0.786243783370214,0,18,peptidase activator activity involved in apoptotic process,MF,
5965,GO:0016507,1,0.983787871862921,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5966,GO:0016508,1,0.952369925058614,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5967,GO:0016509,1,0.955148177417778,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5968,GO:0016514,1,0.802200275730168,0,15,SWI/SNF complex,CC,
5969,GO:0016517,1,0.986774955811059,0,1,interleukin-12 receptor activity,MF,
5970,GO:0016519,1,0.986571612550772,0,1,gastric inhibitory peptide receptor activity,MF,
5971,GO:0016520,1,0.957625987832521,0,4,growth hormone-releasing hormone receptor activity,MF,
5972,GO:0016521,1,0.983661989983942,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5976,GO:0016530,1,0.953451747680292,0,5,metallochaperone activity,MF,
5977,GO:0016531,1,0.969541641722907,0,4,copper chaperone activity,MF,
5978,GO:0016532,1,0.976460571029606,0,2,superoxide dismutase copper chaperone activity,MF,
5979,GO:0016533,1,0.96034982941279,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5980,GO:0016534,1,0.968621929523801,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5982,GO:0016539,1,0.975422809066724,0,2,intein-mediated protein splicing,BP,
5983,GO:0016540,1,0.847195534340278,0,11,protein autoprocessing,BP,
5984,GO:0016553,1,0.868636661150571,0,10,base conversion or substitution editing,BP,
5985,GO:0016554,1,0.952146798506453,0,4,cytidine to uridine editing,BP,
5986,GO:0016556,1,0.8532130066353,0,12,mRNA modification,BP,
5987,GO:0016557,1,0.96350563137857,0,3,peroxisome membrane biogenesis,BP,
5988,GO:0016558,1,0.834174960232576,0,12,protein import into peroxisome matrix,BP,
5989,GO:0016559,1,0.899469532893878,0,9,peroxisome fission,BP,
5990,GO:0016560,1,0.951307270121249,0,3,protein import into peroxisome matrix, docking,BP,
5991,GO:0016561,1,0.970714161469559,0,2,protein import into peroxisome matrix, translocation,BP,
5995,GO:0016571,1,0.160127554794457,0,121,histone methylation,BP,
5996,GO:0016572,1,0.603868415361724,0,34,histone phosphorylation,BP,
5998,GO:0016574,1,0.552075132338007,0,39,histone ubiquitination,BP,
6000,GO:0016576,1,0.911205975194106,0,6,histone dephosphorylation,BP,
6001,GO:0016577,1,0.650032861946108,0,26,histone demethylation,BP,
6002,GO:0016578,1,0.729398099519574,0,21,histone deubiquitination,BP,
6005,GO:0016581,1,0.76446636350015,0,17,NuRD complex,CC,
6006,GO:0016584,1,0.914197791701981,0,8,nucleosome positioning,BP,
6007,GO:0016586,1,0.983406759352021,0,1,RSC complex,CC,
6008,GO:0016589,1,0.902369390333421,0,7,NURF complex,CC,
6009,GO:0016590,1,0.983406759351676,0,1,ACF complex,CC,
6010,GO:0016591,1,0.250560065622129,0,100,DNA-directed RNA polymerase II, holoenzyme,CC,
6011,GO:0016592,1,0.617982870923021,0,35,mediator complex,CC,
6012,GO:0016593,1,0.901404196960438,0,7,Cdc73/Paf1 complex,CC,
6014,GO:0016595,1,0.863995792576095,0,9,glutamate binding,MF,
6015,GO:0016596,1,0.984725543253726,0,1,thienylcyclohexylpiperidine binding,MF,
6017,GO:0016598,1,0.973500739921068,0,2,protein arginylation,BP,
6019,GO:0016601,1,0.625716793863007,0,30,Rac protein signal transduction,BP,
6020,GO:0016602,1,0.946003559329722,0,4,CCAAT-binding factor complex,CC,
6021,GO:0016603,1,0.974346209985325,0,2,glutaminyl-peptide cyclotransferase activity,MF,
6025,GO:0016608,1,0.991015799258579,0,2,growth hormone-releasing hormone activity,MF,
6027,GO:0016615,1,0.899701806066736,0,8,malate dehydrogenase activity,MF,
6029,GO:0016618,1,0.990877190928817,0,1,hydroxypyruvate reductase activity,MF,
6030,GO:0016620,1,0.598938515338598,0,35,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
6031,GO:0016623,1,0.957818915067299,0,3,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
6032,GO:0016624,1,0.890705333736707,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
6035,GO:0016634,1,0.875278519610891,0,9,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
6036,GO:0016635,1,0.954003135686662,0,4,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
6038,GO:0016639,1,0.959477085843823,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
6039,GO:0016641,1,0.806255457411707,0,14,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
6041,GO:0016645,1,0.696339890493088,0,25,oxidoreductase activity, acting on the CH-NH group of donors,MF,
6042,GO:0016646,1,0.793859568028971,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
6043,GO:0016647,1,0.960264113825183,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
6044,GO:0016649,1,0.969184960236034,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
6045,GO:0016651,1,0.348956514932636,0,98,oxidoreductase activity, acting on NAD(P)H,MF,
6046,GO:0016652,1,0.975445802810265,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
6047,GO:0016653,1,0.834230280945064,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
6048,GO:0016655,1,0.655791266584171,0,51,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
6049,GO:0016657,1,0.976570686515648,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
6050,GO:0016661,1,0.930951400155297,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
6051,GO:0016662,1,0.984615667407723,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
6053,GO:0016668,1,0.835583973262999,0,15,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
6054,GO:0016670,1,0.894551877789175,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
6055,GO:0016671,1,0.883369324359907,0,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
6056,GO:0016672,1,0.983382471556074,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
6057,GO:0016675,1,0.82300275438928,0,27,oxidoreductase activity, acting on a heme group of donors,MF,
6058,GO:0016676,1,0.835658595399198,0,26,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
6059,GO:0016679,1,0.914630703062672,0,9,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
6060,GO:0016681,1,0.928942723257778,0,8,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
6062,GO:0016701,1,0.710346559952105,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
6063,GO:0016702,1,0.717808897530271,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
6064,GO:0016705,1,0.115432407666639,0,146,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
6065,GO:0016706,1,0.531545771742861,0,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
6066,GO:0016708,1,0.972002401272172,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6067,GO:0016709,1,0.598733113626163,0,35,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6068,GO:0016711,1,0.98459790289113,0,1,flavonoid 3'-monooxygenase activity,MF,
6069,GO:0016712,1,0.70327287935178,0,25,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6070,GO:0016713,1,0.903620599845113,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
6071,GO:0016714,1,0.91044548415349,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
6072,GO:0016715,1,0.936422600052982,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6073,GO:0016716,1,0.970689958119316,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,MF,
6074,GO:0016717,1,0.936688345395905,0,4,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
6075,GO:0016721,1,0.952250782116253,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6076,GO:0016722,1,0.795311097560504,0,15,oxidoreductase activity, oxidizing metal ions,MF,
6077,GO:0016723,1,0.876732786894624,0,8,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6078,GO:0016724,1,0.920675663094066,0,6,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6079,GO:0016725,1,0.855462441657842,0,10,oxidoreductase activity, acting on CH or CH2 groups,MF,
6080,GO:0016726,1,0.967087733487721,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
6081,GO:0016727,1,0.983406759351724,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6082,GO:0016728,1,0.951372534454334,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6083,GO:0016730,1,0.987179557575313,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6084,GO:0016731,1,0.987179557575313,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6087,GO:0016742,1,0.885257836464056,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6088,GO:0016743,1,0.972026693246223,0,2,carboxyl- or carbamoyltransferase activity,MF,
6089,GO:0016744,1,0.946862403137297,0,4,transferase activity, transferring aldehyde or ketonic groups,MF,
6092,GO:0016748,1,0.956703901301271,0,3,succinyltransferase activity,MF,
6093,GO:0016749,1,0.97218367390541,0,2,N-succinyltransferase activity,MF,
6094,GO:0016751,1,0.984079163645405,0,1,S-succinyltransferase activity,MF,
6095,GO:0016755,1,0.740334445997952,0,22,transferase activity, transferring amino-acyl groups,MF,
6098,GO:0016763,1,0.522348172704203,0,47,transferase activity, transferring pentosyl groups,MF,
6099,GO:0016765,1,0.538930234501532,0,53,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6100,GO:0016768,1,0.988204013629405,0,1,spermine synthase activity,MF,
6101,GO:0016769,1,0.764348166477513,0,19,transferase activity, transferring nitrogenous groups,MF,
6104,GO:0016774,1,0.957685207903771,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6106,GO:0016776,1,0.580764126593233,0,39,phosphotransferase activity, phosphate group as acceptor,MF,
6107,GO:0016778,1,0.923142796463484,0,6,diphosphotransferase activity,MF,
6108,GO:0016779,1,0.175757280049374,0,122,nucleotidyltransferase activity,MF,
6109,GO:0016780,1,0.771529851036387,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6110,GO:0016781,1,0.970502461701088,0,2,phosphotransferase activity, paired acceptors,MF,
6111,GO:0016782,1,0.387822893195179,0,69,transferase activity, transferring sulfur-containing groups,MF,
6112,GO:0016783,1,0.873920733935111,0,11,sulfurtransferase activity,MF,
6113,GO:0016784,1,0.989425806755353,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6114,GO:0016785,1,0.983406759351775,0,1,transferase activity, transferring selenium-containing groups,MF,
6119,GO:0016793,1,0.98363590712598,0,1,triphosphoric monoester hydrolase activity,MF,
6120,GO:0016794,1,0.992183337888335,0,1,diphosphoric monoester hydrolase activity,MF,
6121,GO:0016796,1,0.496300165409344,0,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6122,GO:0016798,1,0.210373760864975,0,113,hydrolase activity, acting on glycosyl bonds,MF,
6123,GO:0016799,1,0.755500661353096,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6124,GO:0016801,1,0.884911209393384,0,9,hydrolase activity, acting on ether bonds,MF,
6125,GO:0016802,1,0.985557613879444,0,1,trialkylsulfonium hydrolase activity,MF,
6126,GO:0016803,1,0.897884558885423,0,8,ether hydrolase activity,MF,
6130,GO:0016812,1,0.909569000284331,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6131,GO:0016813,1,0.857090317833447,0,11,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6132,GO:0016814,1,0.632549622039282,0,33,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6133,GO:0016815,1,0.990090677622663,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6136,GO:0016820,1,0.199027288919314,0,111,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,
6137,GO:0016822,1,0.967519659706728,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6138,GO:0016823,1,0.967519659706728,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6139,GO:0016826,1,0.984234941936482,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6141,GO:0016830,1,0.52261355890045,0,46,carbon-carbon lyase activity,MF,
6142,GO:0016831,1,0.631472301499429,0,32,carboxy-lyase activity,MF,
6143,GO:0016832,1,0.883292738866076,0,9,aldehyde-lyase activity,MF,
6144,GO:0016833,1,0.948760950616307,0,4,oxo-acid-lyase activity,MF,
6147,GO:0016838,1,0.992937098316418,0,1,carbon-oxygen lyase activity, acting on phosphates,MF,
6148,GO:0016840,1,0.884927735365748,0,9,carbon-nitrogen lyase activity,MF,
6149,GO:0016841,1,0.936029688615717,0,5,ammonia-lyase activity,MF,
6150,GO:0016842,1,0.960087461697798,0,3,amidine-lyase activity,MF,
6151,GO:0016843,1,0.984725543253726,0,1,amine-lyase activity,MF,
6152,GO:0016844,1,0.984725543253726,0,1,strictosidine synthase activity,MF,
6153,GO:0016846,1,0.92745236276568,0,7,carbon-sulfur lyase activity,MF,
6156,GO:0016854,1,0.833737961085791,0,13,racemase and epimerase activity,MF,
6157,GO:0016855,1,0.984950340754611,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6158,GO:0016857,1,0.874439689994814,0,9,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6159,GO:0016859,1,0.634730262222224,0,40,cis-trans isomerase activity,MF,
6161,GO:0016861,1,0.903491279966783,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6162,GO:0016862,1,0.995657766730681,0,1,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6163,GO:0016863,1,0.873330910152552,0,12,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6164,GO:0016864,1,0.761828112530574,0,18,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6165,GO:0016866,1,0.7027437302842,0,26,intramolecular transferase activity,MF,
6166,GO:0016868,1,0.878664249503779,0,10,intramolecular transferase activity, phosphotransferases,MF,
6167,GO:0016872,1,0.985661028735059,0,1,intramolecular lyase activity,MF,
6169,GO:0016875,1,0.517622890678688,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6170,GO:0016876,1,0.517622890678688,0,44,ligase activity, forming aminoacyl-tRNA and related compounds,MF,
6173,GO:0016879,1,0.494860576585059,0,47,ligase activity, forming carbon-nitrogen bonds,MF,
6174,GO:0016880,1,0.967087733487917,0,2,acid-ammonia (or amide) ligase activity,MF,
6175,GO:0016881,1,0.77382239651865,0,17,acid-amino acid ligase activity,MF,
6176,GO:0016882,1,0.976890288111404,0,2,cyclo-ligase activity,MF,
6177,GO:0016884,1,0.877957315073791,0,9,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6178,GO:0016885,1,0.883430522698297,0,8,ligase activity, forming carbon-carbon bonds,MF,
6179,GO:0016886,1,0.883927903129121,0,8,ligase activity, forming phosphoric ester bonds,MF,
6181,GO:0016888,1,0.861488457581217,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6182,GO:0016889,1,0.852856966095453,0,12,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6183,GO:0016890,1,0.972912218970352,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6184,GO:0016891,1,0.710404368898909,0,26,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6185,GO:0016892,1,0.912933043072067,0,9,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6186,GO:0016893,1,0.630395974569016,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6187,GO:0016894,1,0.778554313519276,0,21,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6188,GO:0016895,1,0.761083217978196,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6189,GO:0016896,1,0.647696288153296,0,30,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6190,GO:0016898,1,0.971401834768343,0,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6191,GO:0016899,1,0.960609814105106,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6192,GO:0016900,1,0.984455821611115,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6193,GO:0016901,1,0.922180744110653,0,5,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6194,GO:0016903,1,0.52505133038643,0,44,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6195,GO:0016907,1,0.928712815255303,0,5,G-protein coupled acetylcholine receptor activity,MF,
6196,GO:0016909,1,0.957176665878615,0,3,SAP kinase activity,MF,
6197,GO:0016913,1,0.987086115204292,0,1,follicle-stimulating hormone activity,MF,
6198,GO:0016917,1,0.712519937445105,0,22,GABA receptor activity,MF,
6199,GO:0016918,1,0.873774040666539,0,13,retinal binding,MF,
6200,GO:0016920,1,0.983406759351379,0,1,pyroglutamyl-peptidase activity,MF,
6201,GO:0016922,1,0.721880658615882,0,21,ligand-dependent nuclear receptor binding,MF,
6202,GO:0016925,1,0.266870774281942,0,88,protein sumoylation,BP,
6203,GO:0016926,1,0.895458558224556,0,7,protein desumoylation,BP,
6204,GO:0016929,1,0.895458558224556,0,7,SUMO-specific protease activity,MF,
6205,GO:0016933,1,0.928360227064824,0,5,extracellular-glycine-gated ion channel activity,MF,
6206,GO:0016934,1,0.928360227064824,0,5,extracellular-glycine-gated chloride channel activity,MF,
6207,GO:0016935,1,0.967493457893562,0,2,glycine-gated chloride channel complex,CC,
6209,GO:0016938,1,0.983918352113631,0,1,kinesin I complex,CC,
6210,GO:0016939,1,0.951456561767071,0,3,kinesin II complex,CC,
6212,GO:0016942,1,0.932346238971181,0,5,insulin-like growth factor binding protein complex,CC,
6213,GO:0016964,1,0.983406759349607,0,1,alpha-2 macroglobulin receptor activity,MF,
6214,GO:0016971,1,0.953245136246905,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6215,GO:0016972,1,0.937424600102217,0,4,thiol oxidase activity,MF,
6216,GO:0016973,1,0.816289110903092,0,14,poly(A)+ mRNA export from nucleus,BP,
6217,GO:0016979,1,0.978208186106717,0,2,lipoate-protein ligase activity,MF,
6218,GO:0016990,1,0.985614351305629,0,1,arginine deiminase activity,MF,
6219,GO:0016992,1,0.98829703302956,0,1,lipoate synthase activity,MF,
6220,GO:0016997,1,0.920878285147598,0,6,alpha-sialidase activity,MF,
6221,GO:0016998,1,0.97980501637295,0,3,cell wall macromolecule catabolic process,BP,
6222,GO:0016999,1,0.971784915612084,0,2,antibiotic metabolic process,BP,
6224,GO:0017003,1,0.985571724528833,0,1,protein-heme linkage,BP,
6225,GO:0017004,1,0.715732156912515,0,26,cytochrome complex assembly,BP,
6226,GO:0017005,1,0.983427383816485,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6227,GO:0017006,1,0.985571724528833,0,1,protein-tetrapyrrole linkage,BP,
6228,GO:0017014,1,0.848157452246932,0,12,protein nitrosylation,BP,
6232,GO:0017018,1,0.93525434782928,0,4,myosin phosphatase activity,MF,
6233,GO:0017020,1,0.984052432056505,0,1,myosin phosphatase regulator activity,MF,
6235,GO:0017024,1,0.993211620676457,0,1,myosin I binding,MF,
6236,GO:0017025,1,0.728985690091159,0,23,TBP-class protein binding,MF,
6237,GO:0017034,1,0.923423011074773,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6239,GO:0017040,1,0.931279667711038,0,5,ceramidase activity,MF,
6240,GO:0017042,1,0.971850033729272,0,2,glycosylceramidase activity,MF,
6241,GO:0017045,1,0.990640755393025,0,1,corticotropin-releasing hormone activity,MF,
6244,GO:0017049,1,0.788018136958221,0,16,GTP-Rho binding,MF,
6245,GO:0017050,1,0.97144109814238,0,2,D-erythro-sphingosine kinase activity,MF,
6247,GO:0017055,1,0.968868144335714,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6248,GO:0017056,1,0.741351664024238,0,19,structural constituent of nuclear pore,MF,
6249,GO:0017057,1,0.975786425282687,0,2,6-phosphogluconolactonase activity,MF,
6250,GO:0017059,1,0.891723091857474,0,8,serine C-palmitoyltransferase complex,CC,
6251,GO:0017060,1,0.95702223397837,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6252,GO:0017061,1,0.983406759351921,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6253,GO:0017062,1,0.940338489279629,0,5,respiratory chain complex III assembly,BP,
6254,GO:0017064,1,0.973097269014845,0,2,fatty acid amide hydrolase activity,MF,
6255,GO:0017065,1,0.988881591441105,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6256,GO:0017069,1,0.658827295483642,0,33,snRNA binding,MF,
6257,GO:0017070,1,0.897431700364388,0,9,U6 snRNA binding,MF,
6258,GO:0017071,1,0.983425476929693,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6259,GO:0017075,1,0.741157654188697,0,19,syntaxin-1 binding,MF,
6261,GO:0017077,1,0.966701092776186,0,3,oxidative phosphorylation uncoupler activity,MF,
6262,GO:0017080,1,0.614392837860259,0,36,sodium channel regulator activity,MF,
6264,GO:0017084,1,0.983473444283871,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6265,GO:0017085,1,0.864150283565689,0,10,response to insecticide,BP,
6266,GO:0017089,1,0.964861343953771,0,3,glycolipid transporter activity,MF,
6267,GO:0017090,1,0.983939765873291,0,1,meprin A complex,CC,
6268,GO:0017091,1,0.716055195654779,0,23,AU-rich element binding,MF,
6269,GO:0017095,1,0.951038493517832,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6270,GO:0017096,1,0.990251360910938,0,1,acetylserotonin O-methyltransferase activity,MF,
6271,GO:0017098,1,0.970255857472735,0,2,sulfonylurea receptor binding,MF,
6272,GO:0017099,1,0.974912219428361,0,2,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6273,GO:0017101,1,0.84812560158505,0,11,aminoacyl-tRNA synthetase multienzyme complex,CC,
6274,GO:0017102,1,0.968616950072418,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6275,GO:0017108,1,0.911480193125661,0,6,5'-flap endonuclease activity,MF,
6276,GO:0017109,1,0.967443258148103,0,2,glutamate-cysteine ligase complex,CC,
6277,GO:0017110,1,0.832314830068914,0,13,nucleoside-diphosphatase activity,MF,
6280,GO:0017113,1,0.983704967407228,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6281,GO:0017116,1,0.968236106160786,0,2,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6282,GO:0017119,1,0.8179075398235,0,13,Golgi transport complex,CC,
6283,GO:0017121,1,0.83714196932526,0,12,phospholipid scrambling,BP,
6285,GO:0017125,1,0.983406759351968,0,1,deoxycytidyl transferase activity,MF,
6286,GO:0017126,1,0.983406759351821,0,1,nucleologenesis,BP,
6287,GO:0017127,1,0.798161313256765,0,17,cholesterol transporter activity,MF,
6288,GO:0017128,1,0.863067526173882,0,10,phospholipid scramblase activity,MF,
6289,GO:0017129,1,0.971632496926859,0,2,triglyceride binding,MF,
6290,GO:0017133,1,0.985345203965664,0,1,mitochondrial electron transfer flavoprotein complex,CC,
6291,GO:0017134,1,0.719810106974348,0,23,fibroblast growth factor binding,MF,
6292,GO:0017136,1,0.798100302218029,0,15,NAD-dependent histone deacetylase activity,MF,
6294,GO:0017143,1,0.969285043337573,0,2,insecticide metabolic process,BP,
6295,GO:0017144,1,0.641520703168554,0,32,drug metabolic process,BP,
6297,GO:0017146,1,0.846038577476687,0,10,NMDA selective glutamate receptor complex,CC,
6300,GO:0017150,1,0.961400644954375,0,3,tRNA dihydrouridine synthase activity,MF,
6301,GO:0017151,1,0.883444211571997,0,8,DEAD/H-box RNA helicase binding,MF,
6302,GO:0017153,1,0.952876107429898,0,3,sodium:dicarboxylate symporter activity,MF,
6303,GO:0017154,1,0.833209323197292,0,11,semaphorin receptor activity,MF,
6307,GO:0017159,1,0.970445906498746,0,2,pantetheine hydrolase activity,MF,
6308,GO:0017160,1,0.82514902233937,0,13,Ral GTPase binding,MF,
6309,GO:0017161,1,0.967087733487576,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6310,GO:0017162,1,0.872261999481669,0,9,aryl hydrocarbon receptor binding,MF,
6311,GO:0017166,1,0.861261824468521,0,9,vinculin binding,MF,
6312,GO:0017168,1,0.983406759352069,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6313,GO:0017169,1,0.911705858498005,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6315,GO:0017172,1,0.988641801818656,0,1,cysteine dioxygenase activity,MF,
6316,GO:0017174,1,0.992006646305284,0,1,glycine N-methyltransferase activity,MF,
6317,GO:0017176,1,0.941097230866084,0,5,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6318,GO:0017177,1,0.983407201548215,0,1,glucosidase II complex,CC,
6319,GO:0017182,1,0.913816705745172,0,6,peptidyl-diphthamide metabolic process,BP,
6320,GO:0017183,1,0.913816705745172,0,6,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6321,GO:0017185,1,0.936117123098919,0,4,peptidyl-lysine hydroxylation,BP,
6322,GO:0017186,1,0.974346209985325,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6323,GO:0017187,1,0.875567520266723,0,11,peptidyl-glutamic acid carboxylation,BP,
6324,GO:0017188,1,0.983406759351673,0,1,aspartate N-acetyltransferase activity,MF,
6325,GO:0017196,1,0.917424439436709,0,6,N-terminal peptidyl-methionine acetylation,BP,
6326,GO:0017198,1,0.982554663822603,0,2,N-terminal peptidyl-serine acetylation,BP,
6327,GO:0018002,1,0.982554663822603,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6328,GO:0018003,1,0.985725070531352,0,2,peptidyl-lysine N6-acetylation,BP,
6330,GO:0018009,1,0.986144116361735,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6331,GO:0018011,1,0.984725543253726,0,1,N-terminal peptidyl-alanine methylation,BP,
6332,GO:0018012,1,0.984725543253726,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6333,GO:0018013,1,0.984725543253726,0,1,N-terminal peptidyl-glycine methylation,BP,
6334,GO:0018016,1,0.984725543253726,0,1,N-terminal peptidyl-proline dimethylation,BP,
6335,GO:0018022,1,0.212238005858509,0,102,peptidyl-lysine methylation,BP,
6336,GO:0018023,1,0.627594240109488,0,32,peptidyl-lysine trimethylation,BP,
6337,GO:0018024,1,0.583749785120594,0,35,histone-lysine N-methyltransferase activity,MF,
6338,GO:0018025,1,0.984725543253726,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6339,GO:0018026,1,0.914651724083068,0,6,peptidyl-lysine monomethylation,BP,
6340,GO:0018027,1,0.801353639709997,0,15,peptidyl-lysine dimethylation,BP,
6341,GO:0018032,1,0.983416035861832,0,1,protein amidation,BP,
6342,GO:0018057,1,0.983700920617932,0,1,peptidyl-lysine oxidation,BP,
6343,GO:0018063,1,0.985571724528833,0,1,cytochrome c-heme linkage,BP,
6344,GO:0018065,1,0.923216920822,0,8,protein-cofactor linkage,BP,
6345,GO:0018076,1,0.935254347827922,0,4,N-terminal peptidyl-lysine acetylation,BP,
6346,GO:0018094,1,0.983499919429225,0,1,protein polyglycylation,BP,
6347,GO:0018095,1,0.882116829921196,0,8,protein polyglutamylation,BP,
6348,GO:0018101,1,0.923820443599718,0,5,protein citrullination,BP,
6349,GO:0018103,1,0.931994466113253,0,5,protein C-linked glycosylation,BP,
6351,GO:0018106,1,0.99439100163279,0,1,peptidyl-histidine phosphorylation,BP,
6354,GO:0018114,1,0.984950340754611,0,1,threonine racemase activity,MF,
6355,GO:0018117,1,0.988439538538966,0,1,protein adenylylation,BP,
6356,GO:0018119,1,0.848157452246932,0,12,peptidyl-cysteine S-nitrosylation,BP,
6358,GO:0018126,1,0.766885271257543,0,17,protein hydroxylation,BP,
6361,GO:0018149,1,0.555184341877032,0,59,peptide cross-linking,BP,
6362,GO:0018153,1,0.970376228906397,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6363,GO:0018158,1,0.904337302814867,0,9,protein oxidation,BP,
6364,GO:0018160,1,0.989458188743017,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6365,GO:0018169,1,0.989137840402046,0,1,ribosomal S6-glutamic acid ligase activity,MF,
6366,GO:0018171,1,0.9656248445695,0,3,peptidyl-cysteine oxidation,BP,
6367,GO:0018175,1,0.988439538538966,0,1,protein nucleotidylation,BP,
6368,GO:0018190,1,0.988380144766829,0,1,protein octanoylation,BP,
6369,GO:0018191,1,0.988380144766829,0,1,peptidyl-serine octanoylation,BP,
6370,GO:0018192,1,0.985027751671993,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6372,GO:0018194,1,0.984725543253726,0,1,peptidyl-alanine modification,BP,
6373,GO:0018195,1,0.719721298435984,0,23,peptidyl-arginine modification,BP,
6374,GO:0018196,1,0.5552588255775,0,44,peptidyl-asparagine modification,BP,
6375,GO:0018197,1,0.9510605000625,0,3,peptidyl-aspartic acid modification,BP,
6377,GO:0018199,1,0.945479335042195,0,4,peptidyl-glutamine modification,BP,
6378,GO:0018200,1,0.656600402808209,0,30,peptidyl-glutamic acid modification,BP,
6380,GO:0018202,1,0.893605146295266,0,8,peptidyl-histidine modification,BP,
6382,GO:0018206,1,0.857855261734727,0,12,peptidyl-methionine modification,BP,
6383,GO:0018208,1,0.542927279597885,0,50,peptidyl-proline modification,BP,
6386,GO:0018211,1,0.931994466113253,0,5,peptidyl-tryptophan modification,BP,
6388,GO:0018214,1,0.875567520266723,0,11,protein carboxylation,BP,
6389,GO:0018216,1,0.800265245216735,0,15,peptidyl-arginine methylation,BP,
6390,GO:0018217,1,0.983406759353248,0,1,peptidyl-aspartic acid phosphorylation,BP,
6391,GO:0018230,1,0.909486821980072,0,6,peptidyl-L-cysteine S-palmitoylation,BP,
6392,GO:0018231,1,0.909486821980072,0,6,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6393,GO:0018242,1,0.936674820576729,0,4,protein O-linked glycosylation via serine,BP,
6394,GO:0018243,1,0.936286989025561,0,4,protein O-linked glycosylation via threonine,BP,
6395,GO:0018262,1,0.970376228906397,0,2,isopeptide cross-linking,BP,
6396,GO:0018271,1,0.983406759351672,0,1,biotin-protein ligase activity,MF,
6397,GO:0018272,1,0.987935314300946,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6398,GO:0018277,1,0.968967623155032,0,2,protein deamination,BP,
6399,GO:0018279,1,0.564650243130435,0,43,protein N-linked glycosylation via asparagine,BP,
6400,GO:0018282,1,0.968913217729738,0,2,metal incorporation into metallo-sulfur cluster,BP,
6401,GO:0018283,1,0.968913217729738,0,2,iron incorporation into metallo-sulfur cluster,BP,
6402,GO:0018293,1,0.991090539462019,0,1,protein-FAD linkage,BP,
6403,GO:0018298,1,0.844869315650296,0,13,protein-chromophore linkage,BP,
6404,GO:0018307,1,0.978070161006968,0,2,enzyme active site formation,BP,
6405,GO:0018312,1,0.970893566336357,0,2,peptidyl-serine ADP-ribosylation,BP,
6406,GO:0018315,1,0.98340675935207,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6407,GO:0018317,1,0.931994466113253,0,5,protein C-linked glycosylation via tryptophan,BP,
6408,GO:0018323,1,0.992937098316418,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6409,GO:0018342,1,0.861477257019076,0,10,protein prenylation,BP,
6410,GO:0018343,1,0.957616356328066,0,3,protein farnesylation,BP,
6411,GO:0018344,1,0.904459259564578,0,7,protein geranylgeranylation,BP,
6412,GO:0018345,1,0.695534423768904,0,24,protein palmitoylation,BP,
6413,GO:0018350,1,0.985227329702288,0,1,protein esterification,BP,
6414,GO:0018352,1,0.973404349508799,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6415,GO:0018364,1,0.986900520705067,0,2,peptidyl-glutamine methylation,BP,
6419,GO:0018395,1,0.983431384306763,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6420,GO:0018400,1,0.983406759351479,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6421,GO:0018401,1,0.925044290789592,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6422,GO:0018406,1,0.931994466113253,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6424,GO:0018423,1,0.990536284126743,0,1,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6425,GO:0018444,1,0.967769870042315,0,2,translation release factor complex,CC,
6426,GO:0018455,1,0.990621715844573,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6427,GO:0018467,1,0.984509025344987,0,1,formaldehyde dehydrogenase activity,MF,
6428,GO:0018478,1,0.985951929448957,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6429,GO:0018479,1,0.97418953094798,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6430,GO:0018585,1,0.986039277939019,0,1,fluorene oxygenase activity,MF,
6431,GO:0018636,1,0.970545043139177,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6432,GO:0018675,1,0.97689149140805,0,2,(S)-limonene 6-monooxygenase activity,MF,
6433,GO:0018676,1,0.97689149140805,0,2,(S)-limonene 7-monooxygenase activity,MF,
6434,GO:0018685,1,0.94625604459069,0,4,alkane 1-monooxygenase activity,MF,
6435,GO:0018733,1,0.99117521259016,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6436,GO:0018738,1,0.991155641549848,0,1,S-formylglutathione hydrolase activity,MF,
6437,GO:0018773,1,0.988273030974696,0,1,acetylpyruvate hydrolase activity,MF,
6438,GO:0018872,1,0.984979862530102,0,1,arsonoacetate metabolic process,BP,
6439,GO:0018874,1,0.986460711287939,0,1,benzoate metabolic process,BP,
6440,GO:0018879,1,0.942170217573744,0,4,biphenyl metabolic process,BP,
6441,GO:0018885,1,0.98832109233532,0,1,carbon tetrachloride metabolic process,BP,
6442,GO:0018894,1,0.93923295012629,0,4,dibenzo-p-dioxin metabolic process,BP,
6443,GO:0018904,1,0.854998868116913,0,13,ether metabolic process,BP,
6444,GO:0018910,1,0.98832109233532,0,1,benzene metabolic process,BP,
6445,GO:0018916,1,0.965598225376102,0,3,nitrobenzene metabolic process,BP,
6446,GO:0018917,1,0.986039277939019,0,1,fluorene metabolic process,BP,
6447,GO:0018931,1,0.977480011558776,0,2,naphthalene metabolic process,BP,
6449,GO:0018963,1,0.957264708404657,0,3,phthalate metabolic process,BP,
6450,GO:0018964,1,0.98340675935207,0,1,propylene metabolic process,BP,
6451,GO:0018969,1,0.984003532653388,0,1,thiocyanate metabolic process,BP,
6452,GO:0018979,1,0.987501068351727,0,1,trichloroethylene metabolic process,BP,
6453,GO:0018992,1,0.967087973900934,0,2,germ-line sex determination,BP,
6454,GO:0018993,1,0.968036283750119,0,2,somatic sex determination,BP,
6455,GO:0018995,1,0.809568939366363,0,14,host,CC,
6457,GO:0019002,1,0.972155164617602,0,2,GMP binding,MF,
6459,GO:0019005,1,0.48606948473845,0,50,SCF ubiquitin ligase complex,CC,
6460,GO:0019008,1,0.973302508096372,0,2,molybdopterin synthase complex,CC,
6461,GO:0019012,1,0.94028228781709,0,4,virion,CC,
6462,GO:0019028,1,0.984725543253726,0,1,viral capsid,CC,
6463,GO:0019031,1,0.954870180769942,0,3,viral envelope,CC,
6464,GO:0019034,1,0.967087733488009,0,2,viral replication complex,CC,
6465,GO:0019035,1,0.983406759351724,0,1,viral integration complex,CC,
6466,GO:0019042,1,0.853355457773199,0,11,viral latency,BP,
6467,GO:0019043,1,0.882412461884144,0,9,establishment of viral latency,BP,
6468,GO:0019045,1,0.967087733486655,0,2,latent virus replication,BP,
6469,GO:0019046,1,0.967087733486655,0,2,release from viral latency,BP,
6470,GO:0019048,1,0.589474871250844,0,35,modulation by virus of host morphology or physiology,BP,
6471,GO:0019049,1,0.954368713501299,0,3,evasion or tolerance of host defenses by virus,BP,
6472,GO:0019050,1,0.961570583294691,0,3,suppression by virus of host apoptotic process,BP,
6473,GO:0019054,1,0.719730179455226,0,22,modulation by virus of host process,BP,
6474,GO:0019056,1,0.984041436430165,0,1,modulation by virus of host transcription,BP,
6476,GO:0019060,1,0.93476603090351,0,5,intracellular transport of viral protein in host cell,BP,
6477,GO:0019061,1,0.985617923484445,0,1,uncoating of virus,BP,
6480,GO:0019065,1,0.952262832346246,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6481,GO:0019068,1,0.602593361799947,0,37,virion assembly,BP,
6482,GO:0019072,1,0.967087733487721,0,2,viral genome packaging,BP,
6483,GO:0019074,1,0.967087733487721,0,2,viral RNA genome packaging,BP,
6484,GO:0019075,1,0.969683443564638,0,2,virus maturation,BP,
6485,GO:0019076,1,0.587562307162153,0,35,viral release from host cell,BP,
6487,GO:0019080,1,0.134050601188342,0,185,viral gene expression,BP,
6488,GO:0019081,1,0.870619327624669,0,10,viral translation,BP,
6489,GO:0019082,1,0.983406759352069,0,1,viral protein processing,BP,
6490,GO:0019083,1,0.156759248219998,0,174,viral transcription,BP,
6491,GO:0019085,1,0.967232248402633,0,2,early viral transcription,BP,
6492,GO:0019086,1,0.944496303996769,0,4,late viral transcription,BP,
6493,GO:0019087,1,0.958634940355855,0,3,transformation of host cell by virus,BP,
6494,GO:0019088,1,0.988791781330131,0,1,immortalization of host cell by virus,BP,
6495,GO:0019089,1,0.983406759351574,0,1,transmission of virus,BP,
6496,GO:0019098,1,0.659141485807669,0,29,reproductive behavior,BP,
6497,GO:0019100,1,0.967087973900934,0,2,male germ-line sex determination,BP,
6498,GO:0019101,1,0.983979644948429,0,1,female somatic sex determination,BP,
6499,GO:0019102,1,0.983798136705563,0,1,male somatic sex determination,BP,
6500,GO:0019103,1,0.940293608282892,0,5,pyrimidine nucleotide binding,MF,
6501,GO:0019104,1,0.842866120386217,0,14,DNA N-glycosylase activity,MF,
6503,GO:0019113,1,0.97689149140805,0,2,limonene monooxygenase activity,MF,
6504,GO:0019115,1,0.986799429902972,0,1,benzaldehyde dehydrogenase activity,MF,
6505,GO:0019118,1,0.990090677622663,0,1,phenanthrene-epoxide hydrolase activity,MF,
6506,GO:0019119,1,0.990090677622663,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6507,GO:0019135,1,0.987233815199494,0,1,deoxyhypusine monooxygenase activity,MF,
6508,GO:0019136,1,0.950068965590897,0,4,deoxynucleoside kinase activity,MF,
6509,GO:0019144,1,0.98025216759723,0,2,ADP-sugar diphosphatase activity,MF,
6510,GO:0019145,1,0.984875059645845,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6511,GO:0019153,1,0.988719320625189,0,1,protein-disulfide reductase (glutathione) activity,MF,
6512,GO:0019158,1,0.935597904174762,0,4,mannokinase activity,MF,
6513,GO:0019166,1,0.961830445212872,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6515,GO:0019184,1,0.790219111544545,0,17,nonribosomal peptide biosynthetic process,BP,
6516,GO:0019185,1,0.968136572184272,0,2,snRNA-activating protein complex,CC,
6517,GO:0019187,1,0.983406887266048,0,1,beta-1,4-mannosyltransferase activity,MF,
6518,GO:0019198,1,0.767146303712841,0,16,transmembrane receptor protein phosphatase activity,MF,
6521,GO:0019201,1,0.693304882646771,0,24,nucleotide kinase activity,MF,
6522,GO:0019202,1,0.983473444283871,0,1,amino acid kinase activity,MF,
6524,GO:0019205,1,0.522770583829425,0,47,nucleobase-containing compound kinase activity,MF,
6525,GO:0019206,1,0.835441724444601,0,13,nucleoside kinase activity,MF,
6531,GO:0019212,1,0.615957100670244,0,35,phosphatase inhibitor activity,MF,
6542,GO:0019227,1,0.904903549418185,0,7,neuronal action potential propagation,BP,
6543,GO:0019228,1,0.602519327655379,0,33,neuronal action potential,BP,
6545,GO:0019230,1,0.941875059812739,0,4,proprioception,BP,
6547,GO:0019236,1,0.937177754023071,0,7,response to pheromone,BP,
6548,GO:0019237,1,0.921770345499596,0,5,centromeric DNA binding,MF,
6549,GO:0019238,1,0.914409499783407,0,6,cyclohydrolase activity,MF,
6550,GO:0019239,1,0.691116430950978,0,27,deaminase activity,MF,
6551,GO:0019240,1,0.924491965261821,0,5,citrulline biosynthetic process,BP,
6552,GO:0019242,1,0.986339390427225,0,1,methylglyoxal biosynthetic process,BP,
6553,GO:0019243,1,0.972950869596186,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6554,GO:0019244,1,0.990749018916122,0,1,lactate biosynthetic process from pyruvate,BP,
6555,GO:0019249,1,0.967426460106986,0,3,lactate biosynthetic process,BP,
6556,GO:0019254,1,0.95433611809505,0,3,carnitine metabolic process, CoA-linked,BP,
6557,GO:0019255,1,0.973011245459887,0,2,glucose 1-phosphate metabolic process,BP,
6558,GO:0019262,1,0.955431341287803,0,4,N-acetylneuraminate catabolic process,BP,
6559,GO:0019264,1,0.970966727516621,0,2,glycine biosynthetic process from serine,BP,
6560,GO:0019265,1,0.974557144417809,0,2,glycine biosynthetic process, by transamination of glyoxylate,BP,
6561,GO:0019276,1,0.95565166200689,0,3,UDP-N-acetylgalactosamine metabolic process,BP,
6562,GO:0019285,1,0.967145225332229,0,2,glycine betaine biosynthetic process from choline,BP,
6563,GO:0019287,1,0.964966627944563,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6564,GO:0019290,1,0.983961000675291,0,1,siderophore biosynthetic process,BP,
6565,GO:0019303,1,0.982292393332779,0,2,D-ribose catabolic process,BP,
6566,GO:0019310,1,0.989618254127934,0,1,inositol catabolic process,BP,
6567,GO:0019317,1,0.865450419354663,0,9,fucose catabolic process,BP,
6571,GO:0019321,1,0.867126524228477,0,12,pentose metabolic process,BP,
6572,GO:0019322,1,0.950382653586555,0,4,pentose biosynthetic process,BP,
6573,GO:0019323,1,0.944319377088761,0,5,pentose catabolic process,BP,
6574,GO:0019336,1,0.872260838366292,0,9,phenol-containing compound catabolic process,BP,
6575,GO:0019341,1,0.98459790289113,0,1,dibenzo-p-dioxin catabolic process,BP,
6576,GO:0019343,1,0.972735829113111,0,2,cysteine biosynthetic process via cystathionine,BP,
6577,GO:0019344,1,0.958441904158277,0,3,cysteine biosynthetic process,BP,
6578,GO:0019346,1,0.946539930032596,0,4,transsulfuration,BP,
6579,GO:0019348,1,0.936758794236529,0,5,dolichol metabolic process,BP,
6580,GO:0019355,1,0.954890586254582,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6581,GO:0019359,1,0.686958891513045,0,26,nicotinamide nucleotide biosynthetic process,BP,
6583,GO:0019363,1,0.686958891513045,0,26,pyridine nucleotide biosynthetic process,BP,
6584,GO:0019364,1,0.976431204174188,0,2,pyridine nucleotide catabolic process,BP,
6585,GO:0019367,1,0.902186315265529,0,7,fatty acid elongation, saturated fatty acid,BP,
6586,GO:0019368,1,0.932387738686122,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6588,GO:0019370,1,0.842331978092098,0,16,leukotriene biosynthetic process,BP,
6590,GO:0019372,1,0.818050152058877,0,16,lipoxygenase pathway,BP,
6591,GO:0019373,1,0.756478497073031,0,20,epoxygenase P450 pathway,BP,
6592,GO:0019374,1,0.918456275062477,0,6,galactolipid metabolic process,BP,
6593,GO:0019375,1,0.971894908170225,0,2,galactolipid biosynthetic process,BP,
6594,GO:0019376,1,0.973482130097716,0,2,galactolipid catabolic process,BP,
6595,GO:0019377,1,0.822187775559537,0,14,glycolipid catabolic process,BP,
6596,GO:0019388,1,0.910907394085937,0,7,galactose catabolic process,BP,
6597,GO:0019389,1,0.984516272748412,0,1,glucuronoside metabolic process,BP,
6598,GO:0019391,1,0.984516272748412,0,1,glucuronoside catabolic process,BP,
6600,GO:0019400,1,0.780586099870478,0,19,alditol metabolic process,BP,
6601,GO:0019401,1,0.929672258866497,0,5,alditol biosynthetic process,BP,
6602,GO:0019402,1,0.99009682862248,0,1,galactitol metabolic process,BP,
6603,GO:0019405,1,0.915059131875606,0,6,alditol catabolic process,BP,
6604,GO:0019406,1,0.989852633883451,0,1,hexitol biosynthetic process,BP,
6605,GO:0019407,1,0.98481024597292,0,1,hexitol catabolic process,BP,
6606,GO:0019408,1,0.983406759351968,0,1,dolichol biosynthetic process,BP,
6607,GO:0019413,1,0.967536380030334,0,2,acetate biosynthetic process,BP,
6608,GO:0019417,1,0.967133691613255,0,2,sulfur oxidation,BP,
6609,GO:0019418,1,0.965733124527607,0,3,sulfide oxidation,BP,
6610,GO:0019427,1,0.967536380030334,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6612,GO:0019432,1,0.554509802669471,0,40,triglyceride biosynthetic process,BP,
6616,GO:0019441,1,0.912731723928832,0,7,tryptophan catabolic process to kynurenine,BP,
6617,GO:0019442,1,0.977647907981413,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6618,GO:0019448,1,0.962422288376796,0,3,L-cysteine catabolic process,BP,
6620,GO:0019470,1,0.940543843330018,0,4,4-hydroxyproline catabolic process,BP,
6621,GO:0019471,1,0.863946203028884,0,10,4-hydroxyproline metabolic process,BP,
6622,GO:0019474,1,0.939835550948735,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6623,GO:0019477,1,0.939835550948735,0,4,L-lysine catabolic process,BP,
6624,GO:0019478,1,0.977434131926749,0,2,D-amino acid catabolic process,BP,
6625,GO:0019481,1,0.985704574923737,0,1,L-alanine catabolic process, by transamination,BP,
6626,GO:0019482,1,0.941077858396984,0,4,beta-alanine metabolic process,BP,
6627,GO:0019483,1,0.970335714400827,0,2,beta-alanine biosynthetic process,BP,
6628,GO:0019509,1,0.934588529981625,0,5,L-methionine salvage from methylthioadenosine,BP,
6629,GO:0019510,1,0.985557613879444,0,1,S-adenosylhomocysteine catabolic process,BP,
6630,GO:0019511,1,0.84714531569695,0,11,peptidyl-proline hydroxylation,BP,
6631,GO:0019516,1,0.975534394116345,0,2,lactate oxidation,BP,
6632,GO:0019518,1,0.988797374227199,0,1,L-threonine catabolic process to glycine,BP,
6633,GO:0019519,1,0.98481024597292,0,1,pentitol metabolic process,BP,
6634,GO:0019520,1,0.971890199277356,0,2,aldonic acid metabolic process,BP,
6635,GO:0019521,1,0.971890199277356,0,2,D-gluconate metabolic process,BP,
6636,GO:0019527,1,0.98481024597292,0,1,pentitol catabolic process,BP,
6637,GO:0019530,1,0.898068729212364,0,7,taurine metabolic process,BP,
6638,GO:0019531,1,0.836663189854437,0,11,oxalate transmembrane transporter activity,MF,
6639,GO:0019532,1,0.82719487883723,0,12,oxalate transport,BP,
6640,GO:0019534,1,0.924654037295503,0,5,toxin transporter activity,MF,
6642,GO:0019541,1,0.967536380030334,0,2,propionate metabolic process,BP,
6643,GO:0019542,1,0.967536380030334,0,2,propionate biosynthetic process,BP,
6644,GO:0019546,1,0.985614351305629,0,1,arginine deiminase pathway,BP,
6645,GO:0019547,1,0.989570637951256,0,1,arginine catabolic process to ornithine,BP,
6646,GO:0019550,1,0.971408105835176,0,2,glutamate catabolic process to aspartate,BP,
6647,GO:0019551,1,0.971408105835176,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6648,GO:0019556,1,0.941806894315328,0,4,histidine catabolic process to glutamate and formamide,BP,
6649,GO:0019557,1,0.941806894315328,0,4,histidine catabolic process to glutamate and formate,BP,
6650,GO:0019563,1,0.929177372679634,0,5,glycerol catabolic process,BP,
6651,GO:0019566,1,0.984725543253726,0,1,arabinose metabolic process,BP,
6652,GO:0019585,1,0.73304554121576,0,22,glucuronate metabolic process,BP,
6653,GO:0019605,1,0.986460711287939,0,1,butyrate metabolic process,BP,
6654,GO:0019614,1,0.884384687367106,0,8,catechol-containing compound catabolic process,BP,
6655,GO:0019626,1,0.934940841007191,0,5,short-chain fatty acid catabolic process,BP,
6656,GO:0019627,1,0.842883736756411,0,13,urea metabolic process,BP,
6658,GO:0019640,1,0.941944323047372,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6662,GO:0019673,1,0.92585037479655,0,7,GDP-mannose metabolic process,BP,
6664,GO:0019676,1,0.969729010931953,0,2,ammonia assimilation cycle,BP,
6665,GO:0019677,1,0.983467280377892,0,1,NAD catabolic process,BP,
6667,GO:0019692,1,0.702573659967718,0,29,deoxyribose phosphate metabolic process,BP,
6669,GO:0019694,1,0.898068729212364,0,7,alkanesulfonate metabolic process,BP,
6670,GO:0019695,1,0.86424449344438,0,9,choline metabolic process,BP,
6671,GO:0019706,1,0.68425584973208,0,26,protein-cysteine S-palmitoyltransferase activity,MF,
6672,GO:0019707,1,0.68425584973208,0,26,protein-cysteine S-acyltransferase activity,MF,
6673,GO:0019720,1,0.914333788301599,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6678,GO:0019731,1,0.729162086587612,0,39,antibacterial humoral response,BP,
6679,GO:0019732,1,0.970235141285895,0,2,antifungal humoral response,BP,
6680,GO:0019740,1,0.947734419171315,0,4,nitrogen utilization,BP,
6681,GO:0019742,1,0.985174651492059,0,1,pentacyclic triterpenoid metabolic process,BP,
6682,GO:0019747,1,0.967992920785765,0,3,regulation of isoprenoid metabolic process,BP,
6684,GO:0019751,1,0.215278560868947,0,105,polyol metabolic process,BP,
6686,GO:0019755,1,0.87417731986125,0,10,one-carbon compound transport,BP,
6687,GO:0019763,1,0.951542777350376,0,5,immunoglobulin receptor activity,MF,
6688,GO:0019767,1,0.986816400751674,0,2,IgE receptor activity,MF,
6689,GO:0019770,1,0.98784318268749,0,1,IgG receptor activity,MF,
6690,GO:0019773,1,0.932022301736711,0,8,proteasome core complex, alpha-subunit complex,CC,
6691,GO:0019774,1,0.994216054708451,0,1,proteasome core complex, beta-subunit complex,CC,
6692,GO:0019776,1,0.958396025521159,0,3,Atg8 ligase activity,MF,
6693,GO:0019777,1,0.976288711990786,0,2,Atg12 transferase activity,MF,
6694,GO:0019778,1,0.983406759351921,0,1,Atg12 activating enzyme activity,MF,
6695,GO:0019780,1,0.983406759351527,0,1,FAT10 activating enzyme activity,MF,
6696,GO:0019781,1,0.973942617812615,0,2,NEDD8 activating enzyme activity,MF,
6697,GO:0019782,1,0.983541384586077,0,1,ISG15 activating enzyme activity,MF,
6698,GO:0019783,1,0.159510847743539,0,119,ubiquitin-like protein-specific protease activity,MF,
6699,GO:0019784,1,0.926249249111866,0,6,NEDD8-specific protease activity,MF,
6700,GO:0019785,1,0.970174937510844,0,2,ISG15-specific protease activity,MF,
6702,GO:0019788,1,0.94847514314042,0,5,NEDD8 transferase activity,MF,
6703,GO:0019789,1,0.795715846496505,0,16,SUMO transferase activity,MF,
6704,GO:0019798,1,0.94140893807676,0,4,procollagen-proline dioxygenase activity,MF,
6705,GO:0019799,1,0.984725543253726,0,1,tubulin N-acetyltransferase activity,MF,
6706,GO:0019800,1,0.913222586147789,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6707,GO:0019805,1,0.963757094608705,0,3,quinolinate biosynthetic process,BP,
6708,GO:0019807,1,0.989962050830271,0,1,aspartoacylase activity,MF,
6709,GO:0019808,1,0.96181409040487,0,3,polyamine binding,MF,
6710,GO:0019809,1,0.977867063732007,0,2,spermidine binding,MF,
6711,GO:0019810,1,0.983585198051488,0,1,putrescine binding,MF,
6712,GO:0019811,1,0.983406759352021,0,1,cocaine binding,MF,
6713,GO:0019814,1,0.944820538070975,0,5,immunoglobulin complex,CC,
6714,GO:0019815,1,0.965646519543916,0,3,B cell receptor complex,CC,
6715,GO:0019825,1,0.574627888601623,0,46,oxygen binding,MF,
6716,GO:0019826,1,0.953759995080837,0,3,oxygen sensor activity,MF,
6718,GO:0019828,1,0.979099397101216,0,2,aspartic-type endopeptidase inhibitor activity,MF,
6719,GO:0019829,1,0.435938059259246,0,63,cation-transporting ATPase activity,MF,
6720,GO:0019834,1,0.964075405022944,0,4,phospholipase A2 inhibitor activity,MF,
6721,GO:0019835,1,0.683341299030704,0,31,cytolysis,BP,
6722,GO:0019836,1,0.970300521909226,0,2,hemolysis by symbiont of host erythrocytes,BP,
6725,GO:0019841,1,0.882972204532875,0,13,retinol binding,MF,
6727,GO:0019843,1,0.611777419480406,0,49,rRNA binding,MF,
6728,GO:0019852,1,0.865288890440596,0,11,L-ascorbic acid metabolic process,BP,
6729,GO:0019853,1,0.976604401976937,0,2,L-ascorbic acid biosynthetic process,BP,
6730,GO:0019855,1,0.914045292383316,0,8,calcium channel inhibitor activity,MF,
6731,GO:0019856,1,0.908841142375912,0,6,pyrimidine nucleobase biosynthetic process,BP,
6732,GO:0019857,1,0.983406759350788,0,1,5-methylcytosine metabolic process,BP,
6733,GO:0019858,1,0.960112203437269,0,3,cytosine metabolic process,BP,
6734,GO:0019859,1,0.956479576716435,0,3,thymine metabolic process,BP,
6735,GO:0019860,1,0.959234883794737,0,3,uracil metabolic process,BP,
6736,GO:0019862,1,0.978655795812172,0,2,IgA binding,MF,
6737,GO:0019863,1,0.95129642983234,0,5,IgE binding,MF,
6738,GO:0019864,1,0.884020148733891,0,11,IgG binding,MF,
6739,GO:0019865,1,0.781577861153945,0,21,immunoglobulin binding,MF,
6743,GO:0019870,1,0.903723639740304,0,7,potassium channel inhibitor activity,MF,
6744,GO:0019871,1,0.926500596851514,0,5,sodium channel inhibitor activity,MF,
6745,GO:0019878,1,0.984061834709197,0,1,lysine biosynthetic process via aminoadipic acid,BP,
6747,GO:0019883,1,0.853495941148952,0,11,antigen processing and presentation of endogenous antigen,BP,
6749,GO:0019885,1,0.901502288342012,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6750,GO:0019886,1,0.286062455861353,0,90,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6752,GO:0019888,1,0.370047695512743,0,69,protein phosphatase regulator activity,MF,
6754,GO:0019896,1,0.883197143221855,0,8,axonal transport of mitochondrion,BP,
6764,GO:0019907,1,0.91190148487271,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6765,GO:0019908,1,0.795529271725193,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6766,GO:0019911,1,0.871544453369817,0,10,structural constituent of myelin sheath,MF,
6768,GO:0019915,1,0.415589646346647,0,62,lipid storage,BP,
6769,GO:0019918,1,0.955649416397207,0,3,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6770,GO:0019919,1,0.944673713617665,0,4,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6772,GO:0019933,1,0.512271310205784,0,48,cAMP-mediated signaling,BP,
6776,GO:0019948,1,0.969666105604164,0,2,SUMO activating enzyme activity,MF,
6779,GO:0019956,1,0.755071327552777,0,19,chemokine binding,MF,
6780,GO:0019957,1,0.904990942183136,0,7,C-C chemokine binding,MF,
6781,GO:0019958,1,0.92535253189998,0,5,C-X-C chemokine binding,MF,
6782,GO:0019959,1,0.953341585570729,0,3,interleukin-8 binding,MF,
6783,GO:0019960,1,0.919967654674239,0,5,C-X3-C chemokine binding,MF,
6784,GO:0019961,1,0.967154427093346,0,2,interferon binding,MF,
6785,GO:0019962,1,0.983406759351627,0,1,type I interferon binding,MF,
6786,GO:0019964,1,0.983474573701154,0,1,interferon-gamma binding,MF,
6787,GO:0019966,1,0.893400800046584,0,8,interleukin-1 binding,MF,
6788,GO:0019969,1,0.983416863350452,0,1,interleukin-10 binding,MF,
6789,GO:0019970,1,0.983638474406083,0,1,interleukin-11 binding,MF,
6790,GO:0019972,1,0.975151702846691,0,2,interleukin-12 binding,MF,
6791,GO:0019975,1,0.98964212161881,0,1,interleukin-17 binding,MF,
6792,GO:0019976,1,0.956717005183079,0,3,interleukin-2 binding,MF,
6793,GO:0019981,1,0.967315619071654,0,2,interleukin-6 binding,MF,
6794,GO:0019983,1,0.986053003073054,0,1,interleukin-9 binding,MF,
6795,GO:0019985,1,0.588506663693437,0,38,translesion synthesis,BP,
6796,GO:0019988,1,0.984275768717627,0,1,charged-tRNA amino acid modification,BP,
6797,GO:0019992,1,0.84195756348777,0,11,diacylglycerol binding,MF,
6798,GO:0020003,1,0.984267498897298,0,1,symbiont-containing vacuole,CC,
6799,GO:0020005,1,0.984267498897298,0,1,symbiont-containing vacuole membrane,CC,
6800,GO:0020012,1,0.984363538817272,0,1,evasion or tolerance of host immune response,BP,
6801,GO:0020016,1,0.951108921304956,0,3,ciliary pocket,CC,
6802,GO:0020018,1,0.951108921304956,0,3,ciliary pocket membrane,CC,
6803,GO:0020021,1,0.988791781330131,0,1,immortalization of host cell,BP,
6804,GO:0020027,1,0.8182062700454,0,15,hemoglobin metabolic process,BP,
6806,GO:0021501,1,0.986347676726532,0,1,prechordal plate formation,BP,
6808,GO:0021503,1,0.983406759351034,0,1,neural fold bending,BP,
6809,GO:0021508,1,0.983406759351477,0,1,floor plate formation,BP,
6810,GO:0021509,1,0.986754997942783,0,1,roof plate formation,BP,
6812,GO:0021511,1,0.712571342771978,0,23,spinal cord patterning,BP,
6813,GO:0021512,1,0.98340675935207,0,1,spinal cord anterior/posterior patterning,BP,
6814,GO:0021513,1,0.736853036856036,0,21,spinal cord dorsal/ventral patterning,BP,
6815,GO:0021514,1,0.795541426514452,0,16,ventral spinal cord interneuron differentiation,BP,
6817,GO:0021516,1,0.751179946585415,0,21,dorsal spinal cord development,BP,
6818,GO:0021517,1,0.532258052714225,0,44,ventral spinal cord development,BP,
6819,GO:0021519,1,0.990609033835784,0,1,spinal cord association neuron specification,BP,
6820,GO:0021520,1,0.850471477887962,0,12,spinal cord motor neuron cell fate specification,BP,
6821,GO:0021521,1,0.875259243032138,0,10,ventral spinal cord interneuron specification,BP,
6822,GO:0021522,1,0.637843581928876,0,32,spinal cord motor neuron differentiation,BP,
6823,GO:0021523,1,0.932745657483427,0,5,somatic motor neuron differentiation,BP,
6824,GO:0021524,1,0.961229704677867,0,3,visceral motor neuron differentiation,BP,
6825,GO:0021526,1,0.972742337269204,0,2,medial motor column neuron differentiation,BP,
6826,GO:0021527,1,0.825429487720996,0,14,spinal cord association neuron differentiation,BP,
6827,GO:0021528,1,0.984725543253726,0,1,commissural neuron differentiation in spinal cord,BP,
6828,GO:0021529,1,0.956935605043771,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6829,GO:0021530,1,0.956935605043771,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6832,GO:0021534,1,0.859034290707227,0,11,cell proliferation in hindbrain,BP,
6833,GO:0021535,1,0.799897735995161,0,14,cell migration in hindbrain,BP,
6836,GO:0021538,1,0.967136918705144,0,2,epithalamus development,BP,
6837,GO:0021539,1,0.97472504567581,0,2,subthalamus development,BP,
6838,GO:0021540,1,0.937424362969724,0,4,corpus callosum morphogenesis,BP,
6839,GO:0021541,1,0.98340675935207,0,1,ammon gyrus development,BP,
6840,GO:0021542,1,0.768267386400478,0,17,dentate gyrus development,BP,
6843,GO:0021545,1,0.504187319198909,0,48,cranial nerve development,BP,
6844,GO:0021546,1,0.91355337180578,0,7,rhombomere development,BP,
6845,GO:0021547,1,0.986347676726532,0,1,midbrain-hindbrain boundary initiation,BP,
6846,GO:0021548,1,0.865222421628,0,10,pons development,BP,
6848,GO:0021550,1,0.969027608310221,0,2,medulla oblongata development,BP,
6849,GO:0021551,1,0.969237826023181,0,2,central nervous system morphogenesis,BP,
6850,GO:0021553,1,0.952097559925458,0,3,olfactory nerve development,BP,
6851,GO:0021554,1,0.847317279588526,0,12,optic nerve development,BP,
6852,GO:0021555,1,0.958520478600793,0,4,midbrain-hindbrain boundary morphogenesis,BP,
6853,GO:0021557,1,0.956636273116765,0,4,oculomotor nerve development,BP,
6854,GO:0021558,1,0.972627976982734,0,3,trochlear nerve development,BP,
6855,GO:0021559,1,0.853601521393228,0,11,trigeminal nerve development,BP,
6856,GO:0021560,1,0.968840314744285,0,2,abducens nerve development,BP,
6857,GO:0021561,1,0.861158806451883,0,10,facial nerve development,BP,
6858,GO:0021562,1,0.894114978542705,0,8,vestibulocochlear nerve development,BP,
6859,GO:0021563,1,0.922014002788158,0,5,glossopharyngeal nerve development,BP,
6860,GO:0021564,1,0.956601024376364,0,3,vagus nerve development,BP,
6861,GO:0021566,1,0.983406759351921,0,1,hypoglossal nerve development,BP,
6862,GO:0021568,1,0.97819160705554,0,2,rhombomere 2 development,BP,
6863,GO:0021569,1,0.961083576598347,0,3,rhombomere 3 development,BP,
6864,GO:0021570,1,0.981205873206194,0,2,rhombomere 4 development,BP,
6865,GO:0021571,1,0.960494673238096,0,3,rhombomere 5 development,BP,
6866,GO:0021572,1,0.983528093274303,0,1,rhombomere 6 development,BP,
6868,GO:0021576,1,0.985592982661204,0,1,hindbrain formation,BP,
6869,GO:0021577,1,0.968301912777757,0,2,hindbrain structural organization,BP,
6870,GO:0021578,1,0.91056825898782,0,6,hindbrain maturation,BP,
6871,GO:0021586,1,0.95254724860776,0,3,pons maturation,BP,
6873,GO:0021588,1,0.985592982661204,0,1,cerebellum formation,BP,
6874,GO:0021589,1,0.968301912777757,0,2,cerebellum structural organization,BP,
6875,GO:0021590,1,0.955938433395457,0,3,cerebellum maturation,BP,
6876,GO:0021591,1,0.674511360367387,0,26,ventricular system development,BP,
6877,GO:0021592,1,0.967087733487142,0,2,fourth ventricle development,BP,
6878,GO:0021593,1,0.972044783791162,0,2,rhombomere morphogenesis,BP,
6879,GO:0021594,1,0.984066138667084,0,1,rhombomere formation,BP,
6880,GO:0021598,1,0.968840314744285,0,2,abducens nerve morphogenesis,BP,
6881,GO:0021599,1,0.968840314744285,0,2,abducens nerve formation,BP,
6882,GO:0021602,1,0.667651303793951,0,27,cranial nerve morphogenesis,BP,
6883,GO:0021603,1,0.891705139179467,0,8,cranial nerve formation,BP,
6884,GO:0021604,1,0.862720867627078,0,10,cranial nerve structural organization,BP,
6885,GO:0021610,1,0.861158806451883,0,10,facial nerve morphogenesis,BP,
6886,GO:0021612,1,0.889563697437543,0,8,facial nerve structural organization,BP,
6887,GO:0021615,1,0.937575537187578,0,4,glossopharyngeal nerve morphogenesis,BP,
6888,GO:0021618,1,0.983406759351921,0,1,hypoglossal nerve morphogenesis,BP,
6889,GO:0021622,1,0.971941679426171,0,2,oculomotor nerve morphogenesis,BP,
6890,GO:0021623,1,0.971941679426171,0,2,oculomotor nerve formation,BP,
6891,GO:0021626,1,0.91056825898782,0,6,central nervous system maturation,BP,
6892,GO:0021631,1,0.90703856574841,0,6,optic nerve morphogenesis,BP,
6893,GO:0021633,1,0.969839135290011,0,2,optic nerve structural organization,BP,
6894,GO:0021634,1,0.983406759352069,0,1,optic nerve formation,BP,
6895,GO:0021636,1,0.921294231871183,0,5,trigeminal nerve morphogenesis,BP,
6896,GO:0021637,1,0.921294231871183,0,5,trigeminal nerve structural organization,BP,
6897,GO:0021639,1,0.988188154536935,0,1,trochlear nerve morphogenesis,BP,
6898,GO:0021642,1,0.988188154536935,0,1,trochlear nerve formation,BP,
6899,GO:0021644,1,0.972743830129294,0,2,vagus nerve morphogenesis,BP,
6900,GO:0021648,1,0.932701710415939,0,5,vestibulocochlear nerve morphogenesis,BP,
6901,GO:0021649,1,0.984935697988779,0,1,vestibulocochlear nerve structural organization,BP,
6902,GO:0021650,1,0.946970357396885,0,4,vestibulocochlear nerve formation,BP,
6903,GO:0021658,1,0.972044783791162,0,2,rhombomere 3 morphogenesis,BP,
6904,GO:0021660,1,0.984066138667084,0,1,rhombomere 3 formation,BP,
6905,GO:0021664,1,0.984066138667084,0,1,rhombomere 5 morphogenesis,BP,
6906,GO:0021666,1,0.984066138667084,0,1,rhombomere 5 formation,BP,
6907,GO:0021670,1,0.832340238270209,0,12,lateral ventricle development,BP,
6909,GO:0021678,1,0.96117812274347,0,3,third ventricle development,BP,
6913,GO:0021682,1,0.983406759351724,0,1,nerve maturation,BP,
6916,GO:0021685,1,0.983406759351328,0,1,cerebellar granular layer structural organization,BP,
6917,GO:0021686,1,0.988472078652507,0,1,cerebellar granular layer maturation,BP,
6920,GO:0021691,1,0.96708849286067,0,2,cerebellar Purkinje cell layer maturation,BP,
6923,GO:0021694,1,0.856834408825445,0,10,cerebellar Purkinje cell layer formation,BP,
6928,GO:0021699,1,0.955938433395457,0,3,cerebellar cortex maturation,BP,
6930,GO:0021702,1,0.856834408825445,0,10,cerebellar Purkinje cell differentiation,BP,
6931,GO:0021703,1,0.988188154536935,0,1,locus ceruleus development,BP,
6933,GO:0021718,1,0.968621929523801,0,2,superior olivary nucleus development,BP,
6934,GO:0021722,1,0.968621929523801,0,2,superior olivary nucleus maturation,BP,
6935,GO:0021723,1,0.983817326569247,0,1,medullary reticular formation development,BP,
6936,GO:0021730,1,0.967343277960449,0,2,trigeminal sensory nucleus development,BP,
6937,GO:0021732,1,0.985592982661204,0,1,midbrain-hindbrain boundary maturation,BP,
6938,GO:0021740,1,0.967343277960449,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6939,GO:0021747,1,0.951040137107701,0,3,cochlear nucleus development,BP,
6940,GO:0021750,1,0.984968016038942,0,1,vestibular nucleus development,BP,
6941,GO:0021754,1,0.992395609449106,0,1,facial nucleus development,BP,
6942,GO:0021756,1,0.776191597678943,0,16,striatum development,BP,
6943,GO:0021757,1,0.983427383816485,0,1,caudate nucleus development,BP,
6944,GO:0021758,1,0.983427383816485,0,1,putamen development,BP,
6945,GO:0021759,1,0.938159208913388,0,4,globus pallidus development,BP,
6946,GO:0021761,1,0.216079113358886,0,102,limbic system development,BP,
6947,GO:0021762,1,0.559061956549927,0,42,substantia nigra development,BP,
6948,GO:0021763,1,0.98576332120161,0,1,subthalamic nucleus development,BP,
6949,GO:0021764,1,0.935655226731657,0,4,amygdala development,BP,
6950,GO:0021766,1,0.311797772275578,0,76,hippocampus development,BP,
6951,GO:0021767,1,0.973114725851362,0,2,mammillary body development,BP,
6952,GO:0021768,1,0.983463166197929,0,1,nucleus accumbens development,BP,
6953,GO:0021769,1,0.939510530726483,0,4,orbitofrontal cortex development,BP,
6954,GO:0021771,1,0.983406759351724,0,1,lateral geniculate nucleus development,BP,
6956,GO:0021773,1,0.953552540353814,0,3,striatal medium spiny neuron differentiation,BP,
6957,GO:0021775,1,0.951038409343255,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6958,GO:0021776,1,0.951038409343255,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6959,GO:0021778,1,0.941054070509121,0,4,oligodendrocyte cell fate specification,BP,
6960,GO:0021779,1,0.941054070509121,0,4,oligodendrocyte cell fate commitment,BP,
6961,GO:0021780,1,0.941054070509121,0,4,glial cell fate specification,BP,
6962,GO:0021781,1,0.832951366147935,0,12,glial cell fate commitment,BP,
6964,GO:0021783,1,0.801245070270007,0,16,preganglionic parasympathetic fiber development,BP,
6966,GO:0021785,1,0.890962229211082,0,7,branchiomotor neuron axon guidance,BP,
6967,GO:0021793,1,0.983500858265144,0,1,chemorepulsion of branchiomotor axon,BP,
6968,GO:0021794,1,0.814172140395873,0,15,thalamus development,BP,
6969,GO:0021795,1,0.517791342450846,0,42,cerebral cortex cell migration,BP,
6970,GO:0021796,1,0.923980449860684,0,5,cerebral cortex regionalization,BP,
6973,GO:0021799,1,0.625825810310276,0,30,cerebral cortex radially oriented cell migration,BP,
6974,GO:0021800,1,0.876745019588023,0,8,cerebral cortex tangential migration,BP,
6975,GO:0021801,1,0.708539129014608,0,22,cerebral cortex radial glia guided migration,BP,
6976,GO:0021812,1,0.968301888415412,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6977,GO:0021813,1,0.984641317328617,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6978,GO:0021814,1,0.893116326397555,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6979,GO:0021815,1,0.920973907316469,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6980,GO:0021816,1,0.968384722375916,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6981,GO:0021817,1,0.951047693668054,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6982,GO:0021819,1,0.832212202163068,0,12,layer formation in cerebral cortex,BP,
6983,GO:0021822,1,0.986126164372785,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6984,GO:0021823,1,0.967087733487287,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6985,GO:0021824,1,0.9685914039789,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6986,GO:0021825,1,0.936708722879591,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6987,GO:0021826,1,0.853466955924142,0,10,substrate-independent telencephalic tangential migration,BP,
6988,GO:0021827,1,0.967087733487287,0,2,postnatal olfactory bulb interneuron migration,BP,
6989,GO:0021828,1,0.9685914039789,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6990,GO:0021830,1,0.866214490835337,0,9,interneuron migration from the subpallium to the cortex,BP,
6991,GO:0021831,1,0.96957083119733,0,2,embryonic olfactory bulb interneuron precursor migration,BP,
6992,GO:0021836,1,0.967087733487287,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6993,GO:0021840,1,0.968920078480906,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6994,GO:0021842,1,0.968920078480906,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6995,GO:0021843,1,0.853466955924142,0,10,substrate-independent telencephalic tangential interneuron migration,BP,
6997,GO:0021847,1,0.952927834323409,0,3,ventricular zone neuroblast division,BP,
6998,GO:0021849,1,0.967163036534163,0,2,neuroblast division in subventricular zone,BP,
6999,GO:0021852,1,0.969341394273901,0,2,pyramidal neuron migration,BP,
7000,GO:0021853,1,0.908991219250244,0,6,cerebral cortex GABAergic interneuron migration,BP,
7001,GO:0021854,1,0.745827605139835,0,22,hypothalamus development,BP,
7002,GO:0021855,1,0.944806204017106,0,4,hypothalamus cell migration,BP,
7003,GO:0021856,1,0.9685914039789,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
7004,GO:0021858,1,0.992595721220936,0,1,GABAergic neuron differentiation in basal ganglia,BP,
7005,GO:0021859,1,0.852530752587674,0,10,pyramidal neuron differentiation,BP,
7006,GO:0021860,1,0.866924273316845,0,9,pyramidal neuron development,BP,
7007,GO:0021861,1,0.947920824197625,0,4,forebrain radial glial cell differentiation,BP,
7008,GO:0021869,1,0.911683880913955,0,6,forebrain ventricular zone progenitor cell division,BP,
7009,GO:0021870,1,0.983406759351625,0,1,Cajal-Retzius cell differentiation,BP,
7012,GO:0021873,1,0.87702549134173,0,8,forebrain neuroblast division,BP,
7013,GO:0021874,1,0.983950314107376,0,1,Wnt signaling pathway involved in forebrain neuroblast division,BP,
7017,GO:0021882,1,0.971342487030176,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
7020,GO:0021886,1,0.9685914039789,0,2,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
7021,GO:0021888,1,0.9685914039789,0,2,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
7024,GO:0021892,1,0.837878448512426,0,12,cerebral cortex GABAergic interneuron differentiation,BP,
7025,GO:0021893,1,0.971342487030176,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
7026,GO:0021894,1,0.888503155171823,0,8,cerebral cortex GABAergic interneuron development,BP,
7027,GO:0021895,1,0.717501899824383,0,22,cerebral cortex neuron differentiation,BP,
7028,GO:0021896,1,0.967087733486029,0,2,forebrain astrocyte differentiation,BP,
7029,GO:0021897,1,0.967087733486029,0,2,forebrain astrocyte development,BP,
7031,GO:0021902,1,0.90893497280171,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
7034,GO:0021910,1,0.890751229502522,0,7,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7035,GO:0021912,1,0.984114739975334,0,2,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
7036,GO:0021913,1,0.971693972744302,0,3,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
7037,GO:0021914,1,0.936656113837585,0,4,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7039,GO:0021919,1,0.983450804951178,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
7040,GO:0021920,1,0.990609033835784,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
7041,GO:0021924,1,0.871770305164865,0,10,cell proliferation in external granule layer,BP,
7042,GO:0021930,1,0.871770305164865,0,10,cerebellar granule cell precursor proliferation,BP,
7043,GO:0021932,1,0.854916359724549,0,10,hindbrain radial glia guided cell migration,BP,
7044,GO:0021933,1,0.988472078652507,0,1,radial glia guided migration of cerebellar granule cell,BP,
7045,GO:0021934,1,0.967491515410835,0,2,hindbrain tangential cell migration,BP,
7046,GO:0021935,1,0.983406759350344,0,1,cerebellar granule cell precursor tangential migration,BP,
7047,GO:0021936,1,0.860899077020572,0,10,regulation of cerebellar granule cell precursor proliferation,BP,
7048,GO:0021937,1,0.914295228788553,0,6,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
7049,GO:0021938,1,0.940503066517688,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
7050,GO:0021940,1,0.885648094321664,0,8,positive regulation of cerebellar granule cell precursor proliferation,BP,
7051,GO:0021941,1,0.972069340934023,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
7052,GO:0021942,1,0.924614624547153,0,5,radial glia guided migration of Purkinje cell,BP,
7053,GO:0021943,1,0.935429171891496,0,4,formation of radial glial scaffolds,BP,
7058,GO:0021956,1,0.986724071223318,0,1,central nervous system interneuron axonogenesis,BP,
7059,GO:0021957,1,0.911120416565603,0,6,corticospinal tract morphogenesis,BP,
7060,GO:0021960,1,0.920887995123133,0,5,anterior commissure morphogenesis,BP,
7061,GO:0021965,1,0.951038409342779,0,3,spinal cord ventral commissure morphogenesis,BP,
7062,GO:0021966,1,0.974183452738221,0,2,corticospinal neuron axon guidance,BP,
7063,GO:0021972,1,0.983406759351921,0,1,corticospinal neuron axon guidance through spinal cord,BP,
7065,GO:0021979,1,0.912442518430087,0,6,hypothalamus cell differentiation,BP,
7068,GO:0021985,1,0.968102075221048,0,2,neurohypophysis development,BP,
7069,GO:0021986,1,0.967136918705144,0,2,habenula development,BP,
7072,GO:0021993,1,0.98340675935187,0,1,initiation of neural tube closure,BP,
7073,GO:0021997,1,0.967087733486853,0,2,neural plate axis specification,BP,
7074,GO:0021998,1,0.983431384306763,0,1,neural plate mediolateral regionalization,BP,
7076,GO:0022004,1,0.985592982661204,0,1,midbrain-hindbrain boundary maturation during brain development,BP,
7077,GO:0022007,1,0.951959761363184,0,3,convergent extension involved in neural plate elongation,BP,
7080,GO:0022010,1,0.805638220453371,0,15,central nervous system myelination,BP,
7082,GO:0022012,1,0.983406759351087,0,1,subpallium cell proliferation in forebrain,BP,
7083,GO:0022013,1,0.983406759351035,0,1,pallium cell proliferation in forebrain,BP,
7084,GO:0022018,1,0.983406759351087,0,1,lateral ganglionic eminence cell proliferation,BP,
7085,GO:0022027,1,0.923912517747751,0,5,interkinetic nuclear migration,BP,
7086,GO:0022028,1,0.891734976197402,0,7,tangential migration from the subventricular zone to the olfactory bulb,BP,
7087,GO:0022029,1,0.423063401516682,0,55,telencephalon cell migration,BP,
7088,GO:0022030,1,0.708539129014608,0,22,telencephalon glial cell migration,BP,
7090,GO:0022038,1,0.809306583858869,0,14,corpus callosum development,BP,
7092,GO:0022401,1,0.825201589244794,0,14,negative adaptation of signaling pathway,BP,
7104,GO:0022417,1,0.929239242846511,0,7,protein maturation by protein folding,BP,
7106,GO:0022601,1,0.967651151219005,0,2,menstrual cycle phase,BP,
7110,GO:0022605,1,0.923512510562653,0,6,oogenesis stage,BP,
7114,GO:0022613,1,0.0048708664652231,0,420,ribonucleoprotein complex biogenesis,BP,
7116,GO:0022615,1,0.902647052164069,0,7,protein to membrane docking,BP,
7117,GO:0022616,1,0.719470493239507,0,22,DNA strand elongation,BP,
7119,GO:0022618,1,0.0845152794490532,0,183,ribonucleoprotein complex assembly,BP,
7120,GO:0022622,1,0.99404187805355,0,1,root system development,BP,
7121,GO:0022624,1,0.75196166516589,0,24,proteasome accessory complex,CC,
7122,GO:0022625,1,0.632808377886459,0,59,cytosolic large ribosomal subunit,CC,
7123,GO:0022626,1,0.414892337843382,0,111,cytosolic ribosome,CC,
7124,GO:0022627,1,0.727533396216461,0,44,cytosolic small ribosomal subunit,CC,
7127,GO:0022820,1,0.904652260332481,0,6,potassium ion symporter activity,MF,
7128,GO:0022821,1,0.775572415188168,0,16,potassium ion antiporter activity,MF,
7129,GO:0022824,1,0.471612576280593,0,49,transmitter-gated ion channel activity,MF,
7132,GO:0022833,1,0.881423416557325,0,8,mechanically gated channel activity,MF,
7134,GO:0022835,1,0.471612576280593,0,49,transmitter-gated channel activity,MF,
7137,GO:0022839,1,0.504970304517917,0,45,ion gated channel activity,MF,
7138,GO:0022840,1,0.89996264761834,0,7,leak channel activity,MF,
7139,GO:0022841,1,0.942031411959812,0,4,potassium ion leak channel activity,MF,
7140,GO:0022842,1,0.89996264761834,0,7,narrow pore channel activity,MF,
7142,GO:0022848,1,0.792206096578788,0,16,acetylcholine-gated cation-selective channel activity,MF,
7143,GO:0022850,1,0.938765843353745,0,5,serotonin-gated cation-selective channel activity,MF,
7144,GO:0022851,1,0.923407884127369,0,5,GABA-gated chloride ion channel activity,MF,
7145,GO:0022852,1,0.967253221013595,0,2,glycine-gated chloride ion channel activity,MF,
7146,GO:0022853,1,0.165017162358413,0,124,active ion transmembrane transporter activity,MF,
7148,GO:0022858,1,0.893630375729438,0,7,alanine transmembrane transporter activity,MF,
7149,GO:0022865,1,0.983869725649074,0,1,transmembrane electron transfer carrier,MF,
7150,GO:0022884,1,0.797121668818122,0,20,macromolecule transmembrane transporter activity,MF,
7151,GO:0022889,1,0.881067810087849,0,9,serine transmembrane transporter activity,MF,
7155,GO:0022897,1,0.939276422461688,0,4,proton-dependent peptide secondary active transmembrane transporter activity,MF,
7157,GO:0022900,1,0.38721156584629,0,99,electron transport chain,BP,
7158,GO:0022904,1,0.399547602769936,0,97,respiratory electron transport chain,BP,
7160,GO:0023016,1,0.954878053801092,0,3,signal transduction by trans-phosphorylation,BP,
7162,GO:0023021,1,0.955488732149668,0,3,termination of signal transduction,BP,
7163,GO:0023023,1,0.777111142778204,0,20,MHC protein complex binding,MF,
7164,GO:0023024,1,0.964432017617575,0,3,MHC class I protein complex binding,MF,
7165,GO:0023025,1,0.969748777756146,0,2,MHC class Ib protein complex binding,MF,
7166,GO:0023026,1,0.817348057442421,0,16,MHC class II protein complex binding,MF,
7167,GO:0023029,1,0.923245674986488,0,5,MHC class Ib protein binding,MF,
7168,GO:0023030,1,0.969748777756146,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7169,GO:0023035,1,0.892909918501823,0,8,CD40 signaling pathway,BP,
7170,GO:0023041,1,0.914637109546228,0,6,neuronal signal transduction,BP,
7175,GO:0023058,1,0.799415074652891,0,16,adaptation of signaling pathway,BP,
7178,GO:0030002,1,0.821690754502475,0,13,cellular anion homeostasis,BP,
7181,GO:0030007,1,0.881831545659547,0,8,cellular potassium ion homeostasis,BP,
7182,GO:0030008,1,0.918786054536059,0,8,TRAPP complex,CC,
7184,GO:0030011,1,0.793932895259532,0,16,maintenance of cell polarity,BP,
7185,GO:0030014,1,0.790449805471186,0,15,CCR4-NOT complex,CC,
7186,GO:0030015,1,0.951817591394772,0,3,CCR4-NOT core complex,CC,
7190,GO:0030020,1,0.906483645458642,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7191,GO:0030021,1,0.938757832902428,0,6,extracellular matrix structural constituent conferring compression resistance,MF,
7192,GO:0030023,1,0.919731344254053,0,5,extracellular matrix constituent conferring elasticity,MF,
7198,GO:0030033,1,0.78936406771667,0,15,microvillus assembly,BP,
7201,GO:0030037,1,0.983406759351921,0,1,actin filament reorganization involved in cell cycle,BP,
7205,GO:0030043,1,0.956560328948812,0,3,actin filament fragmentation,BP,
7207,GO:0030047,1,0.951422193840555,0,3,actin modification,BP,
7210,GO:0030050,1,0.935254731869129,0,4,vesicle transport along actin filament,BP,
7215,GO:0030060,1,0.953943587249348,0,4,L-malate dehydrogenase activity,MF,
7216,GO:0030061,1,0.927668687615315,0,5,mitochondrial crista,CC,
7217,GO:0030062,1,0.920294765492014,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7218,GO:0030070,1,0.956984896740041,0,3,insulin processing,BP,
7219,GO:0030071,1,0.531832882228229,0,44,regulation of mitotic metaphase/anaphase transition,BP,
7222,GO:0030091,1,0.924560124256352,0,7,protein repair,BP,
7228,GO:0030103,1,0.97917413448317,0,2,vasopressin secretion,BP,
7230,GO:0030107,1,0.984058405067898,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7231,GO:0030108,1,0.989425806755353,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7232,GO:0030109,1,0.971413797220806,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7233,GO:0030110,1,0.988686032532428,0,1,HLA-C specific inhibitory MHC class I receptor activity,MF,
7235,GO:0030117,1,0.254552670479343,0,91,membrane coat,CC,
7236,GO:0030118,1,0.477178828381213,0,48,clathrin coat,CC,
7237,GO:0030119,1,0.513984043378339,0,43,AP-type membrane coat adaptor complex,CC,
7238,GO:0030120,1,0.484289665912473,0,49,vesicle coat,CC,
7239,GO:0030121,1,0.913673671392155,0,6,AP-1 adaptor complex,CC,
7240,GO:0030122,1,0.81881127702555,0,13,AP-2 adaptor complex,CC,
7241,GO:0030123,1,0.854015168710217,0,10,AP-3 adaptor complex,CC,
7242,GO:0030125,1,0.699936832436736,0,24,clathrin vesicle coat,CC,
7243,GO:0030126,1,0.83479075064156,0,13,COPI vesicle coat,CC,
7244,GO:0030127,1,0.829404064702935,0,12,COPII vesicle coat,CC,
7245,GO:0030128,1,0.805213385248102,0,14,clathrin coat of endocytic vesicle,CC,
7246,GO:0030130,1,0.839929127695415,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7247,GO:0030131,1,0.628314934817084,0,30,clathrin adaptor complex,CC,
7248,GO:0030132,1,0.76595873740151,0,18,clathrin coat of coated pit,CC,
7250,GO:0030134,1,0.357737192282883,0,75,ER to Golgi transport vesicle,CC,
7253,GO:0030137,1,0.723193285406331,0,23,COPI-coated vesicle,CC,
7255,GO:0030140,1,0.655665996343704,0,29,trans-Golgi network transport vesicle,CC,
7257,GO:0030144,1,0.954192484379175,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7258,GO:0030145,1,0.492554760125536,0,47,manganese ion binding,MF,
7259,GO:0030148,1,0.321954045871794,0,76,sphingolipid biosynthetic process,BP,
7260,GO:0030149,1,0.745510224217228,0,21,sphingolipid catabolic process,BP,
7261,GO:0030150,1,0.830688204514356,0,16,protein import into mitochondrial matrix,BP,
7262,GO:0030151,1,0.940534470676015,0,4,molybdenum ion binding,MF,
7265,GO:0030156,1,0.994339897231706,0,1,benzodiazepine receptor binding,MF,
7267,GO:0030158,1,0.952348651235087,0,3,protein xylosyltransferase activity,MF,
7269,GO:0030160,1,0.938901524879385,0,4,GKAP/Homer scaffold activity,MF,
7273,GO:0030166,1,0.399806038693829,0,58,proteoglycan biosynthetic process,BP,
7274,GO:0030167,1,0.940266997959064,0,4,proteoglycan catabolic process,BP,
7276,GO:0030169,1,0.801568145970306,0,14,low-density lipoprotein particle binding,MF,
7278,GO:0030171,1,0.973210872151932,0,2,voltage-gated proton channel activity,MF,
7279,GO:0030172,1,0.976455842286699,0,3,troponin C binding,MF,
7280,GO:0030173,1,0.452755702496508,0,53,integral component of Golgi membrane,CC,
7281,GO:0030174,1,0.925210557915394,0,5,regulation of DNA-dependent DNA replication initiation,BP,
7283,GO:0030176,1,0.148047014993816,0,137,integral component of endoplasmic reticulum membrane,CC,
7288,GO:0030184,1,0.984267498897298,0,1,nitric oxide transmembrane transporter activity,MF,
7290,GO:0030186,1,0.979811893822075,0,2,melatonin metabolic process,BP,
7291,GO:0030187,1,0.979811893822075,0,2,melatonin biosynthetic process,BP,
7293,GO:0030194,1,0.70883840696848,0,24,positive regulation of blood coagulation,BP,
7295,GO:0030197,1,0.962695868857688,0,3,extracellular matrix constituent, lubricant activity,MF,
7297,GO:0030199,1,0.556099216752233,0,37,collagen fibril organization,BP,
7298,GO:0030200,1,0.956135304707225,0,3,heparan sulfate proteoglycan catabolic process,BP,
7299,GO:0030201,1,0.615948181101167,0,30,heparan sulfate proteoglycan metabolic process,BP,
7300,GO:0030202,1,0.874827376036303,0,8,heparin metabolic process,BP,
7302,GO:0030204,1,0.528668284172504,0,41,chondroitin sulfate metabolic process,BP,
7303,GO:0030205,1,0.819714072938161,0,13,dermatan sulfate metabolic process,BP,
7304,GO:0030206,1,0.674070879893466,0,25,chondroitin sulfate biosynthetic process,BP,
7305,GO:0030207,1,0.810179897978734,0,14,chondroitin sulfate catabolic process,BP,
7306,GO:0030208,1,0.831431677501351,0,12,dermatan sulfate biosynthetic process,BP,
7307,GO:0030209,1,0.985917419369727,0,1,dermatan sulfate catabolic process,BP,
7308,GO:0030210,1,0.874827376036303,0,8,heparin biosynthetic process,BP,
7311,GO:0030214,1,0.809348492464962,0,14,hyaluronan catabolic process,BP,
7312,GO:0030215,1,0.860359914171865,0,10,semaphorin receptor binding,MF,
7318,GO:0030221,1,0.972987080418202,0,2,basophil differentiation,BP,
7319,GO:0030222,1,0.942380234518019,0,5,eosinophil differentiation,BP,
7320,GO:0030223,1,0.934487568503706,0,5,neutrophil differentiation,BP,
7323,GO:0030226,1,0.967087733486077,0,2,apolipoprotein receptor activity,MF,
7324,GO:0030228,1,0.77458512777201,0,16,lipoprotein particle receptor activity,MF,
7325,GO:0030229,1,0.936535233648981,0,4,very-low-density lipoprotein particle receptor activity,MF,
7326,GO:0030233,1,0.988466648285194,0,1,deoxynucleotide transmembrane transporter activity,MF,
7332,GO:0030240,1,0.934418868946239,0,5,skeletal muscle thin filament assembly,BP,
7334,GO:0030242,1,0.936509944360601,0,4,pexophagy,BP,
7336,GO:0030247,1,0.744332554818808,0,21,polysaccharide binding,MF,
7337,GO:0030249,1,0.923558435867394,0,8,guanylate cyclase regulator activity,MF,
7338,GO:0030250,1,0.937099318607165,0,7,guanylate cyclase activator activity,MF,
7339,GO:0030251,1,0.985554093900647,0,1,guanylate cyclase inhibitor activity,MF,
7340,GO:0030252,1,0.821987199889387,0,15,growth hormone secretion,BP,
7342,GO:0030259,1,0.922476610577858,0,6,lipid glycosylation,BP,
7344,GO:0030261,1,0.650677176124526,0,31,chromosome condensation,BP,
7345,GO:0030262,1,0.675331587725117,0,28,apoptotic nuclear changes,BP,
7346,GO:0030263,1,0.935663805707074,0,4,apoptotic chromosome condensation,BP,
7347,GO:0030264,1,0.98340675935207,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7348,GO:0030267,1,0.990877190928817,0,1,glyoxylate reductase (NADP) activity,MF,
7349,GO:0030272,1,0.993296574005966,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7350,GO:0030273,1,0.985135309247412,0,1,melanin-concentrating hormone receptor activity,MF,
7352,GO:0030275,1,0.788067563960635,0,17,LRR domain binding,MF,
7354,GO:0030277,1,0.785340115069208,0,17,maintenance of gastrointestinal epithelium,BP,
7359,GO:0030283,1,0.977976700603993,0,2,testosterone dehydrogenase [NAD(P)] activity,MF,
7360,GO:0030284,1,0.936999507083371,0,4,estrogen receptor activity,MF,
7362,GO:0030286,1,0.510212628783541,0,47,dynein complex,CC,
7363,GO:0030289,1,0.963630110892352,0,3,protein phosphatase 4 complex,CC,
7364,GO:0030290,1,0.983440633839794,0,1,sphingolipid activator protein activity,MF,
7366,GO:0030292,1,0.957239953119887,0,3,protein tyrosine kinase inhibitor activity,MF,
7367,GO:0030294,1,0.985862336865803,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7370,GO:0030297,1,0.89445073359525,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7371,GO:0030298,1,0.990967421310024,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7372,GO:0030299,1,0.836170831840947,0,14,intestinal cholesterol absorption,BP,
7373,GO:0030300,1,0.921062414870476,0,7,regulation of intestinal cholesterol absorption,BP,
7374,GO:0030301,1,0.353265059950623,0,76,cholesterol transport,BP,
7375,GO:0030302,1,0.988466648285194,0,1,deoxynucleotide transport,BP,
7376,GO:0030305,1,0.971438325784679,0,2,heparanase activity,MF,
7377,GO:0030306,1,0.882606595063897,0,8,ADP-ribosylation factor binding,MF,
7382,GO:0030312,1,0.985719188185092,0,1,external encapsulating structure,CC,
7384,GO:0030315,1,0.498660390018242,0,44,T-tubule,CC,
7386,GO:0030317,1,0.393936379896871,0,72,flagellated sperm motility,BP,
7388,GO:0030320,1,0.821690754502475,0,13,cellular monovalent inorganic anion homeostasis,BP,
7389,GO:0030321,1,0.930514544950249,0,5,transepithelial chloride transport,BP,
7390,GO:0030322,1,0.985737523509417,0,1,stabilization of membrane potential,BP,
7395,GO:0030327,1,0.95259327831669,0,3,prenylated protein catabolic process,BP,
7396,GO:0030328,1,0.968405932332871,0,2,prenylcysteine catabolic process,BP,
7397,GO:0030329,1,0.968405932332871,0,2,prenylcysteine metabolic process,BP,
7399,GO:0030331,1,0.557538544452965,0,38,estrogen receptor binding,MF,
7404,GO:0030337,1,0.975128256090938,0,2,DNA polymerase processivity factor activity,MF,
7405,GO:0030342,1,0.983659251457671,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7406,GO:0030343,1,0.973019546856867,0,2,vitamin D3 25-hydroxylase activity,MF,
7407,GO:0030345,1,0.938757832902428,0,6,structural constituent of tooth enamel,MF,
7408,GO:0030346,1,0.922277693956521,0,6,protein phosphatase 2B binding,MF,
7409,GO:0030348,1,0.954685258145369,0,3,syntaxin-3 binding,MF,
7410,GO:0030350,1,0.967125447859793,0,2,iron-responsive element binding,MF,
7411,GO:0030351,1,0.98408794163048,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7412,GO:0030354,1,0.994223328944418,0,1,melanin-concentrating hormone activity,MF,
7413,GO:0030366,1,0.978275753661022,0,2,molybdopterin synthase activity,MF,
7414,GO:0030368,1,0.880229083350516,0,8,interleukin-17 receptor activity,MF,
7415,GO:0030369,1,0.955499177509533,0,3,ICAM-3 receptor activity,MF,
7416,GO:0030371,1,0.694478392868104,0,24,translation repressor activity,MF,
7417,GO:0030372,1,0.983406759351968,0,1,high molecular weight B cell growth factor receptor binding,MF,
7420,GO:0030377,1,0.989636151042471,0,1,urokinase plasminogen activator receptor activity,MF,
7421,GO:0030378,1,0.984950340754611,0,1,serine racemase activity,MF,
7422,GO:0030379,1,0.98340675935138,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7423,GO:0030380,1,0.990925476771405,0,1,interleukin-17E receptor binding,MF,
7424,GO:0030382,1,0.987943033714,0,1,sperm mitochondrion organization,BP,
7425,GO:0030387,1,0.98966602857139,0,1,fructosamine-3-kinase activity,MF,
7426,GO:0030388,1,0.919691029123603,0,7,fructose 1,6-bisphosphate metabolic process,BP,
7427,GO:0030389,1,0.98966602857139,0,1,fructosamine metabolic process,BP,
7428,GO:0030393,1,0.98966602857139,0,1,fructoselysine metabolic process,BP,
7429,GO:0030395,1,0.968671512451218,0,3,lactose binding,MF,
7430,GO:0030397,1,0.500752015916091,0,46,membrane disassembly,BP,
7431,GO:0030407,1,0.987174857733756,0,1,formimidoyltransferase activity,MF,
7432,GO:0030409,1,0.987174857733756,0,1,glutamate formimidoyltransferase activity,MF,
7433,GO:0030412,1,0.987174857733756,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7435,GO:0030421,1,0.993197483687486,0,1,defecation,BP,
7436,GO:0030422,1,0.945056329357391,0,4,production of siRNA involved in RNA interference,BP,
7437,GO:0030423,1,0.961400947071629,0,3,targeting of mRNA for destruction involved in RNA interference,BP,
7442,GO:0030429,1,0.989355420771269,0,1,kynureninase activity,MF,
7443,GO:0030430,1,0.940418774967235,0,4,host cell cytoplasm,CC,
7446,GO:0030433,1,0.353100066627082,0,71,ubiquitin-dependent ERAD pathway,BP,
7447,GO:0030449,1,0.638388535308359,0,31,regulation of complement activation,BP,
7448,GO:0030450,1,0.962407250993915,0,3,regulation of complement activation, classical pathway,BP,
7449,GO:0030451,1,0.983406759350836,0,1,regulation of complement activation, alternative pathway,BP,
7450,GO:0030473,1,0.951047693668054,0,3,nuclear migration along microtubule,BP,
7451,GO:0030478,1,0.936108085884689,0,4,actin cap,CC,
7453,GO:0030488,1,0.687537417843797,0,26,tRNA methylation,BP,
7454,GO:0030490,1,0.537049745981926,0,48,maturation of SSU-rRNA,BP,
7455,GO:0030492,1,0.966544516888936,0,5,hemoglobin binding,MF,
7457,GO:0030497,1,0.894357294347135,0,8,fatty acid elongation,BP,
7460,GO:0030502,1,0.813199848483698,0,16,negative regulation of bone mineralization,BP,
7461,GO:0030504,1,0.983406759351087,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7462,GO:0030505,1,0.967087733486465,0,2,inorganic diphosphate transport,BP,
7467,GO:0030511,1,0.691416122241009,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7471,GO:0030515,1,0.705057156348432,0,28,snoRNA binding,MF,
7474,GO:0030518,1,0.159974319329754,0,124,intracellular steroid hormone receptor signaling pathway,BP,
7475,GO:0030520,1,0.488013156923988,0,48,intracellular estrogen receptor signaling pathway,BP,
7476,GO:0030521,1,0.381379533110125,0,65,androgen receptor signaling pathway,BP,
7478,GO:0030523,1,0.983406759352021,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7479,GO:0030526,1,0.983406759351971,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7481,GO:0030532,1,0.431860908757388,0,65,small nuclear ribonucleoprotein complex,CC,
7486,GO:0030544,1,0.619631345958767,0,33,Hsp70 protein binding,MF,
7489,GO:0030547,1,0.818005168011131,0,15,receptor inhibitor activity,MF,
7490,GO:0030548,1,0.931306606441576,0,6,acetylcholine receptor regulator activity,MF,
7491,GO:0030549,1,0.991461057385688,0,1,acetylcholine receptor activator activity,MF,
7492,GO:0030550,1,0.950075708221458,0,4,acetylcholine receptor inhibitor activity,MF,
7495,GO:0030553,1,0.810765941681746,0,14,cGMP binding,MF,
7497,GO:0030572,1,0.983410518075759,0,1,phosphatidyltransferase activity,MF,
7498,GO:0030573,1,0.957378487219731,0,3,bile acid catabolic process,BP,
7499,GO:0030574,1,0.368198095168982,0,66,collagen catabolic process,BP,
7500,GO:0030575,1,0.854592040363764,0,10,nuclear body organization,BP,
7501,GO:0030576,1,0.969947931476431,0,2,Cajal body organization,BP,
7502,GO:0030578,1,0.941633701542566,0,4,PML body organization,BP,
7503,GO:0030579,1,0.915245877205314,0,6,ubiquitin-dependent SMAD protein catabolic process,BP,
7504,GO:0030580,1,0.990704363325434,0,1,quinone cofactor methyltransferase activity,MF,
7505,GO:0030581,1,0.93476603090351,0,5,symbiont intracellular protein transport in host,BP,
7506,GO:0030586,1,0.983565412210262,0,1,[methionine synthase] reductase activity,MF,
7508,GO:0030594,1,0.273349632719559,0,95,neurotransmitter receptor activity,MF,
7510,GO:0030611,1,0.993098701691907,0,1,arsenate reductase activity,MF,
7511,GO:0030613,1,0.97659538025103,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7512,GO:0030614,1,0.97659538025103,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7513,GO:0030616,1,0.98340675935099,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7514,GO:0030617,1,0.968046683082611,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7515,GO:0030618,1,0.920192949045013,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7516,GO:0030619,1,0.928850015611339,0,6,U1 snRNA binding,MF,
7517,GO:0030620,1,0.952895954848043,0,5,U2 snRNA binding,MF,
7518,GO:0030621,1,0.924153797026209,0,5,U4 snRNA binding,MF,
7519,GO:0030622,1,0.969564422223939,0,2,U4atac snRNA binding,MF,
7520,GO:0030623,1,0.983406759351328,0,1,U5 snRNA binding,MF,
7521,GO:0030624,1,0.983406759352021,0,1,U6atac snRNA binding,MF,
7522,GO:0030626,1,0.970823702122558,0,2,U12 snRNA binding,MF,
7523,GO:0030627,1,0.975342393504938,0,2,pre-mRNA 5'-splice site binding,MF,
7524,GO:0030628,1,0.929433876562315,0,6,pre-mRNA 3'-splice site binding,MF,
7525,GO:0030638,1,0.916709419667519,0,8,polyketide metabolic process,BP,
7527,GO:0030643,1,0.869532049641071,0,9,cellular phosphate ion homeostasis,BP,
7528,GO:0030644,1,0.945011399062196,0,4,cellular chloride ion homeostasis,BP,
7529,GO:0030647,1,0.903584943468402,0,9,aminoglycoside antibiotic metabolic process,BP,
7530,GO:0030653,1,0.983406759351921,0,1,beta-lactam antibiotic metabolic process,BP,
7536,GO:0030663,1,0.805677204542556,0,16,COPI-coated vesicle membrane,CC,
7545,GO:0030676,1,0.780246234861695,0,15,Rac guanyl-nucleotide exchange factor activity,MF,
7546,GO:0030677,1,0.889178739344344,0,10,ribonuclease P complex,CC,
7547,GO:0030678,1,0.962585368749426,0,3,mitochondrial ribonuclease P complex,CC,
7548,GO:0030681,1,0.923751754727114,0,7,multimeric ribonuclease P complex,CC,
7549,GO:0030682,1,0.984363538817272,0,1,evasion or tolerance of host defense response,BP,
7550,GO:0030683,1,0.984363538817272,0,1,evasion or tolerance by virus of host immune response,BP,
7551,GO:0030684,1,0.393649560422887,0,67,preribosome,CC,
7552,GO:0030686,1,0.654124191772541,0,29,90S preribosome,CC,
7553,GO:0030687,1,0.749181927770319,0,22,preribosome, large subunit precursor,CC,
7554,GO:0030688,1,0.850333001858244,0,11,preribosome, small subunit precursor,CC,
7555,GO:0030689,1,0.957194016986195,0,3,Noc complex,CC,
7556,GO:0030690,1,0.984149667495778,0,1,Noc1p-Noc2p complex,CC,
7557,GO:0030691,1,0.984149667495778,0,1,Noc2p-Noc3p complex,CC,
7558,GO:0030692,1,0.9726120012371,0,2,Noc4p-Nop14p complex,CC,
7560,GO:0030696,1,0.983669389396671,0,1,tRNA (m5U54) methyltransferase activity,MF,
7561,GO:0030697,1,0.983669389396671,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7562,GO:0030705,1,0.126833631465921,0,138,cytoskeleton-dependent intracellular transport,BP,
7563,GO:0030718,1,0.958786279067007,0,3,germ-line stem cell population maintenance,BP,
7564,GO:0030719,1,0.968400394610989,0,2,P granule organization,BP,
7566,GO:0030729,1,0.983539006644756,0,1,acetoacetate-CoA ligase activity,MF,
7567,GO:0030730,1,0.824801756163712,0,15,sequestering of triglyceride,BP,
7568,GO:0030731,1,0.992430006796556,0,1,guanidinoacetate N-methyltransferase activity,MF,
7570,GO:0030748,1,0.98473360677907,0,1,amine N-methyltransferase activity,MF,
7571,GO:0030760,1,0.98884221466863,0,1,pyridine N-methyltransferase activity,MF,
7572,GO:0030791,1,0.984979862530102,0,1,arsenite methyltransferase activity,MF,
7573,GO:0030792,1,0.984979862530102,0,1,methylarsonite methyltransferase activity,MF,
7580,GO:0030805,1,0.951617182431085,0,3,regulation of cyclic nucleotide catabolic process,BP,
7581,GO:0030806,1,0.967676233155805,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7582,GO:0030807,1,0.983406759351672,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7586,GO:0030811,1,0.951617182431085,0,3,regulation of nucleotide catabolic process,BP,
7587,GO:0030812,1,0.967676233155805,0,2,negative regulation of nucleotide catabolic process,BP,
7588,GO:0030813,1,0.983406759351672,0,1,positive regulation of nucleotide catabolic process,BP,
7594,GO:0030819,1,0.365788357312165,0,78,positive regulation of cAMP biosynthetic process,BP,
7595,GO:0030820,1,0.951617182431085,0,3,regulation of cAMP catabolic process,BP,
7596,GO:0030821,1,0.967676233155805,0,2,negative regulation of cAMP catabolic process,BP,
7597,GO:0030822,1,0.983406759351672,0,1,positive regulation of cAMP catabolic process,BP,
7599,GO:0030824,1,0.97554674488087,0,2,negative regulation of cGMP metabolic process,BP,
7602,GO:0030827,1,0.97554674488087,0,2,negative regulation of cGMP biosynthetic process,BP,
7610,GO:0030838,1,0.31166264859562,0,83,positive regulation of actin filament polymerization,BP,
7611,GO:0030842,1,0.983406759351773,0,1,regulation of intermediate filament depolymerization,BP,
7612,GO:0030844,1,0.983406759351773,0,1,positive regulation of intermediate filament depolymerization,BP,
7613,GO:0030845,1,0.984073933253676,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7614,GO:0030846,1,0.983406759350443,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7618,GO:0030852,1,0.822933885102415,0,14,regulation of granulocyte differentiation,BP,
7619,GO:0030853,1,0.881906429352028,0,8,negative regulation of granulocyte differentiation,BP,
7620,GO:0030854,1,0.917697769736294,0,7,positive regulation of granulocyte differentiation,BP,
7626,GO:0030860,1,0.96712532070195,0,2,regulation of polarized epithelial cell differentiation,BP,
7627,GO:0030862,1,0.96712532070195,0,2,positive regulation of polarized epithelial cell differentiation,BP,
7632,GO:0030867,1,0.750063653756078,0,21,rough endoplasmic reticulum membrane,CC,
7634,GO:0030870,1,0.922931788612751,0,5,Mre11 complex,CC,
7635,GO:0030874,1,0.988072634922144,0,1,nucleolar chromatin,CC,
7639,GO:0030880,1,0.169061171414252,0,127,RNA polymerase complex,CC,
7640,GO:0030881,1,0.889276479391876,0,9,beta-2-microglobulin binding,MF,
7641,GO:0030882,1,0.933232231040112,0,5,lipid antigen binding,MF,
7642,GO:0030883,1,0.933232231040112,0,5,endogenous lipid antigen binding,MF,
7643,GO:0030884,1,0.933232231040112,0,5,exogenous lipid antigen binding,MF,
7644,GO:0030885,1,0.946463058001553,0,5,regulation of myeloid dendritic cell activation,BP,
7645,GO:0030886,1,0.964411736869439,0,3,negative regulation of myeloid dendritic cell activation,BP,
7646,GO:0030887,1,0.989103365555998,0,1,positive regulation of myeloid dendritic cell activation,BP,
7648,GO:0030889,1,0.802803996924009,0,15,negative regulation of B cell proliferation,BP,
7650,GO:0030891,1,0.94116437961437,0,5,VCB complex,CC,
7651,GO:0030893,1,0.910275604129333,0,6,meiotic cohesin complex,CC,
7652,GO:0030894,1,0.662393073878621,0,30,replisome,CC,
7653,GO:0030895,1,0.958530071690922,0,3,apolipoprotein B mRNA editing enzyme complex,CC,
7654,GO:0030896,1,0.9226404684053,0,6,checkpoint clamp complex,CC,
7655,GO:0030897,1,0.798185479842365,0,14,HOPS complex,CC,
7657,GO:0030899,1,0.974698937775187,0,2,calcium-dependent ATPase activity,MF,
7662,GO:0030904,1,0.741144816069904,0,20,retromer complex,CC,
7663,GO:0030905,1,0.941179540954841,0,4,retromer, tubulation complex,CC,
7664,GO:0030906,1,0.944528668366249,0,4,retromer, cargo-selective complex,CC,
7665,GO:0030908,1,0.975422809066724,0,2,protein splicing,BP,
7667,GO:0030911,1,0.910606678642339,0,6,TPR domain binding,MF,
7668,GO:0030913,1,0.897684625690192,0,7,paranodal junction assembly,BP,
7669,GO:0030914,1,0.83582864942315,0,13,STAGA complex,CC,
7670,GO:0030915,1,0.931424175552718,0,6,Smc5-Smc6 complex,CC,
7673,GO:0030920,1,0.982554663822603,0,2,peptidyl-serine acetylation,BP,
7674,GO:0030934,1,0.951038409341921,0,3,anchoring collagen complex,CC,
7675,GO:0030935,1,0.984554178720758,0,1,sheet-forming collagen trimer,CC,
7676,GO:0030936,1,0.983777200604435,0,1,transmembrane collagen trimer,CC,
7677,GO:0030942,1,0.962627461712315,0,3,endoplasmic reticulum signal peptide binding,MF,
7678,GO:0030943,1,0.967438797873592,0,3,mitochondrion targeting sequence binding,MF,
7680,GO:0030948,1,0.901028059198887,0,7,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7682,GO:0030950,1,0.937576386256591,0,4,establishment or maintenance of actin cytoskeleton polarity,BP,
7683,GO:0030951,1,0.951894420737982,0,3,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7684,GO:0030952,1,0.892461984999422,0,7,establishment or maintenance of cytoskeleton polarity,BP,
7685,GO:0030953,1,0.906396120696971,0,6,astral microtubule organization,BP,
7686,GO:0030955,1,0.802034568416637,0,14,potassium ion binding,MF,
7687,GO:0030956,1,0.980253348253404,0,2,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7689,GO:0030961,1,0.984725543253726,0,1,peptidyl-arginine hydroxylation,BP,
7690,GO:0030964,1,0.729688227960272,0,42,NADH dehydrogenase complex,CC,
7692,GO:0030969,1,0.953041441987964,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7693,GO:0030970,1,0.683421486248794,0,26,retrograde protein transport, ER to cytosol,BP,
7695,GO:0030974,1,0.988466648285194,0,1,thiamine pyrophosphate transport,BP,
7696,GO:0030975,1,0.985325278825704,0,1,thiamine binding,MF,
7697,GO:0030976,1,0.924663292372997,0,5,thiamine pyrophosphate binding,MF,
7698,GO:0030977,1,0.987594608375605,0,1,taurine binding,MF,
7699,GO:0030981,1,0.968222273827885,0,2,cortical microtubule cytoskeleton,CC,
7700,GO:0030983,1,0.827262859200441,0,12,mismatched DNA binding,MF,
7701,GO:0030984,1,0.991365350258681,0,1,kininogen binding,MF,
7702,GO:0030990,1,0.658264095090064,0,28,intraciliary transport particle,CC,
7703,GO:0030991,1,0.891838654996202,0,7,intraciliary transport particle A,CC,
7704,GO:0030992,1,0.770840813773293,0,18,intraciliary transport particle B,CC,
7705,GO:0030997,1,0.953780501647023,0,3,regulation of centriole-centriole cohesion,BP,
7707,GO:0031001,1,0.984725543253726,0,1,response to brefeldin A,BP,
7708,GO:0031002,1,0.990780980970108,0,1,actin rod,CC,
7709,GO:0031005,1,0.837748959175971,0,11,filamin binding,MF,
7710,GO:0031010,1,0.845383753853406,0,11,ISWI-type complex,CC,
7711,GO:0031011,1,0.838773731377051,0,14,Ino80 complex,CC,
7713,GO:0031013,1,0.950173341896471,0,5,troponin I binding,MF,
7714,GO:0031014,1,0.975237635175961,0,4,troponin T binding,MF,
7716,GO:0031017,1,0.92627781329228,0,6,exocrine pancreas development,BP,
7718,GO:0031021,1,0.963361878954905,0,3,interphase microtubule organizing center,CC,
7719,GO:0031022,1,0.967088001125644,0,2,nuclear migration along microfilament,BP,
7724,GO:0031038,1,0.986257186080042,0,1,myosin II filament organization,BP,
7727,GO:0031048,1,0.984725543253726,0,1,chromatin silencing by small RNA,BP,
7728,GO:0031049,1,0.984121084602615,0,1,programmed DNA elimination,BP,
7730,GO:0031052,1,0.984121084602615,0,1,chromosome breakage,BP,
7731,GO:0031053,1,0.865187296777188,0,9,primary miRNA processing,BP,
7732,GO:0031054,1,0.819601906386358,0,13,pre-miRNA processing,BP,
7733,GO:0031055,1,0.675004825368449,0,41,chromatin remodeling at centromere,BP,
7735,GO:0031057,1,0.552177542905107,0,39,negative regulation of histone modification,BP,
7737,GO:0031060,1,0.410123809348824,0,58,regulation of histone methylation,BP,
7738,GO:0031061,1,0.741585944431041,0,19,negative regulation of histone methylation,BP,
7739,GO:0031062,1,0.60460037610911,0,33,positive regulation of histone methylation,BP,
7740,GO:0031063,1,0.69470929222658,0,25,regulation of histone deacetylation,BP,
7741,GO:0031064,1,0.93780449652779,0,5,negative regulation of histone deacetylation,BP,
7742,GO:0031065,1,0.779463630716074,0,16,positive regulation of histone deacetylation,BP,
7744,GO:0031071,1,0.985262919577013,0,1,cysteine desulfurase activity,MF,
7746,GO:0031074,1,0.943552001633638,0,4,nucleocytoplasmic shuttling complex,CC,
7748,GO:0031077,1,0.908209826026358,0,7,post-embryonic camera-type eye development,BP,
7749,GO:0031078,1,0.841938494680204,0,11,histone deacetylase activity (H3-K14 specific),MF,
7750,GO:0031080,1,0.860648162410722,0,10,nuclear pore outer ring,CC,
7751,GO:0031081,1,0.983406759352069,0,1,nuclear pore distribution,BP,
7752,GO:0031082,1,0.766887855810942,0,19,BLOC complex,CC,
7753,GO:0031083,1,0.832057316336789,0,14,BLOC-1 complex,CC,
7754,GO:0031084,1,0.95211155155898,0,3,BLOC-2 complex,CC,
7755,GO:0031085,1,0.968100937628405,0,2,BLOC-3 complex,CC,
7756,GO:0031086,1,0.885757207044819,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7757,GO:0031087,1,0.900324005862054,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7758,GO:0031088,1,0.919321964841294,0,6,platelet dense granule membrane,CC,
7759,GO:0031089,1,0.856785104597261,0,13,platelet dense granule lumen,CC,
7762,GO:0031092,1,0.778020459276691,0,17,platelet alpha granule membrane,CC,
7765,GO:0031095,1,0.874790332958502,0,8,platelet dense tubular network membrane,CC,
7771,GO:0031104,1,0.983406759352069,0,1,dendrite regeneration,BP,
7772,GO:0031105,1,0.917130365362982,0,6,septin complex,CC,
7773,GO:0031106,1,0.983406759351968,0,1,septin ring organization,BP,
7776,GO:0031111,1,0.683985043589385,0,26,negative regulation of microtubule polymerization or depolymerization,BP,
7779,GO:0031114,1,0.772303267061207,0,18,regulation of microtubule depolymerization,BP,
7780,GO:0031115,1,0.866553526234496,0,10,negative regulation of microtubule polymerization,BP,
7782,GO:0031117,1,0.963135138314956,0,3,positive regulation of microtubule depolymerization,BP,
7783,GO:0031118,1,0.945108281144011,0,6,rRNA pseudouridine synthesis,BP,
7784,GO:0031119,1,0.950962574363252,0,4,tRNA pseudouridine synthesis,BP,
7785,GO:0031120,1,0.96495223179451,0,4,snRNA pseudouridine synthesis,BP,
7787,GO:0031123,1,0.192907199163224,0,114,RNA 3'-end processing,BP,
7788,GO:0031124,1,0.269333295607647,0,89,mRNA 3'-end processing,BP,
7789,GO:0031125,1,0.900763234671452,0,10,rRNA 3'-end processing,BP,
7790,GO:0031126,1,0.929540483913834,0,7,snoRNA 3'-end processing,BP,
7791,GO:0031127,1,0.967418487781962,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7793,GO:0031129,1,0.983406759351872,0,1,inductive cell-cell signaling,BP,
7795,GO:0031134,1,0.968384722376208,0,2,sister chromatid biorientation,BP,
7797,GO:0031145,1,0.398447634111394,0,80,anaphase-promoting complex-dependent catabolic process,BP,
7798,GO:0031146,1,0.426229270411167,0,71,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7799,GO:0031151,1,0.983406759351281,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7800,GO:0031161,1,0.983685099661596,0,1,phosphatidylinositol catabolic process,BP,
7801,GO:0031163,1,0.815763234426403,0,18,metallo-sulfur cluster assembly,BP,
7802,GO:0031166,1,0.951562680038445,0,3,integral component of vacuolar membrane,CC,
7803,GO:0031167,1,0.814209995603865,0,16,rRNA methylation,BP,
7806,GO:0031179,1,0.97089570495633,0,2,peptide modification,BP,
7808,GO:0031204,1,0.979128899779128,0,2,posttranslational protein targeting to membrane, translocation,BP,
7809,GO:0031205,1,0.962880566922804,0,3,endoplasmic reticulum Sec complex,CC,
7810,GO:0031208,1,0.968366328029629,0,2,POZ domain binding,MF,
7811,GO:0031209,1,0.87617495347179,0,8,SCAR complex,CC,
7813,GO:0031211,1,0.891723091857474,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7814,GO:0031213,1,0.967088848133446,0,2,RSF complex,CC,
7820,GO:0031227,1,0.136930933896691,0,142,intrinsic component of endoplasmic reticulum membrane,CC,
7821,GO:0031228,1,0.419526550271706,0,58,intrinsic component of Golgi membrane,CC,
7822,GO:0031229,1,0.80796195082747,0,14,intrinsic component of nuclear inner membrane,CC,
7823,GO:0031231,1,0.82996806118951,0,14,intrinsic component of peroxisomal membrane,CC,
7825,GO:0031233,1,0.718528560261706,0,25,intrinsic component of external side of plasma membrane,CC,
7828,GO:0031247,1,0.971103469575097,0,2,actin rod assembly,BP,
7829,GO:0031248,1,0.277699819577332,0,88,protein acetyltransferase complex,CC,
7830,GO:0031249,1,0.985122822835756,0,1,denatured protein binding,MF,
7831,GO:0031251,1,0.967087733487623,0,2,PAN complex,CC,
7836,GO:0031257,1,0.984725543253726,0,1,cell trailing edge membrane,CC,
7837,GO:0031258,1,0.748415555850494,0,19,lamellipodium membrane,CC,
7838,GO:0031259,1,0.984725543253726,0,1,uropod membrane,CC,
7839,GO:0031260,1,0.991905278206824,0,1,pseudopodium membrane,CC,
7840,GO:0031261,1,0.931933553614212,0,5,DNA replication preinitiation complex,CC,
7841,GO:0031262,1,0.958784278841614,0,4,Ndc80 complex,CC,
7842,GO:0031264,1,0.876056742164721,0,9,death-inducing signaling complex,CC,
7843,GO:0031265,1,0.914454869928141,0,6,CD95 death-inducing signaling complex,CC,
7845,GO:0031268,1,0.800579097553263,0,16,pseudopodium organization,BP,
7846,GO:0031269,1,0.807118310026452,0,15,pseudopodium assembly,BP,
7847,GO:0031271,1,0.984725543253726,0,1,lateral pseudopodium assembly,BP,
7848,GO:0031272,1,0.833488875867905,0,13,regulation of pseudopodium assembly,BP,
7849,GO:0031274,1,0.846426452365903,0,12,positive regulation of pseudopodium assembly,BP,
7850,GO:0031275,1,0.984725543253726,0,1,regulation of lateral pseudopodium assembly,BP,
7851,GO:0031279,1,0.292132273775044,0,89,regulation of cyclase activity,BP,
7852,GO:0031280,1,0.673936428873756,0,30,negative regulation of cyclase activity,BP,
7853,GO:0031281,1,0.435547702379635,0,59,positive regulation of cyclase activity,BP,
7854,GO:0031282,1,0.859702134168345,0,13,regulation of guanylate cyclase activity,BP,
7855,GO:0031283,1,0.97554674488087,0,2,negative regulation of guanylate cyclase activity,BP,
7856,GO:0031284,1,0.881263075198557,0,11,positive regulation of guanylate cyclase activity,BP,
7857,GO:0031289,1,0.983792679714628,0,1,actin phosphorylation,BP,
7858,GO:0031290,1,0.723176586348325,0,21,retinal ganglion cell axon guidance,BP,
7859,GO:0031291,1,0.98340675935207,0,1,Ran protein signal transduction,BP,
7860,GO:0031293,1,0.785356335434419,0,16,membrane protein intracellular domain proteolysis,BP,
7863,GO:0031296,1,0.969012793861,0,4,B cell costimulation,BP,
7864,GO:0031297,1,0.691495764489158,0,24,replication fork processing,BP,
7865,GO:0031298,1,0.921787901008457,0,6,replication fork protection complex,CC,
7868,GO:0031302,1,0.983406759351869,0,1,intrinsic component of endosome membrane,CC,
7869,GO:0031304,1,0.719919259766337,0,25,intrinsic component of mitochondrial inner membrane,CC,
7870,GO:0031305,1,0.719919259766337,0,25,integral component of mitochondrial inner membrane,CC,
7871,GO:0031306,1,0.717459166558574,0,24,intrinsic component of mitochondrial outer membrane,CC,
7872,GO:0031307,1,0.72958097702139,0,23,integral component of mitochondrial outer membrane,CC,
7873,GO:0031308,1,0.984725543253726,0,1,intrinsic component of nuclear outer membrane,CC,
7874,GO:0031309,1,0.984725543253726,0,1,integral component of nuclear outer membrane,CC,
7875,GO:0031310,1,0.951562680038445,0,3,intrinsic component of vacuolar membrane,CC,
7876,GO:0031312,1,0.659569727728307,0,28,extrinsic component of organelle membrane,CC,
7877,GO:0031313,1,0.914408584941105,0,6,extrinsic component of endosome membrane,CC,
7878,GO:0031314,1,0.918488610448569,0,6,extrinsic component of mitochondrial inner membrane,CC,
7879,GO:0031315,1,0.967733673573994,0,2,extrinsic component of mitochondrial outer membrane,CC,
7880,GO:0031320,1,0.98481024597292,0,1,hexitol dehydrogenase activity,MF,
7890,GO:0031332,1,0.84160143252204,0,11,RNAi effector complex,CC,
7893,GO:0031335,1,0.970740306851967,0,2,regulation of sulfur amino acid metabolic process,BP,
7894,GO:0031337,1,0.985637625278431,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7895,GO:0031338,1,0.36901281896169,0,66,regulation of vesicle fusion,BP,
7896,GO:0031339,1,0.924561721001267,0,5,negative regulation of vesicle fusion,BP,
7897,GO:0031340,1,0.898793142184604,0,8,positive regulation of vesicle fusion,BP,
7898,GO:0031341,1,0.467956737326384,0,57,regulation of cell killing,BP,
7899,GO:0031342,1,0.806906090832397,0,16,negative regulation of cell killing,BP,
7900,GO:0031343,1,0.621667433246995,0,36,positive regulation of cell killing,BP,
7907,GO:0031362,1,0.768393744832332,0,20,anchored component of external side of plasma membrane,CC,
7909,GO:0031369,1,0.669243071561584,0,29,translation initiation factor binding,MF,
7910,GO:0031370,1,0.983406759351968,0,1,eukaryotic initiation factor 4G binding,MF,
7911,GO:0031371,1,0.884920011079071,0,9,ubiquitin conjugating enzyme complex,CC,
7912,GO:0031372,1,0.974075012325962,0,2,UBC13-MMS2 complex,CC,
7913,GO:0031379,1,0.967243764347811,0,2,RNA-directed RNA polymerase complex,CC,
7914,GO:0031380,1,0.983565412210262,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7915,GO:0031386,1,0.92486810264437,0,8,protein tag,MF,
7916,GO:0031389,1,0.98400191984867,0,1,Rad17 RFC-like complex,CC,
7917,GO:0031390,1,0.893187267084878,0,8,Ctf18 RFC-like complex,CC,
7918,GO:0031392,1,0.921606318083324,0,6,regulation of prostaglandin biosynthetic process,BP,
7919,GO:0031393,1,0.967384874854449,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7920,GO:0031394,1,0.952684384520756,0,4,positive regulation of prostaglandin biosynthetic process,BP,
7922,GO:0031397,1,0.18342114939102,0,134,negative regulation of protein ubiquitination,BP,
7927,GO:0031402,1,0.814162363383704,0,13,sodium ion binding,MF,
7928,GO:0031403,1,0.96718355770948,0,2,lithium ion binding,MF,
7929,GO:0031404,1,0.885004830209419,0,9,chloride ion binding,MF,
7931,GO:0031407,1,0.985305465340027,0,1,oxylipin metabolic process,BP,
7933,GO:0031414,1,0.871512223202613,0,10,N-terminal protein acetyltransferase complex,CC,
7934,GO:0031415,1,0.938368313886662,0,5,NatA complex,CC,
7935,GO:0031416,1,0.975565483771805,0,2,NatB complex,CC,
7936,GO:0031417,1,0.952038226220068,0,3,NatC complex,CC,
7937,GO:0031418,1,0.761878602144062,0,18,L-ascorbic acid binding,MF,
7938,GO:0031419,1,0.882853400565353,0,9,cobalamin binding,MF,
7939,GO:0031420,1,0.737960989958991,0,19,alkali metal ion binding,MF,
7941,GO:0031427,1,0.939873665193363,0,4,response to methotrexate,BP,
7942,GO:0031428,1,0.95450459382933,0,4,box C/D snoRNP complex,CC,
7943,GO:0031429,1,0.956788082847872,0,5,box H/ACA snoRNP complex,CC,
7944,GO:0031430,1,0.660749842515047,0,29,M band,CC,
7946,GO:0031433,1,0.907224612543923,0,7,telethonin binding,MF,
7948,GO:0031435,1,0.7732101009537,0,16,mitogen-activated protein kinase kinase kinase binding,MF,
7949,GO:0031436,1,0.968281682431491,0,2,BRCA1-BARD1 complex,CC,
7950,GO:0031437,1,0.969124428026234,0,2,regulation of mRNA cleavage,BP,
7951,GO:0031438,1,0.983760999990501,0,1,negative regulation of mRNA cleavage,BP,
7952,GO:0031439,1,0.985122822835756,0,1,positive regulation of mRNA cleavage,BP,
7953,GO:0031440,1,0.733830494654662,0,20,regulation of mRNA 3'-end processing,BP,
7954,GO:0031441,1,0.879490970139457,0,8,negative regulation of mRNA 3'-end processing,BP,
7955,GO:0031442,1,0.887116414804614,0,8,positive regulation of mRNA 3'-end processing,BP,
7956,GO:0031443,1,0.967133468273445,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7957,GO:0031444,1,0.96760423110353,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7958,GO:0031445,1,0.972096085356458,0,2,regulation of heterochromatin assembly,BP,
7959,GO:0031446,1,0.983453262681897,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7960,GO:0031448,1,0.983453262681897,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7961,GO:0031449,1,0.983406759351625,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7962,GO:0031453,1,0.972096085356458,0,2,positive regulation of heterochromatin assembly,BP,
7963,GO:0031455,1,0.967145225332229,0,2,glycine betaine metabolic process,BP,
7964,GO:0031456,1,0.967145225332229,0,2,glycine betaine biosynthetic process,BP,
7965,GO:0031460,1,0.983406759351921,0,1,glycine betaine transport,BP,
7966,GO:0031461,1,0.0773193181473462,0,171,cullin-RING ubiquitin ligase complex,CC,
7967,GO:0031462,1,0.890293389202332,0,9,Cul2-RING ubiquitin ligase complex,CC,
7968,GO:0031463,1,0.33856716010628,0,70,Cul3-RING ubiquitin ligase complex,CC,
7969,GO:0031464,1,0.864953925842268,0,10,Cul4A-RING E3 ubiquitin ligase complex,CC,
7970,GO:0031465,1,0.935251189198793,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7971,GO:0031466,1,0.928011179745646,0,6,Cul5-RING ubiquitin ligase complex,CC,
7972,GO:0031467,1,0.949059882449462,0,4,Cul7-RING ubiquitin ligase complex,CC,
7973,GO:0031468,1,0.791921791461412,0,17,nuclear envelope reassembly,BP,
7974,GO:0031475,1,0.989160875801517,0,1,myosin V complex,CC,
7980,GO:0031493,1,0.956873445093993,0,3,nucleosomal histone binding,MF,
7981,GO:0031494,1,0.984725543253726,0,1,regulation of mating type switching,BP,
7982,GO:0031497,1,0.214280630792486,0,149,chromatin assembly,BP,
7983,GO:0031498,1,0.762281755995702,0,20,chromatin disassembly,BP,
7984,GO:0031501,1,0.963446290523113,0,4,mannosyltransferase complex,CC,
7986,GO:0031506,1,0.987784806077991,0,1,cell wall glycoprotein biosynthetic process,BP,
7987,GO:0031507,1,0.847757845584492,0,12,heterochromatin assembly,BP,
7988,GO:0031508,1,0.952452515318729,0,4,pericentric heterochromatin assembly,BP,
7989,GO:0031509,1,0.965414989152667,0,3,telomeric heterochromatin assembly,BP,
7990,GO:0031510,1,0.959546057590359,0,3,SUMO activating enzyme complex,CC,
7991,GO:0031514,1,0.174324390046047,0,128,motile cilium,CC,
7992,GO:0031515,1,0.957139105732109,0,3,tRNA (m1A) methyltransferase complex,CC,
7993,GO:0031519,1,0.510406834181768,0,44,PcG protein complex,CC,
7994,GO:0031523,1,0.967998621087957,0,2,Myb complex,CC,
7995,GO:0031526,1,0.458576766677853,0,52,brush border membrane,CC,
7999,GO:0031531,1,0.981670541591923,0,3,thyrotropin-releasing hormone receptor binding,MF,
8001,GO:0031536,1,0.94393011226827,0,5,positive regulation of exit from mitosis,BP,
8002,GO:0031543,1,0.861448294368836,0,10,peptidyl-proline dioxygenase activity,MF,
8003,GO:0031544,1,0.983817326569247,0,1,peptidyl-proline 3-dioxygenase activity,MF,
8004,GO:0031545,1,0.875626000175132,0,9,peptidyl-proline 4-dioxygenase activity,MF,
8005,GO:0031547,1,0.919731182616032,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
8006,GO:0031548,1,0.967087733487914,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8007,GO:0031549,1,0.983406759351821,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8008,GO:0031550,1,0.983406759352069,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8009,GO:0031554,1,0.983406759350443,0,1,regulation of DNA-templated transcription, termination,BP,
8010,GO:0031559,1,0.98340675935207,0,1,oxidosqualene cyclase activity,MF,
8014,GO:0031573,1,0.814466627247408,0,15,intra-S DNA damage checkpoint,BP,
8015,GO:0031577,1,0.600529684274336,0,35,spindle checkpoint,BP,
8016,GO:0031579,1,0.725946403539823,0,23,membrane raft organization,BP,
8017,GO:0031580,1,0.888035642351843,0,9,membrane raft distribution,BP,
8020,GO:0031584,1,0.924484824083069,0,6,activation of phospholipase D activity,BP,
8021,GO:0031585,1,0.935255037677456,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8022,GO:0031587,1,0.95103911078772,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8025,GO:0031590,1,0.968948892627227,0,2,wybutosine metabolic process,BP,
8026,GO:0031591,1,0.968948892627227,0,2,wybutosine biosynthetic process,BP,
8027,GO:0031592,1,0.983406759351183,0,1,centrosomal corona,CC,
8028,GO:0031593,1,0.547687993879211,0,39,polyubiquitin binding,MF,
8029,GO:0031594,1,0.43742413717792,0,55,neuromuscular junction,CC,
8030,GO:0031595,1,0.910513854630279,0,8,nuclear proteasome complex,CC,
8031,GO:0031597,1,0.88498979052178,0,10,cytosolic proteasome complex,CC,
8032,GO:0031616,1,0.889270828866004,0,9,spindle pole centrosome,CC,
8033,GO:0031618,1,0.884917768292691,0,8,nuclear pericentric heterochromatin,CC,
8034,GO:0031620,1,0.889563987318178,0,8,regulation of fever generation,BP,
8035,GO:0031622,1,0.90458008856695,0,7,positive regulation of fever generation,BP,
8036,GO:0031623,1,0.311349386586551,0,79,receptor internalization,BP,
8039,GO:0031626,1,0.983406759351872,0,1,beta-endorphin binding,MF,
8040,GO:0031627,1,0.952152912077278,0,3,telomeric loop formation,BP,
8041,GO:0031628,1,0.891694653686607,0,9,opioid receptor binding,MF,
8042,GO:0031629,1,0.810250119392487,0,15,synaptic vesicle fusion to presynaptic active zone membrane,BP,
8043,GO:0031630,1,0.95675314785403,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
8044,GO:0031635,1,0.970952318299779,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
8049,GO:0031642,1,0.906226690731733,0,7,negative regulation of myelination,BP,
8050,GO:0031643,1,0.841048762204491,0,11,positive regulation of myelination,BP,
8052,GO:0031645,1,0.819059050435475,0,16,negative regulation of neurological system process,BP,
8053,GO:0031646,1,0.728446186617759,0,22,positive regulation of neurological system process,BP,
8056,GO:0031649,1,0.769580517337013,0,17,heat generation,BP,
8057,GO:0031650,1,0.832155743209913,0,12,regulation of heat generation,BP,
8058,GO:0031651,1,0.983406759352069,0,1,negative regulation of heat generation,BP,
8059,GO:0031652,1,0.86049388537257,0,10,positive regulation of heat generation,BP,
8061,GO:0031658,1,0.983406759351773,0,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
8063,GO:0031660,1,0.986326983415046,0,1,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,BP,
8064,GO:0031662,1,0.986326983415046,0,1,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,BP,
8067,GO:0031665,1,0.897478844490345,0,9,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
8073,GO:0031672,1,0.566325324457613,0,41,A band,CC,
8074,GO:0031673,1,0.983406759349068,0,1,H zone,CC,
8076,GO:0031681,1,0.875853720398959,0,9,G-protein beta-subunit binding,MF,
8077,GO:0031682,1,0.983803030357479,0,1,G-protein gamma-subunit binding,MF,
8079,GO:0031685,1,0.967405661682131,0,2,adenosine receptor binding,MF,
8080,GO:0031686,1,0.983730030123656,0,1,A1 adenosine receptor binding,MF,
8082,GO:0031691,1,0.973212452641763,0,2,alpha-1A adrenergic receptor binding,MF,
8083,GO:0031692,1,0.957063053806399,0,3,alpha-1B adrenergic receptor binding,MF,
8085,GO:0031695,1,0.985011199028935,0,1,alpha-2B adrenergic receptor binding,MF,
8086,GO:0031696,1,0.96866682317201,0,2,alpha-2C adrenergic receptor binding,MF,
8087,GO:0031697,1,0.951038955129426,0,3,beta-1 adrenergic receptor binding,MF,
8088,GO:0031698,1,0.942010264337312,0,4,beta-2 adrenergic receptor binding,MF,
8089,GO:0031699,1,0.968181292598201,0,2,beta-3 adrenergic receptor binding,MF,
8090,GO:0031700,1,0.989582527111997,0,1,adrenomedullin receptor binding,MF,
8091,GO:0031701,1,0.846763462013044,0,11,angiotensin receptor binding,MF,
8092,GO:0031702,1,0.858894303811342,0,10,type 1 angiotensin receptor binding,MF,
8093,GO:0031703,1,0.984675140077779,0,1,type 2 angiotensin receptor binding,MF,
8094,GO:0031704,1,0.983619275014404,0,1,apelin receptor binding,MF,
8098,GO:0031710,1,0.992309809408833,0,1,neuromedin B receptor binding,MF,
8099,GO:0031711,1,0.969201465073084,0,2,bradykinin receptor binding,MF,
8100,GO:0031714,1,0.983406759351869,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8101,GO:0031715,1,0.983406759351869,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8102,GO:0031716,1,0.987080171453351,0,2,calcitonin receptor binding,MF,
8103,GO:0031720,1,0.98611818478647,0,3,haptoglobin binding,MF,
8104,GO:0031721,1,0.993782107614422,0,1,hemoglobin alpha binding,MF,
8105,GO:0031724,1,0.991123064544678,0,1,CXCR5 chemokine receptor binding,MF,
8106,GO:0031726,1,0.969381851057809,0,5,CCR1 chemokine receptor binding,MF,
8107,GO:0031727,1,0.979274202728636,0,2,CCR2 chemokine receptor binding,MF,
8108,GO:0031728,1,0.985911248502596,0,3,CCR3 chemokine receptor binding,MF,
8109,GO:0031729,1,0.986256873983031,0,2,CCR4 chemokine receptor binding,MF,
8110,GO:0031730,1,0.943113459715672,0,6,CCR5 chemokine receptor binding,MF,
8112,GO:0031732,1,0.988131496132754,0,2,CCR7 chemokine receptor binding,MF,
8113,GO:0031735,1,0.979254649488847,0,3,CCR10 chemokine receptor binding,MF,
8114,GO:0031737,1,0.983581970456042,0,1,CX3C chemokine receptor binding,MF,
8115,GO:0031739,1,0.98621248489368,0,1,cholecystokinin receptor binding,MF,
8116,GO:0031741,1,0.98621248489368,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8117,GO:0031748,1,0.890803847656996,0,8,D1 dopamine receptor binding,MF,
8118,GO:0031749,1,0.955998525144075,0,3,D2 dopamine receptor binding,MF,
8119,GO:0031750,1,0.972660524452661,0,2,D3 dopamine receptor binding,MF,
8120,GO:0031751,1,0.988323769123988,0,1,D4 dopamine receptor binding,MF,
8121,GO:0031752,1,0.955794234889208,0,3,D5 dopamine receptor binding,MF,
8122,GO:0031753,1,0.984189595856599,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8123,GO:0031755,1,0.984189595856599,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8124,GO:0031762,1,0.973212452641763,0,2,follicle-stimulating hormone receptor binding,MF,
8125,GO:0031763,1,0.99404187805355,0,1,galanin receptor binding,MF,
8126,GO:0031764,1,0.99404187805355,0,1,type 1 galanin receptor binding,MF,
8127,GO:0031765,1,0.99404187805355,0,1,type 2 galanin receptor binding,MF,
8128,GO:0031766,1,0.99404187805355,0,1,type 3 galanin receptor binding,MF,
8129,GO:0031768,1,0.994515375845619,0,1,ghrelin receptor binding,MF,
8130,GO:0031770,1,0.996481206273501,0,1,growth hormone-releasing hormone receptor binding,MF,
8131,GO:0031771,1,0.995545341753087,0,1,type 1 hypocretin receptor binding,MF,
8132,GO:0031772,1,0.995545341753087,0,1,type 2 hypocretin receptor binding,MF,
8133,GO:0031773,1,0.994530032375714,0,1,kisspeptin receptor binding,MF,
8134,GO:0031775,1,0.983406759351084,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8135,GO:0031779,1,0.966248423214253,0,4,melanocortin receptor binding,MF,
8136,GO:0031780,1,0.979754727868728,0,2,corticotropin hormone receptor binding,MF,
8137,GO:0031781,1,0.966248423214253,0,4,type 3 melanocortin receptor binding,MF,
8138,GO:0031782,1,0.966248423214253,0,4,type 4 melanocortin receptor binding,MF,
8139,GO:0031783,1,0.979754727868728,0,2,type 5 melanocortin receptor binding,MF,
8140,GO:0031798,1,0.983406759351231,0,1,type 1 metabotropic glutamate receptor binding,MF,
8141,GO:0031800,1,0.960080287715356,0,3,type 3 metabotropic glutamate receptor binding,MF,
8142,GO:0031802,1,0.968376820290686,0,2,type 5 metabotropic glutamate receptor binding,MF,
8143,GO:0031811,1,0.983407323635702,0,1,G-protein coupled nucleotide receptor binding,MF,
8144,GO:0031812,1,0.983407323635702,0,1,P2Y1 nucleotide receptor binding,MF,
8145,GO:0031821,1,0.90039428156256,0,7,G-protein coupled serotonin receptor binding,MF,
8146,GO:0031826,1,0.96237976806188,0,3,type 2A serotonin receptor binding,MF,
8147,GO:0031834,1,0.991540580239407,0,1,neurokinin receptor binding,MF,
8148,GO:0031835,1,0.991540580239407,0,1,substance P receptor binding,MF,
8149,GO:0031838,1,0.976458441722735,0,4,haptoglobin-hemoglobin complex,CC,
8150,GO:0031848,1,0.854563901994203,0,10,protection from non-homologous end joining at telomere,BP,
8152,GO:0031851,1,0.993933419012857,0,1,kappa-type opioid receptor binding,MF,
8153,GO:0031852,1,0.940507935323782,0,4,mu-type opioid receptor binding,MF,
8154,GO:0031854,1,0.996816517928063,0,1,orexigenic neuropeptide QRFP receptor binding,MF,
8155,GO:0031855,1,0.9960265787534,0,1,oxytocin receptor binding,MF,
8156,GO:0031856,1,0.993803685087953,0,1,parathyroid hormone receptor binding,MF,
8157,GO:0031857,1,0.993803685087953,0,1,type 1 parathyroid hormone receptor binding,MF,
8158,GO:0031858,1,0.983661989983942,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8159,GO:0031859,1,0.987146719930508,0,1,platelet activating factor receptor binding,MF,
8160,GO:0031860,1,0.951057865042726,0,3,telomeric 3' overhang formation,BP,
8161,GO:0031861,1,0.997938828980996,0,1,prolactin-releasing peptide receptor binding,MF,
8162,GO:0031862,1,0.967089785609025,0,2,prostanoid receptor binding,MF,
8163,GO:0031867,1,0.983408845957924,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8164,GO:0031870,1,0.983406759351625,0,1,thromboxane A2 receptor binding,MF,
8165,GO:0031871,1,0.955089630382725,0,3,proteinase activated receptor binding,MF,
8166,GO:0031877,1,0.983406759351479,0,1,somatostatin receptor binding,MF,
8167,GO:0031883,1,0.986285821290181,0,1,taste receptor binding,MF,
8168,GO:0031893,1,0.964901590649313,0,3,vasopressin receptor binding,MF,
8169,GO:0031894,1,0.978717361700969,0,2,V1A vasopressin receptor binding,MF,
8170,GO:0031895,1,0.995231811220186,0,1,V1B vasopressin receptor binding,MF,
8171,GO:0031896,1,0.98588505217645,0,1,V2 vasopressin receptor binding,MF,
8175,GO:0031904,1,0.707531786329166,0,29,endosome lumen,CC,
8176,GO:0031905,1,0.976104409950979,0,2,early endosome lumen,CC,
8177,GO:0031906,1,0.92769416589261,0,7,late endosome lumen,CC,
8178,GO:0031907,1,0.561613328162341,0,43,microbody lumen,CC,
8179,GO:0031914,1,0.929852285281976,0,5,negative regulation of synaptic plasticity,BP,
8180,GO:0031915,1,0.876312338467332,0,9,positive regulation of synaptic plasticity,BP,
8182,GO:0031930,1,0.989499512273344,0,1,mitochondria-nucleus signaling pathway,BP,
8183,GO:0031931,1,0.898298896523699,0,7,TORC1 complex,CC,
8185,GO:0031933,1,0.958360505222319,0,3,telomeric heterochromatin,CC,
8186,GO:0031935,1,0.721441997504478,0,21,regulation of chromatin silencing,BP,
8187,GO:0031936,1,0.873775219686638,0,9,negative regulation of chromatin silencing,BP,
8188,GO:0031937,1,0.879651768044197,0,8,positive regulation of chromatin silencing,BP,
8189,GO:0031938,1,0.975710384441948,0,2,regulation of chromatin silencing at telomere,BP,
8190,GO:0031940,1,0.988499272489636,0,1,positive regulation of chromatin silencing at telomere,BP,
8199,GO:0031953,1,0.835595461491452,0,11,negative regulation of protein autophosphorylation,BP,
8202,GO:0031958,1,0.777619825776428,0,16,corticosteroid receptor signaling pathway,BP,
8203,GO:0031959,1,0.983406759351821,0,1,mineralocorticoid receptor signaling pathway,BP,
8205,GO:0031962,1,0.983406759351676,0,1,mineralocorticoid receptor binding,MF,
8206,GO:0031965,1,0.0155592575432312,0,280,nuclear membrane,CC,
8217,GO:0031985,1,0.252038125834959,0,90,Golgi cisterna,CC,
8218,GO:0031987,1,0.868659085764376,0,9,locomotion involved in locomotory behavior,BP,
8219,GO:0031989,1,0.980074879049148,0,2,bombesin receptor signaling pathway,BP,
8220,GO:0031990,1,0.969097133477792,0,2,mRNA export from nucleus in response to heat stress,BP,
8222,GO:0031995,1,0.896399983365728,0,8,insulin-like growth factor II binding,MF,
8223,GO:0031996,1,0.810059091212326,0,14,thioesterase binding,MF,
8224,GO:0031997,1,0.960080287715356,0,3,N-terminal myristoylation domain binding,MF,
8227,GO:0032000,1,0.877233465212755,0,9,positive regulation of fatty acid beta-oxidation,BP,
8228,GO:0032002,1,0.957074434940051,0,3,interleukin-28 receptor complex,CC,
8229,GO:0032003,1,0.984725543253726,0,1,interleukin-28 receptor binding,MF,
8233,GO:0032009,1,0.882201170856333,0,8,early phagosome,CC,
8234,GO:0032010,1,0.934607652223038,0,5,phagolysosome,CC,
8235,GO:0032011,1,0.779313206422008,0,15,ARF protein signal transduction,BP,
8236,GO:0032012,1,0.779313206422008,0,15,regulation of ARF protein signal transduction,BP,
8237,GO:0032020,1,0.932083896804861,0,6,ISG15-protein conjugation,BP,
8238,GO:0032021,1,0.94028228781709,0,4,NELF complex,CC,
8239,GO:0032023,1,0.985603653174881,0,1,trypsinogen activation,BP,
8240,GO:0032024,1,0.418216213873135,0,63,positive regulation of insulin secretion,BP,
8241,GO:0032025,1,0.878640756398356,0,9,response to cobalt ion,BP,
8243,GO:0032027,1,0.91554652032403,0,6,myosin light chain binding,MF,
8244,GO:0032028,1,0.986261267829129,0,1,myosin head/neck binding,MF,
8247,GO:0032038,1,0.986287706801283,0,2,myosin II heavy chain binding,MF,
8248,GO:0032039,1,0.838593248985908,0,11,integrator complex,CC,
8249,GO:0032040,1,0.654873990562621,0,30,small-subunit processome,CC,
8250,GO:0032041,1,0.841938494680204,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8252,GO:0032044,1,0.972932986409013,0,2,DSIF complex,CC,
8253,GO:0032045,1,0.831772681628903,0,12,guanyl-nucleotide exchange factor complex,CC,
8254,GO:0032048,1,0.813918054981545,0,14,cardiolipin metabolic process,BP,
8255,GO:0032049,1,0.897919023154199,0,7,cardiolipin biosynthetic process,BP,
8256,GO:0032050,1,0.934763232437927,0,5,clathrin heavy chain binding,MF,
8257,GO:0032051,1,0.915995684275415,0,6,clathrin light chain binding,MF,
8259,GO:0032053,1,0.954080322450493,0,3,ciliary basal body organization,BP,
8261,GO:0032056,1,0.911553367265534,0,6,positive regulation of translation in response to stress,BP,
8262,GO:0032057,1,0.902170164709292,0,7,negative regulation of translational initiation in response to stress,BP,
8263,GO:0032058,1,0.937022972888428,0,4,positive regulation of translational initiation in response to stress,BP,
8264,GO:0032059,1,0.897048433224191,0,7,bleb,CC,
8265,GO:0032060,1,0.863668205304501,0,10,bleb assembly,BP,
8266,GO:0032066,1,0.951756964048281,0,3,nucleolus to nucleoplasm transport,BP,
8270,GO:0032072,1,0.983493076439758,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8271,GO:0032074,1,0.904007084537202,0,7,negative regulation of nuclease activity,BP,
8273,GO:0032076,1,0.977660811791653,0,2,negative regulation of deoxyribonuclease activity,BP,
8275,GO:0032078,1,0.993204551396276,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8278,GO:0032089,1,0.967663601099718,0,2,NACHT domain binding,MF,
8279,GO:0032090,1,0.9767768919258,0,2,Pyrin domain binding,MF,
8282,GO:0032093,1,0.984725543253726,0,1,SAM domain binding,MF,
8284,GO:0032095,1,0.83571353508921,0,17,regulation of response to food,BP,
8285,GO:0032096,1,0.894288772164336,0,10,negative regulation of response to food,BP,
8286,GO:0032097,1,0.970420629746256,0,4,positive regulation of response to food,BP,
8287,GO:0032098,1,0.80718676112667,0,21,regulation of appetite,BP,
8288,GO:0032099,1,0.894288772164336,0,10,negative regulation of appetite,BP,
8289,GO:0032100,1,0.970420629746256,0,4,positive regulation of appetite,BP,
8293,GO:0032104,1,0.761342013037367,0,23,regulation of response to extracellular stimulus,BP,
8294,GO:0032105,1,0.867393643285324,0,12,negative regulation of response to extracellular stimulus,BP,
8295,GO:0032106,1,0.942552757409186,0,6,positive regulation of response to extracellular stimulus,BP,
8296,GO:0032107,1,0.761342013037367,0,23,regulation of response to nutrient levels,BP,
8297,GO:0032108,1,0.867393643285324,0,12,negative regulation of response to nutrient levels,BP,
8298,GO:0032109,1,0.942552757409186,0,6,positive regulation of response to nutrient levels,BP,
8299,GO:0032113,1,0.991071049420841,0,1,regulation of carbohydrate phosphatase activity,BP,
8300,GO:0032116,1,0.968384722374901,0,2,SMC loading complex,CC,
8301,GO:0032119,1,0.850571362064374,0,12,sequestering of zinc ion,BP,
8302,GO:0032127,1,0.967357673106455,0,2,dense core granule membrane,CC,
8303,GO:0032129,1,0.972097952485832,0,2,histone deacetylase activity (H3-K9 specific),MF,
8304,GO:0032133,1,0.939853242569745,0,5,chromosome passenger complex,CC,
8305,GO:0032135,1,0.911676140389872,0,6,DNA insertion or deletion binding,MF,
8306,GO:0032137,1,0.952823167938424,0,3,guanine/thymine mispair binding,MF,
8307,GO:0032138,1,0.936165705296934,0,4,single base insertion or deletion binding,MF,
8308,GO:0032139,1,0.957923382201201,0,3,dinucleotide insertion or deletion binding,MF,
8309,GO:0032142,1,0.951298345834268,0,3,single guanine insertion binding,MF,
8310,GO:0032143,1,0.967352038347753,0,2,single thymine insertion binding,MF,
8311,GO:0032144,1,0.983406759351921,0,1,4-aminobutyrate transaminase complex,CC,
8312,GO:0032145,1,0.983406759351921,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8318,GO:0032156,1,0.901906790652914,0,7,septin cytoskeleton,CC,
8319,GO:0032173,1,0.983851570765422,0,1,septin collar,CC,
8320,GO:0032181,1,0.967352038347705,0,2,dinucleotide repeat insertion binding,MF,
8322,GO:0032183,1,0.777674340005812,0,16,SUMO binding,MF,
8323,GO:0032184,1,0.921451698006455,0,5,SUMO polymer binding,MF,
8324,GO:0032185,1,0.968384722376208,0,2,septin cytoskeleton organization,BP,
8326,GO:0032194,1,0.98342653957286,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8327,GO:0032196,1,0.794963473542143,0,16,transposition,BP,
8328,GO:0032197,1,0.983406946647756,0,1,transposition, RNA-mediated,BP,
8329,GO:0032200,1,0.126974337483925,0,160,telomere organization,BP,
8330,GO:0032201,1,0.911813649968655,0,6,telomere maintenance via semi-conservative replication,BP,
8331,GO:0032202,1,0.945037858211713,0,4,telomere assembly,BP,
8332,GO:0032203,1,0.987372346804205,0,1,telomere formation via telomerase,BP,
8333,GO:0032204,1,0.340881739503462,0,71,regulation of telomere maintenance,BP,
8334,GO:0032205,1,0.615824341453677,0,31,negative regulation of telomere maintenance,BP,
8335,GO:0032206,1,0.487286644082331,0,48,positive regulation of telomere maintenance,BP,
8336,GO:0032207,1,0.984000309954091,0,1,regulation of telomere maintenance via recombination,BP,
8337,GO:0032208,1,0.984000309954091,0,1,negative regulation of telomere maintenance via recombination,BP,
8338,GO:0032210,1,0.495609934101209,0,47,regulation of telomere maintenance via telomerase,BP,
8339,GO:0032211,1,0.797168697971715,0,15,negative regulation of telomere maintenance via telomerase,BP,
8340,GO:0032212,1,0.616042322151683,0,33,positive regulation of telomere maintenance via telomerase,BP,
8341,GO:0032213,1,0.968201160648909,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8342,GO:0032214,1,0.968201160648909,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8345,GO:0032222,1,0.889655203689954,0,9,regulation of synaptic transmission, cholinergic,BP,
8346,GO:0032223,1,0.984673829223965,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8347,GO:0032224,1,0.917792722993576,0,7,positive regulation of synaptic transmission, cholinergic,BP,
8349,GO:0032226,1,0.909769140650504,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8350,GO:0032227,1,0.951287049631524,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8353,GO:0032230,1,0.834608344505461,0,13,positive regulation of synaptic transmission, GABAergic,BP,
8355,GO:0032232,1,0.707309012034353,0,23,negative regulation of actin filament bundle assembly,BP,
8357,GO:0032237,1,0.940403380491802,0,4,activation of store-operated calcium channel activity,BP,
8359,GO:0032240,1,0.967087733486563,0,2,negative regulation of nucleobase-containing compound transport,BP,
8365,GO:0032261,1,0.914846334065285,0,7,purine nucleotide salvage,BP,
8366,GO:0032262,1,0.93875658605913,0,5,pyrimidine nucleotide salvage,BP,
8367,GO:0032264,1,0.942999370789261,0,4,IMP salvage,BP,
8368,GO:0032266,1,0.637616361147285,0,29,phosphatidylinositol-3-phosphate binding,MF,
8376,GO:0032275,1,0.87843731994061,0,9,luteinizing hormone secretion,BP,
8381,GO:0032280,1,0.943607694173112,0,4,symmetric synapse,CC,
8382,GO:0032281,1,0.681376407889207,0,27,AMPA glutamate receptor complex,CC,
8383,GO:0032286,1,0.93878315722152,0,4,central nervous system myelin maintenance,BP,
8385,GO:0032288,1,0.754227407088425,0,18,myelin assembly,BP,
8386,GO:0032289,1,0.954957245748052,0,3,central nervous system myelin formation,BP,
8387,GO:0032290,1,0.968384722374853,0,2,peripheral nervous system myelin formation,BP,
8388,GO:0032291,1,0.805638220453371,0,15,axon ensheathment in central nervous system,BP,
8390,GO:0032296,1,0.940819828510553,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8391,GO:0032298,1,0.98573568654092,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8392,GO:0032299,1,0.964949998513984,0,3,ribonuclease H2 complex,CC,
8393,GO:0032300,1,0.877023600571688,0,8,mismatch repair complex,CC,
8394,GO:0032301,1,0.967352038347753,0,2,MutSalpha complex,CC,
8395,GO:0032302,1,0.967352038347705,0,2,MutSbeta complex,CC,
8397,GO:0032304,1,0.953449960429764,0,3,negative regulation of icosanoid secretion,BP,
8403,GO:0032311,1,0.979908687365414,0,2,angiogenin-PRI complex,CC,
8404,GO:0032324,1,0.903752332481818,0,7,molybdopterin cofactor biosynthetic process,BP,
8405,GO:0032328,1,0.852903500585396,0,10,alanine transport,BP,
8406,GO:0032329,1,0.867551611362705,0,10,serine transport,BP,
8424,GO:0032356,1,0.887318465773745,0,8,oxidized DNA binding,MF,
8425,GO:0032357,1,0.887318465773745,0,8,oxidized purine DNA binding,MF,
8426,GO:0032358,1,0.9935956493984,0,1,oxidized pyrimidine DNA binding,MF,
8427,GO:0032361,1,0.986706463820984,0,1,pyridoxal phosphate catabolic process,BP,
8429,GO:0032365,1,0.641531609652659,0,30,intracellular lipid transport,BP,
8430,GO:0032366,1,0.781543435037219,0,17,intracellular sterol transport,BP,
8431,GO:0032367,1,0.781543435037219,0,17,intracellular cholesterol transport,BP,
8435,GO:0032371,1,0.579708129939842,0,42,regulation of sterol transport,BP,
8436,GO:0032372,1,0.874437521922037,0,12,negative regulation of sterol transport,BP,
8437,GO:0032373,1,0.76050236874922,0,19,positive regulation of sterol transport,BP,
8438,GO:0032374,1,0.579708129939842,0,42,regulation of cholesterol transport,BP,
8439,GO:0032375,1,0.874437521922037,0,12,negative regulation of cholesterol transport,BP,
8440,GO:0032376,1,0.76050236874922,0,19,positive regulation of cholesterol transport,BP,
8441,GO:0032377,1,0.906043684532919,0,7,regulation of intracellular lipid transport,BP,
8442,GO:0032378,1,0.983427728128022,0,1,negative regulation of intracellular lipid transport,BP,
8443,GO:0032379,1,0.96265073556154,0,3,positive regulation of intracellular lipid transport,BP,
8444,GO:0032380,1,0.906043684532919,0,7,regulation of intracellular sterol transport,BP,
8445,GO:0032381,1,0.983427728128022,0,1,negative regulation of intracellular sterol transport,BP,
8446,GO:0032382,1,0.96265073556154,0,3,positive regulation of intracellular sterol transport,BP,
8447,GO:0032383,1,0.906043684532919,0,7,regulation of intracellular cholesterol transport,BP,
8448,GO:0032384,1,0.983427728128022,0,1,negative regulation of intracellular cholesterol transport,BP,
8449,GO:0032385,1,0.96265073556154,0,3,positive regulation of intracellular cholesterol transport,BP,
8453,GO:0032389,1,0.937498518726165,0,4,MutLalpha complex,CC,
8455,GO:0032392,1,0.29656742308793,0,80,DNA geometric change,BP,
8456,GO:0032393,1,0.89674774730511,0,9,MHC class I receptor activity,MF,
8457,GO:0032394,1,0.973726433079469,0,2,MHC class Ib receptor activity,MF,
8458,GO:0032395,1,0.9004669685448,0,10,MHC class II receptor activity,MF,
8459,GO:0032396,1,0.945004177753097,0,4,inhibitory MHC class I receptor activity,MF,
8460,GO:0032397,1,0.989425806755353,0,1,activating MHC class I receptor activity,MF,
8461,GO:0032398,1,0.988278359815249,0,1,MHC class Ib protein complex,CC,
8462,GO:0032399,1,0.973508068846599,0,3,HECT domain binding,MF,
8467,GO:0032404,1,0.89120096375389,0,8,mismatch repair complex binding,MF,
8468,GO:0032405,1,0.931119838744821,0,5,MutLalpha complex binding,MF,
8469,GO:0032407,1,0.930358785834077,0,5,MutSalpha complex binding,MF,
8476,GO:0032415,1,0.92823952246145,0,6,regulation of sodium:proton antiporter activity,BP,
8477,GO:0032416,1,0.975593888295427,0,2,negative regulation of sodium:proton antiporter activity,BP,
8478,GO:0032417,1,0.951465846938252,0,4,positive regulation of sodium:proton antiporter activity,BP,
8480,GO:0032419,1,0.985770719433395,0,1,extrinsic component of lysosome membrane,CC,
8483,GO:0032422,1,0.970895868713514,0,2,purine-rich negative regulatory element binding,MF,
8484,GO:0032423,1,0.951395858211246,0,3,regulation of mismatch repair,BP,
8485,GO:0032425,1,0.967451189470491,0,2,positive regulation of mismatch repair,BP,
8488,GO:0032428,1,0.983440633839794,0,1,beta-N-acetylgalactosaminidase activity,MF,
8489,GO:0032429,1,0.880254927907031,0,10,regulation of phospholipase A2 activity,BP,
8490,GO:0032430,1,0.946014195196514,0,5,positive regulation of phospholipase A2 activity,BP,
8491,GO:0032431,1,0.959994393914903,0,4,activation of phospholipase A2 activity,BP,
8492,GO:0032432,1,0.437436086611051,0,55,actin filament bundle,CC,
8495,GO:0032435,1,0.727464923745878,0,23,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8497,GO:0032437,1,0.942316898081124,0,4,cuticular plate,CC,
8499,GO:0032439,1,0.936626526789755,0,4,endosome localization,BP,
8500,GO:0032440,1,0.990793780952098,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8501,GO:0032444,1,0.953522530409652,0,3,activin responsive factor complex,CC,
8502,GO:0032445,1,0.985456784122933,0,1,fructose import,BP,
8504,GO:0032448,1,0.988814169145597,0,1,DNA hairpin binding,MF,
8505,GO:0032449,1,0.951352465833723,0,3,CBM complex,CC,
8506,GO:0032450,1,0.951065741678,0,3,maltose alpha-glucosidase activity,MF,
8507,GO:0032451,1,0.579747980546087,0,34,demethylase activity,MF,
8508,GO:0032452,1,0.670530759570023,0,24,histone demethylase activity,MF,
8509,GO:0032453,1,0.904778778406465,0,6,histone demethylase activity (H3-K4 specific),MF,
8510,GO:0032454,1,0.860889239892485,0,9,histone demethylase activity (H3-K9 specific),MF,
8511,GO:0032455,1,0.94382658707948,0,4,nerve growth factor processing,BP,
8513,GO:0032458,1,0.983407750640456,0,1,slow endocytic recycling,BP,
8515,GO:0032460,1,0.822411521628054,0,15,negative regulation of protein oligomerization,BP,
8517,GO:0032462,1,0.80404158263585,0,16,regulation of protein homooligomerization,BP,
8518,GO:0032463,1,0.867292762594148,0,10,negative regulation of protein homooligomerization,BP,
8519,GO:0032464,1,0.912356822414629,0,7,positive regulation of protein homooligomerization,BP,
8520,GO:0032465,1,0.386673113005933,0,66,regulation of cytokinesis,BP,
8521,GO:0032466,1,0.904258860866093,0,7,negative regulation of cytokinesis,BP,
8522,GO:0032467,1,0.59473767163437,0,37,positive regulation of cytokinesis,BP,
8523,GO:0032468,1,0.983463501695474,0,1,Golgi calcium ion homeostasis,BP,
8524,GO:0032469,1,0.74675885262643,0,20,endoplasmic reticulum calcium ion homeostasis,BP,
8525,GO:0032470,1,0.967133468273109,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8526,GO:0032471,1,0.91706158038881,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8527,GO:0032472,1,0.970546425180148,0,2,Golgi calcium ion transport,BP,
8528,GO:0032473,1,0.983406759350836,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8529,GO:0032474,1,0.967089224751128,0,2,otolith morphogenesis,BP,
8531,GO:0032480,1,0.536321656465447,0,43,negative regulation of type I interferon production,BP,
8532,GO:0032481,1,0.349743537216822,0,71,positive regulation of type I interferon production,BP,
8533,GO:0032482,1,0.91001257359704,0,6,Rab protein signal transduction,BP,
8534,GO:0032483,1,0.935697858849293,0,4,regulation of Rab protein signal transduction,BP,
8535,GO:0032484,1,0.951209606443397,0,3,Ral protein signal transduction,BP,
8536,GO:0032485,1,0.951209606443397,0,3,regulation of Ral protein signal transduction,BP,
8537,GO:0032486,1,0.811031984745959,0,13,Rap protein signal transduction,BP,
8538,GO:0032487,1,0.951057380551848,0,3,regulation of Rap protein signal transduction,BP,
8539,GO:0032488,1,0.915683507151763,0,8,Cdc42 protein signal transduction,BP,
8540,GO:0032489,1,0.956319723422957,0,5,regulation of Cdc42 protein signal transduction,BP,
8541,GO:0032490,1,0.85455922833697,0,11,detection of molecule of bacterial origin,BP,
8542,GO:0032493,1,0.901693263502314,0,7,response to bacterial lipoprotein,BP,
8543,GO:0032494,1,0.896141721941482,0,8,response to peptidoglycan,BP,
8546,GO:0032497,1,0.956060009952359,0,4,detection of lipopolysaccharide,BP,
8547,GO:0032498,1,0.983406759352021,0,1,detection of muramyl dipeptide,BP,
8548,GO:0032499,1,0.975658977587172,0,2,detection of peptidoglycan,BP,
8549,GO:0032500,1,0.983406759352021,0,1,muramyl dipeptide binding,MF,
8555,GO:0032508,1,0.342085688758507,0,71,DNA duplex unwinding,BP,
8556,GO:0032509,1,0.848695796679189,0,12,endosome transport via multivesicular body sorting pathway,BP,
8557,GO:0032510,1,0.937699647095271,0,4,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8558,GO:0032511,1,0.931854799758278,0,6,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8559,GO:0032515,1,0.812082621137648,0,15,negative regulation of phosphoprotein phosphatase activity,BP,
8560,GO:0032516,1,0.793996750576754,0,15,positive regulation of phosphoprotein phosphatase activity,BP,
8561,GO:0032525,1,0.878899471451928,0,10,somite rostral/caudal axis specification,BP,
8563,GO:0032527,1,0.579014826303049,0,37,protein exit from endoplasmic reticulum,BP,
8564,GO:0032528,1,0.695234430679536,0,23,microvillus organization,BP,
8565,GO:0032530,1,0.811230467966097,0,13,regulation of microvillus organization,BP,
8566,GO:0032532,1,0.895991352181472,0,7,regulation of microvillus length,BP,
8567,GO:0032534,1,0.905440807623218,0,6,regulation of microvillus assembly,BP,
8570,GO:0032541,1,0.940542348014366,0,4,cortical endoplasmic reticulum,CC,
8572,GO:0032543,1,0.305348687374796,0,114,mitochondrial translation,BP,
8573,GO:0032545,1,0.974670114476852,0,2,CURI complex,CC,
8576,GO:0032551,1,0.968424655254934,0,2,pyrimidine ribonucleoside binding,MF,
8577,GO:0032552,1,0.924434335815865,0,6,deoxyribonucleotide binding,MF,
8579,GO:0032554,1,0.932188895200978,0,5,purine deoxyribonucleotide binding,MF,
8581,GO:0032556,1,0.991683767070938,0,1,pyrimidine deoxyribonucleotide binding,MF,
8582,GO:0032557,1,0.954973633543056,0,3,pyrimidine ribonucleotide binding,MF,
8583,GO:0032558,1,0.947700580957522,0,4,adenyl deoxyribonucleotide binding,MF,
8585,GO:0032560,1,0.98363590712598,0,1,guanyl deoxyribonucleotide binding,MF,
8587,GO:0032564,1,0.947700580957522,0,4,dATP binding,MF,
8588,GO:0032567,1,0.98363590712598,0,1,dGTP binding,MF,
8591,GO:0032574,1,0.983406792657203,0,1,5'-3' RNA helicase activity,MF,
8592,GO:0032575,1,0.983406792657203,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8593,GO:0032580,1,0.326214160393126,0,73,Golgi cisterna membrane,CC,
8594,GO:0032581,1,0.98743038401092,0,1,ER-dependent peroxisome organization,BP,
8595,GO:0032584,1,0.91100558074943,0,6,growth cone membrane,CC,
8598,GO:0032588,1,0.31941340897775,0,80,trans-Golgi network membrane,CC,
8600,GO:0032590,1,0.73163925256708,0,21,dendrite membrane,CC,
8601,GO:0032591,1,0.861184684397553,0,9,dendritic spine membrane,CC,
8602,GO:0032592,1,0.481844784661411,0,54,integral component of mitochondrial membrane,CC,
8603,GO:0032593,1,0.908042472042649,0,7,insulin-responsive compartment,CC,
8604,GO:0032594,1,0.881457988645523,0,9,protein transport within lipid bilayer,BP,
8605,GO:0032595,1,0.985986684999225,0,1,B cell receptor transport within lipid bilayer,BP,
8606,GO:0032596,1,0.913758346563203,0,6,protein transport into membrane raft,BP,
8607,GO:0032597,1,0.985986684999225,0,1,B cell receptor transport into membrane raft,BP,
8608,GO:0032599,1,0.985986684999225,0,1,protein transport out of membrane raft,BP,
8609,GO:0032600,1,0.985986684999225,0,1,chemokine receptor transport out of membrane raft,BP,
8610,GO:0032601,1,0.98387363474856,0,2,connective tissue growth factor production,BP,
8612,GO:0032603,1,0.993084615412648,0,1,fractalkine production,BP,
8613,GO:0032604,1,0.823423447921343,0,15,granulocyte macrophage colony-stimulating factor production,BP,
8616,GO:0032607,1,0.71821432894462,0,22,interferon-alpha production,BP,
8617,GO:0032608,1,0.489804204094394,0,47,interferon-beta production,BP,
8623,GO:0032615,1,0.480572086180474,0,51,interleukin-12 production,BP,
8624,GO:0032616,1,0.759839818151107,0,21,interleukin-13 production,BP,
8625,GO:0032618,1,0.976150630905082,0,2,interleukin-15 production,BP,
8626,GO:0032620,1,0.719543532738435,0,25,interleukin-17 production,BP,
8627,GO:0032621,1,0.894534381012045,0,7,interleukin-18 production,BP,
8629,GO:0032625,1,0.983444463922309,0,1,interleukin-21 production,BP,
8630,GO:0032627,1,0.899562954107123,0,8,interleukin-23 production,BP,
8631,GO:0032632,1,0.944782310474838,0,4,interleukin-3 production,BP,
8633,GO:0032634,1,0.758958917235458,0,20,interleukin-5 production,BP,
8636,GO:0032639,1,0.972285219571943,0,2,TRAIL production,BP,
8638,GO:0032641,1,0.962365759181802,0,3,lymphotoxin A production,BP,
8640,GO:0032643,1,0.990609033835784,0,1,regulation of connective tissue growth factor production,BP,
8641,GO:0032644,1,0.993084615412648,0,1,regulation of fractalkine production,BP,
8642,GO:0032645,1,0.823423447921343,0,15,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8644,GO:0032647,1,0.725780832586348,0,21,regulation of interferon-alpha production,BP,
8645,GO:0032648,1,0.504022047588257,0,45,regulation of interferon-beta production,BP,
8651,GO:0032655,1,0.49653397308018,0,49,regulation of interleukin-12 production,BP,
8652,GO:0032656,1,0.773399000732884,0,19,regulation of interleukin-13 production,BP,
8653,GO:0032658,1,0.987734351900206,0,1,regulation of interleukin-15 production,BP,
8654,GO:0032660,1,0.748660681999863,0,22,regulation of interleukin-17 production,BP,
8655,GO:0032661,1,0.924987484337455,0,5,regulation of interleukin-18 production,BP,
8657,GO:0032667,1,0.899562954107123,0,8,regulation of interleukin-23 production,BP,
8658,GO:0032672,1,0.96072519009775,0,3,regulation of interleukin-3 production,BP,
8660,GO:0032674,1,0.765916934346517,0,19,regulation of interleukin-5 production,BP,
8663,GO:0032679,1,0.972285219571943,0,2,regulation of TRAIL production,BP,
8665,GO:0032681,1,0.984347074825103,0,1,regulation of lymphotoxin A production,BP,
8666,GO:0032682,1,0.810854939309547,0,16,negative regulation of chemokine production,BP,
8667,GO:0032685,1,0.983584117820016,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8669,GO:0032687,1,0.932096242251169,0,5,negative regulation of interferon-alpha production,BP,
8670,GO:0032688,1,0.839555107481743,0,12,negative regulation of interferon-beta production,BP,
8672,GO:0032690,1,0.989677996813037,0,1,negative regulation of interleukin-1 alpha production,BP,
8673,GO:0032691,1,0.868659806144313,0,12,negative regulation of interleukin-1 beta production,BP,
8676,GO:0032695,1,0.798314116090453,0,15,negative regulation of interleukin-12 production,BP,
8677,GO:0032696,1,0.941206027514957,0,5,negative regulation of interleukin-13 production,BP,
8678,GO:0032700,1,0.85537112335948,0,11,negative regulation of interleukin-17 production,BP,
8679,GO:0032701,1,0.972319733923727,0,2,negative regulation of interleukin-18 production,BP,
8680,GO:0032703,1,0.772803767292869,0,18,negative regulation of interleukin-2 production,BP,
8681,GO:0032707,1,0.968942130715792,0,2,negative regulation of interleukin-23 production,BP,
8682,GO:0032712,1,0.985453353462232,0,1,negative regulation of interleukin-3 production,BP,
8684,GO:0032714,1,0.912930277567807,0,7,negative regulation of interleukin-5 production,BP,
8686,GO:0032717,1,0.804967987363948,0,16,negative regulation of interleukin-8 production,BP,
8689,GO:0032723,1,0.990609033835784,0,1,positive regulation of connective tissue growth factor production,BP,
8690,GO:0032724,1,0.993084615412648,0,1,positive regulation of fractalkine production,BP,
8691,GO:0032725,1,0.842369471943468,0,13,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8692,GO:0032727,1,0.77871120277511,0,16,positive regulation of interferon-alpha production,BP,
8693,GO:0032728,1,0.638319675464198,0,29,positive regulation of interferon-beta production,BP,
8698,GO:0032733,1,0.673670008046933,0,29,positive regulation of interleukin-10 production,BP,
8699,GO:0032735,1,0.643445714255488,0,32,positive regulation of interleukin-12 production,BP,
8700,GO:0032736,1,0.821751247533421,0,14,positive regulation of interleukin-13 production,BP,
8701,GO:0032738,1,0.987734351900206,0,1,positive regulation of interleukin-15 production,BP,
8702,GO:0032740,1,0.850322606326159,0,13,positive regulation of interleukin-17 production,BP,
8703,GO:0032741,1,0.967185723994073,0,2,positive regulation of interleukin-18 production,BP,
8705,GO:0032747,1,0.941695932920745,0,5,positive regulation of interleukin-23 production,BP,
8706,GO:0032752,1,0.974908321653815,0,2,positive regulation of interleukin-3 production,BP,
8707,GO:0032753,1,0.731577932133077,0,22,positive regulation of interleukin-4 production,BP,
8708,GO:0032754,1,0.850407906088549,0,11,positive regulation of interleukin-5 production,BP,
8711,GO:0032759,1,0.972285219571943,0,2,positive regulation of TRAIL production,BP,
8713,GO:0032761,1,0.984347074825103,0,1,positive regulation of lymphotoxin A production,BP,
8715,GO:0032763,1,0.93660663611779,0,5,regulation of mast cell cytokine production,BP,
8716,GO:0032764,1,0.972623407158667,0,2,negative regulation of mast cell cytokine production,BP,
8717,GO:0032765,1,0.962973646712084,0,3,positive regulation of mast cell cytokine production,BP,
8718,GO:0032767,1,0.963420477591922,0,3,copper-dependent protein binding,MF,
8720,GO:0032769,1,0.857141163357195,0,11,negative regulation of monooxygenase activity,BP,
8722,GO:0032771,1,0.98340675935207,0,1,regulation of monophenol monooxygenase activity,BP,
8723,GO:0032773,1,0.98340675935207,0,1,positive regulation of monophenol monooxygenase activity,BP,
8725,GO:0032775,1,0.983422376003528,0,1,DNA methylation on adenine,BP,
8726,GO:0032776,1,0.93973003721441,0,4,DNA methylation on cytosine,BP,
8727,GO:0032777,1,0.942569024244925,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8728,GO:0032780,1,0.876827296259558,0,11,negative regulation of ATPase activity,BP,
8730,GO:0032782,1,0.910977526526817,0,6,bile acid secretion,BP,
8731,GO:0032783,1,0.975867248200112,0,2,ELL-EAF complex,CC,
8734,GO:0032786,1,0.72782773214519,0,22,positive regulation of DNA-templated transcription, elongation,BP,
8736,GO:0032788,1,0.988553869511422,0,1,saturated monocarboxylic acid metabolic process,BP,
8737,GO:0032789,1,0.988553869511422,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8738,GO:0032790,1,0.889317519163578,0,8,ribosome disassembly,BP,
8739,GO:0032792,1,0.933043448869731,0,5,negative regulation of CREB transcription factor activity,BP,
8740,GO:0032793,1,0.805036526844029,0,14,positive regulation of CREB transcription factor activity,BP,
8743,GO:0032796,1,0.972165941855449,0,2,uropod organization,BP,
8744,GO:0032797,1,0.860302507295244,0,11,SMN complex,CC,
8745,GO:0032798,1,0.969683443564638,0,2,Swi5-Sfr1 complex,CC,
8746,GO:0032799,1,0.819950671652063,0,14,low-density lipoprotein receptor particle metabolic process,BP,
8749,GO:0032802,1,0.932253956260979,0,5,low-density lipoprotein particle receptor catabolic process,BP,
8750,GO:0032803,1,0.932253956260979,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8751,GO:0032804,1,0.972098763581745,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8752,GO:0032805,1,0.974845100012808,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8753,GO:0032806,1,0.708681491801981,0,24,carboxy-terminal domain protein kinase complex,CC,
8754,GO:0032807,1,0.958657923450935,0,3,DNA ligase IV complex,CC,
8756,GO:0032809,1,0.749185122220793,0,19,neuronal cell body membrane,CC,
8757,GO:0032810,1,0.972522066365549,0,2,sterol response element binding,MF,
8759,GO:0032812,1,0.993077574671597,0,1,positive regulation of epinephrine secretion,BP,
8760,GO:0032813,1,0.569117102818964,0,43,tumor necrosis factor receptor superfamily binding,MF,
8762,GO:0032815,1,0.921301246286522,0,7,negative regulation of natural killer cell activation,BP,
8764,GO:0032817,1,0.883353541755337,0,9,regulation of natural killer cell proliferation,BP,
8765,GO:0032819,1,0.912943336253329,0,7,positive regulation of natural killer cell proliferation,BP,
8767,GO:0032824,1,0.971643565933374,0,3,negative regulation of natural killer cell differentiation,BP,
8769,GO:0032826,1,0.960391178964028,0,4,regulation of natural killer cell differentiation involved in immune response,BP,
8770,GO:0032827,1,0.971643565933374,0,3,negative regulation of natural killer cell differentiation involved in immune response,BP,
8771,GO:0032829,1,0.965197752259262,0,3,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8772,GO:0032831,1,0.965197752259262,0,3,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8773,GO:0032832,1,0.979490687952011,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8774,GO:0032834,1,0.979490687952011,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8777,GO:0032838,1,0.397780704796575,0,62,cell projection cytoplasm,CC,
8778,GO:0032839,1,0.715547694402313,0,22,dendrite cytoplasm,CC,
8779,GO:0032841,1,0.983432360355796,0,1,calcitonin binding,MF,
8783,GO:0032847,1,0.940370618920314,0,5,regulation of cellular pH reduction,BP,
8784,GO:0032848,1,0.983408545672986,0,1,negative regulation of cellular pH reduction,BP,
8785,GO:0032849,1,0.956238936228939,0,4,positive regulation of cellular pH reduction,BP,
8792,GO:0032875,1,0.889671371410773,0,7,regulation of DNA endoreduplication,BP,
8793,GO:0032876,1,0.93526220569217,0,4,negative regulation of DNA endoreduplication,BP,
8794,GO:0032877,1,0.96709772291165,0,2,positive regulation of DNA endoreduplication,BP,
8795,GO:0032878,1,0.725806350908123,0,20,regulation of establishment or maintenance of cell polarity,BP,
8801,GO:0032889,1,0.984818604914749,0,1,regulation of vacuole fusion, non-autophagic,BP,
8805,GO:0032897,1,0.713362764981514,0,24,negative regulation of viral transcription,BP,
8809,GO:0032901,1,0.983407484570706,0,1,positive regulation of neurotrophin production,BP,
8810,GO:0032902,1,0.967237293961657,0,2,nerve growth factor production,BP,
8811,GO:0032905,1,0.869887799877805,0,9,transforming growth factor beta1 production,BP,
8812,GO:0032906,1,0.880487265080824,0,8,transforming growth factor beta2 production,BP,
8813,GO:0032907,1,0.953533762183737,0,3,transforming growth factor beta3 production,BP,
8814,GO:0032908,1,0.869887799877805,0,9,regulation of transforming growth factor beta1 production,BP,
8815,GO:0032909,1,0.880487265080824,0,8,regulation of transforming growth factor beta2 production,BP,
8816,GO:0032910,1,0.953533762183737,0,3,regulation of transforming growth factor beta3 production,BP,
8817,GO:0032911,1,0.9510946024676,0,3,negative regulation of transforming growth factor beta1 production,BP,
8818,GO:0032912,1,0.967144870966691,0,2,negative regulation of transforming growth factor beta2 production,BP,
8819,GO:0032913,1,0.985986684999225,0,1,negative regulation of transforming growth factor beta3 production,BP,
8820,GO:0032914,1,0.914634490012449,0,6,positive regulation of transforming growth factor beta1 production,BP,
8821,GO:0032915,1,0.973443376822099,0,2,positive regulation of transforming growth factor beta2 production,BP,
8822,GO:0032916,1,0.967087733486462,0,2,positive regulation of transforming growth factor beta3 production,BP,
8823,GO:0032917,1,0.970748170002122,0,3,polyamine acetylation,BP,
8824,GO:0032918,1,0.970748170002122,0,3,spermidine acetylation,BP,
8825,GO:0032919,1,0.992720656742466,0,1,spermine acetylation,BP,
8826,GO:0032920,1,0.992720656742466,0,1,putrescine acetylation,BP,
8827,GO:0032922,1,0.45432154258794,0,51,circadian regulation of gene expression,BP,
8831,GO:0032927,1,0.888652001835189,0,8,positive regulation of activin receptor signaling pathway,BP,
8832,GO:0032928,1,0.846396678675934,0,13,regulation of superoxide anion generation,BP,
8833,GO:0032929,1,0.977397710503241,0,2,negative regulation of superoxide anion generation,BP,
8834,GO:0032930,1,0.880601087046024,0,10,positive regulation of superoxide anion generation,BP,
8835,GO:0032933,1,0.881036171525352,0,8,SREBP signaling pathway,BP,
8836,GO:0032934,1,0.529078654429181,0,48,sterol binding,MF,
8837,GO:0032937,1,0.953168913907635,0,3,SREBP-SCAP-Insig complex,CC,
8845,GO:0032954,1,0.967227622468252,0,2,regulation of cytokinetic process,BP,
8847,GO:0032957,1,0.867093075404986,0,9,inositol trisphosphate metabolic process,BP,
8848,GO:0032958,1,0.746247324784697,0,20,inositol phosphate biosynthetic process,BP,
8849,GO:0032959,1,0.896447472939143,0,7,inositol trisphosphate biosynthetic process,BP,
8850,GO:0032960,1,0.92696543185141,0,5,regulation of inositol trisphosphate biosynthetic process,BP,
8851,GO:0032962,1,0.942610187525129,0,4,positive regulation of inositol trisphosphate biosynthetic process,BP,
8855,GO:0032966,1,0.907344102823615,0,7,negative regulation of collagen biosynthetic process,BP,
8857,GO:0032968,1,0.827114970106382,0,13,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8859,GO:0032971,1,0.95451084203445,0,4,regulation of muscle filament sliding,BP,
8860,GO:0032972,1,0.986229150835776,0,2,regulation of muscle filament sliding speed,BP,
8861,GO:0032976,1,0.993810880445406,0,1,release of matrix enzymes from mitochondria,BP,
8862,GO:0032980,1,0.985141571208458,0,1,keratinocyte activation,BP,
8863,GO:0032981,1,0.610796593016403,0,55,mitochondrial respiratory chain complex I assembly,BP,
8865,GO:0032983,1,0.967736968036543,0,2,kainate selective glutamate receptor complex,CC,
8867,GO:0032986,1,0.773052319742033,0,20,protein-DNA complex disassembly,BP,
8868,GO:0032988,1,0.8280790691974,0,13,ribonucleoprotein complex disassembly,BP,
8872,GO:0032993,1,0.153477638976754,0,188,protein-DNA complex,CC,
8873,GO:0032994,1,0.635361991262135,0,39,protein-lipid complex,CC,
8874,GO:0032996,1,0.987326696740113,0,1,Bcl3-Bcl10 complex,CC,
8875,GO:0032997,1,0.98063382101586,0,2,Fc receptor complex,CC,
8876,GO:0032998,1,0.98063382101586,0,2,Fc-epsilon receptor I complex,CC,
8878,GO:0033003,1,0.599576261731301,0,37,regulation of mast cell activation,BP,
8879,GO:0033004,1,0.845950372250469,0,12,negative regulation of mast cell activation,BP,
8880,GO:0033005,1,0.825906116575305,0,15,positive regulation of mast cell activation,BP,
8881,GO:0033006,1,0.676123358936704,0,29,regulation of mast cell activation involved in immune response,BP,
8882,GO:0033007,1,0.895256138673795,0,8,negative regulation of mast cell activation involved in immune response,BP,
8883,GO:0033008,1,0.853058800065221,0,13,positive regulation of mast cell activation involved in immune response,BP,
8885,GO:0033011,1,0.946250587061867,0,4,perinuclear theca,CC,
8886,GO:0033013,1,0.475505974677931,0,57,tetrapyrrole metabolic process,BP,
8887,GO:0033014,1,0.68715383856105,0,27,tetrapyrrole biosynthetic process,BP,
8888,GO:0033015,1,0.925101853984493,0,7,tetrapyrrole catabolic process,BP,
8896,GO:0033029,1,0.927174780689429,0,5,regulation of neutrophil apoptotic process,BP,
8897,GO:0033030,1,0.983406759351627,0,1,negative regulation of neutrophil apoptotic process,BP,
8898,GO:0033031,1,0.942823054959013,0,4,positive regulation of neutrophil apoptotic process,BP,
8901,GO:0033034,1,0.88894730521444,0,8,positive regulation of myeloid cell apoptotic process,BP,
8903,GO:0033037,1,0.983406759351724,0,1,polysaccharide localization,BP,
8904,GO:0033038,1,0.867055606511032,0,18,bitter taste receptor activity,MF,
8905,GO:0033040,1,0.967449747326673,0,2,sour taste receptor activity,MF,
8906,GO:0033041,1,0.969788752974161,0,2,sweet taste receptor activity,MF,
8909,GO:0033045,1,0.410177394862585,0,61,regulation of sister chromatid segregation,BP,
8910,GO:0033046,1,0.613234217133401,0,33,negative regulation of sister chromatid segregation,BP,
8911,GO:0033047,1,0.476340629257659,0,51,regulation of mitotic sister chromatid segregation,BP,
8912,GO:0033048,1,0.623601887028093,0,32,negative regulation of mitotic sister chromatid segregation,BP,
8913,GO:0033058,1,0.967087733485835,0,2,directional locomotion,BP,
8915,GO:0033061,1,0.904319797373595,0,7,DNA recombinase mediator complex,CC,
8916,GO:0033063,1,0.932601107318608,0,5,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8917,GO:0033065,1,0.977630183399489,0,2,Rad51C-XRCC3 complex,CC,
8918,GO:0033076,1,0.963021635866149,0,3,isoquinoline alkaloid metabolic process,BP,
8920,GO:0033078,1,0.960469515597519,0,3,extrathymic T cell differentiation,BP,
8924,GO:0033082,1,0.972018716508116,0,2,regulation of extrathymic T cell differentiation,BP,
8930,GO:0033089,1,0.850564068973799,0,11,positive regulation of T cell differentiation in thymus,BP,
8931,GO:0033091,1,0.959462024088057,0,3,positive regulation of immature T cell proliferation,BP,
8932,GO:0033092,1,0.974424459529244,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8934,GO:0033106,1,0.984623328793536,0,1,cis-Golgi network membrane,CC,
8935,GO:0033108,1,0.466952763574709,0,77,mitochondrial respiratory chain complex assembly,BP,
8936,GO:0033116,1,0.399735238474053,0,66,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8937,GO:0033119,1,0.699664624862829,0,25,negative regulation of RNA splicing,BP,
8939,GO:0033121,1,0.951617182431085,0,3,regulation of purine nucleotide catabolic process,BP,
8940,GO:0033122,1,0.967676233155805,0,2,negative regulation of purine nucleotide catabolic process,BP,
8941,GO:0033123,1,0.983406759351672,0,1,positive regulation of purine nucleotide catabolic process,BP,
8942,GO:0033127,1,0.827163864564106,0,13,regulation of histone phosphorylation,BP,
8943,GO:0033128,1,0.960510885876256,0,3,negative regulation of histone phosphorylation,BP,
8944,GO:0033129,1,0.887953381911317,0,8,positive regulation of histone phosphorylation,BP,
8945,GO:0033130,1,0.885029652453977,0,8,acetylcholine receptor binding,MF,
8946,GO:0033131,1,0.904349332750864,0,8,regulation of glucokinase activity,BP,
8947,GO:0033132,1,0.947211185709,0,4,negative regulation of glucokinase activity,BP,
8948,GO:0033133,1,0.954759385570013,0,4,positive regulation of glucokinase activity,BP,
8950,GO:0033136,1,0.890332669999308,0,8,serine phosphorylation of STAT3 protein,BP,
8951,GO:0033137,1,0.708622279333042,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8954,GO:0033140,1,0.971748179550951,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8956,GO:0033142,1,0.969568187342907,0,2,progesterone receptor binding,MF,
8957,GO:0033143,1,0.379258611283716,0,64,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8958,GO:0033144,1,0.618539819757735,0,31,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8959,GO:0033145,1,0.807717652186089,0,15,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8960,GO:0033146,1,0.626141132659507,0,30,regulation of intracellular estrogen receptor signaling pathway,BP,
8961,GO:0033147,1,0.815219430422505,0,13,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8962,GO:0033148,1,0.867040648630142,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8963,GO:0033149,1,0.967103515517835,0,2,FFAT motif binding,MF,
8964,GO:0033150,1,0.960197451575544,0,3,cytoskeletal calyx,CC,
8965,GO:0033151,1,0.817561683149294,0,13,V(D)J recombination,BP,
8966,GO:0033152,1,0.942183947100463,0,4,immunoglobulin V(D)J recombination,BP,
8967,GO:0033153,1,0.920430563820922,0,5,T cell receptor V(D)J recombination,BP,
8971,GO:0033160,1,0.840057053007263,0,12,positive regulation of protein import into nucleus, translocation,BP,
8973,GO:0033165,1,0.958593282314298,0,3,interphotoreceptor matrix,CC,
8974,GO:0033167,1,0.983406759350592,0,1,ARC complex,CC,
8975,GO:0033168,1,0.983406759350592,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8976,GO:0033169,1,0.847710836969214,0,10,histone H3-K9 demethylation,BP,
8977,GO:0033170,1,0.893170915093693,0,8,protein-DNA loading ATPase activity,MF,
8979,GO:0033176,1,0.750227690221533,0,23,proton-transporting V-type ATPase complex,CC,
8980,GO:0033177,1,0.804625277731121,0,21,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8981,GO:0033178,1,0.830902095332993,0,16,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8982,GO:0033179,1,0.878098530378911,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8983,GO:0033180,1,0.888496748320318,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8984,GO:0033182,1,0.864581949541119,0,9,regulation of histone ubiquitination,BP,
8985,GO:0033183,1,0.95276986341133,0,3,negative regulation of histone ubiquitination,BP,
8986,GO:0033184,1,0.921511075198405,0,5,positive regulation of histone ubiquitination,BP,
8987,GO:0033185,1,0.977806361183351,0,3,dolichol-phosphate-mannose synthase complex,CC,
8988,GO:0033186,1,0.953254523228613,0,3,CAF-1 complex,CC,
8989,GO:0033188,1,0.95670555546659,0,3,sphingomyelin synthase activity,MF,
8990,GO:0033189,1,0.796420204561865,0,17,response to vitamin A,BP,
8991,GO:0033192,1,0.935510890871669,0,4,calmodulin-dependent protein phosphatase activity,MF,
8992,GO:0033193,1,0.983406759351921,0,1,Lsd1/2 complex,CC,
8993,GO:0033194,1,0.810568958288711,0,16,response to hydroperoxide,BP,
8994,GO:0033197,1,0.843484989297651,0,12,response to vitamin E,BP,
8995,GO:0033198,1,0.647701080223089,0,31,response to ATP,BP,
8996,GO:0033202,1,0.838773731377051,0,14,DNA helicase complex,CC,
8997,GO:0033204,1,0.984940082545127,0,1,ribonuclease P RNA binding,MF,
8998,GO:0033206,1,0.920778200071624,0,5,meiotic cytokinesis,BP,
9000,GO:0033210,1,0.876306033617253,0,9,leptin-mediated signaling pathway,BP,
9001,GO:0033211,1,0.914586560566245,0,6,adiponectin-activated signaling pathway,BP,
9002,GO:0033212,1,0.985285763596706,0,1,iron assimilation,BP,
9003,GO:0033214,1,0.985285763596706,0,1,iron assimilation by chelation and transport,BP,
9004,GO:0033216,1,0.928424936381504,0,5,ferric iron import,BP,
9006,GO:0033227,1,0.924239628916583,0,5,dsRNA transport,BP,
9007,GO:0033229,1,0.983416086204809,0,1,cysteine transmembrane transporter activity,MF,
9008,GO:0033231,1,0.983406761279341,0,1,carbohydrate export,BP,
9009,GO:0033233,1,0.742128424453956,0,21,regulation of protein sumoylation,BP,
9010,GO:0033234,1,0.8673991745781,0,10,negative regulation of protein sumoylation,BP,
9011,GO:0033235,1,0.855904211241949,0,11,positive regulation of protein sumoylation,BP,
9012,GO:0033238,1,0.40802361455098,0,76,regulation of cellular amine metabolic process,BP,
9013,GO:0033239,1,0.937621501688966,0,4,negative regulation of cellular amine metabolic process,BP,
9014,GO:0033240,1,0.88445243508911,0,9,positive regulation of cellular amine metabolic process,BP,
9015,GO:0033241,1,0.983406759350938,0,1,regulation of cellular amine catabolic process,BP,
9016,GO:0033242,1,0.983406759350938,0,1,negative regulation of cellular amine catabolic process,BP,
9017,GO:0033256,1,0.902624305074192,0,7,I-kappaB/NF-kappaB complex,CC,
9018,GO:0033257,1,0.97130173952771,0,2,Bcl3/NF-kappaB2 complex,CC,
9019,GO:0033260,1,0.652552494785422,0,29,nuclear DNA replication,BP,
9020,GO:0033262,1,0.816166641426663,0,13,regulation of nuclear cell cycle DNA replication,BP,
9021,GO:0033263,1,0.935717064235972,0,4,CORVET complex,CC,
9022,GO:0033265,1,0.94087502018903,0,4,choline binding,MF,
9025,GO:0033269,1,0.938664034592875,0,4,internode region of axon,CC,
9028,GO:0033274,1,0.983406759351379,0,1,response to vitamin B2,BP,
9030,GO:0033276,1,0.821179846700307,0,14,transcription factor TFTC complex,CC,
9031,GO:0033277,1,0.969326106633623,0,2,abortive mitotic cell cycle,BP,
9034,GO:0033290,1,0.983406759352069,0,1,eukaryotic 48S preinitiation complex,CC,
9035,GO:0033291,1,0.997072800433802,0,1,eukaryotic 80S initiation complex,CC,
9036,GO:0033292,1,0.957470542311399,0,3,T-tubule organization,BP,
9038,GO:0033299,1,0.931578938436725,0,5,secretion of lysosomal enzymes,BP,
9039,GO:0033300,1,0.937171410277151,0,4,dehydroascorbic acid transporter activity,MF,
9040,GO:0033301,1,0.983416916641788,0,1,cell cycle comprising mitosis without cytokinesis,BP,
9041,GO:0033306,1,0.970901789818518,0,2,phytol metabolic process,BP,
9042,GO:0033313,1,0.898695185296182,0,8,meiotic cell cycle checkpoint,BP,
9043,GO:0033314,1,0.881437463063253,0,9,mitotic DNA replication checkpoint,BP,
9044,GO:0033315,1,0.992505835125385,0,1,meiotic DNA replication checkpoint,BP,
9045,GO:0033316,1,0.983811692138999,0,1,meiotic spindle assembly checkpoint,BP,
9046,GO:0033319,1,0.986318727036125,0,1,UDP-D-xylose metabolic process,BP,
9047,GO:0033320,1,0.986318727036125,0,1,UDP-D-xylose biosynthetic process,BP,
9048,GO:0033326,1,0.953636474936766,0,3,cerebrospinal fluid secretion,BP,
9050,GO:0033328,1,0.983432658119759,0,1,peroxisome membrane targeting sequence binding,MF,
9051,GO:0033341,1,0.968478992548699,0,2,regulation of collagen binding,BP,
9052,GO:0033342,1,0.98482139756825,0,1,negative regulation of collagen binding,BP,
9053,GO:0033343,1,0.983406759351183,0,1,positive regulation of collagen binding,BP,
9054,GO:0033344,1,0.594564616692248,0,40,cholesterol efflux,BP,
9055,GO:0033345,1,0.985258044246709,0,1,asparagine catabolic process via L-aspartate,BP,
9056,GO:0033353,1,0.93745155359737,0,4,S-adenosylmethionine cycle,BP,
9058,GO:0033364,1,0.97436527121893,0,2,mast cell secretory granule organization,BP,
9060,GO:0033366,1,0.990806589577474,0,1,protein localization to secretory granule,BP,
9061,GO:0033367,1,0.990806589577474,0,1,protein localization to mast cell secretory granule,BP,
9062,GO:0033368,1,0.990806589577474,0,1,protease localization to mast cell secretory granule,BP,
9063,GO:0033370,1,0.990806589577474,0,1,maintenance of protein location in mast cell secretory granule,BP,
9064,GO:0033371,1,0.990806589577474,0,1,T cell secretory granule organization,BP,
9065,GO:0033373,1,0.990806589577474,0,1,maintenance of protease location in mast cell secretory granule,BP,
9066,GO:0033374,1,0.990806589577474,0,1,protein localization to T cell secretory granule,BP,
9067,GO:0033375,1,0.990806589577474,0,1,protease localization to T cell secretory granule,BP,
9068,GO:0033377,1,0.990806589577474,0,1,maintenance of protein location in T cell secretory granule,BP,
9069,GO:0033379,1,0.990806589577474,0,1,maintenance of protease location in T cell secretory granule,BP,
9070,GO:0033380,1,0.990806589577474,0,1,granzyme B localization to T cell secretory granule,BP,
9071,GO:0033382,1,0.990806589577474,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
9072,GO:0033383,1,0.973673941280527,0,2,geranyl diphosphate metabolic process,BP,
9073,GO:0033384,1,0.973673941280527,0,2,geranyl diphosphate biosynthetic process,BP,
9074,GO:0033385,1,0.984153410256655,0,1,geranylgeranyl diphosphate metabolic process,BP,
9075,GO:0033386,1,0.984153410256655,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
9076,GO:0033387,1,0.970049791875831,0,2,putrescine biosynthetic process from ornithine,BP,
9077,GO:0033388,1,0.985902160426923,0,1,putrescine biosynthetic process from arginine,BP,
9078,GO:0033391,1,0.826317051400094,0,12,chromatoid body,CC,
9079,GO:0033477,1,0.986741725911151,0,1,S-methylmethionine metabolic process,BP,
9081,GO:0033484,1,0.961095602399232,0,3,nitric oxide homeostasis,BP,
9082,GO:0033488,1,0.983759861238514,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
9083,GO:0033489,1,0.959843800087275,0,3,cholesterol biosynthetic process via desmosterol,BP,
9084,GO:0033490,1,0.959843800087275,0,3,cholesterol biosynthetic process via lathosterol,BP,
9085,GO:0033499,1,0.984938620238289,0,1,galactose catabolic process via UDP-galactose,BP,
9087,GO:0033503,1,0.932431164868955,0,5,HULC complex,CC,
9088,GO:0033504,1,0.908383902088033,0,7,floor plate development,BP,
9089,GO:0033505,1,0.969988208782527,0,2,floor plate morphogenesis,BP,
9090,GO:0033512,1,0.954007359579459,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
9091,GO:0033514,1,0.98514784566868,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9092,GO:0033522,1,0.749665425279935,0,19,histone H2A ubiquitination,BP,
9093,GO:0033523,1,0.857375759660028,0,10,histone H2B ubiquitination,BP,
9094,GO:0033539,1,0.899046893532005,0,8,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
9095,GO:0033540,1,0.828358326314429,0,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9097,GO:0033552,1,0.994296144488195,0,1,response to vitamin B3,BP,
9098,GO:0033553,1,0.940788615843943,0,4,rDNA heterochromatin,CC,
9100,GO:0033555,1,0.3851686395346,0,66,multicellular organismal response to stress,BP,
9101,GO:0033557,1,0.954870180769942,0,3,Slx1-Slx4 complex,CC,
9104,GO:0033560,1,0.983407061187744,0,1,folate reductase activity,MF,
9107,GO:0033564,1,0.919756259510644,0,5,anterior/posterior axon guidance,BP,
9108,GO:0033565,1,0.95203705085126,0,3,ESCRT-0 complex,CC,
9109,GO:0033566,1,0.970086975793883,0,2,gamma-tubulin complex localization,BP,
9110,GO:0033567,1,0.942639651757407,0,4,DNA replication, Okazaki fragment processing,BP,
9111,GO:0033570,1,0.983406759351872,0,1,transferrin transmembrane transporter activity,MF,
9114,GO:0033577,1,0.969025210431016,0,2,protein glycosylation in endoplasmic reticulum,BP,
9115,GO:0033578,1,0.926096760281129,0,5,protein glycosylation in Golgi,BP,
9116,GO:0033588,1,0.913479281629134,0,6,Elongator holoenzyme complex,CC,
9117,GO:0033590,1,0.958741651360449,0,3,response to cobalamin,BP,
9118,GO:0033591,1,0.930813553878961,0,5,response to L-ascorbic acid,BP,
9119,GO:0033592,1,0.921852057983966,0,5,RNA strand annealing activity,MF,
9120,GO:0033593,1,0.983406759350344,0,1,BRCA2-MAGE-D1 complex,CC,
9121,GO:0033594,1,0.950787857884364,0,4,response to hydroxyisoflavone,BP,
9122,GO:0033595,1,0.969564452470218,0,2,response to genistein,BP,
9123,GO:0033596,1,0.951069809633389,0,3,TSC1-TSC2 complex,CC,
9125,GO:0033599,1,0.78359679602917,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9126,GO:0033600,1,0.92782942116301,0,5,negative regulation of mammary gland epithelial cell proliferation,BP,
9127,GO:0033601,1,0.893303281884643,0,7,positive regulation of mammary gland epithelial cell proliferation,BP,
9128,GO:0033602,1,0.952076782727122,0,3,negative regulation of dopamine secretion,BP,
9132,GO:0033606,1,0.985986684999225,0,1,chemokine receptor transport within lipid bilayer,BP,
9133,GO:0033609,1,0.984725543253726,0,1,oxalate metabolic process,BP,
9136,GO:0033615,1,0.958362861724997,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9137,GO:0033617,1,0.832772181957352,0,14,mitochondrial respiratory chain complex IV assembly,BP,
9138,GO:0033619,1,0.444000341008014,0,55,membrane protein proteolysis,BP,
9139,GO:0033622,1,0.753328570929076,0,18,integrin activation,BP,
9140,GO:0033623,1,0.855251550973023,0,10,regulation of integrin activation,BP,
9141,GO:0033624,1,0.967177980509397,0,2,negative regulation of integrin activation,BP,
9142,GO:0033625,1,0.928833681270211,0,5,positive regulation of integrin activation,BP,
9143,GO:0033626,1,0.983417965090516,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9146,GO:0033629,1,0.874670498918882,0,9,negative regulation of cell adhesion mediated by integrin,BP,
9147,GO:0033630,1,0.797569139276764,0,17,positive regulation of cell adhesion mediated by integrin,BP,
9149,GO:0033632,1,0.895847130255109,0,8,regulation of cell-cell adhesion mediated by integrin,BP,
9150,GO:0033633,1,0.983406759351971,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9151,GO:0033634,1,0.951116460283936,0,4,positive regulation of cell-cell adhesion mediated by integrin,BP,
9152,GO:0033643,1,0.866100689903568,0,9,host cell part,CC,
9153,GO:0033644,1,0.983406759352069,0,1,host cell membrane,CC,
9154,GO:0033646,1,0.89558981984603,0,7,host intracellular part,CC,
9155,GO:0033647,1,0.925268646851732,0,5,host intracellular organelle,CC,
9156,GO:0033648,1,0.925268646851732,0,5,host intracellular membrane-bounded organelle,CC,
9157,GO:0033650,1,0.987891692314826,0,1,host cell mitochondrion,CC,
9158,GO:0033655,1,0.940418774967235,0,4,host cell cytoplasm part,CC,
9159,GO:0033668,1,0.945612440285844,0,4,negative regulation by symbiont of host apoptotic process,BP,
9162,GO:0033676,1,0.989828424662486,0,1,double-stranded DNA-dependent ATPase activity,MF,
9163,GO:0033677,1,0.96903067771909,0,2,DNA/RNA helicase activity,MF,
9164,GO:0033678,1,0.984463798294144,0,1,5'-3' DNA/RNA helicase activity,MF,
9165,GO:0033680,1,0.984463798294144,0,1,ATP-dependent DNA/RNA helicase activity,MF,
9166,GO:0033682,1,0.984463798294144,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9167,GO:0033683,1,0.590471802404887,0,39,nucleotide-excision repair, DNA incision,BP,
9168,GO:0033684,1,0.908344719080986,0,7,regulation of luteinizing hormone secretion,BP,
9169,GO:0033685,1,0.959728561092493,0,3,negative regulation of luteinizing hormone secretion,BP,
9170,GO:0033686,1,0.946468909701862,0,4,positive regulation of luteinizing hormone secretion,BP,
9173,GO:0033689,1,0.862366147218702,0,9,negative regulation of osteoblast proliferation,BP,
9175,GO:0033691,1,0.868229467982569,0,9,sialic acid binding,MF,
9177,GO:0033693,1,0.951669185318963,0,3,neurofilament bundle assembly,BP,
9178,GO:0033695,1,0.943534489555406,0,4,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9179,GO:0033699,1,0.986623475189904,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9180,GO:0033700,1,0.884624867232026,0,12,phospholipid efflux,BP,
9181,GO:0033735,1,0.992846138431164,0,1,aspartate dehydrogenase activity,MF,
9182,GO:0033737,1,0.984875059645845,0,1,1-pyrroline dehydrogenase activity,MF,
9183,GO:0033743,1,0.947072245633476,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9184,GO:0033746,1,0.983431384306763,0,1,histone demethylase activity (H3-R2 specific),MF,
9185,GO:0033749,1,0.983431384306763,0,1,histone demethylase activity (H4-R3 specific),MF,
9186,GO:0033750,1,0.863627364480595,0,12,ribosome localization,BP,
9187,GO:0033753,1,0.863627364480595,0,12,establishment of ribosome localization,BP,
9188,GO:0033754,1,0.974554711777496,0,2,indoleamine 2,3-dioxygenase activity,MF,
9190,GO:0033764,1,0.747920845795745,0,25,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9191,GO:0033765,1,0.955855760037396,0,3,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9192,GO:0033768,1,0.983772522505291,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9193,GO:0033778,1,0.983406860491098,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9194,GO:0033780,1,0.984220960393285,0,1,taurochenodeoxycholate 6alpha-hydroxylase activity,MF,
9195,GO:0033781,1,0.986347676726532,0,1,cholesterol 24-hydroxylase activity,MF,
9196,GO:0033787,1,0.98408794163048,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9197,GO:0033791,1,0.985467094617143,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9198,GO:0033798,1,0.986298138481011,0,1,thyroxine 5-deiodinase activity,MF,
9199,GO:0033814,1,0.989743997431019,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9200,GO:0033819,1,0.992776359527565,0,1,lipoyl(octanoyl) transferase activity,MF,
9201,GO:0033823,1,0.983865649318172,0,1,procollagen glucosyltransferase activity,MF,
9202,GO:0033829,1,0.96042680877973,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9203,GO:0033842,1,0.967227635098509,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9204,GO:0033857,1,0.967087733487673,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9205,GO:0033858,1,0.983662907208073,0,1,N-acetylgalactosamine kinase activity,MF,
9206,GO:0033860,1,0.91744524572852,0,8,regulation of NAD(P)H oxidase activity,BP,
9207,GO:0033861,1,0.972504424009813,0,3,negative regulation of NAD(P)H oxidase activity,BP,
9208,GO:0033862,1,0.983869725649074,0,1,UMP kinase activity,MF,
9209,GO:0033864,1,0.94339052591335,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9210,GO:0033865,1,0.637678507789975,0,33,nucleoside bisphosphate metabolic process,BP,
9211,GO:0033866,1,0.794792699878945,0,16,nucleoside bisphosphate biosynthetic process,BP,
9212,GO:0033867,1,0.988461220721683,0,1,Fas-activated serine/threonine kinase activity,MF,
9213,GO:0033869,1,0.992395609449106,0,1,nucleoside bisphosphate catabolic process,BP,
9214,GO:0033871,1,0.986952701688737,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9215,GO:0033872,1,0.971615738976827,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9216,GO:0033875,1,0.637678507789975,0,33,ribonucleoside bisphosphate metabolic process,BP,
9217,GO:0033878,1,0.983410069435008,0,1,hormone-sensitive lipase activity,MF,
9218,GO:0033882,1,0.991404902088132,0,1,choloyl-CoA hydrolase activity,MF,
9219,GO:0033883,1,0.978460807515616,0,2,pyridoxal phosphatase activity,MF,
9220,GO:0033885,1,0.985864225629554,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9221,GO:0033897,1,0.990806589577474,0,1,ribonuclease T2 activity,MF,
9222,GO:0033906,1,0.973025756555011,0,2,hyaluronoglucuronidase activity,MF,
9223,GO:0033919,1,0.983407201548215,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9224,GO:0033925,1,0.983406759352021,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9225,GO:0033961,1,0.987914760602315,0,1,cis-stilbene-oxide hydrolase activity,MF,
9226,GO:0033962,1,0.758886711515109,0,18,cytoplasmic mRNA processing body assembly,BP,
9227,GO:0033967,1,0.991339022669521,0,1,box C/D snoRNA metabolic process,BP,
9228,GO:0033979,1,0.984676451729454,0,1,box H/ACA snoRNA metabolic process,BP,
9229,GO:0033981,1,0.99503127951627,0,1,D-dopachrome decarboxylase activity,MF,
9230,GO:0033989,1,0.984401532673474,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9232,GO:0034014,1,0.985566427273525,0,1,response to triglyceride,BP,
9233,GO:0034021,1,0.990748682521097,0,2,response to silicon dioxide,BP,
9234,GO:0034030,1,0.794792699878945,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
9235,GO:0034031,1,0.992395609449106,0,1,ribonucleoside bisphosphate catabolic process,BP,
9236,GO:0034032,1,0.637678507789975,0,33,purine nucleoside bisphosphate metabolic process,BP,
9237,GO:0034033,1,0.794792699878945,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
9238,GO:0034034,1,0.992395609449106,0,1,purine nucleoside bisphosphate catabolic process,BP,
9239,GO:0034035,1,0.774825618053406,0,19,purine ribonucleoside bisphosphate metabolic process,BP,
9240,GO:0034036,1,0.911479136184227,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9241,GO:0034038,1,0.991214410346877,0,1,deoxyhypusine synthase activity,MF,
9242,GO:0034039,1,0.987102383296377,0,1,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9243,GO:0034040,1,0.951497010656392,0,3,lipid-transporting ATPase activity,MF,
9244,GO:0034041,1,0.967554041834974,0,2,sterol-transporting ATPase activity,MF,
9245,GO:0034045,1,0.801393434920096,0,14,pre-autophagosomal structure membrane,CC,
9246,GO:0034046,1,0.923459077157601,0,5,poly(G) binding,MF,
9247,GO:0034056,1,0.937070438872845,0,4,estrogen response element binding,MF,
9248,GO:0034057,1,0.96849969062192,0,2,RNA strand-exchange activity,MF,
9249,GO:0034058,1,0.863008670129857,0,9,endosomal vesicle fusion,BP,
9251,GO:0034061,1,0.613194344960032,0,33,DNA polymerase activity,MF,
9252,GO:0034062,1,0.575168346035395,0,42,5'-3' RNA polymerase activity,MF,
9253,GO:0034063,1,0.848818595021159,0,10,stress granule assembly,BP,
9254,GO:0034066,1,0.990488997213336,0,1,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9255,GO:0034067,1,0.602573795575653,0,32,protein localization to Golgi apparatus,BP,
9256,GO:0034080,1,0.708751378551694,0,37,CENP-A containing nucleosome assembly,BP,
9257,GO:0034085,1,0.955999629077809,0,3,establishment of sister chromatid cohesion,BP,
9258,GO:0034086,1,0.873201414676197,0,9,maintenance of sister chromatid cohesion,BP,
9259,GO:0034088,1,0.873201414676197,0,9,maintenance of mitotic sister chromatid cohesion,BP,
9260,GO:0034091,1,0.930315948474103,0,5,regulation of maintenance of sister chromatid cohesion,BP,
9261,GO:0034092,1,0.967087733485254,0,2,negative regulation of maintenance of sister chromatid cohesion,BP,
9262,GO:0034093,1,0.961981959297305,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9264,GO:0034098,1,0.868662073817306,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9270,GO:0034110,1,0.719205957899873,0,22,regulation of homotypic cell-cell adhesion,BP,
9271,GO:0034111,1,0.8164279280197,0,13,negative regulation of homotypic cell-cell adhesion,BP,
9272,GO:0034112,1,0.956348097069068,0,4,positive regulation of homotypic cell-cell adhesion,BP,
9275,GO:0034115,1,0.882150412958123,0,9,negative regulation of heterotypic cell-cell adhesion,BP,
9277,GO:0034117,1,0.99568778541406,0,1,erythrocyte aggregation,BP,
9278,GO:0034118,1,0.99568778541406,0,1,regulation of erythrocyte aggregation,BP,
9279,GO:0034120,1,0.99568778541406,0,1,positive regulation of erythrocyte aggregation,BP,
9282,GO:0034123,1,0.766079933540068,0,18,positive regulation of toll-like receptor signaling pathway,BP,
9283,GO:0034124,1,0.946441136106316,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9284,GO:0034125,1,0.975232451065671,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9285,GO:0034127,1,0.894968667334561,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9286,GO:0034128,1,0.906929273405826,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9287,GO:0034130,1,0.984086179954569,0,1,toll-like receptor 1 signaling pathway,BP,
9288,GO:0034134,1,0.865042713126754,0,10,toll-like receptor 2 signaling pathway,BP,
9289,GO:0034135,1,0.935332416946956,0,5,regulation of toll-like receptor 2 signaling pathway,BP,
9290,GO:0034136,1,0.967446879449387,0,2,negative regulation of toll-like receptor 2 signaling pathway,BP,
9291,GO:0034137,1,0.966809418197268,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
9292,GO:0034138,1,0.781320896129807,0,16,toll-like receptor 3 signaling pathway,BP,
9293,GO:0034139,1,0.869388646633543,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9294,GO:0034140,1,0.951644182741759,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9295,GO:0034141,1,0.898989256040189,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9296,GO:0034142,1,0.663457154112701,0,28,toll-like receptor 4 signaling pathway,BP,
9297,GO:0034143,1,0.807200064192356,0,14,regulation of toll-like receptor 4 signaling pathway,BP,
9298,GO:0034144,1,0.922083094930932,0,5,negative regulation of toll-like receptor 4 signaling pathway,BP,
9299,GO:0034145,1,0.87544839814668,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9300,GO:0034146,1,0.967087733488112,0,2,toll-like receptor 5 signaling pathway,BP,
9301,GO:0034147,1,0.983406759352021,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9302,GO:0034148,1,0.983406759352021,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9303,GO:0034150,1,0.983406759351673,0,1,toll-like receptor 6 signaling pathway,BP,
9304,GO:0034154,1,0.923616880991467,0,5,toll-like receptor 7 signaling pathway,BP,
9305,GO:0034155,1,0.983459242838332,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
9306,GO:0034157,1,0.983459242838332,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
9307,GO:0034158,1,0.98340675935207,0,1,toll-like receptor 8 signaling pathway,BP,
9308,GO:0034162,1,0.750285968863892,0,18,toll-like receptor 9 signaling pathway,BP,
9309,GO:0034163,1,0.951172664297084,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
9310,GO:0034164,1,0.983406759351479,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
9311,GO:0034165,1,0.967224244666956,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9312,GO:0034166,1,0.983554337629796,0,1,toll-like receptor 10 signaling pathway,BP,
9313,GO:0034182,1,0.930315948474103,0,5,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9314,GO:0034183,1,0.967087733485254,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9315,GO:0034184,1,0.961981959297305,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9316,GO:0034185,1,0.778345731138512,0,16,apolipoprotein binding,MF,
9317,GO:0034186,1,0.94461486923969,0,4,apolipoprotein A-I binding,MF,
9318,GO:0034188,1,0.967087733486077,0,2,apolipoprotein A-I receptor activity,MF,
9319,GO:0034189,1,0.967135631911997,0,2,very-low-density lipoprotein particle binding,MF,
9320,GO:0034190,1,0.930777998533457,0,6,apolipoprotein receptor binding,MF,
9321,GO:0034191,1,0.949968862052155,0,4,apolipoprotein A-I receptor binding,MF,
9322,GO:0034196,1,0.935294164813082,0,5,acylglycerol transport,BP,
9323,GO:0034197,1,0.935294164813082,0,5,triglyceride transport,BP,
9326,GO:0034201,1,0.929263337420138,0,5,response to oleic acid,BP,
9327,GO:0034203,1,0.983406759351869,0,1,glycolipid translocation,BP,
9328,GO:0034204,1,0.682174454199732,0,23,lipid translocation,BP,
9329,GO:0034205,1,0.813298797389261,0,14,beta-amyloid formation,BP,
9330,GO:0034211,1,0.983406759350836,0,1,GTP-dependent protein kinase activity,MF,
9331,GO:0034212,1,0.393862989371368,0,63,peptide N-acetyltransferase activity,MF,
9332,GO:0034213,1,0.989000507743162,0,1,quinolinate catabolic process,BP,
9333,GO:0034214,1,0.899162402185625,0,7,protein hexamerization,BP,
9336,GO:0034224,1,0.972685584897076,0,2,cellular response to zinc ion starvation,BP,
9337,GO:0034226,1,0.96833515219048,0,2,lysine import,BP,
9338,GO:0034227,1,0.936960186341812,0,5,tRNA thio-modification,BP,
9339,GO:0034230,1,0.983406759351968,0,1,enkephalin processing,BP,
9340,GO:0034231,1,0.983406759351968,0,1,islet amyloid polypeptide processing,BP,
9341,GO:0034235,1,0.902566586751186,0,7,GPI anchor binding,MF,
9343,GO:0034237,1,0.770290643126402,0,16,protein kinase A regulatory subunit binding,MF,
9344,GO:0034238,1,0.953591220970348,0,3,macrophage fusion,BP,
9345,GO:0034239,1,0.953591220970348,0,3,regulation of macrophage fusion,BP,
9346,GO:0034241,1,0.953591220970348,0,3,positive regulation of macrophage fusion,BP,
9347,GO:0034242,1,0.962084851382888,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9350,GO:0034245,1,0.983409775239993,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9351,GO:0034247,1,0.980668929351076,0,2,snoRNA splicing,BP,
9354,GO:0034250,1,0.195972176222719,0,116,positive regulation of cellular amide metabolic process,BP,
9355,GO:0034255,1,0.98609242153372,0,1,regulation of urea metabolic process,BP,
9357,GO:0034271,1,0.969725120876325,0,2,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9358,GO:0034272,1,0.969725120876325,0,2,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9359,GO:0034274,1,0.95122496973022,0,3,Atg12-Atg5-Atg16 complex,CC,
9360,GO:0034275,1,0.988864699562379,0,1,kynurenic acid metabolic process,BP,
9361,GO:0034276,1,0.988864699562379,0,1,kynurenic acid biosynthetic process,BP,
9364,GO:0034287,1,0.947316746879277,0,4,detection of monosaccharide stimulus,BP,
9365,GO:0034308,1,0.488846768053282,0,53,primary alcohol metabolic process,BP,
9366,GO:0034309,1,0.992937098316418,0,1,primary alcohol biosynthetic process,BP,
9367,GO:0034310,1,0.830733600370547,0,15,primary alcohol catabolic process,BP,
9368,GO:0034311,1,0.860601050440305,0,11,diol metabolic process,BP,
9369,GO:0034312,1,0.8918793003278,0,8,diol biosynthetic process,BP,
9370,GO:0034314,1,0.638696765909554,0,32,Arp2/3 complex-mediated actin nucleation,BP,
9371,GO:0034315,1,0.788282604335102,0,16,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9372,GO:0034316,1,0.936683258160356,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9378,GO:0034334,1,0.967087733487869,0,2,adherens junction maintenance,BP,
9379,GO:0034337,1,0.983408061308264,0,1,RNA folding,BP,
9380,GO:0034338,1,0.984095018807551,0,1,short-chain carboxylesterase activity,MF,
9383,GO:0034342,1,0.971119937305831,0,2,response to type III interferon,BP,
9384,GO:0034343,1,0.951501641605237,0,3,type III interferon production,BP,
9385,GO:0034344,1,0.951501641605237,0,3,regulation of type III interferon production,BP,
9386,GO:0034346,1,0.983802416431969,0,1,positive regulation of type III interferon production,BP,
9390,GO:0034354,1,0.99078737987985,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9391,GO:0034356,1,0.840615888106792,0,11,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
9392,GO:0034358,1,0.655112161955221,0,37,plasma lipoprotein particle,CC,
9393,GO:0034359,1,0.983406759349757,0,1,mature chylomicron,CC,
9394,GO:0034360,1,0.983406759349757,0,1,chylomicron remnant,CC,
9395,GO:0034361,1,0.821757216607314,0,19,very-low-density lipoprotein particle,CC,
9396,GO:0034362,1,0.86160844881374,0,12,low-density lipoprotein particle,CC,
9397,GO:0034363,1,0.965421057712137,0,4,intermediate-density lipoprotein particle,CC,
9398,GO:0034364,1,0.781284959020616,0,26,high-density lipoprotein particle,CC,
9399,GO:0034365,1,0.987402181482173,0,2,discoidal high-density lipoprotein particle,CC,
9400,GO:0034366,1,0.938499909786843,0,8,spherical high-density lipoprotein particle,CC,
9401,GO:0034367,1,0.758696288969012,0,25,macromolecular complex remodeling,BP,
9402,GO:0034368,1,0.758696288969012,0,25,protein-lipid complex remodeling,BP,
9403,GO:0034369,1,0.758696288969012,0,25,plasma lipoprotein particle remodeling,BP,
9404,GO:0034370,1,0.902488160676778,0,11,triglyceride-rich lipoprotein particle remodeling,BP,
9405,GO:0034371,1,0.967729760797021,0,3,chylomicron remodeling,BP,
9406,GO:0034372,1,0.902488160676778,0,11,very-low-density lipoprotein particle remodeling,BP,
9407,GO:0034373,1,0.988669425431939,0,1,intermediate-density lipoprotein particle remodeling,BP,
9408,GO:0034374,1,0.870265198079344,0,12,low-density lipoprotein particle remodeling,BP,
9409,GO:0034375,1,0.85725109432964,0,15,high-density lipoprotein particle remodeling,BP,
9410,GO:0034377,1,0.785944182458941,0,20,plasma lipoprotein particle assembly,BP,
9411,GO:0034378,1,0.973103072371141,0,2,chylomicron assembly,BP,
9412,GO:0034379,1,0.903396875273627,0,8,very-low-density lipoprotein particle assembly,BP,
9413,GO:0034380,1,0.899661584453133,0,10,high-density lipoprotein particle assembly,BP,
9414,GO:0034381,1,0.670044959596053,0,32,plasma lipoprotein particle clearance,BP,
9415,GO:0034382,1,0.938485163907827,0,7,chylomicron remnant clearance,BP,
9416,GO:0034383,1,0.779868149156182,0,18,low-density lipoprotein particle clearance,BP,
9417,GO:0034384,1,0.921441934779143,0,9,high-density lipoprotein particle clearance,BP,
9418,GO:0034385,1,0.821757216607314,0,19,triglyceride-rich plasma lipoprotein particle,CC,
9419,GO:0034388,1,0.911970866802252,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9420,GO:0034389,1,0.810636084431341,0,15,lipid particle organization,BP,
9424,GO:0034393,1,0.899590396442372,0,8,positive regulation of smooth muscle cell apoptotic process,BP,
9426,GO:0034395,1,0.972696752159452,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9427,GO:0034397,1,0.816846049387455,0,13,telomere localization,BP,
9428,GO:0034398,1,0.909502213789001,0,6,telomere tethering at nuclear periphery,BP,
9430,GO:0034402,1,0.969097133478719,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9432,GO:0034414,1,0.96942274822836,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9433,GO:0034416,1,0.98408794163048,0,1,bisphosphoglycerate phosphatase activity,MF,
9434,GO:0034417,1,0.98408794163048,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9435,GO:0034418,1,0.971417986673538,0,2,urate biosynthetic process,BP,
9436,GO:0034421,1,0.953300818258196,0,3,post-translational protein acetylation,BP,
9437,GO:0034423,1,0.984535740695012,0,1,autophagosome lumen,CC,
9438,GO:0034427,1,0.920959385773671,0,7,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9439,GO:0034431,1,0.946675313860854,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9440,GO:0034432,1,0.946675313860854,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9441,GO:0034433,1,0.849637440286742,0,14,steroid esterification,BP,
9442,GO:0034434,1,0.849637440286742,0,14,sterol esterification,BP,
9443,GO:0034435,1,0.849637440286742,0,14,cholesterol esterification,BP,
9444,GO:0034436,1,0.960353632489357,0,3,glycoprotein transport,BP,
9445,GO:0034437,1,0.967572350328642,0,2,glycoprotein transporter activity,MF,
9446,GO:0034439,1,0.975221308267302,0,2,lipoprotein lipid oxidation,BP,
9448,GO:0034441,1,0.971605707753177,0,3,plasma lipoprotein oxidation,BP,
9449,GO:0034442,1,0.959371565229938,0,4,regulation of lipoprotein oxidation,BP,
9450,GO:0034443,1,0.975475752834873,0,3,negative regulation of lipoprotein oxidation,BP,
9451,GO:0034444,1,0.983749229461952,0,2,regulation of plasma lipoprotein oxidation,BP,
9452,GO:0034445,1,0.983749229461952,0,2,negative regulation of plasma lipoprotein oxidation,BP,
9454,GO:0034447,1,0.951258150486813,0,6,very-low-density lipoprotein particle clearance,BP,
9455,GO:0034448,1,0.987564956923625,0,1,EGO complex,CC,
9456,GO:0034450,1,0.829633851881349,0,13,ubiquitin-ubiquitin ligase activity,MF,
9457,GO:0034451,1,0.678542970157433,0,25,centriolar satellite,CC,
9460,GO:0034454,1,0.905826046105721,0,6,microtubule anchoring at centrosome,BP,
9461,GO:0034455,1,0.968643609158853,0,2,t-UTP complex,CC,
9462,GO:0034456,1,0.974670114476852,0,2,UTP-C complex,CC,
9463,GO:0034457,1,0.968260890748082,0,3,Mpp10 complex,CC,
9464,GO:0034458,1,0.984938620238289,0,1,3'-5' RNA helicase activity,MF,
9465,GO:0034462,1,0.985708223654261,0,1,small-subunit processome assembly,BP,
9466,GO:0034463,1,0.997072800433802,0,1,90S preribosome assembly,BP,
9467,GO:0034464,1,0.871882073035059,0,9,BBSome,CC,
9468,GO:0034465,1,0.949078037390371,0,4,response to carbon monoxide,BP,
9469,GO:0034466,1,0.984236952281666,0,1,chromaffin granule lumen,CC,
9470,GO:0034470,1,0.00994680102939332,0,372,ncRNA processing,BP,
9471,GO:0034471,1,0.953791390928245,0,3,ncRNA 5'-end processing,BP,
9472,GO:0034472,1,0.906900016655913,0,8,snRNA 3'-end processing,BP,
9473,GO:0034474,1,0.98340675935138,0,1,U2 snRNA 3'-end processing,BP,
9474,GO:0034475,1,0.952258668077645,0,5,U4 snRNA 3'-end processing,BP,
9475,GO:0034477,1,0.984725543253726,0,1,U6 snRNA 3'-end processing,BP,
9476,GO:0034481,1,0.915575511389248,0,6,chondroitin sulfotransferase activity,MF,
9477,GO:0034483,1,0.795139442797667,0,15,heparan sulfate sulfotransferase activity,MF,
9478,GO:0034485,1,0.937674073880166,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9479,GO:0034486,1,0.986567309955495,0,1,vacuolar transmembrane transport,BP,
9480,GO:0034497,1,0.890959546169413,0,7,protein localization to pre-autophagosomal structure,BP,
9481,GO:0034498,1,0.901462701818316,0,7,early endosome to Golgi transport,BP,
9482,GO:0034499,1,0.967087733487433,0,2,late endosome to Golgi transport,BP,
9483,GO:0034501,1,0.800549919902289,0,15,protein localization to kinetochore,BP,
9484,GO:0034502,1,0.398010887164753,0,63,protein localization to chromosome,BP,
9487,GO:0034506,1,0.983406759352069,0,1,chromosome, centromeric core domain,CC,
9488,GO:0034508,1,0.592293627599195,0,49,centromere complex assembly,BP,
9489,GO:0034511,1,0.935011383350801,0,5,U3 snoRNA binding,MF,
9490,GO:0034513,1,0.956788082847872,0,5,box H/ACA snoRNA binding,MF,
9491,GO:0034516,1,0.989355420771269,0,1,response to vitamin B6,BP,
9492,GO:0034518,1,0.828755482258798,0,13,RNA cap binding complex,CC,
9493,GO:0034545,1,0.988273030974696,0,1,fumarylpyruvate hydrolase activity,MF,
9494,GO:0034551,1,0.940338489279629,0,5,mitochondrial respiratory chain complex III assembly,BP,
9495,GO:0034552,1,0.982768772838128,0,2,respiratory chain complex II assembly,BP,
9496,GO:0034553,1,0.982768772838128,0,2,mitochondrial respiratory chain complex II assembly,BP,
9497,GO:0034584,1,0.95133644752737,0,3,piRNA binding,MF,
9498,GO:0034587,1,0.783230120014628,0,16,piRNA metabolic process,BP,
9499,GO:0034589,1,0.983406759352021,0,1,hydroxyproline transport,BP,
9500,GO:0034590,1,0.983406759352021,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9501,GO:0034593,1,0.659449551089802,0,26,phosphatidylinositol bisphosphate phosphatase activity,MF,
9502,GO:0034594,1,0.910568120808645,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9503,GO:0034595,1,0.808110838771972,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9504,GO:0034596,1,0.852002580616398,0,10,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9505,GO:0034597,1,0.941455300281453,0,4,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9507,GO:0034602,1,0.983406759352021,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9508,GO:0034603,1,0.916895101534733,0,6,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9509,GO:0034604,1,0.916895101534733,0,6,pyruvate dehydrogenase (NAD+) activity,MF,
9514,GO:0034616,1,0.804702942936391,0,14,response to laminar fluid shear stress,BP,
9515,GO:0034617,1,0.940323721057821,0,4,tetrahydrobiopterin binding,MF,
9516,GO:0034618,1,0.913225146832161,0,6,arginine binding,MF,
9519,GO:0034625,1,0.964122573392062,0,3,fatty acid elongation, monounsaturated fatty acid,BP,
9520,GO:0034626,1,0.94241351891055,0,4,fatty acid elongation, polyunsaturated fatty acid,BP,
9521,GO:0034627,1,0.946091860342714,0,4,'de novo' NAD biosynthetic process,BP,
9522,GO:0034628,1,0.954890586254582,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9524,GO:0034632,1,0.992965141711302,0,1,retinol transporter activity,MF,
9525,GO:0034633,1,0.992965141711302,0,1,retinol transport,BP,
9526,GO:0034634,1,0.983406759351574,0,1,glutathione transmembrane transporter activity,MF,
9527,GO:0034635,1,0.970324264525182,0,2,glutathione transport,BP,
9529,GO:0034638,1,0.908064161051224,0,7,phosphatidylcholine catabolic process,BP,
9531,GO:0034643,1,0.777357030469018,0,17,establishment of mitochondrion localization, microtubule-mediated,BP,
9534,GO:0034647,1,0.967087733486076,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9535,GO:0034648,1,0.935579157114852,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9536,GO:0034649,1,0.983407484570706,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9539,GO:0034653,1,0.953147815621575,0,4,retinoic acid catabolic process,BP,
9542,GO:0034656,1,0.921330786750869,0,7,nucleobase-containing small molecule catabolic process,BP,
9543,GO:0034657,1,0.957766371536845,0,3,GID complex,CC,
9545,GO:0034661,1,0.71500397526056,0,23,ncRNA catabolic process,BP,
9546,GO:0034663,1,0.868592021121175,0,10,endoplasmic reticulum chaperone complex,CC,
9547,GO:0034665,1,0.96709377839262,0,2,integrin alpha1-beta1 complex,CC,
9548,GO:0034666,1,0.951397566618932,0,3,integrin alpha2-beta1 complex,CC,
9550,GO:0034668,1,0.983406932135447,0,1,integrin alpha4-beta1 complex,CC,
9551,GO:0034669,1,0.967878752188904,0,2,integrin alpha4-beta7 complex,CC,
9552,GO:0034670,1,0.983406759350742,0,1,chemotaxis to arachidonic acid,BP,
9553,GO:0034673,1,0.957173724929627,0,3,inhibin-betaglycan-ActRII complex,CC,
9554,GO:0034676,1,0.983406759351724,0,1,integrin alpha6-beta4 complex,CC,
9555,GO:0034677,1,0.983412905837377,0,1,integrin alpha7-beta1 complex,CC,
9556,GO:0034678,1,0.951202369276234,0,3,integrin alpha8-beta1 complex,CC,
9557,GO:0034679,1,0.983406764950463,0,1,integrin alpha9-beta1 complex,CC,
9558,GO:0034680,1,0.967093778392521,0,2,integrin alpha10-beta1 complex,CC,
9559,GO:0034681,1,0.967093778392572,0,2,integrin alpha11-beta1 complex,CC,
9560,GO:0034683,1,0.967087733487431,0,2,integrin alphav-beta3 complex,CC,
9562,GO:0034685,1,0.968824851514995,0,2,integrin alphav-beta6 complex,CC,
9564,GO:0034687,1,0.967599515941845,0,2,integrin alphaL-beta2 complex,CC,
9565,GO:0034693,1,0.985000715014039,0,1,U11/U12 snRNP,CC,
9570,GO:0034699,1,0.937295626327073,0,4,response to luteinizing hormone,BP,
9575,GO:0034706,1,0.722192899309202,0,20,sodium channel complex,CC,
9577,GO:0034708,1,0.313633853540788,0,83,methyltransferase complex,CC,
9578,GO:0034709,1,0.892408969488011,0,12,methylosome,CC,
9579,GO:0034711,1,0.932193171436244,0,5,inhibin binding,MF,
9580,GO:0034713,1,0.870276171199404,0,9,type I transforming growth factor beta receptor binding,MF,
9581,GO:0034714,1,0.953675796632907,0,3,type III transforming growth factor beta receptor binding,MF,
9582,GO:0034715,1,0.946713179342794,0,6,pICln-Sm protein complex,CC,
9583,GO:0034718,1,0.983406759351821,0,1,SMN-Gemin2 complex,CC,
9584,GO:0034719,1,0.82606160575417,0,17,SMN-Sm protein complex,CC,
9585,GO:0034720,1,0.904778778406465,0,6,histone H3-K4 demethylation,BP,
9586,GO:0034721,1,0.967087733486076,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9587,GO:0034722,1,0.98932328287838,0,1,gamma-glutamyl-peptidase activity,MF,
9588,GO:0034723,1,0.818609862007187,0,32,DNA replication-dependent nucleosome organization,BP,
9589,GO:0034724,1,0.592178234783117,0,49,DNA replication-independent nucleosome organization,BP,
9590,GO:0034727,1,0.967094359503926,0,2,piecemeal microautophagy of nucleus,BP,
9591,GO:0034728,1,0.188862261454191,0,159,nucleosome organization,BP,
9592,GO:0034729,1,0.958545895001152,0,3,histone H3-K79 methylation,BP,
9593,GO:0034736,1,0.970091073434178,0,2,cholesterol O-acyltransferase activity,MF,
9594,GO:0034739,1,0.975180317959097,0,2,histone deacetylase activity (H4-K16 specific),MF,
9595,GO:0034750,1,0.967171752446892,0,2,Scrib-APC-beta-catenin complex,CC,
9596,GO:0034751,1,0.959626132802949,0,3,aryl hydrocarbon receptor complex,CC,
9597,GO:0034752,1,0.983406759351575,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9598,GO:0034753,1,0.983406759351575,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9601,GO:0034756,1,0.960187047338788,0,4,regulation of iron ion transport,BP,
9602,GO:0034757,1,0.980155789539954,0,2,negative regulation of iron ion transport,BP,
9603,GO:0034758,1,0.9796286563165,0,2,positive regulation of iron ion transport,BP,
9604,GO:0034759,1,0.980155789539954,0,2,regulation of iron ion transmembrane transport,BP,
9605,GO:0034760,1,0.980155789539954,0,2,negative regulation of iron ion transmembrane transport,BP,
9612,GO:0034769,1,0.969998426723932,0,2,basement membrane disassembly,BP,
9613,GO:0034770,1,0.908088786011368,0,6,histone H4-K20 methylation,BP,
9614,GO:0034773,1,0.939001371211152,0,4,histone H4-K20 trimethylation,BP,
9616,GO:0034775,1,0.983406759351574,0,1,glutathione transmembrane transport,BP,
9617,GO:0034776,1,0.859350139922617,0,10,response to histamine,BP,
9618,GO:0034875,1,0.943534489555406,0,4,caffeine oxidase activity,MF,
9619,GO:0034899,1,0.986370525721699,0,1,trimethylamine monooxygenase activity,MF,
9620,GO:0034959,1,0.983406759351869,0,1,endothelin maturation,BP,
9621,GO:0034963,1,0.991339022669521,0,1,box C/D snoRNA processing,BP,
9622,GO:0034964,1,0.984676451729454,0,1,box H/ACA snoRNA processing,BP,
9623,GO:0034968,1,0.232801335108809,0,96,histone lysine methylation,BP,
9624,GO:0034969,1,0.850895128659339,0,11,histone arginine methylation,BP,
9625,GO:0034970,1,0.968658868398275,0,2,histone H3-R2 methylation,BP,
9626,GO:0034971,1,0.97019776676244,0,2,histone H3-R17 methylation,BP,
9627,GO:0034972,1,0.985864225629554,0,1,histone H3-R26 methylation,BP,
9628,GO:0034975,1,0.831456871191934,0,12,protein folding in endoplasmic reticulum,BP,
9630,GO:0034979,1,0.798100302218029,0,15,NAD-dependent protein deacetylase activity,MF,
9631,GO:0034982,1,0.885483859022629,0,10,mitochondrial protein processing,BP,
9632,GO:0034983,1,0.900509218608832,0,7,peptidyl-lysine deacetylation,BP,
9633,GO:0034986,1,0.983406759351379,0,1,iron chaperone activity,MF,
9634,GO:0034987,1,0.921349351446645,0,6,immunoglobulin receptor binding,MF,
9635,GO:0034988,1,0.968699801870041,0,2,Fc-gamma receptor I complex binding,MF,
9636,GO:0034991,1,0.941262319693884,0,4,nuclear meiotic cohesin complex,CC,
9637,GO:0034992,1,0.898281676526082,0,7,microtubule organizing center attachment site,CC,
9638,GO:0034993,1,0.898281676526082,0,7,LINC complex,CC,
9639,GO:0034998,1,0.984725543253726,0,1,oligosaccharyltransferase I complex,CC,
9640,GO:0035003,1,0.985554093900647,0,1,subapical complex,CC,
9645,GO:0035020,1,0.822791217474272,0,12,regulation of Rac protein signal transduction,BP,
9646,GO:0035021,1,0.93868361958247,0,4,negative regulation of Rac protein signal transduction,BP,
9647,GO:0035022,1,0.96708773348782,0,2,positive regulation of Rac protein signal transduction,BP,
9650,GO:0035025,1,0.692055157402877,0,25,positive regulation of Rho protein signal transduction,BP,
9651,GO:0035026,1,0.967227927747352,0,2,leading edge cell differentiation,BP,
9652,GO:0035032,1,0.912262104057122,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9653,GO:0035033,1,0.968716557321635,0,3,histone deacetylase regulator activity,MF,
9654,GO:0035034,1,0.970221902366082,0,2,histone acetyltransferase regulator activity,MF,
9655,GO:0035035,1,0.670780175038544,0,26,histone acetyltransferase binding,MF,
9656,GO:0035036,1,0.546735698938536,0,45,sperm-egg recognition,BP,
9657,GO:0035037,1,0.983406759352021,0,1,sperm entry,BP,
9658,GO:0035038,1,0.96948008712334,0,2,female pronucleus assembly,BP,
9659,GO:0035039,1,0.982415299850038,0,2,male pronucleus assembly,BP,
9660,GO:0035041,1,0.996892934256278,0,1,sperm chromatin decondensation,BP,
9661,GO:0035042,1,0.996892934256278,0,1,fertilization, exchange of chromosomal proteins,BP,
9662,GO:0035048,1,0.983420996453038,0,1,splicing factor protein import into nucleus,BP,
9666,GO:0035061,1,0.951038409344304,0,3,interchromatin granule,CC,
9667,GO:0035063,1,0.967101024350075,0,2,nuclear speck organization,BP,
9668,GO:0035064,1,0.444147882965664,0,53,methylated histone binding,MF,
9671,GO:0035067,1,0.786262828325387,0,16,negative regulation of histone acetylation,BP,
9672,GO:0035068,1,0.915034605939726,0,6,micro-ribonucleoprotein complex,CC,
9673,GO:0035082,1,0.543924795033984,0,42,axoneme assembly,BP,
9674,GO:0035087,1,0.946713690383443,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9677,GO:0035090,1,0.846009181957759,0,12,maintenance of apical/basal cell polarity,BP,
9679,GO:0035092,1,0.906083282748861,0,8,sperm chromatin condensation,BP,
9680,GO:0035093,1,0.955742330896083,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9682,GO:0035095,1,0.894920808718063,0,7,behavioral response to nicotine,BP,
9683,GO:0035097,1,0.391164356867583,0,63,histone methyltransferase complex,CC,
9684,GO:0035098,1,0.768527853751682,0,17,ESC/E(Z) complex,CC,
9685,GO:0035101,1,0.953591218330569,0,3,FACT complex,CC,
9686,GO:0035102,1,0.832029506240135,0,12,PRC1 complex,CC,
9687,GO:0035105,1,0.983689981131194,0,1,sterol regulatory element binding protein import into nucleus,BP,
9688,GO:0035106,1,0.95300938308001,0,3,operant conditioning,BP,
9695,GO:0035120,1,0.983406759350394,0,1,post-embryonic appendage morphogenesis,BP,
9696,GO:0035127,1,0.983406759350394,0,1,post-embryonic limb morphogenesis,BP,
9697,GO:0035128,1,0.983406759350394,0,1,post-embryonic forelimb morphogenesis,BP,
9700,GO:0035145,1,0.743080217493524,0,20,exon-exon junction complex,CC,
9704,GO:0035166,1,0.951704517706048,0,3,post-embryonic hemopoiesis,BP,
9705,GO:0035173,1,0.792508567854311,0,16,histone kinase activity,MF,
9706,GO:0035174,1,0.925627402095069,0,6,histone serine kinase activity,MF,
9707,GO:0035175,1,0.988114483012288,0,1,histone kinase activity (H3-S10 specific),MF,
9708,GO:0035176,1,0.50093512978437,0,47,social behavior,BP,
9709,GO:0035184,1,0.910833461365687,0,6,histone threonine kinase activity,MF,
9710,GO:0035188,1,0.983595118214331,0,1,hatching,BP,
9711,GO:0035189,1,0.954420706416041,0,3,Rb-E2F complex,CC,
9715,GO:0035197,1,0.884440919794709,0,8,siRNA binding,MF,
9716,GO:0035198,1,0.808021444588089,0,14,miRNA binding,MF,
9717,GO:0035226,1,0.983758724930472,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9718,GO:0035227,1,0.983758724930472,0,1,regulation of glutamate-cysteine ligase activity,BP,
9719,GO:0035229,1,0.983758724930472,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9721,GO:0035235,1,0.654130226335651,0,26,ionotropic glutamate receptor signaling pathway,BP,
9723,GO:0035240,1,0.862535226080091,0,13,dopamine binding,MF,
9724,GO:0035241,1,0.955752455862559,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
9725,GO:0035242,1,0.944673713617665,0,4,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9726,GO:0035243,1,0.955649416397207,0,3,protein-arginine omega-N symmetric methyltransferase activity,MF,
9727,GO:0035246,1,0.850101825140613,0,11,peptidyl-arginine N-methylation,BP,
9728,GO:0035247,1,0.902767217290698,0,7,peptidyl-arginine omega-N-methylation,BP,
9729,GO:0035248,1,0.984049883415872,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9732,GO:0035251,1,0.876946082407153,0,9,UDP-glucosyltransferase activity,MF,
9733,GO:0035252,1,0.912107415574628,0,6,UDP-xylosyltransferase activity,MF,
9734,GO:0035253,1,0.882350175610736,0,8,ciliary rootlet,CC,
9735,GO:0035254,1,0.601501122805584,0,33,glutamate receptor binding,MF,
9736,GO:0035255,1,0.711767198054602,0,22,ionotropic glutamate receptor binding,MF,
9737,GO:0035256,1,0.917848584173931,0,6,G-protein coupled glutamate receptor binding,MF,
9739,GO:0035258,1,0.279053871399538,0,84,steroid hormone receptor binding,MF,
9740,GO:0035259,1,0.816462352223202,0,13,glucocorticoid receptor binding,MF,
9741,GO:0035261,1,0.967087733485352,0,2,external genitalia morphogenesis,BP,
9742,GO:0035262,1,0.969185762973261,0,2,gonad morphogenesis,BP,
9745,GO:0035267,1,0.779573928097888,0,18,NuA4 histone acetyltransferase complex,CC,
9746,GO:0035268,1,0.806833877195163,0,16,protein mannosylation,BP,
9747,GO:0035269,1,0.877289558737961,0,11,protein O-linked mannosylation,BP,
9750,GO:0035276,1,0.956739909473111,0,3,ethanol binding,MF,
9751,GO:0035278,1,0.823978812355685,0,13,miRNA mediated inhibition of translation,BP,
9752,GO:0035279,1,0.968415012244438,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9753,GO:0035280,1,0.899845677195513,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9754,GO:0035281,1,0.975525524056801,0,2,pre-miRNA export from nucleus,BP,
9756,GO:0035283,1,0.956031487021147,0,3,central nervous system segmentation,BP,
9757,GO:0035284,1,0.956031487021147,0,3,brain segmentation,BP,
9758,GO:0035290,1,0.952563281659545,0,3,trunk segmentation,BP,
9761,GO:0035299,1,0.983406759352021,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9767,GO:0035308,1,0.731828221177907,0,22,negative regulation of protein dephosphorylation,BP,
9768,GO:0035312,1,0.908877841549851,0,6,5'-3' exodeoxyribonuclease activity,MF,
9771,GO:0035325,1,0.889136422757255,0,9,Toll-like receptor binding,MF,
9772,GO:0035326,1,0.237621818048371,0,96,enhancer binding,MF,
9773,GO:0035327,1,0.775227689008079,0,21,transcriptionally active chromatin,CC,
9775,GO:0035330,1,0.864046439193839,0,9,regulation of hippo signaling,BP,
9776,GO:0035331,1,0.907948919479023,0,6,negative regulation of hippo signaling,BP,
9777,GO:0035332,1,0.983406759350987,0,1,positive regulation of hippo signaling,BP,
9782,GO:0035339,1,0.950913752112423,0,4,SPOTS complex,CC,
9783,GO:0035349,1,0.969582674838051,0,2,coenzyme A transmembrane transport,BP,
9784,GO:0035350,1,0.969704837623964,0,2,FAD transmembrane transport,BP,
9785,GO:0035354,1,0.967852767683927,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9786,GO:0035355,1,0.983406759351673,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9787,GO:0035356,1,0.906214925556803,0,7,cellular triglyceride homeostasis,BP,
9788,GO:0035357,1,0.736732189534771,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9789,GO:0035358,1,0.831896065207707,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9790,GO:0035359,1,0.957454726965606,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9791,GO:0035360,1,0.897547197033289,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9792,GO:0035363,1,0.972257987481295,0,2,histone locus body,CC,
9793,GO:0035368,1,0.938260472536257,0,5,selenocysteine insertion sequence binding,MF,
9794,GO:0035370,1,0.970442989995589,0,2,UBC13-UEV1A complex,CC,
9795,GO:0035371,1,0.75865162591251,0,17,microtubule plus-end,CC,
9796,GO:0035372,1,0.866035893992154,0,9,protein localization to microtubule,BP,
9797,GO:0035373,1,0.956465313294336,0,3,chondroitin sulfate proteoglycan binding,MF,
9798,GO:0035374,1,0.913295404891562,0,6,chondroitin sulfate binding,MF,
9799,GO:0035375,1,0.983406759351231,0,1,zymogen binding,MF,
9800,GO:0035376,1,0.904591541785548,0,9,sterol import,BP,
9801,GO:0035377,1,0.96793424792159,0,2,transepithelial water transport,BP,
9802,GO:0035378,1,0.971501316604484,0,2,carbon dioxide transmembrane transport,BP,
9803,GO:0035379,1,0.971501316604484,0,2,carbon dioxide transmembrane transporter activity,MF,
9804,GO:0035381,1,0.892043223797354,0,8,ATP-gated ion channel activity,MF,
9807,GO:0035385,1,0.892775435126,0,7,Roundabout signaling pathway,BP,
9808,GO:0035397,1,0.970581045533191,0,2,helper T cell enhancement of adaptive immune response,BP,
9809,GO:0035400,1,0.983406759351821,0,1,histone tyrosine kinase activity,MF,
9810,GO:0035401,1,0.983406759351821,0,1,histone kinase activity (H3-Y41 specific),MF,
9811,GO:0035402,1,0.968480580722229,0,2,histone kinase activity (H3-T11 specific),MF,
9812,GO:0035403,1,0.967087733486853,0,2,histone kinase activity (H3-T6 specific),MF,
9813,GO:0035404,1,0.869426111535666,0,10,histone-serine phosphorylation,BP,
9814,GO:0035405,1,0.910833461365687,0,6,histone-threonine phosphorylation,BP,
9815,GO:0035406,1,0.983406759351821,0,1,histone-tyrosine phosphorylation,BP,
9816,GO:0035407,1,0.968480580722229,0,2,histone H3-T11 phosphorylation,BP,
9817,GO:0035408,1,0.967087733486853,0,2,histone H3-T6 phosphorylation,BP,
9818,GO:0035409,1,0.983406759351821,0,1,histone H3-Y41 phosphorylation,BP,
9819,GO:0035410,1,0.990960962472649,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9822,GO:0035413,1,0.840214369752134,0,11,positive regulation of catenin import into nucleus,BP,
9823,GO:0035414,1,0.846836130867903,0,11,negative regulation of catenin import into nucleus,BP,
9825,GO:0035419,1,0.967357673106407,0,2,activation of MAPK activity involved in innate immune response,BP,
9826,GO:0035425,1,0.956534568623841,0,3,autocrine signaling,BP,
9827,GO:0035426,1,0.923313484524151,0,5,extracellular matrix-cell signaling,BP,
9829,GO:0035434,1,0.92032504476523,0,6,copper ion transmembrane transport,BP,
9830,GO:0035435,1,0.761611847839657,0,18,phosphate ion transmembrane transport,BP,
9831,GO:0035437,1,0.865228428959348,0,10,maintenance of protein localization in endoplasmic reticulum,BP,
9832,GO:0035438,1,0.988219898228933,0,1,cyclic-di-GMP binding,MF,
9833,GO:0035441,1,0.951057541143532,0,3,cell migration involved in vasculogenesis,BP,
9834,GO:0035442,1,0.973001272191829,0,2,dipeptide transmembrane transport,BP,
9835,GO:0035443,1,0.983406759351574,0,1,tripeptide transmembrane transport,BP,
9836,GO:0035445,1,0.983715246434126,0,1,borate transmembrane transport,BP,
9838,GO:0035456,1,0.763606166176593,0,22,response to interferon-beta,BP,
9840,GO:0035458,1,0.82821794460973,0,14,cellular response to interferon-beta,BP,
9841,GO:0035459,1,0.852229673480884,0,10,cargo loading into vesicle,BP,
9842,GO:0035461,1,0.87010808243531,0,9,vitamin transmembrane transport,BP,
9843,GO:0035469,1,0.920966149422381,0,5,determination of pancreatic left/right asymmetry,BP,
9844,GO:0035470,1,0.976065816277684,0,2,positive regulation of vascular wound healing,BP,
9845,GO:0035472,1,0.983741971792908,0,1,choriogonadotropin hormone receptor activity,MF,
9846,GO:0035473,1,0.91646730302568,0,6,lipase binding,MF,
9847,GO:0035478,1,0.985603653174881,0,1,chylomicron binding,MF,
9848,GO:0035480,1,0.991411501090547,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9849,GO:0035481,1,0.991411501090547,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9850,GO:0035482,1,0.972621107336438,0,3,gastric motility,BP,
9851,GO:0035483,1,0.984061822857672,0,2,gastric emptying,BP,
9852,GO:0035490,1,0.983669856550392,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9853,GO:0035491,1,0.983669856550392,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9855,GO:0035494,1,0.955681480125415,0,3,SNARE complex disassembly,BP,
9856,GO:0035497,1,0.81955777673479,0,13,cAMP response element binding,MF,
9857,GO:0035498,1,0.983406808891365,0,1,carnosine metabolic process,BP,
9858,GO:0035499,1,0.983406808891365,0,1,carnosine biosynthetic process,BP,
9859,GO:0035500,1,0.967796153521181,0,2,MH2 domain binding,MF,
9860,GO:0035501,1,0.984121084602615,0,1,MH1 domain binding,MF,
9862,GO:0035504,1,0.989276674890875,0,1,regulation of myosin light chain kinase activity,BP,
9863,GO:0035505,1,0.989276674890875,0,1,positive regulation of myosin light chain kinase activity,BP,
9864,GO:0035507,1,0.893921764849799,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9865,GO:0035508,1,0.983406759351773,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9866,GO:0035509,1,0.924354099862427,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9867,GO:0035510,1,0.727616201604835,0,24,DNA dealkylation,BP,
9868,GO:0035511,1,0.935094127725721,0,5,oxidative DNA demethylation,BP,
9869,GO:0035513,1,0.941711249873833,0,4,oxidative RNA demethylation,BP,
9870,GO:0035514,1,0.976391733900067,0,2,DNA demethylase activity,MF,
9871,GO:0035515,1,0.941711249873833,0,4,oxidative RNA demethylase activity,MF,
9872,GO:0035516,1,0.98340675935207,0,1,oxidative DNA demethylase activity,MF,
9873,GO:0035517,1,0.967117873193841,0,2,PR-DUB complex,CC,
9874,GO:0035518,1,0.836769023423901,0,12,histone H2A monoubiquitination,BP,
9875,GO:0035519,1,0.958219563008788,0,4,protein K29-linked ubiquitination,BP,
9876,GO:0035520,1,0.861698863797211,0,9,monoubiquitinated protein deubiquitination,BP,
9877,GO:0035521,1,0.936873487678984,0,4,monoubiquitinated histone deubiquitination,BP,
9878,GO:0035522,1,0.936873487678984,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9879,GO:0035523,1,0.939857997291493,0,4,protein K29-linked deubiquitination,BP,
9880,GO:0035524,1,0.891459428890825,0,7,proline transmembrane transport,BP,
9881,GO:0035525,1,0.984676451729454,0,1,NF-kappaB p50/p65 complex,CC,
9882,GO:0035526,1,0.967087733488061,0,2,retrograde transport, plasma membrane to Golgi,BP,
9883,GO:0035529,1,0.930897757569653,0,5,NADH pyrophosphatase activity,MF,
9884,GO:0035538,1,0.983589562847325,0,1,carbohydrate response element binding,MF,
9885,GO:0035539,1,0.981216229000929,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9886,GO:0035542,1,0.869416865627683,0,9,regulation of SNARE complex assembly,BP,
9887,GO:0035543,1,0.988825379264125,0,1,positive regulation of SNARE complex assembly,BP,
9888,GO:0035544,1,0.967087733488061,0,2,negative regulation of SNARE complex assembly,BP,
9889,GO:0035545,1,0.983406918392831,0,1,determination of left/right asymmetry in nervous system,BP,
9890,GO:0035546,1,0.984058405067898,0,1,interferon-beta secretion,BP,
9891,GO:0035547,1,0.984058405067898,0,1,regulation of interferon-beta secretion,BP,
9892,GO:0035548,1,0.984058405067898,0,1,negative regulation of interferon-beta secretion,BP,
9893,GO:0035552,1,0.95752234604124,0,3,oxidative single-stranded DNA demethylation,BP,
9894,GO:0035553,1,0.956387934253281,0,3,oxidative single-stranded RNA demethylation,BP,
9896,GO:0035561,1,0.729322515017085,0,20,regulation of chromatin binding,BP,
9897,GO:0035562,1,0.875855766978115,0,8,negative regulation of chromatin binding,BP,
9898,GO:0035563,1,0.846768614261177,0,11,positive regulation of chromatin binding,BP,
9899,GO:0035564,1,0.936555571208362,0,4,regulation of kidney size,BP,
9900,GO:0035565,1,0.984174220502037,0,1,regulation of pronephros size,BP,
9901,GO:0035566,1,0.967677825038882,0,2,regulation of metanephros size,BP,
9903,GO:0035568,1,0.984725543253726,0,1,N-terminal peptidyl-proline methylation,BP,
9904,GO:0035570,1,0.984725543253726,0,1,N-terminal peptidyl-serine methylation,BP,
9905,GO:0035572,1,0.984725543253726,0,1,N-terminal peptidyl-serine dimethylation,BP,
9906,GO:0035573,1,0.984725543253726,0,1,N-terminal peptidyl-serine trimethylation,BP,
9907,GO:0035574,1,0.983406759351625,0,1,histone H4-K20 demethylation,BP,
9908,GO:0035575,1,0.983406759351625,0,1,histone demethylase activity (H4-K20 specific),MF,
9910,GO:0035578,1,0.326801820324725,0,88,azurophil granule lumen,CC,
9913,GO:0035581,1,0.8887037626733,0,8,sequestering of extracellular ligand from receptor,BP,
9914,GO:0035582,1,0.950052442312106,0,4,sequestering of BMP in extracellular matrix,BP,
9915,GO:0035583,1,0.951038409341494,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9917,GO:0035585,1,0.983406759349856,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9921,GO:0035589,1,0.824998064817819,0,14,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9922,GO:0035590,1,0.73586679838351,0,22,purinergic nucleotide receptor signaling pathway,BP,
9924,GO:0035594,1,0.941236672877239,0,4,ganglioside binding,MF,
9925,GO:0035596,1,0.970399491198428,0,2,methylthiotransferase activity,MF,
9926,GO:0035597,1,0.986606140176491,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9927,GO:0035598,1,0.983574245168322,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9928,GO:0035600,1,0.970399491198428,0,2,tRNA methylthiolation,BP,
9930,GO:0035602,1,0.983406759352069,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9931,GO:0035603,1,0.983406759352069,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9932,GO:0035604,1,0.983406759352069,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9933,GO:0035605,1,0.990401065929616,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9934,GO:0035606,1,0.985988988447041,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9935,GO:0035607,1,0.967087733487865,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9936,GO:0035608,1,0.879970981983292,0,8,protein deglutamylation,BP,
9937,GO:0035609,1,0.924510199688973,0,5,C-terminal protein deglutamylation,BP,
9938,GO:0035610,1,0.920332614986431,0,5,protein side chain deglutamylation,BP,
9939,GO:0035611,1,0.984094131490536,0,1,protein branching point deglutamylation,BP,
9940,GO:0035612,1,0.892567792179291,0,7,AP-2 adaptor complex binding,MF,
9941,GO:0035613,1,0.849828545959274,0,11,RNA stem-loop binding,MF,
9942,GO:0035614,1,0.963883308443912,0,3,snRNA stem-loop binding,MF,
9943,GO:0035615,1,0.846200009160968,0,11,clathrin adaptor activity,MF,
9944,GO:0035616,1,0.951278686950533,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9945,GO:0035617,1,0.954779621508301,0,3,stress granule disassembly,BP,
9946,GO:0035620,1,0.96708773348782,0,2,ceramide transporter activity,MF,
9947,GO:0035621,1,0.97041995215035,0,2,ER to Golgi ceramide transport,BP,
9948,GO:0035622,1,0.9834070038051,0,1,intrahepatic bile duct development,BP,
9949,GO:0035623,1,0.98360269892516,0,1,renal glucose absorption,BP,
9952,GO:0035627,1,0.923558703217407,0,5,ceramide transport,BP,
9954,GO:0035631,1,0.844545748149587,0,11,CD40 receptor complex,CC,
9955,GO:0035633,1,0.937398682551371,0,4,maintenance of permeability of blood-brain barrier,BP,
9956,GO:0035634,1,0.945783539996531,0,5,response to stilbenoid,BP,
9959,GO:0035638,1,0.983406759351968,0,1,signal maturation,BP,
9962,GO:0035641,1,0.838197506278564,0,12,locomotory exploration behavior,BP,
9963,GO:0035642,1,0.983882099407595,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9964,GO:0035643,1,0.988172320962222,0,1,L-DOPA receptor activity,MF,
9965,GO:0035644,1,0.983842346953565,0,1,phosphoanandamide dephosphorylation,BP,
9966,GO:0035645,1,0.98340675935207,0,1,enteric smooth muscle cell differentiation,BP,
9972,GO:0035662,1,0.980210965853193,0,3,Toll-like receptor 4 binding,MF,
9973,GO:0035663,1,0.955884167894475,0,3,Toll-like receptor 2 binding,MF,
9974,GO:0035664,1,0.987734351900206,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9975,GO:0035665,1,0.987734351900206,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9976,GO:0035666,1,0.6754882969083,0,28,TRIF-dependent toll-like receptor signaling pathway,BP,
9977,GO:0035668,1,0.967544390092945,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9978,GO:0035669,1,0.967544390092945,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9979,GO:0035671,1,0.932425063215676,0,5,enone reductase activity,MF,
9980,GO:0035672,1,0.910309595884227,0,6,oligopeptide transmembrane transport,BP,
9981,GO:0035673,1,0.935575831170905,0,4,oligopeptide transmembrane transporter activity,MF,
9982,GO:0035674,1,0.972497341254685,0,2,tricarboxylic acid transmembrane transport,BP,
9983,GO:0035684,1,0.994296144488195,0,1,helper T cell extravasation,BP,
9984,GO:0035686,1,0.913161942259757,0,7,sperm fibrous sheath,CC,
9986,GO:0035691,1,0.973972611914872,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9987,GO:0035692,1,0.973972611914776,0,2,macrophage migration inhibitory factor receptor complex,CC,
9988,GO:0035693,1,0.990407332080951,0,1,NOS2-CD74 complex,CC,
9989,GO:0035694,1,0.940699907769998,0,4,mitochondrial protein catabolic process,BP,
9990,GO:0035695,1,0.983406759352021,0,1,mitophagy by induced vacuole formation,BP,
9991,GO:0035696,1,0.952475201041161,0,3,monocyte extravasation,BP,
9992,GO:0035697,1,0.959898651609354,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9993,GO:0035698,1,0.974624601787999,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9994,GO:0035700,1,0.972826021445874,0,2,astrocyte chemotaxis,BP,
9996,GO:0035704,1,0.984892242795262,0,1,helper T cell chemotaxis,BP,
9997,GO:0035705,1,0.984892242795262,0,1,T-helper 17 cell chemotaxis,BP,
9998,GO:0035708,1,0.983466930130704,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9999,GO:0035709,1,0.969578798142045,0,2,memory T cell activation,BP,
10001,GO:0035711,1,0.974640780062392,0,2,T-helper 1 cell activation,BP,
10002,GO:0035712,1,0.967316446413113,0,2,T-helper 2 cell activation,BP,
10003,GO:0035713,1,0.983466930130704,0,1,response to nitrogen dioxide,BP,
10004,GO:0035714,1,0.983466930130704,0,1,cellular response to nitrogen dioxide,BP,
10005,GO:0035717,1,0.984442781329775,0,1,chemokine (C-C motif) ligand 7 binding,MF,
10006,GO:0035718,1,0.990407332080951,0,1,macrophage migration inhibitory factor binding,MF,
10007,GO:0035720,1,0.955729790104558,0,3,intraciliary anterograde transport,BP,
10008,GO:0035721,1,0.870923482046772,0,9,intraciliary retrograde transport,BP,
10009,GO:0035722,1,0.954296192789091,0,3,interleukin-12-mediated signaling pathway,BP,
10010,GO:0035723,1,0.955904834945512,0,3,interleukin-15-mediated signaling pathway,BP,
10011,GO:0035724,1,0.983406759351477,0,1,CD24 biosynthetic process,BP,
10012,GO:0035725,1,0.11108239755456,0,144,sodium ion transmembrane transport,BP,
10013,GO:0035726,1,0.907644767442851,0,7,common myeloid progenitor cell proliferation,BP,
10014,GO:0035727,1,0.941055913347517,0,4,lysophosphatidic acid binding,MF,
10017,GO:0035730,1,0.992755458394187,0,1,S-nitrosoglutathione binding,MF,
10018,GO:0035731,1,0.992755458394187,0,1,dinitrosyl-iron complex binding,MF,
10019,GO:0035732,1,0.992755458394187,0,1,nitric oxide storage,BP,
10020,GO:0035733,1,0.893411588700444,0,7,hepatic stellate cell activation,BP,
10021,GO:0035735,1,0.581812980658208,0,38,intraciliary transport involved in cilium assembly,BP,
10022,GO:0035739,1,0.932095112029405,0,5,CD4-positive, alpha-beta T cell proliferation,BP,
10023,GO:0035740,1,0.948579663290231,0,4,CD8-positive, alpha-beta T cell proliferation,BP,
10024,GO:0035743,1,0.849643134370098,0,13,CD4-positive, alpha-beta T cell cytokine production,BP,
10025,GO:0035744,1,0.977825363430415,0,2,T-helper 1 cell cytokine production,BP,
10026,GO:0035745,1,0.875046242147072,0,11,T-helper 2 cell cytokine production,BP,
10027,GO:0035746,1,0.990999747210216,0,1,granzyme A production,BP,
10029,GO:0035748,1,0.907578571250736,0,6,myelin sheath abaxonal region,CC,
10030,GO:0035749,1,0.916819302539143,0,6,myelin sheath adaxonal region,CC,
10031,GO:0035750,1,0.983406759351821,0,1,protein localization to myelin sheath abaxonal region,BP,
10032,GO:0035751,1,0.876536983757078,0,10,regulation of lysosomal lumen pH,BP,
10033,GO:0035752,1,0.987149060736051,0,1,lysosomal lumen pH elevation,BP,
10035,GO:0035755,1,0.984693575781511,0,1,cardiolipin hydrolase activity,MF,
10036,GO:0035757,1,0.986013886613784,0,1,chemokine (C-C motif) ligand 19 binding,MF,
10037,GO:0035758,1,0.986013886613784,0,1,chemokine (C-C motif) ligand 21 binding,MF,
10038,GO:0035759,1,0.97779486207581,0,2,mesangial cell-matrix adhesion,BP,
10039,GO:0035766,1,0.921510291217497,0,7,cell chemotaxis to fibroblast growth factor,BP,
10041,GO:0035768,1,0.921510291217497,0,7,endothelial cell chemotaxis to fibroblast growth factor,BP,
10042,GO:0035769,1,0.991123064544678,0,1,B cell chemotaxis across high endothelial venule,BP,
10043,GO:0035770,1,0.0661997337236147,0,185,ribonucleoprotein granule,CC,
10044,GO:0035771,1,0.919894103613438,0,6,interleukin-4-mediated signaling pathway,BP,
10045,GO:0035772,1,0.98785592335369,0,1,interleukin-13-mediated signaling pathway,BP,
10046,GO:0035773,1,0.455615048885343,0,55,insulin secretion involved in cellular response to glucose stimulus,BP,
10047,GO:0035774,1,0.70538530891177,0,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
10048,GO:0035782,1,0.990999747210216,0,1,mature natural killer cell chemotaxis,BP,
10049,GO:0035783,1,0.983466930130704,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
10050,GO:0035786,1,0.984725543253726,0,1,protein complex oligomerization,BP,
10054,GO:0035790,1,0.951040186188716,0,3,platelet-derived growth factor receptor-alpha signaling pathway,BP,
10058,GO:0035795,1,0.950395257796648,0,4,negative regulation of mitochondrial membrane permeability,BP,
10059,GO:0035799,1,0.935761100754928,0,4,ureter maturation,BP,
10060,GO:0035800,1,0.973559779586101,0,2,deubiquitinase activator activity,MF,
10063,GO:0035803,1,0.97967744706064,0,2,egg coat formation,BP,
10064,GO:0035805,1,0.985719188185092,0,1,egg coat,CC,
10067,GO:0035811,1,0.955483060987672,0,5,negative regulation of urine volume,BP,
10073,GO:0035822,1,0.936739051911252,0,4,gene conversion,BP,
10074,GO:0035825,1,0.531452373786156,0,43,reciprocal DNA recombination,BP,
10075,GO:0035826,1,0.928264602027371,0,5,rubidium ion transport,BP,
10076,GO:0035838,1,0.951038409344251,0,3,growing cell tip,CC,
10077,GO:0035841,1,0.96708773348748,0,2,new growing cell tip,CC,
10079,GO:0035845,1,0.869570612008707,0,9,photoreceptor cell outer segment organization,BP,
10080,GO:0035846,1,0.985589431962327,0,1,oviduct epithelium development,BP,
10081,GO:0035847,1,0.985589431962327,0,1,uterine epithelium development,BP,
10082,GO:0035849,1,0.985589431962327,0,1,nephric duct elongation,BP,
10084,GO:0035851,1,0.98389187450385,0,1,Krueppel-associated box domain binding,MF,
10085,GO:0035852,1,0.985589431962327,0,1,horizontal cell localization,BP,
10086,GO:0035853,1,0.983406759352021,0,1,chromosome passenger complex localization to spindle midzone,BP,
10087,GO:0035854,1,0.973095909410302,0,2,eosinophil fate commitment,BP,
10090,GO:0035860,1,0.910744232497175,0,6,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
10091,GO:0035861,1,0.647626670385635,0,29,site of double-strand break,CC,
10092,GO:0035862,1,0.983406759351672,0,1,dITP metabolic process,BP,
10093,GO:0035863,1,0.983406759351672,0,1,dITP catabolic process,BP,
10094,GO:0035864,1,0.839085075336093,0,12,response to potassium ion,BP,
10095,GO:0035865,1,0.90457619813166,0,7,cellular response to potassium ion,BP,
10096,GO:0035867,1,0.935254347827548,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10098,GO:0035870,1,0.975330021285085,0,2,dITP diphosphatase activity,MF,
10099,GO:0035871,1,0.850387374869005,0,10,protein K11-linked deubiquitination,BP,
10100,GO:0035872,1,0.596240343903337,0,34,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10101,GO:0035873,1,0.910908816577429,0,6,lactate transmembrane transport,BP,
10102,GO:0035877,1,0.946157012164507,0,4,death effector domain binding,MF,
10104,GO:0035879,1,0.954095353739107,0,3,plasma membrane lactate transport,BP,
10105,GO:0035880,1,0.956940625498593,0,3,embryonic nail plate morphogenesis,BP,
10106,GO:0035881,1,0.886133519073822,0,8,amacrine cell differentiation,BP,
10109,GO:0035887,1,0.987935314300946,0,1,aortic smooth muscle cell differentiation,BP,
10110,GO:0035890,1,0.587562307162153,0,35,exit from host,BP,
10111,GO:0035891,1,0.587562307162153,0,35,exit from host cell,BP,
10112,GO:0035897,1,0.915908280031772,0,6,proteolysis in other organism,BP,
10113,GO:0035898,1,0.955063774804512,0,3,parathyroid hormone secretion,BP,
10117,GO:0035905,1,0.942102414837339,0,4,ascending aorta development,BP,
10120,GO:0035910,1,0.942102414837339,0,4,ascending aorta morphogenesis,BP,
10123,GO:0035915,1,0.986526583473666,0,1,pore formation in membrane of other organism,BP,
10124,GO:0035921,1,0.986306364919517,0,1,desmosome disassembly,BP,
10125,GO:0035922,1,0.972563058367712,0,2,foramen ovale closure,BP,
10127,GO:0035925,1,0.839503127460139,0,11,mRNA 3'-UTR AU-rich region binding,MF,
10128,GO:0035926,1,0.938229154946358,0,4,chemokine (C-C motif) ligand 2 secretion,BP,
10129,GO:0035927,1,0.947535328334854,0,5,RNA import into mitochondrion,BP,
10130,GO:0035928,1,0.967995038941712,0,3,rRNA import into mitochondrion,BP,
10135,GO:0035933,1,0.910292480336761,0,8,glucocorticoid secretion,BP,
10136,GO:0035934,1,0.967247688722476,0,3,corticosterone secretion,BP,
10137,GO:0035935,1,0.98357632905632,0,1,androgen secretion,BP,
10138,GO:0035936,1,0.967226405785868,0,2,testosterone secretion,BP,
10139,GO:0035938,1,0.95625772711693,0,3,estradiol secretion,BP,
10141,GO:0035945,1,0.984938620238289,0,1,mitochondrial ncRNA surveillance,BP,
10142,GO:0035946,1,0.984938620238289,0,1,mitochondrial mRNA surveillance,BP,
10143,GO:0035947,1,0.91237763657662,0,6,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10144,GO:0035948,1,0.942641617177869,0,4,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10145,GO:0035962,1,0.949632660366298,0,4,response to interleukin-13,BP,
10146,GO:0035963,1,0.95632121271574,0,3,cellular response to interleukin-13,BP,
10147,GO:0035964,1,0.944145571915669,0,4,COPI-coated vesicle budding,BP,
10148,GO:0035965,1,0.91873015500264,0,6,cardiolipin acyl-chain remodeling,BP,
10152,GO:0035971,1,0.990999747210216,0,1,peptidyl-histidine dephosphorylation,BP,
10153,GO:0035973,1,0.935437824574204,0,4,aggrephagy,BP,
10154,GO:0035976,1,0.939167340619827,0,5,transcription factor AP-1 complex,CC,
10155,GO:0035977,1,0.939599517386371,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10156,GO:0035978,1,0.984121084602615,0,1,histone H2A-S139 phosphorylation,BP,
10157,GO:0035981,1,0.972650756196509,0,2,tongue muscle cell differentiation,BP,
10158,GO:0035983,1,0.952131760974312,0,3,response to trichostatin A,BP,
10159,GO:0035984,1,0.952131760974312,0,3,cellular response to trichostatin A,BP,
10160,GO:0035985,1,0.950776086132097,0,4,senescence-associated heterochromatin focus,CC,
10161,GO:0035986,1,0.962807316486798,0,3,senescence-associated heterochromatin focus assembly,BP,
10169,GO:0035995,1,0.957303389418878,0,4,detection of muscle stretch,BP,
10170,GO:0035998,1,0.98692313693549,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10171,GO:0035999,1,0.882246409230892,0,9,tetrahydrofolate interconversion,BP,
10172,GO:0036002,1,0.687173194886651,0,27,pre-mRNA binding,MF,
10174,GO:0036004,1,0.990915810008669,0,1,GAF domain binding,MF,
10175,GO:0036005,1,0.867643554070758,0,10,response to macrophage colony-stimulating factor,BP,
10176,GO:0036006,1,0.867643554070758,0,10,cellular response to macrophage colony-stimulating factor stimulus,BP,
10177,GO:0036009,1,0.991339022669521,0,1,protein-glutamine N-methyltransferase activity,MF,
10179,GO:0036015,1,0.939063160436957,0,5,response to interleukin-3,BP,
10180,GO:0036016,1,0.939063160436957,0,5,cellular response to interleukin-3,BP,
10181,GO:0036017,1,0.950819977189027,0,6,response to erythropoietin,BP,
10182,GO:0036018,1,0.95397405542657,0,5,cellular response to erythropoietin,BP,
10183,GO:0036019,1,0.752660530556758,0,19,endolysosome,CC,
10184,GO:0036020,1,0.809151010757824,0,14,endolysosome membrane,CC,
10185,GO:0036021,1,0.942571315780735,0,4,endolysosome lumen,CC,
10186,GO:0036022,1,0.95879711979306,0,3,limb joint morphogenesis,BP,
10187,GO:0036023,1,0.95879711979306,0,3,embryonic skeletal limb joint morphogenesis,BP,
10195,GO:0036031,1,0.991490844992869,0,1,recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex,BP,
10196,GO:0036033,1,0.935254347827034,0,4,mediator complex binding,MF,
10197,GO:0036034,1,0.970027704711239,0,2,mediator complex assembly,BP,
10199,GO:0036037,1,0.796861247409446,0,16,CD8-positive, alpha-beta T cell activation,BP,
10200,GO:0036038,1,0.852135368392836,0,12,MKS complex,CC,
10201,GO:0036041,1,0.906474693203495,0,10,long-chain fatty acid binding,MF,
10202,GO:0036042,1,0.97341433494054,0,3,long-chain fatty acyl-CoA binding,MF,
10203,GO:0036046,1,0.983680274622243,0,1,protein demalonylation,BP,
10204,GO:0036047,1,0.983680274622243,0,1,peptidyl-lysine demalonylation,BP,
10205,GO:0036048,1,0.983680274622243,0,1,protein desuccinylation,BP,
10206,GO:0036049,1,0.983680274622243,0,1,peptidyl-lysine desuccinylation,BP,
10207,GO:0036053,1,0.984344893426395,0,1,glomerular endothelium fenestra,CC,
10208,GO:0036054,1,0.983680274622243,0,1,protein-malonyllysine demalonylase activity,MF,
10209,GO:0036055,1,0.983680274622243,0,1,protein-succinyllysine desuccinylase activity,MF,
10210,GO:0036056,1,0.878960164844518,0,8,filtration diaphragm,CC,
10211,GO:0036057,1,0.878960164844518,0,8,slit diaphragm,CC,
10212,GO:0036058,1,0.983406759352069,0,1,filtration diaphragm assembly,BP,
10213,GO:0036060,1,0.983406759352069,0,1,slit diaphragm assembly,BP,
10215,GO:0036065,1,0.694747140223056,0,23,fucosylation,BP,
10216,GO:0036066,1,0.838374026925483,0,11,protein O-linked fucosylation,BP,
10217,GO:0036071,1,0.983567422310223,0,1,N-glycan fucosylation,BP,
10218,GO:0036072,1,0.914238347601417,0,6,direct ossification,BP,
10220,GO:0036079,1,0.952526934294867,0,3,purine nucleotide-sugar transport,BP,
10221,GO:0036080,1,0.952526934294867,0,3,purine nucleotide-sugar transmembrane transporter activity,MF,
10222,GO:0036085,1,0.984725543253726,0,1,GDP-fucose import into Golgi lumen,BP,
10223,GO:0036088,1,0.988702664278225,0,1,D-serine catabolic process,BP,
10225,GO:0036090,1,0.97346386906659,0,2,cleavage furrow ingression,BP,
10228,GO:0036093,1,0.931437649978679,0,6,germ cell proliferation,BP,
10230,GO:0036100,1,0.943130664048602,0,4,leukotriene catabolic process,BP,
10231,GO:0036101,1,0.943130664048602,0,4,leukotriene B4 catabolic process,BP,
10232,GO:0036102,1,0.943130664048602,0,4,leukotriene B4 metabolic process,BP,
10233,GO:0036105,1,0.983432658119759,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10234,GO:0036109,1,0.832009350603549,0,13,alpha-linolenic acid metabolic process,BP,
10235,GO:0036111,1,0.984401532673474,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10236,GO:0036112,1,0.957984239249709,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10237,GO:0036114,1,0.989100496900187,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10238,GO:0036115,1,0.989100496900187,0,1,fatty-acyl-CoA catabolic process,BP,
10239,GO:0036116,1,0.989100496900187,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10240,GO:0036117,1,0.971392015119438,0,2,hyaluranon cable,CC,
10242,GO:0036119,1,0.739024249557942,0,20,response to platelet-derived growth factor,BP,
10243,GO:0036120,1,0.751131425020072,0,19,cellular response to platelet-derived growth factor stimulus,BP,
10244,GO:0036122,1,0.883841459305824,0,9,BMP binding,MF,
10245,GO:0036123,1,0.906867507253796,0,7,histone H3-K9 dimethylation,BP,
10246,GO:0036124,1,0.779896942499717,0,16,histone H3-K9 trimethylation,BP,
10247,GO:0036125,1,0.983787871862921,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10248,GO:0036126,1,0.388934968118819,0,71,sperm flagellum,CC,
10249,GO:0036128,1,0.892706682035996,0,8,CatSper complex,CC,
10250,GO:0036130,1,0.990960962472649,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10251,GO:0036131,1,0.990960962472649,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10252,GO:0036132,1,0.959481486092469,0,3,13-prostaglandin reductase activity,MF,
10253,GO:0036134,1,0.986238855333363,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10254,GO:0036135,1,0.96838472237558,0,2,Schwann cell migration,BP,
10255,GO:0036137,1,0.971047709946888,0,2,kynurenine aminotransferase activity,MF,
10256,GO:0036138,1,0.983406759351429,0,1,peptidyl-histidine hydroxylation,BP,
10257,GO:0036139,1,0.983406759351429,0,1,peptidyl-histidine dioxygenase activity,MF,
10258,GO:0036140,1,0.983406759351429,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10259,GO:0036143,1,0.993531337817349,0,1,kringle domain binding,MF,
10260,GO:0036145,1,0.987749458035225,0,1,dendritic cell homeostasis,BP,
10261,GO:0036146,1,0.968384724274265,0,2,cellular response to mycotoxin,BP,
10262,GO:0036148,1,0.796175748982751,0,17,phosphatidylglycerol acyl-chain remodeling,BP,
10263,GO:0036149,1,0.817594302057187,0,16,phosphatidylinositol acyl-chain remodeling,BP,
10264,GO:0036150,1,0.755473971045503,0,21,phosphatidylserine acyl-chain remodeling,BP,
10267,GO:0036153,1,0.984157165576615,0,1,triglyceride acyl-chain remodeling,BP,
10268,GO:0036155,1,0.901127405058577,0,7,acylglycerol acyl-chain remodeling,BP,
10269,GO:0036156,1,0.967087733484188,0,2,inner dynein arm,CC,
10270,GO:0036157,1,0.924556545560501,0,5,outer dynein arm,CC,
10271,GO:0036158,1,0.850583489044898,0,12,outer dynein arm assembly,BP,
10272,GO:0036159,1,0.881551022030877,0,9,inner dynein arm assembly,BP,
10273,GO:0036164,1,0.991797619199864,0,1,cell-abiotic substrate adhesion,BP,
10275,GO:0036179,1,0.984261330799067,0,1,osteoclast maturation,BP,
10276,GO:0036194,1,0.978455018864713,0,2,muscle cell projection,CC,
10277,GO:0036195,1,0.978455018864713,0,2,muscle cell projection membrane,CC,
10279,GO:0036215,1,0.951519080646728,0,3,response to stem cell factor,BP,
10280,GO:0036216,1,0.951519080646728,0,3,cellular response to stem cell factor stimulus,BP,
10281,GO:0036219,1,0.994515375845619,0,1,GTP diphosphatase activity,MF,
10282,GO:0036220,1,0.99178755111599,0,1,ITP diphosphatase activity,MF,
10283,GO:0036222,1,0.99178755111599,0,1,XTP diphosphatase activity,MF,
10284,GO:0036228,1,0.968974546397991,0,2,protein targeting to nuclear inner membrane,BP,
10286,GO:0036233,1,0.970448567363846,0,2,glycine import,BP,
10287,GO:0036245,1,0.972981306859485,0,2,cellular response to menadione,BP,
10288,GO:0036250,1,0.987039832328744,0,1,peroxisome transport along microtubule,BP,
10290,GO:0036258,1,0.660545115326948,0,30,multivesicular body assembly,BP,
10291,GO:0036260,1,0.657162137535536,0,34,RNA capping,BP,
10292,GO:0036261,1,0.983419575562369,0,1,7-methylguanosine cap hypermethylation,BP,
10293,GO:0036265,1,0.958120290977929,0,4,RNA (guanine-N7)-methylation,BP,
10294,GO:0036266,1,0.984751175989133,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10295,GO:0036269,1,0.972455473278518,0,2,swimming behavior,BP,
10296,GO:0036284,1,0.98925923922269,0,1,tubulobulbar complex,CC,
10297,GO:0036289,1,0.909801610082381,0,6,peptidyl-serine autophosphorylation,BP,
10298,GO:0036290,1,0.983406759352069,0,1,protein trans-autophosphorylation,BP,
10299,GO:0036292,1,0.973414648348264,0,2,DNA rewinding,BP,
10302,GO:0036295,1,0.896583497334988,0,7,cellular response to increased oxygen levels,BP,
10304,GO:0036297,1,0.528036454982433,0,43,interstrand cross-link repair,BP,
10305,GO:0036301,1,0.939035847801469,0,4,macrophage colony-stimulating factor production,BP,
10306,GO:0036302,1,0.891552910886099,0,7,atrioventricular canal development,BP,
10307,GO:0036303,1,0.75397000097332,0,18,lymph vessel morphogenesis,BP,
10309,GO:0036305,1,0.983406759351724,0,1,ameloblast differentiation,BP,
10310,GO:0036306,1,0.988710989379348,0,1,embryonic heart tube elongation,BP,
10311,GO:0036309,1,0.967087733483511,0,2,protein localization to M-band,BP,
10312,GO:0036310,1,0.881227428003961,0,8,annealing helicase activity,MF,
10314,GO:0036313,1,0.969002304577972,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10315,GO:0036314,1,0.688196965813608,0,24,response to sterol,BP,
10316,GO:0036315,1,0.770723927342904,0,16,cellular response to sterol,BP,
10317,GO:0036317,1,0.984725543253726,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10318,GO:0036323,1,0.983406759351968,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10319,GO:0036324,1,0.975096927647755,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10320,GO:0036326,1,0.983406759351968,0,1,VEGF-A-activated receptor activity,MF,
10321,GO:0036327,1,0.983406759351968,0,1,VEGF-B-activated receptor activity,MF,
10322,GO:0036332,1,0.983406759351968,0,1,placental growth factor-activated receptor activity,MF,
10323,GO:0036333,1,0.984536964273923,0,1,hepatocyte homeostasis,BP,
10324,GO:0036335,1,0.98340675935187,0,1,intestinal stem cell homeostasis,BP,
10326,GO:0036337,1,0.93829332857101,0,4,Fas signaling pathway,BP,
10327,GO:0036338,1,0.954870180769942,0,3,viral membrane,CC,
10329,GO:0036343,1,0.983407051059899,0,1,psychomotor behavior,BP,
10331,GO:0036345,1,0.972310069448569,0,2,platelet maturation,BP,
10332,GO:0036351,1,0.985473983702695,0,1,histone H2A-K13 ubiquitination,BP,
10333,GO:0036352,1,0.985473983702695,0,1,histone H2A-K15 ubiquitination,BP,
10334,GO:0036353,1,0.967127786004014,0,2,histone H2A-K119 monoubiquitination,BP,
10335,GO:0036361,1,0.984950340754611,0,1,racemase activity, acting on amino acids and derivatives,MF,
10336,GO:0036363,1,0.968424655255177,0,2,transforming growth factor beta activation,BP,
10337,GO:0036367,1,0.968775743558609,0,2,light adaption,BP,
10338,GO:0036369,1,0.967087733486609,0,2,transcription factor catabolic process,BP,
10339,GO:0036371,1,0.983406759351134,0,1,protein localization to T-tubule,BP,
10340,GO:0036372,1,0.992644241741727,0,1,opsin transport,BP,
10341,GO:0036374,1,0.927550808547416,0,6,glutathione hydrolase activity,MF,
10342,GO:0036376,1,0.903997295897338,0,8,sodium ion export from cell,BP,
10343,GO:0036378,1,0.958343038543843,0,3,calcitriol biosynthetic process from calciol,BP,
10345,GO:0036387,1,0.971985278910257,0,2,pre-replicative complex,CC,
10346,GO:0036388,1,0.971985278910257,0,2,pre-replicative complex assembly,BP,
10347,GO:0036392,1,0.983417626569944,0,1,chemokine (C-C motif) ligand 20 production,BP,
10348,GO:0036393,1,0.984003532653388,0,1,thiocyanate peroxidase activity,MF,
10349,GO:0036396,1,0.945707477683692,0,4,MIS complex,CC,
10350,GO:0036398,1,0.968894140405754,0,2,TCR signalosome,CC,
10351,GO:0036399,1,0.98357355435276,0,1,TCR signalosome assembly,BP,
10352,GO:0036402,1,0.937272552641522,0,6,proteasome-activating ATPase activity,MF,
10353,GO:0036403,1,0.984552943897809,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10354,GO:0036404,1,0.983406759350592,0,1,conversion of ds siRNA to ss siRNA,BP,
10355,GO:0036413,1,0.969258841520549,0,2,histone H3-R26 citrullination,BP,
10356,GO:0036414,1,0.923820443599718,0,5,histone citrullination,BP,
10357,GO:0036435,1,0.958107608109912,0,3,K48-linked polyubiquitin binding,MF,
10358,GO:0036438,1,0.940282915009377,0,4,maintenance of lens transparency,BP,
10359,GO:0036440,1,0.9838765730806,0,1,citrate synthase activity,MF,
10360,GO:0036442,1,0.761459489626033,0,22,hydrogen-exporting ATPase activity,MF,
10361,GO:0036444,1,0.938288476231819,0,4,mitochondrial calcium uptake,BP,
10362,GO:0036445,1,0.808922024811878,0,13,neuronal stem cell division,BP,
10363,GO:0036446,1,0.951062885363978,0,3,myofibroblast differentiation,BP,
10364,GO:0036449,1,0.935684446666405,0,4,microtubule minus-end,CC,
10365,GO:0036452,1,0.690535588372766,0,27,ESCRT complex,CC,
10366,GO:0036454,1,0.932346238971181,0,5,growth factor complex,CC,
10367,GO:0036455,1,0.991633715656112,0,1,iron-sulfur transferase activity,MF,
10368,GO:0036457,1,0.960330989657555,0,3,keratohyalin granule,CC,
10369,GO:0036458,1,0.985917419369727,0,1,hepatocyte growth factor binding,MF,
10370,GO:0036459,1,0.184575895476854,0,109,thiol-dependent ubiquitinyl hydrolase activity,MF,
10372,GO:0036462,1,0.909488242984345,0,7,TRAIL-activated apoptotic signaling pathway,BP,
10373,GO:0036464,1,0.0785340417911596,0,174,cytoplasmic ribonucleoprotein granule,CC,
10375,GO:0036466,1,0.967087733488009,0,2,synaptic vesicle recycling via endosome,BP,
10376,GO:0036468,1,0.986625645402232,0,1,L-dopa decarboxylase activity,MF,
10377,GO:0036470,1,0.992937098316418,0,1,tyrosine 3-monooxygenase activator activity,MF,
10378,GO:0036471,1,0.992937098316418,0,1,cellular response to glyoxal,BP,
10380,GO:0036474,1,0.72194222064403,0,23,cell death in response to hydrogen peroxide,BP,
10381,GO:0036475,1,0.775153141411909,0,17,neuron death in response to oxidative stress,BP,
10382,GO:0036476,1,0.961293189993128,0,3,neuron death in response to hydrogen peroxide,BP,
10384,GO:0036478,1,0.992937098316418,0,1,L-dopa decarboxylase activator activity,MF,
10385,GO:0036479,1,0.983406759350836,0,1,peroxidase inhibitor activity,MF,
10386,GO:0036480,1,0.899370101615621,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10387,GO:0036481,1,0.925374832452041,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10388,GO:0036482,1,0.977514847404296,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10389,GO:0036483,1,0.983406759352018,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10390,GO:0036484,1,0.952563281659545,0,3,trunk neural crest cell migration,BP,
10391,GO:0036486,1,0.952563281659545,0,3,ventral trunk neural crest cell migration,BP,
10392,GO:0036487,1,0.983406759350938,0,1,nitric-oxide synthase inhibitor activity,MF,
10393,GO:0036488,1,0.98068987047618,0,2,CHOP-C/EBP complex,CC,
10395,GO:0036491,1,0.896416172714136,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10396,GO:0036492,1,0.896416172714136,0,7,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10397,GO:0036493,1,0.956681656902564,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10398,GO:0036494,1,0.983406759351773,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10399,GO:0036496,1,0.974855196567646,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10400,GO:0036497,1,0.985259668579407,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10401,GO:0036498,1,0.392660082716897,0,64,IRE1-mediated unfolded protein response,BP,
10402,GO:0036499,1,0.7617794822564,0,20,PERK-mediated unfolded protein response,BP,
10403,GO:0036500,1,0.864149099366167,0,10,ATF6-mediated unfolded protein response,BP,
10404,GO:0036501,1,0.983406759352021,0,1,UFD1-NPL4 complex,CC,
10405,GO:0036502,1,0.983696910616957,0,1,Derlin-1-VIMP complex,CC,
10406,GO:0036503,1,0.280617722938316,0,87,ERAD pathway,BP,
10407,GO:0036505,1,0.969182214747517,0,2,prosaposin receptor activity,MF,
10408,GO:0036506,1,0.955138230998599,0,3,maintenance of unfolded protein,BP,
10409,GO:0036507,1,0.7005464783957,0,24,protein demannosylation,BP,
10410,GO:0036508,1,0.7005464783957,0,24,protein alpha-1,2-demannosylation,BP,
10411,GO:0036509,1,0.971580179819429,0,2,trimming of terminal mannose on B branch,BP,
10412,GO:0036510,1,0.955456606213284,0,3,trimming of terminal mannose on C branch,BP,
10413,GO:0036511,1,0.971580179819429,0,2,trimming of first mannose on A branch,BP,
10414,GO:0036512,1,0.971580179819429,0,2,trimming of second mannose on A branch,BP,
10415,GO:0036513,1,0.849079991837331,0,11,Derlin-1 retrotranslocation complex,CC,
10420,GO:0036520,1,0.985592982661204,0,1,astrocyte-dopaminergic neuron signaling,BP,
10421,GO:0036524,1,0.992937098316418,0,1,protein deglycase activity,MF,
10422,GO:0036525,1,0.992937098316418,0,1,protein deglycation,BP,
10423,GO:0036526,1,0.992937098316418,0,1,peptidyl-cysteine deglycation,BP,
10424,GO:0036527,1,0.992937098316418,0,1,peptidyl-arginine deglycation,BP,
10425,GO:0036528,1,0.992937098316418,0,1,peptidyl-lysine deglycation,BP,
10426,GO:0036529,1,0.992937098316418,0,1,protein deglycation, glyoxal removal,BP,
10427,GO:0036530,1,0.992937098316418,0,1,protein deglycation, methylglyoxal removal,BP,
10428,GO:0036531,1,0.992937098316418,0,1,glutathione deglycation,BP,
10430,GO:0038002,1,0.983406759351821,0,1,endocrine signaling,BP,
10431,GO:0038003,1,0.876818633513641,0,10,opioid receptor signaling pathway,BP,
10432,GO:0038007,1,0.935279846213694,0,4,netrin-activated signaling pathway,BP,
10433,GO:0038009,1,0.99005688908311,0,1,regulation of signal transduction by receptor internalization,BP,
10434,GO:0038016,1,0.96917936991459,0,2,insulin receptor internalization,BP,
10435,GO:0038018,1,0.967087733487576,0,2,Wnt receptor catabolic process,BP,
10436,GO:0038021,1,0.98340675935207,0,1,leptin receptor activity,MF,
10438,GO:0038024,1,0.3896449058845,0,61,cargo receptor activity,MF,
10439,GO:0038025,1,0.96711500910027,0,2,reelin receptor activity,MF,
10440,GO:0038026,1,0.935280729250707,0,4,reelin-mediated signaling pathway,BP,
10441,GO:0038027,1,0.923168908138256,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10445,GO:0038033,1,0.92913130487193,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10447,GO:0038036,1,0.89023907664744,0,8,sphingosine-1-phosphate receptor activity,MF,
10448,GO:0038037,1,0.951038409343922,0,3,G-protein coupled receptor dimeric complex,CC,
10449,GO:0038038,1,0.983406759351429,0,1,G-protein coupled receptor homodimeric complex,CC,
10450,GO:0038039,1,0.967087733487816,0,2,G-protein coupled receptor heterodimeric complex,CC,
10451,GO:0038042,1,0.983406759351429,0,1,dimeric G-protein coupled receptor signaling pathway,BP,
10452,GO:0038043,1,0.970247021654019,0,2,interleukin-5-mediated signaling pathway,BP,
10453,GO:0038044,1,0.92199428926525,0,5,transforming growth factor-beta secretion,BP,
10454,GO:0038046,1,0.987794931320213,0,1,enkephalin receptor activity,MF,
10455,GO:0038047,1,0.987336285518239,0,1,morphine receptor activity,MF,
10456,GO:0038048,1,0.983406759351921,0,1,dynorphin receptor activity,MF,
10457,GO:0038049,1,0.967087733485932,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10458,GO:0038051,1,0.983406759351528,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10459,GO:0038052,1,0.968670087730675,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10469,GO:0038085,1,0.942054192609691,0,4,vascular endothelial growth factor binding,MF,
10470,GO:0038086,1,0.951086892414487,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10471,GO:0038089,1,0.913709349259926,0,6,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10472,GO:0038091,1,0.951086892414487,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10473,GO:0038092,1,0.827163245966042,0,14,nodal signaling pathway,BP,
10478,GO:0038097,1,0.983406759351821,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10479,GO:0038098,1,0.970185485193459,0,2,sequestering of BMP from receptor via BMP binding,BP,
10480,GO:0038100,1,0.975934793131153,0,2,nodal binding,MF,
10481,GO:0038101,1,0.988015391037315,0,1,sequestering of nodal from receptor via nodal binding,BP,
10482,GO:0038106,1,0.983741971792908,0,1,choriogonadotropin hormone binding,MF,
10483,GO:0038107,1,0.914706751739544,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10484,GO:0038108,1,0.938588563702986,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10485,GO:0038109,1,0.951519080646728,0,3,Kit signaling pathway,BP,
10486,GO:0038110,1,0.929683559519251,0,5,interleukin-2-mediated signaling pathway,BP,
10487,GO:0038111,1,0.976827335329865,0,2,interleukin-7-mediated signaling pathway,BP,
10488,GO:0038112,1,0.969429615636244,0,2,interleukin-8-mediated signaling pathway,BP,
10489,GO:0038113,1,0.986053003073054,0,1,interleukin-9-mediated signaling pathway,BP,
10490,GO:0038114,1,0.983583400093628,0,1,interleukin-21-mediated signaling pathway,BP,
10491,GO:0038115,1,0.986013886613784,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10492,GO:0038116,1,0.986013886613784,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10493,GO:0038117,1,0.986013886613784,0,1,C-C motif chemokine 19 receptor activity,MF,
10494,GO:0038118,1,0.992122035120751,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10495,GO:0038121,1,0.986013886613784,0,1,C-C motif chemokine 21 receptor activity,MF,
10496,GO:0038123,1,0.956981769872882,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10497,GO:0038124,1,0.943318381877445,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10500,GO:0038129,1,0.957469233860879,0,3,ERBB3 signaling pathway,BP,
10501,GO:0038131,1,0.987104710231928,0,1,neuregulin receptor activity,MF,
10503,GO:0038133,1,0.986537274964175,0,1,ERBB2-ERBB3 signaling pathway,BP,
10504,GO:0038145,1,0.931200248308663,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10505,GO:0038154,1,0.983638474406083,0,1,interleukin-11-mediated signaling pathway,BP,
10506,GO:0038155,1,0.971124208501899,0,2,interleukin-23-mediated signaling pathway,BP,
10507,GO:0038156,1,0.971686770884834,0,2,interleukin-3-mediated signaling pathway,BP,
10508,GO:0038158,1,0.972081605320398,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10509,GO:0038161,1,0.925404426599761,0,5,prolactin signaling pathway,BP,
10510,GO:0038162,1,0.971018649981583,0,2,erythropoietin-mediated signaling pathway,BP,
10511,GO:0038163,1,0.964089615431536,0,3,thrombopoietin-mediated signaling pathway,BP,
10512,GO:0038164,1,0.98342637353775,0,1,thrombopoietin receptor activity,MF,
10513,GO:0038165,1,0.939255926315464,0,4,oncostatin-M-mediated signaling pathway,BP,
10515,GO:0038167,1,0.983406759351821,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10516,GO:0038168,1,0.983406759351821,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10517,GO:0038169,1,0.933390366489372,0,5,somatostatin receptor signaling pathway,BP,
10518,GO:0038170,1,0.933390366489372,0,5,somatostatin signaling pathway,BP,
10519,GO:0038171,1,0.910176666927572,0,6,cannabinoid signaling pathway,BP,
10520,GO:0038172,1,0.969227163590814,0,2,interleukin-33-mediated signaling pathway,BP,
10521,GO:0038178,1,0.970346539678431,0,2,complement component C5a signaling pathway,BP,
10523,GO:0038180,1,0.883792944039735,0,8,nerve growth factor signaling pathway,BP,
10525,GO:0038182,1,0.98932328287838,0,1,G-protein coupled bile acid receptor activity,MF,
10527,GO:0038184,1,0.98932328287838,0,1,cell surface bile acid receptor signaling pathway,BP,
10528,GO:0038185,1,0.98609242153372,0,1,intracellular bile acid receptor signaling pathway,BP,
10530,GO:0038187,1,0.799529095416042,0,17,pattern recognition receptor activity,MF,
10531,GO:0038188,1,0.974636035586167,0,2,cholecystokinin signaling pathway,BP,
10532,GO:0038189,1,0.968640778170181,0,2,neuropilin signaling pathway,BP,
10533,GO:0038190,1,0.968640778170181,0,2,VEGF-activated neuropilin signaling pathway,BP,
10534,GO:0038191,1,0.983406759351775,0,1,neuropilin binding,MF,
10535,GO:0038192,1,0.986571612550772,0,1,gastric inhibitory peptide signaling pathway,BP,
10536,GO:0038193,1,0.985637625278431,0,1,thromboxane A2 signaling pathway,BP,
10537,GO:0038194,1,0.974391565265069,0,2,thyroid-stimulating hormone signaling pathway,BP,
10538,GO:0038195,1,0.989636151042471,0,1,urokinase plasminogen activator signaling pathway,BP,
10542,GO:0039003,1,0.967088800164192,0,2,pronephric field specification,BP,
10543,GO:0039007,1,0.983406759351773,0,1,pronephric nephron morphogenesis,BP,
10544,GO:0039008,1,0.983406759351773,0,1,pronephric nephron tubule morphogenesis,BP,
10545,GO:0039017,1,0.967088800164192,0,2,pattern specification involved in pronephros development,BP,
10546,GO:0039019,1,0.951801177360092,0,3,pronephric nephron development,BP,
10547,GO:0039020,1,0.967842511100186,0,2,pronephric nephron tubule development,BP,
10548,GO:0039022,1,0.983406759351773,0,1,pronephric duct development,BP,
10549,GO:0039023,1,0.983406759351773,0,1,pronephric duct morphogenesis,BP,
10550,GO:0039506,1,0.967918135718358,0,2,modulation by virus of host molecular function,BP,
10551,GO:0039507,1,0.967918135718358,0,2,suppression by virus of host molecular function,BP,
10552,GO:0039513,1,0.984251115939407,0,1,suppression by virus of host catalytic activity,BP,
10553,GO:0039516,1,0.984251115939407,0,1,modulation by virus of host catalytic activity,BP,
10554,GO:0039519,1,0.967087733487774,0,2,modulation by virus of host autophagy,BP,
10555,GO:0039520,1,0.983406759351773,0,1,induction by virus of host autophagy,BP,
10556,GO:0039521,1,0.983406759351921,0,1,suppression by virus of host autophagy,BP,
10557,GO:0039526,1,0.961570583294691,0,3,modulation by virus of host apoptotic process,BP,
10558,GO:0039528,1,0.712322179352862,0,22,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10559,GO:0039529,1,0.765402459385883,0,17,RIG-I signaling pathway,BP,
10560,GO:0039530,1,0.880626218275376,0,9,MDA-5 signaling pathway,BP,
10561,GO:0039531,1,0.780700890020917,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10562,GO:0039532,1,0.885580358240337,0,8,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10563,GO:0039533,1,0.917831667546376,0,6,regulation of MDA-5 signaling pathway,BP,
10564,GO:0039534,1,0.959856067917026,0,3,negative regulation of MDA-5 signaling pathway,BP,
10565,GO:0039535,1,0.80483726586343,0,14,regulation of RIG-I signaling pathway,BP,
10566,GO:0039536,1,0.912944705714769,0,6,negative regulation of RIG-I signaling pathway,BP,
10567,GO:0039552,1,0.983406759351774,0,1,RIG-I binding,MF,
10568,GO:0039650,1,0.984251115939407,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10569,GO:0039656,1,0.956154990350449,0,3,modulation by virus of host gene expression,BP,
10571,GO:0039689,1,0.95389661177189,0,3,negative stranded viral RNA replication,BP,
10572,GO:0039692,1,0.864505955769436,0,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10573,GO:0039694,1,0.715607972269657,0,22,viral RNA genome replication,BP,
10574,GO:0039702,1,0.753778540048301,0,21,viral budding via host ESCRT complex,BP,
10575,GO:0039703,1,0.715607972269657,0,22,RNA replication,BP,
10577,GO:0039713,1,0.98348594567814,0,1,viral factory,CC,
10578,GO:0039714,1,0.98348594567814,0,1,cytoplasmic viral factory,CC,
10582,GO:0040009,1,0.969206506593794,0,2,regulation of growth rate,BP,
10587,GO:0040015,1,0.8589542764947,0,10,negative regulation of multicellular organism growth,BP,
10588,GO:0040016,1,0.89119288699255,0,8,embryonic cleavage,BP,
10593,GO:0040023,1,0.80928602958205,0,13,establishment of nucleus localization,BP,
10595,GO:0040030,1,0.978971062348903,0,2,regulation of molecular function, epigenetic,BP,
10596,GO:0040031,1,0.949784896295363,0,5,snRNA modification,BP,
10597,GO:0040032,1,0.987205458806561,0,1,post-embryonic body morphogenesis,BP,
10598,GO:0040033,1,0.823978812355685,0,13,negative regulation of translation, ncRNA-mediated,BP,
10602,GO:0040038,1,0.951218431387587,0,3,polar body extrusion after meiotic divisions,BP,
10603,GO:0040040,1,0.983406759351625,0,1,thermosensory behavior,BP,
10604,GO:0042000,1,0.98514627588204,0,1,translocation of peptides or proteins into host,BP,
10605,GO:0042007,1,0.989756029307442,0,1,interleukin-18 binding,MF,
10606,GO:0042008,1,0.983455810184603,0,1,interleukin-18 receptor activity,MF,
10607,GO:0042011,1,0.983723637727737,0,1,interleukin-16 binding,MF,
10608,GO:0042012,1,0.983723637727737,0,1,interleukin-16 receptor activity,MF,
10609,GO:0042015,1,0.954821168677776,0,3,interleukin-20 binding,MF,
10610,GO:0042017,1,0.984172312870225,0,1,interleukin-22 binding,MF,
10611,GO:0042018,1,0.984172312870225,0,1,interleukin-22 receptor activity,MF,
10612,GO:0042019,1,0.971124208501899,0,2,interleukin-23 binding,MF,
10613,GO:0042020,1,0.971124208501899,0,2,interleukin-23 receptor activity,MF,
10614,GO:0042022,1,0.986774955811059,0,1,interleukin-12 receptor complex,CC,
10615,GO:0042023,1,0.889671371410773,0,7,DNA endoreduplication,BP,
10616,GO:0042025,1,0.952342694391161,0,3,host cell nucleus,CC,
10617,GO:0042026,1,0.707166249555204,0,24,protein refolding,BP,
10618,GO:0042030,1,0.951155573785309,0,4,ATPase inhibitor activity,MF,
10622,GO:0042040,1,0.98340675935207,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10623,GO:0042043,1,0.824344308963003,0,12,neurexin family protein binding,MF,
10626,GO:0042048,1,0.875639537304977,0,8,olfactory behavior,BP,
10627,GO:0042053,1,0.783086907737951,0,17,regulation of dopamine metabolic process,BP,
10628,GO:0042054,1,0.490994331571983,0,47,histone methyltransferase activity,MF,
10634,GO:0042069,1,0.783086907737951,0,17,regulation of catecholamine metabolic process,BP,
10635,GO:0042073,1,0.522469289237323,0,45,intraciliary transport,BP,
10637,GO:0042078,1,0.953837882181439,0,4,germ-line stem cell division,BP,
10638,GO:0042083,1,0.988791781330131,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10639,GO:0042084,1,0.983406759350544,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10642,GO:0042090,1,0.892919065131306,0,8,interleukin-12 biosynthetic process,BP,
10643,GO:0042091,1,0.954854611411843,0,3,interleukin-10 biosynthetic process,BP,
10644,GO:0042092,1,0.631615324500832,0,34,type 2 immune response,BP,
10646,GO:0042094,1,0.747811965818106,0,21,interleukin-2 biosynthetic process,BP,
10651,GO:0042101,1,0.775730771712384,0,19,T cell receptor complex,CC,
10652,GO:0042102,1,0.285399267748705,0,95,positive regulation of T cell proliferation,BP,
10653,GO:0042104,1,0.709940716997838,0,27,positive regulation of activated T cell proliferation,BP,
10654,GO:0042105,1,0.949368149768062,0,5,alpha-beta T cell receptor complex,CC,
10657,GO:0042109,1,0.962365759181802,0,3,lymphotoxin A biosynthetic process,BP,
10661,GO:0042117,1,0.908708477285406,0,8,monocyte activation,BP,
10662,GO:0042118,1,0.863269813166084,0,10,endothelial cell activation,BP,
10664,GO:0042126,1,0.941073019278021,0,4,nitrate metabolic process,BP,
10666,GO:0042128,1,0.985412426360754,0,1,nitrate assimilation,BP,
10669,GO:0042131,1,0.984814421877401,0,1,thiamine phosphate phosphatase activity,MF,
10670,GO:0042132,1,0.979613973101819,0,2,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10671,GO:0042133,1,0.644575822410766,0,29,neurotransmitter metabolic process,BP,
10672,GO:0042134,1,0.979024887378093,0,2,rRNA primary transcript binding,MF,
10673,GO:0042135,1,0.845001433318856,0,11,neurotransmitter catabolic process,BP,
10674,GO:0042136,1,0.76522988194072,0,17,neurotransmitter biosynthetic process,BP,
10675,GO:0042137,1,0.971229684954588,0,2,sequestering of neurotransmitter,BP,
10676,GO:0042138,1,0.938583650226103,0,5,meiotic DNA double-strand break formation,BP,
10677,GO:0042140,1,0.984725543253726,0,1,late meiotic recombination nodule assembly,BP,
10678,GO:0042144,1,0.968476246048884,0,2,vacuole fusion, non-autophagic,BP,
10680,GO:0042148,1,0.891024683769317,0,8,strand invasion,BP,
10684,GO:0042159,1,0.879982313139427,0,9,lipoprotein catabolic process,BP,
10685,GO:0042160,1,0.947527737194978,0,5,lipoprotein modification,BP,
10686,GO:0042161,1,0.947527737194978,0,5,lipoprotein oxidation,BP,
10687,GO:0042162,1,0.607747872747457,0,32,telomeric DNA binding,MF,
10688,GO:0042163,1,0.98964212161881,0,1,interleukin-12 beta subunit binding,MF,
10689,GO:0042164,1,0.985358549378959,0,1,interleukin-12 alpha subunit binding,MF,
10690,GO:0042165,1,0.718712420501527,0,22,neurotransmitter binding,MF,
10691,GO:0042166,1,0.776309381708772,0,17,acetylcholine binding,MF,
10692,GO:0042167,1,0.925101853984493,0,7,heme catabolic process,BP,
10693,GO:0042168,1,0.691497178727143,0,29,heme metabolic process,BP,
10694,GO:0042169,1,0.625038610205681,0,30,SH2 domain binding,MF,
10698,GO:0042177,1,0.255437348723091,0,99,negative regulation of protein catabolic process,BP,
10699,GO:0042178,1,0.885846514310477,0,10,xenobiotic catabolic process,BP,
10702,GO:0042182,1,0.909888802982358,0,7,ketone catabolic process,BP,
10703,GO:0042196,1,0.975967535062617,0,2,chlorinated hydrocarbon metabolic process,BP,
10704,GO:0042197,1,0.975967535062617,0,2,halogenated hydrocarbon metabolic process,BP,
10705,GO:0042214,1,0.971414776880539,0,2,terpene metabolic process,BP,
10706,GO:0042219,1,0.750605514231173,0,21,cellular modified amino acid catabolic process,BP,
10707,GO:0042220,1,0.499757442706271,0,50,response to cocaine,BP,
10710,GO:0042223,1,0.974908321653815,0,2,interleukin-3 biosynthetic process,BP,
10711,GO:0042225,1,0.995418209170563,0,1,interleukin-5 biosynthetic process,BP,
10712,GO:0042226,1,0.791092963912546,0,18,interleukin-6 biosynthetic process,BP,
10713,GO:0042228,1,0.850142703218758,0,13,interleukin-8 biosynthetic process,BP,
10714,GO:0042231,1,0.975031705056775,0,2,interleukin-13 biosynthetic process,BP,
10715,GO:0042241,1,0.983604239074011,0,1,interleukin-18 biosynthetic process,BP,
10716,GO:0042245,1,0.968317174959338,0,2,RNA repair,BP,
10718,GO:0042247,1,0.9839360319995,0,1,establishment of planar polarity of follicular epithelium,BP,
10720,GO:0042253,1,0.945526073004571,0,5,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10721,GO:0042254,1,0.032564389082645,0,292,ribosome biogenesis,BP,
10722,GO:0042255,1,0.608473184492469,0,48,ribosome assembly,BP,
10723,GO:0042256,1,0.940188084735067,0,5,mature ribosome assembly,BP,
10724,GO:0042262,1,0.951470858432166,0,5,DNA protection,BP,
10725,GO:0042264,1,0.967110195450969,0,2,peptidyl-aspartic acid hydroxylation,BP,
10726,GO:0042265,1,0.983406759351429,0,1,peptidyl-asparagine hydroxylation,BP,
10728,GO:0042268,1,0.899520992507213,0,9,regulation of cytolysis,BP,
10729,GO:0042269,1,0.648270290863233,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10730,GO:0042270,1,0.960275363700833,0,3,protection from natural killer cell mediated cytotoxicity,BP,
10731,GO:0042271,1,0.959454835505427,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10732,GO:0042272,1,0.939101138141258,0,4,nuclear RNA export factor complex,CC,
10733,GO:0042273,1,0.518158870974267,0,58,ribosomal large subunit biogenesis,BP,
10734,GO:0042274,1,0.48392331662466,0,61,ribosomal small subunit biogenesis,BP,
10735,GO:0042275,1,0.989155113046344,0,1,error-free postreplication DNA repair,BP,
10736,GO:0042276,1,0.767748594402167,0,20,error-prone translesion synthesis,BP,
10739,GO:0042281,1,0.971803177957729,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10740,GO:0042282,1,0.983406759352021,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10741,GO:0042284,1,0.977374086502577,0,2,sphingolipid delta-4 desaturase activity,MF,
10742,GO:0042285,1,0.912107415574628,0,6,xylosyltransferase activity,MF,
10743,GO:0042287,1,0.660430979494444,0,29,MHC protein binding,MF,
10744,GO:0042288,1,0.764804549714051,0,19,MHC class I protein binding,MF,
10745,GO:0042289,1,0.93486064671449,0,5,MHC class II protein binding,MF,
10746,GO:0042292,1,0.985027751671993,0,1,URM1 activating enzyme activity,MF,
10747,GO:0042296,1,0.952531598678141,0,4,ISG15 transferase activity,MF,
10749,GO:0042301,1,0.847503357014869,0,11,phosphate ion binding,MF,
10751,GO:0042304,1,0.604118158444833,0,37,regulation of fatty acid biosynthetic process,BP,
10755,GO:0042309,1,0.9762892249854,0,2,homoiothermy,BP,
10759,GO:0042316,1,0.983406759351921,0,1,penicillin metabolic process,BP,
10760,GO:0042320,1,0.952650953946453,0,6,regulation of circadian sleep/wake cycle, REM sleep,BP,
10762,GO:0042322,1,0.985207248916109,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10764,GO:0042324,1,0.995545341753087,0,1,hypocretin receptor binding,MF,
10768,GO:0042328,1,0.967209167598394,0,2,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10770,GO:0042335,1,0.953395262254477,0,3,cuticle development,BP,
10772,GO:0042340,1,0.830883610065753,0,12,keratan sulfate catabolic process,BP,
10774,GO:0042346,1,0.719206161072117,0,24,positive regulation of NF-kappaB import into nucleus,BP,
10777,GO:0042350,1,0.96225764296983,0,3,GDP-L-fucose biosynthetic process,BP,
10778,GO:0042351,1,0.978495273288669,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10779,GO:0042352,1,0.983406995012697,0,1,GDP-L-fucose salvage,BP,
10780,GO:0042354,1,0.865450419354663,0,9,L-fucose metabolic process,BP,
10781,GO:0042355,1,0.865450419354663,0,9,L-fucose catabolic process,BP,
10782,GO:0042356,1,0.990090677622663,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10783,GO:0042357,1,0.973184526843208,0,2,thiamine diphosphate metabolic process,BP,
10785,GO:0042360,1,0.947189898208958,0,4,vitamin E metabolic process,BP,
10786,GO:0042361,1,0.969181598429904,0,2,menaquinone catabolic process,BP,
10788,GO:0042363,1,0.880480977923992,0,9,fat-soluble vitamin catabolic process,BP,
10789,GO:0042364,1,0.872622737382808,0,9,water-soluble vitamin biosynthetic process,BP,
10790,GO:0042365,1,0.98009178129896,0,2,water-soluble vitamin catabolic process,BP,
10792,GO:0042369,1,0.95315629795291,0,3,vitamin D catabolic process,BP,
10793,GO:0042371,1,0.98342653957286,0,1,vitamin K biosynthetic process,BP,
10794,GO:0042373,1,0.929712178228808,0,6,vitamin K metabolic process,BP,
10795,GO:0042374,1,0.961172477954136,0,3,phylloquinone metabolic process,BP,
10796,GO:0042376,1,0.961172477954136,0,3,phylloquinone catabolic process,BP,
10797,GO:0042377,1,0.969181598429904,0,2,vitamin K catabolic process,BP,
10799,GO:0042382,1,0.910121024615525,0,6,paraspeckles,CC,
10802,GO:0042392,1,0.974839414647233,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10803,GO:0042393,1,0.0873199050671773,0,180,histone binding,MF,
10804,GO:0042396,1,0.988938071724141,0,1,phosphagen biosynthetic process,BP,
10805,GO:0042398,1,0.577035193714589,0,39,cellular modified amino acid biosynthetic process,BP,
10806,GO:0042401,1,0.771308685219191,0,21,cellular biogenic amine biosynthetic process,BP,
10807,GO:0042402,1,0.732916506667671,0,24,cellular biogenic amine catabolic process,BP,
10808,GO:0042403,1,0.742652766829027,0,20,thyroid hormone metabolic process,BP,
10809,GO:0042404,1,0.986298138481011,0,1,thyroid hormone catabolic process,BP,
10810,GO:0042405,1,0.836760730740357,0,11,nuclear inclusion body,CC,
10811,GO:0042406,1,0.93329670409973,0,5,extrinsic component of endoplasmic reticulum membrane,CC,
10812,GO:0042407,1,0.858460433310498,0,12,cristae formation,BP,
10813,GO:0042412,1,0.973186586464852,0,2,taurine biosynthetic process,BP,
10814,GO:0042413,1,0.984909539662242,0,1,carnitine catabolic process,BP,
10816,GO:0042415,1,0.858531139786479,0,10,norepinephrine metabolic process,BP,
10817,GO:0042416,1,0.840629135081304,0,12,dopamine biosynthetic process,BP,
10820,GO:0042420,1,0.898969563979629,0,7,dopamine catabolic process,BP,
10821,GO:0042421,1,0.911793746467534,0,6,norepinephrine biosynthetic process,BP,
10823,GO:0042424,1,0.884384687367106,0,8,catecholamine catabolic process,BP,
10824,GO:0042426,1,0.906321938976883,0,6,choline catabolic process,BP,
10825,GO:0042427,1,0.960027400808747,0,3,serotonin biosynthetic process,BP,
10826,GO:0042428,1,0.848212434249147,0,11,serotonin metabolic process,BP,
10827,GO:0042430,1,0.70271023256369,0,26,indole-containing compound metabolic process,BP,
10828,GO:0042431,1,0.985688193475059,0,1,indole metabolic process,BP,
10829,GO:0042435,1,0.94064300998448,0,5,indole-containing compound biosynthetic process,BP,
10830,GO:0042436,1,0.868271959574948,0,11,indole-containing compound catabolic process,BP,
10832,GO:0042439,1,0.953173014436874,0,3,ethanolamine-containing compound metabolic process,BP,
10834,GO:0042441,1,0.942944951255989,0,4,eye pigment metabolic process,BP,
10837,GO:0042447,1,0.867882266544015,0,10,hormone catabolic process,BP,
10838,GO:0042448,1,0.811727719278828,0,16,progesterone metabolic process,BP,
10839,GO:0042450,1,0.986746146968489,0,1,arginine biosynthetic process via ornithine,BP,
10840,GO:0042451,1,0.78555059696642,0,21,purine nucleoside biosynthetic process,BP,
10841,GO:0042454,1,0.815752926241236,0,17,ribonucleoside catabolic process,BP,
10842,GO:0042455,1,0.622182139623566,0,39,ribonucleoside biosynthetic process,BP,
10848,GO:0042473,1,0.878043017677129,0,9,outer ear morphogenesis,BP,
10854,GO:0042483,1,0.938886375191958,0,4,negative regulation of odontogenesis,BP,
10856,GO:0042488,1,0.961462705511231,0,3,positive regulation of odontogenesis of dentin-containing tooth,BP,
10857,GO:0042489,1,0.969295168245274,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10862,GO:0042494,1,0.935994301560101,0,4,detection of bacterial lipoprotein,BP,
10863,GO:0042495,1,0.967852767683927,0,2,detection of triacyl bacterial lipopeptide,BP,
10864,GO:0042496,1,0.967184509016619,0,2,detection of diacyl bacterial lipopeptide,BP,
10865,GO:0042497,1,0.983505161131814,0,1,triacyl lipopeptide binding,MF,
10866,GO:0042500,1,0.926968530009751,0,5,aspartic endopeptidase activity, intramembrane cleaving,MF,
10868,GO:0042502,1,0.984725543253726,0,1,tyrosine phosphorylation of Stat2 protein,BP,
10870,GO:0042504,1,0.936677601003265,0,5,tyrosine phosphorylation of Stat4 protein,BP,
10871,GO:0042505,1,0.962915823293559,0,3,tyrosine phosphorylation of Stat6 protein,BP,
10872,GO:0042506,1,0.758568273004318,0,22,tyrosine phosphorylation of Stat5 protein,BP,
10877,GO:0042512,1,0.963933855822897,0,3,negative regulation of tyrosine phosphorylation of Stat1 protein,BP,
10880,GO:0042518,1,0.900888950129399,0,7,negative regulation of tyrosine phosphorylation of Stat3 protein,BP,
10881,GO:0042519,1,0.936677601003265,0,5,regulation of tyrosine phosphorylation of Stat4 protein,BP,
10882,GO:0042520,1,0.95219483420356,0,4,positive regulation of tyrosine phosphorylation of Stat4 protein,BP,
10883,GO:0042521,1,0.983707004650127,0,1,negative regulation of tyrosine phosphorylation of Stat4 protein,BP,
10884,GO:0042522,1,0.789498498785849,0,19,regulation of tyrosine phosphorylation of Stat5 protein,BP,
10885,GO:0042523,1,0.825318375484587,0,16,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,
10886,GO:0042524,1,0.956632538438556,0,3,negative regulation of tyrosine phosphorylation of Stat5 protein,BP,
10887,GO:0042525,1,0.962915823293559,0,3,regulation of tyrosine phosphorylation of Stat6 protein,BP,
10888,GO:0042526,1,0.974468417428061,0,2,positive regulation of tyrosine phosphorylation of Stat6 protein,BP,
10889,GO:0042527,1,0.988145988406047,0,1,negative regulation of tyrosine phosphorylation of Stat6 protein,BP,
10891,GO:0042532,1,0.862066408066169,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10892,GO:0042533,1,0.773159287119846,0,19,tumor necrosis factor biosynthetic process,BP,
10893,GO:0042534,1,0.773159287119846,0,19,regulation of tumor necrosis factor biosynthetic process,BP,
10894,GO:0042535,1,0.85428858182299,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10895,GO:0042536,1,0.932665590756535,0,6,negative regulation of tumor necrosis factor biosynthetic process,BP,
10896,GO:0042537,1,0.780162425155307,0,19,benzene-containing compound metabolic process,BP,
10898,GO:0042539,1,0.967350642020703,0,2,hypotonic salinity response,BP,
10899,GO:0042541,1,0.885273814895896,0,9,hemoglobin biosynthetic process,BP,
10901,GO:0042543,1,0.995755386099721,0,1,protein N-linked glycosylation via arginine,BP,
10902,GO:0042546,1,0.987784806077991,0,1,cell wall biogenesis,BP,
10906,GO:0042555,1,0.838604363443476,0,11,MCM complex,CC,
10907,GO:0042558,1,0.65085082834362,0,31,pteridine-containing compound metabolic process,BP,
10908,GO:0042559,1,0.821578168032263,0,15,pteridine-containing compound biosynthetic process,BP,
10909,GO:0042560,1,0.960878797059327,0,3,pteridine-containing compound catabolic process,BP,
10911,GO:0042564,1,0.983406759352021,0,1,NLS-dependent protein nuclear import complex,CC,
10912,GO:0042565,1,0.975525524056801,0,2,RNA nuclear export complex,CC,
10913,GO:0042567,1,0.939191251191888,0,4,insulin-like growth factor ternary complex,CC,
10914,GO:0042568,1,0.992713701462584,0,1,insulin-like growth factor binary complex,CC,
10915,GO:0042571,1,0.978436224841126,0,2,immunoglobulin complex, circulating,CC,
10916,GO:0042572,1,0.680818272886011,0,28,retinol metabolic process,BP,
10917,GO:0042573,1,0.74188333832662,0,22,retinoic acid metabolic process,BP,
10918,GO:0042574,1,0.848486896853567,0,11,retinal metabolic process,BP,
10919,GO:0042575,1,0.785962427946984,0,17,DNA polymerase complex,CC,
10920,GO:0042577,1,0.969714109974115,0,2,lipid phosphatase activity,MF,
10926,GO:0042584,1,0.910629810569529,0,6,chromaffin granule membrane,CC,
10927,GO:0042585,1,0.969401715985012,0,2,germinal vesicle,CC,
10928,GO:0042586,1,0.991424705107005,0,1,peptide deformylase activity,MF,
10931,GO:0042589,1,0.857981154199495,0,11,zymogen granule membrane,CC,
10936,GO:0042595,1,0.976593678791657,0,2,behavioral response to starvation,BP,
10937,GO:0042596,1,0.628808914390081,0,32,fear response,BP,
10938,GO:0042599,1,0.794723353494198,0,17,lamellar body,CC,
10939,GO:0042602,1,0.993481401363712,0,1,riboflavin reductase (NADPH) activity,MF,
10940,GO:0042605,1,0.754599606338319,0,23,peptide antigen binding,MF,
10941,GO:0042608,1,0.912505547064883,0,7,T cell receptor binding,MF,
10942,GO:0042609,1,0.907707600000792,0,7,CD4 receptor binding,MF,
10943,GO:0042610,1,0.97279853654582,0,2,CD8 receptor binding,MF,
10944,GO:0042611,1,0.785925240971386,0,24,MHC protein complex,CC,
10945,GO:0042612,1,0.920859210581239,0,8,MHC class I protein complex,CC,
10946,GO:0042613,1,0.853515991870837,0,16,MHC class II protein complex,CC,
10947,GO:0042622,1,0.799492949094063,0,16,photoreceptor outer segment membrane,CC,
10949,GO:0042624,1,0.994698943007998,0,1,ATPase activity, uncoupled,MF,
10950,GO:0042625,1,0.356575618266674,0,75,ATPase coupled ion transmembrane transporter activity,MF,
10951,GO:0042626,1,0.203892932766919,0,109,ATPase activity, coupled to transmembrane movement of substances,MF,
10952,GO:0042627,1,0.879667884334769,0,13,chylomicron,CC,
10953,GO:0042628,1,0.985666447909236,0,1,mating plug formation,BP,
10955,GO:0042631,1,0.951071986845443,0,3,cellular response to water deprivation,BP,
10956,GO:0042632,1,0.39847589131752,0,68,cholesterol homeostasis,BP,
10960,GO:0042636,1,0.929509472730416,0,5,negative regulation of hair cycle,BP,
10961,GO:0042637,1,0.947748176609434,0,4,catagen,BP,
10963,GO:0042641,1,0.389726099982256,0,61,actomyosin,CC,
10964,GO:0042643,1,0.967621241825997,0,2,actomyosin, actin portion,CC,
10965,GO:0042645,1,0.578341415456773,0,38,mitochondrial nucleoid,CC,
10966,GO:0042658,1,0.990407332080951,0,1,MHC class II protein binding, via antigen binding groove,MF,
10968,GO:0042660,1,0.967622305116622,0,2,positive regulation of cell fate specification,BP,
10969,GO:0042661,1,0.905963343995468,0,7,regulation of mesodermal cell fate specification,BP,
10970,GO:0042662,1,0.952063843760795,0,4,negative regulation of mesodermal cell fate specification,BP,
10971,GO:0042663,1,0.948845287472046,0,4,regulation of endodermal cell fate specification,BP,
10972,GO:0042664,1,0.991411501090547,0,1,negative regulation of endodermal cell fate specification,BP,
10975,GO:0042667,1,0.992054094792906,0,1,auditory receptor cell fate specification,BP,
10976,GO:0042668,1,0.972339314483209,0,3,auditory receptor cell fate determination,BP,
10977,GO:0042670,1,0.870576206343233,0,9,retinal cone cell differentiation,BP,
10978,GO:0042684,1,0.983950314107376,0,1,cardioblast cell fate commitment,BP,
10979,GO:0042685,1,0.983950314107376,0,1,cardioblast cell fate specification,BP,
10980,GO:0042686,1,0.983950314107376,0,1,regulation of cardioblast cell fate specification,BP,
10983,GO:0042694,1,0.993674415140632,0,1,muscle cell fate specification,BP,
10986,GO:0042699,1,0.930177907294314,0,5,follicle-stimulating hormone signaling pathway,BP,
10987,GO:0042700,1,0.967417405995865,0,2,luteinizing hormone signaling pathway,BP,
10988,GO:0042701,1,0.953125705090147,0,4,progesterone secretion,BP,
10989,GO:0042703,1,0.983979644948429,0,1,menstruation,BP,
10990,GO:0042704,1,0.96732590710231,0,2,uterine wall breakdown,BP,
10991,GO:0042709,1,0.985338549851725,0,1,succinate-CoA ligase complex,CC,
10992,GO:0042710,1,0.970235141285895,0,2,biofilm formation,BP,
10993,GO:0042711,1,0.834213130883097,0,13,maternal behavior,BP,
10994,GO:0042713,1,0.916248847627716,0,6,sperm ejaculation,BP,
10995,GO:0042719,1,0.951997476391904,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10996,GO:0042720,1,0.983131220149715,0,2,mitochondrial inner membrane peptidase complex,CC,
10997,GO:0042721,1,0.988326446618948,0,1,mitochondrial inner membrane protein insertion complex,CC,
10998,GO:0042723,1,0.902000208866824,0,7,thiamine-containing compound metabolic process,BP,
11000,GO:0042727,1,0.971410305787271,0,2,flavin-containing compound biosynthetic process,BP,
11001,GO:0042728,1,0.983407843952928,0,1,flavin-containing compound catabolic process,BP,
11003,GO:0042731,1,0.943493235157209,0,4,PH domain binding,MF,
11004,GO:0042732,1,0.969273669720494,0,3,D-xylose metabolic process,BP,
11007,GO:0042737,1,0.822297915027514,0,14,drug catabolic process,BP,
11008,GO:0042738,1,0.85351203390421,0,11,exogenous drug catabolic process,BP,
11010,GO:0042743,1,0.595782444938366,0,42,hydrogen peroxide metabolic process,BP,
11011,GO:0042744,1,0.770968333106428,0,22,hydrogen peroxide catabolic process,BP,
11013,GO:0042746,1,0.946945986877327,0,6,circadian sleep/wake cycle, wakefulness,BP,
11014,GO:0042747,1,0.918909264187794,0,9,circadian sleep/wake cycle, REM sleep,BP,
11018,GO:0042753,1,0.802517660024716,0,18,positive regulation of circadian rhythm,BP,
11020,GO:0042755,1,0.670015504506189,0,32,eating behavior,BP,
11021,GO:0042756,1,0.882999278877786,0,10,drinking behavior,BP,
11022,GO:0042758,1,0.898332094243529,0,7,long-chain fatty acid catabolic process,BP,
11023,GO:0042759,1,0.856174762498287,0,10,long-chain fatty acid biosynthetic process,BP,
11024,GO:0042760,1,0.9241464374136,0,5,very long-chain fatty acid catabolic process,BP,
11025,GO:0042761,1,0.88017492383845,0,9,very long-chain fatty acid biosynthetic process,BP,
11026,GO:0042762,1,0.737932593801723,0,19,regulation of sulfur metabolic process,BP,
11027,GO:0042765,1,0.929153192970106,0,5,GPI-anchor transamidase complex,CC,
11028,GO:0042766,1,0.983406759351084,0,1,nucleosome mobilization,BP,
11029,GO:0042769,1,0.628591173991229,0,36,DNA damage response, detection of DNA damage,BP,
11033,GO:0042773,1,0.480487225535595,0,83,ATP synthesis coupled electron transport,BP,
11034,GO:0042774,1,0.984725543253726,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
11035,GO:0042775,1,0.487962715567391,0,82,mitochondrial ATP synthesis coupled electron transport,BP,
11036,GO:0042776,1,0.857546103719629,0,19,mitochondrial ATP synthesis coupled proton transport,BP,
11037,GO:0042779,1,0.96942274822836,0,2,tRNA 3'-trailer cleavage,BP,
11038,GO:0042780,1,0.929110558258189,0,5,tRNA 3'-end processing,BP,
11039,GO:0042781,1,0.96942274822836,0,2,3'-tRNA processing endoribonuclease activity,MF,
11041,GO:0042788,1,0.903507517147499,0,7,polysomal ribosome,CC,
11042,GO:0042789,1,0.772290145934898,0,18,mRNA transcription from RNA polymerase II promoter,BP,
11043,GO:0042790,1,0.827402688583143,0,13,transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
11044,GO:0042791,1,0.915175980621265,0,6,5S class rRNA transcription from RNA polymerase III type 1 promoter,BP,
11045,GO:0042795,1,0.406455399052754,0,65,snRNA transcription from RNA polymerase II promoter,BP,
11046,GO:0042796,1,0.941274960704735,0,4,snRNA transcription from RNA polymerase III promoter,BP,
11047,GO:0042797,1,0.915175980621265,0,6,tRNA transcription from RNA polymerase III promoter,BP,
11048,GO:0042799,1,0.983406759350094,0,1,histone methyltransferase activity (H4-K20 specific),MF,
11049,GO:0042800,1,0.831462781672848,0,13,histone methyltransferase activity (H3-K4 specific),MF,
11050,GO:0042801,1,0.983406759351672,0,1,polo kinase kinase activity,MF,
11053,GO:0042805,1,0.529629279427531,0,40,actinin binding,MF,
11054,GO:0042806,1,0.946242375865556,0,4,fucose binding,MF,
11055,GO:0042809,1,0.796854676223712,0,15,vitamin D receptor binding,MF,
11057,GO:0042816,1,0.925510848822628,0,5,vitamin B6 metabolic process,BP,
11058,GO:0042819,1,0.953813176675169,0,3,vitamin B6 biosynthetic process,BP,
11059,GO:0042820,1,0.986706463820984,0,1,vitamin B6 catabolic process,BP,
11060,GO:0042822,1,0.954296864894942,0,3,pyridoxal phosphate metabolic process,BP,
11061,GO:0042823,1,0.967155550317044,0,2,pyridoxal phosphate biosynthetic process,BP,
11062,GO:0042824,1,0.939302693092378,0,4,MHC class I peptide loading complex,CC,
11063,GO:0042825,1,0.951580537770938,0,3,TAP complex,CC,
11064,GO:0042826,1,0.21191697749329,0,102,histone deacetylase binding,MF,
11065,GO:0042827,1,0.774536823308766,0,20,platelet dense granule,CC,
11067,GO:0042834,1,0.880842614589155,0,10,peptidoglycan binding,MF,
11068,GO:0042835,1,0.967087733488108,0,2,BRE binding,MF,
11069,GO:0042839,1,0.989425806755353,0,1,D-glucuronate metabolic process,BP,
11070,GO:0042840,1,0.989425806755353,0,1,D-glucuronate catabolic process,BP,
11071,GO:0042843,1,0.991905278206824,0,1,D-xylose catabolic process,BP,
11072,GO:0042851,1,0.946127170059946,0,4,L-alanine metabolic process,BP,
11073,GO:0042853,1,0.946127170059946,0,4,L-alanine catabolic process,BP,
11074,GO:0042866,1,0.932714773815458,0,5,pyruvate biosynthetic process,BP,
11075,GO:0042883,1,0.983416086204809,0,1,cysteine transport,BP,
11077,GO:0042887,1,0.648944534821826,0,33,amide transmembrane transporter activity,MF,
11078,GO:0042891,1,0.987343484720486,0,1,antibiotic transport,BP,
11079,GO:0042895,1,0.987343484720486,0,1,antibiotic transporter activity,MF,
11080,GO:0042903,1,0.970575073725998,0,2,tubulin deacetylase activity,MF,
11081,GO:0042904,1,0.941972140538712,0,4,9-cis-retinoic acid biosynthetic process,BP,
11082,GO:0042905,1,0.941972140538712,0,4,9-cis-retinoic acid metabolic process,BP,
11083,GO:0042908,1,0.846055612610643,0,10,xenobiotic transport,BP,
11084,GO:0042910,1,0.860340263709759,0,9,xenobiotic transporter activity,MF,
11085,GO:0042918,1,0.983406759351527,0,1,alkanesulfonate transport,BP,
11086,GO:0042921,1,0.790753647420765,0,15,glucocorticoid receptor signaling pathway,BP,
11087,GO:0042922,1,0.993782107614422,0,1,neuromedin U receptor binding,MF,
11088,GO:0042923,1,0.763568652977937,0,21,neuropeptide binding,MF,
11089,GO:0042924,1,0.986443828165976,0,1,neuromedin U binding,MF,
11090,GO:0042927,1,0.984725543253726,0,1,siderophore transporter activity,MF,
11091,GO:0042930,1,0.984725543253726,0,1,enterobactin transport,BP,
11092,GO:0042931,1,0.984725543253726,0,1,enterobactin transporter activity,MF,
11093,GO:0042936,1,0.983688021750732,0,1,dipeptide transporter activity,MF,
11094,GO:0042937,1,0.983406759351574,0,1,tripeptide transporter activity,MF,
11095,GO:0042938,1,0.957127910627771,0,3,dipeptide transport,BP,
11096,GO:0042939,1,0.970324264525182,0,2,tripeptide transport,BP,
11097,GO:0042940,1,0.908896135042184,0,6,D-amino acid transport,BP,
11098,GO:0042941,1,0.986929948559013,0,1,D-alanine transport,BP,
11099,GO:0042942,1,0.971796815420812,0,2,D-serine transport,BP,
11100,GO:0042946,1,0.984725543253726,0,1,glucoside transport,BP,
11101,GO:0042947,1,0.984725543253726,0,1,glucoside transmembrane transporter activity,MF,
11103,GO:0042954,1,0.951038409339019,0,3,lipoprotein transporter activity,MF,
11104,GO:0042959,1,0.983406759351527,0,1,alkanesulfonate transporter activity,MF,
11106,GO:0042975,1,0.859860633356174,0,10,peroxisome proliferator activated receptor binding,MF,
11107,GO:0042976,1,0.840497724537627,0,13,activation of Janus kinase activity,BP,
11108,GO:0042977,1,0.868853353825109,0,11,activation of JAK2 kinase activity,BP,
11109,GO:0042978,1,0.967087733486368,0,2,ornithine decarboxylase activator activity,MF,
11110,GO:0042979,1,0.940226289730015,0,5,ornithine decarboxylase regulator activity,MF,
11112,GO:0042982,1,0.63480498527768,0,31,amyloid precursor protein metabolic process,BP,
11113,GO:0042983,1,0.902290278275455,0,7,amyloid precursor protein biosynthetic process,BP,
11114,GO:0042984,1,0.902290278275455,0,7,regulation of amyloid precursor protein biosynthetic process,BP,
11115,GO:0042985,1,0.94207525104699,0,4,negative regulation of amyloid precursor protein biosynthetic process,BP,
11116,GO:0042986,1,0.970651912557235,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
11117,GO:0042987,1,0.734235067376307,0,21,amyloid precursor protein catabolic process,BP,
11118,GO:0042988,1,0.983406759351872,0,1,X11-like protein binding,MF,
11119,GO:0042989,1,0.920967122490868,0,7,sequestering of actin monomers,BP,
11124,GO:0042994,1,0.737706865446472,0,22,cytoplasmic sequestering of transcription factor,BP,
11126,GO:0042996,1,0.908402694631221,0,6,regulation of Golgi to plasma membrane protein transport,BP,
11127,GO:0042997,1,0.93932531225877,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
11128,GO:0042998,1,0.967088360124549,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
11129,GO:0042999,1,0.983406759352018,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
11130,GO:0043000,1,0.973176067413626,0,2,Golgi to plasma membrane CFTR protein transport,BP,
11131,GO:0043001,1,0.640224707408647,0,30,Golgi to plasma membrane protein transport,BP,
11132,GO:0043002,1,0.983406759352018,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
11133,GO:0043004,1,0.983406759352018,0,1,cytoplasmic sequestering of CFTR protein,BP,
11135,GO:0043006,1,0.971370300901588,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
11136,GO:0043008,1,0.882975309162966,0,8,ATP-dependent protein binding,MF,
11139,GO:0043011,1,0.787664453035233,0,19,myeloid dendritic cell differentiation,BP,
11140,GO:0043012,1,0.984636161757203,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11141,GO:0043014,1,0.717054029165422,0,22,alpha-tubulin binding,MF,
11143,GO:0043016,1,0.984347074825103,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11144,GO:0043017,1,0.984347074825103,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11145,GO:0043020,1,0.88381988236774,0,10,NADPH oxidase complex,CC,
11146,GO:0043021,1,0.250299525954265,0,99,ribonucleoprotein complex binding,MF,
11147,GO:0043022,1,0.521191530679124,0,45,ribosome binding,MF,
11148,GO:0043023,1,0.919695890014005,0,7,ribosomal large subunit binding,MF,
11149,GO:0043024,1,0.83125897229792,0,13,ribosomal small subunit binding,MF,
11155,GO:0043031,1,0.919447646064439,0,7,negative regulation of macrophage activation,BP,
11157,GO:0043033,1,0.98340675935133,0,1,isoamylase complex,CC,
11159,GO:0043035,1,0.983411005526953,0,1,chromatin insulator sequence binding,MF,
11160,GO:0043038,1,0.481144567115108,0,51,amino acid activation,BP,
11161,GO:0043039,1,0.489269065677993,0,50,tRNA aminoacylation,BP,
11162,GO:0043041,1,0.983443323720461,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11164,GO:0043044,1,0.446582659516522,0,69,ATP-dependent chromatin remodeling,BP,
11165,GO:0043045,1,0.904048503087442,0,7,DNA methylation involved in embryo development,BP,
11166,GO:0043046,1,0.737537514404785,0,20,DNA methylation involved in gamete generation,BP,
11167,GO:0043047,1,0.869484433521959,0,9,single-stranded telomeric DNA binding,MF,
11168,GO:0043048,1,0.985898353279622,0,1,dolichyl monophosphate biosynthetic process,BP,
11169,GO:0043049,1,0.983766730501423,0,1,otic placode formation,BP,
11170,GO:0043060,1,0.984982832020166,0,1,meiotic metaphase I plate congression,BP,
11172,GO:0043063,1,0.983406759351921,0,1,intercellular bridge organization,BP,
11178,GO:0043073,1,0.799657764213708,0,17,germ cell nucleus,CC,
11180,GO:0043084,1,0.887048385633864,0,9,penile erection,BP,
11184,GO:0043090,1,0.762773274545797,0,17,amino acid import,BP,
11185,GO:0043091,1,0.94233297211285,0,4,L-arginine import,BP,
11186,GO:0043092,1,0.786955480851778,0,15,L-amino acid import,BP,
11187,GO:0043094,1,0.647340831340698,0,33,cellular metabolic compound salvage,BP,
11188,GO:0043095,1,0.994530032375714,0,1,regulation of GTP cyclohydrolase I activity,BP,
11189,GO:0043096,1,0.984158419585502,0,2,purine nucleobase salvage,BP,
11190,GO:0043097,1,0.868404468816989,0,11,pyrimidine nucleoside salvage,BP,
11191,GO:0043101,1,0.821947687945068,0,15,purine-containing compound salvage,BP,
11192,GO:0043102,1,0.908251817578316,0,7,amino acid salvage,BP,
11193,GO:0043103,1,0.98976807092467,0,1,hypoxanthine salvage,BP,
11194,GO:0043105,1,0.994530032375714,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11195,GO:0043111,1,0.990596360661074,0,1,replication fork arrest,BP,
11199,GO:0043116,1,0.862743667269685,0,10,negative regulation of vascular permeability,BP,
11200,GO:0043117,1,0.882201989812031,0,9,positive regulation of vascular permeability,BP,
11201,GO:0043120,1,0.954637557763455,0,3,tumor necrosis factor binding,MF,
11202,GO:0043121,1,0.847939016492251,0,10,neurotrophin binding,MF,
11207,GO:0043126,1,0.989276674890875,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11208,GO:0043128,1,0.989276674890875,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11209,GO:0043129,1,0.907437508572601,0,7,surfactant homeostasis,BP,
11211,GO:0043132,1,0.96957489550954,0,2,NAD transport,BP,
11212,GO:0043133,1,0.988655045431925,0,2,hindgut contraction,BP,
11213,GO:0043134,1,0.988655045431925,0,2,regulation of hindgut contraction,BP,
11214,GO:0043136,1,0.983697909677509,0,1,glycerol-3-phosphatase activity,MF,
11215,GO:0043137,1,0.958236965605265,0,3,DNA replication, removal of RNA primer,BP,
11216,GO:0043138,1,0.828525452045215,0,12,3'-5' DNA helicase activity,MF,
11217,GO:0043139,1,0.902237339623942,0,7,5'-3' DNA helicase activity,MF,
11218,GO:0043140,1,0.904491239631241,0,6,ATP-dependent 3'-5' DNA helicase activity,MF,
11219,GO:0043141,1,0.930462071616745,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11220,GO:0043142,1,0.837789073403954,0,12,single-stranded DNA-dependent ATPase activity,MF,
11221,GO:0043143,1,0.985331908137301,0,1,regulation of translation by machinery localization,BP,
11222,GO:0043144,1,0.911566048455649,0,9,snoRNA processing,BP,
11224,GO:0043152,1,0.943093419001587,0,4,induction of bacterial agglutination,BP,
11225,GO:0043153,1,0.754378636171482,0,19,entrainment of circadian clock by photoperiod,BP,
11227,GO:0043159,1,0.960679636267278,0,3,acrosomal matrix,CC,
11228,GO:0043160,1,0.984725543253726,0,1,acrosomal lumen,CC,
11230,GO:0043162,1,0.778281754286166,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11231,GO:0043163,1,0.952787104756525,0,3,cell envelope organization,BP,
11236,GO:0043171,1,0.652327052749048,0,29,peptide catabolic process,BP,
11237,GO:0043173,1,0.844538985938057,0,13,nucleotide salvage,BP,
11238,GO:0043174,1,0.818315190446871,0,16,nucleoside salvage,BP,
11239,GO:0043175,1,0.642361492674192,0,30,RNA polymerase core enzyme binding,MF,
11240,GO:0043176,1,0.854322667351548,0,11,amine binding,MF,
11242,GO:0043178,1,0.382517416867143,0,73,alcohol binding,MF,
11244,GO:0043181,1,0.98343501804159,0,1,vacuolar sequestering,BP,
11245,GO:0043183,1,0.975257959884331,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11247,GO:0043185,1,0.986368444803784,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11248,GO:0043186,1,0.78333335805435,0,16,P granule,CC,
11249,GO:0043189,1,0.779573928097888,0,18,H4/H2A histone acetyltransferase complex,CC,
11250,GO:0043190,1,0.877600468149158,0,8,ATP-binding cassette (ABC) transporter complex,CC,
11253,GO:0043196,1,0.910717905175432,0,8,varicosity,CC,
11256,GO:0043199,1,0.943133517378695,0,4,sulfate binding,MF,
11263,GO:0043208,1,0.892099029680552,0,8,glycosphingolipid binding,MF,
11265,GO:0043210,1,0.987594608375605,0,1,alkanesulfonate binding,MF,
11266,GO:0043215,1,0.983406761279341,0,1,daunorubicin transport,BP,
11269,GO:0043219,1,0.944850462452157,0,4,lateral loop,CC,
11271,GO:0043221,1,0.983407968599808,0,1,SMC family protein binding,MF,
11272,GO:0043225,1,0.804922421514484,0,13,ATPase-coupled anion transmembrane transporter activity,MF,
11284,GO:0043237,1,0.921188449042912,0,6,laminin-1 binding,MF,
11285,GO:0043240,1,0.881575368576057,0,8,Fanconi anaemia nuclear complex,CC,
11290,GO:0043247,1,0.826420260742042,0,12,telomere maintenance in response to DNA damage,BP,
11291,GO:0043248,1,0.864351446657808,0,13,proteasome assembly,BP,
11292,GO:0043249,1,0.861238691331792,0,11,erythrocyte maturation,BP,
11293,GO:0043250,1,0.98925923922269,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11294,GO:0043251,1,0.98925923922269,0,1,sodium-dependent organic anion transport,BP,
11295,GO:0043252,1,0.691453509567656,0,25,sodium-independent organic anion transport,BP,
11299,GO:0043257,1,0.983406759351673,0,1,laminin-8 complex,CC,
11302,GO:0043262,1,0.956866980599241,0,3,adenosine-diphosphatase activity,MF,
11303,GO:0043265,1,0.983689981131194,0,1,ectoplasm,CC,
11310,GO:0043273,1,0.983406759351821,0,1,CTPase activity,MF,
11311,GO:0043274,1,0.800479752385889,0,15,phospholipase binding,MF,
11314,GO:0043278,1,0.6533954396035,0,31,response to morphine,BP,
11318,GO:0043291,1,0.967087733485015,0,2,RAVE complex,CC,
11320,GO:0043293,1,0.971443328680957,0,2,apoptosome,CC,
11325,GO:0043300,1,0.579181315835897,0,39,regulation of leukocyte degranulation,BP,
11326,GO:0043301,1,0.852319694226026,0,11,negative regulation of leukocyte degranulation,BP,
11327,GO:0043302,1,0.791345841538743,0,18,positive regulation of leukocyte degranulation,BP,
11329,GO:0043304,1,0.676123358936704,0,29,regulation of mast cell degranulation,BP,
11330,GO:0043305,1,0.909911068535359,0,7,negative regulation of mast cell degranulation,BP,
11331,GO:0043306,1,0.853058800065221,0,13,positive regulation of mast cell degranulation,BP,
11332,GO:0043307,1,0.914011877320767,0,7,eosinophil activation,BP,
11333,GO:0043308,1,0.925846113005238,0,6,eosinophil degranulation,BP,
11334,GO:0043309,1,0.959400417022039,0,3,regulation of eosinophil degranulation,BP,
11335,GO:0043310,1,0.984892242795262,0,1,negative regulation of eosinophil degranulation,BP,
11336,GO:0043311,1,0.974118755418242,0,2,positive regulation of eosinophil degranulation,BP,
11338,GO:0043313,1,0.922177467368616,0,5,regulation of neutrophil degranulation,BP,
11339,GO:0043314,1,0.967087733487333,0,2,negative regulation of neutrophil degranulation,BP,
11340,GO:0043315,1,0.983406759352069,0,1,positive regulation of neutrophil degranulation,BP,
11342,GO:0043317,1,0.983473070617362,0,1,regulation of cytotoxic T cell degranulation,BP,
11343,GO:0043318,1,0.983473070617362,0,1,negative regulation of cytotoxic T cell degranulation,BP,
11345,GO:0043321,1,0.968427342460352,0,2,regulation of natural killer cell degranulation,BP,
11346,GO:0043323,1,0.968427342460352,0,2,positive regulation of natural killer cell degranulation,BP,
11347,GO:0043324,1,0.942944951255989,0,4,pigment metabolic process involved in developmental pigmentation,BP,
11349,GO:0043328,1,0.959257469122791,0,4,protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11352,GO:0043335,1,0.973468212391735,0,2,protein unfolding,BP,
11353,GO:0043337,1,0.983410518075759,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11354,GO:0043353,1,0.905393226476002,0,7,enucleate erythrocyte differentiation,BP,
11355,GO:0043366,1,0.970593027366375,0,2,beta selection,BP,
11359,GO:0043370,1,0.595775908071718,0,38,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11360,GO:0043371,1,0.813803376112158,0,15,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11361,GO:0043372,1,0.71058817172269,0,25,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11363,GO:0043374,1,0.850668554659578,0,11,CD8-positive, alpha-beta T cell differentiation,BP,
11364,GO:0043375,1,0.983408545672986,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11365,GO:0043376,1,0.967113994193948,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11366,GO:0043378,1,0.983407061187744,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11367,GO:0043379,1,0.874648957000696,0,9,memory T cell differentiation,BP,
11368,GO:0043380,1,0.889414330154518,0,8,regulation of memory T cell differentiation,BP,
11369,GO:0043381,1,0.984725543253726,0,1,negative regulation of memory T cell differentiation,BP,
11370,GO:0043382,1,0.91841879964745,0,6,positive regulation of memory T cell differentiation,BP,
11371,GO:0043383,1,0.828200044987306,0,13,negative T cell selection,BP,
11372,GO:0043385,1,0.985501663355894,0,1,mycotoxin metabolic process,BP,
11373,GO:0043388,1,0.502778037018257,0,49,positive regulation of DNA binding,BP,
11374,GO:0043390,1,0.985501663355894,0,1,aflatoxin B1 metabolic process,BP,
11377,GO:0043394,1,0.604043356601613,0,34,proteoglycan binding,MF,
11378,GO:0043395,1,0.768181244347392,0,18,heparan sulfate proteoglycan binding,MF,
11379,GO:0043396,1,0.95336757066444,0,3,corticotropin-releasing hormone secretion,BP,
11380,GO:0043397,1,0.95336757066444,0,3,regulation of corticotropin-releasing hormone secretion,BP,
11381,GO:0043398,1,0.958503609336038,0,3,HLH domain binding,MF,
11382,GO:0043400,1,0.947876677086885,0,5,cortisol secretion,BP,
11384,GO:0043402,1,0.952313961941878,0,3,glucocorticoid mediated signaling pathway,BP,
11395,GO:0043415,1,0.930046376125494,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11396,GO:0043416,1,0.919660785539111,0,6,regulation of skeletal muscle tissue regeneration,BP,
11397,GO:0043418,1,0.954020420278156,0,3,homocysteine catabolic process,BP,
11398,GO:0043420,1,0.989355420771269,0,1,anthranilate metabolic process,BP,
11399,GO:0043422,1,0.838336226883861,0,12,protein kinase B binding,MF,
11400,GO:0043423,1,0.983406759352021,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11401,GO:0043425,1,0.672792656574866,0,26,bHLH transcription factor binding,MF,
11402,GO:0043426,1,0.923774334014418,0,5,MRF binding,MF,
11405,GO:0043435,1,0.926614131754927,0,5,response to corticotropin-releasing hormone,BP,
11407,GO:0043438,1,0.98403473237974,0,1,acetoacetic acid metabolic process,BP,
11408,GO:0043449,1,0.968259191469624,0,2,cellular alkene metabolic process,BP,
11410,GO:0043456,1,0.957531351123574,0,4,regulation of pentose-phosphate shunt,BP,
11412,GO:0043461,1,0.947781384004057,0,4,proton-transporting ATP synthase complex assembly,BP,
11417,GO:0043471,1,0.870513144344119,0,11,regulation of cellular carbohydrate catabolic process,BP,
11419,GO:0043474,1,0.942944951255989,0,4,pigment metabolic process involved in pigmentation,BP,
11424,GO:0043486,1,0.620036398263372,0,48,histone exchange,BP,
11428,GO:0043490,1,0.967311421391518,0,2,malate-aspartate shuttle,BP,
11430,GO:0043492,1,0.159521394101923,0,124,ATPase activity, coupled to movement of substances,MF,
11431,GO:0043495,1,0.910224873698053,0,7,protein anchor,MF,
11432,GO:0043496,1,0.762838571270367,0,20,regulation of protein homodimerization activity,BP,
11433,GO:0043497,1,0.892628023128834,0,8,regulation of protein heterodimerization activity,BP,
11437,GO:0043503,1,0.977093992043484,0,2,skeletal muscle fiber adaptation,BP,
11438,GO:0043504,1,0.952313961980479,0,3,mitochondrial DNA repair,BP,
11441,GO:0043508,1,0.815170466466358,0,14,negative regulation of JUN kinase activity,BP,
11442,GO:0043509,1,0.986006099597604,0,1,activin A complex,CC,
11443,GO:0043511,1,0.97589895981516,0,2,inhibin complex,CC,
11444,GO:0043512,1,0.97589895981516,0,2,inhibin A complex,CC,
11445,GO:0043513,1,0.989750012150819,0,1,inhibin B complex,CC,
11446,GO:0043514,1,0.975151702846691,0,2,interleukin-12 complex,CC,
11447,GO:0043515,1,0.942712133724573,0,4,kinetochore binding,MF,
11450,GO:0043518,1,0.825230805791853,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11451,GO:0043519,1,0.986257186080042,0,1,regulation of myosin II filament organization,BP,
11452,GO:0043522,1,0.862624322899818,0,11,leucine zipper domain binding,MF,
11455,GO:0043525,1,0.509148429501116,0,48,positive regulation of neuron apoptotic process,BP,
11456,GO:0043527,1,0.936720276927792,0,5,tRNA methyltransferase complex,CC,
11459,GO:0043533,1,0.922436668069639,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11464,GO:0043538,1,0.983792679714628,0,1,regulation of actin phosphorylation,BP,
11465,GO:0043539,1,0.702751271742945,0,25,protein serine/threonine kinase activator activity,MF,
11466,GO:0043540,1,0.987948183556831,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11467,GO:0043541,1,0.951866490280468,0,3,UDP-N-acetylglucosamine transferase complex,CC,
11470,GO:0043544,1,0.983438992748238,0,1,lipoamide binding,MF,
11471,GO:0043545,1,0.903752332481818,0,7,molybdopterin cofactor metabolic process,BP,
11472,GO:0043546,1,0.908743149320624,0,6,molybdopterin cofactor binding,MF,
11479,GO:0043553,1,0.968744951509957,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11481,GO:0043558,1,0.779795602694169,0,17,regulation of translational initiation in response to stress,BP,
11484,GO:0043562,1,0.939247370480361,0,4,cellular response to nitrogen levels,BP,
11485,GO:0043564,1,0.963812753824532,0,3,Ku70:Ku80 complex,CC,
11488,GO:0043568,1,0.842991550626384,0,13,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11490,GO:0043570,1,0.935509992526644,0,4,maintenance of DNA repeat elements,BP,
11491,GO:0043574,1,0.758821903911893,0,18,peroxisomal transport,BP,
11493,GO:0043578,1,0.951047693666719,0,3,nuclear matrix organization,BP,
11497,GO:0043586,1,0.755905395420431,0,20,tongue development,BP,
11498,GO:0043587,1,0.874417141938072,0,9,tongue morphogenesis,BP,
11500,GO:0043589,1,0.863174297255501,0,9,skin morphogenesis,BP,
11501,GO:0043596,1,0.543708072662615,0,43,nuclear replication fork,CC,
11502,GO:0043601,1,0.6689229470119,0,29,nuclear replisome,CC,
11503,GO:0043602,1,0.984866510742938,0,1,nitrate catabolic process,BP,
11506,GO:0043605,1,0.964120971495379,0,3,cellular amide catabolic process,BP,
11507,GO:0043606,1,0.941806894315328,0,4,formamide metabolic process,BP,
11508,GO:0043610,1,0.98340675935099,0,1,regulation of carbohydrate utilization,BP,
11509,GO:0043614,1,0.967087733487964,0,2,multi-eIF complex,CC,
11510,GO:0043615,1,0.90381392994118,0,8,astrocyte cell migration,BP,
11516,GO:0043622,1,0.935779523698568,0,4,cortical microtubule organization,BP,
11519,GO:0043625,1,0.948954734989941,0,4,delta DNA polymerase complex,CC,
11520,GO:0043626,1,0.990254466318836,0,1,PCNA complex,CC,
11522,GO:0043628,1,0.77797010335372,0,20,ncRNA 3'-end processing,BP,
11523,GO:0043631,1,0.548038681073354,0,40,RNA polyadenylation,BP,
11525,GO:0043633,1,0.935292599779118,0,5,polyadenylation-dependent RNA catabolic process,BP,
11526,GO:0043634,1,0.951077310394097,0,4,polyadenylation-dependent ncRNA catabolic process,BP,
11527,GO:0043647,1,0.361376747356067,0,67,inositol phosphate metabolic process,BP,
11528,GO:0043648,1,0.254172340038375,0,96,dicarboxylic acid metabolic process,BP,
11529,GO:0043649,1,0.816032017394907,0,15,dicarboxylic acid catabolic process,BP,
11530,GO:0043650,1,0.81354007696933,0,14,dicarboxylic acid biosynthetic process,BP,
11531,GO:0043651,1,0.788175156917948,0,17,linoleic acid metabolic process,BP,
11532,GO:0043652,1,0.896920955519841,0,7,engulfment of apoptotic cell,BP,
11533,GO:0043653,1,0.908839297580561,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
11534,GO:0043654,1,0.913404719211389,0,7,recognition of apoptotic cell,BP,
11535,GO:0043656,1,0.89558981984603,0,7,intracellular region of host,CC,
11536,GO:0043657,1,0.809568939366363,0,14,host cell,CC,
11537,GO:0043666,1,0.574856847519263,0,37,regulation of phosphoprotein phosphatase activity,BP,
11539,GO:0043682,1,0.967087733486655,0,2,copper-transporting ATPase activity,MF,
11540,GO:0043686,1,0.960990188852263,0,3,co-translational protein modification,BP,
11542,GO:0043691,1,0.826977839307234,0,17,reverse cholesterol transport,BP,
11545,GO:0043733,1,0.991885055232925,0,1,DNA-3-methylbase glycosylase activity,MF,
11546,GO:0043734,1,0.950691205990241,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11547,GO:0043739,1,0.983597371504519,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11548,GO:0043754,1,0.983406759350494,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11549,GO:0043783,1,0.985345203965664,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11550,GO:0043795,1,0.989852633883451,0,1,glyceraldehyde oxidoreductase activity,MF,
11551,GO:0043812,1,0.951339525190702,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11552,GO:0043813,1,0.920013020603289,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11553,GO:0043843,1,0.984728227912546,0,1,ADP-specific glucokinase activity,MF,
11554,GO:0043849,1,0.983969494898759,0,1,Ras palmitoyltransferase activity,MF,
11555,GO:0043855,1,0.864720606358808,0,9,cyclic nucleotide-gated ion channel activity,MF,
11556,GO:0043865,1,0.984213042107821,0,1,methionine transmembrane transporter activity,MF,
11557,GO:0043874,1,0.986653925583247,0,1,acireductone synthase activity,MF,
11558,GO:0043890,1,0.98528903945698,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11559,GO:0043891,1,0.979791773872411,0,2,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11564,GO:0043914,1,0.983406986433628,0,1,NADPH:sulfur oxidoreductase activity,MF,
11565,GO:0043916,1,0.991885055232925,0,1,DNA-7-methylguanine glycosylase activity,MF,
11566,GO:0043921,1,0.699289992723307,0,25,modulation by host of viral transcription,BP,
11567,GO:0043922,1,0.849401978963556,0,12,negative regulation by host of viral transcription,BP,
11568,GO:0043923,1,0.794579231452573,0,15,positive regulation by host of viral transcription,BP,
11569,GO:0043924,1,0.98340675934926,0,1,suramin binding,MF,
11570,GO:0043928,1,0.66842906102368,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11572,GO:0043932,1,0.946890353833226,0,4,ossification involved in bone remodeling,BP,
11574,GO:0043946,1,0.987925031741053,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11575,GO:0043947,1,0.987925031741053,0,1,positive regulation by host of symbiont catalytic activity,BP,
11576,GO:0043949,1,0.748722247307443,0,21,regulation of cAMP-mediated signaling,BP,
11577,GO:0043950,1,0.898635826993189,0,9,positive regulation of cAMP-mediated signaling,BP,
11578,GO:0043951,1,0.917501530922237,0,6,negative regulation of cAMP-mediated signaling,BP,
11581,GO:0043967,1,0.42460866528494,0,58,histone H4 acetylation,BP,
11582,GO:0043968,1,0.813261950333067,0,15,histone H2A acetylation,BP,
11583,GO:0043969,1,0.98340675935099,0,1,histone H2B acetylation,BP,
11584,GO:0043970,1,0.845641216090548,0,11,histone H3-K9 acetylation,BP,
11585,GO:0043973,1,0.98587746825161,0,1,histone H3-K4 acetylation,BP,
11587,GO:0043981,1,0.834633501312954,0,12,histone H4-K5 acetylation,BP,
11588,GO:0043982,1,0.834633501312954,0,12,histone H4-K8 acetylation,BP,
11589,GO:0043983,1,0.945297519781068,0,4,histone H4-K12 acetylation,BP,
11590,GO:0043984,1,0.767129298507963,0,17,histone H4-K16 acetylation,BP,
11591,GO:0043985,1,0.915728011098662,0,6,histone H4-R3 methylation,BP,
11592,GO:0043987,1,0.943114153718208,0,4,histone H3-S10 phosphorylation,BP,
11593,GO:0043988,1,0.95886438846456,0,3,histone H3-S28 phosphorylation,BP,
11594,GO:0043990,1,0.983737595926098,0,1,histone H2A-S1 phosphorylation,BP,
11595,GO:0043995,1,0.868563432091037,0,9,histone acetyltransferase activity (H4-K5 specific),MF,
11596,GO:0043996,1,0.868563432091037,0,9,histone acetyltransferase activity (H4-K8 specific),MF,
11597,GO:0043997,1,0.983705984872474,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11598,GO:0043998,1,0.983537828248968,0,1,H2A histone acetyltransferase activity,MF,
11599,GO:0044003,1,0.526639401957617,0,43,modification by symbiont of host morphology or physiology,BP,
11600,GO:0044004,1,0.946398730395589,0,4,disruption by symbiont of host cell,BP,
11601,GO:0044007,1,0.983406759351574,0,1,dissemination or transmission of symbiont from host,BP,
11602,GO:0044010,1,0.970235141285895,0,2,single-species biofilm formation,BP,
11603,GO:0044020,1,0.945631222634916,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11604,GO:0044026,1,0.957256923085105,0,3,DNA hypermethylation,BP,
11605,GO:0044027,1,0.97340624569273,0,2,hypermethylation of CpG island,BP,
11609,GO:0044033,1,0.0935745986411306,0,209,multi-organism metabolic process,BP,
11610,GO:0044034,1,0.95389661177189,0,3,multi-organism biosynthetic process,BP,
11611,GO:0044035,1,0.98850199571852,0,1,multi-organism catabolic process,BP,
11612,GO:0044036,1,0.957455668876341,0,5,cell wall macromolecule metabolic process,BP,
11613,GO:0044038,1,0.987784806077991,0,1,cell wall macromolecule biosynthetic process,BP,
11615,GO:0044053,1,0.98514627588204,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11621,GO:0044068,1,0.684561425643285,0,25,modulation by symbiont of host cellular process,BP,
11631,GO:0044094,1,0.967087733488009,0,2,host cell nuclear part,CC,
11632,GO:0044106,1,0.232708139647969,0,118,cellular amine metabolic process,BP,
11633,GO:0044107,1,0.934868822382218,0,5,cellular alcohol metabolic process,BP,
11634,GO:0044108,1,0.934868822382218,0,5,cellular alcohol biosynthetic process,BP,
11635,GO:0044110,1,0.797706672684907,0,19,growth involved in symbiotic interaction,BP,
11636,GO:0044111,1,0.972098763581254,0,2,development involved in symbiotic interaction,BP,
11637,GO:0044115,1,0.98850199571852,0,1,development of symbiont involved in interaction with host,BP,
11638,GO:0044116,1,0.797706672684907,0,19,growth of symbiont involved in interaction with host,BP,
11639,GO:0044117,1,0.802110005352957,0,18,growth of symbiont in host,BP,
11640,GO:0044126,1,0.825537740606476,0,15,regulation of growth of symbiont in host,BP,
11641,GO:0044128,1,0.983406759351869,0,1,positive regulation of growth of symbiont in host,BP,
11642,GO:0044130,1,0.839477419374284,0,14,negative regulation of growth of symbiont in host,BP,
11643,GO:0044133,1,0.994515375845619,0,1,growth of symbiont on or near host,BP,
11644,GO:0044139,1,0.994515375845619,0,1,modulation of growth of symbiont on or near host,BP,
11645,GO:0044140,1,0.994515375845619,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11646,GO:0044144,1,0.821006344033091,0,16,modulation of growth of symbiont involved in interaction with host,BP,
11647,GO:0044145,1,0.98850199571852,0,1,modulation of development of symbiont involved in interaction with host,BP,
11648,GO:0044146,1,0.834869829730958,0,15,negative regulation of growth of symbiont involved in interaction with host,BP,
11649,GO:0044147,1,0.98850199571852,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11650,GO:0044148,1,0.983406759351869,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11651,GO:0044154,1,0.89699034993257,0,7,histone H3-K14 acetylation,BP,
11652,GO:0044179,1,0.970300521909226,0,2,hemolysis in other organism,BP,
11653,GO:0044183,1,0.697907391657018,0,27,protein binding involved in protein folding,MF,
11654,GO:0044190,1,0.987891692314826,0,1,host cell mitochondrial envelope,CC,
11655,GO:0044194,1,0.942721283887878,0,4,cytolytic granule,CC,
11656,GO:0044205,1,0.954993052742171,0,3,'de novo' UMP biosynthetic process,BP,
11657,GO:0044206,1,0.93875658605913,0,5,UMP salvage,BP,
11658,GO:0044207,1,0.983406759352069,0,1,translation initiation ternary complex,CC,
11659,GO:0044208,1,0.961832383066893,0,3,'de novo' AMP biosynthetic process,BP,
11660,GO:0044209,1,0.980886562463501,0,2,AMP salvage,BP,
11661,GO:0044210,1,0.968384808079036,0,2,'de novo' CTP biosynthetic process,BP,
11662,GO:0044211,1,0.964871188124143,0,3,CTP salvage,BP,
11664,GO:0044213,1,0.855037331461809,0,11,intronic transcription regulatory region DNA binding,MF,
11665,GO:0044214,1,0.951099703988503,0,3,spanning component of plasma membrane,CC,
11666,GO:0044215,1,0.755633238070976,0,19,other organism,CC,
11667,GO:0044216,1,0.755633238070976,0,19,other organism cell,CC,
11668,GO:0044217,1,0.755633238070976,0,19,other organism part,CC,
11669,GO:0044218,1,0.953803545293607,0,3,other organism cell membrane,CC,
11670,GO:0044220,1,0.983406759351971,0,1,host cell perinuclear region of cytoplasm,CC,
11671,GO:0044221,1,0.983406759352069,0,1,host cell synapse,CC,
11672,GO:0044224,1,0.851580649657461,0,10,juxtaparanode region of axon,CC,
11673,GO:0044228,1,0.983406759351968,0,1,host cell surface,CC,
11674,GO:0044231,1,0.983406759352069,0,1,host cell presynaptic membrane,CC,
11680,GO:0044240,1,0.965767889198394,0,4,multicellular organismal lipid catabolic process,BP,
11681,GO:0044241,1,0.727316827881995,0,27,lipid digestion,BP,
11683,GO:0044243,1,0.332578812491781,0,74,multicellular organismal catabolic process,BP,
11684,GO:0044245,1,0.940140036454533,0,4,polysaccharide digestion,BP,
11686,GO:0044247,1,0.665131441457379,0,27,cellular polysaccharide catabolic process,BP,
11689,GO:0044252,1,0.886995785906822,0,9,negative regulation of multicellular organismal metabolic process,BP,
11691,GO:0044254,1,0.935679926261489,0,4,multicellular organismal protein catabolic process,BP,
11693,GO:0044256,1,0.935679926261489,0,4,protein digestion,BP,
11695,GO:0044258,1,0.985227329702288,0,1,intestinal lipid catabolic process,BP,
11701,GO:0044266,1,0.935679926261489,0,4,multicellular organismal macromolecule catabolic process,BP,
11703,GO:0044268,1,0.920149726220463,0,5,multicellular organismal protein metabolic process,BP,
11707,GO:0044273,1,0.487941013384279,0,50,sulfur compound catabolic process,BP,
11708,GO:0044275,1,0.526348517589825,0,45,cellular carbohydrate catabolic process,BP,
11709,GO:0044279,1,0.953803545293607,0,3,other organism membrane,CC,
11713,GO:0044284,1,0.993176290006283,0,1,mitochondrial crista junction,CC,
11715,GO:0044292,1,0.874274741368911,0,9,dendrite terminus,CC,
11716,GO:0044294,1,0.92015558864043,0,5,dendritic growth cone,CC,
11717,GO:0044295,1,0.771652529631334,0,16,axonal growth cone,CC,
11719,GO:0044298,1,0.749185122220793,0,19,cell body membrane,CC,
11720,GO:0044299,1,0.994296144488195,0,1,C-fiber,CC,
11721,GO:0044300,1,0.92064937087557,0,5,cerebellar mossy fiber,CC,
11722,GO:0044301,1,0.972883538910385,0,2,climbing fiber,CC,
11723,GO:0044302,1,0.967502444620908,0,2,dentate gyrus mossy fiber,CC,
11725,GO:0044305,1,0.935347489898544,0,4,calyx of Held,CC,
11727,GO:0044307,1,0.983406759350102,0,1,dendritic branch,CC,
11728,GO:0044308,1,0.951038409343635,0,3,axonal spine,CC,
11730,GO:0044313,1,0.951045449830127,0,3,protein K6-linked deubiquitination,BP,
11731,GO:0044314,1,0.958312645514877,0,4,protein K27-linked ubiquitination,BP,
11732,GO:0044316,1,0.968363391169555,0,2,cone cell pedicle,CC,
11733,GO:0044317,1,0.990041554179022,0,1,rod spherule,CC,
11737,GO:0044322,1,0.692941440524425,0,25,endoplasmic reticulum quality control compartment,CC,
11738,GO:0044323,1,0.93561778092397,0,4,retinoic acid-responsive element binding,MF,
11739,GO:0044324,1,0.982468793729388,0,2,regulation of transcription involved in anterior/posterior axis specification,BP,
11741,GO:0044326,1,0.95425742067702,0,3,dendritic spine neck,CC,
11742,GO:0044327,1,0.917482565281848,0,6,dendritic spine head,CC,
11744,GO:0044332,1,0.891380698752352,0,7,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11745,GO:0044333,1,0.987269408042126,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11746,GO:0044334,1,0.967171757277233,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11747,GO:0044335,1,0.972866361089726,0,2,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11748,GO:0044336,1,0.953906456544035,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11749,GO:0044337,1,0.983406759351379,0,1,canonical Wnt signaling pathway involved in positive regulation of apoptotic process,BP,
11753,GO:0044341,1,0.869094971663497,0,9,sodium-dependent phosphate transport,BP,
11754,GO:0044342,1,0.775109784655779,0,17,type B pancreatic cell proliferation,BP,
11755,GO:0044343,1,0.967622305117155,0,2,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11757,GO:0044345,1,0.983406759352021,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11759,GO:0044349,1,0.988025773396631,0,1,DNA excision,BP,
11760,GO:0044351,1,0.899998125882996,0,7,macropinocytosis,BP,
11761,GO:0044352,1,0.940142943401309,0,4,pinosome,CC,
11762,GO:0044354,1,0.940142943401309,0,4,macropinosome,CC,
11763,GO:0044355,1,0.989606335213473,0,1,clearance of foreign intracellular DNA,BP,
11764,GO:0044356,1,0.989606335213473,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11765,GO:0044359,1,0.918932807346656,0,7,modulation of molecular function in other organism,BP,
11766,GO:0044362,1,0.918932807346656,0,7,negative regulation of molecular function in other organism,BP,
11768,GO:0044374,1,0.983415786862643,0,1,sequence-specific DNA binding, bending,MF,
11769,GO:0044375,1,0.972377736157544,0,3,regulation of peroxisome size,BP,
11770,GO:0044376,1,0.966765160680757,0,3,RNA polymerase II complex import to nucleus,BP,
11771,GO:0044377,1,0.983415786862643,0,1,RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending,MF,
11772,GO:0044378,1,0.973050753556405,0,2,non-sequence-specific DNA binding, bending,MF,
11773,GO:0044380,1,0.565557224357436,0,36,protein localization to cytoskeleton,BP,
11775,GO:0044387,1,0.890691722565069,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11776,GO:0044388,1,0.944308357386961,0,5,small protein activating enzyme binding,MF,
11779,GO:0044391,1,0.233534539385164,0,177,ribosomal subunit,CC,
11780,GO:0044393,1,0.952103460817889,0,3,microspike,CC,
11781,GO:0044395,1,0.984633588767659,0,1,protein targeting to vacuolar membrane,BP,
11784,GO:0044407,1,0.970235141285895,0,2,single-species biofilm formation in or on host organism,BP,
11786,GO:0044413,1,0.954368713501299,0,3,avoidance of host defenses,BP,
11787,GO:0044415,1,0.954368713501299,0,3,evasion or tolerance of host defenses,BP,
11788,GO:0044416,1,0.975415942898039,0,2,induction by symbiont of host defense response,BP,
11789,GO:0044417,1,0.98514627588204,0,1,translocation of molecules into host,BP,
11794,GO:0044423,1,0.94028228781709,0,4,virion part,CC,
11812,GO:0044447,1,0.705996248540525,0,22,axoneme part,CC,
11817,GO:0044452,1,0.102394530945472,0,161,nucleolar part,CC,
11818,GO:0044453,1,0.795609944926633,0,15,nuclear membrane part,CC,
11820,GO:0044455,1,0.152734264147354,0,179,mitochondrial membrane part,CC,
11822,GO:0044458,1,0.757053483824426,0,20,motile cilium assembly,BP,
11826,GO:0044467,1,0.969067190310818,0,2,glial cell-derived neurotrophic factor secretion,BP,
11827,GO:0044501,1,0.983574937889037,0,1,modulation of signal transduction in other organism,BP,
11828,GO:0044524,1,0.987935314300946,0,1,protein sulfhydration,BP,
11829,GO:0044530,1,0.953951511787706,0,3,supraspliceosomal complex,CC,
11830,GO:0044531,1,0.92991805912918,0,5,modulation of programmed cell death in other organism,BP,
11831,GO:0044532,1,0.92991805912918,0,5,modulation of apoptotic process in other organism,BP,
11832,GO:0044533,1,0.975369653398164,0,2,positive regulation of apoptotic process in other organism,BP,
11833,GO:0044537,1,0.987739384408949,0,1,regulation of circulating fibrinogen levels,BP,
11834,GO:0044539,1,0.917389602941089,0,6,long-chain fatty acid import,BP,
11835,GO:0044540,1,0.987935314300946,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11836,GO:0044546,1,0.851599168202383,0,11,NLRP3 inflammasome complex assembly,BP,
11837,GO:0044547,1,0.924324269253744,0,5,DNA topoisomerase binding,MF,
11838,GO:0044548,1,0.852312289457862,0,13,S100 protein binding,MF,
11839,GO:0044549,1,0.994530032375714,0,1,GTP cyclohydrolase binding,MF,
11842,GO:0044558,1,0.983406759351921,0,1,uterine smooth muscle relaxation,BP,
11843,GO:0044565,1,0.973610777834705,0,2,dendritic cell proliferation,BP,
11844,GO:0044571,1,0.961438948070355,0,4,[2Fe-2S] cluster assembly,BP,
11845,GO:0044594,1,0.984401532673474,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11846,GO:0044595,1,0.990704363325434,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11847,GO:0044596,1,0.990704363325434,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11848,GO:0044597,1,0.916709419667519,0,8,daunorubicin metabolic process,BP,
11849,GO:0044598,1,0.916709419667519,0,8,doxorubicin metabolic process,BP,
11850,GO:0044599,1,0.984725543253726,0,1,AP-5 adaptor complex,CC,
11851,GO:0044609,1,0.986144116361735,0,1,DBIRD complex,CC,
11852,GO:0044610,1,0.985653813887015,0,1,FMN transmembrane transporter activity,MF,
11853,GO:0044611,1,0.951038409344113,0,3,nuclear pore inner ring,CC,
11854,GO:0044613,1,0.92435208867614,0,6,nuclear pore central transport channel,CC,
11855,GO:0044614,1,0.936356020552167,0,4,nuclear pore cytoplasmic filaments,CC,
11856,GO:0044615,1,0.909159978388587,0,6,nuclear pore nuclear basket,CC,
11857,GO:0044620,1,0.994875889508817,0,1,ACP phosphopantetheine attachment site binding,MF,
11859,GO:0044665,1,0.676727623270251,0,27,MLL1/2 complex,CC,
11860,GO:0044666,1,0.901488658394099,0,7,MLL3/4 complex,CC,
11861,GO:0044691,1,0.951038410250496,0,3,tooth eruption,BP,
11866,GO:0044704,1,0.985666447909236,0,1,single-organism reproductive behavior,BP,
11873,GO:0044713,1,0.994515375845619,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11874,GO:0044714,1,0.994515375845619,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11875,GO:0044715,1,0.980340446035913,0,2,8-oxo-dGDP phosphatase activity,MF,
11876,GO:0044716,1,0.989166641157437,0,1,8-oxo-GDP phosphatase activity,MF,
11877,GO:0044717,1,0.989166641157437,0,1,8-hydroxy-dADP phosphatase activity,MF,
11878,GO:0044721,1,0.987039832328744,0,1,protein import into peroxisome matrix, substrate release,BP,
11879,GO:0044722,1,0.983407728180071,0,1,renal phosphate excretion,BP,
11882,GO:0044725,1,0.975772979478441,0,2,chromatin reprogramming in the zygote,BP,
11883,GO:0044726,1,0.992237952672352,0,1,protection of DNA demethylation of female pronucleus,BP,
11884,GO:0044727,1,0.983406759350443,0,1,DNA demethylation of male pronucleus,BP,
11887,GO:0044736,1,0.94028228781709,0,4,acid-sensing ion channel activity,MF,
11888,GO:0044743,1,0.585976576222623,0,42,protein transmembrane import into intracellular organelle,BP,
11890,GO:0044745,1,0.983406759351282,0,1,amino acid transmembrane import,BP,
11892,GO:0044753,1,0.967665170115863,0,2,amphisome,CC,
11893,GO:0044754,1,0.88607369285717,0,9,autolysosome,CC,
11899,GO:0044769,1,0.708760301784267,0,31,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11901,GO:0044771,1,0.938648704421889,0,5,meiotic cell cycle phase transition,BP,
11905,GO:0044778,1,0.956460163276127,0,4,meiotic DNA integrity checkpoint,BP,
11906,GO:0044779,1,0.983811692138999,0,1,meiotic spindle checkpoint,BP,
11909,GO:0044784,1,0.510684309940595,0,47,metaphase/anaphase transition of cell cycle,BP,
11910,GO:0044785,1,0.976161337687424,0,2,metaphase/anaphase transition of meiotic cell cycle,BP,
11911,GO:0044786,1,0.58043713550391,0,36,cell cycle DNA replication,BP,
11912,GO:0044788,1,0.750109973032085,0,20,modulation by host of viral process,BP,
11913,GO:0044789,1,0.920142768454329,0,5,modulation by host of viral release from host cell,BP,
11914,GO:0044791,1,0.920142768454329,0,5,positive regulation by host of viral release from host cell,BP,
11915,GO:0044793,1,0.906027669901891,0,7,negative regulation by host of viral process,BP,
11916,GO:0044794,1,0.827974672635966,0,13,positive regulation by host of viral process,BP,
11917,GO:0044795,1,0.991418102097371,0,1,trans-Golgi network to recycling endosome transport,BP,
11918,GO:0044796,1,0.990254466318836,0,1,DNA polymerase processivity factor complex,CC,
11924,GO:0044804,1,0.823302616576417,0,13,nucleophagy,BP,
11925,GO:0044805,1,0.967094359503926,0,2,late nucleophagy,BP,
11926,GO:0044806,1,0.905450045121076,0,6,G-quadruplex DNA unwinding,BP,
11927,GO:0044815,1,0.477129816877197,0,108,DNA packaging complex,CC,
11930,GO:0044821,1,0.92485345371305,0,5,meiotic telomere tethering at nuclear periphery,BP,
11931,GO:0044827,1,0.845379077417805,0,11,modulation by host of viral genome replication,BP,
11932,GO:0044828,1,0.938260287159736,0,4,negative regulation by host of viral genome replication,BP,
11933,GO:0044829,1,0.90103179317946,0,7,positive regulation by host of viral genome replication,BP,
11934,GO:0044830,1,0.983406759352021,0,1,modulation by host of viral RNA genome replication,BP,
11935,GO:0044837,1,0.951233388312996,0,3,actomyosin contractile ring organization,BP,
11939,GO:0044849,1,0.809614386332534,0,15,estrous cycle,BP,
11942,GO:0044854,1,0.933662452282124,0,5,plasma membrane raft assembly,BP,
11943,GO:0044855,1,0.984304064528247,0,1,plasma membrane raft distribution,BP,
11944,GO:0044856,1,0.984304064528247,0,1,plasma membrane raft localization,BP,
11945,GO:0044857,1,0.933662452282124,0,5,plasma membrane raft organization,BP,
11946,GO:0044858,1,0.984304064528247,0,1,plasma membrane raft polarization,BP,
11947,GO:0044860,1,0.940991294333618,0,4,protein localization to plasma membrane raft,BP,
11948,GO:0044861,1,0.970884207417991,0,2,protein transport into plasma membrane raft,BP,
11949,GO:0044866,1,0.980077621687734,0,2,modulation by host of viral exo-alpha-sialidase activity,BP,
11950,GO:0044867,1,0.980077621687734,0,2,modulation by host of viral catalytic activity,BP,
11951,GO:0044868,1,0.9638136093869,0,3,modulation by host of viral molecular function,BP,
11952,GO:0044869,1,0.980077621687734,0,2,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11953,GO:0044870,1,0.980077621687734,0,2,modulation by host of viral glycoprotein metabolic process,BP,
11954,GO:0044871,1,0.980077621687734,0,2,negative regulation by host of viral glycoprotein metabolic process,BP,
11957,GO:0045002,1,0.89767565848754,0,7,double-strand break repair via single-strand annealing,BP,
11958,GO:0045003,1,0.864895659315495,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11959,GO:0045004,1,0.967154800111647,0,2,DNA replication proofreading,BP,
11960,GO:0045005,1,0.654771695662822,0,28,DNA-dependent DNA replication maintenance of fidelity,BP,
11961,GO:0045006,1,0.90171976162071,0,10,DNA deamination,BP,
11962,GO:0045007,1,0.966793299708244,0,3,depurination,BP,
11963,GO:0045008,1,0.900943992520626,0,8,depyrimidination,BP,
11965,GO:0045010,1,0.548050806206058,0,42,actin nucleation,BP,
11966,GO:0045013,1,0.970750629017808,0,2,carbon catabolite repression of transcription,BP,
11967,GO:0045014,1,0.970750629017808,0,2,negative regulation of transcription by glucose,BP,
11968,GO:0045016,1,0.983532041178545,0,1,mitochondrial magnesium ion transport,BP,
11970,GO:0045019,1,0.850830486791637,0,12,negative regulation of nitric oxide biosynthetic process,BP,
11973,GO:0045025,1,0.968594277933987,0,2,mitochondrial degradosome,CC,
11975,GO:0045027,1,0.986285821290181,0,1,DNA end binding,MF,
11976,GO:0045028,1,0.824998064817819,0,14,G-protein coupled purinergic nucleotide receptor activity,MF,
11977,GO:0045029,1,0.972718768825579,0,2,UDP-activated nucleotide receptor activity,MF,
11978,GO:0045030,1,0.988515622333327,0,1,UTP-activated nucleotide receptor activity,MF,
11979,GO:0045031,1,0.970787357612079,0,2,ATP-activated adenosine receptor activity,MF,
11980,GO:0045032,1,0.983730030123656,0,1,ADP-activated adenosine receptor activity,MF,
11981,GO:0045039,1,0.958463046249347,0,5,protein import into mitochondrial inner membrane,BP,
11982,GO:0045040,1,0.936550691476182,0,6,protein import into mitochondrial outer membrane,BP,
11983,GO:0045041,1,0.974811560859654,0,2,protein import into mitochondrial intermembrane space,BP,
11984,GO:0045046,1,0.910252128236698,0,6,protein import into peroxisome membrane,BP,
11985,GO:0045047,1,0.466736858028197,0,100,protein targeting to ER,BP,
11986,GO:0045048,1,0.931118446922794,0,5,protein insertion into ER membrane,BP,
11987,GO:0045053,1,0.96810207521945,0,2,protein retention in Golgi apparatus,BP,
11992,GO:0045059,1,0.874910674382549,0,10,positive thymic T cell selection,BP,
11993,GO:0045060,1,0.842183444143436,0,12,negative thymic T cell selection,BP,
11995,GO:0045062,1,0.988119726811486,0,1,extrathymic T cell selection,BP,
11996,GO:0045063,1,0.787526835881401,0,17,T-helper 1 cell differentiation,BP,
11997,GO:0045064,1,0.808059898520453,0,16,T-helper 2 cell differentiation,BP,
11998,GO:0045065,1,0.956505491086788,0,3,cytotoxic T cell differentiation,BP,
11999,GO:0045066,1,0.743726985840792,0,21,regulatory T cell differentiation,BP,
12002,GO:0045071,1,0.514978033260878,0,50,negative regulation of viral genome replication,BP,
12005,GO:0045074,1,0.954854611411843,0,3,regulation of interleukin-10 biosynthetic process,BP,
12006,GO:0045075,1,0.892919065131306,0,8,regulation of interleukin-12 biosynthetic process,BP,
12007,GO:0045076,1,0.777144810924248,0,18,regulation of interleukin-2 biosynthetic process,BP,
12008,GO:0045077,1,0.946325389759516,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
12010,GO:0045079,1,0.972804684367258,0,3,negative regulation of chemokine biosynthetic process,BP,
12012,GO:0045081,1,0.983432261610708,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
12013,GO:0045082,1,0.970942887989389,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
12014,GO:0045083,1,0.983406759352069,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
12015,GO:0045084,1,0.923317419454933,0,6,positive regulation of interleukin-12 biosynthetic process,BP,
12016,GO:0045085,1,0.951586878222117,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
12017,GO:0045086,1,0.832768225153755,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
12021,GO:0045091,1,0.889588716392459,0,8,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12022,GO:0045092,1,0.983435229772214,0,1,interleukin-18 receptor complex,CC,
12023,GO:0045095,1,0.382048674331077,0,92,keratin filament,CC,
12024,GO:0045098,1,0.972817471813833,0,2,type III intermediate filament,CC,
12027,GO:0045105,1,0.967119661476429,0,2,intermediate filament polymerization or depolymerization,BP,
12028,GO:0045106,1,0.983406759351773,0,1,intermediate filament depolymerization,BP,
12029,GO:0045108,1,0.983406759351773,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
12033,GO:0045112,1,0.921393325572691,0,6,integrin biosynthetic process,BP,
12034,GO:0045113,1,0.936944433911927,0,5,regulation of integrin biosynthetic process,BP,
12035,GO:0045116,1,0.839234272731191,0,15,protein neddylation,BP,
12037,GO:0045118,1,0.914285084453307,0,6,azole transporter activity,MF,
12038,GO:0045120,1,0.81372950771254,0,14,pronucleus,CC,
12043,GO:0045127,1,0.988836600172444,0,1,N-acetylglucosamine kinase activity,MF,
12044,GO:0045130,1,0.984343803945162,0,1,keratan sulfotransferase activity,MF,
12045,GO:0045131,1,0.983875198227331,0,1,pre-mRNA branch point binding,MF,
12046,GO:0045132,1,0.365855445496442,0,70,meiotic chromosome segregation,BP,
12047,GO:0045134,1,0.939599499869143,0,4,uridine-diphosphatase activity,MF,
12050,GO:0045141,1,0.843010809091552,0,11,meiotic telomere clustering,BP,
12051,GO:0045142,1,0.983406865513707,0,1,triplex DNA binding,MF,
12052,GO:0045143,1,0.508953734099506,0,48,homologous chromosome segregation,BP,
12053,GO:0045144,1,0.915170661097054,0,7,meiotic sister chromatid segregation,BP,
12054,GO:0045145,1,0.968609545536234,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
12055,GO:0045153,1,0.991058066507702,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
12056,GO:0045155,1,0.97461259221047,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
12057,GO:0045159,1,0.940110088759471,0,5,myosin II binding,MF,
12058,GO:0045160,1,0.983406759351968,0,1,myosin I complex,CC,
12061,GO:0045163,1,0.952716352055442,0,3,clustering of voltage-gated potassium channels,BP,
12065,GO:0045174,1,0.983382471556074,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12066,GO:0045176,1,0.8473970629595,0,11,apical protein localization,BP,
12069,GO:0045179,1,0.91609653357247,0,7,apical cortex,CC,
12070,GO:0045180,1,0.919731182615249,0,5,basal cortex,CC,
12071,GO:0045182,1,0.579370234248203,0,37,translation regulator activity,MF,
12074,GO:0045186,1,0.983406759351281,0,1,zonula adherens assembly,BP,
12077,GO:0045189,1,0.993201017345349,0,1,connective tissue growth factor biosynthetic process,BP,
12080,GO:0045196,1,0.95334921269112,0,3,establishment or maintenance of neuroblast polarity,BP,
12083,GO:0045199,1,0.846009181957759,0,12,maintenance of epithelial cell apical/basal polarity,BP,
12084,GO:0045200,1,0.95334921269112,0,3,establishment of neuroblast polarity,BP,
12086,GO:0045204,1,0.951074018209436,0,3,MAPK export from nucleus,BP,
12087,GO:0045208,1,0.983443575083345,0,1,MAPK phosphatase export from nucleus,BP,
12088,GO:0045209,1,0.983443575083345,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
12091,GO:0045212,1,0.984673829223965,0,1,neurotransmitter receptor biosynthetic process,BP,
12092,GO:0045213,1,0.959182987830845,0,3,neurotransmitter receptor metabolic process,BP,
12097,GO:0045219,1,0.983406759351824,0,1,regulation of FasL biosynthetic process,BP,
12098,GO:0045221,1,0.983406759351824,0,1,negative regulation of FasL biosynthetic process,BP,
12099,GO:0045222,1,0.991404902088132,0,1,CD4 biosynthetic process,BP,
12100,GO:0045223,1,0.991404902088132,0,1,regulation of CD4 biosynthetic process,BP,
12101,GO:0045225,1,0.991404902088132,0,1,negative regulation of CD4 biosynthetic process,BP,
12102,GO:0045226,1,0.955020551997093,0,3,extracellular polysaccharide biosynthetic process,BP,
12103,GO:0045229,1,0.952787104756525,0,3,external encapsulating structure organization,BP,
12104,GO:0045234,1,0.987724295493452,0,1,protein palmitoleylation,BP,
12105,GO:0045236,1,0.854575356127408,0,15,CXCR chemokine receptor binding,MF,
12106,GO:0045239,1,0.836599730844287,0,12,tricarboxylic acid cycle enzyme complex,CC,
12107,GO:0045240,1,0.859641699068348,0,10,dihydrolipoyl dehydrogenase complex,CC,
12108,GO:0045244,1,0.985338549851725,0,1,succinate-CoA ligase complex (GDP-forming),CC,
12109,GO:0045251,1,0.985345203965664,0,1,electron transfer flavoprotein complex,CC,
12110,GO:0045252,1,0.91150934040938,0,6,oxoglutarate dehydrogenase complex,CC,
12111,GO:0045254,1,0.888638005467765,0,8,pyruvate dehydrogenase complex,CC,
12112,GO:0045257,1,0.951992044001775,0,4,succinate dehydrogenase complex (ubiquinone),CC,
12113,GO:0045259,1,0.846506051419569,0,21,proton-transporting ATP synthase complex,CC,
12114,GO:0045261,1,0.957046832146352,0,5,proton-transporting ATP synthase complex, catalytic core F(1),CC,
12115,GO:0045263,1,0.916370291957134,0,11,proton-transporting ATP synthase complex, coupling factor F(o),CC,
12116,GO:0045265,1,0.995451832282456,0,1,proton-transporting ATP synthase, stator stalk,CC,
12117,GO:0045267,1,0.987427957467423,0,1,proton-transporting ATP synthase, catalytic core,CC,
12118,GO:0045271,1,0.729688227960272,0,42,respiratory chain complex I,CC,
12119,GO:0045273,1,0.951992044001775,0,4,respiratory chain complex II,CC,
12120,GO:0045275,1,0.893500716373712,0,11,respiratory chain complex III,CC,
12121,GO:0045277,1,0.933040927459964,0,14,respiratory chain complex IV,CC,
12122,GO:0045281,1,0.951992044001775,0,4,succinate dehydrogenase complex,CC,
12123,GO:0045283,1,0.951992044001775,0,4,fumarate reductase complex,CC,
12124,GO:0045292,1,0.783721348837369,0,17,mRNA cis splicing, via spliceosome,BP,
12125,GO:0045293,1,0.945707477683692,0,4,mRNA editing complex,CC,
12129,GO:0045297,1,0.985666447909236,0,1,post-mating behavior,BP,
12130,GO:0045298,1,0.961039938893777,0,3,tubulin complex,CC,
12131,GO:0045299,1,0.983406759350937,0,1,otolith mineralization,BP,
12134,GO:0045322,1,0.98389610454411,0,1,unmethylated CpG binding,MF,
12135,GO:0045323,1,0.955477318251838,0,3,interleukin-1 receptor complex,CC,
12136,GO:0045324,1,0.813943509187583,0,15,late endosome to vacuole transport,BP,
12137,GO:0045329,1,0.927919859270059,0,5,carnitine biosynthetic process,BP,
12138,GO:0045332,1,0.693702520971262,0,22,phospholipid translocation,BP,
12142,GO:0045337,1,0.973673941280527,0,2,farnesyl diphosphate biosynthetic process,BP,
12143,GO:0045338,1,0.960291450027212,0,3,farnesyl diphosphate metabolic process,BP,
12144,GO:0045340,1,0.992937098316418,0,1,mercury ion binding,MF,
12145,GO:0045341,1,0.90060173222839,0,7,MHC class I biosynthetic process,BP,
12146,GO:0045342,1,0.851264888228147,0,13,MHC class II biosynthetic process,BP,
12147,GO:0045343,1,0.90060173222839,0,7,regulation of MHC class I biosynthetic process,BP,
12148,GO:0045345,1,0.906376417359212,0,6,positive regulation of MHC class I biosynthetic process,BP,
12149,GO:0045346,1,0.865635959748419,0,12,regulation of MHC class II biosynthetic process,BP,
12150,GO:0045347,1,0.942823923142183,0,5,negative regulation of MHC class II biosynthetic process,BP,
12151,GO:0045348,1,0.907632286982345,0,8,positive regulation of MHC class II biosynthetic process,BP,
12152,GO:0045349,1,0.91509033826876,0,6,interferon-alpha biosynthetic process,BP,
12153,GO:0045350,1,0.881633374574989,0,8,interferon-beta biosynthetic process,BP,
12154,GO:0045351,1,0.836125127943279,0,12,type I interferon biosynthetic process,BP,
12155,GO:0045352,1,0.98774441978744,0,1,interleukin-1 Type I receptor antagonist activity,MF,
12156,GO:0045353,1,0.98774441978744,0,1,interleukin-1 Type II receptor antagonist activity,MF,
12157,GO:0045354,1,0.91509033826876,0,6,regulation of interferon-alpha biosynthetic process,BP,
12158,GO:0045355,1,0.978051265057041,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
12159,GO:0045356,1,0.935631884881402,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
12160,GO:0045357,1,0.881633374574989,0,8,regulation of interferon-beta biosynthetic process,BP,
12161,GO:0045358,1,0.989381772705624,0,1,negative regulation of interferon-beta biosynthetic process,BP,
12162,GO:0045359,1,0.89109978228695,0,7,positive regulation of interferon-beta biosynthetic process,BP,
12165,GO:0045366,1,0.983406759351821,0,1,regulation of interleukin-13 biosynthetic process,BP,
12166,GO:0045368,1,0.983406759351821,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
12167,GO:0045381,1,0.983604239074011,0,1,regulation of interleukin-18 biosynthetic process,BP,
12168,GO:0045399,1,0.974908321653815,0,2,regulation of interleukin-3 biosynthetic process,BP,
12169,GO:0045401,1,0.974908321653815,0,2,positive regulation of interleukin-3 biosynthetic process,BP,
12172,GO:0045404,1,0.968012508731457,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12173,GO:0045405,1,0.995418209170563,0,1,regulation of interleukin-5 biosynthetic process,BP,
12174,GO:0045407,1,0.995418209170563,0,1,positive regulation of interleukin-5 biosynthetic process,BP,
12175,GO:0045408,1,0.812580175039807,0,16,regulation of interleukin-6 biosynthetic process,BP,
12176,GO:0045409,1,0.940081869461904,0,5,negative regulation of interleukin-6 biosynthetic process,BP,
12177,GO:0045410,1,0.892558373613087,0,8,positive regulation of interleukin-6 biosynthetic process,BP,
12178,GO:0045414,1,0.864496089885374,0,12,regulation of interleukin-8 biosynthetic process,BP,
12179,GO:0045415,1,0.950519245489246,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12180,GO:0045416,1,0.908761334189055,0,8,positive regulation of interleukin-8 biosynthetic process,BP,
12181,GO:0045423,1,0.953648734890764,0,4,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12182,GO:0045425,1,0.959560959084958,0,3,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12188,GO:0045448,1,0.942397573022423,0,4,mitotic cell cycle, embryonic,BP,
12190,GO:0045454,1,0.422124839867447,0,68,cell redox homeostasis,BP,
12192,GO:0045472,1,0.8525163240741,0,12,response to ether,BP,
12193,GO:0045475,1,0.857289640984258,0,11,locomotor rhythm,BP,
12194,GO:0045485,1,0.983406759352021,0,1,omega-6 fatty acid desaturase activity,MF,
12196,GO:0045495,1,0.78333335805435,0,16,pole plasm,CC,
12197,GO:0045499,1,0.870420841877844,0,9,chemorepellent activity,MF,
12198,GO:0045503,1,0.939613142193877,0,4,dynein light chain binding,MF,
12199,GO:0045504,1,0.943895108992549,0,4,dynein heavy chain binding,MF,
12201,GO:0045509,1,0.967490087334271,0,2,interleukin-27 receptor activity,MF,
12202,GO:0045513,1,0.98964212161881,0,1,interleukin-27 binding,MF,
12203,GO:0045517,1,0.990915810008669,0,1,interleukin-20 receptor binding,MF,
12204,GO:0045518,1,0.982470509331772,0,2,interleukin-22 receptor binding,MF,
12205,GO:0045519,1,0.977669306666012,0,2,interleukin-23 receptor binding,MF,
12206,GO:0045523,1,0.983832464405563,0,2,interleukin-27 receptor binding,MF,
12207,GO:0045540,1,0.825263100571449,0,13,regulation of cholesterol biosynthetic process,BP,
12208,GO:0045541,1,0.940287248074578,0,5,negative regulation of cholesterol biosynthetic process,BP,
12209,GO:0045542,1,0.921535219239508,0,5,positive regulation of cholesterol biosynthetic process,BP,
12210,GO:0045545,1,0.911789664207955,0,6,syndecan binding,MF,
12211,GO:0045550,1,0.979770821705243,0,2,geranylgeranyl reductase activity,MF,
12212,GO:0045553,1,0.983817955825448,0,1,TRAIL biosynthetic process,BP,
12213,GO:0045554,1,0.983817955825448,0,1,regulation of TRAIL biosynthetic process,BP,
12214,GO:0045556,1,0.983817955825448,0,1,positive regulation of TRAIL biosynthetic process,BP,
12215,GO:0045569,1,0.945823338210171,0,4,TRAIL binding,MF,
12216,GO:0045575,1,0.979726400264131,0,2,basophil activation,BP,
12218,GO:0045577,1,0.703920779537391,0,24,regulation of B cell differentiation,BP,
12219,GO:0045578,1,0.950216002556868,0,4,negative regulation of B cell differentiation,BP,
12220,GO:0045579,1,0.82889968278709,0,13,positive regulation of B cell differentiation,BP,
12223,GO:0045582,1,0.359163220225922,0,73,positive regulation of T cell differentiation,BP,
12224,GO:0045583,1,0.971988949222975,0,2,regulation of cytotoxic T cell differentiation,BP,
12225,GO:0045585,1,0.971988949222975,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12226,GO:0045586,1,0.919731464986824,0,5,regulation of gamma-delta T cell differentiation,BP,
12227,GO:0045588,1,0.951038701285722,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12228,GO:0045589,1,0.766787207361599,0,19,regulation of regulatory T cell differentiation,BP,
12229,GO:0045590,1,0.954682338902318,0,3,negative regulation of regulatory T cell differentiation,BP,
12230,GO:0045591,1,0.857677479259623,0,12,positive regulation of regulatory T cell differentiation,BP,
12238,GO:0045602,1,0.897042766330115,0,7,negative regulation of endothelial cell differentiation,BP,
12245,GO:0045609,1,0.992054094792906,0,1,positive regulation of auditory receptor cell differentiation,BP,
12247,GO:0045617,1,0.90046318679593,0,8,negative regulation of keratinocyte differentiation,BP,
12252,GO:0045622,1,0.670569839106856,0,30,regulation of T-helper cell differentiation,BP,
12253,GO:0045623,1,0.82747304797948,0,14,negative regulation of T-helper cell differentiation,BP,
12254,GO:0045624,1,0.772181497172096,0,19,positive regulation of T-helper cell differentiation,BP,
12255,GO:0045625,1,0.874401722897222,0,10,regulation of T-helper 1 cell differentiation,BP,
12256,GO:0045626,1,0.952860719439365,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12257,GO:0045627,1,0.924913723627358,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12258,GO:0045628,1,0.843605038788263,0,12,regulation of T-helper 2 cell differentiation,BP,
12259,GO:0045629,1,0.943524054638039,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12260,GO:0045630,1,0.894124326118217,0,8,positive regulation of T-helper 2 cell differentiation,BP,
12263,GO:0045633,1,0.992054094792906,0,1,positive regulation of mechanoreceptor differentiation,BP,
12269,GO:0045643,1,0.977308072192597,0,2,regulation of eosinophil differentiation,BP,
12270,GO:0045645,1,0.977308072192597,0,2,positive regulation of eosinophil differentiation,BP,
12272,GO:0045647,1,0.888201131938161,0,8,negative regulation of erythrocyte differentiation,BP,
12273,GO:0045648,1,0.714679914817451,0,23,positive regulation of erythrocyte differentiation,BP,
12275,GO:0045650,1,0.909212020041091,0,7,negative regulation of macrophage differentiation,BP,
12277,GO:0045652,1,0.806802613284663,0,28,regulation of megakaryocyte differentiation,BP,
12278,GO:0045653,1,0.924031227424175,0,18,negative regulation of megakaryocyte differentiation,BP,
12279,GO:0045654,1,0.909072187221093,0,7,positive regulation of megakaryocyte differentiation,BP,
12280,GO:0045655,1,0.766315967616967,0,18,regulation of monocyte differentiation,BP,
12281,GO:0045656,1,0.903534427548555,0,7,negative regulation of monocyte differentiation,BP,
12282,GO:0045657,1,0.874005842193303,0,9,positive regulation of monocyte differentiation,BP,
12283,GO:0045658,1,0.967111016270857,0,2,regulation of neutrophil differentiation,BP,
12284,GO:0045659,1,0.967111016270857,0,2,negative regulation of neutrophil differentiation,BP,
12287,GO:0045663,1,0.737632370122663,0,21,positive regulation of myoblast differentiation,BP,
12296,GO:0045672,1,0.711204580530799,0,24,positive regulation of osteoclast differentiation,BP,
12303,GO:0045703,1,0.990960962472649,0,1,ketoreductase activity,MF,
12304,GO:0045713,1,0.864966002456725,0,10,low-density lipoprotein particle receptor biosynthetic process,BP,
12305,GO:0045714,1,0.876034298955014,0,9,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12306,GO:0045715,1,0.951038409344113,0,3,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12307,GO:0045716,1,0.952505596316932,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12308,GO:0045717,1,0.822140934879514,0,14,negative regulation of fatty acid biosynthetic process,BP,
12309,GO:0045719,1,0.922311532412609,0,5,negative regulation of glycogen biosynthetic process,BP,
12310,GO:0045720,1,0.971592913752119,0,2,negative regulation of integrin biosynthetic process,BP,
12311,GO:0045721,1,0.832849293587821,0,13,negative regulation of gluconeogenesis,BP,
12312,GO:0045722,1,0.858086405934283,0,10,positive regulation of gluconeogenesis,BP,
12313,GO:0045723,1,0.844644258147746,0,14,positive regulation of fatty acid biosynthetic process,BP,
12314,GO:0045724,1,0.738118219136079,0,20,positive regulation of cilium assembly,BP,
12316,GO:0045726,1,0.952962166517801,0,3,positive regulation of integrin biosynthetic process,BP,
12317,GO:0045727,1,0.245103823028964,0,100,positive regulation of translation,BP,
12318,GO:0045728,1,0.986053003073054,0,1,respiratory burst after phagocytosis,BP,
12323,GO:0045738,1,0.772939359691676,0,17,negative regulation of DNA repair,BP,
12328,GO:0045743,1,0.915229612010191,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12333,GO:0045751,1,0.983604239074011,0,1,negative regulation of Toll signaling pathway,BP,
12334,GO:0045759,1,0.909031400998078,0,7,negative regulation of action potential,BP,
12335,GO:0045760,1,0.854641862259906,0,11,positive regulation of action potential,BP,
12336,GO:0045761,1,0.351688843328256,0,74,regulation of adenylate cyclase activity,BP,
12337,GO:0045762,1,0.507993381657473,0,46,positive regulation of adenylate cyclase activity,BP,
12338,GO:0045763,1,0.967087733486899,0,2,negative regulation of cellular amino acid metabolic process,BP,
12339,GO:0045764,1,0.96506352386251,0,3,positive regulation of cellular amino acid metabolic process,BP,
12342,GO:0045769,1,0.983406759350447,0,1,negative regulation of asymmetric cell division,BP,
12343,GO:0045773,1,0.538598186959344,0,39,positive regulation of axon extension,BP,
12348,GO:0045780,1,0.827833639199503,0,13,positive regulation of bone resorption,BP,
12354,GO:0045794,1,0.919994305777355,0,5,negative regulation of cell volume,BP,
12355,GO:0045795,1,0.983406759351429,0,1,positive regulation of cell volume,BP,
12356,GO:0045796,1,0.968968553918727,0,2,negative regulation of intestinal cholesterol absorption,BP,
12357,GO:0045799,1,0.955963985147839,0,3,positive regulation of chromatin assembly or disassembly,BP,
12360,GO:0045814,1,0.258190146491909,0,130,negative regulation of gene expression, epigenetic,BP,
12361,GO:0045815,1,0.437247770582726,0,79,positive regulation of gene expression, epigenetic,BP,
12362,GO:0045818,1,0.996382437791693,0,1,negative regulation of glycogen catabolic process,BP,
12363,GO:0045819,1,0.983406925169233,0,1,positive regulation of glycogen catabolic process,BP,
12365,GO:0045821,1,0.82360722986682,0,13,positive regulation of glycolytic process,BP,
12369,GO:0045827,1,0.990960962472649,0,1,negative regulation of isoprenoid metabolic process,BP,
12370,GO:0045829,1,0.939848219795793,0,4,negative regulation of isotype switching,BP,
12377,GO:0045838,1,0.894703135455455,0,9,positive regulation of membrane potential,BP,
12380,GO:0045841,1,0.64486378400316,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
12381,GO:0045842,1,0.912781697190292,0,6,positive regulation of mitotic metaphase/anaphase transition,BP,
12384,GO:0045848,1,0.98609242153372,0,1,positive regulation of nitrogen utilization,BP,
12386,GO:0045852,1,0.910913980360611,0,6,pH elevation,BP,
12391,GO:0045869,1,0.90460523334297,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12392,GO:0045870,1,0.983406759351724,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12393,GO:0045872,1,0.973515724206583,0,2,positive regulation of rhodopsin gene expression,BP,
12394,GO:0045875,1,0.951038409341495,0,3,negative regulation of sister chromatid cohesion,BP,
12395,GO:0045876,1,0.902147016689921,0,7,positive regulation of sister chromatid cohesion,BP,
12397,GO:0045880,1,0.651118616952954,0,27,positive regulation of smoothened signaling pathway,BP,
12398,GO:0045887,1,0.983406759351331,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12401,GO:0045896,1,0.951038409344301,0,3,regulation of transcription during mitotic cell cycle,BP,
12402,GO:0045897,1,0.983406759351724,0,1,positive regulation of transcription during mitotic cell cycle,BP,
12403,GO:0045898,1,0.837061190186332,0,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12404,GO:0045899,1,0.878560297944048,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12405,GO:0045900,1,0.944899716548189,0,4,negative regulation of translational elongation,BP,
12406,GO:0045901,1,0.93867251796446,0,5,positive regulation of translational elongation,BP,
12407,GO:0045903,1,0.981209132242345,0,2,positive regulation of translational fidelity,BP,
12408,GO:0045905,1,0.95782396190528,0,3,positive regulation of translational termination,BP,
12409,GO:0045906,1,0.896511279083661,0,7,negative regulation of vasoconstriction,BP,
12411,GO:0045910,1,0.713703171912694,0,21,negative regulation of DNA recombination,BP,
12415,GO:0045914,1,0.969535120885246,0,2,negative regulation of catecholamine metabolic process,BP,
12416,GO:0045915,1,0.920893137136098,0,6,positive regulation of catecholamine metabolic process,BP,
12417,GO:0045916,1,0.889338251987226,0,8,negative regulation of complement activation,BP,
12418,GO:0045917,1,0.955032504130211,0,3,positive regulation of complement activation,BP,
12419,GO:0045918,1,0.965961815382761,0,4,negative regulation of cytolysis,BP,
12420,GO:0045919,1,0.931227534257563,0,5,positive regulation of cytolysis,BP,
12424,GO:0045923,1,0.670703954524551,0,30,positive regulation of fatty acid metabolic process,BP,
12425,GO:0045924,1,0.904364808097689,0,8,regulation of female receptivity,BP,
12426,GO:0045925,1,0.964933208568542,0,3,positive regulation of female receptivity,BP,
12437,GO:0045938,1,0.937551269401603,0,7,positive regulation of circadian sleep/wake cycle, sleep,BP,
12440,GO:0045943,1,0.724329949168184,0,21,positive regulation of transcription from RNA polymerase I promoter,BP,
12442,GO:0045945,1,0.866231686087102,0,9,positive regulation of transcription from RNA polymerase III promoter,BP,
12443,GO:0045947,1,0.749204863785646,0,21,negative regulation of translational initiation,BP,
12444,GO:0045948,1,0.714274350588056,0,23,positive regulation of translational initiation,BP,
12445,GO:0045950,1,0.939732837346372,0,4,negative regulation of mitotic recombination,BP,
12446,GO:0045953,1,0.871755178003013,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12447,GO:0045954,1,0.775127254480401,0,18,positive regulation of natural killer cell mediated cytotoxicity,BP,
12449,GO:0045956,1,0.730202992124314,0,21,positive regulation of calcium ion-dependent exocytosis,BP,
12450,GO:0045957,1,0.983406759350836,0,1,negative regulation of complement activation, alternative pathway,BP,
12451,GO:0045959,1,0.962407250993915,0,3,negative regulation of complement activation, classical pathway,BP,
12452,GO:0045963,1,0.969535120885246,0,2,negative regulation of dopamine metabolic process,BP,
12453,GO:0045964,1,0.920893137136098,0,6,positive regulation of dopamine metabolic process,BP,
12454,GO:0045974,1,0.823978812355685,0,13,regulation of translation, ncRNA-mediated,BP,
12455,GO:0045976,1,0.967172102597502,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12456,GO:0045977,1,0.989558758734677,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12463,GO:0045990,1,0.916726916133,0,6,carbon catabolite regulation of transcription,BP,
12464,GO:0045991,1,0.930332096989262,0,5,carbon catabolite activation of transcription,BP,
12466,GO:0045993,1,0.983406759352021,0,1,negative regulation of translational initiation by iron,BP,
12467,GO:0045994,1,0.971947206627272,0,2,positive regulation of translational initiation by iron,BP,
12469,GO:0046005,1,0.983273746827572,0,3,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12470,GO:0046006,1,0.599716490676879,0,39,regulation of activated T cell proliferation,BP,
12471,GO:0046007,1,0.860214937871694,0,10,negative regulation of activated T cell proliferation,BP,
12472,GO:0046010,1,0.968303008141926,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12473,GO:0046013,1,0.968520153644511,0,3,regulation of T cell homeostatic proliferation,BP,
12474,GO:0046015,1,0.921294399641077,0,6,regulation of transcription by glucose,BP,
12475,GO:0046016,1,0.946033436923204,0,4,positive regulation of transcription by glucose,BP,
12476,GO:0046021,1,0.951038409344301,0,3,regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
12477,GO:0046022,1,0.983406759351724,0,1,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
12478,GO:0046030,1,0.836998848283537,0,11,inositol trisphosphate phosphatase activity,MF,
12480,GO:0046032,1,0.98907757123283,0,1,ADP catabolic process,BP,
12481,GO:0046033,1,0.844661720857303,0,12,AMP metabolic process,BP,
12483,GO:0046035,1,0.990832232705604,0,1,CMP metabolic process,BP,
12484,GO:0046036,1,0.85574231062498,0,14,CTP metabolic process,BP,
12485,GO:0046037,1,0.738422846720484,0,20,GMP metabolic process,BP,
12486,GO:0046038,1,0.98976807092467,0,1,GMP catabolic process,BP,
12488,GO:0046040,1,0.822905383372137,0,13,IMP metabolic process,BP,
12489,GO:0046041,1,0.976430459819816,0,2,ITP metabolic process,BP,
12490,GO:0046048,1,0.98394879876846,0,1,UDP metabolic process,BP,
12491,GO:0046049,1,0.868771643087135,0,10,UMP metabolic process,BP,
12492,GO:0046051,1,0.886725182780701,0,11,UTP metabolic process,BP,
12493,GO:0046054,1,0.992540372159341,0,1,dGMP metabolic process,BP,
12494,GO:0046056,1,0.972781975097494,0,2,dADP metabolic process,BP,
12495,GO:0046057,1,0.989166641157437,0,1,dADP catabolic process,BP,
12497,GO:0046060,1,0.947328966218449,0,5,dATP metabolic process,BP,
12498,GO:0046061,1,0.967535333247733,0,3,dATP catabolic process,BP,
12499,GO:0046065,1,0.991683767070938,0,1,dCTP metabolic process,BP,
12500,GO:0046066,1,0.981787491372651,0,2,dGDP metabolic process,BP,
12501,GO:0046067,1,0.989166641157437,0,1,dGDP catabolic process,BP,
12503,GO:0046069,1,0.895545406962368,0,7,cGMP catabolic process,BP,
12504,GO:0046070,1,0.957817736513548,0,4,dGTP metabolic process,BP,
12505,GO:0046072,1,0.975549463919345,0,2,dTDP metabolic process,BP,
12506,GO:0046073,1,0.973971773613311,0,2,dTMP metabolic process,BP,
12507,GO:0046075,1,0.955323328130025,0,4,dTTP metabolic process,BP,
12508,GO:0046077,1,0.975549463919345,0,2,dUDP metabolic process,BP,
12509,GO:0046078,1,0.965283199824416,0,3,dUMP metabolic process,BP,
12510,GO:0046079,1,0.988786191140326,0,1,dUMP catabolic process,BP,
12511,GO:0046080,1,0.987298000092628,0,1,dUTP metabolic process,BP,
12512,GO:0046083,1,0.984158419585502,0,2,adenine metabolic process,BP,
12513,GO:0046084,1,0.984158419585502,0,2,adenine biosynthetic process,BP,
12514,GO:0046085,1,0.906749642291164,0,7,adenosine metabolic process,BP,
12515,GO:0046086,1,0.970107865157504,0,2,adenosine biosynthetic process,BP,
12516,GO:0046087,1,0.908009652279371,0,9,cytidine metabolic process,BP,
12517,GO:0046090,1,0.989057545717563,0,1,deoxyadenosine metabolic process,BP,
12518,GO:0046092,1,0.983406759351921,0,1,deoxycytidine metabolic process,BP,
12519,GO:0046098,1,0.957522881689919,0,3,guanine metabolic process,BP,
12520,GO:0046099,1,0.98976807092467,0,1,guanine biosynthetic process,BP,
12521,GO:0046100,1,0.965290379338206,0,3,hypoxanthine metabolic process,BP,
12522,GO:0046101,1,0.965290379338206,0,3,hypoxanthine biosynthetic process,BP,
12523,GO:0046102,1,0.974370351618725,0,2,inosine metabolic process,BP,
12524,GO:0046103,1,0.989057545717563,0,1,inosine biosynthetic process,BP,
12525,GO:0046104,1,0.956472181407716,0,3,thymidine metabolic process,BP,
12526,GO:0046108,1,0.972938588902751,0,2,uridine metabolic process,BP,
12527,GO:0046110,1,0.956503957871376,0,3,xanthine metabolic process,BP,
12528,GO:0046111,1,0.989057545717563,0,1,xanthine biosynthetic process,BP,
12529,GO:0046112,1,0.778588201194788,0,17,nucleobase biosynthetic process,BP,
12530,GO:0046113,1,0.90964039673932,0,6,nucleobase catabolic process,BP,
12531,GO:0046116,1,0.941712333273235,0,6,queuosine metabolic process,BP,
12532,GO:0046121,1,0.96128856580197,0,3,deoxyribonucleoside catabolic process,BP,
12533,GO:0046122,1,0.981536021315733,0,2,purine deoxyribonucleoside metabolic process,BP,
12534,GO:0046124,1,0.989057545717563,0,1,purine deoxyribonucleoside catabolic process,BP,
12535,GO:0046125,1,0.956472181407716,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12536,GO:0046127,1,0.983704967407228,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12538,GO:0046129,1,0.78555059696642,0,21,purine ribonucleoside biosynthetic process,BP,
12539,GO:0046130,1,0.924565908424069,0,6,purine ribonucleoside catabolic process,BP,
12540,GO:0046131,1,0.677604048588637,0,32,pyrimidine ribonucleoside metabolic process,BP,
12541,GO:0046132,1,0.770471490492143,0,21,pyrimidine ribonucleoside biosynthetic process,BP,
12542,GO:0046133,1,0.882345135207077,0,11,pyrimidine ribonucleoside catabolic process,BP,
12543,GO:0046134,1,0.697000571074207,0,29,pyrimidine nucleoside biosynthetic process,BP,
12544,GO:0046135,1,0.787118394283412,0,20,pyrimidine nucleoside catabolic process,BP,
12545,GO:0046136,1,0.969017913690411,0,3,positive regulation of vitamin metabolic process,BP,
12546,GO:0046137,1,0.920908175267337,0,6,negative regulation of vitamin metabolic process,BP,
12547,GO:0046144,1,0.988702664278225,0,1,D-alanine family amino acid metabolic process,BP,
12548,GO:0046146,1,0.921651164248646,0,7,tetrahydrobiopterin metabolic process,BP,
12550,GO:0046149,1,0.925101853984493,0,7,pigment catabolic process,BP,
12551,GO:0046160,1,0.967525846480413,0,2,heme a metabolic process,BP,
12552,GO:0046164,1,0.52965496390338,0,46,alcohol catabolic process,BP,
12554,GO:0046166,1,0.975904009919937,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12555,GO:0046167,1,0.954876591004031,0,3,glycerol-3-phosphate biosynthetic process,BP,
12556,GO:0046168,1,0.967707322521919,0,2,glycerol-3-phosphate catabolic process,BP,
12557,GO:0046173,1,0.558957178059881,0,40,polyol biosynthetic process,BP,
12558,GO:0046174,1,0.763658498305889,0,18,polyol catabolic process,BP,
12559,GO:0046176,1,0.984725543253726,0,1,aldonic acid catabolic process,BP,
12560,GO:0046177,1,0.984725543253726,0,1,D-gluconate catabolic process,BP,
12562,GO:0046185,1,0.863401134403558,0,11,aldehyde catabolic process,BP,
12564,GO:0046203,1,0.979500676151192,0,2,spermidine catabolic process,BP,
12565,GO:0046204,1,0.992720656742466,0,1,nor-spermidine metabolic process,BP,
12566,GO:0046208,1,0.953166480876689,0,4,spermine catabolic process,BP,
12568,GO:0046210,1,0.984866510742938,0,1,nitric oxide catabolic process,BP,
12569,GO:0046218,1,0.868271959574948,0,11,indolalkylamine catabolic process,BP,
12570,GO:0046219,1,0.94064300998448,0,5,indolalkylamine biosynthetic process,BP,
12571,GO:0046222,1,0.985501663355894,0,1,aflatoxin metabolic process,BP,
12572,GO:0046226,1,0.979102547103233,0,2,coumarin catabolic process,BP,
12573,GO:0046247,1,0.984068730074366,0,1,terpene catabolic process,BP,
12574,GO:0046271,1,0.979102547103233,0,2,phenylpropanoid catabolic process,BP,
12575,GO:0046272,1,0.985864225629554,0,1,stilbene catabolic process,BP,
12576,GO:0046292,1,0.959607777075185,0,3,formaldehyde metabolic process,BP,
12577,GO:0046293,1,0.983406759351968,0,1,formaldehyde biosynthetic process,BP,
12578,GO:0046294,1,0.975801111372336,0,2,formaldehyde catabolic process,BP,
12579,GO:0046295,1,0.992937098316418,0,1,glycolate biosynthetic process,BP,
12580,GO:0046296,1,0.987912194602553,0,1,glycolate catabolic process,BP,
12581,GO:0046305,1,0.973186586464852,0,2,alkanesulfonate biosynthetic process,BP,
12582,GO:0046314,1,0.988938071724141,0,1,phosphocreatine biosynthetic process,BP,
12583,GO:0046316,1,0.984725543253726,0,1,gluconokinase activity,MF,
12584,GO:0046317,1,0.983406759351869,0,1,regulation of glucosylceramide biosynthetic process,BP,
12585,GO:0046318,1,0.983406759351869,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12587,GO:0046321,1,0.813634505524324,0,14,positive regulation of fatty acid oxidation,BP,
12591,GO:0046325,1,0.845027492911615,0,12,negative regulation of glucose import,BP,
12593,GO:0046327,1,0.984417449295282,0,1,glycerol biosynthetic process from pyruvate,BP,
12599,GO:0046333,1,0.968286448699606,0,2,octopamine metabolic process,BP,
12600,GO:0046337,1,0.792949729546629,0,15,phosphatidylethanolamine metabolic process,BP,
12601,GO:0046338,1,0.968043107019762,0,2,phosphatidylethanolamine catabolic process,BP,
12602,GO:0046339,1,0.813890531389422,0,15,diacylglycerol metabolic process,BP,
12603,GO:0046340,1,0.963525927742913,0,3,diacylglycerol catabolic process,BP,
12604,GO:0046341,1,0.831041974345383,0,12,CDP-diacylglycerol metabolic process,BP,
12605,GO:0046348,1,0.888566612601076,0,9,amino sugar catabolic process,BP,
12606,GO:0046349,1,0.850077067601143,0,11,amino sugar biosynthetic process,BP,
12607,GO:0046351,1,0.942097882876189,0,5,disaccharide biosynthetic process,BP,
12608,GO:0046352,1,0.987345885905482,0,1,disaccharide catabolic process,BP,
12609,GO:0046356,1,0.978632772423284,0,2,acetyl-CoA catabolic process,BP,
12610,GO:0046360,1,0.986228697844103,0,1,2-oxobutyrate biosynthetic process,BP,
12611,GO:0046361,1,0.986228697844103,0,1,2-oxobutyrate metabolic process,BP,
12614,GO:0046368,1,0.946442767412983,0,4,GDP-L-fucose metabolic process,BP,
12615,GO:0046370,1,0.974816383285237,0,2,fructose biosynthetic process,BP,
12616,GO:0046373,1,0.984725543253726,0,1,L-arabinose metabolic process,BP,
12617,GO:0046379,1,0.955020551997093,0,3,extracellular polysaccharide metabolic process,BP,
12618,GO:0046380,1,0.983410946112961,0,1,N-acetylneuraminate biosynthetic process,BP,
12619,GO:0046381,1,0.990870761894025,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12620,GO:0046385,1,0.894568884246667,0,9,deoxyribose phosphate biosynthetic process,BP,
12621,GO:0046386,1,0.791489362584919,0,19,deoxyribose phosphate catabolic process,BP,
12623,GO:0046391,1,0.947949035426248,0,4,5-phosphoribose 1-diphosphate metabolic process,BP,
12626,GO:0046398,1,0.938049786709725,0,4,UDP-glucuronate metabolic process,BP,
12627,GO:0046403,1,0.988025773396631,0,1,polynucleotide 3'-phosphatase activity,MF,
12628,GO:0046404,1,0.959894115260203,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12629,GO:0046415,1,0.850376117410174,0,11,urate metabolic process,BP,
12630,GO:0046416,1,0.962722697504562,0,3,D-amino acid metabolic process,BP,
12632,GO:0046426,1,0.474577153242967,0,49,negative regulation of JAK-STAT cascade,BP,
12635,GO:0046436,1,0.988702664278225,0,1,D-alanine metabolic process,BP,
12636,GO:0046437,1,0.984950340754611,0,1,D-amino acid biosynthetic process,BP,
12637,GO:0046439,1,0.902215010266253,0,7,L-cysteine metabolic process,BP,
12638,GO:0046440,1,0.939835550948735,0,4,L-lysine metabolic process,BP,
12639,GO:0046443,1,0.986837428914268,0,1,FAD metabolic process,BP,
12640,GO:0046444,1,0.984367960048915,0,1,FMN metabolic process,BP,
12641,GO:0046448,1,0.985058090684018,0,1,tropane alkaloid metabolic process,BP,
12642,GO:0046449,1,0.93525434783003,0,4,creatinine metabolic process,BP,
12643,GO:0046452,1,0.96993162582425,0,2,dihydrofolate metabolic process,BP,
12646,GO:0046459,1,0.833960350413877,0,13,short-chain fatty acid metabolic process,BP,
12647,GO:0046460,1,0.541257671172097,0,42,neutral lipid biosynthetic process,BP,
12649,GO:0046462,1,0.972656394219515,0,2,monoacylglycerol metabolic process,BP,
12650,GO:0046463,1,0.541257671172097,0,42,acylglycerol biosynthetic process,BP,
12652,GO:0046465,1,0.901722874262242,0,7,dolichyl diphosphate metabolic process,BP,
12653,GO:0046466,1,0.713247657982845,0,24,membrane lipid catabolic process,BP,
12654,GO:0046467,1,0.189534513921745,0,116,membrane lipid biosynthetic process,BP,
12655,GO:0046469,1,0.917459746633343,0,6,platelet activating factor metabolic process,BP,
12657,GO:0046471,1,0.648164725698249,0,31,phosphatidylglycerol metabolic process,BP,
12658,GO:0046473,1,0.600242596244129,0,35,phosphatidic acid metabolic process,BP,
12660,GO:0046475,1,0.777742819469034,0,17,glycerophospholipid catabolic process,BP,
12661,GO:0046476,1,0.9447981362845,0,4,glycosylceramide biosynthetic process,BP,
12662,GO:0046477,1,0.917729864900519,0,6,glycosylceramide catabolic process,BP,
12663,GO:0046479,1,0.84508728508301,0,12,glycosphingolipid catabolic process,BP,
12665,GO:0046485,1,0.907887211725122,0,7,ether lipid metabolic process,BP,
12669,GO:0046490,1,0.942199541342896,0,5,isopentenyl diphosphate metabolic process,BP,
12670,GO:0046491,1,0.993395968098118,0,1,L-methylmalonyl-CoA metabolic process,BP,
12671,GO:0046493,1,0.994875889508817,0,1,lipid A metabolic process,BP,
12672,GO:0046495,1,0.985150987584955,0,1,nicotinamide riboside metabolic process,BP,
12674,GO:0046498,1,0.923391687671983,0,6,S-adenosylhomocysteine metabolic process,BP,
12675,GO:0046499,1,0.983585198051488,0,1,S-adenosylmethioninamine metabolic process,BP,
12676,GO:0046500,1,0.834616845093734,0,13,S-adenosylmethionine metabolic process,BP,
12677,GO:0046501,1,0.872204802726683,0,10,protoporphyrinogen IX metabolic process,BP,
12678,GO:0046502,1,0.97627901406532,0,2,uroporphyrinogen III metabolic process,BP,
12680,GO:0046504,1,0.941869820187888,0,4,glycerol ether biosynthetic process,BP,
12681,GO:0046511,1,0.97088420741765,0,2,sphinganine biosynthetic process,BP,
12682,GO:0046512,1,0.8918793003278,0,8,sphingosine biosynthetic process,BP,
12683,GO:0046513,1,0.498545209263356,0,47,ceramide biosynthetic process,BP,
12684,GO:0046514,1,0.838207567161141,0,13,ceramide catabolic process,BP,
12685,GO:0046519,1,0.832260744484797,0,13,sphingoid metabolic process,BP,
12686,GO:0046520,1,0.877074607936758,0,9,sphingoid biosynthetic process,BP,
12687,GO:0046521,1,0.987336285518239,0,1,sphingoid catabolic process,BP,
12688,GO:0046523,1,0.983725227849235,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12689,GO:0046525,1,0.988030968847852,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12690,GO:0046526,1,0.98481024597292,0,1,D-xylulose reductase activity,MF,
12691,GO:0046527,1,0.786629058587136,0,16,glucosyltransferase activity,MF,
12695,GO:0046534,1,0.983406759352021,0,1,positive regulation of photoreceptor cell differentiation,BP,
12696,GO:0046538,1,0.957531351123574,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12697,GO:0046539,1,0.993140998787335,0,1,histamine N-methyltransferase activity,MF,
12698,GO:0046540,1,0.790394931411008,0,19,U4/U6 x U5 tri-snRNP complex,CC,
12701,GO:0046544,1,0.983406759351869,0,1,development of secondary male sexual characteristics,BP,
12704,GO:0046548,1,0.865463062668149,0,9,retinal rod cell development,BP,
12705,GO:0046549,1,0.870576206343233,0,9,retinal cone cell development,BP,
12706,GO:0046554,1,0.990444976415237,0,1,malate dehydrogenase (NADP+) activity,MF,
12707,GO:0046556,1,0.984725543253726,0,1,alpha-L-arabinofuranosidase activity,MF,
12708,GO:0046570,1,0.990742633015776,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12709,GO:0046573,1,0.967900783938756,0,3,lactonohydrolase activity,MF,
12710,GO:0046577,1,0.983412716843929,0,1,long-chain-alcohol oxidase activity,MF,
12714,GO:0046581,1,0.907553568401316,0,6,intercellular canaliculus,CC,
12715,GO:0046586,1,0.977076594787865,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12716,GO:0046587,1,0.983839083913376,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12717,GO:0046588,1,0.993126893392477,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12718,GO:0046592,1,0.974742667701771,0,2,polyamine oxidase activity,MF,
12719,GO:0046596,1,0.690918876932796,0,29,regulation of viral entry into host cell,BP,
12720,GO:0046597,1,0.791927644023059,0,19,negative regulation of viral entry into host cell,BP,
12721,GO:0046598,1,0.88739442244735,0,9,positive regulation of viral entry into host cell,BP,
12722,GO:0046599,1,0.794306617155344,0,15,regulation of centriole replication,BP,
12723,GO:0046600,1,0.914478619709387,0,6,negative regulation of centriole replication,BP,
12724,GO:0046601,1,0.95128149334959,0,3,positive regulation of centriole replication,BP,
12725,GO:0046602,1,0.874485940080536,0,9,regulation of mitotic centrosome separation,BP,
12726,GO:0046604,1,0.930231595701672,0,5,positive regulation of mitotic centrosome separation,BP,
12728,GO:0046606,1,0.867604634490421,0,10,negative regulation of centrosome cycle,BP,
12729,GO:0046607,1,0.843678438089177,0,11,positive regulation of centrosome cycle,BP,
12730,GO:0046618,1,0.927086229174731,0,5,drug export,BP,
12731,GO:0046619,1,0.967441755526005,0,2,optic placode formation involved in camera-type eye formation,BP,
12733,GO:0046621,1,0.700534826482812,0,23,negative regulation of organ growth,BP,
12735,GO:0046623,1,0.983406759351921,0,1,sphingolipid-translocating ATPase activity,MF,
12736,GO:0046624,1,0.92611227655608,0,5,sphingolipid transporter activity,MF,
12737,GO:0046625,1,0.815637339341237,0,14,sphingolipid binding,MF,
12739,GO:0046627,1,0.639642267550028,0,30,negative regulation of insulin receptor signaling pathway,BP,
12740,GO:0046628,1,0.838449809131174,0,12,positive regulation of insulin receptor signaling pathway,BP,
12744,GO:0046633,1,0.694020484176066,0,26,alpha-beta T cell proliferation,BP,
12745,GO:0046634,1,0.356573027401315,0,74,regulation of alpha-beta T cell activation,BP,
12746,GO:0046635,1,0.498394456625377,0,50,positive regulation of alpha-beta T cell activation,BP,
12747,GO:0046636,1,0.689700448002947,0,27,negative regulation of alpha-beta T cell activation,BP,
12748,GO:0046637,1,0.478502601282224,0,53,regulation of alpha-beta T cell differentiation,BP,
12749,GO:0046638,1,0.587275060349619,0,38,positive regulation of alpha-beta T cell differentiation,BP,
12750,GO:0046639,1,0.78060148492961,0,18,negative regulation of alpha-beta T cell differentiation,BP,
12751,GO:0046640,1,0.726312870636049,0,23,regulation of alpha-beta T cell proliferation,BP,
12752,GO:0046641,1,0.772895996618246,0,19,positive regulation of alpha-beta T cell proliferation,BP,
12753,GO:0046642,1,0.935943781654347,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12754,GO:0046643,1,0.890040335924626,0,7,regulation of gamma-delta T cell activation,BP,
12755,GO:0046645,1,0.920341084838973,0,5,positive regulation of gamma-delta T cell activation,BP,
12758,GO:0046653,1,0.780194337388844,0,17,tetrahydrofolate metabolic process,BP,
12759,GO:0046654,1,0.910525929677409,0,6,tetrahydrofolate biosynthetic process,BP,
12760,GO:0046655,1,0.769074574444836,0,18,folic acid metabolic process,BP,
12761,GO:0046657,1,0.993296574005966,0,1,folic acid catabolic process,BP,
12762,GO:0046658,1,0.571964525789737,0,44,anchored component of plasma membrane,CC,
12765,GO:0046666,1,0.952658449786203,0,4,retinal cell programmed cell death,BP,
12766,GO:0046668,1,0.970846323434077,0,2,regulation of retinal cell programmed cell death,BP,
12767,GO:0046671,1,0.983408545672986,0,1,negative regulation of retinal cell programmed cell death,BP,
12770,GO:0046680,1,0.986326983415046,0,1,response to DDT,BP,
12772,GO:0046684,1,0.948792486054228,0,4,response to pyrethroid,BP,
12775,GO:0046687,1,0.991827849197741,0,1,response to chromate,BP,
12776,GO:0046688,1,0.72252839823473,0,25,response to copper ion,BP,
12777,GO:0046689,1,0.865391086853165,0,11,response to mercury ion,BP,
12778,GO:0046690,1,0.983468694959197,0,1,response to tellurium ion,BP,
12779,GO:0046691,1,0.984065276371003,0,1,intracellular canaliculus,CC,
12780,GO:0046692,1,0.993346233364737,0,1,sperm competition,BP,
12781,GO:0046696,1,0.922756401713148,0,6,lipopolysaccharide receptor complex,CC,
12784,GO:0046703,1,0.913879548812972,0,9,natural killer cell lectin-like receptor binding,MF,
12785,GO:0046707,1,0.972664826975551,0,2,IDP metabolic process,BP,
12786,GO:0046709,1,0.972664826975551,0,2,IDP catabolic process,BP,
12787,GO:0046710,1,0.806301096956044,0,14,GDP metabolic process,BP,
12788,GO:0046711,1,0.992540372159341,0,1,GDP biosynthetic process,BP,
12789,GO:0046712,1,0.989166641157437,0,1,GDP catabolic process,BP,
12790,GO:0046713,1,0.983715246434126,0,1,borate transport,BP,
12791,GO:0046715,1,0.983715246434126,0,1,borate transmembrane transporter activity,MF,
12792,GO:0046716,1,0.780932009884931,0,17,muscle cell cellular homeostasis,BP,
12795,GO:0046719,1,0.87430284064381,0,9,regulation by virus of viral protein levels in host cell,BP,
12796,GO:0046724,1,0.973350205383178,0,2,oxalic acid secretion,BP,
12797,GO:0046725,1,0.983442576502009,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12798,GO:0046726,1,0.951085557789735,0,3,positive regulation by virus of viral protein levels in host cell,BP,
12799,GO:0046730,1,0.975415942898039,0,2,induction of host immune response by virus,BP,
12800,GO:0046732,1,0.975415942898039,0,2,active induction of host immune response by virus,BP,
12801,GO:0046745,1,0.984725543253726,0,1,viral capsid secondary envelopment,BP,
12802,GO:0046755,1,0.721381694884738,0,24,viral budding,BP,
12804,GO:0046778,1,0.971663171415908,0,2,modification by virus of host mRNA processing,BP,
12805,GO:0046782,1,0.418251632070332,0,64,regulation of viral transcription,BP,
12806,GO:0046784,1,0.898512509222484,0,8,viral mRNA export from host cell nucleus,BP,
12808,GO:0046786,1,0.983406759351921,0,1,viral replication complex formation and maintenance,BP,
12810,GO:0046790,1,0.897974401989924,0,8,virion binding,MF,
12812,GO:0046811,1,0.978746647441688,0,2,histone deacetylase inhibitor activity,MF,
12815,GO:0046817,1,0.990967421310024,0,1,chemokine receptor antagonist activity,MF,
12820,GO:0046826,1,0.918580270481966,0,7,negative regulation of protein export from nucleus,BP,
12822,GO:0046831,1,0.838321827478742,0,11,regulation of RNA export from nucleus,BP,
12823,GO:0046832,1,0.967087733486563,0,2,negative regulation of RNA export from nucleus,BP,
12824,GO:0046833,1,0.955157569276578,0,3,positive regulation of RNA export from nucleus,BP,
12827,GO:0046836,1,0.927412223000957,0,6,glycolipid transport,BP,
12828,GO:0046838,1,0.852015402006709,0,10,phosphorylated carbohydrate dephosphorylation,BP,
12829,GO:0046839,1,0.667928933219622,0,25,phospholipid dephosphorylation,BP,
12831,GO:0046848,1,0.985317016326279,0,3,hydroxyapatite binding,MF,
12835,GO:0046852,1,0.827833639199503,0,13,positive regulation of bone remodeling,BP,
12837,GO:0046855,1,0.86610968867161,0,9,inositol phosphate dephosphorylation,BP,
12838,GO:0046856,1,0.677521580237538,0,24,phosphatidylinositol dephosphorylation,BP,
12839,GO:0046864,1,0.992965141711302,0,1,isoprenoid transport,BP,
12840,GO:0046865,1,0.992965141711302,0,1,terpenoid transport,BP,
12841,GO:0046870,1,0.929920709415824,0,6,cadmium ion binding,MF,
12844,GO:0046874,1,0.94437183747378,0,5,quinolinate metabolic process,BP,
12847,GO:0046878,1,0.955298756152648,0,4,positive regulation of saliva secretion,BP,
12860,GO:0046898,1,0.942113990629201,0,4,response to cycloheximide,BP,
12861,GO:0046899,1,0.969477356692713,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12862,GO:0046900,1,0.984918230711999,0,1,tetrahydrofolylpolyglutamate metabolic process,BP,
12863,GO:0046901,1,0.984918230711999,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12866,GO:0046904,1,0.989654070168948,0,1,calcium oxalate binding,MF,
12869,GO:0046909,1,0.984540639831349,0,1,intermembrane transport,BP,
12870,GO:0046911,1,0.991273345505357,0,1,metal chelating activity,MF,
12875,GO:0046920,1,0.884568673379989,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12876,GO:0046921,1,0.983567422310223,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12877,GO:0046922,1,0.967545042188632,0,2,peptide-O-fucosyltransferase activity,MF,
12878,GO:0046923,1,0.949758583163763,0,4,ER retention sequence binding,MF,
12879,GO:0046928,1,0.464588101519313,0,51,regulation of neurotransmitter secretion,BP,
12880,GO:0046929,1,0.842313522363018,0,11,negative regulation of neurotransmitter secretion,BP,
12881,GO:0046930,1,0.79296495608186,0,17,pore complex,CC,
12882,GO:0046931,1,0.801944322380849,0,15,pore complex assembly,BP,
12883,GO:0046933,1,0.869073976363027,0,16,proton-transporting ATP synthase activity, rotational mechanism,MF,
12887,GO:0046940,1,0.960844667484029,0,3,nucleoside monophosphate phosphorylation,BP,
12889,GO:0046943,1,0.135033906279217,0,131,carboxylic acid transmembrane transporter activity,MF,
12890,GO:0046946,1,0.95189184599814,0,3,hydroxylysine metabolic process,BP,
12891,GO:0046947,1,0.95189184599814,0,3,hydroxylysine biosynthetic process,BP,
12895,GO:0046952,1,0.941934426869689,0,4,ketone body catabolic process,BP,
12896,GO:0046958,1,0.906462231359525,0,6,nonassociative learning,BP,
12897,GO:0046959,1,0.93536198469807,0,4,habituation,BP,
12898,GO:0046960,1,0.969050403272756,0,2,sensitization,BP,
12899,GO:0046961,1,0.783258656134591,0,19,proton-transporting ATPase activity, rotational mechanism,MF,
12900,GO:0046963,1,0.973150642509117,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12901,GO:0046964,1,0.973150642509117,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12903,GO:0046966,1,0.680142497768218,0,27,thyroid hormone receptor binding,MF,
12904,GO:0046967,1,0.967584452208903,0,2,cytosol to ER transport,BP,
12905,GO:0046968,1,0.954993768942977,0,3,peptide antigen transport,BP,
12906,GO:0046969,1,0.972097952485832,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12907,GO:0046970,1,0.986952701688737,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12908,GO:0046972,1,0.868563432091037,0,9,histone acetyltransferase activity (H4-K16 specific),MF,
12909,GO:0046974,1,0.920917151401425,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12910,GO:0046975,1,0.913779165685372,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12911,GO:0046976,1,0.952132548439274,0,3,histone methyltransferase activity (H3-K27 specific),MF,
12912,GO:0046977,1,0.942618326064986,0,4,TAP binding,MF,
12913,GO:0046978,1,0.942618326064986,0,4,TAP1 binding,MF,
12914,GO:0046979,1,0.958526149826587,0,3,TAP2 binding,MF,
12915,GO:0046980,1,0.983406759352069,0,1,tapasin binding,MF,
12918,GO:0046984,1,0.944143707966717,0,4,regulation of hemoglobin biosynthetic process,BP,
12919,GO:0046985,1,0.960077167462782,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12920,GO:0046986,1,0.983406759352021,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12921,GO:0046997,1,0.967559501536214,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12922,GO:0047006,1,0.979755429315894,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12923,GO:0047012,1,0.988708213662624,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12924,GO:0047015,1,0.992814717333676,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12925,GO:0047016,1,0.985944239318523,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12926,GO:0047017,1,0.975824004580957,0,2,prostaglandin-F synthase activity,MF,
12927,GO:0047020,1,0.990960962472649,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12928,GO:0047021,1,0.990851487642679,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12929,GO:0047023,1,0.972354232589553,0,3,androsterone dehydrogenase activity,MF,
12930,GO:0047025,1,0.976123518412257,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12931,GO:0047035,1,0.942777314953706,0,6,testosterone dehydrogenase (NAD+) activity,MF,
12932,GO:0047042,1,0.989980362197353,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12933,GO:0047045,1,0.973584241884541,0,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12934,GO:0047057,1,0.984455821611115,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12935,GO:0047066,1,0.992888085362856,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12936,GO:0047086,1,0.970545043139177,0,3,ketosteroid monooxygenase activity,MF,
12937,GO:0047105,1,0.984875059645845,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12938,GO:0047115,1,0.962687773151717,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12940,GO:0047127,1,0.990032360309125,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12941,GO:0047130,1,0.983406759351673,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12942,GO:0047131,1,0.983406759351673,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12943,GO:0047134,1,0.92696423395801,0,7,protein-disulfide reductase activity,MF,
12945,GO:0047150,1,0.984886502439107,0,1,betaine-homocysteine S-methyltransferase activity,MF,
12946,GO:0047159,1,0.983406825885121,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12947,GO:0047166,1,0.987095406872922,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12948,GO:0047173,1,0.983406759351921,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12949,GO:0047179,1,0.983204941528027,0,2,platelet-activating factor acetyltransferase activity,MF,
12950,GO:0047184,1,0.928864430620307,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12951,GO:0047191,1,0.983406825885121,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12952,GO:0047192,1,0.954606203801469,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12953,GO:0047196,1,0.976190427317539,0,2,long-chain-alcohol O-fatty-acyltransferase activity,MF,
12954,GO:0047198,1,0.991993106288264,0,1,cysteine-S-conjugate N-acetyltransferase activity,MF,
12955,GO:0047220,1,0.984201261277316,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12956,GO:0047223,1,0.954051450197602,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12957,GO:0047224,1,0.98491243352299,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12958,GO:0047225,1,0.985822848464919,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
12959,GO:0047237,1,0.951670032393153,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12960,GO:0047238,1,0.920227656797009,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12961,GO:0047256,1,0.983406759352069,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12962,GO:0047263,1,0.983994698202427,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12963,GO:0047273,1,0.983550555637331,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12964,GO:0047275,1,0.969709724459592,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12965,GO:0047277,1,0.986943591629161,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12966,GO:0047280,1,0.983406759352018,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12967,GO:0047288,1,0.976810450998741,0,2,monosialoganglioside sialyltransferase activity,MF,
12968,GO:0047290,1,0.988450374012827,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12969,GO:0047291,1,0.98549472495242,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12970,GO:0047293,1,0.988482947792151,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12971,GO:0047298,1,0.983406759351921,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12972,GO:0047305,1,0.985704574923737,0,1,(R)-3-amino-2-methylpropionate-pyruvate transaminase activity,MF,
12973,GO:0047322,1,0.967087733486801,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12974,GO:0047323,1,0.986160124869071,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12975,GO:0047325,1,0.983591402321654,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12976,GO:0047326,1,0.987684184735078,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12977,GO:0047341,1,0.983492632555574,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12978,GO:0047372,1,0.86234978779484,0,10,acylglycerol lipase activity,MF,
12979,GO:0047374,1,0.96169043719617,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12980,GO:0047389,1,0.967325907102214,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12981,GO:0047390,1,0.983406899176178,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12982,GO:0047391,1,0.967586168047096,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12983,GO:0047394,1,0.985750403661147,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12984,GO:0047395,1,0.983942765591477,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12985,GO:0047408,1,0.987917327316101,0,1,alkenylglycerophosphocholine hydrolase activity,MF,
12986,GO:0047409,1,0.987917327316101,0,1,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12987,GO:0047429,1,0.893966018757866,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12988,GO:0047442,1,0.98730755402416,0,1,17-alpha-hydroxyprogesterone aldolase activity,MF,
12989,GO:0047444,1,0.990870761894025,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12991,GO:0047464,1,0.983406759351921,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12992,GO:0047484,1,0.878337493206025,0,9,regulation of response to osmotic stress,BP,
12994,GO:0047493,1,0.95670555546659,0,3,ceramide cholinephosphotransferase activity,MF,
12995,GO:0047496,1,0.582717013917338,0,36,vesicle transport along microtubule,BP,
12996,GO:0047497,1,0.777357030469018,0,17,mitochondrion transport along microtubule,BP,
12997,GO:0047498,1,0.900035448471579,0,8,calcium-dependent phospholipase A2 activity,MF,
12998,GO:0047499,1,0.915364135977969,0,6,calcium-independent phospholipase A2 activity,MF,
12999,GO:0047522,1,0.959481486092469,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
13000,GO:0047536,1,0.985802297981742,0,1,2-aminoadipate transaminase activity,MF,
13001,GO:0047545,1,0.983406759351627,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
13002,GO:0047555,1,0.813674620892896,0,14,3',5'-cyclic-GMP phosphodiesterase activity,MF,
13003,GO:0047560,1,0.983406759351872,0,1,3-dehydrosphinganine reductase activity,MF,
13004,GO:0047598,1,0.984483887631901,0,1,7-dehydrocholesterol reductase activity,MF,
13005,GO:0047617,1,0.801191862568556,0,17,acyl-CoA hydrolase activity,MF,
13006,GO:0047620,1,0.983942765591477,0,1,acylglycerol kinase activity,MF,
13007,GO:0047621,1,0.988273030974696,0,1,acylpyruvate hydrolase activity,MF,
13008,GO:0047623,1,0.95274978971535,0,3,adenosine-phosphate deaminase activity,MF,
13009,GO:0047631,1,0.95892991853706,0,4,ADP-ribose diphosphatase activity,MF,
13010,GO:0047635,1,0.970830875297921,0,2,alanine-oxo-acid transaminase activity,MF,
13011,GO:0047638,1,0.984220960393285,0,1,albendazole monooxygenase activity,MF,
13012,GO:0047658,1,0.988182873842877,0,1,alpha-amino-acid esterase activity,MF,
13013,GO:0047661,1,0.984950340754611,0,1,amino-acid racemase activity,MF,
13015,GO:0047685,1,0.989238926880036,0,1,amine sulfotransferase activity,MF,
13016,GO:0047693,1,0.994515375845619,0,1,ATP diphosphatase activity,MF,
13017,GO:0047696,1,0.96885824515423,0,2,beta-adrenergic receptor kinase activity,MF,
13018,GO:0047704,1,0.986768296547333,0,1,bile-salt sulfotransferase activity,MF,
13019,GO:0047708,1,0.977893288753554,0,2,biotinidase activity,MF,
13020,GO:0047710,1,0.975415975920428,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
13021,GO:0047714,1,0.989329120391137,0,1,galactolipase activity,MF,
13022,GO:0047718,1,0.969953040559508,0,3,indanol dehydrogenase activity,MF,
13023,GO:0047726,1,0.984866510742938,0,1,iron-cytochrome-c reductase activity,MF,
13024,GO:0047730,1,0.983406808891365,0,1,carnosine synthase activity,MF,
13025,GO:0047734,1,0.984725543253726,0,1,CDP-glycerol diphosphatase activity,MF,
13026,GO:0047743,1,0.991155641549848,0,1,chlordecone reductase activity,MF,
13027,GO:0047747,1,0.985292318423221,0,1,cholate-CoA ligase activity,MF,
13028,GO:0047750,1,0.984124885005234,0,2,cholestenol delta-isomerase activity,MF,
13029,GO:0047751,1,0.955855760037396,0,3,cholestenone 5-alpha-reductase activity,MF,
13030,GO:0047756,1,0.94472570939,0,4,chondroitin 4-sulfotransferase activity,MF,
13031,GO:0047757,1,0.967087733486996,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
13032,GO:0047760,1,0.903586363890347,0,7,butyrate-CoA ligase activity,MF,
13033,GO:0047783,1,0.967687740650048,0,2,corticosterone 18-monooxygenase activity,MF,
13034,GO:0047787,1,0.975491740459374,0,2,delta4-3-oxosteroid 5beta-reductase activity,MF,
13035,GO:0047800,1,0.983417131680801,0,1,cysteamine dioxygenase activity,MF,
13036,GO:0047801,1,0.986168147179168,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
13037,GO:0047837,1,0.991905278206824,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
13038,GO:0047840,1,0.991683767070938,0,1,dCTP diphosphatase activity,MF,
13039,GO:0047844,1,0.966584868371299,0,3,deoxycytidine deaminase activity,MF,
13040,GO:0047856,1,0.99117521259016,0,1,dihydrocoumarin hydrolase activity,MF,
13041,GO:0047860,1,0.990666172254331,0,1,diiodophenylpyruvate reductase activity,MF,
13042,GO:0047865,1,0.98373977906634,0,1,dimethylglycine dehydrogenase activity,MF,
13043,GO:0047874,1,0.986236822334671,0,1,dolichyldiphosphatase activity,MF,
13044,GO:0047888,1,0.986939041002841,0,1,fatty acid peroxidase activity,MF,
13045,GO:0047894,1,0.970017114630158,0,3,flavonol 3-sulfotransferase activity,MF,
13046,GO:0047915,1,0.988262381781028,0,1,ganglioside galactosyltransferase activity,MF,
13047,GO:0047933,1,0.983406759351034,0,1,glucose-1,6-bisphosphate synthase activity,MF,
13048,GO:0047936,1,0.983406759350887,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
13049,GO:0047939,1,0.989425806755353,0,1,L-glucuronate reductase activity,MF,
13050,GO:0047946,1,0.986414397501559,0,1,glutamine N-acyltransferase activity,MF,
13051,GO:0047961,1,0.952180596320656,0,4,glycine N-acyltransferase activity,MF,
13052,GO:0047962,1,0.988713765778792,0,1,glycine N-benzoyltransferase activity,MF,
13053,GO:0047963,1,0.983492411185385,0,1,glycine N-choloyltransferase activity,MF,
13054,GO:0047969,1,0.987912194602553,0,1,glyoxylate oxidase activity,MF,
13055,GO:0047977,1,0.969946461429303,0,2,hepoxilin-epoxide hydrolase activity,MF,
13056,GO:0047982,1,0.987935314300946,0,1,homocysteine desulfhydrase activity,MF,
13057,GO:0047988,1,0.987160775705518,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
13059,GO:0048003,1,0.902508791781497,0,7,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
13060,GO:0048006,1,0.983411630869698,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
13061,GO:0048007,1,0.902508791781497,0,7,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
13068,GO:0048014,1,0.951038409344588,0,3,Tie signaling pathway,BP,
13073,GO:0048019,1,0.875534388972437,0,10,receptor antagonist activity,MF,
13077,GO:0048023,1,0.947348676697375,0,4,positive regulation of melanin biosynthetic process,BP,
13078,GO:0048024,1,0.362777887602297,0,68,regulation of mRNA splicing, via spliceosome,BP,
13079,GO:0048025,1,0.741360867139358,0,20,negative regulation of mRNA splicing, via spliceosome,BP,
13080,GO:0048026,1,0.806543235497893,0,15,positive regulation of mRNA splicing, via spliceosome,BP,
13081,GO:0048027,1,0.771985470560589,0,21,mRNA 5'-UTR binding,MF,
13082,GO:0048029,1,0.40191439389613,0,62,monosaccharide binding,MF,
13083,GO:0048030,1,0.957351812524178,0,4,disaccharide binding,MF,
13084,GO:0048033,1,0.983852234548494,0,1,heme o metabolic process,BP,
13085,GO:0048034,1,0.983852234548494,0,1,heme O biosynthetic process,BP,
13087,GO:0048038,1,0.807237408985462,0,17,quinone binding,MF,
13088,GO:0048039,1,0.931308750368113,0,6,ubiquinone binding,MF,
13089,GO:0048040,1,0.986318727036125,0,1,UDP-glucuronate decarboxylase activity,MF,
13092,GO:0048050,1,0.931759864921999,0,6,post-embryonic eye morphogenesis,BP,
13093,GO:0048058,1,0.983549620346045,0,1,compound eye corneal lens development,BP,
13095,GO:0048069,1,0.884749275305119,0,8,eye pigmentation,BP,
13097,GO:0048073,1,0.967087733488112,0,2,regulation of eye pigmentation,BP,
13098,GO:0048075,1,0.983406759352021,0,1,positive regulation of eye pigmentation,BP,
13100,GO:0048096,1,0.871460667804136,0,9,chromatin-mediated maintenance of transcription,BP,
13101,GO:0048101,1,0.969605050932977,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
13102,GO:0048102,1,0.919323958878703,0,6,autophagic cell death,BP,
13104,GO:0048104,1,0.935259979276216,0,4,establishment of body hair or bristle planar orientation,BP,
13105,GO:0048105,1,0.935259979276216,0,4,establishment of body hair planar orientation,BP,
13106,GO:0048133,1,0.953837882181439,0,4,male germ-line stem cell asymmetric division,BP,
13107,GO:0048137,1,0.984725543253726,0,1,spermatocyte division,BP,
13108,GO:0048143,1,0.925778460378858,0,5,astrocyte activation,BP,
13112,GO:0048147,1,0.6597766921586,0,31,negative regulation of fibroblast proliferation,BP,
13113,GO:0048148,1,0.78484048793887,0,19,behavioral response to cocaine,BP,
13114,GO:0048149,1,0.843321344244175,0,14,behavioral response to ethanol,BP,
13115,GO:0048156,1,0.866770232538298,0,10,tau protein binding,MF,
13116,GO:0048160,1,0.983406759351972,0,1,primary follicle stage,BP,
13117,GO:0048162,1,0.96103493005771,0,3,multi-layer follicle stage,BP,
13118,GO:0048165,1,0.96708773348782,0,2,fused antrum stage,BP,
13122,GO:0048170,1,0.937352581752895,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
13123,GO:0048172,1,0.803803997033969,0,14,regulation of short-term neuronal synaptic plasticity,BP,
13124,GO:0048174,1,0.983406759352069,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
13129,GO:0048180,1,0.986006099597604,0,1,activin complex,CC,
13131,GO:0048188,1,0.830637465348915,0,13,Set1C/COMPASS complex,CC,
13133,GO:0048194,1,0.869479306014995,0,9,Golgi vesicle budding,BP,
13134,GO:0048199,1,0.382539986761751,0,67,vesicle targeting, to, from or within Golgi,BP,
13135,GO:0048200,1,0.944145571915669,0,4,Golgi transport vesicle coating,BP,
13136,GO:0048203,1,0.971295472898374,0,2,vesicle targeting, trans-Golgi to endosome,BP,
13137,GO:0048205,1,0.944145571915669,0,4,COPI coating of Golgi vesicle,BP,
13138,GO:0048207,1,0.411506323551346,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
13139,GO:0048208,1,0.411506323551346,0,62,COPII vesicle coating,BP,
13140,GO:0048209,1,0.969655607539825,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
13141,GO:0048210,1,0.973790820674727,0,2,Golgi vesicle fusion to target membrane,BP,
13142,GO:0048211,1,0.98340856248272,0,1,Golgi vesicle docking,BP,
13143,GO:0048213,1,0.972175015694956,0,2,Golgi vesicle prefusion complex stabilization,BP,
13144,GO:0048227,1,0.891553971801981,0,8,plasma membrane to endosome transport,BP,
13147,GO:0048239,1,0.970452440651666,0,2,negative regulation of DNA recombination at telomere,BP,
13148,GO:0048240,1,0.770704290770721,0,21,sperm capacitation,BP,
13152,GO:0048244,1,0.988353260404592,0,1,phytanoyl-CoA dioxygenase activity,MF,
13153,GO:0048245,1,0.90292125536455,0,11,eosinophil chemotaxis,BP,
13154,GO:0048246,1,0.712935322590728,0,29,macrophage chemotaxis,BP,
13156,GO:0048248,1,0.953733809068262,0,5,CXCR3 chemokine receptor binding,MF,
13157,GO:0048250,1,0.976456096072973,0,2,mitochondrial iron ion transport,BP,
13159,GO:0048254,1,0.953207359445837,0,4,snoRNA localization,BP,
13161,GO:0048256,1,0.883253339168908,0,8,flap endonuclease activity,MF,
13162,GO:0048257,1,0.970117932341737,0,2,3'-flap endonuclease activity,MF,
13168,GO:0048264,1,0.983840387165893,0,1,determination of ventral identity,BP,
13169,GO:0048265,1,0.656682893195997,0,30,response to pain,BP,
13170,GO:0048266,1,0.813684921101443,0,14,behavioral response to pain,BP,
13171,GO:0048268,1,0.789486286729109,0,16,clathrin coat assembly,BP,
13172,GO:0048269,1,0.970700250886382,0,2,methionine adenosyltransferase complex,CC,
13173,GO:0048270,1,0.986349750170632,0,1,methionine adenosyltransferase regulator activity,MF,
13174,GO:0048273,1,0.92674402167945,0,5,mitogen-activated protein kinase p38 binding,MF,
13176,GO:0048280,1,0.868160145806052,0,10,vesicle fusion with Golgi apparatus,BP,
13181,GO:0048290,1,0.913314903615973,0,6,isotype switching to IgA isotypes,BP,
13182,GO:0048291,1,0.824460506243676,0,14,isotype switching to IgG isotypes,BP,
13184,GO:0048294,1,0.953048539521762,0,3,negative regulation of isotype switching to IgE isotypes,BP,
13186,GO:0048296,1,0.928610005978701,0,5,regulation of isotype switching to IgA isotypes,BP,
13187,GO:0048297,1,0.986152114595554,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13188,GO:0048298,1,0.941653139339417,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13189,GO:0048302,1,0.836622224053858,0,13,regulation of isotype switching to IgG isotypes,BP,
13190,GO:0048304,1,0.877743576584218,0,10,positive regulation of isotype switching to IgG isotypes,BP,
13191,GO:0048305,1,0.774043672578399,0,21,immunoglobulin secretion,BP,
13193,GO:0048308,1,0.819996190971957,0,14,organelle inheritance,BP,
13194,GO:0048311,1,0.816361799478124,0,13,mitochondrion distribution,BP,
13195,GO:0048312,1,0.886098038402001,0,8,intracellular distribution of mitochondria,BP,
13196,GO:0048313,1,0.819996190971957,0,14,Golgi inheritance,BP,
13200,GO:0048321,1,0.986355974988371,0,1,axial mesodermal cell differentiation,BP,
13201,GO:0048322,1,0.986355974988371,0,1,axial mesodermal cell fate commitment,BP,
13202,GO:0048327,1,0.986355974988371,0,1,axial mesodermal cell fate specification,BP,
13205,GO:0048337,1,0.983950314107376,0,1,positive regulation of mesodermal cell fate specification,BP,
13206,GO:0048338,1,0.983431384306763,0,1,mesoderm structural organization,BP,
13210,GO:0048342,1,0.972437035125164,0,2,paraxial mesodermal cell differentiation,BP,
13211,GO:0048343,1,0.972437035125164,0,2,paraxial mesodermal cell fate commitment,BP,
13212,GO:0048352,1,0.983431384306763,0,1,paraxial mesoderm structural organization,BP,
13213,GO:0048364,1,0.99404187805355,0,1,root development,BP,
13214,GO:0048365,1,0.500073124730849,0,44,Rac GTPase binding,MF,
13215,GO:0048368,1,0.814195770732816,0,15,lateral mesoderm development,BP,
13216,GO:0048369,1,0.941589830548972,0,4,lateral mesoderm morphogenesis,BP,
13217,GO:0048370,1,0.941589830548972,0,4,lateral mesoderm formation,BP,
13218,GO:0048371,1,0.952343007989315,0,3,lateral mesodermal cell differentiation,BP,
13219,GO:0048372,1,0.967111951474688,0,2,lateral mesodermal cell fate commitment,BP,
13220,GO:0048377,1,0.967111951474688,0,2,lateral mesodermal cell fate specification,BP,
13221,GO:0048378,1,0.967111951474688,0,2,regulation of lateral mesodermal cell fate specification,BP,
13223,GO:0048384,1,0.650906896744796,0,30,retinoic acid receptor signaling pathway,BP,
13224,GO:0048385,1,0.798924279811682,0,16,regulation of retinoic acid receptor signaling pathway,BP,
13225,GO:0048386,1,0.93855136502643,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13226,GO:0048387,1,0.862904507693383,0,10,negative regulation of retinoic acid receptor signaling pathway,BP,
13227,GO:0048388,1,0.960918837586274,0,3,endosomal lumen acidification,BP,
13232,GO:0048403,1,0.951039110789099,0,3,brain-derived neurotrophic factor binding,MF,
13233,GO:0048406,1,0.906079004785111,0,6,nerve growth factor binding,MF,
13235,GO:0048408,1,0.964299278015506,0,3,epidermal growth factor binding,MF,
13239,GO:0048475,1,0.254552670479343,0,91,coated membrane,CC,
13240,GO:0048476,1,0.939927299493805,0,5,Holliday junction resolvase complex,CC,
13242,GO:0048478,1,0.915764740392975,0,6,replication fork protection,BP,
13247,GO:0048487,1,0.624753834334183,0,34,beta-tubulin binding,MF,
13250,GO:0048490,1,0.79150960619619,0,17,anterograde synaptic vesicle transport,BP,
13251,GO:0048495,1,0.923662856064298,0,5,Roundabout binding,MF,
13252,GO:0048496,1,0.936946584845409,0,4,maintenance of animal organ identity,BP,
13253,GO:0048499,1,0.968738891493795,0,2,synaptic vesicle membrane organization,BP,
13254,GO:0048500,1,0.892312353189103,0,9,signal recognition particle,CC,
13268,GO:0048525,1,0.226764238806664,0,106,negative regulation of viral process,BP,
13272,GO:0048535,1,0.809442686619943,0,16,lymph node development,BP,
13276,GO:0048539,1,0.900453706453037,0,7,bone marrow development,BP,
13280,GO:0048548,1,0.870280259577952,0,9,regulation of pinocytosis,BP,
13281,GO:0048549,1,0.937104984261704,0,4,positive regulation of pinocytosis,BP,
13282,GO:0048550,1,0.928708738765758,0,5,negative regulation of pinocytosis,BP,
13284,GO:0048560,1,0.971980945086196,0,2,establishment of anatomical structure orientation,BP,
13285,GO:0048561,1,0.985815364903543,0,1,establishment of animal organ orientation,BP,
13290,GO:0048567,1,0.984730915754465,0,1,ectodermal digestive tract morphogenesis,BP,
13294,GO:0048571,1,0.994150646961731,0,1,long-day photoperiodism,BP,
13303,GO:0048597,1,0.970505218389233,0,3,post-embryonic camera-type eye morphogenesis,BP,
13308,GO:0048611,1,0.968876099326227,0,2,embryonic ectodermal digestive tract development,BP,
13309,GO:0048613,1,0.984730915754465,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13310,GO:0048617,1,0.867983546662312,0,9,embryonic foregut morphogenesis,BP,
13311,GO:0048619,1,0.953685398955376,0,3,embryonic hindgut morphogenesis,BP,
13312,GO:0048621,1,0.986326983415046,0,1,post-embryonic digestive tract morphogenesis,BP,
13313,GO:0048625,1,0.92720797647673,0,5,myoblast fate commitment,BP,
13314,GO:0048627,1,0.973687808280785,0,2,myoblast development,BP,
13317,GO:0048632,1,0.967812865626176,0,2,negative regulation of skeletal muscle tissue growth,BP,
13326,GO:0048642,1,0.852644187126869,0,11,negative regulation of skeletal muscle tissue development,BP,
13336,GO:0048664,1,0.881858879906332,0,10,neuron fate determination,BP,
13343,GO:0048671,1,0.868647939310621,0,9,negative regulation of collateral sprouting,BP,
13345,GO:0048673,1,0.988802969829853,0,1,collateral sprouting of intact axon in response to injury,BP,
13347,GO:0048677,1,0.951652280925012,0,3,axon extension involved in regeneration,BP,
13349,GO:0048679,1,0.720264020956408,0,22,regulation of axon regeneration,BP,
13350,GO:0048680,1,0.919396695767474,0,6,positive regulation of axon regeneration,BP,
13351,GO:0048681,1,0.836239768226717,0,12,negative regulation of axon regeneration,BP,
13352,GO:0048682,1,0.951652280925012,0,3,sprouting of injured axon,BP,
13353,GO:0048683,1,0.988802969829853,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13354,GO:0048685,1,0.988802969829853,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13355,GO:0048686,1,0.967711921497212,0,2,regulation of sprouting of injured axon,BP,
13356,GO:0048687,1,0.984041436430165,0,1,positive regulation of sprouting of injured axon,BP,
13357,GO:0048688,1,0.983406759351872,0,1,negative regulation of sprouting of injured axon,BP,
13358,GO:0048690,1,0.967711921497212,0,2,regulation of axon extension involved in regeneration,BP,
13359,GO:0048691,1,0.984041436430165,0,1,positive regulation of axon extension involved in regeneration,BP,
13360,GO:0048692,1,0.983406759351872,0,1,negative regulation of axon extension involved in regeneration,BP,
13363,GO:0048698,1,0.983406759351921,0,1,negative regulation of collateral sprouting in absence of injury,BP,
13366,GO:0048702,1,0.892451416640217,0,7,embryonic neurocranium morphogenesis,BP,
13367,GO:0048703,1,0.846529769111841,0,11,embryonic viscerocranium morphogenesis,BP,
13375,GO:0048712,1,0.835905794521501,0,12,negative regulation of astrocyte differentiation,BP,
13377,GO:0048714,1,0.79625959125754,0,16,positive regulation of oligodendrocyte differentiation,BP,
13383,GO:0048733,1,0.895913312500839,0,7,sebaceous gland development,BP,
13387,GO:0048741,1,0.653346702151103,0,29,skeletal muscle fiber development,BP,
13388,GO:0048742,1,0.866744622307423,0,10,regulation of skeletal muscle fiber development,BP,
13389,GO:0048743,1,0.909486055858136,0,7,positive regulation of skeletal muscle fiber development,BP,
13392,GO:0048749,1,0.96722823346996,0,2,compound eye development,BP,
13396,GO:0048755,1,0.864652882284433,0,9,branching morphogenesis of a nerve,BP,
13399,GO:0048763,1,0.935254347822825,0,4,calcium-induced calcium release activity,MF,
13400,GO:0048764,1,0.99404187805355,0,1,trichoblast maturation,BP,
13401,GO:0048765,1,0.99404187805355,0,1,root hair cell differentiation,BP,
13402,GO:0048767,1,0.99404187805355,0,1,root hair elongation,BP,
13403,GO:0048769,1,0.960080651971541,0,3,sarcomerogenesis,BP,
13407,GO:0048787,1,0.937969930528188,0,4,presynaptic active zone membrane,CC,
13408,GO:0048788,1,0.967087733482398,0,2,cytoskeleton of presynaptic active zone,CC,
13409,GO:0048789,1,0.983406759351921,0,1,cytoskeletal matrix organization at active zone,BP,
13410,GO:0048790,1,0.989270860431288,0,1,maintenance of presynaptic active zone structure,BP,
13412,GO:0048792,1,0.98348870588696,0,1,spontaneous exocytosis of neurotransmitter,BP,
13413,GO:0048793,1,0.880727925219624,0,8,pronephros development,BP,
13421,GO:0048817,1,0.967087733487964,0,2,negative regulation of hair follicle maturation,BP,
13425,GO:0048821,1,0.720876830255669,0,23,erythrocyte development,BP,
13426,GO:0048822,1,0.969803485099748,0,2,enucleate erythrocyte development,BP,
13428,GO:0048840,1,0.922798357596901,0,5,otolith development,BP,
13430,GO:0048842,1,0.894163518127041,0,7,positive regulation of axon extension involved in axon guidance,BP,
13439,GO:0048855,1,0.983406759351575,0,1,adenohypophysis morphogenesis,BP,
13441,GO:0048857,1,0.411355398526957,0,62,neural nucleus development,BP,
13443,GO:0048859,1,0.943422073257008,0,5,formation of anatomical boundary,BP,
13447,GO:0048865,1,0.904715298173758,0,8,stem cell fate commitment,BP,
13448,GO:0048866,1,0.965162171958674,0,3,stem cell fate specification,BP,
13449,GO:0048867,1,0.963528217789189,0,3,stem cell fate determination,BP,
13454,GO:0048873,1,0.657000372256345,0,30,homeostasis of number of cells within a tissue,BP,
13455,GO:0048874,1,0.98357355435276,0,1,homeostasis of number of cells in a free-living population,BP,
13456,GO:0048875,1,0.880982946959961,0,9,chemical homeostasis within a tissue,BP,
13458,GO:0048880,1,0.936550213591879,0,4,sensory system development,BP,
13459,GO:0048892,1,0.983817326569247,0,1,lateral line nerve development,BP,
13460,GO:0048894,1,0.983817326569247,0,1,efferent axon development in a lateral line nerve,BP,
13461,GO:0048925,1,0.983817326569247,0,1,lateral line system development,BP,
13462,GO:0048934,1,0.819920414920549,0,13,peripheral nervous system neuron differentiation,BP,
13463,GO:0048935,1,0.819920414920549,0,13,peripheral nervous system neuron development,BP,
13464,GO:0048936,1,0.955403116347845,0,3,peripheral nervous system neuron axonogenesis,BP,
13466,GO:0050023,1,0.987350690451542,0,1,L-fuconate dehydratase activity,MF,
13467,GO:0050031,1,0.98514784566868,0,1,L-pipecolate oxidase activity,MF,
13468,GO:0050038,1,0.993660080874535,0,1,L-xylulose reductase (NADP+) activity,MF,
13469,GO:0050051,1,0.943130664048602,0,4,leukotriene-B4 20-monooxygenase activity,MF,
13470,GO:0050062,1,0.969919214475995,0,2,long-chain-fatty-acyl-CoA reductase activity,MF,
13471,GO:0050072,1,0.905802586393297,0,7,m7G(5')pppN diphosphatase activity,MF,
13472,GO:0050080,1,0.985921241691793,0,1,malonyl-CoA decarboxylase activity,MF,
13473,GO:0050104,1,0.989270860431288,0,1,L-gulonate 3-dehydrogenase activity,MF,
13474,GO:0050113,1,0.989618254127934,0,1,inositol oxygenase activity,MF,
13475,GO:0050115,1,0.983406759351921,0,1,myosin-light-chain-phosphatase activity,MF,
13476,GO:0050119,1,0.967087733487287,0,2,N-acetylglucosamine deacetylase activity,MF,
13477,GO:0050121,1,0.989416988555308,0,1,N-acylglucosamine 2-epimerase activity,MF,
13478,GO:0050124,1,0.983410946112961,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13479,GO:0050129,1,0.983635055599986,0,1,N-formylglutamate deformylase activity,MF,
13480,GO:0050135,1,0.978800614133861,0,2,NAD(P)+ nucleosidase activity,MF,
13481,GO:0050136,1,0.758696640551463,0,38,NADH dehydrogenase (quinone) activity,MF,
13482,GO:0050144,1,0.984725543253726,0,1,nucleoside deoxyribosyltransferase activity,MF,
13483,GO:0050145,1,0.960844667484029,0,3,nucleoside phosphate kinase activity,MF,
13484,GO:0050146,1,0.983406759351821,0,1,nucleoside phosphotransferase activity,MF,
13485,GO:0050152,1,0.990647106311991,0,1,omega-amidase activity,MF,
13486,GO:0050178,1,0.995657766730681,0,1,phenylpyruvate tautomerase activity,MF,
13487,GO:0050197,1,0.985477432871029,0,1,phytanate-CoA ligase activity,MF,
13488,GO:0050201,1,0.983406995012697,0,1,fucokinase activity,MF,
13489,GO:0050211,1,0.983865649318172,0,1,procollagen galactosyltransferase activity,MF,
13491,GO:0050221,1,0.990851487642679,0,1,prostaglandin-E2 9-reductase activity,MF,
13492,GO:0050252,1,0.955300558061594,0,3,retinol O-fatty-acyltransferase activity,MF,
13493,GO:0050253,1,0.96793222265804,0,2,retinyl-palmitate esterase activity,MF,
13494,GO:0050254,1,0.960553198540591,0,3,rhodopsin kinase activity,MF,
13495,GO:0050262,1,0.969683443564638,0,2,ribosylnicotinamide kinase activity,MF,
13496,GO:0050265,1,0.951726681026837,0,3,RNA uridylyltransferase activity,MF,
13497,GO:0050277,1,0.983408772492703,0,1,sedoheptulokinase activity,MF,
13498,GO:0050290,1,0.983406759351968,0,1,sphingomyelin phosphodiesterase D activity,MF,
13499,GO:0050291,1,0.899990040990242,0,7,sphingosine N-acyltransferase activity,MF,
13500,GO:0050294,1,0.956938972773835,0,4,steroid sulfotransferase activity,MF,
13502,GO:0050309,1,0.956695897806699,0,3,sugar-terminal-phosphatase activity,MF,
13503,GO:0050313,1,0.992720656742466,0,1,sulfur dioxygenase activity,MF,
13505,GO:0050333,1,0.987679183819554,0,1,thiamin-triphosphatase activity,MF,
13506,GO:0050346,1,0.984725543253726,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13507,GO:0050347,1,0.972216461946577,0,2,trans-octaprenyltranstransferase activity,MF,
13508,GO:0050353,1,0.984068730074366,0,1,trimethyllysine dioxygenase activity,MF,
13509,GO:0050355,1,0.983406759352021,0,1,triphosphatase activity,MF,
13510,GO:0050379,1,0.983406759351921,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13511,GO:0050405,1,0.967087733486801,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13512,GO:0050421,1,0.984615667407723,0,1,nitrite reductase (NO-forming) activity,MF,
13513,GO:0050427,1,0.774825618053406,0,19,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13514,GO:0050428,1,0.911479136184227,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13515,GO:0050429,1,0.983406759351527,0,1,calcium-dependent phospholipase C activity,MF,
13519,GO:0050434,1,0.572173526606016,0,41,positive regulation of viral transcription,BP,
13520,GO:0050435,1,0.686657353735099,0,26,beta-amyloid metabolic process,BP,
13521,GO:0050436,1,0.967088118440811,0,2,microfibril binding,MF,
13522,GO:0050444,1,0.983565412210262,0,1,aquacobalamin reductase (NADPH) activity,MF,
13523,GO:0050462,1,0.990870761894025,0,1,N-acetylneuraminate synthase activity,MF,
13524,GO:0050473,1,0.953121294443805,0,3,arachidonate 15-lipoxygenase activity,MF,
13525,GO:0050479,1,0.984725543253726,0,1,glyceryl-ether monooxygenase activity,MF,
13526,GO:0050480,1,0.98613214159267,0,1,imidazolonepropionase activity,MF,
13527,GO:0050482,1,0.701052863196466,0,29,arachidonic acid secretion,BP,
13528,GO:0050497,1,0.970399491198428,0,2,transferase activity, transferring alkylthio groups,MF,
13529,GO:0050501,1,0.942387967915165,0,4,hyaluronan synthase activity,MF,
13530,GO:0050508,1,0.951157836419383,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13531,GO:0050509,1,0.967209167598394,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13532,GO:0050510,1,0.93574976658877,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13533,GO:0050512,1,0.986335251764542,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13534,GO:0050528,1,0.985220899278771,0,1,acyloxyacyl hydrolase activity,MF,
13535,GO:0050542,1,0.946083510352417,0,6,icosanoid binding,MF,
13536,GO:0050543,1,0.949863778799463,0,6,icosatetraenoic acid binding,MF,
13537,GO:0050544,1,0.957701324789899,0,5,arachidonic acid binding,MF,
13538,GO:0050560,1,0.983524776113773,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13539,GO:0050561,1,0.983407051059899,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13540,GO:0050567,1,0.980253348253404,0,2,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13541,GO:0050571,1,0.988652843021027,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13542,GO:0050577,1,0.990090677622663,0,1,GDP-L-fucose synthase activity,MF,
13543,GO:0050591,1,0.984220960393285,0,1,quinine 3-monooxygenase activity,MF,
13544,GO:0050610,1,0.983382471556074,0,2,methylarsonate reductase activity,MF,
13545,GO:0050613,1,0.972360585565481,0,2,delta14-sterol reductase activity,MF,
13546,GO:0050614,1,0.98340675935207,0,1,delta24-sterol reductase activity,MF,
13547,GO:0050632,1,0.989743997431019,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13548,GO:0050646,1,0.98787123575268,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13549,GO:0050647,1,0.98787123575268,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13550,GO:0050648,1,0.98787123575268,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13551,GO:0050649,1,0.984220960393285,0,1,testosterone 6-beta-hydroxylase activity,MF,
13552,GO:0050650,1,0.642627771959206,0,29,chondroitin sulfate proteoglycan biosynthetic process,BP,
13553,GO:0050651,1,0.795704672502633,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13554,GO:0050652,1,0.983416599688355,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13555,GO:0050653,1,0.967097469550651,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13556,GO:0050654,1,0.524688536542678,0,42,chondroitin sulfate proteoglycan metabolic process,BP,
13557,GO:0050655,1,0.784488550575717,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13558,GO:0050656,1,0.909480135051883,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13559,GO:0050657,1,0.0655344217363343,0,186,nucleic acid transport,BP,
13560,GO:0050658,1,0.0655344217363343,0,186,RNA transport,BP,
13561,GO:0050659,1,0.967087733487774,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13562,GO:0050660,1,0.330237128884981,0,73,flavin adenine dinucleotide binding,MF,
13566,GO:0050664,1,0.81583199750377,0,14,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13567,GO:0050665,1,0.884489423563208,0,9,hydrogen peroxide biosynthetic process,BP,
13568,GO:0050666,1,0.970740306851967,0,2,regulation of homocysteine metabolic process,BP,
13569,GO:0050667,1,0.811281285510058,0,14,homocysteine metabolic process,BP,
13570,GO:0050668,1,0.985637625278431,0,1,positive regulation of homocysteine metabolic process,BP,
13581,GO:0050681,1,0.528687403171436,0,42,androgen receptor binding,MF,
13582,GO:0050682,1,0.967087733486465,0,2,AF-2 domain binding,MF,
13583,GO:0050683,1,0.983406759352069,0,1,AF-1 domain binding,MF,
13584,GO:0050684,1,0.220963204364892,0,100,regulation of mRNA processing,BP,
13585,GO:0050685,1,0.716671364033521,0,23,positive regulation of mRNA processing,BP,
13586,GO:0050686,1,0.641311197925466,0,29,negative regulation of mRNA processing,BP,
13587,GO:0050687,1,0.738365919550579,0,20,negative regulation of defense response to virus,BP,
13588,GO:0050688,1,0.290258365999613,0,86,regulation of defense response to virus,BP,
13589,GO:0050689,1,0.947971380925894,0,4,negative regulation of defense response to virus by host,BP,
13590,GO:0050690,1,0.673433643216442,0,28,regulation of defense response to virus by virus,BP,
13591,GO:0050691,1,0.655508636606581,0,31,regulation of defense response to virus by host,BP,
13592,GO:0050692,1,0.955223570116068,0,3,DBD domain binding,MF,
13593,GO:0050693,1,0.92138066336792,0,6,LBD domain binding,MF,
13594,GO:0050694,1,0.946705516173557,0,4,galactose 3-O-sulfotransferase activity,MF,
13595,GO:0050698,1,0.968584534035809,0,2,proteoglycan sulfotransferase activity,MF,
13596,GO:0050699,1,0.722414635963039,0,21,WW domain binding,MF,
13597,GO:0050700,1,0.894388984504188,0,7,CARD domain binding,MF,
13600,GO:0050703,1,0.946047731022664,0,5,interleukin-1 alpha secretion,BP,
13602,GO:0050705,1,0.950510101308661,0,4,regulation of interleukin-1 alpha secretion,BP,
13609,GO:0050712,1,0.989677996813037,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13610,GO:0050713,1,0.943841177240924,0,5,negative regulation of interleukin-1 beta secretion,BP,
13614,GO:0050717,1,0.96042527052957,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13617,GO:0050720,1,0.97103134649292,0,3,interleukin-1 beta biosynthetic process,BP,
13619,GO:0050722,1,0.976894795356323,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13620,GO:0050725,1,0.976894795356323,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13627,GO:0050732,1,0.545140127411994,0,41,negative regulation of peptidyl-tyrosine phosphorylation,BP,
13628,GO:0050733,1,0.90679315007164,0,7,RS domain binding,MF,
13629,GO:0050746,1,0.830842189073388,0,14,regulation of lipoprotein metabolic process,BP,
13630,GO:0050747,1,0.936127501681581,0,5,positive regulation of lipoprotein metabolic process,BP,
13631,GO:0050748,1,0.931652372870107,0,6,negative regulation of lipoprotein metabolic process,BP,
13632,GO:0050750,1,0.797689176146405,0,16,low-density lipoprotein particle receptor binding,MF,
13633,GO:0050751,1,0.993084615412648,0,1,fractalkine biosynthetic process,BP,
13634,GO:0050752,1,0.993084615412648,0,1,regulation of fractalkine biosynthetic process,BP,
13635,GO:0050754,1,0.993084615412648,0,1,positive regulation of fractalkine biosynthetic process,BP,
13637,GO:0050756,1,0.993084615412648,0,1,fractalkine metabolic process,BP,
13638,GO:0050757,1,0.976301422435378,0,2,thymidylate synthase biosynthetic process,BP,
13639,GO:0050758,1,0.976301422435378,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13640,GO:0050760,1,0.984522334371722,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13642,GO:0050765,1,0.862168447281098,0,11,negative regulation of phagocytosis,BP,
13651,GO:0050774,1,0.796867893022953,0,15,negative regulation of dendrite morphogenesis,BP,
13652,GO:0050775,1,0.586858328605827,0,33,positive regulation of dendrite morphogenesis,BP,
13656,GO:0050779,1,0.728131688148256,0,20,RNA destabilization,BP,
13657,GO:0050780,1,0.795817104340175,0,15,dopamine receptor binding,MF,
13658,GO:0050783,1,0.985058090684018,0,1,cocaine metabolic process,BP,
13659,GO:0050786,1,0.929711048558848,0,11,RAGE receptor binding,MF,
13660,GO:0050787,1,0.97646057103049,0,2,detoxification of mercury ion,BP,
13668,GO:0050798,1,0.562529070581197,0,43,activated T cell proliferation,BP,
13678,GO:0050811,1,0.817322372673994,0,14,GABA receptor binding,MF,
13679,GO:0050812,1,0.812068398003836,0,13,regulation of acyl-CoA biosynthetic process,BP,
13680,GO:0050815,1,0.919418429035495,0,6,phosphoserine binding,MF,
13681,GO:0050816,1,0.959840598928481,0,3,phosphothreonine binding,MF,
13685,GO:0050820,1,0.697059838092518,0,25,positive regulation of coagulation,BP,
13687,GO:0050822,1,0.983462167645689,0,1,peptide stabilization,BP,
13688,GO:0050823,1,0.983462167645689,0,1,peptide antigen stabilization,BP,
13689,GO:0050828,1,0.984725543253726,0,1,regulation of liquid surface tension,BP,
13693,GO:0050833,1,0.939065122190732,0,4,pyruvate transmembrane transporter activity,MF,
13696,GO:0050847,1,0.939162969111784,0,4,progesterone receptor signaling pathway,BP,
13699,GO:0050850,1,0.612912930937711,0,38,positive regulation of calcium-mediated signaling,BP,
13703,GO:0050854,1,0.518457721643306,0,45,regulation of antigen receptor-mediated signaling pathway,BP,
13704,GO:0050855,1,0.809222043631799,0,14,regulation of B cell receptor signaling pathway,BP,
13705,GO:0050856,1,0.62393284130459,0,33,regulation of T cell receptor signaling pathway,BP,
13706,GO:0050857,1,0.770839134214355,0,18,positive regulation of antigen receptor-mediated signaling pathway,BP,
13707,GO:0050858,1,0.741803134778222,0,21,negative regulation of antigen receptor-mediated signaling pathway,BP,
13708,GO:0050859,1,0.944722050520699,0,4,negative regulation of B cell receptor signaling pathway,BP,
13709,GO:0050860,1,0.773998754860315,0,18,negative regulation of T cell receptor signaling pathway,BP,
13710,GO:0050861,1,0.897912544493721,0,7,positive regulation of B cell receptor signaling pathway,BP,
13711,GO:0050862,1,0.873032092872102,0,10,positive regulation of T cell receptor signaling pathway,BP,
13718,GO:0050869,1,0.645791158289792,0,30,negative regulation of B cell activation,BP,
13722,GO:0050873,1,0.60336933385766,0,39,brown fat cell differentiation,BP,
13728,GO:0050882,1,0.919878358705719,0,5,voluntary musculoskeletal movement,BP,
13729,GO:0050883,1,0.973883611388339,0,2,musculoskeletal movement, spinal reflex action,BP,
13730,GO:0050884,1,0.793833726956102,0,16,neuromuscular process controlling posture,BP,
13736,GO:0050893,1,0.941625042737354,0,4,sensory processing,BP,
13737,GO:0050894,1,0.983406759351479,0,1,determination of affect,BP,
13739,GO:0050897,1,0.983406759351672,0,1,cobalt ion binding,MF,
13741,GO:0050901,1,0.748760264712004,0,21,leukocyte tethering or rolling,BP,
13742,GO:0050902,1,0.968637851122888,0,2,leukocyte adhesive activation,BP,
13743,GO:0050904,1,0.958139367918933,0,3,diapedesis,BP,
13746,GO:0050907,1,0.0358965129735781,0,419,detection of chemical stimulus involved in sensory perception,BP,
13747,GO:0050908,1,0.771397025638772,0,17,detection of light stimulus involved in visual perception,BP,
13748,GO:0050909,1,0.497687671445022,0,62,sensory perception of taste,BP,
13749,GO:0050910,1,0.833022809537202,0,12,detection of mechanical stimulus involved in sensory perception of sound,BP,
13750,GO:0050911,1,0.0559533344278704,0,376,detection of chemical stimulus involved in sensory perception of smell,BP,
13751,GO:0050912,1,0.677319765970992,0,40,detection of chemical stimulus involved in sensory perception of taste,BP,
13752,GO:0050913,1,0.698232438289769,0,38,sensory perception of bitter taste,BP,
13753,GO:0050915,1,0.923783067363727,0,5,sensory perception of sour taste,BP,
13754,GO:0050916,1,0.917971116867146,0,6,sensory perception of sweet taste,BP,
13755,GO:0050917,1,0.916834941540294,0,6,sensory perception of umami taste,BP,
13761,GO:0050923,1,0.935343857694274,0,4,regulation of negative chemotaxis,BP,
13762,GO:0050924,1,0.983406759351921,0,1,positive regulation of negative chemotaxis,BP,
13763,GO:0050925,1,0.967087733487045,0,2,negative regulation of negative chemotaxis,BP,
13766,GO:0050928,1,0.98340675935187,0,1,negative regulation of positive chemotaxis,BP,
13767,GO:0050929,1,0.983406759351921,0,1,induction of negative chemotaxis,BP,
13775,GO:0050955,1,0.951038409344444,0,3,thermoception,BP,
13777,GO:0050960,1,0.983406759352069,0,1,detection of temperature stimulus involved in thermoception,BP,
13779,GO:0050962,1,0.771397025638772,0,17,detection of light stimulus involved in sensory perception,BP,
13781,GO:0050966,1,0.879701417273317,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13782,GO:0050968,1,0.952313961944261,0,3,detection of chemical stimulus involved in sensory perception of pain,BP,
13783,GO:0050974,1,0.691602774083696,0,24,detection of mechanical stimulus involved in sensory perception,BP,
13784,GO:0050975,1,0.960789722993333,0,3,sensory perception of touch,BP,
13785,GO:0050976,1,0.971211242174948,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13786,GO:0050982,1,0.525995177388275,0,42,detection of mechanical stimulus,BP,
13787,GO:0050992,1,0.976409805234678,0,2,dimethylallyl diphosphate biosynthetic process,BP,
13788,GO:0050993,1,0.976409805234678,0,2,dimethylallyl diphosphate metabolic process,BP,
13793,GO:0050998,1,0.788997190238332,0,16,nitric-oxide synthase binding,MF,
13796,GO:0051001,1,0.913953441909093,0,7,negative regulation of nitric-oxide synthase activity,BP,
13797,GO:0051004,1,0.845762139786441,0,15,regulation of lipoprotein lipase activity,BP,
13798,GO:0051005,1,0.950216886134022,0,5,negative regulation of lipoprotein lipase activity,BP,
13799,GO:0051006,1,0.890094777389367,0,10,positive regulation of lipoprotein lipase activity,BP,
13800,GO:0051010,1,0.833377292955364,0,11,microtubule plus-end binding,MF,
13802,GO:0051012,1,0.971686770884737,0,2,microtubule sliding,BP,
13803,GO:0051013,1,0.9121673272399,0,6,microtubule severing,BP,
13804,GO:0051014,1,0.876628641076395,0,9,actin filament severing,BP,
13806,GO:0051016,1,0.794210693227181,0,16,barbed-end actin filament capping,BP,
13809,GO:0051019,1,0.697839246999186,0,23,mitogen-activated protein kinase binding,MF,
13811,GO:0051021,1,0.955392413649368,0,3,GDP-dissociation inhibitor binding,MF,
13812,GO:0051022,1,0.955392413649368,0,3,Rho GDP-dissociation inhibitor binding,MF,
13813,GO:0051023,1,0.819968011496104,0,17,regulation of immunoglobulin secretion,BP,
13814,GO:0051024,1,0.889895674829008,0,11,positive regulation of immunoglobulin secretion,BP,
13815,GO:0051025,1,0.968518187523076,0,2,negative regulation of immunoglobulin secretion,BP,
13816,GO:0051026,1,0.912089207048971,0,6,chiasma assembly,BP,
13817,GO:0051028,1,0.116981385868063,0,143,mRNA transport,BP,
13818,GO:0051029,1,0.943987186226641,0,5,rRNA transport,BP,
13819,GO:0051030,1,0.9628685249982,0,3,snRNA transport,BP,
13820,GO:0051031,1,0.61095070743599,0,33,tRNA transport,BP,
13821,GO:0051032,1,0.951038533065229,0,3,nucleic acid transmembrane transporter activity,MF,
13822,GO:0051033,1,0.951038533065229,0,3,RNA transmembrane transporter activity,MF,
13823,GO:0051036,1,0.933967067842073,0,5,regulation of endosome size,BP,
13824,GO:0051037,1,0.967268962148722,0,2,regulation of transcription involved in meiotic cell cycle,BP,
13825,GO:0051038,1,0.983406759352021,0,1,negative regulation of transcription involved in meiotic cell cycle,BP,
13826,GO:0051039,1,0.983591033443995,0,1,positive regulation of transcription involved in meiotic cell cycle,BP,
13828,GO:0051041,1,0.983581970456042,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13830,GO:0051043,1,0.743306603092783,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13831,GO:0051044,1,0.818052889038535,0,14,positive regulation of membrane protein ectodomain proteolysis,BP,
13832,GO:0051045,1,0.908701552031427,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
13846,GO:0051059,1,0.679178509563006,0,28,NF-kappaB binding,MF,
13847,GO:0051066,1,0.975502546241763,0,2,dihydrobiopterin metabolic process,BP,
13848,GO:0051068,1,0.983438992748238,0,1,dihydrolipoamide metabolic process,BP,
13849,GO:0051081,1,0.500752015916091,0,46,nuclear envelope disassembly,BP,
13850,GO:0051082,1,0.247273605848,0,104,unfolded protein binding,MF,
13851,GO:0051083,1,0.973879436454178,0,2,'de novo' cotranslational protein folding,BP,
13852,GO:0051084,1,0.800516902706055,0,16,'de novo' posttranslational protein folding,BP,
13853,GO:0051085,1,0.845348995880425,0,12,chaperone mediated protein folding requiring cofactor,BP,
13854,GO:0051086,1,0.986871134170579,0,1,chaperone mediated protein folding independent of cofactor,BP,
13855,GO:0051087,1,0.300482178856671,0,86,chaperone binding,MF,
13856,GO:0051088,1,0.951074892137272,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13857,GO:0051089,1,0.983406899176178,0,1,constitutive protein ectodomain proteolysis,BP,
13863,GO:0051095,1,0.876462650921969,0,9,regulation of helicase activity,BP,
13864,GO:0051096,1,0.91672670616413,0,6,positive regulation of helicase activity,BP,
13865,GO:0051097,1,0.956093930405851,0,3,negative regulation of helicase activity,BP,
13870,GO:0051102,1,0.983406759352069,0,1,DNA ligation involved in DNA recombination,BP,
13871,GO:0051103,1,0.864087402915826,0,11,DNA ligation involved in DNA repair,BP,
13872,GO:0051105,1,0.924352981024775,0,5,regulation of DNA ligation,BP,
13873,GO:0051106,1,0.939385202295663,0,4,positive regulation of DNA ligation,BP,
13874,GO:0051107,1,0.98400191984867,0,1,negative regulation of DNA ligation,BP,
13877,GO:0051120,1,0.953983996288199,0,3,hepoxilin A3 synthase activity,MF,
13878,GO:0051121,1,0.925019176944352,0,5,hepoxilin metabolic process,BP,
13879,GO:0051122,1,0.925019176944352,0,5,hepoxilin biosynthetic process,BP,
13880,GO:0051123,1,0.6618223522318,0,30,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13881,GO:0051124,1,0.892146404505126,0,7,synaptic growth at neuromuscular junction,BP,
13882,GO:0051125,1,0.695021206507396,0,24,regulation of actin nucleation,BP,
13883,GO:0051126,1,0.925974357732351,0,6,negative regulation of actin nucleation,BP,
13884,GO:0051127,1,0.810729144777758,0,13,positive regulation of actin nucleation,BP,
13888,GO:0051131,1,0.785484984063261,0,18,chaperone-mediated protein complex assembly,BP,
13889,GO:0051132,1,0.875985728585744,0,10,NK T cell activation,BP,
13890,GO:0051133,1,0.901488094438085,0,8,regulation of NK T cell activation,BP,
13891,GO:0051134,1,0.987221987295889,0,1,negative regulation of NK T cell activation,BP,
13892,GO:0051135,1,0.913160850356732,0,7,positive regulation of NK T cell activation,BP,
13893,GO:0051136,1,0.910952695154415,0,6,regulation of NK T cell differentiation,BP,
13894,GO:0051138,1,0.93718323736701,0,4,positive regulation of NK T cell differentiation,BP,
13895,GO:0051139,1,0.983408102448569,0,1,metal ion:proton antiporter activity,MF,
13896,GO:0051140,1,0.953403737617239,0,4,regulation of NK T cell proliferation,BP,
13897,GO:0051142,1,0.953403737617239,0,4,positive regulation of NK T cell proliferation,BP,
13905,GO:0051152,1,0.866463300331505,0,10,positive regulation of smooth muscle cell differentiation,BP,
13909,GO:0051156,1,0.71031235740243,0,25,glucose 6-phosphate metabolic process,BP,
13910,GO:0051160,1,0.98481024597292,0,1,L-xylitol catabolic process,BP,
13911,GO:0051164,1,0.98481024597292,0,1,L-xylitol metabolic process,BP,
13912,GO:0051167,1,0.941944323047372,0,5,xylulose 5-phosphate metabolic process,BP,
13920,GO:0051176,1,0.922732755454697,0,5,positive regulation of sulfur metabolic process,BP,
13921,GO:0051177,1,0.915170661097054,0,7,meiotic sister chromatid cohesion,BP,
13925,GO:0051182,1,0.910504670524421,0,6,coenzyme transport,BP,
13928,GO:0051185,1,0.940959154150235,0,4,coenzyme transporter activity,MF,
13930,GO:0051187,1,0.783500046087791,0,20,cofactor catabolic process,BP,
13932,GO:0051189,1,0.903752332481818,0,7,prosthetic group metabolic process,BP,
13933,GO:0051192,1,0.994875889508817,0,1,prosthetic group binding,MF,
13944,GO:0051213,1,0.295907654583248,0,82,dioxygenase activity,MF,
13951,GO:0051225,1,0.281877892186751,0,84,spindle assembly,BP,
13952,GO:0051228,1,0.983406759351872,0,1,mitotic spindle disassembly,BP,
13953,GO:0051230,1,0.983406759351872,0,1,spindle disassembly,BP,
13954,GO:0051231,1,0.849611278988546,0,11,spindle elongation,BP,
13955,GO:0051232,1,0.985275954655982,0,1,meiotic spindle elongation,BP,
13959,GO:0051236,1,0.0623247190297322,0,189,establishment of RNA localization,BP,
13973,GO:0051255,1,0.863387376285178,0,10,spindle midzone assembly,BP,
13974,GO:0051256,1,0.876557930875078,0,9,mitotic spindle midzone assembly,BP,
13975,GO:0051257,1,0.984982832020166,0,1,meiotic spindle midzone assembly,BP,
13981,GO:0051264,1,0.984157165576615,0,1,mono-olein transacylation activity,MF,
13982,GO:0051265,1,0.984157165576615,0,1,diolein transacylation activity,MF,
13983,GO:0051267,1,0.98359964269722,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13990,GO:0051281,1,0.630218209146523,0,34,positive regulation of release of sequestered calcium ion into cytosol,BP,
13994,GO:0051286,1,0.890872724934588,0,7,cell tip,CC,
13995,GO:0051287,1,0.475527852491669,0,53,NAD binding,MF,
13997,GO:0051290,1,0.714177473704994,0,43,protein heterotetramerization,BP,
13999,GO:0051292,1,0.870252148278658,0,9,nuclear pore complex assembly,BP,
14002,GO:0051295,1,0.928155734264444,0,5,establishment of meiotic spindle localization,BP,
14003,GO:0051296,1,0.992224288134559,0,1,establishment of meiotic spindle orientation,BP,
14006,GO:0051299,1,0.807804944904643,0,14,centrosome separation,BP,
14010,GO:0051304,1,0.378224828019434,0,66,chromosome separation,BP,
14011,GO:0051305,1,0.905673895871902,0,6,chromosome movement towards spindle pole,BP,
14012,GO:0051306,1,0.498686463314728,0,48,mitotic sister chromatid separation,BP,
14013,GO:0051307,1,0.785218410297877,0,16,meiotic chromosome separation,BP,
14014,GO:0051308,1,0.984725543253726,0,1,male meiosis chromosome separation,BP,
14016,GO:0051311,1,0.984982832020166,0,1,meiotic metaphase plate congression,BP,
14017,GO:0051315,1,0.870361610690188,0,9,attachment of mitotic spindle microtubules to kinetochore,BP,
14021,GO:0051339,1,0.292284376587192,0,90,regulation of lyase activity,BP,
14022,GO:0051340,1,0.898979521380528,0,8,regulation of ligase activity,BP,
14024,GO:0051342,1,0.893945842709668,0,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
14025,GO:0051343,1,0.944530248181849,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
14026,GO:0051344,1,0.931126946851092,0,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
14031,GO:0051349,1,0.439674325561064,0,59,positive regulation of lyase activity,BP,
14032,GO:0051350,1,0.656866643288847,0,32,negative regulation of lyase activity,BP,
14033,GO:0051351,1,0.92559841652827,0,6,positive regulation of ligase activity,BP,
14034,GO:0051352,1,0.971250513033039,0,2,negative regulation of ligase activity,BP,
14036,GO:0051354,1,0.761193341054684,0,22,negative regulation of oxidoreductase activity,BP,
14037,GO:0051355,1,0.983410120254353,0,1,proprioception involved in equilibrioception,BP,
14038,GO:0051365,1,0.953697490905626,0,3,cellular response to potassium ion starvation,BP,
14039,GO:0051371,1,0.748325421947481,0,18,muscle alpha-actinin binding,MF,
14041,GO:0051377,1,0.951401106752483,0,3,mannose-ethanolamine phosphotransferase activity,MF,
14042,GO:0051378,1,0.854322667351548,0,11,serotonin binding,MF,
14044,GO:0051380,1,0.939946433137238,0,4,norepinephrine binding,MF,
14045,GO:0051382,1,0.848595429438378,0,11,kinetochore assembly,BP,
14046,GO:0051383,1,0.796506183778711,0,15,kinetochore organization,BP,
14049,GO:0051386,1,0.841886007219598,0,11,regulation of neurotrophin TRK receptor signaling pathway,BP,
14050,GO:0051387,1,0.941432217469588,0,4,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
14051,GO:0051388,1,0.92091371295333,0,5,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
14052,GO:0051389,1,0.983406759350394,0,1,inactivation of MAPKK activity,BP,
14053,GO:0051391,1,0.98340681697126,0,1,tRNA acetylation,BP,
14054,GO:0051392,1,0.98340681697126,0,1,tRNA N-acetyltransferase activity,MF,
14055,GO:0051393,1,0.600416095319128,0,32,alpha-actinin binding,MF,
14056,GO:0051394,1,0.99005688908311,0,1,regulation of nerve growth factor receptor activity,BP,
14057,GO:0051400,1,0.876301620479059,0,10,BH domain binding,MF,
14060,GO:0051409,1,0.870279373526203,0,10,response to nitrosative stress,BP,
14061,GO:0051410,1,0.936320422434008,0,5,detoxification of nitrogen compound,BP,
14063,GO:0051414,1,0.927524453801781,0,5,response to cortisol,BP,
14064,GO:0051415,1,0.906217624100177,0,6,interphase microtubule nucleation by interphase microtubule organizing center,BP,
14065,GO:0051418,1,0.891174456511092,0,7,microtubule nucleation by microtubule organizing center,BP,
14066,GO:0051424,1,0.987461994909068,0,1,corticotropin-releasing hormone binding,MF,
14067,GO:0051425,1,0.935451678711751,0,4,PTB domain binding,MF,
14070,GO:0051429,1,0.941859601397972,0,6,corticotropin-releasing hormone receptor binding,MF,
14071,GO:0051430,1,0.957178515419676,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
14072,GO:0051431,1,0.970169114460473,0,4,corticotropin-releasing hormone receptor 2 binding,MF,
14073,GO:0051433,1,0.983406759352018,0,1,BH2 domain binding,MF,
14074,GO:0051434,1,0.946693257978052,0,4,BH3 domain binding,MF,
14075,GO:0051436,1,0.440206573586255,0,71,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,
14076,GO:0051437,1,0.408979491644714,0,76,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,
14078,GO:0051439,1,0.4340203318125,0,72,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,
14079,GO:0051440,1,0.983430059982292,0,1,regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle,BP,
14080,GO:0051441,1,0.983430059982292,0,1,positive regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle,BP,
14082,GO:0051444,1,0.383262449010786,0,83,negative regulation of ubiquitin-protein transferase activity,BP,
14086,GO:0051450,1,0.822157304255845,0,14,myoblast proliferation,BP,
14087,GO:0051451,1,0.864155283053997,0,10,myoblast migration,BP,
14090,GO:0051454,1,0.910913980360611,0,6,intracellular pH elevation,BP,
14091,GO:0051457,1,0.794784171134777,0,15,maintenance of protein location in nucleus,BP,
14092,GO:0051458,1,0.922257661837394,0,7,corticotropin secretion,BP,
14093,GO:0051459,1,0.936574723700206,0,6,regulation of corticotropin secretion,BP,
14094,GO:0051460,1,0.987461994909068,0,1,negative regulation of corticotropin secretion,BP,
14095,GO:0051461,1,0.948469237300084,0,5,positive regulation of corticotropin secretion,BP,
14096,GO:0051462,1,0.947876677086885,0,5,regulation of cortisol secretion,BP,
14097,GO:0051463,1,0.983406759351575,0,1,negative regulation of cortisol secretion,BP,
14098,GO:0051464,1,0.963872878838871,0,4,positive regulation of cortisol secretion,BP,
14099,GO:0051466,1,0.969456037419064,0,2,positive regulation of corticotropin-releasing hormone secretion,BP,
14101,GO:0051481,1,0.831131788896177,0,14,negative regulation of cytosolic calcium ion concentration,BP,
14104,GO:0051490,1,0.957617768781421,0,3,negative regulation of filopodium assembly,BP,
14111,GO:0051497,1,0.738226416913359,0,20,negative regulation of stress fiber assembly,BP,
14112,GO:0051499,1,0.97495485113177,0,2,D-aminoacyl-tRNA deacylase activity,MF,
14113,GO:0051500,1,0.97495485113177,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
14114,GO:0051503,1,0.827653913206923,0,13,adenine nucleotide transport,BP,
14115,GO:0051510,1,0.990780980970108,0,1,regulation of unidimensional cell growth,BP,
14116,GO:0051511,1,0.990780980970108,0,1,negative regulation of unidimensional cell growth,BP,
14117,GO:0051525,1,0.927714327193562,0,5,NFAT protein binding,MF,
14119,GO:0051532,1,0.801221148202121,0,15,regulation of NFAT protein import into nucleus,BP,
14120,GO:0051533,1,0.866503840516128,0,10,positive regulation of NFAT protein import into nucleus,BP,
14121,GO:0051534,1,0.924702673200793,0,5,negative regulation of NFAT protein import into nucleus,BP,
14122,GO:0051536,1,0.431538326458187,0,62,iron-sulfur cluster binding,MF,
14123,GO:0051537,1,0.76873214339887,0,21,2 iron, 2 sulfur cluster binding,MF,
14124,GO:0051538,1,0.959727848404047,0,3,3 iron, 4 sulfur cluster binding,MF,
14125,GO:0051539,1,0.574351350597648,0,40,4 iron, 4 sulfur cluster binding,MF,
14126,GO:0051540,1,0.431538326458187,0,62,metal cluster binding,MF,
14133,GO:0051548,1,0.967087733487091,0,2,negative regulation of keratinocyte migration,BP,
14135,GO:0051552,1,0.913196525601844,0,6,flavone metabolic process,BP,
14136,GO:0051560,1,0.794406880078192,0,16,mitochondrial calcium ion homeostasis,BP,
14137,GO:0051561,1,0.89765325451556,0,8,positive regulation of mitochondrial calcium ion concentration,BP,
14138,GO:0051562,1,0.976047495759037,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
14139,GO:0051563,1,0.967151854619875,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
14140,GO:0051567,1,0.605069834021539,0,32,histone H3-K9 methylation,BP,
14141,GO:0051568,1,0.504470540280128,0,47,histone H3-K4 methylation,BP,
14142,GO:0051569,1,0.6946100609572,0,24,regulation of histone H3-K4 methylation,BP,
14143,GO:0051570,1,0.701601983090602,0,23,regulation of histone H3-K9 methylation,BP,
14144,GO:0051571,1,0.806660308710674,0,14,positive regulation of histone H3-K4 methylation,BP,
14145,GO:0051572,1,0.93906194626029,0,4,negative regulation of histone H3-K4 methylation,BP,
14146,GO:0051573,1,0.828925115832137,0,12,negative regulation of histone H3-K9 methylation,BP,
14147,GO:0051574,1,0.860033873799592,0,10,positive regulation of histone H3-K9 methylation,BP,
14148,GO:0051575,1,0.924163377271587,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
14150,GO:0051581,1,0.955783490711133,0,3,negative regulation of neurotransmitter uptake,BP,
14151,GO:0051582,1,0.964037074867435,0,3,positive regulation of neurotransmitter uptake,BP,
14154,GO:0051585,1,0.983663826627692,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
14155,GO:0051586,1,0.964037074867435,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
14157,GO:0051589,1,0.805043459049956,0,14,negative regulation of neurotransmitter transport,BP,
14158,GO:0051590,1,0.812036545955183,0,14,positive regulation of neurotransmitter transport,BP,
14161,GO:0051593,1,0.865488203357476,0,11,response to folic acid,BP,
14162,GO:0051594,1,0.947316746879277,0,4,detection of glucose,BP,
14163,GO:0051595,1,0.973427080761974,0,2,response to methylglyoxal,BP,
14164,GO:0051596,1,0.972950869596186,0,2,methylglyoxal catabolic process,BP,
14165,GO:0051597,1,0.903556260245048,0,7,response to methylmercury,BP,
14166,GO:0051598,1,0.970839909013348,0,2,meiotic recombination checkpoint,BP,
14167,GO:0051599,1,0.911450848878277,0,6,response to hydrostatic pressure,BP,
14175,GO:0051610,1,0.939920998944401,0,4,serotonin uptake,BP,
14176,GO:0051611,1,0.955783490711133,0,3,regulation of serotonin uptake,BP,
14177,GO:0051612,1,0.955783490711133,0,3,negative regulation of serotonin uptake,BP,
14178,GO:0051615,1,0.983406759351775,0,1,histamine uptake,BP,
14179,GO:0051620,1,0.983663826627692,0,1,norepinephrine uptake,BP,
14180,GO:0051621,1,0.983663826627692,0,1,regulation of norepinephrine uptake,BP,
14181,GO:0051622,1,0.983663826627692,0,1,negative regulation of norepinephrine uptake,BP,
14185,GO:0051642,1,0.719568212844738,0,21,centrosome localization,BP,
14186,GO:0051643,1,0.968384722374418,0,2,endoplasmic reticulum localization,BP,
14187,GO:0051645,1,0.834386745844582,0,12,Golgi localization,BP,
14188,GO:0051646,1,0.561479856917762,0,38,mitochondrion localization,BP,
14189,GO:0051647,1,0.719307327012828,0,21,nucleus localization,BP,
14195,GO:0051654,1,0.768140837606095,0,18,establishment of mitochondrion localization,BP,
14197,GO:0051657,1,0.849888850756964,0,10,maintenance of organelle location,BP,
14198,GO:0051659,1,0.969379090954424,0,2,maintenance of mitochondrion location,BP,
14199,GO:0051660,1,0.935526239308437,0,4,establishment of centrosome localization,BP,
14200,GO:0051661,1,0.920667804623298,0,5,maintenance of centrosome location,BP,
14201,GO:0051664,1,0.983406759352069,0,1,nuclear pore localization,BP,
14202,GO:0051665,1,0.873988579574309,0,10,membrane raft localization,BP,
14204,GO:0051673,1,0.97598737063888,0,2,membrane disruption in other organism,BP,
14206,GO:0051683,1,0.905385390064806,0,7,establishment of Golgi localization,BP,
14207,GO:0051684,1,0.951627409169554,0,3,maintenance of Golgi location,BP,
14208,GO:0051685,1,0.984725543253726,0,1,maintenance of ER location,BP,
14209,GO:0051691,1,0.979878822418182,0,2,cellular oligosaccharide metabolic process,BP,
14210,GO:0051692,1,0.979878822418182,0,2,cellular oligosaccharide catabolic process,BP,
14212,GO:0051694,1,0.900865019267655,0,7,pointed-end actin filament capping,BP,
14214,GO:0051697,1,0.945966793429916,0,4,protein delipidation,BP,
14216,GO:0051702,1,0.430917646058245,0,62,interaction with symbiont,BP,
14217,GO:0051703,1,0.50093512978437,0,47,intraspecies interaction between organisms,BP,
14219,GO:0051705,1,0.39673264979235,0,63,multi-organism behavior,BP,
14221,GO:0051708,1,0.93476603090351,0,5,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14222,GO:0051709,1,0.909672151648891,0,7,regulation of killing of cells of other organism,BP,
14223,GO:0051712,1,0.924761697522121,0,6,positive regulation of killing of cells of other organism,BP,
14224,GO:0051715,1,0.970300521909226,0,2,cytolysis in other organism,BP,
14226,GO:0051717,1,0.967757658124631,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14228,GO:0051722,1,0.985006701165382,0,1,protein C-terminal methylesterase activity,MF,
14229,GO:0051723,1,0.985006701165382,0,1,protein methylesterase activity,MF,
14230,GO:0051724,1,0.985653813887015,0,1,NAD transporter activity,MF,
14231,GO:0051725,1,0.946418158412909,0,4,protein de-ADP-ribosylation,BP,
14233,GO:0051728,1,0.983865649318172,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14234,GO:0051729,1,0.983865649318172,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14235,GO:0051731,1,0.943963681302383,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14236,GO:0051732,1,0.987922462885514,0,1,polyribonucleotide kinase activity,MF,
14237,GO:0051733,1,0.959894115260203,0,3,polydeoxyribonucleotide kinase activity,MF,
14238,GO:0051734,1,0.959894115260203,0,3,ATP-dependent polynucleotide kinase activity,MF,
14239,GO:0051736,1,0.987922462885514,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14240,GO:0051747,1,0.99286710446777,0,1,cytosine C-5 DNA demethylase activity,MF,
14241,GO:0051748,1,0.98611224388859,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14242,GO:0051754,1,0.952901545150016,0,3,meiotic sister chromatid cohesion, centromeric,BP,
14243,GO:0051758,1,0.983406759351527,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14244,GO:0051764,1,0.827335103356418,0,12,actin crosslink formation,BP,
14245,GO:0051765,1,0.971476846114097,0,2,inositol tetrakisphosphate kinase activity,MF,
14246,GO:0051766,1,0.85407501812895,0,11,inositol trisphosphate kinase activity,MF,
14251,GO:0051775,1,0.864572405241769,0,11,response to redox state,BP,
14252,GO:0051780,1,0.983406759352069,0,1,behavioral response to nutrient,BP,
14254,GO:0051782,1,0.789279449747455,0,16,negative regulation of cell division,BP,
14258,GO:0051786,1,0.983550555637331,0,1,all-trans-retinol 13,14-reductase activity,MF,
14259,GO:0051787,1,0.826897461570028,0,13,misfolded protein binding,MF,
14260,GO:0051788,1,0.727369213083045,0,22,response to misfolded protein,BP,
14261,GO:0051790,1,0.945277913215189,0,4,short-chain fatty acid biosynthetic process,BP,
14262,GO:0051791,1,0.936232925903986,0,5,medium-chain fatty acid metabolic process,BP,
14263,GO:0051792,1,0.97984284233659,0,2,medium-chain fatty acid biosynthetic process,BP,
14264,GO:0051793,1,0.984585310055812,0,1,medium-chain fatty acid catabolic process,BP,
14265,GO:0051794,1,0.947748176609434,0,4,regulation of timing of catagen,BP,
14266,GO:0051795,1,0.963742212515526,0,3,positive regulation of timing of catagen,BP,
14267,GO:0051796,1,0.98340675935207,0,1,negative regulation of timing of catagen,BP,
14270,GO:0051799,1,0.945117804307437,0,4,negative regulation of hair follicle development,BP,
14271,GO:0051800,1,0.971099946164773,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14272,GO:0051801,1,0.970300521909226,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14273,GO:0051805,1,0.984363538817272,0,1,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14275,GO:0051807,1,0.984363538817272,0,1,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14276,GO:0051808,1,0.98514627588204,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14277,GO:0051817,1,0.268054232072452,0,93,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
14278,GO:0051818,1,0.875322823302478,0,12,disruption of cells of other organism involved in symbiotic interaction,BP,
14279,GO:0051821,1,0.983406759351574,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14280,GO:0051823,1,0.869178260742442,0,9,regulation of synapse structural plasticity,BP,
14282,GO:0051832,1,0.954368713501299,0,3,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14283,GO:0051834,1,0.954368713501299,0,3,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14284,GO:0051835,1,0.943403195413656,0,4,positive regulation of synapse structural plasticity,BP,
14285,GO:0051836,1,0.98514627588204,0,1,translocation of molecules into other organism involved in symbiotic interaction,BP,
14286,GO:0051851,1,0.455785231380758,0,58,modification by host of symbiont morphology or physiology,BP,
14287,GO:0051852,1,0.924915114118447,0,8,disruption by host of symbiont cells,BP,
14288,GO:0051861,1,0.764879748969761,0,19,glycolipid binding,MF,
14289,GO:0051864,1,0.920964915389439,0,5,histone demethylase activity (H3-K36 specific),MF,
14290,GO:0051865,1,0.449585917893427,0,53,protein autoubiquitination,BP,
14291,GO:0051866,1,0.974301555477433,0,2,general adaptation syndrome,BP,
14292,GO:0051867,1,0.990694808173223,0,1,general adaptation syndrome, behavioral process,BP,
14293,GO:0051870,1,0.967545264113297,0,3,methotrexate binding,MF,
14294,GO:0051873,1,0.924915114118447,0,8,killing by host of symbiont cells,BP,
14296,GO:0051877,1,0.968540056502694,0,2,pigment granule aggregation in cell center,BP,
14297,GO:0051878,1,0.983458607178778,0,1,lateral element assembly,BP,
14298,GO:0051879,1,0.626924235967265,0,31,Hsp90 protein binding,MF,
14299,GO:0051880,1,0.889747945176279,0,7,G-quadruplex DNA binding,MF,
14301,GO:0051882,1,0.745102681849899,0,22,mitochondrial depolarization,BP,
14302,GO:0051883,1,0.875322823302478,0,12,killing of cells in other organism involved in symbiotic interaction,BP,
14305,GO:0051886,1,0.983406759351872,0,1,negative regulation of timing of anagen,BP,
14306,GO:0051890,1,0.89341570009969,0,7,regulation of cardioblast differentiation,BP,
14307,GO:0051891,1,0.923320402932274,0,5,positive regulation of cardioblast differentiation,BP,
14308,GO:0051892,1,0.967622305117203,0,2,negative regulation of cardioblast differentiation,BP,
14311,GO:0051895,1,0.80098989913837,0,14,negative regulation of focal adhesion assembly,BP,
14314,GO:0051898,1,0.607880355117158,0,34,negative regulation of protein kinase B signaling,BP,
14316,GO:0051900,1,0.7673831608147,0,19,regulation of mitochondrial depolarization,BP,
14317,GO:0051901,1,0.889357436217383,0,9,positive regulation of mitochondrial depolarization,BP,
14318,GO:0051902,1,0.91855249673181,0,6,negative regulation of mitochondrial depolarization,BP,
14319,GO:0051903,1,0.984509025344987,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14322,GO:0051908,1,0.983635055599986,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14323,GO:0051916,1,0.983896811933824,0,1,granulocyte colony-stimulating factor binding,MF,
14324,GO:0051917,1,0.819057503681288,0,14,regulation of fibrinolysis,BP,
14325,GO:0051918,1,0.870231715293121,0,10,negative regulation of fibrinolysis,BP,
14326,GO:0051919,1,0.94228770395938,0,4,positive regulation of fibrinolysis,BP,
14327,GO:0051920,1,0.92850452794637,0,8,peroxiredoxin activity,MF,
14328,GO:0051923,1,0.806317144062401,0,16,sulfation,BP,
14335,GO:0051933,1,0.93525434782914,0,4,amino acid neurotransmitter reuptake,BP,
14337,GO:0051935,1,0.93525434782914,0,4,glutamate reuptake,BP,
14339,GO:0051938,1,0.86059856739556,0,9,L-glutamate import,BP,
14340,GO:0051939,1,0.983406759352021,0,1,gamma-aminobutyric acid import,BP,
14342,GO:0051941,1,0.967087733487433,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14343,GO:0051944,1,0.964037074867435,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14344,GO:0051945,1,0.983663826627692,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14345,GO:0051946,1,0.967087733487433,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14351,GO:0051957,1,0.8064541631359,0,15,positive regulation of amino acid transport,BP,
14352,GO:0051958,1,0.967771626631759,0,2,methotrexate transport,BP,
14353,GO:0051959,1,0.828768852114994,0,12,dynein light intermediate chain binding,MF,
14362,GO:0051968,1,0.728705224821773,0,20,positive regulation of synaptic transmission, glutamatergic,BP,
14363,GO:0051969,1,0.818797207665444,0,16,regulation of transmission of nerve impulse,BP,
14364,GO:0051970,1,0.950053048032212,0,5,negative regulation of transmission of nerve impulse,BP,
14365,GO:0051971,1,0.91972739225974,0,7,positive regulation of transmission of nerve impulse,BP,
14366,GO:0051972,1,0.518147481433426,0,44,regulation of telomerase activity,BP,
14367,GO:0051973,1,0.591850474147299,0,35,positive regulation of telomerase activity,BP,
14368,GO:0051974,1,0.875723224524721,0,9,negative regulation of telomerase activity,BP,
14369,GO:0051977,1,0.978552259111099,0,2,lysophospholipid transport,BP,
14370,GO:0051978,1,0.985934643707066,0,1,lysophospholipid transporter activity,MF,
14371,GO:0051983,1,0.306572810073131,0,80,regulation of chromosome segregation,BP,
14372,GO:0051984,1,0.74615200049255,0,19,positive regulation of chromosome segregation,BP,
14373,GO:0051985,1,0.608456191259867,0,34,negative regulation of chromosome segregation,BP,
14374,GO:0051987,1,0.94398280880495,0,4,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14375,GO:0051988,1,0.845440188880003,0,11,regulation of attachment of spindle microtubules to kinetochore,BP,
14376,GO:0051990,1,0.970282761672557,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14377,GO:0051996,1,0.986257186080042,0,1,squalene synthase activity,MF,
14378,GO:0051998,1,0.93071032479391,0,5,protein carboxyl O-methyltransferase activity,MF,
14379,GO:0052026,1,0.984041436430165,0,1,modulation by symbiont of host transcription,BP,
14380,GO:0052027,1,0.983574937889037,0,1,modulation by symbiont of host signal transduction pathway,BP,
14381,GO:0052031,1,0.975415942898039,0,2,modulation by symbiont of host defense response,BP,
14382,GO:0052040,1,0.92991805912918,0,5,modulation by symbiont of host programmed cell death,BP,
14383,GO:0052041,1,0.945612440285844,0,4,negative regulation by symbiont of host programmed cell death,BP,
14384,GO:0052042,1,0.975369653398164,0,2,positive regulation by symbiont of host programmed cell death,BP,
14385,GO:0052047,1,0.968932465550423,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14386,GO:0052053,1,0.984251115939407,0,1,negative regulation by symbiont of host catalytic activity,BP,
14387,GO:0052055,1,0.937175117764898,0,5,modulation by symbiont of host molecular function,BP,
14388,GO:0052056,1,0.967918135718358,0,2,negative regulation by symbiont of host molecular function,BP,
14389,GO:0052066,1,0.983406759351429,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14390,GO:0052097,1,0.98357355435276,0,1,interspecies quorum sensing,BP,
14391,GO:0052106,1,0.98357355435276,0,1,quorum sensing involved in interaction with host,BP,
14392,GO:0052126,1,0.587562307162153,0,35,movement in host environment,BP,
14393,GO:0052148,1,0.984251115939407,0,1,modulation by symbiont of host catalytic activity,BP,
14394,GO:0052150,1,0.92991805912918,0,5,modulation by symbiont of host apoptotic process,BP,
14395,GO:0052151,1,0.975369653398164,0,2,positive regulation by symbiont of host apoptotic process,BP,
14396,GO:0052173,1,0.917663491833967,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
14397,GO:0052182,1,0.985282490842866,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14398,GO:0052190,1,0.983406759351429,0,1,modulation by symbiont of host phagocytosis,BP,
14399,GO:0052191,1,0.983406759351429,0,1,positive regulation by symbiont of host phagocytosis,BP,
14400,GO:0052192,1,0.587562307162153,0,35,movement in environment of other organism involved in symbiotic interaction,BP,
14401,GO:0052199,1,0.964641212063932,0,3,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14402,GO:0052200,1,0.917663491833967,0,6,response to host defenses,BP,
14403,GO:0052203,1,0.952991467193387,0,4,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14404,GO:0052204,1,0.918932807346656,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14405,GO:0052205,1,0.918932807346656,0,7,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14406,GO:0052212,1,0.985282490842866,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14407,GO:0052213,1,0.985282490842866,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14408,GO:0052214,1,0.98850199571852,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14409,GO:0052227,1,0.98850199571852,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14410,GO:0052229,1,0.98850199571852,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14411,GO:0052231,1,0.983406759351429,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14412,GO:0052248,1,0.92991805912918,0,5,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14413,GO:0052250,1,0.983574937889037,0,1,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14414,GO:0052251,1,0.975415942898039,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14415,GO:0052255,1,0.975415942898039,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14416,GO:0052312,1,0.688113906489908,0,26,modulation of transcription in other organism involved in symbiotic interaction,BP,
14417,GO:0052314,1,0.973938948176798,0,2,phytoalexin metabolic process,BP,
14418,GO:0052330,1,0.975369653398164,0,2,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14419,GO:0052331,1,0.970300521909226,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14420,GO:0052360,1,0.98850199571852,0,1,catabolism by host of symbiont macromolecule,BP,
14421,GO:0052361,1,0.98850199571852,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14422,GO:0052362,1,0.98850199571852,0,1,catabolism by host of symbiont protein,BP,
14423,GO:0052363,1,0.98850199571852,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14424,GO:0052364,1,0.98850199571852,0,1,catabolism by host of substance in symbiont,BP,
14425,GO:0052370,1,0.983406759351429,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14426,GO:0052381,1,0.986160124869071,0,1,tRNA dimethylallyltransferase activity,MF,
14427,GO:0052403,1,0.980077621687734,0,2,negative regulation by host of symbiont catalytic activity,BP,
14428,GO:0052405,1,0.949397721201623,0,5,negative regulation by host of symbiont molecular function,BP,
14429,GO:0052416,1,0.98850199571852,0,1,metabolism by host of symbiont macromolecule,BP,
14430,GO:0052417,1,0.98850199571852,0,1,metabolism by host of symbiont protein,BP,
14431,GO:0052418,1,0.98850199571852,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14432,GO:0052419,1,0.98850199571852,0,1,metabolism by host of substance in symbiont,BP,
14433,GO:0052422,1,0.952991467193387,0,4,modulation by host of symbiont catalytic activity,BP,
14434,GO:0052428,1,0.934442565742307,0,6,modification by host of symbiont molecular function,BP,
14435,GO:0052433,1,0.92991805912918,0,5,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14436,GO:0052472,1,0.699289992723307,0,25,modulation by host of symbiont transcription,BP,
14437,GO:0052490,1,0.945612440285844,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14438,GO:0052501,1,0.975369653398164,0,2,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14439,GO:0052509,1,0.975415942898039,0,2,positive regulation by symbiont of host defense response,BP,
14440,GO:0052510,1,0.975415942898039,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14441,GO:0052522,1,0.983406759351429,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14444,GO:0052550,1,0.988273030974696,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14445,GO:0052551,1,0.983406759352018,0,1,response to defense-related nitric oxide production by other organism involved in symbiotic interaction,BP,
14446,GO:0052552,1,0.975415942898039,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14447,GO:0052553,1,0.975415942898039,0,2,modulation by symbiont of host immune response,BP,
14448,GO:0052564,1,0.933151909468056,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
14449,GO:0052565,1,0.983406759352018,0,1,response to defense-related host nitric oxide production,BP,
14450,GO:0052567,1,0.988273030974696,0,1,response to defense-related host reactive oxygen species production,BP,
14451,GO:0052572,1,0.933151909468056,0,5,response to host immune response,BP,
14452,GO:0052590,1,0.983406759351676,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14453,GO:0052591,1,0.983406759351676,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14454,GO:0052593,1,0.968228377478806,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14455,GO:0052594,1,0.968228377478806,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14456,GO:0052595,1,0.968228377478806,0,2,aliphatic-amine oxidase activity,MF,
14457,GO:0052596,1,0.968228377478806,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14458,GO:0052629,1,0.835181812476012,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14459,GO:0052642,1,0.972591768097453,0,2,lysophosphatidic acid phosphatase activity,MF,
14460,GO:0052646,1,0.883140916563776,0,8,alditol phosphate metabolic process,BP,
14461,GO:0052650,1,0.893198760084828,0,9,NADP-retinol dehydrogenase activity,MF,
14462,GO:0052651,1,0.972656394219515,0,2,monoacylglycerol catabolic process,BP,
14464,GO:0052654,1,0.972190230503299,0,2,L-leucine transaminase activity,MF,
14465,GO:0052655,1,0.972190230503299,0,2,L-valine transaminase activity,MF,
14466,GO:0052656,1,0.972190230503299,0,2,L-isoleucine transaminase activity,MF,
14467,GO:0052657,1,0.98976807092467,0,1,guanine phosphoribosyltransferase activity,MF,
14468,GO:0052658,1,0.907282979948856,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14469,GO:0052659,1,0.863005601036266,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14470,GO:0052666,1,0.986898217540882,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14471,GO:0052689,1,0.166863100879879,0,132,carboxylic ester hydrolase activity,MF,
14472,GO:0052692,1,0.989750012150819,0,1,raffinose alpha-galactosidase activity,MF,
14473,GO:0052695,1,0.778274452050273,0,17,cellular glucuronidation,BP,
14474,GO:0052696,1,0.928728049816736,0,5,flavonoid glucuronidation,BP,
14475,GO:0052697,1,0.876221977125015,0,9,xenobiotic glucuronidation,BP,
14476,GO:0052723,1,0.926957851736841,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14477,GO:0052724,1,0.926957851736841,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14478,GO:0052725,1,0.983591402321654,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14479,GO:0052726,1,0.983591402321654,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14480,GO:0052731,1,0.98625922657968,0,1,phosphocholine phosphatase activity,MF,
14481,GO:0052732,1,0.98625922657968,0,1,phosphoethanolamine phosphatase activity,MF,
14482,GO:0052739,1,0.965545358305331,0,3,phosphatidylserine 1-acylhydrolase activity,MF,
14483,GO:0052740,1,0.97740114654655,0,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14484,GO:0052741,1,0.97689149140805,0,2,(R)-limonene 6-monooxygenase activity,MF,
14486,GO:0052743,1,0.835163576057108,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14487,GO:0052744,1,0.794511901831205,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
14488,GO:0052745,1,0.737330688277083,0,19,inositol phosphate phosphatase activity,MF,
14489,GO:0052746,1,0.983406759352021,0,1,inositol phosphorylation,BP,
14490,GO:0052794,1,0.948590964845272,0,4,exo-alpha-(2->3)-sialidase activity,MF,
14491,GO:0052795,1,0.948590964845272,0,4,exo-alpha-(2->6)-sialidase activity,MF,
14492,GO:0052796,1,0.948590964845272,0,4,exo-alpha-(2->8)-sialidase activity,MF,
14493,GO:0052798,1,0.986298138481011,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14494,GO:0052803,1,0.860677803055231,0,11,imidazole-containing compound metabolic process,BP,
14495,GO:0052805,1,0.906166357877489,0,7,imidazole-containing compound catabolic process,BP,
14496,GO:0052810,1,0.968135807938647,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14497,GO:0052811,1,0.920730130023714,0,5,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14498,GO:0052812,1,0.952069161489401,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14500,GO:0052815,1,0.975038614578039,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14501,GO:0052816,1,0.983492411185385,0,1,long-chain acyl-CoA hydrolase activity,MF,
14502,GO:0052817,1,0.983492411185385,0,1,very long chain acyl-CoA hydrolase activity,MF,
14503,GO:0052821,1,0.991885055232925,0,1,DNA-7-methyladenine glycosylase activity,MF,
14504,GO:0052822,1,0.991885055232925,0,1,DNA-3-methylguanine glycosylase activity,MF,
14505,GO:0052825,1,0.983591402321654,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14506,GO:0052826,1,0.98408794163048,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14507,GO:0052827,1,0.967939374844504,0,2,inositol pentakisphosphate phosphatase activity,MF,
14508,GO:0052828,1,0.967087733487576,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14509,GO:0052829,1,0.986324918197955,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14510,GO:0052830,1,0.983591402321654,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14511,GO:0052831,1,0.983591402321654,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14512,GO:0052832,1,0.94118100943791,0,4,inositol monophosphate 3-phosphatase activity,MF,
14513,GO:0052833,1,0.94118100943791,0,4,inositol monophosphate 4-phosphatase activity,MF,
14514,GO:0052834,1,0.94118100943791,0,4,inositol monophosphate phosphatase activity,MF,
14515,GO:0052835,1,0.983591402321654,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14516,GO:0052836,1,0.958510037459671,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14517,GO:0052839,1,0.958510037459671,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14518,GO:0052840,1,0.946675313860854,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14519,GO:0052841,1,0.946675313860854,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14520,GO:0052842,1,0.946675313860854,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14521,GO:0052843,1,0.946675313860854,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14522,GO:0052844,1,0.946675313860854,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14523,GO:0052845,1,0.946675313860854,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14524,GO:0052846,1,0.946675313860854,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14525,GO:0052847,1,0.946675313860854,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14526,GO:0052848,1,0.946675313860854,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14527,GO:0052851,1,0.951038556798296,0,3,ferric-chelate reductase (NADPH) activity,MF,
14528,GO:0052852,1,0.97681406979208,0,2,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14529,GO:0052853,1,0.97681406979208,0,2,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14530,GO:0052854,1,0.97681406979208,0,2,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14531,GO:0052858,1,0.983441596143468,0,1,peptidyl-lysine acetyltransferase activity,MF,
14532,GO:0052866,1,0.627285351580311,0,29,phosphatidylinositol phosphate phosphatase activity,MF,
14533,GO:0052869,1,0.985298885672063,0,1,arachidonic acid omega-hydroxylase activity,MF,
14534,GO:0052870,1,0.969394118460237,0,2,tocopherol omega-hydroxylase activity,MF,
14535,GO:0052871,1,0.969394118460237,0,2,alpha-tocopherol omega-hydroxylase activity,MF,
14536,GO:0052872,1,0.985298885672063,0,1,tocotrienol omega-hydroxylase activity,MF,
14537,GO:0052884,1,0.984577792821529,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14538,GO:0052885,1,0.984577792821529,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14539,GO:0052890,1,0.987072199627865,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14540,GO:0052894,1,0.986399736995498,0,1,norspermine:oxygen oxidoreductase activity,MF,
14541,GO:0052895,1,0.986399736995498,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14542,GO:0052899,1,0.988182873842877,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14543,GO:0052901,1,0.974742667701771,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14544,GO:0052902,1,0.988182873842877,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14545,GO:0052903,1,0.988182873842877,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14546,GO:0052904,1,0.988182873842877,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14547,GO:0052906,1,0.98340675935187,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14548,GO:0052907,1,0.984725543253726,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14549,GO:0052909,1,0.984725543253726,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14550,GO:0052917,1,0.985272691223766,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14551,GO:0052918,1,0.983406759351575,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14552,GO:0052925,1,0.989169524810204,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14553,GO:0052926,1,0.983406759351575,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14554,GO:0052927,1,0.985614351305629,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14555,GO:0052928,1,0.985614351305629,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14556,GO:0052929,1,0.985614351305629,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14560,GO:0055005,1,0.954933156149291,0,3,ventricular cardiac myofibril assembly,BP,
14566,GO:0055011,1,0.970046556515123,0,3,atrial cardiac muscle cell differentiation,BP,
14567,GO:0055012,1,0.768375242984231,0,18,ventricular cardiac muscle cell differentiation,BP,
14569,GO:0055014,1,0.970046556515123,0,3,atrial cardiac muscle cell development,BP,
14570,GO:0055015,1,0.834881617324084,0,13,ventricular cardiac muscle cell development,BP,
14575,GO:0055022,1,0.800420485015655,0,15,negative regulation of cardiac muscle tissue growth,BP,
14580,GO:0055029,1,0.177799496032912,0,124,nuclear DNA-directed RNA polymerase complex,CC,
14583,GO:0055048,1,0.98340675935133,0,1,anastral spindle assembly,BP,
14585,GO:0055057,1,0.808922024811878,0,13,neuroblast division,BP,
14586,GO:0055059,1,0.9223877269126,0,5,asymmetric neuroblast division,BP,
14587,GO:0055062,1,0.82767640378958,0,12,phosphate ion homeostasis,BP,
14588,GO:0055064,1,0.929326986475474,0,5,chloride ion homeostasis,BP,
14591,GO:0055069,1,0.691130923761409,0,26,zinc ion homeostasis,BP,
14594,GO:0055073,1,0.978990243006218,0,2,cadmium ion homeostasis,BP,
14598,GO:0055077,1,0.941771963324869,0,4,gap junction hemi-channel activity,MF,
14601,GO:0055081,1,0.554074470583916,0,41,anion homeostasis,BP,
14603,GO:0055083,1,0.769137807934453,0,17,monovalent inorganic anion homeostasis,BP,
14606,GO:0055087,1,0.958545895001726,0,3,Ski complex,CC,
14608,GO:0055089,1,0.831278178644721,0,13,fatty acid homeostasis,BP,
14610,GO:0055091,1,0.888512331811695,0,9,phospholipid homeostasis,BP,
14611,GO:0055092,1,0.39847589131752,0,68,sterol homeostasis,BP,
14613,GO:0055094,1,0.741177183597907,0,22,response to lipoprotein particle,BP,
14614,GO:0055095,1,0.953948618691253,0,3,lipoprotein particle mediated signaling,BP,
14615,GO:0055096,1,0.953948618691253,0,3,low-density lipoprotein particle mediated signaling,BP,
14616,GO:0055098,1,0.798906653497377,0,16,response to low-density lipoprotein particle,BP,
14617,GO:0055099,1,0.96206232789152,0,3,response to high density lipoprotein particle,BP,
14618,GO:0055100,1,0.953701813947248,0,3,adiponectin binding,MF,
14619,GO:0055102,1,0.860104738232685,0,16,lipase inhibitor activity,MF,
14620,GO:0055103,1,0.98359964269722,0,1,ligase regulator activity,MF,
14621,GO:0055105,1,0.964467600161802,0,5,ubiquitin-protein transferase inhibitor activity,MF,
14622,GO:0055106,1,0.821424881883706,0,16,ubiquitin-protein transferase regulator activity,MF,
14623,GO:0055108,1,0.98681281700589,0,1,Golgi to transport vesicle transport,BP,
14624,GO:0055111,1,0.983406759351775,0,1,ingression involved in gastrulation with mouth forming second,BP,
14625,GO:0055113,1,0.983406759350443,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14630,GO:0055120,1,0.992156073995558,0,1,striated muscle dense body,CC,
14632,GO:0055129,1,0.946768074026087,0,4,L-proline biosynthetic process,BP,
14633,GO:0055130,1,0.988702664278225,0,1,D-alanine catabolic process,BP,
14635,GO:0060001,1,0.983406759350987,0,1,minus-end directed microfilament motor activity,MF,
14636,GO:0060002,1,0.951041235405239,0,3,plus-end directed microfilament motor activity,MF,
14637,GO:0060003,1,0.967087733486655,0,2,copper ion export,BP,
14638,GO:0060004,1,0.753469363662018,0,18,reflex,BP,
14639,GO:0060005,1,0.9356877571721,0,4,vestibular reflex,BP,
14640,GO:0060007,1,0.983406759352069,0,1,linear vestibuloocular reflex,BP,
14641,GO:0060008,1,0.764214904779422,0,18,Sertoli cell differentiation,BP,
14642,GO:0060009,1,0.810522147627147,0,14,Sertoli cell development,BP,
14643,GO:0060010,1,0.983548379612761,0,1,Sertoli cell fate commitment,BP,
14644,GO:0060011,1,0.948725142033326,0,4,Sertoli cell proliferation,BP,
14645,GO:0060012,1,0.898573468063817,0,7,synaptic transmission, glycinergic,BP,
14646,GO:0060013,1,0.879254663800839,0,8,righting reflex,BP,
14647,GO:0060014,1,0.974882545423096,0,2,granulosa cell differentiation,BP,
14648,GO:0060016,1,0.990755406988791,0,1,granulosa cell development,BP,
14649,GO:0060017,1,0.897444073822941,0,7,parathyroid gland development,BP,
14650,GO:0060018,1,0.936422456938123,0,4,astrocyte fate commitment,BP,
14652,GO:0060020,1,0.901518911137588,0,7,Bergmann glial cell differentiation,BP,
14654,GO:0060022,1,0.907702578891402,0,6,hard palate development,BP,
14655,GO:0060023,1,0.925095243201771,0,5,soft palate development,BP,
14657,GO:0060025,1,0.967087733487623,0,2,regulation of synaptic activity,BP,
14663,GO:0060032,1,0.967149349165361,0,2,notochord regression,BP,
14664,GO:0060033,1,0.850853352153289,0,11,anatomical structure regression,BP,
14665,GO:0060034,1,0.983406808891365,0,1,notochord cell differentiation,BP,
14666,GO:0060035,1,0.983406808891365,0,1,notochord cell development,BP,
14670,GO:0060040,1,0.949546506784953,0,4,retinal bipolar neuron differentiation,BP,
14674,GO:0060044,1,0.860425205768857,0,10,negative regulation of cardiac muscle cell proliferation,BP,
14676,GO:0060046,1,0.815957538760052,0,19,regulation of acrosome reaction,BP,
14679,GO:0060049,1,0.78891820418886,0,17,regulation of protein glycosylation,BP,
14680,GO:0060050,1,0.89025936637169,0,8,positive regulation of protein glycosylation,BP,
14681,GO:0060051,1,0.959467826301444,0,3,negative regulation of protein glycosylation,BP,
14682,GO:0060052,1,0.870697193633524,0,9,neurofilament cytoskeleton organization,BP,
14683,GO:0060053,1,0.968887725224425,0,2,neurofilament cytoskeleton,CC,
14685,GO:0060055,1,0.761398576138962,0,18,angiogenesis involved in wound healing,BP,
14689,GO:0060059,1,0.885475483491968,0,8,embryonic retina morphogenesis in camera-type eye,BP,
14690,GO:0060060,1,0.967379018679425,0,2,post-embryonic retina morphogenesis in camera-type eye,BP,
14699,GO:0060072,1,0.967094006574618,0,2,large conductance calcium-activated potassium channel activity,MF,
14700,GO:0060073,1,0.89435600784519,0,7,micturition,BP,
14701,GO:0060074,1,0.758529031803662,0,17,synapse maturation,BP,
14704,GO:0060077,1,0.831745288813581,0,12,inhibitory synapse,CC,
14707,GO:0060080,1,0.801068358472263,0,14,inhibitory postsynaptic potential,BP,
14708,GO:0060081,1,0.841630729784156,0,12,membrane hyperpolarization,BP,
14709,GO:0060083,1,0.951218431387873,0,3,smooth muscle contraction involved in micturition,BP,
14710,GO:0060084,1,0.953623494645862,0,3,synaptic transmission involved in micturition,BP,
14711,GO:0060086,1,0.96819276385218,0,2,circadian temperature homeostasis,BP,
14716,GO:0060091,1,0.883222162349439,0,9,kinocilium,CC,
14717,GO:0060099,1,0.847437753905341,0,11,regulation of phagocytosis, engulfment,BP,
14718,GO:0060100,1,0.872013302812814,0,9,positive regulation of phagocytosis, engulfment,BP,
14719,GO:0060101,1,0.987221987295889,0,1,negative regulation of phagocytosis, engulfment,BP,
14720,GO:0060112,1,0.982055480027811,0,2,generation of ovulation cycle rhythm,BP,
14722,GO:0060114,1,0.992554199085501,0,1,vestibular receptor cell differentiation,BP,
14724,GO:0060118,1,0.992554199085501,0,1,vestibular receptor cell development,BP,
14728,GO:0060123,1,0.869302632408712,0,11,regulation of growth hormone secretion,BP,
14729,GO:0060124,1,0.914073399222451,0,8,positive regulation of growth hormone secretion,BP,
14730,GO:0060125,1,0.967087733487287,0,2,negative regulation of growth hormone secretion,BP,
14732,GO:0060127,1,0.98576332120161,0,1,prolactin secreting cell differentiation,BP,
14735,GO:0060133,1,0.980618485122468,0,2,somatotropin secreting cell development,BP,
14736,GO:0060134,1,0.8189525579543,0,13,prepulse inhibition,BP,
14740,GO:0060139,1,0.975369653398164,0,2,positive regulation of apoptotic process by virus,BP,
14741,GO:0060142,1,0.718270684620977,0,26,regulation of syncytium formation by plasma membrane fusion,BP,
14742,GO:0060143,1,0.734208709667367,0,24,positive regulation of syncytium formation by plasma membrane fusion,BP,
14745,GO:0060149,1,0.830891262539131,0,12,negative regulation of posttranscriptional gene silencing,BP,
14746,GO:0060151,1,0.967087733488108,0,2,peroxisome localization,BP,
14747,GO:0060152,1,0.967087733488108,0,2,microtubule-based peroxisome localization,BP,
14748,GO:0060154,1,0.96074560426801,0,3,cellular process regulating host cell cycle in response to virus,BP,
14751,GO:0060158,1,0.858121641256439,0,13,phospholipase C-activating dopamine receptor signaling pathway,BP,
14752,GO:0060159,1,0.868076140787657,0,10,regulation of dopamine receptor signaling pathway,BP,
14753,GO:0060160,1,0.957973671606673,0,3,negative regulation of dopamine receptor signaling pathway,BP,
14754,GO:0060161,1,0.926654627142886,0,5,positive regulation of dopamine receptor signaling pathway,BP,
14755,GO:0060163,1,0.976172733356438,0,2,subpallium neuron fate commitment,BP,
14756,GO:0060164,1,0.95354529541969,0,4,regulation of timing of neuron differentiation,BP,
14757,GO:0060165,1,0.984968016038942,0,1,regulation of timing of subpallium neuron differentiation,BP,
14758,GO:0060166,1,0.958748498634945,0,3,olfactory pit development,BP,
14759,GO:0060167,1,0.95787326796088,0,3,regulation of adenosine receptor signaling pathway,BP,
14760,GO:0060168,1,0.968472132142051,0,2,positive regulation of adenosine receptor signaling pathway,BP,
14761,GO:0060169,1,0.989057545717563,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14763,GO:0060171,1,0.967087733486124,0,2,stereocilium membrane,CC,
14766,GO:0060175,1,0.983406759351379,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14767,GO:0060177,1,0.839616095730306,0,13,regulation of angiotensin metabolic process,BP,
14769,GO:0060179,1,0.921536015273205,0,6,male mating behavior,BP,
14770,GO:0060180,1,0.890545408413052,0,9,female mating behavior,BP,
14771,GO:0060184,1,0.983865649318172,0,1,cell cycle switching,BP,
14772,GO:0060187,1,0.967087733487869,0,2,cell pole,CC,
14774,GO:0060192,1,0.838854625016151,0,15,negative regulation of lipase activity,BP,
14777,GO:0060198,1,0.837199365191533,0,12,clathrin-sculpted vesicle,CC,
14778,GO:0060199,1,0.943830433997579,0,4,clathrin-sculpted glutamate transport vesicle,CC,
14779,GO:0060200,1,0.958404293477109,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14780,GO:0060201,1,0.958404293477109,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14781,GO:0060203,1,0.943830433997579,0,4,clathrin-sculpted glutamate transport vesicle membrane,CC,
14783,GO:0060211,1,0.85228891965803,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14784,GO:0060212,1,0.98755017012104,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14785,GO:0060213,1,0.85228891965803,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14786,GO:0060214,1,0.947332139072507,0,4,endocardium formation,BP,
14789,GO:0060217,1,0.983406759351921,0,1,hemangioblast cell differentiation,BP,
14790,GO:0060218,1,0.76954989800871,0,17,hematopoietic stem cell differentiation,BP,
14791,GO:0060219,1,0.78209316684306,0,16,camera-type eye photoreceptor cell differentiation,BP,
14792,GO:0060221,1,0.956842117108447,0,3,retinal rod cell differentiation,BP,
14793,GO:0060228,1,0.954642514086233,0,6,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14794,GO:0060229,1,0.85418283514379,0,13,lipase activator activity,MF,
14795,GO:0060230,1,0.972901346112619,0,3,lipoprotein lipase activator activity,MF,
14797,GO:0060232,1,0.96869330474178,0,2,delamination,BP,
14800,GO:0060242,1,0.874040037919505,0,9,contact inhibition,BP,
14801,GO:0060243,1,0.98340675935207,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14802,GO:0060244,1,0.94002362489013,0,4,negative regulation of cell proliferation involved in contact inhibition,BP,
14803,GO:0060245,1,0.983414835417473,0,1,detection of cell density,BP,
14804,GO:0060246,1,0.983414835417473,0,1,detection of cell density by contact stimulus,BP,
14805,GO:0060248,1,0.983414835417473,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14808,GO:0060252,1,0.862315741416519,0,10,positive regulation of glial cell proliferation,BP,
14810,GO:0060254,1,0.987584713029126,0,1,regulation of N-terminal protein palmitoylation,BP,
14812,GO:0060259,1,0.79460787599007,0,20,regulation of feeding behavior,BP,
14813,GO:0060260,1,0.683992161526165,0,26,regulation of transcription initiation from RNA polymerase II promoter,BP,
14814,GO:0060261,1,0.764826097746355,0,19,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14815,GO:0060262,1,0.987584713029126,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14816,GO:0060263,1,0.878594846819887,0,11,regulation of respiratory burst,BP,
14817,GO:0060264,1,0.963616989093186,0,4,regulation of respiratory burst involved in inflammatory response,BP,
14818,GO:0060265,1,0.981110250631647,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14819,GO:0060266,1,0.975824540844927,0,3,negative regulation of respiratory burst involved in inflammatory response,BP,
14820,GO:0060267,1,0.948631047409577,0,5,positive regulation of respiratory burst,BP,
14821,GO:0060268,1,0.959630813058035,0,4,negative regulation of respiratory burst,BP,
14826,GO:0060280,1,0.985456784122933,0,1,negative regulation of ovulation,BP,
14828,GO:0060282,1,0.94087352274548,0,4,positive regulation of oocyte development,BP,
14831,GO:0060285,1,0.718700792661009,0,23,cilium-dependent cell motility,BP,
14832,GO:0060287,1,0.887538420533809,0,8,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14833,GO:0060290,1,0.884510557344756,0,8,transdifferentiation,BP,
14834,GO:0060291,1,0.428950382643443,0,56,long-term synaptic potentiation,BP,
14836,GO:0060293,1,0.78333335805435,0,16,germ plasm,CC,
14837,GO:0060294,1,0.834261215473521,0,14,cilium movement involved in cell motility,BP,
14838,GO:0060295,1,0.92524973968747,0,5,regulation of cilium movement involved in cell motility,BP,
14839,GO:0060296,1,0.92524973968747,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14842,GO:0060299,1,0.99005688908311,0,1,negative regulation of sarcomere organization,BP,
14843,GO:0060300,1,0.945265434584313,0,4,regulation of cytokine activity,BP,
14844,GO:0060301,1,0.984935697988779,0,1,positive regulation of cytokine activity,BP,
14845,GO:0060302,1,0.975920787414567,0,2,negative regulation of cytokine activity,BP,
14846,GO:0060304,1,0.983804875945311,0,1,regulation of phosphatidylinositol dephosphorylation,BP,
14847,GO:0060305,1,0.984073933253676,0,1,regulation of cell diameter,BP,
14850,GO:0060309,1,0.986903987680877,0,2,elastin catabolic process,BP,
14851,GO:0060310,1,0.994078100203671,0,1,regulation of elastin catabolic process,BP,
14852,GO:0060311,1,0.994078100203671,0,1,negative regulation of elastin catabolic process,BP,
14853,GO:0060312,1,0.876598126744511,0,9,regulation of blood vessel remodeling,BP,
14854,GO:0060313,1,0.961359937679004,0,3,negative regulation of blood vessel remodeling,BP,
14857,GO:0060316,1,0.898750713122672,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14866,GO:0060327,1,0.984271627281773,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14867,GO:0060330,1,0.747107772389411,0,21,regulation of response to interferon-gamma,BP,
14868,GO:0060331,1,0.95175372996426,0,4,negative regulation of response to interferon-gamma,BP,
14869,GO:0060332,1,0.940683349061077,0,4,positive regulation of response to interferon-gamma,BP,
14870,GO:0060333,1,0.321304626976544,0,84,interferon-gamma-mediated signaling pathway,BP,
14871,GO:0060334,1,0.759577166882179,0,20,regulation of interferon-gamma-mediated signaling pathway,BP,
14872,GO:0060335,1,0.940683349061077,0,4,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14873,GO:0060336,1,0.95175372996426,0,4,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14876,GO:0060339,1,0.915118919132639,0,6,negative regulation of type I interferon-mediated signaling pathway,BP,
14879,GO:0060342,1,0.97169884262617,0,2,photoreceptor inner segment membrane,CC,
14881,GO:0060345,1,0.983526980738733,0,1,spleen trabecula formation,BP,
14882,GO:0060346,1,0.854371330981132,0,10,bone trabecula formation,BP,
14888,GO:0060352,1,0.909591793024288,0,7,cell adhesion molecule production,BP,
14889,GO:0060353,1,0.939569743817927,0,5,regulation of cell adhesion molecule production,BP,
14890,GO:0060354,1,0.993197483687486,0,1,negative regulation of cell adhesion molecule production,BP,
14891,GO:0060355,1,0.946006455619702,0,4,positive regulation of cell adhesion molecule production,BP,
14892,GO:0060356,1,0.985657419779797,0,1,leucine import,BP,
14893,GO:0060359,1,0.195581146406295,0,116,response to ammonium ion,BP,
14895,GO:0060364,1,0.940206657973053,0,4,frontal suture morphogenesis,BP,
14896,GO:0060366,1,0.983406759351087,0,1,lambdoid suture morphogenesis,BP,
14897,GO:0060367,1,0.983406759351087,0,1,sagittal suture morphogenesis,BP,
14898,GO:0060368,1,0.897977929380199,0,7,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14899,GO:0060369,1,0.940428604736741,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14900,GO:0060370,1,0.975645599631951,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14901,GO:0060371,1,0.896217290706346,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14902,GO:0060372,1,0.914649980558282,0,6,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14903,GO:0060373,1,0.911142471935305,0,6,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14907,GO:0060378,1,0.983406759351234,0,1,regulation of brood size,BP,
14909,GO:0060380,1,0.986443828165976,0,1,regulation of single-stranded telomeric DNA binding,BP,
14910,GO:0060381,1,0.986443828165976,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14911,GO:0060382,1,0.967087733487673,0,2,regulation of DNA strand elongation,BP,
14912,GO:0060383,1,0.983406759352069,0,1,positive regulation of DNA strand elongation,BP,
14913,GO:0060384,1,0.66937084207574,0,25,innervation,BP,
14914,GO:0060385,1,0.923173526845713,0,5,axonogenesis involved in innervation,BP,
14915,GO:0060386,1,0.983406759351724,0,1,synapse assembly involved in innervation,BP,
14919,GO:0060392,1,0.9618298409137,0,3,negative regulation of SMAD protein import into nucleus,BP,
14921,GO:0060394,1,0.861510634392854,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14924,GO:0060397,1,0.813072553208676,0,15,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
14925,GO:0060398,1,0.945821227630791,0,4,regulation of growth hormone receptor signaling pathway,BP,
14926,GO:0060399,1,0.961782879506577,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14927,GO:0060400,1,0.983406759351972,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14930,GO:0060404,1,0.983425396802449,0,1,axonemal microtubule depolymerization,BP,
14931,GO:0060405,1,0.921643800842653,0,6,regulation of penile erection,BP,
14932,GO:0060406,1,0.94757017131252,0,4,positive regulation of penile erection,BP,
14933,GO:0060407,1,0.989057545717563,0,1,negative regulation of penile erection,BP,
14937,GO:0060414,1,0.951386580188254,0,3,aorta smooth muscle tissue morphogenesis,BP,
14943,GO:0060422,1,0.985547063166251,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14954,GO:0060434,1,0.968384722376208,0,2,bronchus morphogenesis,BP,
14966,GO:0060446,1,0.984730915754465,0,1,branching involved in open tracheal system development,BP,
14968,GO:0060448,1,0.956860147130055,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14970,GO:0060450,1,0.9960265787534,0,1,positive regulation of hindgut contraction,BP,
14972,GO:0060453,1,0.882772755271953,0,10,regulation of gastric acid secretion,BP,
14973,GO:0060454,1,0.967253815747756,0,2,positive regulation of gastric acid secretion,BP,
14974,GO:0060455,1,0.958069318346878,0,5,negative regulation of gastric acid secretion,BP,
14975,GO:0060456,1,0.881010632342409,0,11,positive regulation of digestive system process,BP,
14977,GO:0060458,1,0.973753867574609,0,2,right lung development,BP,
14978,GO:0060459,1,0.961473558721999,0,3,left lung development,BP,
14979,GO:0060460,1,0.972312747197176,0,2,left lung morphogenesis,BP,
14980,GO:0060461,1,0.984730915754465,0,1,right lung morphogenesis,BP,
14983,GO:0060465,1,0.967268992768905,0,2,pharynx development,BP,
14984,GO:0060466,1,0.983406759351477,0,1,activation of meiosis involved in egg activation,BP,
14985,GO:0060467,1,0.927233243212594,0,6,negative regulation of fertilization,BP,
14986,GO:0060468,1,0.976231692362566,0,2,prevention of polyspermy,BP,
14987,GO:0060473,1,0.990495294871004,0,1,cortical granule,CC,
14988,GO:0060474,1,0.966286718323948,0,4,positive regulation of flagellated sperm motility involved in capacitation,BP,
14989,GO:0060478,1,0.947584938154101,0,4,acrosomal vesicle exocytosis,BP,
14991,GO:0060480,1,0.961257943261473,0,4,lung goblet cell differentiation,BP,
14992,GO:0060481,1,0.945305337768423,0,5,lobar bronchus epithelium development,BP,
14994,GO:0060484,1,0.866164954804045,0,10,lung-associated mesenchyme development,BP,
14996,GO:0060486,1,0.939319132097537,0,4,Clara cell differentiation,BP,
14998,GO:0060488,1,0.967087733486268,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14999,GO:0060489,1,0.967087733486268,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
15000,GO:0060490,1,0.967087733486268,0,2,lateral sprouting involved in lung morphogenesis,BP,
15008,GO:0060509,1,0.926080616994033,0,5,Type I pneumocyte differentiation,BP,
15012,GO:0060514,1,0.983798136705563,0,1,prostate induction,BP,
15013,GO:0060515,1,0.983798136705563,0,1,prostate field specification,BP,
15014,GO:0060516,1,0.972444653077435,0,2,primary prostatic bud elongation,BP,
15015,GO:0060517,1,0.9834070038051,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
15016,GO:0060520,1,0.983798136705563,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
15017,GO:0060523,1,0.956306554199608,0,3,prostate epithelial cord elongation,BP,
15019,GO:0060526,1,0.906715169503726,0,6,prostate glandular acinus morphogenesis,BP,
15020,GO:0060527,1,0.906715169503726,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
15022,GO:0060529,1,0.967087733488112,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
15023,GO:0060532,1,0.967087973901176,0,2,bronchus cartilage development,BP,
15031,GO:0060542,1,0.983406759351724,0,1,regulation of strand invasion,BP,
15032,GO:0060544,1,0.763688854607855,0,19,regulation of necroptotic process,BP,
15033,GO:0060545,1,0.97067555792581,0,2,positive regulation of necroptotic process,BP,
15034,GO:0060546,1,0.868285161998469,0,9,negative regulation of necroptotic process,BP,
15035,GO:0060547,1,0.851664292325086,0,12,negative regulation of necrotic cell death,BP,
15037,GO:0060549,1,0.991071049420841,0,1,regulation of fructose 1,6-bisphosphate 1-phosphatase activity,BP,
15038,GO:0060550,1,0.991071049420841,0,1,positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity,BP,
15039,GO:0060551,1,0.991071049420841,0,1,regulation of fructose 1,6-bisphosphate metabolic process,BP,
15040,GO:0060552,1,0.991071049420841,0,1,positive regulation of fructose 1,6-bisphosphate metabolic process,BP,
15042,GO:0060557,1,0.969017913690411,0,3,positive regulation of vitamin D biosynthetic process,BP,
15044,GO:0060559,1,0.969017913690411,0,3,positive regulation of calcidiol 1-monooxygenase activity,BP,
15049,GO:0060566,1,0.983406759350443,0,1,positive regulation of DNA-templated transcription, termination,BP,
15052,GO:0060573,1,0.875259243032138,0,10,cell fate specification involved in pattern specification,BP,
15056,GO:0060577,1,0.974634369425645,0,2,pulmonary vein morphogenesis,BP,
15057,GO:0060578,1,0.98576332120161,0,1,superior vena cava morphogenesis,BP,
15058,GO:0060579,1,0.822545788063245,0,14,ventral spinal cord interneuron fate commitment,BP,
15059,GO:0060580,1,0.98640182911472,0,1,ventral spinal cord interneuron fate determination,BP,
15060,GO:0060581,1,0.822545788063245,0,14,cell fate commitment involved in pattern specification,BP,
15061,GO:0060582,1,0.98640182911472,0,1,cell fate determination involved in pattern specification,BP,
15065,GO:0060587,1,0.975221308267302,0,2,regulation of lipoprotein lipid oxidation,BP,
15066,GO:0060588,1,0.991590426426472,0,1,negative regulation of lipoprotein lipid oxidation,BP,
15068,GO:0060590,1,0.586997286099956,0,38,ATPase regulator activity,MF,
15069,GO:0060591,1,0.930762193568959,0,5,chondroblast differentiation,BP,
15073,GO:0060596,1,0.951155296081311,0,3,mammary placode formation,BP,
15074,GO:0060598,1,0.990896490863439,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
15076,GO:0060600,1,0.860854187046626,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
15080,GO:0060605,1,0.932746992827217,0,5,tube lumen cavitation,BP,
15082,GO:0060611,1,0.98510418704369,0,1,mammary gland fat development,BP,
15084,GO:0060613,1,0.938203303274335,0,4,fat pad development,BP,
15086,GO:0060620,1,0.977034375851605,0,3,regulation of cholesterol import,BP,
15087,GO:0060621,1,0.992190036991263,0,2,negative regulation of cholesterol import,BP,
15088,GO:0060623,1,0.963293222620786,0,3,regulation of chromosome condensation,BP,
15090,GO:0060628,1,0.829576723363423,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
15091,GO:0060629,1,0.971508946700684,0,2,regulation of homologous chromosome segregation,BP,
15092,GO:0060631,1,0.897089719696931,0,7,regulation of meiosis I,BP,
15093,GO:0060632,1,0.768461819134573,0,17,regulation of microtubule-based movement,BP,
15094,GO:0060633,1,0.922845419484314,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
15099,GO:0060662,1,0.932746992827217,0,5,salivary gland cavitation,BP,
15102,GO:0060666,1,0.921161516847671,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
15104,GO:0060668,1,0.983432163119869,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
15106,GO:0060670,1,0.849588837725025,0,11,branching involved in labyrinthine layer morphogenesis,BP,
15107,GO:0060671,1,0.955697953115808,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
15108,GO:0060672,1,0.955697953115808,0,3,epithelial cell morphogenesis involved in placental branching,BP,
15113,GO:0060678,1,0.985664640752396,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15115,GO:0060683,1,0.984228930394872,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
15121,GO:0060689,1,0.955348449679625,0,3,cell differentiation involved in salivary gland development,BP,
15122,GO:0060690,1,0.987621879994363,0,1,epithelial cell differentiation involved in salivary gland development,BP,
15123,GO:0060691,1,0.987621879994363,0,1,epithelial cell maturation involved in salivary gland development,BP,
15125,GO:0060694,1,0.983732838946567,0,2,regulation of cholesterol transporter activity,BP,
15126,GO:0060695,1,0.996314143661238,0,1,negative regulation of cholesterol transporter activity,BP,
15127,GO:0060696,1,0.930329109182372,0,6,regulation of phospholipid catabolic process,BP,
15128,GO:0060697,1,0.978750968877299,0,2,positive regulation of phospholipid catabolic process,BP,
15129,GO:0060698,1,0.967436119721657,0,2,endoribonuclease inhibitor activity,MF,
15130,GO:0060699,1,0.943583848481527,0,4,regulation of endoribonuclease activity,BP,
15131,GO:0060700,1,0.927922998690389,0,5,regulation of ribonuclease activity,BP,
15132,GO:0060701,1,0.967436119721657,0,2,negative regulation of ribonuclease activity,BP,
15133,GO:0060702,1,0.967436119721657,0,2,negative regulation of endoribonuclease activity,BP,
15134,GO:0060703,1,0.984350353013124,0,1,deoxyribonuclease inhibitor activity,MF,
15143,GO:0060715,1,0.967918135717969,0,2,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
15145,GO:0060717,1,0.907045588281896,0,6,chorion development,BP,
15146,GO:0060718,1,0.922346594677863,0,5,chorionic trophoblast cell differentiation,BP,
15147,GO:0060720,1,0.97657104409481,0,2,spongiotrophoblast cell proliferation,BP,
15148,GO:0060721,1,0.97657104409481,0,2,regulation of spongiotrophoblast cell proliferation,BP,
15149,GO:0060722,1,0.97657104409481,0,2,cell proliferation involved in embryonic placenta development,BP,
15150,GO:0060723,1,0.97657104409481,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
15151,GO:0060729,1,0.925666550396442,0,5,intestinal epithelial structure maintenance,BP,
15152,GO:0060730,1,0.968381634385893,0,2,regulation of intestinal epithelial structure maintenance,BP,
15153,GO:0060731,1,0.98357355435276,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
15154,GO:0060732,1,0.848232751379606,0,12,positive regulation of inositol phosphate biosynthetic process,BP,
15155,GO:0060733,1,0.967094006574811,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
15156,GO:0060734,1,0.968910020460424,0,2,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
15157,GO:0060735,1,0.99007838265945,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
15158,GO:0060736,1,0.837375749874985,0,11,prostate gland growth,BP,
15159,GO:0060737,1,0.940435650760259,0,4,prostate gland morphogenetic growth,BP,
15160,GO:0060738,1,0.972760922061529,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
15161,GO:0060739,1,0.983406759351232,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
15163,GO:0060741,1,0.965742266162729,0,3,prostate gland stromal morphogenesis,BP,
15165,GO:0060743,1,0.953029883811928,0,3,epithelial cell maturation involved in prostate gland development,BP,
15168,GO:0060746,1,0.834213130883097,0,13,parental behavior,BP,
15173,GO:0060752,1,0.968968553918727,0,2,intestinal phytosterol absorption,BP,
15174,GO:0060753,1,0.924802591498351,0,6,regulation of mast cell chemotaxis,BP,
15175,GO:0060754,1,0.934652767220215,0,5,positive regulation of mast cell chemotaxis,BP,
15180,GO:0060763,1,0.961981943447808,0,3,mammary duct terminal end bud growth,BP,
15181,GO:0060764,1,0.97387427833236,0,2,cell-cell signaling involved in mammary gland development,BP,
15182,GO:0060765,1,0.681333225135049,0,26,regulation of androgen receptor signaling pathway,BP,
15183,GO:0060766,1,0.83280833053751,0,12,negative regulation of androgen receptor signaling pathway,BP,
15186,GO:0060769,1,0.956770309106584,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
15187,GO:0060770,1,0.921481846364755,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
15189,GO:0060781,1,0.988853451736982,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
15190,GO:0060782,1,0.988853451736982,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
15191,GO:0060783,1,0.988853451736982,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
15192,GO:0060784,1,0.9834070038051,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
15194,GO:0060789,1,0.914655303824049,0,7,hair follicle placode formation,BP,
15196,GO:0060796,1,0.974868030965423,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15197,GO:0060800,1,0.956393896691025,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15198,GO:0060802,1,0.986355974988371,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15199,GO:0060803,1,0.989340803074695,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15201,GO:0060806,1,0.988230502127254,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15202,GO:0060807,1,0.985371944351204,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15204,GO:0060816,1,0.983406759350544,0,1,random inactivation of X chromosome,BP,
15205,GO:0060817,1,0.985864225629554,0,1,inactivation of paternal X chromosome,BP,
15206,GO:0060821,1,0.983406759350987,0,1,inactivation of X chromosome by DNA methylation,BP,
15208,GO:0060825,1,0.975738741564603,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15209,GO:0060827,1,0.983406759352069,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15211,GO:0060829,1,0.983406759352069,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15212,GO:0060830,1,0.960215775548202,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15214,GO:0060836,1,0.898048896297599,0,7,lymphatic endothelial cell differentiation,BP,
15216,GO:0060838,1,0.967442122921707,0,2,lymphatic endothelial cell fate commitment,BP,
15225,GO:0060849,1,0.967442122921707,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15226,GO:0060850,1,0.817941989764606,0,15,regulation of transcription involved in cell fate commitment,BP,
15229,GO:0060857,1,0.985610782194172,0,1,establishment of glial blood-brain barrier,BP,
15231,GO:0060873,1,0.983406759351087,0,1,anterior semicircular canal development,BP,
15232,GO:0060875,1,0.983406759351087,0,1,lateral semicircular canal development,BP,
15238,GO:0060901,1,0.98340675935207,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15239,GO:0060903,1,0.938647321521548,0,4,positive regulation of meiosis I,BP,
15240,GO:0060904,1,0.983406784092507,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15243,GO:0060912,1,0.95474475125467,0,3,cardiac cell fate specification,BP,
15244,GO:0060913,1,0.961623097711839,0,3,cardiac cell fate determination,BP,
15247,GO:0060916,1,0.924908699754685,0,5,mesenchymal cell proliferation involved in lung development,BP,
15248,GO:0060920,1,0.930676542885342,0,5,cardiac pacemaker cell differentiation,BP,
15249,GO:0060921,1,0.958780749744373,0,3,sinoatrial node cell differentiation,BP,
15250,GO:0060922,1,0.970692596794287,0,2,atrioventricular node cell differentiation,BP,
15252,GO:0060926,1,0.938741031956317,0,4,cardiac pacemaker cell development,BP,
15253,GO:0060927,1,0.987072199627865,0,1,cardiac pacemaker cell fate commitment,BP,
15254,GO:0060928,1,0.970692596794287,0,2,atrioventricular node cell development,BP,
15255,GO:0060929,1,0.987072199627865,0,1,atrioventricular node cell fate commitment,BP,
15256,GO:0060931,1,0.96708773348782,0,2,sinoatrial node cell development,BP,
15257,GO:0060932,1,0.970692596794532,0,2,His-Purkinje system cell differentiation,BP,
15258,GO:0060935,1,0.952754543141412,0,3,cardiac fibroblast cell differentiation,BP,
15259,GO:0060936,1,0.952754543141412,0,3,cardiac fibroblast cell development,BP,
15260,GO:0060938,1,0.952754543141412,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15261,GO:0060939,1,0.952754543141412,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15262,GO:0060940,1,0.968832707729711,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15268,GO:0060965,1,0.859186524286901,0,10,negative regulation of gene silencing by miRNA,BP,
15270,GO:0060967,1,0.830891262539131,0,12,negative regulation of gene silencing by RNA,BP,
15272,GO:0060969,1,0.725936943039718,0,21,negative regulation of gene silencing,BP,
15273,GO:0060971,1,0.94284895245097,0,4,embryonic heart tube left/right pattern formation,BP,
15276,GO:0060974,1,0.983634662844602,0,2,cell migration involved in heart formation,BP,
15277,GO:0060975,1,0.991411501090547,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15280,GO:0060978,1,0.952517227578691,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15282,GO:0060980,1,0.98342653957286,0,1,cell migration involved in coronary vasculogenesis,BP,
15283,GO:0060981,1,0.983406759351724,0,1,cell migration involved in coronary angiogenesis,BP,
15286,GO:0060987,1,0.985456784122933,0,1,lipid tube,CC,
15287,GO:0060988,1,0.95306310189636,0,3,lipid tube assembly,BP,
15288,GO:0060989,1,0.983449958648637,0,1,lipid tube assembly involved in organelle fusion,BP,
15289,GO:0060992,1,0.907817474535841,0,6,response to fungicide,BP,
15292,GO:0060995,1,0.967443458046139,0,2,cell-cell signaling involved in kidney development,BP,
15295,GO:0060998,1,0.393415804624688,0,60,regulation of dendritic spine development,BP,
15296,GO:0060999,1,0.567900436056713,0,37,positive regulation of dendritic spine development,BP,
15297,GO:0061000,1,0.824888586099392,0,12,negative regulation of dendritic spine development,BP,
15298,GO:0061001,1,0.582842292033477,0,34,regulation of dendritic spine morphogenesis,BP,
15299,GO:0061002,1,0.91010700041415,0,6,negative regulation of dendritic spine morphogenesis,BP,
15300,GO:0061003,1,0.757191731263035,0,17,positive regulation of dendritic spine morphogenesis,BP,
15304,GO:0061009,1,0.933230381655078,0,5,common bile duct development,BP,
15305,GO:0061010,1,0.957270846880923,0,3,gall bladder development,BP,
15306,GO:0061011,1,0.987876345605037,0,1,hepatic duct development,BP,
15309,GO:0061015,1,0.988167048776426,0,1,snRNA import into nucleus,BP,
15310,GO:0061017,1,0.972241647397953,0,2,hepatoblast differentiation,BP,
15313,GO:0061026,1,0.983406759350247,0,1,cardiac muscle tissue regeneration,BP,
15317,GO:0061030,1,0.948780754508497,0,4,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15318,GO:0061031,1,0.961740078953399,0,3,endodermal digestive tract morphogenesis,BP,
15321,GO:0061034,1,0.967087733487964,0,2,olfactory bulb mitral cell layer development,BP,
15326,GO:0061040,1,0.98340675935099,0,1,female gonad morphogenesis,BP,
15328,GO:0061042,1,0.874410643145865,0,9,vascular wound healing,BP,
15329,GO:0061043,1,0.944190683605343,0,4,regulation of vascular wound healing,BP,
15330,GO:0061044,1,0.983669856550392,0,1,negative regulation of vascular wound healing,BP,
15334,GO:0061048,1,0.988347891999775,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15338,GO:0061052,1,0.930303453536864,0,5,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15341,GO:0061055,1,0.93843030311225,0,4,myotome development,BP,
15342,GO:0061056,1,0.946865026475381,0,4,sclerotome development,BP,
15345,GO:0061073,1,0.955274366331647,0,3,ciliary body morphogenesis,BP,
15346,GO:0061074,1,0.916522882502556,0,6,regulation of neural retina development,BP,
15347,GO:0061075,1,0.971342487030176,0,2,positive regulation of neural retina development,BP,
15348,GO:0061076,1,0.983693927157384,0,1,negative regulation of neural retina development,BP,
15349,GO:0061077,1,0.424748847088025,0,62,chaperone-mediated protein folding,BP,
15350,GO:0061078,1,0.995657766730681,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15353,GO:0061083,1,0.939778032644725,0,4,regulation of protein refolding,BP,
15354,GO:0061084,1,0.939778032644725,0,4,negative regulation of protein refolding,BP,
15355,GO:0061085,1,0.868728072451341,0,9,regulation of histone H3-K27 methylation,BP,
15356,GO:0061086,1,0.94078681238338,0,4,negative regulation of histone H3-K27 methylation,BP,
15357,GO:0061087,1,0.909745692850378,0,6,positive regulation of histone H3-K27 methylation,BP,
15358,GO:0061088,1,0.857103652703352,0,10,regulation of sequestering of zinc ion,BP,
15359,GO:0061090,1,0.985188934100639,0,1,positive regulation of sequestering of zinc ion,BP,
15360,GO:0061091,1,0.951038411207949,0,3,regulation of phospholipid translocation,BP,
15361,GO:0061092,1,0.951038411207949,0,3,positive regulation of phospholipid translocation,BP,
15364,GO:0061099,1,0.701030364264268,0,23,negative regulation of protein tyrosine kinase activity,BP,
15365,GO:0061100,1,0.984968016038942,0,1,lung neuroendocrine cell differentiation,BP,
15367,GO:0061102,1,0.97468308338909,0,2,stomach neuroendocrine cell differentiation,BP,
15368,GO:0061103,1,0.984968016038942,0,1,carotid body glomus cell differentiation,BP,
15369,GO:0061104,1,0.969338535849827,0,2,adrenal chromaffin cell differentiation,BP,
15370,GO:0061105,1,0.989558758734677,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15371,GO:0061106,1,0.989558758734677,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15373,GO:0061108,1,0.985666447909236,0,1,seminal vesicle epithelium development,BP,
15375,GO:0061113,1,0.944527073288711,0,4,pancreas morphogenesis,BP,
15376,GO:0061114,1,0.983766730501423,0,1,branching involved in pancreas morphogenesis,BP,
15378,GO:0061117,1,0.800420485015655,0,15,negative regulation of heart growth,BP,
15379,GO:0061133,1,0.935570953311167,0,6,endopeptidase activator activity,MF,
15385,GO:0061141,1,0.959099764588453,0,3,lung ciliated cell differentiation,BP,
15387,GO:0061144,1,0.98372682328314,0,1,alveolar secondary septum development,BP,
15388,GO:0061145,1,0.967087973901176,0,2,lung smooth muscle development,BP,
15393,GO:0061152,1,0.974844126750327,0,2,trachea submucosa development,BP,
15394,GO:0061153,1,0.974844126750327,0,2,trachea gland development,BP,
15398,GO:0061157,1,0.740421483951217,0,19,mRNA destabilization,BP,
15401,GO:0061168,1,0.993767729814394,0,1,regulation of hair follicle placode formation,BP,
15402,GO:0061170,1,0.993767729814394,0,1,negative regulation of hair follicle placode formation,BP,
15403,GO:0061178,1,0.501153431189514,0,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15404,GO:0061179,1,0.914935123110514,0,8,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15406,GO:0061181,1,0.98340675935207,0,1,regulation of chondrocyte development,BP,
15409,GO:0061185,1,0.986768296547333,0,1,negative regulation of dermatome development,BP,
15410,GO:0061187,1,0.967087733487527,0,2,regulation of chromatin silencing at rDNA,BP,
15411,GO:0061188,1,0.967087733487527,0,2,negative regulation of chromatin silencing at rDNA,BP,
15412,GO:0061189,1,0.988853451736982,0,1,positive regulation of sclerotome development,BP,
15413,GO:0061190,1,0.988853451736982,0,1,regulation of sclerotome development,BP,
15414,GO:0061193,1,0.992512739064815,0,1,taste bud development,BP,
15415,GO:0061196,1,0.910189989686161,0,6,fungiform papilla development,BP,
15416,GO:0061197,1,0.923459058809873,0,5,fungiform papilla morphogenesis,BP,
15417,GO:0061198,1,0.953909932368569,0,3,fungiform papilla formation,BP,
15418,GO:0061200,1,0.889181241144653,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15419,GO:0061202,1,0.889181241144653,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15421,GO:0061206,1,0.984174220502037,0,1,mesonephros morphogenesis,BP,
15424,GO:0061215,1,0.984174220502037,0,1,mesonephric nephron development,BP,
15429,GO:0061228,1,0.984174220502037,0,1,mesonephric nephron morphogenesis,BP,
15430,GO:0061235,1,0.984174220502037,0,1,mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis,BP,
15432,GO:0061289,1,0.967443458046139,0,2,Wnt signaling pathway involved in kidney development,BP,
15433,GO:0061290,1,0.967443458046139,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15434,GO:0061295,1,0.984174220502037,0,1,regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
15435,GO:0061296,1,0.984174220502037,0,1,negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
15438,GO:0061300,1,0.972746754831417,0,2,cerebellum vasculature development,BP,
15439,GO:0061301,1,0.983406759351331,0,1,cerebellum vasculature morphogenesis,BP,
15442,GO:0061304,1,0.935254347828954,0,4,retinal blood vessel morphogenesis,BP,
15443,GO:0061307,1,0.899884342368096,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
15444,GO:0061308,1,0.899884342368096,0,8,cardiac neural crest cell development involved in heart development,BP,
15445,GO:0061309,1,0.926866378215131,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15449,GO:0061316,1,0.93162468090339,0,5,canonical Wnt signaling pathway involved in heart development,BP,
15450,GO:0061317,1,0.947265441472794,0,4,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15453,GO:0061324,1,0.983492190195988,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15468,GO:0061355,1,0.956660085908052,0,3,Wnt protein secretion,BP,
15469,GO:0061356,1,0.956660085908052,0,3,regulation of Wnt protein secretion,BP,
15470,GO:0061357,1,0.968931959911505,0,2,positive regulation of Wnt protein secretion,BP,
15471,GO:0061358,1,0.987336285518239,0,1,negative regulation of Wnt protein secretion,BP,
15472,GO:0061360,1,0.983406759352069,0,1,optic chiasma development,BP,
15473,GO:0061364,1,0.951038409344159,0,3,apoptotic process involved in luteolysis,BP,
15474,GO:0061365,1,0.880519533298285,0,11,positive regulation of triglyceride lipase activity,BP,
15475,GO:0061366,1,0.958623229216528,0,3,behavioral response to chemical pain,BP,
15476,GO:0061368,1,0.958623229216528,0,3,behavioral response to formalin induced pain,BP,
15480,GO:0061373,1,0.973114725851362,0,2,mammillary axonal complex development,BP,
15481,GO:0061374,1,0.989535030186473,0,1,mammillothalamic axonal tract development,BP,
15483,GO:0061378,1,0.976208379029251,0,2,corpora quadrigemina development,BP,
15484,GO:0061379,1,0.976208379029251,0,2,inferior colliculus development,BP,
15485,GO:0061381,1,0.989535030186473,0,1,cell migration in diencephalon,BP,
15488,GO:0061386,1,0.967087733486655,0,2,closure of optic fissure,BP,
15490,GO:0061394,1,0.974755506905418,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15491,GO:0061395,1,0.988075245097373,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15492,GO:0061402,1,0.969650937774864,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15493,GO:0061408,1,0.986053003073054,0,1,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15496,GO:0061428,1,0.943324097936481,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15497,GO:0061430,1,0.826234006067227,0,12,bone trabecula morphogenesis,BP,
15498,GO:0061433,1,0.986952701688737,0,1,cellular response to caloric restriction,BP,
15504,GO:0061441,1,0.968591403979042,0,2,renal artery morphogenesis,BP,
15506,GO:0061444,1,0.983406759351672,0,1,endocardial cushion cell development,BP,
15509,GO:0061450,1,0.907364791974604,0,8,trophoblast cell migration,BP,
15510,GO:0061451,1,0.983817326569247,0,1,retrotrapezoid nucleus development,BP,
15511,GO:0061452,1,0.983817326569247,0,1,retrotrapezoid nucleus neuron differentiation,BP,
15513,GO:0061459,1,0.983406759351282,0,1,L-arginine transmembrane transporter activity,MF,
15514,GO:0061461,1,0.96833515219048,0,2,L-lysine import,BP,
15516,GO:0061467,1,0.983411501199669,0,1,basolateral protein localization,BP,
15517,GO:0061469,1,0.86586523916386,0,9,regulation of type B pancreatic cell proliferation,BP,
15518,GO:0061470,1,0.939425399990246,0,4,T follicular helper cell differentiation,BP,
15519,GO:0061474,1,0.984768879537809,0,1,phagolysosome membrane,CC,
15520,GO:0061476,1,0.983738140813592,0,1,response to anticoagulant,BP,
15521,GO:0061481,1,0.9935956493984,0,1,response to TNF agonist,BP,
15522,GO:0061484,1,0.907634188321186,0,6,hematopoietic stem cell homeostasis,BP,
15523,GO:0061485,1,0.983406759351281,0,1,memory T cell proliferation,BP,
15524,GO:0061501,1,0.984725543253726,0,1,cyclic-GMP-AMP synthase activity,MF,
15525,GO:0061502,1,0.940166076469969,0,4,early endosome to recycling endosome transport,BP,
15526,GO:0061505,1,0.955309721541157,0,3,DNA topoisomerase II activity,MF,
15527,GO:0061507,1,0.988219898228933,0,1,cyclic-GMP-AMP binding,MF,
15528,GO:0061511,1,0.944616055550646,0,4,centriole elongation,BP,
15529,GO:0061512,1,0.63142049793957,0,31,protein localization to cilium,BP,
15530,GO:0061513,1,0.954105695326802,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15532,GO:0061517,1,0.96884182157992,0,2,macrophage proliferation,BP,
15533,GO:0061518,1,0.96884182157992,0,2,microglial cell proliferation,BP,
15534,GO:0061519,1,0.983437405536308,0,1,macrophage homeostasis,BP,
15535,GO:0061523,1,0.983425396802449,0,1,cilium disassembly,BP,
15537,GO:0061526,1,0.940192249199759,0,4,acetylcholine secretion,BP,
15538,GO:0061528,1,0.983406759351921,0,1,aspartate secretion,BP,
15539,GO:0061534,1,0.98340675935015,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15540,GO:0061535,1,0.967087733486125,0,2,glutamate secretion, neurotransmission,BP,
15541,GO:0061536,1,0.983619275014404,0,1,glycine secretion,BP,
15542,GO:0061537,1,0.983619275014404,0,1,glycine secretion, neurotransmission,BP,
15543,GO:0061542,1,0.990704363325434,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15544,GO:0061547,1,0.967442330844359,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15545,GO:0061548,1,0.810167855528311,0,13,ganglion development,BP,
15546,GO:0061549,1,0.863984607795686,0,9,sympathetic ganglion development,BP,
15547,GO:0061550,1,0.922190759359478,0,5,cranial ganglion development,BP,
15548,GO:0061551,1,0.93767379074241,0,4,trigeminal ganglion development,BP,
15549,GO:0061552,1,0.984935697988779,0,1,ganglion morphogenesis,BP,
15552,GO:0061574,1,0.956394320553007,0,3,ASAP complex,CC,
15553,GO:0061575,1,0.965472915783991,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15554,GO:0061577,1,0.857152491118679,0,10,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15555,GO:0061578,1,0.869234331785902,0,9,Lys63-specific deubiquitinase activity,MF,
15556,GO:0061580,1,0.983406759352069,0,1,colon epithelial cell migration,BP,
15557,GO:0061582,1,0.967087733487721,0,2,intestinal epithelial cell migration,BP,
15558,GO:0061588,1,0.921634175945085,0,5,calcium activated phospholipid scrambling,BP,
15559,GO:0061589,1,0.937189326317101,0,4,calcium activated phosphatidylserine scrambling,BP,
15560,GO:0061590,1,0.921634175945085,0,5,calcium activated phosphatidylcholine scrambling,BP,
15561,GO:0061591,1,0.921634175945085,0,5,calcium activated galactosylceramide scrambling,BP,
15562,GO:0061598,1,0.98340675935207,0,1,molybdopterin adenylyltransferase activity,MF,
15563,GO:0061599,1,0.98340675935207,0,1,molybdopterin molybdotransferase activity,MF,
15564,GO:0061604,1,0.985027751671993,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15565,GO:0061605,1,0.985027751671993,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15566,GO:0061609,1,0.9851010920299,0,1,fructose-1-phosphate aldolase activity,MF,
15567,GO:0061611,1,0.987784806077991,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15570,GO:0061617,1,0.936136862642652,0,6,MICOS complex,CC,
15571,GO:0061618,1,0.983406759350344,0,1,sublamina densa,CC,
15574,GO:0061622,1,0.973883329313367,0,2,glycolytic process through glucose-1-phosphate,BP,
15575,GO:0061623,1,0.99009682862248,0,1,glycolytic process from galactose,BP,
15578,GO:0061627,1,0.986741725911151,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15579,GO:0061628,1,0.953125574525282,0,3,H3K27me3 modified histone binding,MF,
15580,GO:0061629,1,0.989852633883451,0,1,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15582,GO:0061631,1,0.669238111539372,0,29,ubiquitin conjugating enzyme activity,MF,
15583,GO:0061635,1,0.919601870631392,0,6,regulation of protein complex stability,BP,
15585,GO:0061641,1,0.708751378551694,0,37,CENP-A containing chromatin organization,BP,
15588,GO:0061646,1,0.983406759351921,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15589,GO:0061647,1,0.525142498777005,0,41,histone H3-K9 modification,BP,
15590,GO:0061649,1,0.983406759351972,0,1,ubiquitinated histone binding,MF,
15591,GO:0061650,1,0.663287427311657,0,30,ubiquitin-like protein conjugating enzyme activity,MF,
15592,GO:0061656,1,0.991123064544678,0,1,SUMO conjugating enzyme activity,MF,
15594,GO:0061663,1,0.983406759351331,0,1,NEDD8 ligase activity,MF,
15595,GO:0061665,1,0.929159283480543,0,5,SUMO ligase activity,MF,
15596,GO:0061668,1,0.9428514493012,0,4,mitochondrial ribosome assembly,BP,
15597,GO:0061669,1,0.951038409343254,0,3,spontaneous neurotransmitter secretion,BP,
15598,GO:0061670,1,0.989270860431288,0,1,evoked neurotransmitter secretion,BP,
15599,GO:0061673,1,0.96838472237558,0,2,mitotic spindle astral microtubule,CC,
15600,GO:0061676,1,0.943430781628443,0,4,importin-alpha family protein binding,MF,
15601,GO:0061682,1,0.985388757719048,0,1,seminal vesicle morphogenesis,BP,
15602,GO:0061684,1,0.846312213385143,0,11,chaperone-mediated autophagy,BP,
15603,GO:0061687,1,0.947434355788199,0,4,detoxification of inorganic compound,BP,
15604,GO:0061689,1,0.941077597087878,0,4,tricellular tight junction,CC,
15605,GO:0061690,1,0.991332445824465,0,1,lipoamidase activity,MF,
15607,GO:0061697,1,0.983680274622243,0,1,protein-glutaryllysine deglutarylase activity,MF,
15608,GO:0061698,1,0.983680274622243,0,1,protein deglutarylation,BP,
15609,GO:0061699,1,0.983680274622243,0,1,peptidyl-lysine deglutarylation,BP,
15611,GO:0061702,1,0.868932462387846,0,11,inflammasome complex,CC,
15612,GO:0061709,1,0.983406759351481,0,1,reticulophagy,BP,
15613,GO:0061711,1,0.974597587982215,0,2,N(6)-L-threonylcarbamoyladenine synthase,MF,
15614,GO:0061712,1,0.983574245168322,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15615,GO:0061713,1,0.992156073995558,0,1,anterior neural tube closure,BP,
15616,GO:0061714,1,0.983871682926409,0,2,folic acid receptor activity,MF,
15618,GO:0061723,1,0.968696816564543,0,2,glycophagy,BP,
15620,GO:0061726,1,0.330343774506784,0,77,mitochondrion disassembly,BP,
15621,GO:0061727,1,0.972950869596186,0,2,methylglyoxal catabolic process to lactate,BP,
15622,GO:0061731,1,0.951372534454334,0,3,ribonucleoside-diphosphate reductase activity,MF,
15623,GO:0061732,1,0.913250126654152,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15624,GO:0061733,1,0.437222121634997,0,55,peptide-lysine-N-acetyltransferase activity,MF,
15625,GO:0061734,1,0.919766216606705,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15626,GO:0061736,1,0.983406759351724,0,1,engulfment of target by autophagosome,BP,
15627,GO:0061737,1,0.938132721430601,0,5,leukotriene signaling pathway,BP,
15628,GO:0061738,1,0.956683411322603,0,3,late endosomal microautophagy,BP,
15629,GO:0061739,1,0.98359964269722,0,1,protein lipidation involved in autophagosome assembly,BP,
15630,GO:0061740,1,0.970196051136548,0,2,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15631,GO:0061741,1,0.986567309955495,0,1,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15632,GO:0061743,1,0.945462437851109,0,4,motor learning,BP,
15633,GO:0061744,1,0.967088020374916,0,2,motor behavior,BP,
15634,GO:0061749,1,0.967087733487771,0,2,forked DNA-dependent helicase activity,MF,
15635,GO:0061750,1,0.985439661683852,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15636,GO:0061752,1,0.97135749174918,0,2,telomeric repeat-containing RNA binding,MF,
15637,GO:0061753,1,0.983406759351724,0,1,substrate localization to autophagosome,BP,
15638,GO:0061756,1,0.712589249645225,0,24,leukocyte adhesion to vascular endothelial cell,BP,
15639,GO:0061757,1,0.972484453375966,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15640,GO:0061762,1,0.951038409343304,0,3,CAMKK-AMPK signaling cascade,BP,
15641,GO:0061763,1,0.969511040260206,0,2,multivesicular body-lysosome fusion,BP,
15642,GO:0061767,1,0.983406759351676,0,1,negative regulation of lung blood pressure,BP,
15643,GO:0061768,1,0.983406759351971,0,1,magnesium:sodium antiporter activity,MF,
15644,GO:0061769,1,0.969683443564638,0,2,ribosylnicotinate kinase activity,MF,
15645,GO:0061770,1,0.986053003073054,0,1,translation elongation factor binding,MF,
15646,GO:0061771,1,0.986952701688737,0,1,response to caloric restriction,BP,
15648,GO:0061778,1,0.770770006303919,0,16,intracellular chloride channel activity,MF,
15649,GO:0061782,1,0.983406759352069,0,1,vesicle fusion with vesicle,BP,
15650,GO:0061783,1,0.887680265995305,0,15,peptidoglycan muralytic activity,MF,
15651,GO:0061792,1,0.951057865042726,0,3,secretory granule maturation,BP,
15652,GO:0061798,1,0.983406759352069,0,1,GTP 3',8'-cyclase activity,MF,
15653,GO:0061799,1,0.983406759352069,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15654,GO:0061809,1,0.978800614133861,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15655,GO:0061811,1,0.989375912272555,0,1,ADP-ribosyl cyclase activity,MF,
15656,GO:0061812,1,0.989375912272555,0,1,cyclic ADP-ribose hydrolase,MF,
15657,GO:0061819,1,0.953912465589775,0,3,telomeric DNA-containing double minutes formation,BP,
15658,GO:0061820,1,0.864626485518597,0,9,telomeric D-loop disassembly,BP,
15659,GO:0061821,1,0.935256514774612,0,4,telomeric D-loop binding,MF,
15660,GO:0061825,1,0.983406961950764,0,1,podosome core,CC,
15661,GO:0061827,1,0.984766147175537,0,1,sperm head,CC,
15662,GO:0061833,1,0.969449185164431,0,2,protein localization to tricellular tight junction,BP,
15663,GO:0061842,1,0.710059828534373,0,22,microtubule organizing center localization,BP,
15664,GO:0061844,1,0.93688592349869,0,7,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15665,GO:0061845,1,0.983591402321654,0,1,neuron projection branch point,CC,
15666,GO:0061846,1,0.983591402321654,0,1,dendritic spine cytoplasm,CC,
15667,GO:0061847,1,0.985501663355894,0,1,response to cholecystokinin,BP,
15668,GO:0061849,1,0.967087733487771,0,2,telomeric G-quadruplex DNA binding,MF,
15669,GO:0061850,1,0.993275314638483,0,1,growth cone leading edge,CC,
15670,GO:0065001,1,0.943256282312183,0,4,specification of axis polarity,BP,
15671,GO:0065002,1,0.508193194518431,0,53,intracellular protein transmembrane transport,BP,
15673,GO:0065004,1,0.0718826571915554,0,227,protein-DNA complex assembly,BP,
15674,GO:0065005,1,0.749018388162629,0,23,protein-lipid complex assembly,BP,
15675,GO:0065006,1,0.982414753652273,0,2,protein-carbohydrate complex assembly,BP,
15679,GO:0065010,1,0.955853557411783,0,3,extracellular membrane-bounded organelle,CC,
15680,GO:0070001,1,0.718133713092512,0,25,aspartic-type peptidase activity,MF,
15681,GO:0070002,1,0.990495294871004,0,1,glutamic-type peptidase activity,MF,
15682,GO:0070003,1,0.833135404013818,0,21,threonine-type peptidase activity,MF,
15683,GO:0070006,1,0.748218901022483,0,18,metalloaminopeptidase activity,MF,
15684,GO:0070008,1,0.874912313262573,0,9,serine-type exopeptidase activity,MF,
15685,GO:0070009,1,0.983568771766829,0,1,serine-type aminopeptidase activity,MF,
15687,GO:0070012,1,0.985236998689631,0,1,oligopeptidase activity,MF,
15690,GO:0070022,1,0.935527982578295,0,4,transforming growth factor beta receptor complex,CC,
15691,GO:0070025,1,0.984615667407723,0,1,carbon monoxide binding,MF,
15692,GO:0070026,1,0.977482118559158,0,2,nitric oxide binding,MF,
15693,GO:0070032,1,0.946061439462751,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15694,GO:0070033,1,0.956381500274424,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15695,GO:0070034,1,0.803310913070428,0,17,telomerase RNA binding,MF,
15696,GO:0070035,1,0.206096562190199,0,99,purine NTP-dependent helicase activity,MF,
15697,GO:0070037,1,0.992128839243257,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15698,GO:0070039,1,0.971109564460838,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15699,GO:0070044,1,0.96028320729985,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15701,GO:0070051,1,0.952368652486981,0,3,fibrinogen binding,MF,
15702,GO:0070052,1,0.95919852404334,0,3,collagen V binding,MF,
15704,GO:0070054,1,0.953041441987964,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15705,GO:0070055,1,0.953041441987964,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15707,GO:0070060,1,0.983406759350887,0,1,'de novo' actin filament nucleation,BP,
15708,GO:0070061,1,0.928992923154212,0,5,fructose binding,MF,
15710,GO:0070063,1,0.527310638696368,0,44,RNA polymerase binding,MF,
15711,GO:0070064,1,0.759348502803932,0,18,proline-rich region binding,MF,
15712,GO:0070069,1,0.794714753520382,0,28,cytochrome complex,CC,
15713,GO:0070070,1,0.863029373123433,0,9,proton-transporting V-type ATPase complex assembly,BP,
15714,GO:0070071,1,0.817936373209074,0,13,proton-transporting two-sector ATPase complex assembly,BP,
15715,GO:0070072,1,0.863029373123433,0,9,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15717,GO:0070076,1,0.683534959820334,0,23,histone lysine demethylation,BP,
15718,GO:0070077,1,0.983431384306763,0,1,histone arginine demethylation,BP,
15719,GO:0070078,1,0.983431384306763,0,1,histone H3-R2 demethylation,BP,
15720,GO:0070079,1,0.983431384306763,0,1,histone H4-R3 demethylation,BP,
15722,GO:0070081,1,0.931888114338388,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15723,GO:0070083,1,0.931888114338388,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15725,GO:0070086,1,0.949533784533893,0,4,ubiquitin-dependent endocytosis,BP,
15726,GO:0070087,1,0.905027655350258,0,6,chromo shadow domain binding,MF,
15727,GO:0070091,1,0.922419731047587,0,7,glucagon secretion,BP,
15728,GO:0070092,1,0.930567297737262,0,6,regulation of glucagon secretion,BP,
15729,GO:0070093,1,0.967542087975975,0,3,negative regulation of glucagon secretion,BP,
15730,GO:0070094,1,0.994522703476941,0,1,positive regulation of glucagon secretion,BP,
15731,GO:0070095,1,0.958093338231763,0,3,fructose-6-phosphate binding,MF,
15732,GO:0070096,1,0.978866660160089,0,2,mitochondrial outer membrane translocase complex assembly,BP,
15733,GO:0070097,1,0.90560876111756,0,6,delta-catenin binding,MF,
15736,GO:0070100,1,0.926804247833868,0,5,negative regulation of chemokine-mediated signaling pathway,BP,
15738,GO:0070102,1,0.858219041499718,0,10,interleukin-6-mediated signaling pathway,BP,
15739,GO:0070103,1,0.972707268868726,0,2,regulation of interleukin-6-mediated signaling pathway,BP,
15740,GO:0070104,1,0.988145988406047,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15741,GO:0070105,1,0.984376841437579,0,1,positive regulation of interleukin-6-mediated signaling pathway,BP,
15742,GO:0070106,1,0.967490087334271,0,2,interleukin-27-mediated signaling pathway,BP,
15743,GO:0070110,1,0.954518928298195,0,3,ciliary neurotrophic factor receptor complex,CC,
15744,GO:0070119,1,0.983406759352069,0,1,ciliary neurotrophic factor binding,MF,
15745,GO:0070120,1,0.926684218571918,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15746,GO:0070121,1,0.983406759351773,0,1,Kupffer's vesicle development,BP,
15747,GO:0070122,1,0.983407175645064,0,1,isopeptidase activity,MF,
15748,GO:0070123,1,0.983406759351574,0,1,transforming growth factor beta receptor activity, type III,MF,
15749,GO:0070124,1,0.976509838280747,0,2,mitochondrial translational initiation,BP,
15750,GO:0070125,1,0.455693528951234,0,84,mitochondrial translational elongation,BP,
15751,GO:0070126,1,0.448628609576351,0,85,mitochondrial translational termination,BP,
15752,GO:0070127,1,0.924043836224522,0,5,tRNA aminoacylation for mitochondrial protein translation,BP,
15753,GO:0070129,1,0.839086191306453,0,13,regulation of mitochondrial translation,BP,
15754,GO:0070130,1,0.984725543253726,0,1,negative regulation of mitochondrial translation,BP,
15755,GO:0070131,1,0.911561963828332,0,7,positive regulation of mitochondrial translation,BP,
15756,GO:0070137,1,0.951256763167935,0,3,ubiquitin-like protein-specific endopeptidase activity,MF,
15757,GO:0070138,1,0.983407175645064,0,1,ubiquitin-like protein-specific isopeptidase activity,MF,
15758,GO:0070139,1,0.951256763167935,0,3,SUMO-specific endopeptidase activity,MF,
15759,GO:0070140,1,0.983407175645064,0,1,SUMO-specific isopeptidase activity,MF,
15761,GO:0070142,1,0.938674804920883,0,4,synaptic vesicle budding,BP,
15762,GO:0070143,1,0.983406759351968,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15763,GO:0070145,1,0.983524776113773,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15764,GO:0070159,1,0.985246695689669,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15770,GO:0070165,1,0.96840222311603,0,2,positive regulation of adiponectin secretion,BP,
15771,GO:0070166,1,0.818099405302491,0,14,enamel mineralization,BP,
15776,GO:0070171,1,0.968631921312848,0,2,negative regulation of tooth mineralization,BP,
15778,GO:0070173,1,0.948250459794826,0,4,regulation of enamel mineralization,BP,
15779,GO:0070175,1,0.976002511331541,0,2,positive regulation of enamel mineralization,BP,
15780,GO:0070176,1,0.98765920890622,0,1,DRM complex,CC,
15781,GO:0070178,1,0.973822329299347,0,2,D-serine metabolic process,BP,
15782,GO:0070179,1,0.984950340754611,0,1,D-serine biosynthetic process,BP,
15783,GO:0070180,1,0.989917080160313,0,2,large ribosomal subunit rRNA binding,MF,
15784,GO:0070181,1,0.921280920818471,0,8,small ribosomal subunit rRNA binding,MF,
15785,GO:0070182,1,0.796257666907143,0,15,DNA polymerase binding,MF,
15786,GO:0070184,1,0.986053003073054,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15787,GO:0070187,1,0.913923455951276,0,6,shelterin complex,CC,
15788,GO:0070189,1,0.899066456414022,0,8,kynurenine metabolic process,BP,
15789,GO:0070191,1,0.984725543253726,0,1,methionine-R-sulfoxide reductase activity,MF,
15790,GO:0070192,1,0.441284758018542,0,56,chromosome organization involved in meiotic cell cycle,BP,
15791,GO:0070193,1,0.748893050525053,0,21,synaptonemal complex organization,BP,
15792,GO:0070194,1,0.985994441760755,0,1,synaptonemal complex disassembly,BP,
15793,GO:0070195,1,0.978106547756537,0,2,growth hormone receptor complex,CC,
15794,GO:0070197,1,0.92485345371305,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15795,GO:0070198,1,0.668483799396066,0,27,protein localization to chromosome, telomeric region,BP,
15796,GO:0070199,1,0.746953209069798,0,21,establishment of protein localization to chromosome,BP,
15797,GO:0070200,1,0.799100861291865,0,15,establishment of protein localization to telomere,BP,
15799,GO:0070202,1,0.865046927412055,0,10,regulation of establishment of protein localization to chromosome,BP,
15800,GO:0070203,1,0.865046927412055,0,10,regulation of establishment of protein localization to telomere,BP,
15801,GO:0070206,1,0.513781177437167,0,46,protein trimerization,BP,
15802,GO:0070207,1,0.707957115001576,0,26,protein homotrimerization,BP,
15803,GO:0070208,1,0.824164198518028,0,12,protein heterotrimerization,BP,
15804,GO:0070212,1,0.95108614792568,0,3,protein poly-ADP-ribosylation,BP,
15805,GO:0070213,1,0.936623212652925,0,4,protein auto-ADP-ribosylation,BP,
15806,GO:0070217,1,0.987764589990723,0,1,transcription factor TFIIIB complex assembly,BP,
15807,GO:0070221,1,0.965733124527607,0,3,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15816,GO:0070235,1,0.916545484459778,0,6,regulation of activation-induced cell death of T cells,BP,
15817,GO:0070236,1,0.944242461458478,0,4,negative regulation of activation-induced cell death of T cells,BP,
15818,GO:0070237,1,0.983406759351872,0,1,positive regulation of activation-induced cell death of T cells,BP,
15819,GO:0070238,1,0.988315740877163,0,1,activated T cell autonomous cell death,BP,
15820,GO:0070239,1,0.988315740877163,0,1,regulation of activated T cell autonomous cell death,BP,
15821,GO:0070241,1,0.988315740877163,0,1,positive regulation of activated T cell autonomous cell death,BP,
15826,GO:0070246,1,0.990514201266194,0,1,natural killer cell apoptotic process,BP,
15827,GO:0070247,1,0.990514201266194,0,1,regulation of natural killer cell apoptotic process,BP,
15828,GO:0070251,1,0.985477432871029,0,1,pristanate-CoA ligase activity,MF,
15830,GO:0070253,1,0.968497152494292,0,4,somatostatin secretion,BP,
15834,GO:0070257,1,0.91754939541027,0,6,positive regulation of mucus secretion,BP,
15835,GO:0070259,1,0.96840503307903,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15836,GO:0070260,1,0.984725543253726,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15837,GO:0070262,1,0.839370081423395,0,12,peptidyl-serine dephosphorylation,BP,
15838,GO:0070265,1,0.533768752759452,0,48,necrotic cell death,BP,
15839,GO:0070266,1,0.597785300194365,0,36,necroptotic process,BP,
15840,GO:0070267,1,0.983438762725884,0,1,oncosis,BP,
15842,GO:0070269,1,0.934922083155547,0,6,pyroptosis,BP,
15844,GO:0070272,1,0.947781384004057,0,4,proton-transporting ATP synthase complex biogenesis,BP,
15845,GO:0070273,1,0.732859380490436,0,20,phosphatidylinositol-4-phosphate binding,MF,
15846,GO:0070274,1,0.975939381344256,0,2,RES complex,CC,
15849,GO:0070283,1,0.98829703302956,0,1,radical SAM enzyme activity,MF,
15850,GO:0070286,1,0.738853315370156,0,21,axonemal dynein complex assembly,BP,
15851,GO:0070287,1,0.983430059982292,0,1,ferritin receptor activity,MF,
15852,GO:0070288,1,0.984409330669437,0,2,ferritin complex,CC,
15853,GO:0070290,1,0.925127719547987,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15854,GO:0070292,1,0.983749722132083,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
15857,GO:0070295,1,0.957598197939566,0,3,renal water absorption,BP,
15859,GO:0070300,1,0.800800399862031,0,15,phosphatidic acid binding,MF,
15864,GO:0070305,1,0.895005445913204,0,7,response to cGMP,BP,
15867,GO:0070309,1,0.935212645500187,0,5,lens fiber cell morphogenesis,BP,
15868,GO:0070314,1,0.892917606849368,0,8,G1 to G0 transition,BP,
15869,GO:0070315,1,0.954734886847219,0,3,G1 to G0 transition involved in cell differentiation,BP,
15873,GO:0070320,1,0.984446265994769,0,1,inward rectifier potassium channel inhibitor activity,MF,
15874,GO:0070324,1,0.926743888890735,0,6,thyroid hormone binding,MF,
15875,GO:0070325,1,0.760167644848189,0,21,lipoprotein particle receptor binding,MF,
15876,GO:0070326,1,0.947985258737313,0,4,very-low-density lipoprotein particle receptor binding,MF,
15877,GO:0070327,1,0.881436664070707,0,9,thyroid hormone transport,BP,
15879,GO:0070330,1,0.732272406108848,0,22,aromatase activity,MF,
15880,GO:0070335,1,0.983406759351379,0,1,aspartate binding,MF,
15881,GO:0070336,1,0.968384722375967,0,2,flap-structured DNA binding,MF,
15882,GO:0070337,1,0.983406759351724,0,1,3'-flap-structured DNA binding,MF,
15883,GO:0070339,1,0.916913248976294,0,6,response to bacterial lipopeptide,BP,
15884,GO:0070340,1,0.951790799243709,0,3,detection of bacterial lipopeptide,BP,
15886,GO:0070342,1,0.997276090372014,0,1,brown fat cell proliferation,BP,
15889,GO:0070345,1,0.915768983163271,0,6,negative regulation of fat cell proliferation,BP,
15891,GO:0070347,1,0.997276090372014,0,1,regulation of brown fat cell proliferation,BP,
15892,GO:0070349,1,0.997276090372014,0,1,positive regulation of brown fat cell proliferation,BP,
15894,GO:0070351,1,0.993201017345349,0,1,negative regulation of white fat cell proliferation,BP,
15896,GO:0070358,1,0.951038701284871,0,3,actin polymerization-dependent cell motility,BP,
15897,GO:0070361,1,0.983708026742848,0,1,mitochondrial light strand promoter anti-sense binding,MF,
15898,GO:0070362,1,0.983708026742848,0,1,mitochondrial heavy strand promoter anti-sense binding,MF,
15899,GO:0070363,1,0.986998428020563,0,1,mitochondrial light strand promoter sense binding,MF,
15900,GO:0070365,1,0.835460460426415,0,13,hepatocyte differentiation,BP,
15901,GO:0070366,1,0.978085179505877,0,2,regulation of hepatocyte differentiation,BP,
15902,GO:0070367,1,0.98655871367456,0,1,negative regulation of hepatocyte differentiation,BP,
15903,GO:0070368,1,0.991411501090547,0,1,positive regulation of hepatocyte differentiation,BP,
15904,GO:0070369,1,0.967171757277233,0,2,beta-catenin-TCF7L2 complex,CC,
15905,GO:0070370,1,0.957199211131806,0,3,cellular heat acclimation,BP,
15910,GO:0070375,1,0.953459543457164,0,3,ERK5 cascade,BP,
15911,GO:0070376,1,0.984005148370864,0,1,regulation of ERK5 cascade,BP,
15912,GO:0070377,1,0.984005148370864,0,1,negative regulation of ERK5 cascade,BP,
15913,GO:0070381,1,0.983502278313749,0,1,endosome to plasma membrane transport vesicle,CC,
15915,GO:0070383,1,0.93358508165487,0,6,DNA cytosine deamination,BP,
15917,GO:0070389,1,0.898937518396911,0,7,chaperone cofactor-dependent protein refolding,BP,
15918,GO:0070390,1,0.988098768661364,0,1,transcription export complex 2,CC,
15920,GO:0070392,1,0.992122035120751,0,1,detection of lipoteichoic acid,BP,
15921,GO:0070401,1,0.974258753939267,0,2,NADP+ binding,MF,
15923,GO:0070403,1,0.834086610870564,0,13,NAD+ binding,MF,
15924,GO:0070404,1,0.981034558161053,0,2,NADH binding,MF,
15926,GO:0070407,1,0.983708026742848,0,1,oxidation-dependent protein catabolic process,BP,
15927,GO:0070408,1,0.983406759351724,0,1,carbamoyl phosphate metabolic process,BP,
15928,GO:0070409,1,0.983406759351724,0,1,carbamoyl phosphate biosynthetic process,BP,
15929,GO:0070410,1,0.84842143767695,0,11,co-SMAD binding,MF,
15931,GO:0070412,1,0.690436477437034,0,23,R-SMAD binding,MF,
15932,GO:0070417,1,0.912398401651449,0,6,cellular response to cold,BP,
15933,GO:0070418,1,0.983406759351872,0,1,DNA-dependent protein kinase complex,CC,
15934,GO:0070419,1,0.893548007155895,0,8,nonhomologous end joining complex,CC,
15935,GO:0070423,1,0.604400591950272,0,33,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15936,GO:0070424,1,0.877888895146028,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15937,GO:0070425,1,0.967516122294541,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15938,GO:0070426,1,0.954090618092045,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15939,GO:0070427,1,0.941658729345155,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15940,GO:0070428,1,0.96708773348782,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15941,GO:0070429,1,0.983406759352021,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15942,GO:0070430,1,0.983406759351775,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15943,GO:0070431,1,0.870343260306841,0,9,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15944,GO:0070432,1,0.92309212128989,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15945,GO:0070433,1,0.967516122294541,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15946,GO:0070434,1,0.954090618092045,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15947,GO:0070435,1,0.96851261743169,0,2,Shc-EGFR complex,CC,
15948,GO:0070436,1,0.967280057399805,0,2,Grb2-EGFR complex,CC,
15949,GO:0070442,1,0.989986470737502,0,1,integrin alphaIIb-beta3 complex,CC,
15952,GO:0070446,1,0.986952701688737,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15953,GO:0070447,1,0.983771940528376,0,1,positive regulation of oligodendrocyte progenitor proliferation,BP,
15954,GO:0070449,1,0.987302775605837,0,1,elongin complex,CC,
15955,GO:0070458,1,0.965598225376102,0,3,cellular detoxification of nitrogen compound,BP,
15956,GO:0070459,1,0.91840600334353,0,6,prolactin secretion,BP,
15957,GO:0070460,1,0.983407843952928,0,1,thyroid-stimulating hormone secretion,BP,
15958,GO:0070461,1,0.667383782740774,0,28,SAGA-type complex,CC,
15959,GO:0070462,1,0.983425396802449,0,1,plus-end specific microtubule depolymerization,BP,
15960,GO:0070463,1,0.983472327477539,0,1,tubulin-dependent ATPase activity,MF,
15961,GO:0070469,1,0.508508835252167,0,82,respiratory chain,CC,
15965,GO:0070474,1,0.922055812883885,0,6,positive regulation of uterine smooth muscle contraction,BP,
15966,GO:0070475,1,0.94328402910047,0,5,rRNA base methylation,BP,
15967,GO:0070476,1,0.995522884578475,0,1,rRNA (guanine-N7)-methylation,BP,
15968,GO:0070478,1,0.983406759352069,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15969,GO:0070481,1,0.983973384444021,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15971,GO:0070483,1,0.983648935320606,0,1,detection of hypoxia,BP,
15974,GO:0070488,1,0.99238358459957,0,2,neutrophil aggregation,BP,
15975,GO:0070489,1,0.98697095702428,0,1,T cell aggregation,BP,
15976,GO:0070491,1,0.419541450743327,0,58,repressing transcription factor binding,MF,
15977,GO:0070492,1,0.861892383962224,0,11,oligosaccharide binding,MF,
15978,GO:0070493,1,0.826468616880673,0,12,thrombin-activated receptor signaling pathway,BP,
15979,GO:0070494,1,0.956319818725616,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15980,GO:0070495,1,0.956319818725616,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15981,GO:0070498,1,0.744139551294537,0,20,interleukin-1-mediated signaling pathway,BP,
15982,GO:0070506,1,0.969131632443695,0,2,high-density lipoprotein particle receptor activity,MF,
15984,GO:0070508,1,0.904591541785548,0,9,cholesterol import,BP,
15986,GO:0070510,1,0.983406759351379,0,1,regulation of histone H4-K20 methylation,BP,
15987,GO:0070512,1,0.983406759351379,0,1,positive regulation of histone H4-K20 methylation,BP,
15988,GO:0070513,1,0.895894705087137,0,9,death domain binding,MF,
15989,GO:0070522,1,0.939339144231681,0,4,ERCC4-ERCC1 complex,CC,
15990,GO:0070524,1,0.989807273293974,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15991,GO:0070525,1,0.838912500881646,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
15994,GO:0070530,1,0.760087554395571,0,17,K63-linked polyubiquitin binding,MF,
15995,GO:0070531,1,0.897611282566948,0,7,BRCA1-A complex,CC,
15996,GO:0070534,1,0.552777800125295,0,41,protein K63-linked ubiquitination,BP,
15997,GO:0070535,1,0.923343281720169,0,5,histone H2A K63-linked ubiquitination,BP,
15998,GO:0070536,1,0.653342065769704,0,27,protein K63-linked deubiquitination,BP,
15999,GO:0070537,1,0.953232571524542,0,3,histone H2A K63-linked deubiquitination,BP,
16000,GO:0070538,1,0.981645335279293,0,2,oleic acid binding,MF,
16001,GO:0070539,1,0.983458291282927,0,1,linoleic acid binding,MF,
16002,GO:0070541,1,0.967322444073314,0,2,response to platinum ion,BP,
16004,GO:0070543,1,0.970037422393742,0,2,response to linoleic acid,BP,
16005,GO:0070544,1,0.920964915389439,0,5,histone H3-K36 demethylation,BP,
16006,GO:0070545,1,0.941186525533923,0,4,PeBoW complex,CC,
16007,GO:0070546,1,0.956101771139334,0,3,L-phenylalanine aminotransferase activity,MF,
16008,GO:0070547,1,0.984245026222994,0,1,L-tyrosine aminotransferase activity,MF,
16009,GO:0070548,1,0.967493994633408,0,2,L-glutamine aminotransferase activity,MF,
16010,GO:0070551,1,0.984725543253726,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
16011,GO:0070552,1,0.927862700106282,0,5,BRISC complex,CC,
16012,GO:0070553,1,0.984725543253726,0,1,nicotinic acid receptor activity,MF,
16013,GO:0070554,1,0.969771997220093,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
16016,GO:0070560,1,0.984073933253676,0,1,protein secretion by platelet,BP,
16018,GO:0070562,1,0.911071659730618,0,6,regulation of vitamin D receptor signaling pathway,BP,
16019,GO:0070563,1,0.969939418592192,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
16020,GO:0070564,1,0.971286232389605,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
16021,GO:0070566,1,0.698695501045071,0,23,adenylyltransferase activity,MF,
16022,GO:0070567,1,0.881036980108646,0,9,cytidylyltransferase activity,MF,
16023,GO:0070568,1,0.931377452597337,0,5,guanylyltransferase activity,MF,
16024,GO:0070569,1,0.90070594047364,0,7,uridylyltransferase activity,MF,
16025,GO:0070570,1,0.688495178326745,0,25,regulation of neuron projection regeneration,BP,
16026,GO:0070571,1,0.823863746765085,0,13,negative regulation of neuron projection regeneration,BP,
16027,GO:0070572,1,0.907142193615348,0,7,positive regulation of neuron projection regeneration,BP,
16028,GO:0070573,1,0.957052678972589,0,3,metallodipeptidase activity,MF,
16029,GO:0070574,1,0.938532093123473,0,4,cadmium ion transmembrane transport,BP,
16030,GO:0070576,1,0.953223677765962,0,3,vitamin D 24-hydroxylase activity,MF,
16031,GO:0070577,1,0.755396695945379,0,17,lysine-acetylated histone binding,MF,
16032,GO:0070578,1,0.892712257067131,0,8,RISC-loading complex,CC,
16033,GO:0070579,1,0.93644348399524,0,4,methylcytosine dioxygenase activity,MF,
16034,GO:0070584,1,0.764305588867269,0,20,mitochondrion morphogenesis,BP,
16036,GO:0070586,1,0.86836132729309,0,10,cell-cell adhesion involved in gastrulation,BP,
16037,GO:0070587,1,0.882150412958123,0,9,regulation of cell-cell adhesion involved in gastrulation,BP,
16039,GO:0070589,1,0.987784806077991,0,1,cellular component macromolecule biosynthetic process,BP,
16040,GO:0070593,1,0.983406759351379,0,1,dendrite self-avoidance,BP,
16041,GO:0070601,1,0.891306282016675,0,7,centromeric sister chromatid cohesion,BP,
16042,GO:0070602,1,0.951125146992456,0,3,regulation of centromeric sister chromatid cohesion,BP,
16043,GO:0070603,1,0.340312842210467,0,73,SWI/SNF superfamily-type complex,CC,
16044,GO:0070611,1,0.984528416097605,0,1,histone methyltransferase activity (H3-R2 specific),MF,
16045,GO:0070612,1,0.984528416097605,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
16047,GO:0070615,1,0.983406759352069,0,1,nucleosome-dependent ATPase activity,MF,
16048,GO:0070618,1,0.984408334664248,0,1,Grb2-Sos complex,CC,
16049,GO:0070625,1,0.986368444803784,0,1,zymogen granule exocytosis,BP,
16050,GO:0070626,1,0.989393501185617,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
16052,GO:0070628,1,0.854570893457262,0,12,proteasome binding,MF,
16054,GO:0070634,1,0.958346910242036,0,3,transepithelial ammonium transport,BP,
16055,GO:0070637,1,0.985150987584955,0,1,pyridine nucleoside metabolic process,BP,
16056,GO:0070638,1,0.985150987584955,0,1,pyridine nucleoside catabolic process,BP,
16057,GO:0070640,1,0.942438241317172,0,4,vitamin D3 metabolic process,BP,
16058,GO:0070643,1,0.973019546856867,0,2,vitamin D 25-hydroxylase activity,MF,
16062,GO:0070649,1,0.951218431387587,0,3,formin-nucleated actin cable assembly,BP,
16063,GO:0070651,1,0.983973384444021,0,1,nonfunctional rRNA decay,BP,
16064,GO:0070652,1,0.89545444639578,0,8,HAUS complex,CC,
16065,GO:0070653,1,0.985440423963261,0,3,high-density lipoprotein particle receptor binding,MF,
16072,GO:0070667,1,0.983771940528376,0,1,negative regulation of mast cell proliferation,BP,
16074,GO:0070669,1,0.878398363052258,0,9,response to interleukin-2,BP,
16076,GO:0070671,1,0.924482302971734,0,5,response to interleukin-12,BP,
16079,GO:0070676,1,0.963696532666516,0,3,intralumenal vesicle formation,BP,
16080,GO:0070679,1,0.860512116452413,0,9,inositol 1,4,5 trisphosphate binding,MF,
16081,GO:0070681,1,0.980253348253404,0,2,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
16082,GO:0070682,1,0.958701441579578,0,3,proteasome regulatory particle assembly,BP,
16083,GO:0070684,1,0.991557183342713,0,1,seminal clot liquefaction,BP,
16084,GO:0070685,1,0.986242923581684,0,1,macropinocytic cup,CC,
16085,GO:0070694,1,0.984725543253726,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
16086,GO:0070695,1,0.923159396377201,0,5,FHF complex,CC,
16088,GO:0070697,1,0.941145212854398,0,4,activin receptor binding,MF,
16089,GO:0070698,1,0.970612603541964,0,2,type I activin receptor binding,MF,
16090,GO:0070699,1,0.969644115591627,0,2,type II activin receptor binding,MF,
16092,GO:0070701,1,0.967087733484091,0,2,mucus layer,CC,
16093,GO:0070702,1,0.983406759350987,0,1,inner mucus layer,CC,
16094,GO:0070703,1,0.983406759350987,0,1,outer mucus layer,CC,
16095,GO:0070704,1,0.983406759352021,0,1,sterol desaturase activity,MF,
16096,GO:0070715,1,0.98357355435276,0,1,sodium-dependent organic cation transport,BP,
16097,GO:0070717,1,0.751659687590915,0,18,poly-purine tract binding,MF,
16098,GO:0070722,1,0.983464176676437,0,1,Tle3-Aes complex,CC,
16099,GO:0070723,1,0.722428794004273,0,21,response to cholesterol,BP,
16103,GO:0070733,1,0.988439538538966,0,1,protein adenylyltransferase activity,MF,
16104,GO:0070734,1,0.772913178598354,0,18,histone H3-K27 methylation,BP,
16105,GO:0070735,1,0.983499919429225,0,1,protein-glycine ligase activity,MF,
16106,GO:0070736,1,0.983499919429225,0,1,protein-glycine ligase activity, initiating,MF,
16107,GO:0070739,1,0.915184107212679,0,6,protein-glutamic acid ligase activity,MF,
16108,GO:0070740,1,0.956303818966133,0,3,tubulin-glutamic acid ligase activity,MF,
16109,GO:0070741,1,0.646374218594708,0,31,response to interleukin-6,BP,
16111,GO:0070743,1,0.977669306666012,0,2,interleukin-23 complex,CC,
16112,GO:0070761,1,0.924644820517965,0,6,pre-snoRNP complex,CC,
16113,GO:0070765,1,0.918495215390144,0,6,gamma-secretase complex,CC,
16114,GO:0070772,1,0.983723637727737,0,1,PAS complex,CC,
16115,GO:0070773,1,0.990183187916053,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
16116,GO:0070774,1,0.983406759352021,0,1,phytoceramidase activity,MF,
16117,GO:0070775,1,0.894271568321738,0,7,H3 histone acetyltransferase complex,CC,
16118,GO:0070776,1,0.894271568321738,0,7,MOZ/MORF histone acetyltransferase complex,CC,
16119,GO:0070777,1,0.93528125471784,0,4,D-aspartate transport,BP,
16120,GO:0070778,1,0.940656002065271,0,4,L-aspartate transport,BP,
16121,GO:0070779,1,0.93528125471784,0,4,D-aspartate import,BP,
16122,GO:0070780,1,0.974839414647233,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
16123,GO:0070781,1,0.972026693246516,0,2,response to biotin,BP,
16124,GO:0070782,1,0.986064796919425,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
16125,GO:0070813,1,0.939584797955967,0,5,hydrogen sulfide metabolic process,BP,
16126,GO:0070814,1,0.946476098932553,0,4,hydrogen sulfide biosynthetic process,BP,
16127,GO:0070815,1,0.936117123098919,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
16128,GO:0070816,1,0.806709086615342,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
16129,GO:0070818,1,0.987930171593581,0,1,protoporphyrinogen oxidase activity,MF,
16133,GO:0070826,1,0.983406759352069,0,1,paraferritin complex,CC,
16134,GO:0070827,1,0.952520054033473,0,3,chromatin maintenance,BP,
16135,GO:0070828,1,0.80622272302612,0,15,heterochromatin organization,BP,
16136,GO:0070829,1,0.983406759351379,0,1,heterochromatin maintenance,BP,
16138,GO:0070831,1,0.869850660534751,0,9,basement membrane assembly,BP,
16139,GO:0070836,1,0.945506116847641,0,4,caveola assembly,BP,
16140,GO:0070837,1,0.937171410277151,0,4,dehydroascorbic acid transport,BP,
16142,GO:0070839,1,0.967207289079611,0,2,divalent metal ion export,BP,
16143,GO:0070840,1,0.731956774823122,0,19,dynein complex binding,MF,
16144,GO:0070841,1,0.731620390277057,0,21,inclusion body assembly,BP,
16145,GO:0070842,1,0.943969890778077,0,4,aggresome assembly,BP,
16146,GO:0070843,1,0.983406759352069,0,1,misfolded protein transport,BP,
16147,GO:0070844,1,0.983406759352069,0,1,polyubiquitinated protein transport,BP,
16148,GO:0070845,1,0.983406759352069,0,1,polyubiquitinated misfolded protein transport,BP,
16149,GO:0070846,1,0.983406759352069,0,1,Hsp90 deacetylation,BP,
16150,GO:0070847,1,0.930463379284183,0,6,core mediator complex,CC,
16155,GO:0070853,1,0.967087733486609,0,2,myosin VI binding,MF,
16156,GO:0070856,1,0.983406759351625,0,1,myosin VI light chain binding,MF,
16157,GO:0070857,1,0.869782208251968,0,9,regulation of bile acid biosynthetic process,BP,
16158,GO:0070858,1,0.956648703722575,0,3,negative regulation of bile acid biosynthetic process,BP,
16159,GO:0070859,1,0.955025481540931,0,3,positive regulation of bile acid biosynthetic process,BP,
16160,GO:0070860,1,0.985505137178381,0,1,RNA polymerase I core factor complex,CC,
16161,GO:0070861,1,0.725663462796606,0,21,regulation of protein exit from endoplasmic reticulum,BP,
16162,GO:0070862,1,0.875837612687447,0,9,negative regulation of protein exit from endoplasmic reticulum,BP,
16163,GO:0070863,1,0.856795287112696,0,10,positive regulation of protein exit from endoplasmic reticulum,BP,
16165,GO:0070874,1,0.918973875028214,0,6,negative regulation of glycogen metabolic process,BP,
16167,GO:0070876,1,0.939022784748962,0,4,SOSS complex,CC,
16168,GO:0070877,1,0.968384722376257,0,2,microprocessor complex,CC,
16169,GO:0070878,1,0.877310781852653,0,8,primary miRNA binding,MF,
16170,GO:0070883,1,0.949335458608338,0,4,pre-miRNA binding,MF,
16173,GO:0070886,1,0.875827056185059,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16175,GO:0070888,1,0.599187719054027,0,35,E-box binding,MF,
16176,GO:0070889,1,0.970101562064222,0,2,platelet alpha granule organization,BP,
16177,GO:0070890,1,0.968977804748556,0,2,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16178,GO:0070891,1,0.952784764506091,0,4,lipoteichoic acid binding,MF,
16179,GO:0070892,1,0.986406015592142,0,1,lipoteichoic acid receptor activity,MF,
16180,GO:0070893,1,0.967855731242945,0,2,transposon integration,BP,
16181,GO:0070894,1,0.967855731242945,0,2,regulation of transposon integration,BP,
16182,GO:0070895,1,0.967855731242945,0,2,negative regulation of transposon integration,BP,
16183,GO:0070897,1,0.605331637200031,0,36,DNA-templated transcriptional preinitiation complex assembly,BP,
16184,GO:0070898,1,0.968738891492243,0,2,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16185,GO:0070899,1,0.983845626378694,0,1,mitochondrial tRNA wobble uridine modification,BP,
16186,GO:0070900,1,0.886329165169165,0,9,mitochondrial tRNA modification,BP,
16187,GO:0070901,1,0.94935063858177,0,4,mitochondrial tRNA methylation,BP,
16188,GO:0070902,1,0.988342526418377,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
16189,GO:0070903,1,0.986853137428108,0,1,mitochondrial tRNA thio-modification,BP,
16190,GO:0070904,1,0.968977804748556,0,2,transepithelial L-ascorbic acid transport,BP,
16191,GO:0070905,1,0.955325577153108,0,3,serine binding,MF,
16192,GO:0070911,1,0.650879248796792,0,32,global genome nucleotide-excision repair,BP,
16193,GO:0070914,1,0.852459445434687,0,11,UV-damage excision repair,BP,
16197,GO:0070922,1,0.888973024846991,0,8,small RNA loading onto RISC,BP,
16199,GO:0070926,1,0.983407942944767,0,1,regulation of ATP:ADP antiporter activity,BP,
16200,GO:0070931,1,0.983406759351724,0,1,Golgi-associated vesicle lumen,CC,
16201,GO:0070932,1,0.734571897887668,0,20,histone H3 deacetylation,BP,
16202,GO:0070933,1,0.869924162072357,0,9,histone H4 deacetylation,BP,
16203,GO:0070934,1,0.924974833753814,0,5,CRD-mediated mRNA stabilization,BP,
16204,GO:0070935,1,0.855095555261607,0,10,3'-UTR-mediated mRNA stabilization,BP,
16205,GO:0070936,1,0.493869542167691,0,48,protein K48-linked ubiquitination,BP,
16206,GO:0070937,1,0.909621587319864,0,6,CRD-mediated mRNA stability complex,CC,
16207,GO:0070938,1,0.841596287366507,0,11,contractile ring,CC,
16208,GO:0070939,1,0.952071271117947,0,3,Dsl1/NZR complex,CC,
16209,GO:0070940,1,0.926647512132637,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16210,GO:0070942,1,0.945677873417269,0,6,neutrophil mediated cytotoxicity,BP,
16211,GO:0070943,1,0.945677873417269,0,6,neutrophil mediated killing of symbiont cell,BP,
16212,GO:0070944,1,0.952331953853929,0,5,neutrophil mediated killing of bacterium,BP,
16213,GO:0070945,1,0.965718728988984,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16214,GO:0070946,1,0.993007255603144,0,1,neutrophil mediated killing of gram-positive bacterium,BP,
16215,GO:0070947,1,0.993014280257165,0,1,neutrophil mediated killing of fungus,BP,
16216,GO:0070948,1,0.984033063780969,0,1,regulation of neutrophil mediated cytotoxicity,BP,
16217,GO:0070949,1,0.984033063780969,0,1,regulation of neutrophil mediated killing of symbiont cell,BP,
16218,GO:0070950,1,0.984033063780969,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16219,GO:0070951,1,0.984033063780969,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16220,GO:0070960,1,0.984033063780969,0,1,positive regulation of neutrophil mediated cytotoxicity,BP,
16221,GO:0070961,1,0.984033063780969,0,1,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16222,GO:0070962,1,0.984033063780969,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16223,GO:0070963,1,0.984033063780969,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16224,GO:0070966,1,0.951586459764443,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16225,GO:0070970,1,0.850217482302593,0,10,interleukin-2 secretion,BP,
16226,GO:0070971,1,0.846651681057762,0,11,endoplasmic reticulum exit site,CC,
16227,GO:0070972,1,0.316063537466587,0,126,protein localization to endoplasmic reticulum,BP,
16228,GO:0070973,1,0.942766081846588,0,4,protein localization to endoplasmic reticulum exit site,BP,
16229,GO:0070974,1,0.983798136705563,0,1,POU domain binding,MF,
16230,GO:0070975,1,0.983406759351331,0,1,FHA domain binding,MF,
16231,GO:0070976,1,0.984356931307557,0,1,TIR domain binding,MF,
16233,GO:0070979,1,0.714928511232097,0,26,protein K11-linked ubiquitination,BP,
16234,GO:0070980,1,0.985335227444392,0,1,biphenyl catabolic process,BP,
16235,GO:0070981,1,0.985432834318974,0,1,L-asparagine biosynthetic process,BP,
16236,GO:0070982,1,0.985432834318974,0,1,L-asparagine metabolic process,BP,
16237,GO:0070984,1,0.983406759352069,0,1,SET domain binding,MF,
16238,GO:0070985,1,0.97923832869697,0,2,TFIIK complex,CC,
16240,GO:0070987,1,0.784661887505056,0,18,error-free translesion synthesis,BP,
16241,GO:0070988,1,0.423566812882622,0,57,demethylation,BP,
16242,GO:0070989,1,0.847752688708777,0,12,oxidative demethylation,BP,
16243,GO:0070990,1,0.919209111195397,0,8,snRNP binding,MF,
16244,GO:0070991,1,0.968282809755105,0,2,medium-chain-acyl-CoA dehydrogenase activity,MF,
16245,GO:0070992,1,0.98089378648392,0,2,translation initiation complex,CC,
16246,GO:0070993,1,0.967087733488112,0,2,translation preinitiation complex,CC,
16247,GO:0070994,1,0.983406759352018,0,1,detection of oxidative stress,BP,
16248,GO:0070995,1,0.953973595720022,0,3,NADPH oxidation,BP,
16249,GO:0070996,1,0.97063090873452,0,3,type 1 melanocortin receptor binding,MF,
16251,GO:0071000,1,0.97310677443469,0,2,response to magnetism,BP,
16252,GO:0071001,1,0.962006947969053,0,3,U4/U6 snRNP,CC,
16253,GO:0071004,1,0.810112179663235,0,16,U2-type prespliceosome,CC,
16254,GO:0071006,1,0.954967931441823,0,3,U2-type catalytic step 1 spliceosome,CC,
16255,GO:0071007,1,0.985355208378483,0,1,U2-type catalytic step 2 spliceosome,CC,
16256,GO:0071008,1,0.944841575530783,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16257,GO:0071010,1,0.785904161085625,0,19,prespliceosome,CC,
16258,GO:0071011,1,0.765151061896924,0,23,precatalytic spliceosome,CC,
16259,GO:0071012,1,0.943349060744368,0,4,catalytic step 1 spliceosome,CC,
16260,GO:0071013,1,0.271169139590307,0,95,catalytic step 2 spliceosome,CC,
16261,GO:0071014,1,0.909454373933693,0,7,post-mRNA release spliceosomal complex,CC,
16262,GO:0071020,1,0.976099197118285,0,2,post-spliceosomal complex,CC,
16263,GO:0071021,1,0.988119726811486,0,1,U2-type post-spliceosomal complex,CC,
16264,GO:0071025,1,0.862114186503314,0,12,RNA surveillance,BP,
16265,GO:0071026,1,0.984938620238289,0,1,cytoplasmic RNA surveillance,BP,
16266,GO:0071027,1,0.889568358046442,0,10,nuclear RNA surveillance,BP,
16267,GO:0071028,1,0.889568358046442,0,10,nuclear mRNA surveillance,BP,
16268,GO:0071029,1,0.951077310394097,0,4,nuclear ncRNA surveillance,BP,
16269,GO:0071030,1,0.972505984132312,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16270,GO:0071031,1,0.977522270619099,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16271,GO:0071033,1,0.939327556641552,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16272,GO:0071034,1,0.946108812003986,0,4,CUT catabolic process,BP,
16273,GO:0071035,1,0.951077310394097,0,4,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16274,GO:0071038,1,0.977522270619099,0,2,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16275,GO:0071042,1,0.983406759352018,0,1,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16276,GO:0071043,1,0.946108812003986,0,4,CUT metabolic process,BP,
16277,GO:0071044,1,0.853589389170269,0,11,histone mRNA catabolic process,BP,
16278,GO:0071045,1,0.988466648285194,0,1,nuclear histone mRNA catabolic process,BP,
16279,GO:0071046,1,0.951077310394097,0,4,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16280,GO:0071047,1,0.983406759352018,0,1,polyadenylation-dependent mRNA catabolic process,BP,
16281,GO:0071048,1,0.972505984132312,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16282,GO:0071049,1,0.977522270619099,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16283,GO:0071051,1,0.952258668077645,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16285,GO:0071065,1,0.967842551025812,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16288,GO:0071073,1,0.907885154245927,0,7,positive regulation of phospholipid biosynthetic process,BP,
16289,GO:0071074,1,0.970733731217415,0,2,eukaryotic initiation factor eIF2 binding,MF,
16290,GO:0071077,1,0.969582674838051,0,2,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16291,GO:0071103,1,0.0377846038641317,0,265,DNA conformation change,BP,
16292,GO:0071104,1,0.962959712425997,0,3,response to interleukin-9,BP,
16293,GO:0071105,1,0.976581421803534,0,2,response to interleukin-11,BP,
16294,GO:0071106,1,0.969582674838051,0,2,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16295,GO:0071107,1,0.856672676345009,0,11,response to parathyroid hormone,BP,
16296,GO:0071108,1,0.675700544946081,0,25,protein K48-linked deubiquitination,BP,
16297,GO:0071109,1,0.967087733486125,0,2,superior temporal gyrus development,BP,
16298,GO:0071110,1,0.983406759351672,0,1,histone biotinylation,BP,
16299,GO:0071133,1,0.983681235131478,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16300,GO:0071139,1,0.968266660113856,0,2,resolution of recombination intermediates,BP,
16301,GO:0071140,1,0.968266660113856,0,2,resolution of mitotic recombination intermediates,BP,
16302,GO:0071141,1,0.863637928766569,0,9,SMAD protein complex,CC,
16303,GO:0071144,1,0.967087733486317,0,2,SMAD2-SMAD3 protein complex,CC,
16304,GO:0071146,1,0.986160124869071,0,1,SMAD3-SMAD4 protein complex,CC,
16305,GO:0071148,1,0.967087733486704,0,2,TEAD-1-YAP complex,CC,
16306,GO:0071149,1,0.969663283707363,0,2,TEAD-2-YAP complex,CC,
16310,GO:0071159,1,0.978369832861703,0,2,NF-kappaB complex,CC,
16311,GO:0071163,1,0.96297742004018,0,3,DNA replication preinitiation complex assembly,BP,
16312,GO:0071164,1,0.983419575562369,0,1,RNA trimethylguanosine synthase activity,MF,
16313,GO:0071166,1,0.159065102085973,0,127,ribonucleoprotein complex localization,BP,
16314,GO:0071167,1,0.983419575562369,0,1,ribonucleoprotein complex import into nucleus,BP,
16315,GO:0071168,1,0.811799326737546,0,15,protein localization to chromatin,BP,
16316,GO:0071169,1,0.934800832808223,0,6,establishment of protein localization to chromatin,BP,
16317,GO:0071170,1,0.984725543253726,0,1,site-specific DNA replication termination,BP,
16318,GO:0071171,1,0.984725543253726,0,1,site-specific DNA replication termination at RTS1 barrier,BP,
16319,GO:0071173,1,0.664668868052586,0,28,spindle assembly checkpoint,BP,
16320,GO:0071174,1,0.65575943903372,0,29,mitotic spindle checkpoint,BP,
16321,GO:0071203,1,0.940551067768786,0,4,WASH complex,CC,
16322,GO:0071204,1,0.923033531703238,0,6,histone pre-mRNA 3'end processing complex,CC,
16323,GO:0071205,1,0.93525434782708,0,4,protein localization to juxtaparanode region of axon,BP,
16324,GO:0071206,1,0.983406759351231,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16325,GO:0071207,1,0.971625304669778,0,2,histone pre-mRNA stem-loop binding,MF,
16326,GO:0071208,1,0.963933955743404,0,4,histone pre-mRNA DCP binding,MF,
16327,GO:0071209,1,0.96855359957679,0,3,U7 snRNA binding,MF,
16328,GO:0071211,1,0.954095353738818,0,3,protein targeting to vacuole involved in autophagy,BP,
16330,GO:0071215,1,0.983406759352021,0,1,cellular response to abscisic acid stimulus,BP,
16332,GO:0071217,1,0.983406761279341,0,1,cellular response to external biotic stimulus,BP,
16333,GO:0071218,1,0.760355081477035,0,19,cellular response to misfolded protein,BP,
16335,GO:0071220,1,0.916913248976294,0,6,cellular response to bacterial lipoprotein,BP,
16336,GO:0071221,1,0.916913248976294,0,6,cellular response to bacterial lipopeptide,BP,
16339,GO:0071224,1,0.976888977045884,0,2,cellular response to peptidoglycan,BP,
16340,GO:0071225,1,0.921298963739638,0,5,cellular response to muramyl dipeptide,BP,
16341,GO:0071226,1,0.953810531524633,0,3,cellular response to molecule of fungal origin,BP,
16342,GO:0071228,1,0.983954877073464,0,1,cellular response to tumor cell,BP,
16345,GO:0071231,1,0.983871682926409,0,2,cellular response to folic acid,BP,
16347,GO:0071236,1,0.802548595622248,0,15,cellular response to antibiotic,BP,
16349,GO:0071242,1,0.45323181773156,0,55,cellular response to ammonium ion,BP,
16350,GO:0071243,1,0.825507189083053,0,15,cellular response to arsenic-containing substance,BP,
16351,GO:0071245,1,0.983427814800554,0,1,cellular response to carbon monoxide,BP,
16352,GO:0071247,1,0.991827849197741,0,1,cellular response to chromate,BP,
16354,GO:0071250,1,0.983406759351575,0,1,cellular response to nitrite,BP,
16355,GO:0071253,1,0.912554705453255,0,6,connexin binding,MF,
16356,GO:0071256,1,0.965885786396732,0,4,translocon complex,CC,
16357,GO:0071257,1,0.83111804669367,0,12,cellular response to electrical stimulus,BP,
16358,GO:0071258,1,0.983406759352069,0,1,cellular response to gravity,BP,
16359,GO:0071259,1,0.97310677443469,0,2,cellular response to magnetism,BP,
16361,GO:0071262,1,0.967094006574811,0,2,regulation of translational initiation in response to starvation,BP,
16362,GO:0071264,1,0.967094006574811,0,2,positive regulation of translational initiation in response to starvation,BP,
16363,GO:0071265,1,0.897289690796387,0,8,L-methionine biosynthetic process,BP,
16364,GO:0071266,1,0.987935314300946,0,1,'de novo' L-methionine biosynthetic process,BP,
16365,GO:0071267,1,0.908251817578316,0,7,L-methionine salvage,BP,
16366,GO:0071268,1,0.985557613879444,0,1,homocysteine biosynthetic process,BP,
16367,GO:0071275,1,0.986088466109074,0,1,cellular response to aluminum ion,BP,
16370,GO:0071279,1,0.961984160609468,0,3,cellular response to cobalt ion,BP,
16371,GO:0071280,1,0.845864940840131,0,12,cellular response to copper ion,BP,
16373,GO:0071283,1,0.979003039386627,0,2,cellular response to iron(III) ion,BP,
16376,GO:0071286,1,0.910229512956753,0,6,cellular response to magnesium ion,BP,
16377,GO:0071287,1,0.868676473153199,0,9,cellular response to manganese ion,BP,
16378,GO:0071288,1,0.96135238752502,0,3,cellular response to mercury ion,BP,
16379,GO:0071294,1,0.852066204435513,0,18,cellular response to zinc ion,BP,
16381,GO:0071298,1,0.983492632555574,0,1,cellular response to L-ascorbic acid,BP,
16383,GO:0071301,1,0.983406759351331,0,1,cellular response to vitamin B1,BP,
16385,GO:0071306,1,0.970987783623188,0,2,cellular response to vitamin E,BP,
16390,GO:0071314,1,0.962737120716501,0,3,cellular response to cocaine,BP,
16391,GO:0071315,1,0.950129280666665,0,4,cellular response to morphine,BP,
16392,GO:0071316,1,0.895722953661826,0,8,cellular response to nicotine,BP,
16393,GO:0071317,1,0.950129280666665,0,4,cellular response to isoquinoline alkaloid,BP,
16394,GO:0071318,1,0.84121603296282,0,13,cellular response to ATP,BP,
16396,GO:0071321,1,0.904550330202443,0,6,cellular response to cGMP,BP,
16398,GO:0071324,1,0.983406759351921,0,1,cellular response to disaccharide stimulus,BP,
16400,GO:0071329,1,0.983406759351921,0,1,cellular response to sucrose stimulus,BP,
16402,GO:0071332,1,0.927567087808034,0,5,cellular response to fructose stimulus,BP,
16407,GO:0071339,1,0.676727623270251,0,27,MLL1 complex,CC,
16408,GO:0071340,1,0.850759699596,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16409,GO:0071344,1,0.97930401972788,0,2,diphosphate metabolic process,BP,
16413,GO:0071348,1,0.983406759351968,0,1,cellular response to interleukin-11,BP,
16414,GO:0071349,1,0.954296192789091,0,3,cellular response to interleukin-12,BP,
16415,GO:0071350,1,0.955904834945512,0,3,cellular response to interleukin-15,BP,
16417,GO:0071352,1,0.914654518650336,0,6,cellular response to interleukin-2,BP,
16419,GO:0071354,1,0.679747738712657,0,27,cellular response to interleukin-6,BP,
16420,GO:0071355,1,0.986053003073054,0,1,cellular response to interleukin-9,BP,
16425,GO:0071361,1,0.833493762553855,0,12,cellular response to ethanol,BP,
16426,GO:0071362,1,0.917873802476625,0,6,cellular response to ether,BP,
16431,GO:0071373,1,0.953113994867264,0,3,cellular response to luteinizing hormone stimulus,BP,
16432,GO:0071374,1,0.882699462997633,0,8,cellular response to parathyroid hormone stimulus,BP,
16434,GO:0071376,1,0.926614131754927,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16442,GO:0071386,1,0.951184246718655,0,3,cellular response to corticosterone stimulus,BP,
16443,GO:0071387,1,0.983406759351872,0,1,cellular response to cortisol stimulus,BP,
16445,GO:0071391,1,0.826734902896356,0,12,cellular response to estrogen stimulus,BP,
16446,GO:0071392,1,0.608285597072609,0,35,cellular response to estradiol stimulus,BP,
16447,GO:0071393,1,0.983406759352069,0,1,cellular response to progesterone stimulus,BP,
16449,GO:0071395,1,0.961960127897768,0,4,cellular response to jasmonic acid stimulus,BP,
16451,GO:0071397,1,0.809042327409047,0,13,cellular response to cholesterol,BP,
16453,GO:0071400,1,0.96867896954972,0,2,cellular response to oleic acid,BP,
16454,GO:0071401,1,0.985566427273525,0,1,cellular response to triglyceride,BP,
16455,GO:0071402,1,0.815770342814736,0,16,cellular response to lipoprotein particle stimulus,BP,
16456,GO:0071403,1,0.994296144488195,0,1,cellular response to high density lipoprotein particle stimulus,BP,
16457,GO:0071404,1,0.836690432458448,0,13,cellular response to low-density lipoprotein particle stimulus,BP,
16459,GO:0071409,1,0.956455608528868,0,3,cellular response to cycloheximide,BP,
16460,GO:0071412,1,0.985592982661204,0,1,cellular response to genistein,BP,
16461,GO:0071413,1,0.985592982661204,0,1,cellular response to hydroxyisoflavone,BP,
16464,GO:0071418,1,0.990127618737726,0,1,cellular response to amine stimulus,BP,
16465,GO:0071420,1,0.891657006240809,0,7,cellular response to histamine,BP,
16466,GO:0071421,1,0.926464745897998,0,5,manganese ion transmembrane transport,BP,
16467,GO:0071422,1,0.954932315913588,0,3,succinate transmembrane transport,BP,
16468,GO:0071423,1,0.987217261229828,0,1,malate transmembrane transport,BP,
16470,GO:0071426,1,0.164094293486165,0,125,ribonucleoprotein complex export from nucleus,BP,
16471,GO:0071427,1,0.203593753090556,0,108,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16472,GO:0071428,1,0.842197971774836,0,14,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16473,GO:0071431,1,0.624167024427032,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16475,GO:0071436,1,0.874232446936159,0,10,sodium ion export,BP,
16478,GO:0071439,1,0.886559730488243,0,8,clathrin complex,CC,
16479,GO:0071440,1,0.924722191178032,0,5,regulation of histone H3-K14 acetylation,BP,
16480,GO:0071441,1,0.983408648114669,0,1,negative regulation of histone H3-K14 acetylation,BP,
16481,GO:0071442,1,0.940327437397277,0,4,positive regulation of histone H3-K14 acetylation,BP,
16482,GO:0071444,1,0.998333697740101,0,1,cellular response to pheromone,BP,
16483,GO:0071447,1,0.897212986889238,0,8,cellular response to hydroperoxide,BP,
16484,GO:0071449,1,0.993063497994882,0,1,cellular response to lipid hydroperoxide,BP,
16488,GO:0071454,1,0.983406759351281,0,1,cellular response to anoxia,BP,
16489,GO:0071455,1,0.896583497334988,0,7,cellular response to hyperoxia,BP,
16491,GO:0071458,1,0.912805173216113,0,6,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16492,GO:0071459,1,0.766392588318548,0,18,protein localization to chromosome, centromeric region,BP,
16493,GO:0071460,1,0.981980235140341,0,2,cellular response to cell-matrix adhesion,BP,
16494,GO:0071461,1,0.975329270933705,0,2,cellular response to redox state,BP,
16495,GO:0071462,1,0.921849046428063,0,5,cellular response to water stimulus,BP,
16496,GO:0071464,1,0.969279965615519,0,2,cellular response to hydrostatic pressure,BP,
16497,GO:0071466,1,0.241998352215316,0,107,cellular response to xenobiotic stimulus,BP,
16498,GO:0071467,1,0.745710711924374,0,20,cellular response to pH,BP,
16499,GO:0071468,1,0.841228800778888,0,11,cellular response to acidic pH,BP,
16500,GO:0071469,1,0.97121124217582,0,2,cellular response to alkaline pH,BP,
16501,GO:0071470,1,0.646758380447805,0,29,cellular response to osmotic stress,BP,
16502,GO:0071471,1,0.983406759352021,0,1,cellular response to non-ionic osmotic stress,BP,
16503,GO:0071472,1,0.878727133558022,0,8,cellular response to salt stress,BP,
16504,GO:0071474,1,0.884786804543855,0,8,cellular hyperosmotic response,BP,
16505,GO:0071475,1,0.953742130557307,0,3,cellular hyperosmotic salinity response,BP,
16506,GO:0071476,1,0.899600862868382,0,7,cellular hypotonic response,BP,
16507,GO:0071477,1,0.967350642020703,0,2,cellular hypotonic salinity response,BP,
16511,GO:0071481,1,0.821348299621848,0,13,cellular response to X-ray,BP,
16513,GO:0071483,1,0.967262868591393,0,2,cellular response to blue light,BP,
16514,GO:0071484,1,0.967243764347568,0,2,cellular response to light intensity,BP,
16515,GO:0071485,1,0.983565412210262,0,1,cellular response to absence of light,BP,
16516,GO:0071486,1,0.98340675935187,0,1,cellular response to high light intensity,BP,
16517,GO:0071492,1,0.956246222479235,0,3,cellular response to UV-A,BP,
16519,GO:0071494,1,0.951044578749954,0,3,cellular response to UV-C,BP,
16522,GO:0071498,1,0.762413387344303,0,18,cellular response to fluid shear stress,BP,
16523,GO:0071499,1,0.901366532777013,0,7,cellular response to laminar fluid shear stress,BP,
16524,GO:0071500,1,0.928007467843984,0,6,cellular response to nitrosative stress,BP,
16525,GO:0071501,1,0.881036171525352,0,8,cellular response to sterol depletion,BP,
16526,GO:0071502,1,0.933352396506168,0,5,cellular response to temperature stimulus,BP,
16527,GO:0071503,1,0.922059603223853,0,5,response to heparin,BP,
16528,GO:0071504,1,0.935531531842411,0,4,cellular response to heparin,BP,
16532,GO:0071515,1,0.984725543253726,0,1,genetic imprinting at mating-type locus,BP,
16533,GO:0071516,1,0.984725543253726,0,1,establishment of imprinting at mating-type locus,BP,
16534,GO:0071526,1,0.687057468852967,0,23,semaphorin-plexin signaling pathway,BP,
16535,GO:0071527,1,0.985308759830125,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16536,GO:0071528,1,0.983407541105736,0,1,tRNA re-export from nucleus,BP,
16537,GO:0071529,1,0.984664675591122,0,1,cementum mineralization,BP,
16538,GO:0071532,1,0.921423187145156,0,5,ankyrin repeat binding,MF,
16539,GO:0071535,1,0.942788078298715,0,4,RING-like zinc finger domain binding,MF,
16540,GO:0071538,1,0.985501663355894,0,1,SH2 domain-mediated complex assembly,BP,
16541,GO:0071539,1,0.696830413930421,0,23,protein localization to centrosome,BP,
16542,GO:0071540,1,0.983406759351821,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16543,GO:0071541,1,0.918778865677624,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16545,GO:0071543,1,0.946675313860854,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16546,GO:0071544,1,0.990183187916053,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16547,GO:0071545,1,0.843362815431108,0,11,inositol phosphate catabolic process,BP,
16548,GO:0071546,1,0.892909116732129,0,7,pi-body,CC,
16549,GO:0071547,1,0.926060491869921,0,5,piP-body,CC,
16552,GO:0071550,1,0.886830986986344,0,9,death-inducing signaling complex assembly,BP,
16553,GO:0071553,1,0.961546422634693,0,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
16554,GO:0071554,1,0.957455668876341,0,5,cell wall organization or biogenesis,BP,
16555,GO:0071556,1,0.720523562445075,0,28,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16556,GO:0071557,1,0.93525434782914,0,4,histone H3-K27 demethylation,BP,
16557,GO:0071558,1,0.93525434782914,0,4,histone demethylase activity (H3-K27 specific),MF,
16560,GO:0071561,1,0.983406759351921,0,1,nucleus-vacuole junction,CC,
16561,GO:0071564,1,0.835113100751158,0,12,npBAF complex,CC,
16562,GO:0071565,1,0.808441959355225,0,14,nBAF complex,CC,
16563,GO:0071566,1,0.983924935141977,0,1,UFM1 activating enzyme activity,MF,
16564,GO:0071567,1,0.977930574207619,0,2,UFM1 hydrolase activity,MF,
16565,GO:0071568,1,0.976496372833915,0,2,UFM1 transferase activity,MF,
16566,GO:0071569,1,0.925311762690966,0,6,protein ufmylation,BP,
16567,GO:0071573,1,0.983945022755128,0,1,shelterin complex assembly,BP,
16568,GO:0071575,1,0.983435229772214,0,1,integral component of external side of plasma membrane,CC,
16569,GO:0071577,1,0.705700331437751,0,23,zinc II ion transmembrane transport,BP,
16570,GO:0071578,1,0.884580093643317,0,8,zinc II ion transmembrane import,BP,
16571,GO:0071579,1,0.970940411965303,0,2,regulation of zinc ion transport,BP,
16572,GO:0071580,1,0.986649566638589,0,1,regulation of zinc ion transmembrane transport,BP,
16573,GO:0071581,1,0.986649566638589,0,1,regulation of zinc ion transmembrane import,BP,
16574,GO:0071582,1,0.986649566638589,0,1,negative regulation of zinc ion transport,BP,
16575,GO:0071583,1,0.986649566638589,0,1,negative regulation of zinc ion transmembrane transport,BP,
16576,GO:0071584,1,0.986649566638589,0,1,negative regulation of zinc ion transmembrane import,BP,
16577,GO:0071585,1,0.986649566638589,0,1,detoxification of cadmium ion,BP,
16578,GO:0071586,1,0.962354050784948,0,3,CAAX-box protein processing,BP,
16579,GO:0071593,1,0.960365679472111,0,3,lymphocyte aggregation,BP,
16580,GO:0071595,1,0.969683443564638,0,2,Nem1-Spo7 phosphatase complex,CC,
16581,GO:0071596,1,0.951038409343015,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16582,GO:0071598,1,0.960526152366514,0,3,neuronal ribonucleoprotein granule,CC,
16585,GO:0071602,1,0.983406759352021,0,1,phytosphingosine biosynthetic process,BP,
16586,GO:0071603,1,0.936705552802973,0,4,endothelial cell-cell adhesion,BP,
16587,GO:0071604,1,0.654724422485723,0,28,transforming growth factor beta production,BP,
16588,GO:0071605,1,0.855022697844259,0,12,monocyte chemotactic protein-1 production,BP,
16589,GO:0071608,1,0.967405149355479,0,2,macrophage inflammatory protein-1 alpha production,BP,
16590,GO:0071609,1,0.885956096050173,0,8,chemokine (C-C motif) ligand 5 production,BP,
16591,GO:0071611,1,0.95484684935953,0,3,granulocyte colony-stimulating factor production,BP,
16592,GO:0071612,1,0.983406759350245,0,1,IP-10 production,BP,
16593,GO:0071613,1,0.975990650708247,0,2,granzyme B production,BP,
16594,GO:0071614,1,0.987360308246559,0,1,linoleic acid epoxygenase activity,MF,
16595,GO:0071615,1,0.983701928859783,0,1,oxidative deethylation,BP,
16598,GO:0071619,1,0.985623287502985,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16601,GO:0071623,1,0.968384722376162,0,2,negative regulation of granulocyte chemotaxis,BP,
16603,GO:0071625,1,0.763704225593391,0,17,vocalization behavior,BP,
16604,GO:0071626,1,0.979200843279489,0,2,mastication,BP,
16605,GO:0071629,1,0.988466648285194,0,1,ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome,BP,
16606,GO:0071630,1,0.952338754409655,0,3,ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome,BP,
16607,GO:0071633,1,0.976071266008188,0,2,dihydroceramidase activity,MF,
16608,GO:0071634,1,0.665790519155037,0,27,regulation of transforming growth factor beta production,BP,
16609,GO:0071635,1,0.899614122533682,0,7,negative regulation of transforming growth factor beta production,BP,
16610,GO:0071636,1,0.778329100321625,0,17,positive regulation of transforming growth factor beta production,BP,
16611,GO:0071637,1,0.855022697844259,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16612,GO:0071638,1,0.938779610004695,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16613,GO:0071639,1,0.910803402068904,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16614,GO:0071640,1,0.967405149355479,0,2,regulation of macrophage inflammatory protein 1 alpha production,BP,
16615,GO:0071641,1,0.983462167645689,0,1,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16616,GO:0071642,1,0.983674085893709,0,1,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16617,GO:0071649,1,0.896473758062318,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
16618,GO:0071650,1,0.973743920376804,0,2,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16619,GO:0071651,1,0.920654718272746,0,5,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16620,GO:0071655,1,0.95484684935953,0,3,regulation of granulocyte colony-stimulating factor production,BP,
16621,GO:0071656,1,0.985453353462232,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16622,GO:0071657,1,0.968943558303379,0,2,positive regulation of granulocyte colony-stimulating factor production,BP,
16623,GO:0071658,1,0.983406759350245,0,1,regulation of IP-10 production,BP,
16624,GO:0071660,1,0.983406759350245,0,1,positive regulation of IP-10 production,BP,
16625,GO:0071661,1,0.975990650708247,0,2,regulation of granzyme B production,BP,
16626,GO:0071663,1,0.975990650708247,0,2,positive regulation of granzyme B production,BP,
16627,GO:0071664,1,0.951230499768328,0,3,catenin-TCF7L2 complex,CC,
16628,GO:0071665,1,0.983519914615201,0,1,gamma-catenin-TCF7L2 complex,CC,
16629,GO:0071670,1,0.897399668072216,0,8,smooth muscle cell chemotaxis,BP,
16630,GO:0071671,1,0.927656884194932,0,6,regulation of smooth muscle cell chemotaxis,BP,
16631,GO:0071672,1,0.9589424480709,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16632,GO:0071673,1,0.962609076157295,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16634,GO:0071675,1,0.606378759278562,0,40,regulation of mononuclear cell migration,BP,
16635,GO:0071676,1,0.910886405148118,0,6,negative regulation of mononuclear cell migration,BP,
16636,GO:0071677,1,0.790656979786432,0,22,positive regulation of mononuclear cell migration,BP,
16637,GO:0071678,1,0.983406759351231,0,1,olfactory bulb axon guidance,BP,
16638,GO:0071679,1,0.891352563682808,0,7,commissural neuron axon guidance,BP,
16641,GO:0071682,1,0.818001581827855,0,19,endocytic vesicle lumen,CC,
16642,GO:0071684,1,0.983595118214331,0,1,organism emergence from protective structure,BP,
16644,GO:0071691,1,0.983406759351429,0,1,cardiac muscle thin filament assembly,BP,
16645,GO:0071692,1,0.918777529310234,0,6,protein localization to extracellular region,BP,
16646,GO:0071694,1,0.918777529310234,0,6,maintenance of protein location in extracellular region,BP,
16652,GO:0071701,1,0.983406759351971,0,1,regulation of MAPK export from nucleus,BP,
16657,GO:0071707,1,0.990691624215379,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16659,GO:0071711,1,0.731526747312109,0,20,basement membrane organization,BP,
16660,GO:0071712,1,0.873604657979974,0,10,ER-associated misfolded protein catabolic process,BP,
16661,GO:0071714,1,0.98340675935207,0,1,icosanoid transmembrane transporter activity,MF,
16663,GO:0071723,1,0.867257425000436,0,10,lipopeptide binding,MF,
16664,GO:0071724,1,0.943318381877445,0,4,response to diacyl bacterial lipopeptide,BP,
16665,GO:0071725,1,0.956981769872882,0,3,response to triacyl bacterial lipopeptide,BP,
16666,GO:0071726,1,0.943318381877445,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16667,GO:0071727,1,0.956981769872882,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16671,GO:0071763,1,0.923305803555721,0,5,nuclear membrane organization,BP,
16672,GO:0071765,1,0.98340675935207,0,1,nuclear inner membrane organization,BP,
16678,GO:0071787,1,0.940738965916754,0,4,endoplasmic reticulum tubular network formation,BP,
16679,GO:0071791,1,0.9681518390874,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16680,GO:0071796,1,0.990545756566838,0,1,K6-linked polyubiquitin binding,MF,
16681,GO:0071797,1,0.956054758060744,0,3,LUBAC complex,CC,
16682,GO:0071798,1,0.932869972099239,0,5,response to prostaglandin D,BP,
16683,GO:0071799,1,0.932869972099239,0,5,cellular response to prostaglandin D stimulus,BP,
16686,GO:0071802,1,0.983406759352069,0,1,negative regulation of podosome assembly,BP,
16690,GO:0071806,1,0.472561940244076,0,60,protein transmembrane transport,BP,
16691,GO:0071812,1,0.969537505990774,0,2,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16692,GO:0071813,1,0.707621896064364,0,24,lipoprotein particle binding,MF,
16693,GO:0071814,1,0.707621896064364,0,24,protein-lipid complex binding,MF,
16694,GO:0071816,1,0.94683300308539,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16695,GO:0071817,1,0.938667533428391,0,5,MMXD complex,CC,
16696,GO:0071818,1,0.957193451765245,0,3,BAT3 complex,CC,
16697,GO:0071819,1,0.995590284058631,0,1,DUBm complex,CC,
16698,GO:0071820,1,0.989558758734677,0,1,N-box binding,MF,
16699,GO:0071821,1,0.983406759351379,0,1,FANCM-MHF complex,CC,
16701,GO:0071823,1,0.982414753652273,0,2,protein-carbohydrate complex subunit organization,BP,
16702,GO:0071824,1,0.0480963711079778,0,256,protein-DNA complex subunit organization,BP,
16703,GO:0071825,1,0.61739383004349,0,38,protein-lipid complex subunit organization,BP,
16704,GO:0071826,1,0.0710154436360399,0,195,ribonucleoprotein complex subunit organization,BP,
16705,GO:0071827,1,0.647855671558561,0,35,plasma lipoprotein particle organization,BP,
16706,GO:0071830,1,0.938485163907827,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16707,GO:0071837,1,0.778792844843653,0,17,HMG box domain binding,MF,
16708,GO:0071838,1,0.929726071344116,0,6,cell proliferation in bone marrow,BP,
16709,GO:0071839,1,0.941329662129603,0,5,apoptotic process in bone marrow,BP,
16711,GO:0071846,1,0.994920233897673,0,1,actin filament debranching,BP,
16713,GO:0071848,1,0.969537505990774,0,2,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16716,GO:0071863,1,0.929616286881734,0,6,regulation of cell proliferation in bone marrow,BP,
16717,GO:0071864,1,0.929616286881734,0,6,positive regulation of cell proliferation in bone marrow,BP,
16718,GO:0071865,1,0.939798948721505,0,5,regulation of apoptotic process in bone marrow,BP,
16719,GO:0071866,1,0.939798948721505,0,5,negative regulation of apoptotic process in bone marrow,BP,
16726,GO:0071873,1,0.952653417444984,0,3,response to norepinephrine,BP,
16727,GO:0071874,1,0.968729882573751,0,2,cellular response to norepinephrine stimulus,BP,
16729,GO:0071877,1,0.913058070352674,0,6,regulation of adrenergic receptor signaling pathway,BP,
16730,GO:0071878,1,0.951039554136199,0,3,negative regulation of adrenergic receptor signaling pathway,BP,
16731,GO:0071879,1,0.953500145953773,0,3,positive regulation of adrenergic receptor signaling pathway,BP,
16733,GO:0071881,1,0.983407942944767,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16734,GO:0071882,1,0.983407942944767,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16736,GO:0071884,1,0.983406759351627,0,1,vitamin D receptor activator activity,MF,
16737,GO:0071885,1,0.977742487336825,0,2,N-terminal protein N-methyltransferase activity,MF,
16738,GO:0071886,1,0.967319441607041,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16740,GO:0071888,1,0.897989844315085,0,8,macrophage apoptotic process,BP,
16742,GO:0071890,1,0.983406759351872,0,1,bicarbonate binding,MF,
16744,GO:0071894,1,0.983493076439758,0,1,histone H2B conserved C-terminal lysine ubiquitination,BP,
16745,GO:0071895,1,0.953111617741483,0,3,odontoblast differentiation,BP,
16746,GO:0071896,1,0.935254347828344,0,4,protein localization to adherens junction,BP,
16748,GO:0071898,1,0.956946390143728,0,3,regulation of estrogen receptor binding,BP,
16749,GO:0071899,1,0.956946390143728,0,3,negative regulation of estrogen receptor binding,BP,
16753,GO:0071907,1,0.897332069859018,0,7,determination of digestive tract left/right asymmetry,BP,
16754,GO:0071908,1,0.983406759351821,0,1,determination of intestine left/right asymmetry,BP,
16755,GO:0071909,1,0.983406759351821,0,1,determination of stomach left/right asymmetry,BP,
16756,GO:0071910,1,0.905679170348091,0,6,determination of liver left/right asymmetry,BP,
16757,GO:0071914,1,0.983408772492703,0,1,prominosome,CC,
16758,GO:0071918,1,0.939735741512671,0,4,urea transmembrane transport,BP,
16759,GO:0071920,1,0.971148098493829,0,2,cleavage body,CC,
16760,GO:0071921,1,0.955999629077809,0,3,cohesin loading,BP,
16761,GO:0071922,1,0.955999629077809,0,3,regulation of cohesin loading,BP,
16762,GO:0071926,1,0.952783772824203,0,3,endocannabinoid signaling pathway,BP,
16763,GO:0071929,1,0.968679395757035,0,2,alpha-tubulin acetylation,BP,
16764,GO:0071930,1,0.951978846367525,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16765,GO:0071931,1,0.990115295674954,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16766,GO:0071933,1,0.890809625851616,0,8,Arp2/3 complex binding,MF,
16767,GO:0071934,1,0.94310419814714,0,4,thiamine transmembrane transport,BP,
16768,GO:0071936,1,0.875784514368951,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16769,GO:0071941,1,0.823625228534506,0,15,nitrogen cycle metabolic process,BP,
16770,GO:0071942,1,0.959315953015601,0,3,XPC complex,CC,
16772,GO:0071947,1,0.935621447506867,0,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16773,GO:0071949,1,0.780231395899992,0,17,FAD binding,MF,
16774,GO:0071951,1,0.984275768717627,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16775,GO:0071953,1,0.941584907122015,0,4,elastic fiber,CC,
16776,GO:0071954,1,0.983466930130704,0,1,chemokine (C-C motif) ligand 11 production,BP,
16777,GO:0071955,1,0.967087733487431,0,2,recycling endosome to Golgi transport,BP,
16778,GO:0071962,1,0.983441596143468,0,1,mitotic sister chromatid cohesion, centromeric,BP,
16780,GO:0071964,1,0.990780980970108,0,1,establishment of cell polarity regulating cell shape,BP,
16782,GO:0071976,1,0.983563418949266,0,1,cell gliding,BP,
16784,GO:0071986,1,0.91180914230147,0,6,Ragulator complex,CC,
16785,GO:0071987,1,0.95261896676881,0,3,WD40-repeat domain binding,MF,
16786,GO:0071997,1,0.983406759351574,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16788,GO:0072003,1,0.956926774932588,0,3,kidney rudiment formation,BP,
16789,GO:0072004,1,0.967088800164192,0,2,kidney field specification,BP,
16795,GO:0072011,1,0.963342195036283,0,3,glomerular endothelium development,BP,
16799,GO:0072016,1,0.984530854415234,0,1,glomerular parietal epithelial cell development,BP,
16801,GO:0072019,1,0.98613214159267,0,1,proximal convoluted tubule development,BP,
16802,GO:0072021,1,0.942919031965911,0,4,ascending thin limb development,BP,
16803,GO:0072023,1,0.975012205326965,0,2,thick ascending limb development,BP,
16804,GO:0072024,1,0.98928831151242,0,1,macula densa development,BP,
16805,GO:0072025,1,0.928572993605882,0,5,distal convoluted tubule development,BP,
16806,GO:0072027,1,0.984788095004683,0,1,connecting tubule development,BP,
16810,GO:0072036,1,0.983414835417473,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16815,GO:0072046,1,0.989493601381558,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16816,GO:0072047,1,0.936651189927435,0,5,proximal/distal pattern formation involved in nephron development,BP,
16820,GO:0072051,1,0.98928831151242,0,1,juxtaglomerular apparatus development,BP,
16823,GO:0072055,1,0.983406759351921,0,1,renal cortex development,BP,
16824,GO:0072059,1,0.983406759351921,0,1,cortical collecting duct development,BP,
16827,GO:0072069,1,0.956728214343973,0,3,DCT cell differentiation,BP,
16829,GO:0072071,1,0.976904264759243,0,2,kidney interstitial fibroblast differentiation,BP,
16838,GO:0072081,1,0.936651189927435,0,5,specification of nephron tubule identity,BP,
16839,GO:0072086,1,0.948786391858535,0,4,specification of loop of Henle identity,BP,
16844,GO:0072092,1,0.951038409342163,0,3,ureteric bud invasion,BP,
16845,GO:0072093,1,0.935262030036874,0,4,metanephric renal vesicle formation,BP,
16863,GO:0072114,1,0.967842511100186,0,2,pronephros morphogenesis,BP,
16867,GO:0072127,1,0.985664640752396,0,1,renal capsule development,BP,
16868,GO:0072128,1,0.985664640752396,0,1,renal capsule morphogenesis,BP,
16869,GO:0072129,1,0.985664640752396,0,1,renal capsule formation,BP,
16870,GO:0072130,1,0.985664640752396,0,1,renal capsule specification,BP,
16877,GO:0072137,1,0.937805272876872,0,4,condensed mesenchymal cell proliferation,BP,
16879,GO:0072139,1,0.954624045795232,0,3,glomerular parietal epithelial cell differentiation,BP,
16880,GO:0072141,1,0.976904264759243,0,2,renal interstitial fibroblast development,BP,
16890,GO:0072165,1,0.987212538075975,0,1,anterior mesonephric tubule development,BP,
16892,GO:0072167,1,0.987212538075975,0,1,specification of mesonephric tubule identity,BP,
16893,GO:0072168,1,0.987212538075975,0,1,specification of anterior mesonephric tubule identity,BP,
16894,GO:0072169,1,0.987212538075975,0,1,specification of posterior mesonephric tubule identity,BP,
16902,GO:0072177,1,0.891381827644079,0,8,mesonephric duct development,BP,
16905,GO:0072180,1,0.947482184884518,0,4,mesonephric duct morphogenesis,BP,
16906,GO:0072181,1,0.973833412188071,0,2,mesonephric duct formation,BP,
16908,GO:0072183,1,0.970865976939376,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16909,GO:0072184,1,0.987212538075975,0,1,renal vesicle progenitor cell differentiation,BP,
16910,GO:0072185,1,0.972718168716962,0,2,metanephric cap development,BP,
16911,GO:0072186,1,0.972718168716962,0,2,metanephric cap morphogenesis,BP,
16917,GO:0072194,1,0.960007882278079,0,3,kidney smooth muscle tissue development,BP,
16918,GO:0072195,1,0.988853451736982,0,1,kidney smooth muscle cell differentiation,BP,
16926,GO:0072204,1,0.967443458046139,0,2,cell-cell signaling involved in metanephros development,BP,
16928,GO:0072206,1,0.98928831151242,0,1,metanephric juxtaglomerular apparatus development,BP,
16930,GO:0072208,1,0.970830615954817,0,2,metanephric smooth muscle tissue development,BP,
16933,GO:0072213,1,0.985664640752396,0,1,metanephric capsule development,BP,
16934,GO:0072214,1,0.983406759351921,0,1,metanephric cortex development,BP,
16938,GO:0072218,1,0.942919031965911,0,4,metanephric ascending thin limb development,BP,
16939,GO:0072219,1,0.983406759351921,0,1,metanephric cortical collecting duct development,BP,
16940,GO:0072221,1,0.928572993605882,0,5,metanephric distal convoluted tubule development,BP,
16943,GO:0072227,1,0.98928831151242,0,1,metanephric macula densa development,BP,
16944,GO:0072229,1,0.98613214159267,0,1,metanephric proximal convoluted tubule development,BP,
16945,GO:0072233,1,0.975012205326965,0,2,metanephric thick ascending limb development,BP,
16947,GO:0072235,1,0.89800232425866,0,7,metanephric distal tubule development,BP,
16949,GO:0072237,1,0.969768074556681,0,2,metanephric proximal tubule development,BP,
16951,GO:0072240,1,0.956728214343973,0,3,metanephric DCT cell differentiation,BP,
16953,GO:0072244,1,0.954811332014157,0,3,metanephric glomerular epithelium development,BP,
16954,GO:0072248,1,0.954811332014157,0,3,metanephric glomerular visceral epithelial cell differentiation,BP,
16955,GO:0072249,1,0.954811332014157,0,3,metanephric glomerular visceral epithelial cell development,BP,
16959,GO:0072258,1,0.987212538075975,0,1,metanephric interstitial fibroblast differentiation,BP,
16960,GO:0072259,1,0.987212538075975,0,1,metanephric interstitial fibroblast development,BP,
16962,GO:0072265,1,0.985664640752396,0,1,metanephric capsule morphogenesis,BP,
16963,GO:0072266,1,0.985664640752396,0,1,metanephric capsule formation,BP,
16964,GO:0072267,1,0.985664640752396,0,1,metanephric capsule specification,BP,
16965,GO:0072268,1,0.945818436445786,0,4,pattern specification involved in metanephros development,BP,
16966,GO:0072272,1,0.972007616061978,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16968,GO:0072274,1,0.983406759351725,0,1,metanephric glomerular basement membrane development,BP,
16969,GO:0072275,1,0.953317720462994,0,3,metanephric glomerulus morphogenesis,BP,
16970,GO:0072276,1,0.953317720462994,0,3,metanephric glomerulus vasculature morphogenesis,BP,
16971,GO:0072277,1,0.953317720462994,0,3,metanephric glomerular capillary formation,BP,
16973,GO:0072282,1,0.886833966930159,0,8,metanephric nephron tubule morphogenesis,BP,
16976,GO:0072285,1,0.983414835417473,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16977,GO:0072286,1,0.984788095004683,0,1,metanephric connecting tubule development,BP,
16978,GO:0072287,1,0.983406759349757,0,1,metanephric distal tubule morphogenesis,BP,
16979,GO:0072289,1,0.935623861567696,0,4,metanephric nephron tubule formation,BP,
16982,GO:0072300,1,0.920565033408677,0,5,positive regulation of metanephric glomerulus development,BP,
16985,GO:0072303,1,0.983697909677509,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16986,GO:0072304,1,0.967088800164192,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16987,GO:0072305,1,0.967088800164192,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16989,GO:0072308,1,0.983442576502009,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16990,GO:0072309,1,0.967088800164192,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16993,GO:0072312,1,0.954811332014157,0,3,metanephric glomerular epithelial cell differentiation,BP,
16994,GO:0072313,1,0.954811332014157,0,3,metanephric glomerular epithelial cell development,BP,
16995,GO:0072318,1,0.90972858655116,0,6,clathrin coat disassembly,BP,
16996,GO:0072319,1,0.896957708020424,0,7,vesicle uncoating,BP,
16998,GO:0072321,1,0.90303456743156,0,9,chaperone-mediated protein transport,BP,
17003,GO:0072334,1,0.979341034141075,0,2,UDP-galactose transmembrane transport,BP,
17004,GO:0072337,1,0.689338996632626,0,26,modified amino acid transport,BP,
17005,GO:0072338,1,0.908858851812244,0,6,cellular lactam metabolic process,BP,
17006,GO:0072340,1,0.988182873842877,0,1,cellular lactam catabolic process,BP,
17008,GO:0072343,1,0.978099478041645,0,2,pancreatic stellate cell proliferation,BP,
17009,GO:0072344,1,0.983632513687431,0,1,rescue of stalled ribosome,BP,
17010,GO:0072345,1,0.944007703892014,0,4,NAADP-sensitive calcium-release channel activity,MF,
17011,GO:0072348,1,0.589009221242794,0,34,sulfur compound transport,BP,
17012,GO:0072349,1,0.756068683637915,0,18,modified amino acid transmembrane transporter activity,MF,
17013,GO:0072350,1,0.587985427920043,0,38,tricarboxylic acid metabolic process,BP,
17014,GO:0072354,1,0.972495054456853,0,2,histone kinase activity (H3-T3 specific),MF,
17015,GO:0072355,1,0.972495054456853,0,2,histone H3-T3 phosphorylation,BP,
17016,GO:0072356,1,0.967861443986473,0,2,chromosome passenger complex localization to kinetochore,BP,
17017,GO:0072357,1,0.896301867485439,0,7,PTW/PP1 phosphatase complex,CC,
17020,GO:0072361,1,0.967087733485932,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
17021,GO:0072362,1,0.983406759351183,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
17022,GO:0072363,1,0.983406759350691,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
17023,GO:0072364,1,0.967087733485738,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17024,GO:0072365,1,0.983406759350987,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
17025,GO:0072366,1,0.983406759350691,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
17026,GO:0072367,1,0.935738915604384,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
17027,GO:0072368,1,0.967087733487287,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
17028,GO:0072369,1,0.967588725522779,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
17029,GO:0072376,1,0.340480585192333,0,79,protein activation cascade,BP,
17030,GO:0072377,1,0.983947286250032,0,1,blood coagulation, common pathway,BP,
17031,GO:0072378,1,0.689975635167354,0,27,blood coagulation, fibrin clot formation,BP,
17032,GO:0072379,1,0.957193451765245,0,3,ER membrane insertion complex,CC,
17033,GO:0072383,1,0.875127719571317,0,8,plus-end-directed vesicle transport along microtubule,BP,
17034,GO:0072384,1,0.367327145279328,0,66,organelle transport along microtubule,BP,
17035,GO:0072385,1,0.951207394981001,0,3,minus-end-directed organelle transport along microtubule,BP,
17036,GO:0072386,1,0.860598561427303,0,9,plus-end-directed organelle transport along microtubule,BP,
17037,GO:0072387,1,0.970462776378409,0,2,flavin adenine dinucleotide metabolic process,BP,
17038,GO:0072388,1,0.986837428914268,0,1,flavin adenine dinucleotide biosynthetic process,BP,
17039,GO:0072389,1,0.983407843952928,0,1,flavin adenine dinucleotide catabolic process,BP,
17040,GO:0072393,1,0.876071822287776,0,8,microtubule anchoring at microtubule organizing center,BP,
17042,GO:0072396,1,0.909156833213348,0,6,response to cell cycle checkpoint signaling,BP,
17044,GO:0072402,1,0.909156833213348,0,6,response to DNA integrity checkpoint signaling,BP,
17046,GO:0072414,1,0.983406759351379,0,1,response to mitotic cell cycle checkpoint signaling,BP,
17048,GO:0072423,1,0.909156833213348,0,6,response to DNA damage checkpoint signaling,BP,
17049,GO:0072425,1,0.967544390091587,0,2,signal transduction involved in G2 DNA damage checkpoint,BP,
17050,GO:0072428,1,0.987321906705523,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
17051,GO:0072429,1,0.940105623953892,0,4,response to intra-S DNA damage checkpoint signaling,BP,
17053,GO:0072432,1,0.983406759351379,0,1,response to G1 DNA damage checkpoint signaling,BP,
17054,GO:0072434,1,0.967544390091587,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
17055,GO:0072487,1,0.93845927122988,0,4,MSL complex,CC,
17056,GO:0072488,1,0.769578077796109,0,18,ammonium transmembrane transport,BP,
17057,GO:0072492,1,0.987891692314826,0,1,host cell mitochondrial intermembrane space,CC,
17060,GO:0072501,1,0.869532049641071,0,9,cellular divalent inorganic anion homeostasis,BP,
17061,GO:0072502,1,0.869532049641071,0,9,cellular trivalent inorganic anion homeostasis,BP,
17063,GO:0072505,1,0.82767640378958,0,12,divalent inorganic anion homeostasis,BP,
17064,GO:0072506,1,0.82767640378958,0,12,trivalent inorganic anion homeostasis,BP,
17070,GO:0072513,1,0.946185177030752,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
17071,GO:0072517,1,0.98348594567814,0,1,host cell viral assembly compartment,CC,
17072,GO:0072518,1,0.983406759351574,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
17073,GO:0072520,1,0.858913739106821,0,10,seminiferous tubule development,BP,
17078,GO:0072525,1,0.655182185042595,0,29,pyridine-containing compound biosynthetic process,BP,
17079,GO:0072526,1,0.938698906506103,0,5,pyridine-containing compound catabolic process,BP,
17080,GO:0072527,1,0.378754171881648,0,75,pyrimidine-containing compound metabolic process,BP,
17081,GO:0072528,1,0.60904704510983,0,39,pyrimidine-containing compound biosynthetic process,BP,
17082,GO:0072529,1,0.681757068604707,0,31,pyrimidine-containing compound catabolic process,BP,
17083,GO:0072530,1,0.875601551884565,0,9,purine-containing compound transmembrane transport,BP,
17084,GO:0072531,1,0.819994698194917,0,14,pyrimidine-containing compound transmembrane transport,BP,
17085,GO:0072534,1,0.967087733487045,0,2,perineuronal net,CC,
17086,GO:0072535,1,0.960551022440392,0,3,tumor necrosis factor (ligand) superfamily member 11 production,BP,
17087,GO:0072536,1,0.971124208501899,0,2,interleukin-23 receptor complex,CC,
17088,GO:0072537,1,0.854300835383962,0,10,fibroblast activation,BP,
17089,GO:0072538,1,0.758633496795052,0,21,T-helper 17 type immune response,BP,
17090,GO:0072539,1,0.781766995626188,0,19,T-helper 17 cell differentiation,BP,
17091,GO:0072540,1,0.858715295728971,0,12,T-helper 17 cell lineage commitment,BP,
17092,GO:0072542,1,0.906371954853331,0,7,protein phosphatase activator activity,MF,
17093,GO:0072544,1,0.988172320962222,0,1,L-DOPA binding,MF,
17094,GO:0072545,1,0.97438960831268,0,2,tyrosine binding,MF,
17095,GO:0072546,1,0.776951805757657,0,18,ER membrane protein complex,CC,
17096,GO:0072553,1,0.912742252558895,0,6,terminal button organization,BP,
17097,GO:0072554,1,0.969080766458201,0,2,blood vessel lumenization,BP,
17098,GO:0072556,1,0.983406759352069,0,1,other organism presynaptic membrane,CC,
17099,GO:0072557,1,0.966160074780685,0,3,IPAF inflammasome complex,CC,
17100,GO:0072558,1,0.960159157388146,0,4,NLRP1 inflammasome complex,CC,
17101,GO:0072559,1,0.930849174428831,0,6,NLRP3 inflammasome complex,CC,
17102,GO:0072560,1,0.975535832326748,0,2,type B pancreatic cell maturation,BP,
17104,GO:0072563,1,0.97255328678827,0,2,endothelial microparticle,CC,
17105,GO:0072564,1,0.974911656379434,0,2,blood microparticle formation,BP,
17106,GO:0072566,1,0.971607866918115,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
17107,GO:0072567,1,0.875623979344654,0,10,chemokine (C-X-C motif) ligand 2 production,BP,
17108,GO:0072572,1,0.986128156026328,0,1,poly-ADP-D-ribose binding,MF,
17109,GO:0072573,1,0.983406759352021,0,1,tolerance induction to lipopolysaccharide,BP,
17114,GO:0072578,1,0.883508786451399,0,8,neurotransmitter-gated ion channel clustering,BP,
17115,GO:0072579,1,0.98340675935207,0,1,glycine receptor clustering,BP,
17118,GO:0072586,1,0.983406759352021,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
17119,GO:0072587,1,0.983406759352021,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
17120,GO:0072588,1,0.956788082847872,0,5,box H/ACA RNP complex,CC,
17121,GO:0072589,1,0.966359467656932,0,4,box H/ACA scaRNP complex,CC,
17122,GO:0072590,1,0.967087733486317,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
17123,GO:0072591,1,0.983406759351725,0,1,citrate-L-glutamate ligase activity,MF,
17124,GO:0072592,1,0.937723662625002,0,5,oxygen metabolic process,BP,
17128,GO:0072599,1,0.436426849911467,0,104,establishment of protein localization to endoplasmic reticulum,BP,
17129,GO:0072600,1,0.692461915013631,0,22,establishment of protein localization to Golgi,BP,
17131,GO:0072603,1,0.917873956410473,0,6,interleukin-5 secretion,BP,
17134,GO:0072608,1,0.900130179734406,0,8,interleukin-10 secretion,BP,
17135,GO:0072610,1,0.88240794938931,0,9,interleukin-12 secretion,BP,
17136,GO:0072611,1,0.901414686115596,0,8,interleukin-13 secretion,BP,
17137,GO:0072615,1,0.98609242153372,0,1,interleukin-17 secretion,BP,
17138,GO:0072616,1,0.983406759403497,0,1,interleukin-18 secretion,BP,
17139,GO:0072619,1,0.983444463922309,0,1,interleukin-21 secretion,BP,
17140,GO:0072641,1,0.955445934501757,0,3,type I interferon secretion,BP,
17141,GO:0072642,1,0.970925919472914,0,2,interferon-alpha secretion,BP,
17142,GO:0072643,1,0.770957438065376,0,17,interferon-gamma secretion,BP,
17146,GO:0072658,1,0.983406759350691,0,1,maintenance of protein location in membrane,BP,
17148,GO:0072660,1,0.983406759350691,0,1,maintenance of protein location in plasma membrane,BP,
17150,GO:0072662,1,0.771626363420461,0,17,protein localization to peroxisome,BP,
17151,GO:0072663,1,0.771626363420461,0,17,establishment of protein localization to peroxisome,BP,
17153,GO:0072666,1,0.630655945665582,0,31,establishment of protein localization to vacuole,BP,
17154,GO:0072669,1,0.931496682135294,0,7,tRNA-splicing ligase complex,CC,
17155,GO:0072671,1,0.984751175989133,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
17157,GO:0072673,1,0.801908010859351,0,14,lamellipodium morphogenesis,BP,
17158,GO:0072674,1,0.937764961880062,0,4,multinuclear osteoclast differentiation,BP,
17159,GO:0072675,1,0.952313961941642,0,3,osteoclast fusion,BP,
17161,GO:0072677,1,0.848826544652001,0,15,eosinophil migration,BP,
17164,GO:0072680,1,0.983681235131478,0,1,extracellular matrix-dependent thymocyte migration,BP,
17165,GO:0072681,1,0.983681235131478,0,1,fibronectin-dependent thymocyte migration,BP,
17166,GO:0072682,1,0.983498522917573,0,1,eosinophil extravasation,BP,
17167,GO:0072683,1,0.954422592182739,0,4,T cell extravasation,BP,
17168,GO:0072684,1,0.983409634916451,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17169,GO:0072686,1,0.369370007064753,0,65,mitotic spindle,CC,
17170,GO:0072687,1,0.894627777658204,0,8,meiotic spindle,CC,
17171,GO:0072695,1,0.970452440651666,0,2,regulation of DNA recombination at telomere,BP,
17172,GO:0072697,1,0.974723143068208,0,2,protein localization to cell cortex,BP,
17173,GO:0072698,1,0.594594946837301,0,33,protein localization to microtubule cytoskeleton,BP,
17174,GO:0072702,1,0.983406759351775,0,1,response to methyl methanesulfonate,BP,
17175,GO:0072703,1,0.983406759351775,0,1,cellular response to methyl methanesulfonate,BP,
17176,GO:0072706,1,0.984700197831977,0,1,response to sodium dodecyl sulfate,BP,
17177,GO:0072707,1,0.984700197831977,0,1,cellular response to sodium dodecyl sulfate,BP,
17178,GO:0072708,1,0.94122268900514,0,4,response to sorbitol,BP,
17179,GO:0072709,1,0.970945620564294,0,2,cellular response to sorbitol,BP,
17180,GO:0072710,1,0.892760574035393,0,7,response to hydroxyurea,BP,
17181,GO:0072711,1,0.906614194729928,0,6,cellular response to hydroxyurea,BP,
17182,GO:0072714,1,0.987958491802573,0,1,response to selenite ion,BP,
17183,GO:0072715,1,0.987958491802573,0,1,cellular response to selenite ion,BP,
17184,GO:0072716,1,0.949247298833818,0,4,response to actinomycin D,BP,
17185,GO:0072717,1,0.963973698437456,0,3,cellular response to actinomycin D,BP,
17186,GO:0072718,1,0.870309941043313,0,9,response to cisplatin,BP,
17187,GO:0072719,1,0.912985464415104,0,6,cellular response to cisplatin,BP,
17188,GO:0072720,1,0.969683443564638,0,2,response to dithiothreitol,BP,
17189,GO:0072721,1,0.984725543253726,0,1,cellular response to dithiothreitol,BP,
17190,GO:0072733,1,0.945157301583194,0,4,response to staurosporine,BP,
17191,GO:0072734,1,0.945157301583194,0,4,cellular response to staurosporine,BP,
17192,GO:0072737,1,0.970934550403092,0,2,response to diamide,BP,
17193,GO:0072738,1,0.970934550403092,0,2,cellular response to diamide,BP,
17194,GO:0072739,1,0.984725543253726,0,1,response to anisomycin,BP,
17195,GO:0072750,1,0.990583696333685,0,1,cellular response to leptomycin B,BP,
17196,GO:0072752,1,0.983406759351528,0,1,cellular response to rapamycin,BP,
17197,GO:0072755,1,0.983413137854219,0,1,cellular response to benomyl,BP,
17198,GO:0072757,1,0.953310528538853,0,3,cellular response to camptothecin,BP,
17199,GO:0075136,1,0.917663491833967,0,6,response to host,BP,
17200,GO:0075509,1,0.952262832346246,0,3,endocytosis involved in viral entry into host cell,BP,
17201,GO:0075519,1,0.994647465757837,0,1,microtubule-dependent intracellular transport of viral material,BP,
17202,GO:0075521,1,0.994647465757837,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17203,GO:0075522,1,0.904686395192097,0,7,IRES-dependent viral translational initiation,BP,
17204,GO:0075525,1,0.934347002763661,0,5,viral translational termination-reinitiation,BP,
17205,GO:0075528,1,0.975415942898039,0,2,modulation by virus of host immune response,BP,
17206,GO:0075606,1,0.994647465757837,0,1,transport of viral material towards nucleus,BP,
17207,GO:0075713,1,0.894205959431102,0,8,establishment of integrated proviral latency,BP,
17208,GO:0075732,1,0.96708773348782,0,2,viral penetration into host nucleus,BP,
17210,GO:0080008,1,0.670347673915038,0,26,Cul4-RING E3 ubiquitin ligase complex,CC,
17211,GO:0080009,1,0.945707477683692,0,4,mRNA methylation,BP,
17212,GO:0080019,1,0.969919214475995,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17213,GO:0080025,1,0.739636179196696,0,20,phosphatidylinositol-3,5-bisphosphate binding,MF,
17214,GO:0080033,1,0.983406759351575,0,1,response to nitrite,BP,
17215,GO:0080048,1,0.984725543253726,0,1,GDP-D-glucose phosphorylase activity,MF,
17216,GO:0080058,1,0.990115295674954,0,1,protein deglutathionylation,BP,
17217,GO:0080084,1,0.925385531328306,0,5,5S rDNA binding,MF,
17219,GO:0080101,1,0.992519644739583,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17220,GO:0080111,1,0.788702147403146,0,18,DNA demethylation,BP,
17221,GO:0080120,1,0.962354050784948,0,3,CAAX-box protein maturation,BP,
17222,GO:0080121,1,0.969582674838051,0,2,AMP transport,BP,
17223,GO:0080122,1,0.969582674838051,0,2,AMP transmembrane transporter activity,MF,
17224,GO:0080129,1,0.991844660287456,0,1,proteasome core complex assembly,BP,
17225,GO:0080130,1,0.956101771139334,0,3,L-phenylalanine:2-oxoglutarate aminotransferase activity,MF,
17226,GO:0080132,1,0.985110386459961,0,1,fatty acid alpha-hydroxylase activity,MF,
17229,GO:0080144,1,0.987226716273809,0,1,amino acid homeostasis,BP,
17230,GO:0080146,1,0.987935314300946,0,1,L-cysteine desulfhydrase activity,MF,
17231,GO:0080147,1,0.99404187805355,0,1,root hair cell development,BP,
17232,GO:0080154,1,0.75977061996652,0,25,regulation of fertilization,BP,
17233,GO:0080163,1,0.985216084636704,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17235,GO:0080182,1,0.837739999009764,0,13,histone H3-K4 trimethylation,BP,
17236,GO:0080184,1,0.937003452469215,0,5,response to phenylpropanoid,BP,
17237,GO:0085018,1,0.984267498897298,0,1,maintenance of symbiont-containing vacuole by host,BP,
17238,GO:0085020,1,0.912991828045623,0,7,protein K6-linked ubiquitination,BP,
17240,GO:0085032,1,0.983574937889037,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17246,GO:0086006,1,0.926480837030841,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17247,GO:0086007,1,0.919732573222572,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17252,GO:0086012,1,0.709254400937759,0,22,membrane depolarization during cardiac muscle cell action potential,BP,
17254,GO:0086014,1,0.744399209751337,0,18,atrial cardiac muscle cell action potential,BP,
17255,GO:0086015,1,0.860968125453844,0,9,SA node cell action potential,BP,
17256,GO:0086016,1,0.847455369261663,0,10,AV node cell action potential,BP,
17257,GO:0086017,1,0.942368202032858,0,4,Purkinje myocyte action potential,BP,
17258,GO:0086018,1,0.860968125453844,0,9,SA node cell to atrial cardiac muscle cell signalling,BP,
17260,GO:0086020,1,0.967345105906965,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17261,GO:0086021,1,0.967345105906965,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17263,GO:0086024,1,0.983406759351134,0,1,adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17264,GO:0086026,1,0.744399209751337,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
17265,GO:0086027,1,0.847455369261663,0,10,AV node cell to bundle of His cell signaling,BP,
17266,GO:0086028,1,0.899590272524818,0,7,bundle of His cell to Purkinje myocyte signaling,BP,
17269,GO:0086036,1,0.905067172399772,0,7,regulation of cardiac muscle cell membrane potential,BP,
17270,GO:0086037,1,0.983443827595652,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17271,GO:0086039,1,0.983406759351084,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17272,GO:0086040,1,0.983406759352018,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17273,GO:0086041,1,0.98340675935133,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17275,GO:0086043,1,0.899590272524818,0,7,bundle of His cell action potential,BP,
17276,GO:0086044,1,0.983668456749255,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
17277,GO:0086045,1,0.919731182613778,0,5,membrane depolarization during AV node cell action potential,BP,
17278,GO:0086046,1,0.919731182613499,0,5,membrane depolarization during SA node cell action potential,BP,
17279,GO:0086047,1,0.958016853858206,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17280,GO:0086048,1,0.951039847090163,0,3,membrane depolarization during bundle of His cell action potential,BP,
17281,GO:0086050,1,0.984065276371003,0,1,membrane repolarization during bundle of His cell action potential,BP,
17282,GO:0086052,1,0.984065276371003,0,1,membrane repolarization during SA node cell action potential,BP,
17283,GO:0086053,1,0.967345105906965,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
17284,GO:0086054,1,0.983668456749255,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
17285,GO:0086055,1,0.983668456749255,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
17286,GO:0086056,1,0.951038409342018,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17287,GO:0086057,1,0.983408245826825,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17288,GO:0086059,1,0.967087733486561,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17289,GO:0086060,1,0.983406759351034,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17290,GO:0086061,1,0.983406759351034,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17291,GO:0086062,1,0.974183452737341,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17292,GO:0086063,1,0.983406759351034,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17293,GO:0086064,1,0.701860932577857,0,23,cell communication by electrical coupling involved in cardiac conduction,BP,
17295,GO:0086066,1,0.744399209751337,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
17296,GO:0086067,1,0.833383780238927,0,11,AV node cell to bundle of His cell communication,BP,
17299,GO:0086070,1,0.846673092224751,0,10,SA node cell to atrial cardiac muscle cell communication,BP,
17300,GO:0086072,1,0.984973932989906,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17302,GO:0086075,1,0.951580036843758,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17303,GO:0086076,1,0.983668456749255,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
17304,GO:0086077,1,0.967345105906965,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17305,GO:0086078,1,0.983668456749255,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
17306,GO:0086079,1,0.983668456749255,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
17308,GO:0086082,1,0.984973932989906,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17310,GO:0086087,1,0.984065276371003,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17311,GO:0086089,1,0.937305547120802,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17312,GO:0086090,1,0.984065276371003,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17314,GO:0086092,1,0.971717655030404,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17316,GO:0086098,1,0.968110060610812,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17317,GO:0086100,1,0.967090341150694,0,2,endothelin receptor signaling pathway,BP,
17319,GO:0089700,1,0.935483483383741,0,4,protein kinase D signaling,BP,
17320,GO:0089701,1,0.945085221380014,0,5,U2AF,CC,
17321,GO:0089709,1,0.969449584215117,0,2,L-histidine transmembrane transport,BP,
17322,GO:0089711,1,0.79992906163599,0,14,L-glutamate transmembrane transport,BP,
17323,GO:0089712,1,0.940656002065271,0,4,L-aspartate transmembrane transport,BP,
17324,GO:0089717,1,0.951099703988503,0,3,spanning component of membrane,CC,
17325,GO:0089718,1,0.983406759351282,0,1,amino acid import across plasma membrane,BP,
17326,GO:0089720,1,0.928155649335057,0,6,caspase binding,MF,
17332,GO:0090010,1,0.986355974988371,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17335,GO:0090024,1,0.968384722376162,0,2,negative regulation of neutrophil chemotaxis,BP,
17336,GO:0090025,1,0.775638314047009,0,22,regulation of monocyte chemotaxis,BP,
17337,GO:0090026,1,0.839340147904783,0,17,positive regulation of monocyte chemotaxis,BP,
17338,GO:0090027,1,0.939406599609793,0,4,negative regulation of monocyte chemotaxis,BP,
17342,GO:0090034,1,0.972285208553926,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17343,GO:0090035,1,0.972285208553926,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17346,GO:0090038,1,0.967398685499799,0,2,negative regulation of protein kinase C signaling,BP,
17347,GO:0090042,1,0.900795727710709,0,7,tubulin deacetylation,BP,
17348,GO:0090043,1,0.92811372670364,0,5,regulation of tubulin deacetylation,BP,
17349,GO:0090044,1,0.988691573711516,0,1,positive regulation of tubulin deacetylation,BP,
17350,GO:0090045,1,0.901198188721192,0,7,positive regulation of deacetylase activity,BP,
17352,GO:0090050,1,0.904609062164379,0,7,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17354,GO:0090063,1,0.938256107206762,0,4,positive regulation of microtubule nucleation,BP,
17355,GO:0090065,1,0.983406759352117,0,1,regulation of production of siRNA involved in RNA interference,BP,
17358,GO:0090069,1,0.8511530342237,0,10,regulation of ribosome biogenesis,BP,
17359,GO:0090070,1,0.90825983940193,0,6,positive regulation of ribosome biogenesis,BP,
17360,GO:0090071,1,0.937149283679951,0,4,negative regulation of ribosome biogenesis,BP,
17361,GO:0090073,1,0.900515434414777,0,8,positive regulation of protein homodimerization activity,BP,
17362,GO:0090074,1,0.92847530629039,0,5,negative regulation of protein homodimerization activity,BP,
17364,GO:0090076,1,0.967133468273832,0,2,relaxation of skeletal muscle,BP,
17365,GO:0090077,1,0.620714496144424,0,34,foam cell differentiation,BP,
17366,GO:0090079,1,0.730456071781836,0,20,translation regulator activity, nucleic acid binding,MF,
17367,GO:0090080,1,0.929377717774485,0,5,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17368,GO:0090081,1,0.979156503137794,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17369,GO:0090082,1,0.979156503137794,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17370,GO:0090083,1,0.788184891051268,0,16,regulation of inclusion body assembly,BP,
17371,GO:0090084,1,0.845075378030941,0,11,negative regulation of inclusion body assembly,BP,
17372,GO:0090085,1,0.899692700238364,0,8,regulation of protein deubiquitination,BP,
17373,GO:0090086,1,0.97078791016473,0,3,negative regulation of protein deubiquitination,BP,
17375,GO:0090088,1,0.973001272191829,0,2,regulation of oligopeptide transport,BP,
17376,GO:0090089,1,0.973001272191829,0,2,regulation of dipeptide transport,BP,
17378,GO:0090091,1,0.920701489015173,0,5,positive regulation of extracellular matrix disassembly,BP,
17380,GO:0090094,1,0.972718168716962,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17381,GO:0090095,1,0.985318661920075,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17382,GO:0090096,1,0.985318661920075,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17387,GO:0090104,1,0.983462499175671,0,1,pancreatic epsilon cell differentiation,BP,
17388,GO:0090107,1,0.960481667521296,0,3,regulation of high-density lipoprotein particle assembly,BP,
17389,GO:0090108,1,0.986410205054556,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17391,GO:0090110,1,0.921930755901022,0,5,cargo loading into COPII-coated vesicle,BP,
17392,GO:0090113,1,0.986017784658162,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17393,GO:0090114,1,0.38514505684582,0,66,COPII-coated vesicle budding,BP,
17394,GO:0090116,1,0.95103845435099,0,3,C-5 methylation of cytosine,BP,
17395,GO:0090118,1,0.925020161866088,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17396,GO:0090119,1,0.970272664416973,0,2,vesicle-mediated cholesterol transport,BP,
17397,GO:0090122,1,0.986645210656104,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17398,GO:0090128,1,0.837998514169539,0,11,regulation of synapse maturation,BP,
17399,GO:0090129,1,0.880246327353078,0,8,positive regulation of synapse maturation,BP,
17405,GO:0090135,1,0.957154544782619,0,3,actin filament branching,BP,
17408,GO:0090140,1,0.751220046727149,0,19,regulation of mitochondrial fission,BP,
17409,GO:0090141,1,0.842077613859379,0,12,positive regulation of mitochondrial fission,BP,
17410,GO:0090148,1,0.83862736801684,0,11,membrane fission,BP,
17411,GO:0090149,1,0.969083680122008,0,2,mitochondrial membrane fission,BP,
17413,GO:0090151,1,0.848452322398176,0,15,establishment of protein localization to mitochondrial membrane,BP,
17414,GO:0090152,1,0.984533295947894,0,1,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission,BP,
17415,GO:0090153,1,0.832564553126608,0,13,regulation of sphingolipid biosynthetic process,BP,
17416,GO:0090154,1,0.888552914022382,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17417,GO:0090155,1,0.947195050588576,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17418,GO:0090156,1,0.963179790765586,0,3,cellular sphingolipid homeostasis,BP,
17419,GO:0090158,1,0.955769517539953,0,3,endoplasmic reticulum membrane organization,BP,
17420,GO:0090160,1,0.921005871082969,0,5,Golgi to lysosome transport,BP,
17421,GO:0090161,1,0.836498352167395,0,11,Golgi ribbon formation,BP,
17423,GO:0090164,1,0.968102075220272,0,2,asymmetric Golgi ribbon formation,BP,
17424,GO:0090166,1,0.918687243815235,0,6,Golgi disassembly,BP,
17425,GO:0090168,1,0.945050226791629,0,4,Golgi reassembly,BP,
17426,GO:0090169,1,0.793287110952552,0,16,regulation of spindle assembly,BP,
17427,GO:0090170,1,0.944522772552075,0,4,regulation of Golgi inheritance,BP,
17428,GO:0090171,1,0.983409117130476,0,1,chondrocyte morphogenesis,BP,
17431,GO:0090176,1,0.983406759351773,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17435,GO:0090181,1,0.713403575429003,0,23,regulation of cholesterol metabolic process,BP,
17436,GO:0090182,1,0.97549240554016,0,2,regulation of secretion of lysosomal enzymes,BP,
17441,GO:0090187,1,0.98246821596184,0,2,positive regulation of pancreatic juice secretion,BP,
17449,GO:0090195,1,0.825145138492891,0,13,chemokine secretion,BP,
17450,GO:0090196,1,0.839046013765556,0,12,regulation of chemokine secretion,BP,
17451,GO:0090197,1,0.852669455546648,0,11,positive regulation of chemokine secretion,BP,
17452,GO:0090198,1,0.984033063780969,0,1,negative regulation of chemokine secretion,BP,
17457,GO:0090204,1,0.966599073850881,0,3,protein localization to nuclear pore,BP,
17458,GO:0090205,1,0.906731560975942,0,6,positive regulation of cholesterol metabolic process,BP,
17459,GO:0090206,1,0.940287248074578,0,5,negative regulation of cholesterol metabolic process,BP,
17461,GO:0090208,1,0.781086262894225,0,19,positive regulation of triglyceride metabolic process,BP,
17463,GO:0090210,1,0.968202874771585,0,2,regulation of establishment of blood-brain barrier,BP,
17464,GO:0090212,1,0.968202874771585,0,2,negative regulation of establishment of blood-brain barrier,BP,
17465,GO:0090214,1,0.968396713167961,0,3,spongiotrophoblast layer developmental growth,BP,
17467,GO:0090219,1,0.95294839029917,0,3,negative regulation of lipid kinase activity,BP,
17468,GO:0090220,1,0.830639559024523,0,12,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17469,GO:0090222,1,0.983406759351481,0,1,centrosome-templated microtubule nucleation,BP,
17471,GO:0090230,1,0.915117265728979,0,6,regulation of centromere complex assembly,BP,
17472,GO:0090231,1,0.790976745948762,0,16,regulation of spindle checkpoint,BP,
17473,GO:0090232,1,0.889336641050212,0,8,positive regulation of spindle checkpoint,BP,
17474,GO:0090233,1,0.98442891536618,0,1,negative regulation of spindle checkpoint,BP,
17475,GO:0090234,1,0.952817244961506,0,3,regulation of kinetochore assembly,BP,
17476,GO:0090235,1,0.970653484562713,0,2,regulation of metaphase plate congression,BP,
17477,GO:0090237,1,0.924472840602901,0,6,regulation of arachidonic acid secretion,BP,
17478,GO:0090238,1,0.94007570835437,0,5,positive regulation of arachidonic acid secretion,BP,
17479,GO:0090239,1,0.846735396749605,0,12,regulation of histone H4 acetylation,BP,
17480,GO:0090240,1,0.912408473396092,0,7,positive regulation of histone H4 acetylation,BP,
17481,GO:0090241,1,0.934621396320763,0,5,negative regulation of histone H4 acetylation,BP,
17482,GO:0090244,1,0.94249176746551,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17483,GO:0090245,1,0.921397674355568,0,5,axis elongation involved in somitogenesis,BP,
17484,GO:0090246,1,0.983406759352021,0,1,convergent extension involved in somitogenesis,BP,
17485,GO:0090247,1,0.984643899909647,0,1,cell motility involved in somitogenic axis elongation,BP,
17486,GO:0090249,1,0.984643899909647,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17487,GO:0090251,1,0.983406759350344,0,1,protein localization involved in establishment of planar polarity,BP,
17489,GO:0090258,1,0.952065348949587,0,3,negative regulation of mitochondrial fission,BP,
17490,GO:0090259,1,0.921477560452837,0,5,regulation of retinal ganglion cell axon guidance,BP,
17491,GO:0090260,1,0.967087733488015,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17492,GO:0090261,1,0.950985584181638,0,4,positive regulation of inclusion body assembly,BP,
17494,GO:0090264,1,0.979274202728636,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17495,GO:0090265,1,0.979274202728636,0,2,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17496,GO:0090266,1,0.830929030387889,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17497,GO:0090267,1,0.90420145576344,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17498,GO:0090269,1,0.910252954752341,0,6,fibroblast growth factor production,BP,
17499,GO:0090270,1,0.910252954752341,0,6,regulation of fibroblast growth factor production,BP,
17500,GO:0090271,1,0.952313961943264,0,3,positive regulation of fibroblast growth factor production,BP,
17501,GO:0090272,1,0.955841575150375,0,3,negative regulation of fibroblast growth factor production,BP,
17502,GO:0090273,1,0.979730937713921,0,2,regulation of somatostatin secretion,BP,
17503,GO:0090274,1,0.979730937713921,0,2,positive regulation of somatostatin secretion,BP,
17505,GO:0090277,1,0.326646541462539,0,83,positive regulation of peptide hormone secretion,BP,
17510,GO:0090283,1,0.95630976897138,0,3,regulation of protein glycosylation in Golgi,BP,
17511,GO:0090284,1,0.98340675935133,0,1,positive regulation of protein glycosylation in Golgi,BP,
17512,GO:0090285,1,0.972447680134944,0,2,negative regulation of protein glycosylation in Golgi,BP,
17513,GO:0090286,1,0.893746853162121,0,8,cytoskeletal anchoring at nuclear membrane,BP,
17516,GO:0090289,1,0.939031822723678,0,5,regulation of osteoclast proliferation,BP,
17517,GO:0090290,1,0.970993256347123,0,3,positive regulation of osteoclast proliferation,BP,
17518,GO:0090291,1,0.967087733488108,0,2,negative regulation of osteoclast proliferation,BP,
17519,GO:0090292,1,0.951047693666719,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17520,GO:0090293,1,0.98609242153372,0,1,nitrogen catabolite regulation of transcription,BP,
17521,GO:0090294,1,0.98609242153372,0,1,nitrogen catabolite activation of transcription,BP,
17522,GO:0090296,1,0.943123875933134,0,4,regulation of mitochondrial DNA replication,BP,
17523,GO:0090297,1,0.990628060157684,0,1,positive regulation of mitochondrial DNA replication,BP,
17524,GO:0090298,1,0.952048229378104,0,3,negative regulation of mitochondrial DNA replication,BP,
17525,GO:0090299,1,0.988364005683081,0,1,regulation of neural crest formation,BP,
17526,GO:0090301,1,0.988364005683081,0,1,negative regulation of neural crest formation,BP,
17529,GO:0090305,1,0.0225781050611559,0,271,nucleic acid phosphodiester bond hydrolysis,BP,
17530,GO:0090306,1,0.929602370703125,0,5,spindle assembly involved in meiosis,BP,
17531,GO:0090307,1,0.454469467885657,0,52,mitotic spindle assembly,BP,
17532,GO:0090308,1,0.869900292580802,0,9,regulation of methylation-dependent chromatin silencing,BP,
17533,GO:0090309,1,0.935715804738506,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17534,GO:0090310,1,0.961303319208609,0,3,negative regulation of methylation-dependent chromatin silencing,BP,
17535,GO:0090311,1,0.602550034207627,0,35,regulation of protein deacetylation,BP,
17536,GO:0090312,1,0.733806601543948,0,21,positive regulation of protein deacetylation,BP,
17537,GO:0090313,1,0.685266601098918,0,27,regulation of protein targeting to membrane,BP,
17538,GO:0090314,1,0.73872495370952,0,22,positive regulation of protein targeting to membrane,BP,
17539,GO:0090315,1,0.930352982267759,0,5,negative regulation of protein targeting to membrane,BP,
17542,GO:0090320,1,0.985603653174881,0,1,regulation of chylomicron remnant clearance,BP,
17543,GO:0090321,1,0.985603653174881,0,1,positive regulation of chylomicron remnant clearance,BP,
17545,GO:0090323,1,0.995657766730681,0,1,prostaglandin secretion involved in immune response,BP,
17547,GO:0090325,1,0.941511642905817,0,4,regulation of locomotion involved in locomotory behavior,BP,
17548,GO:0090326,1,0.983564081502994,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17549,GO:0090327,1,0.983406759352069,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17551,GO:0090330,1,0.787686438736969,0,15,regulation of platelet aggregation,BP,
17552,GO:0090331,1,0.855074908660796,0,10,negative regulation of platelet aggregation,BP,
17553,GO:0090335,1,0.829802334816749,0,13,regulation of brown fat cell differentiation,BP,
17554,GO:0090336,1,0.914983799637859,0,7,positive regulation of brown fat cell differentiation,BP,
17555,GO:0090340,1,0.986410205054556,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17556,GO:0090341,1,0.98893241167775,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17557,GO:0090342,1,0.598382876736747,0,35,regulation of cell aging,BP,
17558,GO:0090343,1,0.889794149518544,0,9,positive regulation of cell aging,BP,
17559,GO:0090344,1,0.773164649943903,0,17,negative regulation of cell aging,BP,
17560,GO:0090345,1,0.973827216365609,0,2,cellular organohalogen metabolic process,BP,
17561,GO:0090346,1,0.973827216365609,0,2,cellular organofluorine metabolic process,BP,
17562,GO:0090347,1,0.988791781330131,0,1,regulation of cellular organohalogen metabolic process,BP,
17563,GO:0090348,1,0.988791781330131,0,1,regulation of cellular organofluorine metabolic process,BP,
17564,GO:0090349,1,0.988791781330131,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17565,GO:0090350,1,0.988791781330131,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17566,GO:0090357,1,0.99078737987985,0,1,regulation of tryptophan metabolic process,BP,
17567,GO:0090360,1,0.956735075995177,0,3,platelet-derived growth factor production,BP,
17568,GO:0090361,1,0.956735075995177,0,3,regulation of platelet-derived growth factor production,BP,
17569,GO:0090362,1,0.969897075048872,0,2,positive regulation of platelet-derived growth factor production,BP,
17570,GO:0090365,1,0.979290919938684,0,2,regulation of mRNA modification,BP,
17571,GO:0090366,1,0.99323283792893,0,1,positive regulation of mRNA modification,BP,
17572,GO:0090367,1,0.985963487372327,0,1,negative regulation of mRNA modification,BP,
17573,GO:0090370,1,0.949145108147536,0,4,negative regulation of cholesterol efflux,BP,
17574,GO:0090381,1,0.963439984792209,0,3,regulation of heart induction,BP,
17578,GO:0090386,1,0.983406759351231,0,1,phagosome maturation involved in apoptotic cell clearance,BP,
17579,GO:0090387,1,0.983406759351231,0,1,phagolysosome assembly involved in apoptotic cell clearance,BP,
17580,GO:0090389,1,0.983406759351231,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17581,GO:0090394,1,0.864197903559673,0,9,negative regulation of excitatory postsynaptic potential,BP,
17585,GO:0090402,1,0.971149041572528,0,2,oncogene-induced cell senescence,BP,
17586,GO:0090403,1,0.937586109406915,0,4,oxidative stress-induced premature senescence,BP,
17588,GO:0090409,1,0.985568192257127,0,1,malonyl-CoA synthetase activity,MF,
17589,GO:0090410,1,0.985568192257127,0,1,malonate catabolic process,BP,
17590,GO:0090416,1,0.984712167720936,0,1,nicotinate transporter activity,MF,
17591,GO:0090420,1,0.977480011558776,0,2,naphthalene-containing compound metabolic process,BP,
17592,GO:0090422,1,0.988466648285194,0,1,thiamine pyrophosphate transporter activity,MF,
17593,GO:0090425,1,0.983766730501423,0,1,acinar cell differentiation,BP,
17594,GO:0090427,1,0.956934864048174,0,3,activation of meiosis,BP,
17595,GO:0090435,1,0.908858704082018,0,7,protein localization to nuclear envelope,BP,
17596,GO:0090467,1,0.94233297211285,0,4,arginine import,BP,
17597,GO:0090472,1,0.983406759352069,0,1,dibasic protein processing,BP,
17598,GO:0090480,1,0.984725543253726,0,1,purine nucleotide-sugar transmembrane transport,BP,
17599,GO:0090481,1,0.933919819847939,0,5,pyrimidine nucleotide-sugar transmembrane transport,BP,
17600,GO:0090482,1,0.883888306280869,0,8,vitamin transmembrane transporter activity,MF,
17601,GO:0090484,1,0.706371695495122,0,23,drug transporter activity,MF,
17604,GO:0090498,1,0.954542955008797,0,3,extrinsic component of Golgi membrane,CC,
17605,GO:0090500,1,0.930878743284194,0,5,endocardial cushion to mesenchymal transition,BP,
17606,GO:0090501,1,0.183217481435986,0,127,RNA phosphodiester bond hydrolysis,BP,
17607,GO:0090502,1,0.432096834212801,0,64,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17608,GO:0090503,1,0.613715718564011,0,34,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17611,GO:0090520,1,0.8385947457544,0,12,sphingolipid mediated signaling pathway,BP,
17612,GO:0090521,1,0.937328673472845,0,4,glomerular visceral epithelial cell migration,BP,
17614,GO:0090527,1,0.907448391904011,0,6,actin filament reorganization,BP,
17615,GO:0090529,1,0.987413413405493,0,1,cell septum assembly,BP,
17616,GO:0090533,1,0.814371277664984,0,15,cation-transporting ATPase complex,CC,
17617,GO:0090534,1,0.988114483012288,0,1,calcium ion-transporting ATPase complex,CC,
17618,GO:0090537,1,0.967087733487865,0,2,CERF complex,CC,
17619,GO:0090541,1,0.968384722376257,0,2,MIT domain binding,MF,
17620,GO:0090543,1,0.911277868602814,0,7,Flemming body,CC,
17621,GO:0090544,1,0.709980076332506,0,23,BAF-type complex,CC,
17622,GO:0090545,1,0.76446636350015,0,17,CHD-type complex,CC,
17623,GO:0090554,1,0.935254349661696,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17624,GO:0090555,1,0.967087733487287,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17625,GO:0090556,1,0.967087733486077,0,2,phosphatidylserine-translocating ATPase activity,MF,
17627,GO:0090558,1,0.99404187805355,0,1,plant epidermis development,BP,
17629,GO:0090560,1,0.98606282939131,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17630,GO:0090568,1,0.616158936305464,0,31,nuclear transcriptional repressor complex,CC,
17631,GO:0090571,1,0.943924292587142,0,4,RNA polymerase II transcription repressor complex,CC,
17633,GO:0090576,1,0.8850663271144,0,8,RNA polymerase III transcription factor complex,CC,
17635,GO:0090594,1,0.918744353530701,0,6,inflammatory response to wounding,BP,
17638,GO:0090599,1,0.904491025004893,0,6,alpha-glucosidase activity,MF,
17639,GO:0090600,1,0.983407201548215,0,1,alpha-1,3-glucosidase activity,MF,
17640,GO:0090611,1,0.930762530232231,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17641,GO:0090615,1,0.983406759352018,0,1,mitochondrial mRNA processing,BP,
17642,GO:0090616,1,0.983406759352018,0,1,mitochondrial mRNA 3'-end processing,BP,
17643,GO:0090619,1,0.985335227444392,0,1,meiotic spindle pole,CC,
17644,GO:0090624,1,0.984725543253726,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17645,GO:0090625,1,0.984725543253726,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17646,GO:0090627,1,0.99404187805355,0,1,plant epidermal cell differentiation,BP,
17648,GO:0090631,1,0.975525524056801,0,2,pre-miRNA transporter activity,MF,
17649,GO:0090634,1,0.989183952813612,0,1,microglial cell mediated cytotoxicity,BP,
17650,GO:0090646,1,0.845827355026701,0,12,mitochondrial tRNA processing,BP,
17651,GO:0090648,1,0.983406759351575,0,1,response to environmental enrichment,BP,
17652,GO:0090649,1,0.92590537092203,0,5,response to oxygen-glucose deprivation,BP,
17653,GO:0090650,1,0.92590537092203,0,5,cellular response to oxygen-glucose deprivation,BP,
17654,GO:0090651,1,0.983406759351481,0,1,apical cytoplasm,CC,
17655,GO:0090656,1,0.783480211420798,0,15,t-circle formation,BP,
17656,GO:0090657,1,0.837172731653115,0,11,telomeric loop disassembly,BP,
17658,GO:0090661,1,0.966359467656932,0,4,box H/ACA telomerase RNP complex,CC,
17659,GO:0090662,1,0.356281055098727,0,74,ATP hydrolysis coupled transmembrane transport,BP,
17660,GO:0090665,1,0.737411251072944,0,21,glycoprotein complex,CC,
17661,GO:0090666,1,0.945902030145872,0,4,scaRNA localization to Cajal body,BP,
17662,GO:0090669,1,0.956542936728884,0,3,telomerase RNA stabilization,BP,
17663,GO:0090670,1,0.815213502055954,0,16,RNA localization to Cajal body,BP,
17664,GO:0090671,1,0.815213502055954,0,16,telomerase RNA localization to Cajal body,BP,
17665,GO:0090672,1,0.815213502055954,0,16,telomerase RNA localization,BP,
17666,GO:0090675,1,0.967150058222964,0,2,intermicrovillar adhesion,BP,
17667,GO:0090676,1,0.983950314107376,0,1,calcium ion transmembrane transport via low voltage-gated calcium channel,BP,
17670,GO:0090713,1,0.874648957000696,0,9,immunological memory process,BP,
17671,GO:0090715,1,0.874648957000696,0,9,immunological memory formation process,BP,
17672,GO:0090722,1,0.950802233401797,0,4,receptor-receptor interaction,MF,
17673,GO:0090723,1,0.78470453546838,0,16,growth cone part,CC,
17674,GO:0090724,1,0.926190481842166,0,5,central region of growth cone,CC,
17675,GO:0090725,1,0.97679373565627,0,2,peripheral region of growth cone,CC,
17676,GO:0090731,1,0.991273345505357,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17677,GO:0090732,1,0.990780980970108,0,1,cofilin-actin rod,CC,
17678,GO:0090734,1,0.647626670385635,0,29,site of DNA damage,CC,
17679,GO:0090735,1,0.864895659315495,0,10,DNA repair complex assembly,BP,
17680,GO:0090737,1,0.783480211420798,0,15,telomere maintenance via telomere trimming,BP,
17681,GO:0093001,1,0.983625001323381,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17682,GO:0095500,1,0.749467305500776,0,21,acetylcholine receptor signaling pathway,BP,
17683,GO:0097001,1,0.902291562403626,0,7,ceramide binding,MF,
17684,GO:0097003,1,0.969793651143684,0,2,adipokinetic hormone receptor activity,MF,
17685,GO:0097006,1,0.47211133842967,0,57,regulation of plasma lipoprotein particle levels,BP,
17687,GO:0097010,1,0.952427030030857,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17690,GO:0097013,1,0.97176588479025,0,3,phagocytic vesicle lumen,CC,
17691,GO:0097014,1,0.279415390162894,0,84,ciliary plasm,CC,
17692,GO:0097016,1,0.958313775072585,0,3,L27 domain binding,MF,
17695,GO:0097020,1,0.983521519976902,0,1,COPII adaptor activity,MF,
17697,GO:0097022,1,0.986013886613784,0,1,lymphocyte migration into lymph node,BP,
17698,GO:0097025,1,0.951038409344445,0,3,MPP7-DLG1-LIN7 complex,CC,
17699,GO:0097026,1,0.958141983086425,0,4,dendritic cell dendrite assembly,BP,
17700,GO:0097027,1,0.894043592911551,0,8,ubiquitin-protein transferase activator activity,MF,
17702,GO:0097029,1,0.957901061847025,0,4,mature conventional dendritic cell differentiation,BP,
17703,GO:0097031,1,0.610796593016403,0,55,mitochondrial respiratory chain complex I biogenesis,BP,
17704,GO:0097032,1,0.982768772838128,0,2,mitochondrial respiratory chain complex II biogenesis,BP,
17705,GO:0097033,1,0.940338489279629,0,5,mitochondrial respiratory chain complex III biogenesis,BP,
17706,GO:0097034,1,0.832772181957352,0,14,mitochondrial respiratory chain complex IV biogenesis,BP,
17707,GO:0097035,1,0.561215603059901,0,37,regulation of membrane lipid distribution,BP,
17708,GO:0097037,1,0.983487849871303,0,1,heme export,BP,
17710,GO:0097039,1,0.940187782631653,0,4,protein linear polyubiquitination,BP,
17711,GO:0097045,1,0.983406759351968,0,1,phosphatidylserine exposure on blood platelet,BP,
17713,GO:0097049,1,0.898167529593559,0,7,motor neuron apoptotic process,BP,
17714,GO:0097050,1,0.846010226130332,0,11,type B pancreatic cell apoptotic process,BP,
17715,GO:0097051,1,0.951042995747855,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17716,GO:0097052,1,0.960710060286741,0,3,L-kynurenine metabolic process,BP,
17717,GO:0097053,1,0.989355420771269,0,1,L-kynurenine catabolic process,BP,
17718,GO:0097055,1,0.985902160426923,0,1,agmatine biosynthetic process,BP,
17719,GO:0097056,1,0.94622155881805,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17720,GO:0097057,1,0.978452382422714,0,2,TRAF2-GSTP1 complex,CC,
17726,GO:0097065,1,0.97213304177521,0,2,anterior head development,BP,
17727,GO:0097066,1,0.696058797076158,0,24,response to thyroid hormone,BP,
17728,GO:0097067,1,0.792781935935669,0,15,cellular response to thyroid hormone stimulus,BP,
17729,GO:0097068,1,0.920383011814803,0,5,response to thyroxine,BP,
17730,GO:0097069,1,0.967443258148103,0,2,cellular response to thyroxine stimulus,BP,
17733,GO:0097086,1,0.983424764001049,0,1,amniotic stem cell differentiation,BP,
17734,GO:0097089,1,0.973999140608244,0,2,methyl-branched fatty acid metabolic process,BP,
17735,GO:0097090,1,0.853526657480095,0,10,presynaptic membrane organization,BP,
17738,GO:0097100,1,0.935183739534974,0,5,supercoiled DNA binding,MF,
17742,GO:0097105,1,0.875582031192408,0,8,presynaptic membrane assembly,BP,
17744,GO:0097107,1,0.919731182614928,0,5,postsynaptic density assembly,BP,
17745,GO:0097108,1,0.951081840254083,0,3,hedgehog family protein binding,MF,
17746,GO:0097109,1,0.923265595789436,0,5,neuroligin family protein binding,MF,
17748,GO:0097111,1,0.967087733487045,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17749,GO:0097112,1,0.967468464169187,0,2,gamma-aminobutyric acid receptor clustering,BP,
17750,GO:0097113,1,0.928642374306019,0,5,AMPA glutamate receptor clustering,BP,
17751,GO:0097114,1,0.94273729967479,0,4,NMDA glutamate receptor clustering,BP,
17752,GO:0097115,1,0.983406759351921,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17753,GO:0097116,1,0.95103840934316,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17754,GO:0097117,1,0.983406759351379,0,1,guanylate kinase-associated protein clustering,BP,
17757,GO:0097120,1,0.805827454324249,0,14,receptor localization to synapse,BP,
17758,GO:0097123,1,0.973060386149658,0,2,cyclin A1-CDK2 complex,CC,
17759,GO:0097124,1,0.970134729400555,0,2,cyclin A2-CDK2 complex,CC,
17760,GO:0097125,1,0.974413905630861,0,2,cyclin B1-CDK1 complex,CC,
17761,GO:0097129,1,0.973184852476176,0,2,cyclin D2-CDK4 complex,CC,
17762,GO:0097134,1,0.973225904602039,0,2,cyclin E1-CDK2 complex,CC,
17763,GO:0097135,1,0.970274260678176,0,2,cyclin E2-CDK2 complex,CC,
17764,GO:0097136,1,0.931015877828607,0,5,Bcl-2 family protein complex,CC,
17765,GO:0097144,1,0.993810880445406,0,1,BAX complex,CC,
17766,GO:0097149,1,0.951233584310548,0,3,centralspindlin complex,CC,
17768,GO:0097151,1,0.889450432497298,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17770,GO:0097153,1,0.846682672390561,0,15,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17771,GO:0097154,1,0.806495185262129,0,15,GABAergic neuron differentiation,BP,
17772,GO:0097155,1,0.951038409342874,0,3,fasciculation of sensory neuron axon,BP,
17773,GO:0097156,1,0.967087733487673,0,2,fasciculation of motor neuron axon,BP,
17774,GO:0097157,1,0.900502059206619,0,7,pre-mRNA intronic binding,MF,
17775,GO:0097158,1,0.988472078652507,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17777,GO:0097160,1,0.996694409653219,0,1,polychlorinated biphenyl binding,MF,
17778,GO:0097161,1,0.983406759351575,0,1,DH domain binding,MF,
17779,GO:0097162,1,0.98357632905632,0,1,MADS box domain binding,MF,
17781,GO:0097165,1,0.927983010616666,0,5,nuclear stress granule,CC,
17782,GO:0097166,1,0.970446292568494,0,2,lens epithelial cell proliferation,BP,
17783,GO:0097167,1,0.942606504653979,0,4,circadian regulation of translation,BP,
17784,GO:0097168,1,0.969725120876421,0,2,mesenchymal stem cell proliferation,BP,
17785,GO:0097169,1,0.965302156299459,0,4,AIM2 inflammasome complex,CC,
17786,GO:0097176,1,0.985305465340027,0,1,epoxide metabolic process,BP,
17787,GO:0097177,1,0.979509550963686,0,2,mitochondrial ribosome binding,MF,
17795,GO:0097187,1,0.956776300281179,0,3,dentinogenesis,BP,
17801,GO:0097195,1,0.956379453460191,0,3,pilomotor reflex,BP,
17802,GO:0097196,1,0.971905957501342,0,2,Shu complex,CC,
17804,GO:0097198,1,0.967514194894573,0,2,histone H3-K36 trimethylation,BP,
17805,GO:0097199,1,0.967918135718166,0,2,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17806,GO:0097200,1,0.856637183572994,0,13,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17807,GO:0097201,1,0.822653883533357,0,13,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17808,GO:0097202,1,0.865515401350769,0,10,activation of cysteine-type endopeptidase activity,BP,
17810,GO:0097208,1,0.917573135500022,0,6,alveolar lamellar body,CC,
17811,GO:0097209,1,0.944741311383576,0,4,epidermal lamellar body,CC,
17812,GO:0097210,1,0.924763689797248,0,5,response to gonadotropin-releasing hormone,BP,
17813,GO:0097211,1,0.924763689797248,0,5,cellular response to gonadotropin-releasing hormone,BP,
17814,GO:0097212,1,0.982379726126059,0,2,lysosomal membrane organization,BP,
17815,GO:0097213,1,0.995507918336495,0,1,regulation of lysosomal membrane permeability,BP,
17816,GO:0097214,1,0.995507918336495,0,1,positive regulation of lysosomal membrane permeability,BP,
17817,GO:0097222,1,0.983406759352018,0,1,mitochondrial mRNA polyadenylation,BP,
17819,GO:0097224,1,0.987922462885514,0,1,sperm connecting piece,CC,
17820,GO:0097225,1,0.820368211526285,0,15,sperm midpiece,CC,
17821,GO:0097226,1,0.985582339775545,0,1,sperm mitochondrial sheath,CC,
17822,GO:0097227,1,0.917130261489183,0,6,sperm annulus,CC,
17823,GO:0097228,1,0.742690915059783,0,20,sperm principal piece,CC,
17824,GO:0097229,1,0.990301116363834,0,1,sperm end piece,CC,
17825,GO:0097231,1,0.988083079888577,0,1,cell motility in response to calcium ion,BP,
17826,GO:0097232,1,0.967214339111149,0,2,lamellar body membrane,CC,
17827,GO:0097233,1,0.967214339111149,0,2,alveolar lamellar body membrane,CC,
17828,GO:0097237,1,0.890629450806808,0,8,cellular response to toxic substance,BP,
17829,GO:0097238,1,0.989852633883451,0,1,cellular response to methylglyoxal,BP,
17830,GO:0097240,1,0.92485345371305,0,5,chromosome attachment to the nuclear envelope,BP,
17832,GO:0097242,1,0.902167456852095,0,7,beta-amyloid clearance,BP,
17834,GO:0097254,1,0.986230727841008,0,1,renal tubular secretion,BP,
17835,GO:0097255,1,0.938824344936803,0,5,R2TP complex,CC,
17836,GO:0097258,1,0.969394118460237,0,2,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17837,GO:0097259,1,0.969394118460237,0,2,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17838,GO:0097260,1,0.984412885508288,0,1,eoxin A4 synthase activity,MF,
17839,GO:0097264,1,0.885242206761243,0,8,self proteolysis,BP,
17840,GO:0097267,1,0.876284070167141,0,9,omega-hydroxylase P450 pathway,BP,
17841,GO:0097272,1,0.972026693246566,0,2,ammonia homeostasis,BP,
17842,GO:0097273,1,0.983406759351724,0,1,creatinine homeostasis,BP,
17843,GO:0097274,1,0.967155927509074,0,2,urea homeostasis,BP,
17844,GO:0097275,1,0.983406759351724,0,1,cellular ammonia homeostasis,BP,
17845,GO:0097276,1,0.983406759351724,0,1,cellular creatinine homeostasis,BP,
17846,GO:0097277,1,0.983406759351724,0,1,cellular urea homeostasis,BP,
17848,GO:0097283,1,0.914745590817146,0,6,keratinocyte apoptotic process,BP,
17851,GO:0097291,1,0.986697677859876,0,1,renal phosphate ion absorption,BP,
17852,GO:0097296,1,0.835705941345953,0,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17853,GO:0097298,1,0.983406961950764,0,1,regulation of nucleus size,BP,
17854,GO:0097300,1,0.568148465525196,0,41,programmed necrotic cell death,BP,
17857,GO:0097319,1,0.985456784122933,0,1,carbohydrate import into cell,BP,
17858,GO:0097320,1,0.764175534144827,0,17,plasma membrane tubulation,BP,
17859,GO:0097322,1,0.898291214807957,0,7,7SK snRNA binding,MF,
17860,GO:0097324,1,0.9670877334868,0,2,melanocyte migration,BP,
17862,GO:0097326,1,0.983406759351872,0,1,melanocyte adhesion,BP,
17863,GO:0097327,1,0.941536952306076,0,5,response to antineoplastic agent,BP,
17864,GO:0097332,1,0.976271657544119,0,2,response to antipsychotic drug,BP,
17866,GO:0097340,1,0.850760172698225,0,11,inhibition of cysteine-type endopeptidase activity,BP,
17867,GO:0097341,1,0.850760172698225,0,11,zymogen inhibition,BP,
17868,GO:0097342,1,0.901232564091382,0,7,ripoptosome,CC,
17869,GO:0097343,1,0.938636377659656,0,4,ripoptosome assembly,BP,
17870,GO:0097344,1,0.983762712706552,0,1,Rix1 complex,CC,
17872,GO:0097346,1,0.757612049065123,0,21,INO80-type complex,CC,
17873,GO:0097350,1,0.941466063842084,0,4,neutrophil clearance,BP,
17874,GO:0097352,1,0.622340454293353,0,34,autophagosome maturation,BP,
17875,GO:0097354,1,0.861477257019076,0,10,prenylation,BP,
17876,GO:0097356,1,0.983406759351281,0,1,perinucleolar compartment,CC,
17877,GO:0097359,1,0.967087733486465,0,2,UDP-glucosylation,BP,
17878,GO:0097360,1,0.939220432459646,0,4,chorionic trophoblast cell proliferation,BP,
17879,GO:0097361,1,0.948232427634037,0,4,CIA complex,CC,
17880,GO:0097362,1,0.968657860207666,0,2,MCM8-MCM9 complex,CC,
17881,GO:0097363,1,0.983406759351824,0,1,protein O-GlcNAc transferase activity,MF,
17883,GO:0097368,1,0.943057784603074,0,4,establishment of Sertoli cell barrier,BP,
17884,GO:0097369,1,0.795915967926314,0,14,sodium ion import,BP,
17885,GO:0097371,1,0.908918278335216,0,6,MDM2/MDM4 family protein binding,MF,
17886,GO:0097372,1,0.988072634922144,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17887,GO:0097374,1,0.975443785210729,0,2,sensory neuron axon guidance,BP,
17888,GO:0097376,1,0.989750012150819,0,1,interneuron axon guidance,BP,
17890,GO:0097382,1,0.983406759351672,0,1,deoxynucleoside-diphosphatase activity,MF,
17891,GO:0097383,1,0.983406759351672,0,1,dIDP diphosphatase activity,MF,
17892,GO:0097384,1,0.918797470287403,0,6,cellular lipid biosynthetic process,BP,
17894,GO:0097393,1,0.983406759350394,0,1,telomeric repeat-containing RNA transcription,BP,
17895,GO:0097394,1,0.983406759350394,0,1,telomeric repeat-containing RNA transcription from RNA pol II promoter,BP,
17896,GO:0097396,1,0.983417626569944,0,1,response to interleukin-17,BP,
17897,GO:0097398,1,0.983417626569944,0,1,cellular response to interleukin-17,BP,
17898,GO:0097400,1,0.983417626569944,0,1,interleukin-17-mediated signaling pathway,BP,
17899,GO:0097401,1,0.9838765730806,0,1,synaptic vesicle lumen acidification,BP,
17900,GO:0097402,1,0.984838220026181,0,1,neuroblast migration,BP,
17901,GO:0097403,1,0.983827472000414,0,1,cellular response to raffinose,BP,
17902,GO:0097409,1,0.986900479266678,0,1,glial cytoplasmic inclusion,CC,
17903,GO:0097411,1,0.927102716016418,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17904,GO:0097413,1,0.923567443328109,0,6,Lewy body,CC,
17905,GO:0097414,1,0.986900479266678,0,1,classical Lewy body,CC,
17906,GO:0097418,1,0.920953790452876,0,5,neurofibrillary tangle,CC,
17908,GO:0097422,1,0.923973470013533,0,5,tubular endosome,CC,
17910,GO:0097427,1,0.968384722376257,0,2,microtubule bundle,CC,
17911,GO:0097428,1,0.939561372867519,0,7,protein maturation by iron-sulfur cluster transfer,BP,
17912,GO:0097431,1,0.819248183899648,0,13,mitotic spindle pole,CC,
17913,GO:0097433,1,0.913073789877869,0,6,dense body,CC,
17915,GO:0097440,1,0.820383677534835,0,12,apical dendrite,CC,
17916,GO:0097441,1,0.951843674246015,0,3,basilar dendrite,CC,
17917,GO:0097442,1,0.983406759351773,0,1,CA3 pyramidal cell dendrite,CC,
17918,GO:0097443,1,0.906115982783776,0,6,sorting endosome,CC,
17919,GO:0097444,1,0.983406759351869,0,1,spine apparatus,CC,
17920,GO:0097447,1,0.975871557266799,0,2,dendritic tree,CC,
17922,GO:0097450,1,0.962743229719515,0,3,astrocyte end-foot,CC,
17923,GO:0097451,1,0.967088078015396,0,2,glial limiting end-foot,CC,
17924,GO:0097452,1,0.94976640779355,0,4,GAIT complex,CC,
17925,GO:0097453,1,0.985166744011428,0,1,mesaxon,CC,
17926,GO:0097454,1,0.95755014496798,0,3,Schwann cell microvillus,CC,
17927,GO:0097457,1,0.983453262681897,0,1,hippocampal mossy fiber,CC,
17931,GO:0097461,1,0.935372045640157,0,4,ferric iron import into cell,BP,
17932,GO:0097462,1,0.986900479266678,0,1,Lewy neurite,CC,
17933,GO:0097466,1,0.939599517386371,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17934,GO:0097468,1,0.849689231581323,0,12,programmed cell death in response to reactive oxygen species,BP,
17935,GO:0097470,1,0.920292053395488,0,5,ribbon synapse,CC,
17936,GO:0097472,1,0.683417599589846,0,28,cyclin-dependent protein kinase activity,MF,
17937,GO:0097473,1,0.98340675935187,0,1,retinal rod cell apoptotic process,BP,
17938,GO:0097475,1,0.896268935008787,0,7,motor neuron migration,BP,
17939,GO:0097476,1,0.940911315513485,0,4,spinal cord motor neuron migration,BP,
17940,GO:0097477,1,0.954346258951742,0,3,lateral motor column neuron migration,BP,
17943,GO:0097484,1,0.661941350665595,0,27,dendrite extension,BP,
17945,GO:0097486,1,0.92769416589261,0,7,multivesicular body lumen,CC,
17946,GO:0097487,1,0.960981261729162,0,3,multivesicular body, internal vesicle,CC,
17947,GO:0097489,1,0.984720183487132,0,1,multivesicular body, internal vesicle lumen,CC,
17948,GO:0097490,1,0.936754015741535,0,4,sympathetic neuron projection extension,BP,
17949,GO:0097491,1,0.936754015741535,0,4,sympathetic neuron projection guidance,BP,
17950,GO:0097493,1,0.760619303411207,0,17,structural molecule activity conferring elasticity,MF,
17951,GO:0097494,1,0.972594634904902,0,2,regulation of vesicle size,BP,
17952,GO:0097497,1,0.983674085893709,0,1,blood vessel endothelial cell delamination,BP,
17953,GO:0097498,1,0.970701717653428,0,2,endothelial tube lumen extension,BP,
17954,GO:0097499,1,0.879212461147226,0,9,protein localization to non-motile cilium,BP,
17955,GO:0097500,1,0.929044254370608,0,5,receptor localization to non-motile cilium,BP,
17956,GO:0097501,1,0.947434379627504,0,4,stress response to metal ion,BP,
17957,GO:0097502,1,0.68677714709054,0,28,mannosylation,BP,
17958,GO:0097503,1,0.733883159561916,0,21,sialylation,BP,
17959,GO:0097504,1,0.87150235901227,0,10,Gemini of coiled bodies,CC,
17960,GO:0097505,1,0.983406759351724,0,1,Rad6-Rad18 complex,CC,
17961,GO:0097506,1,0.939502358734182,0,5,deaminated base DNA N-glycosylase activity,MF,
17962,GO:0097510,1,0.986492495624848,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17963,GO:0097512,1,0.928236254319117,0,7,cardiac myofibril,CC,
17964,GO:0097513,1,0.951038409342728,0,3,myosin II filament,CC,
17965,GO:0097517,1,0.474224907523567,0,49,contractile actin filament bundle,CC,
17966,GO:0097524,1,0.922311535238416,0,6,sperm plasma membrane,CC,
17967,GO:0097525,1,0.482973387841492,0,57,spliceosomal snRNP complex,CC,
17968,GO:0097526,1,0.760519453790214,0,24,spliceosomal tri-snRNP complex,CC,
17969,GO:0097527,1,0.917944660350241,0,6,necroptotic signaling pathway,BP,
17973,GO:0097534,1,0.98438577470448,0,1,lymphoid lineage cell migration,BP,
17974,GO:0097535,1,0.98438577470448,0,1,lymphoid lineage cell migration into thymus,BP,
17975,GO:0097536,1,0.970830620820417,0,2,thymus epithelium morphogenesis,BP,
17976,GO:0097539,1,0.86226681236758,0,9,ciliary transition fiber,CC,
17977,GO:0097541,1,0.984725543253726,0,1,axonemal basal plate,CC,
17978,GO:0097542,1,0.526737017331914,0,44,ciliary tip,CC,
17979,GO:0097543,1,0.967725248541124,0,2,ciliary inversin compartment,CC,
17981,GO:0097550,1,0.924514390639617,0,6,transcriptional preinitiation complex,CC,
17983,GO:0097573,1,0.990115295674954,0,1,glutathione oxidoreductase activity,MF,
17984,GO:0097576,1,0.601818192721641,0,36,vacuole fusion,BP,
17985,GO:0097577,1,0.958932363807995,0,5,sequestering of iron ion,BP,
17987,GO:0097598,1,0.968384722376066,0,2,sperm cytoplasmic droplet,CC,
17988,GO:0097602,1,0.822639352800542,0,14,cullin family protein binding,MF,
17989,GO:0097603,1,0.955093766179564,0,3,temperature-gated ion channel activity,MF,
17990,GO:0097604,1,0.971211242175628,0,2,temperature-gated cation channel activity,MF,
17992,GO:0097617,1,0.812326690454804,0,13,annealing activity,MF,
17994,GO:0097625,1,0.983406759351282,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17995,GO:0097626,1,0.983406759351282,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17996,GO:0097627,1,0.983406759351282,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17997,GO:0097629,1,0.952362509774907,0,3,extrinsic component of omegasome membrane,CC,
17998,GO:0097630,1,0.984725543253726,0,1,intrinsic component of omegasome membrane,CC,
17999,GO:0097631,1,0.984725543253726,0,1,integral component of omegasome membrane,CC,
18000,GO:0097632,1,0.968384722376112,0,2,extrinsic component of pre-autophagosomal structure membrane,CC,
18001,GO:0097635,1,0.967087733487917,0,2,extrinsic component of autophagosome membrane,CC,
18002,GO:0097636,1,0.967620814821734,0,2,intrinsic component of autophagosome membrane,CC,
18003,GO:0097637,1,0.967620814821734,0,2,integral component of autophagosome membrane,CC,
18004,GO:0097638,1,0.983406759351282,0,1,L-arginine import across plasma membrane,BP,
18005,GO:0097639,1,0.983406759351282,0,1,L-lysine import across plasma membrane,BP,
18006,GO:0097640,1,0.983406759351282,0,1,L-ornithine import across plasma membrane,BP,
18007,GO:0097642,1,0.945467930100164,0,4,calcitonin family receptor activity,MF,
18008,GO:0097644,1,0.983432360355796,0,1,calcitonin family binding,MF,
18009,GO:0097648,1,0.951038409343922,0,3,G-protein coupled receptor complex,CC,
18012,GO:0097676,1,0.953615026993836,0,3,histone H3-K36 dimethylation,BP,
18013,GO:0097677,1,0.959479175083574,0,3,STAT family protein binding,MF,
18014,GO:0097680,1,0.953666743659817,0,3,double-strand break repair via classical nonhomologous end joining,BP,
18015,GO:0097681,1,0.967087733484914,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
18016,GO:0097688,1,0.928642374306019,0,5,glutamate receptor clustering,BP,
18017,GO:0097689,1,0.983526980738733,0,1,iron channel activity,MF,
18018,GO:0097692,1,0.983406759351575,0,1,histone H3-K4 monomethylation,BP,
18019,GO:0097694,1,0.95155902780368,0,3,establishment of RNA localization to telomere,BP,
18020,GO:0097695,1,0.95155902780368,0,3,establishment of macromolecular complex localization to telomere,BP,
18022,GO:0097699,1,0.983406759352021,0,1,vascular endothelial cell response to fluid shear stress,BP,
18024,GO:0097709,1,0.913556909702004,0,6,connective tissue replacement,BP,
18026,GO:0097718,1,0.619004125855702,0,31,disordered domain specific binding,MF,
18028,GO:0097722,1,0.383736034629204,0,74,sperm motility,BP,
18029,GO:0097724,1,0.987508415210851,0,1,sperm flagellum movement,BP,
18030,GO:0097726,1,0.991653723103978,0,1,LEM domain binding,MF,
18031,GO:0097729,1,0.388934968118819,0,71,9+2 motile cilium,CC,
18034,GO:0097732,1,0.883222162349439,0,9,9+2 non-motile cilium,CC,
18037,GO:0097742,1,0.940199988894011,0,4,de novo centriole assembly,BP,
18039,GO:0097747,1,0.575168346035395,0,42,RNA polymerase activity,MF,
18042,GO:0098501,1,0.94133656423956,0,5,polynucleotide dephosphorylation,BP,
18043,GO:0098502,1,0.968382512579623,0,3,DNA dephosphorylation,BP,
18044,GO:0098503,1,0.988025773396631,0,1,DNA 3' dephosphorylation,BP,
18045,GO:0098504,1,0.988025773396631,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
18046,GO:0098505,1,0.884162982639106,0,8,G-rich strand telomeric DNA binding,MF,
18047,GO:0098506,1,0.988025773396631,0,1,polynucleotide 3' dephosphorylation,BP,
18048,GO:0098507,1,0.972074684313398,0,2,polynucleotide 5' dephosphorylation,BP,
18049,GO:0098518,1,0.960433480873024,0,3,polynucleotide phosphatase activity,MF,
18050,GO:0098519,1,0.929096939907744,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
18051,GO:0098528,1,0.926847489479446,0,5,skeletal muscle fiber differentiation,BP,
18052,GO:0098530,1,0.983406759351724,0,1,positive regulation of strand invasion,BP,
18054,GO:0098532,1,0.920057947417514,0,7,histone H3-K27 trimethylation,BP,
18055,GO:0098533,1,0.714613139471425,0,23,ATPase dependent transmembrane transport complex,CC,
18056,GO:0098534,1,0.642403054844452,0,29,centriole assembly,BP,
18057,GO:0098535,1,0.940199988894011,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
18058,GO:0098536,1,0.940200399230945,0,4,deuterosome,CC,
18060,GO:0098543,1,0.826035577275818,0,13,detection of other organism,BP,
18061,GO:0098547,1,0.985708223654261,0,1,lumenal side of Golgi membrane,CC,
18063,GO:0098553,1,0.720523562445075,0,28,lumenal side of endoplasmic reticulum membrane,CC,
18064,GO:0098554,1,0.877365819146912,0,9,cytoplasmic side of endoplasmic reticulum membrane,CC,
18065,GO:0098556,1,0.98810400393685,0,1,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
18066,GO:0098559,1,0.969599923385928,0,2,cytoplasmic side of early endosome membrane,CC,
18069,GO:0098573,1,0.47382538670833,0,55,intrinsic component of mitochondrial membrane,CC,
18070,GO:0098574,1,0.971094301564445,0,2,cytoplasmic side of lysosomal membrane,CC,
18071,GO:0098575,1,0.972473934049498,0,2,lumenal side of lysosomal membrane,CC,
18072,GO:0098576,1,0.942761086615895,0,4,lumenal side of membrane,CC,
18073,GO:0098581,1,0.779823492637024,0,18,detection of external biotic stimulus,BP,
18074,GO:0098582,1,0.967108017099041,0,2,innate vocalization behavior,BP,
18075,GO:0098583,1,0.979200843279489,0,2,learned vocalization behavior,BP,
18076,GO:0098586,1,0.558495697708946,0,40,cellular response to virus,BP,
18080,GO:0098592,1,0.951509072533359,0,3,cytoplasmic side of apical plasma membrane,CC,
18081,GO:0098594,1,0.994325307730189,0,1,mucin granule,CC,
18082,GO:0098595,1,0.985719188185092,0,1,perivitelline space,CC,
18086,GO:0098599,1,0.935394757852282,0,5,palmitoyl hydrolase activity,MF,
18087,GO:0098601,1,0.983500858265144,0,1,selenomethionine adenosyltransferase activity,MF,
18090,GO:0098619,1,0.98716546679845,0,1,selenocysteine-tRNA ligase activity,MF,
18091,GO:0098621,1,0.983406759351775,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
18092,GO:0098625,1,0.983410490626542,0,1,methylselenol reductase activity,MF,
18093,GO:0098626,1,0.983410490626542,0,1,methylseleninic acid reductase activity,MF,
18096,GO:0098633,1,0.984799145109626,0,1,collagen fibril binding,MF,
18097,GO:0098634,1,0.895277673571864,0,7,protein binding involved in cell-matrix adhesion,MF,
18099,GO:0098637,1,0.983406932135447,0,1,protein complex involved in cell-matrix adhesion,CC,
18100,GO:0098639,1,0.919736932700888,0,5,collagen binding involved in cell-matrix adhesion,MF,
18101,GO:0098640,1,0.973415342485745,0,2,integrin binding involved in cell-matrix adhesion,MF,
18103,GO:0098642,1,0.890488654785018,0,7,network-forming collagen trimer,CC,
18104,GO:0098643,1,0.820621060323964,0,12,banded collagen fibril,CC,
18105,GO:0098644,1,0.718544285214759,0,20,complex of collagen trimers,CC,
18106,GO:0098645,1,0.890488654785018,0,7,collagen network,CC,
18107,GO:0098646,1,0.984554178720758,0,1,collagen sheet,CC,
18108,GO:0098647,1,0.95674687945929,0,3,collagen beaded filament,CC,
18109,GO:0098648,1,0.983406759350836,0,1,collagen anchoring fibril,CC,
18110,GO:0098651,1,0.875705525086354,0,8,basement membrane collagen trimer,CC,
18111,GO:0098652,1,0.983406759350836,0,1,collagen type VII anchoring fibril,CC,
18119,GO:0098664,1,0.743891628668888,0,26,G-protein coupled serotonin receptor signaling pathway,BP,
18120,GO:0098665,1,0.973480288880651,0,2,serotonin receptor complex,CC,
18122,GO:0098679,1,0.967087733485932,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18123,GO:0098680,1,0.983406759352117,0,1,template-free RNA nucleotidyltransferase,MF,
18124,GO:0098687,1,0.00963888187409924,0,331,chromosomal region,CC,
18125,GO:0098700,1,0.901385359713553,0,7,neurotransmitter loading into synaptic vesicle,BP,
18126,GO:0098703,1,0.892971085773586,0,7,calcium ion import across plasma membrane,BP,
18127,GO:0098704,1,0.985456784122933,0,1,carbohydrate import across plasma membrane,BP,
18128,GO:0098706,1,0.983530338896731,0,1,ferric iron import across plasma membrane,BP,
18129,GO:0098711,1,0.983530338896731,0,1,iron ion import across plasma membrane,BP,
18130,GO:0098719,1,0.809357499185487,0,13,sodium ion import across plasma membrane,BP,
18131,GO:0098722,1,0.87979441157196,0,9,asymmetric stem cell division,BP,
18133,GO:0098728,1,0.953837882181439,0,4,germline stem cell asymmetric division,BP,
18135,GO:0098734,1,0.935394757852282,0,5,macromolecule depalmitoylation,BP,
18136,GO:0098735,1,0.929336667780693,0,5,positive regulation of the force of heart contraction,BP,
18137,GO:0098736,1,0.983406759350938,0,1,negative regulation of the force of heart contraction,BP,
18138,GO:0098739,1,0.624445100633575,0,30,import across plasma membrane,BP,
18141,GO:0098745,1,0.987948183556831,0,1,Dcp1-Dcp2 complex,CC,
18142,GO:0098746,1,0.983406759351971,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18143,GO:0098748,1,0.846200009160968,0,11,endocytic adaptor activity,MF,
18144,GO:0098749,1,0.983406759351972,0,1,cerebellar neuron development,BP,
18147,GO:0098756,1,0.983583400093628,0,1,response to interleukin-21,BP,
18148,GO:0098757,1,0.983583400093628,0,1,cellular response to interleukin-21,BP,
18149,GO:0098758,1,0.95362387080695,0,3,response to interleukin-8,BP,
18150,GO:0098759,1,0.95362387080695,0,3,cellular response to interleukin-8,BP,
18151,GO:0098760,1,0.961741601442089,0,3,response to interleukin-7,BP,
18152,GO:0098761,1,0.961741601442089,0,3,cellular response to interleukin-7,BP,
18153,GO:0098770,1,0.967095857689598,0,2,FBXO family protein binding,MF,
18157,GO:0098779,1,0.876700259261592,0,9,positive regulation of macromitophagy in response to mitochondrial depolarization,BP,
18158,GO:0098780,1,0.770470014554484,0,18,response to mitochondrial depolarisation,BP,
18159,GO:0098781,1,0.266831701503496,0,95,ncRNA transcription,BP,
18160,GO:0098782,1,0.987599560370927,0,1,mechanically-gated potassium channel activity,MF,
18161,GO:0098787,1,0.840245423218269,0,12,mRNA cleavage involved in mRNA processing,BP,
18162,GO:0098789,1,0.88166840412962,0,9,pre-mRNA cleavage required for polyadenylation,BP,
18164,GO:0098792,1,0.880624887026934,0,8,xenophagy,BP,
18167,GO:0098795,1,0.968415012244438,0,2,mRNA cleavage involved in gene silencing,BP,
18170,GO:0098798,1,0.303580478228465,0,130,mitochondrial protein complex,CC,
18171,GO:0098799,1,0.871508218250986,0,12,outer mitochondrial membrane protein complex,CC,
18172,GO:0098800,1,0.392710889964515,0,109,inner mitochondrial membrane protein complex,CC,
18175,GO:0098803,1,0.582563202126825,0,70,respiratory chain complex,CC,
18177,GO:0098808,1,0.971827520469242,0,2,mRNA cap binding,MF,
18178,GO:0098809,1,0.984615667407723,0,1,nitrite reductase activity,MF,
18182,GO:0098814,1,0.951038409343254,0,3,spontaneous synaptic transmission,BP,
18184,GO:0098821,1,0.923890352831088,0,5,BMP receptor activity,MF,
18185,GO:0098822,1,0.985027751671993,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18187,GO:0098828,1,0.889450432497298,0,7,modulation of inhibitory postsynaptic potential,BP,
18188,GO:0098829,1,0.983406759351527,0,1,intestinal folate absorption,BP,
18189,GO:0098830,1,0.983406759351971,0,1,presynaptic endosome,CC,
18190,GO:0098831,1,0.967087733482398,0,2,presynaptic active zone cytoplasmic component,CC,
18191,GO:0098833,1,0.983406759351921,0,1,presynaptic endocytic zone,CC,
18192,GO:0098835,1,0.983406759351921,0,1,presynaptic endocytic zone membrane,CC,
18193,GO:0098837,1,0.971314038371396,0,2,postsynaptic recycling endosome,CC,
18194,GO:0098838,1,0.984102144869068,0,1,reduced folate transmembrane transport,BP,
18195,GO:0098839,1,0.891265737054658,0,7,postsynaptic density membrane,CC,
18196,GO:0098840,1,0.518912971438498,0,46,protein transport along microtubule,BP,
18197,GO:0098843,1,0.983406759351231,0,1,postsynaptic endocytic zone,CC,
18198,GO:0098844,1,0.983406759351231,0,1,postsynaptic endocytic zone membrane,CC,
18199,GO:0098845,1,0.940602030440725,0,4,postsynaptic endosome,CC,
18200,GO:0098847,1,0.847002723218941,0,11,sequence-specific single stranded DNA binding,MF,
18201,GO:0098850,1,0.986952701688737,0,1,extrinsic component of synaptic vesicle membrane,CC,
18203,GO:0098855,1,0.951128515515496,0,3,HCN channel complex,CC,
18204,GO:0098856,1,0.836170831840947,0,14,intestinal lipid absorption,BP,
18210,GO:0098870,1,0.904903549418185,0,7,action potential propagation,BP,
18211,GO:0098871,1,0.988198724430627,0,1,postsynaptic actin cytoskeleton,CC,
18212,GO:0098875,1,0.983406759351968,0,1,epididymosome,CC,
18213,GO:0098876,1,0.359248252369292,0,68,vesicle-mediated transport to the plasma membrane,BP,
18214,GO:0098877,1,0.842845621653201,0,11,neurotransmitter receptor transport to plasma membrane,BP,
18215,GO:0098878,1,0.490949650877013,0,47,neurotransmitter receptor complex,CC,
18216,GO:0098881,1,0.940479629377976,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
18217,GO:0098883,1,0.987639280010081,0,1,synapse disassembly,BP,
18218,GO:0098884,1,0.983406759351231,0,1,postsynaptic neurotransmitter receptor internalization,BP,
18219,GO:0098885,1,0.967087733486655,0,2,modification of postsynaptic actin cytoskeleton,BP,
18220,GO:0098886,1,0.968384722376111,0,2,modification of dendritic spine,BP,
18221,GO:0098887,1,0.924155864813107,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18222,GO:0098888,1,0.983406759351328,0,1,extrinsic component of presynaptic membrane,CC,
18223,GO:0098890,1,0.983406759351328,0,1,extrinsic component of postsynaptic membrane,CC,
18224,GO:0098895,1,0.983406759352069,0,1,postsynaptic endosome membrane,CC,
18227,GO:0098902,1,0.920344926160556,0,6,regulation of membrane depolarization during action potential,BP,
18228,GO:0098903,1,0.876791150465514,0,8,regulation of membrane repolarization during action potential,BP,
18229,GO:0098904,1,0.952807729597919,0,3,regulation of AV node cell action potential,BP,
18230,GO:0098905,1,0.977452804444579,0,2,regulation of bundle of His cell action potential,BP,
18231,GO:0098906,1,0.983668456749255,0,1,regulation of Purkinje myocyte action potential,BP,
18232,GO:0098907,1,0.967087733484529,0,2,regulation of SA node cell action potential,BP,
18233,GO:0098908,1,0.932412215493602,0,5,regulation of neuronal action potential,BP,
18234,GO:0098909,1,0.892908697916115,0,8,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18235,GO:0098910,1,0.904705403034387,0,6,regulation of atrial cardiac muscle cell action potential,BP,
18237,GO:0098912,1,0.951038409341779,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18238,GO:0098914,1,0.90955217230425,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18241,GO:0098917,1,0.935254347829422,0,4,retrograde trans-synaptic signaling,BP,
18242,GO:0098918,1,0.987609473003608,0,1,structural constituent of synapse,MF,
18243,GO:0098920,1,0.983406759351724,0,1,retrograde trans-synaptic signaling by lipid,BP,
18244,GO:0098921,1,0.983406759351724,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
18245,GO:0098923,1,0.983406759351379,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18246,GO:0098924,1,0.983406759351379,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18248,GO:0098928,1,0.967087733482398,0,2,presynaptic signal transduction,BP,
18249,GO:0098930,1,0.57542295056987,0,38,axonal transport,BP,
18250,GO:0098935,1,0.951043290108843,0,3,dendritic transport,BP,
18251,GO:0098936,1,0.904464835769611,0,6,intrinsic component of postsynaptic membrane,CC,
18252,GO:0098937,1,0.951043290108843,0,3,anterograde dendritic transport,BP,
18253,GO:0098939,1,0.983406759351527,0,1,dendritic transport of mitochondrion,BP,
18254,GO:0098942,1,0.983406759351921,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18255,GO:0098943,1,0.972594634905827,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
18256,GO:0098948,1,0.951038409341973,0,3,intrinsic component of postsynaptic specialization membrane,CC,
18257,GO:0098953,1,0.989006199657654,0,1,receptor diffusion trapping,BP,
18258,GO:0098957,1,0.983406759351921,0,1,anterograde axonal transport of mitochondrion,BP,
18259,GO:0098960,1,0.740866309026036,0,20,postsynaptic neurotransmitter receptor activity,MF,
18260,GO:0098967,1,0.940479629377976,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18261,GO:0098968,1,0.983406759351872,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18262,GO:0098969,1,0.856939137934279,0,10,neurotransmitter receptor transport to postsynaptic membrane,BP,
18263,GO:0098970,1,0.989006199657654,0,1,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18264,GO:0098971,1,0.967092696276502,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18265,GO:0098972,1,0.983406759351527,0,1,anterograde dendritic transport of mitochondrion,BP,
18266,GO:0098973,1,0.987609473003608,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18267,GO:0098974,1,0.987609473003608,0,1,postsynaptic actin cytoskeleton organization,BP,
18268,GO:0098976,1,0.985051997781775,0,1,excitatory chemical synaptic transmission,BP,
18269,GO:0098982,1,0.983793887965019,0,1,GABA-ergic synapse,CC,
18271,GO:0098988,1,0.920771407167316,0,5,G-protein coupled glutamate receptor activity,MF,
18272,GO:0098989,1,0.972823516018471,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18273,GO:0098992,1,0.984976896186545,0,1,neuronal dense core vesicle,CC,
18274,GO:0098993,1,0.961954677055015,0,3,anchored component of synaptic vesicle membrane,CC,
18275,GO:0098999,1,0.983406759352069,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18277,GO:0099004,1,0.951038409343304,0,3,calmodulin dependent kinase signaling pathway,BP,
18278,GO:0099010,1,0.936508816984823,0,4,modification of postsynaptic structure,BP,
18279,GO:0099011,1,0.935254630099824,0,4,neuronal dense core vesicle exocytosis,BP,
18282,GO:0099038,1,0.983406759351921,0,1,ceramide-translocating ATPase activity,MF,
18283,GO:0099039,1,0.983406759351921,0,1,sphingolipid translocation,BP,
18284,GO:0099040,1,0.983406759351921,0,1,ceramide translocation,BP,
18285,GO:0099046,1,0.989606335213473,0,1,clearance of foreign intracellular nucleic acids,BP,
18286,GO:0099053,1,0.954853076052657,0,3,activating signal cointegrator 1 complex,CC,
18288,GO:0099055,1,0.904464835769611,0,6,integral component of postsynaptic membrane,CC,
18289,GO:0099060,1,0.951038409341973,0,3,integral component of postsynaptic specialization membrane,CC,
18290,GO:0099061,1,0.951038409341973,0,3,integral component of postsynaptic density membrane,CC,
18292,GO:0099072,1,0.914698973438155,0,6,regulation of postsynaptic specialization membrane neurotransmitter receptor levels,BP,
18293,GO:0099073,1,0.967242455632565,0,2,mitochondrion-derived vesicle,CC,
18294,GO:0099074,1,0.968286819847074,0,2,mitochondrion to lysosome transport,BP,
18295,GO:0099075,1,0.968286819847074,0,2,mitochondrion-derived vesicle mediated transport,BP,
18296,GO:0099078,1,0.959873745380758,0,4,BORC complex,CC,
18299,GO:0099082,1,0.983406759352069,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
18301,GO:0099086,1,0.639486615223701,0,32,synaptonemal structure,CC,
18303,GO:0099095,1,0.829399210671514,0,12,ligand-gated anion channel activity,MF,
18305,GO:0099111,1,0.165913347662645,0,121,microtubule-based transport,BP,
18306,GO:0099118,1,0.518912971438498,0,46,microtubule-based protein transport,BP,
18307,GO:0099122,1,0.969717349665414,0,2,RNA polymerase II C-terminal domain binding,MF,
18308,GO:0099131,1,0.386092900567034,0,68,ATP hydrolysis coupled ion transmembrane transport,BP,
18309,GO:0099132,1,0.471993661124163,0,56,ATP hydrolysis coupled cation transmembrane transport,BP,
18310,GO:0099133,1,0.804922421514484,0,13,ATP hydrolysis coupled anion transmembrane transport,BP,
18311,GO:0099142,1,0.983406759351627,0,1,intracellular ATP-gated ion channel activity,MF,
18312,GO:0099400,1,0.983406759350836,0,1,caveola neck,CC,
18313,GO:0099402,1,0.99404187805355,0,1,plant organ development,BP,
18314,GO:0099403,1,0.967087733485254,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18315,GO:0099404,1,0.967087733485254,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18316,GO:0099500,1,0.810250119392487,0,15,vesicle fusion to plasma membrane,BP,
18320,GO:0099509,1,0.984788095004683,0,1,regulation of presynaptic cytosolic calcium ion concentration,BP,
18323,GO:0099514,1,0.79150960619619,0,17,synaptic vesicle cytoskeletal transport,BP,
18324,GO:0099515,1,0.904465240777407,0,6,actin filament-based transport,BP,
18325,GO:0099516,1,0.394963268831016,0,59,ion antiporter activity,MF,
18326,GO:0099517,1,0.79150960619619,0,17,synaptic vesicle transport along microtubule,BP,
18327,GO:0099518,1,0.544907145629663,0,40,vesicle cytoskeletal trafficking,BP,
18328,GO:0099525,1,0.935254630099824,0,4,presynaptic dense core vesicle exocytosis,BP,
18329,GO:0099526,1,0.967087733482398,0,2,presynapse to nucleus signaling pathway,BP,
18330,GO:0099528,1,0.928712815255303,0,5,G-protein coupled neurotransmitter receptor activity,MF,
18331,GO:0099529,1,0.753381906678979,0,19,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18332,GO:0099530,1,0.983406759351183,0,1,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18334,GO:0099532,1,0.96708773348714,0,2,synaptic vesicle endosomal processing,BP,
18337,GO:0099538,1,0.983406759352069,0,1,synaptic signaling via neuropeptide,BP,
18338,GO:0099540,1,0.983406759352069,0,1,trans-synaptic signaling by neuropeptide,BP,
18339,GO:0099541,1,0.951041810545422,0,3,trans-synaptic signaling by lipid,BP,
18340,GO:0099542,1,0.951041810545422,0,3,trans-synaptic signaling by endocannabinoid,BP,
18341,GO:0099543,1,0.983406759351379,0,1,trans-synaptic signaling by soluble gas,BP,
18342,GO:0099545,1,0.967087733487917,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18343,GO:0099548,1,0.983406759351379,0,1,trans-synaptic signaling by nitric oxide,BP,
18344,GO:0099550,1,0.951041810545661,0,3,trans-synaptic signalling, modulating synaptic transmission,BP,
18345,GO:0099552,1,0.967091191848012,0,2,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18346,GO:0099553,1,0.967091191848012,0,2,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18347,GO:0099557,1,0.983406759351921,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18348,GO:0099558,1,0.978685148001803,0,2,maintenance of synapse structure,BP,
18349,GO:0099563,1,0.90833298140138,0,6,modification of synaptic structure,BP,
18351,GO:0099566,1,0.967087733486996,0,2,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18353,GO:0099569,1,0.967087733482398,0,2,presynaptic cytoskeleton,CC,
18354,GO:0099571,1,0.988198724430627,0,1,postsynaptic cytoskeleton,CC,
18356,GO:0099580,1,0.967087733487574,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18357,GO:0099583,1,0.967087733486996,0,2,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18359,GO:0099589,1,0.717335183345762,0,29,serotonin receptor activity,MF,
18360,GO:0099590,1,0.943514351855132,0,4,neurotransmitter receptor internalization,BP,
18362,GO:0099601,1,0.606302940285808,0,34,regulation of neurotransmitter receptor activity,BP,
18363,GO:0099602,1,0.931306606441576,0,6,neurotransmitter receptor regulator activity,MF,
18364,GO:0099604,1,0.753810560836047,0,18,ligand-gated calcium channel activity,MF,
18365,GO:0099607,1,0.983406759350987,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18366,GO:0099609,1,0.96708773348748,0,2,microtubule lateral binding,MF,
18367,GO:0099612,1,0.890233542139765,0,7,protein localization to axon,BP,
18368,GO:0099617,1,0.983506624042998,0,1,matrix side of mitochondrial inner membrane,CC,
18371,GO:0099624,1,0.873905999180498,0,9,atrial cardiac muscle cell membrane repolarization,BP,
18373,GO:0099628,1,0.989006199657654,0,1,neurotransmitter receptor diffusion trapping,BP,
18374,GO:0099634,1,0.87161495831686,0,9,postsynaptic specialization membrane,CC,
18375,GO:0099637,1,0.806117873926705,0,14,neurotransmitter receptor transport,BP,
18376,GO:0099638,1,0.89390092908016,0,7,endosome to plasma membrane protein transport,BP,
18377,GO:0099639,1,0.908961593243648,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18378,GO:0099640,1,0.993211620676457,0,1,axo-dendritic protein transport,BP,
18379,GO:0099641,1,0.993211620676457,0,1,anterograde axonal protein transport,BP,
18381,GO:0099738,1,0.796002355580241,0,16,cell cortex region,CC,
18382,GO:0100001,1,0.983406759351821,0,1,regulation of skeletal muscle contraction by action potential,BP,
18384,GO:0100012,1,0.963439984792209,0,3,regulation of heart induction by canonical Wnt signaling pathway,BP,
18385,GO:0100057,1,0.983406759351232,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18388,GO:0101005,1,0.17991472381212,0,111,ubiquitinyl hydrolase activity,MF,
18389,GO:0101020,1,0.932215722836493,0,5,estrogen 16-alpha-hydroxylase activity,MF,
18390,GO:0101023,1,0.988499272489636,0,1,vascular endothelial cell proliferation,BP,
18391,GO:0101030,1,0.990251360910938,0,1,tRNA-guanine transglycosylation,BP,
18392,GO:0101031,1,0.844604062385146,0,12,chaperone complex,CC,
18393,GO:0102005,1,0.989218646126002,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18394,GO:0102007,1,0.967900783938756,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18395,GO:0102008,1,0.983406759351921,0,1,cytosolic dipeptidase activity,MF,
18396,GO:0102009,1,0.987193674591034,0,1,proline dipeptidase activity,MF,
18397,GO:0102076,1,0.984068730074366,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18398,GO:0102077,1,0.973097269014845,0,2,oleamide hydrolase activity,MF,
18399,GO:0102084,1,0.969652692165568,0,2,L-dopa O-methyltransferase activity,MF,
18401,GO:0102279,1,0.983406759351921,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18402,GO:0102320,1,0.984220960393285,0,1,1,8-cineole 2-exo-monooxygenase activity,MF,
18403,GO:0102336,1,0.902186315265529,0,7,3-oxo-arachidoyl-CoA synthase activity,MF,
18404,GO:0102337,1,0.902186315265529,0,7,3-oxo-cerotoyl-CoA synthase activity,MF,
18405,GO:0102338,1,0.902186315265529,0,7,3-oxo-lignoceronyl-CoA synthase activity,MF,
18406,GO:0102339,1,0.984774353792716,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18407,GO:0102340,1,0.984774353792716,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18408,GO:0102341,1,0.984774353792716,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18409,GO:0102342,1,0.984774353792716,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18410,GO:0102390,1,0.984516272748412,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18412,GO:0102483,1,0.98824908620679,0,1,scopolin beta-glucosidase activity,MF,
18413,GO:0102490,1,0.954304273952356,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18414,GO:0102522,1,0.985845372198112,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18415,GO:0102549,1,0.989329120391137,0,1,1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity,MF,
18416,GO:0102571,1,0.983406759351869,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18417,GO:0102704,1,0.983989121954792,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18418,GO:0102867,1,0.984303005945753,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18419,GO:0102991,1,0.918043637027806,0,7,myristoyl-CoA hydrolase activity,MF,
18420,GO:0103046,1,0.983406759351921,0,1,alanylglutamate dipeptidase activity,MF,
18421,GO:0103053,1,0.977632954711095,0,2,1-ethyladenine demethylase activity,MF,
18422,GO:0103073,1,0.973097269014845,0,2,anandamide amidohydrolase activity,MF,
18423,GO:0103095,1,0.976190427317539,0,2,wax ester synthase activity,MF,
18424,GO:0106001,1,0.936356874573403,0,4,intestinal hexose absorption,BP,
18427,GO:1900003,1,0.880405394777319,0,13,regulation of serine-type endopeptidase activity,BP,
18428,GO:1900004,1,0.902678584042788,0,11,negative regulation of serine-type endopeptidase activity,BP,
18429,GO:1900005,1,0.959150195927251,0,3,positive regulation of serine-type endopeptidase activity,BP,
18431,GO:1900010,1,0.987461994909068,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18432,GO:1900011,1,0.987461994909068,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18433,GO:1900015,1,0.711290402843848,0,24,regulation of cytokine production involved in inflammatory response,BP,
18434,GO:1900016,1,0.881105391411589,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18435,GO:1900017,1,0.877758735079891,0,10,positive regulation of cytokine production involved in inflammatory response,BP,
18438,GO:1900024,1,0.542025141851858,0,42,regulation of substrate adhesion-dependent cell spreading,BP,
18439,GO:1900025,1,0.839939577391364,0,11,negative regulation of substrate adhesion-dependent cell spreading,BP,
18440,GO:1900026,1,0.65643010878086,0,30,positive regulation of substrate adhesion-dependent cell spreading,BP,
18442,GO:1900028,1,0.935136674302815,0,5,negative regulation of ruffle assembly,BP,
18444,GO:1900034,1,0.325050622466785,0,74,regulation of cellular response to heat,BP,
18445,GO:1900035,1,0.984344893426395,0,1,negative regulation of cellular response to heat,BP,
18446,GO:1900036,1,0.985405648431003,0,1,positive regulation of cellular response to heat,BP,
18447,GO:1900037,1,0.868642163194584,0,10,regulation of cellular response to hypoxia,BP,
18448,GO:1900038,1,0.925829782339227,0,5,negative regulation of cellular response to hypoxia,BP,
18449,GO:1900039,1,0.974934283434203,0,2,positive regulation of cellular response to hypoxia,BP,
18450,GO:1900040,1,0.892425918981615,0,7,regulation of interleukin-2 secretion,BP,
18451,GO:1900041,1,0.937237310651458,0,4,negative regulation of interleukin-2 secretion,BP,
18452,GO:1900042,1,0.9522003055752,0,3,positive regulation of interleukin-2 secretion,BP,
18453,GO:1900044,1,0.891517307087801,0,7,regulation of protein K63-linked ubiquitination,BP,
18454,GO:1900045,1,0.937004217556338,0,4,negative regulation of protein K63-linked ubiquitination,BP,
18457,GO:1900048,1,0.70883840696848,0,24,positive regulation of hemostasis,BP,
18458,GO:1900052,1,0.990960962472649,0,1,regulation of retinoic acid biosynthetic process,BP,
18459,GO:1900053,1,0.990960962472649,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18460,GO:1900060,1,0.947195050588576,0,4,negative regulation of ceramide biosynthetic process,BP,
18461,GO:1900062,1,0.983417459896872,0,1,regulation of replicative cell aging,BP,
18462,GO:1900063,1,0.95417491397689,0,3,regulation of peroxisome organization,BP,
18463,GO:1900073,1,0.988833793934524,0,1,regulation of neuromuscular synaptic transmission,BP,
18464,GO:1900075,1,0.988833793934524,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18466,GO:1900077,1,0.619382922857084,0,32,negative regulation of cellular response to insulin stimulus,BP,
18468,GO:1900081,1,0.983406759350938,0,1,regulation of arginine catabolic process,BP,
18469,GO:1900082,1,0.983406759350938,0,1,negative regulation of arginine catabolic process,BP,
18470,GO:1900084,1,0.905574120545239,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18471,GO:1900085,1,0.984446265994769,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18472,GO:1900086,1,0.919886703425541,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18473,GO:1900087,1,0.681836732698672,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18474,GO:1900094,1,0.914706751739544,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18475,GO:1900095,1,0.983406759350544,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18476,GO:1900098,1,0.987621879994363,0,1,regulation of plasma cell differentiation,BP,
18477,GO:1900100,1,0.987621879994363,0,1,positive regulation of plasma cell differentiation,BP,
18479,GO:1900102,1,0.882347795202541,0,8,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18483,GO:1900107,1,0.911069213038366,0,7,regulation of nodal signaling pathway,BP,
18484,GO:1900108,1,0.963521015513656,0,3,negative regulation of nodal signaling pathway,BP,
18485,GO:1900109,1,0.952337672765873,0,4,regulation of histone H3-K9 dimethylation,BP,
18486,GO:1900110,1,0.979121222734871,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18487,GO:1900111,1,0.972647684438307,0,2,positive regulation of histone H3-K9 dimethylation,BP,
18488,GO:1900112,1,0.846918739851745,0,11,regulation of histone H3-K9 trimethylation,BP,
18489,GO:1900113,1,0.916179567629042,0,6,negative regulation of histone H3-K9 trimethylation,BP,
18490,GO:1900114,1,0.955041233196953,0,3,positive regulation of histone H3-K9 trimethylation,BP,
18491,GO:1900115,1,0.820862776742711,0,14,extracellular regulation of signal transduction,BP,
18492,GO:1900116,1,0.820862776742711,0,14,extracellular negative regulation of signal transduction,BP,
18493,GO:1900117,1,0.724773522383382,0,23,regulation of execution phase of apoptosis,BP,
18494,GO:1900118,1,0.893335924639942,0,8,negative regulation of execution phase of apoptosis,BP,
18495,GO:1900119,1,0.851055739631369,0,12,positive regulation of execution phase of apoptosis,BP,
18496,GO:1900120,1,0.743090330800778,0,21,regulation of receptor binding,BP,
18497,GO:1900121,1,0.84242702409294,0,12,negative regulation of receptor binding,BP,
18498,GO:1900122,1,0.893802202897627,0,8,positive regulation of receptor binding,BP,
18500,GO:1900126,1,0.953501894217933,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18502,GO:1900130,1,0.983432658119759,0,1,regulation of lipid binding,BP,
18503,GO:1900131,1,0.983432658119759,0,1,negative regulation of lipid binding,BP,
18504,GO:1900133,1,0.936866452644182,0,4,regulation of renin secretion into blood stream,BP,
18505,GO:1900134,1,0.983410275827822,0,1,negative regulation of renin secretion into blood stream,BP,
18506,GO:1900135,1,0.968493270679651,0,2,positive regulation of renin secretion into blood stream,BP,
18507,GO:1900138,1,0.960276356184846,0,3,negative regulation of phospholipase A2 activity,BP,
18508,GO:1900139,1,0.983406759351921,0,1,negative regulation of arachidonic acid secretion,BP,
18511,GO:1900145,1,0.93926933892589,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18512,GO:1900146,1,0.979250836821997,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18513,GO:1900147,1,0.96838472237558,0,2,regulation of Schwann cell migration,BP,
18514,GO:1900148,1,0.984725543253726,0,1,negative regulation of Schwann cell migration,BP,
18515,GO:1900149,1,0.98340675935133,0,1,positive regulation of Schwann cell migration,BP,
18516,GO:1900151,1,0.796198271685557,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18517,GO:1900152,1,0.98755017012104,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18518,GO:1900153,1,0.796198271685557,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18519,GO:1900154,1,0.97180570603597,0,2,regulation of bone trabecula formation,BP,
18520,GO:1900155,1,0.97180570603597,0,2,negative regulation of bone trabecula formation,BP,
18521,GO:1900157,1,0.962931063989356,0,3,regulation of bone mineralization involved in bone maturation,BP,
18522,GO:1900158,1,0.977312836619715,0,2,negative regulation of bone mineralization involved in bone maturation,BP,
18523,GO:1900159,1,0.985285763596706,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18524,GO:1900161,1,0.984192501423316,0,1,regulation of phospholipid scramblase activity,BP,
18525,GO:1900163,1,0.984192501423316,0,1,positive regulation of phospholipid scramblase activity,BP,
18526,GO:1900164,1,0.914706751739544,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18528,GO:1900166,1,0.969067190310818,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18529,GO:1900168,1,0.969067190310818,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18530,GO:1900169,1,0.968384722374224,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18531,GO:1900170,1,0.984725543253726,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18532,GO:1900175,1,0.93926933892589,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18533,GO:1900176,1,0.979250836821997,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18538,GO:1900190,1,0.970235141285895,0,2,regulation of single-species biofilm formation,BP,
18539,GO:1900191,1,0.970235141285895,0,2,negative regulation of single-species biofilm formation,BP,
18542,GO:1900195,1,0.972897366243288,0,2,positive regulation of oocyte maturation,BP,
18543,GO:1900200,1,0.951781762040314,0,3,mesenchymal cell apoptotic process involved in metanephros development,BP,
18544,GO:1900204,1,0.967088800164192,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18545,GO:1900205,1,0.967088800164192,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18546,GO:1900208,1,0.990628060157684,0,1,regulation of cardiolipin metabolic process,BP,
18547,GO:1900210,1,0.990628060157684,0,1,positive regulation of cardiolipin metabolic process,BP,
18548,GO:1900211,1,0.951781762040314,0,3,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18549,GO:1900212,1,0.951781762040314,0,3,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18550,GO:1900214,1,0.967088800164192,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18551,GO:1900215,1,0.967088800164192,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18552,GO:1900217,1,0.967088800164192,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18553,GO:1900218,1,0.967088800164192,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18554,GO:1900220,1,0.967087733487384,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18555,GO:1900221,1,0.917395413169061,0,6,regulation of beta-amyloid clearance,BP,
18556,GO:1900222,1,0.956311992457481,0,3,negative regulation of beta-amyloid clearance,BP,
18557,GO:1900223,1,0.983406759351429,0,1,positive regulation of beta-amyloid clearance,BP,
18558,GO:1900224,1,0.969988208781656,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18559,GO:1900225,1,0.865977031629093,0,10,regulation of NLRP3 inflammasome complex assembly,BP,
18560,GO:1900226,1,0.952347623012752,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18561,GO:1900227,1,0.923774492352796,0,5,positive regulation of NLRP3 inflammasome complex assembly,BP,
18562,GO:1900228,1,0.970235141285895,0,2,regulation of single-species biofilm formation in or on host organism,BP,
18563,GO:1900229,1,0.970235141285895,0,2,negative regulation of single-species biofilm formation in or on host organism,BP,
18564,GO:1900234,1,0.983410120254353,0,1,regulation of Kit signaling pathway,BP,
18565,GO:1900235,1,0.983410120254353,0,1,negative regulation of Kit signaling pathway,BP,
18569,GO:1900242,1,0.885574849688791,0,8,regulation of synaptic vesicle endocytosis,BP,
18570,GO:1900243,1,0.98340675935187,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18571,GO:1900244,1,0.953807248533423,0,3,positive regulation of synaptic vesicle endocytosis,BP,
18572,GO:1900245,1,0.94145407142257,0,4,positive regulation of MDA-5 signaling pathway,BP,
18573,GO:1900246,1,0.897548340207526,0,7,positive regulation of RIG-I signaling pathway,BP,
18574,GO:1900247,1,0.967087733487527,0,2,regulation of cytoplasmic translational elongation,BP,
18575,GO:1900248,1,0.967087733487527,0,2,negative regulation of cytoplasmic translational elongation,BP,
18576,GO:1900259,1,0.987198386091915,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18577,GO:1900260,1,0.987198386091915,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18578,GO:1900262,1,0.923019047733267,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18579,GO:1900264,1,0.923019047733267,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18580,GO:1900271,1,0.735908666766114,0,20,regulation of long-term synaptic potentiation,BP,
18581,GO:1900272,1,0.943843500879734,0,4,negative regulation of long-term synaptic potentiation,BP,
18582,GO:1900273,1,0.841128216806209,0,11,positive regulation of long-term synaptic potentiation,BP,
18584,GO:1900275,1,0.967165611129855,0,2,negative regulation of phospholipase C activity,BP,
18585,GO:1900276,1,0.98348594567814,0,1,regulation of proteinase activated receptor activity,BP,
18586,GO:1900279,1,0.983466930130704,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18587,GO:1900281,1,0.983466930130704,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18588,GO:1900363,1,0.856338221112826,0,10,regulation of mRNA polyadenylation,BP,
18589,GO:1900364,1,0.893234605442771,0,7,negative regulation of mRNA polyadenylation,BP,
18590,GO:1900365,1,0.96969024391865,0,2,positive regulation of mRNA polyadenylation,BP,
18591,GO:1900368,1,0.951038409344206,0,3,regulation of RNA interference,BP,
18592,GO:1900369,1,0.967087733487673,0,2,negative regulation of RNA interference,BP,
18593,GO:1900370,1,0.983406759351821,0,1,positive regulation of RNA interference,BP,
18599,GO:1900378,1,0.947348676697375,0,4,positive regulation of secondary metabolite biosynthetic process,BP,
18600,GO:1900383,1,0.983585559101136,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18601,GO:1900387,1,0.986306364919517,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18602,GO:1900390,1,0.9796286563165,0,2,regulation of iron ion import,BP,
18603,GO:1900402,1,0.867689628145906,0,9,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18606,GO:1900409,1,0.828102002935421,0,14,positive regulation of cellular response to oxidative stress,BP,
18607,GO:1900424,1,0.842391849107037,0,14,regulation of defense response to bacterium,BP,
18608,GO:1900425,1,0.940597481098852,0,4,negative regulation of defense response to bacterium,BP,
18609,GO:1900426,1,0.912596238683883,0,9,positive regulation of defense response to bacterium,BP,
18610,GO:1900449,1,0.603827601340761,0,34,regulation of glutamate receptor signaling pathway,BP,
18611,GO:1900451,1,0.911739345841015,0,6,positive regulation of glutamate receptor signaling pathway,BP,
18614,GO:1900454,1,0.96709472542678,0,2,positive regulation of long term synaptic depression,BP,
18615,GO:1900477,1,0.986380941516767,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18616,GO:1900483,1,0.984633588767659,0,1,regulation of protein targeting to vacuolar membrane,BP,
18617,GO:1900533,1,0.989100496900187,0,1,palmitic acid metabolic process,BP,
18618,GO:1900535,1,0.989100496900187,0,1,palmitic acid biosynthetic process,BP,
18622,GO:1900619,1,0.9379097171519,0,4,acetate ester metabolic process,BP,
18623,GO:1900620,1,0.968167046838403,0,2,acetate ester biosynthetic process,BP,
18624,GO:1900623,1,0.951204452567709,0,3,regulation of monocyte aggregation,BP,
18625,GO:1900625,1,0.951204452567709,0,3,positive regulation of monocyte aggregation,BP,
18626,GO:1900673,1,0.954570281178893,0,3,olefin metabolic process,BP,
18627,GO:1900719,1,0.983406759351921,0,1,regulation of uterine smooth muscle relaxation,BP,
18628,GO:1900721,1,0.983406759351921,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18630,GO:1900737,1,0.98348594567814,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18637,GO:1900747,1,0.944235523210321,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18638,GO:1900748,1,0.951038409344015,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18640,GO:1900756,1,0.96797020924723,0,2,protein processing in phagocytic vesicle,BP,
18641,GO:1900757,1,0.992685897233266,0,1,regulation of D-amino-acid oxidase activity,BP,
18642,GO:1900758,1,0.992685897233266,0,1,negative regulation of D-amino-acid oxidase activity,BP,
18643,GO:1900825,1,0.935878413204426,0,5,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18644,GO:1900826,1,0.99005688908311,0,1,negative regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18645,GO:1900827,1,0.983406759350691,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18646,GO:1900864,1,0.886329165169165,0,9,mitochondrial RNA modification,BP,
18647,GO:1900920,1,0.967087733487433,0,2,regulation of L-glutamate import,BP,
18648,GO:1901004,1,0.990659814744319,0,1,ubiquinone-6 metabolic process,BP,
18649,GO:1901006,1,0.990659814744319,0,1,ubiquinone-6 biosynthetic process,BP,
18655,GO:1901021,1,0.671376360549937,0,28,positive regulation of calcium ion transmembrane transporter activity,BP,
18656,GO:1901026,1,0.938636377659656,0,4,ripoptosome assembly involved in necroptotic process,BP,
18658,GO:1901029,1,0.906625418483001,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18661,GO:1901032,1,0.794258704004781,0,16,negative regulation of response to reactive oxygen species,BP,
18662,GO:1901033,1,0.90145634906122,0,8,positive regulation of response to reactive oxygen species,BP,
18663,GO:1901042,1,0.984675140077779,0,1,positive regulation of L-arginine import,BP,
18664,GO:1901052,1,0.983553385989877,0,1,sarcosine metabolic process,BP,
18665,GO:1901053,1,0.983553385989877,0,1,sarcosine catabolic process,BP,
18667,GO:1901069,1,0.979045101252517,0,2,guanosine-containing compound catabolic process,BP,
18668,GO:1901070,1,0.871415800440057,0,13,guanosine-containing compound biosynthetic process,BP,
18669,GO:1901071,1,0.756877913480891,0,19,glucosamine-containing compound metabolic process,BP,
18670,GO:1901072,1,0.945187979255112,0,4,glucosamine-containing compound catabolic process,BP,
18671,GO:1901073,1,0.967091851055718,0,2,glucosamine-containing compound biosynthetic process,BP,
18672,GO:1901074,1,0.968077231788841,0,2,regulation of engulfment of apoptotic cell,BP,
18673,GO:1901076,1,0.983406759351429,0,1,positive regulation of engulfment of apoptotic cell,BP,
18677,GO:1901080,1,0.983406759351921,0,1,regulation of relaxation of smooth muscle,BP,
18678,GO:1901082,1,0.983406759351921,0,1,positive regulation of relaxation of smooth muscle,BP,
18679,GO:1901086,1,0.983406759351921,0,1,benzylpenicillin metabolic process,BP,
18680,GO:1901090,1,0.970903324180031,0,2,regulation of protein tetramerization,BP,
18681,GO:1901091,1,0.970903324180031,0,2,negative regulation of protein tetramerization,BP,
18682,GO:1901093,1,0.970903324180031,0,2,regulation of protein homotetramerization,BP,
18683,GO:1901094,1,0.970903324180031,0,2,negative regulation of protein homotetramerization,BP,
18684,GO:1901096,1,0.865876000214953,0,9,regulation of autophagosome maturation,BP,
18685,GO:1901097,1,0.970239693289961,0,2,negative regulation of autophagosome maturation,BP,
18686,GO:1901098,1,0.907509512711655,0,6,positive regulation of autophagosome maturation,BP,
18688,GO:1901128,1,0.985688193475059,0,1,gentamycin metabolic process,BP,
18692,GO:1901142,1,0.910182459574399,0,6,insulin metabolic process,BP,
18693,GO:1901143,1,0.967152948850713,0,2,insulin catabolic process,BP,
18695,GO:1901146,1,0.984174220502037,0,1,mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
18696,GO:1901147,1,0.967088800164192,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18697,GO:1901159,1,0.941944323047372,0,5,xylulose 5-phosphate biosynthetic process,BP,
18698,GO:1901160,1,0.823185998151355,0,13,primary amino compound metabolic process,BP,
18699,GO:1901162,1,0.946490813842031,0,4,primary amino compound biosynthetic process,BP,
18700,GO:1901163,1,0.907364791974604,0,8,regulation of trophoblast cell migration,BP,
18701,GO:1901164,1,0.942283405966443,0,5,negative regulation of trophoblast cell migration,BP,
18702,GO:1901165,1,0.96295154143785,0,3,positive regulation of trophoblast cell migration,BP,
18703,GO:1901166,1,0.937145183956142,0,4,neural crest cell migration involved in autonomic nervous system development,BP,
18707,GO:1901187,1,0.968979435068003,0,2,regulation of ephrin receptor signaling pathway,BP,
18708,GO:1901189,1,0.985330249646519,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18709,GO:1901193,1,0.991610395808814,0,1,regulation of formation of translation preinitiation complex,BP,
18710,GO:1901194,1,0.991610395808814,0,1,negative regulation of formation of translation preinitiation complex,BP,
18712,GO:1901202,1,0.98535187047582,0,1,negative regulation of extracellular matrix assembly,BP,
18713,GO:1901203,1,0.863493789616056,0,9,positive regulation of extracellular matrix assembly,BP,
18714,GO:1901204,1,0.967087733486368,0,2,regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18715,GO:1901205,1,0.967087733486368,0,2,negative regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18716,GO:1901206,1,0.983406759351379,0,1,positive regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18717,GO:1901207,1,0.967193367750605,0,2,regulation of heart looping,BP,
18718,GO:1901208,1,0.983514156454023,0,1,negative regulation of heart looping,BP,
18719,GO:1901210,1,0.983514156454023,0,1,regulation of cardiac chamber formation,BP,
18720,GO:1901211,1,0.983514156454023,0,1,negative regulation of cardiac chamber formation,BP,
18724,GO:1901216,1,0.380691885423835,0,67,positive regulation of neuron death,BP,
18725,GO:1901219,1,0.983514156454023,0,1,regulation of cardiac chamber morphogenesis,BP,
18726,GO:1901220,1,0.983514156454023,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18727,GO:1901222,1,0.468278833747564,0,52,regulation of NIK/NF-kappaB signaling,BP,
18728,GO:1901223,1,0.868135922148992,0,10,negative regulation of NIK/NF-kappaB signaling,BP,
18729,GO:1901224,1,0.567164748954795,0,39,positive regulation of NIK/NF-kappaB signaling,BP,
18730,GO:1901228,1,0.93660798413874,0,4,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18731,GO:1901229,1,0.984643899909647,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18732,GO:1901231,1,0.984643899909647,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18733,GO:1901232,1,0.984643899909647,0,1,regulation of convergent extension involved in axis elongation,BP,
18734,GO:1901233,1,0.984643899909647,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18735,GO:1901246,1,0.975284561771581,0,2,regulation of lung ciliated cell differentiation,BP,
18736,GO:1901247,1,0.990609033835784,0,1,negative regulation of lung ciliated cell differentiation,BP,
18737,GO:1901248,1,0.984530854415234,0,1,positive regulation of lung ciliated cell differentiation,BP,
18738,GO:1901249,1,0.990609033835784,0,1,regulation of lung goblet cell differentiation,BP,
18739,GO:1901251,1,0.990609033835784,0,1,positive regulation of lung goblet cell differentiation,BP,
18740,GO:1901252,1,0.962581829288155,0,3,regulation of intracellular transport of viral material,BP,
18741,GO:1901253,1,0.978825141952175,0,2,negative regulation of intracellular transport of viral material,BP,
18742,GO:1901254,1,0.983406759352021,0,1,positive regulation of intracellular transport of viral material,BP,
18743,GO:1901255,1,0.972383760112813,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18744,GO:1901256,1,0.939035847801469,0,4,regulation of macrophage colony-stimulating factor production,BP,
18745,GO:1901257,1,0.985453353462232,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18746,GO:1901258,1,0.968943558303379,0,2,positive regulation of macrophage colony-stimulating factor production,BP,
18749,GO:1901269,1,0.994875889508817,0,1,lipooligosaccharide metabolic process,BP,
18750,GO:1901271,1,0.994875889508817,0,1,lipooligosaccharide biosynthetic process,BP,
18751,GO:1901291,1,0.987102383296377,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18754,GO:1901295,1,0.973150115872483,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18755,GO:1901296,1,0.987639280010081,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18756,GO:1901297,1,0.985330249646519,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18757,GO:1901298,1,0.869891465068161,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18758,GO:1901299,1,0.919228186745567,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18759,GO:1901300,1,0.946346342216888,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18760,GO:1901301,1,0.968015732742346,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18761,GO:1901303,1,0.984350353013124,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18762,GO:1901304,1,0.988182873842877,0,1,regulation of spermidine biosynthetic process,BP,
18763,GO:1901307,1,0.988182873842877,0,1,positive regulation of spermidine biosynthetic process,BP,
18764,GO:1901314,1,0.95276986341133,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18765,GO:1901315,1,0.95276986341133,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18766,GO:1901317,1,0.88804673764906,0,11,regulation of flagellated sperm motility,BP,
18767,GO:1901318,1,0.947989307884405,0,4,negative regulation of flagellated sperm motility,BP,
18768,GO:1901320,1,0.983950314107376,0,1,negative regulation of heart induction,BP,
18769,GO:1901321,1,0.979156503137794,0,2,positive regulation of heart induction,BP,
18770,GO:1901337,1,0.98447322307645,0,1,thioester transport,BP,
18772,GO:1901339,1,0.909695640490214,0,6,regulation of store-operated calcium channel activity,BP,
18773,GO:1901340,1,0.983406759352069,0,1,negative regulation of store-operated calcium channel activity,BP,
18774,GO:1901341,1,0.940403380491802,0,4,positive regulation of store-operated calcium channel activity,BP,
18777,GO:1901344,1,0.990583696333685,0,1,response to leptomycin B,BP,
18778,GO:1901350,1,0.983406759351379,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18779,GO:1901355,1,0.969694107260828,0,2,response to rapamycin,BP,
18784,GO:1901373,1,0.989743997431019,0,1,lipid hydroperoxide transport,BP,
18785,GO:1901374,1,0.900684293181482,0,7,acetate ester transport,BP,
18786,GO:1901375,1,0.957989366921874,0,3,acetate ester transmembrane transporter activity,MF,
18787,GO:1901376,1,0.985501663355894,0,1,organic heteropentacyclic compound metabolic process,BP,
18791,GO:1901382,1,0.939220432459646,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18792,GO:1901383,1,0.96998820878209,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18794,GO:1901386,1,0.868188787275089,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18795,GO:1901387,1,0.910999463619835,0,7,positive regulation of voltage-gated calcium channel activity,BP,
18796,GO:1901388,1,0.984766147175537,0,1,regulation of transforming growth factor beta activation,BP,
18797,GO:1901389,1,0.984766147175537,0,1,negative regulation of transforming growth factor beta activation,BP,
18798,GO:1901407,1,0.881095224188374,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18799,GO:1901409,1,0.895968966589093,0,8,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18800,GO:1901419,1,0.983406759352021,0,1,regulation of response to alcohol,BP,
18801,GO:1901421,1,0.983406759352021,0,1,positive regulation of response to alcohol,BP,
18802,GO:1901474,1,0.914285084453307,0,6,azole transmembrane transporter activity,MF,
18803,GO:1901475,1,0.939065122190732,0,4,pyruvate transmembrane transport,BP,
18805,GO:1901490,1,0.9225752311474,0,5,regulation of lymphangiogenesis,BP,
18806,GO:1901491,1,0.951114037127919,0,3,negative regulation of lymphangiogenesis,BP,
18807,GO:1901492,1,0.970000472516384,0,2,positive regulation of lymphangiogenesis,BP,
18808,GO:1901503,1,0.941869820187888,0,4,ether biosynthetic process,BP,
18809,GO:1901505,1,0.579000641072113,0,38,carbohydrate derivative transporter activity,MF,
18810,GO:1901509,1,0.942813738156335,0,4,regulation of endothelial tube morphogenesis,BP,
18812,GO:1901523,1,0.928721385890562,0,5,icosanoid catabolic process,BP,
18813,GO:1901524,1,0.833900838875934,0,12,regulation of macromitophagy,BP,
18814,GO:1901525,1,0.951207188227543,0,3,negative regulation of macromitophagy,BP,
18815,GO:1901526,1,0.876700259261592,0,9,positive regulation of macromitophagy,BP,
18816,GO:1901529,1,0.951038409344349,0,3,positive regulation of anion channel activity,BP,
18819,GO:1901534,1,0.967164596817115,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18820,GO:1901535,1,0.960406667324732,0,3,regulation of DNA demethylation,BP,
18821,GO:1901536,1,0.960406667324732,0,3,negative regulation of DNA demethylation,BP,
18822,GO:1901538,1,0.904048503087442,0,7,changes to DNA methylation involved in embryo development,BP,
18823,GO:1901545,1,0.983827472000414,0,1,response to raffinose,BP,
18825,GO:1901551,1,0.98340675935207,0,1,negative regulation of endothelial cell development,BP,
18827,GO:1901555,1,0.983406759351429,0,1,response to paclitaxel,BP,
18828,GO:1901557,1,0.983406761279341,0,1,response to fenofibrate,BP,
18829,GO:1901558,1,0.970987783623087,0,2,response to metformin,BP,
18830,GO:1901561,1,0.983413137854219,0,1,response to benomyl,BP,
18831,GO:1901563,1,0.937488911540789,0,4,response to camptothecin,BP,
18835,GO:1901567,1,0.946083510352417,0,6,fatty acid derivative binding,MF,
18837,GO:1901569,1,0.928721385890562,0,5,fatty acid derivative catabolic process,BP,
18842,GO:1901580,1,0.983406759350394,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18843,GO:1901581,1,0.983406759350394,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18844,GO:1901582,1,0.983406759350394,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18845,GO:1901585,1,0.984129305860632,0,1,regulation of acid-sensing ion channel activity,BP,
18846,GO:1901594,1,0.983406759352069,0,1,response to capsazepine,BP,
18849,GO:1901607,1,0.413108371259277,0,61,alpha-amino acid biosynthetic process,BP,
18850,GO:1901608,1,0.990294888903245,0,1,regulation of vesicle transport along microtubule,BP,
18851,GO:1901609,1,0.990294888903245,0,1,negative regulation of vesicle transport along microtubule,BP,
18852,GO:1901611,1,0.911074613650234,0,7,phosphatidylglycerol binding,MF,
18853,GO:1901612,1,0.939119466957502,0,5,cardiolipin binding,MF,
18855,GO:1901616,1,0.413950099310762,0,62,organic hydroxy compound catabolic process,BP,
18857,GO:1901618,1,0.578054005173328,0,37,organic hydroxy compound transmembrane transporter activity,MF,
18860,GO:1901622,1,0.984664675591122,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18862,GO:1901624,1,0.952104572429596,0,4,negative regulation of lymphocyte chemotaxis,BP,
18863,GO:1901625,1,0.984725543253726,0,1,cellular response to ergosterol,BP,
18865,GO:1901627,1,0.985402264103555,0,1,negative regulation of postsynaptic membrane organization,BP,
18866,GO:1901628,1,0.949703468807605,0,4,positive regulation of postsynaptic membrane organization,BP,
18867,GO:1901629,1,0.974824313482092,0,2,regulation of presynaptic membrane organization,BP,
18868,GO:1901630,1,0.991273345505357,0,1,negative regulation of presynaptic membrane organization,BP,
18869,GO:1901631,1,0.983406759351133,0,1,positive regulation of presynaptic membrane organization,BP,
18870,GO:1901639,1,0.983406759351672,0,1,XDP catabolic process,BP,
18871,GO:1901640,1,0.983406759351672,0,1,XTP binding,MF,
18872,GO:1901641,1,0.983406759351672,0,1,ITP binding,MF,
18873,GO:1901642,1,0.901755898671622,0,7,nucleoside transmembrane transport,BP,
18878,GO:1901656,1,0.968384724274265,0,2,glycoside transport,BP,
18880,GO:1901658,1,0.641541264553051,0,35,glycosyl compound catabolic process,BP,
18881,GO:1901659,1,0.545285004743695,0,49,glycosyl compound biosynthetic process,BP,
18882,GO:1901660,1,0.909395999016636,0,6,calcium ion export,BP,
18883,GO:1901661,1,0.702414012703442,0,30,quinone metabolic process,BP,
18884,GO:1901662,1,0.961172477954136,0,3,quinone catabolic process,BP,
18885,GO:1901663,1,0.852472458527443,0,13,quinone biosynthetic process,BP,
18886,GO:1901664,1,0.976519595801642,0,2,regulation of NAD+ ADP-ribosyltransferase activity,BP,
18887,GO:1901666,1,0.976519595801642,0,2,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
18888,GO:1901668,1,0.953852002843949,0,4,regulation of superoxide dismutase activity,BP,
18889,GO:1901671,1,0.968649541588778,0,3,positive regulation of superoxide dismutase activity,BP,
18890,GO:1901673,1,0.819873518486665,0,14,regulation of mitotic spindle assembly,BP,
18892,GO:1901675,1,0.983406759351481,0,1,negative regulation of histone H3-K27 acetylation,BP,
18894,GO:1901677,1,0.761611847839657,0,18,phosphate transmembrane transporter activity,MF,
18896,GO:1901679,1,0.903279337042478,0,7,nucleotide transmembrane transport,BP,
18897,GO:1901680,1,0.983406759350742,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
18899,GO:1901682,1,0.626512631216554,0,30,sulfur compound transmembrane transporter activity,MF,
18900,GO:1901684,1,0.985688193475059,0,1,arsenate ion transmembrane transport,BP,
18901,GO:1901685,1,0.819596854671786,0,22,glutathione derivative metabolic process,BP,
18902,GO:1901687,1,0.819596854671786,0,22,glutathione derivative biosynthetic process,BP,
18907,GO:1901702,1,0.870581944916769,0,10,salt transmembrane transporter activity,MF,
18908,GO:1901706,1,0.98464907466028,0,1,mesenchymal cell differentiation involved in bone development,BP,
18909,GO:1901707,1,0.990583696333685,0,1,leptomycin B binding,MF,
18913,GO:1901725,1,0.890629326897875,0,7,regulation of histone deacetylase activity,BP,
18914,GO:1901726,1,0.983406759350447,0,1,negative regulation of histone deacetylase activity,BP,
18915,GO:1901727,1,0.920950043620424,0,5,positive regulation of histone deacetylase activity,BP,
18916,GO:1901738,1,0.983514156454023,0,1,regulation of vitamin A metabolic process,BP,
18917,GO:1901739,1,0.786654882655658,0,20,regulation of myoblast fusion,BP,
18918,GO:1901740,1,0.978319812475219,0,2,negative regulation of myoblast fusion,BP,
18919,GO:1901741,1,0.804103649363154,0,18,positive regulation of myoblast fusion,BP,
18920,GO:1901748,1,0.984892242795262,0,1,leukotriene D4 metabolic process,BP,
18921,GO:1901750,1,0.984892242795262,0,1,leukotriene D4 biosynthetic process,BP,
18922,GO:1901751,1,0.985305465340027,0,1,leukotriene A4 metabolic process,BP,
18924,GO:1901797,1,0.695391720812038,0,27,negative regulation of signal transduction by p53 class mediator,BP,
18926,GO:1901799,1,0.645434441132821,0,31,negative regulation of proteasomal protein catabolic process,BP,
18928,GO:1901804,1,0.985182578475753,0,1,beta-glucoside metabolic process,BP,
18929,GO:1901805,1,0.985182578475753,0,1,beta-glucoside catabolic process,BP,
18930,GO:1901834,1,0.987948183556831,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18931,GO:1901835,1,0.987948183556831,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18932,GO:1901836,1,0.864691119942381,0,10,regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18933,GO:1901837,1,0.973211837325031,0,2,negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18934,GO:1901838,1,0.888504026889531,0,8,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18936,GO:1901843,1,0.951828319668014,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
18937,GO:1901844,1,0.873808196857016,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
18938,GO:1901846,1,0.983406759352021,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
18939,GO:1901856,1,0.954105121906501,0,3,negative regulation of cellular respiration,BP,
18940,GO:1901857,1,0.928443462215612,0,6,positive regulation of cellular respiration,BP,
18941,GO:1901858,1,0.912368151223887,0,6,regulation of mitochondrial DNA metabolic process,BP,
18942,GO:1901859,1,0.952048229378104,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
18943,GO:1901860,1,0.97418969220392,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
18947,GO:1901873,1,0.983406759351479,0,1,regulation of post-translational protein modification,BP,
18948,GO:1901874,1,0.983406759351479,0,1,negative regulation of post-translational protein modification,BP,
18949,GO:1901876,1,0.982651356303549,0,2,regulation of calcium ion binding,BP,
18950,GO:1901877,1,0.982651356303549,0,2,negative regulation of calcium ion binding,BP,
18955,GO:1901889,1,0.740432020130262,0,19,negative regulation of cell junction assembly,BP,
18957,GO:1901894,1,0.928201561750637,0,6,regulation of calcium-transporting ATPase activity,BP,
18958,GO:1901895,1,0.971718875678672,0,2,negative regulation of calcium-transporting ATPase activity,BP,
18959,GO:1901896,1,0.960532623657421,0,3,positive regulation of calcium-transporting ATPase activity,BP,
18963,GO:1901906,1,0.946675313860854,0,4,diadenosine pentaphosphate metabolic process,BP,
18964,GO:1901907,1,0.946675313860854,0,4,diadenosine pentaphosphate catabolic process,BP,
18965,GO:1901908,1,0.946675313860854,0,4,diadenosine hexaphosphate metabolic process,BP,
18966,GO:1901909,1,0.946675313860854,0,4,diadenosine hexaphosphate catabolic process,BP,
18967,GO:1901910,1,0.946675313860854,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
18968,GO:1901911,1,0.946675313860854,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
18969,GO:1901962,1,0.98578926837925,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
18972,GO:1901970,1,0.912781697190292,0,6,positive regulation of mitotic sister chromatid separation,BP,
18974,GO:1901977,1,0.929403226158523,0,5,negative regulation of cell cycle checkpoint,BP,
18975,GO:1901978,1,0.874892840034297,0,9,positive regulation of cell cycle checkpoint,BP,
18976,GO:1901979,1,0.978423928452391,0,2,regulation of inward rectifier potassium channel activity,BP,
18979,GO:1901984,1,0.733904483825913,0,22,negative regulation of protein acetylation,BP,
18981,GO:1901986,1,0.989846577960741,0,1,response to ketamine,BP,
18984,GO:1901989,1,0.389681029621896,0,66,positive regulation of cell cycle phase transition,BP,
18987,GO:1901992,1,0.429593759330744,0,59,positive regulation of mitotic cell cycle phase transition,BP,
18988,GO:1901993,1,0.938648704421889,0,5,regulation of meiotic cell cycle phase transition,BP,
18989,GO:1901994,1,0.953211364153785,0,4,negative regulation of meiotic cell cycle phase transition,BP,
18990,GO:1901995,1,0.984725543253726,0,1,positive regulation of meiotic cell cycle phase transition,BP,
18993,GO:1902003,1,0.85634823406041,0,10,regulation of beta-amyloid formation,BP,
18994,GO:1902004,1,0.923716697303847,0,5,positive regulation of beta-amyloid formation,BP,
18996,GO:1902017,1,0.542242767627441,0,42,regulation of cilium assembly,BP,
18997,GO:1902018,1,0.8695709383901,0,9,negative regulation of cilium assembly,BP,
18998,GO:1902019,1,0.92524973968747,0,5,regulation of cilium-dependent cell motility,BP,
18999,GO:1902022,1,0.942331255719099,0,4,L-lysine transport,BP,
19000,GO:1902023,1,0.94233297211285,0,4,L-arginine transport,BP,
19001,GO:1902024,1,0.969449584215117,0,2,L-histidine transport,BP,
19002,GO:1902031,1,0.926119836038783,0,6,regulation of NADP metabolic process,BP,
19005,GO:1902036,1,0.907819170013485,0,6,regulation of hematopoietic stem cell differentiation,BP,
19006,GO:1902037,1,0.953561253909281,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19007,GO:1902038,1,0.983484900792073,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19009,GO:1902042,1,0.598987250325494,0,36,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19011,GO:1902044,1,0.96898759810019,0,2,regulation of Fas signaling pathway,BP,
19012,GO:1902045,1,0.985338549851725,0,1,negative regulation of Fas signaling pathway,BP,
19013,GO:1902047,1,0.956093918567182,0,4,polyamine transmembrane transport,BP,
19014,GO:1902065,1,0.875652689099638,0,9,response to L-glutamate,BP,
19015,GO:1902071,1,0.991286464678751,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19016,GO:1902073,1,0.991286464678751,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19018,GO:1902075,1,0.934113109483873,0,5,cellular response to salt,BP,
19019,GO:1902076,1,0.983406759350296,0,1,regulation of lateral motor column neuron migration,BP,
19020,GO:1902078,1,0.983406759350296,0,1,positive regulation of lateral motor column neuron migration,BP,
19021,GO:1902080,1,0.973539011253675,0,2,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19022,GO:1902081,1,0.973539011253675,0,2,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19023,GO:1902083,1,0.937133281593483,0,4,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19024,GO:1902093,1,0.936782336047129,0,7,positive regulation of flagellated sperm motility,BP,
19026,GO:1902099,1,0.527686642575345,0,45,regulation of metaphase/anaphase transition of cell cycle,BP,
19027,GO:1902100,1,0.639840364281557,0,31,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19028,GO:1902101,1,0.912781697190292,0,6,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19029,GO:1902102,1,0.976161337687424,0,2,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19030,GO:1902103,1,0.976161337687424,0,2,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19035,GO:1902109,1,0.966433779727768,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19038,GO:1902116,1,0.652234788471343,0,29,negative regulation of organelle assembly,BP,
19040,GO:1902118,1,0.987724295493452,0,1,calcidiol binding,MF,
19042,GO:1902122,1,0.98609242153372,0,1,chenodeoxycholic acid binding,MF,
19043,GO:1902159,1,0.977390754641912,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19044,GO:1902161,1,0.983406759351627,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19045,GO:1902162,1,0.98095400991514,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19046,GO:1902164,1,0.98095400991514,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19047,GO:1902165,1,0.839341113891637,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19048,GO:1902166,1,0.856935492140758,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19049,GO:1902167,1,0.99549295627636,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19051,GO:1902172,1,0.914745590817146,0,6,regulation of keratinocyte apoptotic process,BP,
19052,GO:1902173,1,0.983651598852488,0,1,negative regulation of keratinocyte apoptotic process,BP,
19053,GO:1902174,1,0.9567769042182,0,3,positive regulation of keratinocyte apoptotic process,BP,
19056,GO:1902177,1,0.923728156806755,0,6,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19057,GO:1902178,1,0.98340675935207,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19058,GO:1902186,1,0.621988704722476,0,31,regulation of viral release from host cell,BP,
19059,GO:1902187,1,0.786616094488961,0,15,negative regulation of viral release from host cell,BP,
19060,GO:1902188,1,0.802734418717404,0,15,positive regulation of viral release from host cell,BP,
19061,GO:1902202,1,0.943016799231031,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19062,GO:1902203,1,0.983406759351921,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19063,GO:1902204,1,0.986669205210651,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19064,GO:1902205,1,0.988145988406047,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19065,GO:1902206,1,0.988145988406047,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19066,GO:1902211,1,0.9730518538566,0,2,regulation of prolactin signaling pathway,BP,
19067,GO:1902212,1,0.988145988406047,0,1,negative regulation of prolactin signaling pathway,BP,
19068,GO:1902213,1,0.984725543253726,0,1,positive regulation of prolactin signaling pathway,BP,
19069,GO:1902214,1,0.976145276465731,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
19070,GO:1902215,1,0.988145988406047,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19071,GO:1902216,1,0.98785592335369,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
19072,GO:1902217,1,0.990313578150617,0,1,erythrocyte apoptotic process,BP,
19073,GO:1902218,1,0.934125692302281,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19074,GO:1902219,1,0.941824337189488,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19075,GO:1902220,1,0.991827849197741,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19076,GO:1902221,1,0.883005937873557,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19077,GO:1902222,1,0.883005937873557,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19079,GO:1902225,1,0.984725543253726,0,1,negative regulation of acrosome reaction,BP,
19080,GO:1902226,1,0.962896232818874,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19081,GO:1902227,1,0.977457627260276,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19082,GO:1902228,1,0.98510418704369,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19083,GO:1902229,1,0.64277059366541,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19084,GO:1902230,1,0.721830388836051,0,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19085,GO:1902231,1,0.905177688199008,0,8,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19086,GO:1902232,1,0.972716096668016,0,2,regulation of positive thymic T cell selection,BP,
19087,GO:1902233,1,0.988145988406047,0,1,negative regulation of positive thymic T cell selection,BP,
19089,GO:1902236,1,0.782610718422716,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19091,GO:1902238,1,0.983406759352069,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19092,GO:1902239,1,0.983406759352069,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19093,GO:1902250,1,0.990313578150617,0,1,regulation of erythrocyte apoptotic process,BP,
19094,GO:1902251,1,0.990313578150617,0,1,negative regulation of erythrocyte apoptotic process,BP,
19095,GO:1902253,1,0.745124275724837,0,24,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19096,GO:1902254,1,0.788830689616241,0,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19097,GO:1902255,1,0.969934644251984,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19098,GO:1902256,1,0.955846912533053,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19099,GO:1902257,1,0.971977045315087,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19100,GO:1902259,1,0.808585059515914,0,15,regulation of delayed rectifier potassium channel activity,BP,
19101,GO:1902260,1,0.910094216933182,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19102,GO:1902261,1,0.94487839907336,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19103,GO:1902262,1,0.937983778984354,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19105,GO:1902267,1,0.956093918567182,0,4,regulation of polyamine transmembrane transport,BP,
19106,GO:1902268,1,0.972228208677445,0,3,negative regulation of polyamine transmembrane transport,BP,
19107,GO:1902269,1,0.98340675935207,0,1,positive regulation of polyamine transmembrane transport,BP,
19111,GO:1902283,1,0.983406759352069,0,1,negative regulation of primary amine oxidase activity,BP,
19113,GO:1902285,1,0.906001829238125,0,6,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19114,GO:1902287,1,0.921294231871183,0,5,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19115,GO:1902292,1,0.991266788976402,0,1,cell cycle DNA replication initiation,BP,
19116,GO:1902294,1,0.984725543253726,0,1,cell cycle DNA replication termination,BP,
19117,GO:1902296,1,0.983566750401539,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19118,GO:1902298,1,0.969385402452718,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19119,GO:1902299,1,0.971985278910257,0,2,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19122,GO:1902304,1,0.977037969834,0,2,positive regulation of potassium ion export,BP,
19123,GO:1902305,1,0.459498246987315,0,56,regulation of sodium ion transmembrane transport,BP,
19124,GO:1902306,1,0.852106716860309,0,11,negative regulation of sodium ion transmembrane transport,BP,
19125,GO:1902307,1,0.776331558682544,0,18,positive regulation of sodium ion transmembrane transport,BP,
19126,GO:1902308,1,0.930014126308684,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19127,GO:1902309,1,0.954941881038439,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19128,GO:1902310,1,0.973900976215261,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19129,GO:1902311,1,0.987794931320213,0,1,regulation of copper ion transmembrane transport,BP,
19130,GO:1902315,1,0.991266788976402,0,1,nuclear cell cycle DNA replication initiation,BP,
19131,GO:1902317,1,0.984725543253726,0,1,nuclear DNA replication termination,BP,
19132,GO:1902319,1,0.983566750401539,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19133,GO:1902336,1,0.968640778170181,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19137,GO:1902340,1,0.97664825221322,0,2,negative regulation of chromosome condensation,BP,
19138,GO:1902356,1,0.987217261229828,0,1,oxaloacetate(2-) transmembrane transport,BP,
19139,GO:1902358,1,0.812247262032357,0,13,sulfate transmembrane transport,BP,
19140,GO:1902359,1,0.970818018550171,0,2,Notch signaling pathway involved in somitogenesis,BP,
19141,GO:1902361,1,0.954870180769942,0,3,mitochondrial pyruvate transmembrane transport,BP,
19142,GO:1902362,1,0.984174220502037,0,1,melanocyte apoptotic process,BP,
19143,GO:1902366,1,0.970818018550171,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19144,GO:1902367,1,0.970818018550171,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19147,GO:1902378,1,0.984935697988779,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19149,GO:1902380,1,0.985122822835756,0,1,positive regulation of endoribonuclease activity,BP,
19150,GO:1902396,1,0.983407163081727,0,1,protein localization to bicellular tight junction,BP,
19154,GO:1902410,1,0.914842801652702,0,6,mitotic cytokinetic process,BP,
19155,GO:1902412,1,0.954138435256086,0,3,regulation of mitotic cytokinesis,BP,
19156,GO:1902414,1,0.879729809372868,0,8,protein localization to cell junction,BP,
19157,GO:1902415,1,0.877357043531905,0,9,regulation of mRNA binding,BP,
19158,GO:1902416,1,0.902610122714996,0,7,positive regulation of mRNA binding,BP,
19159,GO:1902423,1,0.986088466109074,0,1,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19160,GO:1902425,1,0.986088466109074,0,1,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19161,GO:1902426,1,0.98442891536618,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19162,GO:1902430,1,0.9147883621736,0,6,negative regulation of beta-amyloid formation,BP,
19163,GO:1902442,1,0.983415020077322,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19164,GO:1902443,1,0.983415020077322,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19165,GO:1902444,1,0.991217680169042,0,1,riboflavin binding,MF,
19166,GO:1902445,1,0.971704381705066,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19168,GO:1902459,1,0.922532848416148,0,5,positive regulation of stem cell population maintenance,BP,
19169,GO:1902460,1,0.983406759352018,0,1,regulation of mesenchymal stem cell proliferation,BP,
19170,GO:1902462,1,0.983406759352018,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19171,GO:1902463,1,0.969614750432199,0,3,protein localization to cell leading edge,BP,
19172,GO:1902464,1,0.983406759352021,0,1,regulation of histone H3-K27 trimethylation,BP,
19173,GO:1902466,1,0.983406759352021,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19176,GO:1902475,1,0.640901803666947,0,29,L-alpha-amino acid transmembrane transport,BP,
19178,GO:1902480,1,0.985113490861661,0,1,protein localization to mitotic spindle,BP,
19179,GO:1902488,1,0.98340675935099,0,1,cholangiocyte apoptotic process,BP,
19180,GO:1902490,1,0.986799429902972,0,1,regulation of sperm capacitation,BP,
19181,GO:1902493,1,0.277699819577332,0,88,acetyltransferase complex,CC,
19184,GO:1902498,1,0.935902310014598,0,4,regulation of protein autoubiquitination,BP,
19185,GO:1902499,1,0.967757658123712,0,2,positive regulation of protein autoubiquitination,BP,
19186,GO:1902504,1,0.983871089773647,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19187,GO:1902510,1,0.91925262701241,0,7,regulation of apoptotic DNA fragmentation,BP,
19188,GO:1902511,1,0.984350353013124,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19189,GO:1902512,1,0.971630081821239,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19190,GO:1902513,1,0.94312225092008,0,4,regulation of organelle transport along microtubule,BP,
19191,GO:1902514,1,0.900418337694724,0,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19192,GO:1902523,1,0.967524250081785,0,2,positive regulation of protein K63-linked ubiquitination,BP,
19193,GO:1902524,1,0.972972174505446,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19194,GO:1902525,1,0.941129604529203,0,5,regulation of protein monoubiquitination,BP,
19195,GO:1902527,1,0.957000538189343,0,4,positive regulation of protein monoubiquitination,BP,
19196,GO:1902528,1,0.983406759351034,0,1,regulation of protein linear polyubiquitination,BP,
19197,GO:1902530,1,0.983406759351034,0,1,positive regulation of protein linear polyubiquitination,BP,
19201,GO:1902534,1,0.983406759351724,0,1,single-organism membrane invagination,BP,
19202,GO:1902544,1,0.977297635291257,0,2,regulation of DNA N-glycosylase activity,BP,
19203,GO:1902546,1,0.9935956493984,0,1,positive regulation of DNA N-glycosylase activity,BP,
19205,GO:1902548,1,0.928563901607879,0,5,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19207,GO:1902555,1,0.716300976980459,0,25,endoribonuclease complex,CC,
19208,GO:1902559,1,0.973150642509117,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19209,GO:1902560,1,0.976570686515648,0,2,GMP reductase complex,CC,
19210,GO:1902562,1,0.610233656285261,0,34,H4 histone acetyltransferase complex,CC,
19211,GO:1902563,1,0.910389937438395,0,6,regulation of neutrophil activation,BP,
19212,GO:1902564,1,0.954728570227563,0,3,negative regulation of neutrophil activation,BP,
19213,GO:1902565,1,0.983406759352069,0,1,positive regulation of neutrophil activation,BP,
19214,GO:1902566,1,0.947139090308026,0,4,regulation of eosinophil activation,BP,
19215,GO:1902567,1,0.972306487447401,0,2,negative regulation of eosinophil activation,BP,
19216,GO:1902568,1,0.974118755418242,0,2,positive regulation of eosinophil activation,BP,
19217,GO:1902569,1,0.987221987295889,0,1,negative regulation of activation of JAK2 kinase activity,BP,
19218,GO:1902570,1,0.909672239183234,0,7,protein localization to nucleolus,BP,
19219,GO:1902571,1,0.880405394777319,0,13,regulation of serine-type peptidase activity,BP,
19220,GO:1902572,1,0.902678584042788,0,11,negative regulation of serine-type peptidase activity,BP,
19221,GO:1902573,1,0.959150195927251,0,3,positive regulation of serine-type peptidase activity,BP,
19222,GO:1902576,1,0.940103798293426,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19229,GO:1902585,1,0.986706463820984,0,1,single-organism intercellular transport,BP,
19231,GO:1902590,1,0.721381694884738,0,24,multi-organism organelle organization,BP,
19232,GO:1902592,1,0.721381694884738,0,24,multi-organism membrane budding,BP,
19234,GO:1902594,1,0.96708773348782,0,2,multi-organism nuclear import,BP,
19235,GO:1902595,1,0.974340837882081,0,2,regulation of DNA replication origin binding,BP,
19236,GO:1902598,1,0.967130495088187,0,2,creatine transmembrane transport,BP,
19237,GO:1902600,1,0.31704798842632,0,104,hydrogen ion transmembrane transport,BP,
19238,GO:1902603,1,0.944801593847067,0,4,carnitine transmembrane transport,BP,
19239,GO:1902605,1,0.984290366473934,0,1,heterotrimeric G-protein complex assembly,BP,
19240,GO:1902606,1,0.984618630557233,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19241,GO:1902608,1,0.984618630557233,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19244,GO:1902616,1,0.972795515795962,0,2,acyl carnitine transmembrane transport,BP,
19245,GO:1902617,1,0.939515691182426,0,4,response to fluoride,BP,
19246,GO:1902618,1,0.983406759351676,0,1,cellular response to fluoride,BP,
19248,GO:1902623,1,0.968384722376162,0,2,negative regulation of neutrophil migration,BP,
19250,GO:1902626,1,0.977160366379268,0,3,assembly of large subunit precursor of preribosome,BP,
19251,GO:1902630,1,0.967087733487191,0,2,regulation of membrane hyperpolarization,BP,
19252,GO:1902631,1,0.983406759351428,0,1,negative regulation of membrane hyperpolarization,BP,
19253,GO:1902636,1,0.977380211220585,0,2,kinociliary basal body,CC,
19257,GO:1902659,1,0.962873016756618,0,3,regulation of glucose mediated signaling pathway,BP,
19258,GO:1902661,1,0.962873016756618,0,3,positive regulation of glucose mediated signaling pathway,BP,
19261,GO:1902669,1,0.894163518127041,0,7,positive regulation of axon guidance,BP,
19264,GO:1902683,1,0.95984912297827,0,3,regulation of receptor localization to synapse,BP,
19265,GO:1902684,1,0.990294888903245,0,1,negative regulation of receptor localization to synapse,BP,
19266,GO:1902685,1,0.98340675935207,0,1,positive regulation of receptor localization to synapse,BP,
19270,GO:1902691,1,0.98372682328314,0,1,respiratory basal cell differentiation,BP,
19272,GO:1902710,1,0.759373285818963,0,18,GABA receptor complex,CC,
19273,GO:1902711,1,0.772200201687672,0,17,GABA-A receptor complex,CC,
19274,GO:1902713,1,0.863880891980186,0,10,regulation of interferon-gamma secretion,BP,
19275,GO:1902714,1,0.943120581495562,0,4,negative regulation of interferon-gamma secretion,BP,
19276,GO:1902715,1,0.903819604501294,0,7,positive regulation of interferon-gamma secretion,BP,
19277,GO:1902722,1,0.968379451188032,0,2,positive regulation of prolactin secretion,BP,
19278,GO:1902723,1,0.967947138412916,0,2,negative regulation of skeletal muscle satellite cell proliferation,BP,
19279,GO:1902725,1,0.96781286562632,0,2,negative regulation of satellite cell differentiation,BP,
19280,GO:1902728,1,0.96708773348782,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19281,GO:1902730,1,0.967171757277233,0,2,positive regulation of proteoglycan biosynthetic process,BP,
19282,GO:1902731,1,0.952210154931738,0,3,negative regulation of chondrocyte proliferation,BP,
19283,GO:1902732,1,0.960402905109959,0,3,positive regulation of chondrocyte proliferation,BP,
19284,GO:1902737,1,0.983406759352021,0,1,dendritic filopodium,CC,
19285,GO:1902739,1,0.970925919472914,0,2,regulation of interferon-alpha secretion,BP,
19286,GO:1902741,1,0.970925919472914,0,2,positive regulation of interferon-alpha secretion,BP,
19288,GO:1902743,1,0.582419931106306,0,36,regulation of lamellipodium organization,BP,
19289,GO:1902744,1,0.929946143267259,0,5,negative regulation of lamellipodium organization,BP,
19290,GO:1902745,1,0.698536013000537,0,24,positive regulation of lamellipodium organization,BP,
19291,GO:1902746,1,0.944431092452244,0,4,regulation of lens fiber cell differentiation,BP,
19292,GO:1902747,1,0.986821756478542,0,1,negative regulation of lens fiber cell differentiation,BP,
19293,GO:1902748,1,0.983406759350889,0,1,positive regulation of lens fiber cell differentiation,BP,
19296,GO:1902751,1,0.73482813976285,0,21,positive regulation of cell cycle G2/M phase transition,BP,
19297,GO:1902765,1,0.96833515219048,0,2,L-arginine import into cell,BP,
19298,GO:1902766,1,0.977519671160112,0,2,skeletal muscle satellite cell migration,BP,
19299,GO:1902769,1,0.983406759350443,0,1,regulation of choline O-acetyltransferase activity,BP,
19300,GO:1902771,1,0.983406759350443,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19301,GO:1902773,1,0.983803030357479,0,1,GTPase activator complex,CC,
19302,GO:1902774,1,0.915904314901513,0,6,late endosome to lysosome transport,BP,
19303,GO:1902775,1,0.952242507269886,0,3,mitochondrial large ribosomal subunit assembly,BP,
19304,GO:1902803,1,0.568830403267976,0,37,regulation of synaptic vesicle transport,BP,
19305,GO:1902804,1,0.887369065663934,0,8,negative regulation of synaptic vesicle transport,BP,
19306,GO:1902805,1,0.922586668886161,0,5,positive regulation of synaptic vesicle transport,BP,
19309,GO:1902808,1,0.63773703308521,0,32,positive regulation of cell cycle G1/S phase transition,BP,
19310,GO:1902809,1,0.957112268847231,0,3,regulation of skeletal muscle fiber differentiation,BP,
19311,GO:1902811,1,0.972650756196509,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19312,GO:1902822,1,0.947081833211645,0,4,regulation of late endosome to lysosome transport,BP,
19313,GO:1902823,1,0.967242455631401,0,2,negative regulation of late endosome to lysosome transport,BP,
19314,GO:1902824,1,0.979159451819264,0,2,positive regulation of late endosome to lysosome transport,BP,
19315,GO:1902826,1,0.984675140077779,0,1,regulation of L-arginine import into cell,BP,
19316,GO:1902828,1,0.984675140077779,0,1,positive regulation of L-arginine import into cell,BP,
19317,GO:1902837,1,0.890598104578286,0,7,amino acid import into cell,BP,
19318,GO:1902847,1,0.98408970635106,0,1,regulation of neuronal signal transduction,BP,
19320,GO:1902855,1,0.816925698173059,0,13,regulation of non-motile cilium assembly,BP,
19321,GO:1902856,1,0.951060828984571,0,3,negative regulation of non-motile cilium assembly,BP,
19322,GO:1902857,1,0.872178850590297,0,9,positive regulation of non-motile cilium assembly,BP,
19323,GO:1902858,1,0.98613214159267,0,1,propionyl-CoA metabolic process,BP,
19324,GO:1902860,1,0.98613214159267,0,1,propionyl-CoA biosynthetic process,BP,
19325,GO:1902861,1,0.983406759351968,0,1,copper ion import into cell,BP,
19326,GO:1902866,1,0.901309350338853,0,7,regulation of retina development in camera-type eye,BP,
19327,GO:1902867,1,0.983693927157384,0,1,negative regulation of retina development in camera-type eye,BP,
19328,GO:1902868,1,0.971342487030176,0,2,positive regulation of retina development in camera-type eye,BP,
19329,GO:1902869,1,0.955501813034798,0,3,regulation of amacrine cell differentiation,BP,
19330,GO:1902870,1,0.983693927157384,0,1,negative regulation of amacrine cell differentiation,BP,
19331,GO:1902871,1,0.971342487030176,0,2,positive regulation of amacrine cell differentiation,BP,
19334,GO:1902884,1,0.816057923112361,0,15,positive regulation of response to oxidative stress,BP,
19335,GO:1902890,1,0.99404187805355,0,1,regulation of root hair elongation,BP,
19336,GO:1902891,1,0.99404187805355,0,1,negative regulation of root hair elongation,BP,
19340,GO:1902896,1,0.952159465892469,0,3,terminal web assembly,BP,
19342,GO:1902902,1,0.8682630113446,0,10,negative regulation of autophagosome assembly,BP,
19346,GO:1902908,1,0.971774537131863,0,2,regulation of melanosome transport,BP,
19347,GO:1902910,1,0.98340675935207,0,1,positive regulation of melanosome transport,BP,
19349,GO:1902913,1,0.992054094792906,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19350,GO:1902914,1,0.82118840809768,0,13,regulation of protein polyubiquitination,BP,
19351,GO:1902915,1,0.937004217556338,0,4,negative regulation of protein polyubiquitination,BP,
19352,GO:1902916,1,0.891224246332526,0,8,positive regulation of protein polyubiquitination,BP,
19354,GO:1902931,1,0.882212518562268,0,9,negative regulation of alcohol biosynthetic process,BP,
19355,GO:1902932,1,0.757391713986718,0,20,positive regulation of alcohol biosynthetic process,BP,
19357,GO:1902937,1,0.969690243918941,0,2,inward rectifier potassium channel complex,CC,
19358,GO:1902938,1,0.984010013026522,0,1,regulation of intracellular calcium activated chloride channel activity,BP,
19359,GO:1902939,1,0.984010013026522,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19360,GO:1902941,1,0.967087733487721,0,2,regulation of voltage-gated chloride channel activity,BP,
19361,GO:1902943,1,0.967087733487721,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19363,GO:1902947,1,0.954862999528183,0,3,regulation of tau-protein kinase activity,BP,
19364,GO:1902948,1,0.983406759350443,0,1,negative regulation of tau-protein kinase activity,BP,
19365,GO:1902949,1,0.98408970635106,0,1,positive regulation of tau-protein kinase activity,BP,
19366,GO:1902950,1,0.922320994107656,0,6,regulation of dendritic spine maintenance,BP,
19367,GO:1902951,1,0.96195949159883,0,3,negative regulation of dendritic spine maintenance,BP,
19368,GO:1902952,1,0.974824313482927,0,2,positive regulation of dendritic spine maintenance,BP,
19369,GO:1902953,1,0.941012684140885,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19370,GO:1902954,1,0.967087733485785,0,2,regulation of early endosome to recycling endosome transport,BP,
19371,GO:1902955,1,0.983406759350443,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19372,GO:1902956,1,0.946371714914851,0,4,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19373,GO:1902957,1,0.968143461140191,0,2,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19374,GO:1902958,1,0.977514847404296,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19375,GO:1902959,1,0.967091511871711,0,2,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19376,GO:1902960,1,0.983406759350443,0,1,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19377,GO:1902961,1,0.98341060123055,0,1,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19378,GO:1902962,1,0.967091511871711,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19379,GO:1902963,1,0.967091511871711,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19382,GO:1902969,1,0.862885805924417,0,10,mitotic DNA replication,BP,
19383,GO:1902975,1,0.991266788976402,0,1,mitotic DNA replication initiation,BP,
19384,GO:1902977,1,0.98706293719918,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19385,GO:1902979,1,0.984725543253726,0,1,mitotic DNA replication termination,BP,
19386,GO:1902983,1,0.983566750401539,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19387,GO:1902988,1,0.951698968499255,0,3,neurofibrillary tangle assembly,BP,
19388,GO:1902990,1,0.957661642894305,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19389,GO:1902991,1,0.821394259268806,0,13,regulation of amyloid precursor protein catabolic process,BP,
19390,GO:1902992,1,0.885682618963433,0,8,negative regulation of amyloid precursor protein catabolic process,BP,
19391,GO:1902993,1,0.923716697303847,0,5,positive regulation of amyloid precursor protein catabolic process,BP,
19392,GO:1902994,1,0.974824313482386,0,2,regulation of phospholipid efflux,BP,
19393,GO:1902995,1,0.974824313482386,0,2,positive regulation of phospholipid efflux,BP,
19394,GO:1902996,1,0.967759393679082,0,2,regulation of neurofibrillary tangle assembly,BP,
19395,GO:1902997,1,0.983406759350443,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19396,GO:1902998,1,0.98408970635106,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19397,GO:1903000,1,0.991273345505357,0,1,regulation of lipid transport across blood brain barrier,BP,
19398,GO:1903002,1,0.991273345505357,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19399,GO:1903003,1,0.942415686142493,0,4,positive regulation of protein deubiquitination,BP,
19400,GO:1903004,1,0.983407843952928,0,1,regulation of protein K63-linked deubiquitination,BP,
19401,GO:1903006,1,0.983407843952928,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19402,GO:1903007,1,0.983407843952928,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19403,GO:1903008,1,0.244734367503138,0,97,organelle disassembly,BP,
19406,GO:1903012,1,0.898527994231355,0,7,positive regulation of bone development,BP,
19407,GO:1903015,1,0.968559854515279,0,3,regulation of exo-alpha-sialidase activity,BP,
19408,GO:1903016,1,0.980077621687734,0,2,negative regulation of exo-alpha-sialidase activity,BP,
19409,GO:1903017,1,0.98824908620679,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19412,GO:1903020,1,0.765305199148863,0,19,positive regulation of glycoprotein metabolic process,BP,
19414,GO:1903026,1,0.947604502054681,0,6,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19415,GO:1903027,1,0.962407250994299,0,3,regulation of opsonization,BP,
19416,GO:1903028,1,0.983406759351232,0,1,positive regulation of opsonization,BP,
19417,GO:1903031,1,0.972063084100902,0,2,regulation of microtubule plus-end binding,BP,
19418,GO:1903033,1,0.972063084100902,0,2,positive regulation of microtubule plus-end binding,BP,
19425,GO:1903044,1,0.874520868524816,0,9,protein localization to membrane raft,BP,
19426,GO:1903045,1,0.983406759351775,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19430,GO:1903051,1,0.567604537474719,0,42,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19433,GO:1903054,1,0.920425232949865,0,6,negative regulation of extracellular matrix organization,BP,
19434,GO:1903055,1,0.789414337422872,0,15,positive regulation of extracellular matrix organization,BP,
19435,GO:1903056,1,0.971774537130693,0,2,regulation of melanosome organization,BP,
19436,GO:1903059,1,0.931471839819543,0,5,regulation of protein lipidation,BP,
19437,GO:1903060,1,0.987584713029126,0,1,negative regulation of protein lipidation,BP,
19438,GO:1903061,1,0.943184572624477,0,4,positive regulation of protein lipidation,BP,
19439,GO:1903069,1,0.876811600910102,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19440,GO:1903070,1,0.959365548745635,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19441,GO:1903071,1,0.900663555119948,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19442,GO:1903072,1,0.992937098316418,0,1,regulation of death-inducing signaling complex assembly,BP,
19443,GO:1903073,1,0.992937098316418,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19447,GO:1903080,1,0.992122035120751,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19448,GO:1903082,1,0.992122035120751,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19449,GO:1903093,1,0.983549351870484,0,2,regulation of protein K48-linked deubiquitination,BP,
19450,GO:1903094,1,0.983549351870484,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19451,GO:1903095,1,0.968384722376257,0,2,ribonuclease III complex,CC,
19452,GO:1903096,1,0.983811692138999,0,1,protein localization to meiotic spindle midzone,BP,
19454,GO:1903116,1,0.95103842121783,0,3,positive regulation of actin filament-based movement,BP,
19455,GO:1903118,1,0.985308759830125,0,1,urate homeostasis,BP,
19456,GO:1903121,1,0.947310088559805,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19457,GO:1903122,1,0.992937098316418,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19458,GO:1903123,1,0.983406759350836,0,1,regulation of thioredoxin peroxidase activity,BP,
19459,GO:1903124,1,0.983406759350836,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19460,GO:1903125,1,0.983406759350836,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19461,GO:1903126,1,0.986156118227552,0,1,negative regulation of centriole-centriole cohesion,BP,
19463,GO:1903135,1,0.961141945219623,0,3,cupric ion binding,MF,
19464,GO:1903136,1,0.932932897747521,0,6,cuprous ion binding,MF,
19466,GO:1903141,1,0.98340675935207,0,1,negative regulation of establishment of endothelial barrier,BP,
19468,GO:1903146,1,0.497499151225747,0,49,regulation of mitophagy,BP,
19469,GO:1903147,1,0.930985491990953,0,5,negative regulation of mitophagy,BP,
19470,GO:1903165,1,0.984393633848452,0,1,response to polycyclic arene,BP,
19471,GO:1903167,1,0.992937098316418,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19472,GO:1903168,1,0.992937098316418,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19475,GO:1903173,1,0.970901789818518,0,2,fatty alcohol metabolic process,BP,
19476,GO:1903176,1,0.992937098316418,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19477,GO:1903178,1,0.992937098316418,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19478,GO:1903179,1,0.976616786546616,0,2,regulation of dopamine biosynthetic process,BP,
19479,GO:1903181,1,0.976616786546616,0,2,positive regulation of dopamine biosynthetic process,BP,
19480,GO:1903182,1,0.991123064544678,0,1,regulation of SUMO transferase activity,BP,
19481,GO:1903184,1,0.992937098316418,0,1,L-dopa metabolic process,BP,
19482,GO:1903185,1,0.992937098316418,0,1,L-dopa biosynthetic process,BP,
19483,GO:1903189,1,0.992937098316418,0,1,glyoxal metabolic process,BP,
19484,GO:1903195,1,0.992937098316418,0,1,regulation of L-dopa biosynthetic process,BP,
19485,GO:1903197,1,0.992937098316418,0,1,positive regulation of L-dopa biosynthetic process,BP,
19486,GO:1903198,1,0.992937098316418,0,1,regulation of L-dopa decarboxylase activity,BP,
19487,GO:1903200,1,0.992937098316418,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19490,GO:1903203,1,0.781796806175738,0,16,regulation of oxidative stress-induced neuron death,BP,
19491,GO:1903204,1,0.822071136902442,0,13,negative regulation of oxidative stress-induced neuron death,BP,
19492,GO:1903205,1,0.739118890684765,0,21,regulation of hydrogen peroxide-induced cell death,BP,
19493,GO:1903206,1,0.794258704004781,0,16,negative regulation of hydrogen peroxide-induced cell death,BP,
19494,GO:1903207,1,0.961293189993128,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
19495,GO:1903208,1,0.961293189993128,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
19496,GO:1903209,1,0.848879208693369,0,12,positive regulation of oxidative stress-induced cell death,BP,
19497,GO:1903210,1,0.983406759351575,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19498,GO:1903214,1,0.289348446062825,0,91,regulation of protein targeting to mitochondrion,BP,
19499,GO:1903215,1,0.945245085573125,0,4,negative regulation of protein targeting to mitochondrion,BP,
19500,GO:1903216,1,0.974882437102762,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19501,GO:1903217,1,0.974882437102762,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19502,GO:1903223,1,0.96709693623706,0,2,positive regulation of oxidative stress-induced neuron death,BP,
19503,GO:1903224,1,0.917609952222024,0,6,regulation of endodermal cell differentiation,BP,
19504,GO:1903225,1,0.958780749743075,0,3,negative regulation of endodermal cell differentiation,BP,
19506,GO:1903233,1,0.96708773348709,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19507,GO:1903236,1,0.929389133946456,0,7,regulation of leukocyte tethering or rolling,BP,
19508,GO:1903237,1,0.967785358021114,0,4,negative regulation of leukocyte tethering or rolling,BP,
19509,GO:1903238,1,0.960330989660394,0,3,positive regulation of leukocyte tethering or rolling,BP,
19510,GO:1903242,1,0.909785950179112,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
19511,GO:1903243,1,0.951325859886589,0,3,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19512,GO:1903244,1,0.967163564975404,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19513,GO:1903248,1,0.983406759350938,0,1,regulation of citrulline biosynthetic process,BP,
19514,GO:1903249,1,0.983406759350938,0,1,negative regulation of citrulline biosynthetic process,BP,
19515,GO:1903251,1,0.917738826398783,0,6,multi-ciliated epithelial cell differentiation,BP,
19516,GO:1903261,1,0.940165348960633,0,4,regulation of serine phosphorylation of STAT3 protein,BP,
19517,GO:1903262,1,0.971748179550951,0,2,negative regulation of serine phosphorylation of STAT3 protein,BP,
19518,GO:1903263,1,0.967502751835163,0,2,positive regulation of serine phosphorylation of STAT3 protein,BP,
19519,GO:1903265,1,0.927531035527265,0,5,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19520,GO:1903273,1,0.954794625101751,0,4,regulation of sodium ion export,BP,
19521,GO:1903275,1,0.954794625101751,0,4,positive regulation of sodium ion export,BP,
19522,GO:1903276,1,0.954794625101751,0,4,regulation of sodium ion export from cell,BP,
19523,GO:1903278,1,0.954794625101751,0,4,positive regulation of sodium ion export from cell,BP,
19524,GO:1903279,1,0.954772136490323,0,3,regulation of calcium:sodium antiporter activity,BP,
19525,GO:1903280,1,0.983406759351824,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19526,GO:1903281,1,0.970884207418282,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19527,GO:1903282,1,0.983663826627692,0,1,regulation of glutathione peroxidase activity,BP,
19528,GO:1903284,1,0.983663826627692,0,1,positive regulation of glutathione peroxidase activity,BP,
19529,GO:1903285,1,0.983663826627692,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19530,GO:1903286,1,0.94285218396824,0,4,regulation of potassium ion import,BP,
19531,GO:1903288,1,0.958763937982576,0,3,positive regulation of potassium ion import,BP,
19532,GO:1903293,1,0.501319804218167,0,45,phosphatase complex,CC,
19533,GO:1903294,1,0.983406759351921,0,1,regulation of glutamate secretion, neurotransmission,BP,
19534,GO:1903296,1,0.983406759351921,0,1,positive regulation of glutamate secretion, neurotransmission,BP,
19535,GO:1903297,1,0.940558028025461,0,4,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19536,GO:1903298,1,0.940558028025461,0,4,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19537,GO:1903299,1,0.904349332750864,0,8,regulation of hexokinase activity,BP,
19538,GO:1903300,1,0.947211185709,0,4,negative regulation of hexokinase activity,BP,
19539,GO:1903301,1,0.954759385570013,0,4,positive regulation of hexokinase activity,BP,
19546,GO:1903314,1,0.98609242153372,0,1,regulation of nitrogen cycle metabolic process,BP,
19548,GO:1903318,1,0.596864031767092,0,37,negative regulation of protein maturation,BP,
19549,GO:1903319,1,0.758520886077714,0,19,positive regulation of protein maturation,BP,
19551,GO:1903321,1,0.160672338123847,0,143,negative regulation of protein modification by small protein conjugation or removal,BP,
19553,GO:1903332,1,0.906120806695639,0,7,regulation of protein folding,BP,
19554,GO:1903333,1,0.935696232939573,0,5,negative regulation of protein folding,BP,
19555,GO:1903335,1,0.932525328123268,0,5,regulation of vacuolar transport,BP,
19556,GO:1903336,1,0.967242455631401,0,2,negative regulation of vacuolar transport,BP,
19557,GO:1903337,1,0.979159451819264,0,2,positive regulation of vacuolar transport,BP,
19558,GO:1903347,1,0.939954677182082,0,4,negative regulation of bicellular tight junction assembly,BP,
19560,GO:1903349,1,0.937812771053637,0,4,omegasome membrane,CC,
19561,GO:1903350,1,0.823353427213018,0,13,response to dopamine,BP,
19562,GO:1903351,1,0.823353427213018,0,13,cellular response to dopamine,BP,
19563,GO:1903352,1,0.957220350084556,0,3,L-ornithine transmembrane transport,BP,
19564,GO:1903358,1,0.860286486449968,0,10,regulation of Golgi organization,BP,
19565,GO:1903361,1,0.945012334500233,0,5,protein localization to basolateral plasma membrane,BP,
19567,GO:1903363,1,0.496921808200352,0,51,negative regulation of cellular protein catabolic process,BP,
19569,GO:1903365,1,0.944907177196145,0,5,regulation of fear response,BP,
19570,GO:1903367,1,0.944907177196145,0,5,positive regulation of fear response,BP,
19571,GO:1903371,1,0.951038409343254,0,3,regulation of endoplasmic reticulum tubular network organization,BP,
19572,GO:1903373,1,0.967087733487287,0,2,positive regulation of endoplasmic reticulum tubular network organization,BP,
19573,GO:1903375,1,0.9685914039789,0,2,facioacoustic ganglion development,BP,
19574,GO:1903376,1,0.899370101615621,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19575,GO:1903377,1,0.945673681503857,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19576,GO:1903378,1,0.96709693623706,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19577,GO:1903381,1,0.983406759352018,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19578,GO:1903382,1,0.983406759352018,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19579,GO:1903383,1,0.977514847404296,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19580,GO:1903384,1,0.977514847404296,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19581,GO:1903385,1,0.967152948850713,0,2,regulation of homophilic cell adhesion,BP,
19582,GO:1903387,1,0.98340675935187,0,1,positive regulation of homophilic cell adhesion,BP,
19584,GO:1903392,1,0.787686764652454,0,15,negative regulation of adherens junction organization,BP,
19586,GO:1903394,1,0.98535187047582,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19587,GO:1903400,1,0.983406759351282,0,1,L-arginine transmembrane transport,BP,
19588,GO:1903401,1,0.956999794871821,0,3,L-lysine transmembrane transport,BP,
19589,GO:1903402,1,0.983407728180071,0,1,regulation of renal phosphate excretion,BP,
19590,GO:1903403,1,0.983407728180071,0,1,negative regulation of renal phosphate excretion,BP,
19591,GO:1903405,1,0.880603383942793,0,9,protein localization to nuclear body,BP,
19592,GO:1903406,1,0.983427814800554,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19593,GO:1903408,1,0.983427814800554,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19595,GO:1903410,1,0.96833515219048,0,2,L-lysine import into cell,BP,
19596,GO:1903411,1,0.983406759351282,0,1,L-ornithine import into cell,BP,
19597,GO:1903412,1,0.969553499355349,0,3,response to bile acid,BP,
19598,GO:1903413,1,0.969553499355349,0,3,cellular response to bile acid,BP,
19599,GO:1903414,1,0.983526980738733,0,1,iron cation export,BP,
19600,GO:1903416,1,0.910265325629713,0,6,response to glycoside,BP,
19601,GO:1903420,1,0.983406759351574,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19602,GO:1903421,1,0.808533340682185,0,14,regulation of synaptic vesicle recycling,BP,
19603,GO:1903422,1,0.95103893288645,0,3,negative regulation of synaptic vesicle recycling,BP,
19604,GO:1903423,1,0.938157828479909,0,4,positive regulation of synaptic vesicle recycling,BP,
19606,GO:1903427,1,0.767778931240965,0,19,negative regulation of reactive oxygen species biosynthetic process,BP,
19610,GO:1903431,1,0.90990120805348,0,6,positive regulation of cell maturation,BP,
19613,GO:1903434,1,0.983408158637964,0,1,negative regulation of constitutive secretory pathway,BP,
19615,GO:1903436,1,0.967227622468252,0,2,regulation of mitotic cytokinetic process,BP,
19616,GO:1903438,1,0.967227622468252,0,2,positive regulation of mitotic cytokinetic process,BP,
19617,GO:1903441,1,0.899202963309818,0,7,protein localization to ciliary membrane,BP,
19618,GO:1903444,1,0.983674085893709,0,1,negative regulation of brown fat cell differentiation,BP,
19619,GO:1903445,1,0.964664090325123,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19620,GO:1903450,1,0.983406759350984,0,1,regulation of G1 to G0 transition,BP,
19621,GO:1903452,1,0.983406759350984,0,1,positive regulation of G1 to G0 transition,BP,
19622,GO:1903461,1,0.983725759069798,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19623,GO:1903463,1,0.954869944003334,0,3,regulation of mitotic cell cycle DNA replication,BP,
19624,GO:1903464,1,0.970983658612177,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19625,GO:1903465,1,0.983406759351775,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19626,GO:1903487,1,0.979727060329642,0,2,regulation of lactation,BP,
19627,GO:1903488,1,0.992006646305284,0,1,negative regulation of lactation,BP,
19628,GO:1903489,1,0.987621879994363,0,1,positive regulation of lactation,BP,
19629,GO:1903490,1,0.967227622468252,0,2,positive regulation of mitotic cytokinesis,BP,
19630,GO:1903504,1,0.830929030387889,0,13,regulation of mitotic spindle checkpoint,BP,
19636,GO:1903513,1,0.683421486248794,0,26,endoplasmic reticulum to cytosol transport,BP,
19638,GO:1903515,1,0.983406759351084,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19639,GO:1903516,1,0.984000309954091,0,1,regulation of single strand break repair,BP,
19640,GO:1903517,1,0.984000309954091,0,1,negative regulation of single strand break repair,BP,
19646,GO:1903525,1,0.919750880151711,0,5,regulation of membrane tubulation,BP,
19647,GO:1903526,1,0.967108440960706,0,2,negative regulation of membrane tubulation,BP,
19648,GO:1903527,1,0.951038409344019,0,3,positive regulation of membrane tubulation,BP,
19653,GO:1903537,1,0.985275954655982,0,1,meiotic cell cycle process involved in oocyte maturation,BP,
19654,GO:1903538,1,0.985275954655982,0,1,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19655,GO:1903539,1,0.856939137934279,0,10,protein localization to postsynaptic membrane,BP,
19656,GO:1903540,1,0.856939137934279,0,10,establishment of protein localization to postsynaptic membrane,BP,
19658,GO:1903542,1,0.969517489548672,0,2,negative regulation of exosomal secretion,BP,
19662,GO:1903546,1,0.901852671746685,0,7,protein localization to photoreceptor outer segment,BP,
19663,GO:1903547,1,0.983190383518178,0,2,regulation of growth hormone activity,BP,
19670,GO:1903564,1,0.951131257956753,0,3,regulation of protein localization to cilium,BP,
19671,GO:1903565,1,0.983502754819047,0,1,negative regulation of protein localization to cilium,BP,
19672,GO:1903566,1,0.967087733486269,0,2,positive regulation of protein localization to cilium,BP,
19673,GO:1903567,1,0.983502754819047,0,1,regulation of protein localization to ciliary membrane,BP,
19674,GO:1903568,1,0.983502754819047,0,1,negative regulation of protein localization to ciliary membrane,BP,
19675,GO:1903570,1,0.983456885625549,0,1,regulation of protein kinase D signaling,BP,
19676,GO:1903572,1,0.983456885625549,0,1,positive regulation of protein kinase D signaling,BP,
19677,GO:1903573,1,0.580422464487507,0,37,negative regulation of response to endoplasmic reticulum stress,BP,
19678,GO:1903575,1,0.973160938976542,0,2,cornified envelope assembly,BP,
19679,GO:1903576,1,0.986418592932794,0,1,response to L-arginine,BP,
19683,GO:1903584,1,0.983406759352021,0,1,regulation of histone deubiquitination,BP,
19684,GO:1903586,1,0.983406759352021,0,1,positive regulation of histone deubiquitination,BP,
19685,GO:1903587,1,0.942247270183266,0,4,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19686,GO:1903588,1,0.958148857913743,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19687,GO:1903589,1,0.983406759351627,0,1,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19688,GO:1903593,1,0.964164815814547,0,3,regulation of histamine secretion by mast cell,BP,
19689,GO:1903595,1,0.964164815814547,0,3,positive regulation of histamine secretion by mast cell,BP,
19690,GO:1903596,1,0.937609311248862,0,4,regulation of gap junction assembly,BP,
19691,GO:1903597,1,0.983522869320851,0,1,negative regulation of gap junction assembly,BP,
19692,GO:1903598,1,0.953320379649591,0,3,positive regulation of gap junction assembly,BP,
19693,GO:1903599,1,0.767548398828327,0,19,positive regulation of mitophagy,BP,
19694,GO:1903608,1,0.899965743909445,0,7,protein localization to cytoplasmic stress granule,BP,
19695,GO:1903610,1,0.987042139523325,0,1,regulation of calcium-dependent ATPase activity,BP,
19696,GO:1903611,1,0.987042139523325,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19697,GO:1903613,1,0.983406759351821,0,1,regulation of protein tyrosine phosphatase activity,BP,
19698,GO:1903615,1,0.983406759351821,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19699,GO:1903618,1,0.983406759352117,0,1,regulation of transdifferentiation,BP,
19700,GO:1903620,1,0.983406759352117,0,1,positive regulation of transdifferentiation,BP,
19701,GO:1903621,1,0.986959541937901,0,1,protein localization to photoreceptor connecting cilium,BP,
19702,GO:1903624,1,0.907336938954245,0,8,regulation of DNA catabolic process,BP,
19703,GO:1903625,1,0.971594449446495,0,2,negative regulation of DNA catabolic process,BP,
19704,GO:1903626,1,0.971630081821239,0,3,positive regulation of DNA catabolic process,BP,
19705,GO:1903627,1,0.987042139523325,0,1,regulation of dUTP diphosphatase activity,BP,
19706,GO:1903629,1,0.987042139523325,0,1,positive regulation of dUTP diphosphatase activity,BP,
19707,GO:1903630,1,0.978177200460852,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19708,GO:1903631,1,0.987042139523325,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19709,GO:1903632,1,0.99101916806167,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19710,GO:1903633,1,0.987042139523325,0,1,regulation of leucine-tRNA ligase activity,BP,
19711,GO:1903634,1,0.987042139523325,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19712,GO:1903636,1,0.995657766730681,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19713,GO:1903638,1,0.995657766730681,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19714,GO:1903639,1,0.99600393225325,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19715,GO:1903640,1,0.99600393225325,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19716,GO:1903644,1,0.980465444721642,0,2,regulation of chaperone-mediated protein folding,BP,
19717,GO:1903645,1,0.995657766730681,0,1,negative regulation of chaperone-mediated protein folding,BP,
19719,GO:1903650,1,0.984885644545272,0,2,negative regulation of cytoplasmic transport,BP,
19721,GO:1903659,1,0.968884441122897,0,3,regulation of complement-dependent cytotoxicity,BP,
19722,GO:1903660,1,0.968884441122897,0,3,negative regulation of complement-dependent cytotoxicity,BP,
19726,GO:1903673,1,0.987081473754892,0,1,mitotic cleavage furrow formation,BP,
19727,GO:1903674,1,0.987114025278128,0,1,regulation of cap-dependent translational initiation,BP,
19728,GO:1903676,1,0.987114025278128,0,1,positive regulation of cap-dependent translational initiation,BP,
19729,GO:1903677,1,0.958709837167253,0,3,regulation of cap-independent translational initiation,BP,
19730,GO:1903679,1,0.958709837167253,0,3,positive regulation of cap-independent translational initiation,BP,
19731,GO:1903689,1,0.890262343302476,0,7,regulation of wound healing, spreading of epidermal cells,BP,
19732,GO:1903690,1,0.935254347828344,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19733,GO:1903691,1,0.967087733486076,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19734,GO:1903697,1,0.983528652107058,0,1,negative regulation of microvillus assembly,BP,
19735,GO:1903699,1,0.983406759350245,0,1,tarsal gland development,BP,
19736,GO:1903701,1,0.983406759351872,0,1,substantia propria of cornea development,BP,
19737,GO:1903704,1,0.983406759352117,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19741,GO:1903709,1,0.983406759350245,0,1,uterine gland development,BP,
19742,GO:1903712,1,0.983416086204809,0,1,cysteine transmembrane transport,BP,
19744,GO:1903717,1,0.983406759351724,0,1,response to ammonia,BP,
19745,GO:1903718,1,0.983406759351724,0,1,cellular response to ammonia,BP,
19748,GO:1903722,1,0.976766746828436,0,2,regulation of centriole elongation,BP,
19749,GO:1903723,1,0.993140998787335,0,1,negative regulation of centriole elongation,BP,
19750,GO:1903724,1,0.98351313097193,0,1,positive regulation of centriole elongation,BP,
19755,GO:1903742,1,0.990294888903245,0,1,regulation of anterograde synaptic vesicle transport,BP,
19756,GO:1903743,1,0.990294888903245,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19758,GO:1903748,1,0.904114614175984,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19760,GO:1903750,1,0.947368681162935,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19761,GO:1903751,1,0.947368681162935,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19762,GO:1903753,1,0.935954356023705,0,4,negative regulation of p38MAPK cascade,BP,
19763,GO:1903755,1,0.991123064544678,0,1,positive regulation of SUMO transferase activity,BP,
19764,GO:1903756,1,0.96887821603236,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19765,GO:1903758,1,0.96887821603236,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19766,GO:1903759,1,0.983674085893709,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19767,GO:1903760,1,0.951038421217689,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19768,GO:1903762,1,0.967087745560613,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19769,GO:1903763,1,0.951580036843758,0,3,gap junction channel activity involved in cell communication by electrical coupling,MF,
19770,GO:1903764,1,0.96117932094304,0,3,regulation of potassium ion export across plasma membrane,BP,
19771,GO:1903765,1,0.983770198303557,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19772,GO:1903766,1,0.993524199539596,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19773,GO:1903767,1,0.969788752974161,0,2,sweet taste receptor complex,CC,
19774,GO:1903768,1,0.969788752974161,0,2,taste receptor complex,CC,
19775,GO:1903770,1,0.984000309954091,0,1,negative regulation of beta-galactosidase activity,BP,
19776,GO:1903772,1,0.936721991908402,0,5,regulation of viral budding via host ESCRT complex,BP,
19777,GO:1903774,1,0.959858008830068,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19778,GO:1903775,1,0.983517272406953,0,1,regulation of DNA double-strand break processing,BP,
19779,GO:1903778,1,0.968294287580874,0,2,protein localization to vacuolar membrane,BP,
19781,GO:1903781,1,0.95103842121783,0,3,positive regulation of cardiac conduction,BP,
19782,GO:1903786,1,0.984296671549654,0,1,regulation of glutathione biosynthetic process,BP,
19783,GO:1903788,1,0.984296671549654,0,1,positive regulation of glutathione biosynthetic process,BP,
19784,GO:1903789,1,0.970991904698328,0,2,regulation of amino acid transmembrane transport,BP,
19787,GO:1903795,1,0.922431135344115,0,5,regulation of inorganic anion transmembrane transport,BP,
19788,GO:1903796,1,0.967681017414763,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19789,GO:1903797,1,0.953245055496124,0,3,positive regulation of inorganic anion transmembrane transport,BP,
19791,GO:1903799,1,0.892727119531263,0,7,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19793,GO:1903802,1,0.919731182616167,0,5,L-glutamate(1-) import into cell,BP,
19794,GO:1903814,1,0.993524199539596,0,1,regulation of collecting lymphatic vessel constriction,BP,
19795,GO:1903815,1,0.993524199539596,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19796,GO:1903817,1,0.910094216933182,0,7,negative regulation of voltage-gated potassium channel activity,BP,
19797,GO:1903818,1,0.929196151129252,0,5,positive regulation of voltage-gated potassium channel activity,BP,
19798,GO:1903823,1,0.984000309954091,0,1,telomere single strand break repair,BP,
19799,GO:1903824,1,0.984000309954091,0,1,negative regulation of telomere single strand break repair,BP,
19801,GO:1903826,1,0.941117199376225,0,4,arginine transmembrane transport,BP,
19806,GO:1903831,1,0.749467305500776,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19807,GO:1903837,1,0.984968016038942,0,1,regulation of mRNA 3'-UTR binding,BP,
19808,GO:1903839,1,0.984968016038942,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19811,GO:1903846,1,0.691416122241009,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19814,GO:1903850,1,0.98446850423378,0,1,regulation of cristae formation,BP,
19815,GO:1903852,1,0.98446850423378,0,1,positive regulation of cristae formation,BP,
19816,GO:1903859,1,0.759664467855817,0,18,regulation of dendrite extension,BP,
19817,GO:1903860,1,0.980336049325915,0,2,negative regulation of dendrite extension,BP,
19818,GO:1903861,1,0.774918425344597,0,16,positive regulation of dendrite extension,BP,
19819,GO:1903862,1,0.920159112100249,0,7,positive regulation of oxidative phosphorylation,BP,
19821,GO:1903874,1,0.951154689721993,0,3,ferrous iron transmembrane transport,BP,
19822,GO:1903881,1,0.983417626569944,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19823,GO:1903883,1,0.983417626569944,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19824,GO:1903884,1,0.983417626569944,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19825,GO:1903886,1,0.983417626569944,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19826,GO:1903888,1,0.99404187805355,0,1,regulation of plant epidermal cell differentiation,BP,
19827,GO:1903889,1,0.99404187805355,0,1,negative regulation of plant epidermal cell differentiation,BP,
19828,GO:1903891,1,0.967108895018444,0,2,regulation of ATF6-mediated unfolded protein response,BP,
19829,GO:1903892,1,0.983428251747412,0,1,negative regulation of ATF6-mediated unfolded protein response,BP,
19830,GO:1903894,1,0.84381615946972,0,12,regulation of IRE1-mediated unfolded protein response,BP,
19831,GO:1903895,1,0.967818178184436,0,2,negative regulation of IRE1-mediated unfolded protein response,BP,
19832,GO:1903896,1,0.89616662464905,0,8,positive regulation of IRE1-mediated unfolded protein response,BP,
19833,GO:1903897,1,0.865809597604574,0,10,regulation of PERK-mediated unfolded protein response,BP,
19834,GO:1903898,1,0.927066882348378,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19835,GO:1903899,1,0.949705618703178,0,4,positive regulation of PERK-mediated unfolded protein response,BP,
19837,GO:1903901,1,0.309102480514718,0,86,negative regulation of viral life cycle,BP,
19839,GO:1903903,1,0.969074331296008,0,2,regulation of establishment of T cell polarity,BP,
19840,GO:1903905,1,0.984528416097605,0,1,positive regulation of establishment of T cell polarity,BP,
19841,GO:1903906,1,0.984304064528247,0,1,regulation of plasma membrane raft polarization,BP,
19842,GO:1903909,1,0.916140850767268,0,6,regulation of receptor clustering,BP,
19843,GO:1903910,1,0.985402264103555,0,1,negative regulation of receptor clustering,BP,
19844,GO:1903911,1,0.944545687292341,0,4,positive regulation of receptor clustering,BP,
19845,GO:1903912,1,0.926933070525566,0,5,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19846,GO:1903916,1,0.985259668579407,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19847,GO:1903917,1,0.985259668579407,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19848,GO:1903918,1,0.983406759351281,0,1,regulation of actin filament severing,BP,
19849,GO:1903919,1,0.983406759351281,0,1,negative regulation of actin filament severing,BP,
19850,GO:1903921,1,0.96797020924723,0,2,regulation of protein processing in phagocytic vesicle,BP,
19851,GO:1903923,1,0.96797020924723,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19852,GO:1903924,1,0.985804162400415,0,1,estradiol binding,MF,
19853,GO:1903925,1,0.987321906705523,0,1,response to bisphenol A,BP,
19854,GO:1903926,1,0.987321906705523,0,1,cellular response to bisphenol A,BP,
19855,GO:1903935,1,0.928065083388046,0,5,response to sodium arsenite,BP,
19856,GO:1903936,1,0.943697162328175,0,4,cellular response to sodium arsenite,BP,
19857,GO:1903937,1,0.967119661476569,0,2,response to acrylamide,BP,
19858,GO:1903939,1,0.983534335108998,0,1,regulation of TORC2 signaling,BP,
19859,GO:1903943,1,0.98689369629413,0,1,regulation of hepatocyte apoptotic process,BP,
19860,GO:1903944,1,0.98689369629413,0,1,negative regulation of hepatocyte apoptotic process,BP,
19861,GO:1903946,1,0.983770198303557,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19862,GO:1903947,1,0.967087745560613,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19863,GO:1903949,1,0.967087745560661,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19864,GO:1903952,1,0.98340677162746,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19865,GO:1903954,1,0.98340677162746,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19866,GO:1903955,1,0.323961226914875,0,82,positive regulation of protein targeting to mitochondrion,BP,
19869,GO:1903961,1,0.937424520686123,0,4,positive regulation of anion transmembrane transport,BP,
19870,GO:1903963,1,0.701052863196466,0,29,arachidonate transport,BP,
19871,GO:1903969,1,0.962896232818874,0,3,regulation of response to macrophage colony-stimulating factor,BP,
19872,GO:1903970,1,0.977457627260276,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
19873,GO:1903971,1,0.98510418704369,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
19874,GO:1903972,1,0.962896232818874,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19875,GO:1903973,1,0.977457627260276,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19876,GO:1903974,1,0.98510418704369,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19877,GO:1903975,1,0.884847889012928,0,9,regulation of glial cell migration,BP,
19878,GO:1903976,1,0.949014733933952,0,4,negative regulation of glial cell migration,BP,
19879,GO:1903977,1,0.954119451101314,0,3,positive regulation of glial cell migration,BP,
19880,GO:1903978,1,0.981083208497401,0,2,regulation of microglial cell activation,BP,
19881,GO:1903979,1,0.991811049991438,0,1,negative regulation of microglial cell activation,BP,
19882,GO:1903980,1,0.981083208497401,0,2,positive regulation of microglial cell activation,BP,
19883,GO:1903984,1,0.954049766324908,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
19884,GO:1903988,1,0.983526980738733,0,1,ferrous iron export across plasma membrane,BP,
19885,GO:1903989,1,0.9796286563165,0,2,regulation of ferrous iron import into cell,BP,
19886,GO:1903991,1,0.9796286563165,0,2,positive regulation of ferrous iron import into cell,BP,
19887,GO:1903995,1,0.989183952813612,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19888,GO:1903997,1,0.989183952813612,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19889,GO:1903998,1,0.967087733486896,0,2,regulation of eating behavior,BP,
19890,GO:1903999,1,0.983406759351872,0,1,negative regulation of eating behavior,BP,
19891,GO:1904000,1,0.98340675935099,0,1,positive regulation of eating behavior,BP,
19892,GO:1904008,1,0.989846577960741,0,1,response to monosodium glutamate,BP,
19893,GO:1904009,1,0.989846577960741,0,1,cellular response to monosodium glutamate,BP,
19894,GO:1904010,1,0.989846577960741,0,1,response to Aroclor 1254,BP,
19895,GO:1904016,1,0.967087733487091,0,2,response to Thyroglobulin triiodothyronine,BP,
19896,GO:1904017,1,0.967087733487091,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
19899,GO:1904020,1,0.983498060534443,0,1,regulation of G-protein coupled receptor internalization,BP,
19900,GO:1904021,1,0.983498060534443,0,1,negative regulation of G-protein coupled receptor internalization,BP,
19903,GO:1904026,1,0.984799145109626,0,1,regulation of collagen fibril organization,BP,
19904,GO:1904027,1,0.984799145109626,0,1,negative regulation of collagen fibril organization,BP,
19910,GO:1904037,1,0.706311318182782,0,24,positive regulation of epithelial cell apoptotic process,BP,
19911,GO:1904041,1,0.983565412210262,0,1,regulation of cystathionine beta-synthase activity,BP,
19912,GO:1904042,1,0.983565412210262,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19913,GO:1904044,1,0.948349308190753,0,4,response to aldosterone,BP,
19914,GO:1904045,1,0.985852904448046,0,1,cellular response to aldosterone,BP,
19915,GO:1904046,1,0.993275314638483,0,1,negative regulation of vascular endothelial growth factor production,BP,
19916,GO:1904047,1,0.955927601616934,0,3,S-adenosyl-L-methionine binding,MF,
19917,GO:1904048,1,0.967087733486704,0,2,regulation of spontaneous neurotransmitter secretion,BP,
19918,GO:1904049,1,0.983406759350642,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
19919,GO:1904050,1,0.983406759352018,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19920,GO:1904054,1,0.98340675935099,0,1,regulation of cholangiocyte proliferation,BP,
19921,GO:1904056,1,0.98340675935099,0,1,positive regulation of cholangiocyte proliferation,BP,
19922,GO:1904057,1,0.97334203980963,0,2,negative regulation of sensory perception of pain,BP,
19923,GO:1904058,1,0.941826780338393,0,4,positive regulation of sensory perception of pain,BP,
19924,GO:1904059,1,0.967253815745428,0,2,regulation of locomotor rhythm,BP,
19928,GO:1904071,1,0.967087733487142,0,2,presynaptic active zone assembly,BP,
19929,GO:1904073,1,0.983406759351328,0,1,regulation of trophectodermal cell proliferation,BP,
19930,GO:1904075,1,0.983406759351328,0,1,positive regulation of trophectodermal cell proliferation,BP,
19931,GO:1904098,1,0.955919459686024,0,3,regulation of protein O-linked glycosylation,BP,
19932,GO:1904100,1,0.955919459686024,0,3,positive regulation of protein O-linked glycosylation,BP,
19933,GO:1904106,1,0.968499073308146,0,2,protein localization to microvillus,BP,
19934,GO:1904115,1,0.571647766417282,0,38,axon cytoplasm,CC,
19935,GO:1904116,1,0.951789115876911,0,3,response to vasopressin,BP,
19936,GO:1904117,1,0.951789115876911,0,3,cellular response to vasopressin,BP,
19937,GO:1904118,1,0.983721525814145,0,1,regulation of otic vesicle morphogenesis,BP,
19938,GO:1904120,1,0.983721525814145,0,1,positive regulation of otic vesicle morphogenesis,BP,
19939,GO:1904121,1,0.967087733487287,0,2,phosphatidylethanolamine transporter activity,MF,
19940,GO:1904124,1,0.964080589451423,0,3,microglial cell migration,BP,
19941,GO:1904139,1,0.964080589451423,0,3,regulation of microglial cell migration,BP,
19942,GO:1904140,1,0.989183952813612,0,1,negative regulation of microglial cell migration,BP,
19943,GO:1904141,1,0.98510418704369,0,1,positive regulation of microglial cell migration,BP,
19944,GO:1904149,1,0.989183952813612,0,1,regulation of microglial cell mediated cytotoxicity,BP,
19945,GO:1904151,1,0.989183952813612,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
19946,GO:1904152,1,0.826968793859945,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
19947,GO:1904153,1,0.875837612687447,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
19948,GO:1904154,1,0.960117466925793,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
19949,GO:1904155,1,0.983534046848862,0,1,DN2 thymocyte differentiation,BP,
19950,GO:1904156,1,0.983534046848862,0,1,DN3 thymocyte differentiation,BP,
19951,GO:1904158,1,0.954783643499039,0,3,axonemal central apparatus assembly,BP,
19952,GO:1904167,1,0.983406759350544,0,1,regulation of thyroid hormone receptor activity,BP,
19953,GO:1904168,1,0.983406759350544,0,1,negative regulation of thyroid hormone receptor activity,BP,
19954,GO:1904170,1,0.983688021750732,0,1,regulation of bleb assembly,BP,
19955,GO:1904172,1,0.983688021750732,0,1,positive regulation of bleb assembly,BP,
19956,GO:1904177,1,0.929231993888683,0,5,regulation of adipose tissue development,BP,
19957,GO:1904179,1,0.937810836945795,0,4,positive regulation of adipose tissue development,BP,
19958,GO:1904180,1,0.909416015509442,0,7,negative regulation of membrane depolarization,BP,
19959,GO:1904181,1,0.860072670011148,0,11,positive regulation of membrane depolarization,BP,
19960,GO:1904182,1,0.991332445824465,0,1,regulation of pyruvate dehydrogenase activity,BP,
19961,GO:1904192,1,0.98340675935099,0,1,regulation of cholangiocyte apoptotic process,BP,
19962,GO:1904193,1,0.98340675935099,0,1,negative regulation of cholangiocyte apoptotic process,BP,
19963,GO:1904195,1,0.98340675935099,0,1,regulation of granulosa cell proliferation,BP,
19964,GO:1904197,1,0.98340675935099,0,1,positive regulation of granulosa cell proliferation,BP,
19965,GO:1904199,1,0.983406759352069,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19966,GO:1904200,1,0.98340675935099,0,1,iodide transmembrane transport,BP,
19967,GO:1904201,1,0.98340675935099,0,1,regulation of iodide transport,BP,
19968,GO:1904202,1,0.98340675935099,0,1,negative regulation of iodide transport,BP,
19969,GO:1904204,1,0.967087733486609,0,2,regulation of skeletal muscle hypertrophy,BP,
19970,GO:1904205,1,0.983406759351624,0,1,negative regulation of skeletal muscle hypertrophy,BP,
19971,GO:1904206,1,0.98340675935099,0,1,positive regulation of skeletal muscle hypertrophy,BP,
19972,GO:1904207,1,0.96950868329883,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
19973,GO:1904209,1,0.96950868329883,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
19974,GO:1904210,1,0.9899559517978,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19975,GO:1904211,1,0.971378510725633,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
19976,GO:1904212,1,0.98340675935099,0,1,regulation of iodide transmembrane transport,BP,
19977,GO:1904213,1,0.98340675935099,0,1,negative regulation of iodide transmembrane transport,BP,
19978,GO:1904217,1,0.957981101373248,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
19979,GO:1904219,1,0.957981101373248,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
19980,GO:1904220,1,0.943345876310879,0,4,regulation of serine C-palmitoyltransferase activity,BP,
19981,GO:1904222,1,0.957981101373248,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
19982,GO:1904226,1,0.985951929448957,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19983,GO:1904227,1,0.985951929448957,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19984,GO:1904229,1,0.976911857539419,0,2,regulation of succinate dehydrogenase activity,BP,
19985,GO:1904231,1,0.976911857539419,0,2,positive regulation of succinate dehydrogenase activity,BP,
19986,GO:1904232,1,0.976911857539419,0,2,regulation of aconitate hydratase activity,BP,
19987,GO:1904234,1,0.976911857539419,0,2,positive regulation of aconitate hydratase activity,BP,
19988,GO:1904235,1,0.983406759351034,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
19989,GO:1904237,1,0.983406759351034,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
19991,GO:1904239,1,0.9899559517978,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19992,GO:1904240,1,0.9899559517978,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19993,GO:1904245,1,0.971900724494896,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
19994,GO:1904246,1,0.987948183556831,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
19995,GO:1904247,1,0.983757591063752,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
19996,GO:1904251,1,0.859195693380831,0,10,regulation of bile acid metabolic process,BP,
19997,GO:1904252,1,0.956648703722575,0,3,negative regulation of bile acid metabolic process,BP,
19998,GO:1904253,1,0.955025481540931,0,3,positive regulation of bile acid metabolic process,BP,
19999,GO:1904259,1,0.91973118261511,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20000,GO:1904261,1,0.91973118261511,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20002,GO:1904263,1,0.904166695328544,0,7,positive regulation of TORC1 signaling,BP,
20003,GO:1904264,1,0.830762267090455,0,12,ubiquitin protein ligase activity involved in ERAD pathway,MF,
20004,GO:1904265,1,0.983406759351575,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20005,GO:1904266,1,0.98340675935133,0,1,regulation of Schwann cell chemotaxis,BP,
20006,GO:1904268,1,0.98340675935133,0,1,positive regulation of Schwann cell chemotaxis,BP,
20007,GO:1904274,1,0.985807893522371,0,1,tricellular tight junction assembly,BP,
20008,GO:1904282,1,0.986957261121186,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20009,GO:1904283,1,0.986957261121186,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20010,GO:1904288,1,0.93722971197884,0,4,BAT3 complex binding,MF,
20011,GO:1904289,1,0.983871089773647,0,1,regulation of mitotic DNA damage checkpoint,BP,
20012,GO:1904292,1,0.665086044854649,0,27,regulation of ERAD pathway,BP,
20013,GO:1904293,1,0.826769811818376,0,13,negative regulation of ERAD pathway,BP,
20014,GO:1904294,1,0.819825165279785,0,13,positive regulation of ERAD pathway,BP,
20015,GO:1904298,1,0.983406759352069,0,1,regulation of transcytosis,BP,
20016,GO:1904300,1,0.983406759352069,0,1,positive regulation of transcytosis,BP,
20017,GO:1904301,1,0.983406759352069,0,1,regulation of maternal process involved in parturition,BP,
20018,GO:1904303,1,0.983406759352069,0,1,positive regulation of maternal process involved in parturition,BP,
20019,GO:1904304,1,0.983406759352069,0,1,regulation of gastro-intestinal system smooth muscle contraction,BP,
20020,GO:1904306,1,0.983406759352069,0,1,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20021,GO:1904313,1,0.973522719820191,0,2,response to methamphetamine hydrochloride,BP,
20022,GO:1904315,1,0.753381906678979,0,19,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20023,GO:1904316,1,0.983406759352069,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20024,GO:1904317,1,0.983406759352069,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20025,GO:1904321,1,0.860475167691734,0,9,response to forskolin,BP,
20026,GO:1904322,1,0.860475167691734,0,9,cellular response to forskolin,BP,
20027,GO:1904327,1,0.968384722375724,0,2,protein localization to cytosolic proteasome complex,BP,
20028,GO:1904338,1,0.869124799877528,0,10,regulation of dopaminergic neuron differentiation,BP,
20029,GO:1904339,1,0.956835190844258,0,3,negative regulation of dopaminergic neuron differentiation,BP,
20030,GO:1904340,1,0.951867602088117,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20031,GO:1904350,1,0.927842988677458,0,5,regulation of protein catabolic process in the vacuole,BP,
20032,GO:1904351,1,0.967242455633824,0,2,negative regulation of protein catabolic process in the vacuole,BP,
20033,GO:1904352,1,0.973701021836476,0,2,positive regulation of protein catabolic process in the vacuole,BP,
20034,GO:1904353,1,0.671980530885343,0,26,regulation of telomere capping,BP,
20035,GO:1904354,1,0.877858467887925,0,8,negative regulation of telomere capping,BP,
20036,GO:1904355,1,0.778518970810028,0,17,positive regulation of telomere capping,BP,
20037,GO:1904356,1,0.442457480135489,0,54,regulation of telomere maintenance via telomere lengthening,BP,
20038,GO:1904357,1,0.71182390913803,0,22,negative regulation of telomere maintenance via telomere lengthening,BP,
20039,GO:1904358,1,0.595735359840001,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
20040,GO:1904373,1,0.989017591420043,0,1,response to kainic acid,BP,
20044,GO:1904378,1,0.955138230998599,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20045,GO:1904379,1,0.968384722375724,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20046,GO:1904380,1,0.748934303119161,0,20,endoplasmic reticulum mannose trimming,BP,
20047,GO:1904381,1,0.951253513543194,0,3,Golgi apparatus mannose trimming,BP,
20048,GO:1904382,1,0.939599517386371,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20049,GO:1904383,1,0.954625976319736,0,3,response to sodium phosphate,BP,
20051,GO:1904386,1,0.920383011814803,0,5,response to L-phenylalanine derivative,BP,
20052,GO:1904387,1,0.967443258148103,0,2,cellular response to L-phenylalanine derivative,BP,
20053,GO:1904389,1,0.989017591420043,0,1,rod bipolar cell differentiation,BP,
20054,GO:1904391,1,0.989017591420043,0,1,response to ciliary neurotrophic factor,BP,
20055,GO:1904393,1,0.958406371532412,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20056,GO:1904394,1,0.985402264103555,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20057,GO:1904395,1,0.972605838404167,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20058,GO:1904396,1,0.884076461932522,0,8,regulation of neuromuscular junction development,BP,
20059,GO:1904397,1,0.974579516262604,0,2,negative regulation of neuromuscular junction development,BP,
20060,GO:1904398,1,0.956465313295339,0,3,positive regulation of neuromuscular junction development,BP,
20061,GO:1904399,1,0.989017591420043,0,1,heparan sulfate binding,MF,
20062,GO:1904400,1,0.983738140813592,0,1,response to Thyroid stimulating hormone,BP,
20063,GO:1904404,1,0.983406759351331,0,1,response to formaldehyde,BP,
20064,GO:1904406,1,0.850830486791637,0,12,negative regulation of nitric oxide metabolic process,BP,
20066,GO:1904408,1,0.991517356609453,0,1,melatonin binding,MF,
20067,GO:1904412,1,0.983431384306763,0,1,regulation of cardiac ventricle development,BP,
20068,GO:1904414,1,0.983431384306763,0,1,positive regulation of cardiac ventricle development,BP,
20069,GO:1904415,1,0.909877363169287,0,6,regulation of xenophagy,BP,
20070,GO:1904417,1,0.909877363169287,0,6,positive regulation of xenophagy,BP,
20071,GO:1904424,1,0.920750234013175,0,5,regulation of GTP binding,BP,
20072,GO:1904425,1,0.983412386492567,0,1,negative regulation of GTP binding,BP,
20073,GO:1904426,1,0.96784627266264,0,2,positive regulation of GTP binding,BP,
20074,GO:1904427,1,0.487624974857852,0,52,positive regulation of calcium ion transmembrane transport,BP,
20075,GO:1904428,1,0.983406759350494,0,1,negative regulation of tubulin deacetylation,BP,
20076,GO:1904429,1,0.893776788362151,0,7,regulation of t-circle formation,BP,
20077,GO:1904430,1,0.951687725933426,0,3,negative regulation of t-circle formation,BP,
20078,GO:1904431,1,0.9391613142646,0,4,positive regulation of t-circle formation,BP,
20079,GO:1904432,1,0.9796286563165,0,2,regulation of ferrous iron binding,BP,
20080,GO:1904434,1,0.9796286563165,0,2,positive regulation of ferrous iron binding,BP,
20081,GO:1904435,1,0.9796286563165,0,2,regulation of transferrin receptor binding,BP,
20082,GO:1904437,1,0.9796286563165,0,2,positive regulation of transferrin receptor binding,BP,
20083,GO:1904447,1,0.983406759351527,0,1,folic acid import into cell,BP,
20084,GO:1904448,1,0.983406759351921,0,1,regulation of aspartate secretion,BP,
20085,GO:1904450,1,0.983406759351921,0,1,positive regulation of aspartate secretion,BP,
20086,GO:1904454,1,0.983406759351183,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20087,GO:1904455,1,0.967087733487574,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20088,GO:1904456,1,0.98730755402416,0,1,negative regulation of neuronal action potential,BP,
20089,GO:1904457,1,0.985182578475753,0,1,positive regulation of neuronal action potential,BP,
20090,GO:1904464,1,0.987984312332234,0,1,regulation of matrix metallopeptidase secretion,BP,
20091,GO:1904465,1,0.987984312332234,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20092,GO:1904467,1,0.900951281261044,0,7,regulation of tumor necrosis factor secretion,BP,
20093,GO:1904468,1,0.954549056322335,0,3,negative regulation of tumor necrosis factor secretion,BP,
20094,GO:1904469,1,0.943860678286588,0,4,positive regulation of tumor necrosis factor secretion,BP,
20095,GO:1904478,1,0.902877086738846,0,9,regulation of intestinal absorption,BP,
20096,GO:1904479,1,0.949841378580409,0,4,negative regulation of intestinal absorption,BP,
20097,GO:1904481,1,0.985012699887948,0,1,response to tetrahydrofolate,BP,
20098,GO:1904482,1,0.985012699887948,0,1,cellular response to tetrahydrofolate,BP,
20099,GO:1904491,1,0.935017008571291,0,5,protein localization to ciliary transition zone,BP,
20100,GO:1904492,1,0.984618218002672,0,1,Ac-Asp-Glu binding,MF,
20101,GO:1904493,1,0.984618218002672,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20102,GO:1904499,1,0.983492190195988,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20103,GO:1904501,1,0.983492190195988,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20106,GO:1904505,1,0.938080899334796,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20107,GO:1904506,1,0.938080899334796,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20108,GO:1904515,1,0.983534335108998,0,1,positive regulation of TORC2 signaling,BP,
20109,GO:1904526,1,0.912039289013169,0,6,regulation of microtubule binding,BP,
20110,GO:1904527,1,0.968523974610404,0,2,negative regulation of microtubule binding,BP,
20111,GO:1904528,1,0.942596680855462,0,4,positive regulation of microtubule binding,BP,
20112,GO:1904529,1,0.96740830592489,0,2,regulation of actin filament binding,BP,
20113,GO:1904530,1,0.983732718801494,0,1,negative regulation of actin filament binding,BP,
20114,GO:1904531,1,0.983406759351775,0,1,positive regulation of actin filament binding,BP,
20115,GO:1904533,1,0.952133434069447,0,3,regulation of telomeric loop disassembly,BP,
20116,GO:1904534,1,0.968201160648909,0,2,negative regulation of telomeric loop disassembly,BP,
20117,GO:1904535,1,0.983406759352018,0,1,positive regulation of telomeric loop disassembly,BP,
20118,GO:1904542,1,0.98446850423378,0,1,regulation of free ubiquitin chain polymerization,BP,
20119,GO:1904544,1,0.98446850423378,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20120,GO:1904562,1,0.967087733486655,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20121,GO:1904565,1,0.983704459540937,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20122,GO:1904566,1,0.983704459540937,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20123,GO:1904567,1,0.983839083913376,0,1,response to wortmannin,BP,
20124,GO:1904568,1,0.983839083913376,0,1,cellular response to wortmannin,BP,
20125,GO:1904569,1,0.984077490700466,0,2,regulation of selenocysteine incorporation,BP,
20126,GO:1904570,1,0.987958491802573,0,1,negative regulation of selenocysteine incorporation,BP,
20127,GO:1904571,1,0.996071896818273,0,1,positive regulation of selenocysteine incorporation,BP,
20128,GO:1904572,1,0.987958491802573,0,1,negative regulation of mRNA binding,BP,
20129,GO:1904573,1,0.987958491802573,0,1,regulation of selenocysteine insertion sequence binding,BP,
20130,GO:1904574,1,0.987958491802573,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20131,GO:1904576,1,0.972691127936801,0,2,response to tunicamycin,BP,
20132,GO:1904577,1,0.972691127936801,0,2,cellular response to tunicamycin,BP,
20133,GO:1904578,1,0.962281026825853,0,3,response to thapsigargin,BP,
20134,GO:1904579,1,0.962281026825853,0,3,cellular response to thapsigargin,BP,
20135,GO:1904580,1,0.971969766635853,0,2,regulation of intracellular mRNA localization,BP,
20136,GO:1904582,1,0.971969766635853,0,2,positive regulation of intracellular mRNA localization,BP,
20137,GO:1904585,1,0.986056931335688,0,1,response to putrescine,BP,
20138,GO:1904586,1,0.986056931335688,0,1,cellular response to putrescine,BP,
20139,GO:1904587,1,0.930983264991801,0,5,response to glycoprotein,BP,
20140,GO:1904588,1,0.990832232705604,0,1,cellular response to glycoprotein,BP,
20144,GO:1904594,1,0.983406759350443,0,1,regulation of termination of RNA polymerase II transcription,BP,
20145,GO:1904595,1,0.983406759350443,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20146,GO:1904596,1,0.990232740557464,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20147,GO:1904597,1,0.990232740557464,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20148,GO:1904599,1,0.990232740557464,0,1,advanced glycation end-product binding,MF,
20149,GO:1904602,1,0.973480288880651,0,2,serotonin-activated cation-selective channel complex,CC,
20150,GO:1904603,1,0.990232740557464,0,1,regulation of advanced glycation end-product receptor activity,BP,
20151,GO:1904604,1,0.990232740557464,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20152,GO:1904606,1,0.983492632555574,0,1,fat cell apoptotic process,BP,
20153,GO:1904612,1,0.983738140813592,0,1,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20154,GO:1904616,1,0.96740830592489,0,2,regulation of actin binding,BP,
20155,GO:1904617,1,0.983732718801494,0,1,negative regulation of actin binding,BP,
20156,GO:1904618,1,0.983406759351775,0,1,positive regulation of actin binding,BP,
20157,GO:1904627,1,0.926826763464425,0,5,response to phorbol 13-acetate 12-myristate,BP,
20158,GO:1904628,1,0.926826763464425,0,5,cellular response to phorbol 13-acetate 12-myristate,BP,
20159,GO:1904631,1,0.985743038995114,0,1,response to glucoside,BP,
20160,GO:1904633,1,0.983406759351575,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20161,GO:1904635,1,0.983406759351575,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20162,GO:1904636,1,0.942052704347231,0,4,response to ionomycin,BP,
20163,GO:1904637,1,0.942052704347231,0,4,cellular response to ionomycin,BP,
20164,GO:1904638,1,0.983406759351575,0,1,response to resveratrol,BP,
20165,GO:1904639,1,0.983406759351575,0,1,cellular response to resveratrol,BP,
20166,GO:1904640,1,0.961584517351083,0,3,response to methionine,BP,
20167,GO:1904645,1,0.916853055352663,0,6,response to beta-amyloid,BP,
20168,GO:1904646,1,0.957691709619142,0,3,cellular response to beta-amyloid,BP,
20169,GO:1904647,1,0.983406759350889,0,1,response to rotenone,BP,
20170,GO:1904649,1,0.983492632555574,0,1,regulation of fat cell apoptotic process,BP,
20171,GO:1904651,1,0.983492632555574,0,1,positive regulation of fat cell apoptotic process,BP,
20173,GO:1904666,1,0.333797431677286,0,92,regulation of ubiquitin protein ligase activity,BP,
20174,GO:1904667,1,0.41961312666434,0,77,negative regulation of ubiquitin protein ligase activity,BP,
20175,GO:1904668,1,0.361230380235285,0,84,positive regulation of ubiquitin protein ligase activity,BP,
20178,GO:1904674,1,0.967614881352649,0,2,positive regulation of somatic stem cell population maintenance,BP,
20179,GO:1904675,1,0.983942765591477,0,1,regulation of somatic stem cell division,BP,
20180,GO:1904677,1,0.983942765591477,0,1,positive regulation of somatic stem cell division,BP,
20181,GO:1904680,1,0.712421579279405,0,27,peptide transmembrane transporter activity,MF,
20182,GO:1904681,1,0.984393633848452,0,1,response to 3-methylcholanthrene,BP,
20183,GO:1904683,1,0.906542186589549,0,6,regulation of metalloendopeptidase activity,BP,
20184,GO:1904684,1,0.93525800234511,0,4,negative regulation of metalloendopeptidase activity,BP,
20185,GO:1904685,1,0.969304747535759,0,2,positive regulation of metalloendopeptidase activity,BP,
20186,GO:1904688,1,0.950665233705695,0,4,regulation of cytoplasmic translational initiation,BP,
20187,GO:1904689,1,0.991610395808814,0,1,negative regulation of cytoplasmic translational initiation,BP,
20188,GO:1904690,1,0.958709837167253,0,3,positive regulation of cytoplasmic translational initiation,BP,
20189,GO:1904691,1,0.986172162846888,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20190,GO:1904692,1,0.983426874448786,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20191,GO:1904693,1,0.951044479773075,0,3,midbrain morphogenesis,BP,
20192,GO:1904694,1,0.952313961942737,0,3,negative regulation of vascular smooth muscle contraction,BP,
20193,GO:1904700,1,0.984623328793536,0,1,granulosa cell apoptotic process,BP,
20194,GO:1904701,1,0.987639280010081,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20196,GO:1904706,1,0.903292298804766,0,8,negative regulation of vascular smooth muscle cell proliferation,BP,
20198,GO:1904708,1,0.984623328793536,0,1,regulation of granulosa cell apoptotic process,BP,
20199,GO:1904711,1,0.987639280010081,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20200,GO:1904713,1,0.968384722375095,0,2,beta-catenin destruction complex binding,MF,
20201,GO:1904714,1,0.887030574714506,0,8,regulation of chaperone-mediated autophagy,BP,
20202,GO:1904715,1,0.957048304615911,0,3,negative regulation of chaperone-mediated autophagy,BP,
20203,GO:1904716,1,0.985302173953837,0,1,positive regulation of chaperone-mediated autophagy,BP,
20204,GO:1904717,1,0.985051997781775,0,1,regulation of AMPA glutamate receptor clustering,BP,
20205,GO:1904719,1,0.985051997781775,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20206,GO:1904720,1,0.969124428026234,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20207,GO:1904721,1,0.983760999990501,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20208,GO:1904722,1,0.985122822835756,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20209,GO:1904723,1,0.987639280010081,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20210,GO:1904724,1,0.518192716121013,0,55,tertiary granule lumen,CC,
20211,GO:1904729,1,0.921062414870476,0,7,regulation of intestinal lipid absorption,BP,
20212,GO:1904730,1,0.968968553918727,0,2,negative regulation of intestinal lipid absorption,BP,
20213,GO:1904732,1,0.980163289485621,0,2,regulation of electron carrier activity,BP,
20214,GO:1904734,1,0.996702035623669,0,1,positive regulation of electron carrier activity,BP,
20216,GO:1904742,1,0.946472047334115,0,4,regulation of telomeric DNA binding,BP,
20217,GO:1904743,1,0.967087733486317,0,2,negative regulation of telomeric DNA binding,BP,
20218,GO:1904744,1,0.978685644011151,0,2,positive regulation of telomeric DNA binding,BP,
20222,GO:1904749,1,0.93250126082282,0,5,regulation of protein localization to nucleolus,BP,
20223,GO:1904750,1,0.983406759351479,0,1,negative regulation of protein localization to nucleolus,BP,
20224,GO:1904751,1,0.948239057905884,0,4,positive regulation of protein localization to nucleolus,BP,
20226,GO:1904753,1,0.956059478502682,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
20228,GO:1904760,1,0.951062885363978,0,3,regulation of myofibroblast differentiation,BP,
20229,GO:1904761,1,0.967112620803299,0,2,negative regulation of myofibroblast differentiation,BP,
20230,GO:1904762,1,0.983406759389274,0,1,positive regulation of myofibroblast differentiation,BP,
20231,GO:1904764,1,0.986567309955495,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20232,GO:1904772,1,0.984536964273923,0,1,response to tetrachloromethane,BP,
20233,GO:1904779,1,0.912957003792143,0,6,regulation of protein localization to centrosome,BP,
20234,GO:1904780,1,0.983406759351379,0,1,negative regulation of protein localization to centrosome,BP,
20235,GO:1904781,1,0.94237789047201,0,4,positive regulation of protein localization to centrosome,BP,
20236,GO:1904783,1,0.990780980970108,0,1,positive regulation of NMDA glutamate receptor activity,BP,
20237,GO:1904790,1,0.983945022755128,0,1,regulation of shelterin complex assembly,BP,
20238,GO:1904792,1,0.983945022755128,0,1,positive regulation of shelterin complex assembly,BP,
20239,GO:1904793,1,0.983492190195988,0,1,regulation of euchromatin binding,BP,
20240,GO:1904796,1,0.902136073373633,0,7,regulation of core promoter binding,BP,
20241,GO:1904797,1,0.983406759351625,0,1,negative regulation of core promoter binding,BP,
20242,GO:1904798,1,0.917363502156075,0,6,positive regulation of core promoter binding,BP,
20243,GO:1904799,1,0.983406812025873,0,1,regulation of neuron remodeling,BP,
20244,GO:1904800,1,0.983406812025873,0,1,negative regulation of neuron remodeling,BP,
20245,GO:1904803,1,0.99549295627636,0,1,regulation of translation involved in cellular response to UV,BP,
20246,GO:1904806,1,0.969683443564638,0,2,regulation of protein oxidation,BP,
20247,GO:1904808,1,0.969683443564638,0,2,positive regulation of protein oxidation,BP,
20248,GO:1904812,1,0.98340681697126,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20250,GO:1904814,1,0.828330954140946,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20251,GO:1904815,1,0.971219371069468,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20252,GO:1904816,1,0.852893738586107,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20253,GO:1904823,1,0.956795349724992,0,3,purine nucleobase transmembrane transport,BP,
20254,GO:1904826,1,0.983406759351232,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20255,GO:1904828,1,0.983406759351232,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20256,GO:1904829,1,0.987935314300946,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20257,GO:1904831,1,0.987935314300946,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20258,GO:1904833,1,0.968649541588778,0,3,positive regulation of removal of superoxide radicals,BP,
20259,GO:1904835,1,0.984935697988779,0,1,dorsal root ganglion morphogenesis,BP,
20261,GO:1904842,1,0.986053003073054,0,1,response to nitroglycerin,BP,
20262,GO:1904843,1,0.986053003073054,0,1,cellular response to nitroglycerin,BP,
20263,GO:1904844,1,0.964549199233624,0,3,response to L-glutamine,BP,
20264,GO:1904845,1,0.964549199233624,0,3,cellular response to L-glutamine,BP,
20265,GO:1904847,1,0.921510291217497,0,7,regulation of cell chemotaxis to fibroblast growth factor,BP,
20266,GO:1904848,1,0.991123064544678,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20267,GO:1904849,1,0.954031111063047,0,4,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20268,GO:1904850,1,0.983945022755128,0,1,negative regulation of establishment of protein localization to telomere,BP,
20269,GO:1904851,1,0.879169447030106,0,9,positive regulation of establishment of protein localization to telomere,BP,
20270,GO:1904854,1,0.985282490842866,0,1,proteasome core complex binding,MF,
20273,GO:1904863,1,0.983410463311239,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20274,GO:1904864,1,0.983410463311239,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20275,GO:1904867,1,0.880603383942793,0,9,protein localization to Cajal body,BP,
20276,GO:1904868,1,0.967087733485591,0,2,telomerase catalytic core complex assembly,BP,
20277,GO:1904869,1,0.891870937653355,0,8,regulation of protein localization to Cajal body,BP,
20278,GO:1904871,1,0.891870937653355,0,8,positive regulation of protein localization to Cajal body,BP,
20279,GO:1904872,1,0.825647743791649,0,15,regulation of telomerase RNA localization to Cajal body,BP,
20280,GO:1904874,1,0.825647743791649,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20281,GO:1904875,1,0.98400191984867,0,1,regulation of DNA ligase activity,BP,
20282,GO:1904876,1,0.98400191984867,0,1,negative regulation of DNA ligase activity,BP,
20283,GO:1904878,1,0.983406759350544,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20284,GO:1904879,1,0.969038633941303,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20285,GO:1904882,1,0.967087733485591,0,2,regulation of telomerase catalytic core complex assembly,BP,
20286,GO:1904884,1,0.967087733485591,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20289,GO:1904887,1,0.983406759350836,0,1,Wnt signalosome assembly,BP,
20294,GO:1904893,1,0.474577153242967,0,49,negative regulation of STAT cascade,BP,
20296,GO:1904895,1,0.988347891999775,0,1,ESCRT complex assembly,BP,
20297,GO:1904896,1,0.866067149571747,0,10,ESCRT complex disassembly,BP,
20298,GO:1904897,1,0.983547761949543,0,1,regulation of hepatic stellate cell proliferation,BP,
20299,GO:1904899,1,0.983547761949543,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20300,GO:1904902,1,0.988347891999775,0,1,ESCRT III complex assembly,BP,
20301,GO:1904903,1,0.866067149571747,0,10,ESCRT III complex disassembly,BP,
20302,GO:1904907,1,0.967087733485254,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20303,GO:1904908,1,0.967087733485254,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20304,GO:1904910,1,0.983945022755128,0,1,regulation of establishment of RNA localization to telomere,BP,
20305,GO:1904911,1,0.983945022755128,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20306,GO:1904913,1,0.983945022755128,0,1,regulation of establishment of macromolecular complex localization to telomere,BP,
20307,GO:1904914,1,0.983945022755128,0,1,negative regulation of establishment of macromolecular complex localization to telomere,BP,
20308,GO:1904923,1,0.832748398728998,0,13,regulation of mitophagy in response to mitochondrial depolarization,BP,
20309,GO:1904924,1,0.968826408407942,0,2,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20310,GO:1904925,1,0.832748398728998,0,13,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
20311,GO:1904928,1,0.967087733486609,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20312,GO:1904929,1,0.905601961301997,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20315,GO:1904935,1,0.989949855146381,0,1,positive regulation of cell proliferation in midbrain,BP,
20316,GO:1904936,1,0.908991219250244,0,6,interneuron migration,BP,
20318,GO:1904947,1,0.983819847452832,0,1,folic acid import into mitochondrion,BP,
20320,GO:1904949,1,0.702739787474336,0,24,ATPase complex,CC,
20326,GO:1904956,1,0.930779975596012,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20327,GO:1904958,1,0.959182644038106,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20328,GO:1904959,1,0.980163289485621,0,2,regulation of cytochrome-c oxidase activity,BP,
20329,GO:1904960,1,0.996702035623669,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20330,GO:1904970,1,0.921133060507466,0,5,brush border assembly,BP,
20331,GO:1904975,1,0.967087837895097,0,2,response to bleomycin,BP,
20332,GO:1904976,1,0.967087837895097,0,2,cellular response to bleomycin,BP,
20333,GO:1904978,1,0.953324876173759,0,3,regulation of endosome organization,BP,
20334,GO:1904979,1,0.985770719433395,0,1,negative regulation of endosome organization,BP,
20335,GO:1904980,1,0.983406759351379,0,1,positive regulation of endosome organization,BP,
20336,GO:1904990,1,0.985071845570657,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20337,GO:1904992,1,0.985071845570657,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20338,GO:1904994,1,0.874219622967093,0,11,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20339,GO:1904995,1,0.952250605761472,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20340,GO:1904996,1,0.918072229945786,0,6,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20341,GO:1904997,1,0.972484453375966,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20342,GO:1904998,1,0.983950314107376,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20343,GO:1904999,1,0.988347891999775,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20344,GO:1905000,1,0.983406759351035,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20345,GO:1905003,1,0.99078737987985,0,1,picolinic acid metabolic process,BP,
20346,GO:1905004,1,0.99078737987985,0,1,picolinic acid biosynthetic process,BP,
20348,GO:1905006,1,0.970844559838213,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20350,GO:1905008,1,0.984675140077779,0,1,regulation of L-lysine import into cell,BP,
20351,GO:1905010,1,0.984675140077779,0,1,positive regulation of L-lysine import into cell,BP,
20352,GO:1905012,1,0.99078737987985,0,1,regulation of 'de novo' NAD biosynthetic process from tryptophan,BP,
20353,GO:1905024,1,0.935600074156961,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20354,GO:1905025,1,0.983770198303557,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20355,GO:1905026,1,0.967087745560613,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20356,GO:1905030,1,0.687940318758404,0,23,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20357,GO:1905031,1,0.920071194073379,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20358,GO:1905032,1,0.983770198303557,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20359,GO:1905033,1,0.967087745560613,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20361,GO:1905038,1,0.832564553126608,0,13,regulation of membrane lipid metabolic process,BP,
20363,GO:1905040,1,0.984935697988779,0,1,otic placode development,BP,
20364,GO:1905041,1,0.983406759351281,0,1,regulation of epithelium regeneration,BP,
20365,GO:1905044,1,0.984725543253726,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20366,GO:1905045,1,0.984725543253726,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20367,GO:1905048,1,0.827581071592097,0,13,regulation of metallopeptidase activity,BP,
20368,GO:1905049,1,0.91336456385894,0,6,negative regulation of metallopeptidase activity,BP,
20369,GO:1905050,1,0.906113258496676,0,7,positive regulation of metallopeptidase activity,BP,
20370,GO:1905051,1,0.981478494203543,0,2,regulation of base-excision repair,BP,
20371,GO:1905053,1,0.981478494203543,0,2,positive regulation of base-excision repair,BP,
20372,GO:1905062,1,0.984363538817272,0,1,positive regulation of cardioblast proliferation,BP,
20375,GO:1905065,1,0.939836944568149,0,4,positive regulation of vascular smooth muscle cell differentiation,BP,
20376,GO:1905066,1,0.973150115872483,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20377,GO:1905067,1,0.987639280010081,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20378,GO:1905068,1,0.985330249646519,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20380,GO:1905071,1,0.96732590710202,0,2,occluding junction disassembly,BP,
20381,GO:1905073,1,0.96732590710202,0,2,regulation of occluding junction disassembly,BP,
20382,GO:1905075,1,0.96732590710202,0,2,positive regulation of occluding junction disassembly,BP,
20383,GO:1905089,1,0.98340675935015,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20384,GO:1905090,1,0.98340675935015,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20385,GO:1905097,1,0.924597683319061,0,5,regulation of guanyl-nucleotide exchange factor activity,BP,
20386,GO:1905098,1,0.956069868408511,0,3,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20387,GO:1905099,1,0.983406759351575,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20388,GO:1905103,1,0.983406759353248,0,1,integral component of lysosomal membrane,CC,
20390,GO:1905122,1,0.983406759353248,0,1,polyamine import,BP,
20391,GO:1905123,1,0.967087733489271,0,2,regulation of glucosylceramidase activity,BP,
20392,GO:1905132,1,0.976161337687424,0,2,regulation of meiotic chromosome separation,BP,
20393,GO:1905133,1,0.976161337687424,0,2,negative regulation of meiotic chromosome separation,BP,
20394,GO:1905143,1,0.988966411893596,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20395,GO:1905144,1,0.749467305500776,0,21,response to acetylcholine,BP,
20396,GO:1905145,1,0.749467305500776,0,21,cellular response to acetylcholine,BP,
20397,GO:1905146,1,0.93709348249016,0,4,lysosomal protein catabolic process,BP,
20398,GO:1905150,1,0.951194131190242,0,3,regulation of voltage-gated sodium channel activity,BP,
20399,GO:1905152,1,0.983406759351673,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20400,GO:1905153,1,0.833366450734968,0,12,regulation of membrane invagination,BP,
20401,GO:1905154,1,0.970839909013203,0,2,negative regulation of membrane invagination,BP,
20402,GO:1905155,1,0.872013302812814,0,9,positive regulation of membrane invagination,BP,
20403,GO:1905161,1,0.98340675935187,0,1,protein localization to phagocytic vesicle,BP,
20404,GO:1905162,1,0.98340675935187,0,1,regulation of phagosome maturation,BP,
20405,GO:1905165,1,0.952908453685737,0,3,regulation of lysosomal protein catabolic process,BP,
20406,GO:1905166,1,0.967242455633824,0,2,negative regulation of lysosomal protein catabolic process,BP,
20407,GO:1905169,1,0.98340675935187,0,1,regulation of protein localization to phagocytic vesicle,BP,
20408,GO:1905171,1,0.98340675935187,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20411,GO:1905202,1,0.968433844632033,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20412,GO:1905203,1,0.973800905720916,0,2,regulation of connective tissue replacement,BP,
20413,GO:1905204,1,0.990232740557464,0,1,negative regulation of connective tissue replacement,BP,
20414,GO:1905205,1,0.983406759351972,0,1,positive regulation of connective tissue replacement,BP,
20415,GO:1905206,1,0.93064095052739,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20419,GO:1905214,1,0.848465837636887,0,11,regulation of RNA binding,BP,
20420,GO:1905215,1,0.987958491802573,0,1,negative regulation of RNA binding,BP,
20421,GO:1905216,1,0.887626589718402,0,8,positive regulation of RNA binding,BP,
20422,GO:1905217,1,0.983738140813592,0,1,response to astaxanthin,BP,
20423,GO:1905222,1,0.983694422973195,0,1,atrioventricular canal morphogenesis,BP,
20424,GO:1905223,1,0.983406759351575,0,1,epicardium morphogenesis,BP,
20425,GO:1905224,1,0.967087733487917,0,2,clathrin-coated pit assembly,BP,
20426,GO:1905225,1,0.974718846298253,0,2,response to thyrotropin-releasing hormone,BP,
20427,GO:1905229,1,0.990832232705604,0,1,cellular response to thyrotropin-releasing hormone,BP,
20428,GO:1905230,1,0.983406761279341,0,1,response to borneol,BP,
20429,GO:1905231,1,0.983406761279341,0,1,cellular response to borneol,BP,
20430,GO:1905232,1,0.951217052305645,0,3,cellular response to L-glutamate,BP,
20431,GO:1905233,1,0.983406761279341,0,1,response to codeine,BP,
20432,GO:1905235,1,0.983406761279341,0,1,response to quercetin,BP,
20433,GO:1905237,1,0.977797159592339,0,2,response to cyclosporin A,BP,
20434,GO:1905239,1,0.983406759351921,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20435,GO:1905240,1,0.983406759351921,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20436,GO:1905242,1,0.98441973604131,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
20437,GO:1905243,1,0.98441973604131,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20438,GO:1905244,1,0.967353439610029,0,2,regulation of modification of synaptic structure,BP,
20439,GO:1905245,1,0.967091511871711,0,2,regulation of aspartic-type peptidase activity,BP,
20440,GO:1905246,1,0.983406759350443,0,1,negative regulation of aspartic-type peptidase activity,BP,
20441,GO:1905247,1,0.98341060123055,0,1,positive regulation of aspartic-type peptidase activity,BP,
20442,GO:1905255,1,0.983406759351527,0,1,regulation of RNA binding transcription factor activity,BP,
20443,GO:1905258,1,0.982048922972454,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20444,GO:1905259,1,0.982048922972454,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20445,GO:1905267,1,0.96942274822836,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20446,GO:1905268,1,0.482318603306089,0,48,negative regulation of chromatin organization,BP,
20448,GO:1905271,1,0.995157444350668,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20449,GO:1905273,1,0.995157444350668,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20450,GO:1905274,1,0.98340675935133,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20452,GO:1905277,1,0.983768461630855,0,1,negative regulation of epithelial tube formation,BP,
20454,GO:1905279,1,0.983406759350836,0,1,regulation of retrograde transport, endosome to Golgi,BP,
20455,GO:1905285,1,0.983431384306763,0,1,fibrous ring of heart morphogenesis,BP,
20456,GO:1905286,1,0.954954789688209,0,3,serine-type peptidase complex,CC,
20457,GO:1905289,1,0.983406759350836,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20458,GO:1905301,1,0.983406759352018,0,1,regulation of macropinocytosis,BP,
20459,GO:1905302,1,0.983406759352018,0,1,negative regulation of macropinocytosis,BP,
20460,GO:1905304,1,0.98340675935099,0,1,regulation of cardiac myofibril assembly,BP,
20461,GO:1905305,1,0.98340675935099,0,1,negative regulation of cardiac myofibril assembly,BP,
20462,GO:1905313,1,0.985890748093858,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20464,GO:1905323,1,0.91318919396794,0,6,telomerase holoenzyme complex assembly,BP,
20465,GO:1905327,1,0.988853451736982,0,1,tracheoesophageal septum formation,BP,
20469,GO:1905333,1,0.988374762250607,0,1,regulation of gastric motility,BP,
20470,GO:1905335,1,0.983406759349905,0,1,regulation of aggrephagy,BP,
20471,GO:1905337,1,0.983406759349905,0,1,positive regulation of aggrephagy,BP,
20472,GO:1905340,1,0.944307332960664,0,4,regulation of protein localization to kinetochore,BP,
20473,GO:1905341,1,0.98442891536618,0,1,negative regulation of protein localization to kinetochore,BP,
20474,GO:1905342,1,0.944307332960664,0,4,positive regulation of protein localization to kinetochore,BP,
20475,GO:1905344,1,0.984725543253726,0,1,prostaglandin catabolic process,BP,
20476,GO:1905348,1,0.716300976980459,0,25,endonuclease complex,CC,
20477,GO:1905354,1,0.751929554031273,0,22,exoribonuclease complex,CC,
20478,GO:1905355,1,0.983406759351869,0,1,spine apparatus assembly,BP,
20479,GO:1905359,1,0.983811692138999,0,1,protein localization to meiotic spindle,BP,
20480,GO:1905360,1,0.634607057709913,0,35,GTPase complex,CC,
20481,GO:1905361,1,0.881067810087849,0,9,L-serine transporter activity,MF,
20482,GO:1905365,1,0.985770719433395,0,1,regulation of intralumenal vesicle formation,BP,
20483,GO:1905366,1,0.985770719433395,0,1,negative regulation of intralumenal vesicle formation,BP,
20484,GO:1905368,1,0.357226933355744,0,86,peptidase complex,CC,
20485,GO:1905369,1,0.467115926301743,0,66,endopeptidase complex,CC,
20486,GO:1905370,1,0.985174651492059,0,1,serine-type endopeptidase complex,CC,
20487,GO:1905371,1,0.972843492674645,0,2,ceramide phosphoethanolamine metabolic process,BP,
20488,GO:1905373,1,0.972843492674645,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20492,GO:1905392,1,0.99404187805355,0,1,plant organ morphogenesis,BP,
20493,GO:1905394,1,0.954893559682856,0,3,retromer complex binding,MF,
20494,GO:1905395,1,0.961613154931415,0,3,response to flavonoid,BP,
20495,GO:1905397,1,0.989046117028006,0,1,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20496,GO:1905402,1,0.989046117028006,0,1,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20497,GO:1905404,1,0.989046117028006,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20498,GO:1905407,1,0.970991904698328,0,2,regulation of creatine transmembrane transporter activity,BP,
20499,GO:1905408,1,0.970991904698328,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20500,GO:1905419,1,0.987508415210851,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20501,GO:1905421,1,0.99404187805355,0,1,regulation of plant organ morphogenesis,BP,
20502,GO:1905422,1,0.99404187805355,0,1,negative regulation of plant organ morphogenesis,BP,
20503,GO:1905424,1,0.971188683201784,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20504,GO:1905426,1,0.971188683201784,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20505,GO:1905432,1,0.983406759352069,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20506,GO:1905433,1,0.983406759352069,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20508,GO:1905443,1,0.983406759352021,0,1,regulation of clathrin coat assembly,BP,
20509,GO:1905445,1,0.983406759352021,0,1,positive regulation of clathrin coat assembly,BP,
20510,GO:1905446,1,0.922152289093113,0,6,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20511,GO:1905447,1,0.968143461140191,0,2,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20512,GO:1905448,1,0.952501726009168,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20513,GO:1905449,1,0.970968848813594,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20514,GO:1905451,1,0.970968848813594,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20515,GO:1905453,1,0.9836184652422,0,1,regulation of myeloid progenitor cell differentiation,BP,
20518,GO:1905458,1,0.983406772879133,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20519,GO:1905462,1,0.983406759352069,0,1,regulation of DNA duplex unwinding,BP,
20520,GO:1905464,1,0.983406759352069,0,1,positive regulation of DNA duplex unwinding,BP,
20521,GO:1905468,1,0.98340675935187,0,1,regulation of clathrin-coated pit assembly,BP,
20522,GO:1905469,1,0.98340675935187,0,1,negative regulation of clathrin-coated pit assembly,BP,
20527,GO:1905483,1,0.983406759350296,0,1,regulation of motor neuron migration,BP,
20528,GO:1905485,1,0.983406759350296,0,1,positive regulation of motor neuron migration,BP,
20529,GO:1905508,1,0.696830413930421,0,23,protein localization to microtubule organizing center,BP,
20530,GO:1905515,1,0.481407842860008,0,47,non-motile cilium assembly,BP,
20531,GO:1905516,1,0.895255889918502,0,9,positive regulation of fertilization,BP,
20532,GO:1905517,1,0.682122934274194,0,32,macrophage migration,BP,
20533,GO:1905518,1,0.983406759351921,0,1,regulation of presynaptic active zone assembly,BP,
20534,GO:1905520,1,0.983406759351921,0,1,positive regulation of presynaptic active zone assembly,BP,
20535,GO:1905521,1,0.753473413009461,0,22,regulation of macrophage migration,BP,
20536,GO:1905522,1,0.945092563966274,0,4,negative regulation of macrophage migration,BP,
20537,GO:1905523,1,0.819480728160217,0,16,positive regulation of macrophage migration,BP,
20538,GO:1905524,1,0.983406759351231,0,1,negative regulation of protein autoubiquitination,BP,
20539,GO:1905535,1,0.983406759351872,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20540,GO:1905537,1,0.983406759351872,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20541,GO:1905546,1,0.985592982661204,0,1,cellular response to phenylpropanoid,BP,
20542,GO:1905547,1,0.988499272489636,0,1,regulation of telomeric heterochromatin assembly,BP,
20543,GO:1905549,1,0.988499272489636,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20544,GO:1905550,1,0.975991887841734,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20545,GO:1905552,1,0.975991887841734,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20546,GO:1905553,1,0.988499272489636,0,1,regulation of blood vessel branching,BP,
20547,GO:1905555,1,0.988499272489636,0,1,positive regulation blood vessel branching,BP,
20548,GO:1905562,1,0.988499272489636,0,1,regulation of vascular endothelial cell proliferation,BP,
20549,GO:1905564,1,0.988499272489636,0,1,positive regulation of vascular endothelial cell proliferation,BP,
20550,GO:1905572,1,0.984107521597188,0,1,ganglioside GM1 transport to membrane,BP,
20551,GO:1905573,1,0.971416332236746,0,2,ganglioside GM1 binding,MF,
20552,GO:1905574,1,0.984107521597188,0,1,ganglioside GM2 binding,MF,
20553,GO:1905575,1,0.984107521597188,0,1,ganglioside GM3 binding,MF,
20554,GO:1905576,1,0.957005345485536,0,3,ganglioside GT1b binding,MF,
20555,GO:1905577,1,0.984107521597188,0,1,ganglioside GP1c binding,MF,
20556,GO:1905578,1,0.985061141839094,0,1,regulation of ERBB3 signaling pathway,BP,
20557,GO:1905580,1,0.985061141839094,0,1,positive regulation of ERBB3 signaling pathway,BP,
20558,GO:1905581,1,0.98850199571852,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20559,GO:1905590,1,0.983700920617932,0,1,fibronectin fibril organization,BP,
20560,GO:1905594,1,0.991517356609453,0,1,resveratrol binding,MF,
20561,GO:1905595,1,0.972119492231237,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20562,GO:1905596,1,0.983427728128022,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20563,GO:1905597,1,0.98850199571852,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20564,GO:1905598,1,0.983427728128022,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20565,GO:1905599,1,0.98850199571852,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20566,GO:1905600,1,0.956506667417005,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20567,GO:1905601,1,0.983427728128022,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20568,GO:1905602,1,0.972627147616574,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20569,GO:1905603,1,0.983406759351921,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20570,GO:1905605,1,0.983406759351921,0,1,positive regulation of maintenance of permeability of blood-brain barrier,BP,
20571,GO:1905606,1,0.951287049631332,0,3,regulation of presynapse assembly,BP,
20572,GO:1905608,1,0.983406759351921,0,1,positive regulation of presynapse assembly,BP,
20573,GO:1905610,1,0.983406759351872,0,1,regulation of mRNA cap binding,BP,
20574,GO:1905612,1,0.983406759351872,0,1,positive regulation of mRNA cap binding,BP,
20575,GO:1905616,1,0.968384722376112,0,2,regulation of miRNA mediated inhibition of translation,BP,
20576,GO:1905618,1,0.968384722376112,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20577,GO:1905634,1,0.955999629077809,0,3,regulation of protein localization to chromatin,BP,
20578,GO:1905636,1,0.990793780952098,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20579,GO:1905642,1,0.988111862177989,0,1,negative regulation of DNA methylation,BP,
20580,GO:1905643,1,0.988111862177989,0,1,positive regulation of DNA methylation,BP,
20583,GO:1905661,1,0.969707819557078,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20584,GO:1905663,1,0.969707819557078,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20585,GO:1905664,1,0.970911437149562,0,2,regulation of calcium ion import across plasma membrane,BP,
20588,GO:1905671,1,0.969725120876417,0,2,regulation of lysosome organization,BP,
20589,GO:1905672,1,0.986088466109074,0,1,negative regulation of lysosome organization,BP,
20590,GO:1905687,1,0.983406759351724,0,1,regulation of diacylglycerol kinase activity,BP,
20591,GO:1905689,1,0.983406759351724,0,1,positive regulation of diacylglycerol kinase activity,BP,
20592,GO:1905693,1,0.98609242153372,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20593,GO:1905695,1,0.98609242153372,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20594,GO:1905696,1,0.983406759351872,0,1,regulation of polysome binding,BP,
20595,GO:1905705,1,0.983406759351429,0,1,cellular response to paclitaxel,BP,
20596,GO:1905709,1,0.950395257796648,0,4,negative regulation of membrane permeability,BP,
20598,GO:1905711,1,0.983410518075759,0,1,response to phosphatidylethanolamine,BP,
20599,GO:1905715,1,0.984771615077026,0,1,regulation of cornification,BP,
20600,GO:1905716,1,0.984771615077026,0,1,negative regulation of cornification,BP,
20601,GO:1905747,1,0.979200843279489,0,2,negative regulation of saliva secretion,BP,
20602,GO:1905748,1,0.979200843279489,0,2,hard palate morphogenesis,BP,
20603,GO:1905764,1,0.953912465589775,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20604,GO:1905765,1,0.953912465589775,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20605,GO:1905767,1,0.983406759351477,0,1,regulation of double-stranded telomeric DNA binding,BP,
20606,GO:1905768,1,0.983406759351477,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20607,GO:1905770,1,0.905963343995468,0,7,regulation of mesodermal cell differentiation,BP,
20608,GO:1905771,1,0.952063843760795,0,4,negative regulation of mesodermal cell differentiation,BP,
20609,GO:1905772,1,0.983950314107376,0,1,positive regulation of mesodermal cell differentiation,BP,
20610,GO:1905774,1,0.983406759352069,0,1,regulation of DNA helicase activity,BP,
20611,GO:1905776,1,0.983406759352069,0,1,positive regulation of DNA helicase activity,BP,
20612,GO:1905777,1,0.968201160648909,0,2,regulation of exonuclease activity,BP,
20613,GO:1905778,1,0.968201160648909,0,2,negative regulation of exonuclease activity,BP,
20614,GO:1905793,1,0.967087733486414,0,2,protein localization to pericentriolar material,BP,
20615,GO:1905794,1,0.983406759350642,0,1,response to puromycin,BP,
20616,GO:1905795,1,0.983406759350642,0,1,cellular response to puromycin,BP,
20617,GO:1905802,1,0.984079163645405,0,1,regulation of cellular response to manganese ion,BP,
20619,GO:1905818,1,0.510684309940595,0,47,regulation of chromosome separation,BP,
20620,GO:1905819,1,0.639840364281557,0,31,negative regulation of chromosome separation,BP,
20621,GO:1905820,1,0.912781697190292,0,6,positive regulation of chromosome separation,BP,
20622,GO:1905838,1,0.968201160648909,0,2,regulation of telomeric D-loop disassembly,BP,
20623,GO:1905839,1,0.968201160648909,0,2,negative regulation of telomeric D-loop disassembly,BP,
20624,GO:1905853,1,0.991273345505357,0,1,regulation of heparan sulfate binding,BP,
20625,GO:1905855,1,0.991273345505357,0,1,positive regulation of heparan sulfate binding,BP,
20626,GO:1905858,1,0.991273345505357,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20627,GO:1905860,1,0.991273345505357,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20629,GO:1905871,1,0.990780980970108,0,1,regulation of protein localization to cell leading edge,BP,
20630,GO:1905873,1,0.990780980970108,0,1,positive regulation of protein localization to cell leading edge,BP,
20632,GO:1905875,1,0.990780980970108,0,1,negative regulation of postsynaptic density organization,BP,
20635,GO:1905881,1,0.94087352274548,0,4,positive regulation of oogenesis,BP,
20636,GO:1905890,1,0.991273345505357,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20637,GO:1905891,1,0.98408970635106,0,1,regulation of cellular response to thapsigargin,BP,
20638,GO:1905892,1,0.98408970635106,0,1,negative regulation of cellular response to thapsigargin,BP,
20639,GO:1905894,1,0.98408970635106,0,1,regulation of cellular response to tunicamycin,BP,
20640,GO:1905895,1,0.98408970635106,0,1,negative regulation of cellular response to tunicamycin,BP,
20643,GO:1905899,1,0.988853451736982,0,1,regulation of smooth muscle tissue development,BP,
20644,GO:1905900,1,0.988853451736982,0,1,negative regulation of smooth muscle tissue development,BP,
20645,GO:1905901,1,0.988853451736982,0,1,positive regulation of smooth muscle tissue development,BP,
20646,GO:1905902,1,0.905963343995468,0,7,regulation of mesoderm formation,BP,
20647,GO:1905903,1,0.952063843760795,0,4,negative regulation of mesoderm formation,BP,
20648,GO:1905904,1,0.983950314107376,0,1,positive regulation of mesoderm formation,BP,
20649,GO:1905906,1,0.965208120802706,0,3,regulation of amyloid fibril formation,BP,
20650,GO:1905907,1,0.978865400043993,0,2,negative regulation of amyloid fibril formation,BP,
20651,GO:1905912,1,0.987442527581931,0,1,regulation of calcium ion export from cell,BP,
20652,GO:1905913,1,0.987442527581931,0,1,negative regulation of calcium ion export from cell,BP,
20653,GO:1905918,1,0.986049077830394,0,1,regulation of CoA-transferase activity,BP,
20654,GO:1905920,1,0.986049077830394,0,1,positive regulation of CoA-transferase activity,BP,
20655,GO:1905936,1,0.959584870341861,0,4,regulation of germ cell proliferation,BP,
20656,GO:1905937,1,0.966716923992841,0,3,negative regulation of germ cell proliferation,BP,
20657,GO:1905938,1,0.992623436976273,0,1,positive regulation of germ cell proliferation,BP,
20665,GO:1905957,1,0.983406759352021,0,1,regulation of cellular response to alcohol,BP,
20666,GO:1905959,1,0.983406759352021,0,1,positive regulation of cellular response to alcohol,BP,
20667,GO:1990000,1,0.857121952353967,0,11,amyloid fibril formation,BP,
20668,GO:1990001,1,0.865123929816274,0,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
20669,GO:1990005,1,0.98810400393685,0,1,granular vesicle,CC,
20670,GO:1990008,1,0.98810400393685,0,1,neurosecretory vesicle,CC,
20671,GO:1990009,1,0.96710058470649,0,2,retinal cell apoptotic process,BP,
20672,GO:1990015,1,0.985166744011428,0,1,ensheathing process,CC,
20673,GO:1990022,1,0.966765160680757,0,3,RNA polymerase III complex localization to nucleus,BP,
20674,GO:1990023,1,0.862003663508488,0,10,mitotic spindle midzone,CC,
20675,GO:1990026,1,0.983453262681897,0,1,hippocampal mossy fiber expansion,CC,
20676,GO:1990029,1,0.983668456749255,0,1,vasomotion,BP,
20677,GO:1990030,1,0.983407109668831,0,1,pericellular basket,CC,
20678,GO:1990031,1,0.983671261335603,0,1,pinceau fiber,CC,
20679,GO:1990032,1,0.983406759352021,0,1,parallel fiber,CC,
20680,GO:1990034,1,0.924745453611711,0,5,calcium ion export from cell,BP,
20681,GO:1990035,1,0.836899367832003,0,11,calcium ion import into cell,BP,
20682,GO:1990036,1,0.957383063257254,0,3,calcium ion import into sarcoplasmic reticulum,BP,
20683,GO:1990037,1,0.961465051416687,0,3,Lewy body core,CC,
20684,GO:1990038,1,0.986900479266678,0,1,Lewy body corona,CC,
20685,GO:1990046,1,0.990628060157684,0,1,stress-induced mitochondrial fusion,BP,
20686,GO:1990047,1,0.985600093267911,0,1,spindle matrix,CC,
20687,GO:1990050,1,0.982544669140876,0,2,phosphatidic acid transporter activity,MF,
20688,GO:1990051,1,0.967172187495706,0,2,activation of protein kinase C activity,BP,
20689,GO:1990071,1,0.983406759351428,0,1,TRAPPII protein complex,CC,
20690,GO:1990072,1,0.984725543253726,0,1,TRAPPIII protein complex,CC,
20691,GO:1990074,1,0.983457976672881,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20692,GO:1990075,1,0.935672532687444,0,4,periciliary membrane compartment,CC,
20693,GO:1990079,1,0.992492032459149,0,1,cartilage homeostasis,BP,
20694,GO:1990081,1,0.991504096838473,0,1,trimethylamine receptor activity,MF,
20695,GO:1990086,1,0.937542232426324,0,4,lens fiber cell apoptotic process,BP,
20698,GO:1990108,1,0.983406759350984,0,1,protein linear deubiquitination,BP,
20699,GO:1990111,1,0.947174876972639,0,5,spermatoproteasome complex,CC,
20700,GO:1990117,1,0.993810880445406,0,1,B cell receptor apoptotic signaling pathway,BP,
20701,GO:1990118,1,0.809357499185487,0,13,sodium ion import into cell,BP,
20702,GO:1990123,1,0.919731182616167,0,5,L-glutamate import into cell,BP,
20704,GO:1990126,1,0.759904813892587,0,18,retrograde transport, endosome to plasma membrane,BP,
20705,GO:1990127,1,0.983406759352069,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20706,GO:1990130,1,0.942590958277063,0,4,GATOR1 complex,CC,
20708,GO:1990136,1,0.984857990302704,0,1,linoleate 9S-lipoxygenase activity,MF,
20710,GO:1990144,1,0.930279555635658,0,5,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20711,GO:1990145,1,0.983574245168322,0,1,maintenance of translational fidelity,BP,
20712,GO:1990164,1,0.968115857705059,0,2,histone H2A phosphorylation,BP,
20713,GO:1990166,1,0.985320314983219,0,1,protein localization to site of double-strand break,BP,
20714,GO:1990167,1,0.955719430229717,0,3,protein K27-linked deubiquitination,BP,
20715,GO:1990168,1,0.955719430230099,0,3,protein K33-linked deubiquitination,BP,
20716,GO:1990169,1,0.976460571029606,0,2,stress response to copper ion,BP,
20717,GO:1990170,1,0.986649566638589,0,1,stress response to cadmium ion,BP,
20719,GO:1990173,1,0.880603383942793,0,9,protein localization to nucleoplasm,BP,
20720,GO:1990174,1,0.983408245826825,0,1,phosphodiesterase decapping endonuclease activity,MF,
20721,GO:1990175,1,0.983406946647756,0,1,EH domain binding,MF,
20722,GO:1990180,1,0.985614351305629,0,1,mitochondrial tRNA 3'-end processing,BP,
20724,GO:1990183,1,0.993524199539596,0,1,lymphatic vascular process in circulatory system,BP,
20725,GO:1990186,1,0.993524199539596,0,1,regulation of lymphatic vessel size,BP,
20726,GO:1990188,1,0.984556650774837,0,1,euchromatin binding,MF,
20727,GO:1990189,1,0.966378505531518,0,3,peptide-serine-N-acetyltransferase activity,MF,
20728,GO:1990190,1,0.982554663822603,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20729,GO:1990192,1,0.993524199539596,0,1,collecting lymphatic vessel constriction,BP,
20731,GO:1990226,1,0.91570960697536,0,6,histone methyltransferase binding,MF,
20733,GO:1990239,1,0.926833497604077,0,5,steroid hormone binding,MF,
20734,GO:1990246,1,0.969683443564638,0,2,uniplex complex,CC,
20735,GO:1990247,1,0.89047720271672,0,7,N6-methyladenosine-containing RNA binding,MF,
20736,GO:1990253,1,0.906867380251354,0,6,cellular response to leucine starvation,BP,
20737,GO:1990254,1,0.927795598527616,0,5,keratin filament binding,MF,
20738,GO:1990256,1,0.983406759350246,0,1,signal clustering,BP,
20739,GO:1990258,1,0.991339022669521,0,1,histone glutamine methylation,BP,
20740,GO:1990259,1,0.991339022669521,0,1,histone-glutamine methyltransferase activity,MF,
20742,GO:1990264,1,0.983548689119741,0,1,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20744,GO:1990267,1,0.983617657530074,0,1,response to transition metal nanoparticle,BP,
20745,GO:1990268,1,0.983617657530074,0,1,response to gold nanoparticle,BP,
20746,GO:1990269,1,0.969717349665414,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20747,GO:1990272,1,0.987336285518239,0,1,anti-Mullerian hormone receptor activity,MF,
20748,GO:1990275,1,0.984022289927834,0,1,preribosome binding,MF,
20749,GO:1990314,1,0.906588872347062,0,7,cellular response to insulin-like growth factor stimulus,BP,
20751,GO:1990332,1,0.983406759352069,0,1,Ire1 complex,CC,
20752,GO:1990349,1,0.986706463820984,0,1,gap junction-mediated intercellular transport,BP,
20754,GO:1990356,1,0.991123064544678,0,1,sumoylated E2 ligase complex,CC,
20755,GO:1990357,1,0.960344200181671,0,3,terminal web,CC,
20756,GO:1990379,1,0.97733022732748,0,2,lipid transport across blood brain barrier,BP,
20757,GO:1990380,1,0.891042432572221,0,7,Lys48-specific deubiquitinase activity,MF,
20758,GO:1990381,1,0.832352288374354,0,12,ubiquitin-specific protease binding,MF,
20759,GO:1990384,1,0.990621715844573,0,1,hyaloid vascular plexus regression,BP,
20760,GO:1990386,1,0.98681281700589,0,1,mitotic cleavage furrow ingression,BP,
20761,GO:1990390,1,0.983474573701154,0,1,protein K33-linked ubiquitination,BP,
20762,GO:1990391,1,0.577671734305156,0,37,DNA repair complex,CC,
20763,GO:1990393,1,0.922747364523391,0,5,3M complex,CC,
20764,GO:1990399,1,0.983406759351281,0,1,epithelium regeneration,BP,
20765,GO:1990401,1,0.984228930394872,0,1,embryonic lung development,BP,
20766,GO:1990402,1,0.985890748093858,0,1,embryonic liver development,BP,
20767,GO:1990403,1,0.868583371397135,0,9,embryonic brain development,BP,
20768,GO:1990404,1,0.970893566336357,0,2,protein ADP-ribosylase activity,MF,
20769,GO:1990405,1,0.928858845522331,0,5,protein antigen binding,MF,
20770,GO:1990414,1,0.969398036679394,0,2,replication-born double-strand break repair via sister chromatid exchange,BP,
20771,GO:1990415,1,0.971667456492208,0,2,Pex17p-Pex14p docking complex,CC,
20772,GO:1990416,1,0.894927256163336,0,7,cellular response to brain-derived neurotrophic factor stimulus,BP,
20774,GO:1990421,1,0.983406759350394,0,1,subtelomeric heterochromatin,CC,
20775,GO:1990423,1,0.951814133451595,0,3,RZZ complex,CC,
20776,GO:1990425,1,0.983406759351379,0,1,ryanodine receptor complex,CC,
20777,GO:1990426,1,0.969385402452718,0,2,mitotic recombination-dependent replication fork processing,BP,
20779,GO:1990428,1,0.983420664751714,0,1,miRNA transport,BP,
20780,GO:1990429,1,0.971667456492208,0,2,peroxisomal importomer complex,CC,
20783,GO:1990439,1,0.983925670058109,0,1,MAP kinase threonine phosphatase activity,MF,
20784,GO:1990440,1,0.855581015439894,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20785,GO:1990441,1,0.927401494632303,0,5,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20786,GO:1990442,1,0.975284838214227,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
20787,GO:1990446,1,0.940884808632157,0,6,U1 snRNP binding,MF,
20788,GO:1990450,1,0.986331116093662,0,1,linear polyubiquitin binding,MF,
20789,GO:1990451,1,0.985003706518096,0,1,cellular stress response to acidic pH,BP,
20790,GO:1990452,1,0.967300901187486,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
20791,GO:1990454,1,0.905350333722725,0,6,L-type voltage-gated calcium channel complex,CC,
20793,GO:1990460,1,0.955276664823564,0,3,leptin receptor binding,MF,
20794,GO:1990462,1,0.983503232906633,0,1,omegasome,CC,
20795,GO:1990478,1,0.987030610869469,0,1,response to ultrasound,BP,
20796,GO:1990481,1,0.945113633933985,0,4,mRNA pseudouridine synthesis,BP,
20797,GO:1990498,1,0.983406759350984,0,1,mitotic spindle microtubule,CC,
20798,GO:1990502,1,0.967107516149466,0,2,dense core granule maturation,BP,
20799,GO:1990504,1,0.919731460220488,0,5,dense core granule exocytosis,BP,
20800,GO:1990505,1,0.969385402452718,0,2,mitotic DNA replication maintenance of fidelity,BP,
20801,GO:1990511,1,0.984100358761538,0,1,piRNA biosynthetic process,BP,
20802,GO:1990512,1,0.983589196424955,0,1,Cry-Per complex,CC,
20803,GO:1990519,1,0.97307979491638,0,2,mitochondrial pyrimidine nucleotide import,BP,
20804,GO:1990523,1,0.938618908888785,0,4,bone regeneration,BP,
20805,GO:1990539,1,0.985456784122933,0,1,fructose import across plasma membrane,BP,
20806,GO:1990542,1,0.443514336987228,0,70,mitochondrial transmembrane transport,BP,
20807,GO:1990564,1,0.937305144829821,0,5,protein polyufmylation,BP,
20808,GO:1990565,1,0.988305046438691,0,1,HSP90-CDC37 chaperone complex,CC,
20809,GO:1990569,1,0.969717349664978,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
20810,GO:1990572,1,0.983406759352117,0,1,TERT-RMRP complex,CC,
20811,GO:1990573,1,0.876995469231012,0,9,potassium ion import across plasma membrane,BP,
20813,GO:1990579,1,0.983406759352069,0,1,peptidyl-serine trans-autophosphorylation,BP,
20814,GO:1990583,1,0.98681281700589,0,1,phospholipase D activator activity,MF,
20815,GO:1990584,1,0.979898520322966,0,3,cardiac Troponin complex,CC,
20816,GO:1990589,1,0.971679065572732,0,2,ATF4-CREB1 transcription factor complex,CC,
20817,GO:1990590,1,0.973322862906139,0,2,ATF1-ATF4 transcription factor complex,CC,
20818,GO:1990592,1,0.937305144829821,0,5,protein K69-linked ufmylation,BP,
20819,GO:1990595,1,0.986584538151254,0,1,mast cell secretagogue receptor activity,MF,
20820,GO:1990597,1,0.953152965786052,0,3,AIP1-IRE1 complex,CC,
20821,GO:1990599,1,0.953912465589775,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
20822,GO:1990603,1,0.983565412210262,0,1,dark adaptation,BP,
20823,GO:1990604,1,0.937355292950747,0,4,IRE1-TRAF2-ASK1 complex,CC,
20824,GO:1990613,1,0.983455810184603,0,1,mitochondrial membrane fusion,BP,
20825,GO:1990614,1,0.983532041178545,0,1,mitochondrial magnesium ion transmembrane transport,BP,
20826,GO:1990617,1,0.981269827478541,0,2,CHOP-ATF4 complex,CC,
20827,GO:1990619,1,0.972097952485832,0,2,histone H3-K9 deacetylation,BP,
20828,GO:1990622,1,0.979725426233975,0,2,CHOP-ATF3 complex,CC,
20829,GO:1990630,1,0.983406759352069,0,1,IRE1-RACK1-PP2A complex,CC,
20830,GO:1990635,1,0.953957388180585,0,3,proximal dendrite,CC,
20831,GO:1990637,1,0.947632496755901,0,4,response to prolactin,BP,
20832,GO:1990641,1,0.983694603403235,0,2,response to iron ion starvation,BP,
20833,GO:1990646,1,0.97522708864105,0,2,cellular response to prolactin,BP,
20834,GO:1990654,1,0.983406759351921,0,1,sebum secreting cell proliferation,BP,
20835,GO:1990666,1,0.967108355720392,0,2,PCSK9-LDLR complex,CC,
20836,GO:1990667,1,0.972119492231237,0,2,PCSK9-AnxA2 complex,CC,
20837,GO:1990668,1,0.918257440801155,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
20838,GO:1990682,1,0.968757108495196,0,2,CSF1-CSF1R complex,CC,
20839,GO:1990696,1,0.970229984790712,0,2,USH2 complex,CC,
20840,GO:1990697,1,0.985811627690243,0,1,protein depalmitoleylation,BP,
20841,GO:1990698,1,0.971333969507365,0,2,palmitoleoyltransferase activity,MF,
20842,GO:1990699,1,0.985811627690243,0,1,palmitoleyl hydrolase activity,MF,
20843,GO:1990700,1,0.983406865513707,0,1,nucleolar chromatin organization,BP,
20844,GO:1990705,1,0.98340675935099,0,1,cholangiocyte proliferation,BP,
20845,GO:1990707,1,0.983406759350394,0,1,nuclear subtelomeric heterochromatin,CC,
20846,GO:1990708,1,0.983406759351921,0,1,conditioned place preference,BP,
20847,GO:1990709,1,0.956710280021228,0,3,presynaptic active zone organization,BP,
20849,GO:1990715,1,0.970319948508467,0,2,mRNA CDS binding,MF,
20850,GO:1990716,1,0.955561435597273,0,3,axonemal central apparatus,CC,
20851,GO:1990718,1,0.983406759350742,0,1,axonemal central pair projection,CC,
20852,GO:1990723,1,0.983812315624016,0,1,cytoplasmic periphery of the nuclear pore complex,CC,
20853,GO:1990726,1,0.969827793030489,0,4,Lsm1-7-Pat1 complex,CC,
20854,GO:1990729,1,0.98689369629413,0,1,primary miRNA modification,BP,
20855,GO:1990730,1,0.967129118329248,0,2,VCP-NSFL1C complex,CC,
20856,GO:1990736,1,0.983406759352069,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
20857,GO:1990737,1,0.955553857637436,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
20858,GO:1990739,1,0.98340675935099,0,1,granulosa cell proliferation,BP,
20859,GO:1990742,1,0.967087733488061,0,2,microvesicle,CC,
20860,GO:1990743,1,0.983406759350642,0,1,protein sialylation,BP,
20861,GO:1990744,1,0.98689369629413,0,1,primary miRNA methylation,BP,
20862,GO:1990745,1,0.952792018594368,0,3,EARP complex,CC,
20864,GO:1990751,1,0.98340675935133,0,1,Schwann cell chemotaxis,BP,
20865,GO:1990752,1,0.69894736181851,0,22,microtubule end,CC,
20866,GO:1990755,1,0.984725543253726,0,1,mitotic spindle microtubule depolymerization,BP,
20867,GO:1990761,1,0.95218054708009,0,3,growth cone lamellipodium,CC,
20868,GO:1990763,1,0.968545842650952,0,2,arrestin family protein binding,MF,
20870,GO:1990771,1,0.983406759351627,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
20871,GO:1990773,1,0.987984312332234,0,1,matrix metallopeptidase secretion,BP,
20872,GO:1990774,1,0.886072973460299,0,8,tumor necrosis factor secretion,BP,
20874,GO:1990777,1,0.655112161955221,0,37,lipoprotein particle,CC,
20877,GO:1990784,1,0.983406759352069,0,1,response to dsDNA,BP,
20879,GO:1990786,1,0.983406759352069,0,1,cellular response to dsDNA,BP,
20880,GO:1990790,1,0.989949855146381,0,1,response to glial cell derived neurotrophic factor,BP,
20881,GO:1990791,1,0.952878194130847,0,3,dorsal root ganglion development,BP,
20882,GO:1990792,1,0.989949855146381,0,1,cellular response to glial cell derived neurotrophic factor,BP,
20883,GO:1990796,1,0.983929355068966,0,1,photoreceptor cell terminal bouton,CC,
20884,GO:1990809,1,0.985653813887015,0,1,endoplasmic reticulum tubular network membrane organization,BP,
20885,GO:1990812,1,0.952180547081441,0,3,growth cone filopodium,CC,
20886,GO:1990822,1,0.916036170581582,0,6,basic amino acid transmembrane transport,BP,
20887,GO:1990823,1,0.983406759351968,0,1,response to leukemia inhibitory factor,BP,
20888,GO:1990825,1,0.887579093919357,0,8,sequence-specific mRNA binding,MF,
20889,GO:1990828,1,0.986056931335688,0,1,hepatocyte dedifferentiation,BP,
20890,GO:1990829,1,0.970785072854034,0,2,C-rich single-stranded DNA binding,MF,
20891,GO:1990830,1,0.983406759351968,0,1,cellular response to leukemia inhibitory factor,BP,
20892,GO:1990834,1,0.955155387844174,0,3,response to odorant,BP,
20894,GO:1990839,1,0.985501663355894,0,1,response to endothelin,BP,
20896,GO:1990843,1,0.983406759351575,0,1,subsarcolemmal mitochondrion,CC,
20897,GO:1990844,1,0.983406759351575,0,1,interfibrillar mitochondrion,CC,
20898,GO:1990845,1,0.832509857086494,0,13,adaptive thermogenesis,BP,
20900,GO:1990859,1,0.985501663355894,0,1,cellular response to endothelin,BP,
20901,GO:1990868,1,0.968090505899535,0,2,response to chemokine,BP,
20902,GO:1990869,1,0.968090505899535,0,2,cellular response to chemokine,BP,
20904,GO:1990876,1,0.983406759351479,0,1,cytoplasmic side of nuclear pore,CC,
20905,GO:1990879,1,0.969683443564638,0,2,CST complex,CC,
20906,GO:1990882,1,0.98340681697126,0,1,rRNA acetylation,BP,
20907,GO:1990883,1,0.98340681697126,0,1,rRNA cytidine N-acetyltransferase activity,MF,
20908,GO:1990884,1,0.98340681697126,0,1,RNA acetylation,BP,
20909,GO:1990889,1,0.987345885905482,0,1,H4K20me3 modified histone binding,MF,
20911,GO:1990907,1,0.951174961674044,0,3,beta-catenin-TCF complex,CC,
20913,GO:1990910,1,0.964200992160941,0,3,response to hypobaric hypoxia,BP,
20914,GO:1990911,1,0.986053003073054,0,1,response to psychosocial stress,BP,
20915,GO:1990913,1,0.984766147175537,0,1,sperm head plasma membrane,CC,
20916,GO:1990917,1,0.984766147175537,0,1,ooplasm,CC,
20917,GO:1990918,1,0.956590979400035,0,3,double-strand break repair involved in meiotic recombination,BP,
20918,GO:1990922,1,0.983547761949543,0,1,hepatic stellate cell proliferation,BP,
20919,GO:1990923,1,0.956559839616496,0,3,PET complex,CC,
20920,GO:1990926,1,0.970103698014794,0,2,short-term synaptic potentiation,BP,
20921,GO:1990927,1,0.967087733487917,0,2,calcium ion regulated lysosome exocytosis,BP,
20922,GO:1990928,1,0.960783525267062,0,3,response to amino acid starvation,BP,
20923,GO:1990930,1,0.988853451736982,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
20924,GO:1990931,1,0.98340675935207,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
20925,GO:1990932,1,0.983528330180549,0,3,5.8S rRNA binding,MF,
20927,GO:1990938,1,0.983406759353248,0,1,peptidyl-aspartic acid autophosphorylation,BP,
20928,GO:1990939,1,0.708312949384875,0,21,ATP-dependent microtubule motor activity,MF,
20929,GO:1990948,1,0.977643121367183,0,4,ubiquitin ligase inhibitor activity,MF,
20930,GO:1990955,1,0.983406759352069,0,1,G-rich single-stranded DNA binding,MF,
20931,GO:1990962,1,0.983406761279341,0,1,drug transport across blood-brain barrier,BP,
20932,GO:1990963,1,0.983406761279341,0,1,establishment of blood-retinal barrier,BP,
20933,GO:1990966,1,0.942555907456004,0,4,ATP generation from poly-ADP-D-ribose,BP,
20935,GO:1990968,1,0.983406759351527,0,1,modulation by host of RNA binding by virus,BP,
20936,GO:1990969,1,0.983406759351527,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
20937,GO:1990971,1,0.983406932135447,0,1,EMILIN complex,CC,
20938,GO:1990983,1,0.984656860751509,0,1,tRNA demethylation,BP,
20939,GO:1990984,1,0.984656860751509,0,1,tRNA demethylase activity,MF,
20940,GO:2000001,1,0.826565171427957,0,13,regulation of DNA damage checkpoint,BP,
20941,GO:2000002,1,0.944107481182514,0,4,negative regulation of DNA damage checkpoint,BP,
20948,GO:2000010,1,0.839597391644673,0,12,positive regulation of protein localization to cell surface,BP,
20949,GO:2000011,1,0.985879363093538,0,1,regulation of adaxial/abaxial pattern formation,BP,
20951,GO:2000016,1,0.993112794356284,0,1,negative regulation of determination of dorsal identity,BP,
20959,GO:2000035,1,0.932783095629777,0,5,regulation of stem cell division,BP,
20961,GO:2000040,1,0.970393716139218,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
20962,GO:2000041,1,0.970393716139218,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
20963,GO:2000042,1,0.905811953572215,0,6,negative regulation of double-strand break repair via homologous recombination,BP,
20964,GO:2000043,1,0.969556076287946,0,2,regulation of cardiac cell fate specification,BP,
20965,GO:2000044,1,0.983950314107376,0,1,negative regulation of cardiac cell fate specification,BP,
20968,GO:2000048,1,0.950530649075226,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
20971,GO:2000051,1,0.908002634253092,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
20973,GO:2000053,1,0.953101763212987,0,3,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20974,GO:2000054,1,0.969185762974328,0,2,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20975,GO:2000055,1,0.983406759350642,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20976,GO:2000056,1,0.987269408042126,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
20977,GO:2000057,1,0.987269408042126,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
20979,GO:2000059,1,0.855505471234863,0,13,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
20981,GO:2000061,1,0.988853451736982,0,1,regulation of ureter smooth muscle cell differentiation,BP,
20982,GO:2000062,1,0.988853451736982,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
20983,GO:2000063,1,0.988853451736982,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
20987,GO:2000067,1,0.99404187805355,0,1,regulation of root morphogenesis,BP,
20988,GO:2000074,1,0.895575790570682,0,8,regulation of type B pancreatic cell development,BP,
20989,GO:2000077,1,0.96959084068415,0,2,negative regulation of type B pancreatic cell development,BP,
20990,GO:2000078,1,0.967562785956635,0,3,positive regulation of type B pancreatic cell development,BP,
20991,GO:2000079,1,0.967622305117155,0,2,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20992,GO:2000080,1,0.983406759352021,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20993,GO:2000081,1,0.983950314107376,0,1,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20994,GO:2000095,1,0.827484842638159,0,12,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
20995,GO:2000096,1,0.895053729373346,0,7,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
20997,GO:2000098,1,0.975397047924649,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
20998,GO:2000101,1,0.983942765591477,0,1,regulation of mammary stem cell proliferation,BP,
20999,GO:2000103,1,0.983942765591477,0,1,positive regulation of mammary stem cell proliferation,BP,
21000,GO:2000104,1,0.759606136158126,0,18,negative regulation of DNA-dependent DNA replication,BP,
21005,GO:2000109,1,0.908330982824077,0,7,regulation of macrophage apoptotic process,BP,
21006,GO:2000110,1,0.961675212803716,0,3,negative regulation of macrophage apoptotic process,BP,
21007,GO:2000111,1,0.958782591401924,0,3,positive regulation of macrophage apoptotic process,BP,
21010,GO:2000114,1,0.750499633478255,0,18,regulation of establishment of cell polarity,BP,
21013,GO:2000118,1,0.953712631490535,0,3,regulation of sodium-dependent phosphate transport,BP,
21014,GO:2000119,1,0.983889068070084,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21015,GO:2000120,1,0.985688193475059,0,1,positive regulation of sodium-dependent phosphate transport,BP,
21017,GO:2000124,1,0.968862428629158,0,2,regulation of endocannabinoid signaling pathway,BP,
21022,GO:2000142,1,0.594301055581986,0,35,regulation of DNA-templated transcription, initiation,BP,
21023,GO:2000143,1,0.907531576015713,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21024,GO:2000144,1,0.687223563157459,0,26,positive regulation of DNA-templated transcription, initiation,BP,
21028,GO:2000152,1,0.957542315751034,0,4,regulation of ubiquitin-specific protease activity,BP,
21029,GO:2000156,1,0.967696902747371,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21030,GO:2000157,1,0.983549351870484,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21031,GO:2000158,1,0.973559779586101,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21032,GO:2000167,1,0.983406759351821,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21033,GO:2000169,1,0.906388986425492,0,6,regulation of peptidyl-cysteine S-nitrosylation,BP,
21034,GO:2000170,1,0.967201924549184,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21035,GO:2000171,1,0.653444535202322,0,27,negative regulation of dendrite development,BP,
21036,GO:2000172,1,0.937089626859945,0,4,regulation of branching morphogenesis of a nerve,BP,
21037,GO:2000173,1,0.983406812025873,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21038,GO:2000174,1,0.983406772879133,0,1,regulation of pro-T cell differentiation,BP,
21039,GO:2000176,1,0.983406772879133,0,1,positive regulation of pro-T cell differentiation,BP,
21044,GO:2000182,1,0.951320015396259,0,3,regulation of progesterone biosynthetic process,BP,
21045,GO:2000184,1,0.983406759351575,0,1,positive regulation of progesterone biosynthetic process,BP,
21046,GO:2000185,1,0.985688193475059,0,1,regulation of phosphate transmembrane transport,BP,
21047,GO:2000187,1,0.985688193475059,0,1,positive regulation of phosphate transmembrane transport,BP,
21048,GO:2000188,1,0.83814979700047,0,12,regulation of cholesterol homeostasis,BP,
21049,GO:2000189,1,0.946192363804025,0,4,positive regulation of cholesterol homeostasis,BP,
21055,GO:2000196,1,0.986239082411823,0,2,positive regulation of female gonad development,BP,
21056,GO:2000197,1,0.907884700535936,0,6,regulation of ribonucleoprotein complex localization,BP,
21057,GO:2000199,1,0.983733258320348,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21058,GO:2000200,1,0.983733258320348,0,1,regulation of ribosomal subunit export from nucleus,BP,
21059,GO:2000202,1,0.983733258320348,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21060,GO:2000206,1,0.983733258320348,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21061,GO:2000208,1,0.983733258320348,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21063,GO:2000210,1,0.922787705950994,0,7,positive regulation of anoikis,BP,
21064,GO:2000211,1,0.969729010931809,0,2,regulation of glutamate metabolic process,BP,
21065,GO:2000212,1,0.983406759351921,0,1,negative regulation of glutamate metabolic process,BP,
21066,GO:2000213,1,0.98609242153372,0,1,positive regulation of glutamate metabolic process,BP,
21069,GO:2000226,1,0.989558758734677,0,1,regulation of pancreatic A cell differentiation,BP,
21070,GO:2000227,1,0.989558758734677,0,1,negative regulation of pancreatic A cell differentiation,BP,
21071,GO:2000229,1,0.978099478041645,0,2,regulation of pancreatic stellate cell proliferation,BP,
21072,GO:2000230,1,0.987372346804205,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21073,GO:2000231,1,0.990609033835784,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21074,GO:2000232,1,0.87895608991287,0,8,regulation of rRNA processing,BP,
21075,GO:2000233,1,0.967749025209684,0,2,negative regulation of rRNA processing,BP,
21076,GO:2000234,1,0.90825983940193,0,6,positive regulation of rRNA processing,BP,
21082,GO:2000252,1,0.933013209135573,0,7,negative regulation of feeding behavior,BP,
21083,GO:2000253,1,0.932323078989126,0,6,positive regulation of feeding behavior,BP,
21084,GO:2000254,1,0.959584870341861,0,4,regulation of male germ cell proliferation,BP,
21085,GO:2000255,1,0.966716923992841,0,3,negative regulation of male germ cell proliferation,BP,
21086,GO:2000256,1,0.992623436976273,0,1,positive regulation of male germ cell proliferation,BP,
21087,GO:2000257,1,0.631166612484503,0,32,regulation of protein activation cascade,BP,
21088,GO:2000258,1,0.889338251987226,0,8,negative regulation of protein activation cascade,BP,
21089,GO:2000259,1,0.955032504130211,0,3,positive regulation of protein activation cascade,BP,
21090,GO:2000266,1,0.988708213662624,0,1,regulation of blood coagulation, intrinsic pathway,BP,
21093,GO:2000271,1,0.891705058610391,0,7,positive regulation of fibroblast apoptotic process,BP,
21096,GO:2000275,1,0.953947952774263,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21097,GO:2000276,1,0.974447676549072,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21098,GO:2000277,1,0.992937098316418,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21100,GO:2000279,1,0.624967249617766,0,31,negative regulation of DNA biosynthetic process,BP,
21101,GO:2000280,1,0.99404187805355,0,1,regulation of root development,BP,
21102,GO:2000282,1,0.976460571029563,0,2,regulation of cellular amino acid biosynthetic process,BP,
21103,GO:2000283,1,0.983406759350938,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21104,GO:2000284,1,0.992937098316418,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21105,GO:2000286,1,0.953411110748633,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21106,GO:2000287,1,0.985730180216182,0,1,positive regulation of myotome development,BP,
21107,GO:2000288,1,0.916629300856562,0,6,positive regulation of myoblast proliferation,BP,
21108,GO:2000290,1,0.985730180216182,0,1,regulation of myotome development,BP,
21109,GO:2000291,1,0.868412551902354,0,10,regulation of myoblast proliferation,BP,
21110,GO:2000295,1,0.969652137482409,0,3,regulation of hydrogen peroxide catabolic process,BP,
21111,GO:2000296,1,0.98575658361195,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21112,GO:2000297,1,0.951434302263129,0,3,negative regulation of synapse maturation,BP,
21113,GO:2000298,1,0.968977631045065,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21114,GO:2000299,1,0.983523683982408,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21115,GO:2000300,1,0.659047615728332,0,27,regulation of synaptic vesicle exocytosis,BP,
21116,GO:2000301,1,0.942212281402131,0,4,negative regulation of synaptic vesicle exocytosis,BP,
21117,GO:2000302,1,0.951038409344251,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21118,GO:2000303,1,0.832564553126608,0,13,regulation of ceramide biosynthetic process,BP,
21119,GO:2000304,1,0.888552914022382,0,8,positive regulation of ceramide biosynthetic process,BP,
21120,GO:2000307,1,0.960551022440392,0,3,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21121,GO:2000308,1,0.985285763596706,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21122,GO:2000309,1,0.974897395489447,0,2,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21123,GO:2000310,1,0.788438686495636,0,16,regulation of NMDA receptor activity,BP,
21124,GO:2000311,1,0.756170820363402,0,19,regulation of AMPA receptor activity,BP,
21125,GO:2000312,1,0.952996391410431,0,3,regulation of kainate selective glutamate receptor activity,BP,
21126,GO:2000313,1,0.975738741564603,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21127,GO:2000314,1,0.988364005683081,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21128,GO:2000316,1,0.848029447325047,0,13,regulation of T-helper 17 type immune response,BP,
21129,GO:2000317,1,0.935968498772136,0,6,negative regulation of T-helper 17 type immune response,BP,
21130,GO:2000318,1,0.906069446134862,0,7,positive regulation of T-helper 17 type immune response,BP,
21131,GO:2000319,1,0.873876832232033,0,11,regulation of T-helper 17 cell differentiation,BP,
21132,GO:2000320,1,0.935968498772136,0,6,negative regulation of T-helper 17 cell differentiation,BP,
21133,GO:2000321,1,0.933678144741478,0,5,positive regulation of T-helper 17 cell differentiation,BP,
21134,GO:2000322,1,0.881898855146646,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21135,GO:2000323,1,0.9091047512456,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21136,GO:2000324,1,0.970085604832661,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21137,GO:2000325,1,0.983406759351627,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21138,GO:2000327,1,0.983406759351627,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21139,GO:2000328,1,0.928608390682324,0,6,regulation of T-helper 17 cell lineage commitment,BP,
21140,GO:2000329,1,0.978068144175004,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21141,GO:2000330,1,0.949435721571619,0,4,positive regulation of T-helper 17 cell lineage commitment,BP,
21142,GO:2000331,1,0.967242687435452,0,2,regulation of terminal button organization,BP,
21143,GO:2000332,1,0.974911656379434,0,2,regulation of blood microparticle formation,BP,
21144,GO:2000334,1,0.974911656379434,0,2,positive regulation of blood microparticle formation,BP,
21145,GO:2000338,1,0.971607866918115,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21146,GO:2000340,1,0.971607866918115,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21147,GO:2000341,1,0.904824825663474,0,8,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21148,GO:2000342,1,0.96949552383744,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21149,GO:2000343,1,0.933302772727828,0,6,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21150,GO:2000344,1,0.895255889918502,0,9,positive regulation of acrosome reaction,BP,
21153,GO:2000347,1,0.904763749409021,0,7,positive regulation of hepatocyte proliferation,BP,
21154,GO:2000348,1,0.919449809765105,0,6,regulation of CD40 signaling pathway,BP,
21155,GO:2000349,1,0.970332905286249,0,2,negative regulation of CD40 signaling pathway,BP,
21156,GO:2000350,1,0.992122035120751,0,1,positive regulation of CD40 signaling pathway,BP,
21159,GO:2000353,1,0.833164396018601,0,13,positive regulation of endothelial cell apoptotic process,BP,
21160,GO:2000354,1,0.949060088228235,0,4,regulation of ovarian follicle development,BP,
21161,GO:2000355,1,0.9866365075792,0,1,negative regulation of ovarian follicle development,BP,
21162,GO:2000356,1,0.988853451736982,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21163,GO:2000357,1,0.988853451736982,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21164,GO:2000358,1,0.988853451736982,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21165,GO:2000359,1,0.95537949960194,0,4,regulation of binding of sperm to zona pellucida,BP,
21166,GO:2000360,1,0.95537949960194,0,4,negative regulation of binding of sperm to zona pellucida,BP,
21167,GO:2000361,1,0.983406759352021,0,1,regulation of prostaglandin-E synthase activity,BP,
21168,GO:2000363,1,0.983406759352021,0,1,positive regulation of prostaglandin-E synthase activity,BP,
21169,GO:2000364,1,0.958705486093694,0,3,regulation of STAT protein import into nucleus,BP,
21170,GO:2000366,1,0.958705486093694,0,3,positive regulation of STAT protein import into nucleus,BP,
21171,GO:2000367,1,0.98992549238389,0,1,regulation of acrosomal vesicle exocytosis,BP,
21172,GO:2000368,1,0.98992549238389,0,1,positive regulation of acrosomal vesicle exocytosis,BP,
21174,GO:2000370,1,0.907101235827967,0,6,positive regulation of clathrin-dependent endocytosis,BP,
21175,GO:2000371,1,0.940114323744222,0,4,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21176,GO:2000373,1,0.940114323744222,0,4,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21177,GO:2000374,1,0.982094773088651,0,2,regulation of oxygen metabolic process,BP,
21178,GO:2000376,1,0.995507918336495,0,1,positive regulation of oxygen metabolic process,BP,
21180,GO:2000378,1,0.541061592451769,0,44,negative regulation of reactive oxygen species metabolic process,BP,
21182,GO:2000380,1,0.809757678306819,0,16,regulation of mesoderm development,BP,
21183,GO:2000381,1,0.901612259658428,0,8,negative regulation of mesoderm development,BP,
21184,GO:2000382,1,0.939187654450388,0,5,positive regulation of mesoderm development,BP,
21187,GO:2000386,1,0.98992549238389,0,1,positive regulation of ovarian follicle development,BP,
21188,GO:2000387,1,0.98992549238389,0,1,regulation of antral ovarian follicle growth,BP,
21189,GO:2000388,1,0.98992549238389,0,1,positive regulation of antral ovarian follicle growth,BP,
21190,GO:2000389,1,0.951832710315748,0,3,regulation of neutrophil extravasation,BP,
21191,GO:2000391,1,0.951832710315748,0,3,positive regulation of neutrophil extravasation,BP,
21192,GO:2000392,1,0.878948117022327,0,8,regulation of lamellipodium morphogenesis,BP,
21193,GO:2000393,1,0.983406759351872,0,1,negative regulation of lamellipodium morphogenesis,BP,
21194,GO:2000394,1,0.893785758580861,0,7,positive regulation of lamellipodium morphogenesis,BP,
21195,GO:2000395,1,0.981565507613476,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21196,GO:2000397,1,0.981565507613476,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21198,GO:2000402,1,0.914241270104265,0,7,negative regulation of lymphocyte migration,BP,
21201,GO:2000405,1,0.991590426426472,0,1,negative regulation of T cell migration,BP,
21203,GO:2000407,1,0.959898651609354,0,3,regulation of T cell extravasation,BP,
21204,GO:2000409,1,0.972490263837459,0,2,positive regulation of T cell extravasation,BP,
21205,GO:2000410,1,0.961403179428001,0,3,regulation of thymocyte migration,BP,
21206,GO:2000412,1,0.974827252135284,0,2,positive regulation of thymocyte migration,BP,
21207,GO:2000413,1,0.983681235131478,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21208,GO:2000415,1,0.983681235131478,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21209,GO:2000416,1,0.931300574376951,0,6,regulation of eosinophil migration,BP,
21210,GO:2000417,1,0.970930504746261,0,2,negative regulation of eosinophil migration,BP,
21211,GO:2000418,1,0.95918845778589,0,4,positive regulation of eosinophil migration,BP,
21212,GO:2000419,1,0.983498522917573,0,1,regulation of eosinophil extravasation,BP,
21213,GO:2000420,1,0.983498522917573,0,1,negative regulation of eosinophil extravasation,BP,
21214,GO:2000422,1,0.977841465188396,0,2,regulation of eosinophil chemotaxis,BP,
21215,GO:2000424,1,0.977841465188396,0,2,positive regulation of eosinophil chemotaxis,BP,
21217,GO:2000426,1,0.98785592335369,0,1,negative regulation of apoptotic cell clearance,BP,
21219,GO:2000434,1,0.987572535135319,0,2,regulation of protein neddylation,BP,
21220,GO:2000435,1,0.987572535135319,0,2,negative regulation of protein neddylation,BP,
21221,GO:2000437,1,0.952475201041161,0,3,regulation of monocyte extravasation,BP,
21222,GO:2000438,1,0.983406759351477,0,1,negative regulation of monocyte extravasation,BP,
21223,GO:2000439,1,0.968548671167402,0,2,positive regulation of monocyte extravasation,BP,
21224,GO:2000446,1,0.983406759352021,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21225,GO:2000449,1,0.959898651609354,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21226,GO:2000451,1,0.972490263837459,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21227,GO:2000452,1,0.974624601787999,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21228,GO:2000454,1,0.987408571176163,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21229,GO:2000458,1,0.972826021445874,0,2,regulation of astrocyte chemotaxis,BP,
21231,GO:2000464,1,0.984892242795262,0,1,positive regulation of astrocyte chemotaxis,BP,
21232,GO:2000465,1,0.881712793477956,0,8,regulation of glycogen (starch) synthase activity,BP,
21233,GO:2000466,1,0.953706224962139,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21234,GO:2000467,1,0.926420152118972,0,5,positive regulation of glycogen (starch) synthase activity,BP,
21235,GO:2000468,1,0.96734055230533,0,2,regulation of peroxidase activity,BP,
21236,GO:2000469,1,0.983406759350836,0,1,negative regulation of peroxidase activity,BP,
21237,GO:2000470,1,0.983663826627692,0,1,positive regulation of peroxidase activity,BP,
21238,GO:2000471,1,0.968548666949586,0,2,regulation of hematopoietic stem cell migration,BP,
21239,GO:2000473,1,0.968548666949586,0,2,positive regulation of hematopoietic stem cell migration,BP,
21240,GO:2000474,1,0.968738891493893,0,2,regulation of opioid receptor signaling pathway,BP,
21241,GO:2000477,1,0.983406759352018,0,1,regulation of metanephric glomerular visceral epithelial cell development,BP,
21242,GO:2000478,1,0.983406759352018,0,1,positive regulation of metanephric glomerular visceral epithelial cell development,BP,
21245,GO:2000481,1,0.935256144479609,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21247,GO:2000483,1,0.924183907924801,0,6,negative regulation of interleukin-8 secretion,BP,
21249,GO:2000485,1,0.968739936842038,0,2,regulation of glutamine transport,BP,
21250,GO:2000486,1,0.983492632555574,0,1,negative regulation of glutamine transport,BP,
21251,GO:2000487,1,0.985000715014039,0,1,positive regulation of glutamine transport,BP,
21252,GO:2000489,1,0.908167218937741,0,6,regulation of hepatic stellate cell activation,BP,
21253,GO:2000490,1,0.970571044877863,0,2,negative regulation of hepatic stellate cell activation,BP,
21254,GO:2000491,1,0.935711705069924,0,4,positive regulation of hepatic stellate cell activation,BP,
21255,GO:2000492,1,0.983871089773647,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21256,GO:2000494,1,0.983871089773647,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21257,GO:2000501,1,0.922117664788962,0,9,regulation of natural killer cell chemotaxis,BP,
21258,GO:2000502,1,0.968171820297608,0,3,negative regulation of natural killer cell chemotaxis,BP,
21259,GO:2000503,1,0.95243810811067,0,6,positive regulation of natural killer cell chemotaxis,BP,
21260,GO:2000504,1,0.956316834891502,0,3,positive regulation of blood vessel remodeling,BP,
21262,GO:2000506,1,0.978942527649903,0,2,negative regulation of energy homeostasis,BP,
21263,GO:2000507,1,0.921355785724066,0,6,positive regulation of energy homeostasis,BP,
21266,GO:2000511,1,0.990999747210216,0,1,regulation of granzyme A production,BP,
21267,GO:2000513,1,0.990999747210216,0,1,positive regulation of granzyme A production,BP,
21268,GO:2000514,1,0.547158112032208,0,44,regulation of CD4-positive, alpha-beta T cell activation,BP,
21269,GO:2000515,1,0.783808971753963,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21270,GO:2000516,1,0.670225312909717,0,29,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21271,GO:2000517,1,0.990999747210216,0,1,regulation of T-helper 1 cell activation,BP,
21272,GO:2000518,1,0.990999747210216,0,1,negative regulation of T-helper 1 cell activation,BP,
21273,GO:2000520,1,0.961791149121674,0,3,regulation of immunological synapse formation,BP,
21274,GO:2000521,1,0.975435093916944,0,2,negative regulation of immunological synapse formation,BP,
21275,GO:2000522,1,0.986013886613784,0,1,positive regulation of immunological synapse formation,BP,
21276,GO:2000523,1,0.969711106525561,0,2,regulation of T cell costimulation,BP,
21277,GO:2000525,1,0.969711106525561,0,2,positive regulation of T cell costimulation,BP,
21278,GO:2000526,1,0.986013886613784,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21279,GO:2000527,1,0.993346233364737,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21280,GO:2000529,1,0.993346233364737,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21283,GO:2000534,1,0.983406759352018,0,1,positive regulation of renal albumin absorption,BP,
21284,GO:2000535,1,0.923419110189813,0,5,regulation of entry of bacterium into host cell,BP,
21285,GO:2000536,1,0.983406759351429,0,1,negative regulation of entry of bacterium into host cell,BP,
21286,GO:2000537,1,0.974555236705168,0,2,regulation of B cell chemotaxis,BP,
21287,GO:2000538,1,0.974555236705168,0,2,positive regulation of B cell chemotaxis,BP,
21288,GO:2000539,1,0.98488077472156,0,1,regulation of protein geranylgeranylation,BP,
21289,GO:2000541,1,0.98488077472156,0,1,positive regulation of protein geranylgeranylation,BP,
21291,GO:2000543,1,0.915894238097833,0,6,positive regulation of gastrulation,BP,
21292,GO:2000544,1,0.921510291217497,0,7,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21293,GO:2000545,1,0.991123064544678,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21294,GO:2000546,1,0.954031111063047,0,4,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21295,GO:2000547,1,0.974310691127923,0,3,regulation of dendritic cell dendrite assembly,BP,
21296,GO:2000548,1,0.993346233364737,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21297,GO:2000549,1,0.994750480399768,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21298,GO:2000551,1,0.90809278879866,0,8,regulation of T-helper 2 cell cytokine production,BP,
21299,GO:2000552,1,0.985222361909265,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21300,GO:2000553,1,0.921718207675239,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21301,GO:2000554,1,0.990999747210216,0,1,regulation of T-helper 1 cell cytokine production,BP,
21302,GO:2000556,1,0.990999747210216,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21303,GO:2000557,1,0.990999747210216,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21304,GO:2000558,1,0.990999747210216,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21305,GO:2000559,1,0.983406759351477,0,1,regulation of CD24 biosynthetic process,BP,
21306,GO:2000560,1,0.983406759351477,0,1,positive regulation of CD24 biosynthetic process,BP,
21307,GO:2000561,1,0.932095112029405,0,5,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21308,GO:2000562,1,0.963173868180109,0,3,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21309,GO:2000563,1,0.947819390784986,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21310,GO:2000564,1,0.948579663290231,0,4,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21311,GO:2000566,1,0.964549290195722,0,3,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21312,GO:2000567,1,0.969578798142045,0,2,regulation of memory T cell activation,BP,
21313,GO:2000568,1,0.969578798142045,0,2,positive regulation of memory T cell activation,BP,
21314,GO:2000569,1,0.967316446413113,0,2,regulation of T-helper 2 cell activation,BP,
21315,GO:2000570,1,0.967316446413113,0,2,positive regulation of T-helper 2 cell activation,BP,
21316,GO:2000571,1,0.983466930130704,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21317,GO:2000572,1,0.983466930130704,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21319,GO:2000574,1,0.952841591711248,0,3,regulation of microtubule motor activity,BP,
21320,GO:2000583,1,0.967089540193334,0,2,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21321,GO:2000584,1,0.967089540193334,0,2,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21324,GO:2000588,1,0.967087733487384,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21326,GO:2000590,1,0.983406759352018,0,1,negative regulation of metanephric mesenchymal cell migration,BP,
21328,GO:2000592,1,0.967088800164192,0,2,regulation of metanephric DCT cell differentiation,BP,
21329,GO:2000594,1,0.967088800164192,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21330,GO:2000595,1,0.983406759352069,0,1,regulation of optic nerve formation,BP,
21331,GO:2000597,1,0.983406759352069,0,1,positive regulation of optic nerve formation,BP,
21332,GO:2000601,1,0.894628741895366,0,7,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21333,GO:2000606,1,0.983768461630855,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21334,GO:2000607,1,0.983768461630855,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21335,GO:2000609,1,0.932329481880051,0,5,regulation of thyroid hormone generation,BP,
21336,GO:2000611,1,0.954252942082286,0,3,positive regulation of thyroid hormone generation,BP,
21337,GO:2000612,1,0.983407843952928,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21338,GO:2000615,1,0.873339724786431,0,9,regulation of histone H3-K9 acetylation,BP,
21339,GO:2000616,1,0.983406759351872,0,1,negative regulation of histone H3-K9 acetylation,BP,
21340,GO:2000617,1,0.902148882939478,0,7,positive regulation of histone H3-K9 acetylation,BP,
21341,GO:2000618,1,0.926837365181868,0,5,regulation of histone H4-K16 acetylation,BP,
21342,GO:2000619,1,0.958385466894986,0,3,negative regulation of histone H4-K16 acetylation,BP,
21343,GO:2000620,1,0.967087733487091,0,2,positive regulation of histone H4-K16 acetylation,BP,
21344,GO:2000622,1,0.935925507332899,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21345,GO:2000623,1,0.935925507332899,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21346,GO:2000625,1,0.968013582603341,0,2,regulation of miRNA catabolic process,BP,
21347,GO:2000627,1,0.968013582603341,0,2,positive regulation of miRNA catabolic process,BP,
21350,GO:2000631,1,0.98359964269722,0,1,regulation of pre-miRNA processing,BP,
21351,GO:2000632,1,0.98359964269722,0,1,negative regulation of pre-miRNA processing,BP,
21353,GO:2000638,1,0.983415020077322,0,1,regulation of SREBP signaling pathway,BP,
21354,GO:2000639,1,0.983415020077322,0,1,negative regulation of SREBP signaling pathway,BP,
21356,GO:2000642,1,0.984885644545272,0,2,negative regulation of early endosome to late endosome transport,BP,
21358,GO:2000644,1,0.901692757247643,0,7,regulation of receptor catabolic process,BP,
21359,GO:2000645,1,0.955966619108975,0,3,negative regulation of receptor catabolic process,BP,
21360,GO:2000646,1,0.958805939745729,0,3,positive regulation of receptor catabolic process,BP,
21361,GO:2000647,1,0.857343749177996,0,10,negative regulation of stem cell proliferation,BP,
21363,GO:2000649,1,0.531471238055508,0,46,regulation of sodium ion transmembrane transporter activity,BP,
21364,GO:2000650,1,0.856790073605949,0,10,negative regulation of sodium ion transmembrane transporter activity,BP,
21365,GO:2000651,1,0.827231531016218,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21367,GO:2000654,1,0.983408648114669,0,1,regulation of cellular response to testosterone stimulus,BP,
21368,GO:2000655,1,0.983408648114669,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21369,GO:2000656,1,0.987269408042126,0,1,regulation of apolipoprotein binding,BP,
21370,GO:2000657,1,0.987269408042126,0,1,negative regulation of apolipoprotein binding,BP,
21371,GO:2000659,1,0.927091578881528,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
21372,GO:2000660,1,0.955295679137817,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
21373,GO:2000661,1,0.983406759351921,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21374,GO:2000662,1,0.917873956410473,0,6,regulation of interleukin-5 secretion,BP,
21375,GO:2000663,1,0.975106243027598,0,2,negative regulation of interleukin-5 secretion,BP,
21376,GO:2000664,1,0.941312570695202,0,4,positive regulation of interleukin-5 secretion,BP,
21377,GO:2000665,1,0.901414686115596,0,8,regulation of interleukin-13 secretion,BP,
21378,GO:2000666,1,0.975106243027598,0,2,negative regulation of interleukin-13 secretion,BP,
21379,GO:2000667,1,0.924434757795648,0,6,positive regulation of interleukin-13 secretion,BP,
21382,GO:2000670,1,0.956141436058843,0,3,positive regulation of dendritic cell apoptotic process,BP,
21383,GO:2000671,1,0.93938583565365,0,4,regulation of motor neuron apoptotic process,BP,
21384,GO:2000672,1,0.955232426681191,0,3,negative regulation of motor neuron apoptotic process,BP,
21385,GO:2000674,1,0.86029411973869,0,10,regulation of type B pancreatic cell apoptotic process,BP,
21386,GO:2000675,1,0.907947806643543,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21387,GO:2000676,1,0.947535399285694,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
21390,GO:2000679,1,0.723893545383696,0,22,positive regulation of transcription regulatory region DNA binding,BP,
21391,GO:2000680,1,0.928264602027371,0,5,regulation of rubidium ion transport,BP,
21392,GO:2000681,1,0.951198665372224,0,3,negative regulation of rubidium ion transport,BP,
21393,GO:2000682,1,0.983406759351231,0,1,positive regulation of rubidium ion transport,BP,
21394,GO:2000683,1,0.968146235264868,0,2,regulation of cellular response to X-ray,BP,
21395,GO:2000685,1,0.984121084602615,0,1,positive regulation of cellular response to X-ray,BP,
21396,GO:2000686,1,0.935411954999629,0,4,regulation of rubidium ion transmembrane transporter activity,BP,
21397,GO:2000687,1,0.951198665372224,0,3,negative regulation of rubidium ion transmembrane transporter activity,BP,
21398,GO:2000688,1,0.983406759351231,0,1,positive regulation of rubidium ion transmembrane transporter activity,BP,
21399,GO:2000690,1,0.98340675935207,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21400,GO:2000691,1,0.98340675935207,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21402,GO:2000697,1,0.948209296024524,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21404,GO:2000699,1,0.983768461630855,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21405,GO:2000701,1,0.983768461630855,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21406,GO:2000702,1,0.983768461630855,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21407,GO:2000703,1,0.983768461630855,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21409,GO:2000706,1,0.983424764001049,0,1,negative regulation of dense core granule biogenesis,BP,
21411,GO:2000721,1,0.951196423296241,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21412,GO:2000722,1,0.968111204556941,0,2,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21413,GO:2000723,1,0.984447429164683,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21414,GO:2000724,1,0.983406759351429,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21418,GO:2000729,1,0.973446142426023,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21419,GO:2000733,1,0.983768461630855,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21420,GO:2000734,1,0.983768461630855,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21423,GO:2000738,1,0.789515235727683,0,15,positive regulation of stem cell differentiation,BP,
21424,GO:2000739,1,0.904481408910091,0,6,regulation of mesenchymal stem cell differentiation,BP,
21425,GO:2000740,1,0.983424764001049,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21426,GO:2000741,1,0.935254580360847,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21427,GO:2000742,1,0.97213304177521,0,2,regulation of anterior head development,BP,
21428,GO:2000744,1,0.97213304177521,0,2,positive regulation of anterior head development,BP,
21429,GO:2000751,1,0.984193471542078,0,1,histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore,BP,
21430,GO:2000752,1,0.984192501423316,0,1,regulation of glucosylceramide catabolic process,BP,
21431,GO:2000753,1,0.984192501423316,0,1,positive regulation of glucosylceramide catabolic process,BP,
21432,GO:2000754,1,0.984192501423316,0,1,regulation of sphingomyelin catabolic process,BP,
21433,GO:2000755,1,0.984192501423316,0,1,positive regulation of sphingomyelin catabolic process,BP,
21435,GO:2000757,1,0.757631726389839,0,19,negative regulation of peptidyl-lysine acetylation,BP,
21437,GO:2000759,1,0.983406759351921,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21438,GO:2000761,1,0.983406759351921,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21439,GO:2000763,1,0.985308759830125,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21440,GO:2000764,1,0.985308759830125,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21441,GO:2000765,1,0.819809306976831,0,13,regulation of cytoplasmic translation,BP,
21442,GO:2000766,1,0.882240771931202,0,8,negative regulation of cytoplasmic translation,BP,
21443,GO:2000767,1,0.943046798753068,0,4,positive regulation of cytoplasmic translation,BP,
21444,GO:2000768,1,0.955650597704375,0,3,positive regulation of nephron tubule epithelial cell differentiation,BP,
21445,GO:2000769,1,0.990780980970108,0,1,regulation of establishment or maintenance of cell polarity regulating cell shape,BP,
21446,GO:2000771,1,0.990780980970108,0,1,positive regulation of establishment or maintenance of cell polarity regulating cell shape,BP,
21447,GO:2000772,1,0.66283980855108,0,28,regulation of cellular senescence,BP,
21448,GO:2000773,1,0.842379705508196,0,11,negative regulation of cellular senescence,BP,
21449,GO:2000774,1,0.904553523906742,0,8,positive regulation of cellular senescence,BP,
21450,GO:2000775,1,0.986326983415046,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21451,GO:2000777,1,0.972445857970378,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21452,GO:2000778,1,0.778752883432464,0,19,positive regulation of interleukin-6 secretion,BP,
21453,GO:2000779,1,0.552562681894141,0,39,regulation of double-strand break repair,BP,
21454,GO:2000780,1,0.790588070518825,0,15,negative regulation of double-strand break repair,BP,
21455,GO:2000781,1,0.884058785314404,0,8,positive regulation of double-strand break repair,BP,
21456,GO:2000782,1,0.990780980970108,0,1,regulation of establishment of cell polarity regulating cell shape,BP,
21457,GO:2000784,1,0.990780980970108,0,1,positive regulation of establishment of cell polarity regulating cell shape,BP,
21460,GO:2000790,1,0.967089540192466,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21461,GO:2000791,1,0.967089540192466,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21462,GO:2000793,1,0.955843556427634,0,3,cell proliferation involved in heart valve development,BP,
21464,GO:2000795,1,0.983406759351131,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21465,GO:2000797,1,0.983424764001049,0,1,regulation of amniotic stem cell differentiation,BP,
21466,GO:2000798,1,0.983424764001049,0,1,negative regulation of amniotic stem cell differentiation,BP,
21467,GO:2000800,1,0.988374762250607,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21468,GO:2000802,1,0.988374762250607,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21469,GO:2000804,1,0.983406759350443,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21470,GO:2000806,1,0.983406759350443,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21472,GO:2000808,1,0.983406759351773,0,1,negative regulation of synaptic vesicle clustering,BP,
21476,GO:2000812,1,0.974340939515751,0,2,regulation of barbed-end actin filament capping,BP,
21477,GO:2000814,1,0.990780980970108,0,1,positive regulation of barbed-end actin filament capping,BP,
21478,GO:2000816,1,0.64486378400316,0,30,negative regulation of mitotic sister chromatid separation,BP,
21479,GO:2000818,1,0.971978545864971,0,2,negative regulation of myoblast proliferation,BP,
21480,GO:2000819,1,0.968096417931027,0,2,regulation of nucleotide-excision repair,BP,
21482,GO:2000821,1,0.941208906857336,0,4,regulation of grooming behavior,BP,
21483,GO:2000822,1,0.944907177196145,0,5,regulation of behavioral fear response,BP,
21484,GO:2000823,1,0.931165640299793,0,6,regulation of androgen receptor activity,BP,
21485,GO:2000824,1,0.969613601321363,0,2,negative regulation of androgen receptor activity,BP,
21486,GO:2000825,1,0.960352114985471,0,4,positive regulation of androgen receptor activity,BP,
21488,GO:2000827,1,0.984938620238289,0,1,mitochondrial RNA surveillance,BP,
21489,GO:2000828,1,0.970823653679961,0,2,regulation of parathyroid hormone secretion,BP,
21490,GO:2000830,1,0.983406759351775,0,1,positive regulation of parathyroid hormone secretion,BP,
21492,GO:2000832,1,0.967262868590912,0,2,negative regulation of steroid hormone secretion,BP,
21494,GO:2000834,1,0.98357632905632,0,1,regulation of androgen secretion,BP,
21495,GO:2000836,1,0.98357632905632,0,1,positive regulation of androgen secretion,BP,
21496,GO:2000843,1,0.967226405785868,0,2,regulation of testosterone secretion,BP,
21497,GO:2000845,1,0.967226405785868,0,2,positive regulation of testosterone secretion,BP,
21499,GO:2000847,1,0.967262868590912,0,2,negative regulation of corticosteroid hormone secretion,BP,
21501,GO:2000849,1,0.910292480336761,0,8,regulation of glucocorticoid secretion,BP,
21502,GO:2000850,1,0.967262868590912,0,2,negative regulation of glucocorticoid secretion,BP,
21503,GO:2000851,1,0.955717824335025,0,5,positive regulation of glucocorticoid secretion,BP,
21504,GO:2000852,1,0.967247688722476,0,3,regulation of corticosterone secretion,BP,
21505,GO:2000854,1,0.982260181392793,0,2,positive regulation of corticosterone secretion,BP,
21510,GO:2000864,1,0.95625772711693,0,3,regulation of estradiol secretion,BP,
21511,GO:2000866,1,0.972394763708891,0,2,positive regulation of estradiol secretion,BP,
21512,GO:2000870,1,0.982966628243103,0,2,regulation of progesterone secretion,BP,
21513,GO:2000872,1,0.99627623272036,0,1,positive regulation of progesterone secretion,BP,
21514,GO:2000878,1,0.973001272191829,0,2,positive regulation of oligopeptide transport,BP,
21515,GO:2000880,1,0.973001272191829,0,2,positive regulation of dipeptide transport,BP,
21516,GO:2000896,1,0.983677406548395,0,1,amylopectin metabolic process,BP,
21517,GO:2000909,1,0.977034375851605,0,3,regulation of sterol import,BP,
21518,GO:2000910,1,0.992190036991263,0,2,negative regulation of sterol import,BP,
21519,GO:2000969,1,0.935757324677694,0,4,positive regulation of AMPA receptor activity,BP,
21520,GO:2000970,1,0.985154132624775,0,1,regulation of detection of glucose,BP,
21521,GO:2000971,1,0.985154132624775,0,1,negative regulation of detection of glucose,BP,
21524,GO:2000977,1,0.948320174740575,0,4,regulation of forebrain neuron differentiation,BP,
21525,GO:2000978,1,0.980127969357043,0,2,negative regulation of forebrain neuron differentiation,BP,
21526,GO:2000979,1,0.983766730501423,0,1,positive regulation of forebrain neuron differentiation,BP,
21529,GO:2000982,1,0.992054094792906,0,1,positive regulation of inner ear receptor cell differentiation,BP,
21530,GO:2000983,1,0.98580457844038,0,2,regulation of ATP citrate synthase activity,BP,
21531,GO:2000984,1,0.98580457844038,0,2,negative regulation of ATP citrate synthase activity,BP,
21532,GO:2000987,1,0.944907177196145,0,5,positive regulation of behavioral fear response,BP,
21534,GO:2001013,1,0.935832834294235,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21535,GO:2001014,1,0.779496826468627,0,16,regulation of skeletal muscle cell differentiation,BP,
21536,GO:2001015,1,0.928245952528062,0,5,negative regulation of skeletal muscle cell differentiation,BP,
21537,GO:2001016,1,0.925743850292261,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21539,GO:2001021,1,0.450789814785883,0,57,negative regulation of response to DNA damage stimulus,BP,
21541,GO:2001023,1,0.921634066793129,0,5,regulation of response to drug,BP,
21542,GO:2001025,1,0.983406761279341,0,1,positive regulation of response to drug,BP,
21545,GO:2001028,1,0.841602797061301,0,13,positive regulation of endothelial cell chemotaxis,BP,
21546,GO:2001029,1,0.983406759351774,0,1,regulation of cellular glucuronidation,BP,
21547,GO:2001031,1,0.983406759351774,0,1,positive regulation of cellular glucuronidation,BP,
21548,GO:2001032,1,0.896555118535848,0,7,regulation of double-strand break repair via nonhomologous end joining,BP,
21549,GO:2001033,1,0.954868277752572,0,3,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21550,GO:2001034,1,0.954089607894161,0,3,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21551,GO:2001035,1,0.972650756196509,0,2,regulation of tongue muscle cell differentiation,BP,
21552,GO:2001037,1,0.972650756196509,0,2,positive regulation of tongue muscle cell differentiation,BP,
21553,GO:2001038,1,0.967790253355863,0,2,regulation of cellular response to drug,BP,
21555,GO:2001045,1,0.967093197102556,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21557,GO:2001049,1,0.986754997942783,0,1,regulation of tendon cell differentiation,BP,
21558,GO:2001051,1,0.986754997942783,0,1,positive regulation of tendon cell differentiation,BP,
21561,GO:2001055,1,0.973083280015711,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21564,GO:2001065,1,0.982747939728903,0,2,mannan binding,MF,
21565,GO:2001069,1,0.957586655351354,0,3,glycogen binding,MF,
21566,GO:2001070,1,0.968696816564883,0,2,starch binding,MF,
21569,GO:2001106,1,0.967087733487091,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21570,GO:2001108,1,0.983406759351575,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21571,GO:2001109,1,0.970446292568494,0,2,regulation of lens epithelial cell proliferation,BP,
21572,GO:2001111,1,0.970446292568494,0,2,positive regulation of lens epithelial cell proliferation,BP,
21573,GO:2001112,1,0.983406759351921,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21574,GO:2001113,1,0.983406759351921,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21576,GO:2001136,1,0.983530338896731,0,1,negative regulation of endocytic recycling,BP,
21578,GO:2001138,1,0.896498096185346,0,8,regulation of phospholipid transport,BP,
21579,GO:2001140,1,0.896498096185346,0,8,positive regulation of phospholipid transport,BP,
21581,GO:2001142,1,0.984712167720936,0,1,nicotinate transport,BP,
21582,GO:2001144,1,0.985963487372327,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21583,GO:2001145,1,0.985963487372327,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21584,GO:2001148,1,0.973001272191829,0,2,regulation of dipeptide transmembrane transport,BP,
21585,GO:2001150,1,0.973001272191829,0,2,positive regulation of dipeptide transmembrane transport,BP,
21586,GO:2001151,1,0.983619275014404,0,1,regulation of renal water transport,BP,
21587,GO:2001153,1,0.983619275014404,0,1,positive regulation of renal water transport,BP,
21588,GO:2001160,1,0.974721384422367,0,2,regulation of histone H3-K79 methylation,BP,
21589,GO:2001162,1,0.974721384422367,0,2,positive regulation of histone H3-K79 methylation,BP,
21590,GO:2001163,1,0.985623287502985,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21591,GO:2001165,1,0.985623287502985,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21592,GO:2001166,1,0.936739524736311,0,4,regulation of histone H2B ubiquitination,BP,
21593,GO:2001168,1,0.936739524736311,0,4,positive regulation of histone H2B ubiquitination,BP,
21594,GO:2001169,1,0.876742733681585,0,9,regulation of ATP biosynthetic process,BP,
21595,GO:2001170,1,0.952856157034841,0,3,negative regulation of ATP biosynthetic process,BP,
21596,GO:2001171,1,0.905731361185636,0,7,positive regulation of ATP biosynthetic process,BP,
21597,GO:2001176,1,0.970027704711239,0,2,regulation of mediator complex assembly,BP,
21598,GO:2001178,1,0.970027704711239,0,2,positive regulation of mediator complex assembly,BP,
21599,GO:2001179,1,0.91474114954272,0,7,regulation of interleukin-10 secretion,BP,
21600,GO:2001180,1,0.955396954163024,0,3,negative regulation of interleukin-10 secretion,BP,
21601,GO:2001181,1,0.957454056790091,0,4,positive regulation of interleukin-10 secretion,BP,
21602,GO:2001182,1,0.899655116814433,0,7,regulation of interleukin-12 secretion,BP,
21603,GO:2001183,1,0.955375029137055,0,3,negative regulation of interleukin-12 secretion,BP,
21604,GO:2001184,1,0.957543625917389,0,3,positive regulation of interleukin-12 secretion,BP,
21605,GO:2001185,1,0.890969022090061,0,8,regulation of CD8-positive, alpha-beta T cell activation,BP,
21606,GO:2001186,1,0.971222738515539,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21607,GO:2001187,1,0.948542206094097,0,4,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21608,GO:2001188,1,0.939298449264189,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21609,GO:2001189,1,0.959883511090461,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21610,GO:2001190,1,0.978558235771515,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21611,GO:2001191,1,0.984058405067898,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21612,GO:2001193,1,0.984058405067898,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21613,GO:2001197,1,0.91973118261511,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21614,GO:2001198,1,0.890617154702131,0,9,regulation of dendritic cell differentiation,BP,
21615,GO:2001199,1,0.940420136643994,0,5,negative regulation of dendritic cell differentiation,BP,
21616,GO:2001200,1,0.94653239465103,0,4,positive regulation of dendritic cell differentiation,BP,
21617,GO:2001201,1,0.951668693310037,0,3,regulation of transforming growth factor-beta secretion,BP,
21618,GO:2001202,1,0.967728609700277,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21619,GO:2001203,1,0.983406759351872,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21622,GO:2001206,1,0.942052980915906,0,4,positive regulation of osteoclast development,BP,
21623,GO:2001207,1,0.983410120254353,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21624,GO:2001208,1,0.983410120254353,0,1,negative regulation of transcription elongation from RNA polymerase I promoter,BP,
21626,GO:2001213,1,0.983406759351724,0,1,negative regulation of vasculogenesis,BP,
21627,GO:2001214,1,0.873465307061758,0,10,positive regulation of vasculogenesis,BP,
21628,GO:2001222,1,0.654576687380359,0,27,regulation of neuron migration,BP,
21629,GO:2001223,1,0.880530264994856,0,8,negative regulation of neuron migration,BP,
21630,GO:2001224,1,0.862524508776757,0,9,positive regulation of neuron migration,BP,
21631,GO:2001225,1,0.884585609477321,0,8,regulation of chloride transport,BP,
21632,GO:2001226,1,0.952007524912199,0,3,negative regulation of chloride transport,BP,
21633,GO:2001228,1,0.983406759349905,0,1,regulation of response to gamma radiation,BP,
21634,GO:2001229,1,0.983406759349905,0,1,negative regulation of response to gamma radiation,BP,
21643,GO:2001241,1,0.825414676055361,0,14,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21647,GO:2001245,1,0.959173764292948,0,3,regulation of phosphatidylcholine biosynthetic process,BP,
21648,GO:2001246,1,0.983406825885121,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21649,GO:2001247,1,0.983406759352021,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21650,GO:2001248,1,0.98609242153372,0,1,regulation of ammonia assimilation cycle,BP,
21651,GO:2001250,1,0.98609242153372,0,1,positive regulation of ammonia assimilation cycle,BP,
21652,GO:2001251,1,0.180664521472614,0,113,negative regulation of chromosome organization,BP,
21654,GO:2001253,1,0.983840387165893,0,1,regulation of histone H3-K36 trimethylation,BP,
21655,GO:2001256,1,0.916729035918823,0,6,regulation of store-operated calcium entry,BP,
21659,GO:2001260,1,0.985308759830125,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21660,GO:2001262,1,0.985308759830125,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21661,GO:2001263,1,0.99536221867376,0,1,regulation of C-C chemokine binding,BP,
21662,GO:2001264,1,0.99536221867376,0,1,negative regulation of C-C chemokine binding,BP,
21663,GO:2001267,1,0.74590328791293,0,22,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21664,GO:2001268,1,0.944504344381095,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21665,GO:2001269,1,0.789774108325297,0,17,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21666,GO:2001270,1,0.947944656396509,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21667,GO:2001271,1,0.954055962305703,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21668,GO:2001272,1,0.9935956493984,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21670,GO:2001274,1,0.953227842526066,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21672,GO:2001279,1,0.921606318083324,0,6,regulation of unsaturated fatty acid biosynthetic process,BP,
21673,GO:2001280,1,0.952684384520756,0,4,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21676,GO:2001288,1,0.973627960399507,0,2,positive regulation of caveolin-mediated endocytosis,BP,
21677,GO:2001293,1,0.953470464168196,0,3,malonyl-CoA metabolic process,BP,
21678,GO:2001294,1,0.985921241691793,0,1,malonyl-CoA catabolic process,BP,
21679,GO:2001295,1,0.967087733485641,0,2,malonyl-CoA biosynthetic process,BP,
21680,GO:2001300,1,0.929046893338471,0,6,lipoxin metabolic process,BP,
21681,GO:2001301,1,0.969946461429303,0,2,lipoxin biosynthetic process,BP,
21682,GO:2001302,1,0.969946461429303,0,2,lipoxin A4 metabolic process,BP,
21683,GO:2001303,1,0.969946461429303,0,2,lipoxin A4 biosynthetic process,BP,
21684,GO:2001304,1,0.985305465340027,0,1,lipoxin B4 metabolic process,BP,
21685,GO:2001306,1,0.985305465340027,0,1,lipoxin B4 biosynthetic process,BP,
21686,GO:2001311,1,0.987589659261574,0,1,lysobisphosphatidic acid metabolic process,BP,
3487,GO:0006853,1,0.846061345427134,0,11,carnitine shuttle,BP,
3227,GO:0006491,1.00000000000002,0.751610011290444,0,18,N-glycan processing,BP,
3352,GO:0006646,1.00000000000004,0.832690088617461,0,12,phosphatidylethanolamine biosynthetic process,BP,
1612,GO:0003676,1.00000000000572,0,15,3818,nucleic acid binding,MF,POU3F1;NOTCH1;FASN;GADD45A;ZFPM1;SALL4;FOXO4;WNT5A;WT1;HMGN5;MSN;ZCCHC12;LZTS1;VDR;HEY1
